Citrus Sinensis ID: 006747
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 632 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LVM0 | 654 | Probable inactive recepto | yes | no | 0.963 | 0.931 | 0.667 | 0.0 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.993 | 0.981 | 0.631 | 0.0 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.947 | 0.935 | 0.561 | 0.0 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.969 | 0.931 | 0.531 | 1e-176 | |
| Q9SUQ3 | 638 | Probable inactive recepto | no | no | 0.920 | 0.912 | 0.490 | 1e-165 | |
| Q9LP77 | 655 | Probable inactive recepto | no | no | 0.958 | 0.925 | 0.455 | 1e-142 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.930 | 0.877 | 0.471 | 1e-139 | |
| Q9SH71 | 587 | Putative inactive recepto | no | no | 0.895 | 0.964 | 0.444 | 1e-136 | |
| Q9FK10 | 601 | Probable inactive recepto | no | no | 0.898 | 0.945 | 0.441 | 1e-136 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.920 | 0.899 | 0.467 | 1e-134 |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 816 bits (2109), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/614 (66%), Positives = 493/614 (80%), Gaps = 5/614 (0%)
Query: 20 IADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLAVRLPGVGLYG 79
IADLNSD+QALL FAA+VPH R+LNWNS+ +C SWVG+TCT +G+ V A+RLPG+GL G
Sbjct: 42 IADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTCTSDGTSVHALRLPGIGLLG 101
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLN 139
PIP NTL KL+SL ILSLRSN LSG+LP ++ SL SL ++YLQ+NNFSG +PS +S QLN
Sbjct: 102 PIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSGEVPSFVSRQLN 161
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199
+DLSFNS TG IPA+ +NL L GL+LQNN L+G +PN + LR LNLS NHLNGS+P
Sbjct: 162 ILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLRRLNLSNNHLNGSIP 221
Query: 200 LALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPPPPTVLPKPREGSEEKLSTG 259
AL FP SSF GN++LCG PL C+T P PS + PP P +EGS+ KL
Sbjct: 222 SALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPFPH-KEGSKRKLHVS 280
Query: 260 AIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGIRNEKPKEDFGSGVQEAEKN 319
I+ IA GG+A+L L+ ++I CC+KKKD + K K + EK K++FGSGVQE EKN
Sbjct: 281 TIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKTL-TEKAKQEFGSGVQEPEKN 339
Query: 320 KLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFE 379
KLVFF GCSYNFDLEDLLRASAEVLGKGSYGT YKA+LEE TTVVVKRLKEV GKREFE
Sbjct: 340 KLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVAAGKREFE 399
Query: 380 QQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR 439
QQME++ R+ HP+VVP+RAYY+SKDEKL+V D+ AG+ S+LLHGNRG +TPLDW+SR
Sbjct: 400 QQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSR 459
Query: 440 VKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS 499
VKI+L +AKGIAH+HAA G KF GNIKSSNV++ Q+ CISDFGLTPLM P P R
Sbjct: 460 VKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPMRG 519
Query: 500 AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559
AGYRAPEV+ET+K T KSDVYSFGVL+LEMLTGK+P+Q+P +D+VDLPRWVQSVVREEW
Sbjct: 520 AGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMVDLPRWVQSVVREEW 579
Query: 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSE-NQP 618
TSEVFD+ELMR++NIEEEMVQMLQIAM+CVA+VP++RPTM++VVRMIE+IR SDSE +P
Sbjct: 580 TSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIRVSDSETTRP 639
Query: 619 SSED--KLKDSNTQ 630
SS+D K KDSN Q
Sbjct: 640 SSDDNSKPKDSNVQ 653
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 796 bits (2057), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/638 (63%), Positives = 493/638 (77%), Gaps = 10/638 (1%)
Query: 1 MKLRCVFAALSFIWLIPQMI-ADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGIT 59
MK+ F L + + + AD+ SDKQALL+FA+ VPH+RKLNWNS+ +C SW GIT
Sbjct: 2 MKIIAAFLFLLVTTFVSRCLSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGIT 61
Query: 60 CTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFL 119
C+KN +RV A+RLPG GLYGP+P T EKLD+L I+SLRSNHL G++PS +LSL +R L
Sbjct: 62 CSKNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSL 121
Query: 120 YLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF 179
Y NNFSG IP LS +L +DLS NS++GNIP S++NL+ L L+LQNNSL+G IPN
Sbjct: 122 YFHENNFSGTIPPVLSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNL 181
Query: 180 NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFP 239
RL++LNLS+N+LNGSVP +++ FP SSF+GNS+LCG PL C APSPS T
Sbjct: 182 P-PRLKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTPT 240
Query: 240 PPPTVLPKPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKD--SEGTAATKS 297
P R +++ LSTGAIV IA+GGS +LF++ +I CC KK+D + TA K+
Sbjct: 241 EGPGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKA 300
Query: 298 KGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAIL 357
K R++ E+FGSGVQEAEKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGTTYKAIL
Sbjct: 301 KPGRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAIL 360
Query: 358 EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417
EEGTTVVVKRLKEV GKREFEQQME VGR+S H NV P+RAYYFSKDEKLLVYD+ + G
Sbjct: 361 EEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGG 420
Query: 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL 477
+FS LLHGN GR LDWE+R++I L +A+GI+HIH+A G K + GNIKS NVLL+Q+L
Sbjct: 421 NFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQEL 480
Query: 478 QGCISDFGLTPLMNTPT-VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPI 536
C+SDFG+ PLM+ T +PSRS GYRAPE IET+K TQKSDVYSFGVLLLEMLTGKA
Sbjct: 481 HVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAG 540
Query: 537 QAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE-NIEEEMVQMLQIAMSCVAKVPDM 595
+ GHE+VVDLP+WVQSVVREEWT EVFDVEL++ + N+EEEMVQMLQIAM+CV+K PD
Sbjct: 541 KTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDS 600
Query: 596 RPTMEEVVRMIEDIRPS----DSENQPSSEDKLKDSNT 629
RP+MEEVV M+E+IRPS S N+ SS + ++ S++
Sbjct: 601 RPSMEEVVNMMEEIRPSGSGPGSGNRASSPEMIRSSDS 638
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 686 bits (1769), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/629 (56%), Positives = 462/629 (73%), Gaps = 30/629 (4%)
Query: 7 FAALSFIWLIPQMIA-----DLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCT 61
F A SF +L+ A DL SD+QALL+FAA+VPH KLNWN + S+C+SW+GITC
Sbjct: 8 FVAASFFFLLLAATAVLVSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITCD 67
Query: 62 KNG--SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFL 119
++ SRV+AVRLPGVGLYG IP TL KLD+L +LSLRSN L G LPS++LSL SL +L
Sbjct: 68 ESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYL 127
Query: 120 YLQNNNFSGNIPS----SLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGF 175
YLQ+NNFSG + + S+S QL +DLS+NS++GNIP+ +RNLS + L LQNNS G
Sbjct: 128 YLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGP 187
Query: 176 IPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSA 235
I + +L ++ +NLSYN+L+G +P L+K P SF GNS+LCGPPLN CS +PS
Sbjct: 188 IDSLDLPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPS--- 244
Query: 236 TNFPPPPTVLPKPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKK-KDSEGTAA 294
+N P P T P + S I+AI +G S + L ++ C +KK K EG
Sbjct: 245 SNLPRPLTENLHP---VRRRQSKAYIIAIVVGCSVAVLFLGIVFLVCLVKKTKKEEGGGE 301
Query: 295 ---TKSKGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 351
T+ G+ ++KP +DFGSGVQ+ EKNKL FFE C++NFDLEDLL+ASAEVLGKGS+GT
Sbjct: 302 GVRTQMGGVNSKKP-QDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGT 360
Query: 352 TYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411
YKA+LE+ T VVVKRL+EVV K+EFEQQME+VG+++QH N VP+ AYY+SKDEKLLVY
Sbjct: 361 AYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVY 420
Query: 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNV 471
++ GS ++HGNR G +DWE+R+KI+ G++K I+++H+ KF+ G+IKSSN+
Sbjct: 421 KYMTKGSLFGIMHGNR--GDRGVDWETRMKIATGTSKAISYLHSL---KFVHGDIKSSNI 475
Query: 472 LLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT 531
LL++DL+ C+SD L L N PT R+ GY APEVIET++ +Q+SDVYSFGV++LEMLT
Sbjct: 476 LLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLT 535
Query: 532 GKAPIQAPGHED---VVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSC 588
GK P+ PG ED V+DLPRWV+SVVREEWT+EVFDVEL++++NIEEEMVQMLQ+A++C
Sbjct: 536 GKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALAC 595
Query: 589 VAKVPDMRPTMEEVVRMIEDIRPSDSENQ 617
VA+ P+ RP MEEV RMIED+R D Q
Sbjct: 596 VARNPESRPKMEEVARMIEDVRRLDQSQQ 624
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 618 bits (1593), Expect = e-176, Method: Compositional matrix adjust.
Identities = 347/653 (53%), Positives = 453/653 (69%), Gaps = 40/653 (6%)
Query: 6 VFAALSFIWLIPQMI-ADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNG 64
V +L I L+ Q + ++ ++KQALL F +PH +L WN S S C +WVG+ C N
Sbjct: 7 VLNSLFSILLLTQRVNSESTAEKQALLTFLQQIPHENRLQWNESDSAC-NWVGVECNSNQ 65
Query: 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNN 124
S + ++RLPG GL G IP+ +L +L L +LSLRSN LSG +PS+ +L+ LR LYLQ+N
Sbjct: 66 SSIHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHN 125
Query: 125 NFSGNIPSSLSPQLN---WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNL 181
FSG P+S + QLN +D+S N+ TG+IP S+ NL+HL GL L NN +G +P+ +L
Sbjct: 126 EFSGEFPTSFT-QLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL 184
Query: 182 SRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCST--VPPAPSPSATNFP 239
L N+S N+LNGS+P +L +F SF GN LCG PL C + V P+PSPS N
Sbjct: 185 G-LVDFNVSNNNLNGSIPSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLIN-- 241
Query: 240 PPPTVLPKPREGSEEKLST-GAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSK 298
P R S++ + AIVAI + + V LL ++ F CL+K+ A TK
Sbjct: 242 ------PSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSNEARTKQP 295
Query: 299 -----GIRN-------EKPKEDF---GSGVQ-EAEKNKLVFFEGCSYNFDLEDLLRASAE 342
RN KE+ SG+ E E+NKLVF EG Y+FDLEDLLRASAE
Sbjct: 296 KPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAE 355
Query: 343 VLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYF 402
VLGKGS GT+YKA+LEEGTTVVVKRLK+V+ K+EFE QMEVVG++ +HPNV+P+RAYY+
Sbjct: 356 VLGKGSVGTSYKAVLEEGTTVVVKRLKDVMASKKEFETQMEVVGKI-KHPNVIPLRAYYY 414
Query: 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFI 462
SKDEKLLV+DF+ GS SALLHG+RG GRTPLDW++R++I++ +A+G+AH+H V K +
Sbjct: 415 SKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLH--VSAKLV 472
Query: 463 LGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSF 522
GNIK+SN+LL + C+SD+GL L + + P+R AGY APEV+ET+K T KSDVYSF
Sbjct: 473 HGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSF 532
Query: 523 GVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQML 582
GVLLLE+LTGK+P QA E+ +DLPRWV SVVREEWT+EVFDVELMRY NIEEEMVQ+L
Sbjct: 533 GVLLLELLTGKSPNQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLL 592
Query: 583 QIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSEN---QPSSEDKLKDSNTQTP 632
QIAM+CV+ VPD RP M+EV+RMIED+ S++ + + SS+D K S QTP
Sbjct: 593 QIAMACVSTVPDQRPVMQEVLRMIEDVNRSETTDDGLRQSSDDPSKGSEGQTP 645
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 581 bits (1498), Expect = e-165, Method: Compositional matrix adjust.
Identities = 310/632 (49%), Positives = 419/632 (66%), Gaps = 50/632 (7%)
Query: 26 DKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLAVRLPGVGLYGPIPANT 85
DK+ALL+F + R LNWN ++ VC W G+TC ++GSR++AVRLPGVGL G IP NT
Sbjct: 29 DKRALLEFLTIMQPTRSLNWNETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLNGQIPPNT 88
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
+ +L +L +LSLRSN +SG+ P + + L L FLYLQ+NN SG +P S L V+L
Sbjct: 89 ISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWKNLTSVNL 148
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFN-LSRLRHLNLSYNH-LNGSVPLA 201
S N G IP+S+ L + LNL NN+L+G IP+ + LS L+H++LS N+ L G +P
Sbjct: 149 SNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSNNYDLAGPIPDW 208
Query: 202 LQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPPPPTVLPKPREGSEEKLSTGAI 261
L++FP SS+ G +PP + + PPPP+ E + +K S
Sbjct: 209 LRRFPFSSYTG-----------IDIIPPGGNYTLVT-PPPPS------EQTHQKPSK--- 247
Query: 262 VAIAIGGSAVLFLLF-------------LMIAFCCLKKKDSEGTAATKSKGIRNE--KPK 306
A +G S +FLL ++ C +++K G ++ +
Sbjct: 248 -ARFLGLSETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGDGVISDNKLQKKGGMSP 306
Query: 307 EDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVK 366
E F S +++ N+L FFEGC+Y+FDLEDLLRASAEVLGKG++GTTYKA+LE+ T+V VK
Sbjct: 307 EKFVSRMEDV-NNRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVK 365
Query: 367 RLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGN 426
RLK+V GKR+FEQQME++G + +H NVV ++AYY+SKDEKL+VYD+ GS ++LLHGN
Sbjct: 366 RLKDVAAGKRDFEQQMEIIGGI-KHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGN 424
Query: 427 RGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486
RG R PLDWE+R+KI++G+AKGIA IH GK + GNIKSSN+ L+ + GC+SD GL
Sbjct: 425 RGENRIPLDWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGL 484
Query: 487 TPLMNTPTVP--SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV 544
T +M +P P SR AGYRAPEV +T+K +Q SDVYSFGV+LLE+LTGK+PI +++
Sbjct: 485 TAVM-SPLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEI 543
Query: 545 VDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+ L RWV SVVREEWT+EVFD+EL+RY NIEEEMV+MLQIAMSCV K D RP M ++VR
Sbjct: 544 IHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVR 603
Query: 605 MIEDIRPSDSENQPSSEDKLKDSN----TQTP 632
+IE++ + +P E K K N T TP
Sbjct: 604 LIENVGNRRTSIEPEPELKPKSENGASETSTP 635
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 506 bits (1304), Expect = e-142, Method: Compositional matrix adjust.
Identities = 301/661 (45%), Positives = 403/661 (60%), Gaps = 55/661 (8%)
Query: 1 MKLRCVFAALSFIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITC 60
M + VF +L + L DLN+D+ ALL + V R WN + +W G+ C
Sbjct: 11 MAILSVFLSLLLLSLPLPSTQDLNADRTALLSLRSAV-GGRTFRWNIKQTSPCNWAGVKC 69
Query: 61 TKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLY 120
N RV A+RLPGV L G IP L L LSLR N LSG LP ++ + S+LR LY
Sbjct: 70 ESN--RVTALRLPGVALSGDIPEGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLY 127
Query: 121 LQNNNFSGNIPS---SLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIP 177
LQ N FSG IP SLS L ++L+ NS TG I + NL+ L L L+NN L+G IP
Sbjct: 128 LQGNRFSGEIPEVLFSLS-HLVRLNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIP 186
Query: 178 NFNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQC---STVPPAPSPS 234
+ +L L N+S N LNGS+P LQ+F SF S LCG PL C TVP P+
Sbjct: 187 DLDLP-LVQFNVSNNSLNGSIPKNLQRFESDSFLQTS-LCGKPLKLCPDEETVPSQPTSG 244
Query: 235 ATNFPPPPTVLPKPREGSEEK-----LSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDS 289
PP EGSEEK LS GAI I IG V F L ++I +KK +
Sbjct: 245 GNRTPPSV-------EGSEEKKKKNKLSGGAIAGIVIG-CVVGFALIVLILMVLCRKKSN 296
Query: 290 EGTAATKSKGIRNEKP-----KEDFGSG----------------VQEAEKN-----KLVF 323
+ + A I+ ++P KE +G + +E N KLVF
Sbjct: 297 KRSRAVDISTIKQQEPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVF 356
Query: 324 FEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQME 383
F + FDLEDLLRASAEVLGKG++GT YKA+L+ T V VKRLK+V+M +EF++++E
Sbjct: 357 FGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIE 416
Query: 384 VVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKIS 443
+VG + H N+VP+RAYYFS+DEKLLVYDF+ GS SALLHGNRG GR+PL+W+ R +I+
Sbjct: 417 LVGAM-DHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIA 475
Query: 444 LGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM-NTPTVPSRSAGY 502
+G+A+G+ ++H+ G GNIKSSN+LL++ +SDFGL L+ ++ T P+R+ GY
Sbjct: 476 IGAARGLDYLHSQ-GTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNRATGY 534
Query: 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562
RAPEV + K+ +QK DVYSFGV+LLE++TGKAP + +E+ VDLPRWV+SV R+EW E
Sbjct: 535 RAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVKSVARDEWRRE 594
Query: 563 VFDVELMRYENIEEEMV-QMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSENQPSSE 621
VFD EL+ EEEM+ +M+Q+ + C ++ PD RP M EVVR +E++RP +Q +
Sbjct: 595 VFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLRPYSGSDQVNEA 654
Query: 622 D 622
D
Sbjct: 655 D 655
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 494 bits (1273), Expect = e-139, Method: Compositional matrix adjust.
Identities = 296/628 (47%), Positives = 408/628 (64%), Gaps = 40/628 (6%)
Query: 25 SDKQALLDFAANVPHARKLN-WNSSTSVCTSWVGITCTKNGSRVLAVRLPGVGLYGPIPA 83
+D + LL+F KLN WN++T+ C W G++C +N RV + L + L G I +
Sbjct: 30 TDSETLLNFKLTADSTGKLNSWNTTTNPC-QWTGVSCNRN--RVTRLVLEDINLTGSISS 86
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP--QLNWV 141
T SL +LSL+ N+LSG +P N+ +L++L+ L+L NN FSGN P+S++ +L +
Sbjct: 87 LTSLT--SLRVLSLKHNNLSGPIP-NLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRL 143
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
DLSFN+ +G IP + +L+HL+ L L++N +G IPN NLS L+ N+S N+ NG +P +
Sbjct: 144 DLSFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFNGQIPNS 203
Query: 202 LQKFPPSSFEGNSMLCGPPLNQCSTVPPAPS-------PSATNFPPPPTVLPKP------ 248
L +FP S F N LCG PL +C+ + P+ A+ P TV P
Sbjct: 204 LSQFPESVFTQNPSLCGAPLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGG 263
Query: 249 -REGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCL------KKKDSEGTAATKSKGIR 301
+ + ++ST +++AI +G +L + L++ +C KKK S+ K
Sbjct: 264 DKSNNTSRISTISLIAIILGDFIILSFVSLLLYYCFWRQYAVNKKKHSKILEGEKIVYSS 323
Query: 302 NEKPKEDFGSGVQE---AEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILE 358
N P + Q +K K+VFFEG + F+LEDLLRASAE+LGKG +GT YKA+LE
Sbjct: 324 NPYPTSTQNNNNQNQQVGDKGKMVFFEG-TRRFELEDLLRASAEMLGKGGFGTAYKAVLE 382
Query: 359 EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416
+G V VKRLK+ V GK+EFEQQMEV+GRL +H N+V ++AYYF+++EKLLVYD++
Sbjct: 383 DGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRL-RHTNLVSLKAYYFAREEKLLVYDYMPN 441
Query: 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG-KFILGNIKSSNVLLSQ 475
GS LLHGNRG GRTPLDW +R+KI+ G+A+G+A IH + K G+IKS+NVLL +
Sbjct: 442 GSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDR 501
Query: 476 DLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+SDFGL+ + TV ++S GYRAPE+I+ +K TQKSDVYSFGVLLLE+LTGK P
Sbjct: 502 SGNARVSDFGLSIFAPSQTV-AKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCP 560
Query: 536 -IQAPGHED-VVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVP 593
+ GH VDLPRWVQSVVREEWT+EVFD+ELMRY++IEEEMV +LQIAM+C A
Sbjct: 561 NMVETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAA 620
Query: 594 DMRPTMEEVVRMIEDIRPSDSENQPSSE 621
D RP M VV++IEDIR SE P ++
Sbjct: 621 DHRPKMGHVVKLIEDIRGGGSEASPCND 648
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1252), Expect = e-136, Method: Compositional matrix adjust.
Identities = 274/616 (44%), Positives = 382/616 (62%), Gaps = 50/616 (8%)
Query: 10 LSFIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLA 69
L F+ + Q + D DK+ALL F ++ +R L+WN S+ VC SW G+TC +NG R+++
Sbjct: 12 LCFVLISSQTLED---DKKALLHFLSSFNSSR-LHWNQSSDVCHSWTGVTCNENGDRIVS 67
Query: 70 VRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGN 129
VRLP VG G IP T+ +L SL LSLR NH +GD PS+ +L SL LYLQ+N+ SG
Sbjct: 68 VRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLYLQHNHLSGP 127
Query: 130 IPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHL 187
+ + S L +DLS N G+IP S+ L+ L LNL NNS +G IPN +L +L +
Sbjct: 128 LLAIFSELKNLKVLDLSNNGFNGSIPTSLSGLTSLQVLNLANNSFSGEIPNLHLPKLSQI 187
Query: 188 NLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPPPPTVLPK 247
NLS N L G++P +LQ+F S+F GN++ + P S A
Sbjct: 188 NLSNNKLIGTIPKSLQRFQSSAFSGNNL---TERKKQRKTPFGLSQLAF----------- 233
Query: 248 PREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGIRNEKPKE 307
L A + + G L F+MI C K G K + + P
Sbjct: 234 -------LLILSAACVLCVSG-----LSFIMIT--CFGKTRISG----KLRKRDSSSPPG 275
Query: 308 DFGSGVQEAEKN-KLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVK 366
++ S E+ K++FF G ++ FDL+DLL +SAEVLGKG++GTTYK +E+ +TVVVK
Sbjct: 276 NWTSRDDNTEEGGKIIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDMSTVVVK 335
Query: 367 RLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGN 426
RLKEVV+G+REFEQQME++G + +H NV ++AYY+SKD+KL VY + GS +LHGN
Sbjct: 336 RLKEVVVGRREFEQQMEIIGMI-RHENVAELKAYYYSKDDKLAVYSYYNHGSLFEILHGN 394
Query: 427 RG-IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485
RG R PLDW++R++I+ G+A+G+A IH GKFI GNIKSSN+ L GCI D G
Sbjct: 395 RGRYHRVPLDWDARLRIATGAARGLAKIHE---GKFIHGNIKSSNIFLDSQCYGCIGDVG 451
Query: 486 LTPLMNT-PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQ----APG 540
LT +M + P ++GY APE+ +T++ TQ SDVYSFGV+LLE+LTGK+P+ P
Sbjct: 452 LTTIMRSLPQTTCLTSGYHAPEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQAELVPT 511
Query: 541 HEDVVDLPRWVQSVVREEWTSEVFDVELMRYE-NIEEEMVQMLQIAMSCVAKVPDMRPTM 599
+ +DL W++SVV +EWT EVFD+E++ EEEMV+MLQI ++CVA RP +
Sbjct: 512 GGENMDLASWIRSVVAKEWTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALKQQERPHI 571
Query: 600 EEVVRMIEDIRPSDSE 615
+V+++IEDIR D+E
Sbjct: 572 AQVLKLIEDIRSVDAE 587
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FK10|Y5332_ARATH Probable inactive receptor kinase At5g53320 OS=Arabidopsis thaliana GN=At5g53320 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1247), Expect = e-136, Method: Compositional matrix adjust.
Identities = 271/614 (44%), Positives = 379/614 (61%), Gaps = 46/614 (7%)
Query: 1 MKLRCVFAALSFIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITC 60
MK + V + I+ + + DK LL F N+ H+ LNW+ S S+CT W G+TC
Sbjct: 1 MKCQVVLILIVVIFNVCIEAETIKEDKHTLLQFVNNINHSHSLNWSPSLSICTKWTGVTC 60
Query: 61 TKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLY 120
+ S V A+ L GL G I + + +L +L L L SN++SG P+ + +L +L L
Sbjct: 61 NSDHSSVDALHLAATGLRGDIELSIIARLSNLRFLILSSNNISGTFPTTLQALKNLTELK 120
Query: 121 LQNNNFSGNIPSSLSP--QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN 178
L N FSG +PS LS +L +DLS N G+IP+SI L+ L LNL N +G IP+
Sbjct: 121 LDFNEFSGPLPSDLSSWERLQVLDLSNNRFNGSIPSSIGKLTLLHSLNLAYNKFSGEIPD 180
Query: 179 FNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNF 238
++ L+ LNL++N+L G+VP +LQ+FP S+F GN +L AP S+
Sbjct: 181 LHIPGLKLLNLAHNNLTGTVPQSLQRFPLSAFVGNKVL-------------APVHSSLR- 226
Query: 239 PPPPTVLPKPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSK 298
K ++ IA+ +V F + ++A + + SK
Sbjct: 227 -------------KHTKHHNHVVLGIAL---SVCFAILALLAILLVIIIHNREEQRRSSK 270
Query: 299 GIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILE 358
+ K ++D V E + NK+VFFEG + FDLEDLLRASAEVLGKG +GTTYK LE
Sbjct: 271 D-KPSKRRKDSDPNVGEGD-NKIVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYKVDLE 328
Query: 359 EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418
+ T+VVKR+KEV + +REFEQQ+E +G + +H NV +R Y++SKDEKL+VYD+ E GS
Sbjct: 329 DSATIVVKRIKEVSVPQREFEQQIENIGSI-KHENVATLRGYFYSKDEKLVVYDYYEHGS 387
Query: 419 FSALLHGNRGI-GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL 477
S LLHG +G+ R L+WE+R+ + G+A+G+AHIH+ GGK + GNIKSSN+ L+
Sbjct: 388 LSTLLHGQKGLRDRKRLEWETRLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNIFLNGKG 447
Query: 478 QGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQ 537
GCIS G+ LM++ +P + GYRAPE+ +T+K TQ SDVYSFG+L+ E+LTGK+
Sbjct: 448 YGCISGTGMATLMHS--LPRHAVGYRAPEITDTRKGTQPSDVYSFGILIFEVLTGKS--- 502
Query: 538 APGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRP 597
+V +L RWV SVVREEWT EVFD EL+R +EEEMV+MLQ+ M C A++P+ RP
Sbjct: 503 -----EVANLVRWVNSVVREEWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTARLPEKRP 557
Query: 598 TMEEVVRMIEDIRP 611
M EVVRM+E+IRP
Sbjct: 558 NMIEVVRMVEEIRP 571
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 479 bits (1233), Expect = e-134, Method: Compositional matrix adjust.
Identities = 294/629 (46%), Positives = 378/629 (60%), Gaps = 47/629 (7%)
Query: 21 ADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLAVRLPGVGLYGP 80
DL +DK ALL F + V R L W+ + +W G+ C +G RV A+RLPG L G
Sbjct: 29 GDLAADKSALLSFRSAV-GGRTLLWDVKQTSPCNWTGVLC--DGGRVTALRLPGETLSGH 85
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
IP L L LSLR N L+G LP ++ S S LR LYLQ N FSG IP L N
Sbjct: 86 IPEGIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNL 145
Query: 141 VDLSF--NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSV 198
V L+ N +G I + +NL+ L L L+NN L+ L N+S N LNGS+
Sbjct: 146 VRLNLAENEFSGEISSGFKNLTRLKTLYLENNKLS-GSLLDLDLSLDQFNVSNNLLNGSI 204
Query: 199 PLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPPPPTVLPKPREGSEEK--- 255
P +LQKF SF G S LCG PL CS PS + P TV EGSEEK
Sbjct: 205 PKSLQKFDSDSFVGTS-LCGKPLVVCSNEGTVPSQPISVGNIPGTV-----EGSEEKKKR 258
Query: 256 --LSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGIRN---EKPKEDFG 310
LS GAI I IG V L +MI +KK +E T A I++ E P E
Sbjct: 259 KKLSGGAIAGIVIG-CVVGLSLIVMILMVLFRKKGNERTRAIDLATIKHHEVEIPGEKAA 317
Query: 311 ---------------SGVQEAEKN-----KLVFFEGCSYNFDLEDLLRASAEVLGKGSYG 350
S V+ E N KLVFF + FDLEDLLRASAEVLGKG++G
Sbjct: 318 VEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFG 377
Query: 351 TTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLV 410
T YKA+L+ T V VKRLK+V M REF++++EVVG + H N+VP+RAYY+S DEKLLV
Sbjct: 378 TAYKAVLDAVTLVAVKRLKDVTMADREFKEKIEVVGAM-DHENLVPLRAYYYSGDEKLLV 436
Query: 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSN 470
YDF+ GS SALLHGN+G GR PL+WE R I+LG+A+G+ ++H+ GN+KSSN
Sbjct: 437 YDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQ-DPLSSHGNVKSSN 495
Query: 471 VLLSQDLQGCISDFGLTPLMN-TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEM 529
+LL+ +SDFGL L++ + T P+R+ GYRAPEV + ++ +QK+DVYSFGV+LLE+
Sbjct: 496 ILLTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLEL 555
Query: 530 LTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE---NIEEEMVQMLQIAM 586
LTGKAP + +E+ +DL RWV SV REEW +EVFD ELM E ++EEEM +MLQ+ +
Sbjct: 556 LTGKAPSNSVMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGI 615
Query: 587 SCVAKVPDMRPTMEEVVRMIEDIRPSDSE 615
C + PD RP M EVVR I+++R S ++
Sbjct: 616 DCTEQHPDKRPVMVEVVRRIQELRQSGAD 644
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 632 | ||||||
| 255575618 | 633 | Nodulation receptor kinase precursor, pu | 0.966 | 0.965 | 0.752 | 0.0 | |
| 359478866 | 637 | PREDICTED: probable inactive receptor ki | 0.995 | 0.987 | 0.717 | 0.0 | |
| 297745748 | 656 | unnamed protein product [Vitis vinifera] | 0.995 | 0.958 | 0.717 | 0.0 | |
| 224145409 | 636 | predicted protein [Populus trichocarpa] | 0.979 | 0.973 | 0.724 | 0.0 | |
| 224126989 | 635 | predicted protein [Populus trichocarpa] | 0.982 | 0.977 | 0.714 | 0.0 | |
| 255586379 | 635 | Nodulation receptor kinase precursor, pu | 0.985 | 0.981 | 0.715 | 0.0 | |
| 449449843 | 638 | PREDICTED: probable inactive receptor ki | 0.954 | 0.945 | 0.723 | 0.0 | |
| 449531551 | 638 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.954 | 0.945 | 0.723 | 0.0 | |
| 356537708 | 664 | PREDICTED: probable inactive receptor ki | 0.985 | 0.938 | 0.693 | 0.0 | |
| 356500954 | 654 | PREDICTED: probable inactive receptor ki | 0.971 | 0.938 | 0.701 | 0.0 |
| >gi|255575618|ref|XP_002528709.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223531881|gb|EEF33698.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2454), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/619 (75%), Positives = 534/619 (86%), Gaps = 8/619 (1%)
Query: 17 PQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLAVRLPGVG 76
PQ IA+L SDKQALL+F A VPH++KLNW+S+TSVCTSW+GITC NGS VLAVRLPGVG
Sbjct: 20 PQTIANLYSDKQALLNFVAAVPHSQKLNWSSTTSVCTSWIGITC--NGSHVLAVRLPGVG 77
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP 136
LYG IPANTL KLD LM LSLRSN L+GDLPS++LSL SL++++LQ+NNFSG IPSSLSP
Sbjct: 78 LYGHIPANTLGKLDGLMTLSLRSNRLNGDLPSDMLSLPSLQYVFLQHNNFSGTIPSSLSP 137
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNG 196
QLN +DLSFN +GNIPA+I+NL++L LNLQNN LTGFIP FN S L+ LNLSYNHLNG
Sbjct: 138 QLNSLDLSFNFFSGNIPATIQNLTNLTSLNLQNNLLTGFIPEFNSSGLQQLNLSYNHLNG 197
Query: 197 SVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPPPPTV---LPKPREGSE 253
S+P ALQKFP SSFEGNSMLCGPPLNQCS P PSP A F PP ++ PKP+ GS+
Sbjct: 198 SIPPALQKFPTSSFEGNSMLCGPPLNQCSIFTPTPSP-APAFLPPSSLNPQKPKPKVGSK 256
Query: 254 EKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGIRNEKPKEDFGSGV 313
+KL TG+IVAIAIGGS V +L LM CCLK KD+ A K KG RNEKPKEDFGSGV
Sbjct: 257 KKLGTGSIVAIAIGGSVVPLVLLLMTVICCLKTKDNH-NGAVKGKGGRNEKPKEDFGSGV 315
Query: 314 QEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM 373
Q+AEKNKLVFF+G SY+FDLEDLLRASAEVLGKGSYGTTYKAILEEGT VVVKRLK+VV
Sbjct: 316 QDAEKNKLVFFDGSSYSFDLEDLLRASAEVLGKGSYGTTYKAILEEGTIVVVKRLKDVVA 375
Query: 374 GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTP 433
GK+EFEQQME VGR++QHPNVVP+RAYY+SKDEKLLVYD++ AGSF LLHG+ G+ P
Sbjct: 376 GKKEFEQQMEAVGRVAQHPNVVPLRAYYYSKDEKLLVYDYVSAGSFFTLLHGSGAFGQNP 435
Query: 434 LDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493
LDWESRVKI L +A+GIAHIH+A GG+FI NIKSSNVL++QDL G +SDFGLTP+M+ P
Sbjct: 436 LDWESRVKICLETARGIAHIHSAAGGRFIHANIKSSNVLITQDLCGSVSDFGLTPIMSYP 495
Query: 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQS 553
VPSR+AGYRAPEVIET+KPTQKSDVYSFGVLLLEMLTGKAP+Q+ G +DVVDLPRWVQS
Sbjct: 496 AVPSRTAGYRAPEVIETRKPTQKSDVYSFGVLLLEMLTGKAPVQSTGQDDVVDLPRWVQS 555
Query: 554 VVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613
VVREEWT+EVFD+EL++Y+NIEEEMVQMLQIAM+CVA+VPDMRPTM+EVVRMIE+IR D
Sbjct: 556 VVREEWTAEVFDLELLKYQNIEEEMVQMLQIAMACVARVPDMRPTMDEVVRMIEEIRVPD 615
Query: 614 SENQPSSEDKLKDSNTQTP 632
S N PSSE+ K SNTQTP
Sbjct: 616 SLNHPSSEE-YKGSNTQTP 633
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478866|ref|XP_002276162.2| PREDICTED: probable inactive receptor kinase At5g58300 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2402), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/640 (71%), Positives = 539/640 (84%), Gaps = 11/640 (1%)
Query: 1 MKLRCVFAALSFIW----LIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWV 56
MKL L F++ L+P IADL++DKQALLDFA VPH RKLNWNSST VCTSWV
Sbjct: 1 MKLFSTSLVLLFLFVIAILLPLAIADLDADKQALLDFADAVPHRRKLNWNSSTPVCTSWV 60
Query: 57 GITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSL 116
GI CT +GSRV A+RLPG+GL G IPA TL KLD+L ILSLRSN L+G LPS++ SL SL
Sbjct: 61 GINCTGDGSRVRALRLPGIGLTGSIPATTLGKLDALEILSLRSNLLTGKLPSDIPSLPSL 120
Query: 117 RFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFI 176
++L+LQ+NNFSG+IP+S SPQL +DLSFNS TGNIP +I NL+ L GLNLQNNSL+G I
Sbjct: 121 QYLFLQHNNFSGDIPASFSPQLTVLDLSFNSFTGNIPLTIWNLTQLTGLNLQNNSLSGAI 180
Query: 177 PNFNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSAT 236
P+ N S+L+HLNLSYN+LNGS+P +LQ+FP SSF GNS+LCGPPLN CS P +PSP+ +
Sbjct: 181 PDVNPSKLKHLNLSYNNLNGSIPSSLQRFPNSSFVGNSLLCGPPLNNCSLTPLSPSPAPS 240
Query: 237 NFPPPPTVLPKPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATK 296
+ ++GS++KLS G I+AIA+GG+ VLFL+ LMI CCL+KKDSEG+ K
Sbjct: 241 FPS---PPMASEKQGSKKKLSMGIIIAIAVGGAVVLFLVVLMIFLCCLRKKDSEGSGVAK 297
Query: 297 SK---GIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTY 353
K G R+EKPKE+FGSGVQE +KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT Y
Sbjct: 298 GKASGGGRSEKPKEEFGSGVQEPDKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAY 357
Query: 354 KAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413
KA+LEE TTVVVKRLKEVV+GKR+FEQQM++VGR+ QHPNVVP+RAYY+SKDEKLLVYD+
Sbjct: 358 KAVLEESTTVVVKRLKEVVVGKRDFEQQMDIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 417
Query: 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL 473
+ GS SALLHGNR GR+PLDW +RVKISLG A+GI HIH+ GGKF GNIKSSNVLL
Sbjct: 418 VSGGSLSALLHGNRPTGRSPLDWNARVKISLGIARGITHIHSVGGGKFTHGNIKSSNVLL 477
Query: 474 SQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGK 533
+QD +GCISDFGLTPLMN P SR+AGYRAPEVIE++K T KSDVYSFGVLLLEMLTGK
Sbjct: 478 NQDFEGCISDFGLTPLMNFPATSSRNAGYRAPEVIESRKHTHKSDVYSFGVLLLEMLTGK 537
Query: 534 APIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVP 593
AP+Q+PG +D+VDLPRWVQSVVREEWT+EVFD+ELMRY+NIEEEMVQMLQ+AM+CVAKVP
Sbjct: 538 APLQSPGRDDMVDLPRWVQSVVREEWTAEVFDIELMRYQNIEEEMVQMLQLAMACVAKVP 597
Query: 594 DMRPTMEEVVRMIEDIRPSDSENQPSSED-KLKDSNTQTP 632
DMRP+M+EVVRMIE+IR SDSEN+PSSE+ K KDSN QTP
Sbjct: 598 DMRPSMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 637
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745748|emb|CBI15804.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2400), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/640 (71%), Positives = 539/640 (84%), Gaps = 11/640 (1%)
Query: 1 MKLRCVFAALSFIW----LIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWV 56
MKL L F++ L+P IADL++DKQALLDFA VPH RKLNWNSST VCTSWV
Sbjct: 20 MKLFSTSLVLLFLFVIAILLPLAIADLDADKQALLDFADAVPHRRKLNWNSSTPVCTSWV 79
Query: 57 GITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSL 116
GI CT +GSRV A+RLPG+GL G IPA TL KLD+L ILSLRSN L+G LPS++ SL SL
Sbjct: 80 GINCTGDGSRVRALRLPGIGLTGSIPATTLGKLDALEILSLRSNLLTGKLPSDIPSLPSL 139
Query: 117 RFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFI 176
++L+LQ+NNFSG+IP+S SPQL +DLSFNS TGNIP +I NL+ L GLNLQNNSL+G I
Sbjct: 140 QYLFLQHNNFSGDIPASFSPQLTVLDLSFNSFTGNIPLTIWNLTQLTGLNLQNNSLSGAI 199
Query: 177 PNFNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSAT 236
P+ N S+L+HLNLSYN+LNGS+P +LQ+FP SSF GNS+LCGPPLN CS P +PSP+ +
Sbjct: 200 PDVNPSKLKHLNLSYNNLNGSIPSSLQRFPNSSFVGNSLLCGPPLNNCSLTPLSPSPAPS 259
Query: 237 NFPPPPTVLPKPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATK 296
+ ++GS++KLS G I+AIA+GG+ VLFL+ LMI CCL+KKDSEG+ K
Sbjct: 260 FPS---PPMASEKQGSKKKLSMGIIIAIAVGGAVVLFLVVLMIFLCCLRKKDSEGSGVAK 316
Query: 297 SK---GIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTY 353
K G R+EKPKE+FGSGVQE +KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT Y
Sbjct: 317 GKASGGGRSEKPKEEFGSGVQEPDKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAY 376
Query: 354 KAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413
KA+LEE TTVVVKRLKEVV+GKR+FEQQM++VGR+ QHPNVVP+RAYY+SKDEKLLVYD+
Sbjct: 377 KAVLEESTTVVVKRLKEVVVGKRDFEQQMDIVGRVGQHPNVVPLRAYYYSKDEKLLVYDY 436
Query: 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL 473
+ GS SALLHGNR GR+PLDW +RVKISLG A+GI HIH+ GGKF GNIKSSNVLL
Sbjct: 437 VSGGSLSALLHGNRPTGRSPLDWNARVKISLGIARGITHIHSVGGGKFTHGNIKSSNVLL 496
Query: 474 SQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGK 533
+QD +GCISDFGLTPLMN P SR+AGYRAPEVIE++K T KSDVYSFGVLLLEMLTGK
Sbjct: 497 NQDFEGCISDFGLTPLMNFPATSSRNAGYRAPEVIESRKHTHKSDVYSFGVLLLEMLTGK 556
Query: 534 APIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVP 593
AP+Q+PG +D+VDLPRWVQSVVREEWT+EVFD+ELMRY+NIEEEMVQMLQ+AM+CVAKVP
Sbjct: 557 APLQSPGRDDMVDLPRWVQSVVREEWTAEVFDIELMRYQNIEEEMVQMLQLAMACVAKVP 616
Query: 594 DMRPTMEEVVRMIEDIRPSDSENQPSSED-KLKDSNTQTP 632
DMRP+M+EVVRMIE+IR SDSEN+PSSE+ K KDSN QTP
Sbjct: 617 DMRPSMDEVVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 656
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224145409|ref|XP_002325632.1| predicted protein [Populus trichocarpa] gi|222862507|gb|EEF00014.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 926 bits (2392), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/632 (72%), Positives = 529/632 (83%), Gaps = 13/632 (2%)
Query: 7 FAALSFIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSR 66
F L+ I+ P ADL SDKQALLDFA VPH RKLNWN ++SVC SWVG+TC N +R
Sbjct: 12 FIILTIIF--PFAFADLKSDKQALLDFATAVPHLRKLNWNPASSVCNSWVGVTCNSNRTR 69
Query: 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNF 126
V +RLPGVGL G IP NTL KLD+L +LSLRSN L GDLPS++ SL SL L+LQ+NNF
Sbjct: 70 VSQLRLPGVGLVGHIPPNTLGKLDALRVLSLRSNVLEGDLPSDITSLPSLTNLFLQHNNF 129
Query: 127 SGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRH 186
SG IP+S S QLN +DLSFNS TGNIP ++ NL+ L+GL+LQNN+L+G IP+ N +R++
Sbjct: 130 SGGIPTSFSLQLNVLDLSFNSFTGNIPQTLANLTQLIGLSLQNNTLSGPIPDLNHTRIKR 189
Query: 187 LNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTV--PPAPSPSATNFPPPPTV 244
LNLSYNHLNGS+P++LQ FP SSF GNS+LCGPPLN CS V PP+PSP+ + PPPTV
Sbjct: 190 LNLSYNHLNGSIPVSLQNFPNSSFIGNSLLCGPPLNPCSPVIRPPSPSPA---YIPPPTV 246
Query: 245 LPKPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGI---R 301
P+ R S+ KL+ GAI+AIA+GGSAVLFL+ L I CCLKKKD+ G++ K K + R
Sbjct: 247 -PRKRS-SKVKLTMGAIIAIAVGGSAVLFLVVLTILCCCLKKKDNGGSSVLKGKAVSSGR 304
Query: 302 NEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGT 361
EKPKE+FGSGVQE EKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT YKA+LEE T
Sbjct: 305 GEKPKEEFGSGVQEHEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEEST 364
Query: 362 TVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSA 421
TVVVKRL+EVVMGKR+FEQQME VGR+ QHPN+VP+RAYY+SKDEKLLVYD+I GS S
Sbjct: 365 TVVVKRLREVVMGKRDFEQQMENVGRVGQHPNIVPLRAYYYSKDEKLLVYDYIPGGSLST 424
Query: 422 LLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCI 481
LLH NRG GRTPLDW+SRVKI+LG+A+GI+H+H+ G KF GNIKS+NVLLSQD GCI
Sbjct: 425 LLHANRGAGRTPLDWDSRVKIALGTARGISHLHSVGGPKFTHGNIKSTNVLLSQDHDGCI 484
Query: 482 SDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGH 541
SDFGLTPLMN P SRSAGYRAPEVIET+K T KSDVYSFGV+LLEMLTGKAPIQ+PG
Sbjct: 485 SDFGLTPLMNVPATSSRSAGYRAPEVIETRKHTHKSDVYSFGVVLLEMLTGKAPIQSPGR 544
Query: 542 EDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEE 601
+D+VDLPRWVQSVVREEWT+EVFDVELMRY+NIEEEMVQMLQI M+CVAKVPDMRP MEE
Sbjct: 545 DDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMTCVAKVPDMRPNMEE 604
Query: 602 VVRMIEDIRPSDSENQPSSED-KLKDSNTQTP 632
VVRMIE+IR SDSEN+PSSE+ K KDSN QTP
Sbjct: 605 VVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 636
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126989|ref|XP_002319979.1| predicted protein [Populus trichocarpa] gi|222858355|gb|EEE95902.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2344), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/631 (71%), Positives = 524/631 (83%), Gaps = 10/631 (1%)
Query: 6 VFAALSFIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGS 65
+F L+ I+ P I+DL SDKQALLDFAA VPH+RKLNWN ++ VC SWVG+TC N +
Sbjct: 11 LFIILTIIF--PFAISDLKSDKQALLDFAAVVPHSRKLNWNPASLVCKSWVGVTCNSNDT 68
Query: 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNN 125
RV+ +RLPGVGL G +P NTL KLD+L LSLRSN L GDLPS+V SL SL+ L+LQ+NN
Sbjct: 69 RVVELRLPGVGLLGHVPPNTLGKLDALNTLSLRSNVLEGDLPSDVTSLPSLQNLFLQHNN 128
Query: 126 FSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLR 185
FSG +P+S S +LN +DLSFNS TGNIP +I NL+ L GL+LQNN+L+G IP+ N +R++
Sbjct: 129 FSGGVPTSFSLKLNVLDLSFNSFTGNIPQTIANLTQLTGLSLQNNALSGPIPDLNHTRIK 188
Query: 186 HLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPPPPTVL 245
HLNLSYNHLNGS+P++LQKFP SSF GNS+LCGPPLN CS V P P A PP +
Sbjct: 189 HLNLSYNHLNGSIPVSLQKFPNSSFIGNSLLCGPPLNPCSIVLPPPPSPAYTPPPATS-- 246
Query: 246 PKPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGI---RN 302
+ S+ KL+ GAI+AIA+GGSAVLFL+ L++ CCLKKKD+EG K K + R
Sbjct: 247 --HKRSSKLKLTMGAIIAIAVGGSAVLFLVVLIVFCCCLKKKDNEGPGVLKGKAVSSGRG 304
Query: 303 EKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTT 362
EKPKEDFGSGVQE+EKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT YKA+LEE TT
Sbjct: 305 EKPKEDFGSGVQESEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTT 364
Query: 363 VVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSAL 422
VVVKRLKEVV+GKR+FEQQME+ GR+ QHPNVVP+RAYY+SKDE+LLVYD+I GS S L
Sbjct: 365 VVVKRLKEVVVGKRDFEQQMEIAGRVGQHPNVVPLRAYYYSKDERLLVYDYIPGGSLSTL 424
Query: 423 LHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS 482
LH NRG GRTPLDW+SRVKI+LG+A+GI+H+H+A G KF GNIKSSNVLLSQD GCIS
Sbjct: 425 LHANRGAGRTPLDWDSRVKIALGTARGISHLHSAGGPKFTHGNIKSSNVLLSQDHDGCIS 484
Query: 483 DFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHE 542
DFGLTPLMN P SRSAGYRAPEVIET K + KSDVYSFGV+LLEMLTGKAPIQ+P +
Sbjct: 485 DFGLTPLMNVPASSSRSAGYRAPEVIETSKHSHKSDVYSFGVILLEMLTGKAPIQSPRRD 544
Query: 543 DVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEV 602
D+VDLPRWVQSVVREEWT+EVFDVELMRY+NIEEEMVQMLQI M+CVAKVPDMRP MEEV
Sbjct: 545 DMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMTCVAKVPDMRPNMEEV 604
Query: 603 VRMIEDIRPSDSENQPSSE-DKLKDSNTQTP 632
VRMIE+IR SDSEN+PSSE +K KDSN TP
Sbjct: 605 VRMIEEIRQSDSENRPSSEGNKSKDSNVHTP 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586379|ref|XP_002533837.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223526229|gb|EEF28551.1| Nodulation receptor kinase precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 905 bits (2338), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/630 (71%), Positives = 523/630 (83%), Gaps = 7/630 (1%)
Query: 7 FAALSFIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSR 66
F + L IADLNSDKQALL+F+A +PH R LNWN ++S+C SWVG+TC + +R
Sbjct: 9 FRLIVLFTLFSLAIADLNSDKQALLNFSAAIPHYRLLNWNPASSICKSWVGVTCNPSQTR 68
Query: 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNF 126
VL +RLPGVG G IPANTL KLD+L +LSLRSN L G+LPS+V SL SLR LYLQ+NNF
Sbjct: 69 VLELRLPGVGFIGQIPANTLGKLDALRVLSLRSNLLYGNLPSDVTSLPSLRNLYLQHNNF 128
Query: 127 SGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRH 186
S IP+S S QLN +DLSFNS +G+IP +I NL+ L GL+LQNN+L+G IP+ N SRLRH
Sbjct: 129 SSTIPTSFSSQLNVLDLSFNSFSGSIPQTIANLTQLTGLSLQNNTLSGAIPDLNQSRLRH 188
Query: 187 LNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPPPPTVLP 246
LNLSYNHLNGSVP +LQKFP SSF GNS+LCG PLN CS + PSPS + P
Sbjct: 189 LNLSYNHLNGSVPFSLQKFPNSSFTGNSLLCGLPLNPCSPILSPPSPSPAS---SPPPEM 245
Query: 247 KPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGI---RNE 303
++GS+ KL+ GAI+AIA+GG AVLFL+ ++I CCLKKKD+ G++ K K + R E
Sbjct: 246 PHKKGSKAKLTLGAIIAIAVGGFAVLFLIVVIILCCCLKKKDNGGSSVLKGKAVSSGRGE 305
Query: 304 KPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTV 363
KPKE+FGSGVQE EKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT YKA+LEE TTV
Sbjct: 306 KPKEEFGSGVQEPEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTV 365
Query: 364 VVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALL 423
VVKRLKEVV+GKREFEQQME+VGR+ QH NVVP+RAYY+SKDEKLLVYD+I+ GS S LL
Sbjct: 366 VVKRLKEVVVGKREFEQQMEIVGRVGQHQNVVPLRAYYYSKDEKLLVYDYIQGGSLSTLL 425
Query: 424 HGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISD 483
HGNR GRTPLDW++RVKI+LG+A+GIAH+H+A G KF GNIKSSNVLL+QD GCISD
Sbjct: 426 HGNRQAGRTPLDWDNRVKIALGTARGIAHLHSAGGPKFTHGNIKSSNVLLNQDHDGCISD 485
Query: 484 FGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED 543
FGLTPLMN P PSRSAGYRAPEVIET+K T KSDVYSFGVLLLEMLTGKAP+Q+P +D
Sbjct: 486 FGLTPLMNVPATPSRSAGYRAPEVIETRKHTHKSDVYSFGVLLLEMLTGKAPLQSPSRDD 545
Query: 544 VVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603
+VDLPRWVQSVVREEWT+EVFDVELMRY+NIEEEMVQMLQI M+CVAKVPDMRP M+EVV
Sbjct: 546 MVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIGMACVAKVPDMRPNMDEVV 605
Query: 604 RMIEDIRPSDSENQPSSED-KLKDSNTQTP 632
RMIE+IR SDSEN+PSSE+ K KDSN QTP
Sbjct: 606 RMIEEIRQSDSENRPSSEENKSKDSNVQTP 635
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449449843|ref|XP_004142674.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2284), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/611 (72%), Positives = 521/611 (85%), Gaps = 8/611 (1%)
Query: 13 IWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLAVRL 72
I+ + + ADLNSD++ALLDF ++VPH RK+NW+ ST VCT+WVG+TCT + S VLA+RL
Sbjct: 16 IYFLSFIAADLNSDQEALLDFISSVPHGRKINWDPSTPVCTTWVGVTCTSDLSNVLALRL 75
Query: 73 PGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS 132
P +GLYGPIPANTL KLD+L LSLRSN+L+G+LPS+VLSL SL+FLYLQ NNFSG +PS
Sbjct: 76 PAIGLYGPIPANTLGKLDALRTLSLRSNNLNGNLPSDVLSLPSLKFLYLQRNNFSGKVPS 135
Query: 133 SLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYN 192
SLSP L ++DLSFNS+TGNIP S++NL+HL GLN+QNNSL G IP+ RL+ LNLSYN
Sbjct: 136 SLSPSLTFLDLSFNSLTGNIPKSVQNLTHLTGLNVQNNSLNGSIPDIGHLRLKQLNLSYN 195
Query: 193 HLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPPPPTVLPKPREGS 252
L+G +P +LQ FP SSFEGNS+LCG PL CS A PPP LP P++ S
Sbjct: 196 KLSGPIPASLQSFPTSSFEGNSLLCGSPLKNCSV-------GAPLPSPPPASLPPPKKKS 248
Query: 253 EEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAAT-KSKGIRNEKPKEDFGS 311
E+K++ GAIVAI +GG+AVLFLL ++I CC+KKKD E +AA K KG R E+PKEDFGS
Sbjct: 249 EKKINIGAIVAIGLGGAAVLFLLVVLIVVCCMKKKDGESSAAAVKGKGKRTEQPKEDFGS 308
Query: 312 GVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEV 371
GVQE EKN+LVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEG TVVVKRLKEV
Sbjct: 309 GVQEPEKNRLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGVTVVVKRLKEV 368
Query: 372 VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGR 431
V GK+EF+QQME+VGR+ QHPNVVP+RAYY+SKDEKLLVYD+ AGSFSALL G+R GR
Sbjct: 369 VAGKKEFDQQMEIVGRMGQHPNVVPLRAYYYSKDEKLLVYDYAIAGSFSALLRGSREGGR 428
Query: 432 TPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491
P DWE+R+K+SLG AKG+AHIH+A GGKFI GNIKSSN+LL+QDL GCISDFGLTPLMN
Sbjct: 429 APPDWETRLKVSLGCAKGLAHIHSASGGKFIHGNIKSSNILLTQDLNGCISDFGLTPLMN 488
Query: 492 TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWV 551
+P +PSRS GYRAPEVIET+K TQKSDVYSFGV+LLEMLTGKAP Q+PG +DV+DLPRWV
Sbjct: 489 SPAIPSRSVGYRAPEVIETRKSTQKSDVYSFGVILLEMLTGKAPSQSPGRDDVMDLPRWV 548
Query: 552 QSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611
QSVVREEWTSEVFDVELM+Y+NIEEE+VQMLQIAM+CV++VPDMRPTM++VVRMIE+IR
Sbjct: 549 QSVVREEWTSEVFDVELMKYQNIEEELVQMLQIAMACVSRVPDMRPTMDDVVRMIEEIRS 608
Query: 612 SDSENQPSSED 622
DS +PSSED
Sbjct: 609 LDSGTRPSSED 619
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449531551|ref|XP_004172749.1| PREDICTED: LOW QUALITY PROTEIN: probable inactive receptor kinase At5g58300-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2280), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/611 (72%), Positives = 520/611 (85%), Gaps = 8/611 (1%)
Query: 13 IWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLAVRL 72
I+ + + ADLNSD++ALLDF ++VPH RK+NW+ ST VCT+WVG+TCT + S VLA+RL
Sbjct: 16 IYFLSFIAADLNSDQEALLDFISSVPHGRKINWDPSTPVCTTWVGVTCTSDLSNVLALRL 75
Query: 73 PGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS 132
P +GLYGPIPANTL KLD+L LSLRSN+L+G+LPS+VLSL SL+FLYLQ NNFSG +PS
Sbjct: 76 PAIGLYGPIPANTLGKLDALRTLSLRSNNLNGNLPSDVLSLPSLKFLYLQRNNFSGKVPS 135
Query: 133 SLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYN 192
SLSP L ++DLSFNS+TGNIP S++NL+HL GLN+QNNSL G IP+ RL+ LNLSYN
Sbjct: 136 SLSPSLTFLDLSFNSLTGNIPKSVQNLTHLTGLNVQNNSLNGSIPDIGHLRLKQLNLSYN 195
Query: 193 HLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPPPPTVLPKPREGS 252
L+G +P +LQ FP SSFEGNS+LCG PL CS A PPP LP P++ S
Sbjct: 196 KLSGPIPASLQSFPTSSFEGNSLLCGSPLKNCSV-------GAPLPSPPPASLPPPKKKS 248
Query: 253 EEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAAT-KSKGIRNEKPKEDFGS 311
E+K + GAIVAI +GG+AVLFLL ++I CC+KKKD E +AA K KG R E+PKEDFGS
Sbjct: 249 EKKXNIGAIVAIGLGGAAVLFLLVVLIVVCCMKKKDGESSAAAVKGKGKRTEQPKEDFGS 308
Query: 312 GVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEV 371
GVQE EKN+LVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEG TVVVKRLKEV
Sbjct: 309 GVQEPEKNRLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGVTVVVKRLKEV 368
Query: 372 VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGR 431
V GK+EF+QQME+VGR+ QHPNVVP+RAYY+SKDEKLLVYD+ AGSFSALL G+R GR
Sbjct: 369 VAGKKEFDQQMEIVGRMGQHPNVVPLRAYYYSKDEKLLVYDYAIAGSFSALLRGSREGGR 428
Query: 432 TPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491
P DWE+R+K+SLG AKG+AHIH+A GGKFI GNIKSSN+LL+QDL GCISDFGLTPLMN
Sbjct: 429 APPDWETRLKVSLGCAKGLAHIHSASGGKFIHGNIKSSNILLTQDLNGCISDFGLTPLMN 488
Query: 492 TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWV 551
+P +PSRS GYRAPEVIET+K TQKSDVYSFGV+LLEMLTGKAP Q+PG +DV+DLPRWV
Sbjct: 489 SPAIPSRSVGYRAPEVIETRKSTQKSDVYSFGVILLEMLTGKAPSQSPGRDDVMDLPRWV 548
Query: 552 QSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611
QSVVREEWTSEVFDVELM+Y+NIEEE+VQMLQIAM+CV++VPDMRPTM++VVRMIE+IR
Sbjct: 549 QSVVREEWTSEVFDVELMKYQNIEEELVQMLQIAMACVSRVPDMRPTMDDVVRMIEEIRS 608
Query: 612 SDSENQPSSED 622
DS +PSSED
Sbjct: 609 LDSGTRPSSED 619
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537708|ref|XP_003537367.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 880 bits (2274), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 441/636 (69%), Positives = 522/636 (82%), Gaps = 13/636 (2%)
Query: 5 CVFAALSFIWLI----PQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITC 60
C + SF+++I P IADL+SDKQALL+FA VPH R L WN STSVC+SWVGITC
Sbjct: 34 CSTSVASFLFVIVIFFPLAIADLSSDKQALLNFANAVPHRRNLMWNPSTSVCSSWVGITC 93
Query: 61 TKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLY 120
+N +RV+ VRLPGVGL G IP+NTL KLD++ I+SLRSN LSG+LP+++ SL SL++LY
Sbjct: 94 NENRTRVVKVRLPGVGLVGTIPSNTLGKLDAVKIISLRSNLLSGNLPADIGSLPSLQYLY 153
Query: 121 LQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFN 180
LQ+NN SG+IP+SLSPQL +DLS+NS TG IP + +N+S L LNLQNNSL+G IPN N
Sbjct: 154 LQHNNLSGDIPASLSPQLIVLDLSYNSFTGVIPKTFQNMSVLTSLNLQNNSLSGQIPNLN 213
Query: 181 LSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPP 240
++ L+ LNLSYNHLNGS+P AL+ FP SSFEGNS+LCGPPL CS VPP PSP++T
Sbjct: 214 VTLLKLLNLSYNHLNGSIPKALEIFPNSSFEGNSLLCGPPLKPCSAVPPTPSPASTP--- 270
Query: 241 PPTVLPKPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGI 300
R+ S+ KLS AI+ IA+GG+ VLF + L+ CCLKK+D+ G+ K KG
Sbjct: 271 --PPSTTGRQSSKNKLSKIAIIVIAVGGAVVLFFIALVFVICCLKKEDNRGSNVIKGKGP 328
Query: 301 ---RNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAIL 357
R EKPKE+FGSGVQE EKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGT YKAIL
Sbjct: 329 SGGRGEKPKEEFGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTAYKAIL 388
Query: 358 EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417
EE TVVVKRLKEVV+GK++FEQQME++GR+ QH NVVP+RAYY+SKDEKLLVYD++ G
Sbjct: 389 EESMTVVVKRLKEVVVGKKDFEQQMEIMGRVGQHTNVVPLRAYYYSKDEKLLVYDYVPGG 448
Query: 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL 477
+ LLHG R GRTPLDW+SR+KISLG+AKG+AHIH+ G KF GNIKSSNVLL+QD
Sbjct: 449 NLHTLLHGGRTGGRTPLDWDSRIKISLGTAKGLAHIHSVGGPKFTHGNIKSSNVLLNQDN 508
Query: 478 QGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQ 537
GCISDFGL PLMN P PSR+AGYRAPEVIET+K + KSDVYSFGVLLLEMLTGKAP+Q
Sbjct: 509 DGCISDFGLAPLMNVPATPSRAAGYRAPEVIETRKHSHKSDVYSFGVLLLEMLTGKAPLQ 568
Query: 538 APGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRP 597
+PG +D+VDLPRWVQSVVREEWT+EVFDVELMRY+NIEEEMVQMLQIAM+CVAK+PDMRP
Sbjct: 569 SPGRDDMVDLPRWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMACVAKMPDMRP 628
Query: 598 TMEEVVRMIEDIRPSDSENQPSSED-KLKDSNTQTP 632
+M+E VRMIE+IR SDSEN+PSSE+ K KDSN QTP
Sbjct: 629 SMDEAVRMIEEIRQSDSENRPSSEENKSKDSNVQTP 664
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500954|ref|XP_003519295.1| PREDICTED: probable inactive receptor kinase At5g58300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 874 bits (2258), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/626 (70%), Positives = 513/626 (81%), Gaps = 12/626 (1%)
Query: 12 FIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLAVR 71
+ L P IADL+SDKQALLDFAA VPH R L WN +T +C+SWVGITC NG+RV++VR
Sbjct: 36 IVILFPLAIADLSSDKQALLDFAAAVPHRRNLKWNPATPICSSWVGITCNPNGTRVVSVR 95
Query: 72 LPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIP 131
LPG+GL G IPANTL K+DSL +SLR+N LSG LP ++ SL SL++LYLQ+NN SG++P
Sbjct: 96 LPGIGLVGTIPANTLGKIDSLRNISLRANLLSGSLPPDITSLPSLQYLYLQHNNLSGSVP 155
Query: 132 SSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSY 191
+SLS +LN +DLS+NS +G IP +++N++ L+ LNLQNNSL+G IPN N+++LRHLNLSY
Sbjct: 156 TSLSTRLNVLDLSYNSFSGAIPKTLQNITQLIKLNLQNNSLSGQIPNLNVTKLRHLNLSY 215
Query: 192 NHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPPPPTVLPKPREG 251
NHLNGS+P ALQ FP SSFEGNS LCG PL CS V P PS P P R
Sbjct: 216 NHLNGSIPDALQIFPNSSFEGNS-LCGLPLKSCSVVSSTP-PSTPVSPSTPA-----RHS 268
Query: 252 SEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGI---RNEKPKED 308
S+ KLS AI+AIA+GG +L L+ L+I CCLKKKD + TK KG R+EKPKE+
Sbjct: 269 SKSKLSKAAIIAIAVGGGVLLLLVALIIVLCCLKKKDDRSPSVTKGKGPSGGRSEKPKEE 328
Query: 309 FGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRL 368
FGSGVQE EKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGT YKAILEE TTVVVKRL
Sbjct: 329 FGSGVQEPEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTAYKAILEESTTVVVKRL 388
Query: 369 KEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRG 428
KEVV+GKREFEQQME+VGR+ HPNVVP+RAYY+SKDEKLLVYD+I +G+ S LLHGNR
Sbjct: 389 KEVVVGKREFEQQMEIVGRVGHHPNVVPLRAYYYSKDEKLLVYDYIPSGNLSTLLHGNRA 448
Query: 429 IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488
GRTPLDW SR+KIS+G A+GIAHIH+ G KF GN+KSSNVLL+ D GCISDFGLTP
Sbjct: 449 SGRTPLDWNSRIKISVGIARGIAHIHSVGGPKFTHGNVKSSNVLLNHDNDGCISDFGLTP 508
Query: 489 LMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP 548
LMN P PSR+AGYRAPEVIET+K T KSDVYSFG+LLLEMLTGKAP Q+PG +D+VDLP
Sbjct: 509 LMNVPATPSRAAGYRAPEVIETRKHTHKSDVYSFGILLLEMLTGKAPQQSPGRDDMVDLP 568
Query: 549 RWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
RWVQSVVREEWT+EVFDVELMRY+NIEEEMVQMLQIAM+CVAKVPDMRP+M+EVVRMIE+
Sbjct: 569 RWVQSVVREEWTAEVFDVELMRYQNIEEEMVQMLQIAMACVAKVPDMRPSMDEVVRMIEE 628
Query: 609 IRPSDSENQPSSEDKL--KDSNTQTP 632
IR SDSEN+PSSE+ ++S QTP
Sbjct: 629 IRLSDSENRPSSEENRSKEESAAQTP 654
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 632 | ||||||
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.963 | 0.931 | 0.651 | 1e-212 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.993 | 0.981 | 0.608 | 2.5e-200 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.947 | 0.935 | 0.553 | 1.1e-172 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.973 | 0.934 | 0.522 | 2.7e-164 | |
| TAIR|locus:2128414 | 638 | AT4G23740 [Arabidopsis thalian | 0.965 | 0.956 | 0.485 | 9.8e-151 | |
| TAIR|locus:2024517 | 587 | AT1G64210 [Arabidopsis thalian | 0.525 | 0.565 | 0.494 | 3.8e-129 | |
| TAIR|locus:2198090 | 655 | RKL1 "receptor-like kinase 1" | 0.512 | 0.494 | 0.528 | 2.1e-128 | |
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.506 | 0.494 | 0.525 | 6.4e-125 | |
| TAIR|locus:2075502 | 627 | AT3G02880 [Arabidopsis thalian | 0.939 | 0.947 | 0.430 | 1.9e-122 | |
| TAIR|locus:2178712 | 614 | AT5G24100 [Arabidopsis thalian | 0.898 | 0.925 | 0.416 | 3.8e-117 |
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2056 (728.8 bits), Expect = 1.0e-212, P = 1.0e-212
Identities = 400/614 (65%), Positives = 481/614 (78%)
Query: 20 IADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLAVRLPGVGLYG 79
IADLNSD+QALL FAA+VPH R+LNWNS+ +C SWVG+TCT +G+ V A+RLPG+GL G
Sbjct: 42 IADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTCTSDGTSVHALRLPGIGLLG 101
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLN 139
PIP NTL KL+SL ILSLRSN LSG+LP ++ SL SL ++YLQ+NNFSG +PS +S QLN
Sbjct: 102 PIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSGEVPSFVSRQLN 161
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199
+DLSFNS TG IPA+ +NL L GL+LQNN L+G +PN + LR LNLS NHLNGS+P
Sbjct: 162 ILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVSLRRLNLSNNHLNGSIP 221
Query: 200 LALQKFPPSSFEGNSMLCGPPLNQCSTVXXXXXXXXXXXXXXXXVLPKPREGSEEKLSTX 259
AL FP SSF GN++LCG PL C+T P +EGS+ KL
Sbjct: 222 SALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPFPH-KEGSKRKLHVS 280
Query: 260 XXXXXXXXXSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGIRNEKPKEDFGSGVQEAEKN 319
+A+L L+ ++I CC+KKKD + K K + EK K++FGSGVQE EKN
Sbjct: 281 TIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKVKTL-TEKAKQEFGSGVQEPEKN 339
Query: 320 KLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFE 379
KLVFF GCSYNFDLEDLLRASAEVLGKGSYGT YKA+LEE TTVVVKRLKEV GKREFE
Sbjct: 340 KLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVAAGKREFE 399
Query: 380 QQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR 439
QQME++ R+ HP+VVP+RAYY+SKDEKL+V D+ AG+ S+LLHGNRG +TPLDW+SR
Sbjct: 400 QQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSR 459
Query: 440 VKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS 499
VKI+L +AKGIAH+HAA G KF GNIKSSNV++ Q+ CISDFGLTPLM P P R
Sbjct: 460 VKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPMRG 519
Query: 500 AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559
AGYRAPEV+ET+K T KSDVYSFGVL+LEMLTGK+P+Q+P +D+VDLPRWVQSVVREEW
Sbjct: 520 AGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMVDLPRWVQSVVREEW 579
Query: 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSEN-QP 618
TSEVFD+ELMR++NIEEEMVQMLQIAM+CVA+VP++RPTM++VVRMIE+IR SDSE +P
Sbjct: 580 TSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIRVSDSETTRP 639
Query: 619 SSED--KLKDSNTQ 630
SS+D K KDSN Q
Sbjct: 640 SSDDNSKPKDSNVQ 653
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1939 (687.6 bits), Expect = 2.5e-200, P = 2.5e-200
Identities = 388/638 (60%), Positives = 477/638 (74%)
Query: 1 MKLRCVFAALSFIWLIPQMI-ADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGIT 59
MK+ F L + + + AD+ SDKQALL+FA+ VPH+RKLNWNS+ +C SW GIT
Sbjct: 2 MKIIAAFLFLLVTTFVSRCLSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGIT 61
Query: 60 CTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFL 119
C+KN +RV A+RLPG GLYGP+P T EKLD+L I+SLRSNHL G++PS +LSL +R L
Sbjct: 62 CSKNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSL 121
Query: 120 YLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF 179
Y NNFSG IP LS +L +DLS NS++GNIP S++NL+ L L+LQNNSL+G IPN
Sbjct: 122 YFHENNFSGTIPPVLSHRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNL 181
Query: 180 NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVXXXXXXXXXXXX 239
RL++LNLS+N+LNGSVP +++ FP SSF+GNS+LCG PL C
Sbjct: 182 P-PRLKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTPT 240
Query: 240 XXXXVLPKPREGSEEKLSTXXXXXXXXXXSAVLFLLFLMIAFCCLKKKDS--EGTAATKS 297
R +++ LST S +LF++ +I CC KK+D + TA K+
Sbjct: 241 EGPGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKA 300
Query: 298 KGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAIL 357
K R++ E+FGSGVQEAEKNKLVFFEG SYNFDLEDLLRASAEVLGKGSYGTTYKAIL
Sbjct: 301 KPGRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAIL 360
Query: 358 EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417
EEGTTVVVKRLKEV GKREFEQQME VGR+S H NV P+RAYYFSKDEKLLVYD+ + G
Sbjct: 361 EEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGG 420
Query: 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL 477
+FS LLHGN GR LDWE+R++I L +A+GI+HIH+A G K + GNIKS NVLL+Q+L
Sbjct: 421 NFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQEL 480
Query: 478 QGCISDFGLTPLMNTPT-VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPI 536
C+SDFG+ PLM+ T +PSRS GYRAPE IET+K TQKSDVYSFGVLLLEMLTGKA
Sbjct: 481 HVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAG 540
Query: 537 QAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE-NIEEEMVQMLQIAMSCVAKVPDM 595
+ GHE+VVDLP+WVQSVVREEWT EVFDVEL++ + N+EEEMVQMLQIAM+CV+K PD
Sbjct: 541 KTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDS 600
Query: 596 RPTMEEVVRMIEDIRPSDSE----NQPSSEDKLKDSNT 629
RP+MEEVV M+E+IRPS S N+ SS + ++ S++
Sbjct: 601 RPSMEEVVNMMEEIRPSGSGPGSGNRASSPEMIRSSDS 638
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1678 (595.7 bits), Expect = 1.1e-172, P = 1.1e-172
Identities = 348/629 (55%), Positives = 455/629 (72%)
Query: 7 FAALSFIWLIPQ-----MIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCT 61
F A SF +L+ + ADL SD+QALL+FAA+VPH KLNWN + S+C+SW+GITC
Sbjct: 8 FVAASFFFLLLAATAVLVSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITCD 67
Query: 62 KNG--SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFL 119
++ SRV+AVRLPGVGLYG IP TL KLD+L +LSLRSN L G LPS++LSL SL +L
Sbjct: 68 ESNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYL 127
Query: 120 YLQNNNFSGNIPS----SLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGF 175
YLQ+NNFSG + + S+S QL +DLS+NS++GNIP+ +RNLS + L LQNNS G
Sbjct: 128 YLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGP 187
Query: 176 IPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVXXXXXXXX 235
I + +L ++ +NLSYN+L+G +P L+K P SF GNS+LCGPPLN CS
Sbjct: 188 IDSLDLPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSG-GAISPSSN 246
Query: 236 XXXXXXXXVLPKPREGSEEKLSTXXXXXXXXXXSAVLFLLFLMIAFCCLKK-KDSEGTAA 294
+ P R S+ + AVLFL + + C +KK K EG
Sbjct: 247 LPRPLTENLHPVRRRQSKAYIIAIVVGCSV----AVLFLGIVFLV-CLVKKTKKEEGGGE 301
Query: 295 ---TKSKGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 351
T+ G+ ++KP +DFGSGVQ+ EKNKL FFE C++NFDLEDLL+ASAEVLGKGS+GT
Sbjct: 302 GVRTQMGGVNSKKP-QDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGT 360
Query: 352 TYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411
YKA+LE+ T VVVKRL+EVV K+EFEQQME+VG+++QH N VP+ AYY+SKDEKLLVY
Sbjct: 361 AYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVY 420
Query: 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNV 471
++ GS ++HGNRG R +DWE+R+KI+ G++K I+++H+ KF+ G+IKSSN+
Sbjct: 421 KYMTKGSLFGIMHGNRG-DRG-VDWETRMKIATGTSKAISYLHSL---KFVHGDIKSSNI 475
Query: 472 LLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT 531
LL++DL+ C+SD L L N PT R+ GY APEVIET++ +Q+SDVYSFGV++LEMLT
Sbjct: 476 LLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLT 535
Query: 532 GKAPIQAPGHED---VVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSC 588
GK P+ PG ED V+DLPRWV+SVVREEWT+EVFDVEL++++NIEEEMVQMLQ+A++C
Sbjct: 536 GKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALAC 595
Query: 589 VAKVPDMRPTMEEVVRMIEDIRPSDSENQ 617
VA+ P+ RP MEEV RMIED+R D Q
Sbjct: 596 VARNPESRPKMEEVARMIEDVRRLDQSQQ 624
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1599 (567.9 bits), Expect = 2.7e-164, P = 2.7e-164
Identities = 340/651 (52%), Positives = 446/651 (68%)
Query: 6 VFAALSFIWLIPQMI-ADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNG 64
V +L I L+ Q + ++ ++KQALL F +PH +L WN S S C +WVG+ C N
Sbjct: 7 VLNSLFSILLLTQRVNSESTAEKQALLTFLQQIPHENRLQWNESDSAC-NWVGVECNSNQ 65
Query: 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNN 124
S + ++RLPG GL G IP+ +L +L L +LSLRSN LSG +PS+ +L+ LR LYLQ+N
Sbjct: 66 SSIHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHN 125
Query: 125 NFSGNIPSSLSPQLN---WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNL 181
FSG P+S + QLN +D+S N+ TG+IP S+ NL+HL GL L NN +G +P+ +L
Sbjct: 126 EFSGEFPTSFT-QLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL 184
Query: 182 SRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVXXXXXXXXXXXXXX 241
L N+S N+LNGS+P +L +F SF GN LCG PL C +
Sbjct: 185 G-LVDFNVSNNNLNGSIPSSLSRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSL---- 239
Query: 242 XXVLPKPREGSEE-KLSTXXXXXXXXXXSAVLFLLFLMIAFCCLKKKDSEGTAATKSK-- 298
+ P R S++ KLS + V LL ++ F CL+K+ A TK
Sbjct: 240 --INPSNRLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSNEARTKQPKP 297
Query: 299 -GI--RN-EKP------KEDF---GSGVQ-EAEKNKLVFFEGCSYNFDLEDLLRASAEVL 344
G+ RN + P KE+ SG+ E E+NKLVF EG Y+FDLEDLLRASAEVL
Sbjct: 298 AGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVL 357
Query: 345 GKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK 404
GKGS GT+YKA+LEEGTTVVVKRLK+V+ K+EFE QMEVVG++ +HPNV+P+RAYY+SK
Sbjct: 358 GKGSVGTSYKAVLEEGTTVVVKRLKDVMASKKEFETQMEVVGKI-KHPNVIPLRAYYYSK 416
Query: 405 DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILG 464
DEKLLV+DF+ GS SALLHG+RG GRTPLDW++R++I++ +A+G+AH+H V K + G
Sbjct: 417 DEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLH--VSAKLVHG 474
Query: 465 NIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGV 524
NIK+SN+LL + C+SD+GL L + + P+R AGY APEV+ET+K T KSDVYSFGV
Sbjct: 475 NIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGV 534
Query: 525 LLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQI 584
LLLE+LTGK+P QA E+ +DLPRWV SVVREEWT+EVFDVELMRY NIEEEMVQ+LQI
Sbjct: 535 LLLELLTGKSPNQASLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQI 594
Query: 585 AMSCVAKVPDMRPTMEEVVRMIEDIRPSDSEN---QPSSEDKLKDSNTQTP 632
AM+CV+ VPD RP M+EV+RMIED+ S++ + + SS+D K S QTP
Sbjct: 595 AMACVSTVPDQRPVMQEVLRMIEDVNRSETTDDGLRQSSDDPSKGSEGQTP 645
|
|
| TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1471 (522.9 bits), Expect = 9.8e-151, P = 9.8e-151
Identities = 309/636 (48%), Positives = 420/636 (66%)
Query: 10 LSFIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLA 69
LS +I +D DK+ALL+F + R LNWN ++ VC W G+TC ++GSR++A
Sbjct: 13 LSLCLIIYGANSDPLEDKRALLEFLTIMQPTRSLNWNETSQVCNIWTGVTCNQDGSRIIA 72
Query: 70 VRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGN 129
VRLPGVGL G IP NT+ +L +L +LSLRSN +SG+ P + + L L FLYLQ+NN SG
Sbjct: 73 VRLPGVGLNGQIPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGP 132
Query: 130 IPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFN-LSRLRH 186
+P S L V+LS N G IP+S+ L + LNL NN+L+G IP+ + LS L+H
Sbjct: 133 LPLDFSVWKNLTSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQH 192
Query: 187 LNLSYNH-LNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVXXXXXXXXXXXXXXXXVL 245
++LS N+ L G +P L++FP SS+ G ++ PP + V
Sbjct: 193 IDLSNNYDLAGPIPDWLRRFPFSSYTGIDII--PPGGNYTLVTPPPPSEQTHQ------- 243
Query: 246 PKPREGSEEKLSTXXXXXXXXXXSAVLFL-LFLMIAFCCLKKKDSEGTAATKSKGIRNE- 303
KP + LS S V+ L ++ C +++K G ++ +
Sbjct: 244 -KPSKARFLGLSETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGDGVISDNKLQKKG 302
Query: 304 -KPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTT 362
E F S +++ N+L FFEGC+Y+FDLEDLLRASAEVLGKG++GTTYKA+LE+ T+
Sbjct: 303 GMSPEKFVSRMEDVN-NRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATS 361
Query: 363 VVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSAL 422
V VKRLK+V GKR+FEQQME++G + +H NVV ++AYY+SKDEKL+VYD+ GS ++L
Sbjct: 362 VAVKRLKDVAAGKRDFEQQMEIIGGI-KHENVVELKAYYYSKDEKLMVYDYFSRGSVASL 420
Query: 423 LHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS 482
LHGNRG R PLDWE+R+KI++G+AKGIA IH GK + GNIKSSN+ L+ + GC+S
Sbjct: 421 LHGNRGENRIPLDWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVS 480
Query: 483 DFGLTPLMNTPTVP--SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540
D GLT +M+ P P SR AGYRAPEV +T+K +Q SDVYSFGV+LLE+LTGK+PI
Sbjct: 481 DLGLTAVMS-PLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTA 539
Query: 541 HEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTME 600
++++ L RWV SVVREEWT+EVFD+EL+RY NIEEEMV+MLQIAMSCV K D RP M
Sbjct: 540 GDEIIHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMS 599
Query: 601 EVVRMIEDI--RPSDSENQPSSEDKLKD--SNTQTP 632
++VR+IE++ R + E +P + K ++ S T TP
Sbjct: 600 DLVRLIENVGNRRTSIEPEPELKPKSENGASETSTP 635
|
|
| TAIR|locus:2024517 AT1G64210 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 829 (296.9 bits), Expect = 3.8e-129, Sum P(2) = 3.8e-129
Identities = 173/350 (49%), Positives = 240/350 (68%)
Query: 274 LLFLMIAFCCLKKKDSEGTAATKSKGIRNEKPKEDFGSGVQEAEKN-KLVFFEGCSYNFD 332
L F+MI C K G + + P ++ S E+ K++FF G ++ FD
Sbjct: 248 LSFIMIT--CFGKTRISGKLRKRD----SSSPPGNWTSRDDNTEEGGKIIFFGGRNHLFD 301
Query: 333 LEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHP 392
L+DLL +SAEVLGKG++GTTYK +E+ +TVVVKRLKEVV+G+REFEQQME++G + +H
Sbjct: 302 LDDLLSSSAEVLGKGAFGTTYKVTMEDMSTVVVKRLKEVVVGRREFEQQMEIIGMI-RHE 360
Query: 393 NVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRG-IGRTPLDWESRVKISLGSAKGIA 451
NV ++AYY+SKD+KL VY + GS +LHGNRG R PLDW++R++I+ G+A+G+A
Sbjct: 361 NVAELKAYYYSKDDKLAVYSYYNHGSLFEILHGNRGRYHRVPLDWDARLRIATGAARGLA 420
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT-PTVPSRSAGYRAPEVIET 510
IH GKFI GNIKSSN+ L GCI D GLT +M + P ++GY APE+ +T
Sbjct: 421 KIHE---GKFIHGNIKSSNIFLDSQCYGCIGDVGLTTIMRSLPQTTCLTSGYHAPEITDT 477
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPI-QA---PGHEDVVDLPRWVQSVVREEWTSEVFDV 566
++ TQ SDVYSFGV+LLE+LTGK+P+ QA P + +DL W++SVV +EWT EVFD+
Sbjct: 478 RRSTQFSDVYSFGVVLLELLTGKSPVSQAELVPTGGENMDLASWIRSVVAKEWTGEVFDM 537
Query: 567 ELMRYEN-IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSE 615
E++ EEEMV+MLQI ++CVA RP + +V+++IEDIR D+E
Sbjct: 538 EILSQSGGFEEEMVEMLQIGLACVALKQQERPHIAQVLKLIEDIRSVDAE 587
|
|
| TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 865 (309.6 bits), Expect = 2.1e-128, Sum P(2) = 2.1e-128
Identities = 176/333 (52%), Positives = 242/333 (72%)
Query: 292 TAATKSKGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 351
+AA + N K E G+G A K KLVFF + FDLEDLLRASAEVLGKG++GT
Sbjct: 330 SAAAAAAMTGNGKASE--GNG--PATK-KLVFFGNATKVFDLEDLLRASAEVLGKGTFGT 384
Query: 352 TYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411
YKA+L+ T V VKRLK+V+M +EF++++E+VG + H N+VP+RAYYFS+DEKLLVY
Sbjct: 385 AYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAMD-HENLVPLRAYYFSRDEKLLVY 443
Query: 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNV 471
DF+ GS SALLHGNRG GR+PL+W+ R +I++G+A+G+ ++H+ G GNIKSSN+
Sbjct: 444 DFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQ-GTSTSHGNIKSSNI 502
Query: 472 LLSQDLQGCISDFGLTPLM-NTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEML 530
LL++ +SDFGL L+ ++ T P+R+ GYRAPEV + K+ +QK DVYSFGV+LLE++
Sbjct: 503 LLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELI 562
Query: 531 TGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMV-QMLQIAMSCV 589
TGKAP + +E+ VDLPRWV+SV R+EW EVFD EL+ EEEM+ +M+Q+ + C
Sbjct: 563 TGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECT 622
Query: 590 AKVPDMRPTMEEVVRMIEDIRPSDSENQPSSED 622
++ PD RP M EVVR +E++RP +Q + D
Sbjct: 623 SQHPDQRPEMSEVVRKMENLRPYSGSDQVNEAD 655
|
|
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 842 (301.5 bits), Expect = 6.4e-125, Sum P(2) = 6.4e-125
Identities = 172/327 (52%), Positives = 232/327 (70%)
Query: 294 ATKSKGIRNE-KPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTT 352
A +++ NE P V + KLVFF + FDLEDLLRASAEVLGKG++GT
Sbjct: 320 APENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTA 379
Query: 353 YKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412
YKA+L+ T V VKRLK+V M REF++++EVVG + H N+VP+RAYY+S DEKLLVYD
Sbjct: 380 YKAVLDAVTLVAVKRLKDVTMADREFKEKIEVVGAMD-HENLVPLRAYYYSGDEKLLVYD 438
Query: 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVL 472
F+ GS SALLHGN+G GR PL+WE R I+LG+A+G+ ++H+ GN+KSSN+L
Sbjct: 439 FMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQ-DPLSSHGNVKSSNIL 497
Query: 473 LSQDLQGCISDFGLTPLMN-TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT 531
L+ +SDFGL L++ + T P+R+ GYRAPEV + ++ +QK+DVYSFGV+LLE+LT
Sbjct: 498 LTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLELLT 557
Query: 532 GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE---NIEEEMVQMLQIAMSC 588
GKAP + +E+ +DL RWV SV REEW +EVFD ELM E ++EEEM +MLQ+ + C
Sbjct: 558 GKAPSNSVMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDC 617
Query: 589 VAKVPDMRPTMEEVVRMIEDIRPSDSE 615
+ PD RP M EVVR I+++R S ++
Sbjct: 618 TEQHPDKRPVMVEVVRRIQELRQSGAD 644
|
|
| TAIR|locus:2075502 AT3G02880 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1204 (428.9 bits), Expect = 1.9e-122, P = 1.9e-122
Identities = 271/629 (43%), Positives = 383/629 (60%)
Query: 12 FIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLAVR 71
F++ + + +DL SD++ALL +V R L WN S S +W G+ C + RV A+R
Sbjct: 15 FVFYLAAVTSDLESDRRALLAVRNSV-RGRPLLWNMSASSPCNWHGVHC--DAGRVTALR 71
Query: 72 LPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIP 131
LPG GL+G +P + L L LSLR N LSG +PS+ +L LR+LYLQ N FSG IP
Sbjct: 72 LPGSGLFGSLPIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVLLRYLYLQGNAFSGEIP 131
Query: 132 SSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNL 189
S L P + ++L N +G IP ++ + + LV L L+ N L+G IP L L+ N+
Sbjct: 132 SLLFTLPSIIRINLGENKFSGRIPDNVNSATRLVTLYLERNQLSGPIPEITLP-LQQFNV 190
Query: 190 SYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVXXXXXXXXXXXXXXXXVLPKPR 249
S N LNGS+P +L +P ++FEGN+ LCG PL+ C P P
Sbjct: 191 SSNQLNGSIPSSLSSWPRTAFEGNT-LCGKPLDTCEAESPNGGDAGGPNT------P-PE 242
Query: 250 EGSEEKLSTXXXXXXXXXXSAVLFLLFLMIAFC-CLKKKDSEGT----------AATKSK 298
+ +KLS V LL L+I FC C K+K E AAT S
Sbjct: 243 KKDSDKLSAGAIVGIVIG-CVVGLLLLLLILFCLCRKRKKEENVPSRNVEAPVAAATSSA 301
Query: 299 GIRNEK-----PKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTY 353
I E P + GS K+ L FF FDL+ LL+ASAEVLGKG+ G++Y
Sbjct: 302 AIPKETVVVVPPAKATGSESGAVNKD-LTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSY 360
Query: 354 KAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413
KA E G V VKRL++VV+ ++EF +++ V+G +S H N+V + AYYFS+DEKLLV+++
Sbjct: 361 KASFEHGLVVAVKRLRDVVVPEKEFRERLHVLGSMS-HANLVTLIAYYFSRDEKLLVFEY 419
Query: 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL 473
+ GS SA+LHGN+G GRTPL+WE+R I+LG+A+ I+++H+ G GNIKSSN+LL
Sbjct: 420 MSKGSLSAILHGNKGNGRTPLNWETRAGIALGAARAISYLHSR-DGTTSHGNIKSSNILL 478
Query: 474 SQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGK 533
S + +SD+GL P++++ + P+R GYRAPE+ + +K +QK+DVYSFGVL+LE+LTGK
Sbjct: 479 SDSYEAKVSDYGLAPIISSTSAPNRIDGYRAPEITDARKISQKADVYSFGVLILELLTGK 538
Query: 534 APIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE-NIEEEMVQMLQIAMSCVAKV 592
+P +E+ VDLPRWVQSV ++ S+V D EL RY+ E ++++L+I MSC A+
Sbjct: 539 SPTHQQLNEEGVDLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQF 598
Query: 593 PDMRPTMEEVVRMIEDIRPSDSENQPSSE 621
PD RP+M EV R+IE++ S P S+
Sbjct: 599 PDSRPSMAEVTRLIEEVSHSSGSPNPVSD 627
|
|
| TAIR|locus:2178712 AT5G24100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1154 (411.3 bits), Expect = 3.8e-117, P = 3.8e-117
Identities = 257/617 (41%), Positives = 366/617 (59%)
Query: 15 LIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLAVRLPG 74
L Q+ DL D+QALLDF N+ H R L WN+S+ VCT+W G+TC +G+RV A+ LPG
Sbjct: 22 LYSQVTGDLAGDRQALLDFLNNIIHPRSLAWNTSSPVCTTWPGVTCDIDGTRVTALHLPG 81
Query: 75 VGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL 134
L G IP T+ +L L ILSLRSN L G P + L L L+ + L NN FSG +PS
Sbjct: 82 ASLLGVIPPGTISRLSELQILSLRSNGLRGPFPIDFLQLKKLKAISLGNNRFSGPLPSDY 141
Query: 135 SPQLNW--VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYN 192
+ N +DL N G+IPA NL+ LV LNL NS +G IP+ NL LR LN S N
Sbjct: 142 ATWTNLTVLDLYSNRFNGSIPAGFANLTGLVSLNLAKNSFSGEIPDLNLPGLRRLNFSNN 201
Query: 193 HLNGSVPLALQKFPPSSFEGNSMLC--GPPLNQCSTVXXXXXXXXXXXXXXXXVLPKPRE 250
+L GS+P +L++F S+F GN+++ PP V K ++
Sbjct: 202 NLTGSIPNSLKRFGNSAFSGNNLVFENAPP--------------------PAVVSFKEQK 241
Query: 251 GSEEKLSTXXXXXXXXXXSAVLFLLFLMIAFCCLKKKDSEGTAATK------SKGIRNEK 304
+ +S V+F + ++ C K+ + K +K + +EK
Sbjct: 242 KNGIYISEPAILGIAISVCFVIFFVIAVVIIVCYVKRQRKSETEPKPDKLKLAKKMPSEK 301
Query: 305 PKEDFGS--GVQEAEK----NKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILE 358
G +++ E NK++FFEG + F+LEDLL ASAE LGKG +G TYKA+LE
Sbjct: 302 EVSKLGKEKNIEDMEDKSEINKVMFFEGSNLAFNLEDLLIASAEFLGKGVFGMTYKAVLE 361
Query: 359 EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418
+ + VKRLK++V+ +++F+ QME+VG + +H NV P+RAY SK+EKL+VYD+ GS
Sbjct: 362 DSKVIAVKRLKDIVVSRKDFKHQMEIVGNI-KHENVAPLRAYVCSKEEKLMVYDYDSNGS 420
Query: 419 FSALLHG-NRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL 477
S LHG N G PL+WE+R++ +G AKG+ HIH GNIKSSNV ++ +
Sbjct: 421 LSLRLHGKNADEGHVPLNWETRLRFMIGVAKGLGHIHTQ---NLAHGNIKSSNVFMNSEG 477
Query: 478 QGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQKSDVYSFGVLLLEMLTG 532
GCIS+ GL PL+ P V + S+ YRAPEV +T++ T +SD+YSFG+L+LE LTG
Sbjct: 478 YGCISEAGL-PLLTNPVVRADSSARSVLRYRAPEVTDTRRSTPESDIYSFGILMLETLTG 536
Query: 533 KAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKV 592
++ + ++ +DL WV V+ ++WT EVFD+EL++ N+E +++QMLQ+ SC A V
Sbjct: 537 RSIMD--DRKEGIDLVVWVNDVISKQWTGEVFDLELVKTPNVEAKLLQMLQLGTSCTAMV 594
Query: 593 PDMRPTMEEVVRMIEDI 609
P RP M +VV +E+I
Sbjct: 595 PAKRPDMVKVVETLEEI 611
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LVM0 | Y5830_ARATH | No assigned EC number | 0.6677 | 0.9636 | 0.9311 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 632 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-33 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-32 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-25 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-15 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-13 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-13 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-12 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-06 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-06 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-06 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-05 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-04 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-04 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 8e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 0.002 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.003 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-48
Identities = 160/547 (29%), Positives = 244/547 (44%), Gaps = 79/547 (14%)
Query: 83 ANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWV- 141
+ LE LD L N SG +P + SLS L L L N SG IP LS V
Sbjct: 474 SKRLENLD------LSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS 527
Query: 142 -DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHL---NLSYNHLNGS 197
DLS N ++G IPAS + L L+L N L+G IP NL + L N+S+NHL+GS
Sbjct: 528 LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK-NLGNVESLVQVNISHNHLHGS 586
Query: 198 VPL--ALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATNFPPPPTVLPKPREGSEEK 255
+P A S+ GN LCG + + PP V P
Sbjct: 587 LPSTGAFLAINASAVAGNIDLCG-------------GDTTSGLPPCKRVRKTPSWWFYIT 633
Query: 256 LSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGIRNEKPKEDFGSGVQE 315
+ GA + +A+ +F+ G + K + NE G E
Sbjct: 634 CTLGAFLVLALVAFGFVFI---------------RGRNNLELKRVENE-------DGTWE 671
Query: 316 AEKNKLVFFEG-CSYNFDLEDLLRASAE--VLGKGSYGTTYKA-ILEEGTTVVVKRLKEV 371
L FF+ S + + D+L + E V+ +G G +YK ++ G VVK + +V
Sbjct: 672 -----LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDV 726
Query: 372 VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGR 431
M G+L QHPN+V + S+ L++++IE + S +L
Sbjct: 727 NSIPSSEIADM---GKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------ 776
Query: 432 TPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS-QDLQGCISDFGLTPLM 490
L WE R KI++G AK + +H ++GN+ +++ +D L L+
Sbjct: 777 --LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR--LSLPGLL 832
Query: 491 NTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP--IQAPGHEDVVDLP 548
T T S+ Y APE ETK T+KSD+Y FG++L+E+LTGK+P + H +V+
Sbjct: 833 CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA 892
Query: 549 RWVQSVVR-EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607
R+ S + W ++ +N E+V+++ +A+ C A P RP +V++ +E
Sbjct: 893 RYCYSDCHLDMWIDPSIRGDVSVNQN---EIVEVMNLALHCTATDPTARPCANDVLKTLE 949
Query: 608 DIRPSDS 614
S S
Sbjct: 950 SASRSSS 956
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 74/270 (27%), Positives = 119/270 (44%), Gaps = 27/270 (10%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQ-MEV-VGRLSQHPNVVPIR 398
LG GS+GT YKA G V VK LK+ ++ + E+ + R HPN+V +
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+ KD LV ++ E G L PL + KI+L +G+ ++H+
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRGLEYLHSN-- 117
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR----SAGYRAPEVIETKKP- 513
I ++K N+LL ++ I+DFGL + + + Y APEV+
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 514 TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573
K DV+S GV+L E+LTGK P E+++D + ++ ++ + E
Sbjct: 177 GPKVDVWSLGVILYELLTGKPPFS---GENILDQLQLIRRILGPPLEFDEPKWSSGSEE- 232
Query: 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603
+ C+ K P RPT EE++
Sbjct: 233 -------AKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 57/195 (29%), Positives = 98/195 (50%), Gaps = 17/195 (8%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLK--EVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
LG+G +GT Y A + G V +K +K + E +++E++ +L HPN+V +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
+ ++ LV ++ E GS LL N G L + ++I L +G+ ++H+
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLHSN---G 112
Query: 461 FILGNIKSSNVLLSQDLQGC-ISDFGL----TPLMNTPTVPSRSAGYRAPEVIETKKP-T 514
I ++K N+LL D ++DFGL T + + Y APEV+ K +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 515 QKSDVYSFGVLLLEM 529
+KSD++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 65/270 (24%), Positives = 121/270 (44%), Gaps = 29/270 (10%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEV-VGRLSQHPNVVPIRA 399
E LG+GS+G Y A + G V +K +K+ + K E+ + + +HPN+V +
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 400 YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGIAHIHAAVG 458
+ +D+ LV ++ E G LL + E + + ++H+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLS------EDEARFYLRQILSALEYLHSK-- 116
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEVIETKKPTQ 515
+ ++K N+LL +D ++DFGL ++ + G Y APEV+ K +
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 516 KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575
D++S GV+L E+LTGK P PG + +++L + + + + +I
Sbjct: 176 AVDIWSLGVILYELLTGKPPF--PGDDQLLEL---FKKIGKPKPPFP------PPEWDIS 224
Query: 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605
E +++ + K P+ R T EE ++
Sbjct: 225 PEAKDLIR---KLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 78/286 (27%), Positives = 131/286 (45%), Gaps = 53/286 (18%)
Query: 342 EVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNV 394
+ LG+G++G YK L T V VK LKE + EF ++ ++ +L HPN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
V + + +V +++ G L + L + ++++L AKG+ ++
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLE 119
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP-LMNTPTVPSRSAGYR-----APEVI 508
+ F+ ++ + N L++++L ISDFGL+ + R G APE +
Sbjct: 120 S---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 509 ETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVD-------LPRWVQSVVREEWT 560
+ K T KSDV+SFGVLL E+ T G+ P +E+V++ LPR E
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR------PENCP 230
Query: 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606
E++++ MLQ C A P+ RPT E+V +
Sbjct: 231 DELYEL--------------MLQ----CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 76/285 (26%), Positives = 136/285 (47%), Gaps = 42/285 (14%)
Query: 342 EVLGKGSYGTTYKAILEEG----TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVV 395
+ LG+G++G YK L+ T V VK LKE +++F ++ V+ +L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGI----GRTPLDWESRVKISLGSAKGIA 451
+ ++ LV +++E G L +R + ++ L + + ++ AKG+
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR------AP 505
++ + KF+ ++ + N L+ +DL ISDFGL+ + + G + AP
Sbjct: 120 YLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 506 EVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDV--VDLPRWVQSVVREEWTSE 562
E ++ T KSDV+SFGVLL E+ T G P + + ++ +++ R
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP-----YPGLSNEEVLEYLRKGYR------ 225
Query: 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607
L + E +E+ +++ SC P+ RPT E+V +E
Sbjct: 226 -----LPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 76/278 (27%), Positives = 131/278 (47%), Gaps = 38/278 (13%)
Query: 342 EVLGKGSYGTTYKAILE-----EGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNV 394
+ LG+G++G YK L+ + V VK LKE + EF ++ ++ +L HPNV
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
V + ++ +V +++E G + L NR L + +L A+G+ ++
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP----KLSLSDLLSFALQIARGMEYLE 119
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSRSAG--YR--APEVIE 509
+ FI ++ + N L+ ++L ISDFGL+ L + R R APE ++
Sbjct: 120 S---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176
Query: 510 TKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568
K T KSDV+SFGVLL E+ T G+ P ++ ++++ R L
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQP---YPGMSNEEVLEYLKNGYR-----------L 222
Query: 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606
+ N E+ + + C A+ P+ RPT E+V ++
Sbjct: 223 PQPPNCPPELY---DLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 73/278 (26%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 342 EVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNV 394
+ LG+G++G YK L + V VK LKE EF ++ ++ +L HPN+
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
V + ++ ++V +++ G L NR L + +L A+G+ ++
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE 120
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSRSAG--YR--APEVIE 509
+ FI ++ + N L+ ++L ISDFGL+ L + + R APE ++
Sbjct: 121 S---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 510 TKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568
K T KSDV+SFGVLL E+ T G+ P ++ +++ R L
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP---YPGMSNAEVLEYLKKGYR-----------L 223
Query: 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606
+ N E+ +++ C A+ P+ RPT E+V ++
Sbjct: 224 PKPPNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 7e-31
Identities = 74/180 (41%), Positives = 103/180 (57%), Gaps = 8/180 (4%)
Query: 30 LLDFAANV--PHARKLNWNSSTSVCTSWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLE 87
LL F +++ P NWNSS VC W GITC N SRV+++ L G + G I +
Sbjct: 34 LLSFKSSINDPLKYLSNWNSSADVC-LWQGITCN-NSSRVVSIDLSGKNISGKISSAIF- 90
Query: 88 KLDSLMILSLRSNHLSGDLPSNVLSLS-SLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFN 146
+L + ++L +N LSG +P ++ + S SLR+L L NNNF+G+IP P L +DLS N
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNN 150
Query: 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQK 204
++G IP I + S L L+L N L G IPN NL+ L L L+ N L G +P L +
Sbjct: 151 MLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQ 210
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E +GKG +G YKA G V +K +K K+E + + +HPN+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRV-KISLGSAKGIAHIHAAVGG 459
Y KDE +V +F GS LL L ES++ + KG+ ++H+
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKSTNQ----TLT-ESQIAYVCKELLKGLEYLHSN--- 117
Query: 460 KFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEVIETKKPTQK 516
I +IK++N+LL+ D + + DFGL+ ++ + G + APEVI K K
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 517 SDVYSFGVLLLEMLTGKAP 535
+D++S G+ +E+ GK P
Sbjct: 178 ADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 63/280 (22%), Positives = 113/280 (40%), Gaps = 30/280 (10%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKRE----FEQQMEVVGRLSQHPNVVPI 397
LG+GS+G Y A + V +K L + + K + F ++++++ L+ PN+V +
Sbjct: 6 RKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
++ + LV ++++ GS LL G + + + ++H+
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI--LSALEYLHS-- 119
Query: 458 GGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLMNTPTVPSR----------SAGYRAPE 506
I +IK N+LL +D + DFGL L+ P S + GY APE
Sbjct: 120 -KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 507 VIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563
V+ + SD++S G+ L E+LTG P + E ++ E T +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG---EKNSSATSQTLKIILELPTPSL 235
Query: 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603
+ N E + +AK P R + +
Sbjct: 236 A--SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLS--QHPNVVPIR 398
E+LG+GS+G+ Y A+ ++ G + VK ++ + E E + LS QHPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 399 AYYFSK--DEKLLVYDFIE---AGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKGIAH 452
YY S+ +EK + F+E GS S+LL + E ++ +G+A+
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP------EPVIRKYTRQILEGLAY 116
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR------APE 506
+H+ + +IK +N+L+ D ++DFG + + R APE
Sbjct: 117 LHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
VI ++ + +D++S G ++EM TGK P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 53/202 (26%), Positives = 101/202 (50%), Gaps = 17/202 (8%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS--QHPNVVPIR 398
+++G+G++G YK + LE G V +K++ + + + M+ + L +HPN+V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA-KGIAHIHAAV 457
+ D ++ ++ E GS ++ ES V + + +G+A++H
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFP------ESLVAVYVYQVLQGLAYLH--- 116
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS-AG---YRAPEVIETKKP 513
I +IK++N+L ++D ++DFG+ +N + S G + APEVIE
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 514 TQKSDVYSFGVLLLEMLTGKAP 535
+ SD++S G ++E+LTG P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 8e-22
Identities = 67/286 (23%), Positives = 123/286 (43%), Gaps = 56/286 (19%)
Query: 342 EVLGKGSYGTTYKA-ILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIR 398
+ +GKGS+G Y +G V+K + M ++E E + V L + HPN++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII--- 62
Query: 399 AYY--FSKDEKLL-VYDFIEAGSFSALLHGNRGIGRTP------LDWESRVKISLGSAKG 449
YY F + KL V ++ + G S + + P LDW V++ L
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDW--FVQLCLA---- 115
Query: 450 IAHIHAAVGGKFILG-NIKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSRSAG---YRA 504
+ ++H + IL +IK N+ L+ + + DFG+ L +T + G Y +
Sbjct: 116 LKYLH----SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171
Query: 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564
PE+ + K KSD++S G +L E+ T K P + +L +++ +
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE------NLLELALKILKGQ------ 219
Query: 565 DVELMRYENIEE----EMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606
Y I E+ ++ S + K P+ RP++ ++++
Sbjct: 220 ------YPPIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 69/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 334 EDLLRASAEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEV---VGRLS 389
DL R VLG+GS G YK G +K++ V G EF +Q+ R
Sbjct: 1 SDLERVK--VLGQGSSGVVYKVRHKPTGKIYALKKIH--VDGDEEFRKQLLRELKTLRSC 56
Query: 390 QHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKG 449
+ P VV ++ + E +V ++++ GS + LL I L I+ KG
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVL-----AYIARQILKG 111
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS----AGYRAP 505
+ ++H I +IK SN+L++ + I+DFG++ ++ + Y +P
Sbjct: 112 LDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169
Query: 506 EVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565
E I+ + + +D++S G+ LLE GK P PG +L +Q++
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICDGP------- 219
Query: 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEE 601
+ E E + C+ K P RP+ E
Sbjct: 220 PPSLPAEEFSPEFRDFISA---CLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIR 398
+GKGS+G +K + + + +K++ M +RE E+ ++ L++ ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII--- 62
Query: 399 AYY--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
YY F KL +V ++ E G LL RG PL + + + G+AH+H+
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHS 119
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS----AGYRAPEVIETK 511
K + +IKS N+ L I D G+ L++ T + + Y +PE+ E K
Sbjct: 120 K---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 512 KPTQKSDVYSFGVLLLEMLTGKAPIQA 538
+KSDV++ GV+L E TGK P A
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-20
Identities = 69/271 (25%), Positives = 116/271 (42%), Gaps = 29/271 (10%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+GKG +G G V VK LK+ + F + V+ L +HPN+V +
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVV 69
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
+ +V +++ GS L R GR + ++ +L +G+ ++ F
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPLMN-TPTVPSRSAGYRAPEVIETKKPTQKSDVY 520
+ ++ + NVL+S+DL +SDFGL + + APE + KK + KSDV+
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 521 SFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL-MRYENIEEEM 578
SFG+LL E+ + G+ P +DVV VE R E E
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVP------------------HVEKGYRMEAPEGCP 225
Query: 579 VQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
++ ++ C P RPT +++ + I
Sbjct: 226 PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 3e-20
Identities = 59/139 (42%), Positives = 83/139 (59%), Gaps = 5/139 (3%)
Query: 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNN 124
S + + L G L G IP N+L L SL L+L SN L G +P + + SL+++YL N
Sbjct: 164 SSLKVLDLGGNVLVGKIP-NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN 222
Query: 125 NFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FN 180
N SG IP + LN +DL +N++TG IP+S+ NL +L L L N L+G IP F+
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 181 LSRLRHLNLSYNHLNGSVP 199
L +L L+LS N L+G +P
Sbjct: 283 LQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 53/230 (23%), Positives = 97/230 (42%), Gaps = 51/230 (22%)
Query: 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQM---------EVVGRLSQH 391
+++G+GS+ T A E +K L KR+ ++ EV+ RL+ H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILD-----KRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 392 PNVVPIRAYY-FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKG 449
P + I+ YY F +E L V ++ G + G LD + +
Sbjct: 62 PGI--IKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGS----LDEKCTRFYAAEILLA 114
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS---------- 499
+ ++H+ I ++K N+LL +D+ I+DFG +++ + P +
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 500 --------------AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
A Y +PE++ K + SD+++ G ++ +MLTGK P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 14/209 (6%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403
+G G +G + E V +K ++E M + +F ++ +V+ +LS HP +V +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLS-HPKLVQLYGVCTE 70
Query: 404 KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFIL 463
+ LV++F+E G S L RG E+ + + L +G+A++ ++ I
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLESS---NVIH 123
Query: 464 GNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQKSD 518
++ + N L+ ++ +SDFG+T + S + + +PEV K + KSD
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 519 VYSFGVLLLEMLT-GKAPIQAPGHEDVVD 546
V+SFGVL+ E+ + GK P + + +VV+
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVE 212
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 34/209 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRL----------KEVVMGKREFEQQMEVVGRLSQ 390
E LG+GSYG+ YKAI E G V +K + KE+ + K+
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQ------------CD 56
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
P +V YF + +V ++ AGS S ++ + +T L E I + KG+
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKT-LTEEEIAAILYQTLKGL 112
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSRSAG---YRAPE 506
++H+ K I +IK+ N+LL+++ Q ++DFG+ L +T + G + APE
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPE 169
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
VI+ K+D++S G+ +EM GK P
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 75/273 (27%), Positives = 132/273 (48%), Gaps = 31/273 (11%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ LG G +G + T V +K LK+ M F + ++ +L QHP +V + A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAV- 69
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
+++ ++ +++E GS L GI L + ++ A+G+A I +
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERK---NY 123
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQK 516
I +++++N+L+S+ L I+DFGL L+ +R + APE I T K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 517 SDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575
SDV+SFG+LL E++T G+ P PG + P +Q++ R + R +N
Sbjct: 184 SDVWSFGILLTEIVTYGRIPY--PGMTN----PEVIQNLER--------GYRMPRPDNCP 229
Query: 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
EE+ +++ C + P+ RPT E + ++ED
Sbjct: 230 EELYELM---RLCWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 31/271 (11%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403
LG G +G + A + T V VK +K M F + V+ L QH +V + A +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAV-VT 71
Query: 404 KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFIL 463
K+ ++ +F+ GS L + G + PL + S A+G+A I +I
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEG-SKQPL--PKLIDFSAQIAEGMAFIEQR---NYIH 125
Query: 464 GNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQKSD 518
+++++N+L+S L I+DFGL ++ +R + APE I T KSD
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 519 VYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEE 577
V+SFG+LL+E++T G+ P PG + P ++++ R + R EN EE
Sbjct: 186 VWSFGILLMEIVTYGRIPY--PGMSN----PEVIRALER--------GYRMPRPENCPEE 231
Query: 578 MVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
+ ++ M C P+ RPT E + +++D
Sbjct: 232 LYNIM---MRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 344 LGKGSYGTTYKAIL----EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPI 397
+G+GS+G KAIL E+G V+K + M +E E+ + V LS HPN+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGI---GRTPLDWESRVKISLGSAKGIAHIH 454
+ + +V D+ E G ++ RG+ LDW V+I L + H+H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--FVQICLA----LKHVH 118
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA----GYRAPEVIET 510
K + +IKS N+ L++D + DFG+ ++N+ +R+ Y +PE+ E
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN 175
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV 545
+ KSD+++ G +L EM T K +A +++V
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 5e-18
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 28/218 (12%)
Query: 344 LGKGSYGTTYKA-ILEEGTTVVVKRL-KEVVMGKREFEQ-QMEV-VGRLSQHPNVVPIRA 399
LGKGS+G + G +K L K+ ++ ++E E E + HP +V +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59
Query: 400 YYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-----ISLGSAKGIAHI 453
Y F +EKL LV ++ G + L E R + I L + ++
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS------EERARFYAAEIVLA----LEYL 109
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSRSAG---YRAPEVIE 509
H+ I ++K N+LL D ++DFGL L + + + G Y APEV+
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL 166
Query: 510 TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547
K + D +S GVLL EMLTGK P A +++ +
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK 204
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 8e-18
Identities = 71/271 (26%), Positives = 129/271 (47%), Gaps = 30/271 (11%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403
LG G +G + T V VK LK M + F ++ ++ L QH +V + A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTK 72
Query: 404 KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFIL 463
++ ++ +++ GS L + G G+ L + S A+G+A+I +I
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEG-GKVLL--PKLIDFSAQIAEGMAYIERK---NYIH 126
Query: 464 GNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQKSD 518
+++++NVL+S+ L I+DFGL ++ +R + APE I T KSD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 519 VYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEE 577
V+SFG+LL E++T GK P + DV+ S ++ + + R EN +E
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVM-------SALQRGY-------RMPRMENCPDE 232
Query: 578 MVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
+ +++ +C + + RPT + + +++D
Sbjct: 233 LYDIMK---TCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 9e-17
Identities = 53/139 (38%), Positives = 74/139 (53%), Gaps = 7/139 (5%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP 136
L G IP + +L +L IL L SN+ +G +P + SL L+ L L +N FSG IP +L
Sbjct: 296 LSGEIP-ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354
Query: 137 QLNW--VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLS---RLRHLNLSY 191
N +DLS N++TG IP + + +L L L +NSL G IP +L LR + L
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK-SLGACRSLRRVRLQD 413
Query: 192 NHLNGSVPLALQKFPPSSF 210
N +G +P K P F
Sbjct: 414 NSFSGELPSEFTKLPLVYF 432
|
Length = 968 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 31/271 (11%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403
LG+G +G + T V +K LK M F Q+ +V+ +L +H +V + A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAV-VS 71
Query: 404 KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFIL 463
++ +V +++ GS L G G L V ++ A G+A++ ++
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERM---NYVH 125
Query: 464 GNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQKSD 518
+++++N+L+ ++L ++DFGL L+ +R + APE + T KSD
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 519 VYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEE 577
V+SFG+LL E+ T G+ P + +V+D V+ R E E++ +
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLD---QVERGYRMPCPPEC-------PESLHDL 235
Query: 578 MVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
M Q C K P+ RPT E + +ED
Sbjct: 236 MCQ-------CWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 70/302 (23%), Positives = 122/302 (40%), Gaps = 64/302 (21%)
Query: 344 LGKGSYGTTYKA---ILEEGTT--VVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNV 394
LG+G +G L + T V VK L G + +FE+++E++ L H N+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLN--HSGEEQHRSDFEREIEILRTL-DHENI 68
Query: 395 VPIR--AYYFSKDEKLLVYDFIEAGSFSALLHGNRG-IGRTPLDWESRVKISLGSAKGIA 451
V + L+ +++ +GS L +R I L + S KG+
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQICKGMD 123
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--VPSRSAG-----YRA 504
++ + ++I ++ + N+L+ + ISDFGL ++ + G + A
Sbjct: 124 YLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP------------GHEDVVDLPRWVQ 552
PE + T K + SDV+SFGV L E+ T P Q+P G V L ++
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 553 SVVR----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
R EV+D LM+ C P RP+ +++ +++
Sbjct: 241 EGERLPRPPSCPDEVYD--LMK----------------LCWEAEPQDRPSFADLILIVDR 282
Query: 609 IR 610
+R
Sbjct: 283 LR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 67/279 (24%), Positives = 126/279 (45%), Gaps = 48/279 (17%)
Query: 343 VLGKGSYGTTYKAIL----EEGTTVVVK-----RLKEVVMGKREFEQQMEVVGRLSQHPN 393
VLGKG++G +A L E+ + VV K RL E R+ ++ ++ L QHPN
Sbjct: 7 VLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKER--RDALNEIVILSLL-QHPN 60
Query: 394 VVPIRAYY--FSKDEKLLV-YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
++ AYY F D LL+ ++ G+ + +G + E + +
Sbjct: 61 II---AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAV 114
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA----GYRAPE 506
++IH A + +IK+ N+ L++ + DFG++ ++ + + + Y +PE
Sbjct: 115 SYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPE 171
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566
+ + K KSD+++ G +L E+LT K A + V +V+ +T
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT------NPLNLVVKIVQGNYT-----P 220
Query: 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605
+ Y E++ ++ S + + P+ RPT +EV+
Sbjct: 221 VVSVY---SSELISLVH---SLLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 29/270 (10%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403
LG+G +G + T V +K LK M F Q+ +++ +L +H +VP+ A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAV-VS 71
Query: 404 KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFIL 463
++ +V +F+ GS L G G+ L V ++ A G+A+I +I
Sbjct: 72 EEPIYIVTEFMGKGSLLDFL--KEGDGKY-LKLPQLVDMAAQIADGMAYIERM---NYIH 125
Query: 464 GNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQKSD 518
+++++N+L+ +L I+DFGL L+ +R + APE + T KSD
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 519 VYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEM 578
V+SFG+LL E++T K + PG V RE + + E +
Sbjct: 186 VWSFGILLTELVT-KGRVPYPG------------MVNREVLEQVERGYRMPCPQGCPESL 232
Query: 579 VQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
+++++ C K PD RPT E + +ED
Sbjct: 233 HELMKL---CWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 29/270 (10%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403
LG G +G + T V VK LK M F ++ +++ +L +H +V + A S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAV-VS 71
Query: 404 KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFIL 463
++ +V +++ GS L G GR L + V ++ A G+A+I +I
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL--KDGEGRA-LKLPNLVDMAAQVAAGMAYIERM---NYIH 125
Query: 464 GNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQKSD 518
+++S+N+L+ L I+DFGL L+ +R + APE + T KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 519 VYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEM 578
V+SFG+LL E++T K + PG + R V V + R ++
Sbjct: 186 VWSFGILLTELVT-KGRVPYPGMNN-----REVLEQVERGY----------RMPCPQDCP 229
Query: 579 VQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
+ + ++ + C K P+ RPT E + +ED
Sbjct: 230 ISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 75/284 (26%), Positives = 134/284 (47%), Gaps = 45/284 (15%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
EV+G+G+YG YKA ++ G V +K + + + E +++ ++ + S HPN+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 401 YFSK------DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
+ K D+ LV + GS + L+ G R G+ L E I + +G+A++H
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYLH 130
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVI- 508
K I +IK N+LL+++ + + DFG++ +++ T+ R+ + APEVI
Sbjct: 131 E---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-TLGRRNTFIGTPYWMAPEVIA 186
Query: 509 --ETKKPT--QKSDVYSFGVLLLEMLTGKAPIQAPGHED--VVDLPRWVQSVVR--EEWT 560
E + +SDV+S G+ +E+ GK P+ H + +PR ++ E W+
Sbjct: 187 CDEQPDASYDARSDVWSLGITAIELADGKPPL-CDMHPMRALFKIPRNPPPTLKSPENWS 245
Query: 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+ D I E C+ K + RP MEE++
Sbjct: 246 KKFNDF-------ISE-----------CLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 64/266 (24%), Positives = 115/266 (43%), Gaps = 30/266 (11%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS--QHPNVVPIRAY 400
LGKGSYG+ YK L + +K + M ++E E + + L+ HPN++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
+ ++ +V ++ G S + R R + + +I + +G+ +H K
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---K 123
Query: 461 FILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEVIETKKPTQKS 517
+ ++KS+N+LL + I D G++ ++ + G Y APEV + + + KS
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVL-KKNMAKTQIGTPHYMAPEVWKGRPYSYKS 182
Query: 518 DVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEE 577
D++S G LL EM T P +A + DL VQ +Y I
Sbjct: 183 DIWSLGCLLYEMATFAPPFEA---RSMQDLRYKVQR---------------GKYPPIPPI 224
Query: 578 MVQ-MLQIAMSCVAKVPDMRPTMEEV 602
Q + S + P +RP +++
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 74/277 (26%), Positives = 124/277 (44%), Gaps = 40/277 (14%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403
LG G +G + T V VK LK M F Q+ +++ +L +H +V + A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE 72
Query: 404 KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFIL 463
++ +V +++ GS L G L V ++ A+G+A++ + +I
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKK---LRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 464 GNIKSSNVLLSQDLQGCISDFGLTPL-MNTPTVPSRSAGY----RAPEVIETKKPTQKSD 518
++ + N+L+ ++L I+DFGL L + A + APE + T KSD
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186
Query: 519 VYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD-VE----LMRYE 572
V+SFG+LL E++T G+ P PG + EV + VE + R
Sbjct: 187 VWSFGILLTEIVTYGRVPY--PGMTN-----------------REVLEQVERGYRMPRPP 227
Query: 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
N EE+ ++ + C K P+ RPT E + +ED
Sbjct: 228 NCPEELYDLM---LQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 49/207 (23%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNVV 395
+V+G G +G + L ++ V +K LK K +F + ++G+ HPN++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNII 68
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ +++ +++E GS L N G V + G A G+ ++ +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYL-S 123
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--PTVPSRS----AGYRAPEVIE 509
+ ++ ++ + N+L++ +L +SDFGL+ + T ++ + APE I
Sbjct: 124 EMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181
Query: 510 TKKPTQKSDVYSFGVLLLEMLT-GKAP 535
+K T SDV+SFG+++ E+++ G+ P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 67/271 (24%), Positives = 123/271 (45%), Gaps = 30/271 (11%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403
LG G +G ++ + T V VK LK M ++F + +++ +L +HP ++ + A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTL 72
Query: 404 KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFIL 463
++ +V + ++ GS L G G L + ++ A G+A++ A +I
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126
Query: 464 GNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQKSD 518
++ + NVL+ ++ ++DFGL ++ +R + APE + + KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 519 VYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEE 577
V+SFG+LL E++T G+ P PG + +Q V + R
Sbjct: 187 VWSFGILLTEIVTYGRMPY--PGMTN----AEVLQQVDQG-----------YRMPCPPGC 229
Query: 578 MVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
++ I + C + PD RPT E + +ED
Sbjct: 230 PKELYDIMLDCWKEDPDDRPTFETLQWKLED 260
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 77/287 (26%), Positives = 129/287 (44%), Gaps = 45/287 (15%)
Query: 344 LGKGSYGTTYKAIL------EEGTTVVVKRLKE-VVMGKR-EFEQQMEVVGRLSQHPNVV 395
LG+GS+G Y+ + E T V +K + E M +R EF + V+ + H +VV
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNR-----GIGRTPLDWESRVKISLGSAKGI 450
+ + L+V + + G + L R G P + ++++ A G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR------- 503
A++ A KF+ ++ + N ++++DL I DFG+T + T R G
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWM 188
Query: 504 APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562
APE ++ T KSDV+SFGV+L EM T + P Q +E+V+
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF--------------- 233
Query: 563 VFDVELMRY-ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
V D + EN + ++L++ C P MRPT E+V ++D
Sbjct: 234 VIDGGHLDLPENCPD---KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 67/257 (26%), Positives = 118/257 (45%), Gaps = 43/257 (16%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPN 393
E LG+G++G YK L T+V +K LKE K +EF Q+ E++ L QHPN
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPN 69
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGN-----------RGIGRTPLDWESRVKI 442
+V + + ++++++ G L N ++ LD + I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 443 SLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---TVPSRS 499
++ A G+ ++ + F+ ++ + N L+ + L ISDFGL+ + + V S+S
Sbjct: 130 AIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 500 ---AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVV---------- 545
+ PE I K T +SD++SFGV+L E+ + G P +++V+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
Query: 546 ---DLPRWVQSVVREEW 559
D P V +++ E W
Sbjct: 247 CPEDCPARVYALMIECW 263
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 44/283 (15%)
Query: 332 DLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQ---MEV-VGR 387
DLE L LG G+ G K +L T ++ K + + E Q+ E+ +
Sbjct: 2 DLEYL-----GELGAGNSGVVSK-VLHRPTGKIMAV-KTIRLEINEAIQKQILRELDILH 54
Query: 388 LSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA 447
P +V +++ + + ++++ GS +L GR P KI++
Sbjct: 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILG--KIAVAVL 110
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSRSAG---YR 503
KG+ ++H K I ++K SN+L++ Q + DFG+ L+N+ + G Y
Sbjct: 111 KGLTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--LAKTFVGTSSYM 166
Query: 504 APEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP--GHEDVVDLPRWVQSVVREE--- 558
APE I+ + KSD++S G+ L+E+ TG+ P + + +L +Q +V E
Sbjct: 167 APERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL---LQYIVNEPPPR 223
Query: 559 WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEE 601
S F + + N+ C+ K P RP+ +E
Sbjct: 224 LPSGKFSPDFQDFVNL-------------CLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 53/218 (24%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--------HPNV 394
+G+G+YG YKA G V +K++K FE + L + HPN+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKELNHPNI 60
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGIAHI 453
+ + + K + LV++F++ + + RG+ ES +K +G+A
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLP------ESLIKSYLYQLLQGLAFC 114
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT------PLMNTPTVPSRSAGYRAPEV 507
H+ + ++K N+L++ + ++DFGL T V +R YRAPE+
Sbjct: 115 HSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR--WYRAPEL 169
Query: 508 IETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV 544
+ K + D++S G + E+L+ + P+ PG ++
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR-PL-FPGKSEI 205
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-14
Identities = 50/130 (38%), Positives = 74/130 (56%), Gaps = 5/130 (3%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS- 135
L GPIP ++ L L+ L L N LSG++P V+ L +L L+L +NNF+G IP +L+
Sbjct: 272 LSGPIP-PSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
Query: 136 -PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYN 192
P+L + L N +G IP ++ ++L L+L N+LTG IP + L L L N
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSN 390
Query: 193 HLNGSVPLAL 202
L G +P +L
Sbjct: 391 SLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 28/211 (13%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKR--EFEQQMEVVGRLSQ--HPNVVP 396
EV+G G+ Y AI L V +KR+ + K ++ + V +SQ HPNVV
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRID---LEKCQTSVDELRKEVQAMSQCNHPNVV- 62
Query: 397 IRAYY--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI 453
YY F ++L LV ++ GS ++ R LD + KG+ ++
Sbjct: 63 --KYYTSFVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG--------YRAP 505
H+ I +IK+ N+LL +D I+DFG++ + +R + AP
Sbjct: 119 HS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 506 EVIETKKP-TQKSDVYSFGVLLLEMLTGKAP 535
EV+E K+D++SFG+ +E+ TG AP
Sbjct: 176 EVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 66/270 (24%), Positives = 119/270 (44%), Gaps = 34/270 (12%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVK--RLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRA 399
E +GKG++G YK +L+ T V VK R KR+F Q+ E++ + HPN+V +
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLIG 59
Query: 400 YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459
K +V + + GS L + L + +++SL +A G+ ++ +
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESK--- 112
Query: 460 KFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR-------APEVIETKK 512
I ++ + N L+ ++ ISDFG++ + + S G + APE + +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
Query: 513 PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572
T +SDV+S+G+LL E + P RE S + +
Sbjct: 172 YTSESDVWSYGILLWETFSLGD----------TPYPGMSNQQTRERIES---GYRMPAPQ 218
Query: 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEV 602
EE+ +++ + C A P+ RP+ E+
Sbjct: 219 LCPEEIYRLM---LQCWAYDPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 21/205 (10%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQ-QMEV-VGRLSQHPNVVPIR 398
+ +G G+YG YKA + G V +K +K + +FE Q E+ + + +HPN+V
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
Y +D+ +V ++ GS + RG PL + + KG+A++H
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHET-- 120
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-----SAGYRAPEVIETKKP 513
GK I +IK +N+LL++D ++DFG++ + T T+ R + + APEV ++
Sbjct: 121 GK-IHRDIKGANILLTEDGDVKLADFGVSAQL-TATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 514 ---TQKSDVYSFGVLLLEMLTGKAP 535
K D+++ G+ +E+ + P
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ +GKG +G G V VK +K + F + V+ +L +H N+V +
Sbjct: 12 QTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQ-AFLAEASVMTQL-RHSNLVQLLGVI 68
Query: 402 FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
+ L +V +++ GS L R GR+ L + +K SL + + ++ A
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NN 122
Query: 461 FILGNIKSSNVLLSQDLQGCISDFGLT----PLMNTPTVPSRSAGYRAPEVIETKKPTQK 516
F+ ++ + NVL+S+D +SDFGLT +T +P + + APE + KK + K
Sbjct: 123 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK---WTAPEALREKKFSTK 179
Query: 517 SDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPR 549
SDV+SFG+LL E+ + G+ P +DVV PR
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVV--PR 211
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 75/295 (25%), Positives = 130/295 (44%), Gaps = 46/295 (15%)
Query: 344 LGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMGKR--EFEQQMEVVGRLSQHPNVV 395
LG+GS+G Y+ E T V VK + E + EF + V+ + H +VV
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVV 72
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNR-----GIGRTPLDWESRVKISLGSAKGI 450
+ L+V + + G + L R GR P + ++++ A G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-------YR 503
A+++A KF+ ++ + N +++ D I DFG+T + T R G +
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWM 188
Query: 504 APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562
APE ++ T SD++SFGV+L E+ + + P Q +E V+
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF--------------- 233
Query: 563 VFD-VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI-EDIRPSDSE 615
V D L + +N E + ++++ C P MRPT E+V ++ +D+ PS E
Sbjct: 234 VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 14/211 (6%)
Query: 344 LGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYF 402
LG G YG Y+ + ++ TV VK LKE M EF ++ V+ + +HPN+V +
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCT 72
Query: 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFI 462
+ ++ +F+ G+ LL R R ++ + ++ + + ++ FI
Sbjct: 73 REPPFYIITEFMTYGN---LLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFI 126
Query: 463 LGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQKS 517
++ + N L+ ++ ++DFGL+ LM T + + + APE + K + KS
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 518 DVYSFGVLLLEMLT-GKAPIQAPGHEDVVDL 547
DV++FGVLL E+ T G +P V +L
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 217
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 77/282 (27%), Positives = 123/282 (43%), Gaps = 45/282 (15%)
Query: 344 LGKGSYGTTYKAILEEGT----TVVVKRLKE--VVMGKREFEQQMEVVGRLSQHPNVVPI 397
LG G++G+ K + + V VK LK+ + GK+EF ++ V+ +L HP +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV-- 59
Query: 398 RAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPL-DWESRVKISLGSAKGIAHIHA 455
R K E L LV + G L R I + L + +V A G+A++
Sbjct: 60 RLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLE- 112
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--VPSRSAG-----YRAPEVI 508
F+ ++ + NVLL Q ISDFG++ + + + +AG + APE I
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 509 ETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567
K + KSDV+S+GV L E + G P +V+ + ++S R
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM---LESGER----------- 216
Query: 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
L R E +E+ ++ SC P+ RPT E+
Sbjct: 217 LPRPEECPQEIYSIML---SCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 6e-14
Identities = 66/270 (24%), Positives = 120/270 (44%), Gaps = 33/270 (12%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403
LG G +G + V +K + E M + +F ++ +V+ +LS HP +V +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQ 70
Query: 404 KDEKLLVYDFIEAGSFSALLHGNRG-IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFI 462
+ +V +F+E G L +G + + L + + +G+ ++ FI
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLERN---SFI 122
Query: 463 LGNIKSSNVLLSQDLQGCISDFGLTP-LMNTPTVPSRSAGY----RAPEVIETKKPTQKS 517
++ + N L+S +SDFG+T +++ S A + PEV K + KS
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 518 DVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEE 576
DV+SFGVL+ E+ T GK P + + +VV++ + R + S
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASM-------------- 228
Query: 577 EMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606
+ ++ SC + P+ RPT E++R I
Sbjct: 229 ---TVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 49/221 (22%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM--EV-VGRLSQHPNVVPIRA 399
+G+G+YG YKA + G V +K+++ + K F E+ + + +HPN+V ++
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 400 YYFSKDEK--LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAK--------G 449
SK + +V+++++ H G+ +P VK + K G
Sbjct: 66 IVTSKGKGSIYMVFEYMD--------HDLTGLLDSPE-----VKFTESQIKCYMKQLLEG 112
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-------- 501
+ ++H+ + +IK SN+L++ D ++DFGL R++
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYT-----KRNSADYTNRVIT 164
Query: 502 --YRAPEVI--ETKKPTQKSDVYSFGVLLLEMLTGKAPIQA 538
YR PE++ T+ + D++S G +L E+ GK Q
Sbjct: 165 LWYRPPELLLGATRYGP-EVDMWSVGCILAELFLGKPIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQ------MEV-VGRLSQHPNV 394
E +G+G+ G YKA KEV + K +Q E+ + + +HPN+
Sbjct: 25 EKIGEGASGEVYKAT-------DRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGIAHI 453
V Y DE +V ++++ GS + ++ N ++ E ++ + +G+ ++
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF----VRMN-EPQIAYVCREVLQGLEYL 132
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA--G---YRAPEVI 508
H+ I +IKS N+LLS+D ++DFG + T R++ G + APEVI
Sbjct: 133 HSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL-TKEKSKRNSVVGTPYWMAPEVI 188
Query: 509 ETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ K K D++S G++ +EM G+ P
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 9e-14
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYF 402
+G+GS G A G V VK++ +RE V+ R QHPN+V + + Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFI 462
DE +V +F+E G+ + + + T ++ E + L K ++ +HA I
Sbjct: 87 VGDELWVVMEFLEGGALTDI------VTHTRMNEEQIATVCLAVLKALSFLHAQ---GVI 137
Query: 463 LGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-----SAGYRAPEVIETKKPTQKS 517
+IKS ++LL+ D + +SDFG + + VP R + + APEVI +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPEVISRLPYGTEV 196
Query: 518 DVYSFGVLLLEMLTGKAP 535
D++S G++++EM+ G+ P
Sbjct: 197 DIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-13
Identities = 63/196 (32%), Positives = 85/196 (43%), Gaps = 50/196 (25%)
Query: 95 LSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNI 152
L L + L G +P+++ L L+ + L N+ GNIP SL L +DLS+NS G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 153 PASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEG 212
P S+ L+ L LNL NSL+G +P RL H S+N F
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLH-RASFN-----------------FTD 524
Query: 213 NSMLCG-PPLNQCSTVPPAPSPSATNFPPPPTVLPKPREGSEEKLSTGAIVAIAIGGSAV 271
N+ LCG P L C P LS GA + IA G S V
Sbjct: 525 NAGLCGIPGLRACG----------------PH------------LSVGAKIGIAFGVS-V 555
Query: 272 LFLLFLMIAFCCLKKK 287
FL ++ A C K++
Sbjct: 556 AFLFLVICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 71/238 (29%), Positives = 109/238 (45%), Gaps = 49/238 (20%)
Query: 343 VLGKGSYGTTYKAILEE--GTT--VVVKRLK-EVVMGKREFEQQM---EVVGRLSQHPNV 394
VLGKGS+G K +L E GT +K LK +VV+ + E M V+ +HP +
Sbjct: 2 VLGKGSFG---KVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL 58
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
+ + +K+ V +++ G L+ + GR E+R A +
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGD---LMFHIQSSGRFD---EAR-----------ARFY 101
Query: 455 AA---VGGKF------ILGNIKSSNVLLSQDLQGCISDFGLTPL-MNTPTVPSRSAG--- 501
AA G +F I ++K NVLL +D I+DFG+ MN S G
Sbjct: 102 AAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD 161
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD--------LPRWV 551
Y APE+++ +K + D +SFGVLL EML G++P +++ D PRW+
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 59/238 (24%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGK-REFEQQMEVVGRLSQHPNVVPIRAYYF 402
LG G +G ++ + + V +K LK + K ++F+++++ + RL +H +++ + A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCS 72
Query: 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFI 462
+ ++ + +E GS A L G L S + ++ A+G+A++ I
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQ---NSI 126
Query: 463 LGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG----YRAPEVIETKKPTQKSD 518
++ + N+L+ +DL ++DFGL L+ S + APE + KSD
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186
Query: 519 VYSFGVLLLEMLT-GKAPIQAPGHEDVVDL-------------PRWVQSVVREEWTSE 562
V+SFG+LL EM T G+ P + +V D P+ + ++ E W +E
Sbjct: 187 VWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAE 244
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 332 DLEDLLRASAEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGK--REFEQQMEVVGRL 388
DL+DL +G+G++GT K + + GT + VKR++ V K + ++VV R
Sbjct: 5 DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS 59
Query: 389 SQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAK 448
S P +V F + + + + ++ S + ++ + E KI++ + K
Sbjct: 60 SDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVK 118
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS--DFGLTPLMNTPTVPSRSAG---YR 503
+ ++ + K I ++K SN+LL D G I DFG++ + +R AG Y
Sbjct: 119 ALNYLKEEL--KIIHRDVKPSNILL--DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 174
Query: 504 APEVIETKKPTQ---KSDVYSFGVLLLEMLTGKAP 535
APE I+ +SDV+S G+ L E+ TGK P
Sbjct: 175 APERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 64/259 (24%), Positives = 111/259 (42%), Gaps = 43/259 (16%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPN 393
LG+G++G + + V VK LKE +++FE++ E++ QH N
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHEN 69
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALL--HG---NRGIGR----TPLDWESRVKISL 444
+V D ++V++++E G + L HG L ++I++
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 445 GSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR- 503
A G+ ++ F+ ++ + N L+ DL I DFG++ + T T R G+
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT-TDYYRVGGHTM 185
Query: 504 ------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVV----------- 545
PE I +K T +SDV+SFGV+L E+ T GK P +E+V+
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR 245
Query: 546 --DLPRWVQSVVREEWTSE 562
P V ++ W +
Sbjct: 246 PRTCPSEVYDIMLGCWKRD 264
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 24/212 (11%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
EV+G G+YG YK ++ G +K + + E + ++ ++ + S H N+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 401 YFSK------DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
+ K D+ LV +F AGS + L+ +G DW + I +G+AH+H
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAY--ICREILRGLAHLH 138
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA-----GYRAPEVI- 508
A K I +IK NVLL+++ + + DFG++ ++ TV R+ + APEVI
Sbjct: 139 AH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMAPEVIA 194
Query: 509 --ETKKPTQ--KSDVYSFGVLLLEMLTGKAPI 536
E T +SD++S G+ +EM G P+
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 343 VLGKGSYGTTYKAI-LEEGTT----VVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNVV 395
VLG G++GT YK + + EG V +K L+E K +E + V+ + HP+VV
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVV 72
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRG-IG-RTPLDWESRVKISLGSAKGIAHI 453
+ S + L+ + G + ++ IG + L+W V+I AKG++++
Sbjct: 73 RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQI----AKGMSYL 125
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR------APEV 507
+ + ++ + NVL+ I+DFGL L++ + G + A E
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 508 IETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDL 547
I + T KSDV+S+GV + E++T G P + ++ DL
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL 223
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 16/198 (8%)
Query: 344 LGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYF 402
+G+GS G A ++ G V VK++ +RE V+ R QH NVV + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFI 462
DE +V +F+E G+ + + + T ++ E + L K ++ +HA I
Sbjct: 88 VGDELWVVMEFLEGGALTDI------VTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVI 138
Query: 463 LGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-----SAGYRAPEVIETKKPTQKS 517
+IKS ++LL+ D + +SDFG ++ VP R + + APE+I +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK-EVPRRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 518 DVYSFGVLLLEMLTGKAP 535
D++S G++++EM+ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 72/286 (25%), Positives = 118/286 (41%), Gaps = 44/286 (15%)
Query: 344 LGKGSYGTTYKAILEEGTT---VVVKRLKEVVMGKRE--FEQQMEVVGRLSQHPNVVPIR 398
+G G +G G + VVVK L+ + F Q+++ R HPNV+
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPY-RELNHPNVLQCL 61
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
LLV +F G L NRG+ + +++ A G+ +H A
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-- 119
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLT---------PLMNTPTVPSRSAGYRAPEVIE 509
FI ++ N L+ DL I D+GL + VP R + APE++E
Sbjct: 120 -DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR---WLAPELVE 175
Query: 510 -------TKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTS 561
K T+KS+++S GV + E+ T P E V ++ VVRE+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVREQ--- 226
Query: 562 EVFDVELMRYENIEEEMV-QMLQIAMSCVAKVPDMRPTMEEVVRMI 606
D++L + ++ + + ++ C P+ RPT EEV ++
Sbjct: 227 ---DIKLPK-PQLDLKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 24/212 (11%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E++G G+YG YK ++ G +K + + E +Q++ ++ + S H N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 401 YFSK------DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
+ K D+ LV +F AGS + L+ +G L E I +G++H+H
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH 128
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-----SAGYRAPEVI- 508
K I +IK NVLL+++ + + DFG++ ++ TV R + + APEVI
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TVGRRNTFIGTPYWMAPEVIA 184
Query: 509 --ETKKPTQ--KSDVYSFGVLLLEMLTGKAPI 536
E T KSD++S G+ +EM G P+
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 16/214 (7%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS--QHPNVVPIR 398
E +GKGS+GT K +G +V K + M ++E +Q + V L +HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62
Query: 399 AYY---FSKDEKLL--VYDFIEAGSFSALL-HGNRGIGRTPLDWESRVKISLGSAKGIAH 452
YY + + L V ++ E G + L+ + ++ R+ L A H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS-AG---YRAPEVI 508
+ G + ++K +N+ L + + DFGL ++ + +++ G Y +PE +
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 509 ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHE 542
+KSD++S G L+ E+ P A
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E +G+G+ GT Y AI + G V +K++ K+E +V R ++HPN+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
Y DE +V +++ GS + + + T +D + + + +H+ +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDV------VTETCMDEGQIAAVCRECLQALEFLHS---NQ 135
Query: 461 FILGNIKSSNVLLSQDLQGCISDFG----LTPLMNTPTVPSRSAGYRAPEVIETKKPTQK 516
I +IKS N+LL D ++DFG +TP + + + + APEV+ K K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 517 SDVYSFGVLLLEMLTGKAP 535
D++S G++ +EM+ G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 342 EVLGKGSYGTTYK-AILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E +GKG+YG YK ++G+ VK L + E E + ++ L HPNVV
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 401 YFSKDEKL-----LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
++ D+ + LV + GS + L+ G G+ LD I G+ G+ H+H
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLH- 145
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP-LMNTPTVPSRSAG---YRAPEVIETK 511
+ I ++K +N+LL+ + + DFG++ L +T + S G + APEVI +
Sbjct: 146 --NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203
Query: 512 KPTQKS-----DVYSFGVLLLEMLTGKAPI 536
+ S DV+S G+ +E+ G P+
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 65/273 (23%), Positives = 124/273 (45%), Gaps = 38/273 (13%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEV-VMGKREFEQQMEVVGRLSQ--HPNVVPIRA 399
+GKG + YKAI L +G V +K+++ +M + + ++ + L Q HPNV+ A
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 400 YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRT---PLDWESRVKISLGSAKGIAHIHAA 456
+ +E +V + +AG S ++ + R W+ V++ + H+H+
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----CSALEHMHSK 125
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS-AG---YRAPEVIETKK 512
+ + +IK +NV ++ + D GL ++ T + S G Y +PE I
Sbjct: 126 ---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 513 PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT---SEVFDVELM 569
KSD++S G LL EM A +Q+P + D ++L + + + ++ ++ + EL
Sbjct: 183 YNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL- 237
Query: 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEV 602
++V C+ P+ RP + V
Sbjct: 238 ------RDLVSR------CINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 8e-13
Identities = 53/199 (26%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E +G+G+ GT Y AI + G V +K++ K+E +V R +++PN+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
Y DE +V +++ GS + + + T +D + + + +H+ +
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDV------VTETCMDEGQIAAVCRECLQALDFLHS---NQ 135
Query: 461 FILGNIKSSNVLLSQDLQGCISDFG----LTPLMNTPTVPSRSAGYRAPEVIETKKPTQK 516
I +IKS N+LL D ++DFG +TP + + + + APEV+ K K
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 517 SDVYSFGVLLLEMLTGKAP 535
D++S G++ +EM+ G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 8e-13
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E +GKG+YG +K + + G+ VK L + E E + ++ LS HPNVV
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 401 YFSKDEK-----LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA-KGIAHIH 454
Y+ KD K LV + GS + L+ G + R E + L A G+ H+H
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGF--LKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP-LMNTPTVPSRSAG---YRAPEVIET 510
K I ++K +N+LL+ + + DFG++ L +T + S G + APEVI
Sbjct: 142 V---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 511 KKPTQKS-----DVYSFGVLLLEMLTGKAPI 536
++ + DV+S G+ +E+ G P+
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 69/288 (23%), Positives = 126/288 (43%), Gaps = 46/288 (15%)
Query: 343 VLGKGSYGTTY----KAILEEG--TTVVVKRLKEV--VMGKREFEQQMEVVGRLSQHPNV 394
LG+G +G + K I EEG T V+VK L++ + EF +++++ +LS H NV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNV 70
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRT----PLDWESRVKISLGSAKGI 450
V + + ++ ++ + G L + PL + +V + A G+
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT---------PLMNTPTVPSRSAG 501
H+ A +F+ ++ + N L+S + +S L+ L N +P R
Sbjct: 131 DHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA-LIPLR--- 183
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560
+ APE ++ + KSDV+SFGVL+ E+ T G+ P + D + V+
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP-----FYGLSD-----EEVLNR--- 230
Query: 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
+ +EL E + +++ C A P RP+ E+V + +
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMT---RCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 344 LGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYF 402
+G+GS G A + G V VK++ +RE V+ R H NVV + Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFI 462
DE +V +F+E G+ + + + T ++ E + L + ++++H I
Sbjct: 90 VGDELWVVMEFLEGGALTDI------VTHTRMNEEQIATVCLSVLRALSYLHNQ---GVI 140
Query: 463 LGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-----SAGYRAPEVIETKKPTQKS 517
+IKS ++LL+ D + +SDFG + + VP R + + APEVI +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 518 DVYSFGVLLLEMLTGKAP 535
D++S G++++EM+ G+ P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 56/221 (25%), Positives = 109/221 (49%), Gaps = 24/221 (10%)
Query: 342 EVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNVV 395
EV+G G +G + L+ V +K LK K R+F + ++G+ HPN++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNII 68
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ +++ +F+E G+ + L N G T + V + G A G+ ++
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQL---VGMLRGIAAGMKYLSE 124
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM----NTPTVPSRSAG-----YRAPE 506
++ ++ + N+L++ +L +SDFGL+ + + PT S G + APE
Sbjct: 125 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVD 546
I +K T SDV+S+G+++ E+++ G+ P ++DV++
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 62/270 (22%), Positives = 116/270 (42%), Gaps = 33/270 (12%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403
LG G +G + V +K ++E M + +F ++ +V+ +LS HPN+V +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLS-HPNLVQLYGVCTK 70
Query: 404 KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFIL 463
+ +V +++ G L +G T + + + + ++ + FI
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVC----EAMEYLESN---GFIH 123
Query: 464 GNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR------APEVIETKKPTQKS 517
++ + N L+ +D +SDFGL + S S G + PEV + + + KS
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKS 182
Query: 518 DVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEE 576
DV+SFGVL+ E+ + GK P R+ S V E S + R +
Sbjct: 183 DVWSFGVLMWEVFSEGKMP-----------YERFSNSEVVES-VSAGY-----RLYRPKL 225
Query: 577 EMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606
++ I SC + P+ RP ++++ +
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 2e-12
Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 26/215 (12%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVG--RLSQHPNVVPIR 398
+ LG G++G+ Y A E G V +K++K+ E EV +L++HPN+V ++
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGIAHIHAAV 457
+ DE V++++E G+ L+ +G P ES ++ I +G+AHIH
Sbjct: 65 EVFRENDELYFVFEYME-GNLYQLMKDRKGK---PFS-ESVIRSIIYQILQGLAHIHKH- 118
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLT-------PLMNTPTVPSRSAGYRAPEVI-E 509
F ++K N+L+S I+DFGL P T V +R YRAPE++
Sbjct: 119 --GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY--TDYVSTR--WYRAPEILLR 172
Query: 510 TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV 544
+ + D+++ G ++ E+ T + P+ PG ++
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR-PL-FPGSSEI 205
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 53/200 (26%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E +G+G+ GT Y A+ + G V ++++ K+E +V R +++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
Y DE +V +++ GS + + + T +D + + + +H+ +
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDV------VTETCMDEGQIAAVCRECLQALEFLHS---NQ 136
Query: 461 FILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQ 515
I +IKS N+LL D ++DFG + TP RS + APEV+ K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 516 KSDVYSFGVLLLEMLTGKAP 535
K D++S G++ +EM+ G+ P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 54/234 (23%), Positives = 93/234 (39%), Gaps = 35/234 (14%)
Query: 346 KGSYGTTYKA------------ILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPN 393
KG++G+ Y A +L++ + ++ V + Q + P
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQ-------GESPY 58
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI 453
V + + SKD LV +++ G ++L+ + +G P DW + + G+ +
Sbjct: 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEV--VLGVEDL 113
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKP 513
H I +IK N+L+ Q ++DFGL+ + Y APE I
Sbjct: 114 H---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGD 170
Query: 514 TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD--LPRWVQSVVREEWTSEVFD 565
+ SD +S G ++ E L G P A + V D L R + W EV +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN------WPEEVKE 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 75/301 (24%), Positives = 135/301 (44%), Gaps = 55/301 (18%)
Query: 343 VLGKGSYGTTYKAILEE------GTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNV 394
LG+G +G KA TTV VK LKE R+ + ++ +++ HP+V
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHV 65
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG-----------RTPLDWESRVKIS 443
+ + LL+ ++ + GS + L +R +G + LD ++
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 444 LGS--------AKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPT 494
+G ++G+ ++ K + ++ + NVL+++ + ISDFGL+ + +
Sbjct: 126 MGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 495 VPSRSAG-----YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLP 548
RS G + A E + T +SDV+SFGVLL E++T G P E + +L
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL- 241
Query: 549 RWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
+++ R E R EN EEM ++ ++C + PD RPT ++ + +E
Sbjct: 242 --LKTGYRME-----------RPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEK 285
Query: 609 I 609
+
Sbjct: 286 M 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 80/320 (25%), Positives = 137/320 (42%), Gaps = 52/320 (16%)
Query: 305 PKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVV 364
P +++ E +L F E D E L E+ G GS+G Y A + T V
Sbjct: 1 PSTSRAGSLKDPEIAELFFKE------DPEKLFTDLREI-GHGSFGAVYFA-RDVRTNEV 52
Query: 365 VKRLKEVVMGKREFEQQMEVVGRLS-----QHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419
V K GK+ E+ +++ + +HPN + + Y + LV ++ GS
Sbjct: 53 VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSA 111
Query: 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG 479
S LL + + PL I+ G+ +G+A++H+ I +IK+ N+LL++ Q
Sbjct: 112 SDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQV 164
Query: 480 CISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQ---KSDVYSFGVLLLEMLTGKAPI 536
++DFG + + + + APEVI Q K DV+S G+ +E+ K P+
Sbjct: 165 KLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
Query: 537 ------QAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVA 590
A H + P ++ EW+ + N + SC+
Sbjct: 225 FNMNAMSALYHIAQNESP----TLQSNEWSD--------YFRNFVD----------SCLQ 262
Query: 591 KVPDMRPTMEEVVRMIEDIR 610
K+P RPT EE+++ + +R
Sbjct: 263 KIPQDRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 55/199 (27%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
E++G+G +G + G V VK +K V + F ++ V+ +L H N+V +
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQ-AFLEETAVMTKL-HHKNLVRLLGVI 68
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
+V + + G+ L R GR + ++ SL A+G+ ++ + K
Sbjct: 69 LHNG-LYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KL 121
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPL----MNTPTVPSRSAGYRAPEVIETKKPTQKS 517
+ ++ + N+L+S+D +SDFGL + ++ +P + + APE ++ KK + KS
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK---WTAPEALKHKKFSSKS 178
Query: 518 DVYSFGVLLLEMLT-GKAP 535
DV+S+GVLL E+ + G+AP
Sbjct: 179 DVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 38/221 (17%)
Query: 343 VLGKGSYGTTYKAIL-------EEGTTVVVKRLKE--VVMGKREFEQQM---EVVGRLSQ 390
VLG G+YG K L + G +K LK+ +V + E +V+ + +
Sbjct: 7 VLGTGAYG---KVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR 63
Query: 391 HPNVVPIRAYYFSKDEKL-LVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGS-A 447
P +V + Y F D KL L+ D++ G F+ L R ES V++ +
Sbjct: 64 CPFLVTLH-YAFQTDTKLHLILDYVNGGELFTHLYQ------REHFT-ESEVRVYIAEIV 115
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG------ 501
+ H+H I +IK N+LL + ++DFGL+ R+
Sbjct: 116 LALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIE 171
Query: 502 YRAPEVIETKKPTQKS--DVYSFGVLLLEMLTGKAPIQAPG 540
Y APEVI D +S GVL E+LTG +P G
Sbjct: 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 15/197 (7%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRA 399
E+LGKG++G +K L++ T V VK KE + K +F + ++ + HPN+V +
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKLIG 59
Query: 400 YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459
+ +V + + G F + L + L + VK +L +A G+A++ +
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKK----KDELKTKQLVKFALDAAAGMAYLESK--- 112
Query: 460 KFILGNIKSSNVLLSQDLQGCISDFGLTP-----LMNTPTVPSRSAGYRAPEVIETKKPT 514
I ++ + N L+ ++ ISDFG++ + ++ + + APE + + +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 515 QKSDVYSFGVLLLEMLT 531
+SDV+S+G+LL E +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 6e-12
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 18/211 (8%)
Query: 332 DLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ- 390
D E+L E +GKGS+G +K I VV ++ ++ + E E + + LSQ
Sbjct: 1 DPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 391 -HPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAK 448
P V Y KD KL ++ +++ GS LL PLD I K
Sbjct: 60 DSPYVTKYYGSYL-KDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILK 112
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSRSAG---YRA 504
G+ ++H+ K I +IK++NVLLS+ + ++DFG+ L +T + G + A
Sbjct: 113 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
PEVI+ K+D++S G+ +E+ G+ P
Sbjct: 170 PEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 26/220 (11%)
Query: 342 EVLGKGSYGTTY---KAILEE-GTTVVVKRLKEVVMGKRE-FEQQME--VVGRLSQHPNV 394
+VLG+GS+G + K + G +K LK+ + R+ +ME ++ + HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFI 60
Query: 395 VPIRAYYFSKDEKL-LVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGS-AKGIA 451
V + Y F + KL L+ DF+ G F+ L + + E VK L A +
Sbjct: 61 VKLH-YAFQTEGKLYLILDFLRGGDLFTRL-------SKEVMFTEEDVKFYLAELALALD 112
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT--PLMNTPTVPS--RSAGYRAPEV 507
H+H+ +G I ++K N+LL ++ ++DFGL+ + + S + Y APEV
Sbjct: 113 HLHS-LG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 169
Query: 508 IETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547
+ + TQ +D +SFGVL+ EMLTG P Q ++ + +
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 64/270 (23%), Positives = 121/270 (44%), Gaps = 31/270 (11%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403
LG G +G V +K +KE M + EF ++ +V+ +LS H +V +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLS-HEKLVQLYGVCTK 70
Query: 404 KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFIL 463
+ +V +++ G LL+ R G+ +++ +G+A++ + +FI
Sbjct: 71 QRPIYIVTEYMSNG---CLLNYLREHGKRF-QPSQLLEMCKDVCEGMAYLESK---QFIH 123
Query: 464 GNIKSSNVLLSQDLQGCISDFGLTPLM----NTPTVPSR-SAGYRAPEVIETKKPTQKSD 518
++ + N L+ +SDFGL+ + T +V S+ + PEV+ K + KSD
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 519 VYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEE 577
V++FGVL+ E+ + GK P + + + V+ + R SE
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASE--------------- 228
Query: 578 MVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607
++ I SC + + RPT ++++ IE
Sbjct: 229 --KVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 36/213 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK------REFEQQMEVVGRLSQHPNV 394
E+LG GS+G+ Y+ + L++G VK + G+ ++ EQ++ ++ +L QHPN+
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNI 64
Query: 395 VPIRAYYFSK--DEKLLVY-DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA---K 448
V Y ++ ++ L ++ + + GS + LL G P+ I L +
Sbjct: 65 V---QYLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPV-------IRLYTRQILL 113
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCI--SDFGLTP-LMNTPTVPS--RSAGYR 503
G+ ++H + +IK +N+L+ D G + +DFG+ ++ S S +
Sbjct: 114 GLEYLH---DRNTVHRDIKGANILV--DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWM 168
Query: 504 APEVIETKKP-TQKSDVYSFGVLLLEMLTGKAP 535
APEVI + +D++S G +LEM TGK P
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 46/279 (16%)
Query: 344 LGKGSYGTTY----KAILEEGT---TVVVKRLKE--VVMGKREFEQQMEVVGRLSQHPNV 394
LG G++G Y IL G+ V VK L++ K+EF ++ ++ HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTP---LDWESRVKISLGSAKGIA 451
V + + + ++ + +E G + L R + R L + + I L AKG
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDAR-VERFGPPLLTLKELLDICLDVAKGCV 120
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGC-----ISDFGLT-PLMNTPTVPSRSAG---- 501
++ FI ++ + N L+S+ I DFGL + + G
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 502 -YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEW 559
+ APE + K T +SDV+SFGVL+ E+LT G+ P A +++V+ + V + R
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL---QHVTAGGR--- 231
Query: 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPT 598
L + EN +++ Q++ +C A+ P RPT
Sbjct: 232 --------LQKPENCPDKIYQLMT---NCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 67/281 (23%), Positives = 126/281 (44%), Gaps = 46/281 (16%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS-----QHPNVVPIR 398
LG G+ G+ K + T V+ + + K +Q ++ L + P +V
Sbjct: 13 LGAGNGGSVSK-VKHIPTGTVMAKKVVHIGAKSSVRKQ--ILRELQIMHECRSPYIVSFY 69
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+ +++ + +F++ GS + + G P+ E KI++ +G+ +++
Sbjct: 70 GAFLNENNICMCMEFMDCGSLDRIY---KKGG--PIPVEILGKIAVAVVEGLTYLYNVH- 123
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNT--PTVPSRSAGYRAPEVIETKKPTQ 515
+ + +IK SN+L++ Q + DFG++ L+N+ T S Y +PE I+ K T
Sbjct: 124 -RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTST-YMSPERIQGGKYTV 181
Query: 516 KSDVYSFGVLLLEMLTGKAPIQAPGHED--------VVDLPRWVQSVVREE---WTSEVF 564
KSDV+S G+ ++E+ GK P +D ++DL +Q +V+E S F
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL---LQQIVQEPPPRLPSSDF 238
Query: 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605
+L + V C+ K P RPT +++ M
Sbjct: 239 PEDL-------RDFVDA------CLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLS--QHPNVVPIR 398
+ +G+GS+G Y A + + V+K + M +E E + V L+ +HPN+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTP---LDWESRVKISLGSAKGIAHIHA 455
A + +V ++ + G ++ RG+ + L W V+ISLG + HIH
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG----LKHIHD 119
Query: 456 AVGGKFILGNIKSSNVLLSQD-LQGCISDFGLTPLMNTPTVPSRS-AG---YRAPEVIET 510
K + +IKS N+ LS++ + + DFG+ +N + + G Y +PE+ +
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQA 538
+ K+D++S G +L E+ T K P +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E +G+G+ GT + AI + G V +K++ K+E +V + ++PN+V
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
+ DE +V +++ GS + + + T +D + + + +HA +
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDV------VTETCMDEAQIAAVCRECLQALEFLHA---NQ 135
Query: 461 FILGNIKSSNVLLSQDLQGCISDFG----LTPLMNTPTVPSRSAGYRAPEVIETKKPTQK 516
I +IKS NVLL D ++DFG +TP + + + + APEV+ K K
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 517 SDVYSFGVLLLEMLTGKAP 535
D++S G++ +EM+ G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 332 DLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ- 390
D E+L E +GKGS+G +K I VV ++ ++ + E E + + LSQ
Sbjct: 1 DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 391 -HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA-K 448
P V Y + ++ +++ GS LL P D E ++ L K
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG------PFD-EFQIATMLKEILK 112
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSRSAG---YRA 504
G+ ++H+ K I +IK++NVLLS+ ++DFG+ L +T + G + A
Sbjct: 113 GLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169
Query: 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
PEVI+ K+D++S G+ +E+ G+ P
Sbjct: 170 PEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 69/297 (23%), Positives = 131/297 (44%), Gaps = 58/297 (19%)
Query: 342 EVLGKGSYGTTYKAIL--EEGTT--VVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVV 395
++LG+G +G+ + L ++G+ V VK +K + E E+ + + HPNV+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 396 PIRAYYFSKDEK------LLVYDFIEAGSFSALLHGNRGIGRTP--LDWESRVKISLGSA 447
+ F +++ F++ G + L +R +G P L ++ +K + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR-LGGLPEKLPLQTLLKFMVDIA 123
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR---- 503
G+ ++ FI ++ + N +L +D+ C++DFGL+ + S YR
Sbjct: 124 LGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK-----KIYSGDY-YRQGRI 174
Query: 504 --------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSV 554
A E + + T KSDV++FGV + E+ T G+ P PG E+
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY--PGVEN----------- 221
Query: 555 VREEWTSEVFDVEL--MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
E++D R + E+ + ++ + SC P RPT ++ ++E+I
Sbjct: 222 ------HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 36/213 (16%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQ---QMEVVGRLSQHPNVVPIRA 399
+G G++G Y A+ L+ G + VK ++ + ++ +M+V+ L HPN+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLV---K 63
Query: 400 YYFSK--DEKLLVY-DFIEAGSFSALLHGNRGIGRTPLDWESRVKI-SLGSAKGIAHIHA 455
YY + EK+ ++ ++ G+ LL R + E +++ +L +G+A++H+
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHS 117
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCI--SDFGLTPLMNTPTVPSRSAG--------YRAP 505
+ +IK +N+ L D G I DFG + T Y AP
Sbjct: 118 H---GIVHRDIKPANIFL--DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 506 EVIETKKPTQK---SDVYSFGVLLLEMLTGKAP 535
EVI K +D++S G ++LEM TGK P
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 67/292 (22%), Positives = 109/292 (37%), Gaps = 64/292 (21%)
Query: 342 EVLGKGSYGT----TYKAILEEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNVV 395
+ LG GS+G + + V VK LK + +F ++ ++ L H N+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENL- 58
Query: 396 PIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLD--WESRVKISLGSAKGIAH 452
IR Y L +V + GS L +G + + V+I A G+ +
Sbjct: 59 -IRLYGVVLTHPLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQI----ANGMRY 112
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YR---- 503
+ + +FI ++ + N+LL+ D + I DFGL R+ Y
Sbjct: 113 LESK---RFIHRDLAARNILLASDDKVKIGDFGL----------MRALPQNEDHYVMEEH 159
Query: 504 --------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSV 554
APE + T+ + SDV+ FGV L EM T G+ P ++
Sbjct: 160 LKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL--------- 210
Query: 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606
+ D E R E E + + + C A P RPT + +
Sbjct: 211 -------KKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLK------EVVMGKRE--FEQQMEVVGRLSQHP 392
E++G+G+YG Y+ + G V +K + +V +RE Q+ R SQ P
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQL----RQSQPP 62
Query: 393 NVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
N+ Y ++ ++ E GS L+ P+ + I + +
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKY 116
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS--AG---YRAPEV 507
IH I +IK++N+L++ + DFG+ L+N + RS G + APEV
Sbjct: 117 IHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-KRSTFVGTPYWMAPEV 172
Query: 508 I-ETKKPTQKSDVYSFGVLLLEMLTGKAP 535
I E K K+D++S G+ + EM TG P
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 56/217 (25%), Positives = 99/217 (45%), Gaps = 30/217 (13%)
Query: 344 LGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMGKR-EFEQQMEVVGRLSQHPNVVP 396
LG+G++G + A ++ V VK LKE R +F+++ E++ L QH ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVR 71
Query: 397 IRAYYFSKDEKLLVYDFIEAGSF----------SALLHGNRGIGRTPLDWESRVKISLGS 446
L+V++++ G + +L G + L + I+
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 447 AKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG----- 501
A G+ ++ F+ ++ + N L+ Q L I DFG++ + + T R G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGGRTMLP 187
Query: 502 --YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAP 535
+ PE I +K T +SD++SFGV+L E+ T GK P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 41/220 (18%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQ----QMEVVGRLSQ------- 390
E++GKG+YG Y A+ TT + +K+V + + Q ++V L
Sbjct: 7 ELIGKGTYGRVYLAL--NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 391 --HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA- 447
H N+V + +++ + +++ GS + L RT +E ++
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL-------RTYGRFEEQLVRFFTEQV 117
Query: 448 -KGIAHIHAAVGGKFILG-NIKSSNVLLSQDLQG-C-ISDFGLTP-----LMNTPTVPSR 498
+G+A++H+ K IL ++K+ N+L+ D G C ISDFG++ N + +
Sbjct: 118 LEGLAYLHS----KGILHRDLKADNLLV--DADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 499 -SAGYRAPEVIETKKP--TQKSDVYSFGVLLLEMLTGKAP 535
S + APEVI + + K D++S G ++LEM G+ P
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 65/271 (23%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEV-VMGKREFEQQMEVVGRLSQ--HPNVVPIRA 399
+G+G + Y+A L +G V +K+++ +M + ++ + L Q HPNV+ A
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 400 YYFSKDEKLLVYDFIEAGSFSALL-HGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+ +E +V + +AG S ++ H + P + + L SA + H+H+
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LEHMHSR-- 125
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS----AGYRAPEVIETKKPT 514
+ + +IK +NV ++ + D GL ++ T + S Y +PE I
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 515 QKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574
KSD++S G LL EM A +Q+P + D ++L + + E D + ++
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKI-------EQCDYPPLPSDHY 233
Query: 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605
EE+ Q++ + C+ P+ RP + V +
Sbjct: 234 SEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 71/302 (23%), Positives = 128/302 (42%), Gaps = 50/302 (16%)
Query: 329 YNFDLEDLLRASAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGR 387
D E L E+ G GS+G Y A + V +K++ GK+ E+ +++
Sbjct: 9 SKDDPEKLFTDLREI-GHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKE 65
Query: 388 LS-----QHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKI 442
+ +HPN + + Y + LV ++ GS S +L + + PL I
Sbjct: 66 VRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILE----VHKKPLQEVEIAAI 120
Query: 443 SLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGY 502
G+ +G+A++H+ + I +IK+ N+LL++ ++DFG L++ + +
Sbjct: 121 CHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYW 177
Query: 503 RAPEVIETKKPTQ---KSDVYSFGVLLLEMLTGKAPI------QAPGHEDVVDLPRWVQS 553
APEVI Q K DV+S G+ +E+ K P+ A H D P +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP----T 233
Query: 554 VVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDIRP 611
+ +W+ + + SC+ K+P RP+ EE+++ + RP
Sbjct: 234 LSSNDWS---------------DYFRNFVD---SCLQKIPQDRPSSEELLKHRFVLRERP 275
Query: 612 SD 613
Sbjct: 276 PT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 52/214 (24%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 342 EVLGKGSYGTTYKAILEEG---TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVP 396
+V+G+G++G +A++++ +K LKE R+F ++EV+ +L HPN++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTP-----------LDWESRVKISLG 445
+ ++ + ++ G+ L +R + P L + ++ +
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 446 SAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT---PLMNTPTVPSRSAGY 502
A G+ ++ +FI ++ + NVL+ ++L I+DFGL+ + T+ +
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRW 184
Query: 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAP 535
A E + T KSDV+SFGVLL E+++ G P
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 38/218 (17%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRL----KEVVMGKREFEQQMEVVGRLS--QHPNVV 395
EVLGKG+YGT Y + +G + VK++ V+ ++E+E+ E V L +H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ + +F+ GS S++L NR G PL K + G+A++H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NR-FG--PLPEPVFCKYTKQILDGVAYLH- 119
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFG-----------------LTPLMNTPTVPSR 498
+ +IK +NV+L + + DFG L + TP
Sbjct: 120 --NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY---- 173
Query: 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPI 536
+ APEVI +KSD++S G + EM TGK P+
Sbjct: 174 ---WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 75/290 (25%), Positives = 122/290 (42%), Gaps = 46/290 (15%)
Query: 329 YNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRL 388
Y D E++ E+ G GS+G Y A T VV K GK+ E+ +++ +
Sbjct: 15 YKDDPEEIFVGLHEI-GHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEV 72
Query: 389 S-----QHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKIS 443
+HPN + + Y + LV ++ GS S LL + + PL I+
Sbjct: 73 KFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAIT 127
Query: 444 LGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR 503
G+ +G+A++H+ I +IK+ N+LL++ Q ++DFG + + +
Sbjct: 128 HGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWM 184
Query: 504 APEVIETKKPTQ---KSDVYSFGVLLLEMLTGKAPI------QAPGHEDVVDLPRWVQSV 554
APEVI Q K DV+S G+ +E+ K P+ A H D P +QS
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT-LQS- 242
Query: 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
EWT + + C+ K+P RP E++R
Sbjct: 243 --NEWTD-----SFRGFVDY-------------CLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 9e-11
Identities = 55/237 (23%), Positives = 110/237 (46%), Gaps = 36/237 (15%)
Query: 342 EVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVMGKR--EFEQQMEVVGRLSQHPNV 394
E LG+ ++G YK L + V +K LK++ ++ EF+Q+ ++ L HPN+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNI 69
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALL-----HGNRGIG-------RTPLDWESRVKI 442
V + + ++++++ G L H + G ++ LD + I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 443 SLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP---------LMNTP 493
++ A G+ ++ + F+ ++ + N+L+ + L ISD GL+ +
Sbjct: 130 AIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPR 549
+P R + PE I K + SD++SFGV+L E+ + G P +++V+++ R
Sbjct: 187 LLPIR---WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 65/288 (22%), Positives = 128/288 (44%), Gaps = 38/288 (13%)
Query: 342 EVLGKGSYGTTYKA-ILEEGTTV--VVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVP 396
+V+G+G++G KA I ++G + +KR+KE R+F ++EV+ +L HPN++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ + L ++ G+ L +R + P + S S++ + H A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 457 VG--------GKFILGNIKSSNVLLSQDLQGCISDFGLT---PLMNTPTVPSRSAGYRAP 505
V +FI ++ + N+L+ ++ I+DFGL+ + T+ + A
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI 192
Query: 506 EVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564
E + T SDV+S+GVLL E+++ G P + E +
Sbjct: 193 ESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------------YCGMTCAELYEKLPQ 238
Query: 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV----RMIED 608
L + N ++E+ +++ C + P RP+ +++ RM+E+
Sbjct: 239 GYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 337 LRASAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS-----Q 390
L + +G GS+G Y A + V +K++ GK+ E+ +++ + +
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
HPN + R Y + LV ++ GS S LL + + PL ++ G+ +G+
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAVTHGALQGL 128
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIET 510
A++H+ I ++K+ N+LLS+ + DFG +M + + APEVI
Sbjct: 129 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILA 185
Query: 511 KKPTQ---KSDVYSFGVLLLEMLTGKAPI 536
Q K DV+S G+ +E+ K P+
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (152), Expect = 1e-10
Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 40/222 (18%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS----------Q 390
E LG+G+YG YKA + G V +K+++ + + E + + +
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIR--------LDNEEEGIPSTALREISLLKELK 56
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKG 449
HPN+V + ++ + LV+++ + L G PL + +K I +G
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG----PLS-PNLIKSIMYQLLRG 110
Query: 450 IAHIHAAVGGKFILG-NIKSSNVLLSQDLQGC--ISDFGL----TPLMNTPTVPSRSAGY 502
+A+ H+ IL ++K N+L+++D G ++DFGL + T T + Y
Sbjct: 111 LAYCHS----HRILHRDLKPQNILINRD--GVLKLADFGLARAFGIPLRTYTHEVVTLWY 164
Query: 503 RAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED 543
RAPE++ +K + D++S G + EM+TGK D
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 52/214 (24%), Positives = 106/214 (49%), Gaps = 34/214 (15%)
Query: 342 EVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVMGKR--EFEQQMEVVGRLSQHPNVV 395
+V+G G +G ++ IL+ + V +K LK K+ +F + ++G+ S H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH-NII 69
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ +++ +++E G+ L + G E +G +GIA
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIA---- 117
Query: 456 AVGGKFILG------NIKSSNVLLSQDLQGCISDFGLTPLM-NTPTVPSRSAG------Y 502
G K++ ++ + N+L++ +L+ +SDFGL+ ++ + P ++G +
Sbjct: 118 -AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176
Query: 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAP 535
APE I +K T SDV+SFG+++ E+++ G+ P
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 50/214 (23%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 342 EVLGKGSYGTTYKAILEEG---TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVP 396
+V+G+G++G KA +++ +KR+KE R+F ++EV+ +L HPN++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTP-----------LDWESRVKISLG 445
+ + L ++ G+ L +R + P L + + +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 446 SAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT---PLMNTPTVPSRSAGY 502
A+G+ ++ +FI ++ + N+L+ ++ I+DFGL+ + T+ +
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177
Query: 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAP 535
A E + T SDV+S+GVLL E+++ G P
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 74/280 (26%), Positives = 123/280 (43%), Gaps = 53/280 (18%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
E LG+ +G YK L E+ V +K LK+ G + EF+ + + RL QHPN
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPN 69
Query: 394 VVPIRAYYFSKDEKL-LVYDFIEAG---SFSALLHGNRGIGRTPLDWESRVKISLGSAKG 449
+V + +K++ L +++ + F + + +G T D + VK +L A
Sbjct: 70 IVCLLGV-VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGST--DDDKTVKSTLEPAD- 125
Query: 450 IAHIHA--AVGGKFILG------NIKSSNVLLSQDLQGCISDFGL---------TPLMNT 492
HI A G +F+ ++ + NVL+ L ISD GL LM
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 493 PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVV------ 545
+P R + +PE I K + SD++S+GV+L E+ + G P ++DV+
Sbjct: 186 SLLPIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR 242
Query: 546 -------DLPRWVQSVVREEWTSEVFDVELMRYENIEEEM 578
D P WV +++ E W F R+++I +
Sbjct: 243 QVLPCPDDCPAWVYTLMLECWNE--FPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 56/217 (25%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLK-EVVMGKREFEQQM--EVVGRLSQHPNV 394
++LGKG++G K IL G +K LK EV++ K E + V + ++HP +
Sbjct: 1 KLLGKGTFG---KVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
++ + +KD V +++ G H + R + E R + A+ ++ +
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGEL--FFH----LSRERVFSEDRTRFY--GAEIVSALD 109
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP--LMNTPTVPS--RSAGYRAPEVIET 510
GK + ++K N++L +D I+DFGL + + T+ + + Y APEV+E
Sbjct: 110 YLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED 169
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547
+ D + GV++ EM+ G+ P HE + +L
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 59/213 (27%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS--QHPNVVPIRAYY 401
LG G++G YKA +E + ++ E + E E M + L+ HP +V + +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIET-KSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 402 FSKDEKLLVYDFIEAGSFSA-LLHGNRGIGRTPLDWESRVK-ISLGSAKGIAHIHAAVGG 459
+ + ++ +F G+ A +L +RG+ E +++ I + + ++H+
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLT------EPQIQVICRQMLEALQYLHSM--- 129
Query: 460 KFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA-----GYRAPEVI--ETKK 512
K I ++K+ NVLL+ D ++DFG++ N T+ R + + APEV+ ET K
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 513 PTQ---KSDVYSFGVLLLEMLTGKAPIQAPGHE 542
T K+D++S G+ L+EM A I+ P HE
Sbjct: 189 DTPYDYKADIWSLGITLIEM----AQIEPPHHE 217
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 25/227 (11%)
Query: 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLK-EVVMGKREFEQQM---EVVGRLSQHPNVVP 396
+VLGKGS+G A L+ +G VK LK +VV+ + E M V+ ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ + +K+ V +F+ G L+ + GR L + + +A+ + +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGD---LMFHIQDKGRFDL-----YRATFYAAEIVCGLQFL 112
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM----NTPTVPSRSAGYRAPEVIETKK 512
I ++K NV+L +D I+DFG+ N + + Y APE+++ K
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK 172
Query: 513 PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD--------LPRWV 551
T D +SFGVLL EML G++P +++ + PRW+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 64/272 (23%), Positives = 127/272 (46%), Gaps = 38/272 (13%)
Query: 343 VLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQ-QMEV-VGRLSQHPNVVPIRA 399
V+G+G++G + + V++K++ M K E Q E V +L HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII---E 63
Query: 400 YY--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
YY F +D+ L +V ++ G+ + + + LD ++ + + + H+H
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT- 119
Query: 457 VGGKFILG-NIKSSNVLLSQDLQGC-ISDFGLTPLMNTPTVPSRSAG---YRAPEVIETK 511
K IL ++K+ N+LL + I DFG++ ++++ + G Y +PE+ E K
Sbjct: 120 ---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK 176
Query: 512 KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571
QKSD+++ G +L E+ + K +A +LP V ++ + + + D RY
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEA------ANLPALVLKIMSGTF-APISD----RY 225
Query: 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603
+ Q+ +S + P RP + +++
Sbjct: 226 SP------DLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 344 LGKGSYGTTYKA-ILEEGTTVVVKRL---------KEVVMGKREFEQQMEVVGRLSQHPN 393
+G+G++G +KA E G TV +K++ + RE + QHP
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQAL--REIKALQAC-----QHPY 60
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGIAH 452
VV + + +LV +++ S +L + PL E++VK KG+A+
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLR-DE---ERPLP-EAQVKSYMRMLLKGVAY 114
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEV 507
+HA + ++K +N+L+S D I+DFGL L + S YRAPE+
Sbjct: 115 MHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171
Query: 508 I-ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPR 549
+ +K D+++ G + E+L G +P+ PG D+ L
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNG-SPL-FPGENDIEQLAI 212
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 52/198 (26%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 344 LGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYF 402
+G+GS G A + G V VK + +RE V+ R QH NVV + Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFI 462
+E ++ +F++ G+ + + + +T L+ E + + + ++H+ I
Sbjct: 89 VGEELWVLMEFLQGGALTDI------VSQTRLNEEQIATVCESVLQALCYLHSQ---GVI 139
Query: 463 LGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-----SAGYRAPEVIETKKPTQKS 517
+IKS ++LL+ D + +SDFG + + VP R + + APEVI +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 518 DVYSFGVLLLEMLTGKAP 535
D++S G++++EM+ G+ P
Sbjct: 199 DIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 49/224 (21%), Positives = 92/224 (41%), Gaps = 37/224 (16%)
Query: 358 EEGTTVVVKRLKE-VVMGKRE---FEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLL-VYD 412
G V +K L+ + + F ++ + RL HPN+V + + L V++
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGLLFAVFE 59
Query: 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVL 472
++ + +L G L ++ L +A H + ++K N++
Sbjct: 60 YVPGRTLREVL-AADG----ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIM 111
Query: 473 LSQ-DLQGC--ISDFGLTPLM--------NTPTVPSRSAG---YRAPEVIETKKPTQKSD 518
+SQ ++ + DFG+ L+ T T + G Y APE + + T SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 519 VYSFGVLLLEMLTGKAPIQAPGHEDV---------VDLPRWVQS 553
+Y++G++ LE LTG+ +Q ++ V LP W+
Sbjct: 172 LYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAG 215
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 64/291 (21%), Positives = 131/291 (45%), Gaps = 46/291 (15%)
Query: 343 VLGKGSYGTTYKAIL--EEGT--TVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVP 396
+LGKG +G+ +A L E+G+ V VK LK + + E+ + + + HPNV+
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 397 IRAYYFSKDEK------LLVYDFIEAGSFSALLHGNRGIGRTP--LDWESRVKISLGSAK 448
+ K +++ F++ G L +R IG P L ++ V+ + A
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR-IGEEPFTLPLQTLVRFMIDIAS 124
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAP--- 505
G+ ++ + FI ++ + N +L++++ C++DFGL+ + + + + P
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 506 ---EVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTS 561
E + T SDV++FGV + E++T G+ P G E+ S
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY--AGVEN-----------------S 222
Query: 562 EVFD--VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610
E+++ ++ R + + + + ++ C + P RP+ + + +E I
Sbjct: 223 EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 66/237 (27%), Positives = 104/237 (43%), Gaps = 49/237 (20%)
Query: 343 VLGKGSYGTTYKAILEE--GTTVV--VKRL-KEVVMGKREFEQQM---EVVGRLSQHPNV 394
VLGKGS+G K +L E GT + VK L K+V++ + E M V+ +HP +
Sbjct: 2 VLGKGSFG---KVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR-----VKISLG---- 445
+ + + +KD V +++ G + H R GR E R +I LG
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQR-SGRFD---EPRARFYAAEIVLGLQFL 112
Query: 446 SAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR----SAG 501
+GI I ++K NVLL + I+DFG+ V + +
Sbjct: 113 HERGI-----------IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD 161
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV--------VDLPRW 550
Y APE++ + D ++ GVLL EML G++P + +++ V PRW
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW 218
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIRA 399
E +GKGS+G YK I VV ++ ++ + E E + + LSQ P +
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 400 YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459
Y + ++ +++ GS LL PL+ I KG+ ++H+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHSE--- 120
Query: 460 KFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSRSAG---YRAPEVIETKKPTQ 515
+ I +IK++NVLLS+ ++DFG+ L +T + G + APEVI+
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180
Query: 516 KSDVYSFGVLLLEMLTGKAP 535
K+D++S G+ +E+ G+ P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 65/291 (22%), Positives = 124/291 (42%), Gaps = 51/291 (17%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM-------GKREFEQ-------QMEVVGR 387
E LG G++G YK + ++ LKE+ + KRE ++ ++ ++
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLA-LKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 388 LSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS----FSALLHGNRGIGRTPLDWESRVKIS 443
+HPN+V + D +V D IE F++L + + W V++
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMV 123
Query: 444 LGSAKGIAHIHAAVGGKFILG-NIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG- 501
L + ++H K I+ ++ +N++L +D + I+DFGL + + G
Sbjct: 124 LA----LRYLHKE---KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGT 176
Query: 502 --YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559
Y PE+++ + +K+DV++FG +L +M T +Q P + ++ +V
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCT----LQPPFYST--NMLSLATKIVEAV- 229
Query: 560 TSEVFDVELMRYENIEEEMV--QMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
YE + E M + + SC+ + RP + +V MI D
Sbjct: 230 -----------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 66/307 (21%), Positives = 127/307 (41%), Gaps = 75/307 (24%)
Query: 344 LGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVV 395
+G+G++G ++A E T V VK LKE + +F+++ ++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-HPNIV 71
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNR-----------------GIGRTPLDWES 438
+ L+++++ G + L G+ PL
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 439 RVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT---------PL 489
++ I+ A G+A++ KF+ ++ + N L+ +++ I+DFGL+
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 490 MNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLP 548
+P R + PE I + T +SDV+++GV+L E+ + G P HE+V+
Sbjct: 189 SENDAIPIR---WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI--- 242
Query: 549 RWVQSVVR--------EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTME 600
VR + E+++ LMR C +K+P RP+
Sbjct: 243 ----YYVRDGNVLSCPDNCPLELYN--LMR----------------LCWSKLPSDRPSFA 280
Query: 601 EVVRMIE 607
+ R+++
Sbjct: 281 SINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 6e-10
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 39/212 (18%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLK--EVVMGK--------RE--FEQQMEVVGRLSQ 390
LG+G+Y YKA E G V +K++K E K RE Q++ +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-------K 60
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
HPN++ + + K LV++F+E ++ ++ I TP D +S + ++L +G+
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIK-DKSIVLTPADIKSYMLMTL---RGL 115
Query: 451 AHIHAAVGGKFILG-NIKSSNVLLSQDLQGCISDFGL-----TPLMN-TPTVPSRSAGYR 503
++H+ +IL ++K +N+L++ D ++DFGL +P T V +R YR
Sbjct: 116 EYLHS----NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTR--WYR 169
Query: 504 APEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
APE++ + D++S G + E+L
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 58/213 (27%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 343 VLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS---------QHP 392
++G GS+G+ Y + G + VK+++ + +++ ++ L+ QH
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 393 NVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
N+V D + +++ GS +ALL+ N G L + V+ L KG+ +
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETL-VRNFVRQIL---KGLNY 121
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP-----LMNTPTVPSR-----SAGY 502
+H I +IK +N+L+ ISDFG++ ++T T +R S +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
APEV++ T+K+D++S G L++EMLTGK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 68/300 (22%), Positives = 113/300 (37%), Gaps = 57/300 (19%)
Query: 342 EVLGKGSYGTTYKA-ILEEGTTVVVKRLK-----EVVMGK--REFEQQMEVVGRLSQHPN 393
V+G+G+YG K G V +K+ K E V RE + V R +H N
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK-----VLRQLRHEN 61
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTP--LDWESRVKISLGSAKGIA 451
+V ++ + K LV++++E LL + +P L ++ + IA
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVE----RTLLE---LLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-------VPSRSAGYRA 504
+ H I +IK N+L+S+ + DFG + V +R YRA
Sbjct: 115 YCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR--WYRA 169
Query: 505 PEVIETKKPTQKS-DVYSFGVLLLEMLTGKAPIQAPGHEDVVDL-----------PRWVQ 552
PE++ K DV++ G ++ E+L G+ PG D+ L P +
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF--PGDSDIDQLYLIQKCLGPLPPSHQE 227
Query: 553 -----SVVREEWTSEVFDVELM--RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605
E E + RY L +C+ P R T +E+++
Sbjct: 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPA--LDFLKACLRMDPKERLTCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 343 VLGKGSYGTTYKAILEEGTTVVVK-RLKEVVMGKR----EFEQQMEVVGRLSQHPNVVPI 397
V+G+GS+G +A+L + K +KE+ + K E ++ V+ +HPN+V
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRG---IGRTPLDWESRVKISLGSAKGIAHIH 454
+ + + +V ++ + G + RG T L W V++ LG + HIH
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW--FVQMCLG----VQHIH 117
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPS----RSAGYRAPEVIET 510
+ + +IKS N+ L+Q+ + + DFG L+ +P + + Y PE+ E
Sbjct: 118 EK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQA 538
KSD++S G +L E+ T K P QA
Sbjct: 175 MPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 69/288 (23%), Positives = 127/288 (44%), Gaps = 46/288 (15%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPN 393
+ LG+G++G KA E +TV VK LK+ K + +ME++ + +H N
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 77
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG-----------RTPLDWESRVKI 442
++ + + +V ++ G+ L R G L + V
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 443 SLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSRSAG 501
+ A+G+ + + K I ++ + NVL+++D I+DFGL + + + G
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 502 -----YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVV 555
+ APE + + T +SDV+SFGVLL E+ T G +P E++ L +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL-------L 247
Query: 556 REEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603
+E + E + +N +E+ ++ C +VP RPT +++V
Sbjct: 248 KEGYRME-------KPQNCTQELYHLM---RDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-09
Identities = 17/42 (40%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 23 LNSDKQALLDFAANV---PHARKLNWNSSTSVCTSWVGITCT 61
LN D+ ALL F +++ P +WN S+S SW G+TC
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 66/293 (22%), Positives = 126/293 (43%), Gaps = 45/293 (15%)
Query: 339 ASAEVLGKGSYGTTYKAILEEGTT---VVVKRLKEVVMGKREFEQQME--VVGRLSQHPN 393
A + LG+G +G+ + L + + V VK +K + + E E + V + HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 394 VVPIRAYYFSKDEK------LLVYDFIEAGSFSALLHGNRGIGRTPLDWESR--VKISLG 445
V+ + E +++ F++ G + L +R +G P ++ VK
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR-LGDCPQYLPTQMLVKFMTD 120
Query: 446 SAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM------NTPTVPSRS 499
A G+ ++ + FI ++ + N +L++++ C++DFGL+ + +
Sbjct: 121 IASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 500 AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREE 558
+ A E + + T KSDV+SFGV + E+ T G+ P PG E+
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY--PGVEN--------------- 220
Query: 559 WTSEVFDV--ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
SE++D + R + + + + + SC P RP+ E + +E
Sbjct: 221 --SEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 29/213 (13%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIRAYY 401
LG G++G YKA +E + ++ + + E E M + L+ HPN+V + +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 402 FSKDEKLLVYDFIEAGSFSA-LLHGNRGIGRTPLDWESRVKISLG-SAKGIAHIHAAVGG 459
+ ++ ++ +F G+ A +L R PL E ++++ + + + ++H
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELER-----PLT-EPQIRVVCKQTLEALNYLHEN--- 122
Query: 460 KFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA-----GYRAPEVI--ETKK 512
K I ++K+ N+L + D ++DFG++ NT T+ R + + APEV+ ET K
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 513 PTQ---KSDVYSFGVLLLEMLTGKAPIQAPGHE 542
K+DV+S G+ L+EM A I+ P HE
Sbjct: 182 DRPYDYKADVWSLGITLIEM----AQIEPPHHE 210
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 57/223 (25%), Positives = 108/223 (48%), Gaps = 34/223 (15%)
Query: 343 VLGKGSYGTTYKAILE----EGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNVVP 396
V+G G +G L+ V +K LK K R+F + ++G+ HPN++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIH 69
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ ++V +++E GS A L + G + V +G +GIA
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIAS---- 117
Query: 457 VGGKFI--LG----NIKSSNVLLSQDLQGCISDFGLTPLM-NTPTVPSRSAG------YR 503
G K++ +G ++ + N+L++ +L +SDFGL+ ++ + P + G +
Sbjct: 118 -GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176
Query: 504 APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVV 545
APE I +K T SDV+S+G+++ E+++ G+ P ++DV+
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 64/276 (23%), Positives = 125/276 (45%), Gaps = 28/276 (10%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQ-MEVVGRLSQ--HPNVVPIRA 399
+G+G + Y+A L + V +K+++ M + Q ++ + L Q HPNV+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 400 YYFSKDEKLLVYDFIEAGSFSALL-HGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+ +E +V + +AG S ++ + + P + + L SA + H+H+
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VEHMHSR-- 125
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS----AGYRAPEVIETKKPT 514
+ + +IK +NV ++ + D GL ++ T + S Y +PE I
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184
Query: 515 QKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574
KSD++S G LL EM A +Q+P + D ++L Q + E D + E+
Sbjct: 185 FKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQKI-------EQCDYPPLPTEHY 233
Query: 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610
E++ +++ + C+ PD RP + V ++ + +
Sbjct: 234 SEKLRELVSM---CIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 69/286 (24%), Positives = 130/286 (45%), Gaps = 43/286 (15%)
Query: 344 LGKGSYGTTYKAIL------EEGTTVVVKRLKEVV-MGKR-EFEQQMEVVGRLSQHPNVV 395
LG+GS+G Y+ I E T V +K + E M +R EF + V+ + H +VV
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNR-----GIGRTPLDWESRVKISLGSAKGI 450
+ L++ + + G + L R + P + ++++ A G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-------YR 503
A+++A KF+ ++ + N ++++D I DFG+T + T R G +
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-YETDYYRKGGKGLLPVRWM 188
Query: 504 APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562
+PE ++ T SDV+SFGV+L E+ T + P Q +E V+ R+V
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL---RFVME--------- 236
Query: 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
L + +N + + +++++ C P MRP+ E++ I++
Sbjct: 237 --GGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 342 EVLGKGSYGTTYKAILE-EGTTVVVKRL-KEVVMGKREFEQQM---EVVGRLSQHPNVVP 396
+V+GKGS+G A + +G VK L K++V+ ++E + M V+ + +HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 397 IRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKGIAHIH 454
+ Y F EKL V DF+ G L R E R + A + ++H
Sbjct: 61 LH-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP------EPRARFYAAEIASALGYLH 113
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGL----TPLMNTPTVPSRSAGYRAPEVIET 510
+ + ++K N+LL ++DFGL +T T + Y APEVI
Sbjct: 114 SI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAP 535
+ D + G +L EML G P
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 43/214 (20%)
Query: 343 VLGKGSYGTTYKAILEEGTTVVVKRLKEV-------------VMGKREFEQQMEVVGRLS 389
V+GKG++G I+++ T + +K + V+ +R Q++
Sbjct: 7 VIGKGAFGKVC--IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN------ 58
Query: 390 QHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKI---SLG 445
HP +V + Y F +E + LV D + G H + + E +VK +
Sbjct: 59 -HPFLVNLW-YSFQDEENMYLVVDLLLGGDLR--YH----LSQKVKFSEEQVKFWICEIV 110
Query: 446 SAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG----LTPLMNTPTVPSRSAG 501
A + ++H+ I +IK N+LL + I+DF +TP T + S + G
Sbjct: 111 LA--LEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST-SGTPG 164
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
Y APEV+ + + D +S GV E L GK P
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 21/208 (10%)
Query: 344 LGKGSYGTTYKA-ILEEGTTVVVKRLKEVVMGKREFEQ----QMEVVGRLSQHPNVVPIR 398
LGKG +G + G K+L + + KR+ EQ + +++ ++S +V +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLA 59
Query: 399 AYYFSKDEKLLVYDFIEAGS--FSALLHGNRGIGRTPLDWESRVKI-SLGSAKGIAHIHA 455
+ +KD+ LV + G + G G E+R + G+ H+H
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP------EARAIFYAAQIICGLEHLHQ 113
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEVIETKK 512
+ + ++K NVLL ISD GL + AG Y APEV++ +
Sbjct: 114 R---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 513 PTQKSDVYSFGVLLLEMLTGKAPIQAPG 540
D ++ G L EM+ G++P +
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFRQRK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 51/221 (23%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQME-------VVGRLSQHPN 393
+ LG G++ + Y+A ++ GT + VK++ V E E+ +E ++ RL HP+
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPH 64
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI 453
++ + L +++ GS S LL G + + +G++++
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYG----AFKEAVIINYTEQLLRGLSYL 119
Query: 454 HAAVGGKFILGNIKSSNVLLS---QDLQGCISDFGLTPLMNTPTVPSR--------SAGY 502
H + I ++K +N+L+ Q L+ I+DFG + + + +
Sbjct: 120 HE---NQIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED 543
APEV+ ++ + DV+S G +++EM T K P A H +
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 33/209 (15%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGR----LSQ--HPNV 394
E +GKGS+G YKAI V +K V+ E E ++E + + LSQ P +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIK-----VIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 395 VPIRAYY--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIA 451
YY F K KL ++ ++ GS LL LD I G+
Sbjct: 62 T---KYYGSFLKGSKLWIIMEYCGGGSCLDLLK------PGKLDETYIAFILREVLLGLE 112
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS--AG---YRAPE 506
++H GK I +IK++N+LLS++ ++DFG++ + T T+ R+ G + APE
Sbjct: 113 YLHE--EGK-IHRDIKAANILLSEEGDVKLADFGVSGQL-TSTMSKRNTFVGTPFWMAPE 168
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
VI+ +K+D++S G+ +E+ G+ P
Sbjct: 169 VIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS-----QHPNVVPIR 398
LG+G+ G+ K L+ + + + + Q +++ L + P +V
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALK---TITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 399 AYYFSKDEKLL--VYDFIEAGSFSALL-----HGNRGIGRTPLDWESRVKISLGSAKGIA 451
+ + + ++ E GS ++ G R IG L KI+ KG++
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLG-----KIAESVLKGLS 119
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-----TPLMNTPTVPSRSAGYRAPE 506
++H+ K I +IK SN+LL++ Q + DFG+ L T T S Y APE
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF---YMAPE 173
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV 545
I+ K + SDV+S G+ LLE+ + P G +
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 75/283 (26%), Positives = 114/283 (40%), Gaps = 54/283 (19%)
Query: 343 VLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIRA 399
VLGKG+YG Y A L + +K + E R + E + S H N+V
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIV---Q 69
Query: 400 YYFSKDEKLLVYDFIE---AGSFSALLHGNRGIGRTPLDWESRVKISLGSA--KGIAHIH 454
Y S E F+E GS SALL G PL + I +G+ ++H
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLH 125
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGC-ISDFG-------LTPLMNTPTVPSRSAGYRAPE 506
+ + +IK NVL++ ISDFG + P T T + Y APE
Sbjct: 126 DN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPE 179
Query: 507 VIETKKPT---QKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563
VI+ K P +D++S G ++EM TGK P G E + +
Sbjct: 180 VID-KGPRGYGAPADIWSLGCTIVEMATGKPPFIELG-----------------EPQAAM 221
Query: 564 FDVELMR-YENIEEEM-VQMLQIAMSCVAKVPDMRPTMEEVVR 604
F V + + + I E + + + C PD R + ++++
Sbjct: 222 FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 67/289 (23%), Positives = 133/289 (46%), Gaps = 45/289 (15%)
Query: 344 LGKGSYGTTYKAIL------EEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVP 396
LG+G++G + A ++ V VK LK+ +++F ++ E++ L QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVK 71
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALL--HGNRGI----GRTP--LDWESRVKISLGSAK 448
D ++V+++++ G + L HG + G P L + I+ A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG------- 501
G+ ++ + F+ ++ + N L+ ++L I DFG++ + + T R G
Sbjct: 132 GMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYS-TDYYRVGGHTMLPIR 187
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560
+ PE I +K T +SDV+S GV+L E+ T GK P + +V++ Q V
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC--ITQGRV----- 240
Query: 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
L R +E+ ++ + C + P MR ++E+ +++++
Sbjct: 241 -------LQRPRTCPKEVYDLM---LGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 70/285 (24%), Positives = 128/285 (44%), Gaps = 60/285 (21%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMG-KREFEQQMEVVGRLS--QHPNVVPIRAY 400
LG G++G YKA + T + K + + + E E M + LS +HPN+V +
Sbjct: 13 LGDGAFGKVYKA--QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGIAHIHAAVGG 459
YF +++ ++ +F + G+ +++ + R L E +++ + + + +H+
Sbjct: 71 YFYENKLWILIEFCDGGALDSIM---LELER-GLT-EPQIRYVCRQMLEALNFLHSH--- 122
Query: 460 KFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA-----GYRAPEVI--ETKK 512
K I ++K+ N+LL+ D ++DFG++ N T+ R + APEV+ ET K
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 513 PT---QKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV----------DLPRWVQSVVREEW 559
K+D++S G+ L+E+ A ++ P HE + P Q +W
Sbjct: 182 DNPYDYKADIWSLGITLIEL----AQMEPPHHELNPMRVLLKILKSEPPTLDQP---SKW 234
Query: 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+S D SC+ K PD RPT E+++
Sbjct: 235 SSSFND------------------FLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 343 VLGKGSYGTTYKA-ILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPN---VVPIR 398
VLGKG +G + G K+L++ + KR+ E ++ + N VV +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
Y +KD LV + G ++ +G + V + G+ +H
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYH---MGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---TVPSR--SAGYRAPEVIETKKP 513
+ + ++K N+LL ISD GL ++ P T+ R + GY APEV++ ++
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERY 178
Query: 514 TQKSDVYSFGVLLLEMLTGKAPIQ 537
T D ++ G LL EM+ G++P Q
Sbjct: 179 TFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 27/205 (13%)
Query: 344 LGKGSYGTT----YKAILEE-GTTVVVKRLKEVVMGK-REFEQQMEVVGRLSQHPNVVPI 397
LGKG++G+ Y + + G V VK+L+ R+FE+++E++ L QH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKY 70
Query: 398 RAYYFS--KDEKLLVYDFIEAGSFSALL--HGNRGIGRTPLDWESRVKISLGSAKGIAHI 453
+ +S + LV +++ GS L H R R L + S++ KG+ ++
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKGMEYL 124
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM------NTPTVPSRSAGY-RAPE 506
+ +++ ++ + N+L+ + + I DFGLT ++ P S + APE
Sbjct: 125 GSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLT 531
+ K + SDV+SFGV+L E+ T
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 5e-09
Identities = 66/219 (30%), Positives = 106/219 (48%), Gaps = 50/219 (22%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFE--------QQM--EVV--GRLSQH 391
LGKG+YG +KAI +R KEVV K+ F+ Q+ E++ L H
Sbjct: 15 LGKGAYGIVWKAI--------DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 392 PNVVPIRAYYFSKDEK--LLVYDFIEAGSFSALLHG--NRGIGRTPLDWESRVKISLGSA 447
PN+V + ++++K LV++++E LH I L+ + I
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMETD-----LHAVIRANI----LEDVHKRYIMYQLL 117
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL----TPLMNTPTVP------- 496
K + +IH+ G I ++K SN+LL+ D + ++DFGL + L P P
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 497 SRSAGYRAPEV-IETKKPTQKSDVYSFGVLLLEMLTGKA 534
+R YRAPE+ + + + T+ D++S G +L EML GK
Sbjct: 175 TR--WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 30/212 (14%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQ---QMEVVGRLSQHPNVVPI 397
E LG+G+YG K GT + VKR++ V +E ++ +++ R P V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATV-NSQEQKRLLMDLDISMRSVDCPYTVTF 65
Query: 398 RAYYFSKDEKLLVYDFIEAGSFS-------ALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
F + + V+ +E S G P D KI++ K +
Sbjct: 66 YGALFREGD---VWICMEVMDTSLDKFYKKVYDKGL----TIPEDILG--KIAVSIVKAL 116
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEV 507
++H+ + I ++K SNVL++++ Q + DFG++ + + AG Y APE
Sbjct: 117 EYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPER 174
Query: 508 IETKKPTQ----KSDVYSFGVLLLEMLTGKAP 535
I + + KSDV+S G+ ++E+ TG+ P
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 46/195 (23%), Positives = 81/195 (41%), Gaps = 25/195 (12%)
Query: 360 GTTVVVKR--LKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417
T V VK+ L + QQ + R QHPN++P + E +V + G
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84
Query: 418 SFSALL--HGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ 475
S LL H G+ + + I + +IH+ FI ++K+S++LLS
Sbjct: 85 SCEDLLKTHFPEGLPELAIAF-----ILKDVLNALDYIHSK---GFIHRSVKASHILLSG 136
Query: 476 DLQGCIS-----------DFGLTPLMNTPTVPSRSAGYRAPEVIET--KKPTQKSDVYSF 522
D + +S + + P ++ + +PEV++ + +KSD+YS
Sbjct: 137 DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSV 196
Query: 523 GVLLLEMLTGKAPIQ 537
G+ E+ G P +
Sbjct: 197 GITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (140), Expect = 6e-09
Identities = 51/228 (22%), Positives = 93/228 (40%), Gaps = 65/228 (28%)
Query: 343 VLGKGSYGTTYKAI-LEEGTTVVVKRL----KEVVMGKREFEQQMEVV-GRLSQHPNVV- 395
+G G+YG A+ G V +K++ +++ KR E+ R +H N++
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR---EIKLLRHLRHENIIG 63
Query: 396 ------PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAK- 448
P F ++ +V + +E LH + I +S ++ +
Sbjct: 64 LLDILRPPSPEDF--NDVYIVTELMETD-----LH--KVI-------KSPQPLTDDHIQY 107
Query: 449 -------GIAHIHAAVGGKFILGNI-----KSSNVLLSQDLQGCISDFGL---------T 487
G+ ++H+A N+ K SN+L++ + I DFGL
Sbjct: 108 FLYQILRGLKYLHSA--------NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
Query: 488 PLMNTPTVPSRSAGYRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
T V +R YRAPE++ + + T+ D++S G + E+LT K
Sbjct: 160 KGFLTEYVVTRW--YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 67/254 (26%), Positives = 110/254 (43%), Gaps = 54/254 (21%)
Query: 324 FEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAI-LEEGTTVVVKRL-----KEV--VMGK 375
F GCS D E L LG+G++G YKA ++ G V +K++ K+ +
Sbjct: 1 FYGCSKLRDYEIL-----GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL 55
Query: 376 REFEQQMEVVGRLSQHPNVVPI--RAYYFSKDEK------LLVYDFIEAGSFSALLHGNR 427
RE ++++ +L +HPNVVP+ A K +V +++ S LL
Sbjct: 56 RE----IKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS 109
Query: 428 GIGRTPLDWESRVK-ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486
+ T S++K L +GI ++H + +IK++N+L+ I+DFGL
Sbjct: 110 -VKLTE----SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161
Query: 487 T-PLMNTPTVPSRSAG--------------YRAPE-VIETKKPTQKSDVYSFGVLLLEML 530
P P P G YR PE ++ ++ T D++ G + EM
Sbjct: 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
Query: 531 TGKAPIQAPGHEDV 544
T + PI G D+
Sbjct: 222 TRR-PI-LQGKSDI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 1e-08
Identities = 22/60 (36%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHL 194
L +DLS N +T + + L +L L+L N+LT P L LR L+LS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 70/304 (23%), Positives = 128/304 (42%), Gaps = 68/304 (22%)
Query: 342 EVLGKGSYGTTYKAIL--------EEGTTVVVKRLKEVVMGKRE--FEQQMEVVGRLSQH 391
VLG+G +G K L G V VK LK + +++++ ++ L H
Sbjct: 10 RVLGEGHFG---KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YH 65
Query: 392 PNVVPIRAYYFSKDEK--LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS--- 446
N+V + + K L+ +++ GS D+ + K++L
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSL--------------RDYLPKHKLNLAQLLL 111
Query: 447 -----AKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG 501
+G+A++H+ +I ++ + NVLL D I DFGL VP
Sbjct: 112 FAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK-----AVPEGHEY 163
Query: 502 YR------------APEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP--GHEDVVDL 547
YR A E ++ K + SDV+SFGV L E+LT Q+P E+++
Sbjct: 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP 223
Query: 548 PRWVQSVVREEWTSEVFD--VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605
+ +VVR E+ + + L +N +E+ +++ +C RPT ++ +
Sbjct: 224 KQGQMTVVR---LIELLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPI 277
Query: 606 IEDI 609
++++
Sbjct: 278 LKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 15/153 (9%)
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRV-KISLGSAKGI 450
P +V ++S E + + ++ GS +L + GR P E+ + KIS+ +G+
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIP---ENILGKISIAVLRGL 112
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG----LTPLMNTPTVPSRSAGYRAPE 506
++ K + ++K SN+L++ + + DFG L M V +RS Y +PE
Sbjct: 113 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPE 168
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539
++ T +SD++S G+ L+EM G+ PI P
Sbjct: 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 53/237 (22%)
Query: 326 GCSYNFDLEDLLRASAEVLGKGSYGTTYKA-ILEEGTTVVVKRL---------KEVVMGK 375
G Y DL DL +G G+ G YK + G + VK++ K ++M
Sbjct: 7 GQKYPADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILM-- 62
Query: 376 REFEQQMEVVGRLSQHPNVVPIRAY-YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPL 434
++VV + P +V + Y YF D + + + + LL R G P
Sbjct: 63 -----DLDVVLKSHDCPYIV--KCYGYFITDSDVFICMELMSTCLDKLL--KRIQGPIPE 113
Query: 435 DWESRVKISLGSA-------KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS--DFG 485
D ++ +++ A G+ H ++K SN+LL D G + DFG
Sbjct: 114 DILGKMTVAIVKALHYLKEKHGVIH-----------RDVKPSNILL--DASGNVKLCDFG 160
Query: 486 LTPLMNTPTVPSRSAG---YRAPEVIETKKPTQK----SDVYSFGVLLLEMLTGKAP 535
++ + +RSAG Y APE I+ P K +DV+S G+ L+E+ TG+ P
Sbjct: 161 ISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 67/299 (22%), Positives = 126/299 (42%), Gaps = 58/299 (19%)
Query: 344 LGKGSYGTTYKAIL--------EEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPN 393
LG+G +G A +E TV VK LK+ K + +ME++ + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG-----------RTPLDWESRVKI 442
++ + ++ ++ G+ L R G + ++ V
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 443 SLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGY 502
+ A+G+ ++ + K I ++ + NVL++++ I+DFGL +N ++
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 503 R------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVV 555
R APE + + T +SDV+SFGVL+ E+ T G +P PG +P
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY--PG------IP------- 244
Query: 556 REEWTSEVFDV-----ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
E+F + + + N E+ M++ C +P RPT +++V ++ I
Sbjct: 245 ----VEELFKLLKEGHRMDKPANCTNELYMMMR---DCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 21/207 (10%)
Query: 343 VLGKGSYGTTYKA-ILEEGTTVVVKRLKEVVMGKREFE-------QQMEVVGRLSQHPNV 394
VLGKG +G + G K+L++ + KR+ E Q +E V V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV----NSRFV 62
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
V + Y +KD LV + G ++ +G D E V + G+ +H
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYN---MGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSR--SAGYRAPEVIETK 511
+ + ++K N+LL ISD GL + T+ R + GY APEV++ +
Sbjct: 120 RE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE 176
Query: 512 KPTQKSDVYSFGVLLLEMLTGKAPIQA 538
+ T D + G L+ EM+ GK+P +
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-----TPLMNTPTVPSRSAGYR 503
GI H+H+A I ++K SN+++ D I DFGL T M TP V +R YR
Sbjct: 135 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRY--YR 189
Query: 504 APEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED 543
APEVI + D++S G ++ E++ G Q H D
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 59/228 (25%), Positives = 99/228 (43%), Gaps = 25/228 (10%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLK-EVVMGKREFEQQM---EVVGRLSQHPNVVP 396
VLGKGS+G A L+E G VK LK +V++ + E M ++ HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ + + D V +F+ G + +R E+R + +A+ + +
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD------EARARFY--AAEITSALMFL 112
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTP--LMNTPTVPS--RSAGYRAPEVIETKK 512
I ++K NVLL + ++DFG+ + N T + + Y APE+++
Sbjct: 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 513 PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV--------VDLPRWVQ 552
D ++ GVLL EML G AP +A +D+ V P W+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 74/296 (25%), Positives = 127/296 (42%), Gaps = 53/296 (17%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIR 398
++G+GSYG K +E G V +K+ E K + M + L Q H N+V +
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA-KGIAHIHAAV 457
+ K LV++F++ L G+ ESRV+ L +GI H+
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLD------ESRVRKYLFQILRGIEFCHS-- 118
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT------VPSRSAGYRAPEVI--E 509
I +IK N+L+SQ + DFG + P V +R YRAPE++ +
Sbjct: 119 -HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR--WYRAPELLVGD 175
Query: 510 TK--KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV------------- 554
TK + D+++ G L+ EMLTG+ P+ PG D+ L ++ +
Sbjct: 176 TKYGRAV---DIWAVGCLVTEMLTGE-PL-FPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230
Query: 555 ------VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+R E+ +E R+ + ++ + + C+ PD RP+ +++
Sbjct: 231 NPLFAGMRLPEVKEIEPLE-KRFPKLSGLVLDLAK---QCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 343 VLGKGSYGTTYKAI-LEEGTTVVVKRL-KEVVMGKREFEQQM---EVVGRLSQHPNVVPI 397
V+GKGS+G A +G VK L K+ ++ K+E + M V+ + +HP +V +
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 398 RAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKI---SLGSAKGIAHI 453
Y F +KL V D++ G L R P E R + + SA G H
Sbjct: 62 H-YSFQTADKLYFVLDYVNGGELFFHLQRER---SFP---EPRARFYAAEIASALGYLH- 113
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL----TPLMNTPTVPSRSAGYRAPEVIE 509
I ++K N+LL ++DFGL T + + Y APEV+
Sbjct: 114 ----SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 510 TKKPTQKS-DVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
K+P ++ D + G +L EML G P + ++ D
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 2e-08
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 43/214 (20%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRL-KEVVMGKREFEQQM---EVVGRLSQHPNVVP 396
+ LG GS+G + G +K L K ++ ++ E + ++ + +HP +V
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLV- 64
Query: 397 IRAYYFSKDEKLL--VYDFIEAGSFSALLHGNRGIGRTPLDWESRV---KISLGSAKGIA 451
Y +D+ L V +++ G + L R GR P +R ++ L +
Sbjct: 65 -NLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPV-ARFYAAQVVLA----LE 115
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCI--SDFGLT--------PLMNTPTVPSRSAG 501
++H+ + ++K N+LL D G I +DFG L TP
Sbjct: 116 YLHSL---DIVYRDLKPENLLL--DSDGYIKITDFGFAKRVKGRTYTLCGTPE------- 163
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
Y APE+I +K + D ++ G+L+ EML G P
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 40/211 (18%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGK----------REFEQQMEVVGRLSQHPN 393
+G+G+YG Y+A + T+ + LK+V M RE + + +HPN
Sbjct: 15 IGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-----RHPN 67
Query: 394 VVPIRAYYFSK--DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGI 450
+V ++ K D LV ++ E ++LL TP ES+VK + L +G+
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNM----PTPFS-ESQVKCLMLQLLRGL 121
Query: 451 AHIHAAVGGKFILG-NIKSSNVLLSQDLQGC--ISDFGLTPLMNTPTVPSR----SAGYR 503
++H FI+ ++K SN+LL+ +GC I+DFGL P P + YR
Sbjct: 122 QYLHE----NFIIHRDLKVSNLLLTD--KGCLKIADFGLARTYGLPAKPMTPKVVTLWYR 175
Query: 504 APEVI-ETKKPTQKSDVYSFGVLLLEMLTGK 533
APE++ T D+++ G +L E+L K
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/229 (24%), Positives = 110/229 (48%), Gaps = 31/229 (13%)
Query: 344 LGKGSYGTTYKA------ILEEGTTVVVKRLKEVVMGKR-EFEQQMEVVGRLSQHPNVVP 396
LG+G++G + A ++ V VK LK+ + R +F+++ E++ L QH ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVK 71
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR-VKISLGSAKGIAHIHA 455
D ++V+++++ G + L + +D + R K LG ++ + HI +
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ-MLHIAS 130
Query: 456 AVGG--------KFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---------TVPSR 498
+ F+ ++ + N L+ +L I DFG++ + + +P R
Sbjct: 131 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190
Query: 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVD 546
+ PE I +K T +SDV+SFGV+L E+ T GK P + +V++
Sbjct: 191 ---WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 25/221 (11%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTV----VVKRLKEVVMGKREFEQQMEVVGRLS-QHPNVV 395
+VLG G++GT YK I + EG TV +K L E K E E + S HP++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNR-GIG-RTPLDWESRVKISLGSAKGIAHI 453
+ S +L V + G +H ++ IG + L+W ++ AKG+ ++
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAP------EV 507
+ + ++ + NVL+ I+DFGL L+ + G + P E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 182
Query: 508 IETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDL 547
I +K T +SDV+S+GV + E++T G P ++ DL
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL 223
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 342 EVLGKGSYGTTYKAILEE--GTTVV--VKRL-KEVVMGKREFEQQM---EVVGRLSQHPN 393
+VLGKGS+G K +L E GT V +K L K+V++ + + M ++ ++HP
Sbjct: 1 KVLGKGSFG---KVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKI---SLGSAKGI 450
+ + + +KD V +++ G + +R E R + + A
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD------EPRSRFYAAEVTLALMF 111
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP--LMN--TPTVPSRSAGYRAPE 506
H H I ++K N+LL + ++DFG+ ++N T T + Y APE
Sbjct: 112 LHRHGV-----IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
+++ + D ++ GVL+ EM+ G+ P +A +D+ +
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 39/283 (13%)
Query: 342 EVLGKGSYGTTYKAIL--EEG--TTVVVKRLKEVVMGKREFEQQME--VVGRLSQHPNVV 395
V+GKG +G Y L +G VK L + E EQ ++ ++ + HPNV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 396 PIRAYYFSKD-EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
+ + L+V +++ G L + R P + + L AKG+ ++
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGD---LRNFIRSETHNP-TVKDLIGFGLQVAKGMEYLA 115
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV--PSRSAGYRAP------E 506
+ KF+ ++ + N +L + ++DFGL + G + P E
Sbjct: 116 SK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566
++T+K T KSDV+SFGVLL E++T AP D D+ ++ R
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP--DVDSFDITVYLLQGRR---------- 220
Query: 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
L++ E + + +++ SC P+MRPT E+V IE I
Sbjct: 221 -LLQPEYCPDPLYEVML---SCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 339 ASAEVLGKGSYGTTYKAI-LEEGTTVVVKRL----KEVVMGKREFEQQMEVVGRLSQHPN 393
S + +G G+YG+ AI G V +K+L + + KR + +++ ++ + QH N
Sbjct: 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHM-QHEN 75
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSAL-LHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
V+ + + S DF + L G PL + + G+ +
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH---PLSEDKVQYLVYQMLCGLKY 132
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN---TPTVPSRSAGYRAPEVIE 509
IH+A I ++K N+ +++D + I DFGL + T V +R YRAPEVI
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--WYRAPEVIL 187
Query: 510 T-KKPTQKSDVYSFGVLLLEMLTGK 533
Q D++S G ++ EMLTGK
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 13/203 (6%)
Query: 343 VLGKGSYGTTYKA-ILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPN---VVPIR 398
VLGKG +G + G KRL++ + KR+ E ++ + N VV +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
Y +KD LV + G ++ +G + E + + G+ +H
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYN---MGNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSR--SAGYRAPEVIETKKPTQ 515
+ ++K N+LL ISD GL + ++ R + GY APEV+ ++ T
Sbjct: 122 -NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180
Query: 516 KSDVYSFGVLLLEMLTGKAPIQA 538
D + G L+ EM+ G++P +
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 33/217 (15%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRL----KEVVMGKREFEQQMEVVGRLSQHPNVVPIR 398
+G G+YGT A+ G V +K+L + + KR + +++ ++ + +H NV+ +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHM-KHENVIGL- 79
Query: 399 AYYFSKDEKL-------LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGI 450
F+ D L LV F+ + H E R++ + KG+
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS--------EDRIQFLVYQMLKGL 131
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL---TPLMNTPTVPSRSAGYRAPEV 507
+IHAA I ++K N+ +++D + I DFGL T T V +R YRAPEV
Sbjct: 132 KYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR--WYRAPEV 186
Query: 508 IET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED 543
I TQ D++S G ++ EMLTGK + H D
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 67/301 (22%), Positives = 130/301 (43%), Gaps = 50/301 (16%)
Query: 344 LGKGSYGTTYKAIL--------EEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPN 393
LG+G +G +A ++ TV VK LK+ K + +ME++ + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG-----------RTPLDWESRVKI 442
++ + + ++ ++ G+ L R G L ++ V
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 443 SLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGY 502
+ A+G+ ++ + + I ++ + NVL+++D I+DFGL ++ +++
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 503 R------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVV 555
R APE + + T +SDV+SFG+L+ E+ T G +P E++ L R +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMD 256
Query: 556 R-EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614
+ T E++ LMR C VP RPT +++V ++ + + S
Sbjct: 257 KPSNCTHELY--MLMR----------------ECWHAVPTQRPTFKQLVEALDKVLAAVS 298
Query: 615 E 615
E
Sbjct: 299 E 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 51/205 (24%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIR 398
E +G+G++G + L + T V VK +E + K +F Q+ ++ + S HPN+V +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLI 59
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
K +V + ++ G F L G L + +++ +A G+ ++ +
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLR-TEG---PRLKVKELIQMVENAAAGMEYLESK-- 113
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR-------APEVIETK 511
I ++ + N L+++ ISDFG++ V + + G + APE +
Sbjct: 114 -HCIHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 512 KPTQKSDVYSFGVLLLEMLT-GKAP 535
+ + +SDV+SFG+LL E + G P
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 342 EVLGKGSYGTTY--KAIL--EEGTTVVVKRLKE--VVMGKREFEQ---QMEVVGRLSQHP 392
+VLG G+YG + + + + G +K LK+ +V + E + +V+ + Q P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 393 NVVPIRAYYFSKDEKL-LVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGS-AKG 449
+V + Y F D KL L+ D+I G F+ L R E V+I G
Sbjct: 66 FLVTLH-YAFQTDTKLHLILDYINGGELFTHLSQRERFK-------EQEVQIYSGEIVLA 117
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-----SAGYRA 504
+ H+H I +IK N+LL + ++DFGL+ + V + Y A
Sbjct: 118 LEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174
Query: 505 PEVIETKKPTQKS--DVYSFGVLLLEMLTGKAPIQAPGHED 543
P+++ D +S GVL+ E+LTG +P G ++
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 68/283 (24%), Positives = 123/283 (43%), Gaps = 57/283 (20%)
Query: 343 VLGKGSYG-TTYKAILEEGTTVVVKRLKEVVMGKRE---FEQQMEVVGRLSQHPNVVPIR 398
V+GKGSYG + +G V+K+L +RE EQ+ +++ +L +HPN+V R
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYR 65
Query: 399 AYYFSKDEKL-LVYDFIEAGSFSALLHGNRG---IGRTPLDWESRVKISLGSAKGIAHIH 454
+ +D L +V F E G L +G ++W ++ ++L ++H
Sbjct: 66 ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYLH 119
Query: 455 AAVGGKFILG-NIKSSNVLLSQDLQGCISDFGLTPLM-NTPTVPSRSAG---YRAPEVIE 509
K IL ++K+ NV L++ + D G+ ++ N + S G Y +PE+
Sbjct: 120 E----KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 510 TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569
K KSDV++ G + EM T K A D+ +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAK-------------------------DMNSL 210
Query: 570 RYENIEEEMVQM--------LQIAMSCVAKVPDMRPTMEEVVR 604
Y IE ++ M ++ + ++K P+ RP+++ ++R
Sbjct: 211 VYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKRE--FEQ---QMEVVGRLSQHPNVVPIR 398
LGKG+YG+ YK + T V +KE+ + E F Q +++++ + P +V
Sbjct: 9 LGKGNYGSVYKVL--HRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFY 65
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+F + + ++++AGS L G P D R I+ KG+ +
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEEH- 122
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFG----LTPLMNTPTVPSRSAGYRAPEVIETKKPT 514
I ++K +NVL++ + Q + DFG L + + +S Y APE I++ P
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS--YMAPERIKSGGPN 179
Query: 515 Q------KSDVYSFGVLLLEMLTGKAP 535
Q +SDV+S G+ +LEM G+ P
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 24/210 (11%)
Query: 344 LGKGSYGTTYKAILEE-GTTVVVKRL-KEVVMGKREF-----EQQMEVVGRLSQHPNVVP 396
+GKG++G Y+ ++ +K L K+ ++ K+E E+ + V L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 397 IRAYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGS-AKGIAHIH 454
++ + + + LV D++ G F L GR E R K + + H+H
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE----GRFS---EDRAKFYIAELVLALEHLH 113
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSRSAG---YRAPEVI-E 509
+ ++K N+LL + DFGL+ + + G Y APEV+ +
Sbjct: 114 KY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD 170
Query: 510 TKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539
K T+ D +S GVL+ EM G +P A
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 65/270 (24%), Positives = 122/270 (45%), Gaps = 33/270 (12%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVK--RLKEVVMGKREFEQQMEVVGRLSQHPNVVPIR 398
E+LG G+ GT YKA L + VK L V +++ ++E++ + P ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFY 65
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+F ++ + +F++ GS + P R+ +++ KG+ ++
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAV--VKGLTYLW---S 113
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGL-TPLMNT-PTVPSRSAGYRAPEVIETKKPTQK 516
K + ++K SN+L++ Q + DFG+ T L+N+ + Y APE I ++
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 517 SDVYSFGVLLLEMLTGKAP---IQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573
SDV+S G+ +E+ G+ P IQ ++ L + +Q +V E+ V V
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQK-NQGSLMPL-QLLQCIVDED--PPVLPVGQF---- 225
Query: 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603
E+ V + C+ K P RP E ++
Sbjct: 226 -SEKFVHFIT---QCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 56/188 (29%), Positives = 88/188 (46%), Gaps = 26/188 (13%)
Query: 429 IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT- 487
+ + PL E + S A+G+ + + K I ++ + N+LLS++ I DFGL
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLAR 221
Query: 488 PLMNTPT-VPSRSA----GYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGH 541
+ P V A + APE I K T +SDV+SFGVLL E+ + G +P PG
Sbjct: 222 DIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY--PG- 278
Query: 542 EDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEE 601
VQ + EE+ + + MR E ++ I + C P+ RPT E
Sbjct: 279 ---------VQ--IDEEFCRRLKEGTRMRAP--EYATPEIYSIMLDCWHNNPEDRPTFSE 325
Query: 602 VVRMIEDI 609
+V ++ D+
Sbjct: 326 LVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 8e-08
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 38/218 (17%)
Query: 344 LGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLS--------QHPNV 394
+ KG+YG + A + G +K V+ K + ++ +V L+ Q P V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIK-----VIKKADMIRKNQVDQVLTERDILSQAQSPYV 55
Query: 395 VPIRAYY-FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
V + YY F + L LV +++ G ++LL N G LD + + +
Sbjct: 56 V--KLYYSFQGKKNLYLVMEYLPGGDLASLLE-NVGS----LDEDVARIYIAEIVLALEY 108
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL---------TPLMNTPTVPSRSAG-- 501
+H+ I ++K N+L+ + ++DFGL L + R G
Sbjct: 109 LHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 502 -YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQA 538
Y APEVI + ++ D +S G +L E L G P
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 9e-08
Identities = 47/202 (23%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYF 402
+G G+YG YKA + G +K +K QQ ++ + +H N+V Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFI 462
+D+ + +F GS + H + + + + SR + +G+ ++H+ GK +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK--GK-M 128
Query: 463 LGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA-----GYRAPEVIETKKP---T 514
+IK +N+LL+ + ++DFG++ + T T+ R + + APEV ++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQI-TATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 515 QKSDVYSFGVLLLEMLTGKAPI 536
Q D+++ G+ +E+ + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 57/227 (25%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVM---GKREFEQ---QMEVVGRLSQHPNV 394
++LG G +GT +K I + EG ++ + + + G++ F++ M +G L H +
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD-HAYI 71
Query: 395 VPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTP---LDWESRVKISLGSAKGI 450
V R L LV GS + +R P L+W ++ AKG+
Sbjct: 72 V--RLLGICPGASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQI------AKGM 122
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM---------NTPTVPSRSAG 501
++ + + N+ + N+LL D I+DFG+ L+ + P +
Sbjct: 123 YYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK--- 176
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDL 547
+ A E I + T +SDV+S+GV + EM++ G P +V DL
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 26/186 (13%)
Query: 431 RTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PL 489
++PL E + S A+G+ + + K I ++ + N+LLS++ I DFGL +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 224
Query: 490 MNTPTVPSRSAG-----YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHED 543
P + + + APE I K T +SDV+SFGVLL E+ + G +P PG
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY--PG--- 279
Query: 544 VVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603
VQ + EE+ + D MR E ++ +I ++C P RPT +V
Sbjct: 280 -------VQ--INEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERPTFSALV 328
Query: 604 RMIEDI 609
++ D+
Sbjct: 329 EILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 57/240 (23%), Positives = 101/240 (42%), Gaps = 39/240 (16%)
Query: 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLK-EVVMGKREFEQQM---EVVGRLSQHPNVVP 396
++LGKGS+G + A L+ +K LK +VV+ + E M V+ +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ + +K+ V +++ G L+ + + L + + +A+ I +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGD---LMFHIQSCHKFDLP-----RATFYAAEIICGLQFL 112
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGL-----------TPLMNTPTVPSRSAGYRAP 505
+ ++K N+LL D I+DFG+ TP Y AP
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD-------YIAP 165
Query: 506 EVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD--------LPRWVQSVVRE 557
E++ +K D +SFGVLL EML G++P E++ PRW+ ++
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKD 225
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 71/316 (22%), Positives = 131/316 (41%), Gaps = 43/316 (13%)
Query: 313 VQEAEKNKLVFFEGCSYNFDLE-DLLRASAE---VLGKGSYG-----TTYKAILEEGT-T 362
++ N+ V+ + +DL+ + R + LG G++G T Y +
Sbjct: 8 IESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMK 67
Query: 363 VVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420
V VK LK + +++++ L H N+V + L++ ++ G
Sbjct: 68 VAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLL 127
Query: 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC 480
L R + L E + S AKG+A + + I ++ + NVLL+
Sbjct: 128 NFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181
Query: 481 ISDFGLT-PLMNTPTVPSRSAG-----YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GK 533
I DFGL +MN + + APE I T +SDV+S+G+LL E+ + G
Sbjct: 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241
Query: 534 APIQAPGHEDVVDLPRWVQSVVREEWTSEVFD-VELMRYENIEEEMVQMLQIAMSCVAKV 592
P PG +P V ++ + + + + E+ E+ +++ +C
Sbjct: 242 NPY--PG------MP------VDSKFYKLIKEGYRMAQPEHAPAEIYDIMK---TCWDAD 284
Query: 593 PDMRPTMEEVVRMIED 608
P RPT +++V++I
Sbjct: 285 PLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 53/204 (25%), Positives = 100/204 (49%), Gaps = 31/204 (15%)
Query: 344 LGKGSYGTTY-----KAILEEGTTVVVKRLKEVVMGKR------EFEQQMEVVGRLSQHP 392
LGKGS+GT Y KA+ EE +K LKE+ +G+ + Q+ +++ +L HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEER----LKVLKEIPVGELNPNETVQANQEAQLLSKLD-HP 62
Query: 393 NVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRT---PLDWESRVKISLGSAKG 449
+V A + +D ++ ++ E L + G+T E +++ LG
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG---- 118
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM----NTPTVPSRSAGYRAP 505
+ ++H + + ++K+ N+ L +L I DFG++ L+ + T + + Y +P
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
Query: 506 EVIETKKPTQKSDVYSFGVLLLEM 529
E ++ + KSD++S G +L EM
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFE-----QQMEVVGRLSQHPNVVP 396
E LG+G+Y T YK TT + LKE+ + E +++ ++ L +H N+V
Sbjct: 6 EKLGEGTYATVYKG--RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVR 62
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSAL-LHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ ++++ +LV+++++ + HG RG LD + + KGIA H
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRG----ALDPNTVKSFTYQLLKGIAFCHE 118
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--TVPSR--SAGYRAPEVIETK 511
+ + ++K N+L+++ + ++DFGL P T + + YRAP+V+
Sbjct: 119 ---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175
Query: 512 KPTQKS-DVYSFGVLLLEMLTGKAPIQAPGHED 543
+ S D++S G ++ EM+TG+ +ED
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 13/202 (6%)
Query: 343 VLGKGSYGTTYKA-ILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPN---VVPIR 398
VLGKG +G + G K+L++ + KR+ E R+ + N VV +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
Y +KD LV + G ++ +G D + + + G+ +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYN---MGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSR--SAGYRAPEVIETKKPTQ 515
+ + ++K N+LL ISD GL + TV R + GY APEVI +K T
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180
Query: 516 KSDVYSFGVLLLEMLTGKAPIQ 537
D + G L+ EM+ G++P +
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 34/90 (37%), Positives = 48/90 (53%), Gaps = 10/90 (11%)
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-----TPLMNTPTVPSRSAGYR 503
GI H+H+A I ++K SN+++ D I DFGL T M TP V +R YR
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YR 184
Query: 504 APEVIETKKPTQKSDVYSFGVLLLEMLTGK 533
APEVI + D++S G ++ EM+ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 62/236 (26%), Positives = 99/236 (41%), Gaps = 35/236 (14%)
Query: 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLK--EVVMGKR--EFEQQMEVVGRLSQHPNVVP 396
E LG GS+G A + G +K LK E++ K+ Q+ ++ LS HP +V
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVN 82
Query: 397 IRAYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ + ++ + +F+ G F+ L R GR P D L A ++H+
Sbjct: 83 MMCSFQDENRVYFLLEFVVGGELFTHL----RKAGRFPNDVAKFYHAELVLA--FEYLHS 136
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS------AGYRAPEVIE 509
I ++K N+LL ++DFG VP R+ Y APEVI+
Sbjct: 137 K---DIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPEVIQ 188
Query: 510 TKKPTQKSDVYSFGVLLLEMLTGKAPI--QAP--GHEDV----VDLPRWVQSVVRE 557
+K + D ++ GVLL E + G P P +E + + P W R+
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244
|
Length = 329 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 73/305 (23%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKR--------------LKEVVMGKREFEQQMEVVGRL 388
+G+GSYG +K E G V +K+ L+E+ M K+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQ------------ 56
Query: 389 SQHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA 447
+HPN+V + F + KL LV+++ + + L RG + KI +
Sbjct: 57 LKHPNLVNLIEV-FRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTL 110
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT------VPSRSAG 501
+ + H I ++K N+L+++ Q + DFG ++ P V +R
Sbjct: 111 QAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR--W 165
Query: 502 YRAPEVI--ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL-----------P 548
YRAPE++ +T+ DV++ G + E+LTG+ PG DV L P
Sbjct: 166 YRAPELLVGDTQYGP-PVDVWAIGCVFAELLTGQP--LWPGKSDVDQLYLIRKTLGDLIP 222
Query: 549 RWVQSVVREEW--------TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTME 600
R Q ++ +E ++ NI + L+ C+ P R + E
Sbjct: 223 RHQQIFSTNQFFKGLSIPEPETREPLE-SKFPNISSPALSFLK---GCLQMDPTERLSCE 278
Query: 601 EVVRM 605
E++
Sbjct: 279 ELLEH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 342 EVLGKGSYGTTYKAILE-EGTTVVVKRL-KEVVMGKREFEQQM---EVVGRLSQHPNVVP 396
+V+GKGS+G A + +G+ VK L K+ ++ K+E M V+ + +HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 397 IRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKGIAHIH 454
+ Y F EKL V D++ G L R E R + A I ++H
Sbjct: 61 LH-YSFQTAEKLYFVLDYVNGGELFFHLQRERCFL------EPRARFYAAEVASAIGYLH 113
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQG--CISDFGLT-----PLMNTPTVPSRSAGYRAPEV 507
+ I ++K N+LL D QG ++DFGL P T T + Y APEV
Sbjct: 114 SL---NIIYRDLKPENILL--DSQGHVVLTDFGLCKEGVEPEETTSTFCG-TPEYLAPEV 167
Query: 508 IETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ + + D + G +L EML G P
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 35/208 (16%)
Query: 344 LGKGSYGTTYKA---ILEEGTTVVVKRLKEVVMGKRE--FEQQMEVVGRLSQHPNVVPIR 398
+G G++G + I E + V + EV+ K+E + V+ +S HP + IR
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFI--IR 65
Query: 399 AYYFSKDEKLL--VYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
++ D++ L + +++ G FS L + R T L + S + + ++H
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI------VCALEYLH- 118
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP--------LMNTPTVPSRSAGYRAPEV 507
+ + ++K N+LL ++ ++DFG L TP Y APEV
Sbjct: 119 --SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE-------YLAPEV 169
Query: 508 IETKKPTQKSDVYSFGVLLLEMLTGKAP 535
I++K + D ++ G+L+ EML G P
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 342 EVLGKGSYGTTY---KAI-LEEGTTVVVKRLKEVVMGKREFEQQ-----MEVVGRLSQHP 392
+VLG G+YG + K + G +K L++ + ++ + V+ + Q P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 393 NVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA-KGI 450
+V + Y F + KL L+ D++ G L+ E V+ G +
Sbjct: 66 FLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS------EDEVRFYSGEIILAL 118
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-----SAGYRAP 505
H+H + +IK N+LL + ++DFGL+ + + Y AP
Sbjct: 119 EHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 506 EVIETKKPTQKS-DVYSFGVLLLEMLTGKAPIQAPGHED 543
E+I K K+ D +S G+L+ E+LTG +P G +
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 50/165 (30%), Positives = 68/165 (41%), Gaps = 28/165 (16%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSS--LSPQLNWVDL 143
L L +L L L N LS DLP + +LS+L L L N S ++P L L +DL
Sbjct: 159 LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFI-----------------------PNFN 180
S NSI + +S+ NL +L GL L NN L +
Sbjct: 217 SNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGS 275
Query: 181 LSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCS 225
L+ LR L+LS N L+ ++PL N +L L
Sbjct: 276 LTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKL 320
|
Length = 394 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 17/223 (7%)
Query: 344 LGKGSYGTTYKA-ILEEGTTVVVKRLKEVVMGKREFEQ----QMEVVGRLSQHPNVVPIR 398
LGKG +G + G K+L + + K+ E+ + E++ +++ P +V +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+ SK LV + G ++ +G L+ E + S GI H+H+
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYN---VGERGLEMERVIHYSAQITCGILHLHSM-- 114
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLM---NTPTVPSRSAGYRAPEVIETKKPTQ 515
+ ++K NVLL +SD GL + T T + + GY APE+++ + +
Sbjct: 115 -DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 516 KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE 558
D ++ G + EM+ G+ P + H++ V + + +E
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFK--DHKEKVAKEELKRRTLEDE 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 69/296 (23%), Positives = 125/296 (42%), Gaps = 52/296 (17%)
Query: 344 LGKGSYGTTY--------KAILEEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPN 393
LG+G +G K + TV VK LK+ K + +ME++ + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG--------RTP---LDWESRVKI 442
++ + ++ ++ G+ L R G + P L ++ V
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 443 SLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGY 502
+ A+G+ ++ + K I ++ + NVL+++D I+DFGL ++ ++
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 503 R------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVV 555
R APE + + T +SDV+SFGVLL E+ T G +P PG +P
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY--PG------IP------- 241
Query: 556 REEWTSEVFDV--ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
E+F + E R + ++ I C VP RPT +++V ++ +
Sbjct: 242 ----VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 331 FDLEDLLRASAEVLGKGSYGTTYKAI-LEEGTTVVVKRL----KEVVMGKREFEQQMEV- 384
FD+ + E +G G+YG AI G V +K++ + KR E+
Sbjct: 1 FDVGSRYKPI-ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR---ELK 56
Query: 385 VGRLSQHPNVVPIRAYYFSKDEKL----LVYDFIEAGSFSALLHGNRGIGRTPLDWESRV 440
+ R +H N++ IR +V D +E ++H ++ PL E +
Sbjct: 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ-----PLT-EEHI 109
Query: 441 KISLGSA-KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSR 498
+ L +G+ +IH+A I ++K SN+L+++D + I DFG+ L ++PT
Sbjct: 110 RYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 499 -------SAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPI 536
+ YRAPE++ + + T D++S G + EML G+ +
Sbjct: 167 FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 43/230 (18%), Positives = 102/230 (44%), Gaps = 38/230 (16%)
Query: 353 YKAILEEGTTVVVKRLKEVVMGK----REFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKL 408
YK I V+++ K+ G E +++ + R+ N++ I + + L
Sbjct: 37 YKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDL 94
Query: 409 ----LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILG 464
L+ ++ G +L + L +++++ +++ KG+ +++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKPY--K 147
Query: 465 NIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEVIET--KKPTQKSDV 519
N+ S + L++++ + I GL ++++P P ++ Y + +++ + T K D+
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDI 205
Query: 520 YSFGVLLLEMLTGKAPIQAPGHEDVVDL--------------PRWVQSVV 555
YS GV+L E+ TGK P + +++ DL P ++ +V
Sbjct: 206 YSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV 255
|
Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 48/238 (20%)
Query: 343 VLGKGSYGTTYKAILEE----GTTVVVKRLK-EVVMGKREFEQQM------EVVGRLSQH 391
VLG+G +G K +L E G +K LK ++ + E E M E +H
Sbjct: 6 VLGRGHFG---KVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS-ERH 61
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIA 451
P +V + A + ++D V ++ G +H + + + + V + G+
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL------GLQ 115
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-----------TPLMNTPTVPSRSA 500
++H K + ++K N+LL + I+DFGL + TP
Sbjct: 116 YLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPE------ 166
Query: 501 GYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE 558
+ APEV+ T+ D + GVL+ EML G++P E+V D S+V +E
Sbjct: 167 -FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SIVNDE 217
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 47/241 (19%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLK--EVVMGKREFEQQMEVVG------------RL 388
LG+G+YG KA G V +K++K E+ + Q + + G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 389 SQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSA 447
+H N++ + Y D LV D I A ++ +R I T ES+VK I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVV--DRKIRLT----ESQVKCILLQIL 129
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT------PLMNTPTVPSRSAG 501
G+ +H F+ ++ +N+ ++ I+DFGL P +T +
Sbjct: 130 NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 502 ------------YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP 548
YRAPE++ +K D++S G + E+LTGK PG ++ L
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF--PGENEIDQLG 244
Query: 549 R 549
R
Sbjct: 245 R 245
|
Length = 335 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-----TPLMNTPTVPSRSAGYR 503
GI H+H+A I ++K SN+++ D I DFGL T M TP V +R YR
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YR 192
Query: 504 APEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV 544
APEVI + D++S G ++ EM+ G + PG + +
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG--VLFPGTDHI 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 35/220 (15%)
Query: 343 VLGKGSYGTTYKAILEE--GTT--VVVKRLK-EVVMGKREFEQQM---EVVGRLSQHPNV 394
VLGKGS+G K +L E GT +K LK +VV+ + E M V+ + P +
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGR--TPLDWESRVKISLG----SAK 448
+ + + + D V +++ G L++ + +GR P +I++G +K
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGD---LMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR----SAGYRA 504
GI I ++K NV+L + I+DFG+ V ++ + Y A
Sbjct: 121 GI-----------IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIA 169
Query: 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV 544
PE+I + + D ++FGVLL EML G+AP + +++
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 23/218 (10%)
Query: 342 EVLGKGSYGTTYKAILEE----GTTVVVKRLK-EVVMGKREFEQQM--EVVGRLSQHPNV 394
++LGKG++G K IL + G +K LK EV++ K E + V + S+HP +
Sbjct: 1 KLLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKGIAHI 453
++ + + D V ++ G H + R + E R + + ++
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARFYGAEIVSALDYL 111
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP--LMNTPTVPS--RSAGYRAPEVIE 509
H+ + ++K N++L +D I+DFGL + + T+ + + Y APEV+E
Sbjct: 112 HSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169
Query: 510 TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547
+ D + GV++ EM+ G+ P HE + +L
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 52/215 (24%)
Query: 347 GSYGTTYKAI-LEEGTTVVVKRLKEVVMGK----------REFEQQMEVVGRLSQHPNVV 395
G+YG Y+A + G V +K+LK M K RE ++ QHPN+V
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLK-----LQHPNIV 67
Query: 396 PIRAYYFSK--DEKLLVYDFIEAGSFSALLHGNRGI---GRTPLDWESRVK---ISLGSA 447
++ D+ +V +++E H + + + P +S VK + L S
Sbjct: 68 TVKEVVVGSNLDKIYMVMEYVE--------HDLKSLMETMKQPFL-QSEVKCLMLQLLS- 117
Query: 448 KGIAHIHAAVGGKFILG-NIKSSNVLLSQDLQGCISDFGL-----TPLMN-TPTVPSRSA 500
G+AH+H +IL ++K+SN+LL+ I DFGL +PL T V +
Sbjct: 118 -GVAHLHD----NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVT--L 170
Query: 501 GYRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
YRAPE++ K+ + D++S G + E+LT K
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 43/214 (20%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKE----VVMGKREFE-----QQMEVVGRLSQH 391
+G G+YG A + G V +K+L + KR + + M H
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-------DH 73
Query: 392 PNVVPIRAYYFSKDEKL-------LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISL 444
NV+ + F+ L LV + A N + L + ++ +
Sbjct: 74 ENVIGLLDV-FTPASSLEDFQDVYLVTHLMGADL-------NNIVKCQKLS-DDHIQFLV 124
Query: 445 GSA-KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN---TPTVPSRSA 500
+G+ +IH+A I ++K SN+ +++D + I DFGL + T V +R
Sbjct: 125 YQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-- 179
Query: 501 GYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGK 533
YRAPE++ Q D++S G ++ E+LTGK
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 69/290 (23%), Positives = 111/290 (38%), Gaps = 48/290 (16%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNVVP 396
+G+G +G Y+ + E V VK K RE Q + R HP++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ +++ +V + G + L N+ LD S + S + +A++
Sbjct: 72 LIGV-ITENPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE-- 124
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETK 511
+F+ +I + NVL+S + DFGL+ + + S G + APE I +
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 512 KPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570
+ T SDV+ FGV + E+L G P Q + DV+ R
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-----------------------GR 220
Query: 571 YENIE-----EEMVQMLQIAMS-CVAKVPDMRPTMEEVVRMIEDIRPSDS 614
EN E L M+ C A P RP E+ + DI +
Sbjct: 221 IENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEEK 270
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 73/292 (25%), Positives = 123/292 (42%), Gaps = 57/292 (19%)
Query: 344 LGKGSYGTTYKAILEE------GTTVVVKRLKEVVMGKR--EFEQQMEVVGRLSQHPNVV 395
+G G +G K +L E VVVK LK K EF QQ + R+ QHPN++
Sbjct: 3 IGNGWFG---KVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPY-RILQHPNIL 58
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGN---RGIGRTPLDWESRVKISLGSAKGIAH 452
LLV+++ E G + L R + L +I A G+ H
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI----AAGVTH 114
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM---------NTPTVPSRSAGYR 503
+H F+ ++ N L+ DL + D+G+ P + VP R +
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR---WL 168
Query: 504 APEVIE-------TKKPTQKSDVYSFGVLLLEMLTGKA-PIQAPGHEDVVDLPRWVQSVV 555
APE++ T + T+ S+V++ GV L E+ A P +V++ V+
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------HVI 222
Query: 556 REEWTSEVFDVEL-MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606
+++ ++F +L + Y E++Q ++ P+ R T EEV R++
Sbjct: 223 KDQQV-KLFKPQLELPYSERWYEVLQFCWLS-------PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 51/225 (22%)
Query: 345 GKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ-------------H 391
G+G+YG YKA + G +K +F+ E +SQ H
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIK-------KFKGDKEQYTGISQSACREIALLRELKH 61
Query: 392 PNVVPIRAYYFSKDEKL--LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA-- 447
NVV + + +K L++D+ E ++ +R R + S VK S
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIP-PSMVK----SLLW 115
Query: 448 ---KGIAHIHAAVGGKFILG-NIKSSNVLLSQDLQGC----ISDFGLTPLMNTPTVPSRS 499
G+ ++H+ ++L ++K +N+L+ + I D GL L N P P
Sbjct: 116 QILNGVHYLHS----NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 500 AG-------YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKAPI 536
YRAPE++ + T+ D+++ G + E+LT + PI
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 9e-07
Identities = 52/224 (23%), Positives = 89/224 (39%), Gaps = 57/224 (25%)
Query: 344 LGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQM----EVVGRLSQHPNVVPIR 398
LG G +G ++ + T +K +K+ + + ++ + E++ + HP +V +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59
Query: 399 AYYFSKDEKLLVY---DFIEAGSFSALLHGNRGIGRTPLDWESRVKIS--------LGSA 447
+ KD+K +Y ++ G +L R G ++ +R I+ L
Sbjct: 60 RTF--KDKKY-IYMLMEYCLGGELWTIL---RDRGLFD-EYTARFYIACVVLAFEYL-HN 111
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS--DFGLT----------PLMNTPTV 495
+GI I ++K N+LL D G + DFG TP
Sbjct: 112 RGI-----------IYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTP-- 156
Query: 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539
Y APE+I K D +S G+LL E+LTG+ P
Sbjct: 157 -----EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 343 VLGKGSYGTTYKAILEE--GTTVV--VKRLK-EVVMGKREFEQQM---EVVGRLSQHPNV 394
VLGKGS+G K +L E GT + +K LK +V++ + E M V+ + P +
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG--RTPLDWESRVKISLG----SAK 448
+ + + + D V +++ G L++ + +G + P +I++G +K
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGD---LMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR----SAGYRA 504
GI I ++K NV+L + I+DFG+ +R + Y A
Sbjct: 121 GI-----------IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIA 169
Query: 505 PEVIETKKPTQKS-DVYSFGVLLLEMLTGKAP 535
PE+I +P KS D ++FGVLL EML G+ P
Sbjct: 170 PEII-AYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRL-KEVVMGKREFEQQM--EVVGRLSQHPNV 394
++LGKG++G K IL G +K L KEV++ K E + V + ++HP +
Sbjct: 1 KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKGIAHI 453
++ + + D V ++ G H + R + E R + + ++
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARFYGAEIVSALEYL 111
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP--LMNTPTVPS--RSAGYRAPEVIE 509
H+ + +IK N++L +D I+DFGL + + T+ + + Y APEV+E
Sbjct: 112 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 168
Query: 510 TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547
+ D + GV++ EM+ G+ P HE + +L
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 43/170 (25%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 385 VGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALL--HGNRGIGRTPLDWESRVKI 442
V +L HPN+VP RA + + +E +V F+ GS L+ H G+ + + I
Sbjct: 52 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY-----I 106
Query: 443 SLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT---------- 492
G K + +IH ++ ++K+S++L+S D + +S GL ++
Sbjct: 107 LQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVV 161
Query: 493 ---PTVPSRSAGYRAPEVIET--KKPTQKSDVYSFGVLLLEMLTGKAPIQ 537
P + + +PEV++ + KSD+YS G+ E+ G P +
Sbjct: 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 24/220 (10%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEV-VGRLSQHPNVVPIRAYYF 402
+G+G+YG YKA ++G LK++ E+ + R +HPNV+ ++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 403 SKDEK--LLVYDFIEAGSFSAL-LHGNRGIGRTPLDWESRVKISL--GSAKGIAHIHAAV 457
S ++ L++D+ E + + H + P+ + SL GI ++HA
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-- 126
Query: 458 GGKFILG-NIKSSNVLL----SQDLQGCISDFGLTPLMNTPTVPSRSAG-------YRAP 505
++L ++K +N+L+ + + I+D G L N+P P YRAP
Sbjct: 127 --NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 506 E-VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV 544
E ++ + T+ D+++ G + E+LT + PI ED+
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 13/104 (12%)
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-------- 501
+ H+H+ I +IKS+N+LL + + DFG + M TV S G
Sbjct: 156 VHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSK-MYAATV-SDDVGRTFCGTPY 210
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV 545
Y APE+ K ++K+D++S GVLL E+LT K P E+V+
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254
|
Length = 496 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMG------KREFEQQMEVVGRLSQHPNVVPI 397
+G G+ GT YK I T + LK V+ G +R+ +++E++ R HPNVV
Sbjct: 82 IGSGAGGTVYKVI--HRPTGRLYALK-VIYGNHEDTVRRQICREIEIL-RDVNHPNVVKC 137
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
+ E ++ +F++ GS L G L +R +S GIA++H
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGS----LEGTHIADEQFLADVARQILS-----GIAYLHRR- 187
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA----GYRAPEVIET--- 510
+ +IK SN+L++ I+DFG++ ++ P S+ Y +PE I T
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLN 245
Query: 511 --KKPTQKSDVYSFGVLLLEMLTGKAP 535
D++S GV +LE G+ P
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 49/219 (22%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRL----------KEVVMGKREFEQQMEVVGRLSQHP 392
LG+G++G Y ++ G + VK++ KEV E +++++ L QH
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEV----NALECEIQLLKNL-QHE 64
Query: 393 NVVPIRAYYFSKDEKLLVYDFIE---AGSFSALL--HGNRGIGRTPLDWESRVKISLGSA 447
+V YY + + F+E GS L +G L K +
Sbjct: 65 RIV---QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-------ALTETVTRKYTRQIL 114
Query: 448 KGIAH------IHAAVGGKFIL----GNIKSSNVLLSQDLQG-CISDFGLTPLMNTPTVP 496
+G+ + +H + G IL GN+K + S+ LQ C S G+ + TP
Sbjct: 115 EGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY-- 172
Query: 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ +PEVI + +K+DV+S G ++EMLT K P
Sbjct: 173 -----WMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 48/203 (23%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAY 400
LG G+ G +K + ++ ++L + + + + ++++V+ + P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGA 71
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
++S E + + ++ GS +L + GR P +V I++ KG+ ++ K
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKGLTYLREK--HK 124
Query: 461 FILGNIKSSNVLLSQDLQGCISDFG----LTPLMNTPTVPSRSAGYRAPEVIETKKPTQK 516
+ ++K SN+L++ + + DFG L M V +RS Y +PE ++ + +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPERLQGTHYSVQ 182
Query: 517 SDVYSFGVLLLEMLTGKAPIQAP 539
SD++S G+ L+EM G+ PI P
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPP 205
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 67/297 (22%), Positives = 125/297 (42%), Gaps = 54/297 (18%)
Query: 344 LGKGSYGTTYKAILEEG-----------TTVVVKRLKEVVMGK--REFEQQMEVVGRLSQ 390
LG+G +G + ++ E T V VK LK K + +ME++ + +
Sbjct: 26 LGEGCFG---QVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG--------RTP---LDWESR 439
H N++ + ++ ++ G+ L R G + P L ++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 440 VKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS 499
V + A+G+ ++ + K I ++ + NVL+++D I+DFGL ++ ++
Sbjct: 143 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 500 AGYR------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQ 552
R APE + + T +SDV+SFGVLL E+ T G +P E++ L +
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH 259
Query: 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
+ + N E+ M++ C VP RPT +++V ++ I
Sbjct: 260 --------------RMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 342 EVLGKGSYGTTYKAIL-EEGTT---VVVKRL-KEVVMGKREFEQQM--EVVGRLSQHPNV 394
++LGKG++G K IL E T +K L KEV++ K E + V + ++HP +
Sbjct: 1 KLLGKGTFG---KVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKI---SLGSAKGIA 451
++ + + D V ++ G H + R + E R + + SA G
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL--FFH----LSRERVFSEDRARFYGAEIVSALGYL 111
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL----TPLMNTPTVPSRSAGYRAPEV 507
H + ++K N++L +D I+DFGL T + Y APEV
Sbjct: 112 H-----SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166
Query: 508 IETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547
+E + D + GV++ EM+ G+ P HE + +L
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 39/103 (37%), Positives = 54/103 (52%), Gaps = 13/103 (12%)
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-----TPLMNTPTVPSRSAGYR 503
GI H+H+A I ++K SN+++ D I DFGL T M TP V +R YR
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YR 185
Query: 504 APEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
APEVI + D++S G ++ EM+ K I PG D +D
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK--ILFPG-RDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 40/238 (16%)
Query: 336 LLRASAEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMGKREFEQQME--VVGR 387
LLRA LG G++G Y+ + V VK L E + E + ME ++ +
Sbjct: 10 LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 388 LSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRG-IGR-TPLDWESRVKISLG 445
+ H N+V + F + + ++ + + G + L NR R + L + + +
Sbjct: 66 FN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 446 SAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG---CISDFGLTPLMNTPTVPSRSAGY 502
AKG ++ FI +I + N LL+ G I+DFG+ + R++ Y
Sbjct: 125 VAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI------YRASYY 175
Query: 503 R------------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDL 547
R PE T K+DV+SFGVLL E+ + G P +++V++
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 11 SFIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSRVLAV 70
S + + LN LL +++ L+ S S +S G N + ++
Sbjct: 40 SNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSP-SGISSLDGSENLLNLLPLPSL 98
Query: 71 RLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNV-LSLSSLRFLYLQNNNFSGN 129
L L I + L +L +L L L +N+++ D+P + L S+L+ L L +N +
Sbjct: 99 DLNLNRLRSNI--SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-S 154
Query: 130 IPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFN-LSRLRH 186
+PS L P L +DLSFN ++ ++P + NLS+L L+L N ++ P LS L
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEE 213
Query: 187 LNLSYNHLNGSVPLALQKFP 206
L+LS N + + +L
Sbjct: 214 LDLSNNSII-ELLSSLSNLK 232
|
Length = 394 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 53/217 (24%), Positives = 96/217 (44%), Gaps = 47/217 (21%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLK-----EVV--MGKREFEQQMEVVGRLSQHPN 393
E +G+G+YG YKA G V +K+++ E V RE E+ HPN
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHPN 60
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAK----- 448
+V + ++++ LV++F+ ++ + + +D I L K
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-----------HQDLKKF-MDASPLSGIPLPLIKSYLFQ 108
Query: 449 ---GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---- 501
G+A H+ + + ++K N+L++ + ++DFGL VP R+
Sbjct: 109 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG---VPVRTYTHEVV 162
Query: 502 ---YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
YRAPE++ K + D++S G + EM+T +A
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 84/313 (26%), Positives = 142/313 (45%), Gaps = 56/313 (17%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVG--------RLSQHP 392
EV+GKGSYG AI G V +K++ +V FE + RL +HP
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDV------FEHVSDATRILREIKLLRLLRHP 59
Query: 393 NVVPIRAYYFSKDEK-----LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA 447
++V I+ + +V++ +E+ ++ N + TP + + L
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDL--TPEHHQFFLYQLL--- 113
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM--NTPT-------VPSR 498
+ + +IH A ++K N+L + D + I DFGL + +TPT V +R
Sbjct: 114 RALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 499 SAGYRAPEVIET--KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV---DLPRWVQS 553
YRAPE+ + K T D++S G + E+LTGK P+ PG ++VV DL +
Sbjct: 171 --WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PL-FPG-KNVVHQLDLITDLLG 225
Query: 554 VVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613
E S V + + RY + M + + S K P+ P +R++E + D
Sbjct: 226 TPSPETISRVRNEKARRYLS---SMRKKQPVPFS--QKFPNADPL---ALRLLERLLAFD 277
Query: 614 SENQPSSEDKLKD 626
+++P++E+ L D
Sbjct: 278 PKDRPTAEEALAD 290
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 29/207 (14%)
Query: 413 FIEAGSFSALLH---GNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSS 469
F+E S S + + + L E + S AKG+ + + K I ++ +
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAAR 208
Query: 470 NVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR------APEVIETKKPTQKSDVYSFG 523
N+LLS++ I DFGL + R R APE I + T +SDV+SFG
Sbjct: 209 NILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 268
Query: 524 VLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQML 582
VLL E+ + G +P PG + + EE+ + + MR + +M
Sbjct: 269 VLLWEIFSLGASPY--PGVK------------IDEEFCRRLKEGTRMRAP--DYTTPEMY 312
Query: 583 QIAMSCVAKVPDMRPTMEEVVRMIEDI 609
Q + C P RPT E+V + ++
Sbjct: 313 QTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 53/213 (24%), Positives = 96/213 (45%), Gaps = 33/213 (15%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTT----VVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNV 394
+VLG G++GT YK + + EG V +K L+E K +E + V+ + +P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 71
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALL-----HGNRGIGRTPLDWESRVKISLGSAKG 449
+ + +L+ + F LL H + + L+W ++ AKG
Sbjct: 72 CRLLGICLTSTVQLIT----QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAP---- 505
+ ++ + + ++ + NVL+ I+DFGL L+ + G + P
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 506 --EVIETKKPTQKSDVYSFGVLLLEMLT-GKAP 535
E I + T +SDV+S+GV + E++T G P
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 24/220 (10%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEV-VGRLSQHPNVVPIRAYYF 402
+G+G+YG YKA ++G LK++ E+ + R +HPNV+ ++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 403 SK-DEKL-LVYDFIEAGSFSAL-LHGNRGIGRTPLDWESRVKISL--GSAKGIAHIHAAV 457
S D K+ L++D+ E + + H + P+ + SL GI ++HA
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-- 126
Query: 458 GGKFILG-NIKSSNVLL----SQDLQGCISDFGLTPLMNTPTVPSRSAG-------YRAP 505
++L ++K +N+L+ + + I+D G L N+P P YRAP
Sbjct: 127 --NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 506 E-VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV 544
E ++ + T+ D+++ G + E+LT + PI ED+
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 45/203 (22%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAY 400
LG G+ G K + ++ ++L + + + + ++++V+ + P +V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGA 71
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
++S E + + ++ GS +L + I L K+S+ +G+A++ +
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREK--HQ 124
Query: 461 FILGNIKSSNVLLSQDLQGCISDFG----LTPLMNTPTVPSRSAGYRAPEVIETKKPTQK 516
+ ++K SN+L++ + + DFG L M V +RS Y +PE ++ + +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS--YMSPERLQGTHYSVQ 182
Query: 517 SDVYSFGVLLLEMLTGKAPIQAP 539
SD++S G+ L+E+ G+ PI P
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPP 205
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 38/220 (17%)
Query: 344 LGKGSYGTTYKAIL-EEGTTVVVKRLKE--VVM-----GKREFEQQMEVVGRLSQHPNVV 395
LG+G++ YK +L + +V +E VV+ R+ E +SQ +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 396 PIRAYYFS-KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA------K 448
++ Y +DE ++V ++++ G LH + L W+ V L SA K
Sbjct: 63 LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK 120
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQ--DLQGC-----ISDFGLTPLMNTPTVPSRSAG 501
+ H GN+ N+L+++ +G +SD G+ + +
Sbjct: 121 KLVH-----------GNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP 169
Query: 502 YRAPEVIE--TKKPTQKSDVYSFGVLLLEMLT-GKAPIQA 538
+ APE I T +D +SFG LLE+ + G+ P+
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 48/286 (16%)
Query: 343 VLGKGSYGTTYKAI-LEEGTT----VVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNVV 395
VLG G++GT YK I + +G V +K L+E K +E + V+ + P V
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS-PYVC 72
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRG-IG-RTPLDWESRVKISLGSAKGIAHI 453
+ + +L V + G + N+ IG + L+W ++ AKG++++
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAP------EV 507
+ + ++ + NVL+ I+DFGL L++ + G + P E
Sbjct: 126 EEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 508 IETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDL----PRWVQSVVREEWTSE 562
I ++ T +SDV+S+GV + E++T G P ++ DL R Q + T +
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPI---CTID 239
Query: 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
V+ + MV+ I C P R ++E RM D
Sbjct: 240 VYMI-----------MVKCWMIDSEC---RPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 49/202 (24%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYF 402
+G G+YG YKA L G VK +K QQ + + +H N+V Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFI 462
S+++ + ++ GS + H + + + R + +G+A++H+ GK +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSK--GK-M 128
Query: 463 LGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA-----GYRAPEVIETKKP---T 514
+IK +N+LL+ + ++DFG+ + T T+ R + + APEV +K
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKI-TATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 515 QKSDVYSFGVLLLEMLTGKAPI 536
Q D+++ G+ +E+ + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 343 VLGKGSYGTTYKAILEEGTTVVVKRL--KEVVMGKREF---EQQMEVVGRLSQHPNVVPI 397
V+G+GSY L++ + ++ KE+V + + + V + S HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
+ + ++ V +++ G + R + + S +ISL + ++H
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS-AEISLA----LNYLHER- 115
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFG-----LTPLMNTPTVPSRSAGYRAPEVIETKK 512
I ++K NVLL + ++D+G L P +T + + Y APE++ +
Sbjct: 116 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGED 172
Query: 513 PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
D ++ GVL+ EM+ G++P G D D
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 344 LGKGSYGTTYKAILEEGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQ--HPNVVPI 397
+GKGS+G + + + T + LK + ++ + E + L+Q P +VP+
Sbjct: 1 IGKGSFGKVMQ--VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAK-GIAHIHAA 456
+ + S ++ LV FI G L H + GR SR + + ++H
Sbjct: 59 KFSFQSPEKLYLVLAFINGGE---LFHHLQREGRFD---LSRARFYTAELLCALENLHKF 112
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCIS--DFGLTPL-MNTPTVPSRSAG---YRAPEVIET 510
I ++K N+LL D QG I+ DFGL L M + G Y APE++
Sbjct: 113 ---NVIYRDLKPENILL--DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG 167
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAP 535
T+ D ++ GVLL EMLTG P
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 28/236 (11%)
Query: 344 LGKGSYGTTYKAILEE-GTTVVVKRL-KEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+G+G YG + A ++ G V +KR+ K ++ E + L+ + ++ Y
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 402 -FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAK-GIAHIHAAVG 458
F DE L L +++ G F LL+ N G+ +S A+ +A + AV
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLN-NLGV------------LSEDHARFYMAEMFEAVD 115
Query: 459 GKFILGNI----KSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEVIETK 511
LG I K N L+ ++DFGL+ T + G Y APEV+ K
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTYANSVVGSPDYMAPEVLRGK 173
Query: 512 KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV-VDLPRWVQSVVREEWTSEVFDV 566
D +S G +L E L G P + +L W +++ R + F++
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 17/146 (11%)
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
HP+V+ ++ S +V + ++ L +R PL + + I +G+
Sbjct: 116 HPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSR-----PLPIDQALIIEKQILEGL 170
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGY------RA 504
++HA + I ++K+ N+ ++ Q CI D G P V G A
Sbjct: 171 RYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLAGTVETNA 224
Query: 505 PEVIETKKPTQKSDVYSFGVLLLEML 530
PEV+ K K+D++S G++L EML
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 56/240 (23%), Positives = 100/240 (41%), Gaps = 28/240 (11%)
Query: 306 KEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGT--TV 363
K+D S + KNK+ + + +NF LG GS+G A + V
Sbjct: 12 KKDSDSTKEPKRKNKMKYED---FNF---------IRTLGTGSFGRVILATYKNEDFPPV 59
Query: 364 VVKRL-KEVVMGKREFEQQMEVVGRLS--QHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420
+KR K ++ +++ + L+ HP V + + + LV +F+ G F
Sbjct: 60 AIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119
Query: 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG-KFILGNIKSSNVLLSQDLQG 479
L N+ R P D + A I I + + ++K N+LL +D
Sbjct: 120 TFLRRNK---RFPND------VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFI 170
Query: 480 CISDFGLTPLMNTPTVP-SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQA 538
++DFG +++T T + Y APE++ + +D ++ G+ + E+L G P A
Sbjct: 171 KMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230
|
Length = 340 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 343 VLGKGSYGTTYKAILEE----GTTVVVKRLK-EVVMGKREFEQQM---EVVGRLSQHPNV 394
VLGKGS+G K +L E +K LK +VV+ + E M V+ + P +
Sbjct: 7 VLGKGSFG---KVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFL 63
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNR-GIGRTPLDWESRVKISLG----SAKG 449
+ + + + D V +++ G + H + G + P +IS+G +G
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS----AGYRAP 505
I I ++K NV+L + I+DFG+ V +R+ Y AP
Sbjct: 122 I-----------IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAP 170
Query: 506 EVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
E+I + + D +++GVLL EML G+ P
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 20/101 (19%)
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQ--DLQGCISDFGL----TPL-----MNTPTVP 496
+G+ +IH+A + ++K SN+LL+ DL+ C DFGL P T V
Sbjct: 117 RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKIC--DFGLARIADPEHDHTGFLTEYVA 171
Query: 497 SRSAGYRAPEVIETKKPTQKS-DVYSFGVLLLEMLTGKAPI 536
+R YRAPE++ K K+ D++S G +L EML+ + P+
Sbjct: 172 TR--WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR----SAGYRA 504
G+ H+H + I ++K NVLL D ISD GL + ++ + G+ A
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMA 165
Query: 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540
PE+++ ++ D ++ GV L EM+ + P +A G
Sbjct: 166 PELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 32/91 (35%), Positives = 53/91 (58%), Gaps = 11/91 (12%)
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT----PLMNTPTVPSRSAGYR 503
+G+ ++H+A + ++K SN+L++++ I DFGL P M T V +R YR
Sbjct: 119 RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM-TGYVSTRY--YR 172
Query: 504 APEVIET-KKPTQKSDVYSFGVLLLEMLTGK 533
APE++ T +K + D++S G + EML GK
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 344 LGKGSYGTTYKAILE---EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
LG G++G K + + + V +K LK K ++ M + Q N +R
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLK-NENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 401 YFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459
+ E L LV + G + L G + + + V++ + G+ ++ G
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLE---GK 114
Query: 460 KFILGNIKSSNVLLSQDLQGCISDFGLTPLM--NTPTVPSRSAG-----YRAPEVIETKK 512
F+ ++ + NVLL ISDFGL+ + + +RSAG + APE I +K
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 513 PTQKSDVYSFGVLLLEMLT-GKAP 535
+ +SDV+S+G+ + E + G+ P
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 344 LGKGSYGTTYKAILE---EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
LG G++GT K + + TV VK LK ++ + + Q N +R
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 401 YFSKDEK-LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459
+ E +LV + E G + L N+ + + E ++S+G
Sbjct: 63 GICEAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-ELVHQVSMGMKYLEET------- 114
Query: 460 KFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--VPSRSAG-----YRAPEVIETKK 512
F+ ++ + NVLL ISDFGL+ + +++ G + APE + K
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 513 PTQKSDVYSFGVLLLEMLT-GKAP 535
+ KSDV+SFGVL+ E + G+ P
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 21/216 (9%)
Query: 342 EVLGKGSYGTTYKA--ILEEGTTVVVKRLKEVVMGKREFEQQME---VVGRLSQHPNVVP 396
+V+GKGS+G A EE V K+ ++ K+E + M V+ + +HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKGIAHIHA 455
+ + + D+ V D+I G L R E R + A + ++H+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCF------LEPRARFYAAEIASALGYLHS 114
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGL-----TPLMNTPTVPSRSAGYRAPEVIET 510
+ ++K N+LL ++DFGL T T + Y APEV+
Sbjct: 115 L---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG-TPEYLAPEVLHK 170
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
+ + D + G +L EML G P + ++ D
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 51/228 (22%), Positives = 90/228 (39%), Gaps = 43/228 (18%)
Query: 344 LGKGSYGTTYKAILEE-GTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIR 398
+GKG G Y A V +K+++E + K+ F ++ ++ L HP +VP+
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVY 68
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS--------AKGI 450
+ D +IE + +LL + K S+G+ I
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELA--EKTSVGAFLSIFHKICATI 126
Query: 451 AHIHAAVGGKFILG-NIKSSNVLLSQDLQGCISDFGLTPLMNTP---------------- 493
++H+ K +L ++K N+LL + I D+G
Sbjct: 127 EYVHS----KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 494 ---TVPSRSAG---YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
T+P + G Y APE + ++ +D+Y+ GV+L +MLT P
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 39/175 (22%), Positives = 76/175 (43%), Gaps = 14/175 (8%)
Query: 364 VVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALL 423
+ KR+K + E ++ +GRL+ H N++ I S+ ++ + +S +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLN-HENILKIEEILRSEANTYMITQKYDFDLYSFMY 254
Query: 424 HGNRGIGRTPLDWESR-VKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS 482
PL ++R + L A + +IH K I +IK N+ L+ D + +
Sbjct: 255 DEAFDWKDRPLLKQTRAIMKQLLCA--VEYIHDK---KLIHRDIKLENIFLNCDGKIVLG 309
Query: 483 DFGLTPLMNTPTVPSRSAGY------RAPEVIETKKPTQKSDVYSFGVLLLEMLT 531
DFG G+ +PE++ + +D++S G++LL+ML+
Sbjct: 310 DFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 50/184 (27%), Positives = 84/184 (45%), Gaps = 32/184 (17%)
Query: 434 LDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493
LD E + S AKG++ + + I ++ + N+LL+ I DFGL +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 494 T---------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHED 543
+ +P + + APE I T +SDV+S+G+LL E+ + G +P PG
Sbjct: 268 SNYVVKGNARLPVK---WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY--PGMP- 321
Query: 544 VVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603
VD + +++E + R + E +M I SC P RPT +++V
Sbjct: 322 -VDSKFY--KMIKEGY----------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIV 368
Query: 604 RMIE 607
++IE
Sbjct: 369 QLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 344 LGKGSYGT----TYKAILEEGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVV 395
LG+G+YG E TV +K++ V ++ KR ++++++ H N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNIT 65
Query: 396 PIR----AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIA 451
+ + + +E L + +EA ++ G T ++S + L G+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRS--GQPLTDAHFQSFIYQIL---CGLK 119
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-----------TPLMNTPTVPSRSA 500
+IH+A + ++K N+L++ D + I DFGL M T V +R
Sbjct: 120 YIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATR-- 173
Query: 501 GYRAPEVIETKKPTQKS-DVYSFGVLLLEMLTGK 533
YRAPE++ + + K+ DV+S G +L E+L K
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 37/111 (33%), Positives = 61/111 (54%), Gaps = 11/111 (9%)
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN---TPTVPSRSAGYRA 504
+G+ +IH+A I ++K SNV +++D + I DFGL + T V +R YRA
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR--WYRA 183
Query: 505 PEV-IETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV 554
PE+ + Q D++S G ++ E+L GKA PG++ + L R ++ V
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF--PGNDYIDQLKRIMEVV 232
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 45/206 (21%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 343 VLGKGSYGTTYKAILEEGTTVVVKRL--KEVVMGKREF---EQQMEVVGRLSQHPNVVPI 397
V+G+GSY L++ + ++ KE+V + + + V + S +P +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDW---ESRVKISLGSAKGIAHIH 454
+ + + LV +++ G + R + + E + ++ +GI
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGI---- 117
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFG-----LTPLMNTPTVPSRSAGYRAPEVIE 509
I ++K NVLL D ++D+G L P T T + Y APE++
Sbjct: 118 -------IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCG-TPNYIAPEILR 169
Query: 510 TKKPTQKSDVYSFGVLLLEMLTGKAP 535
++ D ++ GVL+ EM+ G++P
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 58/218 (26%), Positives = 105/218 (48%), Gaps = 29/218 (13%)
Query: 342 EVLGKGSYGTTYKAILE-EGTTVVVK--RLKEVVMGKREFEQQMEVVGRLSQHPNVVPIR 398
E LG+GSY T YK + G V +K RL+E ++ ++ L +H N+V +
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLH 69
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKGIAHIHAAV 457
+K+ LV++++ + + G G P VK+ L +G+++IH
Sbjct: 70 DIIHTKETLTLVFEYVHT-DLCQYMDKHPG-GLHP----ENVKLFLFQLLRGLSYIHQ-- 121
Query: 458 GGKFILG-NIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-------YRAPEV-I 508
++IL ++K N+L+S + ++DFGL +VPS + YR P+V +
Sbjct: 122 --RYILHRDLKPQNLLISDTGELKLADFGLA---RAKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 509 ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
+ + + D++ G + +EM+ G A PG +D+ D
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAF--PGMKDIQD 212
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 24/66 (36%), Positives = 39/66 (59%), Gaps = 1/66 (1%)
Query: 69 AVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG 128
++ L G + G IP +L + SL +L L N +G +P ++ L+SLR L L N+ SG
Sbjct: 446 SINLSGNSIRGNIPP-SLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504
Query: 129 NIPSSL 134
+P++L
Sbjct: 505 RVPAAL 510
|
Length = 623 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 74/326 (22%), Positives = 141/326 (43%), Gaps = 55/326 (16%)
Query: 342 EVLGKGSYGTTYKAILEEGTTV-VVKRLKEVVMGKRE----FEQQMEVVGRLSQHPNVVP 396
+V+G+G++G L+ V +K L + M KR F ++ +V+ ++ +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVL--VNGDNQWIT 64
Query: 397 IRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLD----WESRVKISLGSAKGIA 451
Y F + L LV D+ G LL ++ R P D + + + I++ S +
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG-LTPLMNTPTVPSRSA----GYRAPE 506
++H +IK N+L+ + ++DFG LM TV S A Y +PE
Sbjct: 123 YVHR---------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173
Query: 507 VIETKKPTQ-----KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD-LPRWVQSVVREEWT 560
+++ + + + D +S GV + EML G+ P A E +V+ + + R ++
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA---ESLVETYGKIMNHKERFQFP 230
Query: 561 SEVFDVELMRYENIEEEMVQML--------QIAMSCVAKVPDMRPTMEEVVR------MI 606
++V DV E+ ++ + +++ Q + + P + +R +
Sbjct: 231 AQVTDVS----EDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIP 286
Query: 607 EDIRPSDSENQPSSEDKLKDSNTQTP 632
E P+D+ N +D LK+S T P
Sbjct: 287 EVSSPTDTSNFDVDDDCLKNSETMPP 312
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 9e-05
Identities = 17/47 (36%), Positives = 23/47 (48%), Gaps = 2/47 (4%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNF 126
IP + L +L +L L N+L+ + S L SLR L L NN
Sbjct: 15 IPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 27/167 (16%)
Query: 465 NIKSSNVLLSQDLQGCISDFGLTPLMNTPT---VPSRSAG---YRAPEVIETKKPTQKSD 518
++KS+N+ L + DFG + + V S G Y APE+ E K+ ++K+D
Sbjct: 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKAD 253
Query: 519 VYSFGVLLLEMLTGKAPIQAPGHEDVVD---------LPRWVQSVVREEWTSEVFDVELM 569
++S GV+L E+LT P + P +++ P V S ++ + D L
Sbjct: 254 MWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMK-----ALLDPLLS 308
Query: 570 RYENIEEEMVQMLQIA-MSCVAKVPDMRPTMEEVVRMIEDIRPSDSE 615
+ + Q+L + VA + +++VR E I P D E
Sbjct: 309 KNPALRPTTQQLLHTEFLKYVANL------FQDIVRHSETISPHDRE 349
|
Length = 478 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 12/88 (13%)
Query: 453 IHAAVGGKFIL----GNIKSSNVLLSQDLQG-CISDFGLTPLMNTPTVPSRSAGYRAPEV 507
+H + G IL GN+K + S+ LQ C+S G+ + TP + +PEV
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY-------WMSPEV 180
Query: 508 IETKKPTQKSDVYSFGVLLLEMLTGKAP 535
I + +K+DV+S G ++EMLT K P
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 42/194 (21%), Positives = 82/194 (42%), Gaps = 40/194 (20%)
Query: 363 VVVKRLK--EVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420
V VK L+ + +F ++++++ RL PN+ + ++ +++E G +
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 421 ALLH------GNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS 474
L L + + + ++ A G+ ++ + F+ ++ + N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVG 164
Query: 475 QDLQGCISDFGLTPLMNTPTVPSRSAGY---------RAP--------EVIETKKPTQKS 517
++ I+DFG+ SR+ Y RAP E + K T KS
Sbjct: 165 KNYTIKIADFGM----------SRNL-YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKS 213
Query: 518 DVYSFGVLLLEMLT 531
DV++FGV L E+LT
Sbjct: 214 DVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 42/224 (18%)
Query: 342 EVLGKGSYGTTY-------KAILEEGTT--------VVVKRLKEVVM--GKREFEQQMEV 384
E LG+G +G + L EG V VK L+ V + +F +++++
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70
Query: 385 VGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRT--------PLDW 436
+ RL ++PN++ + S D ++ +++E G + L R I T +
Sbjct: 71 MSRL-KNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL-SQREIESTFTHANNIPSVSI 128
Query: 437 ESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP-------- 488
+ + +++ A G+ ++ + F+ ++ + N L+ I+DFG++
Sbjct: 129 ANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 489 -LMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT 531
+ +P R + A E I K T SDV++FGV L EM T
Sbjct: 186 RIQGRAVLPIR---WMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 2e-04
Identities = 20/61 (32%), Positives = 31/61 (50%), Gaps = 4/61 (6%)
Query: 91 SLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNS 147
+L L L +N L+ +P L +L+ L L NN + P + S P L +DLS N+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 148 I 148
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 2e-04
Identities = 19/60 (31%), Positives = 29/60 (48%), Gaps = 2/60 (3%)
Query: 115 SLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSL 172
+L+ L L NN + + P L +DLS N++T P + L L L+L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 31/110 (28%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 449 GIAHIHAAVGGKFIL-GNIKSSNVLLSQDLQGCISDFGLTPLMN--TPTVPSRSAGYRAP 505
G+ H+H +F++ ++K +N+LL + ISD GL + P + GY AP
Sbjct: 109 GLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAP 164
Query: 506 EVIETKKPTQKS-DVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV 554
EV++ S D +S G +L ++L G +P + +D ++ R +V
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 19/183 (10%)
Query: 360 GTTVVVKRLKEVVMGKR--EFEQQMEVVGRLSQHPNVVPIRAYYFSKDEK--LLVYDFIE 415
G V VK LK G + ++++E++ L H N+V + L+ +F+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ 475
+GS L N+ ++ + ++K ++ KG+ ++ + +++ ++ + NVL+
Sbjct: 92 SGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVES 144
Query: 476 DLQGCISDFGLTPLMNTP----TVPS---RSAGYRAPEVIETKKPTQKSDVYSFGVLLLE 528
+ Q I DFGLT + T TV + APE + K SDV+SFGV L E
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204
Query: 529 MLT 531
+LT
Sbjct: 205 LLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 9/104 (8%)
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL---TPLMNTPTVPSRSAGYRA 504
+G+ +IH+A I ++K SN+ +++D + I DFGL T T V +R YRA
Sbjct: 131 RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR--WYRA 185
Query: 505 PEV-IETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547
PE+ + Q D++S G ++ E+LTG+ H D + L
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 18/38 (47%), Positives = 22/38 (57%)
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539
Y APEV+ TQ D +S GV+L EML G+ P A
Sbjct: 210 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAD 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 49/225 (21%), Positives = 96/225 (42%), Gaps = 39/225 (17%)
Query: 344 LGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQ---QMEVVGRLSQHPNVVPIRA 399
LG GS G + A+ + V VK++ V+ + + +++++ RL H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIRRL-DHDNIVKVYE 69
Query: 400 YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA------------ 447
L D +++ I + ++ + + G
Sbjct: 70 VLGPSGSDL-TEDVGSLTELNSVY-----IVQEYMETDLANVLEQGPLSEEHARLFMYQL 123
Query: 448 -KGIAHIHAAVGGKFILGNIKSSNVLLSQ-DLQGCISDFGLTPLMNTP-------TVPSR 498
+G+ +IH+A + ++K +NV ++ DL I DFGL +++ +
Sbjct: 124 LRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 499 SAGYRAPE-VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHE 542
+ YR+P ++ T+ D+++ G + EMLTGK P+ A HE
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHE 224
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 53/233 (22%), Positives = 89/233 (38%), Gaps = 51/233 (21%)
Query: 343 VLGKGSYGTTYKAILEEGTTVV-VKRLKEVVMGKREFEQQMEV---VGRLSQHPNVVPIR 398
V+G+G++G + ++ V +K L++ M KR + + + P +V +
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 399 AYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
Y F +E L LV +++ G LL + + E + + A+ + + +
Sbjct: 68 -YSFQDEEHLYLVMEYMPGGDLMNLLI-RKDV----FP-EETARFYI--AELVLALDSVH 118
Query: 458 GGKFILGNIKSSNVLLSQDLQGCI--SDFGL------------------TPLMNTPTVPS 497
FI +IK N+L+ D G I +DFGL L +
Sbjct: 119 KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176
Query: 498 RSA---------------GYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
R Y APEV+ + D +S GV+L EML G P
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 63/230 (27%), Positives = 111/230 (48%), Gaps = 37/230 (16%)
Query: 343 VLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
++G GS+G Y+AI ++ V +K+ V+ +++ + ++ + H N++ ++ YY
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKK----VLQDPQYKNRELLIMKNLNHINIIFLKDYY 128
Query: 402 FS----KDEKLL----VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKI-SLGSAKGIAH 452
++ K+EK + V +FI + H R PL VK+ S + +A+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL---FLVKLYSYQLCRALAY 185
Query: 453 IHAAVGGKFILG-NIKSSNVLL---SQDLQGCISDFG-----LTPLMNTPTVPSRSAGYR 503
IH+ KFI ++K N+L+ + L+ C DFG L + + SR YR
Sbjct: 186 IHS----KFICHRDLKPQNLLIDPNTHTLKLC--DFGSAKNLLAGQRSVSYICSRF--YR 237
Query: 504 APEV-IETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ 552
APE+ + T D++S G ++ EM+ G PI + G V L R +Q
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFS-GQSSVDQLVRIIQ 285
|
Length = 440 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVV--VKRLKEVVMGKRE----FEQQMEVVGRLSQHPNVV 395
+V+G+G++G + + + + V +K L + M KR F ++ +++ + +V
Sbjct: 49 KVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAH-ANSEWIV 106
Query: 396 PIRAYYFSKDEKLL--VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI 453
+ +Y +D+K L V +++ G L+ N I P W + A + I
Sbjct: 107 QL--HYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDI---PEKWARFYTAEVVLA--LDAI 158
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN-TPTVPSRSA----GYRAPEVI 508
H+ FI ++K N+LL + ++DFG M+ V +A Y +PEV+
Sbjct: 159 HSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215
Query: 509 ETKKPT----QKSDVYSFGVLLLEMLTGKAPIQA 538
+++ ++ D +S GV L EML G P A
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 54/220 (24%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 343 VLGKGSYGTTYKAILEEGTTVV--VKRLKEVVMGKRE----FEQQMEVVGRLSQHPNVVP 396
++G+G +G + + E+ T + +K +K+ V+ +E FE++ +++ S P +
Sbjct: 8 LVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI-SNSPWIPQ 65
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
++ + KD LV ++ G +LL NR D E + L A+ + IH+
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYED--QFD-EDMAQFYL--AELVLAIHSV 118
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT-----PTVPSRSAGYRAPEVIETK 511
++ +IK NVL+ + ++DFG + +P + Y APEV+ T
Sbjct: 119 HQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 512 KPTQKS------DVYSFGVLLLEMLTGKAPIQAPGHEDVV 545
K D +S GV+ EM+ G++P HE
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPF----HEGTS 214
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 41/219 (18%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKR--------------LKEVVMGKREFEQQMEVVG 386
E +G+G+YG YKA G V +K+ L+E+ + QM
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISL------LQM---- 56
Query: 387 RLSQHPNVVPIRAYYFSKDEK-----LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK 441
LS+ +V + +++ LV++++++ + N PL ++
Sbjct: 57 -LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKS 114
Query: 442 ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC-ISDFGLTPLMNTP----TVP 496
KG+AH H + ++K N+L+ + I+D GL + P T
Sbjct: 115 FMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 497 SRSAGYRAPEV-IETKKPTQKSDVYSFGVLLLEMLTGKA 534
+ YRAPEV + + + D++S G + EM +
Sbjct: 172 IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 12/88 (13%)
Query: 453 IHAAVGGKFIL----GNIKSSNVLLSQDLQG-CISDFGLTPLMNTPTVPSRSAGYRAPEV 507
+H + G IL GN+K + S+ LQ C+S G+ + TP + +PEV
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY-------WMSPEV 180
Query: 508 IETKKPTQKSDVYSFGVLLLEMLTGKAP 535
I + +K+D++S G ++EMLT K P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 42/197 (21%), Positives = 90/197 (45%), Gaps = 32/197 (16%)
Query: 375 KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALL----------H 424
+ +F ++++++ RL PN++ + +D ++ +++E G + L +
Sbjct: 63 RNDFLKEVKILSRLKD-PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 425 GNRGIGRT----PLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC 480
GN + + + S + ++L A G+ ++ + F+ ++ + N L+ ++L
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIK 178
Query: 481 ISDFGLTP---------LMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT 531
I+DFG++ + +P R + A E I K T SDV++FGV L E+L
Sbjct: 179 IADFGMSRNLYAGDYYRIQGRAVLPIR---WMAWECILMGKFTTASDVWAFGVTLWEILM 235
Query: 532 --GKAPIQAPGHEDVVD 546
+ P E V++
Sbjct: 236 LCKEQPYGELTDEQVIE 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 3e-04
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 42/227 (18%)
Query: 343 VLGKGSYGTTYKAILEEGT-------------TVVVKRLKEVVMGKREFEQQMEVVGRLS 389
VLGKG YG ++ G +V+ K+ K E +E V
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAE-RNILEAV---- 57
Query: 390 QHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNR-GI--GRTPLDWESRVKISLG 445
+HP +V + Y F KL L+ +++ G +H R GI T + S + ++L
Sbjct: 58 KHPFIVDL-IYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALE 114
Query: 446 SAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCI--SDFGL-TPLMNTPTVPSRSAG- 501
H+H I ++K N+LL D QG + +DFGL ++ TV G
Sbjct: 115 ------HLHQQ---GIIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEGTVTHTFCGT 163
Query: 502 --YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
Y APE++ + D +S G L+ +MLTG P A + +D
Sbjct: 164 IEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 46/215 (21%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 343 VLGKGSYGTTYKAILE----EGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNVVP 396
+LG G +G + L+ V + L+ K R F + +G+ H N+V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSNIVR 70
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ + ++V +++ G+ + L + G L + + G A G+ ++ +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEG----QLVAGQLMGMLPGLASGMKYL-SE 125
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETK 511
+G ++ + + VL++ DL IS F + + + +G + APE I+
Sbjct: 126 MG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 512 KPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVV 545
+ SDV+SFG+++ E+++ G+ P +DV+
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 57/230 (24%)
Query: 343 VLGKGSYGTTYKAILEE-GTTVVVKRL-----KE--VVMGKREFEQQMEVVGRLSQHPNV 394
+G+G+YG YKA ++ G V +K++ KE + RE + + R H N+
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK-----ILRQLNHRNI 68
Query: 395 VPIR--------AYYFSKDEK--LLVYDFIEAGSF----SALLHGN----RGIGRTPLDW 436
V ++ A F KD+ LV+++++ S L+H + + + L+
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE- 127
Query: 437 ESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493
G+ + H F+ +IK SN+LL+ Q ++DFGL L N+
Sbjct: 128 ------------GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 494 --TVPSRSAGYRAPEVI---ETKKPTQKSDVYSFGVLLLEMLTGKAPIQA 538
T + YR PE++ E P DV+S G +L E+ T K QA
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPA--IDVWSCGCILGELFTKKPIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 50/211 (23%), Positives = 89/211 (42%), Gaps = 46/211 (21%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEV--VGRLSQHPNVVPIRAY 400
+G+G++ KA + G +K +K+ + E+ + RLS HPN++ +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 401 YFSKDEKLL----------VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKG 449
F + L +Y+ I+ R + PL E RVK + K
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIK----------GR---KRPLP-EKRVKSYMYQLLKS 112
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR--------SAG 501
+ H+H G F +IK N+L+ D+ ++DFG + + S+ +
Sbjct: 113 LDHMHR--NGIF-HRDIKPENILIKDDI-LKLADFG-----SCRGIYSKPPYTEYISTRW 163
Query: 502 YRAPEVIETKKP-TQKSDVYSFGVLLLEMLT 531
YRAPE + T K D+++ G + E+L+
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 47/227 (20%), Positives = 96/227 (42%), Gaps = 35/227 (15%)
Query: 340 SAEVLGKGSYGTTYKAILEEGTTVVVKR--LKEVVMGKREFEQQMEVVGRLS----QHPN 393
+++L +G++G + IL + + +K V E + + + H N
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQN 69
Query: 394 VVPI-RAYYFSKDEKLLVYDFIEAGSFSALL----HGNRGIGRTPLDWESRVKISLGSAK 448
++PI + ++Y ++ G+ L G + L + V +++ A
Sbjct: 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA-LSTQQLVHMAIQIAC 128
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPS----------R 498
G++++H I +I + N ++ ++LQ I+D L+ P R
Sbjct: 129 GMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALS----RDLFPMDYHCLGDNENR 181
Query: 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDV 544
+ A E + K+ + SDV+SFGVLL E++T G+ P + ++
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP-----YVEI 223
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 5e-04
Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 13/148 (8%)
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKG 449
+PN + + + +L+ D+I+ G LL L E+ VK I +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-----KLS-EAEVKKIIRQLVEA 121
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLMNTPTVPSRSAGYRAPEVI 508
+ +H I +IK NVL + + + D+GL ++ TP+ + Y +PE I
Sbjct: 122 LNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKI 178
Query: 509 ETKKPTQKS-DVYSFGVLLLEMLTGKAP 535
+ S D ++ GVL E+LTGK P
Sbjct: 179 K-GHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 68/297 (22%), Positives = 115/297 (38%), Gaps = 76/297 (25%)
Query: 342 EVLGKGSYGTTYKAILEE--------GTTVVVKRLKEVVMGKREF-EQQMEVVGRLSQ-- 390
E LG+G++ +K I E T V++K L + R + E E +SQ
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLS 57
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA--- 447
H ++V DE ++V ++++ GS L N+ + + W+ V L A
Sbjct: 58 HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNL--INISWKLEVAKQLAWALHF 115
Query: 448 ---KGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGC-----ISDFGLTPLMNTPTVP 496
KG+ H GN+ + NVLL + G +SD G++ + +
Sbjct: 116 LEDKGLTH-----------GNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL 164
Query: 497 SRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTG-KAPIQAPG-------HEDVVDL 547
+ PE IE + + +D +SFG L E+ +G P+ A +ED L
Sbjct: 165 LERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQL 224
Query: 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
P +WT E+ ++ C+ PD RP+ ++R
Sbjct: 225 P-------APKWT----------------ELANLIN---QCMDYEPDFRPSFRAIIR 255
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 56/220 (25%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKRE---FEQQMEV-VGRLSQHPNVVPI 397
+ LG+GSY T YK + +V LKE+ + E F E + + +H N+V +
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVA--LKEIRLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKGIAHIHAA 456
+K LV+++++ + G+ V++ L +G+A+ H
Sbjct: 69 HDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLS------MHNVRLFLFQLLRGLAYCH-- 120
Query: 457 VGGKFILG-NIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-------YRAPEVI 508
+ +L ++K N+L+S+ + ++DFGL +VPS++ YR P+V+
Sbjct: 121 --QRRVLHRDLKPQNLLISERGELKLADFGLA---RAKSVPSKTYSNEVVTLWYRPPDVL 175
Query: 509 --ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
T+ T D++ G + EM TG+ PG DV D
Sbjct: 176 LGSTEYSTS-LDMWGVGCIFYEMATGRPLF--PGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 10/110 (9%)
Query: 433 PLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMN 491
PLD + ++ S A+G+ + + I ++ + NVLL+ I DFGL +MN
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 492 TPTVPSRSAG-----YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAP 535
+ + APE I T +SDV+S+G+LL E+ + GK+P
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 30/110 (27%), Positives = 55/110 (50%), Gaps = 8/110 (7%)
Query: 449 GIAHIHAAVGGKFIL-GNIKSSNVLLSQDLQGCISDFGLTPLMNT--PTVPSRSAGYRAP 505
G+ H+H +F++ ++K +N+LL + ISD GL + P + GY AP
Sbjct: 109 GLEHMH----NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAP 164
Query: 506 EVIETKKPTQKS-DVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV 554
EV++ S D +S G +L ++L G +P + +D ++ R ++
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 20/38 (52%), Positives = 24/38 (63%)
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539
Y APEV+ K TQ D +S GV+L EML G+ P AP
Sbjct: 214 YIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAP 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 34/224 (15%)
Query: 337 LRASAE------VLGKGSYGTTYKAILEEGTTVV--VKRLKEVVMGKRE----FEQQMEV 384
LR AE V+G+G++G + + + T V +K L + M KR F ++ ++
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 385 VGRLSQHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKIS 443
+ + P VV + Y F D L +V +++ G L+ + + + V ++
Sbjct: 97 MA-FANSPWVVQL-FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA 154
Query: 444 LGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV-----PSR 498
L + + IH ++K N+LL + ++DFG MN +
Sbjct: 155 LDAIHSMGFIHR---------DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205
Query: 499 SAGYRAPEVIETKKPT----QKSDVYSFGVLLLEMLTGKAPIQA 538
+ Y +PEV++++ ++ D +S GV L EML G P A
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 27/102 (26%), Positives = 49/102 (48%), Gaps = 15/102 (14%)
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL--------MNTPTVPSRS 499
+G+ ++H+A + +IK N+L++ + I DFGL + M V +
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV---T 167
Query: 500 AGYRAPEVIE-TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540
YRAPE++ ++ T D++S G + E+L + QA
Sbjct: 168 QYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 71/287 (24%), Positives = 112/287 (39%), Gaps = 54/287 (18%)
Query: 344 LGKGSYGTTYKAILEE------GTTVVVKRLK--EVVMGKREFEQQMEVVGRLSQHPNVV 395
+G G +G K IL E VVVK L+ V + +F ++ + R QH N++
Sbjct: 3 IGNGWFG---KVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPY-RSLQHSNLL 58
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
LLV +F G L R D + +++ A G+ H+H
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL------MNTPT---VPSRSAGYRAPE 506
FI ++ N LL+ DL I D+GL+ TP VP R + APE
Sbjct: 119 ---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR---WIAPE 172
Query: 507 VIE-------TKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREE 558
+++ T++S+V+S GV + E+ G P + E V+ VRE+
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY------TVREQ 226
Query: 559 ---WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEV 602
+ L ++ C + P+ RP+ EEV
Sbjct: 227 QLKLPKPRLKLPLSDR---------WYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 52/212 (24%), Positives = 95/212 (44%), Gaps = 39/212 (18%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS----------Q 390
E +G+G+YG YKA G V +K+++ E + E V +
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIR--------LETEDEGVPSTAIREISLLKELN 56
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKG 449
HPN+V + S+++ LV++F++ L T LD +K L +G
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLD-PPLIKSYLYQLLQG 111
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-------Y 502
IA+ H + + ++K N+L+ ++ ++DFGL VP R+ Y
Sbjct: 112 IAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFG---VPVRTYTHEVVTLWY 165
Query: 503 RAPEV-IETKKPTQKSDVYSFGVLLLEMLTGK 533
RAPE+ + +++ + D++S G + EM+ +
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 66/247 (26%), Positives = 105/247 (42%), Gaps = 45/247 (18%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNV------- 394
+V+G+G++G A+++ T + +K ++ K E ++ E + NV
Sbjct: 7 KVIGRGAFGEV--AVVKMKHTERIYAMK--ILNKWEMLKRAETAC-FREERNVLVNGDCQ 61
Query: 395 -VPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
+ Y F + L LV D+ G LL ++ R P D +R I A+ +
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLPEDM-ARFYI----AEMVLA 114
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCI--SDFGLTPLMNTP-TVPSRSA----GYRAP 505
IH+ ++ +IK NVLL D+ G I +DFG MN TV S A Y +P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 506 EVIETK-----KPTQKSDVYSFGVLLLEMLTGKAPIQAPG----------HEDVVDLPRW 550
E+++ K + D +S GV + EML G+ P A HE+ P
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSH 232
Query: 551 VQSVVRE 557
+ V E
Sbjct: 233 ITDVSEE 239
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 46/186 (24%), Positives = 88/186 (47%), Gaps = 24/186 (12%)
Query: 363 VVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420
V VK L+E + +F ++++++ RL + PN++ + A + D ++ +++E G +
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK------FILGNIKSSNVLLS 474
L +R + + V IS + +A A G K F+ ++ + N L+
Sbjct: 108 QFL--SRHEPQEAAEKADVVTISYSTLIFMA-TQIASGMKYLSSLNFVHRDLATRNCLVG 164
Query: 475 QDLQGCISDFGLTP---------LMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVL 525
++ I+DFG++ + +P R + + E I K T SDV++FGV
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR---WMSWESILLGKFTTASDVWAFGVT 221
Query: 526 LLEMLT 531
L E+LT
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 12/88 (13%)
Query: 453 IHAAVGGKFIL----GNIKSSNVLLSQDLQG-CISDFGLTPLMNTPTVPSRSAGYRAPEV 507
+H + G IL GN+K + S+ +Q C+S G+ + TP + +PEV
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY-------WMSPEV 180
Query: 508 IETKKPTQKSDVYSFGVLLLEMLTGKAP 535
I + +K+DV+S ++EMLT K P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 343 VLGKGSYGTTYKAILEEGTTV----VVKRLKEVVMGKREF---EQQMEVVGRLSQHPNVV 395
V+G+GSY L++ + V+K KE+V + + + V S HP +V
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIK--KELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ + + ++ V +F+ G + R + P E + SA+ ++
Sbjct: 60 GLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR---KLP---EEHARFY--SAEISLALNF 111
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFG-----LTPLMNTPTVPSRSAGYRAPEVIET 510
I ++K NVLL + ++D+G + P T T + Y APE++
Sbjct: 112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG-TPNYIAPEILRG 170
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
+ D ++ GVL+ EM+ G++P G D D
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 35.2 bits (82), Expect = 0.004
Identities = 14/34 (41%), Positives = 19/34 (55%)
Query: 161 HLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
+L L+L NN +T P NL L L+LS N +
Sbjct: 2 NLETLDLSNNQITDLPPLSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 632 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.74 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.49 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.42 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.27 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.26 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.21 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.19 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.16 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.15 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.06 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.97 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.95 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.91 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.91 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.89 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.8 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.75 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.75 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.7 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.7 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.66 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.66 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.58 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.56 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.44 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.35 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.35 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.31 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.31 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.29 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.29 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.08 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.07 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.02 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.0 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.99 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.97 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-61 Score=570.18 Aligned_cols=491 Identities=30% Similarity=0.472 Sum_probs=334.1
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEcc
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLS 144 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls 144 (632)
+..|+|++|.+.|.+|. .+ .+++|+.|+|++|+++|.+|..+.++++|++|+|++|+++|.+|..+. ++|++|+|+
T Consensus 454 L~~L~L~~n~~~~~~p~-~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 531 (968)
T PLN00113 454 LQMLSLARNKFFGGLPD-SF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531 (968)
T ss_pred CcEEECcCceeeeecCc-cc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECC
Confidence 44455555555555554 22 346667777777777777777777777777777777777777776664 567777777
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCccc--ccCCCCCCccCCCCCCCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLA--LQKFPPSSFEGNSMLCGPP 220 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~n~~~c~~~ 220 (632)
+|.++|.+|..|.++++|+.|+|++|+++|.+|.. .+++|+.|++++|+++|.+|.. +..+...++.||..+|+.+
T Consensus 532 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~ 611 (968)
T PLN00113 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD 611 (968)
T ss_pred CCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCc
Confidence 77777777777777777777777777777777753 6677777777777777777753 4455566677777777643
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccccceeeehhhHHHHHHHHHHHHHhhhhccCCCCCcccccCCCc
Q 006747 221 LNQCSTVPPAPSPSATNFPPPPTVLPKPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGTAATKSKGI 300 (632)
Q Consensus 221 ~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ii~ivi~~~~~v~l~~~~i~~~~~~~~~~~~~~~~~~~~~ 300 (632)
...- . + +... .........+++++++++++ ++++++++++++++++......
T Consensus 612 ~~~~-------~------~------~c~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~------ 663 (968)
T PLN00113 612 TTSG-------L------P------PCKR--VRKTPSWWFYITCTLGAFLV-LALVAFGFVFIRGRNNLELKRV------ 663 (968)
T ss_pred cccC-------C------C------CCcc--ccccceeeeehhHHHHHHHH-HHHHHHHHHHHHhhhccccccc------
Confidence 1100 0 0 0000 00011111222222222221 1122222222222221111000
Q ss_pred cCCCCCcccCCcchhcccCceEEec-CCCcCCCHHHHHHHH--HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHH
Q 006747 301 RNEKPKEDFGSGVQEAEKNKLVFFE-GCSYNFDLEDLLRAS--AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKR 376 (632)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~--~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~ 376 (632)
+..... .....+. .....++++++.... .++||+|+||.||+|.. .++..||||+++.....
T Consensus 664 --~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-- 729 (968)
T PLN00113 664 --ENEDGT----------WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-- 729 (968)
T ss_pred --cccccc----------ccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc--
Confidence 000000 0000011 011224455554433 35799999999999986 57899999998754322
Q ss_pred HHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhc
Q 006747 377 EFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456 (632)
Q Consensus 377 ~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~ 456 (632)
...|++.+.++ +|||||+++|+|.+.+..++||||+++|+|.++++. ++|..+.+|+.|+|+||+|||+.
T Consensus 730 -~~~~~~~l~~l-~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~ 799 (968)
T PLN00113 730 -PSSEIADMGKL-QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCR 799 (968)
T ss_pred -cHHHHHHHhhC-CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccC
Confidence 23457888999 999999999999999999999999999999999952 78999999999999999999987
Q ss_pred cCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCC
Q 006747 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPI 536 (632)
Q Consensus 457 ~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~ 536 (632)
+.++|+||||||+||++++++.+++. ||.+..........++.+|+|||++.+..++.++|||||||++|||+||+.||
T Consensus 800 ~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~ 878 (968)
T PLN00113 800 CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA 878 (968)
T ss_pred CCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence 77799999999999999999998886 77665554444456788999999999999999999999999999999999999
Q ss_pred CCCCCCCCCChhHHHHHHhhhcccccccccccccc-CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 537 QAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY-ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
+... .....+.+|++....+......+|+.+... ....+++.++.+++.+||+.||++||||+||++.|+++....
T Consensus 879 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 879 DAEF-GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred Cccc-CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 5432 233456777766554444444555554322 233566778899999999999999999999999999986653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-56 Score=462.03 Aligned_cols=281 Identities=39% Similarity=0.685 Sum_probs=249.7
Q ss_pred CcCCCHHHHHHHH-----HhHhCccceeEEEEEEEcCCcEEEEEEecccccC-HHHHHHHHHHHHhhcCCCCccceeEEE
Q 006747 328 SYNFDLEDLLRAS-----AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNVVPIRAYY 401 (632)
Q Consensus 328 ~~~~~~~~l~~~~-----~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~ 401 (632)
...|+++++..+| .+.||+|+||.||+|.+.+|..||||++...... .++|..|++++.++ +|||+|+|+|||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYC 140 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEE
Confidence 4568999999998 4689999999999999999999999998876554 67799999999999 799999999999
Q ss_pred EeCC-ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeE
Q 006747 402 FSKD-EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC 480 (632)
Q Consensus 402 ~~~~-~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~k 480 (632)
.+.+ +.+||||||++|+|.++|+..... +++|..|++|+.++|+||+|||+.+.++||||||||+|||||+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9998 599999999999999999976432 799999999999999999999999999999999999999999999999
Q ss_pred EcccCCCCCCCC-CCCC----CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh
Q 006747 481 ISDFGLTPLMNT-PTVP----SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV 555 (632)
Q Consensus 481 i~DfGla~~~~~-~~~~----~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 555 (632)
|+|||+|+.... .... .||.||+|||++..+..+.|+|||||||+|+|++||+.|.+.........+..|+...+
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999977654 3221 68999999999999999999999999999999999999987654444455899999999
Q ss_pred hhccccccccccccccCCc-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 556 REEWTSEVFDVELMRYENI-EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 556 ~~~~~~~~~d~~~~~~~~~-~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.+....+++|+.+...... .+++.++.+++.+|++.+|++||+|.||+++|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 9989999999998643333 36888899999999999999999999999999776544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=401.08 Aligned_cols=258 Identities=31% Similarity=0.462 Sum_probs=210.5
Q ss_pred CCHHHHHHHHHhHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCC-c
Q 006747 331 FDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-E 406 (632)
Q Consensus 331 ~~~~~l~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~ 406 (632)
++.+++. ..+.+|+|+||+||+|.+.....||||++.....+ .++|.+|+.++.++ +|||||+++|+|.+.. .
T Consensus 38 i~~~~l~--~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELP--IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhh--hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCc
Confidence 4455553 35669999999999999975445999999876433 45899999999999 9999999999999887 7
Q ss_pred eEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCC-ceecCCCCCCeeecCCC-CeEEccc
Q 006747 407 KLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK-FILGNIKSSNVLLSQDL-QGCISDF 484 (632)
Q Consensus 407 ~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivHrDlk~~NILl~~~~-~~ki~Df 484 (632)
.++|||||++|+|.++++.. ....+++..+++++.+||+||.|||+. + ||||||||+|||++.++ ++||+||
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCC
Confidence 99999999999999999874 234699999999999999999999998 6 99999999999999997 9999999
Q ss_pred CCCCCCCC----CCCCCCCCcccCCcccc--CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006747 485 GLTPLMNT----PTVPSRSAGYRAPEVIE--TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE 558 (632)
Q Consensus 485 Gla~~~~~----~~~~~~t~~y~aPE~~~--~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (632)
|+++.... .+...||..|||||++. ...|+.|+|||||||+||||+||+.||..... .+. ........
T Consensus 189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~---~~~v~~~~ 262 (362)
T KOG0192|consen 189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQV---ASAVVVGG 262 (362)
T ss_pred ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHH---HHHHHhcC
Confidence 99987653 23356899999999999 56899999999999999999999999976432 111 11111111
Q ss_pred cccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 559 WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 559 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
.. ..-..+....+..++.+||..||+.||++.+++..|+.+....
T Consensus 263 ~R----------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 263 LR----------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CC----------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 11 1111224456778888999999999999999999999886543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=398.60 Aligned_cols=258 Identities=27% Similarity=0.450 Sum_probs=218.3
Q ss_pred cCCCHHHHHHHHHhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceE
Q 006747 329 YNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKL 408 (632)
Q Consensus 329 ~~~~~~~l~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 408 (632)
..++.+++ ...+.||+|.||.||.|.++....||+|.++.......+|.+|+++|.++ +|+|||+++|+|..++.++
T Consensus 201 wei~r~~l--~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 201 WEIPREEL--KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred eeecHHHH--HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecCCceE
Confidence 34555555 45789999999999999998888999999998888889999999999999 9999999999999988999
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
||||||+.|+|.++|+.. ....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+
T Consensus 278 IVtE~m~~GsLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred EEEEecccCcHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence 999999999999999873 234578889999999999999999999 99999999999999999999999999999
Q ss_pred CCCCCCCCC-----CCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 489 LMNTPTVPS-----RSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 489 ~~~~~~~~~-----~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
....+.+.. -...|.|||.+..+.++.|||||||||+||||+| |+.||.++...+.. .. +..++
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~------~~-le~Gy--- 421 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL------EL-LERGY--- 421 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH------HH-HhccC---
Confidence 655543322 2345999999999999999999999999999999 99999876543322 11 22222
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
+...+..+...+.+||..||..+|++|||++.+...|+++...
T Consensus 422 -------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 422 -------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred -------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 2233344556788899999999999999999999999988554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=370.35 Aligned_cols=254 Identities=24% Similarity=0.398 Sum_probs=207.3
Q ss_pred CCHHHHHHHHHhHhCccceeEEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC-c
Q 006747 331 FDLEDLLRASAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-E 406 (632)
Q Consensus 331 ~~~~~l~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~ 406 (632)
+.+.|+. ..+.||+|..|+|||+.++ +++.+|+|.+.... ...+++.+|++++.+. +||+||.++|.|.... +
T Consensus 76 i~~~dle--~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 76 ISLSDLE--RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cCHHHhh--hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCce
Confidence 5566663 4678999999999999965 57889999995432 3367899999999999 9999999999999998 5
Q ss_pred eEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCC
Q 006747 407 KLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486 (632)
Q Consensus 407 ~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 486 (632)
..|+||||++|+|++++...+ .+++...-+|+.+|++||.|||+. .+||||||||+|||++..|++||||||.
T Consensus 153 isI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccc
Confidence 999999999999999998652 377888899999999999999963 2999999999999999999999999999
Q ss_pred CCCCCCC--CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 487 TPLMNTP--TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 487 a~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
++.+... .+..||..|||||.+.+..|+.++||||||++++|+.+|+.||... ........+.+..+..+.-
T Consensus 226 S~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv~~pp----- 299 (364)
T KOG0581|consen 226 SGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIVDEPP----- 299 (364)
T ss_pred cHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHhcCCC-----
Confidence 9887654 3456999999999999999999999999999999999999999764 1222233333333332211
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+.+.. . ....++..++..|+++||.+|||++|++++
T Consensus 300 -P~lP~--~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 -PRLPE--G--EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -CCCCc--c--cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111 1 244567788889999999999999999874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=411.97 Aligned_cols=260 Identities=25% Similarity=0.439 Sum_probs=217.3
Q ss_pred CCCHHHHHHHHHhHhCccceeEEEEEEE------cCCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEE
Q 006747 330 NFDLEDLLRASAEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYY 401 (632)
Q Consensus 330 ~~~~~~l~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~ 401 (632)
.|...++. ..+.||+|.||+||+|+. .+.+.||||.+++.... ..+|++|++++..+ +|||||+|+|.|
T Consensus 482 ~i~r~~i~--~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlGVC 558 (774)
T KOG1026|consen 482 EIPRSDIV--FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLGVC 558 (774)
T ss_pred Eechhhee--ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEEEE
Confidence 34444442 357899999999999984 34678999999987443 67899999999999 999999999999
Q ss_pred EeCCceEEEEecccCCCHhhhhccCCCC--------C-CCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCee
Q 006747 402 FSKDEKLLVYDFIEAGSFSALLHGNRGI--------G-RTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVL 472 (632)
Q Consensus 402 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~--------~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIL 472 (632)
.+++.+++|+|||..|||.++|...... . +.+|+..+.+.||.|||.||+||-++ .+|||||..+|+|
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCL 635 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCL 635 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhce
Confidence 9999999999999999999999744321 1 34589999999999999999999998 9999999999999
Q ss_pred ecCCCCeEEcccCCCCCCCCCCCCC------CCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 006747 473 LSQDLQGCISDFGLTPLMNTPTVPS------RSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVV 545 (632)
Q Consensus 473 l~~~~~~ki~DfGla~~~~~~~~~~------~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~ 545 (632)
|.++..+||+|||+++.....++.. -...||+||.|..+++|++||||||||||||++| |+.||.+...++..
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 9999999999999998765544332 2457999999999999999999999999999999 99999887665543
Q ss_pred ChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 546 DLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
+. ++.+.. ...++.+..+++.||..||+.+|++||+++||-..|+.....
T Consensus 716 e~-------i~~g~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 716 EC-------IRAGQL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HH-------HHcCCc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 22 222221 234455667899999999999999999999999999987554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=356.58 Aligned_cols=242 Identities=23% Similarity=0.417 Sum_probs=193.1
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEeccccc--------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVM--------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.||+|+||.|-+|. .++|+.||||++.+... ......+|+++|+++ +|||||++.++|...+..|+||
T Consensus 177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecCCceEEEE
Confidence 5789999999999998 56799999999976421 123467999999999 9999999999999999999999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC---CCeEEcccCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD---LQGCISDFGLTP 488 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~---~~~ki~DfGla~ 488 (632)
|||+||+|.+.+-.++. +.+..-..++.|++.|+.|||+. +|+||||||+|||+..+ ..+||+|||+|+
T Consensus 256 E~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999876643 45556677899999999999999 99999999999999766 889999999999
Q ss_pred CCCCC---CCCCCCCcccCCccccCCC---CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 489 LMNTP---TVPSRSAGYRAPEVIETKK---PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 489 ~~~~~---~~~~~t~~y~aPE~~~~~~---~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
..+.. .+.+||+.|.|||++.+.. +..++|+||+||+||-+++|.+||.+..... .....+....+.
T Consensus 328 ~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~-----sl~eQI~~G~y~-- 400 (475)
T KOG0615|consen 328 VSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP-----SLKEQILKGRYA-- 400 (475)
T ss_pred ccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-----cHHHHHhcCccc--
Confidence 98754 3458999999999997654 3458899999999999999999997643222 111111111111
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
+.+. .+. +-..+..+++.++|..||++|||+.|+++
T Consensus 401 -f~p~--~w~---~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 401 -FGPL--QWD---RISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -ccCh--hhh---hhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1100 112 22345667788999999999999999987
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=369.22 Aligned_cols=238 Identities=21% Similarity=0.396 Sum_probs=201.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.++||+|||+.||+++. ..|..||+|++.+. ...++...+|+++...+ +|||||+++++|++.+++|||.|+|+
T Consensus 23 g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FEDs~nVYivLELC~ 101 (592)
T KOG0575|consen 23 GRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFEDSNNVYIVLELCH 101 (592)
T ss_pred eeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeecCCceEEEEEecC
Confidence 57899999999999996 88999999999874 23457799999999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|..+++.. .++++.....+..||+.||.|||+. +|||||||-.|++|++++++||+|||||..+...
T Consensus 102 ~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 102 RGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred CccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccc
Confidence 99999998843 4689999999999999999999999 9999999999999999999999999999887643
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
.+.+||+.|+|||++....++..+||||+||+||-|+.|++||+...-.+ -...+...++
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke------ty~~Ik~~~Y------------ 235 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE------TYNKIKLNEY------------ 235 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH------HHHHHHhcCc------------
Confidence 34579999999999999899999999999999999999999997532111 1111111111
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..+.....+..+|+...|+.||.+|||+++|+.+
T Consensus 236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111233456678889999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=346.54 Aligned_cols=190 Identities=26% Similarity=0.427 Sum_probs=171.1
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||+||+|+++ ++..||||.+.+.... .+-...|+++|+.+ +|||||++++++..++.+|+|||||.+|
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~~~i~lVMEyC~gG 94 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDDDFIYLVMEYCNGG 94 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence 45999999999999954 5899999999766422 34578999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC------CCeEEcccCCCCCCC
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD------LQGCISDFGLTPLMN 491 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~------~~~ki~DfGla~~~~ 491 (632)
||.++++..+ .+++.....++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+|+.+.
T Consensus 95 DLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 95 DLSDYIRRRG-----RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999999764 488889999999999999999999 99999999999999865 568999999999998
Q ss_pred CCC---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 006747 492 TPT---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540 (632)
Q Consensus 492 ~~~---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~ 540 (632)
... +.+|++-|||||++..++|+.|+|+||.|+++||+++|+.||+...
T Consensus 167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 653 3479999999999999999999999999999999999999998544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=380.52 Aligned_cols=247 Identities=23% Similarity=0.476 Sum_probs=212.8
Q ss_pred HhHhCccceeEEEEEEEcC----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.++||.|.||.||+|+++- ...||||.++.... .+++|..|..+|+++ +||||++|.|+.......+||+|||
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTks~PvMIiTEyM 712 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTKSKPVMIITEYM 712 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEecCceeEEEhhhh
Confidence 4689999999999999643 46899999997643 367899999999999 9999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
+||+|+.+|+.+.+ .+.+.+.+-+..+||.||.||-+. ++|||||.++|||++.+..+||+|||+++.+.++.
T Consensus 713 ENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 713 ENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999997642 388899999999999999999988 99999999999999999999999999999986654
Q ss_pred CC-CC------CCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 495 VP-SR------SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 495 ~~-~~------t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
.. .. ...|.|||.|..++++.++|||||||||||.++ |.+||+.+.+.+.. ..+.+++
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI-------kaIe~gy------- 851 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI-------KAIEQGY------- 851 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH-------HHHHhcc-------
Confidence 22 22 245999999999999999999999999999988 99999987654432 1222222
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
+...+.++...+.+||..||++|-.+||++.+|+..|+++...
T Consensus 852 ---RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 852 ---RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ---CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 3344556778899999999999999999999999999997544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=332.55 Aligned_cols=250 Identities=23% Similarity=0.404 Sum_probs=202.3
Q ss_pred HHhHhCccceeEEEEEE-EcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeE-EEEeCCc-eEEEEec
Q 006747 340 SAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRA-YYFSKDE-KLLVYDF 413 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~-~~~~~~~-~~lv~E~ 413 (632)
..+.||+|+||+|||+. +.+|..||.|.+.-...+ +.+...|+.+|+++ +|||||++++ .+.++.+ ++|||||
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHHHHHh
Confidence 46899999999999998 678999999999855433 45788999999999 9999999999 4444444 8999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccC-CCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG-GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
+..|||..+++..+. ....+++..++++..|++.||.++|+... .-|+||||||.||+|+.+|.+|++|||+++++..
T Consensus 102 c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 999999999986653 34568999999999999999999999532 2389999999999999999999999999999876
Q ss_pred CC----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 493 PT----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 493 ~~----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
.. ...||+.||+||.+.+..|+.|+||||+||++|||..-..||.+. .+.+..+.+...+ ...+
T Consensus 181 ~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd-~~~~----- 248 (375)
T KOG0591|consen 181 KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGD-YPPL----- 248 (375)
T ss_pred hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCC-CCCC-----
Confidence 54 346999999999999999999999999999999999999999864 2333333322221 1100
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
.......++..|+..|+..||+.||+...+++.+.
T Consensus 249 ----p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 249 ----PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 11334556788899999999999999655555444
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=389.67 Aligned_cols=252 Identities=25% Similarity=0.445 Sum_probs=208.3
Q ss_pred HhHhCccceeEEEEEEEcC--Cc----EEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILEE--GT----TVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~--~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|.||.||+|.+.+ |. .||||.+++.. ....+|.+|..+|+.+ +|||||+++|.|.+....+|++|
T Consensus 697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecCCCCcEEEeh
Confidence 5689999999999999654 33 49999998763 3467899999999999 99999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC--CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGI--GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
||++|||..+|++.+.. ....+.....+.++.+||+|+.||+++ ++|||||.++|+||++...+||+|||+|+.+
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 99999999999976432 234688899999999999999999999 9999999999999999999999999999954
Q ss_pred CCCCCC-C-----CCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 491 NTPTVP-S-----RSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 491 ~~~~~~-~-----~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
....+. . -...|||||.+..+.+++|+|||||||+|||++| |..||......+... .....+
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~gg----- 921 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGG----- 921 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCC-----
Confidence 332221 1 2346999999999999999999999999999999 999997655433211 111121
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
+...+..+...++++|..||+.+|++||++..++..+..+.+..
T Consensus 922 ------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 922 ------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 22333445567889999999999999999999999999876553
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.82 Aligned_cols=255 Identities=24% Similarity=0.316 Sum_probs=197.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
...+|+|+||.|||++.+ .|+.||||++.....+ ++...+|+++|.++ +|+|+|.++.+|..+...++||||++.
T Consensus 7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhcceeEEEeeecch
Confidence 357899999999999965 4899999999876543 56789999999999 999999999999999999999999998
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
--|.++-+... .++.....++..|+++|+.|+|++ ++|||||||+||||+.++.+|+||||+|+.+....
T Consensus 86 TvL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 86 TVLHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred HHHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcch
Confidence 55554433222 367788899999999999999998 99999999999999999999999999999887432
Q ss_pred --CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH--------HHHhh-hccccc
Q 006747 495 --VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWV--------QSVVR-EEWTSE 562 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~-~~~~~~ 562 (632)
....|.+|+|||.+.| .+|...+|||+.||++.||+||.+-|.+.++-+....+... ..++. ......
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 2347889999999988 67999999999999999999999999876654443322211 11111 111111
Q ss_pred cccccccccCCcHH----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 563 VFDVELMRYENIEE----EMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 563 ~~d~~~~~~~~~~~----~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
+.-+.....+..+. ....+++++..|++.||.+|++.+|++.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111111112221 2235789999999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=352.97 Aligned_cols=275 Identities=26% Similarity=0.416 Sum_probs=214.4
Q ss_pred CCCHHHHHHHHHhHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCc
Q 006747 330 NFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE 406 (632)
Q Consensus 330 ~~~~~~l~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~ 406 (632)
.+..+++ ...+.||+|+||+||+|++. ..||||.++..... .+.|+.|+..+++- +|.||+-+.|||.....
T Consensus 388 eIp~~ev--~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 388 EIPPEEV--LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPPL 462 (678)
T ss_pred ccCHHHh--hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCce
Confidence 3445554 34688999999999999985 57999999876433 46799999999999 99999999999988776
Q ss_pred eEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCC
Q 006747 407 KLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486 (632)
Q Consensus 407 ~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 486 (632)
.||+.+++|.+|+.++|..+ ..++..+.+.|+.|||+||.|||.+ +|||||||+.||++.+++.|||+|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence 99999999999999999753 4688899999999999999999999 999999999999999999999999999
Q ss_pred CCCCCC------CCCCCCCCcccCCccccCC---CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 006747 487 TPLMNT------PTVPSRSAGYRAPEVIETK---KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE 557 (632)
Q Consensus 487 a~~~~~------~~~~~~t~~y~aPE~~~~~---~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (632)
+..-.. .....+...|||||++..+ +|++.+||||||+|+|||+||..||.....+... |. +..
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi----fm---VGr 607 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII----FM---VGR 607 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE----EE---ecc
Confidence 854322 1223456679999999753 5899999999999999999999999732211111 00 011
Q ss_pred ccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC-CCCCCCCCccccCCCCCC
Q 006747 558 EWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS-DSENQPSSEDKLKDSNTQ 630 (632)
Q Consensus 558 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~-~~~~~~~~~~~~~~~~~~ 630 (632)
++. +.|.. .....+.+++.+|+..||..++++||.+.+|+..|+++..+ .-..+..|+|-++.+.-+
T Consensus 608 G~l--~pd~s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~~~~~~~~ 675 (678)
T KOG0193|consen 608 GYL--MPDLS----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPVLLRSSAE 675 (678)
T ss_pred ccc--Cccch----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccchhhhhhh
Confidence 110 11111 11123445677788899999999999999999999998774 344566677777665443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=336.99 Aligned_cols=231 Identities=21% Similarity=0.353 Sum_probs=191.3
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.++||+|+||+||.++.+ .++.+|+|++++... +.+....|..++.++ +||.||.+...|++.+.+|+|+||+.
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEecccCCeEEEEEeccC
Confidence 578999999999999854 488999999987632 245688999999998 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
||.|..+|++.+ .+++.....++.+++.||.|||+. +||||||||+|||||++|+++|+|||+++.....
T Consensus 109 GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 109 GGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred CccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 999999998654 367777778899999999999999 9999999999999999999999999999864332
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
.+.+||+.|||||++.+..|+..+|.||+|+++|||++|.+||.... ...+...+...... ...
T Consensus 181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k~~--------~~p 246 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGKLP--------LPP 246 (357)
T ss_pred ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCcCC--------CCC
Confidence 23479999999999999999999999999999999999999997643 23344444433210 001
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRP 597 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RP 597 (632)
.... .+..+++...++.||++|.
T Consensus 247 ~~ls---~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 GYLS---EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ccCC---HHHHHHHHHHhccCHHHhc
Confidence 1122 3456777799999999995
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=350.91 Aligned_cols=249 Identities=26% Similarity=0.442 Sum_probs=202.6
Q ss_pred CCCHHHHHHHHHhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEE
Q 006747 330 NFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLL 409 (632)
Q Consensus 330 ~~~~~~l~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 409 (632)
.+.++++. -.+-||.|+.|.||+|+++ ++.||||+++.- -+.+|+-|.++ +|+||+.|.|+|....-++|
T Consensus 120 eiPFe~Is--ELeWlGSGaQGAVF~Grl~-netVAVKKV~el------kETdIKHLRkL-kH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 120 EIPFEEIS--ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL------KETDIKHLRKL-KHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred cCCHHHhh--hhhhhccCcccceeeeecc-CceehhHHHhhh------hhhhHHHHHhc-cCcceeeEeeeecCCceeEE
Confidence 34455552 2468999999999999996 799999998643 34578889999 99999999999999999999
Q ss_pred EEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 410 VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 410 v~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
||||+..|-|..+|+..+ ++.-...+.+..+||.||.|||.+ +|||||||+-||||..+..+||+|||-++.
T Consensus 190 iMEfCa~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred eeeccccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHh
Confidence 999999999999998654 466677889999999999999998 999999999999999999999999999987
Q ss_pred CCCCC---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 490 MNTPT---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 490 ~~~~~---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
..... ...||..|||||+|...++++|+||||||||||||+||..||...+...+. | +. ..
T Consensus 262 ~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----w-------GV-----Gs 325 (904)
T KOG4721|consen 262 LSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----W-------GV-----GS 325 (904)
T ss_pred hhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----E-------ec-----cC
Confidence 76543 346899999999999999999999999999999999999999653221110 0 00 00
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.......+..+...+.-|++.||+..|..||+|++++.+|+-..+.
T Consensus 326 NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 326 NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 1111222334445566677899999999999999999999876544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.02 Aligned_cols=256 Identities=22% Similarity=0.322 Sum_probs=200.0
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~~ 414 (632)
.++||+|.||.||+|+ ..+|..||+|++..... ......+||.+|.++ +||||++|.+...+. ..+|||||||
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siYlVFeYM 200 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIYLVFEYM 200 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEEEEEecc
Confidence 5789999999999998 66799999999986532 245678999999999 999999999999887 6899999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
+. ||..++... ...++..++..++.|++.||+|+|.. +|+|||||.+|||||.+|.+||+|||+|+++....
T Consensus 201 dh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 201 DH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred cc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 98 888888753 23588899999999999999999999 99999999999999999999999999999876543
Q ss_pred -----CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc-------
Q 006747 495 -----VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTS------- 561 (632)
Q Consensus 495 -----~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------- 561 (632)
....|..|+|||++.|.. |+..+|+||.||||.||++|++.|++..+-++.+.+-..-....+.++.
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 224688899999998864 9999999999999999999999998866444333221111111112111
Q ss_pred ccccccccccCCcHHH----HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 562 EVFDVELMRYENIEEE----MVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 562 ~~~d~~~~~~~~~~~~----~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..+.+.-.-...+.|. ....++|+...|..||.+|.|+.++++.
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1111111001111121 2346778889999999999999999863
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=336.11 Aligned_cols=248 Identities=26% Similarity=0.419 Sum_probs=196.4
Q ss_pred HHhHhCccceeEEEEEEEcC-CcEEEEEEecccccC-HHHHHHHHHHHHhhcCCCCccceeEEEEeCC--ceEEEEeccc
Q 006747 340 SAEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD--EKLLVYDFIE 415 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~E~~~ 415 (632)
..+.||+|+||.||++...+ |...|||.+...... .+.+++|+.+|.++ +|||||+++|...... ..++.|||++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeeeeccC
Confidence 35789999999999999654 899999998765221 46689999999999 6999999999866555 5899999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-CCCeEEcccCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-DLQGCISDFGLTPLMNT-- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~-- 492 (632)
+|+|.+++.+.++ .+++.....+..++++||+|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 100 ~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 100 GGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999987642 488999999999999999999998 9999999999999999 79999999999987663
Q ss_pred -----CCCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 493 -----PTVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 493 -----~~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
.....||+.|||||++..+. ...++||||+||++.||+||+.||... .....++-....+....
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP----- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC-----
Confidence 12345899999999998543 345999999999999999999999752 11122222222222111
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
.+. .... .+..+++.+|++.+|++|||+.+++++---..
T Consensus 243 ~ip--~~ls---~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 243 EIP--DSLS---DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CCC--cccC---HHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 111 1122 34556778999999999999999999765433
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=347.07 Aligned_cols=251 Identities=25% Similarity=0.400 Sum_probs=216.0
Q ss_pred HHhHhCccceeEEEEEEEcC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 340 SAEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
....||.|.||.||.|.++. .-.||||.++...+..++|..|..+|+.+ +|||+|+|+|+|......|||+|||.+|+
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 36789999999999999765 56899999999888899999999999999 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCCC-
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPS- 497 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~- 497 (632)
|.+||++.. +..++-...+.++-||+.||+||..+ ++|||||.++|+|+.++..+||+|||++++|..++++.
T Consensus 350 LLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 350 LLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred HHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecc
Confidence 999999764 34466667788999999999999998 99999999999999999999999999999998776653
Q ss_pred -C---CCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 498 -R---SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 498 -~---t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
| ...|.|||.+....++.|+|||+|||+|||+.| |-.||.+.+ ...+...+..++ +.+
T Consensus 424 AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY~LLEkgy----------RM~ 486 (1157)
T KOG4278|consen 424 AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYGLLEKGY----------RMD 486 (1157)
T ss_pred cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHHHHhccc----------ccc
Confidence 2 345999999999999999999999999999999 889997643 122333333333 223
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCC
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~ 614 (632)
..+.+...+++||+.||++.|.+||+++|+.+.++.+-....
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 344556678899999999999999999999999998866644
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=341.79 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=205.7
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|-||.|.+.....+..||||.++.... .+++|..|+++|.++ +|||||+++|+|..++.+++|+|||++|+
T Consensus 543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 689999999999999998889999999987643 357899999999999 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCCC-
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPS- 497 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~- 497 (632)
|.+++..... +.+.-..-++|+.|||.||+||.+. ++|||||.++|+|+|+++++||+|||+++-+....+..
T Consensus 622 LnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 622 LNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred HHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 9999986532 1134455678999999999999998 99999999999999999999999999999765544332
Q ss_pred -----CCCcccCCccccCCCCCccchhhHHHHHHHHHHh--CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 498 -----RSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT--GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 498 -----~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
-...|||||.+.-+++++++|||+||++|||+++ ...||.....+.. ++-....++++-..-+ +.+
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~----l~~ 768 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVV----LSR 768 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCccee----ccC
Confidence 2467999999999999999999999999999877 7789976554332 2222222322221111 111
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
+.-+...+++++.+||..|-++|||++++...|++.
T Consensus 769 ---P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 769 ---PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ---CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122345677999999999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=312.48 Aligned_cols=256 Identities=22% Similarity=0.378 Sum_probs=201.0
Q ss_pred HHHhHhCccceeEEEEEE-EcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 339 ASAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 339 ~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
...+.+|+|.||.||+|. .+.|+.||||+++..... .....+|++.|..+ +|+||+.+++.|...+...+|+|||
T Consensus 5 ~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 5 EKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccCCCceEEEEEec
Confidence 345789999999999998 567999999999866432 56789999999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
+- +|...++... ..+.-.....++.++.+|++|+|++ .|+||||||.|+|++++|.+||+|||+|+......
T Consensus 84 ~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 84 PT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred cc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 86 9999998653 4688888999999999999999999 99999999999999999999999999999987543
Q ss_pred C----CCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH---hhhcccc-----
Q 006747 495 V----PSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV---VREEWTS----- 561 (632)
Q Consensus 495 ~----~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~----- 561 (632)
. ...|..|+|||.+.|.+ |+..+|+||.|||+.||+-|.+-|.+.++-+ ++...++.. ..+.|..
T Consensus 156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHHHHcCCCCcccCccccccc
Confidence 2 24678899999988755 8999999999999999999988887654322 222211111 1112211
Q ss_pred ccccccc----cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 562 EVFDVEL----MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 562 ~~~d~~~----~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+..+-.. ....-...+..+.++++..++..||.+|+|+.|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0000000 0000112234456899999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=352.93 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=202.9
Q ss_pred HhHhCccceeEEEEEEEcCC----cE-EEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILEEG----TT-VVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~----~~-vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.||+|+||.||+|.+..+ .. ||||..+.. .....+|.+|.+++.++ +|||||+++|++.....+|+||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCccEEEE
Confidence 37899999999999996542 23 899999852 22357899999999999 9999999999999999999999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
|++.||+|.++|+.+.. .++..+++.++.+.|.||+|||++ ++|||||.++|+|++.++.+||+|||+++...
T Consensus 241 El~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999997642 488999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCC----CCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 492 TPTVP----SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 492 ~~~~~----~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
..... .-...|+|||.+....|++++|||||||++||+++ |..||.+.... .....+...++....
T Consensus 314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~~~~r~~~--- 384 (474)
T KOG0194|consen 314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVKNGYRMPI--- 384 (474)
T ss_pred ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHhcCccCCC---
Confidence 22111 23457999999999999999999999999999999 88899764321 111222233332211
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
.......+..++.+||..+|++||+|.++.+.|+.+....
T Consensus 385 -------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 385 -------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred -------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 1122345566777999999999999999999999986653
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.25 Aligned_cols=260 Identities=21% Similarity=0.369 Sum_probs=202.6
Q ss_pred HHHHhHhCccceeEEEEEE-EcCCcEEEEEEecccccCHHH--HHHHHHHHHhhcCCCCccceeEEEEeCC-ceEEEEec
Q 006747 338 RASAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKRE--FEQQMEVVGRLSQHPNVVPIRAYYFSKD-EKLLVYDF 413 (632)
Q Consensus 338 ~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~--~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~E~ 413 (632)
+.+.+.||.|.||.||+|+ ..+|..||||++++.....++ -.+|++.|.++..|||||++.+.+.+.+ .+++||||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~ 91 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEF 91 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHh
Confidence 4457889999999999998 567899999999877554444 4689999999944999999999999988 89999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
|+. +|.+++++. +.++++.....|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||.....
T Consensus 92 Md~-NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 92 MDC-NLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred hhh-hHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 976 999999865 35799999999999999999999998 9999999999999999999999999999987654
Q ss_pred ---CCCCCCCcccCCcccc-CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHHhhhcccc-----cc
Q 006747 494 ---TVPSRSAGYRAPEVIE-TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV-DLPRWVQSVVREEWTS-----EV 563 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~-~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~ 563 (632)
+....|.+|+|||++. .+.|+.+.|+|++|||++|+.+-++-|.+..+-|.. .+.+.+...-.+.|.. ..
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~ 243 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA 243 (538)
T ss_pred CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence 3345788999999876 456899999999999999999999999876543321 1111110000011100 00
Q ss_pred cccccccc------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 564 FDVELMRY------ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 564 ~d~~~~~~------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+.-.+... .-......+.++++.+|+++||.+|||+.+++++
T Consensus 244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 11111000 0112245678889999999999999999999885
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=337.60 Aligned_cols=256 Identities=17% Similarity=0.331 Sum_probs=203.5
Q ss_pred CCCHHHHHHHHHhHhCccceeEEEEEEEcCCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEe--
Q 006747 330 NFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFS-- 403 (632)
Q Consensus 330 ~~~~~~l~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~-- 403 (632)
.++.+++.......||+|++|.||+|.+ +|+.||||+++..... .+.+.+|++++.++ +||||++++|++.+
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~ 91 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIV 91 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecc
Confidence 3455666444446799999999999998 5899999999765433 25678999999999 89999999999977
Q ss_pred --CCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEE
Q 006747 404 --KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCI 481 (632)
Q Consensus 404 --~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki 481 (632)
....++||||+++|+|.+++.... .++|....+++.+++.||+|||+.. +++||||||+|||+++++.+||
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl 164 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKI 164 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEE
Confidence 346889999999999999997542 4789999999999999999999742 6789999999999999999999
Q ss_pred cccCCCCCCCCC-CCCCCCCcccCCccccC--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006747 482 SDFGLTPLMNTP-TVPSRSAGYRAPEVIET--KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE 558 (632)
Q Consensus 482 ~DfGla~~~~~~-~~~~~t~~y~aPE~~~~--~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (632)
+|||+++..... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...........
T Consensus 165 ~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~ 238 (283)
T PHA02988 165 ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKN 238 (283)
T ss_pred cccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcC
Confidence 999999865443 23457888999999976 6789999999999999999999999975321 11122211111
Q ss_pred cccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 559 WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 559 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
... .. . ......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 239 ~~~-----~~--~---~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 NSL-----KL--P---LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCC-----CC--C---CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 110 00 0 112335778888999999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=345.72 Aligned_cols=240 Identities=25% Similarity=0.386 Sum_probs=199.8
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEecccccCH-HHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK-REFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
...||+|+.|.||.+. ..+++.||||++....+.+ +-+..|+.+|... +|+|||.++..|...+++|+|||||++|+
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 4679999999999998 5678999999998776554 4578999999999 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
|.+++.... +++.+...|+.+++.||+|||.. +|+|||||.+|||++.+|.+||+|||++..+... .
T Consensus 357 LTDvVt~~~------~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 357 LTDVVTKTR------MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred hhhhhhccc------ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 999998653 88899999999999999999999 9999999999999999999999999999776543 3
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
+..||+.|||||++....|++|+||||||++++||+-|++||-... - .+-+.. +...-.. .+ ...
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~---P---lrAlyL-Ia~ng~P-----~l---k~~ 492 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN---P---LRALYL-IATNGTP-----KL---KNP 492 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC---h---HHHHHH-HhhcCCC-----Cc---CCc
Confidence 4469999999999999999999999999999999999999996421 1 111111 1111111 11 222
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+.....+.++..+||+.|+++|+++.|++++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 2233456677789999999999999999974
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=345.84 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=197.0
Q ss_pred HhHhCccceeEEEEEEE------cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC-ceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-EKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~ 411 (632)
.+.||+|+||.||+|.. .++..||||+++.... ..+.+.+|++++.++.+||||++++++|...+ ..++||
T Consensus 12 ~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ 91 (338)
T cd05102 12 GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIV 91 (338)
T ss_pred eeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEE
Confidence 56899999999999973 2356899999975432 23568899999999988999999999987644 588999
Q ss_pred ecccCCCHhhhhccCCCC---------------------------------------------------------CCCcC
Q 006747 412 DFIEAGSFSALLHGNRGI---------------------------------------------------------GRTPL 434 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~---------------------------------------------------------~~~~l 434 (632)
||+++|+|.+++...+.. ...++
T Consensus 92 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 171 (338)
T cd05102 92 EFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPL 171 (338)
T ss_pred ecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCC
Confidence 999999999998753210 02358
Q ss_pred CHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC------CCCCCCcccCCccc
Q 006747 435 DWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT------VPSRSAGYRAPEVI 508 (632)
Q Consensus 435 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~------~~~~t~~y~aPE~~ 508 (632)
++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...++..|+|||++
T Consensus 172 ~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 172 TMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248 (338)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHh
Confidence 8889999999999999999998 99999999999999999999999999997653221 12345679999999
Q ss_pred cCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHH
Q 006747 509 ETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMS 587 (632)
Q Consensus 509 ~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~ 587 (632)
.+..++.++|||||||++|||++ |+.||......+ . ......++... .........+.+++.+
T Consensus 249 ~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~-~~~~~~~~~~~----------~~~~~~~~~l~~li~~ 312 (338)
T cd05102 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----E-FCQRLKDGTRM----------RAPENATPEIYRIMLA 312 (338)
T ss_pred hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----H-HHHHHhcCCCC----------CCCCCCCHHHHHHHHH
Confidence 99999999999999999999997 999997532211 1 11111111110 0011123457788999
Q ss_pred ccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 588 CVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 588 Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
||+.||++|||+.|+++.|+++..
T Consensus 313 cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 313 CWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=341.23 Aligned_cols=239 Identities=21% Similarity=0.342 Sum_probs=196.5
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
++.||+|+|++||+|. .+.++.||||++.+... ..+.+..|-+.|.++.+||.|++|+..|++...+|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 5789999999999998 45689999999976532 234577888899999899999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.++++..+ .+++.....++.+|+.||+|||+. +||||||||+|||||+||++||+|||.|+.+...
T Consensus 158 nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~ 229 (604)
T KOG0592|consen 158 NGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK 229 (604)
T ss_pred CCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence 999999999764 378888889999999999999998 9999999999999999999999999999887432
Q ss_pred ---------------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006747 494 ---------------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE 558 (632)
Q Consensus 494 ---------------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (632)
....||+.|++||++.....+..+|+|+||||||+|+.|++||.+..+--. ++.+
T Consensus 230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli------FqkI---- 299 (604)
T KOG0592|consen 230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI------FQKI---- 299 (604)
T ss_pred cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH------HHHH----
Confidence 112478899999999999999999999999999999999999976431110 1111
Q ss_pred cccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 559 WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 559 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
++....-.+... ..+.+|+.+.|..||.+|+|.++|-++
T Consensus 300 -----~~l~y~fp~~fp---~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 -----QALDYEFPEGFP---EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----HHhcccCCCCCC---HHHHHHHHHHHccCccccccHHHHhhC
Confidence 111111112222 346677779999999999999888765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=325.81 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=198.1
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHH--hhcCCCCccceeEEEEeCC----ceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVG--RLSQHPNVVPIRAYYFSKD----EKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~--~l~~h~niv~l~~~~~~~~----~~~lv~E~~ 414 (632)
.+++|+|.||.||||.+. ++.||||++... ++..|..|-++.. .+ +|+||++++++-.... +.+||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m-~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGM-KHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCc-cchhHHHhhchhccCCccccceeEEeeec
Confidence 468999999999999996 599999999753 3567878877766 44 8999999999876554 789999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc------CCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV------GGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
+.|+|.++|..+ .++|....+|+..+++||+|||+.. .|+|+|||||++|||+.+|+++.|+|||+|.
T Consensus 291 ~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 291 PKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred cCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999876 4899999999999999999999764 5789999999999999999999999999997
Q ss_pred CCCCCC------CCCCCCcccCCccccCCCC------CccchhhHHHHHHHHHHhCCCCCC--------CCCCCCCCCh-
Q 006747 489 LMNTPT------VPSRSAGYRAPEVIETKKP------TQKSDVYSFGVLLLEMLTGKAPIQ--------APGHEDVVDL- 547 (632)
Q Consensus 489 ~~~~~~------~~~~t~~y~aPE~~~~~~~------~~~~DV~s~Gvvl~elltg~~p~~--------~~~~~~~~~~- 547 (632)
.+.... ...||..|||||++.+..- -.+.||||+|.|||||++...-++ ...+.+...-
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 765432 2458999999999977542 246899999999999999654432 1111111111
Q ss_pred -hHHHHHH-hhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCCC
Q 006747 548 -PRWVQSV-VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSE 615 (632)
Q Consensus 548 -~~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 615 (632)
.+.++.. +++.....+-+ .+... ..+..+.+.+..||..||+.|.|+.=|.+++.++......
T Consensus 445 t~e~mq~~VV~kK~RP~~p~----~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPD----AWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CHHHHHHHHHhhccCCCChh----hhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1111111 11111111111 11111 4566788899999999999999999999999988666443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.87 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=196.3
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.++||.|..++||+|+ .+.+..||||++...... -+.+.+|+..++.+ +||||++++..|..+..+|+||.||.+|
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv~~~LWvVmpfMa~G 109 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVVDSELWVVMPFMAGG 109 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEecceeEEeehhhcCC
Confidence 4689999999999998 566899999999865432 46789999999999 9999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
++.++++..... .+++..+..|..++++||.|||+. +.||||||+.||||+++|.+||+|||.+-.+...
T Consensus 110 S~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 110 SLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999876432 388899999999999999999998 9999999999999999999999999987555332
Q ss_pred ----CCCCCCCcccCCccccC--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIET--KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~~--~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 567 (632)
....+|+.|||||++.. ..|+.|+||||||++..||.+|..||....... ........+..... -.
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-----vLl~tLqn~pp~~~---t~ 255 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-----VLLLTLQNDPPTLL---TS 255 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-----HHHHHhcCCCCCcc---cc
Confidence 22358899999999644 348999999999999999999999997432111 11111111110000 00
Q ss_pred ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 568 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
....+........+.+++..|+++||++|||++++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 0011111222346778888999999999999999876
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=334.95 Aligned_cols=238 Identities=22% Similarity=0.376 Sum_probs=201.0
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEecccccCH---HHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGK---REFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
..+.||+|+||.||||+.+ +.+.||+|.+.+....+ +.+.+|+++++++ +|||||.++++|++..+.++|+||+.
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcccceEEEEehhhh
Confidence 4578999999999999854 57899999998764433 4589999999999 99999999999999999999999998
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 495 (632)
+ +|+.+|.... .+++.....|+.++..||.|||+. +|+|||+||.|||++..+++|+||||+|+.+...+.
T Consensus 85 g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 85 G-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred h-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence 7 9999998654 378899999999999999999998 999999999999999999999999999999987543
Q ss_pred ----CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 496 ----PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 496 ----~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
..||+-|||||+..++.|+..+|.||+||++||+++|++||.... +...++.+..+..
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~v------------ 217 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDPV------------ 217 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCCC------------
Confidence 358999999999999999999999999999999999999996422 2233334333321
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..+......+..++...+.+||.+|.|..+++.+
T Consensus 218 ~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1112334456777789999999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.03 Aligned_cols=254 Identities=21% Similarity=0.368 Sum_probs=194.7
Q ss_pred HhHhCccceeEEEEEEEcC-----------------CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEE
Q 006747 341 AEVLGKGSYGTTYKAILEE-----------------GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYY 401 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 401 (632)
.+.||+|+||.||++..++ +..||+|.+..... ...++.+|++++.++ +||||+++++++
T Consensus 10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 88 (304)
T cd05096 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNIIRLLGVC 88 (304)
T ss_pred eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEE
Confidence 4679999999999997532 34699999875422 245789999999999 899999999999
Q ss_pred EeCCceEEEEecccCCCHhhhhccCCC--------------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCC
Q 006747 402 FSKDEKLLVYDFIEAGSFSALLHGNRG--------------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIK 467 (632)
Q Consensus 402 ~~~~~~~lv~E~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk 467 (632)
.+.+..++||||+++|+|.+++..... .....++|....+++.|++.||+|||+. +|+|||||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlk 165 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcc
Confidence 999999999999999999998864321 0123478899999999999999999998 99999999
Q ss_pred CCCeeecCCCCeEEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh--CCCCCCCC
Q 006747 468 SSNVLLSQDLQGCISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT--GKAPIQAP 539 (632)
Q Consensus 468 ~~NILl~~~~~~ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt--g~~p~~~~ 539 (632)
|+|||+++++.+||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ +..||...
T Consensus 166 p~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 245 (304)
T cd05096 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245 (304)
T ss_pred hhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence 999999999999999999997654321 1234667999999998899999999999999999987 55677543
Q ss_pred CCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 540 GHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
... .....+.......... .. ... .......+.+++.+||+.||++|||+.+|.+.|++
T Consensus 246 ~~~---~~~~~~~~~~~~~~~~-~~---~~~---~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 246 TDE---QVIENAGEFFRDQGRQ-VY---LFR---PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CHH---HHHHHHHHHhhhcccc-cc---ccC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 221 1222222221111100 00 000 11123467889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.22 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=197.5
Q ss_pred HHhHhCccceeEEEEEEE------cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 340 SAEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
..+.||+|+||.||+|.. ..+..||||+++.... ..+.+.+|++++..+.+||||++++++|...+..++||
T Consensus 39 ~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred hhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeee
Confidence 367899999999999963 2356899999975432 24568899999999878999999999999999999999
Q ss_pred ecccCCCHhhhhccCCC---------------------------------------------------------------
Q 006747 412 DFIEAGSFSALLHGNRG--------------------------------------------------------------- 428 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~--------------------------------------------------------------- 428 (632)
||+++|+|.++++..+.
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 99999999999865321
Q ss_pred -------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC------
Q 006747 429 -------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV------ 495 (632)
Q Consensus 429 -------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~------ 495 (632)
.....++|....+++.+++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 275 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCC
Confidence 0112578999999999999999999998 999999999999999999999999999976543221
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++|||||||++|||++ |..||....... ... ..+.++.... ....
T Consensus 276 ~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~----~~~~~~~~~~-------~~~~- 341 (375)
T cd05104 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY----KMIKEGYRML-------SPEC- 341 (375)
T ss_pred CCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH----HHHHhCccCC-------CCCC-
Confidence 123456999999999999999999999999999998 888886532111 111 1122221110 0011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
...++.+++.+||+.||++|||+.||++.|++.
T Consensus 342 --~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 342 --APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 123577889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.03 Aligned_cols=244 Identities=21% Similarity=0.335 Sum_probs=196.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccc-----c-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEV-----V-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~-----~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||+|+.|.. .++..||+|+++.. . ...+.+.+|+.++.++..||||++++.++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 46799999999999974 46899999977653 1 12345678999999994499999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeEEcccCCCCCCC-
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGCISDFGLTPLMN- 491 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~- 491 (632)
+.+|+|.+++.... ++.+....+++.|++.|++|+|+. +|+||||||+|||+|.+ +++||+|||++....
T Consensus 102 ~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 102 CSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred cCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 99999999998732 367788889999999999999998 99999999999999999 999999999999872
Q ss_pred ---CCCCCCCCCcccCCccccCCC-CC-ccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 492 ---TPTVPSRSAGYRAPEVIETKK-PT-QKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 492 ---~~~~~~~t~~y~aPE~~~~~~-~~-~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
.....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.. ..+...+.+......
T Consensus 174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~------~~~~l~~ki~~~~~~------ 241 (370)
T KOG0583|consen 174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS------NVPNLYRKIRKGEFK------ 241 (370)
T ss_pred CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc------cHHHHHHHHhcCCcc------
Confidence 235567999999999999977 75 7899999999999999999999752 222222222211110
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
-..... ..++.+++.+|+..+|.+|+|+.+++ .-.-++
T Consensus 242 ---~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 242 ---IPSYLL--SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred ---CCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 011110 34577888899999999999999999 433333
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=328.91 Aligned_cols=234 Identities=22% Similarity=0.330 Sum_probs=188.0
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
+..+||+|+||.||+++.+ .|..+|+|++++...- .+.+..|..+|... ++++||+|+..|++.+.+||||||+
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEEEEEec
Confidence 4578999999999999954 5899999999987542 34578889999996 9999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC--
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT-- 492 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~-- 492 (632)
+|||+..+|.... .|++.....++.+++.|+.-||+. ++|||||||+|+|||..|++||+||||+..+..
T Consensus 224 PGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 224 PGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred CCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999999998653 477777778889999999999998 999999999999999999999999999843210
Q ss_pred -----------------------C-----C---------------------CCCCCCcccCCccccCCCCCccchhhHHH
Q 006747 493 -----------------------P-----T---------------------VPSRSAGYRAPEVIETKKPTQKSDVYSFG 523 (632)
Q Consensus 493 -----------------------~-----~---------------------~~~~t~~y~aPE~~~~~~~~~~~DV~s~G 523 (632)
. . ...||+-|||||++.+..|+..+|.||+|
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 0 11368889999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCC-CChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 006747 524 VLLLEMLTGKAPIQAPGHEDV-VDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPT 598 (632)
Q Consensus 524 vvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs 598 (632)
||+|||+.|.+||.+....+. ..+..|....... .... ...+..+||.+|+. ||++|--
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP------------~~~~---~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP------------EEVD---LSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC------------CcCc---ccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999987543322 1233332211100 0011 12456788889999 9999976
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.86 Aligned_cols=243 Identities=23% Similarity=0.314 Sum_probs=193.3
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++.. .+++.||+|.+..... ....+.+|++++.++ +|+||+++++++.+.+..++||||+++
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 5799999999999985 5689999999875421 234577899999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++......
T Consensus 85 g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05631 85 GDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158 (285)
T ss_pred CcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence 99998876432 23588999999999999999999998 9999999999999999999999999999765432
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+........ . ..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~--------~---~~ 224 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQ--------E---EY 224 (285)
T ss_pred cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhccc--------c---cC
Confidence 233578899999999999999999999999999999999999975432111 111111111100 0 00
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPT-----MEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 605 (632)
..+....+.+|+.+||+.||++||+ +++++++
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0112235677888999999999997 7888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=315.40 Aligned_cols=242 Identities=25% Similarity=0.430 Sum_probs=197.9
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||++..+++..+|+|.++.......++..|++++.++ +||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 357999999999999988888999999886666677899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-----
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV----- 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~----- 495 (632)
++++... ..++|..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||.++.......
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05114 88 NYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence 9987542 2478999999999999999999998 999999999999999999999999999876533221
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...+..... +.. ...+ .
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~-~~~--~~~~-----~-- 224 (256)
T cd05114 161 AKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISR-GFR--LYRP-----K-- 224 (256)
T ss_pred CCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHC-CCC--CCCC-----C--
Confidence 123456999999998889999999999999999999 8999864321 111122111 111 0001 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
.....+.+++.+||+.+|++|||++++++.|.
T Consensus 225 -~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 -LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11235788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=333.19 Aligned_cols=239 Identities=25% Similarity=0.355 Sum_probs=197.5
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
++.||+|+-|.|..|+ ...|+.+|||++.+.. .....+++|+-+|+-+ .||||+++++.|.++.++|+|.||++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeeccCceEEEEEEecC
Confidence 4679999999999998 4679999999997652 1245688999988888 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|.|++++...+ ++.+....+++.||..|+.|+|.. +|+||||||+|+|||..+.+||+|||+|......
T Consensus 96 gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 96 GGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKL 167 (786)
T ss_pred CchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCcc
Confidence 999999998653 578888999999999999999998 9999999999999999999999999999776544
Q ss_pred -CCCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 -TVPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
.+.+|++.|.|||++.|.+| ..++||||+|||||.|+||+.||++.. +...... ++.+. +
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LLlK-V~~G~----f------- 229 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLLLK-VQRGV----F------- 229 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHHHH-HHcCc----c-------
Confidence 45689999999999999998 678999999999999999999997421 1111111 11111 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
.-+..-..++-+|+.+++..||+.|.|++||+++-
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 11111223456778899999999999999999864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=335.95 Aligned_cols=232 Identities=23% Similarity=0.347 Sum_probs=192.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.++||+|+||+|+++.++ +++.+|||++++... +.+....|.+++....+||.+++++.+|++++++|.||||..
T Consensus 373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~ 452 (694)
T KOG0694|consen 373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA 452 (694)
T ss_pred EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence 578999999999999964 578999999997632 345677888888888789999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC----
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN---- 491 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~---- 491 (632)
|||+..+.+.. .+++.....++..|+.||+|||++ +||+||||-+|||||.+|++||+|||+++..-
T Consensus 453 Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 453 GGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred CCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence 99966555533 388888899999999999999999 99999999999999999999999999998642
Q ss_pred CCCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 492 TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 492 ~~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
..++.+||+.|||||++.+..|+..+|.|||||+||||+.|..||.+.++++.. ..++.++.. .
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F------dsI~~d~~~-------y--- 587 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF------DSIVNDEVR-------Y--- 587 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHhcCCCC-------C---
Confidence 234457999999999999999999999999999999999999999986654432 222222211 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTM 599 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 599 (632)
+.-...+.+.|+.+.+.++|++|--+
T Consensus 588 --P~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 588 --PRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCcccHHHHHHHHHHhccCcccccCC
Confidence 11123456778889999999999876
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=336.19 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=196.9
Q ss_pred HHhHhCccceeEEEEEEE------cCCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 340 SAEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
..+.||+|+||.||+|.. .++..||+|+++..... ...+.+|++++..+.+|+|||+++++|...+..++||
T Consensus 42 ~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ 121 (374)
T cd05106 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT 121 (374)
T ss_pred ehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeH
Confidence 467899999999999873 23457999999754322 3468889999999878999999999999999999999
Q ss_pred ecccCCCHhhhhccCCC---------------------------------------------------------------
Q 006747 412 DFIEAGSFSALLHGNRG--------------------------------------------------------------- 428 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~--------------------------------------------------------------- 428 (632)
||+++|+|.++++....
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 99999999998864310
Q ss_pred --CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC------CCCCC
Q 006747 429 --IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV------PSRSA 500 (632)
Q Consensus 429 --~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~------~~~t~ 500 (632)
....++++....+++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..++.
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~ 278 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCcc
Confidence 0113578899999999999999999998 999999999999999999999999999976543221 12345
Q ss_pred cccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHH
Q 006747 501 GYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMV 579 (632)
Q Consensus 501 ~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 579 (632)
.|+|||++.+..++.++|||||||++|||++ |+.||....... ............ . .... ...
T Consensus 279 ~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~~~~-----~--~~~~---~~~ 342 (374)
T cd05106 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRGYQM-----S--RPDF---APP 342 (374)
T ss_pred ceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcccCc-----c--CCCC---CCH
Confidence 7999999998899999999999999999997 999997532211 011111111100 0 0011 124
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 580 QMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 580 ~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
++.+++.+||+.||++|||+.+|++.|+++.
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 5778888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=329.61 Aligned_cols=256 Identities=23% Similarity=0.392 Sum_probs=210.8
Q ss_pred CCCHHHHHHHHHhHhCccceeEEEEEEEcC-----CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEE
Q 006747 330 NFDLEDLLRASAEVLGKGSYGTTYKAILEE-----GTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYF 402 (632)
Q Consensus 330 ~~~~~~l~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 402 (632)
++.+..-.....+.||.|-||.||+|.+.+ .-.||||..+... .+.+.|.+|.-++..+ +|||||+++|.|.
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~ 461 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCV 461 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeee
Confidence 343333333568899999999999998533 2468999988753 3467799999999999 9999999999997
Q ss_pred eCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEc
Q 006747 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS 482 (632)
Q Consensus 403 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 482 (632)
+ ...+||||.++.|.|..+|+.++ ..++......++.|++.+|+|||+. .+|||||.++|||+.....+|++
T Consensus 462 e-~P~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 462 E-QPMWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred c-cceeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence 6 46899999999999999998764 3477788899999999999999999 99999999999999999999999
Q ss_pred ccCCCCCCCCCCCCCCC-----CcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 006747 483 DFGLTPLMNTPTVPSRS-----AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR 556 (632)
Q Consensus 483 DfGla~~~~~~~~~~~t-----~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 556 (632)
|||+++.+....+...+ ..|||||.+...+++.++|||-|||.+||++. |..||.+-...+..... .
T Consensus 534 DFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-------E 606 (974)
T KOG4257|consen 534 DFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-------E 606 (974)
T ss_pred ccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-------c
Confidence 99999998876554433 35999999999999999999999999999988 99999876555432110 0
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
. ..+...++.+...+..|+.+||+.+|.+||.+.++...|.++.+
T Consensus 607 n----------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 607 N----------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred C----------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 0 11233444556678899999999999999999999999887755
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.39 Aligned_cols=238 Identities=24% Similarity=0.381 Sum_probs=195.9
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|+||.||+|.. ..++.||+|++..... ..+++.+|+.++..+ +++||.+++|.|..+..++++|||+.+|+
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 6899999999999985 4588999999986633 357899999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
+.+.++... ++++....-|..++..|+.|||.+ +.+|||||+.|||+..+|.+|++|||++-.+... .
T Consensus 98 v~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 98 VLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred hhhhhccCC-----CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 999998653 246666677888999999999999 9999999999999999999999999999776543 3
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
+..||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+..........++ .... -+.+..
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------pk~~-----PP~L~~---- 233 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------PKSA-----PPRLDG---- 233 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------cCCC-----CCcccc----
Confidence 446999999999999889999999999999999999999999765432222111 0000 111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.....+.+++..|+.+||+.|||+.+++++
T Consensus 234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 -DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred -ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 223346778889999999999999998763
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=321.38 Aligned_cols=248 Identities=25% Similarity=0.454 Sum_probs=197.9
Q ss_pred HhHhCccceeEEEEEEEcC------CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILEE------GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|.... ...||+|.++.... ....+.+|++++.++ +||||+++++++...+..+++||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e 88 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTKEQPTCMLFE 88 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcCCCceEEEEe
Confidence 5789999999999998543 25799999875432 245688999999999 89999999999999899999999
Q ss_pred cccCCCHhhhhccCCCCC-----------CCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEE
Q 006747 413 FIEAGSFSALLHGNRGIG-----------RTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCI 481 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki 481 (632)
|+++|+|.+++....... ...+++.....++.+++.||+|||+. +++||||||+||++++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L 165 (283)
T cd05048 89 YLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEE
Confidence 999999999987542211 14588899999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 006747 482 SDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSV 554 (632)
Q Consensus 482 ~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 554 (632)
+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+ +.. .
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~----~ 238 (283)
T cd05048 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIE----M 238 (283)
T ss_pred CCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----H
Confidence 9999987653321 2234677999999998899999999999999999998 999987543211 111 1
Q ss_pred hhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 555 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
+...... ........++.+|+.+||+.||++||++.||+++|+.+
T Consensus 239 i~~~~~~----------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IRSRQLL----------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHcCCcC----------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111111 01122335677888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=307.13 Aligned_cols=257 Identities=22% Similarity=0.297 Sum_probs=196.3
Q ss_pred HHhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEec
Q 006747 340 SAEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDF 413 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~ 413 (632)
..+.|++|+||.||+|+. .++..||+|+++-.... .-.-.+|+.+|.++ +|||||.+..+.... +.+|+||||
T Consensus 80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceeeeeHHH
Confidence 357899999999999995 45889999999854321 23468899999999 899999998887643 579999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
++. ||..+++..+ +++.......+..|+++|++|||.. -|+|||||++|+|+...|.+||+|||+|+.++..
T Consensus 159 ~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 159 VEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 998 9999998653 4678888889999999999999998 8999999999999999999999999999998765
Q ss_pred C----CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 494 T----VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 494 ~----~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
. ....|..|+|||.+.+.+ |++..|+||+|||+.||+++++-|.+.++-++.+.+-.......+..+..+.....
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 2 234688999999998865 89999999999999999999999987664443322111111111111111111110
Q ss_pred c----ccC--------CcHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 569 M----RYE--------NIEE--EMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 569 ~----~~~--------~~~~--~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. ..+ .+.. -...-++++...+..||++|.|+.|.+++
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 000 0000 11345678889999999999999998874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=316.23 Aligned_cols=244 Identities=19% Similarity=0.357 Sum_probs=195.6
Q ss_pred HhHhCccceeEEEEEEEc----CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|... .+..||+|.++..... .+.+.+|++.+.++ +||||+++++++...+..++||||+
T Consensus 10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEecCCCcEEEEEeC
Confidence 467999999999999753 3678999999865322 35688999999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.+++.... ..++|..++.++.+++.||+|||+. +++||||||+||+++.++.+|++|||.+.......
T Consensus 89 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 89 SNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 9999999987542 3588999999999999999999998 99999999999999999999999999876543221
Q ss_pred -----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 495 -----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 495 -----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
...++..|+|||.+.+..++.++|||||||++||+++ |+.||...... ..... ..+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~~~-~~~~~~~------- 227 (266)
T cd05064 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKA-VEDGFRL------- 227 (266)
T ss_pred hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHH-HHCCCCC-------
Confidence 1123567999999999999999999999999999875 99999754321 11111 1111110
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.........+.+++.+||+.+|++||++.++.+.|+++
T Consensus 228 ---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 ---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112234577888999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=322.93 Aligned_cols=241 Identities=29% Similarity=0.527 Sum_probs=188.2
Q ss_pred hHhCccceeEEEEEEEc-----CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 342 EVLGKGSYGTTYKAILE-----EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
+.||.|.||.||+|.+. .+..|+||.++.... ..+++.+|++.+.++ +||||++++|+|...+..++||||+
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-ccccccccccccccccccccccccc
Confidence 57999999999999976 367899999965422 257899999999999 9999999999999888899999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 493 (632)
++|+|.++++.. ....+++..+.+|+.|+|.||+|||+. +++|+||+++||++++++.+||+|||+++.....
T Consensus 84 ~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 84 PGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccc---ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999876 234589999999999999999999998 9999999999999999999999999999776321
Q ss_pred -----CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccccc
Q 006747 494 -----TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567 (632)
Q Consensus 494 -----~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 567 (632)
........|+|||.+.+..++.++||||||+++|||+| |+.||.... ........ .+.....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~~~-~~~~~~~----- 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIEKL-KQGQRLP----- 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHHHH-HTTEETT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccccc-cccccce-----
Confidence 12234557999999998889999999999999999999 778875431 12222222 2221111
Q ss_pred ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 568 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
........+.+++..||+.+|++||||.++++.|
T Consensus 226 -----~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 -----IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111234577889999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=314.40 Aligned_cols=245 Identities=27% Similarity=0.447 Sum_probs=199.8
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|...++..||+|.+.......+.+.+|+.++.++ +|+||+++++++...+..++||||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05072 11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89 (261)
T ss_pred eeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence 467999999999999988889999999876555567899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-----
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV----- 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~----- 495 (632)
++++... ...+++..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 90 ~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05072 90 DFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163 (261)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCC
Confidence 9987542 23578889999999999999999998 999999999999999999999999999977643221
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++|||||||++|||+| |+.||......+ .. ..+....... ...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~~-------~~~-- 227 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VM----SALQRGYRMP-------RME-- 227 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HH----HHHHcCCCCC-------CCC--
Confidence 124557999999998889999999999999999999 999986532111 11 1111111100 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.....+.+++.+||+.+|++||+++++.+.|+++
T Consensus 228 -~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 -NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1224577888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=325.92 Aligned_cols=234 Identities=21% Similarity=0.315 Sum_probs=188.4
Q ss_pred hCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 344 LGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 344 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
||+|+||.||++... +++.||+|+++... .....+..|++++.++ +||||+++++++...+..++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 699999999999865 57899999997532 2235677899999999 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 80 L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 151 (312)
T cd05585 80 LFHHLQREG-----RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151 (312)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence 999987542 478899999999999999999998 9999999999999999999999999999764322 2
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...+|..|+|||.+.+..++.++|||||||++|||+||+.||.... ............. . ....
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~~~~-------~--~~~~- 215 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQEPL-------R--FPDG- 215 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHcCCC-------C--CCCc-
Confidence 2357889999999999999999999999999999999999996532 1222222221110 0 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC---HHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPT---MEEVVR 604 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs---~~evl~ 604 (632)
....+.+++.+||+.||++||+ +.|++.
T Consensus 216 --~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 --FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred --CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 1234667888999999999985 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=328.90 Aligned_cols=236 Identities=21% Similarity=0.330 Sum_probs=190.5
Q ss_pred HhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||++.. .+|+.||+|+++.... ....+..|++++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 689999999999985 4688999999975421 224577899999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcc
Confidence 9999987542 478899999999999999999998 9999999999999999999999999998754221
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....+|+.|+|||.+.+..++.++|||||||++|||+||+.||...... .......... ... ...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~~~-------~~~--p~~ 217 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEE-------IRF--PRT 217 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHHHHHcCC-------CCC--CCC
Confidence 2235888999999999999999999999999999999999999653211 1111111110 000 111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
....+.+++.+||+.||++|| ++.+++++
T Consensus 218 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 ---LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 123466788899999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.21 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=207.1
Q ss_pred HHHhHhCccceeEEEEEE-EcCC----cEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 339 ASAEVLGKGSYGTTYKAI-LEEG----TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 339 ~~~~~lg~G~fg~V~~~~-~~~~----~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
...++||+|+||+||+|. ..+| .+||+|++..... ...++..|+-+|.++ +|||+++|+|+|.... ..||+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch-HHHHH
Confidence 346799999999999998 3443 4789999876533 357899999999999 9999999999998876 88999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
+||+.|.|.++++..+ .++-.+..+.|..|||+||.|||++ ++|||||.++|||+.+-..+||.|||+++.+.
T Consensus 777 q~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 9999999999998764 3577788999999999999999998 99999999999999999999999999999987
Q ss_pred CCCCCC------CCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 492 TPTVPS------RSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 492 ~~~~~~------~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.+.... ..+.|||-|.+....|+.++|||||||++||++| |..||++...++.-++ ++.+.
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~ge----- 917 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKGE----- 917 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------Hhccc-----
Confidence 765433 2345999999999999999999999999999999 9999987664443222 21111
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
+...++-+..++..++.+||..|++.||+++++...+.++...
T Consensus 918 -----RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 -----RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -----cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1233344556788889999999999999999999999887554
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.90 Aligned_cols=245 Identities=25% Similarity=0.402 Sum_probs=199.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||+|... .+..||+|.++.......++.+|++++.++ +|+||+++++++...+..++||||+++|+|
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 89 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 89 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcCCCCcEEEEEeCCCCcH
Confidence 357999999999999854 488999999986655567799999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCC---
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVP--- 496 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~--- 496 (632)
.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 90 ~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 163 (263)
T cd05052 90 LDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163 (263)
T ss_pred HHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccC
Confidence 99987542 24588999999999999999999998 9999999999999999999999999999876543221
Q ss_pred --CCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 497 --SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 497 --~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
..+..|+|||.+.+..++.++|||||||++|||++ |..||.+... ...... ....... . ...
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~------~~~~~~-~~~~~~~-----~--~~~- 228 (263)
T cd05052 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYEL-LEKGYRM-----E--RPE- 228 (263)
T ss_pred CCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-HHCCCCC-----C--CCC-
Confidence 23457999999999999999999999999999998 9999865321 111111 1111110 0 011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.....+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 229 --~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 --GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred --CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1224577888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=314.38 Aligned_cols=245 Identities=25% Similarity=0.436 Sum_probs=200.5
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|...+++.||+|.++......+++.+|++++.++ +|+||+++++++...+..++||||+++++|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 467999999999999988888999999987655677899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC--CC-
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV--PS- 497 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~--~~- 497 (632)
+++.... ...++|..+.+++.+++.|++|||+. +|+||||||+||++++++.+||+|||+++....... ..
T Consensus 90 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (261)
T cd05068 90 EYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163 (261)
T ss_pred HHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCC
Confidence 9987542 23588999999999999999999998 999999999999999999999999999977653221 11
Q ss_pred --CCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 498 --RSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 498 --~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
.+..|+|||.+.+..++.++||||||+++|||+| |+.||.+.... ... ......... ...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~-~~~~~~~~~----------~~~ 226 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA------EVL-QQVDQGYRM----------PCP 226 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHH-HHHHcCCCC----------CCC
Confidence 2346999999999899999999999999999999 99998643211 111 111111100 001
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
......+.+++.+||+.+|++||++.++.+.|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 12234678889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=326.60 Aligned_cols=244 Identities=20% Similarity=0.313 Sum_probs=192.5
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+||+|+||.||++... +++.||+|+++.... ..+.+..|..++.++.+||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6899999999999854 588999999986422 23457788899988878999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC----C
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT----P 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~----~ 493 (632)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.... .
T Consensus 82 ~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 82 DLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 999888643 2488999999999999999999998 999999999999999999999999999875321 1
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC--CCChhHHHHHHhhhcccccccccccccc
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED--VVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....+|..|+|||++.+..++.++|||||||++|||+||+.||+.....+ ......+....+.+... .+ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~--p 225 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RI--P 225 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CC--C
Confidence 23357889999999999999999999999999999999999997433221 11122233222222111 00 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPT------MEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs------~~evl~~ 605 (632)
.. ....+.+++.+|++.||++||+ +.+++++
T Consensus 226 ~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 226 RS---LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CC---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11 1234677888999999999997 6777643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=315.51 Aligned_cols=261 Identities=21% Similarity=0.307 Sum_probs=190.3
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc-----eEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE-----KLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lv~E~~ 414 (632)
.+++|+|+||.||+|.+. ++..||||++... ++.--+|+++|+++ +|||||+|..+|....+ ..+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d---~r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD---KRYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCC---CCcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 368999999999999954 4689999998643 22334688899988 99999999998875432 34899999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeEEcccCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGCISDFGLTPLMNTP 493 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~ 493 (632)
+. +|.++++.... ....++.....-+..|+.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+...
T Consensus 105 P~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 105 PE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred hH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 98 89988875321 122355566777899999999999997 99999999999999987 99999999999998765
Q ss_pred CCCC---CCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH--hhhcccc------
Q 006747 494 TVPS---RSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV--VREEWTS------ 561 (632)
Q Consensus 494 ~~~~---~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~------ 561 (632)
.... -|..|+|||.+.|.. |+.+.||||.|||+.||+-|++-|.+.+..++ +...++-. ..++...
T Consensus 180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHHHhhcCccc
Confidence 4433 466799999998765 89999999999999999999999987543332 22111110 0000000
Q ss_pred -cccccccccc----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhhCCC
Q 006747 562 -EVFDVELMRY----ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDIRPS 612 (632)
Q Consensus 562 -~~~d~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i~~~ 612 (632)
+.-.+.+... ........+.++++.++++.+|.+|.++.|++. ..++++..
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0001111100 011223356788899999999999999999886 34554443
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.56 Aligned_cols=239 Identities=22% Similarity=0.365 Sum_probs=186.6
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
..+.||+|+||.||+|... +++.||||++...... ...+.+|++++.++ +|+||+++++++...+..++||||+++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEeccCCeEEEEEecCCC
Confidence 3578999999999999854 6899999999654322 45788999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.... ...+.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 157 ~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 157 GSLEGTH---------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred Ccccccc---------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 9986432 245567788999999999999998 9999999999999999999999999999776432
Q ss_pred -CCCCCCCcccCCccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccc
Q 006747 494 -TVPSRSAGYRAPEVIET-----KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~-----~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 567 (632)
....++..|+|||.+.. ...+.++|||||||++|||++|+.||......+ ............ .
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~-~------- 293 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMSQ-P------- 293 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhccC-C-------
Confidence 23457889999998843 234568999999999999999999997322211 111111111000 0
Q ss_pred ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 568 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.........++.+++.+||+.||++|||+.|++++
T Consensus 294 ---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 ---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111123457788899999999999999999985
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=299.55 Aligned_cols=198 Identities=22% Similarity=0.366 Sum_probs=174.8
Q ss_pred CCHHHHHHHHHhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC
Q 006747 331 FDLEDLLRASAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD 405 (632)
Q Consensus 331 ~~~~~l~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 405 (632)
+.++|. .+.+.||.|+||+|.+++.+ +|..+|+|++++... ..+....|..+|..+ .||+++++.+.|.+.+
T Consensus 41 ~~l~df--e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 41 YSLQDF--ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKDNS 117 (355)
T ss_pred cchhhh--hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeeccCC
Confidence 445554 24578999999999999954 588999999986532 134467888899999 8999999999999999
Q ss_pred ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 406 EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 406 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
..|+||||++||.|..+++..+ .++......++.+|+.||+|||+. .|++|||||+|||+|.+|.+||+|||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFG 189 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFG 189 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEecc
Confidence 9999999999999999998764 377788889999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCCCC-CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 486 LTPLMNTPTV-PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 486 la~~~~~~~~-~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
+|+.....+. -+||+.|+|||.+....|+..+|.|||||++|||+.|.+||...
T Consensus 190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 9988766543 47999999999999999999999999999999999999999754
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.96 Aligned_cols=247 Identities=22% Similarity=0.370 Sum_probs=195.1
Q ss_pred HhHhCccceeEEEEEEEc-CCc----EEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGT----TVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|... ++. .||+|.++.... ..+++..|+.++..+ +||||++++|+|... ..++|+||
T Consensus 12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC-Cceeeeec
Confidence 367999999999999853 333 389999875432 246788999999999 999999999999764 57899999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++.... ..+++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 90 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred CCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999998643 3478889999999999999999998 9999999999999999999999999999876533
Q ss_pred CC------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 TV------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ~~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
.. ...+..|+|||.+.+..++.++|||||||++|||++ |+.||.+.... .. .........
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~------~~-~~~~~~~~~------ 229 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS------EI-SSILEKGER------ 229 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHhCCCC------
Confidence 22 123557999999999999999999999999999998 99998643211 11 111111110
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
. .........+.+++.+||+.+|++|||+.+++..|..+....
T Consensus 230 -~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 230 -L---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred -C---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0 000112245778899999999999999999999999886553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=305.81 Aligned_cols=261 Identities=20% Similarity=0.327 Sum_probs=199.0
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCC-ccceeEEEEeCC------ceEE
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPN-VVPIRAYYFSKD------EKLL 409 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~------~~~l 409 (632)
.+.||+|+||+||+|+ ..+|+.||+|+++.... -.....+|+.++.++ +|+| ||++++++.+.+ ..++
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccccceEEE
Confidence 4679999999999999 55689999999986644 235678999999999 8999 999999999877 7899
Q ss_pred EEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 410 VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 410 v~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
||||++. +|..++....... ..++......++.|++.||+|||++ +|+||||||.|||++++|.+||+|||+|+.
T Consensus 95 vfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 95 VFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred EEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHH
Confidence 9999976 9999987654211 3456678889999999999999999 999999999999999999999999999987
Q ss_pred CCCCC----CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH--h-hhcccc
Q 006747 490 MNTPT----VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV--V-REEWTS 561 (632)
Q Consensus 490 ~~~~~----~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--~-~~~~~~ 561 (632)
..... ....|..|+|||++.+. .|++..||||+|||+.||++++.-|.+..+.+. +.+..+.. . .+.|..
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHHHHHHcCCCCccCCCC
Confidence 65332 23478889999999987 589999999999999999999999987654221 11111100 0 112221
Q ss_pred ccc----cccccccC---CcHHH----HHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhh
Q 006747 562 EVF----DVELMRYE---NIEEE----MVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDI 609 (632)
Q Consensus 562 ~~~----d~~~~~~~---~~~~~----~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i 609 (632)
... +.....+. ..... .....+++.+|++.+|++|.|++.++.+ +..+
T Consensus 248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 110 11111111 11111 1356788899999999999999999987 5554
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=326.22 Aligned_cols=191 Identities=21% Similarity=0.372 Sum_probs=167.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||++... ++..||+|.+..... ....+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 88 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEeecCCCC
Confidence 357999999999999865 578899999875422 245689999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--CC
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--TV 495 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~ 495 (632)
+|.+++.... .+++.....++.+++.||.|||+.. +|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 89 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (331)
T cd06649 89 SLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (331)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccccccc
Confidence 9999997542 4788889999999999999999852 6999999999999999999999999998765432 22
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
..++..|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 35788999999999999999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.11 Aligned_cols=244 Identities=20% Similarity=0.321 Sum_probs=190.8
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||++... +++.||+|+++.... ....+..|+.++.++.+||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 6899999999999854 578999999976422 23456778888887768999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC----C
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT----P 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~----~ 493 (632)
+|..++.... .+++.....++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... .
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 82 DLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 9998886542 478899999999999999999998 999999999999999999999999999875322 1
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCC--CChhHHHHHHhhhcccccccccccccc
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV--VDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....+|..|+|||++.+..++.++|||||||++|||+||+.||........ .....+.......... .+ .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~--p 225 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI--P 225 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC--C
Confidence 223578899999999999999999999999999999999999964322211 1112222222211111 00 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPT------MEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs------~~evl~~ 605 (632)
. .....+.+++.+||+.||++||+ +.+++++
T Consensus 226 ~---~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 226 R---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred C---CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1 12234668888999999999998 4666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=329.15 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=198.1
Q ss_pred HHhHhCccceeEEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 340 SAEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
..+.||+|+||.||+|... .+..||||+++.... ....+.+|++++.++..||||++++++|.+.+..++||
T Consensus 41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence 3578999999999999742 134799999975432 24568999999999955999999999999999999999
Q ss_pred ecccCCCHhhhhccCCCC--------------------------------------------------------------
Q 006747 412 DFIEAGSFSALLHGNRGI-------------------------------------------------------------- 429 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~-------------------------------------------------------------- 429 (632)
||+++|+|.++++..+..
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 999999999988653210
Q ss_pred -----------------------------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeE
Q 006747 430 -----------------------------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC 480 (632)
Q Consensus 430 -----------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~k 480 (632)
....+++..+.+++.|++.||+|||+. +|+||||||+|||+++++.+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~k 277 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVK 277 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEE
Confidence 012478888999999999999999998 999999999999999999999
Q ss_pred EcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 006747 481 ISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQS 553 (632)
Q Consensus 481 i~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 553 (632)
|+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||......+ ....
T Consensus 278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~------~~~~ 351 (400)
T cd05105 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS------TFYN 351 (400)
T ss_pred EEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH------HHHH
Confidence 99999997653321 1234567999999999899999999999999999997 999986532111 1111
Q ss_pred HhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 554 VVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 554 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
....+... .........+.+++.+||+.+|++|||+.+|.++|+++.+
T Consensus 352 ~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 KIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111100 0111223457789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=324.91 Aligned_cols=236 Identities=22% Similarity=0.319 Sum_probs=189.9
Q ss_pred HhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||++.. .+|..||+|+++.... ....+..|++++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 589999999999985 4689999999975421 234567889999999 9999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|..++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcc
Confidence 9998886542 478899999999999999999998 9999999999999999999999999998754221
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....++..|+|||.+.+..++.++|||||||++|||++|+.||....... .......... .. ...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~~~-------~~--p~~ 217 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEEI-------RF--PRT 217 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCCC-------CC--CCC
Confidence 22357889999999999999999999999999999999999996532111 1111111110 00 111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
....+.+++.+||+.||++|| ++.+++++
T Consensus 218 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 ---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ---CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 123466788899999999998 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=309.03 Aligned_cols=247 Identities=23% Similarity=0.421 Sum_probs=202.2
Q ss_pred HHHhHhCccceeEEEEEEEcCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 339 ASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 339 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
...+.||+|+||.||+|...++..+|+|.+..... ....+..|++++.++ +|+||+++++++...+..++||||+++|
T Consensus 9 ~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 9 TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred HHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEecCCCeEEEEeecccC
Confidence 34678999999999999988899999999986644 456789999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.++++... ...+++..+..++.+++.|++|||+. +|+||||||+||++++++.+||+|||.+.......
T Consensus 88 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 88 SLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred CHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 9999997643 23578999999999999999999988 99999999999999999999999999997764332
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ....... ..... .
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~~~~~~~-~~~~~----------~ 224 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------EVYDQIT-AGYRM----------P 224 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHH-hCCcC----------C
Confidence 1224567999999988889999999999999999998 89999653211 1111111 11100 0
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
........+.+++.+||+.+|++|||++++++.|+.+
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1112234577889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=320.46 Aligned_cols=238 Identities=15% Similarity=0.245 Sum_probs=193.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++.++ +||||+++++++.+....++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 84 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHDQRFLYMLMEYVP 84 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhccCCeEEEEEeCCC
Confidence 357999999999999965 58899999996532 1235688899999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++...+ .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~ 156 (291)
T cd05612 85 GGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW 156 (291)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCCcc
Confidence 999999987542 478888899999999999999998 99999999999999999999999999998765432
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...+++.|+|||.+.+..++.++|||||||++|||++|+.||..... ........... . .. ...
T Consensus 157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~-~------~~--~~~- 220 (291)
T cd05612 157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILAGK-L------EF--PRH- 220 (291)
T ss_pred cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-c------CC--Ccc-
Confidence 33578899999999998899999999999999999999999965321 11111111110 0 00 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPT-----MEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 605 (632)
....+.+++.+||+.||++||+ +.|++++
T Consensus 221 --~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 221 --LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1234678888999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.98 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=197.1
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|...++..+|+|.++.......++.+|++++.++ +||||+++++++...+..++||||+++|+|.
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLL 87 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccCCCcEEEEEcCCCCcHH
Confidence 357999999999999987777899999986655667899999999999 8999999999999988999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-----
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV----- 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~----- 495 (632)
+++.... ..+++..+.+++.+++.||+|||+. +++|+||||+||++++++.+||+|||.++.......
T Consensus 88 ~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 88 NYLREHG----KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9987542 2588999999999999999999998 999999999999999999999999999876543221
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++|||||||++|||+| |+.||..... ............. . . .
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~-~-------~---~ 223 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQGLRL-Y-------R---P 223 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHhcCCCC-C-------C---C
Confidence 123456999999998889999999999999999999 9999864321 1111111111110 0 0 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
......+.+++.+||+.+|++||++.++++.|+
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112346788899999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=324.43 Aligned_cols=236 Identities=22% Similarity=0.361 Sum_probs=190.8
Q ss_pred HhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||++.. .+++.||+|++..... ....+.+|++++.++ +||||+++.+++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 589999999999985 4689999999975421 234678899999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|..++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccc
Confidence 9998886542 478899999999999999999998 9999999999999999999999999998764321
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... .......... ..+ ...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~~~~-------~~~--p~~ 217 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMED-------IKF--PRT 217 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhccCC-------ccC--CCC
Confidence 2235788999999999989999999999999999999999999653211 1111111110 000 011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
. ...+.+++.+||+.||++|| ++.+++++
T Consensus 218 ~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 L---SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred C---CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1 23466788899999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.15 Aligned_cols=254 Identities=26% Similarity=0.388 Sum_probs=197.3
Q ss_pred HHhHhCccceeEEEEEEEc------CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeC-CceEEE
Q 006747 340 SAEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSK-DEKLLV 410 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv 410 (632)
..+.||+|+||.||+|... .++.||+|+++..... .+.+..|++++.++.+|+||++++++|... ...+++
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred hhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEE
Confidence 3578999999999999632 2478999998754322 345778999999997899999999988754 568899
Q ss_pred EecccCCCHhhhhccCCCC--------------------------------------------------------CCCcC
Q 006747 411 YDFIEAGSFSALLHGNRGI--------------------------------------------------------GRTPL 434 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~--------------------------------------------------------~~~~l 434 (632)
|||+++|+|.+++...... ...++
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 9999999999988643210 01368
Q ss_pred CHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC------CCCCCCcccCCccc
Q 006747 435 DWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT------VPSRSAGYRAPEVI 508 (632)
Q Consensus 435 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~------~~~~t~~y~aPE~~ 508 (632)
+|..+.+++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++.+.... ...++..|+|||++
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~ 247 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESI 247 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHh
Confidence 9999999999999999999998 99999999999999999999999999998753321 12245679999999
Q ss_pred cCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHH
Q 006747 509 ETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMS 587 (632)
Q Consensus 509 ~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~ 587 (632)
.+..++.++|||||||++|||++ |+.||.+....+ .......+.... .........+.+++.+
T Consensus 248 ~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~----------~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 248 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRM----------RAPEYATPEIYSIMLD 311 (337)
T ss_pred cCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCC----------CCCccCCHHHHHHHHH
Confidence 99999999999999999999998 999996532111 011111111110 0011123457888999
Q ss_pred ccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 588 CVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 588 Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
||+.+|++||++.|++++|+++.+.
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.65 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=204.4
Q ss_pred HhHhCccceeEEEEEEEcCC-cEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeE-EEEe------CCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILEEG-TTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRA-YYFS------KDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~-~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~-~~~~------~~~~~lv~ 411 (632)
.++|.+|||+.||.|....+ ..||+|++-... ..-+...+|+++|++|..|+|||.+++ .... ..+++|.|
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm 121 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM 121 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence 47899999999999997766 999999987653 235678999999999988999999999 3332 13678999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
|||.+|.|-+++..... ..|.+..+++|+.++++|+++||.. .++|||||||-+||||+.++..||||||.+..--
T Consensus 122 EyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 122 EYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred hhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 99999999999875432 2388999999999999999999985 7789999999999999999999999999985432
Q ss_pred CCC-------------CCCCCCcccCCccc---cCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh
Q 006747 492 TPT-------------VPSRSAGYRAPEVI---ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV 555 (632)
Q Consensus 492 ~~~-------------~~~~t~~y~aPE~~---~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 555 (632)
... ....|+-|+|||.+ .+...++|+|||++||+||-|+..+.||+..+.-.
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la------------ 265 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA------------ 265 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee------------
Confidence 211 11357889999988 46678999999999999999999999997643211
Q ss_pred hhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCCCC
Q 006747 556 REEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSEN 616 (632)
Q Consensus 556 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~~ 616 (632)
+++... .....+.....+.+||+.||+.+|.+||++-+|+..+.++.......
T Consensus 266 -------Ilng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 266 -------ILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI 318 (738)
T ss_pred -------EEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence 222222 11223456778899999999999999999999999999997776544
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=311.38 Aligned_cols=248 Identities=24% Similarity=0.414 Sum_probs=198.6
Q ss_pred HHhHhCccceeEEEEEEEcC------CcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 340 SAEVLGKGSYGTTYKAILEE------GTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
..+.||+|+||.||+|...+ +..||+|.++..... ...+.+|++++.++ +|+||+++++++......++||
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~ 87 (280)
T cd05049 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEGDPPIMVF 87 (280)
T ss_pred HHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecCCCeEEEE
Confidence 35789999999999998633 478999999765433 46799999999999 8999999999999999999999
Q ss_pred ecccCCCHhhhhccCCC---------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEc
Q 006747 412 DFIEAGSFSALLHGNRG---------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS 482 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 482 (632)
||+++|+|.+++..... .....+++.....++.+++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 88 EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred ecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEEC
Confidence 99999999999975421 1234578899999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHh
Q 006747 483 DFGLTPLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVV 555 (632)
Q Consensus 483 DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 555 (632)
|||+++..... .....+..|+|||++.+..++.++|||||||++|||++ |+.||.....++ .....
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~~~~~- 237 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VIECI- 237 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHH-
Confidence 99998754322 12234567999999999999999999999999999999 999986543211 11111
Q ss_pred hhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 556 REEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 556 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
..+.... ........+.+++.+||+.+|++||++.||++.|++
T Consensus 238 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HcCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111100 001123457788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=319.30 Aligned_cols=252 Identities=17% Similarity=0.314 Sum_probs=189.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... ++..||+|+++.... ....+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~- 87 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHTERCLTLVFEYLDS- 87 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEeCCCc-
Confidence 367999999999999854 588999999875422 245678899999999 999999999999999999999999985
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 88 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 88 DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 8998886432 2477888999999999999999998 9999999999999999999999999998764322
Q ss_pred CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh----hhcccc-------
Q 006747 494 TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV----REEWTS------- 561 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~------- 561 (632)
....++..|+|||.+.+ ..++.++||||+||++|||+||+.||.+....+... ...... .+.+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH---LIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHHhhccccchhh
Confidence 22346788999999876 458999999999999999999999997643222111 000000 000000
Q ss_pred -ccccccccccCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 562 -EVFDVELMRYENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 562 -~~~d~~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....+.. ..... .....+..+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~-~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQY-RAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCcc-CCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 00000 0112346788999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.40 Aligned_cols=238 Identities=19% Similarity=0.295 Sum_probs=189.4
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||++... +++.||+|+++.... ..+.+..|+.++.++.+|+||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 6899999999999864 578999999986422 23457788888888878999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC----C
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT----P 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~----~ 493 (632)
+|..++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.... .
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 82 DLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 9998886432 488999999999999999999998 999999999999999999999999999875321 1
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....+|..|+|||++.+..++.++|||||||++|||++|+.||.............+.......... .....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~p~~ 225 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI--------RIPRF 225 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC--------CCCCC
Confidence 2335788999999999999999999999999999999999999754333222222333222222110 00111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTM 599 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~ 599 (632)
. ...+.+++.+||+.||++|+++
T Consensus 226 ~---~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 226 L---SVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred C---CHHHHHHHHHHhccCHHHcCCC
Confidence 1 2345678889999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=314.54 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=195.1
Q ss_pred HhHhCccceeEEEEEEE-----cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 411 (632)
.+.||+|+||+||++.. .++..||+|.++.... ....+.+|++++.++ +||||+++++++... ...++||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCceEEEEe
Confidence 46799999999988653 3578999999976432 356788999999999 999999999998764 3578999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++|+|.+++... .+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 88 e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 88 EYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred cCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999998753 389999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCC-------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 492 TPTV-------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 492 ~~~~-------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.... ..++..|+|||.+.+..++.++||||||+++|||+||+.|+....... .....+...........+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence 3221 123456999999988889999999999999999999999986432110 00000000000000000000
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
+... ...........+.+++..||+.+|++|||++++++.|+++.
T Consensus 238 ~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1000 00111122356788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=326.88 Aligned_cols=245 Identities=18% Similarity=0.270 Sum_probs=194.8
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|... +++.||+|+++.... ..+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 57999999999999965 488999999975421 235678899999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-CC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-TV 495 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~~ 495 (632)
|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 86 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~ 157 (333)
T cd05600 86 GDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS 157 (333)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccccccCC
Confidence 99999997542 478888999999999999999998 9999999999999999999999999999766442 33
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..+++.|+|||.+.+..++.++|||||||++|||++|+.||......+. ....... ...+.... ......
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~---~~~~~~~~-~~~~~~ 227 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYW---KETLQRPV-YDDPRF 227 (333)
T ss_pred cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHhc---cccccCCC-CCcccc
Confidence 4588999999999999999999999999999999999999975332111 1111000 00000000 000001
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....++.+++.+||+.+|++||++.+++++
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 123456778889999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=307.33 Aligned_cols=240 Identities=22% Similarity=0.379 Sum_probs=202.6
Q ss_pred HHHhHhCccceeEEEEEE-EcCCcEEEEEEecccccC-H---HHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 339 ASAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMG-K---REFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 339 ~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~-~---~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
...+.||+|.||+|-+|. ...|+.||||.+++.... + -.+++|+++|..+ +||||+.++.+|...+.+.|||||
T Consensus 56 E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFENkdKIvivMEY 134 (668)
T KOG0611|consen 56 EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFENKDKIVIVMEY 134 (668)
T ss_pred HHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcCCceEEEEEEe
Confidence 345789999999999998 467999999999876432 2 3478999999999 999999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
..+|.|++|+.+.+ .|++.....++.||..|+.|+|.. +++|||||-+|||+|+++++||+|||++-.+...
T Consensus 135 aS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 135 ASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred cCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999998764 478888889999999999999998 9999999999999999999999999999887665
Q ss_pred ---CCCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
.+.+|++-|.+||.+.|.+| .+.+|.||+||+||-|+.|..||++.+ ....++++-+..+. .+
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~GaYr----EP--- 273 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISRGAYR----EP--- 273 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhccccc----CC---
Confidence 34578899999999999998 678999999999999999999997643 23344444333321 11
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
+......-|+++++..+|++|-|+.||..+-
T Consensus 274 ------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1123455678899999999999999998753
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=309.69 Aligned_cols=243 Identities=23% Similarity=0.399 Sum_probs=197.5
Q ss_pred HHhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 340 SAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
..+.||+|+||.||++..+++..+|+|.+.........+.+|++++.++ +|+||+++++++...+..++||||+++++|
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTKQRPIFIVTEYMANGCL 86 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcCCCceEEEEecCCCCCH
Confidence 3578999999999999987778999999876655667889999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC----
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV---- 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 495 (632)
.+++.... ..++|..+..++.+++.|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 87 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 87 LNYLRERK----GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred HHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99987543 2588999999999999999999998 999999999999999999999999999876543221
Q ss_pred -CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 496 -PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 496 -~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...+..|+|||.+.+..++.++|||||||++|||+| |+.||......+ .. .. ..... ... ..
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~-~~~~~-----~~~--~~-- 223 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV---ES-VSAGY-----RLY--RP-- 223 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH---HH-HHcCC-----cCC--CC--
Confidence 112346999999999999999999999999999999 899986432211 11 11 11110 000 11
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
......+.+++.+||..+|++|||+.|+++.|.
T Consensus 224 -~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 224 -KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred -CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 112346778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=323.70 Aligned_cols=236 Identities=23% Similarity=0.339 Sum_probs=187.2
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||+|... +++.||+|+++... .....+..|..++....+||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 5899999999999965 47899999997642 223456677778876669999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC----C
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT----P 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~----~ 493 (632)
+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.... .
T Consensus 82 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 82 DLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 999998753 2478889999999999999999998 999999999999999999999999999875321 1
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....+|..|+|||++.+..++.++|||||||++|||++|+.||...... ...... .... +... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~i-~~~~------~~~~--~~ 218 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------ELFQSI-RMDN------PCYP--RW 218 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------HHHHHH-HhCC------CCCC--cc
Confidence 2234788999999999989999999999999999999999999753211 111111 1110 0000 01
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTME-EVVR 604 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl~ 604 (632)
....+.+++.+||+.||++||++. ++.+
T Consensus 219 ---~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 ---LTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 123466788899999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.86 Aligned_cols=238 Identities=20% Similarity=0.274 Sum_probs=192.4
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 101 (329)
T PTZ00263 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQDENRVYFLLEFVV 101 (329)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence 467999999999999964 58899999997542 2235688999999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 102 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 173 (329)
T PTZ00263 102 GGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173 (329)
T ss_pred CChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcc
Confidence 999999987542 467788888999999999999998 99999999999999999999999999998765432
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...+++.|+|||.+.+..++.++|||||||++|||+||+.||..... ....... .++.. .. ....
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i-~~~~~------~~--p~~~ 238 (329)
T PTZ00263 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKI-LAGRL------KF--PNWF 238 (329)
T ss_pred eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHH-hcCCc------CC--CCCC
Confidence 34588899999999999999999999999999999999999964321 1111111 11110 00 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPT-----MEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 605 (632)
...+.+++.+||+.||++||+ +++++.+
T Consensus 239 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 239 ---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 134667888999999999997 6777754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.35 Aligned_cols=231 Identities=24% Similarity=0.338 Sum_probs=186.2
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||+|+.. +++.||+|+++... ...+.+..|.+++..+.+||||+++++++...+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6899999999999864 57899999997542 223456778888887768999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC----C
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT----P 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~----~ 493 (632)
+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.... .
T Consensus 82 ~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 82 DLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred hHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 9999887542 478889999999999999999998 999999999999999999999999999875422 1
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....+|+.|+|||.+.+..++.++|||||||++|||++|+.||..... ............ . ....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~----~-----~~~~ 218 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEV----V-----YPTW 218 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCC----C-----CCCC
Confidence 233578899999999998999999999999999999999999975321 111122111110 0 0011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTM 599 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~ 599 (632)
....+.+++.+|++.||++||++
T Consensus 219 ---~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 219 ---LSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ---CCHHHHHHHHHHcccCHHHCCCC
Confidence 12346778889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.44 Aligned_cols=255 Identities=17% Similarity=0.221 Sum_probs=191.7
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||++... +++.||+|+++.... ..+.+.+|++++.++ +|+||+++++++...+..++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEecCCEEEEEEecCCC
Confidence 357999999999999975 578999999975422 245688899999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
+.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 85 NMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 8776554322 2478888999999999999999998 99999999999999999999999999998764321
Q ss_pred ---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChh---------HHHHHHhhhccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP---------RWVQSVVREEWTSE 562 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 562 (632)
...++..|+|||++.+..++.++|||||||++|||++|+.||......+..... .+......+.....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 234788899999999888999999999999999999999999764321110000 00000000000000
Q ss_pred cccccccccCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 563 VFDVELMRYENI-----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 563 ~~d~~~~~~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
...+........ ......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 012245788999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=319.23 Aligned_cols=191 Identities=21% Similarity=0.378 Sum_probs=166.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||++... ++..+|+|.+..... ....+.+|++++.++ +|+||++++++|.+.+..++||||+++|
T Consensus 10 ~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (333)
T cd06650 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 88 (333)
T ss_pred eccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEECCEEEEEEecCCCC
Confidence 468999999999999865 578899998875432 235688999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--CC
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--TV 495 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~ 495 (632)
+|.+++.... .+++.....++.+++.||+|||+.. +|+||||||+|||+++++.+||+|||++...... ..
T Consensus 89 ~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 161 (333)
T cd06650 89 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 161 (333)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcccc
Confidence 9999997542 4788888999999999999999742 6999999999999999999999999998765432 23
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
..++..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 35788899999999988999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=310.27 Aligned_cols=237 Identities=20% Similarity=0.338 Sum_probs=187.0
Q ss_pred HhCccceeEEEEEEEcC-------------CcEEEEEEecccccC-HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceE
Q 006747 343 VLGKGSYGTTYKAILEE-------------GTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKL 408 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~-------------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 408 (632)
.||+|+||.||+|...+ ...|++|.+...... ...+.+|+.++..+ +||||+++++++......+
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCE
Confidence 58999999999998532 235888887654322 34678888899998 9999999999999999999
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC-------eEE
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ-------GCI 481 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~-------~ki 481 (632)
+||||+++|+|..+++... .++++..+.+++.|++.||+|||+. +|+||||||+|||++.++. +|+
T Consensus 81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 9999999999999886532 3588899999999999999999998 9999999999999987664 899
Q ss_pred cccCCCCCCCCCCCCCCCCcccCCcccc-CCCCCccchhhHHHHHHHHHH-hCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 482 SDFGLTPLMNTPTVPSRSAGYRAPEVIE-TKKPTQKSDVYSFGVLLLEML-TGKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 482 ~DfGla~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~~DV~s~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
+|||++..........++..|+|||.+. +..++.++|||||||++|||+ +|+.|+......+ .........
T Consensus 154 ~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~ 226 (262)
T cd05077 154 SDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFYEGQC 226 (262)
T ss_pred CCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHHhcCc
Confidence 9999998776555556788899999887 466899999999999999998 5888875422111 001111100
Q ss_pred ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 560 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
. ... .....+.+++.+||+.||++||++.++++.+
T Consensus 227 ~---------~~~---~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 M---------LVT---PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred c---------CCC---CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 001 1124577889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=313.75 Aligned_cols=243 Identities=19% Similarity=0.299 Sum_probs=190.6
Q ss_pred hCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 344 LGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 344 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
||+|+||+||++... +++.||+|.+..... ..+.+..|++++.++ +|+||+++.+++......++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 699999999999854 688999999875422 124567899999999 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 494 (632)
|..++..... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 80 L~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 80 LRYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred HHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 9988754321 234588999999999999999999998 99999999999999999999999999997654332
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...++..|+|||.+.+..++.++|||||||++|||++|+.||........ .......... ... ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~---------~~~---~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRILN---------DSV---TYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhcc---------cCC---CCc
Confidence 23578889999999999999999999999999999999999975432111 0111111110 000 001
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
......+.+++.+||+.||++|| ++++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 11234567788899999999999 66777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=313.34 Aligned_cols=238 Identities=19% Similarity=0.324 Sum_probs=185.6
Q ss_pred HhCccceeEEEEEEEcC-------------------------CcEEEEEEecccccC-HHHHHHHHHHHHhhcCCCCccc
Q 006747 343 VLGKGSYGTTYKAILEE-------------------------GTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNVVP 396 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~-------------------------~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~~h~niv~ 396 (632)
.||+|+||.||+|.... ...|++|.+...... ...+.+|++++.++ +||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 58999999999997421 235889988654322 34677888888888 8999999
Q ss_pred eeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC
Q 006747 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD 476 (632)
Q Consensus 397 l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~ 476 (632)
++++|......++||||+++|+|..++.... ..+++..+..++.|+++||+|||+. +|+||||||+|||++++
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 9999999999999999999999999986532 2478889999999999999999988 99999999999999865
Q ss_pred C-------CeEEcccCCCCCCCCCCCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHH-hCCCCCCCCCCCCCCCh
Q 006747 477 L-------QGCISDFGLTPLMNTPTVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEML-TGKAPIQAPGHEDVVDL 547 (632)
Q Consensus 477 ~-------~~ki~DfGla~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~ell-tg~~p~~~~~~~~~~~~ 547 (632)
+ .+|++|||++..........++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+ .
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---K 230 (274)
T ss_pred CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---H
Confidence 4 389999999876544444456778999998875 55799999999999999995 6999986532211 1
Q ss_pred hHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
.. ....... . .. .....+.+++.+||+.+|++|||+.++++.|.
T Consensus 231 ~~----~~~~~~~-------~--~~---~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ER----FYEKKHR-------L--PE---PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH----HHHhccC-------C--CC---CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 1111100 0 00 11235778889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=291.57 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=201.4
Q ss_pred CCHHHHHHHHHhHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC
Q 006747 331 FDLEDLLRASAEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD 405 (632)
Q Consensus 331 ~~~~~l~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 405 (632)
++++++ ..++.||+|-||.||.|+. +++-.||+|++.+.+. ...++.+|+++-+.+ +||||.++++||.+..
T Consensus 19 ~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 19 WTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDSK 95 (281)
T ss_pred cchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheeccc
Confidence 445544 2467899999999999995 4577899999987642 356799999999999 9999999999999999
Q ss_pred ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 406 EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 406 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
..|+++||.+.|++...|.+.+. ..++......+..|+|.|+.|+|.. +||||||||+|+|++.++..||+|||
T Consensus 96 riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred eeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCC
Confidence 99999999999999999986542 3467777788999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCC--CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 486 LTPLMNTP--TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 486 la~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
-+...... .+.+||.-|.+||...+..++..+|+|++|++.||++.|.+||.....++.. +. +.. .++
T Consensus 170 wsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY------kr-I~k---~~~ 239 (281)
T KOG0580|consen 170 WSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY------KR-IRK---VDL 239 (281)
T ss_pred ceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH------HH-HHH---ccc
Confidence 98665432 3457999999999999999999999999999999999999999765422211 11 111 111
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.++ ..+. ....+++.+|+..+|.+|.+..|++.+
T Consensus 240 ~~p-----~~is---~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 KFP-----STIS---GGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred cCC-----cccC---hhHHHHHHHHhccCccccccHHHHhhh
Confidence 111 1222 345677889999999999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=310.29 Aligned_cols=245 Identities=22% Similarity=0.287 Sum_probs=192.2
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEeccccc---------------CHHHHHHHHHHHHhhcCCCCccceeEEEEeC
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVM---------------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK 404 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~---------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~ 404 (632)
.+.||+|.||.|-+|+ ..+++.||||++.+... ..+...+|+.+|+++ +|||||+|+.+..+.
T Consensus 102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~LiEvLDDP 180 (576)
T KOG0585|consen 102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLIEVLDDP 180 (576)
T ss_pred hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEEEeecCc
Confidence 5679999999999998 45689999999965321 125789999999999 999999999998764
Q ss_pred --CceEEEEecccCCCHhhhhccCCCCCCCc-CCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEE
Q 006747 405 --DEKLLVYDFIEAGSFSALLHGNRGIGRTP-LDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCI 481 (632)
Q Consensus 405 --~~~~lv~E~~~~g~L~~~l~~~~~~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki 481 (632)
+.+|||+||+..|.+...=. ..+ +...+..++..++..||+|||.+ +||||||||+|+||+++|++||
T Consensus 181 ~s~~~YlVley~s~G~v~w~p~------d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 181 ESDKLYLVLEYCSKGEVKWCPP------DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred ccCceEEEEEeccCCccccCCC------CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEe
Confidence 57999999999988753322 223 88899999999999999999999 9999999999999999999999
Q ss_pred cccCCCCCCCCC---------CCCCCCCcccCCccccCCC----CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChh
Q 006747 482 SDFGLTPLMNTP---------TVPSRSAGYRAPEVIETKK----PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP 548 (632)
Q Consensus 482 ~DfGla~~~~~~---------~~~~~t~~y~aPE~~~~~~----~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~ 548 (632)
+|||.+...... ..+.||+.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-+... .
T Consensus 252 sDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~------~ 325 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE------L 325 (576)
T ss_pred eccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH------H
Confidence 999999766322 2356899999999998743 36778999999999999999999965321 1
Q ss_pred HHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 549 RWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 549 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.....+.. ..+. ....++....+.+|+.++|++||++|.+..+|..+.=-...
T Consensus 326 ~l~~KIvn---------~pL~-fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 326 ELFDKIVN---------DPLE-FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHHhc---------Cccc-CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 11122221 1121 11222445667788899999999999999999876644433
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.97 Aligned_cols=249 Identities=22% Similarity=0.403 Sum_probs=195.0
Q ss_pred hHhCccceeEEEEEEEcC-Cc--EEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILEE-GT--TVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|...+ +. .+++|.++... .....+..|++++.++.+||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 57888887532 22457889999999997899999999999999999999999999
Q ss_pred CCHhhhhccCCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 417 GSFSALLHGNRGI-----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 417 g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
|+|.++++..+.. ....+++..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 9999999764321 123478999999999999999999987 99999999999999999999999999
Q ss_pred CCCCCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006747 486 LTPLMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTS 561 (632)
Q Consensus 486 la~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (632)
+++..... .....+..|+|||++.+..++.++|||||||++|||++ |..||..... ....... ......
T Consensus 158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~-~~~~~~ 230 (270)
T cd05047 158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKL-PQGYRL 230 (270)
T ss_pred CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHH-hCCCCC
Confidence 98643321 11223456999999988889999999999999999997 9999864321 1111111 111110
Q ss_pred ccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 562 EVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 562 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
+ ........+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus 231 ~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 E----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 01112235778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=318.63 Aligned_cols=236 Identities=22% Similarity=0.333 Sum_probs=186.0
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||+|... +++.||+|+++... ...+.+..|.+++....+||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6899999999999864 57889999997542 123445667777776658999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|..++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 82 DLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 9999987542 478888889999999999999998 9999999999999999999999999999754321
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....+|..|+|||.+.+..++.++|||||||++|||++|+.||.+.... ....... .... .. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~-~~~~------~~--~~~ 218 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSIL-NDRP------HF--PRW 218 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-cCCC------CC--CCC
Confidence 2235788999999999999999999999999999999999999753311 1111111 1100 00 011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTME-EVVR 604 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl~ 604 (632)
...++.+++.+||+.+|++||++. ++++
T Consensus 219 ---~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 ---ISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 123456788899999999999976 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=309.38 Aligned_cols=248 Identities=21% Similarity=0.352 Sum_probs=195.7
Q ss_pred HHhHhCccceeEEEEEEEc------CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 340 SAEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
..+.||+|+||.||+|... ++..||+|+++..... .+.+.+|++++.++ +||||+++++++...+..++++
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCCCceEEEE
Confidence 4678999999999999853 2578999999755332 35688899999999 8999999999999999999999
Q ss_pred ecccCCCHhhhhccCCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeE
Q 006747 412 DFIEAGSFSALLHGNRG-----------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC 480 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~k 480 (632)
||+++++|.+++..... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceE
Confidence 99999999999853210 1123588889999999999999999998 999999999999999999999
Q ss_pred EcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 006747 481 ISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQS 553 (632)
Q Consensus 481 i~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 553 (632)
|+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |..||.+... ..+...
T Consensus 165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~ 238 (283)
T cd05091 165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVIEM 238 (283)
T ss_pred ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Confidence 99999988654322 1234567999999988889999999999999999998 8888864321 112222
Q ss_pred HhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 554 VVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 554 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
..... .. ....+....+.+++.+||+.+|++||++.+|++.|+.
T Consensus 239 i~~~~-~~----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNRQ-VL----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCC-cC----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111 10 0011223447788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=289.75 Aligned_cols=253 Identities=20% Similarity=0.296 Sum_probs=199.1
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeC-----CceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK-----DEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~E~ 413 (632)
.+.||+|||+.||.++ ..++..+|+|++.... .+.+...+|++..+++ +||||++++++...+ .+.|+++.|
T Consensus 26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~~~yll~Py 104 (302)
T KOG2345|consen 26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKHEAYLLLPY 104 (302)
T ss_pred eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCceeEEEEeeh
Confidence 3679999999999998 6778999999998664 4567789999999999 999999999887643 358999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
...|+|.+.+..... +...+++.+.+.|+.++++||++||+. .+++.||||||.|||+.+++.+++.|||.+......
T Consensus 105 y~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~ 182 (302)
T KOG2345|consen 105 YKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQ 182 (302)
T ss_pred hccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceE
Confidence 999999999986543 345689999999999999999999987 457999999999999999999999999998765321
Q ss_pred C-------------CCCCCCcccCCccccCC---CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 006747 494 T-------------VPSRSAGYRAPEVIETK---KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE 557 (632)
Q Consensus 494 ~-------------~~~~t~~y~aPE~~~~~---~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (632)
- ...-|..|+|||.+.-. ..++++|||||||+||+|+.|..||+.... .+..+
T Consensus 183 i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSl---------- 251 (302)
T KOG2345|consen 183 IEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSL---------- 251 (302)
T ss_pred eechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeE----------
Confidence 0 11246779999999644 468999999999999999999999975322 11100
Q ss_pred ccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 558 EWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 558 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
...+....+..+. .......+.+++.+|++.||.+||++.+++..++.+.
T Consensus 252 --aLAv~n~q~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 252 --ALAVQNAQISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --EEeeeccccccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0011111111111 1114456788888999999999999999999998763
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.22 Aligned_cols=238 Identities=18% Similarity=0.268 Sum_probs=192.0
Q ss_pred HhHhCccceeEEEEEEEcC--CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEE--GTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|.... +..||+|++.... .....+.+|++++..+ +||||+++++++.+.+..++||||+
T Consensus 35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~Ey~ 113 (340)
T PTZ00426 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDESYLYLVLEFV 113 (340)
T ss_pred EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeCCEEEEEEeCC
Confidence 4679999999999998543 3689999986542 2235678899999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 114 ~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~ 185 (340)
T PTZ00426 114 IGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT 185 (340)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCCc
Confidence 9999999997542 478888999999999999999998 99999999999999999999999999998765432
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...+|+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+.. .-...
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~~~i~~~~~--------~~p~~ 250 (340)
T PTZ00426 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIYQKILEGII--------YFPKF 250 (340)
T ss_pred ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCC--------CCCCC
Confidence 345888999999999988999999999999999999999999753211 11111111110 00111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
.. ..+.+++.+|++.||++|+ ++++++++
T Consensus 251 ~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 LD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 12 2356788899999999995 89988775
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=322.62 Aligned_cols=236 Identities=24% Similarity=0.330 Sum_probs=187.1
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|... +|..||+|+++... .....+..|.+++....+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999999999965 57899999997642 22345667777777665899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC----
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT---- 492 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~---- 492 (632)
|+|..++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence 99999887542 478888899999999999999998 999999999999999999999999999875321
Q ss_pred CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 493 PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 493 ~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
.....+|..|+|||++.+..++.++|||||||++|||++|+.||...... ...... .... +... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~-~~~~------~~~~--~ 217 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESI-RVDT------PHYP--R 217 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHH-HhCC------CCCC--C
Confidence 12335788999999999999999999999999999999999999753211 111111 1110 0010 1
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTME-EVV 603 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl 603 (632)
. ...++.+++.+||+.||++||++. ++.
T Consensus 218 ~---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 W---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 123466788899999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.65 Aligned_cols=244 Identities=26% Similarity=0.450 Sum_probs=197.9
Q ss_pred HHhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 340 SAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
..+.||+|+||.||+|..+++..||+|.++........+.+|++++.++ +|+|++++++++. ....++||||+++++|
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L 87 (260)
T cd05070 10 LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVS-EEPIYIVTEYMSKGSL 87 (260)
T ss_pred hhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence 4578999999999999988888999999987655667899999999999 8999999999875 4568999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC----
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV---- 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 495 (632)
.++++... ...+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 88 LDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 99997542 23478999999999999999999998 999999999999999999999999999976543221
Q ss_pred -CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 496 -PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 496 -~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +..... ...... ..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~-~~~~~~----------~~ 224 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQV-ERGYRM----------PC 224 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHH-HcCCCC----------CC
Confidence 123457999999988889999999999999999999 88998653211 111111 111100 00
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.......+.+++.+||+.+|++|||+.++...|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11223457789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=312.12 Aligned_cols=251 Identities=22% Similarity=0.418 Sum_probs=199.1
Q ss_pred HhHhCccceeEEEEEEE------cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||++.. .++..+|+|.+..... ....+..|++++.++ +|+||+++++++...+..++||||
T Consensus 10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEc
Confidence 46799999999999974 2345689999875432 245789999999999 899999999999999999999999
Q ss_pred ccCCCHhhhhccCCC--------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 414 IEAGSFSALLHGNRG--------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
+++|+|.+++..... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg 165 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 165 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCC
Confidence 999999999874421 1223589999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006747 486 LTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREE 558 (632)
Q Consensus 486 la~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (632)
+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||...... ...... ..+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~~~~~i-~~~ 238 (288)
T cd05093 166 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIECI-TQG 238 (288)
T ss_pred ccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-HcC
Confidence 997653321 1224567999999998889999999999999999999 89998643211 111111 111
Q ss_pred cccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 559 WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 559 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.... .... ....+.+++.+||+.+|.+|||+.++++.|+++...
T Consensus 239 ~~~~-------~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 239 RVLQ-------RPRT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CcCC-------CCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1100 0011 123578889999999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.21 Aligned_cols=238 Identities=21% Similarity=0.327 Sum_probs=190.1
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
++||+|+||.||+|... +++.||+|+++... ...+.+..|.+++..+.+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999865 47899999997642 12345677888888776899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|..++...+ .+++.....++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 99999886542 478888999999999999999998 9999999999999999999999999998753221
Q ss_pred -CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 -TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....++..|+|||++.+..++.++|||||||++|||+||+.||...... ............ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~~~~~---------~p~ 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILHDDVL---------YPV 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCCC---------CCC
Confidence 2234788999999999989999999999999999999999999754321 111222111110 000
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRP-------TMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RP-------s~~evl~~ 605 (632)
. ...++.+++.+|++.||++|| ++.+++++
T Consensus 218 ~---~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 W---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C---CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 123467788899999999999 78887754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=306.37 Aligned_cols=244 Identities=22% Similarity=0.443 Sum_probs=196.9
Q ss_pred HhHhCccceeEEEEEEEcC----CcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|.... ...||||.++..... ..+|..|+.++.++ +|+||+++++++...+..++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEecCCceEEEEEcC
Confidence 4679999999999998642 458999998754332 45788999999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.+++.... ..+++..+.+++.+++.|++|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 88 ENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred CCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999997643 2588999999999999999999997 99999999999999999999999999998764211
Q ss_pred C------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccccc
Q 006747 495 V------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567 (632)
Q Consensus 495 ~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 567 (632)
. ...+..|+|||.+.+..++.++||||||+++|||++ |..||...... .... ...+.+...
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~-~~~~~~~~~----- 228 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIK-AVEDGYRLP----- 228 (266)
T ss_pred cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHH-HHHcCCCCC-----
Confidence 1 123467999999998899999999999999999998 99998543211 1111 111111100
Q ss_pred ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 568 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
........+.+++.+||+.+|++||++.+++++|+++
T Consensus 229 -----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 -----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112234577899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=308.04 Aligned_cols=244 Identities=26% Similarity=0.428 Sum_probs=197.1
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|...++..||+|+++......+.+.+|++++.++ +|+||+++++++. .+..++||||+++|+|.
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~ 88 (262)
T cd05071 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 88 (262)
T ss_pred eeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEEC-CCCcEEEEEcCCCCcHH
Confidence 467999999999999987777899999987555567899999999999 8999999999874 45689999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-----
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV----- 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~----- 495 (632)
+++.... ...+++..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||.++.......
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~ 162 (262)
T cd05071 89 DFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162 (262)
T ss_pred HHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence 9997532 23478999999999999999999998 999999999999999999999999999976543321
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||...+..++.++|||||||++|||+| |+.||......+ .... ...... ....
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~-~~~~~~----------~~~~ 225 (262)
T cd05071 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQ-VERGYR----------MPCP 225 (262)
T ss_pred CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHH-HhcCCC----------CCCc
Confidence 224557999999988889999999999999999999 888886432111 1111 111100 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.+....+.+++.+|++.+|++||++.++++.|++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 22345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=320.50 Aligned_cols=237 Identities=20% Similarity=0.322 Sum_probs=189.4
Q ss_pred hHhCccceeEEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVV-----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
+.||+|+||.||++.. .+++.||+|+++... .....+..|++++.++ +||||+++++++..++..++|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecCCeEEEEEe
Confidence 4699999999999985 357899999997542 1234577899999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++|+|.+++.... .+.+.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 81 YLSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 999999999987542 467778888999999999999998 999999999999999999999999999875322
Q ss_pred C----CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 493 P----TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 493 ~----~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
. ....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~~~---------~ 217 (323)
T cd05584 153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILKGK---------L 217 (323)
T ss_pred CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCC---------C
Confidence 1 223578899999999988899999999999999999999999975321 11111111111 0
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
..... ....+.+++.+||+.+|++|| ++.+++++
T Consensus 218 ~~~~~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPY---LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCC---CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 00111 123467888899999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=308.55 Aligned_cols=251 Identities=20% Similarity=0.367 Sum_probs=199.8
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. .+++.||||.++.... ....+..|++++.++ +||||+++++++...+..++|+||++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIEDNELNIVLELAD 85 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEECCeEEEEEEecC
Confidence 35799999999999985 4689999998864321 134688899999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++..... ....+++.....++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 86 AGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 9999998864321 223578888999999999999999998 99999999999999999999999999987765422
Q ss_pred ---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.......... .
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~----------~ 227 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLCQKIEQCDYP----------P 227 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHHHHHhcCCCC----------C
Confidence 23467789999999888899999999999999999999999864321 111222111110100 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
.........+.+++.+||+.+|++||++.+|++.|++++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111223356788899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=324.82 Aligned_cols=252 Identities=22% Similarity=0.357 Sum_probs=197.6
Q ss_pred HHhHhCccceeEEEEEEEc------CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 340 SAEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
..+.||+|+||.||+|... .+..||+|+++..... ...+..|++++.++..|||||+++++|...+..++||
T Consensus 41 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 41 LGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred hhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEE
Confidence 4688999999999999853 3468999999764322 3468899999999944999999999999999999999
Q ss_pred ecccCCCHhhhhccCCC---------------------------------------------------------------
Q 006747 412 DFIEAGSFSALLHGNRG--------------------------------------------------------------- 428 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~--------------------------------------------------------------- 428 (632)
||+++|+|.++++..+.
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 99999999999975421
Q ss_pred ------------------------------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC
Q 006747 429 ------------------------------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ 478 (632)
Q Consensus 429 ------------------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~ 478 (632)
.....++|...++++.+++.||+|||+. +|+||||||+|||+++++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~ 277 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKL 277 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCE
Confidence 0112477888899999999999999987 9999999999999999999
Q ss_pred eEEcccCCCCCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 006747 479 GCISDFGLTPLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWV 551 (632)
Q Consensus 479 ~ki~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 551 (632)
+||+|||+++..... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ ..
T Consensus 278 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~------~~ 351 (401)
T cd05107 278 VKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE------QF 351 (401)
T ss_pred EEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH------HH
Confidence 999999999765321 12235667999999998889999999999999999998 888986432111 11
Q ss_pred HHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 552 QSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 552 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
...+..+.... ... .....+.+++.+||..+|++||+++||++.|+++.
T Consensus 352 ~~~~~~~~~~~-------~p~---~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 YNAIKRGYRMA-------KPA---HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHcCCCCC-------CCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111111000 011 12245778888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=327.49 Aligned_cols=196 Identities=26% Similarity=0.384 Sum_probs=171.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC-----CCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQH-----PNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h-----~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.++||+|+||.|.++.. +.++.||||+++....-.++...|+.+|..+.+| -|+|++++||..+++.|||+|.+
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL 270 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL 270 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh
Confidence 47899999999999984 5589999999998765567778899999999534 38999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC--CCeEEcccCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD--LQGCISDFGLTPLMNT 492 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~--~~~ki~DfGla~~~~~ 492 (632)
+. +|.++++.++ ...++......++.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.|++...
T Consensus 271 ~~-NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q 343 (586)
T KOG0667|consen 271 ST-NLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ 343 (586)
T ss_pred hh-hHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCC
Confidence 76 9999999874 45588899999999999999999988 99999999999999753 4799999999998766
Q ss_pred CCC-CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC
Q 006747 493 PTV-PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED 543 (632)
Q Consensus 493 ~~~-~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~ 543 (632)
... ...+..|+|||++.|.+|+.+.||||||||+.||+||.+-|.+..+.+
T Consensus 344 ~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 344 RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 543 346778999999999999999999999999999999988888765443
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=306.97 Aligned_cols=242 Identities=22% Similarity=0.382 Sum_probs=193.0
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|+||.||+|.. .+++.||+|.+..... ....+.+|++++.++ +||||++++++|...+..++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 3689999999999986 4689999998865422 245689999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCC--
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVP-- 496 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~-- 496 (632)
|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 80 L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRTEG----PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 999987532 3478999999999999999999988 9999999999999999999999999998765432111
Q ss_pred ----CCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 497 ----SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 497 ----~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
..+..|+|||.+.++.++.++|||||||++|||++ |..||...... ............
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~~~~~---------- 215 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQGVRL---------- 215 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCCCC----------
Confidence 12345999999999899999999999999999998 88888543211 111111111000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.........+.+++.+||+.+|++|||+.++.+.|++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 216 PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 0111123457788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=311.26 Aligned_cols=244 Identities=21% Similarity=0.335 Sum_probs=191.6
Q ss_pred hCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 344 LGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 344 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
||+|+||.||++... +|+.||+|++..... ....+..|++++.++ +||||+++.+++......++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 699999999999854 589999999965321 234466799999999 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---V 495 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~ 495 (632)
|.+++.... ...+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....... .
T Consensus 80 L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 153 (277)
T cd05607 80 LKYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ 153 (277)
T ss_pred HHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence 998886542 34588999999999999999999998 99999999999999999999999999987654332 2
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..++..|+|||++.+..++.++|||||||++|||++|+.||...... ............... .. ...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~-----~~---~~~--- 220 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTLEDEV-----KF---EHQ--- 220 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhhcccc-----cc---ccc---
Confidence 35788999999999888999999999999999999999999643211 111111111111110 00 001
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
....++.+++.+||+.||++||+++|+++.+.
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 12235678889999999999999987765444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=310.00 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=188.1
Q ss_pred HhCccceeEEEEEEEcC---CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILEE---GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||+|...+ +..+|+|.++.... ....+.+|+.++.++ +||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999998643 35799999875532 234688899999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.++++..........++.....++.|++.|++|||+. +++||||||+||++++++++|++|||+++......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999764332234567788889999999999999998 99999999999999999999999999987543321
Q ss_pred ---CCCCCCcccCCccccCC-------CCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 495 ---VPSRSAGYRAPEVIETK-------KPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~-------~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
...++..|+|||++.+. .++.++|||||||++|||++ |+.||......+. .. ...... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~---~~~~~~-~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LT---YTVREQ-QLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HH---HHhhcc-cCCC
Confidence 22356679999998642 35789999999999999996 9999965322111 00 011111 1111
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
.++... .. ....+.+++..|| .+|++|||++||++.|+
T Consensus 231 ~~~~~~--~~---~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK--LP---LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC--CC---CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111110 01 1224667888999 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=323.35 Aligned_cols=241 Identities=23% Similarity=0.358 Sum_probs=198.6
Q ss_pred HHhHhCccceeEEEEEEEcC--C--cEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 340 SAEVLGKGSYGTTYKAILEE--G--TTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~~--~--~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
..+.||+|+||.|++|.+.. | ..||||+++..... -.+|.+|+.+|.++ +|+|+++|+|...+ ...++|||+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc-chhhHHhhh
Confidence 46889999999999998642 3 46899999876543 57899999999999 99999999999988 678999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
++.|+|.+.|+.. ....+-......++.|||+||+||.++ ++|||||.++|+|+-....+||+|||+.+.+...
T Consensus 192 aplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred cccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 9999999999873 234566777788999999999999999 9999999999999999999999999999988654
Q ss_pred CCC-------CCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 494 TVP-------SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 494 ~~~-------~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
... .-...|.|||.+....++.++|||+|||++|||+| |+.||.+.....+ .. .+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI---L~-------------~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI---LK-------------NID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH---HH-------------hcc
Confidence 322 12446999999999999999999999999999999 8889876432111 11 111
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...+....+.+..+++++|..||..+|++||||.++...
T Consensus 330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 111233444566789999999999999999999999743
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=307.18 Aligned_cols=248 Identities=22% Similarity=0.379 Sum_probs=192.6
Q ss_pred HhHhCccceeEEEEEEEcCCc---EEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceE
Q 006747 341 AEVLGKGSYGTTYKAILEEGT---TVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~---~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~ 408 (632)
.+.||+|+||.||+|...++. .||+|.++.... ..+.+..|++++.++ +|+||+++++++... ...+
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCCcE
Confidence 467999999999999965432 589998875432 245688899999999 999999999988542 2468
Q ss_pred EEEecccCCCHhhhhccCCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRG-IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
+||||+++|+|.+++...+. .....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999998753321 1234589999999999999999999998 9999999999999999999999999999
Q ss_pred CCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 488 PLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 488 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
+.+.... ....+..|+|||...+..++.++|||||||++|||++ |+.||...... .. ...+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~-~~~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EI-YDYLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HHHHHcCCC
Confidence 8764322 1234567999999999899999999999999999999 88898653211 11 111111111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.. ........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 233 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK----------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0111234577889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.81 Aligned_cols=236 Identities=21% Similarity=0.317 Sum_probs=189.2
Q ss_pred HhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||++.. .++..||+|+++.... ....+..|++++..+ +||||+++.+++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 589999999999985 4689999999976421 234567888889888 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-ccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA-AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
+|..++...+ .+++.....++.|++.||+|||+ . +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 9999886542 47889999999999999999997 5 8999999999999999999999999998753221
Q ss_pred -CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 -TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....+|..|+|||.+.+..++.++|||||||++|||+||+.||.....+ ........... .+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~------~~~~~i~~~~~-------~~--p~ 217 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILMEEI-------RF--PR 217 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH------HHHHHHhcCCC-------CC--CC
Confidence 2235888999999999999999999999999999999999999653211 11111111100 00 01
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
. ...++.+++.+||+.||++|+ ++.+++++
T Consensus 218 ~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 T---LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C---CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1 123466788899999999996 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=312.18 Aligned_cols=247 Identities=23% Similarity=0.410 Sum_probs=194.3
Q ss_pred HhHhCccceeEEEEEEE-----cCCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|.. .++..||+|.++..... ...+.+|++++.++ +|+||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 88 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQEQPVCMLFEY 88 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecCCceEEEEEc
Confidence 36799999999999974 34678999999754322 35688999999999 899999999999999999999999
Q ss_pred ccCCCHhhhhccCCC------------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEE
Q 006747 414 IEAGSFSALLHGNRG------------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCI 481 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki 481 (632)
+++|+|.+++..... .....+++...+.++.+++.||+|||+. +++||||||+||++++++.+||
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (283)
T cd05090 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKI 165 (283)
T ss_pred CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEe
Confidence 999999999853211 0123578899999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 006747 482 SDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSV 554 (632)
Q Consensus 482 ~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 554 (632)
+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+ +...
T Consensus 166 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-------~~~~ 238 (283)
T cd05090 166 SDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-------VIEM 238 (283)
T ss_pred ccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence 9999997653321 2234567999999998889999999999999999999 999986532111 1111
Q ss_pred hhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 555 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
....... ..... ....+.+++.+||+.+|++||++.++.++|+.
T Consensus 239 ~~~~~~~-------~~~~~---~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRKRQLL-------PCSED---CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcC-------CCCCC---CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111100 00111 12356778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=317.99 Aligned_cols=237 Identities=24% Similarity=0.326 Sum_probs=190.2
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||++... +++.||+|+++... .....+..|.+++..+.+||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6899999999999865 47899999998642 223456778888888768999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|..++.... .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 82 DLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 9999887542 488999999999999999999998 9999999999999999999999999998653221
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ........... . . ...
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~~~-~------~--~~~- 217 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILEDE-V------R--YPR- 217 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcCC-C------C--CCC-
Confidence 123478889999999999999999999999999999999999965321 11111111111 0 0 001
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTM-----EEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~evl~~ 605 (632)
.....+.+++.+||+.||++|||+ .+++++
T Consensus 218 --~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 --WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred --cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 112356788899999999999999 887653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=305.58 Aligned_cols=243 Identities=27% Similarity=0.475 Sum_probs=198.1
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|..++++.||+|.+........++.+|++++.++ +|+||+++++++ ..+..++||||+++|+|.
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVV-TQEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEE-ccCCcEEEEEcCCCCCHH
Confidence 467999999999999988899999999987766678899999999999 899999999986 456789999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----C
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-----V 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-----~ 495 (632)
+++.... ...+++..+..++.+++.||+|||+. +++||||||+||++++++.++|+|||++....... .
T Consensus 89 ~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 89 DFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 9987543 23588999999999999999999987 99999999999999999999999999997655221 1
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... ....... ...
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~-~~~~~~~-------~~~-- 226 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN------PEVIQNL-ERGYRMP-------RPD-- 226 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHH-HcCCCCC-------CCC--
Confidence 224567999999998889999999999999999999 9999965321 1111111 1111000 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
....++.+++.+||+.+|++|||++++...|+.
T Consensus 227 -~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 -NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 122457888899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=310.61 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=196.9
Q ss_pred HhHhCccceeEEEEEEEcC-C--cEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEE-G--TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|...+ + ..+++|.++.... ..+.+.+|++++.++.+||||+++++++...+..++|+||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 3579999999999998654 3 3478888874322 245688999999999779999999999999999999999999
Q ss_pred CCCHhhhhccCCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEccc
Q 006747 416 AGSFSALLHGNRGI-----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDF 484 (632)
Q Consensus 416 ~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~Df 484 (632)
+|+|.++++..... ....+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+||
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~df 163 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADF 163 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCc
Confidence 99999999754311 113488899999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 485 GLTPLMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 485 Gla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
|++...... .....+..|+|||.+.+..++.++|||||||++|||+| |+.||..... ........ .+..
T Consensus 164 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------~~~~~~~~-~~~~ 236 (297)
T cd05089 164 GLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------AELYEKLP-QGYR 236 (297)
T ss_pred CCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHh-cCCC
Confidence 998654322 11123456999999998889999999999999999998 9999965321 11111111 1110
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
. .........+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 237 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 237 M----------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 00011224567889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.73 Aligned_cols=251 Identities=22% Similarity=0.413 Sum_probs=199.3
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEecccccC-HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|... ++..+++|.++..... .+.+.+|++.+.++ +|+||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGDGDPLIMVFEY 88 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCceEEEEec
Confidence 357999999999999742 3567899998754332 35789999999999 899999999999999999999999
Q ss_pred ccCCCHhhhhccCCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEc
Q 006747 414 IEAGSFSALLHGNRG-----------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS 482 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 482 (632)
+++++|.+++..... .....++|..+++++.+++.|++|||+. +|+||||||+||++++++.+||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~ 165 (291)
T cd05094 89 MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIG 165 (291)
T ss_pred CCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEEC
Confidence 999999999865321 1123488999999999999999999998 99999999999999999999999
Q ss_pred ccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHh
Q 006747 483 DFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVV 555 (632)
Q Consensus 483 DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 555 (632)
|||+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |+.||...... ..... .
T Consensus 166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~~~~-~ 238 (291)
T cd05094 166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------EVIEC-I 238 (291)
T ss_pred CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-H
Confidence 999997654321 2234667999999999999999999999999999999 99998643221 11111 1
Q ss_pred hhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 556 REEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 556 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
..+.... ........+.+++.+||+.+|++|||+.+|+++|+++...
T Consensus 239 ~~~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 TQGRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred hCCCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111110 0011234577889999999999999999999999998553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.00 Aligned_cols=241 Identities=24% Similarity=0.431 Sum_probs=194.9
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
++||+|+||.||+|...++..||+|.+...... ...+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 368999999999999888999999998765322 34688999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC----
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV---- 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 495 (632)
.+++.... ..+++..+..++.+++.+|.|||+. +++||||||+||++++++.+||+|||++........
T Consensus 80 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRKKK----DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 99986542 2478999999999999999999988 999999999999999999999999999876443211
Q ss_pred -CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 496 -PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 496 -~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...+..|+|||++.+..++.++||||||+++||+++ |..||...... . ........... ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~-~~~~~~~~~~~----------~~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------Q-AREQVEKGYRM----------SC 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------H-HHHHHHcCCCC----------CC
Confidence 123456999999998889999999999999999999 99998643211 1 11111111110 00
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
.......+.+++.+||+.+|++||++.|+++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1112346788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=303.90 Aligned_cols=266 Identities=22% Similarity=0.323 Sum_probs=199.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCCccceeEEEEe-----CCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEV---VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS-----KDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-----~~~~~lv~ 411 (632)
.+.||+|+||.|+.+.. .+|..||||++... ....+...+|++++..+ +|+||+.+.+.+.. -..+|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccccccceeEEeh
Confidence 36799999999999984 56899999999744 23456788999999999 89999999998875 34789999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
|+|+ .||..+++... .+.......+..|+++||.|+|+. +|+||||||+|+|++.+..+||+|||+|+...
T Consensus 106 elMe-tDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 106 ELME-TDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred hHHh-hHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecc
Confidence 9995 59999998653 477888888999999999999999 99999999999999999999999999999885
Q ss_pred CC------CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH--------HHHhh
Q 006747 492 TP------TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWV--------QSVVR 556 (632)
Q Consensus 492 ~~------~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~ 556 (632)
.. +....|..|+|||.+.. ..|+...||||.|||+.||++|+.-|.+.+.-++..++..+ ...+.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 31 33457888999998754 56999999999999999999999999886544333222111 01111
Q ss_pred hcccccccccccccc-CC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCCCCCCC
Q 006747 557 EEWTSEVFDVELMRY-EN----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRPSDSEN 616 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~-~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~~~~~~ 616 (632)
.+.....+....... .. .+..-...+++..+++..||.+|+|++|++++ |........++
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 100000000000000 00 11223456788889999999999999999984 55554444333
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.36 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=199.9
Q ss_pred HHhHhCccceeEEEEEEE--------cCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEE
Q 006747 340 SAEVLGKGSYGTTYKAIL--------EEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLL 409 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~--------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 409 (632)
..+.||+|+||.||++.. .++..||+|.++... ...+++.+|++++..+.+|+||+++++++......++
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 98 (304)
T cd05101 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 98 (304)
T ss_pred ecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEE
Confidence 357899999999999973 134579999987542 2246788999999998789999999999999999999
Q ss_pred EEecccCCCHhhhhccCCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC
Q 006747 410 VYDFIEAGSFSALLHGNRGI-----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ 478 (632)
Q Consensus 410 v~E~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~ 478 (632)
||||+++|+|.+++...... ....++|..+..++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~ 175 (304)
T cd05101 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNV 175 (304)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCc
Confidence 99999999999999764321 123578899999999999999999998 9999999999999999999
Q ss_pred eEEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 006747 479 GCISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWV 551 (632)
Q Consensus 479 ~ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 551 (632)
+||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|||++ |..||.... ...+.
T Consensus 176 ~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~ 249 (304)
T cd05101 176 MKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELF 249 (304)
T ss_pred EEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------HHHHH
Confidence 9999999998764322 1224567999999988889999999999999999999 788885432 11122
Q ss_pred HHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 552 QSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 552 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.. ........ . .......+.+++.+||+.+|++|||+.|+++.|+++...
T Consensus 250 ~~-~~~~~~~~-------~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 250 KL-LKEGHRMD-------K---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HH-HHcCCcCC-------C---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11 11111100 0 112234577788899999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.44 Aligned_cols=247 Identities=23% Similarity=0.339 Sum_probs=191.6
Q ss_pred HhHhCccceeEEEEEEEc-CCc----EEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGT----TVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|... ++. .|++|.+..... ...++..|+..+.++ +||||+++++++. ....++++||
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~-~~~~~~i~e~ 89 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICP-GASLQLVTQL 89 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEEC-CCccEEEEEe
Confidence 468999999999999853 344 477777754322 124577777788888 8999999999875 4557899999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++.... ..++|.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 90 SPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred CCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999997542 3588999999999999999999998 8999999999999999999999999999765332
Q ss_pred C------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 T------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
. ...++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.... .. ...+..+... ..+
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~--~~~ 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EV----PDLLEKGERL--AQP 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHHCCCcC--CCC
Confidence 1 2235567999999998899999999999999999998 99998653211 11 1111111110 000
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
. .....+.+++.+||..+|++|||+.|+++.|+.+....
T Consensus 234 -----~---~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 234 -----Q---ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -----C---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 0 11234667888999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=308.80 Aligned_cols=247 Identities=24% Similarity=0.394 Sum_probs=193.9
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|... .+..||+|.+..... ...++.+|+.++.++ +|+||+++++++......++|||
T Consensus 11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~e 89 (277)
T cd05062 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME 89 (277)
T ss_pred eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCeEEEEe
Confidence 467999999999998753 246799999865322 245688999999998 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC-----CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 413 FIEAGSFSALLHGNRGI-----GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
|+++|+|.+++...+.. ....++|..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~ 166 (277)
T cd05062 90 LMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCc
Confidence 99999999998753211 123468889999999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 488 PLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 488 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
+...... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||.....+ ....... +...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~~~~~-~~~~ 239 (277)
T cd05062 167 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVLRFVM-EGGL 239 (277)
T ss_pred cccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHH-cCCc
Confidence 7654321 1234567999999998889999999999999999999 78888643211 1111111 1111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.. .. ......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ~~-------~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 240 LD-------KP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CC-------CC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00 00 1123457788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.64 Aligned_cols=256 Identities=23% Similarity=0.387 Sum_probs=196.9
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHh-hcCCCCccceeEEEEeCC----ceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGR-LSQHPNVVPIRAYYFSKD----EKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~-l~~h~niv~l~~~~~~~~----~~~lv~E~~~ 415 (632)
.+.||+|.||.||+|.+. |..||||++... +++.+.+|.++... +.+|+||..+++.-..+. +++||++|.+
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR--DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEeccc--chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 467999999999999996 899999999753 46678888887763 239999999999866543 6899999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc-----CCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV-----GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
.|||+|+|... .++-...++++..+|.||+|||-.. .|.|.|||||+.|||+.+++.+.|+|+|+|-..
T Consensus 293 ~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 293 HGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred CCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 99999999864 4888899999999999999999643 588999999999999999999999999999665
Q ss_pred CCC--------CCCCCCCcccCCccccCCC------CCccchhhHHHHHHHHHHhC----------CCCCCCCCCCCCCC
Q 006747 491 NTP--------TVPSRSAGYRAPEVIETKK------PTQKSDVYSFGVLLLEMLTG----------KAPIQAPGHEDVVD 546 (632)
Q Consensus 491 ~~~--------~~~~~t~~y~aPE~~~~~~------~~~~~DV~s~Gvvl~elltg----------~~p~~~~~~~~~~~ 546 (632)
... ....||..|||||++.... .-..+||||||.|+||+... +.||.+.-..+..
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs- 445 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS- 445 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC-
Confidence 443 2335899999999996543 13468999999999999863 3566543222110
Q ss_pred hhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 547 LPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
. +.++..+-. +-+.+.+...-...+.+..+.++|+.||..+|..|-|+-.+-+.|.++.+
T Consensus 446 ~-eeMrkVVCv----~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 446 F-EEMRKVVCV----QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred H-HHHhcceee----cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 0 111111111 11122222223345678889999999999999999999999999998865
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=333.82 Aligned_cols=242 Identities=19% Similarity=0.276 Sum_probs=192.5
Q ss_pred HhHhCccceeEEEEEEEc-C-CcEEEEEEecccccC-HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-E-GTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~-~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... + +..||+|.+...... ...+..|++++.++ +|||||++++++...+..++||||+++|
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 467999999999999843 3 577888877543222 34578899999999 9999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.++++.... ...++++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 151 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~ 226 (478)
T PTZ00267 151 DLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226 (478)
T ss_pred CHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence 99998864321 234688899999999999999999998 9999999999999999999999999999875432
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....||++|+|||++.+..++.++|||||||++|||+||+.||..... ............. +
T Consensus 227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~~-----~----- 290 (478)
T PTZ00267 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYGKYD-----P----- 290 (478)
T ss_pred cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-----C-----
Confidence 223488899999999999999999999999999999999999965321 1112222111110 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
........+.+++.+||+.+|++||++.+++.
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 00111235778888999999999999999865
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=306.76 Aligned_cols=238 Identities=21% Similarity=0.367 Sum_probs=190.7
Q ss_pred hHhCccceeEEEEEEEcCCc-----------EEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEE
Q 006747 342 EVLGKGSYGTTYKAILEEGT-----------TVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLV 410 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 410 (632)
+.||+|+||.||+|...+.. .|++|.+.........+.+|++++.++ +|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec-CCcEEE
Confidence 36899999999999976433 578888765543367889999999999 89999999999988 778999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-------CeEEcc
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL-------QGCISD 483 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~-------~~ki~D 483 (632)
|||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999997643 1578899999999999999999988 999999999999999888 799999
Q ss_pred cCCCCCCCCCCCCCCCCcccCCccccCC--CCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 484 FGLTPLMNTPTVPSRSAGYRAPEVIETK--KPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 484 fGla~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
||++..........++..|+|||++.+. .++.++|||||||++|||++ |..||......+ +..... ....
T Consensus 152 fg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~~~~~~-~~~~ 224 (259)
T cd05037 152 PGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KERFYQ-DQHR 224 (259)
T ss_pred CCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------HHHHHh-cCCC
Confidence 9999877654445567789999999877 78999999999999999999 577775432111 111110 0000
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
... . ....+.+++.+||..+|.+|||+.++++.|+
T Consensus 225 -------~~~-~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 225 -------LPM-P----DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------CCC-C----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 0 1156778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=312.46 Aligned_cols=243 Identities=24% Similarity=0.338 Sum_probs=193.2
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++.. .+++.||+|++..... ....+.+|++++.++ +|+||+++++++.+.+..++||||+++
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 5799999999999985 4688999999975422 234577899999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|+|.+++.... ...+++.....++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05605 85 GDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI 158 (285)
T ss_pred CcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence 99998886432 23588999999999999999999998 99999999999999999999999999997754322
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.+...... ...+...+.... ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~-----------~~~ 224 (285)
T cd05605 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---REEVERRVKEDQ-----------EEY 224 (285)
T ss_pred ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---HHHHHHHhhhcc-----------ccc
Confidence 23578899999999988899999999999999999999999975332111 111111111100 000
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
.......+.+++.+||+.||++|| ++++++++
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 111234567888999999999999 88888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=309.92 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=197.6
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|... ....+++|.+...... ...+.+|++++.++ +||||+++++++...+..++|+|
T Consensus 5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCCcEEEEE
Confidence 467999999999999853 2357888888754322 35688999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCC-------------------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee
Q 006747 413 FIEAGSFSALLHGNRG-------------------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL 473 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl 473 (632)
|+++|+|.+++...+. ....++++...+.++.+++.||+|||+. +++||||||+||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence 9999999999864321 1123588999999999999999999988 99999999999999
Q ss_pred cCCCCeEEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006747 474 SQDLQGCISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVD 546 (632)
Q Consensus 474 ~~~~~~ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~ 546 (632)
++++.+||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|||+| |+.||.+...
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----- 235 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP----- 235 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-----
Confidence 999999999999997653221 1234567999999988889999999999999999999 9999864321
Q ss_pred hhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 547 LPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
..+.......... .........+.+++.+||+.+|++||++.++++.|+++..+
T Consensus 236 --~~~~~~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 --ERLFNLLKTGYRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred --HHHHHHHhCCCCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111111111110 00111224577889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.35 Aligned_cols=249 Identities=18% Similarity=0.288 Sum_probs=188.0
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||++.. ..++.||+|... ...+.+|++++.++ +|||||++++++......++|+||+. ++|
T Consensus 97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L 169 (391)
T PHA03212 97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-NHPSIIQLKGTFTYNKFTCLILPRYK-TDL 169 (391)
T ss_pred EEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhC-CCCCCCCEeEEEEECCeeEEEEecCC-CCH
Confidence 46799999999999985 458899999754 23578899999999 99999999999999999999999995 688
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-----C
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-----T 494 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-----~ 494 (632)
..++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 170 ~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 170 YCYLAAKR-----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 88886542 478899999999999999999998 9999999999999999999999999999754321 1
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCC-CChhHHHHHHhhh------ccc-------
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV-VDLPRWVQSVVRE------EWT------- 560 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~------~~~------- 560 (632)
...+|+.|+|||++.+..++.++|||||||++|||+||+.||......+. .+........+.. ...
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 23588999999999999999999999999999999999988754321111 0000001000000 000
Q ss_pred cccc---------ccc-ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 561 SEVF---------DVE-LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 561 ~~~~---------d~~-~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
...+ .+. ...+....+...++.+++.+||+.||++|||++|+++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000 0000011122346778999999999999999999986
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=319.22 Aligned_cols=243 Identities=21% Similarity=0.309 Sum_probs=190.0
Q ss_pred HhHhCccceeEEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVV-----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.||+|+||.||+++. .++..||+|++++.. ...+.+..|++++.++.+|+||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 35799999999999875 357899999997532 123457889999999977999999999999999999999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 85 DYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999987542 478888999999999999999998 99999999999999999999999999997643
Q ss_pred CCC-----CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 492 TPT-----VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 492 ~~~-----~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
... ...+|..|+|||.+.+.. ++.++|||||||++|||+||+.||........ ...+....... +
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~------~ 227 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILKC------D 227 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhcC------C
Confidence 221 235788999999998754 78899999999999999999999975332211 11111111110 1
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
+.+ ... ....+.+++.+||+.||++|| ++++++++
T Consensus 228 ~~~--~~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 PPF--PSF---IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCC--CCC---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111 011 123466788899999999999 77787754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=314.39 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=186.8
Q ss_pred HhHhCccceeEEEEEEEc--CCcEEEEEEeccccc---CHHHHHHHHHHHHhhc--CCCCccceeEEEEe-----CCceE
Q 006747 341 AEVLGKGSYGTTYKAILE--EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLS--QHPNVVPIRAYYFS-----KDEKL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~-----~~~~~ 408 (632)
.+.||+|+||.||+|... ++..||+|+++.... ....+.+|++++.++. +||||++++++|.. ....+
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~ 85 (290)
T cd07862 6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 85 (290)
T ss_pred eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence 357999999999999853 468899999875422 2345667777776653 69999999999863 34689
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
+||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 86 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 86 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 9999997 58999887542 23488899999999999999999998 99999999999999999999999999997
Q ss_pred CCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh----hhcccc
Q 006747 489 LMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV----REEWTS 561 (632)
Q Consensus 489 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~ 561 (632)
..... ....++..|+|||.+.+..++.++|||||||++|||++|+.||.+....+. ...+.... .+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDWPR 235 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChhhchh
Confidence 65432 223478889999999988899999999999999999999999976432211 11111000 001100
Q ss_pred c------cccccccccCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 562 E------VFDVELMRYENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 562 ~------~~d~~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
+ .+... ..... .+....+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSK--SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCC--CCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 00000 00000 011234568899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=302.54 Aligned_cols=243 Identities=27% Similarity=0.431 Sum_probs=196.0
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|....+..||+|.+.......+.+.+|++++.++ +|+|++++++++. .+..++||||+++|+|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 357999999999999988777899999876555567789999999999 8999999998875 45689999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-----
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV----- 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~----- 495 (632)
++++... ...++|..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05069 89 DFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162 (260)
T ss_pred HHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCC
Confidence 9997542 23578999999999999999999988 999999999999999999999999999976543221
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||...+..++.++|||||||++|||+| |+.||...... ...... ...... ...
T Consensus 163 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~-~~~~~~----------~~~ 225 (260)
T cd05069 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR------EVLEQV-ERGYRM----------PCP 225 (260)
T ss_pred CccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-HcCCCC----------CCC
Confidence 224567999999998889999999999999999999 89998653211 111111 111100 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
......+.+++.+||+.+|++||++++|++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1223457788899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.51 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=190.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC-----ceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-----EKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~ 411 (632)
.+.||+|+||.||+|.. .++..||||+++... .....+.+|++++.++ +||||+++++++.... ..++||
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceEEEEE
Confidence 35799999999999985 468999999987532 2234688999999999 8999999999886432 479999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+. ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 84 e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 84 ELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred ecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9996 68998886542 488999999999999999999998 99999999999999999999999999997643
Q ss_pred CC-------CCCCCCCcccCCccccC--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCCh---------hHHHHH
Q 006747 492 TP-------TVPSRSAGYRAPEVIET--KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL---------PRWVQS 553 (632)
Q Consensus 492 ~~-------~~~~~t~~y~aPE~~~~--~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~---------~~~~~~ 553 (632)
.. ....++..|+|||++.+ ..++.++|||||||++|||+||+.||.+......... ..+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 21 12357888999999876 5789999999999999999999999975432111000 000000
Q ss_pred Hhhhcccccccccccc-ccCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCC
Q 006747 554 VVREEWTSEVFDVELM-RYENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRP 611 (632)
Q Consensus 554 ~~~~~~~~~~~d~~~~-~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~ 611 (632)
+........+..-.. ..... ......+.+++.+||+.||++|||++|++++ ++.+..
T Consensus 235 -i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 235 -VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred -hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000000000000000 00000 0112346788999999999999999999975 555444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=305.15 Aligned_cols=248 Identities=23% Similarity=0.402 Sum_probs=195.2
Q ss_pred HhHhCccceeEEEEEEEcC----CcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCc------e
Q 006747 341 AEVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE------K 407 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~ 407 (632)
.+.||+|+||.||+|.... +..||+|+++..... ...+.+|++.+.++ +|+||+++++++...+. .
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccCccc
Confidence 4679999999999998642 367999999764332 34688899999999 89999999999876554 7
Q ss_pred EEEEecccCCCHhhhhccCCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCC
Q 006747 408 LLVYDFIEAGSFSALLHGNRG-IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486 (632)
Q Consensus 408 ~lv~E~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 486 (632)
++|+||+++|+|..++...+. .....+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 899999999999999865421 1234688999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCCCC------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 487 TPLMNTPTV------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 487 a~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
++....... ...+..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+...... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------~~~~~~~~-~~~ 232 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIYDYLR-HGN 232 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH-cCC
Confidence 986643321 123557999999988889999999999999999999 8888864321 11111111 111
Q ss_pred ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 560 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.. .........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 233 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 233 RL----------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC----------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01112334678888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=302.61 Aligned_cols=241 Identities=22% Similarity=0.365 Sum_probs=190.9
Q ss_pred HhCccceeEEEEEEEc---CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILE---EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||+|.+. ++..||+|++...... .+.+.+|++++.++ +|+||+++++++. .+..++||||+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999753 3557999998765322 35688999999999 9999999999885 45789999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC--
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV-- 495 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-- 495 (632)
+|.+++.... ..+++..+.+++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++.......
T Consensus 80 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999987532 3588999999999999999999998 999999999999999999999999999976543211
Q ss_pred -----CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 496 -----PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 496 -----~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
..++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .+. ..+..+...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~-~~~~~~~~~-------- 217 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP------EVM-SFIEQGKRL-------- 217 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH------HHH-HHHHCCCCC--------
Confidence 112457999999988889999999999999999996 99999653211 111 111111110
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
........++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 218 --~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 --DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 00111234567888999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=302.52 Aligned_cols=240 Identities=25% Similarity=0.354 Sum_probs=190.9
Q ss_pred HhCccceeEEEEEEE---cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 343 VLGKGSYGTTYKAIL---EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~---~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.||+|+||.||+|.. .++..+|+|+++..... .+++..|+.++.++ +|+||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999964 35789999998754332 45688999999999 8999999999885 4567899999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV- 495 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 495 (632)
|+|.+++... ..+++....+++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 80 GPLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999998643 2478899999999999999999998 999999999999999999999999999987643321
Q ss_pred ------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 496 ------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 496 ------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
..++..|+|||.+....++.++|||||||++|||++ |+.||...... .+... +..+....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~-i~~~~~~~------ 218 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQM-IESGERME------ 218 (257)
T ss_pred eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHCCCCCC------
Confidence 123457999999988888999999999999999998 99999653211 11111 11111110
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
... ....++.+++.+||+.||++||++.+|.+.|++.
T Consensus 219 -~~~---~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 -CPQ---RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred -CCC---CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 011 1224567888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=315.71 Aligned_cols=241 Identities=21% Similarity=0.380 Sum_probs=203.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc-eEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE-KLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-~~lv~E~~~ 415 (632)
.+++|+|+||.++..+. .++..|++|.+..... .++...+|+.+++++ +|||||.+.+.|..++. .+|||+|++
T Consensus 9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcCCceEEEEEeecC
Confidence 57899999999999874 4578999999976543 345789999999998 99999999999999998 999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
||++.+.+...+ ...+++....+++.|++.|+.|||+. .|+|||||+.||+++.+..+||+|||+|+.+....
T Consensus 88 Gg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 88 GGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred CCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999998765 24578889999999999999999988 99999999999999999999999999999997764
Q ss_pred ---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...||+.||.||.+.+.+|..|+||||+||++|||++-+.+|...+ ....+..+.+.. +.
T Consensus 162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~------m~~Li~ki~~~~-----~~------ 224 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN------MSELILKINRGL-----YS------ 224 (426)
T ss_pred hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc------hHHHHHHHhhcc-----CC------
Confidence 3469999999999999999999999999999999999999997532 222333332221 11
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.-...+..++..++..|++.+|..||++.+++.+
T Consensus 225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1112344567788889999999999999999875
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=304.75 Aligned_cols=251 Identities=20% Similarity=0.370 Sum_probs=200.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++.. .++..+|||.+..... ...++.+|++++.++ +|+||+++++++...+..+++|||++
T Consensus 7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeCCeEEEEEEecC
Confidence 46899999999999994 5789999998865322 235688899999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+++|.+++..... ....+++.....++.+++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 86 AGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 9999998864321 234588999999999999999999998 99999999999999999999999999987764332
Q ss_pred ---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...++..|+|||.+.+..++.++||||||+++|||++|..||...... ............ .+..
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~------~~~~--- 228 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCD------YPPL--- 228 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhcCC------CCCC---
Confidence 234677899999998888999999999999999999999998643211 111111111000 0000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
........+.+++.+||+.+|++||||.+|++.++++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 -PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11122345778888999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=311.49 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=192.7
Q ss_pred HhHhCccceeEEEEEEE-----cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E 412 (632)
.+.||+|+||.||++.. .++..||+|++..... ..+.+.+|++++.++ +||||+++++++... ...++|||
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCceEEEEE
Confidence 36799999999999974 3578999999875432 245789999999999 899999999987643 46889999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++|+|.+++...+ ..++|..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 88 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 88 YLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999997542 3488999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCC-------CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCC------C---ChhHHHHHHhh
Q 006747 493 PTVP-------SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV------V---DLPRWVQSVVR 556 (632)
Q Consensus 493 ~~~~-------~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~------~---~~~~~~~~~~~ 556 (632)
.... .++..|+|||.+.+..++.++|||||||++|||++|..|+......-. . ...........
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 3211 123359999999988899999999999999999998877543221100 0 00000000111
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
+.. ...........+.+++.+||+.+|++|||+.||++.|+.++
T Consensus 241 ~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 241 NNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred cCC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 100 00011112345778899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=321.20 Aligned_cols=233 Identities=23% Similarity=0.355 Sum_probs=187.6
Q ss_pred hHhCccceeEEEEEEE----cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
+.||+|+||.||++.. .+|+.||+|+++.... ....+..|++++.++ +||||+++++++.+.+..++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCEEEEEEcCC
Confidence 4689999999999874 3578999999976432 234577899999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 493 (632)
++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 81 RGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999998653 2488999999999999999999998 9999999999999999999999999999765433
Q ss_pred ---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
....++..|+|||.+.+..++.++|||||||++|||+||+.||..... ............ ..
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~~~~---------~~ 217 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILKAKL---------GM 217 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHcCCC---------CC
Confidence 123478889999999988899999999999999999999999975321 111111111110 00
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEE 601 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e 601 (632)
... ....+.+++.+||+.||++||++.+
T Consensus 218 p~~---~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQF---LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCC---CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111 1234667888999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.20 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=188.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... +++.||+|+++.... ....+.+|++++.++ +||||+++++++.+.+..++||||++ +
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~-~ 87 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTLVFEYVH-T 87 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence 367999999999999965 688999999975432 234678899999999 99999999999999999999999996 5
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 88 DLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 7877776432 2477888899999999999999998 9999999999999999999999999998754322
Q ss_pred CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hcccc----ccc
Q 006747 494 TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR----EEWTS----EVF 564 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~----~~~ 564 (632)
....++..|+|||.+.+. .++.++||||+||++|||+||+.||.+... .......+..... +.+.. ..+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 223467889999998754 578899999999999999999999975321 1000111100000 00000 000
Q ss_pred ccccc---ccCCcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 565 DVELM---RYENIEE------EMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 565 d~~~~---~~~~~~~------~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
++... ....... ....+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 0001110 1234678889999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.43 Aligned_cols=242 Identities=26% Similarity=0.411 Sum_probs=191.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv~E~ 413 (632)
.+.||+|+||.||+|... +++.||+|++.........+..|++++.++.+|+||+++++++... ...++||||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 90 (272)
T cd06637 11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 90 (272)
T ss_pred HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence 467999999999999854 5789999999766556678899999999987799999999998753 357899999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++.... ...++|.....++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~ 164 (272)
T cd06637 91 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 164 (272)
T ss_pred CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence 99999999987542 23588999999999999999999998 9999999999999999999999999998765332
Q ss_pred ----CCCCCCCcccCCccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIET-----KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~~-----~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ... .......
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~-~~~~~~~------ 232 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RAL-FLIPRNP------ 232 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHH-HHHhcCC------
Confidence 22347788999999863 35788999999999999999999998642211 000 0001100
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.... ... .....+.+++.+||..+|.+|||+.++++
T Consensus 233 ~~~~-~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRL-KSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCC-CCC---CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 001 12235778889999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.61 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=184.9
Q ss_pred HhCccceeEEEEEEEcC---CcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILEE---GTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||+|...+ ...+++|.+...... ...+.+|++.+..+ +|+||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999997543 346888887644322 35678899999998 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++...+.......++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999765432233356778889999999999999998 9999999999999999999999999998754322
Q ss_pred --CCCCCCCcccCCccccC-------CCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 494 --TVPSRSAGYRAPEVIET-------KKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~-------~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
....++..|+|||++.. ..++.++|||||||++|||++ |..||......+ .......... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhccC-ccC
Confidence 12234567999998743 346889999999999999999 778886432111 1111111111 111
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
.++.. .......+.+++..|| .||++|||+++|++.|.
T Consensus 231 ~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 1112234556777898 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=325.52 Aligned_cols=242 Identities=23% Similarity=0.304 Sum_probs=186.7
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||+||+|.. .+++.||+|++..... ....+.+|++++.++ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEecCCEEEEEEecCC
Confidence 35799999999999985 4578999999975422 234688899999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++++||+|||+++....
T Consensus 85 gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 85 GGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999987542 477888888999999999999998 999999999999999999999999999753210
Q ss_pred ------------------------------------------------CCCCCCCCcccCCccccCCCCCccchhhHHHH
Q 006747 493 ------------------------------------------------PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGV 524 (632)
Q Consensus 493 ------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gv 524 (632)
.....||..|+|||.+.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 01124788999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHH--ccCCCCCCCCCHHHH
Q 006747 525 LLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMS--CVAKVPDMRPTMEEV 602 (632)
Q Consensus 525 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~--Cl~~~P~~RPs~~ev 602 (632)
++|||+||+.||......+. .......... ........... ++.+++.+ |+..+|..||++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~~~~-----~~~~~~~~~s~---~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET------QLKVINWENT-----LHIPPQVKLSP---EAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH------HHHHHccccc-----cCCCCCCCCCH---HHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999975432110 0111100000 00101111222 34455545 667777789999999
Q ss_pred HHH
Q 006747 603 VRM 605 (632)
Q Consensus 603 l~~ 605 (632)
+.+
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=308.40 Aligned_cols=250 Identities=25% Similarity=0.407 Sum_probs=197.8
Q ss_pred HhHhCccceeEEEEEEEcC------CcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILEE------GTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||++...+ ...+|+|.+...... ..++.+|++++.++.+|+||+++++++...+..+++||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 4679999999999998542 368999998754322 34588899999988679999999999999999999999
Q ss_pred cccCCCHhhhhccCCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEE
Q 006747 413 FIEAGSFSALLHGNRG-----------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCI 481 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki 481 (632)
|+++|+|..+++.... .....+++..+++++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL 173 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKI 173 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEe
Confidence 9999999999875321 1234689999999999999999999988 9999999999999999999999
Q ss_pred cccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 006747 482 SDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSV 554 (632)
Q Consensus 482 ~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 554 (632)
+|||+++.+.... ...++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .. ..
T Consensus 174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~-~~ 246 (293)
T cd05053 174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------LF-KL 246 (293)
T ss_pred CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH------HH-HH
Confidence 9999998765322 1123457999999988889999999999999999998 999986432111 11 11
Q ss_pred hhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 555 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
....... .........+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus 247 ~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 LKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111100 011122345778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=316.13 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=195.7
Q ss_pred HHhHhCccceeEEEEEEE------cCCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeC-CceEEE
Q 006747 340 SAEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSK-DEKLLV 410 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv 410 (632)
..+.||+|+||.||+|.. .+++.||||+++..... ...+.+|++++.++.+|+||++++++|... ...++|
T Consensus 11 ~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv 90 (343)
T cd05103 11 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 90 (343)
T ss_pred ccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEE
Confidence 457899999999999973 34789999999754322 346888999999997899999999988764 467899
Q ss_pred EecccCCCHhhhhccCCCC-------------------------------------------------------------
Q 006747 411 YDFIEAGSFSALLHGNRGI------------------------------------------------------------- 429 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~------------------------------------------------------------- 429 (632)
|||+++|+|.++++.....
T Consensus 91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T cd05103 91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED 170 (343)
T ss_pred EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence 9999999999998653210
Q ss_pred -CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC------CCCCCCcc
Q 006747 430 -GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT------VPSRSAGY 502 (632)
Q Consensus 430 -~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~------~~~~t~~y 502 (632)
....++|....+++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...... ...++..|
T Consensus 171 ~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 247 (343)
T cd05103 171 LYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 247 (343)
T ss_pred hhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcce
Confidence 012478888999999999999999998 99999999999999999999999999987653221 12235569
Q ss_pred cCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHH
Q 006747 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQM 581 (632)
Q Consensus 503 ~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 581 (632)
+|||.+.+..++.++|||||||++|||++ |..||....... .......++.... .... ....+
T Consensus 248 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~-------~~~~---~~~~~ 311 (343)
T cd05103 248 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMR-------APDY---TTPEM 311 (343)
T ss_pred ECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCC-------CCCC---CCHHH
Confidence 99999988889999999999999999997 999986532111 1111111111100 0001 12357
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 582 LQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 582 ~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.+++.+||+.+|++|||+.|++++|+.+.+
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=310.36 Aligned_cols=252 Identities=23% Similarity=0.364 Sum_probs=198.6
Q ss_pred HhHhCccceeEEEEEEEc--------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEE
Q 006747 341 AEVLGKGSYGTTYKAILE--------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 410 (632)
.+.||+|+||.||++... +...+|+|.++.... ...++..|++++.++.+|+||+++++++...+..++|
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (307)
T cd05098 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 102 (307)
T ss_pred eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 568999999999999742 235799999975422 2356888999999987899999999999999999999
Q ss_pred EecccCCCHhhhhccCCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCe
Q 006747 411 YDFIEAGSFSALLHGNRGI-----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG 479 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ 479 (632)
|||+++|+|.+++...+.. ....++|..+++++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~ 179 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVM 179 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcE
Confidence 9999999999999764321 123589999999999999999999988 99999999999999999999
Q ss_pred EEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 006747 480 CISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 480 ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 552 (632)
||+|||.++...... ....+..|+|||.+.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 180 kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~------~~~~~ 253 (307)
T cd05098 180 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EELFK 253 (307)
T ss_pred EECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHH
Confidence 999999987654321 1123457999999998889999999999999999998 8888854321 11111
Q ss_pred HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 553 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
........ ........++.+++.+||..+|++|||+.++++.|+++.+.
T Consensus 254 -~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 254 -LLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -HHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11111110 11112234677888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=322.41 Aligned_cols=190 Identities=25% Similarity=0.345 Sum_probs=166.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||+||++... +++.||+|+++.... ....+..|++++.++ +|+||+++++++.+....++||||++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCeEEEEEcCCC
Confidence 357999999999999854 588999999975421 234577899999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 85 GGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 99999999754 2478899999999999999999998 9999999999999999999999999998754321
Q ss_pred -------------------------------------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCC
Q 006747 494 -------------------------------------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPI 536 (632)
Q Consensus 494 -------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~ 536 (632)
....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 1235788999999999999999999999999999999999999
Q ss_pred CCC
Q 006747 537 QAP 539 (632)
Q Consensus 537 ~~~ 539 (632)
.+.
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.74 Aligned_cols=254 Identities=22% Similarity=0.397 Sum_probs=197.3
Q ss_pred HhHhCccceeEEEEEEEc-CCc--EEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGT--TVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~--~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... ++. .+|+|.++... .....+.+|++++.++.+|+||+++++++...+..++||||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 467999999999999864 343 46777776432 2245788999999999789999999999999999999999999
Q ss_pred CCCHhhhhccCCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEccc
Q 006747 416 AGSFSALLHGNRGI-----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDF 484 (632)
Q Consensus 416 ~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~Df 484 (632)
+|+|.++++..... ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+||
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~df 168 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 168 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCcc
Confidence 99999999754321 123578999999999999999999988 9999999999999999999999999
Q ss_pred CCCCCCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 485 GLTPLMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 485 Gla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
|+++..... .....+..|+|||.+.+..++.++|||||||++|||+| |..||...... ...... .....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~-~~~~~ 241 (303)
T cd05088 169 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKL-PQGYR 241 (303)
T ss_pred ccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHHHH-hcCCc
Confidence 998653221 11123456999999988889999999999999999998 99998643221 111111 11100
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCC
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~ 614 (632)
.. ... .....+.+++.+||+.+|++||++.++++.|+++.....
T Consensus 242 ~~-------~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 242 LE-------KPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred CC-------CCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 00 001 112356788999999999999999999999998755543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.60 Aligned_cols=247 Identities=22% Similarity=0.377 Sum_probs=194.4
Q ss_pred HhHhCccceeEEEEEEEcC------CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILEE------GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|...+ +..||+|.+..... ....+..|+.++.++ +|+||+++++++.+.+..++|||
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCcEEEEe
Confidence 3579999999999998653 56889998865432 245688999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC--CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC---CeEEcccCCC
Q 006747 413 FIEAGSFSALLHGNRGI--GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL---QGCISDFGLT 487 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~---~~ki~DfGla 487 (632)
|+++|+|.++++..+.. ....++|..+.+++.+++.||+|||+. +++||||||+||+++.++ .+||+|||++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~ 166 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccc
Confidence 99999999998765321 123589999999999999999999998 999999999999998764 6999999999
Q ss_pred CCCCCCCC------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 488 PLMNTPTV------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 488 ~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
+....... ...+..|+|||++.+..++.++|||||||++|||++ |+.||.....++ ...........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~ 240 (277)
T cd05036 167 RDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVTGGGRL 240 (277)
T ss_pred cccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHcCCcC
Confidence 87633211 122456999999998899999999999999999997 999987533211 11111111100
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.........+.+++.+||+.+|++|||+.+|+++|++
T Consensus 241 -----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 241 -----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 0011122457788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=301.38 Aligned_cols=244 Identities=26% Similarity=0.426 Sum_probs=199.4
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|... |+.||+|.++......+.+..|+.++.++ +|+||+++++++...+..++||||+++++|.
T Consensus 11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 467999999999999875 89999999987655567789999999999 8999999999999989999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-CCCC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV-PSRS 499 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-~~~t 499 (632)
+++.... ...++|..+..++.+++.||.|||+. +++||||||+||++++++.+||+|||.++....... ...+
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 162 (256)
T cd05039 89 DYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLP 162 (256)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccccCCCc
Confidence 9987542 23589999999999999999999998 999999999999999999999999999987643322 2235
Q ss_pred CcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHH
Q 006747 500 AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEM 578 (632)
Q Consensus 500 ~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 578 (632)
..|+|||.+.+..++.++||||||+++|||++ |+.||...... ............. ......
T Consensus 163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~~~~----------~~~~~~ 225 (256)
T cd05039 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKGYRME----------APEGCP 225 (256)
T ss_pred ccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcCCCCC----------CccCCC
Confidence 56999999988889999999999999999997 99998643211 1111111111100 011123
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 579 VQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 579 ~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
..+.+++.+||+.+|++|||+.|++++|+.+
T Consensus 226 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 226 PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 4577889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.26 Aligned_cols=236 Identities=23% Similarity=0.324 Sum_probs=185.9
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHH---HhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVV---GRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l---~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
+.||+|+||.||+|... +++.||||+++... ...+.+.+|++++ .++ +||||+++++++...+..++||||
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l-~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSE-RHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcccc-CCCChhceeeEEEcCCEEEEEEcC
Confidence 57999999999999854 58999999997542 1234466666655 345 799999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|..+++.. .+++.....++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 84 AAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred CCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999888642 488999999999999999999998 9999999999999999999999999998753221
Q ss_pred ----CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
....+++.|+|||.+.+..++.++|||||||++|||++|+.||.+.... ............
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~~~~--------- 219 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVNDEVR--------- 219 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---------
Confidence 2235788999999999999999999999999999999999999754321 111111111100
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
.... ....+.+++.+||+.||++|| ++.+++++
T Consensus 220 ~p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 YPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred CCCC---CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0011 123466788899999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=309.28 Aligned_cols=239 Identities=22% Similarity=0.387 Sum_probs=187.7
Q ss_pred hHhCccceeEEEEEEEcC--------CcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 342 EVLGKGSYGTTYKAILEE--------GTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
+.||+|+||.||+|.... ...||+|.+..... ..+.+..|+.++..+ +||||+++++++...+..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeCCCcEEEEe
Confidence 368999999999998532 23488888765432 235688899999998 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC--------eEEccc
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ--------GCISDF 484 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~--------~ki~Df 484 (632)
|+++|+|..+++... ..+++..+.+++.|++.||+|||+. +|+||||||+||+++.++. +|++||
T Consensus 80 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 80 YVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred cCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999997643 2578899999999999999999998 9999999999999988765 699999
Q ss_pred CCCCCCCCCCCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 485 GLTPLMNTPTVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGK-APIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 485 Gla~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
|++..........++..|+|||++.+. .++.++|||||||++|||++|. .|+...... ... .......
T Consensus 153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~-~~~~~~~--- 222 (258)
T cd05078 153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKL-QFYEDRH--- 222 (258)
T ss_pred ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHH-HHHHccc---
Confidence 998776655555678889999999874 4799999999999999999985 555432110 010 0111100
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
.+ ......++.+++.+||+.+|++|||++++++.|+
T Consensus 223 ----~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 ----QL-----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----cC-----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0011235778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=304.22 Aligned_cols=242 Identities=24% Similarity=0.373 Sum_probs=194.7
Q ss_pred hHhCccceeEEEEEEEcC--C--cEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAILEE--G--TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~--~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
+.||+|+||.||+|...+ + ..||+|.+..... ..+.+..|++++.++ +|+||+++++++.. ...++|+||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999998643 2 3699999987644 346789999999999 89999999999988 88999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++..... ..++|.....++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999976531 4589999999999999999999998 99999999999999999999999999998764421
Q ss_pred ------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccccc
Q 006747 495 ------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567 (632)
Q Consensus 495 ------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 567 (632)
...++.+|+|||.+.+..++.++|||||||++|||+| |+.||..... .+...........
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~~------- 219 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------SQILKKIDKEGER------- 219 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcCCc-------
Confidence 1235668999999998899999999999999999999 9999864321 1111111111100
Q ss_pred ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 568 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
. .........+.+++.+||+.+|++|||+.++++.|.
T Consensus 220 ~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 L---ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred C---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 001112346778899999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.08 Aligned_cols=247 Identities=22% Similarity=0.379 Sum_probs=195.0
Q ss_pred HhHhCccceeEEEEEEE-cCCc----EEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGT----TVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|.. .++. .||+|.++.... ..+++..|+.++.++ +|+||+++++++.. ...++++||
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-~~~~l~~~~ 89 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT-STVQLVTQL 89 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC-CCcEEEEEc
Confidence 36799999999999984 3444 489999875432 245688899999999 89999999999975 457899999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.++++... ..+++...+.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 90 MPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred CCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 99999999997542 2488899999999999999999998 9999999999999999999999999999876432
Q ss_pred CC------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 TV------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ~~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
.. ..++..|+|||.+.+..++.++|||||||++|||++ |..||...... .+..+ +......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~----- 230 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDL----LEKGERL----- 230 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH----HHCCCcC-----
Confidence 21 123557999999998899999999999999999998 88998643211 11111 1111100
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
.........+.+++.+||+.||++||++.++++.|+++....
T Consensus 231 -----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 -----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 001112345778899999999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=300.99 Aligned_cols=243 Identities=26% Similarity=0.417 Sum_probs=194.6
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe-CCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS-KDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||++... +..||+|.++... ..+.+..|+.++.++ +|+|++++++++.. .+..++|+||+++|+|
T Consensus 11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhC-CCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 467999999999999765 7889999986542 356789999999999 89999999998654 4578999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-CCCC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-VPSR 498 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~~ 498 (632)
.++++... ...+++....+++.+++.||+|||+. +++||||||+||++++++.+|++|||+++...... ....
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 161 (256)
T cd05082 88 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 161 (256)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCCCCcc
Confidence 99987543 23578999999999999999999998 99999999999999999999999999987654332 2234
Q ss_pred CCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHH
Q 006747 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEE 577 (632)
Q Consensus 499 t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 577 (632)
+..|+|||.+.+..++.++|||||||++|||++ |+.||.... ........ ..+..... ....
T Consensus 162 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~-~~~~~~~~----------~~~~ 224 (256)
T cd05082 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKGYKMDA----------PDGC 224 (256)
T ss_pred ceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-hcCCCCCC----------CCCC
Confidence 567999999998889999999999999999998 999986422 11111111 11111110 1112
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 578 MVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 578 ~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
...+.+++.+||+.+|++|||+.++++.|+++
T Consensus 225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 225 PPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 34577888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.72 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=200.8
Q ss_pred HHHhHhCccceeEEEEEEEc--------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceE
Q 006747 339 ASAEVLGKGSYGTTYKAILE--------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKL 408 (632)
Q Consensus 339 ~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 408 (632)
...+.||+|+||.||++... .+..||+|.++.... ..+++.+|++++.++.+|+||++++++|...+..+
T Consensus 15 ~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (334)
T cd05100 15 TLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY 94 (334)
T ss_pred eecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceE
Confidence 34678999999999999742 124789998875432 24578899999999977999999999999999999
Q ss_pred EEEecccCCCHhhhhccCCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRG-----------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL 477 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~ 477 (632)
+++||+++|+|.+++..... .....++|..++.++.|++.||+|||+. +|+||||||+||++++++
T Consensus 95 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~ 171 (334)
T cd05100 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDN 171 (334)
T ss_pred EEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCC
Confidence 99999999999999875421 1234588999999999999999999998 999999999999999999
Q ss_pred CeEEcccCCCCCCCCCCC------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHH
Q 006747 478 QGCISDFGLTPLMNTPTV------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRW 550 (632)
Q Consensus 478 ~~ki~DfGla~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 550 (632)
.+||+|||+++....... ..++..|+|||.+.+..++.++|||||||++|||++ |..||.... ...+
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~ 245 (334)
T cd05100 172 VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------VEEL 245 (334)
T ss_pred cEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------HHHH
Confidence 999999999976543221 123456999999999999999999999999999998 888886432 1222
Q ss_pred HHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 551 VQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 551 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
.... ......+ ........+.+++.+||+.+|++|||+.|+++.|+++....
T Consensus 246 ~~~~-~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 246 FKLL-KEGHRMD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHH-HcCCCCC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 2221 1111110 01112345778899999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.12 Aligned_cols=251 Identities=21% Similarity=0.374 Sum_probs=201.3
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +|+.||+|.++... .....+.+|++++.++ +|+||+++++++...+..++||||++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIENNELNIVLELAD 85 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecCCeEEEEEecCC
Confidence 357999999999999976 78999999886421 1245788999999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|..++..... ....+++..+..++.+++.||+|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 86 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 86 AGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 9999999865322 234588999999999999999999998 99999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.... ....+...... .+... .
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~-~~~~~---------~ 227 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIE-KCDYP---------P 227 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhh-cCCCC---------C
Confidence 2346778999999998889999999999999999999999986432 12222221111 11000 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
.........+.+++.+||..+|++|||+.+|+++|+++.
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 011123346778899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=299.66 Aligned_cols=245 Identities=30% Similarity=0.482 Sum_probs=198.9
Q ss_pred hHhCccceeEEEEEEEcC----CcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
+.||+|+||.||+|...+ +..|++|.++..... .+.+.+|++.+.++ +|+||+++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecCCCceEEEEEecc
Confidence 368999999999999654 789999999866443 57789999999999 79999999999999999999999999
Q ss_pred CCCHhhhhccCCCC----CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 416 AGSFSALLHGNRGI----GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 416 ~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
+|+|.+++...... ....+++..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999865211 124689999999999999999999998 99999999999999999999999999998775
Q ss_pred CCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 492 TPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 492 ~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
... ...++..|+|||.+....++.++||||+||++|||++ |+.||..... ....... .+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~-~~~~~~--- 226 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYL-RKGYRL--- 226 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHH-HcCCCC---
Confidence 432 2345778999999988889999999999999999999 6999875421 1111111 111100
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
........++.+++.+||+.+|++|||+.|++++|+
T Consensus 227 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011112346778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=308.01 Aligned_cols=254 Identities=19% Similarity=0.339 Sum_probs=196.0
Q ss_pred HhHhCccceeEEEEEEEcC-----------------CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEE
Q 006747 341 AEVLGKGSYGTTYKAILEE-----------------GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYY 401 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 401 (632)
.+.||+|+||.||++...+ +..||+|.+..... ....+.+|++++.++ +|+||+++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 88 (296)
T cd05051 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIARLLGVC 88 (296)
T ss_pred cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEeEEEEEE
Confidence 4689999999999987542 24689999875432 245788999999999 899999999999
Q ss_pred EeCCceEEEEecccCCCHhhhhccCCCC------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC
Q 006747 402 FSKDEKLLVYDFIEAGSFSALLHGNRGI------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ 475 (632)
Q Consensus 402 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~ 475 (632)
...+..++|+||+++++|.+++...... ....+++.....++.+++.||+|||+. +|+||||||+||++++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~ 165 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecC
Confidence 9999999999999999999999765421 123689999999999999999999998 9999999999999999
Q ss_pred CCCeEEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh--CCCCCCCCCCCCCCCh
Q 006747 476 DLQGCISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT--GKAPIQAPGHEDVVDL 547 (632)
Q Consensus 476 ~~~~ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt--g~~p~~~~~~~~~~~~ 547 (632)
++.+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||...... ..
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~ 242 (296)
T cd05051 166 NYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QV 242 (296)
T ss_pred CCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HH
Confidence 9999999999987653321 2234567999999998889999999999999999998 66777543211 11
Q ss_pred hHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
................. ........++.+++.+||+.||++|||+.+|++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 243 IENAGHFFRDDGRQIYL-------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHHHHhccccccccccC-------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111111100000 0111122467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=305.42 Aligned_cols=252 Identities=24% Similarity=0.358 Sum_probs=195.4
Q ss_pred HHHhHhCccceeEEEEEEE-----cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEE
Q 006747 339 ASAEVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLL 409 (632)
Q Consensus 339 ~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~l 409 (632)
...+.||+|+||.||++.+ .++..||+|.++.... ....+.+|++++.++ +|+||+++.+++... ...++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCceEE
Confidence 3457899999999999974 3578899999875432 235789999999999 999999999999875 56889
Q ss_pred EEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 410 VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 410 v~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
||||+++++|.+++.... ..++|..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 86 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999986532 2589999999999999999999998 999999999999999999999999999986
Q ss_pred CCCCC-------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCC---------CCCChhHHHHH
Q 006747 490 MNTPT-------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHE---------DVVDLPRWVQS 553 (632)
Q Consensus 490 ~~~~~-------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~~~ 553 (632)
..... ...++..|+|||.+.+..++.++|||||||++|||+|++.|....... .......++..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 64321 123455699999998888999999999999999999988765322110 00011111111
Q ss_pred HhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 554 VVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 554 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
..+... ..........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 239 -~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 -LEEGKR----------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHcCcc----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111110 000111235688899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=309.71 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=198.0
Q ss_pred HHhHhCccceeEEEEEEEc--------CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEE
Q 006747 340 SAEVLGKGSYGTTYKAILE--------EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLL 409 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 409 (632)
..+.||+|+||.||++... ....||+|.++..... ..++..|++++.++.+||||+++++++...+..++
T Consensus 16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence 3578999999999999742 2457999998754322 35688899999998679999999999999889999
Q ss_pred EEecccCCCHhhhhccCCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC
Q 006747 410 VYDFIEAGSFSALLHGNRG-----------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ 478 (632)
Q Consensus 410 v~E~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~ 478 (632)
||||+++|+|.+++..... .....++|....+++.|++.||.|||+. +++||||||+||++++++.
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~ 172 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNV 172 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCc
Confidence 9999999999999975421 1124589999999999999999999998 9999999999999999999
Q ss_pred eEEcccCCCCCCCCCCC------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHH
Q 006747 479 GCISDFGLTPLMNTPTV------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWV 551 (632)
Q Consensus 479 ~ki~DfGla~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 551 (632)
+||+|||+++....... ..++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-------~~ 245 (314)
T cd05099 173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-------EL 245 (314)
T ss_pred EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-------HH
Confidence 99999999986643211 123356999999998889999999999999999999 88888643211 11
Q ss_pred HHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 552 QSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 552 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
..........+ .......++.+++.+||+.+|++|||+.++++.|+++..
T Consensus 246 ~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 246 FKLLREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111111110 011122356688899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=300.23 Aligned_cols=242 Identities=26% Similarity=0.392 Sum_probs=193.1
Q ss_pred hHhCccceeEEEEEEEcC----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
+.||+|+||.||+|.... +..||+|.+..... ..+++..|++++.++ +|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 368999999999997432 26899999986544 356788999999999 8999999999876 456899999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 495 (632)
+|+|.+++.... .+++..+..++.+++.||+|||.. +++||||||+||++++++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999997542 478999999999999999999988 999999999999999999999999999976643321
Q ss_pred C-------CCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccccc
Q 006747 496 P-------SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567 (632)
Q Consensus 496 ~-------~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 567 (632)
. .++..|+|||.+.+..++.++|||||||++|||++ |+.||..... .+...++ ......
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~----~~~~~~------ 217 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAML----ESGERL------ 217 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHH----HcCCcC------
Confidence 1 12346999999998899999999999999999998 9999864321 1111111 111110
Q ss_pred ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 568 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
.........+.+++.+||+.+|++||++.++++.|+++.
T Consensus 218 ----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 ----PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 011112245778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=330.49 Aligned_cols=243 Identities=23% Similarity=0.342 Sum_probs=192.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCC--------ceE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD--------EKL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~ 408 (632)
.+.||+|+||.||++.. .+++.||||++...... ...+.+|+..+..+ +|+||+++.+.+...+ ..+
T Consensus 37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCcccceEEE
Confidence 35799999999999984 56899999999755332 34577889999988 8999999888776433 267
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
+||||+++|+|.++++.... ...++++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 99999999999999875432 234688899999999999999999998 99999999999999999999999999997
Q ss_pred CCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 489 LMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 489 ~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
..... ....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.... ....+........
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~~~~--- 262 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLAGRY--- 262 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhcCCC---
Confidence 65432 22357889999999999999999999999999999999999996532 1222222221111
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
++ + ......++.+++.+||+.||++||++.+++++
T Consensus 263 --~~-~-----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 263 --DP-L-----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --CC-C-----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 0 01122457788889999999999999999864
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=317.84 Aligned_cols=237 Identities=22% Similarity=0.324 Sum_probs=184.9
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHH-HHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEV-VGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
+.||+|+||.||++.. .+|+.||+|++..... ....+..|... +..+ +||||+++++++...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEecCCEEEEEEcCCC
Confidence 3689999999999985 4689999999975421 23345566554 4455 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
+|+|..++... .++++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 80 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 80 GGELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99999888653 2478889999999999999999998 999999999999999999999999999875322
Q ss_pred -CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 493 -PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ............ .+ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~~~~---~~-----~- 216 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILHKPL---VL-----R- 216 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHcCCc---cC-----C-
Confidence 1223578899999999999999999999999999999999999965321 111122111110 00 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. ....+.+++.+|++.+|++||++++.++.
T Consensus 217 ~~---~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 217 PG---ASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CC---CCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 11 12346678889999999999988644333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=287.84 Aligned_cols=243 Identities=21% Similarity=0.350 Sum_probs=195.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---------HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 410 (632)
++.||+|..+.|.+... +.|...|+|++...... .+.-.+|+.+|.++..||+|+.+.++|+++...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 56799999999988764 56889999999754221 234678999999999999999999999999999999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
+|.|+.|.|.++|... ..+++....+|+.++..|++|||.. .||||||||+|||+|++.++||+|||+|+.+
T Consensus 102 Fdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999865 3578888899999999999999998 9999999999999999999999999999998
Q ss_pred CCCC---CCCCCCcccCCccccCC------CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006747 491 NTPT---VPSRSAGYRAPEVIETK------KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTS 561 (632)
Q Consensus 491 ~~~~---~~~~t~~y~aPE~~~~~------~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (632)
.... ..+||+||+|||.+... .|+..+|.|++||+||.|+-|.+||+.... + -..+. +.++..
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----m-lMLR~-ImeGky- 245 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----M-LMLRM-IMEGKY- 245 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----H-HHHHH-HHhccc-
Confidence 7664 35799999999999643 378889999999999999999999975311 0 01111 112111
Q ss_pred ccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 562 EVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 562 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. +.+...+......+++.+|++.||.+|.|++|++++
T Consensus 246 qF------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 246 QF------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 00 111122233445678889999999999999999873
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.78 Aligned_cols=231 Identities=22% Similarity=0.326 Sum_probs=182.4
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHH-HHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEV-VGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.||+|+||+||+|... +|+.||+|++..... ....+..|... +..+ +||||+++++++...+..++||||+++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 5899999999999964 689999999975421 12344555554 4556 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|..++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc
Confidence 99999987542 478888899999999999999998 9999999999999999999999999998754221
Q ss_pred -CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 -TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....+|..|+|||.+.+..++.++|||||||++|||++|+.||..... ........... .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~---------~~~~~ 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNKP---------LRLKP 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcCC---------CCCCC
Confidence 223478899999999999999999999999999999999999975321 11111111110 00001
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTME 600 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ 600 (632)
. ....+.+++.+|++.||++||++.
T Consensus 218 ~---~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 N---ISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C---CCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 123567788899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=303.79 Aligned_cols=242 Identities=21% Similarity=0.338 Sum_probs=190.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|.. .+++.||+|.+..... ..+.+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 84 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVENRISICTEFMDGG 84 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence 35799999999999984 5688999999865422 235688999999999 9999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--CC
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--TV 495 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~ 495 (632)
+|..+. .+++.....++.+++.||+|||+. +|+|+||||+||+++.++.+||+|||++...... ..
T Consensus 85 ~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 152 (279)
T cd06619 85 SLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT 152 (279)
T ss_pred ChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccC
Confidence 997542 256778889999999999999998 9999999999999999999999999999765433 23
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC-hhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD-LPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++|||||||++|||++|+.||......+... ...+... ..+... +....
T Consensus 153 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~---- 222 (279)
T cd06619 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVDEDP-----PVLPV---- 222 (279)
T ss_pred CCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-HhccCC-----CCCCC----
Confidence 357888999999999899999999999999999999999997533222111 1111111 111100 00000
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.....++.+++.+||+.+|++||+++|++++
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1122356788889999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=316.17 Aligned_cols=233 Identities=23% Similarity=0.313 Sum_probs=185.4
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... ++..||+|+++.... ..+.+..|.+++..+.+|++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 357999999999999865 478999999975421 223466777788777679999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 85 GGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999886542 478889999999999999999998 999999999999999999999999999875432
Q ss_pred -CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 493 -PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
.....+|+.|+|||++.+..++.++|||||||++|||+||+.||...... ....... +... . ..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~i~-~~~~------~--~p 221 (323)
T cd05616 157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIM-EHNV------A--YP 221 (323)
T ss_pred ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCC------C--CC
Confidence 12335788999999999999999999999999999999999999753311 1111111 1100 0 01
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTM 599 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 599 (632)
.. ...++.+++.+|++.+|++|++.
T Consensus 222 ~~---~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KS---MSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred Cc---CCHHHHHHHHHHcccCHHhcCCC
Confidence 11 22356778889999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=301.37 Aligned_cols=244 Identities=26% Similarity=0.440 Sum_probs=200.2
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|..++++.||||.+.......+++.+|++++.++ +|+||+++++++......++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 467999999999999988889999999987666678899999999999 8999999999999888999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----C
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-----V 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-----~ 495 (632)
+++.... ...+++..+..++.+++.|++|||+. +++|+||||+||++++++.+|++|||+++...... .
T Consensus 90 ~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 163 (261)
T cd05034 90 DFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163 (261)
T ss_pred HHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhc
Confidence 9997642 23588999999999999999999998 99999999999999999999999999987765321 1
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...+..|+|||.+.+..++.++|||||||++||++| |+.||.+.... ....... .... ....
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~-~~~~----------~~~~ 226 (261)
T cd05034 164 AKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLEQVE-RGYR----------MPRP 226 (261)
T ss_pred cCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH-cCCC----------CCCC
Confidence 123457999999998889999999999999999999 99998643211 1111111 1100 0000
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.+....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1113457788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=305.06 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=198.5
Q ss_pred HhHhCccceeEEEEEEEcC-----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEe-CCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILEE-----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFS-KDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~E 412 (632)
.+.||+|+||.||+|...+ +..|++|+++.... ....+.+|++++.++ +|+||+++++++.. ....++++|
T Consensus 11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCCEEEEE
Confidence 4679999999999999765 78899999875422 245688899999999 99999999999876 467899999
Q ss_pred cccCCCHhhhhccCCCC---CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 413 FIEAGSFSALLHGNRGI---GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
|+++|+|.+++...... ....+++..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~ 166 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRD 166 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCccc
Confidence 99999999998754321 124689999999999999999999988 999999999999999999999999999986
Q ss_pred CCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 490 MNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 490 ~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
+.... ...++..|+|||++.+..++.++|||||||++||+++ |+.||..... ..+.. ...++...
T Consensus 167 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~~~- 238 (280)
T cd05043 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMAA-YLKDGYRL- 238 (280)
T ss_pred ccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HHHHH-HHHcCCCC-
Confidence 64321 1234567999999998889999999999999999999 9999864321 11111 11111110
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.........+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 239 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 239 ---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0011122457789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=306.83 Aligned_cols=247 Identities=24% Similarity=0.380 Sum_probs=196.6
Q ss_pred HhHhCccceeEEEEEEE------cCCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||++.. ..+..||+|+++..... .+.+.+|++++.++.+|+||+++++++...+..++|||
T Consensus 40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 119 (302)
T cd05055 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119 (302)
T ss_pred cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence 56899999999999974 23457999998754322 35688999999999779999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++|+|.++++... ...+++.....++.+++.||+|||+. +|+|+||||+||++++++.+|++|||+++....
T Consensus 120 ~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 120 YCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred cCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999997543 12378999999999999999999998 999999999999999999999999999976543
Q ss_pred CC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 493 PT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 493 ~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
.. ...++..|+|||.+.+..++.++|||||||++|||+| |+.||......+ .............
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~~--- 264 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS------KFYKLIKEGYRMA--- 264 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH------HHHHHHHcCCcCC---
Confidence 22 1224567999999999899999999999999999998 999986532211 1111111111100
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
... ....++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 265 ----~~~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 265 ----QPE---HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----CCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001 1123577889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=322.55 Aligned_cols=240 Identities=20% Similarity=0.333 Sum_probs=193.0
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|... +++.||+|+++... .....+..|++++..+ +|+||+++++++.+.+..++||||+++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheecCCeEEEEEcCCCC
Confidence 57999999999999965 68999999997542 2245688899999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 86 GDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 9999999754 2478888999999999999999997 99999999999999999999999999997654332
Q ss_pred -------------------------------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC
Q 006747 495 -------------------------------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED 543 (632)
Q Consensus 495 -------------------------------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~ 543 (632)
...+|..|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~- 236 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ- 236 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH-
Confidence 234788899999999999999999999999999999999999753311
Q ss_pred CCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 006747 544 VVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPT-MEEVVRM 605 (632)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~evl~~ 605 (632)
........ +.... ....... ....+.+++.+|++ +|++||+ +++++++
T Consensus 237 -----~~~~~i~~--~~~~~---~~p~~~~---~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 -----ETYNKIIN--WKESL---RFPPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred -----HHHHHHhc--cCCcc---cCCCCCC---CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111 00000 0000011 22456678889997 9999999 9999885
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=299.42 Aligned_cols=242 Identities=24% Similarity=0.467 Sum_probs=197.3
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||++...++..+|+|.++.......++.+|++++.++ +||||+++++++......++||||+++|+|.
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 367999999999999987788999999987666677899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----C
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-----V 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-----~ 495 (632)
+++.... .++++..+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||+++...... .
T Consensus 88 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05112 88 DYLRAQR----GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160 (256)
T ss_pred HHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCC
Confidence 9987543 2478899999999999999999998 99999999999999999999999999987553321 1
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...+.+|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ..+... ...+..
T Consensus 161 ~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~-~~~~~~--~~~~~~------ 225 (256)
T cd05112 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVET-INAGFR--LYKPRL------ 225 (256)
T ss_pred CccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHH-HhCCCC--CCCCCC------
Confidence 123457999999998889999999999999999998 99998643211 11111 111110 011111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
....+.+++.+||+.+|++|||+.+++++|.
T Consensus 226 --~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 --ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=301.61 Aligned_cols=244 Identities=20% Similarity=0.450 Sum_probs=195.6
Q ss_pred HhHhCccceeEEEEEEEcC-C---cEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEE-G---TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|.... + ..+|+|.++.... ....+..|++++.++ +|+||+++.+++...+..++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTKFKPAMIITEYM 88 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEccCCCcEEEEEcC
Confidence 4679999999999998643 3 3799999875432 245688999999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++++|.+++.... ..+++..+..++.+++.|++|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 89 ENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 9999999987532 3488999999999999999999998 99999999999999999999999999987664321
Q ss_pred CC-------CCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 495 VP-------SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 495 ~~-------~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
.. ..+..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....... .....
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i-~~~~~------ 228 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAI-NDGFR------ 228 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHH-hcCCC------
Confidence 11 12346999999998889999999999999999998 9999864321 1112211 11100
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.....+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 ----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 229 ----LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011112234578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=305.25 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=194.7
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||++... ++..+|+|.++.... ....+.+|++++.++ +|+||+++++++...+..++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 88 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEGRPLLMVFEY 88 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecCCceEEEEec
Confidence 578999999999999642 356899998875432 246799999999999 999999999999999999999999
Q ss_pred ccCCCHhhhhccCCC----------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcc
Q 006747 414 IEAGSFSALLHGNRG----------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISD 483 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~D 483 (632)
+++|+|.+++..... .....+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~d 165 (280)
T cd05092 89 MRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGD 165 (280)
T ss_pred CCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECC
Confidence 999999999875421 1123588999999999999999999988 999999999999999999999999
Q ss_pred cCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 006747 484 FGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR 556 (632)
Q Consensus 484 fGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 556 (632)
||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||...... +......
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~- 238 (280)
T cd05092 166 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------EAIECIT- 238 (280)
T ss_pred CCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------HHHHHHH-
Confidence 99987553221 1224567999999999999999999999999999998 89998543211 1111111
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
...... ... .....+.+++.+||+.||++||++.+|.+.|+.
T Consensus 239 ~~~~~~-------~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 QGRELE-------RPR---TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred cCccCC-------CCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111000 001 122346788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=307.70 Aligned_cols=254 Identities=20% Similarity=0.352 Sum_probs=194.6
Q ss_pred HhHhCccceeEEEEEEEc-----------------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-----------------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYY 401 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~ 401 (632)
.+.||+|+||.||++... +...||+|.+..... ...++.+|++++.++ +|+||+++++++
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~ 88 (296)
T cd05095 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNIIRLLAVC 88 (296)
T ss_pred eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence 467999999999998532 234689999875432 245789999999999 899999999999
Q ss_pred EeCCceEEEEecccCCCHhhhhccCCCCC------CCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC
Q 006747 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIG------RTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ 475 (632)
Q Consensus 402 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~ 475 (632)
...+..++||||+++|+|.+++....... ...+++.....++.+++.||+|||+. +++||||||+||++++
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~ 165 (296)
T cd05095 89 ITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165 (296)
T ss_pred ecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcC
Confidence 99999999999999999999987643211 12478889999999999999999998 9999999999999999
Q ss_pred CCCeEEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh--CCCCCCCCCCCCCCCh
Q 006747 476 DLQGCISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT--GKAPIQAPGHEDVVDL 547 (632)
Q Consensus 476 ~~~~ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt--g~~p~~~~~~~~~~~~ 547 (632)
++.+||+|||+++.+.... ....+..|+|||...++.++.++|||||||++|||+| |..||......+ .
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~---~ 242 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ---V 242 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---H
Confidence 9999999999997654322 1123457999999888889999999999999999998 678886432211 1
Q ss_pred hHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.................. . .......+.+++.+||+.||++||++.+|.+.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~~----~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IENTGEFFRDQGRQVYLP----K---PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHhhccccccCC----C---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111111111111100000 0 11123567789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=314.72 Aligned_cols=233 Identities=23% Similarity=0.312 Sum_probs=184.7
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +++.||+|+++... ...+.+..|.+++..+.+|++|+++++++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 357999999999999865 46789999997542 2235677888888888555678899999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 85 GGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999999987542 478889999999999999999998 999999999999999999999999999865321
Q ss_pred -CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 493 -PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
.....+|..|+|||++.+..++.++|||||||++|||+||+.||...... ....... +... .. .
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~-~~~~------~~--~ 221 (324)
T cd05587 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQSIM-EHNV------SY--P 221 (324)
T ss_pred ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHH-cCCC------CC--C
Confidence 12235788999999999999999999999999999999999999753211 1111111 1100 00 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTM 599 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 599 (632)
... ...+.+++.+||..||++|++.
T Consensus 222 ~~~---~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSL---SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCC---CHHHHHHHHHHhhcCHHHcCCC
Confidence 111 2346678889999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=309.67 Aligned_cols=254 Identities=21% Similarity=0.335 Sum_probs=192.9
Q ss_pred HhHhCccceeEEEEEEEcC---------------CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILEE---------------GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFS 403 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~---------------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~ 403 (632)
.+.||+|+||.||++...+ ...||+|.++.... ....+.+|++++.++ +|+||+++++++..
T Consensus 10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~ 88 (295)
T cd05097 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRLLGVCVS 88 (295)
T ss_pred hhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEcC
Confidence 4679999999999987542 23589999875422 235689999999999 99999999999999
Q ss_pred CCceEEEEecccCCCHhhhhccCCC-------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC
Q 006747 404 KDEKLLVYDFIEAGSFSALLHGNRG-------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD 476 (632)
Q Consensus 404 ~~~~~lv~E~~~~g~L~~~l~~~~~-------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~ 476 (632)
.+..++||||+++++|.+++..... .....++|..++.++.+++.||+|||+. +++||||||+||+++++
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~ 165 (295)
T cd05097 89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNH 165 (295)
T ss_pred CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCC
Confidence 9999999999999999999864321 0112478899999999999999999998 99999999999999999
Q ss_pred CCeEEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh--CCCCCCCCCCCCCCChh
Q 006747 477 LQGCISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT--GKAPIQAPGHEDVVDLP 548 (632)
Q Consensus 477 ~~~ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt--g~~p~~~~~~~~~~~~~ 548 (632)
+.+||+|||++....... ...++..|+|||.+.+..++.++|||||||++|||++ |..||.....++ ..
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~ 242 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VI 242 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HH
Confidence 999999999997653321 1123567999999998889999999999999999998 566775432211 11
Q ss_pred HHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 549 RWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 549 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
................. ... .....+.+++.+||+.+|++|||+.+|++.|++
T Consensus 243 ~~~~~~~~~~~~~~~~~----~~~---~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 243 ENTGEFFRNQGRQIYLS----QTP---LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHhhhhccccccCC----CCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111110000000 001 122468889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=294.00 Aligned_cols=240 Identities=25% Similarity=0.389 Sum_probs=202.5
Q ss_pred HHhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 340 SAEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
..+.||+|+||.||++.+ +.|+.||||.+... .+-.++..|+.++.++ +.|+||+++|.|.....+++|||||..|+
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQC-KSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHc-CCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 457899999999999985 46999999998753 3567888999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
..++++-. +.++.+.....+....++||+|||.. .-||||||+.|||++.+|.+|++|||+|-.+... .
T Consensus 115 iSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 115 ISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred HHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 99999754 35799999999999999999999988 8899999999999999999999999999776542 4
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc--cccC
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL--MRYE 572 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~--~~~~ 572 (632)
+..||+.|||||++..-.|++++||||+|++..||..|++||......... .+-+.- ....
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-----------------FMIPT~PPPTF~ 250 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-----------------FMIPTKPPPTFK 250 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-----------------EeccCCCCCCCC
Confidence 457999999999999999999999999999999999999999753321110 001111 1123
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.+++...++-++++.|+-+.|++|-|+.+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 445566778999999999999999999887664
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=306.15 Aligned_cols=243 Identities=23% Similarity=0.300 Sum_probs=191.3
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||+||++.. .+++.||+|.+...... ...+.+|++++.++ +|+||+++.+++..++..++||||+++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEecCCEEEEEEEeccC
Confidence 5699999999999985 46889999998754221 23577899999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... ..++++.....++.|++.||.|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 85 GDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred ccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99998886432 23589999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....++..|+|||.+.+..++.++|||||||++|||++|+.||........ ...+.....+... . ...
T Consensus 159 ~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~~--~------~~~- 226 (285)
T cd05632 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETEE--V------YSA- 226 (285)
T ss_pred cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhcccc--c------cCc-
Confidence 223578899999999988999999999999999999999999975321110 1111111111000 0 001
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPT-----MEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 605 (632)
.....+.+++.+||+.||++||+ +.+++.+
T Consensus 227 --~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 227 --KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11234677888999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.37 Aligned_cols=244 Identities=25% Similarity=0.411 Sum_probs=187.9
Q ss_pred hHhCccceeEEEEEEEcC----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEe-CCceEEEEecc
Q 006747 342 EVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFS-KDEKLLVYDFI 414 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~E~~ 414 (632)
+.||+|+||.||+|...+ +..||+|++..... ..+.+.+|+.++..+ +||||+++++++.. +...++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999998532 45799999864322 245688899999998 99999999998764 45678999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
.+|+|.+++.... ..+.+.....++.+++.||+|||+. +++||||||+|||+++++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 9999999997542 2357778889999999999999998 99999999999999999999999999987653211
Q ss_pred --------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 495 --------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTG-KAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 495 --------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
...++..|+|||.+.+..++.++|||||||++|||++| ..||.... ..............
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~~~~~~~~~----- 221 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD------SFDITVYLLQGRRL----- 221 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhcCCCC-----
Confidence 12245679999999888899999999999999999995 45554321 11112111111100
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
.... .....+.+++.+||+.+|++||++.|+++.|+++.
T Consensus 222 ---~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 ---LQPE---YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---CCCC---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0001 11235778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=315.51 Aligned_cols=236 Identities=21% Similarity=0.292 Sum_probs=182.9
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHH-HHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEV-VGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~-l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.||+|+||.||++... +++.||+|++..... ....+..|... +..+ +|+||+++++++...+..++||||+++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 6899999999999865 578899999975421 12344444444 4556 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... .+.+.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC
Confidence 99999987542 366777788999999999999998 9999999999999999999999999998754221
Q ss_pred -CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 -TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~---------~~~~ 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNKPL---------QLKP 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhCCc---------CCCC
Confidence 223588899999999999999999999999999999999999975321 111111111110 0001
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. ...+.+++.+|++.+|.+||++.+.+..
T Consensus 218 ~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 218 NI---TNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CC---CHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 11 2346677889999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=314.22 Aligned_cols=231 Identities=21% Similarity=0.330 Sum_probs=181.0
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHH-HHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQME-VVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+||+|+||.||+|... +++.||+|++..... ....+..|.. ++..+ +||||+++++++.+.+..++||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 6899999999999964 588999999975421 2234555555 45566 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|..++... ..+.+.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc
Confidence 9999888643 2467778888999999999999998 9999999999999999999999999998753221
Q ss_pred -CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 -TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....++..|+|||.+.+..++.++|||||||++|||++|+.||.... ............ .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~---------~~~~~ 217 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILHKP---------LQLPG 217 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhcCC---------CCCCC
Confidence 22347889999999999889999999999999999999999997532 111111111110 00011
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTME 600 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~ 600 (632)
.....+.+++.+|++.||++||++.
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 ---GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ---CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1223567888899999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.88 Aligned_cols=240 Identities=25% Similarity=0.389 Sum_probs=195.2
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... ++..|++|.+.... .....+.+|++++.++ +||||+++++++.+.+..++||||++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 57999999999999864 58999999986542 2346788999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.++++... ...+++.....++.+++.||.|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~ 158 (256)
T cd08529 85 DLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA 158 (256)
T ss_pred cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence 9999998642 23588899999999999999999988 99999999999999999999999999987664432
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...++..|+|||++.+..++.++|||||||++|||++|+.||..... ......... +... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~----------~~ 221 (256)
T cd08529 159 NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKIIR-GVFP----------PV 221 (256)
T ss_pred hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHc-CCCC----------CC
Confidence 22467789999999998899999999999999999999999965331 111111111 1110 00
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.......+.+++.+||+.+|++||++.++++.
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11223467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=307.62 Aligned_cols=239 Identities=22% Similarity=0.361 Sum_probs=192.7
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|+||.||+|.. .+++.||+|.+..... ..+.+.+|++++..+ +|+||+++++++......++||||+++++|
T Consensus 26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 5799999999999985 4688999999875433 346688999999998 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----C
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT----V 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~----~ 495 (632)
.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 105 ~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9998643 378889999999999999999998 99999999999999999999999999987654322 2
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..++..|+|||.+.+..++.++|||||||++|||++|+.||....... +.......... .. ....
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~~------~~---~~~~ 240 (296)
T cd06654 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP------EL---QNPE 240 (296)
T ss_pred ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCCC------CC---CCcc
Confidence 356778999999998889999999999999999999999996532111 11011111100 00 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.....+.+++.+||..+|++|||+.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 222456788899999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=303.01 Aligned_cols=247 Identities=27% Similarity=0.421 Sum_probs=195.5
Q ss_pred HhHhCccceeEEEEEEEcC------CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILEE------GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|...+ +..||+|.+..... ....+.+|++++.++ +|+||+++++++......++|||
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e 89 (277)
T cd05032 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSTGQPTLVVME 89 (277)
T ss_pred EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcCCCCcEEEEe
Confidence 4679999999999998642 36899999875432 235688899999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC-----CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 413 FIEAGSFSALLHGNRGI-----GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
|+++|+|.+++...... ....++|.....++.+++.||.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 90 LMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred cCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccc
Confidence 99999999998754321 123478899999999999999999988 9999999999999999999999999998
Q ss_pred CCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 488 PLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 488 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
+...... ...++..|+|||.+.+..++.++|||||||++||++| |+.||......+ . . ........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~---~-~~~~~~~~ 239 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---V---L-KFVIDGGH 239 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---H---H-HHHhcCCC
Confidence 7654321 2235678999999988889999999999999999998 999986432111 1 1 11111111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.. ........+.+++.+||+.+|++|||+.+++..|++
T Consensus 240 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 240 LD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 00 011123467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=336.75 Aligned_cols=256 Identities=21% Similarity=0.284 Sum_probs=197.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... .++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d~~~lyLVMEY~e 85 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSDGDPVYYTMPYIE 85 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEeeCCEEEEEEEcCC
Confidence 357999999999999864 589999999975422 135688999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCC------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 416 AGSFSALLHGNRGI------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 416 ~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
+|+|.+++...... .....++...++++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 GGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~ 162 (932)
T PRK13184 86 GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIF 162 (932)
T ss_pred CCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCccee
Confidence 99999998642111 123466788899999999999999998 999999999999999999999999999976
Q ss_pred CCCC----------------------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 006747 490 MNTP----------------------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547 (632)
Q Consensus 490 ~~~~----------------------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~ 547 (632)
.... ....||+.|+|||.+.+..++.++|||||||++|||+||+.||.........
T Consensus 163 i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~-- 240 (932)
T PRK13184 163 KKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS-- 240 (932)
T ss_pred cccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh--
Confidence 5110 1124788999999999999999999999999999999999999653211110
Q ss_pred hHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhhCCCCCC
Q 006747 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRP-TMEEVVRMIEDIRPSDSE 615 (632)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~i~~~~~~ 615 (632)
. ... ..++.- .....+....+.+++.+|++.||++|| +++++.+.|+.......+
T Consensus 241 --~------~~~---i~~P~~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~ 296 (932)
T PRK13184 241 --Y------RDV---ILSPIE--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE 296 (932)
T ss_pred --h------hhh---ccChhh--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence 0 000 000000 000111223467788899999999995 677788888887655433
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=319.25 Aligned_cols=241 Identities=17% Similarity=0.257 Sum_probs=189.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... ++..||+|++.... .....+..|++++..+ +||||+++++++.+.+..++||||++
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05596 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEcCCC
Confidence 467999999999999864 58899999997532 2234577899999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++... .++......++.+++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 127 gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 127 GGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 99999998653 266777888899999999999998 9999999999999999999999999999765432
Q ss_pred ---CCCCCCCcccCCccccCC----CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETK----KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~----~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ..............
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~----- 266 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKNSL----- 266 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCCcC-----
Confidence 234588899999998653 378999999999999999999999975321 11111111111000
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDM--RPTMEEVVRM 605 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~ 605 (632)
.. .........+.+++.+|++.+|++ |||+.|++++
T Consensus 267 ~~---~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TF---PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC---CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 000012245667888999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=302.81 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=198.2
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
..+.||+|+||+||++... +++.||+|++..... ..+.+.+|++++..+ +||||+++++++......++||||+++
T Consensus 9 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (284)
T cd06620 9 TISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNENNICMCMEFMDC 87 (284)
T ss_pred HHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecCCEEEEEEecCCC
Confidence 4678999999999999854 588999998865422 246788999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--C
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--T 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~ 494 (632)
|+|.+++... .++++.....++.+++.||.|||+.. +++||||||+||++++++.++|+|||++...... .
T Consensus 88 ~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~ 160 (284)
T cd06620 88 GSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD 160 (284)
T ss_pred CCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence 9999988753 24789999999999999999999742 7999999999999999999999999998765322 2
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCC-----CChhHHHHHHhhhcccccccccccc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV-----VDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
...++..|+|||.+.+..++.++|||||||++|||+||+.||......+. ..+..+......+... .+
T Consensus 161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~- 233 (284)
T cd06620 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP------RL- 233 (284)
T ss_pred ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC------CC-
Confidence 23578889999999888899999999999999999999999975432111 1112222222211100 00
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
...+....+.+++.+||+.||++|||+.|++++.-
T Consensus 234 ---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 234 ---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred ---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00112345778889999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.02 Aligned_cols=241 Identities=20% Similarity=0.329 Sum_probs=189.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... +++.||||+++.... ....+.+|++++..+ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQDENYLYLIMEYLP 84 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEcCCeEEEEECCCC
Confidence 367999999999999864 589999999975421 234577899999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 85 ~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 85 GGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999987542 478889999999999999999998 99999999999999999999999999986542110
Q ss_pred -----------------------------------------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCC
Q 006747 495 -----------------------------------------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGK 533 (632)
Q Consensus 495 -----------------------------------------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~ 533 (632)
...||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 124788999999999989999999999999999999999
Q ss_pred CCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 006747 534 APIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPT---MEEVVRM 605 (632)
Q Consensus 534 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs---~~evl~~ 605 (632)
.||...... ........ +.... ......... ..+.+++.+|+. +|.+|++ +.|++++
T Consensus 237 ~Pf~~~~~~------~~~~~i~~--~~~~~---~~~~~~~~s---~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQ------ETYRKIIN--WKETL---QFPDEVPLS---PEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHH------HHHHHHHc--CCCcc---CCCCCCCCC---HHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999753211 11111111 00000 000111112 245567778886 8999998 8888773
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=302.67 Aligned_cols=244 Identities=20% Similarity=0.302 Sum_probs=191.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.++.++ +||||+++++++...+..++||||+++|+
T Consensus 14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~~~~~~iv~e~~~~~~ 92 (267)
T cd06646 14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLSREKLWICMEYCGGGS 92 (267)
T ss_pred hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEeCCEEEEEEeCCCCCc
Confidence 46899999999999995 5688999999875432 345678899999999 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
|.++++.. .++++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..... .
T Consensus 93 L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 93 LQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99998743 2478899999999999999999998 9999999999999999999999999999765432 2
Q ss_pred CCCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 VPSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...++..|+|||.+. ...++.++|||||||++|||++|+.||......+... .+ ... .+... ..
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~-----~~~----~~~~~--~~ 231 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LM-----SKS----NFQPP--KL 231 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--ee-----ecC----CCCCC--CC
Confidence 234677899999884 3447889999999999999999999985432111100 00 000 00000 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
.........+.+++.+||+.+|++|||+++++++|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 01111234677889999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=298.46 Aligned_cols=243 Identities=27% Similarity=0.458 Sum_probs=196.2
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||++...++..+|+|.+.........+.+|++++.++ +|+||+++.+++.. ...+++|||+++|+|.
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 367999999999999988888899999876544567789999999999 89999999999877 7789999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-----
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV----- 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~----- 495 (632)
+++.... ...+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||.+........
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 162 (260)
T cd05073 89 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162 (260)
T ss_pred HHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccC
Confidence 9997542 23578899999999999999999987 999999999999999999999999999876543221
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||++.+..++.++|||||||++||++| |+.||...... ..... ....... ...
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~------~~~~~-~~~~~~~----------~~~ 225 (260)
T cd05073 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRA-LERGYRM----------PRP 225 (260)
T ss_pred CcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH------HHHHH-HhCCCCC----------CCc
Confidence 123456999999998889999999999999999999 89998653211 11111 1111110 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.....++.+++.+||+.+|++||++.++.+.|+.
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223457788899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=306.19 Aligned_cols=242 Identities=23% Similarity=0.325 Sum_probs=191.3
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++... +++.||+|.+...... ...+..|+.++.++ +|+||+.+.+.+.+.+..++||||+++
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 57999999999999854 5889999998754221 23467899999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|+|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 85 ~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 85 GDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99999886432 23588899999999999999999988 99999999999999999999999999987654322
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...++..|+|||.+.+..++.++|||||||++|||++|+.||......... ......... ... ..
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~-~~~-----~~----- 224 (285)
T cd05630 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKE-VQE-----EY----- 224 (285)
T ss_pred cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhh-hhh-----hc-----
Confidence 235788899999999999999999999999999999999999753221100 000111000 000 00
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPT-----MEEVVR 604 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 604 (632)
.......+.+++.+||+.||++||| +.|+++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0111234678888999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.19 Aligned_cols=247 Identities=23% Similarity=0.419 Sum_probs=195.7
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|... ++..||+|.+..... ..+++.+|++++.++ +||||+++++++...+..++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCccEEEEe
Confidence 467999999999999853 467899999875432 246688999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCC-----------------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC
Q 006747 413 FIEAGSFSALLHGNRG-----------------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ 475 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~ 475 (632)
|+++|+|.+++..... .....+++..++.++.+++.||+|||+. +++||||||+||++++
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~ 165 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGE 165 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecC
Confidence 9999999999874321 1223578899999999999999999998 9999999999999999
Q ss_pred CCCeEEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChh
Q 006747 476 DLQGCISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLP 548 (632)
Q Consensus 476 ~~~~ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 548 (632)
++.+||+|||+++...... ....+..|+|||.+.+..++.++|||||||++|||++ |..||.+... .
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~------~ 239 (288)
T cd05050 166 NMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH------E 239 (288)
T ss_pred CCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------H
Confidence 9999999999987543221 1223456999999998899999999999999999998 8888864321 1
Q ss_pred HHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 549 RWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 549 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
...... .+..... .......++.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ~~~~~~-~~~~~~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIYYV-RDGNVLS----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHH-hcCCCCC----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 122211 1111100 011123457788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=301.08 Aligned_cols=244 Identities=23% Similarity=0.471 Sum_probs=194.4
Q ss_pred HhHhCccceeEEEEEEEcC-C---cEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEE-G---TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|.... + ..||+|.++.... ...+|..|++++.++ +||||+++++++......++||||+
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~ 87 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSRPVMIITEFM 87 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECCCCceEEEEecC
Confidence 4679999999999998643 3 3699999875422 245799999999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||+++......
T Consensus 88 ~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 88 ENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred CCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999987542 2478999999999999999999998 99999999999999999999999999987654321
Q ss_pred CC------C---CCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 495 VP------S---RSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 495 ~~------~---~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.. . .+..|+|||.+.+..++.++|||||||++|||++ |+.||...... ....++ .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i----~~~~~---- 229 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI----EQDYR---- 229 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH----HcCCc----
Confidence 11 1 1346999999999999999999999999999987 99998653211 111111 11110
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
. ....+....+.+++.+||+.+|.+||++.+++..|+++
T Consensus 230 ---~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ---L---PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---C---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01112234567888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=334.44 Aligned_cols=259 Identities=26% Similarity=0.383 Sum_probs=208.8
Q ss_pred CCCHHHHHHHHHhHhCccceeEEEEEEEc--------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeE
Q 006747 330 NFDLEDLLRASAEVLGKGSYGTTYKAILE--------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRA 399 (632)
Q Consensus 330 ~~~~~~l~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~ 399 (632)
.++.+.+ ...+.||+|.||.|++|... ....||||.++.... ..+.+..|++++..+.+|+||+.++|
T Consensus 292 e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 292 EIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred eechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 3444444 33458999999999999743 146799999987643 36789999999999999999999999
Q ss_pred EEEeCCceEEEEecccCCCHhhhhccCC---C------CCC--CcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCC
Q 006747 400 YYFSKDEKLLVYDFIEAGSFSALLHGNR---G------IGR--TPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKS 468 (632)
Q Consensus 400 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~---~------~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~ 468 (632)
+|..++..++|.||+..|+|.++|+..+ . ... ..+.....+.++.|||.|++||++. ++|||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999999876 1 111 2388899999999999999999999 999999999
Q ss_pred CCeeecCCCCeEEcccCCCCCCCCCCCC-----CC--CCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCC
Q 006747 469 SNVLLSQDLQGCISDFGLTPLMNTPTVP-----SR--SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPG 540 (632)
Q Consensus 469 ~NILl~~~~~~ki~DfGla~~~~~~~~~-----~~--t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~ 540 (632)
+|||++++..+||+|||+|+........ .+ ...|||||.+....|+.|+|||||||+||||+| |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999865443221 11 234999999999999999999999999999999 899997521
Q ss_pred CCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 541 HEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 541 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
. .... -..++++.. .+.+..+..++.++|+.||+.+|++||++.++.+.++..
T Consensus 527 ~-----~~~l-~~~l~~G~r----------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 P-----TEEL-LEFLKEGNR----------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred c-----HHHH-HHHHhcCCC----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 0 1111 223444432 223334456788999999999999999999999999885
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=303.05 Aligned_cols=251 Identities=24% Similarity=0.406 Sum_probs=198.5
Q ss_pred HhHhCccceeEEEEEEEc-----CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEe--CCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-----EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFS--KDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~ 411 (632)
.+.||+|+||.||+|... .+..||||.++..... ...+..|++++.++ +|+||+++++++.. ....++||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRSLRLIM 87 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCceEEEE
Confidence 467999999999999853 3689999999866553 56799999999999 89999999999887 55789999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++++|.+++.... ..+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||.+....
T Consensus 88 e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 88 EYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999997643 2489999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCC-------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHHHHHHh
Q 006747 492 TPTV-------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV---------DLPRWVQSVV 555 (632)
Q Consensus 492 ~~~~-------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~~~~~~ 555 (632)
.... ...+..|+|||.+.+..++.++||||||+++|||+||+.|+......... ....+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE-LL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH-HH
Confidence 3211 12344599999998888999999999999999999999998653221100 0111111 11
Q ss_pred hhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 556 REEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 556 ~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
.... ..........++.+++.+||+.+|++|||+.||+++|+.+.
T Consensus 240 ~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 240 KEGE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HcCC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1100 00111122356888999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=329.57 Aligned_cols=256 Identities=16% Similarity=0.229 Sum_probs=184.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhc-----CCCCccceeEEEEeC-CceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLS-----QHPNVVPIRAYYFSK-DEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~-~~~~lv~E~ 413 (632)
.+.||+|+||+||+|... .++.||||+++......+++..|++++.++. +|.+++++++++... ...++|||+
T Consensus 134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~ 213 (467)
T PTZ00284 134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK 213 (467)
T ss_pred EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence 357999999999999854 5788999999764444456677787777762 244588898988765 468899998
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC----------------
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL---------------- 477 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~---------------- 477 (632)
+ +++|.+++... .++++.....|+.|++.||+|||+. .+||||||||+|||++.++
T Consensus 214 ~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 214 Y-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred c-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 8 67888888653 2488899999999999999999973 2899999999999998765
Q ss_pred CeEEcccCCCCCCCCC-CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChh--------
Q 006747 478 QGCISDFGLTPLMNTP-TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP-------- 548 (632)
Q Consensus 478 ~~ki~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~-------- 548 (632)
.+||+|||.+...... ....+|..|+|||++.+..++.++|||||||++|||+||+.||......+.....
T Consensus 286 ~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p 365 (467)
T PTZ00284 286 RVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLP 365 (467)
T ss_pred eEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCC
Confidence 4999999988654332 3346889999999999999999999999999999999999999764322111110
Q ss_pred -HHHHH--------Hhhh-cccccccccc-c---cccCCcH--HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 549 -RWVQS--------VVRE-EWTSEVFDVE-L---MRYENIE--EEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 549 -~~~~~--------~~~~-~~~~~~~d~~-~---~~~~~~~--~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.|... .... .......++. + ....... .....+.+|+.+||+.||++|||++|+++
T Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 366 SEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 01100 0000 0000000000 0 0000000 01235779999999999999999999997
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.84 Aligned_cols=245 Identities=27% Similarity=0.450 Sum_probs=193.0
Q ss_pred HhCccceeEEEEEEEcC-------CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 343 VLGKGSYGTTYKAILEE-------GTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.||+|+||.||+|...+ +..+|+|.+.... .....+.+|++++.++ +||||+++++++...+..++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998643 2579999886543 2356788999999999 999999999999999999999999
Q ss_pred ccCCCHhhhhccCCCC--CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-----CeEEcccCC
Q 006747 414 IEAGSFSALLHGNRGI--GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL-----QGCISDFGL 486 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~-----~~ki~DfGl 486 (632)
+++|+|.+++...... ....++|..++.++.+++.||+|||+. +++|+||||+||+++.++ .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999754221 123478899999999999999999988 899999999999999887 899999999
Q ss_pred CCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 487 TPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 487 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
++...... ....+..|+|||.+.+..++.++|||||||++|||+| |+.||..... ...... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------~~~~~~-~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------QEVLQH-VTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH------HHHHHH-HhcCC
Confidence 87553221 1234567999999999999999999999999999998 9999864321 111111 11110
Q ss_pred ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 560 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
. . .........+.+++.+||+.+|++||++.++++.|++
T Consensus 231 ~-------~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 R-------L---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred c-------c---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 0 0011123456788999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=322.02 Aligned_cols=241 Identities=19% Similarity=0.273 Sum_probs=186.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++.. .+++.||||++..... ..+.+.+|++++.++ +||||+++++++.+.+..|+||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~~~~~lv~E~~~ 84 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQDAQYLYLIMEFLP 84 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCeeEEEEeCCC
Confidence 36799999999999985 4688999999865421 134578899999998 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 85 GGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999987542 477888888999999999999998 9999999999999999999999999998632110
Q ss_pred -------------------------------------------------CCCCCCCcccCCccccCCCCCccchhhHHHH
Q 006747 494 -------------------------------------------------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGV 524 (632)
Q Consensus 494 -------------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gv 524 (632)
....||++|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0124788899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCC---CCHHH
Q 006747 525 LLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMR---PTMEE 601 (632)
Q Consensus 525 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R---Ps~~e 601 (632)
++|||+||+.||......+ ........ .... ....... ...++.+++.+|+. +|.+| +++.|
T Consensus 237 il~elltG~~Pf~~~~~~~------~~~~i~~~--~~~~---~~p~~~~---~s~~~~dli~~lL~-~~~~r~~r~~~~~ 301 (377)
T cd05629 237 IMFECLIGWPPFCSENSHE------TYRKIINW--RETL---YFPDDIH---LSVEAEDLIRRLIT-NAENRLGRGGAHE 301 (377)
T ss_pred hhhhhhcCCCCCCCCCHHH------HHHHHHcc--CCcc---CCCCCCC---CCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence 9999999999996533211 11111110 0000 0000001 12345677788997 66665 69999
Q ss_pred HHHH
Q 006747 602 VVRM 605 (632)
Q Consensus 602 vl~~ 605 (632)
++++
T Consensus 302 ~l~h 305 (377)
T cd05629 302 IKSH 305 (377)
T ss_pred HhcC
Confidence 8875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.64 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=194.5
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|... .+..||+|.++..... ...+.+|+.++.++ +|+||+++++++...+..++|||
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e 89 (288)
T cd05061 11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKGQPTLVVME 89 (288)
T ss_pred eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCCcEEEEe
Confidence 467999999999999753 2458999998754322 34578899999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCC-----CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 413 FIEAGSFSALLHGNRG-----IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
|+++|+|.+++..... .+..+..+....+++.+++.||+|||+. +|+||||||+||++++++.+|++|||++
T Consensus 90 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 90 LMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred CCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCcc
Confidence 9999999999975321 1234567788899999999999999998 9999999999999999999999999998
Q ss_pred CCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 488 PLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 488 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
+...... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||.....+ +...........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~~ 240 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKFVMDGGYL 240 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC
Confidence 7653321 1123567999999998889999999999999999999 78888643221 111111111100
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.........+.+++.+||+.+|++|||+.++++.|++.
T Consensus 241 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 241 -----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 00111234678889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=310.70 Aligned_cols=232 Identities=22% Similarity=0.302 Sum_probs=185.5
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|... +++.||+|+++... ...+.+..|.+++..+.+|++|+++.+++.+.+..++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~ 85 (323)
T cd05615 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG 85 (323)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence 57999999999999854 58899999997542 12345777888888886678899999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 86 GDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 99999986542 488999999999999999999998 9999999999999999999999999998754322
Q ss_pred -CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 -TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....+|..|+|||++.+..++.++|||||||++|||+||+.||...... ........... . ...
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~~-------~--~p~ 222 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIMEHNV-------S--YPK 222 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC-------C--CCc
Confidence 2234788999999999989999999999999999999999999753211 11111111110 0 001
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTM 599 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 599 (632)
. ....+.+++.+|++.+|++|++.
T Consensus 223 ~---~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 S---LSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred c---CCHHHHHHHHHHcccCHhhCCCC
Confidence 1 12346778889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.55 Aligned_cols=193 Identities=22% Similarity=0.398 Sum_probs=158.6
Q ss_pred hHhCccceeEEEEEEEc---CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe--CCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE---EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS--KDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~E~~~~ 416 (632)
..||+|+||.||+|... +++.||+|.++.... ...+.+|++++.++ +||||+++++++.. ....++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 57999999999999864 467899999875432 34578899999999 99999999998865 3467899999865
Q ss_pred CCHhhhhccCCC----CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee----cCCCCeEEcccCCCC
Q 006747 417 GSFSALLHGNRG----IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL----SQDLQGCISDFGLTP 488 (632)
Q Consensus 417 g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl----~~~~~~ki~DfGla~ 488 (632)
+|.+++..... .....+++.....++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 88877653321 1123588888999999999999999998 99999999999999 456899999999997
Q ss_pred CCCCC-------CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 006747 489 LMNTP-------TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540 (632)
Q Consensus 489 ~~~~~-------~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~ 540 (632)
..... ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76432 123468889999999874 57999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.29 Aligned_cols=242 Identities=19% Similarity=0.299 Sum_probs=190.4
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... +++.||+|+++.... ..+.+..|++++..+ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQDKDNLYLVMEYQP 84 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEecCCeEEEEECCCC
Confidence 357999999999999854 688999999986532 235578888888888 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 85 GGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999997642 3588889999999999999999998 99999999999999999999999999997664322
Q ss_pred ----CCCCCCcccCCcccc------CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 495 ----VPSRSAGYRAPEVIE------TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 495 ----~~~~t~~y~aPE~~~------~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
...+|..|+|||++. ...++.++|||||||++|||++|+.||..... ...............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~-- 229 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRFLK-- 229 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCccC--
Confidence 235788999999986 45678999999999999999999999965321 111111111110000
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...... ....+.+++..|++ +|++|||+.+++++
T Consensus 230 ---~~~~~~---~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 ---FPEDPK---VSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---CCCCCC---CCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000011 12346677789997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=298.09 Aligned_cols=242 Identities=24% Similarity=0.432 Sum_probs=195.0
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|+||.||++...+++.||+|.++.... ....+..|++++.++ +|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 36899999999999987799999999876533 245789999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC----
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV---- 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 495 (632)
.+++.... ..+++.....++.+++.|++|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 80 ~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99987542 2478889999999999999999998 999999999999999999999999999976542211
Q ss_pred --CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 496 --PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 496 --~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
...+..|+|||.+.++.++.++|||||||++|||+| |..||...... ... ..+..... ..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~------~~~-~~~~~~~~----------~~ 215 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ------QTR-ERIESGYR----------MP 215 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH------HHH-HHHhcCCC----------CC
Confidence 112456999999998899999999999999999999 88888643211 111 11111100 00
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
........+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 111223467889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=310.56 Aligned_cols=255 Identities=18% Similarity=0.328 Sum_probs=188.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... ++..||+|+++.... ....+.+|++++.++ +|+||+++++++...+..++||||+++
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~- 88 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTDKSLTLVFEYLDK- 88 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence 357999999999999854 578899999875422 234677899999999 899999999999999999999999985
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 89 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 89 DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 8888776542 2478888899999999999999998 9999999999999999999999999998764332
Q ss_pred CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH-hhhccc-----cccccc
Q 006747 494 TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV-VREEWT-----SEVFDV 566 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~d~ 566 (632)
....++..|+|||.+.+ ..++.++|||||||++|||+||+.||......+........... ..+.+. ....+.
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 12346788999998865 45789999999999999999999999764432211100000000 000000 000000
Q ss_pred ccccc--C----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 567 ELMRY--E----NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 567 ~~~~~--~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..... . .......++.+++.+|++.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 0 00011234668889999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.69 Aligned_cols=257 Identities=20% Similarity=0.284 Sum_probs=184.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeC--------CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--------DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~lv~ 411 (632)
.+.||+|+||.||+|... .++.||||++... .....+|+.++.++ +|+|||++++++... ...++||
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 467999999999999864 5889999988643 23345799999999 999999999987542 1356899
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-CeEEcccCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLM 490 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~ 490 (632)
||+++ ++.+++..... ....+++.....++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 147 E~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred ecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 99985 67666643211 224588899999999999999999998 999999999999999664 7999999999876
Q ss_pred CCC---CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---cc---
Q 006747 491 NTP---TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE---WT--- 560 (632)
Q Consensus 491 ~~~---~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~--- 560 (632)
... ....+|+.|+|||++.+. .++.++|||||||++|||+||+.||.+....+. +..... ..... ..
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~-~~~~p~~~~~~~~ 298 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQ-VLGTPTEDQLKEM 298 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-HhCCCCHHHHHHh
Confidence 432 233578889999998764 589999999999999999999999976432111 111110 00000 00
Q ss_pred -ccccccccccc--CC-----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhh
Q 006747 561 -SEVFDVELMRY--EN-----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDI 609 (632)
Q Consensus 561 -~~~~d~~~~~~--~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i 609 (632)
....+...... .. ......++.+++.+||+.||++|||+.|++++ ++.+
T Consensus 299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 00000000000 00 00112457789999999999999999999863 4444
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.48 Aligned_cols=253 Identities=20% Similarity=0.313 Sum_probs=192.3
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||++... ++..+|+|.++.... ....+.+|++++.++ +||||+++++++...+..++||||++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ey~~~~ 84 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGG 84 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence 357999999999999854 578899998865422 235688999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--CC
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--TV 495 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~~ 495 (632)
+|.++++.. .++++.....++.+++.||.|||+.. +++||||||+||++++++.+||+|||++...... ..
T Consensus 85 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (308)
T cd06615 85 SLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 157 (308)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccccccc
Confidence 999999754 24788889999999999999999742 8999999999999999999999999998765432 22
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc---------------
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT--------------- 560 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 560 (632)
..++..|+|||.+.+..++.++|||||||++|||++|+.||....... ...+..........
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCCCcc
Confidence 346788999999988889999999999999999999999986432111 11100000000000
Q ss_pred ---------cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 561 ---------SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 561 ---------~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.......... .........+.+++.+||+.+|++|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPK-LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCcc-CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 0000122357789999999999999999999886
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.06 Aligned_cols=244 Identities=23% Similarity=0.466 Sum_probs=194.9
Q ss_pred HhHhCccceeEEEEEEEc----CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|... ++..+|+|.++.... ..+.+..|++++.++ +||||+++++++...+..++||||+
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTKSKPVMIVTEYM 87 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEecCCccEEEEEcC
Confidence 468999999999999853 234799999875432 245788999999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.+++.... ..+++.....++.+++.||+|||+. +++||||||+||++++++.+|++|||++.......
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 88 ENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999997542 3478899999999999999999998 99999999999999999999999999998764432
Q ss_pred C-------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 495 V-------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 495 ~-------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
. ...+..|+|||.+.+..++.++|||||||++||+++ |+.||......+ . ... ..+....
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~---~~~-~~~~~~~----- 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---V---IKA-IEEGYRL----- 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---H---HHH-HhCCCcC-----
Confidence 1 112346999999998889999999999999999887 999986532211 1 111 1111110
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
... ......+.+++.+||+.+|++||+|.++++.|+++
T Consensus 229 --~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 --PAP---MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCC---CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 001 11234567888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=296.84 Aligned_cols=240 Identities=26% Similarity=0.417 Sum_probs=195.0
Q ss_pred HhHhCccceeEEEEEEEcC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||+|...+ +..|++|.+..... ..++.+|++++.++ +|+||+++++++......++++||+++++|
T Consensus 8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-DSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-CCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 4679999999999999765 78999999875433 67899999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----C
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT----V 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~----~ 495 (632)
.+++.... ..+++.....++.+++.||.|||+. +++||||+|+||++++++.+||+|||++....... .
T Consensus 86 ~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 86 SDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 99986532 3589999999999999999999998 99999999999999999999999999987765432 2
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..++..|+|||.+.+..++.++|||||||++|||++|+.||......... .. .... . .. ......
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~~-~----~~---~~~~~~ 223 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPNK-P----PP---TLSDPE 223 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hccC-C----CC---CCCchh
Confidence 23677899999999888999999999999999999999998653221110 00 0000 0 00 001111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.....+.+++.+||+.+|++|||+.|+++
T Consensus 224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12245778889999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=318.25 Aligned_cols=241 Identities=18% Similarity=0.260 Sum_probs=186.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... +++.||+|++.+.. .....+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05621 48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence 357999999999999965 57899999986532 1234577889999888 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 127 gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~ 197 (370)
T cd05621 127 GGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM 197 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence 99999998643 267788889999999999999998 9999999999999999999999999999876432
Q ss_pred ---CCCCCCCcccCCccccCCC----CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETKK----PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~----~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
....+|+.|+|||.+.+.. ++.++||||+||++|||++|+.||..... ..............
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~----- 266 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSL----- 266 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCccc-----
Confidence 2345889999999987643 78899999999999999999999975321 11111111111000
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDM--RPTMEEVVRM 605 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~ 605 (632)
...... +....+.+++..|++.++.+ |+++.|++++
T Consensus 267 ~~p~~~---~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPEDV---EISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCcc---cCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000001 11234556777888755543 8999999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.46 Aligned_cols=190 Identities=25% Similarity=0.335 Sum_probs=163.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|++++.++ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 35799999999999985 4578999999975422 234678899999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 85 GGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999987542 467778888999999999999998 999999999999999999999999999753210
Q ss_pred ------------------------------------------------CCCCCCCCcccCCccccCCCCCccchhhHHHH
Q 006747 493 ------------------------------------------------PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGV 524 (632)
Q Consensus 493 ------------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gv 524 (632)
.....||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 01124788899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 006747 525 LLLEMLTGKAPIQAP 539 (632)
Q Consensus 525 vl~elltg~~p~~~~ 539 (632)
++|||++|+.||...
T Consensus 237 il~elltG~~Pf~~~ 251 (382)
T cd05625 237 ILYEMLVGQPPFLAQ 251 (382)
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=296.52 Aligned_cols=247 Identities=24% Similarity=0.378 Sum_probs=183.8
Q ss_pred HhCccceeEEEEEEEcCCc---EEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILEEGT---TVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~~~---~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||+|...++. .+++|.++... ...+.+.+|+.++..+ +||||++++++|......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecCCCccEEEEecCCCC
Confidence 5899999999999754443 45666665432 2346789999999998 9999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC-----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT----- 492 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~----- 492 (632)
+|.++++.... .....++.....++.|++.||+|||+. +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 99999976432 123466677788999999999999998 999999999999999999999999999864321
Q ss_pred -CCCCCCCCcccCCccccC-------CCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 493 -PTVPSRSAGYRAPEVIET-------KKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~-------~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||..... .........+.. ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~-~~~ 229 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKDQQ-VKL 229 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhhcc-ccc
Confidence 122346778999998753 235789999999999999997 5667754221 122222222211 122
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
.++.+.. . ....+.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~~~~~--~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL--P---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC--C---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222211 1 1234566778999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=285.93 Aligned_cols=242 Identities=19% Similarity=0.341 Sum_probs=192.9
Q ss_pred HHhHhCccceeEEEEEE-EcCCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 340 SAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEV---VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
..++||+|.|+.||+.. ...|+.+|+|++... ..+.+++++|+.+...+ +|||||+|...+.+....|+|+|+|.
T Consensus 15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~~~~~ylvFe~m~ 93 (355)
T KOG0033|consen 15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVT 93 (355)
T ss_pred HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcccceeEEEEeccc
Confidence 45789999999999987 456899999988654 33567899999999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---CCCeEEcccCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGCISDFGLTPLMNT 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~ 492 (632)
||+|..-+-.. .-.++...-....|++.+|.|+|.. +|||||+||+|+|+-. .--+|++|||+|..++.
T Consensus 94 G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 94 GGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred chHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99997655432 2355666778899999999999998 9999999999999953 35689999999998874
Q ss_pred CCCC---CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 493 PTVP---SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 493 ~~~~---~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
.... .||++|||||++...+|+..+|||+.|||||-|+.|..||++.+..+. ...+. ...+|-...
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl------ye~I~-----~g~yd~~~~ 234 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL------YEQIK-----AGAYDYPSP 234 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH------HHHHh-----ccccCCCCc
Confidence 4333 589999999999999999999999999999999999999987443221 11111 112222222
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.+....++ ..+|+++++..||++|.|+.|.++
T Consensus 235 ~w~~is~~---Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 235 EWDTVTPE---AKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccCcCCHH---HHHHHHHHhccChhhhccHHHHhC
Confidence 33344444 446677999999999999998654
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.64 Aligned_cols=241 Identities=21% Similarity=0.296 Sum_probs=185.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++.. .+++.||+|++.+.. .....+.+|++++.++ +|+||+++++.+.+.+..++||||++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQDKDNLYFVMDYIP 84 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCEEEEEEeCCC
Confidence 35799999999999985 458899999997542 1235678899999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 85 GGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999997542 467778888999999999999998 999999999999999999999999999753210
Q ss_pred --------------------------------------------CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHH
Q 006747 493 --------------------------------------------PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLE 528 (632)
Q Consensus 493 --------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~e 528 (632)
.....||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 011247889999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 006747 529 MLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRP---TMEEVVRM 605 (632)
Q Consensus 529 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP---s~~evl~~ 605 (632)
|++|+.||......+ ...... . +.... ......... ..+.+++.+|+ .+|.+|+ ++.+++++
T Consensus 237 ll~G~~Pf~~~~~~~------~~~~i~-~-~~~~~---~~~~~~~~s---~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAE------TQLKVI-N-WETTL---HIPSQAKLS---REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHH------HHHHHh-c-cCccc---cCCCCCCCC---HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999997543211 111111 0 00000 000011112 23445555665 4999999 88998875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=308.52 Aligned_cols=240 Identities=26% Similarity=0.395 Sum_probs=197.4
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||.|+||.||.|.. .+...||||++.-.... -.++..|+.+|.++ +|||++.+.|+|......|+|||||-
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre~TaWLVMEYCl 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLREHTAWLVMEYCL 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeeccchHHHHHHHHh
Confidence 46799999999999984 45789999999754221 35789999999999 99999999999999999999999995
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 495 (632)
|+-.+++.-. +.|+....+..|..+++.||+|||+. +.||||||+.|||+++.|.||++|||.|..+.....
T Consensus 110 -GSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAns 181 (948)
T KOG0577|consen 110 -GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANS 181 (948)
T ss_pred -ccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchhc
Confidence 4778877643 34788889999999999999999999 999999999999999999999999999999999988
Q ss_pred CCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 496 PSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 496 ~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
..||+.|||||+|. .+.|+-|+||||+|++..||.-.++|+..+.... -...+...+. +.+
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------ALYHIAQNes------PtL---- 245 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNES------PTL---- 245 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------HHHHHHhcCC------CCC----
Confidence 99999999999986 4679999999999999999999999975432111 1111111111 111
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...+....+..++..|+++-|.+|||.++++++
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 123445567788889999999999999987654
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=306.23 Aligned_cols=192 Identities=25% Similarity=0.364 Sum_probs=161.0
Q ss_pred HhHhCcc--ceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKG--SYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G--~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.++||+| +|++||++.. .+|+.||+|+++..... .+.+.+|++++..+ +||||++++++|..++..++||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEECCEEEEEEecc
Confidence 3679999 7899999985 56899999999765322 24577788889888 9999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC--
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT-- 492 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~-- 492 (632)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.++++||+.......
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999986532 22478999999999999999999998 999999999999999999999999986533211
Q ss_pred ---------CCCCCCCCcccCCccccC--CCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 493 ---------PTVPSRSAGYRAPEVIET--KKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 493 ---------~~~~~~t~~y~aPE~~~~--~~~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 111235567999999976 45899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=300.21 Aligned_cols=243 Identities=20% Similarity=0.330 Sum_probs=190.4
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
..+.||+|+||.||+|... ++..+++|.+.... ...+.+.+|++++..+ +|+||+++++++...+..++|+||+++|
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 4577999999999999965 46788999886543 2245688899999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|..++.... .++++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 88 ~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 88 AVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 9998876432 3589999999999999999999998 9999999999999999999999999998665322
Q ss_pred CCCCCCCcccCCcccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 494 TVPSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~-----~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
....++..|+|||++. +..++.++|||||||++|||++|+.||...... ..+........ . ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~-~-----~~ 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEP-P-----TL 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcCC-C-----CC
Confidence 2234778899999984 345788999999999999999999998643211 11111111100 0 00
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.... .....+.+++.+||+.+|.+||++.+++++
T Consensus 229 ~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 AQPS---RWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 112356788889999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.10 Aligned_cols=251 Identities=19% Similarity=0.227 Sum_probs=187.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||++... .++.||||.... ..+.+|++++.++ +|+|||++++++...+..++||||+. ++|
T Consensus 174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L-~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L 246 (461)
T PHA03211 174 HRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRL-SHPAVLALLDVRVVGGLTCLVLPKYR-SDL 246 (461)
T ss_pred EEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEEccC-CCH
Confidence 457999999999999965 478899996432 3467899999999 99999999999999999999999995 688
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT----- 494 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~----- 494 (632)
..++.... .+++|..+..|+.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 247 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 247 YTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 88876432 3589999999999999999999998 99999999999999999999999999997653321
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC-CCChhHHHHHHhhhccc--cccc------
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED-VVDLPRWVQSVVREEWT--SEVF------ 564 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~------ 564 (632)
...+|..|+|||++.+..++.++|||||||++|||++|..|+....... .......+...+..... .+..
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 2347889999999999999999999999999999999887654322111 11111111111111000 0000
Q ss_pred -------------ccccc--ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 565 -------------DVELM--RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 565 -------------d~~~~--~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.+... .+.........+.+|+.+||+.||++|||+.|++++
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 000000111246778999999999999999999875
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.05 Aligned_cols=239 Identities=25% Similarity=0.368 Sum_probs=192.8
Q ss_pred HhCccceeEEEEEEEcC-CcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 343 VLGKGSYGTTYKAILEE-GTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
+||+|.||+||.|+..+ ...+|||.+.... ....-...|+.+-+++ +|+|||+++|.+.+++..-|.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 79999999999999554 5679999997553 2334577888888888 9999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-CCCeEEcccCCCCCCCCC----CC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-DLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~----~~ 495 (632)
++|+..- +...=++.+.-.+..||++||.|||+. .|||||||-+|||++. .|.+||+|||-++.+..- .+
T Consensus 661 sLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 9998654 222226777888999999999999998 9999999999999964 799999999999887543 23
Q ss_pred CCCCCcccCCccccCCC--CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc--c
Q 006747 496 PSRSAGYRAPEVIETKK--PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR--Y 571 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~--~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~ 571 (632)
..||.-|||||++..++ |...+|||||||++.||.||++||...+... ..++...+.. +
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-----------------AAMFkVGmyKvHP 798 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-----------------AAMFKVGMYKVHP 798 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-----------------HhhhhhcceecCC
Confidence 45888999999998665 8999999999999999999999997544221 1122222221 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.-+++-..+...++.+|+.+||.+||+++++++
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 223344456777899999999999999999986
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=299.46 Aligned_cols=239 Identities=24% Similarity=0.378 Sum_probs=192.9
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
..+.||+|+||.||+|... ++..||+|.++.... ..+.+..|++++.++ +|+||+++++++......++||||+++
T Consensus 8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06642 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhcccccCCceEEEEEccCC
Confidence 3567999999999999854 578899999875432 235688999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
++|.+++... ++++.....++.+++.|++|||+. +++|+||+|+||++++++.+|++|||++.......
T Consensus 87 ~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 87 GSALDLLKPG------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchh
Confidence 9999988642 478899999999999999999988 99999999999999999999999999997664332
Q ss_pred --CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 495 --VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
...++..|+|||.+.+..++.++|||||||++|||+||+.|+........ .. ....... +.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~-~~~~~~~-----~~~---- 221 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF-LIPKNSP-----PTL---- 221 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh-hhhcCCC-----CCC----
Confidence 12467789999999988899999999999999999999999864321110 00 0111100 000
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.......+.+++.+||+.+|++||++.+++++
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 -EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11223457788899999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.33 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=186.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC------ceEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD------EKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv 410 (632)
.+.||+|+||.||++.. .+|..||+|++.... .....+.+|+.++..+ +||||+++++++...+ ..++|
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccccceeEEE
Confidence 46799999999999985 458899999997542 2245678899999999 8999999999987543 46999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
|||+++ +|...++. .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 105 MELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred EeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 999976 56665542 267788889999999999999998 9999999999999999999999999999765
Q ss_pred CCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC------------ChhH----HH
Q 006747 491 NTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV------------DLPR----WV 551 (632)
Q Consensus 491 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~------------~~~~----~~ 551 (632)
... ....+|..|+|||.+.+..++.++|||||||++|||+||+.||.+....+.. .... .+
T Consensus 174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 432 2235788899999999999999999999999999999999999754321100 0000 00
Q ss_pred HHHhhhcc--cccccccccccc------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 552 QSVVREEW--TSEVFDVELMRY------ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 552 ~~~~~~~~--~~~~~d~~~~~~------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
........ ....+......+ .........+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 000000000000 0000112456788999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=311.26 Aligned_cols=182 Identities=23% Similarity=0.338 Sum_probs=156.4
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||+|... ++..||+|..... ....|+.++.++ +|+||+++++++......++|+||+. |+|
T Consensus 71 ~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 143 (357)
T PHA03209 71 IKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNV-NHPSVIRMKDTLVSGAITCMVLPHYS-SDL 143 (357)
T ss_pred EEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhC-CCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence 467999999999999965 4678999975432 235688899999 99999999999999999999999995 588
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---CCC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---TVP 496 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---~~~ 496 (632)
.+++.... .+++|..+..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ...
T Consensus 144 ~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 216 (357)
T PHA03209 144 YTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL 216 (357)
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence 88886532 3589999999999999999999998 9999999999999999999999999999754322 223
Q ss_pred CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCC
Q 006747 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPI 536 (632)
Q Consensus 497 ~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~ 536 (632)
.+|..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 5788899999999999999999999999999999966554
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.40 Aligned_cols=236 Identities=20% Similarity=0.280 Sum_probs=181.4
Q ss_pred hCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhc--CCCCccceeEEEEeCCceEEEEecccC
Q 006747 344 LGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLS--QHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 344 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
||+|+||+||+|... +++.||+|++..... ....+..|.+++.+.. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999854 589999999965321 1223445666666554 799999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|..++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 99999887542 478889999999999999999998 9999999999999999999999999998764321
Q ss_pred -CCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 -TVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....+|..|+|||.+.+.. ++.++|||||||++|||+||+.||..... ........ .+.. .+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~-~~~~------~~~~- 218 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIA-FGKV------RFPK- 218 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHH-cCCC------CCCC-
Confidence 2235788999999987654 79999999999999999999999965321 11111111 1100 0000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC----CHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRP----TMEEVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RP----s~~evl~ 604 (632)
.. ....+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NV---LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cc---CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01 123456788899999999998 4556554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.84 Aligned_cols=255 Identities=19% Similarity=0.302 Sum_probs=189.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC-----ceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-----EKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~ 411 (632)
.+.||+|+||.||++.. .+++.||+|++..... ..+.+.+|++++..+ +|+||+++++++...+ ..++|+
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceEEEEe
Confidence 46799999999999985 4689999999865422 235688999999999 8999999999998776 789999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+. ++|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...
T Consensus 84 e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 84 ELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred eccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9997 5788777543 2588899999999999999999998 99999999999999999999999999997654
Q ss_pred CC-----CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChh---------HHHHHHh-
Q 006747 492 TP-----TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP---------RWVQSVV- 555 (632)
Q Consensus 492 ~~-----~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~---------~~~~~~~- 555 (632)
.. ....++..|+|||.+.+. .++.++|||||||++|||++|+.||.+....+..... .......
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 32 122467789999999875 4789999999999999999999999764322111000 0000000
Q ss_pred --hhccccccccc-cccc-cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 556 --REEWTSEVFDV-ELMR-YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 556 --~~~~~~~~~d~-~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..........+ .... .....+...++.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000000 0000 00001113457788999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=295.03 Aligned_cols=240 Identities=20% Similarity=0.285 Sum_probs=191.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||++.. .+++.||+|.+..... ....+.+|++++.++ +||||+++++++...+..++|+||
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccCCeEEEEEEE
Confidence 46899999999999985 4589999999864421 124688899999999 999999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++++|.+++.... .+++....+++.+++.||+|||+. +|+||||+|+||++++++.+||+|||+++.....
T Consensus 86 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 86 MPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred CCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999987542 477888899999999999999998 9999999999999999999999999998765332
Q ss_pred -------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 -------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 -------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~----- 226 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTNP----- 226 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCCC-----
Confidence 1223567899999999988999999999999999999999998643211 1111111110000
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.........+.+++.+||..+|++|||+.+++++
T Consensus 227 -----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 -----QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0011122356778889999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=303.16 Aligned_cols=238 Identities=24% Similarity=0.383 Sum_probs=192.2
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||.|+||.||+|.. .+++.|++|.+..... ..+.+.+|++++..+ +|+||+++++++...+..++|+||+++++|
T Consensus 25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 5699999999999984 5689999999875433 356788899999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----C
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT----V 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~----~ 495 (632)
..++... .+++..+..++.+++.|++|||+. +++||||||+||++++++.+||+|||++....... .
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 104 TDVVTET------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 9988643 478999999999999999999998 99999999999999999999999999987654332 2
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..++..|+|||.+.+..++.++|||||||++|||++|+.||....... ......... ... + ....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~~~-~~~-----~---~~~~ 239 (296)
T cd06655 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNG-TPE-----L---QNPE 239 (296)
T ss_pred cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-Ccc-----c---CCcc
Confidence 246778999999998889999999999999999999999996532111 111111000 000 0 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.....+.+++.+||..+|++|||+.++++
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 12235667888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.63 Aligned_cols=239 Identities=23% Similarity=0.366 Sum_probs=192.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||++.. .+++.||+|.+..... ..+.+.+|+.++..+ +|+||+++++++...+..++||||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 46799999999999985 5689999999975433 345678899999998 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 494 (632)
|.+++... .+++..+..++.+++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 103 L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 103 LTDVVTET------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred HHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 99998643 378889999999999999999998 99999999999999999999999999987654322
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.......... .....+ . +. ....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~-~-----~~---~~~~ 238 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-T-----PE---LQNP 238 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCC-C-----CC---CCCc
Confidence 2346778999999998889999999999999999999999996533211100 000000 0 00 0011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
......+.+++.+||+.+|++||+++++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112234667888999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=296.38 Aligned_cols=246 Identities=22% Similarity=0.377 Sum_probs=195.8
Q ss_pred HhHhCccceeEEEEEEEcC-Cc----EEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILEE-GT----TVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|...+ |. .||+|.++.... ....+.+|++.+.++ +|+||+++++++.. ...++||||
T Consensus 12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~ 89 (279)
T cd05057 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS-SQVQLITQL 89 (279)
T ss_pred cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec-CceEEEEec
Confidence 4689999999999998543 32 589998876533 235788999999999 89999999999987 788999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++.... ..+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 90 MPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred CCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999997643 2488999999999999999999997 9999999999999999999999999999876533
Q ss_pred CCC------CCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 TVP------SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ~~~------~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
... ..+..|+|||.+....++.++|||||||++||+++ |+.||..... .++... ......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~-~~~~~~------ 229 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIPDL-LEKGER------ 229 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHH-HhCCCC------
Confidence 211 12456999999988889999999999999999999 9999865321 111111 111110
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
. .........+.+++.+||..+|++||++.++++.|+++...
T Consensus 230 -~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 -L---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred -C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 0 00011223567888999999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=282.46 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=196.4
Q ss_pred CCCcCCCHHHHHHHHHhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEE
Q 006747 326 GCSYNFDLEDLLRASAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYF 402 (632)
Q Consensus 326 ~~~~~~~~~~l~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 402 (632)
+..+..++.|+. ....||.|+.|.|++.+.. .|..+|||.+....- +.+.+...+.++.+-.+.|+||+.+|||.
T Consensus 84 g~r~~~dindl~--~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 84 GQRYQADINDLE--NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred CcccccChHHhh--hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 445566777774 3567999999999999865 488999999986532 23456667777766645799999999999
Q ss_pred eCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEc
Q 006747 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS 482 (632)
Q Consensus 403 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 482 (632)
.+...++.||.|.- .+..++...+ .++++...-++...+.+||.||.+++ +|+|||+||+|||+|+.|++|+|
T Consensus 162 ~n~dV~IcMelMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 162 TNTDVFICMELMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred eCchHHHHHHHHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEee
Confidence 99999999999965 5555665432 35777777889999999999999885 99999999999999999999999
Q ss_pred ccCCCCCCCCCCC---CCCCCcccCCccccC---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 006747 483 DFGLTPLMNTPTV---PSRSAGYRAPEVIET---KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR 556 (632)
Q Consensus 483 DfGla~~~~~~~~---~~~t~~y~aPE~~~~---~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 556 (632)
|||++-++..+.. ..|-+.|||||.+.- ..|+-++||||||++|+||.||..||.+...+- +.+...+.
T Consensus 235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln 309 (391)
T KOG0983|consen 235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLN 309 (391)
T ss_pred cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHh
Confidence 9999988765543 345566999999964 458999999999999999999999998743221 11222222
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
++- +.+..... ....+.++...|+++|+.+||...+++++
T Consensus 310 ~eP------P~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 EEP------PLLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cCC------CCCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 211 11111111 23457788889999999999999987763
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=300.63 Aligned_cols=247 Identities=24% Similarity=0.399 Sum_probs=189.8
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe-----CCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS-----KDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-----~~~~~lv~E~~ 414 (632)
.+.||+|+||.||++.. .+++.+|+|+++........+..|++++.++.+|+||+++++++.. .+..++||||+
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence 35799999999999985 4578999999875444456788899999998679999999998853 34689999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 493 (632)
++|+|.++++.... ....+++.....++.+++.||.|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 103 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 178 (286)
T cd06638 103 NGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 178 (286)
T ss_pred CCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence 99999998764321 223578888999999999999999998 9999999999999999999999999998765432
Q ss_pred ---CCCCCCCcccCCccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIET-----KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~-----~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
....++..|+|||++.. ..++.++|||||||++|||++|+.||........ .... .........+
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------~~~~-~~~~~~~~~~ 251 (286)
T cd06638 179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------LFKI-PRNPPPTLHQ 251 (286)
T ss_pred CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------Hhhc-cccCCCcccC
Confidence 22347888999999853 4478899999999999999999999864321110 0000 0000000000
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
+ . .....+.+++.+||+.+|++|||+.|++++.
T Consensus 252 ~-----~---~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 252 P-----E---LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred C-----C---CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 0 1123577889999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=305.14 Aligned_cols=192 Identities=22% Similarity=0.398 Sum_probs=157.5
Q ss_pred hHhCccceeEEEEEEEc---CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe--CCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE---EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS--KDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~E~~~~ 416 (632)
..||+|+||.||+|... ++..||+|.+..... ...+.+|++++.++ +||||+++++++.. ....++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 47999999999999865 357899999875432 34678899999999 89999999999864 4567899999875
Q ss_pred CCHhhhhccCCC----CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee----cCCCCeEEcccCCCC
Q 006747 417 GSFSALLHGNRG----IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL----SQDLQGCISDFGLTP 488 (632)
Q Consensus 417 g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl----~~~~~~ki~DfGla~ 488 (632)
+|.+++..... .....+++.....++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 77777643211 1223588899999999999999999998 99999999999999 567899999999998
Q ss_pred CCCCCC-------CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 489 LMNTPT-------VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 489 ~~~~~~-------~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
...... ...+|..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 764321 22467889999998764 4799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=303.02 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=186.4
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhc--CCCCccceeEEEEeC-----CceEEE
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLS--QHPNVVPIRAYYFSK-----DEKLLV 410 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~-----~~~~lv 410 (632)
+.||+|+||.||+|... +++.||+|.++.... ....+.+|++++.++. +||||+++++++... ...++|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 57999999999999854 588999999875422 2345667777776653 699999999988652 357899
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
|||+++ +|.+++.... ...+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 86 ~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 86 FEHVDQ-DLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred Eccccc-CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 999985 8888886542 23488999999999999999999998 9999999999999999999999999999876
Q ss_pred CCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH---hhhccccc--
Q 006747 491 NTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV---VREEWTSE-- 562 (632)
Q Consensus 491 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~-- 562 (632)
... ....++..|+|||++.+..++.++|||||||++|||++|+.||......+. +....... ....+...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChhhCccccc
Confidence 533 223467889999999988999999999999999999999999865322111 11100000 00001000
Q ss_pred ----ccccccccc--CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 563 ----VFDVELMRY--ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 563 ----~~d~~~~~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.+.+..... ....+....+.+++.+|++.||++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 000112234678899999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=299.54 Aligned_cols=247 Identities=22% Similarity=0.388 Sum_probs=193.3
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
..+.||+|+||.||++... ++..||+|.++..... ...+.+|++++.++ +|+||+++++++...+..++||||+++
T Consensus 5 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheecCCeEEEEEeecCC
Confidence 3578999999999999865 6899999998754222 35688999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--C
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--T 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~ 494 (632)
++|..+++... ....+++.....++.+++.||.|||+.. +|+||||||+||+++.++.+||+|||++...... .
T Consensus 84 ~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 84 GSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred CCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 99999887532 1235899999999999999999999642 8999999999999999999999999998765332 2
Q ss_pred CCCCCCcccCCccccCCC------CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 495 VPSRSAGYRAPEVIETKK------PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~------~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
...++.+|+|||.+.+.. ++.++|||||||++|||++|+.||....... ......... .....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~-~~~~~------- 228 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIV-DGDPP------- 228 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHh-hcCCC-------
Confidence 234677899999986543 4889999999999999999999996432111 111111111 11000
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....+....+.+++.+||+.+|++||++.+++.+
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 ---TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111233557788899999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.47 Aligned_cols=251 Identities=16% Similarity=0.238 Sum_probs=188.8
Q ss_pred HhHhCccceeEEEEEEEc---CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE---EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||++... .+..||+|.+... +...+|++++.++ +|||||++++++......++||||+. +
T Consensus 97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 170 (392)
T PHA03207 97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTI-SHRAIINLIHAYRWKSTVCMVMPKYK-C 170 (392)
T ss_pred EEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhc-CCCCccceeeeEeeCCEEEEEehhcC-C
Confidence 467999999999999753 3578999988643 3456899999999 89999999999999999999999996 5
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++... .++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 171 DLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 888888432 3588999999999999999999998 99999999999999999999999999997654322
Q ss_pred ---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---ccc-------
Q 006747 495 ---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE---WTS------- 561 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~------- 561 (632)
...+|..|+|||++.+..++.++|||||||++|||++|+.||.+............+....... ...
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 322 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC 322 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence 2357889999999999999999999999999999999999997644322111111111000000 000
Q ss_pred -------ccccccccccCCc--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 562 -------EVFDVELMRYENI--EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 562 -------~~~d~~~~~~~~~--~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....+........ .....++.+++.+|+..||++|||+.|++.+
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 0012346678889999999999999999875
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.42 Aligned_cols=239 Identities=24% Similarity=0.363 Sum_probs=193.9
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
..+.||+|+||.||+|... ++..||+|.++.... ....+..|++++.++ +|+||+++++++.+....++||||+++
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEecCCC
Confidence 3467999999999999864 588999999875432 245688899999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|+|.+++... ++++.....++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 87 ~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06640 87 GSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccc
Confidence 9999998643 377888899999999999999988 99999999999999999999999999986654322
Q ss_pred --CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 495 --VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
...++..|+|||.+.+..++.++|||||||++|||+||+.||........ ... ..... ...
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~-~~~~~----------~~~ 220 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------LFL-IPKNN----------PPT 220 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------hhh-hhcCC----------CCC
Confidence 22467789999999988899999999999999999999999865321111 000 00000 011
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
........+.+++.+||+.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 122344567789999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=307.15 Aligned_cols=242 Identities=20% Similarity=0.345 Sum_probs=199.5
Q ss_pred HhHhCccceeEEEEEEEcC-CcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|.||.||++..+. |+.+|+|.+.+... ....+.+|+++|.++..|||||.+.+.|.+....++|||++.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 3689999999999999665 99999999976633 346899999999999669999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC----CCeEEcccCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD----LQGCISDFGLTPLMN 491 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~----~~~ki~DfGla~~~~ 491 (632)
||.|.+.+... .+++.....++.+++.+++|||+. +|+||||||+|+|+... +.+|++|||++....
T Consensus 120 GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 120 GGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred CchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999998765 278889999999999999999998 99999999999999643 579999999998877
Q ss_pred CC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 492 TP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 492 ~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
.. ....||+.|+|||++....|+..+||||.||++|.|++|..||.+........ .+....+ +-.
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~-----~f~- 258 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF-----DFT- 258 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-----CCC-
Confidence 62 34579999999999999999999999999999999999999998754322211 1111111 101
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..........+-+++..|+..||.+|+|+.+++++
T Consensus 259 --~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 259 --SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11122223456677889999999999999999994
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=299.66 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=194.7
Q ss_pred HhHhCccceeEEEEEEEcC----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|...+ ...||+|....... ..+.+.+|++++.++ +|+||+++++++.. +..++||||+
T Consensus 11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC-CCcEEEEEcC
Confidence 4679999999999998643 24689998875432 245789999999999 89999999998875 5678999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.+++.... ..+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 89 PLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999997542 2488999999999999999999987 99999999999999999999999999987654332
Q ss_pred -----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 495 -----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 495 -----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
...++..|+|||.+.+..++.++|||||||++||+++ |+.||......+. ..........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~-------- 227 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV------IGRIENGERL-------- 227 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHcCCcC--------
Confidence 1123457999999988889999999999999999996 9999965432111 1111111100
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
... ......+.+++.+|+..+|++|||+.++++.|+++...
T Consensus 228 ~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 PMP---PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011 11234577888899999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=300.33 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=190.9
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC-----ceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-----EKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~E~~~ 415 (632)
+.||+|+||.||++.. .+++.+|+|++.........+.+|+.++.++.+|||++++++++...+ ..++||||++
T Consensus 28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~ 107 (291)
T cd06639 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCN 107 (291)
T ss_pred EEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECC
Confidence 5799999999999986 468899999987654445678889999999878999999999987643 5799999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.++++.... ....+++..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 108 ~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 183 (291)
T cd06639 108 GGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183 (291)
T ss_pred CCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcccccc
Confidence 9999998864321 223588999999999999999999998 99999999999999999999999999987654322
Q ss_pred ---CCCCCCcccCCccccCCC-----CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKK-----PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~-----~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
...++..|+|||.+.... ++.++|||||||++|||++|+.||....... -+.... ......+
T Consensus 184 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~------~~~~~~-~~~~~~~--- 253 (291)
T cd06639 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK------TLFKIP-RNPPPTL--- 253 (291)
T ss_pred cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH------HHHHHh-cCCCCCC---
Confidence 234677899999986543 6889999999999999999999986432111 011111 0000001
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....+....+.+++.+||+.+|++||++.|++++
T Consensus 254 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 -----LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111223457788999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=299.91 Aligned_cols=243 Identities=28% Similarity=0.488 Sum_probs=191.1
Q ss_pred hHhCccceeEEEEEEEcC-CcEEEEEEecccccCHH---HHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKR---EFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~---~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||+||++.... ++.||+|++........ ....|++++.++ +|+||+++++++......++||||++++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 5 KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccccccccccccccccc
Confidence 579999999999999654 56899999987643322 335589999999 9999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC----CC
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN----TP 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~----~~ 493 (632)
+|.+++... ..+++..+..++.++++||+|||+. +|+|+||||+||++++++.++|+|||.+.... ..
T Consensus 84 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~ 155 (260)
T PF00069_consen 84 SLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF 155 (260)
T ss_dssp BHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred ccccccccc-----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence 999999832 2488999999999999999999998 99999999999999999999999999986531 12
Q ss_pred CCCCCCCcccCCcccc-CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 TVPSRSAGYRAPEVIE-TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~-~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....++..|+|||.+. +..++.++||||+|+++|||++|+.||......+ ............. .... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~~-----~~~~---~ 224 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD---QLEIIEKILKRPL-----PSSS---Q 224 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH---HHHHHHHHHHTHH-----HHHT---T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchh---hhhhhhhcccccc-----cccc---c
Confidence 2345778899999998 7888999999999999999999999997541001 1111111110000 0000 0
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
........+.+++.+||+.||++|||+.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011256788899999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=299.70 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=193.0
Q ss_pred HhHhCccceeEEEEEEEc-CCc----EEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGT----TVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|... ++. .||+|.+...... ..++.+|+.++.++ +||||++++++|... ..++++||
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC-Cceeeehh
Confidence 467999999999999853 343 4788888654322 34688899999999 899999999998754 46799999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 90 MPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999987542 2478899999999999999999998 9999999999999999999999999999865432
Q ss_pred CC------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 TV------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ~~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
.. ..++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.... ....+ .......
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~~~----- 230 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDL----LEKGERL----- 230 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHCCCCC-----
Confidence 21 223567999999998889999999999999999998 89998643211 11111 1111100
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
... ......+.+++.+||..+|++||+++++++.|+++....
T Consensus 231 --~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 231 --PQP---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred --CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 000 112245778899999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=294.45 Aligned_cols=249 Identities=20% Similarity=0.362 Sum_probs=193.6
Q ss_pred HhHhCccceeEEEEEEEcC--CcEEEEEEecccc-----------cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCce
Q 006747 341 AEVLGKGSYGTTYKAILEE--GTTVVVKRLKEVV-----------MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEK 407 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~-----------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~ 407 (632)
.+.||+|+||.||+|.... +..+|+|.+.... ....++..|++++.+..+|+||+++++++...+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 4679999999999999765 6889999885321 11234667888777644899999999999999999
Q ss_pred EEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 408 LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 408 ~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
++||||+++++|.+++..... ....+++..+.+++.+++.||.|||+. .+++|+||+|+||++++++.+||+|||++
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccce
Confidence 999999999999998754221 223588899999999999999999963 17999999999999999999999999999
Q ss_pred CCCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 488 PLMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 488 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
...... ....++..|+|||.+.+..++.++||||||+++|||++|+.||.... .............. ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~~~~~~-~~- 233 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKIVEAVYE-PL- 233 (269)
T ss_pred eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHHhhccCC-cC-
Confidence 776543 23346778999999998889999999999999999999999986421 11122221111110 00
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.. ......+.+++.+||+.||++||++.|+..++++
T Consensus 234 -----~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 234 -----PE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -----Cc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 00 0122457788889999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.40 Aligned_cols=242 Identities=19% Similarity=0.269 Sum_probs=186.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... +++.||+|++.... .....+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (371)
T cd05622 48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMP 126 (371)
T ss_pred EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCC
Confidence 467999999999999865 57899999986532 1234577888888888 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++... .++......++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 127 gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 127 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 99999998653 267777888999999999999998 9999999999999999999999999999765432
Q ss_pred ---CCCCCCCcccCCccccCCC----CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETKK----PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~----~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+........
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~~---- 267 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSLT---- 267 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCccc----
Confidence 2345889999999987543 78999999999999999999999975321 111112111110000
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDM--RPTMEEVVRMI 606 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~L 606 (632)
..... .....+.+++..|++..+.+ ||++.|++++.
T Consensus 268 -~~~~~---~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 -FPDDN---DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -CCCcC---CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 00111 12234567778999844433 78999988854
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=311.91 Aligned_cols=240 Identities=22% Similarity=0.382 Sum_probs=192.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccc---cc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc--eEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEV---VM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE--KLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~--~~lv~E 412 (632)
..+||+|+|-+||||... +|..||--.++.. .. ..+.|..|+++|+.| +|+|||+++.+|.+... .-+|+|
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCceeeeeee
Confidence 357999999999999854 4778876554432 12 236799999999999 99999999999998665 778999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeEEcccCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGCISDFGLTPLMN 491 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~ 491 (632)
.|..|+|+.|+++.+. ++.....+|+.||++||.|||++ .|+|||||||.+||+|+.+ |.+||+|.|||..+.
T Consensus 124 L~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999987653 66778899999999999999997 7899999999999999875 899999999998876
Q ss_pred CCCC--CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 492 TPTV--PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 492 ~~~~--~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
.... ..||+.|||||.+. ..|++.+||||||++|+||+|+..||..... +..+...+..+.....+.
T Consensus 198 ~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~---- 266 (632)
T KOG0584|consen 198 KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALS---- 266 (632)
T ss_pred ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhh----
Confidence 5543 46999999999987 7899999999999999999999999965321 222333333332222111
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..+ ..++.+|+.+|+.. .++|||+.|+++
T Consensus 267 kV~-----dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 KVK-----DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ccC-----CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111 12466788899999 999999999987
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=295.19 Aligned_cols=244 Identities=20% Similarity=0.311 Sum_probs=190.6
Q ss_pred HHhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 340 SAEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
..+.||+|+||.||+|.. .+++.||+|.++.... ....+.+|+.++..+ +||||+++++++...+..++|+||++++
T Consensus 13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 91 (267)
T cd06645 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLRRDKLWICMEFCGGG 91 (267)
T ss_pred HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence 457899999999999985 4588999999875432 234578899999999 9999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++.... .+++.....++.+++.|++|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 92 ~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 92 SLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 9999986542 478899999999999999999998 9999999999999999999999999998655322
Q ss_pred CCCCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 TVPSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
....++..|+|||.+. ...++.++|||||||++|||++|+.||........ +.......... +....
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~------~~~~~~~~~~~----~~~~~ 233 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LFLMTKSNFQP----PKLKD 233 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh------HHhhhccCCCC----Ccccc
Confidence 2235788899999874 45578999999999999999999999864321110 00000010000 00000
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. .....+.+++.+|++.+|++||++++++++
T Consensus 234 ~~---~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 KM---KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cC---CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00 112346788899999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=291.68 Aligned_cols=241 Identities=25% Similarity=0.432 Sum_probs=192.2
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||++.. .+..||+|.++.. .....+.+|+.++.++ +||||+++++++... ..++||||+++|+|.
T Consensus 11 ~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~ 86 (254)
T cd05083 11 GEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKL-HHKNLVRLLGVILHN-GLYIVMELMSKGNLV 86 (254)
T ss_pred eeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence 46899999999999975 5788999998653 2356788999999999 999999999998654 579999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-CCCCCC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-TVPSRS 499 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~~~~~t 499 (632)
+++.... ...+++..+.+++.+++.|++|||+. +++||||||+||+++.++.+||+|||+++..... .....+
T Consensus 87 ~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (254)
T cd05083 87 NFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160 (254)
T ss_pred HHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence 9997542 23578899999999999999999987 9999999999999999999999999998765432 122345
Q ss_pred CcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHH
Q 006747 500 AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEM 578 (632)
Q Consensus 500 ~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 578 (632)
..|+|||.+.+..++.++|||||||++|||++ |+.||..... ...... ....... .......
T Consensus 161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~-~~~~~~~----------~~~~~~~ 223 (254)
T cd05083 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKEC-VEKGYRM----------EPPEGCP 223 (254)
T ss_pred ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHH-HhCCCCC----------CCCCcCC
Confidence 57999999998889999999999999999998 9999865321 111111 1111110 0011123
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 579 VQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 579 ~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
..+.+++.+||+.+|++||++++++..|++
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 456788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=296.04 Aligned_cols=240 Identities=24% Similarity=0.361 Sum_probs=190.7
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccC-------HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG-------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|...+++.+|+|.++..... ...+.+|++++.++ +|+||+++++++.+.+..++||||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecCCeEEEEEec
Confidence 4679999999999999888999999998743211 24578899999999 899999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++++|.+++.... ++++.....++.+++.||+|||+. +|+|+||+|+||++++++.+||+|||++......
T Consensus 84 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 84 VPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999997532 477888889999999999999988 8999999999999999999999999998754211
Q ss_pred ----------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 494 ----------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 494 ----------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
....++..|+|||.+.+..++.++|||||||++|||++|+.||....... .. .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~--- 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----AM-FYIGAHRGL--- 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----HH-HHhhhccCC---
Confidence 12246778999999998889999999999999999999999996432111 00 000000000
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.+.. .......+.+++.+||+.+|++||++.++++
T Consensus 227 -~~~~-----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -MPRL-----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCC-----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011 0112245677888999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.37 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=188.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 410 (632)
.+.||+|+||.||+|.. .++..||||++..... ..+.+.+|++++.++ +|+||+++++++... ...+++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 98 (343)
T cd07878 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIENFNEVYLV 98 (343)
T ss_pred heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccccCcEEEE
Confidence 46899999999999985 4678999999875422 235577899999999 899999999987643 356899
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
+|++ +++|.+++... .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 99 ~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 99 TNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred eecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceec
Confidence 9998 77998887542 388899999999999999999998 9999999999999999999999999999876
Q ss_pred CCC-CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH----------Hhhhc
Q 006747 491 NTP-TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQS----------VVREE 558 (632)
Q Consensus 491 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~~ 558 (632)
... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+. +..+... .+...
T Consensus 169 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07878 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVGTPSPEVLKKISSE 246 (343)
T ss_pred CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhcchh
Confidence 543 23357888999999877 4689999999999999999999999965321110 0000000 00000
Q ss_pred cccccccccccccC--Cc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhh
Q 006747 559 WTSEVFDVELMRYE--NI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDI 609 (632)
Q Consensus 559 ~~~~~~d~~~~~~~--~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i 609 (632)
....... .+.... .. ......+.+++.+|++.||++|||+.|++++ +...
T Consensus 247 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 247 HARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0000000 000000 00 0011246788999999999999999999975 4443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=298.08 Aligned_cols=242 Identities=20% Similarity=0.326 Sum_probs=189.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++.++ +|+||+++++++..+...++||||+++++
T Consensus 17 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 95 (292)
T cd06644 17 IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYWDGKLWIMIEFCPGGA 95 (292)
T ss_pred hheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence 567999999999999965 478999999875432 245688899999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
|..++.... ..+++..+..++.|++.+++|||+. +++||||||+||+++.++.+||+|||++...... .
T Consensus 96 l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 96 VDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 998876432 3488999999999999999999988 9999999999999999999999999998654322 2
Q ss_pred CCCCCCcccCCccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 495 VPSRSAGYRAPEVIET-----KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~-----~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ........... . +..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-~-----~~~- 235 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-P-----PTL- 235 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC-C-----ccC-
Confidence 2346778999999853 3468899999999999999999999864221 11111111110 0 000
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
........++.+++.+||+.+|++||++.+++++
T Consensus 236 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 236 --SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0111122357788899999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=304.22 Aligned_cols=245 Identities=18% Similarity=0.332 Sum_probs=194.3
Q ss_pred HHHHHhHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 337 LRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 337 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+...+.||+||.++||++...+.+.+|+|++.....+ ...|..|++.|.++..|.+||+|++|=..++.+|+||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 34456899999999999999988999999988765433 456999999999999999999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
-+. ||..+|..... ....| .+..+..|++.++.++|++ +|||.||||.|+|+-+ |.+||+|||+|..+..+
T Consensus 442 Gd~-DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 442 GDI-DLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ccc-cHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 754 99999987642 33456 5667899999999999999 9999999999999875 79999999999988776
Q ss_pred CC------CCCCCcccCCccccCCC-----------CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 006747 494 TV------PSRSAGYRAPEVIETKK-----------PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR 556 (632)
Q Consensus 494 ~~------~~~t~~y~aPE~~~~~~-----------~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 556 (632)
++ ..||..||+||.+.... .+.++||||+|||||+|+.|+.||.. +......
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--------~~n~~aK--- 581 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--------IINQIAK--- 581 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--------HHHHHHH---
Confidence 54 36999999999985432 46789999999999999999999953 1111111
Q ss_pred hccccccccccccc-cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 557 EEWTSEVFDVELMR-YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 557 ~~~~~~~~d~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...+.|+.-.. ..... ...+++++|+.||+.||++|||+.+++++
T Consensus 582 ---l~aI~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 ---LHAITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHhhcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12233332110 11111 11238889999999999999999999874
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=298.96 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=191.4
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.++ +|+||+++++++......++||||++++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 57899999999999865 589999999865421 235678999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
.|..+.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07847 86 VLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY 157 (286)
T ss_pred HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence 888876543 2488999999999999999999997 99999999999999999999999999998765433
Q ss_pred -CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh------------hccc
Q 006747 495 -VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR------------EEWT 560 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~ 560 (632)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+.. ........ ..+.
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL---YLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChHHhhhccccccc
Confidence 2235677999999876 45789999999999999999999999754322111 00000000 0000
Q ss_pred cccccccccccCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 561 SEVFDVELMRYENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 561 ~~~~d~~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.....+........ ......+.+++.+||+.+|++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000000000000 1113457789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=299.24 Aligned_cols=242 Identities=24% Similarity=0.403 Sum_probs=189.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe------CCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS------KDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|.. .+++.||+|++........++..|+.++.++.+|+||+++++++.. ....+++|||
T Consensus 21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 46799999999999986 4588999999876544556788899999998789999999999863 3567999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++...+ ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 101 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~ 174 (282)
T cd06636 101 CGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 174 (282)
T ss_pred CCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence 99999999987543 23477888889999999999999998 9999999999999999999999999998765322
Q ss_pred ----CCCCCCCcccCCcccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~-----~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
....++..|+|||.+. ...++.++|||||||++|||++|+.||......... .. ......
T Consensus 175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~~-~~~~~~---- 243 (282)
T cd06636 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------FL-IPRNPP---- 243 (282)
T ss_pred ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------hh-HhhCCC----
Confidence 2234778899999886 345788999999999999999999999643211100 00 000000
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
... ........+.+++.+||+.||.+|||+.|+++
T Consensus 244 -~~~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 244 -PKL----KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -CCC----cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 01112346788899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=287.51 Aligned_cols=249 Identities=20% Similarity=0.311 Sum_probs=197.7
Q ss_pred CCHHHHHHHHHhHhCccceeEEEEEEEcC-CcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCC
Q 006747 331 FDLEDLLRASAEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD 405 (632)
Q Consensus 331 ~~~~~l~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 405 (632)
+.++.+ ...+.||+|.-|+||++.+.+ +..+|+|++.+.... ....+.|.+||..+ +||.++.|++.+++++
T Consensus 74 l~l~~f--~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 74 LGLRHF--RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFETDK 150 (459)
T ss_pred cCHHHH--HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeeccc
Confidence 445544 245789999999999999765 589999999876433 23567788899999 9999999999999999
Q ss_pred ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 406 EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 406 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
..++|||||+||+|..+.+.+. ...++......++.+|..||+|||-. |||.|||||+||||.++|++-++||.
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecc
Confidence 9999999999999999988664 34578888888999999999999998 99999999999999999999999999
Q ss_pred CCCCCCC---------------------------------C-C--------------------------CCCCCCcccCC
Q 006747 486 LTPLMNT---------------------------------P-T--------------------------VPSRSAGYRAP 505 (632)
Q Consensus 486 la~~~~~---------------------------------~-~--------------------------~~~~t~~y~aP 505 (632)
++..... . . .-.||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 8632100 0 0 00256669999
Q ss_pred ccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHH
Q 006747 506 EVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIA 585 (632)
Q Consensus 506 E~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~ 585 (632)
|++.|...+.++|+|+|||++|||+.|+.||.+.+.++.. ..+ +...+ ......+....+.+||
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl------~NI---------v~~~l-~Fp~~~~vs~~akDLI 368 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL------RNI---------VGQPL-KFPEEPEVSSAAKDLI 368 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH------HHH---------hcCCC-cCCCCCcchhHHHHHH
Confidence 9999999999999999999999999999999987654431 111 11111 1111123446678899
Q ss_pred HHccCCCCCCCCC----HHHHHH
Q 006747 586 MSCVAKVPDMRPT----MEEVVR 604 (632)
Q Consensus 586 ~~Cl~~~P~~RPs----~~evl~ 604 (632)
++.|.+||++|.- +.||-+
T Consensus 369 r~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 369 RKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHhccChhhhhccccchHHhhc
Confidence 9999999999998 666654
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.39 Aligned_cols=189 Identities=24% Similarity=0.347 Sum_probs=165.3
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++... +++.||+|+++... .....+..|++++.++ +|+||+++++++.+.+..++||||+++
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 57999999999999864 58899999997532 1234678899999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 86 GDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 99999987542 478888899999999999999998 9999999999999999999999999998654211
Q ss_pred ------------------------------------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCC
Q 006747 494 ------------------------------------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQ 537 (632)
Q Consensus 494 ------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~ 537 (632)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 12347889999999999999999999999999999999999997
Q ss_pred CC
Q 006747 538 AP 539 (632)
Q Consensus 538 ~~ 539 (632)
..
T Consensus 238 ~~ 239 (360)
T cd05627 238 SE 239 (360)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=292.35 Aligned_cols=241 Identities=20% Similarity=0.348 Sum_probs=192.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||++... ++..+|+|.++... ...+.+..|++++.++ +|+||+++.+++.+.+..++||||+++|
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 83 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEADGHLYIVMEYCDGG 83 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence 357999999999999854 58899999986432 2346688899999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++.... ...+++.....++.+++.||.|||+. +|+|+||||+||++++++.++++|||.+.......
T Consensus 84 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 157 (255)
T cd08219 84 DLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157 (255)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccccc
Confidence 9999886532 23478888999999999999999998 99999999999999999999999999987664322
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ........ .......
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~---------- 220 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVC-QGSYKPL---------- 220 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHh-cCCCCCC----------
Confidence 23467789999999988899999999999999999999999964321 11111111 1111000
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.......+.+++.+||+.||++|||+.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122356788899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=309.51 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=187.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 410 (632)
.+.||+|+||.||++... .++.||||++..... ....+.+|+.++..+ +||||+++++++... ...++|
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccccceeEEE
Confidence 467999999999999853 588999999975432 235677899999999 899999999988643 246999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
|||+++ ++.+.+.. .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..
T Consensus 101 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 101 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred hhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 999975 66666542 377888889999999999999998 9999999999999999999999999999876
Q ss_pred CCCC---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhH-------HH
Q 006747 491 NTPT---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD---------LPR-------WV 551 (632)
Q Consensus 491 ~~~~---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~---------~~~-------~~ 551 (632)
.... ...+|..|+|||.+.+..++.++|||||||++|||++|+.||.+....+... .+. .+
T Consensus 170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 5432 2357888999999999899999999999999999999999997543111000 000 00
Q ss_pred HHHhhhcc-cccccccc-----ccc--cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 552 QSVVREEW-TSEVFDVE-----LMR--YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 552 ~~~~~~~~-~~~~~d~~-----~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
........ ......+. ... ..........+.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 11100000 00000000 000 00001123457789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=303.05 Aligned_cols=252 Identities=17% Similarity=0.302 Sum_probs=188.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... ++..||+|.++... .....+.+|++++.++ +|+||+++++++...+..++||||++ +
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~~~~~~lv~e~~~-~ 88 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD-K 88 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEecCCeEEEEEeccc-c
Confidence 357999999999999864 57899999987542 2245677899999999 99999999999999999999999997 5
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|..++.... ..+++.....++.+++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 89 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 89 DLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 8988886542 2478889999999999999999998 99999999999999999999999999987654322
Q ss_pred -CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hccccccccc---
Q 006747 495 -VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR---EEWTSEVFDV--- 566 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~--- 566 (632)
...++..|+|||.+.+. .++.++|||||||++|||+||+.||......+. ......... +.....+.+.
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhccccc
Confidence 23457789999988764 478899999999999999999999975432111 111111000 0000000000
Q ss_pred ---ccccc--CC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 567 ---ELMRY--EN----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 567 ---~~~~~--~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..... .. .......+.+++.+|++.||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00 0011234678899999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=295.23 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=187.9
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
..||+|+||.||+|... ++..||+|.+..... ..+.+.+|++++.++ +|+||+++++++...+..++|+||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 46999999999999854 578899999875432 345788999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcC--CHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-CCCeEEcccCCCCCCCCC---
Q 006747 420 SALLHGNRGIGRTPL--DWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-DLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~--- 493 (632)
.+++.... .++ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++......
T Consensus 93 ~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 93 SALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred HHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 99997542 124 7788889999999999999998 9999999999999986 679999999998765322
Q ss_pred -CCCCCCCcccCCccccCCC--CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 -TVPSRSAGYRAPEVIETKK--PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~--~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
....++..|+|||++.+.. ++.++||||||+++|||++|+.||........ ..+....... .+.+
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~~-------~~~~-- 233 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFKI-------HPEI-- 233 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhcc-------CCCC--
Confidence 1234677899999987644 78899999999999999999999864321110 0110000000 0000
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
......++.+++.+||+.+|++|||+.|++.+
T Consensus 234 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 ---PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11122356778899999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=292.25 Aligned_cols=248 Identities=22% Similarity=0.420 Sum_probs=192.1
Q ss_pred HhHhCccceeEEEEEEEc----CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCC------ce
Q 006747 341 AEVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD------EK 407 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~ 407 (632)
.+.||+|+||.||+|... .++.||+|+++..... .+++.+|++++.++ +||||+++++++...+ ..
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcccce
Confidence 367999999999999853 3688999999764322 45688899999999 8999999999886542 24
Q ss_pred EEEEecccCCCHhhhhccCCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCC
Q 006747 408 LLVYDFIEAGSFSALLHGNRG-IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486 (632)
Q Consensus 408 ~lv~E~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 486 (632)
++++||+++|+|.+++...+. .....+++....+++.+++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 789999999999988753321 1223478889999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 487 TPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 487 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
++...... ...++..|++||.+....++.++|||||||++|||++ |+.||...... .+ .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~---~~~~~~~~~ 233 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EI---YNYLIKGNR 233 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HH---HHHHHcCCc
Confidence 98664321 1224457999999988889999999999999999999 88888643211 11 111111100
Q ss_pred ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 560 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
. .........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 234 ~-----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 L-----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C-----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 00012234688899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=301.17 Aligned_cols=239 Identities=21% Similarity=0.332 Sum_probs=191.3
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
..||+|+||.||++... +++.||+|++.... ...+.+.+|+.++..+ +||||+++++++...+..++|+||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 46999999999999854 68999999986542 2355688899999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 495 (632)
..++... .+++..+..++.+++.||+|||+. +++||||||+||+++.++.+||+|||++...... ..
T Consensus 106 ~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 106 TDIVSQT------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 9987542 378899999999999999999998 9999999999999999999999999998654332 22
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..++..|+|||++.+..++.++|||||||++|||++|+.||......+ .... +...... .......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~-~~~~~~~-----~~~~~~~-- 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKR-LRDSPPP-----KLKNAHK-- 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HhccCCC-----CccccCC--
Confidence 347788999999998889999999999999999999999986432111 1111 1111000 0000111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....+.+++.+||+.+|++||++.+++++
T Consensus 243 -~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 -ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 12346678889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=291.98 Aligned_cols=239 Identities=22% Similarity=0.353 Sum_probs=193.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||.|+||.||+|... +++.||+|.+.... .....+.+|++++.++ +|+||+++++++.+....++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (274)
T cd06609 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKGSKLWIIMEYCGGG 84 (274)
T ss_pred hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEECCeEEEEEEeeCCC
Confidence 467999999999999854 58899999987543 2245688999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++... ++++.....++.|++.|+.|||+. +++||||+|+||++++++.++|+|||+++.....
T Consensus 85 ~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 85 SCLDLLKPG------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred cHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 999998753 588999999999999999999998 9999999999999999999999999999776543
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....++..|+|||.+.+..++.++|||||||++|||+||+.||....... .. ......... .+.. ..
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~-~~~~~~~~~-----~~~~-~~ 222 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VL-FLIPKNNPP-----SLEG-NK 222 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HH-HHhhhcCCC-----CCcc-cc
Confidence 22346778999999999889999999999999999999999996432111 11 111111111 1100 00
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....+.+++.+||..+|++|||+++++++
T Consensus 223 ---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 223 ---FSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ---cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 22356778889999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=294.64 Aligned_cols=255 Identities=20% Similarity=0.343 Sum_probs=188.7
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... ++..||+|+++.... ..+.+.+|++++.++ +||||+++++++..++..++||||++ +
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 57899999999999864 689999999865422 235688899999999 89999999999999999999999997 6
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++.... ....+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 84 DLKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred CHHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 8888886543 124588999999999999999999998 99999999999999999999999999987654321
Q ss_pred -CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhccc--ccc--cc
Q 006747 495 -VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV---REEWT--SEV--FD 565 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~--~d 565 (632)
...++..|+|||.+.+. .++.++|||||||++|||+||+.||......+ .......... ...+. ... ..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 22357789999988654 46889999999999999999999997532111 0000000000 00000 000 00
Q ss_pred cccccc--CC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 566 VELMRY--EN----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 566 ~~~~~~--~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...... .. ......++.+++.+||+.||++|||+.+|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00 00112345688899999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=300.13 Aligned_cols=240 Identities=21% Similarity=0.340 Sum_probs=191.0
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
...||+|+||.||++.. .++..||+|.+..... ..+.+.+|+.++.++ +|+||+++++++...+..++||||+++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 45699999999999985 4588999999865432 345688999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 494 (632)
|.+++... .+++.....++.+++.||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 106 L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~ 176 (292)
T cd06658 106 LTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK 176 (292)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence 99988542 378889999999999999999998 99999999999999999999999999986543221
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.. ..... ...... .
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~-~~~~~-----~~~~~~---~ 241 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL------QAMRR-IRDNL-----PPRVKD---S 241 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhcC-----CCcccc---c
Confidence 234677899999998888999999999999999999999998643211 00111 11110 111101 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
......+.+++.+||..||++|||+++++++
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122346677889999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=288.92 Aligned_cols=242 Identities=22% Similarity=0.354 Sum_probs=195.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||.++. .++..+++|.+.... ...+.+.+|++++.++ +|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMDDNTLLIEMEYANG 83 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEecCCeEEEEEEecCC
Confidence 36799999999999884 458899999986542 2345688999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|+|.+++.... ...+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||+++......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 157 (256)
T cd08221 84 GTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157 (256)
T ss_pred CcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccccc
Confidence 99999997542 23578899999999999999999988 99999999999999999999999999987654432
Q ss_pred --CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 495 --VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.... ...............
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~~~~----------- 220 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN------PLNLVVKIVQGNYTP----------- 220 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCCC-----------
Confidence 2346788999999988888999999999999999999999986422 112222221111100
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
........+.+++.+||+.+|++||++.++++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 0011234577888899999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=308.60 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=187.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 410 (632)
.+.||+|+||.||++... .++.||||++..... ....+.+|+.++..+ +||||+++++++... ...++|
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccccCeEEEE
Confidence 467999999999999854 588999999975422 245678899999999 899999999987643 357999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
|||+++ +|.+.+.. .+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 108 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 108 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred EeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 999975 67766642 267888899999999999999998 9999999999999999999999999999876
Q ss_pred CCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHH-------
Q 006747 491 NTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD---------LPRWV------- 551 (632)
Q Consensus 491 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~---------~~~~~------- 551 (632)
... ....+|..|+|||++.+..++.++|||||||++|||++|+.||......+... .+.+.
T Consensus 177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 543 22357888999999999999999999999999999999999997543211100 00000
Q ss_pred HHHhhhccc------cccccccccc--cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 552 QSVVREEWT------SEVFDVELMR--YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 552 ~~~~~~~~~------~~~~d~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.....+... ...+...... ..........+.+++.+|++.||++|||+.|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 0000000000 00000112457789999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=295.30 Aligned_cols=247 Identities=23% Similarity=0.402 Sum_probs=193.7
Q ss_pred hHhCccceeEEEEEEEc------CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 342 EVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
+.||+|+||.||+|+.+ +...|++|.+...... ...+.+|++++.++ +|+||+++++++...+..++||||
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECCCCcceEEEEe
Confidence 57999999999999854 3467999988754332 35789999999999 999999999999998899999999
Q ss_pred ccCCCHhhhhccCCCCC----CCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 414 IEAGSFSALLHGNRGIG----RTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
+++|+|.++++...... ...+++..+..++.+++.||+|||+. +|+||||||+||++++++.+|++|||+++.
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~ 166 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKD 166 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccc
Confidence 99999999997553211 22589999999999999999999988 999999999999999999999999999875
Q ss_pred CCCCC-----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 490 MNTPT-----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 490 ~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
..... ...++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..+... .......
T Consensus 167 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~~~~~~-~~~~~~~- 238 (275)
T cd05046 167 VYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------EVLNRL-QAGKLEL- 238 (275)
T ss_pred cCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------HHHHHH-HcCCcCC-
Confidence 43221 1224556999999988888999999999999999999 78888543211 111111 1111000
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.........+.+++.+||+.+|++|||+.|+++.|.+
T Consensus 239 --------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 239 --------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 0001122457788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.58 Aligned_cols=243 Identities=21% Similarity=0.355 Sum_probs=191.7
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
..+.||+|+||.||++... ++..||+|.+..... ..+.+..|++++.++ +|+||+++++++......++||||++++
T Consensus 9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd06611 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFYENKLWILIEFCDGG 87 (280)
T ss_pred HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEecCCeEEEEeeccCCC
Confidence 4578999999999999864 588999999875422 235688999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++.... .++++.....++.+++.||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 88 ~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 88 ALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred cHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 9999987532 3588899999999999999999998 9999999999999999999999999998655332
Q ss_pred CCCCCCCcccCCcccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 494 TVPSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~-----~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
....++..|+|||.+. ...++.++|||||||++|||++|+.||...... ....... .... +.+
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~-----~~~ 228 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKIL-KSEP-----PTL 228 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHHh-cCCC-----CCc
Confidence 1234778899999975 344678999999999999999999999653211 1111111 1100 000
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ......+.+++.+||+.+|++||++.+++++
T Consensus 229 ~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 DQP---SKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCc---ccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011 1122356678889999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=288.95 Aligned_cols=241 Identities=23% Similarity=0.369 Sum_probs=191.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC-ceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-EKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... +++.||+|++..... ..+.+.+|++++.++ +|+|++++++.+...+ ..++||||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCCCCEEEEEecccC
Confidence 367999999999999854 478899999875432 245688899999999 8999999999876544 5789999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+++|.+++.... ..++++.....++.+++.|++|||+. +++||||||+||++++++.++|+|||++......
T Consensus 84 ~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 84 GGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 999999997542 23588999999999999999999998 9999999999999999999999999998766432
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....++..|+|||.+.+..++.++|||||||+++||++|+.||.... ......... .+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~-~~~~~~--------- 221 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRII-EGKLPP--------- 221 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHH-hcCCCC---------
Confidence 22346778999999999989999999999999999999999986432 112222211 111100
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
........+.+++.+||+.+|++|||+.+++++
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 -MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 011223457788999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.49 Aligned_cols=241 Identities=24% Similarity=0.374 Sum_probs=191.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +++.||+|++..... ..+++.+|++++.++ +||||+++.++|...+..++||||++
T Consensus 20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 98 (307)
T cd06607 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLREHTAWLVMEYCL 98 (307)
T ss_pred heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeCCeEEEEHHhhC
Confidence 467999999999999864 689999999864322 124688999999999 89999999999999999999999997
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 495 (632)
|++.+++.... .++++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||++........
T Consensus 99 -g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 99 -GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred -CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 57777765332 3588999999999999999999988 999999999999999999999999999987765555
Q ss_pred CCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 496 PSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 496 ~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
..++..|+|||.+. ...++.++||||||+++|||+||+.||..... ........... . +. .
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~~~~-~-----~~----~ 234 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQND-S-----PT----L 234 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHhcCC-C-----CC----C
Confidence 56788899999884 35678999999999999999999999864321 11111111000 0 00 0
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
........+.+++.+||+.+|++||++.+++.+.
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 1112334678889999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=289.31 Aligned_cols=242 Identities=22% Similarity=0.369 Sum_probs=192.9
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|+||.||+|... ++..+++|.+..... ..+.+.+|++++.++ +||||+++++++......+++|||+++++|
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 56999999999999864 578899999875432 356789999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 495 (632)
.+++.... .++++.....++.|++.||+|||+. +++|+||||+||++++++.+||+|||++...... ..
T Consensus 88 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 88 QDIYQVTR----GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99987542 3578899999999999999999998 9999999999999999999999999998765432 22
Q ss_pred CCCCCcccCCccccCC---CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 496 PSRSAGYRAPEVIETK---KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~---~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
..++..|+|||.+.+. .++.++|||||||++|||+||+.||........ ......... ... ...
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~------~~~~~~~~~-----~~~--~~~ 227 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA------LFLISKSNF-----PPP--KLK 227 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccC-----CCc--ccc
Confidence 3467789999999776 789999999999999999999999965321110 000111100 000 001
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
........+.+++.+||+.+|.+|||+.+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11223346788999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.21 Aligned_cols=240 Identities=22% Similarity=0.399 Sum_probs=194.3
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.+|++.. .+++.||+|++..... ..+++.+|+++++++ +|+||+++++++...+..++||||++++
T Consensus 6 ~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 5799999999999985 4688999999875422 245789999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++.... ...+++..+.+++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 158 (256)
T cd08218 85 DLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA 158 (256)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence 9999987542 23478889999999999999999998 99999999999999999999999999997664432
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...++..|+|||.+.+..++.++|||||||+++||+||+.||.... ....+......... ..
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~~~~~~-----------~~ 221 (256)
T cd08218 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKIIRGSYP-----------PV 221 (256)
T ss_pred hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHhcCCCC-----------CC
Confidence 2246778999999998889999999999999999999999986421 12222222211110 01
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.......+.+++.+||+.+|++||++.+|+++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11223457788899999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=290.39 Aligned_cols=238 Identities=24% Similarity=0.374 Sum_probs=190.0
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC----------HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG----------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLL 409 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 409 (632)
...||+|+||.||+|.. .+++.||+|.+...... .+.+.+|++++.++ +||||+++++++...+..++
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCccEE
Confidence 35799999999999985 45789999988654221 14578899999999 99999999999999999999
Q ss_pred EEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 410 VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 410 v~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
||||+++++|.+++... .++++.....++.+++.||+|||+. +++||||+|+||++++++.+||+|||.++.
T Consensus 84 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 84 FLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 99999999999999754 2478888899999999999999988 999999999999999999999999999876
Q ss_pred CCCCC----------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 490 MNTPT----------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 490 ~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
..... ...++..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFKI-GEN- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHHH-hcc-
Confidence 64211 123567899999999888999999999999999999999999753211 111110 010
Q ss_pred ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 560 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..+.. .......+.+++.+||+.||++||++.++++
T Consensus 228 ----~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ----ASPEI-----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----CCCcC-----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00011 1112345677888999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.03 Aligned_cols=244 Identities=19% Similarity=0.252 Sum_probs=186.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+++.. +++.||+|++.+.. .....+.+|..++..+ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~~~~~~lv~Ey~~ 84 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQDENYLYLVMDYYV 84 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 357999999999999864 57889999987532 1234477888888888 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 85 GGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999997532 2478888889999999999999998 99999999999999999999999999987654322
Q ss_pred ----CCCCCCcccCCccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 495 ----VPSRSAGYRAPEVIET-----KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 495 ----~~~~t~~y~aPE~~~~-----~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
...++.+|+|||++.+ +.++.++|||||||++|||++|+.||..... .............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~----- 226 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEER----- 226 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCc-----
Confidence 2358889999999876 4578899999999999999999999964321 1111111111100
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDM--RPTMEEVVRM 605 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~ 605 (632)
........+....+.+++.+|+..++++ |+++++++++
T Consensus 227 --~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 --FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0000111112245667777888765544 5688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=294.25 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=193.1
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~~~~ 416 (632)
+.||.|++|.||++... +++.+|+|.+..... ....+.+|++++.++ +||||++++++|... ...++||||+++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 57899999999999974 578999999875432 246689999999999 899999999998754 368999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
++|.+++..... ....+++.....++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 161 (287)
T cd06621 86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG 161 (287)
T ss_pred CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccccc
Confidence 999988764321 233578888999999999999999998 99999999999999999999999999987654322
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...++..|+|||.+.+..++.++|||||||++|||++|+.||........ ......... ....... +.... ...
T Consensus 162 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~~~~~~-~~~~~---~~~ 235 (287)
T cd06621 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELLSYI-VNMPNPE-LKDEP---GNG 235 (287)
T ss_pred cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHHHHH-hcCCchh-hccCC---CCC
Confidence 23467789999999988999999999999999999999999976532111 111111111 1111100 00000 000
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
......+.+++.+||+.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 112346788999999999999999999988
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.14 Aligned_cols=243 Identities=17% Similarity=0.256 Sum_probs=184.9
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++... .++.||+|++.+.. .....+..|+.++..+ +|+||+++++++.+.+..++||||+++
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 57999999999999865 47789999986532 1234578888888888 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 86 GDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 99999997532 2478888899999999999999998 9999999999999999999999999998654322
Q ss_pred --CCCCCCCcccCCcccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~-----~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
....+|..|+|||++. ...++.++|||||||++|||++|+.||.... ................
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~---- 228 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQ---- 228 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCcccc----
Confidence 1235889999999986 3457899999999999999999999996532 1112222211110000
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHH
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVP--DMRPTMEEVVRM 605 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P--~~RPs~~evl~~ 605 (632)
. ..........+.+++.+|+..++ ..|+++.|++++
T Consensus 229 -~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -F--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -C--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 00011112345566667775544 447899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.34 Aligned_cols=253 Identities=20% Similarity=0.327 Sum_probs=190.6
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC------HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
+.||+|+||.||+|... +++.||+|+++..... ...+..|++++.++ +|+||+++++++.+.+..++||||+
T Consensus 6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeecCCEEEEEEccc
Confidence 56999999999999854 6899999999765322 34567899999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
+|+|.+++.... ..+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||+++......
T Consensus 85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 899999997542 2589999999999999999999998 99999999999999999999999999997765432
Q ss_pred ----CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhcc-----cc
Q 006747 495 ----VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV---REEW-----TS 561 (632)
Q Consensus 495 ----~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~-----~~ 561 (632)
...++..|+|||.+.+ ..++.++|||||||++|||++|..||......+. +........ ...+ ..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhhccccc
Confidence 1234667999998865 4578999999999999999999877765332110 100000000 0000 00
Q ss_pred cccccccccc----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 562 EVFDVELMRY----ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 562 ~~~d~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.......... .........+.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000 0011123567789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=293.89 Aligned_cols=240 Identities=19% Similarity=0.309 Sum_probs=183.0
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEecccccC----HHHHHHHHHHHHhh--cCCCCccceeEEEEeCCceEEEEeccc
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG----KREFEQQMEVVGRL--SQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l--~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.||+|+||.||++... +++.||+|.+...... ...+.++..++..+ .+|+||+.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 5889999998654221 22233444333322 279999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||++......
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~ 152 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence 99999988754 2489999999999999999999998 9999999999999999999999999998755432
Q ss_pred CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....++..|+|||.+.. ..++.++|||||||++|||++|+.||........ ......... ....+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~------~~~~~---- 218 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLT------VNVEL---- 218 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH----HHHHHHhhc------CCcCC----
Confidence 22357889999999864 5579999999999999999999999975432211 111111000 00011
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
......++.+++.+||..||++|| |+++++++
T Consensus 219 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 -PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred -ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 111234567788899999999999 69988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.96 Aligned_cols=245 Identities=27% Similarity=0.422 Sum_probs=191.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC------ceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD------EKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~E~ 413 (632)
.+.||+|+||.||+|... +++.+++|++.........+.+|++++.++.+|+||+++++++.... ..++||||
T Consensus 11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 90 (275)
T cd06608 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL 90 (275)
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence 467999999999999964 57899999988665556789999999999877999999999997654 38999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 91 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 91 CGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred CCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 999999998865321 124588999999999999999999998 9999999999999999999999999998765332
Q ss_pred ----CCCCCCCcccCCccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIET-----KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~~-----~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
....++..|+|||.+.. ..++.++|||||||++|||++|+.||...... ......... ..
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~---- 235 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIPRN-PP---- 235 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhhcc-CC----
Confidence 22346778999998754 23678899999999999999999999642211 001111110 00
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
+ ...........+.+++.+||..||++|||+.|+++
T Consensus 236 -~---~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 -P---TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -C---CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0 01111123346778899999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=293.90 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=187.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||++... +++.||+|.+..... ....+..|+.++.++.+|+||+++++++......+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 468999999999999854 589999999875432 2456888999999995699999999999999999999999874
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---C
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---T 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---~ 494 (632)
++.++...........+++....+++.+++.||+|||+.. +++||||||+||++++++.+||+|||+++..... .
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 165 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT 165 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccc
Confidence 5544322110011245888999999999999999999742 8999999999999999999999999998765432 2
Q ss_pred CCCCCCcccCCccccCC---CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 VPSRSAGYRAPEVIETK---KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~---~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...++..|+|||.+.+. .++.++|||||||++|||++|+.||.... ............. . +.+..
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~-~-----~~~~~- 233 (288)
T cd06616 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD-P-----PILSN- 233 (288)
T ss_pred cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC-C-----CcCCC-
Confidence 23467889999999876 58999999999999999999999986432 1111111111100 0 01100
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.........+.+++.+||+.+|++|||+.+|+++
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111233457788999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.28 Aligned_cols=190 Identities=22% Similarity=0.333 Sum_probs=163.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... +++.||+|++.+.. ...+.+.+|+.++..+ +|+||+++++++.+.+..++||||++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~ 84 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQDENNLYLVMDYYV 84 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEecCCeEEEEEecCC
Confidence 357999999999999954 58899999997532 1234578888888888 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 85 g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999996532 2478888899999999999999998 99999999999999999999999999986654322
Q ss_pred ----CCCCCCcccCCccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCC
Q 006747 495 ----VPSRSAGYRAPEVIET-----KKPTQKSDVYSFGVLLLEMLTGKAPIQA 538 (632)
Q Consensus 495 ----~~~~t~~y~aPE~~~~-----~~~~~~~DV~s~Gvvl~elltg~~p~~~ 538 (632)
...+|+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 1347889999999863 4578899999999999999999999964
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=287.20 Aligned_cols=242 Identities=29% Similarity=0.485 Sum_probs=194.4
Q ss_pred HhHhCccceeEEEEEEEcC-----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILEE-----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||++...+ +..||+|.++.... ..+.+..|++.+.++ +|+||+++++++.+.+..+++|||
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCCCeeEEEEec
Confidence 3579999999999998654 48899999976543 356789999999999 999999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++++|.+++..... ..+++..+..++.+++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 83 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 83 MEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred cCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999976431 1288999999999999999999998 9999999999999999999999999999766543
Q ss_pred CC-----CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccccc
Q 006747 494 TV-----PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567 (632)
Q Consensus 494 ~~-----~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 567 (632)
.. ..++..|+|||.+.+..++.++||||+|++++||++ |+.||.... ........... ...
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~-~~~------ 223 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS------NEEVLEYLKKG-YRL------ 223 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcC-CCC------
Confidence 11 225678999999988889999999999999999998 788876421 11111111111 110
Q ss_pred ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 568 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
........++.+++.+|++.+|++|||+.|+++.|
T Consensus 224 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00111234577888999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=292.92 Aligned_cols=244 Identities=24% Similarity=0.377 Sum_probs=186.5
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|+||.||++... +|..||+|+++.... ....+..|++++.+..+|+||+++++++...+..++||||++ |+
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (283)
T cd06617 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS 85 (283)
T ss_pred EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence 56999999999999864 589999999976532 234566677765555599999999999999999999999997 68
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---V 495 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~ 495 (632)
|.+++..... ....+++.....++.|++.||+|||+.+ +++||||||+||++++++.+||+|||+++...... .
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (283)
T cd06617 86 LDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI 162 (283)
T ss_pred HHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 8887765322 2246899999999999999999999753 79999999999999999999999999997654322 2
Q ss_pred CCCCCcccCCccccC----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 496 PSRSAGYRAPEVIET----KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~----~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
..++..|+|||.+.+ ..++.++|+|||||++|||++|+.||..... . . .......... . +....
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~--~-~~~~~~~~~~-~-----~~~~~- 230 (283)
T cd06617 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--P--F-QQLKQVVEEP-S-----PQLPA- 230 (283)
T ss_pred ccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--C--H-HHHHHHHhcC-C-----CCCCc-
Confidence 346778999998865 3468899999999999999999999853211 0 0 1111111110 0 00000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
......+.+++.+||+.+|++||++.++++
T Consensus 231 ---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 231 ---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011235778888999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=325.90 Aligned_cols=251 Identities=18% Similarity=0.313 Sum_probs=191.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~~ 414 (632)
.+.||+|+||.||++... .+..||+|.+...... ...+..|+.++.++ +|||||+++++|... ...|+||||+
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~lyIVMEY~ 96 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFC 96 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence 357999999999999854 4678999998754322 45688999999999 899999999988654 4689999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccC----CCceecCCCCCCeeecC---------------
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG----GKFILGNIKSSNVLLSQ--------------- 475 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivHrDlk~~NILl~~--------------- 475 (632)
++|+|.+++..... ....+++...+.|+.|++.||+|||+... .+||||||||+||||+.
T Consensus 97 ~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ 175 (1021)
T PTZ00266 97 DAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175 (1021)
T ss_pred CCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence 99999999875321 12358999999999999999999998531 35999999999999964
Q ss_pred --CCCeEEcccCCCCCCCCC---CCCCCCCcccCCccccC--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChh
Q 006747 476 --DLQGCISDFGLTPLMNTP---TVPSRSAGYRAPEVIET--KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP 548 (632)
Q Consensus 476 --~~~~ki~DfGla~~~~~~---~~~~~t~~y~aPE~~~~--~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~ 548 (632)
...+||+|||+++..... ....+|+.|+|||++.+ ..++.++|||||||+||||+||+.||..... ..
T Consensus 176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~-----~~ 250 (1021)
T PTZ00266 176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN-----FS 250 (1021)
T ss_pred CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-----HH
Confidence 345899999999876433 23357889999999864 4478999999999999999999999964221 11
Q ss_pred HHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhhC
Q 006747 549 RWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDIR 610 (632)
Q Consensus 549 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i~ 610 (632)
..+.. +.... .+. .......+.+|+..||+.+|.+||++.|+++ .++.+.
T Consensus 251 qli~~-lk~~p-------~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 251 QLISE-LKRGP-------DLP----IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHHH-HhcCC-------CCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 11111 11110 000 0112245778889999999999999999984 555443
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=292.69 Aligned_cols=241 Identities=25% Similarity=0.413 Sum_probs=195.4
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||+|... ++..|++|++.........+..|++.+.++ +|+||+++++++...+..++|+||+++++|
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 102 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEECCEEEEEEeccCCCcH
Confidence 467999999999999976 688999999976544466788999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 495 (632)
.+++.... ..+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.+||+|||++...... ..
T Consensus 103 ~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 175 (286)
T cd06614 103 TDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175 (286)
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence 99998642 3589999999999999999999997 9999999999999999999999999988655432 22
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..++..|+|||.+.+..++.++|||||||++|||++|+.||...... .......... ... .....
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~--------~~~~~ 240 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITTKG-IPP--------LKNPE 240 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC-CCC--------Ccchh
Confidence 34677899999998888999999999999999999999998642211 1111111111 000 01111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.....+.+++.+||+.+|.+|||+.+++.
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12345677889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.23 Aligned_cols=243 Identities=17% Similarity=0.252 Sum_probs=190.4
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++... .++.|++|.+..... ....+.+|++++..+ +|+||+++++++...+..++||||+++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 57999999999999864 478999999875432 234677899999998 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... ++++.....++.+++.||+|||+. +++||||||+||++++++.+|++|||+++.....
T Consensus 86 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 86 GDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 99999996542 478888999999999999999998 9999999999999999999999999998642100
Q ss_pred ----------------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 006747 494 ----------------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE 557 (632)
Q Consensus 494 ----------------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (632)
....++..|+|||.+.+..++.++|||||||++|||++|+.||.+.... .+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~~~~ 231 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQVISD 231 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhc
Confidence 1123566799999998888999999999999999999999999643211 111111111
Q ss_pred ccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 558 EWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 558 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.. ..+. ........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 232 ~~----~~~~-----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 DI----EWPE-----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cc----CCCC-----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 10 0000 000122346788899999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=295.33 Aligned_cols=247 Identities=25% Similarity=0.388 Sum_probs=195.7
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. .++..||+|++..... ....+..|++++.++ +|+|++++++++......++||||+.
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 56799999999999985 4688999999864321 134688899999999 89999999999999999999999997
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 495 (632)
|++.+++.... .+++|..+..++.+++.||.|||+. +|+||||+|+||++++++.+||+|||++........
T Consensus 109 -g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (317)
T cd06635 109 -GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS 180 (317)
T ss_pred -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCccc
Confidence 47777765432 3589999999999999999999998 999999999999999999999999999887766556
Q ss_pred CCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 496 PSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 496 ~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
..++..|+|||.+. .+.++.++|||||||++|||++|+.||..... .............. .
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~~~----------~ 244 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESPT----------L 244 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhccCCC----------C
Confidence 66888899999974 45688999999999999999999999864311 11111111111100 0
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
........+.+++.+||+.+|++||++.++++++-.+...
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 1112234577888999999999999999999877655444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=277.43 Aligned_cols=277 Identities=19% Similarity=0.331 Sum_probs=209.9
Q ss_pred CHHHHHHHHHhHhCccceeEEEEEE-EcCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEE
Q 006747 332 DLEDLLRASAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLL 409 (632)
Q Consensus 332 ~~~~l~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 409 (632)
.++|+..-+.+.||+|+|+.|-.+. +.+|..+|||++.+... .+..+.+|++++.....|+||++|+++|.++...|+
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL 153 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence 4688888899999999999999887 77899999999988743 356788999999999999999999999999999999
Q ss_pred EEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC---CeEEcccCC
Q 006747 410 VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL---QGCISDFGL 486 (632)
Q Consensus 410 v~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~---~~ki~DfGl 486 (632)
|||-|.||.|..+++..+ -+++...-++..+||.||.|||.+ +|.||||||+|||..+.. -+|||||.+
T Consensus 154 VfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDL 225 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDL 225 (463)
T ss_pred EEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccc
Confidence 999999999999998654 477888889999999999999999 999999999999997654 489999998
Q ss_pred CCCCCC-----------CCCCCCCCcccCCcccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC----C
Q 006747 487 TPLMNT-----------PTVPSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV----D 546 (632)
Q Consensus 487 a~~~~~-----------~~~~~~t~~y~aPE~~~-----~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~----~ 546 (632)
...+.. -.++.|+..|||||+.. ...|+.++|.||+|||||-|+.|..||.+...++.. .
T Consensus 226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe 305 (463)
T KOG0607|consen 226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE 305 (463)
T ss_pred ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence 744321 11235677799999873 345899999999999999999999999886544321 1
Q ss_pred hhHHHH----HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhhCCCCCCCCCCC
Q 006747 547 LPRWVQ----SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDIRPSDSENQPSS 620 (632)
Q Consensus 547 ~~~~~~----~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i~~~~~~~~~~~ 620 (632)
..+-.+ ..++++.. +.-|. .+..+. .+..+++...+..|+.+|-++.++++ ..+.+.+....+.|.-
T Consensus 306 ~Cr~CQ~~LFesIQEGkY-eFPdk---dWahIS---~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~v 378 (463)
T KOG0607|consen 306 VCRVCQNKLFESIQEGKY-EFPDK---DWAHIS---SEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQV 378 (463)
T ss_pred ccHHHHHHHHHHHhccCC-cCChh---hhHHhh---HHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCcc
Confidence 122121 12222211 11111 111122 23445666777899999999999987 4555555555454444
Q ss_pred ccc
Q 006747 621 EDK 623 (632)
Q Consensus 621 ~~~ 623 (632)
.++
T Consensus 379 ~~r 381 (463)
T KOG0607|consen 379 LQR 381 (463)
T ss_pred ccc
Confidence 433
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=289.07 Aligned_cols=246 Identities=22% Similarity=0.370 Sum_probs=195.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||++... +++.||+|++..... ....+.+|++++.++ +||||+++++++......++|+||++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICMEYMDGG 84 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecCCEEEEEEEecCCC
Confidence 468999999999999865 588999999876532 345688999999999 7999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-ccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--C
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA-AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--T 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--~ 494 (632)
+|.+++.... .++++.....++.+++.|++|||+ . +++|+||||+||++++++.+||+|||.+...... .
T Consensus 85 ~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 85 SLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 9999987542 357888889999999999999998 6 9999999999999999999999999998765322 1
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...++..|+|||.+.+..++.++||||||+++|||++|+.||....... .......+....... . .+ ..
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~-~-----~~----~~ 226 (265)
T cd06605 158 TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP-P-----RL----PS 226 (265)
T ss_pred cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC-C-----CC----Ch
Confidence 2456778999999999999999999999999999999999996542211 111222222211110 0 00 00
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
......+.+++.+||..+|++|||+.+++.+
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1123457788899999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=290.93 Aligned_cols=243 Identities=21% Similarity=0.260 Sum_probs=188.0
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|.. .+++.||+|.+...... ...+..|..++....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999985 45889999998754321 223455555555444899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVP 496 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 496 (632)
++|.+++.... ++++..+..++.|++.||.|||+. +++||||+|+||++++++.+||+|||+++........
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF 153 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccccccC
Confidence 99999987542 477888899999999999999998 9999999999999999999999999999876554455
Q ss_pred CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHH
Q 006747 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEE 576 (632)
Q Consensus 497 ~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 576 (632)
.++..|+|||.+.+..++.++||||||+++|||+||+.||...... ....... ..... ... .....
T Consensus 154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~--~~~-----~~~~~ 219 (260)
T cd05611 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNIL-SRRIN--WPE-----EVKEF 219 (260)
T ss_pred CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hcccC--CCC-----ccccc
Confidence 6778899999998888999999999999999999999999643211 1111111 10000 000 00011
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 577 EMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 577 ~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
....+.+++.+||+.+|++||++.++.+.|
T Consensus 220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 220 CSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 234577888999999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.80 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=189.8
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... .++.||+|++..... ..+.+.+|++++.++ +|+||+++++++...+..++||||++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 67999999999999975 489999999865432 245688899999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|..+.... ..++|..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 157 (286)
T cd07846 86 VLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 157 (286)
T ss_pred HHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence 998876543 2378999999999999999999998 99999999999999999999999999987654322
Q ss_pred -CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHH-------HHHhh-hcccccc
Q 006747 495 -VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV-DLPRWV-------QSVVR-EEWTSEV 563 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~-------~~~~~-~~~~~~~ 563 (632)
...++..|+|||++.+. .++.++|||||||++|||++|+.||......+.. .+..+. ..... ......+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 12356789999998764 4688999999999999999999998643211100 000000 00000 0000000
Q ss_pred ccccccccCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 564 FDVELMRYEN----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 564 ~d~~~~~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..+....... .......+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000 01123457789999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=285.79 Aligned_cols=241 Identities=20% Similarity=0.400 Sum_probs=192.7
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||++.. .+++.+|+|.+..... ....+..|++++.++ +|+||+++++.+...+..++||||+++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEecCCEEEEEEecCCC
Confidence 35799999999999985 4688999999875432 245788999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeEEcccCCCCCCCCCC-
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~~- 494 (632)
++|.+++.... ...+++..+.+++.+++.||+|||+. +++|+||||+||+++++ +.+||+|||++.......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 84 GTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999997642 23578899999999999999999998 99999999999999865 568999999998765432
Q ss_pred --CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 495 --VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
...++..|+|||.+.+..++.++||||||+++|||++|+.||..... ............ ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~~-~~~--------- 221 (256)
T cd08220 158 AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLKIMSGTF-API--------- 221 (256)
T ss_pred ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHHHHhcCC-CCC---------
Confidence 23467789999999988889999999999999999999999864321 122222111110 000
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.......+.+++.+||+.+|++|||+.|++++
T Consensus 222 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 -SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00122356788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=293.68 Aligned_cols=240 Identities=23% Similarity=0.353 Sum_probs=192.0
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||++.. .++..||+|.+.... ...+.+..|+.++.++ +||||+++++++...+..++|+||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (293)
T cd06647 24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (293)
T ss_pred eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence 46799999999999985 467899999986543 2345688899999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 494 (632)
|.+++... .+++..+..++.+++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 103 L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 103 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 99998643 367889999999999999999998 99999999999999999999999999886554322
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...++..|+|||.+.+..++.++|||||||++||+++|+.||......+... .....+. + .....
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~~------~---~~~~~ 238 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGT------P---ELQNP 238 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCCC------C---CCCCc
Confidence 2246677999999988889999999999999999999999996543211110 0000000 0 00111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
......+.+++.+||+.+|++||++.+++.+
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122356778899999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.35 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=187.0
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... +|..||+|+++.... ....+.+|++++.++ +|+||+++++++.+....++|+||++ +
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 83 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHSDKKLTLVFEYCD-Q 83 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhccCCceEEEEecCC-C
Confidence 56899999999999864 688999999875422 235678899999999 89999999999999999999999997 4
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++.... ..+++.....++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 84 DLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence 7888776432 2488999999999999999999998 99999999999999999999999999997654322
Q ss_pred -CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----ccc--cccccc
Q 006747 495 -VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE----EWT--SEVFDV 566 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~d~ 566 (632)
...++..|+|||.+.+.. ++.++|||||||++|||+||+.|+....... ............ .+. ....+.
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 234577899999987654 6899999999999999999999864322110 000000000000 000 000000
Q ss_pred -ccccc-------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 567 -ELMRY-------ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 567 -~~~~~-------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..... .........+.+++.+||+.||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 0001122456788899999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=289.47 Aligned_cols=240 Identities=22% Similarity=0.366 Sum_probs=190.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc--cCHHHHHHHHHHHHhhc--CCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLS--QHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. .++..||+|.++... ....++.+|++++.++. .|||++++++++......++||||++
T Consensus 6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06917 6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE 85 (277)
T ss_pred hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence 46799999999999995 568999999987542 23456888999999883 39999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+++|.+++... ++++.....++.+++.||.|||+. +|+|+||+|+||++++++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 99999998642 488999999999999999999998 99999999999999999999999999987664432
Q ss_pred ---CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
...++..|+|||.+.++ .++.++|||||||++|||++|+.||....... +.... ... ..+.+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~~-~~~-----~~~~~~~ 224 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMMLI-PKS-----KPPRLED 224 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhcc-ccC-----CCCCCCc
Confidence 22467789999988754 46899999999999999999999996532111 11000 000 0011100
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. ....++.+++.+||+.||++||++.+++++
T Consensus 225 -~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 225 -N---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -c---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0 123457788899999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=289.04 Aligned_cols=244 Identities=22% Similarity=0.356 Sum_probs=189.7
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---C--------HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---G--------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~--------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~ 408 (632)
.+.||+|+||.||+|.. .+++.||+|.++.... . .+.+..|++++.++ +|+||+++++++...+..+
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEeccCCceE
Confidence 35799999999999985 4688999998864211 0 13577899999999 8999999999999999999
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
+||||+++|+|.+++... .++++..+..++.+++.||.|||+. +++||||+|+||++++++.+|++|||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 999999999999999754 2478888999999999999999998 99999999999999999999999999997
Q ss_pred CCCCCC------CCCCCCcccCCccccCCC--CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 489 LMNTPT------VPSRSAGYRAPEVIETKK--PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 489 ~~~~~~------~~~~t~~y~aPE~~~~~~--~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
...... ...++..|+|||.+.... ++.++||||||+++||+++|+.||..... ..... ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~~-~~ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMF-KLGNK-RS 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHH-Hhhcc-cc
Confidence 654321 224677899999987654 78999999999999999999999853211 11111 10000 00
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...+... ...+....+.+++.+||..+|++|||+.+|+++
T Consensus 230 ~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 APPIPPD-----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CCcCCcc-----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0011111 011123467778889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=287.89 Aligned_cols=238 Identities=21% Similarity=0.317 Sum_probs=184.4
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc------CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 411 (632)
.+.||+|+||.||+|.. .++..||+|++..... ....+.+|++++.++ +|+||+++++++... ...++++
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCEEEEEE
Confidence 46799999999999985 4588999999864321 124588899999999 899999999988763 5678999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++++|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 86 EYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999987542 478888899999999999999987 99999999999999999999999999987653
Q ss_pred CC-------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 492 TP-------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 492 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.. ....++.+|+|||.+.+..++.++|||||||++|||++|+.||..... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~----- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT----- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC-----
Confidence 21 112367789999999988899999999999999999999999964311 111111111110
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.+.+ .......+.+++ +||..+|++||+++||++
T Consensus 227 ~~~~-----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQL-----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCC-----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111 111112334444 689899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=292.69 Aligned_cols=238 Identities=24% Similarity=0.395 Sum_probs=191.4
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|++|.||++.. .+++.|++|++..... ..+.+.+|+.++.++ +|+||+++++++...+..++|+||+++++|
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 5899999999999985 4688999999865432 245678899999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 495 (632)
.+++... ++++..+..++.+++.||+|||+. +++||||+|+||++++++.+||+|||.+...... ..
T Consensus 104 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 174 (285)
T cd06648 104 TDIVTHT------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS 174 (285)
T ss_pred HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccc
Confidence 9998752 378889999999999999999998 9999999999999999999999999988654332 12
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..++..|+|||.+.+..++.++|||||||++|||++|+.||..... ....... ...... .. ....
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~-~~~~~~-----~~---~~~~ 239 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRI-RDNLPP-----KL---KNLH 239 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHH-HhcCCC-----CC---cccc
Confidence 3477889999999988899999999999999999999999864221 1111111 111110 00 0011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.....+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 12245788899999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=287.75 Aligned_cols=235 Identities=23% Similarity=0.314 Sum_probs=184.9
Q ss_pred hCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhhh
Q 006747 344 LGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSAL 422 (632)
Q Consensus 344 lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 422 (632)
||+|+||.||++.. .++..+|+|.+........ |+.....+.+|+||+++++++...+..++||||+++|+|.++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~ 99 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL 99 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence 69999999999985 4578899999875432211 222222233799999999999999999999999999999999
Q ss_pred hccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-CeEEcccCCCCCCCCCCCCCCCCc
Q 006747 423 LHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLMNTPTVPSRSAG 501 (632)
Q Consensus 423 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~~~~~t~~ 501 (632)
+.... +++|.....++.|+++||+|||+. +++||||||+||+++.++ .++|+|||+++.........++..
T Consensus 100 l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 171 (267)
T PHA03390 100 LKKEG-----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLD 171 (267)
T ss_pred HHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCc
Confidence 97542 589999999999999999999998 899999999999999998 999999999987766655668889
Q ss_pred ccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHH
Q 006747 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQM 581 (632)
Q Consensus 502 y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 581 (632)
|+|||.+.+..++.++|||||||++|||++|+.||.....++ .....+.... .. .. .........+
T Consensus 172 y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~---------~~---~~~~~~~~~~ 237 (267)
T PHA03390 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK---------KL---PFIKNVSKNA 237 (267)
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc---------cC---CcccccCHHH
Confidence 999999999889999999999999999999999997443222 1222222111 00 00 0111223457
Q ss_pred HHHHHHccCCCCCCCCC-HHHHHH
Q 006747 582 LQIAMSCVAKVPDMRPT-MEEVVR 604 (632)
Q Consensus 582 ~~l~~~Cl~~~P~~RPs-~~evl~ 604 (632)
.+++.+||+.+|.+||+ ++++++
T Consensus 238 ~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 238 NDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHhccChhhCCchHHHHhc
Confidence 78888999999999996 688874
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=288.41 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=194.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||+||+|.. .++..+++|++..... ....+.+|++.+..+ +|+||+++++.+...+..++|+||++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVVGDELWLVMPYLSGG 84 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEeeCCEEEEEEeccCCC
Confidence 35799999999999985 4678999999875432 356789999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC--
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV-- 495 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~-- 495 (632)
+|.++++.... ...+++.....++.+++.||+|||+. +++||||||+||++++++.+||+|||++..+.....
T Consensus 85 ~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 85 SLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred cHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999975421 23588999999999999999999988 999999999999999999999999999876544322
Q ss_pred ------CCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 496 ------PSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 496 ------~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
..++..|+|||.+... .++.++|||||||++|||++|+.||....... .......... ...
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~~------~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQNDP------PSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCCC------CCc
Confidence 2367789999998877 68999999999999999999999996432211 0111111110 001
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
............+.+++.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000011223456788889999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=286.44 Aligned_cols=238 Identities=24% Similarity=0.358 Sum_probs=190.7
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|++++.++ +|+||+++++++......++|+||+
T Consensus 6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEecCCeEEEEEEec
Confidence 57999999999999975 789999999865421 235688999999999 9999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++++|.+++... .++++..+..++.+++.|++|||+. +|+|+||+|+||+++.++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 85 PGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 999999998754 2478899999999999999999998 99999999999999999999999999987654332
Q ss_pred ---CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
...++..|+|||.+.... ++.++|+|||||++|||++|+.||..... ............... +
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~-~------ 223 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP-I------ 223 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC-c------
Confidence 334677899999987776 89999999999999999999999864321 111111110000000 0
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.......+.+++.+||+.+|++||++.++++
T Consensus 224 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 ---PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111234667888999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=283.28 Aligned_cols=249 Identities=21% Similarity=0.342 Sum_probs=188.8
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
..||.|+||+|+|-.+ +.|+..|||+++.... +.+.+..|.+...+-.+-||||+++|.+..++..|+-||+|+- +
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-S 148 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-S 148 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-h
Confidence 6799999999999874 5699999999987644 3456888888888877999999999999999999999999965 6
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---V 495 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~ 495 (632)
+..+.+.-.......+++...-+|...+..||.||.+.. +|||||+||+|||+|..|.+|+||||++-.+..+- .
T Consensus 149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~ 226 (361)
T KOG1006|consen 149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV 226 (361)
T ss_pred HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh
Confidence 665433211112334777777888888999999999874 89999999999999999999999999997765542 2
Q ss_pred CCCCCcccCCccccCC--CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 496 PSRSAGYRAPEVIETK--KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~--~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
..|-..|||||.+... .|+-++||||+|++|+|+.||+.||..-. .+.+.+......... .+.....
T Consensus 227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdpp------~l~~~~~ 295 (361)
T KOG1006|consen 227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDPP------ILLFDKE 295 (361)
T ss_pred ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCCC------eecCccc
Confidence 2355569999999643 48999999999999999999999996422 111222222211111 1111111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..+....+.+++..|+.+|-..||+..++.+
T Consensus 296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1234456888999999999999999998765
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=295.17 Aligned_cols=258 Identities=19% Similarity=0.272 Sum_probs=189.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc-----eEEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE-----KLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lv~ 411 (632)
.+.||+|+||.||+|... +++.||+|.++.... ....+.+|++++.++.+|+||+++++++...+. .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 357999999999999864 689999999865432 235688899999999678999999999987665 89999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-CCCeEEcccCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-DLQGCISDFGLTPLM 490 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~ 490 (632)
||+++ +|.+++.........++++.....++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++..
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~ 161 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceec
Confidence 99985 888888654332234689999999999999999999998 9999999999999998 899999999998765
Q ss_pred CCC----CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---ccccc
Q 006747 491 NTP----TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE---EWTSE 562 (632)
Q Consensus 491 ~~~----~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 562 (632)
... ....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+..... .+..... .+.. .....
T Consensus 162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~ 238 (295)
T cd07837 162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFK-LLGTPTEQVWPG 238 (295)
T ss_pred CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHH-HhCCCChhhCcc
Confidence 332 12235677999998865 457899999999999999999999997532111 0100000 0000 00000
Q ss_pred ccccc----cc--ccC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 563 VFDVE----LM--RYE----NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 563 ~~d~~----~~--~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..... .. ... ..+.....+.+++.+||+.+|++||++.|++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 00 000 001123457788999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=286.92 Aligned_cols=241 Identities=24% Similarity=0.385 Sum_probs=191.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||+|... +++.|++|.++.... ..+.+..|++++.++ +|+||+++++++...+..++|+||+++
T Consensus 5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEecCCEEEEEEecCCC
Confidence 357999999999999854 689999999976544 346789999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV- 495 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 495 (632)
++|.+++.... .+++..+..++.+++.||+|||+. +|+|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 84 GTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999987542 367888899999999999999998 999999999999999999999999999877643322
Q ss_pred -------CCCCCcccCCccccCCC---CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 496 -------PSRSAGYRAPEVIETKK---PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 496 -------~~~t~~y~aPE~~~~~~---~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
..++..|+|||.+.+.. ++.++||||||+++||+++|+.||...... . ....... .. ..
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~---~~~~~~~-~~-----~~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--F---QIMFHVG-AG-----HK 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--H---HHHHHHh-cC-----CC
Confidence 23567899999998776 889999999999999999999999643211 0 0000000 00 00
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
+.+... ......+.+++.+||+.+|++|||+.|++.
T Consensus 225 ~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPDS---LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCcc---cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111110 111234667888999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=295.87 Aligned_cols=240 Identities=22% Similarity=0.324 Sum_probs=190.9
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++... ++..||+|.+..... ..+.+..|++++.++ +|+||+++++++......++||||+.+
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeecCCEEEEEEEecCC
Confidence 57999999999999865 489999999976532 235688899999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
++|.+++.... ...+++.....++.|++.||+|||.. +++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 86 GELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred CCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 99999987542 24588899999999999999999998 99999999999999999999999999986543211
Q ss_pred -------------------------------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC
Q 006747 495 -------------------------------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED 543 (632)
Q Consensus 495 -------------------------------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~ 543 (632)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 1135677999999999889999999999999999999999997543211
Q ss_pred CCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 006747 544 VVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPT----MEEVVR 604 (632)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs----~~evl~ 604 (632)
.......... ...........+.+++.+||+.+|++||| ++++++
T Consensus 240 ------~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 ------TFSNILKKEV----------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ------HHHHHhcCCc----------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 0111111100 00111112356778889999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=287.08 Aligned_cols=245 Identities=22% Similarity=0.367 Sum_probs=193.2
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~~~ 415 (632)
+.||.|+||.||++.. .++..||+|++...... .+.+..|++++.++ +|+||+++++++... ...+++|||++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEEehhcc
Confidence 5789999999999984 46789999998754322 34678899999999 999999999988643 45789999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc--CCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV--GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|.+++..... ...++++.....++.+++.||+|||..+ ..+++|+||||+||++++++.+||+|||++......
T Consensus 85 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 163 (265)
T cd08217 85 GGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163 (265)
T ss_pred CCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCC
Confidence 9999999875422 2346899999999999999999999332 339999999999999999999999999999876543
Q ss_pred C----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 494 T----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 494 ~----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
. ...++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...... .......
T Consensus 164 ~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~-------- 228 (265)
T cd08217 164 SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLASK-IKEGKFR-------- 228 (265)
T ss_pred cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHHHH-HhcCCCC--------
Confidence 3 23467889999999988899999999999999999999999975321 111111 1111110
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.........+.+++.+|++.+|++||++.+|+++
T Consensus 229 --~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 --RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0111223467788999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=293.88 Aligned_cols=245 Identities=21% Similarity=0.366 Sum_probs=187.9
Q ss_pred HHhHhCccceeEEEEEEEcC-CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 340 SAEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
..+.||+|+||.||+|...+ ++.||||.++.... ....+..|++++.+..+|+||+++++++.+....++||||+.+
T Consensus 19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 98 (296)
T cd06618 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMST 98 (296)
T ss_pred eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCc
Confidence 35789999999999999765 89999999976432 2345677777777775699999999999999999999999864
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
++.+++.... .++++..+.+++.+++.||+|||+. ++|+||||+|+||++++++.+||+|||++.......
T Consensus 99 -~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 99 -CLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred -CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 7777665432 2688999999999999999999973 289999999999999999999999999987654322
Q ss_pred -CCCCCCcccCCccccCCC----CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 495 -VPSRSAGYRAPEVIETKK----PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~----~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
...++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... .........+. .. ...
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~-----~~~ 240 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PP-----SLP 240 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CC-----CCC
Confidence 223567899999987654 788999999999999999999998642111 11111111111 00 000
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ....++.+++.+||+.||++||++.+++++
T Consensus 241 ~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 241 PNE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC---CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001 123457788899999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=294.46 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=190.6
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|++++.++ +|+||+++++++...+..++||||++++
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEECCEEEEEEecCCCC
Confidence 57999999999999865 578999999875422 246789999999999 8999999999999999999999999987
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
.+..+.... ..+++.....++.+++.||+|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 86 LLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 777665432 2478899999999999999999998 99999999999999999999999999987765433
Q ss_pred --CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh------------hcc
Q 006747 495 --VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR------------EEW 559 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~ 559 (632)
...++..|+|||++.+. .++.++||||||+++|||++|+.||......+. ......... +..
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccCcc
Confidence 22356779999999888 789999999999999999999999875322110 000000000 000
Q ss_pred cc-----ccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 560 TS-----EVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 560 ~~-----~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.. ...+..............++.+++.+||..+|++|||++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 0000000000000111456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=287.70 Aligned_cols=242 Identities=21% Similarity=0.357 Sum_probs=191.7
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||++.. .++..||+|.+..... ..+.+.+|++++.++ +|+||+++++++...+..++|+|
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceeccCCeEEEEEe
Confidence 36799999999999984 5689999999875321 135688999999999 99999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-CeEEcccCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLMN 491 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~ 491 (632)
|+++++|.+++... .++++.....++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||.+....
T Consensus 84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 84 WMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred ccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 99999999998754 2578899999999999999999998 999999999999998776 59999999987764
Q ss_pred CCC--------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 492 TPT--------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 492 ~~~--------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
... ...++..|+|||.+.+..++.++||||+|++++||++|+.||....... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~---- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIASATT---- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhccCC----
Confidence 321 1235778999999988889999999999999999999999986432111 1111111100000
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..........++.+++.+|++.+|++||++.++++
T Consensus 229 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111223356778889999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=286.96 Aligned_cols=238 Identities=24% Similarity=0.384 Sum_probs=191.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|.. .++..||+|.+..... ....+.+|++++.++ +|+||+++++++..+...++||||+++|
T Consensus 9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 46799999999999985 4678999999864432 235688999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++... .+++.....++.+++.++.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 88 ~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 88 SALDLLEPG------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 999998643 478999999999999999999998 99999999999999999999999999987654321
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...++..|+|||.+.+..++.++|||||||++|||++|+.||...... .+... ....... .+
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~-~~--------- 221 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFL-IPKNNPP-TL--------- 221 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHH-HhcCCCC-CC---------
Confidence 224677899999998888899999999999999999999998642211 11111 1111000 00
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.......+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 01122456778889999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.32 Aligned_cols=191 Identities=24% Similarity=0.400 Sum_probs=170.8
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
++||+|+||.||-... ..|+.+|.|++.+.. .+......|-+++.++ +.+.||.+-..|.+++.+++|+..|.|
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecCCCceEEEEEeecC
Confidence 6899999999999874 458999999987653 3345578888999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|||.-+|.+.. ...+++...+.++.+|+.||++||.. .||.|||||+|||+|++|+++|+|.|+|..+....
T Consensus 270 GDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 270 GDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred CceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999987653 35688999999999999999999999 99999999999999999999999999998776543
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
...||.||||||++..+.|+...|.||+||++|||+.|+.||...
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 236899999999999999999999999999999999999999653
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=284.59 Aligned_cols=238 Identities=18% Similarity=0.271 Sum_probs=191.1
Q ss_pred hCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 344 LGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 344 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
||.|+||.||++... +++.||+|++..... ..+.+.+|++++.++ +|+||+++++++.+....++|+||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 699999999999965 488999999875422 245688999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---CC
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---TV 495 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---~~ 495 (632)
|.+++.... .+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||+++..... ..
T Consensus 80 L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~ 151 (262)
T cd05572 80 LWTILRDRG-----LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151 (262)
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence 999997542 378888999999999999999997 9999999999999999999999999999876543 22
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||..... +.............. .....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~----------~~~~~ 217 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNGK----------LEFPN 217 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCCC----------CCCCc
Confidence 3467789999999888899999999999999999999999975432 112222221110000 00111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPT-----MEEVVR 604 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 604 (632)
.....+.+++.+||+.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11346788899999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=284.54 Aligned_cols=239 Identities=19% Similarity=0.258 Sum_probs=185.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc------CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 411 (632)
.+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|++++.++ +|+||+++++++.+. ...++||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCceEEEEE
Confidence 367999999999999864 588999998863311 124678899999999 899999999988764 4578999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++|+|.+++.... .+++....+++.+++.||+|||+. +++|+||||+||++++++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 86 EHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999987432 367888899999999999999998 99999999999999999999999999987653
Q ss_pred CC-------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 492 TP-------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 492 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.. ....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~----- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPT----- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHHHHHhcCCC-----
Confidence 21 223467789999999888899999999999999999999999864211 111111111100
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...........+.+++.+|+. +|++||+++|++++
T Consensus 227 -----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 -----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 001112223456677888985 89999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=290.15 Aligned_cols=251 Identities=20% Similarity=0.322 Sum_probs=188.5
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... +++.||||+++.... ....+..|++++.++ +||||+++++++.+.+..++||||+. +
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 57899999999999864 689999999875422 235688999999999 99999999999999999999999996 6
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|..++.... ...+++.....++.+++.||+|||+. +++||||+|+||++++++.+||+|||+++......
T Consensus 84 ~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 84 DLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred CHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 8988886542 23588999999999999999999988 99999999999999999999999999987654322
Q ss_pred -CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc------
Q 006747 495 -VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV------ 566 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~------ 566 (632)
...++..|+|||.+.+.. ++.++|||||||++|||+||+.||......+ ...+..... +.......+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~ 232 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTL---GTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHh---CCCChhhhhhhhHHH
Confidence 223567899999887655 5889999999999999999999997533111 111111000 000000000
Q ss_pred ----ccc--ccCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 567 ----ELM--RYENIE----EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 567 ----~~~--~~~~~~----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ...... .....+.+++.+||+.||++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000 000000 012345678999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=291.09 Aligned_cols=252 Identities=20% Similarity=0.284 Sum_probs=187.6
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|.. .++..||+|+++.... .......|+..+.++.+|+||+++++++.+. +..++|+||++
T Consensus 5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~- 83 (282)
T cd07831 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD- 83 (282)
T ss_pred eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-
Confidence 5689999999999985 4688999999876422 2334557888888886699999999999987 88999999997
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|++.+.+.... ..++|..+..++.+++.||+|||+. +++||||||+||++++ +.+||+|||+++......
T Consensus 84 ~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 84 MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 58888776532 3589999999999999999999998 9999999999999999 999999999997764332
Q ss_pred -CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh-----------hhcccc
Q 006747 495 -VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV-----------REEWTS 561 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~ 561 (632)
...++..|+|||.+.. ..++.++|||||||++|||++|+.||......+ ...+..... ......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2246778999997654 557889999999999999999999997543211 111111110 000000
Q ss_pred ccccccccc---cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 562 EVFDVELMR---YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 562 ~~~d~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....+.... ..........+.+++.+||+.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 00011224568889999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=285.81 Aligned_cols=242 Identities=24% Similarity=0.393 Sum_probs=196.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|++|.||+|... +++.|++|++..... ....+..|++.+.++ +|+||+++++++......++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKEGEISIVLEYMDGG 84 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence 367999999999999976 489999999876543 356799999999999 7999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-ccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA-AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV- 495 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 495 (632)
+|.+++... .++++..+..++.++++|++|||+ . +++||||+|+||++++++.++|+|||++........
T Consensus 85 ~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 85 SLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999999754 358889999999999999999999 7 999999999999999999999999999877654332
Q ss_pred ---CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 496 ---PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 496 ---~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
..++..|+|||.+.+..++.++||||||+++|||+||+.||........ ........... .. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~-~~-----~~---- 223 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF---FELMQAICDGP-PP-----SL---- 223 (264)
T ss_pred ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH---HHHHHHHhcCC-CC-----CC----
Confidence 2366789999999988899999999999999999999999975432111 11111111111 00 00
Q ss_pred CcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEE-EMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~-~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ....+.+++.+||+.+|++|||+.+++++
T Consensus 224 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 -PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011 23457788889999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=295.10 Aligned_cols=258 Identities=20% Similarity=0.308 Sum_probs=189.8
Q ss_pred hHhCccceeEEEEEEEc---CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEe
Q 006747 342 EVLGKGSYGTTYKAILE---EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYD 412 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E 412 (632)
+.||+|+||.||+|... ++..||+|.+.... .....+.+|++++.++ +||||+++++++... +..++|||
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceEEEEEe
Confidence 56999999999999964 47899999998632 1235678899999999 899999999999988 78999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC----CCCeEEcccCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ----DLQGCISDFGLTP 488 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~----~~~~ki~DfGla~ 488 (632)
|+++ ++.+++.........++++.....++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9975 677766543322234688889999999999999999998 9999999999999999 9999999999988
Q ss_pred CCCCCC-------CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChh-------HHHHH
Q 006747 489 LMNTPT-------VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP-------RWVQS 553 (632)
Q Consensus 489 ~~~~~~-------~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~-------~~~~~ 553 (632)
...... ...++..|+|||.+.+. .++.++|||||||+++||++|+.||...........+ ..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 754322 22457789999988764 4789999999999999999999999765433211110 00000
Q ss_pred Hh----------h--hcccc---ccccccccccCCcH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 554 VV----------R--EEWTS---EVFDVELMRYENIE-------EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 554 ~~----------~--~~~~~---~~~d~~~~~~~~~~-------~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. . .++.. ......... .... .....+.+++.+|++.||++|||+.|++++
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPS-NSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCC-ccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 0 00000 000000000 0001 123457889999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=285.02 Aligned_cols=240 Identities=20% Similarity=0.382 Sum_probs=192.7
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... +|..||+|.+.... ...+.+.+|++++.++ +|+||+++++++...+..++|+||++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheeccCCeEEEEEecCCCC
Confidence 57999999999999964 57899999986542 2345688999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-CeEEcccCCCCCCCCCC--
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~~-- 494 (632)
+|.+++.... ...+++..+..++.+++.||+|||+. +++|+||||+||++++++ .+||+|||.+.......
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 85 DLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 9999987542 23578999999999999999999998 999999999999999885 56999999987664432
Q ss_pred --CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 495 --VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
...++..|+|||.+.+..++.++|||||||++|||++|+.||.... ...++....... .... ..
T Consensus 159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~~-------~~ 224 (257)
T cd08225 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQGY-FAPI-------SP 224 (257)
T ss_pred ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhccc-CCCC-------CC
Confidence 2246778999999988889999999999999999999999986432 222222222111 1100 01
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.....+.+++.+||+.+|++|||+.|++++
T Consensus 225 ---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 ---NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 112357788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=291.24 Aligned_cols=252 Identities=20% Similarity=0.316 Sum_probs=186.7
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|+||.||+|... +++.||+|.+..... ....+.+|++++.++ +|+||+++++++.+.+..++||||+++ +
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 88 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHTKKTLTLVFEYLDT-D 88 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEecCCeEEEEEecCCC-C
Confidence 57999999999999865 689999999875422 234567899999999 999999999999999999999999985 9
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
|.+++.... ..+++.....++.+++.||.|||+. +|+||||||+||++++++.+||+|||+++..... .
T Consensus 89 L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (291)
T cd07844 89 LKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161 (291)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence 999887542 2578899999999999999999998 9999999999999999999999999998654321 1
Q ss_pred CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hccccc------c-
Q 006747 495 VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR---EEWTSE------V- 563 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~------~- 563 (632)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .+.......... +..... .
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 1235677999999876 44789999999999999999999999653310 000000000000 000000 0
Q ss_pred ------c-cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 564 ------F-DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 564 ------~-d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
. ...+............+.+++.+|++.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000000000001145678889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=288.39 Aligned_cols=243 Identities=20% Similarity=0.337 Sum_probs=199.9
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|.|+.|-+|+ .-.|..||||++.+...+ ...+.+|++-|+-+ +|||||+|+.+..+...+|+|+|+-++
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQTKlyLiLELGD~ 101 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQTKLYLILELGDG 101 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcccceEEEEEEecCC
Confidence 3679999999999987 457999999999877543 45788999999888 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee-cCCCCeEEcccCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL-SQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl-~~~~~~ki~DfGla~~~~~~-- 493 (632)
|+|++++-... ..+.+....+++.||..|+.|+|+. .+|||||||+||.+ .+-|-+|+.|||++-.+...
T Consensus 102 GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 102 GDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred chHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999986542 3478888899999999999999998 99999999999976 55689999999999766543
Q ss_pred -CCCCCCCcccCCccccCCCCC-ccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 -TVPSRSAGYRAPEVIETKKPT-QKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~~-~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
.+.+|+..|-|||.+.|..|+ +++||||+|||||-|+.|+.||+.....+.... ++|=. +
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDCK---Y 236 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDCK---Y 236 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhccc---c
Confidence 456788999999999999985 678999999999999999999986544332211 11211 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhh
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDI 609 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i 609 (632)
.-+.....++.+|+.+|+..||++|-|.++|+. .|+.+
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCC
Confidence 223344556788889999999999999999875 34444
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=291.30 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=192.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||+|.. .+|..||+|++..... ....+.+|++++.++ +|+||+++++++......++||||+ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEecCCeeEEEeccc-C
Confidence 35799999999999986 4689999999875532 246789999999999 8999999999999999999999999 9
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
++|.+++.... .++++..+..++.+++.||+|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 83 SDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999987542 4589999999999999999999998 99999999999999999999999999988765432
Q ss_pred ---CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc------------
Q 006747 495 ---VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE------------ 558 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 558 (632)
...++..|+|||.+.+.. ++.++||||+||+++||+||+.||....... ...++.......
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcc
Confidence 234677899999987654 6899999999999999999987775432111 011111100000
Q ss_pred -ccccccccccc-c-cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 559 -WTSEVFDVELM-R-YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 559 -~~~~~~d~~~~-~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+....+..... . .....+....+.+++.+|++.+|++|||+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 0 00001123567888999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=286.82 Aligned_cols=240 Identities=19% Similarity=0.300 Sum_probs=187.3
Q ss_pred hCccceeEEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 344 LGKGSYGTTYKAIL-EEGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 344 lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
||+|+||+||++.. .+|+.||+|.+.... .....+..|++++.++ +||||+++++++...+..++||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 69999999999985 458899999986532 1234567899999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---V 495 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~ 495 (632)
|.+++.... ...+++..+..++.+++.||.|||+. +++||||+|+||++++++.+||+|||.+....... .
T Consensus 80 L~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 153 (277)
T cd05577 80 LKYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG 153 (277)
T ss_pred HHHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence 999987543 23588999999999999999999998 99999999999999999999999999987654321 2
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..++..|+|||.+.+..++.++|||||||++|||++|+.||........ .. ... ..... .......
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~-~~~----~~~~~----~~~~~~~--- 219 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KE-ELK----RRTLE----MAVEYPD--- 219 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HH-HHH----hcccc----ccccCCc---
Confidence 2456789999999888899999999999999999999999965432111 00 000 00000 0000001
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRP-----TMEEVVR 604 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 604 (632)
.....+.+++.+||+.+|++|| ++.+++.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1123567888899999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.49 Aligned_cols=252 Identities=20% Similarity=0.284 Sum_probs=184.6
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|+||.||+|.. .++..||+|++..... ....+.+|++++.++ +|+||+++.+++...+..++|+||+. ++
T Consensus 11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 5799999999999985 4688999999875432 234678899999999 89999999999999999999999996 67
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
+.+++.... ..+.+.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 89 LAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 776665332 2467788888999999999999998 9999999999999999999999999998764322 2
Q ss_pred CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh-------------hccc
Q 006747 495 VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR-------------EEWT 560 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~ 560 (632)
...++..|+|||.+.+. .++.++|||||||++|||+||+.||...... ..........+. ..+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEKIWTVLGVPTEDTWPGVSKLPNYK 239 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence 22357789999998764 4788999999999999999999999753211 000000000000 0000
Q ss_pred ccccc----ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 561 SEVFD----VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 561 ~~~~d----~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.+... ..+............+.+++.+|++.||++|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000 000000000011245678889999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.43 Aligned_cols=253 Identities=20% Similarity=0.286 Sum_probs=187.0
Q ss_pred hHhCcc--ceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 342 EVLGKG--SYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G--~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
..||+| +||+||++.. .+|+.||+|++...... .+.+.+|+.++..+ +||||+++++++...+..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEecCCceEEEEeccc
Confidence 457777 9999999986 46899999998754322 35678888888888 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|++.+++.... ...+++.....++.|++.||+|||+. +|+||||||+||+++.++.+|++||+.+......
T Consensus 83 ~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 83 YGSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred CCCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 999999987643 23478888899999999999999988 9999999999999999999999999854322110
Q ss_pred ---------CCCCCCCcccCCccccCC--CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH----------
Q 006747 494 ---------TVPSRSAGYRAPEVIETK--KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ---------- 552 (632)
Q Consensus 494 ---------~~~~~t~~y~aPE~~~~~--~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~---------- 552 (632)
....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ......
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDIT 234 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCcccc
Confidence 111234569999999764 478999999999999999999999965421110 000000
Q ss_pred ------HHh----------------hhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 553 ------SVV----------------REEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 553 ------~~~----------------~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
... .......+.+..+ ...........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL-RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccc-cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 0000000000000 11112234567889999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=286.76 Aligned_cols=240 Identities=19% Similarity=0.312 Sum_probs=182.9
Q ss_pred HhCccceeEEEEEEEc-CCcEEEEEEecccccC----HHHHHHHHHHHHhh--cCCCCccceeEEEEeCCceEEEEeccc
Q 006747 343 VLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG----KREFEQQMEVVGRL--SQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l--~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
+||+|+||.||++... +++.||+|.+...... ...+..|..++..+ .+||||+++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3799999999999854 5889999998754221 12233443333322 279999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++... ..+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~ 152 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 152 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence 99999988643 2589999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....++..|+|||.+.++ .++.++|||||||++|||++|+.||.......... ....... ....+. .
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~------~~~~~~--~ 220 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------MAVELP--D 220 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc------cCCCCC--C
Confidence 233578889999998754 58999999999999999999999997542211111 0000000 001110 0
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
.....+.+++.+|+..+|.+|| ++.+++++
T Consensus 221 ---~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 221 ---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ---cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 1124577888899999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.05 Aligned_cols=240 Identities=23% Similarity=0.363 Sum_probs=191.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
...||+|+||.||++.. .++..||+|++..... ....+.+|+.++.++ +|+||+++++++...+..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 36799999999999986 4689999999864332 345688899999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 494 (632)
|.+++... .+++.....++.+++.|++|||+. +++|+||+|+||++++++.++|+|||++.......
T Consensus 104 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 104 LTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 99987543 378889999999999999999998 99999999999999999999999999986554321
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...++.+|+|||.+.+..++.++|||||||++|||++|+.||...... ..+.. ...... ..... .
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~------~~~~~-~~~~~~-----~~~~~---~ 239 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKM-IRDNLP-----PKLKN---L 239 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhhCC-----cccCC---c
Confidence 234678899999998888899999999999999999999998643211 11111 111110 00001 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
......+.+++.+||+.+|.+||++.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 1122346678889999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=302.60 Aligned_cols=241 Identities=20% Similarity=0.346 Sum_probs=190.9
Q ss_pred hHhCccceeEEEEEEEcCC-cEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAILEEG-TTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~-~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
..||.|+||+||+|..++. ...|.|++.... ..-++|.-|+++|..+ +||+||+|++.|...+.++|+.|||.||-.
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~enkLwiliEFC~GGAV 116 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFENKLWILIEFCGGGAV 116 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccCceEEEEeecCCchH
Confidence 4589999999999986654 445677776543 2357899999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC----CCCC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN----TPTV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~----~~~~ 495 (632)
+.++-+-. .+|...++.-++.+++.||.|||+. .|||||||+.|||++-+|.++++|||++.... .-+.
T Consensus 117 DaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 117 DAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred hHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 98876543 3688899999999999999999999 99999999999999999999999999975432 2345
Q ss_pred CCCCCcccCCcccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 496 PSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 496 ~~~t~~y~aPE~~~-----~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
..||+.|||||+.. ..+|+.++||||||++|.||..+.+|..... .-+.+-.+...+ . +.+.
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVllKiaKSe-P-----PTLl- 256 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSE-P-----PTLL- 256 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHHHhhcC-C-----Cccc-
Confidence 67999999999875 4579999999999999999999999964321 111111111111 1 1111
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.+......+.++..+|+.++|..||++++++++
T Consensus 257 --qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 --QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred --CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 223344567788889999999999999998763
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=290.38 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=189.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|... +++.+|+|.++..... ...+.+|++++.++ +||||+++.+++... ...++||||+
T Consensus 10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~lv~e~~ 88 (293)
T cd07843 10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYMVMEYV 88 (293)
T ss_pred hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEEEEehhc
Confidence 578999999999999965 5889999999754322 23567899999999 899999999999877 8899999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 493 (632)
++ +|.+++.... ..+++.....++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++.....
T Consensus 89 ~~-~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 89 EH-DLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred Cc-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 74 9998887542 2589999999999999999999998 9999999999999999999999999998876543
Q ss_pred ---CCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC-hhH---------HHHHHhhh--
Q 006747 494 ---TVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD-LPR---------WVQSVVRE-- 557 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~---------~~~~~~~~-- 557 (632)
....++..|+|||.+.+.. ++.++|+||||+++|||++|+.||......+... +.. |.......
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 1234577899999987654 6899999999999999999999997543211100 000 00000000
Q ss_pred --ccccccccccccccCCcHH--HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 558 --EWTSEVFDVELMRYENIEE--EMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 558 --~~~~~~~d~~~~~~~~~~~--~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..........+ . ..... ....+.+++.+||+.+|++|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 241 KKKTFTKYPYNQL-R-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cccccccccchhh-h-ccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000 0 00011 13456788899999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=290.18 Aligned_cols=256 Identities=21% Similarity=0.237 Sum_probs=187.8
Q ss_pred HHhHhCccceeEEEEEEEcCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 340 SAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
..+.+|.|+++.||++.. +++.||||+++... ...+.+..|++++.++ +|+||+++++++...+..+++|||+++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecCCeEEEEEeccCC
Confidence 345566777777777665 68999999987542 2345789999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++..... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 84 GSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred CCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 999999975432 2477888889999999999999998 9999999999999999999999999988654321
Q ss_pred --------CCCCCCCcccCCccccCC--CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hcc
Q 006747 494 --------TVPSRSAGYRAPEVIETK--KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR----EEW 559 (632)
Q Consensus 494 --------~~~~~t~~y~aPE~~~~~--~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 559 (632)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ...+....... ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKST 235 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCc
Confidence 112356679999998763 47899999999999999999999997532110 01110000000 000
Q ss_pred -------ccc----ccccccc---ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 560 -------TSE----VFDVELM---RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 560 -------~~~----~~d~~~~---~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ..+.... ..........++.+++.+||+.||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000 0000000 000111223457789999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=287.67 Aligned_cols=236 Identities=18% Similarity=0.266 Sum_probs=190.4
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++... +++.||+|.+.... ...+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEcCCeEEEEEecCCC
Confidence 57999999999999854 58999999986542 1245688899999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-C
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-V 495 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~ 495 (632)
++|.+++... ..+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||+++...... .
T Consensus 86 ~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 157 (290)
T cd05580 86 GELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT 157 (290)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCC
Confidence 9999998754 2478889999999999999999998 99999999999999999999999999998765442 2
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........ .... .+ ....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~------~~--~~~~- 221 (290)
T cd05580 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKIL-EGKV------RF--PSFF- 221 (290)
T ss_pred CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHh-cCCc------cC--CccC-
Confidence 3477889999999888889999999999999999999999864321 11111111 1100 00 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRP-----TMEEVVR 604 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 604 (632)
...+.+++.+||+.+|.+|+ +++|+++
T Consensus 222 --~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 222 --SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred --CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 23566788899999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=293.10 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=190.4
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC--ceEEEEec
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD--EKLLVYDF 413 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~E~ 413 (632)
..+.||+|+||.||+|... ++..||+|++.... .....+.+|++++.++.+|+||+++++++...+ ..++||||
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY 90 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence 3578999999999999865 57899999886431 223457789999999978999999999987543 57999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
++ ++|..++... .++|..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 91 ~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 91 ME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 97 5998888643 478899999999999999999998 9999999999999999999999999999765432
Q ss_pred CC---------CCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChh-HHH-------HHHh
Q 006747 494 TV---------PSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP-RWV-------QSVV 555 (632)
Q Consensus 494 ~~---------~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~-------~~~~ 555 (632)
.. ..++..|+|||.+.+ ..++.++|||||||++|||+||+.||......+...-. ... ...+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 236778999998765 45788999999999999999999999654321110000 000 0000
Q ss_pred hhcccccccccccc-ccC----CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhC
Q 006747 556 REEWTSEVFDVELM-RYE----NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIR 610 (632)
Q Consensus 556 ~~~~~~~~~d~~~~-~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~ 610 (632)
.......+++.... ... ...+....+.+++.+||+.+|++|||+.+++++ ++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 00000001100000 000 001123457889999999999999999999975 55553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=285.47 Aligned_cols=239 Identities=19% Similarity=0.265 Sum_probs=192.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... ++..||+|.+.... ...+.+.+|++++.++ +||||+++++++.+....++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQDEENMYLVVDLLL 83 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcCCCeEEEEEeCCC
Confidence 357999999999999965 58999999997542 2246788999999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+++|.+++... .++++.....++.+++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 84 GGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 99999998754 2578899999999999999999988 9999999999999999999999999998766443
Q ss_pred -CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 -TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...+........ . ..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~--~---------~~ 220 (258)
T cd05578 156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETA--D---------VL 220 (258)
T ss_pred ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccc--c---------cc
Confidence 2234677899999998888999999999999999999999999754322 111221111110 0 00
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTM--EEVV 603 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~--~evl 603 (632)
........+.+++.+||+.||.+||++ +|++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111122567788899999999999999 5544
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.43 Aligned_cols=239 Identities=26% Similarity=0.398 Sum_probs=190.7
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+..||.|.||.||.|. ..+|...|+|.++-... ....+.+|+.++..+ +|||+|+++|+=..++..+|.||||++
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHHHHHHHHHhcc
Confidence 4589999999999998 56688999999875432 235678999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|+|.+.+...+. +++.....+..|++.|++|||++ +||||||||.||+|+.+|.+|.+|||.|.......
T Consensus 1319 GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1319 GSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred CcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 999999986542 45555566788999999999999 99999999999999999999999999997765432
Q ss_pred ------CCCCCCcccCCccccCCC---CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 495 ------VPSRSAGYRAPEVIETKK---PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 495 ------~~~~t~~y~aPE~~~~~~---~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
...||+.|||||++.+.. ...+.||||+|||++||+||+.||...+.+ |. -++.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~a----------IMy~ 1453 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WA----------IMYH 1453 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hH----------HHhH
Confidence 124899999999998754 456789999999999999999999654321 11 1222
Q ss_pred ccccccCCcHHH-HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 566 VELMRYENIEEE-MVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 566 ~~~~~~~~~~~~-~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.........++. ..+-.+++.+|++.||++|.++.|++++
T Consensus 1454 V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 222222222222 2345678889999999999998876554
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=288.21 Aligned_cols=253 Identities=21% Similarity=0.361 Sum_probs=190.3
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|++|.||+|... +|..||+|+++.... ....+.+|++++.++ +|+||+++++++...+..++||||+++ +
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 57999999999999964 588999999875432 245678899999999 899999999999999999999999985 8
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
|.+++.... ...++++..+..++.|++.||+|||+. +++||||||+||++++++.+|++|||++...... .
T Consensus 84 l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 84 LKKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred HHHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 888876543 134589999999999999999999988 9999999999999999999999999999765432 1
Q ss_pred CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hcccc-----cccc
Q 006747 495 VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR---EEWTS-----EVFD 565 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~~d 565 (632)
...++..|++||.+.+. .++.++|||||||++|||++|+.||.+....+.. ........ +.... ..+.
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL---LKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhCCCChhhHHHHhcCchhc
Confidence 23457789999988664 4688999999999999999999999754322110 00000000 00000 0000
Q ss_pred ccccccC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 566 VELMRYE------NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 566 ~~~~~~~------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
....... ..+.....+.+++.+|++.||.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 00112345678899999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=289.58 Aligned_cols=247 Identities=24% Similarity=0.374 Sum_probs=193.6
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
..+.||+|+||.||+|... ++..+|+|.+..... ..+++.+|++++.++ +|+|++++.+++......++||||+
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~ 97 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYC 97 (308)
T ss_pred HHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcCCeeEEEEEcc
Confidence 3567999999999999954 578899999864311 134677899999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
. |++.+++.... .++++..+..++.+++.|+.|||+. +++||||||+||++++++.+||+|||++.......
T Consensus 98 ~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 169 (308)
T cd06634 98 L-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (308)
T ss_pred C-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence 7 58877765432 3478899999999999999999998 99999999999999999999999999998776655
Q ss_pred CCCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 VPSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...++..|+|||.+. ...++.++|||||||++|||++|+.||...... .......... .. .
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~-~~-----~---- 233 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNE-SP-----A---- 233 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHHHhhcC-CC-----C----
Confidence 566788999999975 345788999999999999999999998643211 1111111111 00 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.........+.+++.+||+.+|++||++.+++.+--....
T Consensus 234 ~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0011223456788899999999999999999987554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=313.59 Aligned_cols=260 Identities=18% Similarity=0.226 Sum_probs=176.9
Q ss_pred HhHhCccceeEEEEEEEcC--CcEEEEE------------------EecccccCHHHHHHHHHHHHhhcCCCCccceeEE
Q 006747 341 AEVLGKGSYGTTYKAILEE--GTTVVVK------------------RLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~ 400 (632)
.+.||+|+||+||++..+. +..+++| .++........+++|++++.++ +|+|||+++++
T Consensus 153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 231 (501)
T PHA03210 153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEI 231 (501)
T ss_pred EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCcCcEeEE
Confidence 4689999999999987532 2222222 1111111234688999999999 99999999999
Q ss_pred EEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeE
Q 006747 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC 480 (632)
Q Consensus 401 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~k 480 (632)
+...+..|+|+|++.+ +|..++..................|+.|++.||+|||+. +||||||||+|||++.++.+|
T Consensus 232 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 232 LRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 9999999999999864 677766543211111223455668999999999999998 999999999999999999999
Q ss_pred EcccCCCCCCCCCC-----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCC-CCCCCCCCChhHHHHHH
Q 006747 481 ISDFGLTPLMNTPT-----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQ-APGHEDVVDLPRWVQSV 554 (632)
Q Consensus 481 i~DfGla~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~-~~~~~~~~~~~~~~~~~ 554 (632)
|+|||+++.+.... ...+|..|+|||++.+..++.++|||||||++|||++|+.++. .........+...+...
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~ 387 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence 99999998764322 2357889999999999999999999999999999999886543 22211111111111100
Q ss_pred h--hhcccc------ccccc-ccc-ccCCcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 555 V--REEWTS------EVFDV-ELM-RYENIEE------EMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 555 ~--~~~~~~------~~~d~-~~~-~~~~~~~------~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. .++... +.++. ... ....... ....+.+++.+|++.||++|||+.|++.+
T Consensus 388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 000000 00000 000 0000011 11235667889999999999999999864
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=284.90 Aligned_cols=254 Identities=20% Similarity=0.336 Sum_probs=190.0
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|++|.||+|.. .+|..||+|++..... ....+.+|++++.++ +|+|++++++++.+.+..++||||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheeccCCeEEEEEeccC-
Confidence 35799999999999985 4699999999875432 235688899999999 89999999999999999999999995
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
++|.+++.... ...+++..+.+++.++++||+|||+. +++||||+|+||++++++.+||+|||+++......
T Consensus 82 ~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 82 LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 68999887543 23589999999999999999999998 99999999999999999999999999997654321
Q ss_pred --CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---hhcc-----cccc
Q 006747 495 --VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV---REEW-----TSEV 563 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~-----~~~~ 563 (632)
...++..|+|||.+.+. .++.++|||||||++|||++|+.||....... .+....+... ...+ ..+.
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchhh
Confidence 22356789999988764 46889999999999999999999996532111 0111111000 0000 0000
Q ss_pred ccccccc--cCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 564 FDVELMR--YEN----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 564 ~d~~~~~--~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. ..... ... .......+.+++.+||+.+|++|||++|++++
T Consensus 234 ~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 234 K-PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred h-hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 00000 000 01112457788999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=279.90 Aligned_cols=241 Identities=27% Similarity=0.433 Sum_probs=195.8
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|++|.||++... ++..+++|++..... ....+.+|++.+.++ +|+||+++++++......++++||+++++|
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 57999999999999975 688999999976543 456799999999999 799999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---VP 496 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---~~ 496 (632)
.+++.... ..+++..+..++.+++.+|+|||.. +++||||+|+||++++++.+||+|||.+....... ..
T Consensus 85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 157 (253)
T cd05122 85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM 157 (253)
T ss_pred HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence 99987642 3589999999999999999999997 99999999999999999999999999997765542 34
Q ss_pred CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHH
Q 006747 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEE 576 (632)
Q Consensus 497 ~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 576 (632)
.++..|+|||.+.+..++.++||||||++++||++|+.||..... ......... ....... ....
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~~~--------~~~~ 222 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKIAT-NGPPGLR--------NPEK 222 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHh-cCCCCcC--------cccc
Confidence 567789999999988899999999999999999999999864321 111111111 1010000 0010
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 577 EMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 577 ~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....+.+++.+||+.||++|||+.|++++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 12457788889999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=290.99 Aligned_cols=256 Identities=20% Similarity=0.276 Sum_probs=184.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc--------eE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE--------KL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~--------~~ 408 (632)
.+.||+|+||.||+|... +++.||||.+..... ....+.+|++++.++ +||||+++++++...+. .+
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccCCCceEE
Confidence 357999999999999864 589999999864322 134567899999999 89999999999876543 49
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
+||||+.+ +|.+.+.... ..+++.....++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.
T Consensus 96 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 96 LVFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred EEEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 99999975 8888776432 2478999999999999999999998 99999999999999999999999999997
Q ss_pred CCCCCC--------CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 489 LMNTPT--------VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 489 ~~~~~~--------~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
...... ...++..|+|||.+.+.. ++.++||||||+++|||+||+.||..............+........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 654322 123566799999887654 68899999999999999999999865332111111000000000000
Q ss_pred ccc-----cccc-ccccc--CCcHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 560 TSE-----VFDV-ELMRY--ENIEE------EMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 560 ~~~-----~~d~-~~~~~--~~~~~------~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ..+. ..... ..... ....+.+++.+||..||++|||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000 0000 00000 00000 12346789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=282.41 Aligned_cols=239 Identities=21% Similarity=0.323 Sum_probs=190.6
Q ss_pred hCccceeEEEEEEEcC-CcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 344 LGKGSYGTTYKAILEE-GTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 344 lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
||+|+||.||++...+ |+.|++|.+..... ..+.+.+|++++.++ +|+||+++++.+...+..++||||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999764 89999999975432 245688899999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 494 (632)
|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 80 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 80 LASLLENVG-----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 999997542 588899999999999999999998 99999999999999999999999999987643321
Q ss_pred --------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 495 --------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 495 --------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
...++..|+|||......++.++||||||+++||+++|+.||...... ........ +..
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~------ 218 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN-GKI------ 218 (265)
T ss_pred ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CCc------
Confidence 123567799999998888999999999999999999999999643211 11111111 000
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
...........+.+++.+||+.+|++|||+.++.+.|+
T Consensus 219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 ---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00000001345678888999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.13 Aligned_cols=244 Identities=13% Similarity=0.193 Sum_probs=172.4
Q ss_pred HhHhCccceeEEEEEEEcCC----cEEEEEEecccccC---H---------HHHHHHHHHHHhhcCCCCccceeEEEEeC
Q 006747 341 AEVLGKGSYGTTYKAILEEG----TTVVVKRLKEVVMG---K---------REFEQQMEVVGRLSQHPNVVPIRAYYFSK 404 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~----~~vavK~~~~~~~~---~---------~~~~~e~~~l~~l~~h~niv~l~~~~~~~ 404 (632)
.+.||+|+||.||+|...++ ..+|+|........ . .....+...+..+ +|+|++++++++...
T Consensus 17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYYGCGSFK 95 (294)
T ss_pred eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEEEeeeEe
Confidence 36799999999999996543 45666654322111 0 0111222334455 899999999977654
Q ss_pred C----ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeE
Q 006747 405 D----EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC 480 (632)
Q Consensus 405 ~----~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~k 480 (632)
. ..++++|++.. ++.+.+.... ..++.....++.|++.||+|||+. +|+||||||+|||++.++.+|
T Consensus 96 ~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 96 RCRMYYRFILLEKLVE-NTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred cCCceEEEEEEehhcc-CHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence 3 34677887643 5665554321 246777889999999999999998 999999999999999999999
Q ss_pred EcccCCCCCCCCC-----------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC-Ch-
Q 006747 481 ISDFGLTPLMNTP-----------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV-DL- 547 (632)
Q Consensus 481 i~DfGla~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~-~~- 547 (632)
|+|||+|+..... ....+|+.|+|||...+..++.++|||||||++|||++|+.||......... ..
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 9999999765321 1224788899999999999999999999999999999999999765322110 00
Q ss_pred -hHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 548 -PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 548 -~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
..+..... . ... ........+.+++..||+.+|++||++.++.+.++
T Consensus 247 ~~~~~~~~~-~--------~~~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 247 KCDFIKRLH-E--------GKI----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHHHhh-h--------hhh----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 01111110 0 000 01112345778888999999999999999998763
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=284.88 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=193.1
Q ss_pred CCHHHHHHHHHhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-C---HHHHHHHHHHHHhhcCCCCccceeEEEEeCC
Q 006747 331 FDLEDLLRASAEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-G---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD 405 (632)
Q Consensus 331 ~~~~~l~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 405 (632)
.+.+++. ...+.||+|+||.||+|.. .++..|++|++..... . ...+..|++++.++ +|+|++++++++.+..
T Consensus 17 ~~~~~~~-~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 94 (313)
T cd06633 17 DDPEEIF-VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKEH 94 (313)
T ss_pred CCHHHHh-hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeCC
Confidence 3445542 2345699999999999985 4588999999864322 1 24578899999999 8999999999999999
Q ss_pred ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 406 EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 406 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
..++||||+. |++.+++.... .++++..+..++.+++.+++|||+. +++|+||+|+||++++++.+||+|||
T Consensus 95 ~~~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg 166 (313)
T cd06633 95 TAWLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFG 166 (313)
T ss_pred EEEEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecC
Confidence 9999999996 57777775432 3588999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 486 LTPLMNTPTVPSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 486 la~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
++..........++..|+|||.+. ...++.++|||||||++|||++|+.||..... ............. .
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~~-~ 239 (313)
T cd06633 167 SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNDSP-T 239 (313)
T ss_pred CCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCCC-C
Confidence 987665555556788899999984 45678899999999999999999999865321 1111111111110 0
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. .......+.+++.+||+.+|++||++.+++++
T Consensus 240 ~~---------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 LQ---------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CC---------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 01112346778889999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=286.76 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=189.5
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~~~ 415 (632)
+.||+|+||.||+|... ++..+|+|++.... .....+.+|++++.++ +|+|++++++++... +..++|+||++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEecccc
Confidence 56899999999999865 48899999998653 2245688899999999 899999999999988 78999999998
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+ +|.+++.... ..+++.....++.+++.||+|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 84 H-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred c-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 5 8888886542 3588999999999999999999998 99999999999999999999999999997665432
Q ss_pred ----CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---cccccccc-
Q 006747 495 ----VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE---EWTSEVFD- 565 (632)
Q Consensus 495 ----~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d- 565 (632)
...++..|+|||.+.+. .++.++||||||+++|||+||+.||....... ....+...... .......+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccccc
Confidence 22356679999987653 57899999999999999999999997533211 11111110000 00000000
Q ss_pred -------ccccccC----CcHH-HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 566 -------VELMRYE----NIEE-EMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 566 -------~~~~~~~----~~~~-~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
....... .... +...+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000 0001 1456788999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=294.73 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=187.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCH---------------HHHHHHHHHHHhhcCCCCccceeEEEEeC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGK---------------REFEQQMEVVGRLSQHPNVVPIRAYYFSK 404 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~e~~~l~~l~~h~niv~l~~~~~~~ 404 (632)
.+.||+|+||.||+|... +++.||+|.++...... ..+.+|++++.++ +|+||+++++++...
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGLVDVYVEG 92 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeeeeEEEecC
Confidence 467999999999999854 68999999986542211 2477899999999 899999999999999
Q ss_pred CceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEccc
Q 006747 405 DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDF 484 (632)
Q Consensus 405 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~Df 484 (632)
+..++||||++ |+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCc
Confidence 99999999997 6899888643 2478889999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCC------------------CCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC
Q 006747 485 GLTPLMNTP------------------TVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV 545 (632)
Q Consensus 485 Gla~~~~~~------------------~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~ 545 (632)
|+++..... ....++..|+|||.+.+.. ++.++|||||||++|||+||+.||......+.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~- 242 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ- 242 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 998765411 1123466799999987654 68999999999999999999999975432111
Q ss_pred ChhHHHHHHhhh----ccccccccccc----c-ccCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 546 DLPRWVQSVVRE----EWTSEVFDVEL----M-RYEN----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 546 ~~~~~~~~~~~~----~~~~~~~d~~~----~-~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
...+...... .+......+.. . .... .......+.+++.+||+.+|++|||++|++.
T Consensus 243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 --LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred --HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111100 00000000000 0 0000 0112345778999999999999999999986
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=294.15 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=189.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC-----ceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-----EKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~E 412 (632)
.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|++++.++ +|+||+++++++.... ..++|+|
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 88 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFNDVYIVQE 88 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccceEEEEeh
Confidence 35799999999999984 468999999986432 2245678899999999 8999999999876543 5799999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++ +|..++... ++++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 89 ~~~~-~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 89 LMET-DLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred hccc-CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 9975 888777543 488899999999999999999998 999999999999999999999999999876543
Q ss_pred CC-------CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc---cc
Q 006747 493 PT-------VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW---TS 561 (632)
Q Consensus 493 ~~-------~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 561 (632)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ............. ..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 159 EHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLN 235 (336)
T ss_pred cccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHH
Confidence 21 1246778999998765 457899999999999999999999996532111 0111111000000 00
Q ss_pred cccccc-------cc--ccCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCC
Q 006747 562 EVFDVE-------LM--RYEN----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRP 611 (632)
Q Consensus 562 ~~~d~~-------~~--~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~ 611 (632)
.+.+.. .. .... ......++.+++.+||+.+|++|||+.|++++ ++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000000 00 0000 01123457889999999999999999999997 666543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.82 Aligned_cols=260 Identities=20% Similarity=0.323 Sum_probs=192.2
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeC-----CceEEEEe
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK-----DEKLLVYD 412 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~E 412 (632)
+.||+|+||.||+|.. .++..||||.+.... .....+.+|++++.++ +|+||+++++++... ...++|||
T Consensus 11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~~~~lv~e 89 (337)
T cd07858 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFNDVYIVYE 89 (337)
T ss_pred EEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccCcEEEEEe
Confidence 5799999999999985 468999999987532 2244677899999999 899999999988654 34799999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+. ++|.+++... .++++.....++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 90 LMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 996 6888888643 2488899999999999999999998 999999999999999999999999999976643
Q ss_pred C----CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh-----------h
Q 006747 493 P----TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV-----------R 556 (632)
Q Consensus 493 ~----~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~ 556 (632)
. ....++..|+|||.+.. ..++.++|||||||++|||++|+.||........ ........ .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhcC
Confidence 3 22346778999998865 4588999999999999999999999965321110 00000000 0
Q ss_pred hccccccccc--ccccc---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCCCCC
Q 006747 557 EEWTSEVFDV--ELMRY---ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRPSDS 614 (632)
Q Consensus 557 ~~~~~~~~d~--~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~~~~ 614 (632)
.......++. ..... .........+.+++.+||+.+|++|||+++++++ ++.+.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~ 302 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD 302 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence 0000000000 00000 0001123457789999999999999999999987 777655543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=291.33 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=186.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|... +|+.||+|.++..... ...+.+|++++.++ +|+||+++++++... +..++||||+
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~ 90 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSIFLVMEYC 90 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeEEEEEecC
Confidence 357999999999999964 5899999998754221 23466899999999 899999999998765 4689999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
.+ +|.+++.... .++++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++......
T Consensus 91 ~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 91 EQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred CC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 75 8888876532 3589999999999999999999998 99999999999999999999999999998765431
Q ss_pred ----CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---ccccc----
Q 006747 495 ----VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE---EWTSE---- 562 (632)
Q Consensus 495 ----~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~---- 562 (632)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+. ...+...... .....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchhhhcc
Confidence 1234667999999876 4578999999999999999999999975432111 1001010000 00000
Q ss_pred ----cccccccccCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 563 ----VFDVELMRYENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 563 ----~~d~~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.+.......... ......+.+++.+|++.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000 0113456788999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=276.79 Aligned_cols=240 Identities=25% Similarity=0.370 Sum_probs=195.2
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~~~ 415 (632)
+.||+|++|.||+|... ++..|++|++..... ..+.+.+|++.+.++ +|+||+++++.+... ...++|+||++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 57999999999999975 689999999976542 356788999999999 899999999999988 88999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+++|.+++.... .+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||.+.......
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 999999987542 589999999999999999999997 99999999999999999999999999987765433
Q ss_pred -----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 495 -----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 495 -----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
...++..|+|||.+.+..++.++||||||++++||++|+.||.... ................
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~-------- 223 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPP-------- 223 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCc--------
Confidence 2346778999999988889999999999999999999999997543 1111111111000000
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.........+.+++.+|++.+|++||++.|++++
T Consensus 224 --~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 --EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0111123467788889999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=273.80 Aligned_cols=249 Identities=21% Similarity=0.346 Sum_probs=201.1
Q ss_pred HhHhCccceeEEEEEEE------cCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeC-CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK-DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~ 411 (632)
..++-+|.||+||+|.+ .+.+.|.||.++... .....+..|.-.+..+ .|||+..+.+.+.+. +..+++|
T Consensus 289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeeccCcceEEE
Confidence 45688999999999954 345677788876542 2234577777777788 799999999998765 4678999
Q ss_pred ecccCCCHhhhhccCCCC---CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 412 DFIEAGSFSALLHGNRGI---GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
.++.-|+|..+|...++. ..+.+.-.+.+.++.|++.|++|||.+ +|||.||.++|++||+...+||+|=.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhcc
Confidence 999999999999854432 234567778889999999999999998 99999999999999999999999999998
Q ss_pred CCCCCCCC------CCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006747 489 LMNTPTVP------SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTS 561 (632)
Q Consensus 489 ~~~~~~~~------~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (632)
.+-..++. .+...||+||.+....|+..+|||||||+||||+| |+.||...+ +..+..++.+++..
T Consensus 445 DLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID-------PfEm~~ylkdGyRl 517 (563)
T KOG1024|consen 445 DLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID-------PFEMEHYLKDGYRL 517 (563)
T ss_pred ccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC-------HHHHHHHHhcccee
Confidence 87655443 35667999999999999999999999999999999 999986433 34455566665431
Q ss_pred ccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 562 EVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 562 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
..+-.+..+++.+|.-||+.+|++||+++|++..|.++.
T Consensus 518 ----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 518 ----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 223345567888899999999999999999999998863
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=287.05 Aligned_cols=252 Identities=19% Similarity=0.289 Sum_probs=184.9
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... +++.||+|.+..... ..+.+.+|++++.++ +|+||+++++++......++||||++ +
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~-~ 85 (294)
T PLN00009 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHSEKRLYLVFEYLD-L 85 (294)
T ss_pred EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEecCCeEEEEEeccc-c
Confidence 57899999999999864 688999999865422 235688899999999 89999999999999999999999996 5
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-CCCeEEcccCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-DLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~--- 493 (632)
+|.+++.... ...+++.....++.+++.||+|||+. +++||||+|+||++++ ++.+||+|||++......
T Consensus 86 ~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 86 DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred cHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 7877775432 22357778888999999999999998 9999999999999985 567999999999765432
Q ss_pred -CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---ccccccc---c
Q 006747 494 -TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE---EWTSEVF---D 565 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---d 565 (632)
....++..|+|||.+.+. .++.++|||||||++|||+||+.||......+. +.... ..... ....... +
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFKIF-RILGTPNEETWPGVTSLPD 236 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHhCCCChhhccccccchh
Confidence 122456789999988764 478999999999999999999999975322110 00000 00000 0000000 0
Q ss_pred --ccccc--cCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 566 --VELMR--YEN----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 566 --~~~~~--~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..... ... .......+.+++.+|++.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 000 0111234678889999999999999999986
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=295.07 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=191.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC------ceEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD------EKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv 410 (632)
.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|++++.++ +|+||+++++++.... ..++|
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCCceEEEE
Confidence 35799999999999985 4689999999875421 235678899999999 9999999999987543 46899
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
+||+.. +|..+.. ..+++.....++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 99 ~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 99 MPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 999974 7766542 1378889999999999999999998 9999999999999999999999999999765
Q ss_pred CCCC-CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHHHHhhhcc
Q 006747 491 NTPT-VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD---------LPRWVQSVVREEW 559 (632)
Q Consensus 491 ~~~~-~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~~~ 559 (632)
.... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .+.+... ..+..
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 246 (342)
T cd07879 168 DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK-LEDKA 246 (342)
T ss_pred CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH-hcccc
Confidence 4332 2345778999999876 458899999999999999999999997532111000 0000000 00000
Q ss_pred cccccc--ccccccC---CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCCCCCCCC
Q 006747 560 TSEVFD--VELMRYE---NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRPSDSENQ 617 (632)
Q Consensus 560 ~~~~~d--~~~~~~~---~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~~~~~~~ 617 (632)
...... +...... ........+.+++.+||+.||++||++++++.+ ++.+++.+..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~ 311 (342)
T cd07879 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETE 311 (342)
T ss_pred hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCC
Confidence 000000 0000000 000112356788999999999999999999965 888776544443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=284.33 Aligned_cols=246 Identities=20% Similarity=0.298 Sum_probs=192.1
Q ss_pred hHhCccceeEEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVV-----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
+.||+|+||.||++.. .++..||||.++... ...+.+..|++++.++.+|+||+++++.+......++|||
T Consensus 6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e 85 (288)
T cd05583 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILD 85 (288)
T ss_pred EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEe
Confidence 5799999999999874 357889999987532 1235688899999999779999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++|+|.+++... ..+++.....++.|+++||+|||+. +++||||||+||+++.++.++|+|||+++....
T Consensus 86 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 86 YVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred cCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 99999999998643 2478888899999999999999987 999999999999999999999999999876543
Q ss_pred CC-----CCCCCCcccCCccccCCC--CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 493 PT-----VPSRSAGYRAPEVIETKK--PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 493 ~~-----~~~~t~~y~aPE~~~~~~--~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
.. ...++..|+|||.+.+.. .+.++||||||+++|||++|+.||...... ..............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~------- 228 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSK------- 228 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccC-------
Confidence 22 123677899999987765 788999999999999999999998642211 11111111111110
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.. .... ....+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 229 ~~--~~~~---~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 PP--FPKT---MSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred CC--CCcc---cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 00 0011 123466788899999999999999888877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=291.19 Aligned_cols=253 Identities=21% Similarity=0.314 Sum_probs=187.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 410 (632)
.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|++++.++ +|+||+++++++... ...++|
T Consensus 21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccccCcEEEE
Confidence 36799999999999985 4689999999865322 234677899999999 999999999988644 346999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
|||+.+ +|.+.+... +++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 100 ~e~~~~-~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 100 MELMDA-NLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred EeccCC-CHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 999964 888777532 67788889999999999999998 9999999999999999999999999999876
Q ss_pred CCCC---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHHHH------
Q 006747 491 NTPT---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV---------DLPRWVQ------ 552 (632)
Q Consensus 491 ~~~~---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~~~------ 552 (632)
.... ...++..|+|||.+.+..++.++|||||||++|||++|+.||......+.. ....+..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 5432 224677899999999999999999999999999999999999754311100 0000000
Q ss_pred -HHhhhcc------cccccccccccc---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 553 -SVVREEW------TSEVFDVELMRY---ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 553 -~~~~~~~------~~~~~d~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....... ....+....... .........+.+++.+||+.||++|||+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000000000000 0011224457789999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=279.39 Aligned_cols=254 Identities=22% Similarity=0.349 Sum_probs=189.2
Q ss_pred hHhCccceeEEEEEEEcC-CcEEEEEEecccccC---HHHHHHHHHHHHhhc--CCCCccceeEEEEeCCc-----eEEE
Q 006747 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMG---KREFEQQMEVVGRLS--QHPNVVPIRAYYFSKDE-----KLLV 410 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~-----~~lv 410 (632)
+.||+|+||.||+|.... ++.||+|+++..... ...+.+|++++.++. +|+||+++++++...+. .+++
T Consensus 5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence 578999999999999764 899999999743221 345667877776663 59999999999998776 8999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
|||+.+ +|.+++.... ...+++..+..++.+++.||+|||+. +++|+||+|+||++++++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 85 FEHVDQ-DLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred ehhccc-CHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 999975 8988887542 23588999999999999999999998 9999999999999999999999999998776
Q ss_pred CCCCC---CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hccccc--
Q 006747 491 NTPTV---PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR---EEWTSE-- 562 (632)
Q Consensus 491 ~~~~~---~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~-- 562 (632)
..... ..++..|+|||.+.+..++.++|||||||++|||++|+.||......+ .+.+....... ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCCCcc
Confidence 44322 235677999999999899999999999999999999999987533211 11111110000 000000
Q ss_pred ----cccccccc--cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 563 ----VFDVELMR--YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 563 ----~~d~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.+...... .....+....+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0011122355778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=285.97 Aligned_cols=252 Identities=19% Similarity=0.303 Sum_probs=192.1
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|++|.||++... +++.+++|+++..... ...+..|++++.++ +|+||+++++++...+..++|+||+++
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 57999999999999864 6889999998765332 46788899999999 899999999999999999999999975
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
++.+++.... .++++..+..++.+++.||+|||+. +|+|+||||+||++++++.+||+|||.+.......
T Consensus 83 ~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~ 155 (283)
T cd05118 83 DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155 (283)
T ss_pred CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccc
Confidence 8888876532 3588999999999999999999998 99999999999999999999999999987665432
Q ss_pred -CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---ccccccc----
Q 006747 495 -VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE---WTSEVFD---- 565 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d---- 565 (632)
...++..|+|||.+.+. .++.++||||||+++|||+||+.||......+. .......+... ......+
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhhhh
Confidence 23356679999998876 689999999999999999999999965432111 00000000000 0000000
Q ss_pred --cccc-----c-cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 566 --VELM-----R-YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 566 --~~~~-----~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.... . .....+...++.+++.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 0 00011234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=283.04 Aligned_cols=258 Identities=21% Similarity=0.355 Sum_probs=190.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... +++.|++|++...... .....+|+..+.++.+|+||+++++++...+..++||||+ +|
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 357999999999999975 4788999998765332 2345678888999933999999999999999999999999 88
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence 9999887643 23589999999999999999999998 99999999999999999999999999997665432
Q ss_pred CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC----------hhHHHHHHhhhcccccc
Q 006747 495 VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD----------LPRWVQSVVREEWTSEV 563 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~ 563 (632)
...++..|+|||.+.+ ..++.++||||||++++||++|+.||......+... -..|.............
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence 2346778999998754 457899999999999999999999986543211100 00011111001000000
Q ss_pred ccccccc--cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 564 FDVELMR--YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 564 ~d~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+...... ..........+.+++.+||+.+|++|||++|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 00001113567889999999999999999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=271.00 Aligned_cols=194 Identities=24% Similarity=0.412 Sum_probs=164.9
Q ss_pred HhHhCccceeEEEEEEEcC-----CcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEe-CCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILEE-----GTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFS-KDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~ 411 (632)
...||+|.||.||+|.-.+ ...+|+|+++..... ....-+|+.++..+ +||||+.|..++.+ +..+++++
T Consensus 29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhccCceEEEEe
Confidence 4579999999999996332 347999999865322 34577899999999 99999999999887 67899999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC----CCeEEcccCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD----LQGCISDFGLT 487 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~----~~~ki~DfGla 487 (632)
||.+. ||..+++..+......++-.....|..|++.|+.|||+. =|+||||||.|||+..+ |.+||+|||++
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99988 999998866555556788889999999999999999998 79999999999999887 99999999999
Q ss_pred CCCCCC-------CCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 488 PLMNTP-------TVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 488 ~~~~~~-------~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
+.+... .....|..|+|||.+.|.+ ||.+.|||+.|||+.||+|-++-|.+.
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 887653 2334688899999999876 799999999999999999998888654
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=292.34 Aligned_cols=260 Identities=19% Similarity=0.325 Sum_probs=196.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC-----ceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-----EKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-----~~~lv~ 411 (632)
.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|++++..+ +|+||+++.+++.... ..++||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccceEEEe
Confidence 357999999999999965 48999999987643 2346788999999999 8999999999988775 789999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||++ ++|.+++.... ++++..+..++.+++.||+|||+. +|+||||||+||++++++.++|+|||++....
T Consensus 84 e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 84 ELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred cchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9998 48888886532 688999999999999999999998 99999999999999999999999999997765
Q ss_pred CCC-------CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh-------
Q 006747 492 TPT-------VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR------- 556 (632)
Q Consensus 492 ~~~-------~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 556 (632)
... ...++..|+|||.+.+. .++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhHh
Confidence 432 22357779999999887 789999999999999999999999976542111 000000000
Q ss_pred ----hccccccccccccc-c----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCCCC
Q 006747 557 ----EEWTSEVFDVELMR-Y----ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRPSD 613 (632)
Q Consensus 557 ----~~~~~~~~d~~~~~-~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~~~ 613 (632)
.......+...... . ....+....+.+++.+||+.+|++|||+.+++++ ++.++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~ 299 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccc
Confidence 00000000000000 0 0001123457789999999999999999999985 77776553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=282.26 Aligned_cols=243 Identities=22% Similarity=0.343 Sum_probs=188.2
Q ss_pred HhHhCccceeEEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVV-----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.||+|+||.||++.. .+|..||+|+++... ...+.+..|++++.++.+|+||+++++++..+...++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 35799999999999985 368999999997532 123567889999999977999999999999988999999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++++|.+++... .++++.....++.+++.||+|||+. +++||||||+|||+++++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 85 DYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 999999999998754 2477888888999999999999998 99999999999999999999999999987654
Q ss_pred CCC-----CCCCCCcccCCccccCC--CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 492 TPT-----VPSRSAGYRAPEVIETK--KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 492 ~~~-----~~~~t~~y~aPE~~~~~--~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
... ...++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ...............
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~----- 229 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP----- 229 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC-----
Confidence 322 22467789999998753 3678999999999999999999998643211 111122111111100
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
.. .......+.+++.+||+.+|++|| ++.+++.+
T Consensus 230 --~~-----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 230 --PY-----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --CC-----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00 011223466788899999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.30 Aligned_cols=252 Identities=21% Similarity=0.345 Sum_probs=187.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEe----CCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFS----KDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~E 412 (632)
.+.||+|+||.||+|.. .++..||+|++.... .....+..|++++.++ +|+||+++++++.. ....++|||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e 88 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKDVYVVMD 88 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCceEEEEEe
Confidence 35799999999999985 458999999987542 2245677899999999 89999999998764 346799999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+. |+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 89 ~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 89 LME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred hhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 996 6898888643 2488999999999999999999998 999999999999999999999999999876533
Q ss_pred CC--------CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh--------
Q 006747 493 PT--------VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV-------- 555 (632)
Q Consensus 493 ~~--------~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 555 (632)
.. ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~~~~~~ 236 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSPSEEVL 236 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCChhHhh
Confidence 21 2246778999999865 45899999999999999999999999754321110 0000000
Q ss_pred ---hhcccccccccccc-ccCC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 556 ---REEWTSEVFDVELM-RYEN----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 556 ---~~~~~~~~~d~~~~-~~~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.........+.... .... .......+.+++.+||+.+|++|||+++++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000000 0000 01124567889999999999999999998873
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=275.09 Aligned_cols=243 Identities=21% Similarity=0.358 Sum_probs=195.4
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||++.. .++..+|+|.+..... ....+..|++++.++ +|+||+++.+++......++||||+++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDGNKLCIVMEYAPF 83 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccCCEEEEEehhcCC
Confidence 35799999999999974 4678999999875432 245677899999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
++|.+++..... ....+++.....++.+++.||+|||+. +++|+||+|+||++++++.+|++|||+++......
T Consensus 84 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 159 (256)
T cd08530 84 GDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK 159 (256)
T ss_pred CCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence 999999875321 234688999999999999999999998 99999999999999999999999999997765432
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ..... ....... ...
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~----------~~~ 222 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ------DLRYK-VQRGKYP----------PIP 222 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HhcCCCC----------CCc
Confidence 234677899999999888999999999999999999999999653311 11111 1111110 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.....++.+++.+|++.+|++||++.+++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=288.54 Aligned_cols=237 Identities=19% Similarity=0.340 Sum_probs=192.8
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
...||+|.|++|..|.. ..+..||+|.+.+...+ ...+.+|+++|..+ +|||||+++.+..+...+|+||||..+
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t~~~lylV~eya~~ 139 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIETEATLYLVMEYASG 139 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeeecceeEEEEEeccC
Confidence 35799999999999985 45899999999887543 34589999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|.+++++..... ........++.|+..+++|+|++ .|||||||++||||+.+.++||+|||++.++...
T Consensus 140 ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 140 GELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred chhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccccc
Confidence 999999987753 22355667888999999999999 9999999999999999999999999999887643
Q ss_pred CCCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 TVPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
.+.+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||++..-.+. ++. ++...+....
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------r~r----vl~gk~rIp~ 276 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------RPR----VLRGKYRIPF 276 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------cch----heeeeecccc
Confidence 45678999999999999887 7889999999999999999999986432221 110 1111111111
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.... +.-+++++.+-.+|.+|++++++.+
T Consensus 277 ~ms~---dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 277 YMSC---DCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeec---hhHHHHHHhhccCccccCCHHHhhh
Confidence 1222 3446677899999999999999866
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=285.53 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=186.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC----------c
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD----------E 406 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----------~ 406 (632)
.+.||+|+||.||+|... +++.||+|+++... .....+.+|++++.++ +||||+++++++.+.. .
T Consensus 12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhccccCCc
Confidence 467999999999999975 58899999997542 2235678899999999 8999999999987654 7
Q ss_pred eEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCC
Q 006747 407 KLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486 (632)
Q Consensus 407 ~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 486 (632)
.++|+||+++ ++...+... ...+++.....++.+++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred EEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccc
Confidence 8999999986 677766543 23588999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCCCC-----CCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc--
Q 006747 487 TPLMNTPTV-----PSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE-- 558 (632)
Q Consensus 487 a~~~~~~~~-----~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 558 (632)
+........ ...+..|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~ 239 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLCGSPCP 239 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCCh
Confidence 987644321 2346679999988654 4688999999999999999999999643211 1111111110000
Q ss_pred -cccccc--------ccccccc----CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 559 -WTSEVF--------DVELMRY----ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 559 -~~~~~~--------d~~~~~~----~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....+. +...... .........+.+++.+||+.+|++||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 0000000 0000112457788899999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=282.87 Aligned_cols=253 Identities=19% Similarity=0.329 Sum_probs=187.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEe-CCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFS-KDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... ++..||+|++.... ...+.+..|++++.++ +||||+++.+++.. ....++|+||+
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 367999999999999844 78999999886432 2245688899999999 89999999999876 45789999998
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+++|..++... ++++.....++.|++.||+|||+. +|+||||+|+||++++++.+||+|||.+.......
T Consensus 93 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 163 (328)
T cd07856 93 GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT 163 (328)
T ss_pred ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCcC
Confidence 56898888643 367788888999999999999998 99999999999999999999999999997654432
Q ss_pred CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHHHHhhhccccccc
Q 006747 495 VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD---------LPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~ 564 (632)
...++..|+|||.+.+ ..++.++|||||||++|||+||+.||.......... ..++......+. ..+.+
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 242 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN-TLRFV 242 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh-hHHHH
Confidence 2346778999998866 568999999999999999999999996543211000 011111110000 00000
Q ss_pred -cccccccCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 565 -DVELMRYENIE----EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 565 -d~~~~~~~~~~----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
........... .....+.+++.+||+.+|++|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000011 112467788999999999999999999876
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=272.73 Aligned_cols=238 Identities=24% Similarity=0.448 Sum_probs=193.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|++|.||++... +++.|++|.+..... ....+.+|++++.++ +|+|++++++++.+....++||||+++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETSDSLYIILEYAEN 83 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeCCEEEEEEecCCC
Confidence 367999999999999854 578999999987643 345788999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV- 495 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 495 (632)
++|.+++... .++++..+..++.+++.|+.|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 84 GSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999998754 3588999999999999999999988 999999999999999999999999999977654332
Q ss_pred ---CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 496 ---PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 496 ---~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
..++..|+|||...+..++.++||||+|+++|||++|+.||..... ...... ..... ...+ ..
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~-~~~~~--~~~~------~~ 221 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFR-IVQDD--HPPL------PE 221 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH-HhccC--CCCC------CC
Confidence 3467789999999888889999999999999999999999864321 111111 00000 0000 01
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.....+.+++.+||..+|++|||+.+++.
T Consensus 222 ---~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 ---GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ---CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11245678888999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=272.04 Aligned_cols=242 Identities=20% Similarity=0.394 Sum_probs=195.9
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||++... ++..|++|++..... ....+.+|++++.++ +|+|++++.+.+...+..++|+||++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecCCEEEEEEEecCCC
Confidence 57899999999999964 588999999976533 346788999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++..... ....+++.....++.+++.||+|||+. +++|+||+|+||++++++.+||+|||.+.......
T Consensus 85 ~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 85 DLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 99999976431 224689999999999999999999998 99999999999999999999999999987665432
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...++..|+|||...+..++.++||||+|+++++|++|+.||.... ............ ... +
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~-~~~-----~----- 223 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKGQ-YPP-----I----- 223 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcCC-CCC-----C-----
Confidence 2346777999999988889999999999999999999999986432 111222211111 000 0
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.......+.+++.+||..+|++|||+.+++++
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00122457788889999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=287.82 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=184.3
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceEEEE
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKLLVY 411 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv~ 411 (632)
+.||+|+||.||+|.. .+++.||+|+++.... ..+.+.+|++++.++ +|+||+++++++... ...++++
T Consensus 23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccccccccEEEEe
Confidence 5699999999999984 5688999999975422 235677899999999 999999999988643 3467888
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
|++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 876 77998887642 378899999999999999999998 99999999999999999999999999987764
Q ss_pred CCC-CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC-hhH-------HHHHHhhhcccc
Q 006747 492 TPT-VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD-LPR-------WVQSVVREEWTS 561 (632)
Q Consensus 492 ~~~-~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~-~~~-------~~~~~~~~~~~~ 561 (632)
... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +.. .......+....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 432 2346778999998866 457889999999999999999999996532211000 000 000000000000
Q ss_pred ccccccccc--cCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 562 EVFDVELMR--YENIE----EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 562 ~~~d~~~~~--~~~~~----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..+ ..+.. ..... .....+.+++.+|++.||.+||++.+++.+
T Consensus 252 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 252 NYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHH-HHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000 00000 00000 112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=288.72 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=190.4
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCC------ceEEEE
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD------EKLLVY 411 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~ 411 (632)
+.||+|+||.||++.. .++..||||++...... ...+..|++++.++ +|+||+++++++.... ..++||
T Consensus 21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccccceEEEEE
Confidence 5799999999999984 46899999998653222 34678899999999 9999999999987653 358999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 100 e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 100 PFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 999 67998887632 478899999999999999999998 99999999999999999999999999998765
Q ss_pred CCC-CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC-C--------hhHHHHHHhhhccc
Q 006747 492 TPT-VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV-D--------LPRWVQSVVREEWT 560 (632)
Q Consensus 492 ~~~-~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~-~--------~~~~~~~~~~~~~~ 560 (632)
... ...++..|+|||.+.+ ..++.++|||||||++||+++|+.||......... . ...+..... ....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 248 (343)
T cd07880 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ-SEDA 248 (343)
T ss_pred cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc-chhH
Confidence 432 2346778999999876 45789999999999999999999999753211000 0 000000000 0000
Q ss_pred ccccccccccc--CC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHH--HHHhhhCCCCC
Q 006747 561 SEVFDVELMRY--EN----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVV--RMIEDIRPSDS 614 (632)
Q Consensus 561 ~~~~d~~~~~~--~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl--~~L~~i~~~~~ 614 (632)
.... ..+... .. .......+.+++.+|++.||++|||+.+++ ..++.......
T Consensus 249 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~ 309 (343)
T cd07880 249 KNYV-KKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED 309 (343)
T ss_pred HHHH-HhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence 0000 000000 00 011123477899999999999999999999 45666655433
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=279.67 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=191.2
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... +++.||+|.+.... ...+.+..|++++.++ +|+||+++++++...+..++||||++ +
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~-~ 82 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTERKLYLVFEYCD-M 82 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence 57999999999999965 48999999998653 2245678899999999 89999999999999999999999998 5
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||+|+||++++++.+||+|||+++......
T Consensus 83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence 8999997642 3588999999999999999999998 99999999999999999999999999987764432
Q ss_pred -CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hcccc---cc--c
Q 006747 495 -VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR---EEWTS---EV--F 564 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~---~~--~ 564 (632)
....+..|+|||.+.+. .++.++|||||||++|||++|+.||......+ ....+..... +.... .. .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID---QLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12345679999998776 78999999999999999999999986533111 0011100000 00000 00 0
Q ss_pred cccccccC------CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 565 DVELMRYE------NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 565 d~~~~~~~------~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
+....... ........+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00010000 00111346788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=284.45 Aligned_cols=253 Identities=20% Similarity=0.279 Sum_probs=183.6
Q ss_pred hHhCccceeEEEEEEEc-C--CcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeC----CceEEEE
Q 006747 342 EVLGKGSYGTTYKAILE-E--GTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK----DEKLLVY 411 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~--~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~----~~~~lv~ 411 (632)
+.||+|+||.||++... . +..||+|++..... ..+.+.+|++++.++.+|+||+++++++... ...++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 85 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence 57999999999999954 3 67899999875321 2456788999999986799999999876533 3578899
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+. ++|.+++... .++++.....++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 86 e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 86 ELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred eccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 9986 5898888643 3588999999999999999999998 99999999999999999999999999997654
Q ss_pred CCC--------CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHHH
Q 006747 492 TPT--------VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD---------LPRWVQS 553 (632)
Q Consensus 492 ~~~--------~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~---------~~~~~~~ 553 (632)
... ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+... ...+...
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 221 1246778999998766 458999999999999999999999986533111000 0000000
Q ss_pred Hhhhccccccccc-cccccCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 554 VVREEWTSEVFDV-ELMRYENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 554 ~~~~~~~~~~~d~-~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..... ....... ........ ......+.+++.+|++.+|++|||+.+++.
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 237 IGSPK-AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhh-HHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0000000 00000000 011345778999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=270.57 Aligned_cols=231 Identities=24% Similarity=0.339 Sum_probs=187.6
Q ss_pred hCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 344 LGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 344 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
||+|+||.||++... +++.+|+|++..... ....+..|++++.++ +|+||+++++.+...+..++||||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 699999999999865 489999999876532 234788999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
|.+++.... .+++.....++.+++.|+.|||+. +++|+||+|+||++++++.++|+|||++...... .
T Consensus 80 L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (250)
T cd05123 80 LFSHLSKEG-----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN 151 (250)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence 999997542 478899999999999999999997 9999999999999999999999999998766442 2
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...++..|+|||...+...+.++|+||||+++||+++|+.||..... ........... .......
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~---------~~~~~~~ 216 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDP---------LRFPEFL 216 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCC---------CCCCCCC
Confidence 23467789999999888889999999999999999999999964321 11111111110 0001111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEE 601 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~e 601 (632)
...+.+++.+||..||++||++.+
T Consensus 217 ---~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 ---SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CHHHHHHHHHHhcCCHhhCCCccc
Confidence 245678888999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=273.46 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=198.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC-----CccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHP-----NVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~-----niv~l~~~~~~~~~~~lv~E~~ 414 (632)
...+|+|.||.|.+.... .+..||||+++....-.+...-|++++.++.++. -+|.+.+||.-.++.+||+|.+
T Consensus 94 ~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell 173 (415)
T KOG0671|consen 94 VDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL 173 (415)
T ss_pred hhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence 467999999999999854 3689999999987666677888999999995432 3788889999999999999998
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-------------------
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ------------------- 475 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~------------------- 475 (632)
|-|+.+++.++ +..+++......++.|++++++|||+. +++|-||||+|||+.+
T Consensus 174 -G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ 246 (415)
T KOG0671|consen 174 -GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL 246 (415)
T ss_pred -ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence 44999999876 356788899999999999999999998 9999999999999831
Q ss_pred -CCCeEEcccCCCCCCCCCCC-CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC-------
Q 006747 476 -DLQGCISDFGLTPLMNTPTV-PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD------- 546 (632)
Q Consensus 476 -~~~~ki~DfGla~~~~~~~~-~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~------- 546 (632)
+..+||+|||.|.+...... ...|..|+|||++.+-.++.++||||+||||.|+.||..-|+.....+...
T Consensus 247 ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlG 326 (415)
T KOG0671|consen 247 KSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILG 326 (415)
T ss_pred CCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhC
Confidence 34589999999988766543 457888999999999999999999999999999999999998655333221
Q ss_pred -hhHHH------HHHhhhc---ccc--------ccccccc---cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 547 -LPRWV------QSVVREE---WTS--------EVFDVEL---MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 547 -~~~~~------~~~~~~~---~~~--------~~~d~~~---~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
++.-+ ..+...+ |.. .+++... .......++..++++|+++++..||.+|+|+.|++++
T Consensus 327 p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 327 PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 11111 0111111 000 0000000 0011234566789999999999999999999999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=243.94 Aligned_cols=256 Identities=20% Similarity=0.303 Sum_probs=190.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|.||+||+|+. +.++.||+|+++....+ .....+|+-++..+ +|+|||++++....+....+|+||+..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhccCceeEEeHHHhhH
Confidence 46899999999999994 45788999999765332 45688999999999 899999999999999999999999976
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
+|..+.....+ .++......++.|+.+||.|+|++ ++.||||||.|.||+.+|++|++|||+++..+...
T Consensus 86 -dlkkyfdslng----~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 86 -DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred -HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 88888765542 377788889999999999999998 99999999999999999999999999999876542
Q ss_pred --CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc---ccc
Q 006747 495 --VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF---DVE 567 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---d~~ 567 (632)
....|..|++|.++.+.+ |++..|+||-||++.|+.. |++-|.+.+..+...-+-|+-....+..+..+. |-.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 334688899999998866 8999999999999999998 666676654333322122221112222221111 111
Q ss_pred cc-ccC---CcHHHH----HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 568 LM-RYE---NIEEEM----VQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 568 ~~-~~~---~~~~~~----~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. .+. ....-+ ..=.++....+.-+|.+|.++++.+++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 00 000 011111 112356667777799999999988764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=266.68 Aligned_cols=192 Identities=24% Similarity=0.381 Sum_probs=167.0
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEeccccc-CHHH---HHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVM-GKRE---FEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~---~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.++||+|.||+|-+++ ...++.+|+|++++... .+.+ -..|-++|... +||.+..+...|++.++++.||||..
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt~drlCFVMeyan 251 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQTQDRLCFVMEYAN 251 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhccCceEEEEEEEcc
Confidence 5789999999999988 45689999999987632 3333 45667788888 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC----
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN---- 491 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~---- 491 (632)
||.|.-+|...+ .+++.....+-.+|..||.|||+. +||.||||-+|.|+|.||++||+|||+++.--
T Consensus 252 GGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~ 323 (516)
T KOG0690|consen 252 GGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD 323 (516)
T ss_pred CceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccccc
Confidence 999999987654 356666667888999999999998 99999999999999999999999999997642
Q ss_pred CCCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 006747 492 TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGH 541 (632)
Q Consensus 492 ~~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~ 541 (632)
...+.+||+.|+|||++....|...+|.|.+|||||||+.|+.||...+.
T Consensus 324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch
Confidence 33456899999999999999999999999999999999999999986543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=273.59 Aligned_cols=242 Identities=23% Similarity=0.341 Sum_probs=186.7
Q ss_pred HhHhCccceeEEEEEEEcC-CcEEEEEEecccc------cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVV------MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||++.... +..+++|.++... .....+..|++++.++ +||||+++++++.+.+..++||||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcCCceEEEEEe
Confidence 3579999999999998543 4456666655321 1234567788899999 899999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++++|.+++..... ....+++.....++.+++.||.|||+. +++|+||||+||++++ +.+||+|||+++.....
T Consensus 84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 84 CEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred CCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 999999998875322 234689999999999999999999998 9999999999999975 56999999998765432
Q ss_pred C----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 494 T----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 494 ~----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
. ...++..|+|||.+.+..++.++||||||+++|+|++|..||.... .......... ....
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~~~~-------- 223 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-GPTP-------- 223 (260)
T ss_pred cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-CCCC--------
Confidence 1 2346778999999988888999999999999999999999985321 1111111111 1000
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.........+.+++.+||+.+|++||++.|++++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 --SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0111233467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=271.19 Aligned_cols=239 Identities=19% Similarity=0.273 Sum_probs=185.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc------cCHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV------MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 411 (632)
.+.||+|+||.||+|.. .++..||+|.+.... .....+.+|++++.++ +|+||+++++++.+. ...++|+
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~v~ 85 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFV 85 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCEEEEEE
Confidence 46799999999999985 458999999875321 1234688899999999 899999999998764 4578999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++++|.+++.... ++++.....++.+++.||.|||+. +++|+||||+||+++.++.++|+|||+++...
T Consensus 86 e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 86 EYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999987532 377888899999999999999988 99999999999999999999999999997653
Q ss_pred CC-------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 492 TP-------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 492 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.. ....++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~~- 229 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQP-TKPM- 229 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCC-CCCC-
Confidence 21 122467789999999988899999999999999999999999964311 11111111100 0000
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
........+.+++.+||+ +|..||++.+++.+
T Consensus 230 --------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 230 --------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred --------CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 011122456677889999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=277.03 Aligned_cols=237 Identities=20% Similarity=0.333 Sum_probs=190.5
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++... +++.||+|++.... ...+.+..|.+++.++.+|+||+++++++...+..++||||+++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd05581 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPN 86 (280)
T ss_pred eeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCC
Confidence 56999999999999864 68999999987532 22356888899999993399999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC-
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV- 495 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~- 495 (632)
++|.+++.... .+++.....++.+++.||+|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 87 ~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 87 GELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 99999997542 589999999999999999999998 999999999999999999999999999876543221
Q ss_pred -----------------------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006747 496 -----------------------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 496 -----------------------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 552 (632)
..++..|+|||...+..++.++||||||++++|+++|+.||...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~ 232 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------LTFQ 232 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH
Confidence 12467799999998888999999999999999999999999754310 0011
Q ss_pred HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 006747 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTM----EEVVR 604 (632)
Q Consensus 553 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~----~evl~ 604 (632)
......+ .........+.+++.+||+.+|++|||+ +++++
T Consensus 233 ~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 233 KILKLEY------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHhcCC------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111100 0111113457788899999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=283.14 Aligned_cols=252 Identities=22% Similarity=0.335 Sum_probs=182.7
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC--------ceE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD--------EKL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--------~~~ 408 (632)
.+.||+|+||.||+|... +++.||+|++..... ....+.+|++++.++ +|+||+++++++.... ..+
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccccCceEE
Confidence 357999999999999854 588999999864422 234577899999999 8999999999876543 369
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
+|+||+.+ ++...+.... ..+++.....++.++++||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 92 lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 92 MVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred EEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 99999975 6777665432 3588999999999999999999998 99999999999999999999999999987
Q ss_pred CCCCCCC---------------CCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006747 489 LMNTPTV---------------PSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 489 ~~~~~~~---------------~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 552 (632)
....... ..++..|+|||.+.+. .++.++|||||||++|||++|+.||.+....... ..+.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~---~~~~ 240 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL---HLIF 240 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence 6543211 1245679999988654 4789999999999999999999999653321110 0000
Q ss_pred HHhh---h-cc-----cccccc-cccccc-CCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 553 SVVR---E-EW-----TSEVFD-VELMRY-ENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 553 ~~~~---~-~~-----~~~~~d-~~~~~~-~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.... + .+ .....+ ...... ... ......+.+++.+|++.+|++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 0 00 000000 000000 000 111245778999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=292.38 Aligned_cols=242 Identities=26% Similarity=0.424 Sum_probs=201.2
Q ss_pred hHhCccceeEEEEEE-EcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe-----CCceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS-----KDEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-----~~~~~lv~E~~~ 415 (632)
++||+|.+|.||+++ .++++.+|+|++.-.....++++.|.++++...+|||++.++|+|.. ++++|+|||||.
T Consensus 25 evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~ 104 (953)
T KOG0587|consen 25 EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCG 104 (953)
T ss_pred EEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccC
Confidence 579999999999998 56789999999987777788899999999999999999999999874 468999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+..+++++.. ...+.|....-|+.++++|++|||.. .++|||||-.|||++.++.+|++|||++..+...
T Consensus 105 gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g 178 (953)
T KOG0587|consen 105 GGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG 178 (953)
T ss_pred CccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence 999999998775 34589999999999999999999998 9999999999999999999999999999776543
Q ss_pred --CCCCCCCcccCCccccCCC-----CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKK-----PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~-----~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
.+..||+.|||||++.... |+.++|+||+|++..||--|.+|+.++.....+ -.+.+. -.+
T Consensus 179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------F~IpRN------PPP 246 (953)
T KOG0587|consen 179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPRN------PPP 246 (953)
T ss_pred cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------ccCCCC------CCc
Confidence 3456899999999997543 678899999999999999999998654321110 000000 011
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.....+....++.+++..|+.+|-++||++.++++
T Consensus 247 ---kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 247 ---KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 12234456678889999999999999999998775
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=288.36 Aligned_cols=193 Identities=26% Similarity=0.416 Sum_probs=165.9
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC------ceEEEE
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD------EKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~ 411 (632)
.+.||+|+||.||+|+ .+.|+.||||.++... ...+..-+|+++++++ +|+|||++++.=.+.. ...+||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCcccccceEEE
Confidence 4679999999999999 6679999999998753 2356688999999999 7999999998765433 568999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec--CCC--CeEEcccCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS--QDL--QGCISDFGLT 487 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~--~~~--~~ki~DfGla 487 (632)
||+.+|||+..+....+ -..|++...+.+..+++.||.|||+. +|+||||||.||++- ++| .-||+|||.|
T Consensus 97 EyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred eecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999986543 23488899999999999999999988 999999999999983 334 4699999999
Q ss_pred CCCCCCCC---CCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 488 PLMNTPTV---PSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 488 ~~~~~~~~---~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
+.+.+.+. ..||..|.+||.+.. +.|+..+|.|||||++||.+||..||...
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 99877643 359999999999985 77899999999999999999999999754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=303.07 Aligned_cols=245 Identities=24% Similarity=0.351 Sum_probs=176.1
Q ss_pred CCHHHHHHHHHhHhCccceeEEEEEEE-cCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC--
Q 006747 331 FDLEDLLRASAEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-- 405 (632)
Q Consensus 331 ~~~~~l~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-- 405 (632)
-+++++ +.||+||||.||+++. -||+.||||++.... .....+.+|++.++++ +|||||+++..|.+..
T Consensus 479 ~DFEEL-----~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 479 NDFEEL-----ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhhHHH-----HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCc
Confidence 355655 6899999999999994 479999999998663 2345688999999999 9999999976643211
Q ss_pred --------------------------------------------------------------------------------
Q 006747 406 -------------------------------------------------------------------------------- 405 (632)
Q Consensus 406 -------------------------------------------------------------------------------- 405 (632)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred -------------------------------------ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHH
Q 006747 406 -------------------------------------EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAK 448 (632)
Q Consensus 406 -------------------------------------~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 448 (632)
-+||=||||+...++++++.+.... .-...++++.+|+.
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILE 708 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHH
Confidence 1245566666666666665442110 23455788999999
Q ss_pred HHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC----------------------CCCCCCCCCcccCCc
Q 006747 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN----------------------TPTVPSRSAGYRAPE 506 (632)
Q Consensus 449 ~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~----------------------~~~~~~~t~~y~aPE 506 (632)
||+|+|+. +||||||||.||++|++..+||+|||+|+... +.+...||.-|+|||
T Consensus 709 GLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 99999999 89999999999999999999999999997721 012234788899999
Q ss_pred cccCCC---CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHH
Q 006747 507 VIETKK---PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQ 583 (632)
Q Consensus 507 ~~~~~~---~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 583 (632)
++.+.. |+.|+|+||+|||++||+. ||.... +. ... -..++++....- .....+++..-.+
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ER---a~i-L~~LR~g~iP~~-------~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ER---ASI-LTNLRKGSIPEP-------ADFFDPEHPEEAS 849 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCchH--HH---HHH-HHhcccCCCCCC-------cccccccchHHHH
Confidence 997654 9999999999999999995 453211 11 111 111222221110 0112233444567
Q ss_pred HHHHccCCCCCCCCCHHHHHH
Q 006747 584 IAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 584 l~~~Cl~~~P~~RPs~~evl~ 604 (632)
++.++++.||.+|||+.|+++
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhh
Confidence 888999999999999999876
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-34 Score=263.48 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=193.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccc--ccC-HHHHHHHHHHHHhhcCCCCccceeEEEEeC--------CceE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEV--VMG-KREFEQQMEVVGRLSQHPNVVPIRAYYFSK--------DEKL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~ 408 (632)
...||+|.||.||+|+.+ .|+.||+|++--. ..+ .....+|+++|..+ +|+|++.++..|.+. ...|
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcccccceee
Confidence 468999999999999854 4778898876432 112 35678899999999 899999999988753 2479
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
+||++++. +|..+|.+.. ..+....+.+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||+++
T Consensus 101 lVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 101 LVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 99999987 8888887542 3477788999999999999999998 99999999999999999999999999998
Q ss_pred CCCCCCCC--------CCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 489 LMNTPTVP--------SRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 489 ~~~~~~~~--------~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
.+...... ..|..|++||.+.|.+ |+++.|||.-|||+.||+||.+-+++..+....++++..-..+..+.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 77544322 2377899999998765 89999999999999999999999987665444443333222222222
Q ss_pred cccccccccc---------c--cCCcHHHHH------HHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 560 TSEVFDVELM---------R--YENIEEEMV------QMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 560 ~~~~~d~~~~---------~--~~~~~~~~~------~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
+.++..-.+. . ....++.+. +.++++...+..||.+|+++.+++.+-
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 2222111111 0 011222233 567888899999999999999987653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=261.57 Aligned_cols=245 Identities=20% Similarity=0.294 Sum_probs=193.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe----CCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS----KDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~E~~~ 415 (632)
.++||-|-.|+|..... ..++.+|+|++.+.. ..++|++.--+...|||||.++++|.. ...+.+|||.|+
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 47899999999998874 458889999997643 456777776666789999999998864 345789999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---CCCeEEcccCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGCISDFGLTPLMNT 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~ 492 (632)
||.|+..++..+ ...+++...-.|..+|+.|+.|||+. .|.||||||+|+|... |-.+|++|||+|+....
T Consensus 143 GGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 143 GGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred chHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999998763 45788999999999999999999998 9999999999999964 56899999999998763
Q ss_pred C---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 493 P---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 493 ~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
. .+.+-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||..... ..+..-++..++.+.. +.-+
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gqy-~FP~---- 288 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQY-EFPE---- 288 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccCc-cCCC----
Confidence 2 455678899999999999999999999999999999999999986532 2222233333333221 0101
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+...+..+...++++..++.+|.+|.|+.++..+
T Consensus 289 --pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 289 --PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred --hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1122233445677888999999999999998763
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=284.71 Aligned_cols=256 Identities=22% Similarity=0.291 Sum_probs=183.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--------------
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK-------------- 404 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-------------- 404 (632)
.+.||+|+||.||+|.. .++..||+|.+..... ..+.+.+|++++.++ +||||+++++++...
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccccccccc
Confidence 35799999999999985 4588999999865433 346688999999999 999999999876653
Q ss_pred CceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-CCCeEEcc
Q 006747 405 DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-DLQGCISD 483 (632)
Q Consensus 405 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-~~~~ki~D 483 (632)
...++||||++ ++|.+++... .+++.....++.|++.||.|||+. +|+||||||+||+++. ++.+|++|
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECC
Confidence 34789999997 5888887532 378889999999999999999998 9999999999999984 56799999
Q ss_pred cCCCCCCCCC-------CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH-
Q 006747 484 FGLTPLMNTP-------TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV- 554 (632)
Q Consensus 484 fGla~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~- 554 (632)
||+++..... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+. ........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~ 236 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILESVP 236 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcC
Confidence 9999765322 11235677999998754 4578899999999999999999999965421110 00000000
Q ss_pred ---------hhhccccccccccccccCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhh
Q 006747 555 ---------VREEWTSEVFDVELMRYENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDI 609 (632)
Q Consensus 555 ---------~~~~~~~~~~d~~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i 609 (632)
.................... .....++.+++.+||+.||++|||+.+++. .++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 00000000000000000000 112245778999999999999999999985 45544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=269.05 Aligned_cols=219 Identities=18% Similarity=0.205 Sum_probs=172.8
Q ss_pred cceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhhhhcc
Q 006747 347 GSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHG 425 (632)
Q Consensus 347 G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 425 (632)
|.||.||++.. .+++.||+|++.... .+..|...+... .||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPH-CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhc-CCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999985 468899999997643 233444444455 699999999999999999999999999999999865
Q ss_pred CCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-CCCCCCcccC
Q 006747 426 NRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-VPSRSAGYRA 504 (632)
Q Consensus 426 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~~t~~y~a 504 (632)
.. ++++.....++.+++.||+|||+. +|+||||||+||++++++.++++|||.+....... ...++..|+|
T Consensus 79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~a 150 (237)
T cd05576 79 FL-----NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCA 150 (237)
T ss_pred hc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccC
Confidence 42 488999999999999999999998 99999999999999999999999999876654432 2335667999
Q ss_pred CccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHH
Q 006747 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQI 584 (632)
Q Consensus 505 PE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l 584 (632)
||.+.+..++.++||||+||++|||++|+.|+....... ... ....+ .. .....+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-----~~~~~--~~---~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-----TTLNI--PE---WVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-----cccCC--cc---cCCHHHHHH
Confidence 999988889999999999999999999998875321100 000 00000 00 112356778
Q ss_pred HHHccCCCCCCCCCHH
Q 006747 585 AMSCVAKVPDMRPTME 600 (632)
Q Consensus 585 ~~~Cl~~~P~~RPs~~ 600 (632)
+.+|++.||++||++.
T Consensus 209 i~~~l~~dp~~R~~~~ 224 (237)
T cd05576 209 LQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHccCCHHHhcCCC
Confidence 8899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=284.80 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=186.5
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc------eEEEE
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE------KLLVY 411 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lv~ 411 (632)
+.||+|+||.||+|... ++..||+|++..... ....+.+|++++.++ +|+||+++.+++...+. .++|+
T Consensus 21 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccccccEEEEE
Confidence 57999999999999964 578999999875321 234577899999999 99999999998876554 89999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+ +++|.+++... ++++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 100 e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 100 HLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 998 56999888642 488999999999999999999998 99999999999999999999999999998765
Q ss_pred CC-CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhHHHHHHhhhccc
Q 006747 492 TP-TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD---------LPRWVQSVVREEWT 560 (632)
Q Consensus 492 ~~-~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~---------~~~~~~~~~~~~~~ 560 (632)
.. ....++..|+|||.+.+. .++.++|||||||++|||+||+.||.......... ...+......+. .
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~ 248 (343)
T cd07851 170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES-A 248 (343)
T ss_pred ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh-H
Confidence 43 223467789999998653 57899999999999999999999996532211000 000000000000 0
Q ss_pred ccccc-ccccccCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 561 SEVFD-VELMRYENIE----EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 561 ~~~~d-~~~~~~~~~~----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...+. .......... .....+.+++.+|++.+|++|||+.+|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000 0000000000 113567889999999999999999999873
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=304.97 Aligned_cols=138 Identities=22% Similarity=0.320 Sum_probs=122.8
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|... +++.||||+++..... ...+..|++++..+ +|+||+++++++......++||||+++
T Consensus 10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 57999999999999965 6899999999754321 35688889999888 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
|+|.+++.... .+++.....|+.|++.||+|||.. +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999997542 377888899999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=283.36 Aligned_cols=233 Identities=20% Similarity=0.281 Sum_probs=187.3
Q ss_pred hHhCccceeEEEEEE-EcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
..+|.|+|+.|-++. ..+++..+||++.+. ..+-.+|+.++.+..+||||+++.+.+.+..+.|+|||++.+|-+.
T Consensus 328 ~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 328 EELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred cccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 459999999999887 456889999999765 3345567778888889999999999999999999999999999988
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee-cCCCCeEEcccCCCCCCCCC-CCCCC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL-SQDLQGCISDFGLTPLMNTP-TVPSR 498 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl-~~~~~~ki~DfGla~~~~~~-~~~~~ 498 (632)
+.+...+ .....+..|+.+++.++.|||++ +||||||||+|||+ ++.++++|+|||.++..... ...+-
T Consensus 405 ~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~ 475 (612)
T KOG0603|consen 405 RRIRSKP------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL 475 (612)
T ss_pred HHHHhcc------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence 8876543 22366778999999999999998 99999999999999 68999999999999887665 23356
Q ss_pred CCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHH
Q 006747 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEM 578 (632)
Q Consensus 499 t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 578 (632)
|..|.|||++....|++++|+||||++||||++|+.||.....+ . .+...+...... ... .
T Consensus 476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~-ei~~~i~~~~~s----------~~v---S 536 (612)
T KOG0603|consen 476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----I-EIHTRIQMPKFS----------ECV---S 536 (612)
T ss_pred hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----H-HHHHhhcCCccc----------ccc---C
Confidence 77899999999899999999999999999999999999754332 0 111111111000 122 2
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 579 VQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 579 ~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....+|+..||+.||.+||+|.++..+
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhccC
Confidence 345567779999999999999998763
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=295.53 Aligned_cols=190 Identities=22% Similarity=0.331 Sum_probs=165.5
Q ss_pred HHhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 340 SAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
..++||+|+||.|..++.+ .++.||+|++.+..+ +..-|..|..+|..- +.+-||.+...|++..++|+|||||
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQDERYLYLVMDYM 157 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcCccceEEEEecc
Confidence 4689999999999999964 578999999987532 345588888888776 8899999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 493 (632)
+||||-.++.... +++......++..+..||.-||+. |+|||||||+|||||.+|++|++|||.+-.+..+
T Consensus 158 pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 158 PGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred cCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 9999999998652 466666667888999999999998 9999999999999999999999999998777643
Q ss_pred ----CCCCCCCcccCCcccc----C-CCCCccchhhHHHHHHHHHHhCCCCCCC
Q 006747 494 ----TVPSRSAGYRAPEVIE----T-KKPTQKSDVYSFGVLLLEMLTGKAPIQA 538 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~----~-~~~~~~~DV~s~Gvvl~elltg~~p~~~ 538 (632)
....|||-|++||++. + +.|+..+|.||+||++|||+.|..||+.
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 3457999999999985 3 5689999999999999999999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=268.36 Aligned_cols=193 Identities=24% Similarity=0.343 Sum_probs=164.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc-C---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM-G---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
..+||+|+||+|-+|..+ ....+|||++++... . .+--..|-++|+.-.+-|.++++..+|++-+.+|.||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 368999999999999854 457899999987632 1 22234556667666678999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
||+|-.+++.... +.+...+.++.+||-||-|||++ +||.||||..||++|.+|++||+|||+++.--.
T Consensus 434 GGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~ 505 (683)
T KOG0696|consen 434 GGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGV 505 (683)
T ss_pred CchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccCCc
Confidence 9999998886542 45567788999999999999999 999999999999999999999999999976432
Q ss_pred -CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 006747 493 -PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGH 541 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~ 541 (632)
..+.+||+.|+|||.+...+|+..+|.|||||+||||+.|..||++.++
T Consensus 506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 2334799999999999999999999999999999999999999987554
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=240.13 Aligned_cols=196 Identities=23% Similarity=0.402 Sum_probs=161.1
Q ss_pred HHHhHhCccceeEEEEEE-EcCCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 339 ASAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 339 ~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.....||+|++|.|-+-+ ..+|+..|+|+++..... .+....|+.+..+....|.+|+++|.+......++.||.|+
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 346789999999988776 456999999999866433 45567788888777789999999999999999999999997
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 495 (632)
- ||..+-.+--. ....+++...-+|+..+..||.|||++. .+||||+||+|||++.+|.+||||||.+-.+..+-.
T Consensus 129 t-Sldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 129 T-SLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred h-hHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 5 77765432211 1234777888899999999999999985 899999999999999999999999999987765422
Q ss_pred ---CCCCCcccCCccccCC----CCCccchhhHHHHHHHHHHhCCCCCCC
Q 006747 496 ---PSRSAGYRAPEVIETK----KPTQKSDVYSFGVLLLEMLTGKAPIQA 538 (632)
Q Consensus 496 ---~~~t~~y~aPE~~~~~----~~~~~~DV~s~Gvvl~elltg~~p~~~ 538 (632)
..|-..|||||.+..+ .|+-|+||||+|+++.||.+++.||+.
T Consensus 205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 2355569999998643 589999999999999999999999965
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=270.14 Aligned_cols=239 Identities=20% Similarity=0.349 Sum_probs=188.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.++||.|.||+||-|+. ++|+.||||++.+.. ......+.|+++|..+ +||.||.+...|++.+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecCCceEEEEehhhcc
Confidence 68999999999999984 569999999998763 3356799999999999 999999999999999999999999976
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC---CCeEEcccCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD---LQGCISDFGLTPLMNTP 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~---~~~ki~DfGla~~~~~~ 493 (632)
.-|..+|...+ ..++......+..||+.||.|||.+ +|+|+||||+|||+.+. -.+||||||+|++.++.
T Consensus 648 DMLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 648 DMLEMILSSEK----GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred hHHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh
Confidence 55555665432 2377777777889999999999999 99999999999999653 47999999999998876
Q ss_pred C---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 T---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 ~---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
. ...||+.|+|||++....|+..-|+||.|||+|--++|..||... ++.. +.++ .. .-++ .
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIn---dQIQ----NA--aFMy-----P 784 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDIN---DQIQ----NA--AFMY-----P 784 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchh---HHhh----cc--cccc-----C
Confidence 4 346999999999999999999999999999999999999999642 1211 1111 10 0011 1
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl 603 (632)
.....|-....++++...++..-.+|-|....+
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 122233344566777788888888887776643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=254.02 Aligned_cols=234 Identities=24% Similarity=0.369 Sum_probs=189.0
Q ss_pred ceeEEEEEEEcC-CcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhhhhc
Q 006747 348 SYGTTYKAILEE-GTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLH 424 (632)
Q Consensus 348 ~fg~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~ 424 (632)
+||.||+|...+ ++.+|+|++...... .+.+.+|++.+.++ +|+||+++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999764 899999999765332 57899999999999 99999999999999999999999999999999987
Q ss_pred cCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---CCCCCCCc
Q 006747 425 GNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---TVPSRSAG 501 (632)
Q Consensus 425 ~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---~~~~~t~~ 501 (632)
... .+++..+..++.+++.+++|||+. +++|+||+|+||++++++.++|+|||.+...... ....++..
T Consensus 80 ~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T smart00220 80 KRG-----RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE 151 (244)
T ss_pred hcc-----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence 543 278899999999999999999998 9999999999999999999999999999876553 33446778
Q ss_pred ccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHH
Q 006747 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQM 581 (632)
Q Consensus 502 y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 581 (632)
|++||...+..++.++||||||++++||++|+.||..... ........ ...... ..........++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-----~~~~~~~~-~~~~~~--------~~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-----LLELFKKI-GKPKPP--------FPPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHH-hccCCC--------CccccccCCHHH
Confidence 9999999888889999999999999999999999864211 11111111 111000 000000023467
Q ss_pred HHHHHHccCCCCCCCCCHHHHHH
Q 006747 582 LQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 582 ~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 78899999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=260.68 Aligned_cols=245 Identities=20% Similarity=0.311 Sum_probs=184.9
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEeccccc---C-----HHHHHHHHHHHHhhcCCCCccceeEEEEe-CCceEEE
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVM---G-----KREFEQQMEVVGRLSQHPNVVPIRAYYFS-KDEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~---~-----~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv 410 (632)
...||+|||+.||+|. +...+.||||+-..... . .+...+|..+-..+ +||.||++++|+.- .+..+-|
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeeccccceee
Confidence 5689999999999998 56688999998643211 1 12355677788888 99999999999975 4568899
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec---CCCCeEEcccCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS---QDLQGCISDFGLT 487 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~---~~~~~ki~DfGla 487 (632)
+||++|.+|+-+|+..+ .+++.....|+.||+.||.||.+. .++|||-||||.|||+- ..|.+||.|||++
T Consensus 547 LEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 99999999999998765 367788889999999999999986 67999999999999995 4589999999999
Q ss_pred CCCCCCCCC-----------CCCCcccCCccccCC----CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006747 488 PLMNTPTVP-----------SRSAGYRAPEVIETK----KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 488 ~~~~~~~~~-----------~~t~~y~aPE~~~~~----~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 552 (632)
+.|...+.. .||.+|++||.+.-+ +.+.|+||||.|||+|..+.|+.||...-.. .
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--Q------- 691 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--Q------- 691 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--H-------
Confidence 999765432 378889999988533 3689999999999999999999999643211 0
Q ss_pred HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 553 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.++.+................. ..+.-.++++|++..-++|....++..
T Consensus 692 dILqeNTIlkAtEVqFP~KPvV---sseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 DILQENTILKATEVQFPPKPVV---SSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHHhhhchhcceeccCCCCCcc---CHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111111111111111111112 234556788999999999988877765
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-30 Score=275.21 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=171.1
Q ss_pred HhHhCccceeEEEEEEE-----------------cCCcEEEEEEecccccC-HH--------------HHHHHHHHHHhh
Q 006747 341 AEVLGKGSYGTTYKAIL-----------------EEGTTVVVKRLKEVVMG-KR--------------EFEQQMEVVGRL 388 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-----------------~~~~~vavK~~~~~~~~-~~--------------~~~~e~~~l~~l 388 (632)
.++||+|+||.||+|.. .+++.||||+++..... .+ .+..|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 46899999999999963 24578999998653221 12 234466677777
Q ss_pred cCCCC-----ccceeEEEEe--------CCceEEEEecccCCCHhhhhccCCC-------------------CCCCcCCH
Q 006747 389 SQHPN-----VVPIRAYYFS--------KDEKLLVYDFIEAGSFSALLHGNRG-------------------IGRTPLDW 436 (632)
Q Consensus 389 ~~h~n-----iv~l~~~~~~--------~~~~~lv~E~~~~g~L~~~l~~~~~-------------------~~~~~l~~ 436 (632)
+|.+ ++++++||.. .+..++||||+++|+|.++++...+ .....++|
T Consensus 230 -~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~ 308 (507)
T PLN03224 230 -KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDI 308 (507)
T ss_pred -hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCH
Confidence 4544 4778888764 3568999999999999999875321 01123577
Q ss_pred HHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----CCCCCCcccCCccccCC
Q 006747 437 ESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-----VPSRSAGYRAPEVIETK 511 (632)
Q Consensus 437 ~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-----~~~~t~~y~aPE~~~~~ 511 (632)
..+..++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.... ....++.|+|||.+...
T Consensus 309 ~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~ 385 (507)
T PLN03224 309 NVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMP 385 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCC
Confidence 88899999999999999998 99999999999999999999999999997654321 12246789999988643
Q ss_pred CC----------------------CccchhhHHHHHHHHHHhCCC-CCCCCCCCC------CCChhHHHHHHhhhccccc
Q 006747 512 KP----------------------TQKSDVYSFGVLLLEMLTGKA-PIQAPGHED------VVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 512 ~~----------------------~~~~DV~s~Gvvl~elltg~~-p~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 562 (632)
.. ..+.||||+||+++||++|.. |+....... ..++..|.... ..
T Consensus 386 ~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~-~~----- 459 (507)
T PLN03224 386 QSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK-GQ----- 459 (507)
T ss_pred CCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc-cc-----
Confidence 21 134799999999999999875 664321000 01111221100 00
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVP---DMRPTMEEVVRM 605 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P---~~RPs~~evl~~ 605 (632)
..+.. .... ......+++.+++..+| .+|+|++|++++
T Consensus 460 ~~~~~--~~d~---~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KYDFS--LLDR---NKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCCcc--cccc---cChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00100 1111 12345567778888765 789999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=284.46 Aligned_cols=252 Identities=18% Similarity=0.184 Sum_probs=159.4
Q ss_pred HhHhCccceeEEEEEEEcC-----CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEE------EEeCCceEE
Q 006747 341 AEVLGKGSYGTTYKAILEE-----GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY------YFSKDEKLL 409 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~------~~~~~~~~l 409 (632)
.+.||+|+||.||+|.+.+ +..||+|++...... +.+..+ .+... .+.+++.+... +....+.++
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~L 212 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRA-CPNSCADFVYGFLEPVSSKKEDEYWL 212 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhh-chhhHHHHHHhhhcccccccCCceEE
Confidence 4689999999999999654 689999998643211 111111 11111 22333322221 234567899
Q ss_pred EEecccCCCHhhhhccCCCC---------------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec
Q 006747 410 VYDFIEAGSFSALLHGNRGI---------------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS 474 (632)
Q Consensus 410 v~E~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~ 474 (632)
||||+++++|.++++..... ............++.|++.||+|||+. +|+||||||+|||++
T Consensus 213 V~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl~ 289 (566)
T PLN03225 213 VWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIFS 289 (566)
T ss_pred EEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEEe
Confidence 99999999999998753210 000011233457899999999999998 999999999999998
Q ss_pred C-CCCeEEcccCCCCCCCCC-----CCCCCCCcccCCccccCC----------------------CCCccchhhHHHHHH
Q 006747 475 Q-DLQGCISDFGLTPLMNTP-----TVPSRSAGYRAPEVIETK----------------------KPTQKSDVYSFGVLL 526 (632)
Q Consensus 475 ~-~~~~ki~DfGla~~~~~~-----~~~~~t~~y~aPE~~~~~----------------------~~~~~~DV~s~Gvvl 526 (632)
+ ++.+||+|||+++.+... ....++++|+|||.+... .++.++|||||||+|
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL 369 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIF 369 (566)
T ss_pred CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHH
Confidence 6 589999999999865432 233578899999966422 134567999999999
Q ss_pred HHHHhCCCCCCCCCC-------CCCCChhHHHHHHhhhccccccccccccc-cCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 006747 527 LEMLTGKAPIQAPGH-------EDVVDLPRWVQSVVREEWTSEVFDVELMR-YENIEEEMVQMLQIAMSCVAKVPDMRPT 598 (632)
Q Consensus 527 ~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs 598 (632)
|||+++..|++.... ....+...|....... ..+.+.. ............+|+.+|++.||++|||
T Consensus 370 ~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 370 LQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 999997766432100 0001111221111000 0000000 0000001123457889999999999999
Q ss_pred HHHHHHH
Q 006747 599 MEEVVRM 605 (632)
Q Consensus 599 ~~evl~~ 605 (632)
+.|++++
T Consensus 444 a~e~L~H 450 (566)
T PLN03225 444 AKAALAH 450 (566)
T ss_pred HHHHhCC
Confidence 9999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=280.13 Aligned_cols=240 Identities=25% Similarity=0.437 Sum_probs=182.9
Q ss_pred HHhHhCccceeE-EEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 340 SAEVLGKGSYGT-TYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 340 ~~~~lg~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
..+++|.|+-|+ ||+|.++ |+.||||++-... ..-..+|+..+..--+|||||++++.=.++...||..|.|.. +
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s 588 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S 588 (903)
T ss_pred cHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence 357899999885 7999985 8999999986432 334678999988887999999998888888899999999965 9
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---C--CCeEEcccCCCCCCCCC
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---D--LQGCISDFGLTPLMNTP 493 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~--~~~ki~DfGla~~~~~~ 493 (632)
|.+++.... .......-...+.+..|++.||+|||+. +||||||||.||||+. + ..++|+|||+++.+...
T Consensus 589 L~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 589 LQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred HHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 999998741 1111111133466788999999999997 9999999999999976 3 57999999999987643
Q ss_pred C-------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 494 T-------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTG-KAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 494 ~-------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
. ...||-||+|||.+....-+..+|+||+|||+|+.+|| +.||......+. .++.....
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~----- 731 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYT----- 731 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccc-----
Confidence 2 33588999999999998888899999999999999995 899965322111 01111110
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
+.......++ +..+|+.+++..+|..||++.+|+.
T Consensus 732 --L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 --LVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --eeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1111122222 6778899999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-31 Score=265.74 Aligned_cols=248 Identities=17% Similarity=0.236 Sum_probs=193.1
Q ss_pred CCHHHHHHHHHhHhCccceeEEEEEEEcCCc-EEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC
Q 006747 331 FDLEDLLRASAEVLGKGSYGTTYKAILEEGT-TVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD 405 (632)
Q Consensus 331 ~~~~~l~~~~~~~lg~G~fg~V~~~~~~~~~-~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 405 (632)
..++++. ....||-|+||.|=++..+... .+|+|++++... ..+.+..|-.+|... +.|.||+++-.|.+..
T Consensus 417 v~l~dl~--~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 417 VKLSDLK--RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRDSK 493 (732)
T ss_pred cchhhhh--hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhccch
Confidence 3445542 2457999999999999876433 489999986522 234577888999999 8999999999999999
Q ss_pred ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 406 EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 406 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
.+|++||-|-||.+...++... .++......++..+.+|++|||++ +||.|||||+|.++|.+|-+|+.|||
T Consensus 494 yvYmLmEaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence 9999999999999999998654 356666677888899999999999 99999999999999999999999999
Q ss_pred CCCCCCCCCCC---CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 486 LTPLMNTPTVP---SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 486 la~~~~~~~~~---~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
+|+.......+ +||+.|.|||.+.....+..+|.||+|+++|||+||++||.+.+..... ..+..+..
T Consensus 566 FAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY-------n~ILkGid-- 636 (732)
T KOG0614|consen 566 FAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY-------NLILKGID-- 636 (732)
T ss_pred hHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH-------HHHHhhhh--
Confidence 99998766443 6999999999999999999999999999999999999999875432111 11111110
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPT-----MEEVVRM 605 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 605 (632)
....+..-.....+++++.+..+|.+|.- +.|+-++
T Consensus 637 -------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 637 -------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 01111112234556777888899999976 5555543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=242.93 Aligned_cols=238 Identities=20% Similarity=0.328 Sum_probs=185.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
..+||+|+|++|..+++. ..+.+|+|++++.... ..-...|-.+.....+||.+|-+..+|++...++.|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 468999999999999854 4688999999876322 23356667777777899999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC----
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN---- 491 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~---- 491 (632)
+|+|--+++..+ .+++.....+..+|..||.|||+. +||.||||..|||+|..|++|+.|||+++.--
T Consensus 335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 999988777554 477888888999999999999999 99999999999999999999999999997642
Q ss_pred CCCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC-CCChhHHHHHHhhhccccccccccccc
Q 006747 492 TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED-VVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 492 ~~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
..++.+||+.|+|||.+.+..|...+|.|++||+|+||+.|+.||+-.+... .....++.-+.+.+.... .
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--------i 478 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--------I 478 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------c
Confidence 2344579999999999999999999999999999999999999997433211 122233333333222111 1
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCC
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRP 597 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP 597 (632)
+.... .....+.+.-+.+||++|.
T Consensus 479 prsls---vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRSLS---VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cceee---hhhHHHHHHhhcCCcHHhc
Confidence 11111 1233455577889999884
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=259.52 Aligned_cols=200 Identities=24% Similarity=0.345 Sum_probs=164.1
Q ss_pred hHhCccceeEEEEEEEcC-CcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||-|+||+|.++...| ...+|+|.+++...- ......|..||... +.+-||+|+..|++++.+|+||||++|
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEeccCCceEEEEeccCC
Confidence 469999999999998544 567899999765321 23467888899998 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC------
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM------ 490 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~------ 490 (632)
||+-.+|-... .+.+.....++.++..|+++.|.. ++|||||||+|||||.||++||.||||+.-+
T Consensus 714 GDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 714 GDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred ccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99999887543 355666666778899999999998 9999999999999999999999999997432
Q ss_pred ---CCC------C-------------------------------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHH
Q 006747 491 ---NTP------T-------------------------------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEML 530 (632)
Q Consensus 491 ---~~~------~-------------------------------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ell 530 (632)
... + ...||..|+|||++....|+..+|.||.|||||||+
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML 865 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence 100 0 012688899999999999999999999999999999
Q ss_pred hCCCCCCCCCCCC-CCChhHH
Q 006747 531 TGKAPIQAPGHED-VVDLPRW 550 (632)
Q Consensus 531 tg~~p~~~~~~~~-~~~~~~~ 550 (632)
.|+.||-.....+ ...+..|
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred hCCCCccCCCCCcceeeeeeh
Confidence 9999997655433 2334444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-30 Score=239.48 Aligned_cols=256 Identities=18% Similarity=0.300 Sum_probs=187.2
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeC-----CceEEEEe
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK-----DEKLLVYD 412 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~E 412 (632)
+.||-|+||.||.+.. ++|+.||.|++..... ..+.+.+|++++... +|.||...++...-. .++|+|+|
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 5799999999999874 4699999999876532 356788999999999 999999998876643 36789999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
.|.. +|..++-.- .+++-....-+..||++||.|||+. +|.||||||.|.|++.+..+||||||+++..+.
T Consensus 138 LmQS-DLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHh-hhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 9965 888887643 4566677777889999999999999 999999999999999999999999999998765
Q ss_pred CCCC-----CCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH--------HHHhhhc
Q 006747 493 PTVP-----SRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWV--------QSVVREE 558 (632)
Q Consensus 493 ~~~~-----~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 558 (632)
.... ..|-.|+|||.+.|.+ |+...||||.|||+.|++..+.-|+..+.-+..+++... .+..-++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 4332 2456799999998865 899999999999999999998888765433322221100 0111111
Q ss_pred cccccccccc--------cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 559 WTSEVFDVEL--------MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 559 ~~~~~~d~~~--------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
....++.... .........-.+.+.+....+..||..|.+..+.+..+.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111111111 011111111223445666788999999999999887654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=228.68 Aligned_cols=205 Identities=29% Similarity=0.519 Sum_probs=180.3
Q ss_pred hCccceeEEEEEEEcC-CcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 344 LGKGSYGTTYKAILEE-GTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 344 lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
||+|++|.||++...+ ++.+++|++...... ...+.+|++.+.++ +|++|+++++++......++++||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999754 899999999866442 56799999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-CCCeEEcccCCCCCCCCC----CC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-DLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~----~~ 495 (632)
+++.... ..+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+...... ..
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence 9987542 3578899999999999999999998 9999999999999999 899999999998766543 22
Q ss_pred CCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..+...|++||.+... .++.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 3466779999999887 788999999999999998
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246678889999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-29 Score=251.29 Aligned_cols=269 Identities=18% Similarity=0.261 Sum_probs=201.3
Q ss_pred CCHHHHHHHH---HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhc-----CCCCccceeEEE
Q 006747 331 FDLEDLLRAS---AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS-----QHPNVVPIRAYY 401 (632)
Q Consensus 331 ~~~~~l~~~~---~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~ 401 (632)
+.+.|++... ....|+|-|++|.+|.. ..|..||||++.......+.-..|+++|.+|. .--|+++|+-.|
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 3445554333 34579999999999984 45889999999987766777889999999985 234899999999
Q ss_pred EeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeE
Q 006747 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGC 480 (632)
Q Consensus 402 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~k 480 (632)
...+++|||||-+.- +|.++|+..+. ...|....+..++.|+..||.+|... +|+|+||||.|||+++. ..+|
T Consensus 504 ~hknHLClVFE~Lsl-NLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLSL-NLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILK 577 (752)
T ss_pred hhcceeEEEehhhhc-hHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceee
Confidence 999999999998754 99999987642 23466788889999999999999987 99999999999999875 6789
Q ss_pred EcccCCCCCCCCCCCC--CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH-----H
Q 006747 481 ISDFGLTPLMNTPTVP--SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ-----S 553 (632)
Q Consensus 481 i~DfGla~~~~~~~~~--~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-----~ 553 (632)
|||||.|........+ ..+..|.|||++.|-+|+...|+||.||+||||.||+..|.+......+.+...+. .
T Consensus 578 LCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 578 LCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred eccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 9999999877654322 34556999999999999999999999999999999999998876544332111110 0
Q ss_pred Hhhhc-ccccccccccc--------------------------------cc----CCcHHHHHHHHHHHHHccCCCCCCC
Q 006747 554 VVREE-WTSEVFDVELM--------------------------------RY----ENIEEEMVQMLQIAMSCVAKVPDMR 596 (632)
Q Consensus 554 ~~~~~-~~~~~~d~~~~--------------------------------~~----~~~~~~~~~~~~l~~~Cl~~~P~~R 596 (632)
.++.+ .....||..+. .. ..-...+.++.+|+..|+..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 01110 00111111110 00 1112235668889999999999999
Q ss_pred CCHHHHHHH
Q 006747 597 PTMEEVVRM 605 (632)
Q Consensus 597 Ps~~evl~~ 605 (632)
.|..+++++
T Consensus 738 it~nqAL~H 746 (752)
T KOG0670|consen 738 ITVNQALKH 746 (752)
T ss_pred CCHHHHhcC
Confidence 999998864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=236.92 Aligned_cols=128 Identities=17% Similarity=0.236 Sum_probs=107.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC-------CCccceeEEEEe----CCceE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQH-------PNVVPIRAYYFS----KDEKL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h-------~niv~l~~~~~~----~~~~~ 408 (632)
.+.||-|.|++||++.. ...+.||+|+.+....-.+....||++|.++..+ ..||+|+++|.. ..+++
T Consensus 83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVC 162 (590)
T KOG1290|consen 83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVC 162 (590)
T ss_pred EEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEE
Confidence 46899999999999984 5578999999998766667788999999988643 379999999985 45889
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS 474 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~ 474 (632)
+|+|++ |-+|..++.... ...++...+.+|+.||+.||.|||+.| +|||-||||+|||+.
T Consensus 163 MVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 163 MVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred EEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 999999 447888876542 234777889999999999999999998 999999999999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=230.69 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=183.2
Q ss_pred hHhCccceeEEEEEE-EcCCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceEEEE
Q 006747 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEV---VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKLLVY 411 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv~ 411 (632)
..+|.|.- .|.-+. .-.++.||+|++... ....+...+|...+..+ +|+||++++.++.-. .+.|+||
T Consensus 23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHHHHhHHHHH
Confidence 45677776 455444 224789999998654 23345677888888888 999999999998743 3579999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
|||.. +|...++.. ++-.+...|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+...
T Consensus 101 e~m~~-nl~~vi~~e-------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 101 ELMDA-NLCQVILME-------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred Hhhhh-HHHHHHHHh-------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccC
Confidence 99975 888887732 56677788999999999999998 99999999999999999999999999998765
Q ss_pred CC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC----------------ChhHHHH
Q 006747 492 TP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV----------------DLPRWVQ 552 (632)
Q Consensus 492 ~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~----------------~~~~~~~ 552 (632)
.. +....|..|+|||++.+..+.+.+||||.||++.||++|+.-|.+...-+.. ++..-++
T Consensus 170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 54 2334677899999999999999999999999999999999988754321111 0111111
Q ss_pred HHhh--hcccc----ccccccccc--cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 553 SVVR--EEWTS----EVFDVELMR--YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 553 ~~~~--~~~~~----~~~d~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.+.+ +++.. +.+...... .+...-....+.+++.+++-.+|++|.|+++++++
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111 01110 011100000 01111234557789999999999999999999885
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=222.62 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=187.3
Q ss_pred CCHHHHHHHHHhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeE-EEEeCCceE
Q 006747 331 FDLEDLLRASAEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRA-YYFSKDEKL 408 (632)
Q Consensus 331 ~~~~~l~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~-~~~~~~~~~ 408 (632)
.+++|.. ...+.+|+|.||.+-++.++ ..+.+++|.+.......++|.+|..---.+..|.||+.-++ .|++.+..+
T Consensus 20 v~l~d~y-~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 20 VDLEDVY-TINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred cchhhhh-hHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 4455542 34678999999999999865 46789999999888888999999876666778999998665 466777888
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec--CCCCeEEcccCC
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS--QDLQGCISDFGL 486 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~--~~~~~ki~DfGl 486 (632)
.++||++.|||..-+...+ +-+....+++.|++.|+.|||++ .+||||||.+||||- +...+|+||||+
T Consensus 99 F~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence 9999999999998886542 56677888999999999999999 999999999999993 345899999999
Q ss_pred CCCCCCCC-CCCCCCcccCCccccCC-----CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 487 TPLMNTPT-VPSRSAGYRAPEVIETK-----KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 487 a~~~~~~~-~~~~t~~y~aPE~~~~~-----~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
++..+... ....+..|-|||..... ...+.+|||.||++++.++||+.||+.....+ ....+|.+.. .+..
T Consensus 170 t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~w~--~rk~ 246 (378)
T KOG1345|consen 170 TRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQWL--KRKN 246 (378)
T ss_pred ccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHHHh--cccC
Confidence 87665432 22345568999987543 24778999999999999999999998433222 1233333322 2111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
. .++ .........+.++-++-+..+|++|-...++.++.+
T Consensus 247 ~-----~~P--~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 247 P-----ALP--KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred c-----cCc--hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 1 111 111112233455556888999999966666655543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-28 Score=246.24 Aligned_cols=189 Identities=22% Similarity=0.342 Sum_probs=163.1
Q ss_pred HHhHhCccceeEEEEEEEcC-CcEEEEEEecccccCH---------HHHHHHHHHHHhhcC---CCCccceeEEEEeCCc
Q 006747 340 SAEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGK---------REFEQQMEVVGRLSQ---HPNVVPIRAYYFSKDE 406 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~---------~~~~~e~~~l~~l~~---h~niv~l~~~~~~~~~ 406 (632)
+.+.+|+|+||.|+.+.++. ...|+||.+.+.+.-. ..+-.|+++|+++ + |+||++++++|++++.
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l-~~~sH~NIlKlLdfFEddd~ 643 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATL-NKHSHENILKLLDFFEDDDY 643 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHh-hhcCccchhhhhheeecCCe
Confidence 45789999999999999654 5688999987653211 2356789999998 5 9999999999999999
Q ss_pred eEEEEecc-cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 407 KLLVYDFI-EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 407 ~~lv~E~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
.||+||-. ++-+|++++.... .+++.....|.+||+.|+++||+. +|||||||-+||.++.+|-+||+|||
T Consensus 644 yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 644 YYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred eEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 99999975 5679999998653 477888889999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCC--CCCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCC
Q 006747 486 LTPLMNTP--TVPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQ 537 (632)
Q Consensus 486 la~~~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~ 537 (632)
.|...... ....||.+|.|||++.|.+| ...-|||++|++||.++....||.
T Consensus 716 saa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98766543 34569999999999999998 566899999999999999999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=215.19 Aligned_cols=250 Identities=17% Similarity=0.279 Sum_probs=185.6
Q ss_pred HHhHhCccceeEEEEEE-EcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC--ceEEEEecccC
Q 006747 340 SAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD--EKLLVYDFIEA 416 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~E~~~~ 416 (632)
..+.+|+|.|+.||.|. ..+.+.++||+++.. .++.+.+|+++|..+..||||+++++...+.. ...+|+||+.+
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 35789999999999998 566889999999854 36779999999999988999999999987653 56799999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeEEcccCCCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~~~ 495 (632)
-+...+.. .++-.....+..++++||.|+|+. ||+|||+||.|++||.. -.++++|+|+|.++.....
T Consensus 120 ~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 120 TDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred ccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 88776653 255567778899999999999999 99999999999999964 6799999999998876533
Q ss_pred C---CCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH--------HHhhhcccccc
Q 006747 496 P---SRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ--------SVVREEWTSEV 563 (632)
Q Consensus 496 ~---~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 563 (632)
. ..+..|.-||.+.. +.|+..-|+|||||++..|+..+.||-.... ...+++..++ .++..... .
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~KY~i--~ 265 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLNKYQI--D 265 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHHHHcc--C
Confidence 2 34556889998865 4578889999999999999999999854321 1112222111 11111000 0
Q ss_pred ccccccc---------c------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 564 FDVELMR---------Y------ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 564 ~d~~~~~---------~------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+|+.... + +...-...+.++++...+..|-.+|+|++|...+
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1221110 0 0000012456778889999999999999998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=223.53 Aligned_cols=189 Identities=28% Similarity=0.447 Sum_probs=166.3
Q ss_pred hHhCccceeEEEEEEEcC-CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|++|.||++...+ ++.+++|.+..... ..+.+.+|++.+.++ +|+|++++++++......++++||+++++
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecCCceEEEEeccCCCC
Confidence 568999999999999765 88999999986543 356789999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 494 (632)
|.+++..... .+++.....++.+++.++.|||.. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999976431 178899999999999999999998 99999999999999999999999999988765542
Q ss_pred -CCCCCCcccCCccc-cCCCCCccchhhHHHHHHHHHHhCCCCCCC
Q 006747 495 -VPSRSAGYRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKAPIQA 538 (632)
Q Consensus 495 -~~~~t~~y~aPE~~-~~~~~~~~~DV~s~Gvvl~elltg~~p~~~ 538 (632)
...++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 23466679999998 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-27 Score=247.64 Aligned_cols=241 Identities=21% Similarity=0.333 Sum_probs=189.0
Q ss_pred hHhCccceeEEEEEE-EcCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
..+|.|.||.|||++ ...+...|+|+++.... +.....+|+-++... +|+|||.++|.|...+..++.|||+.+|+|
T Consensus 21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 579999999999998 45689999999987643 345677888888888 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC----CCC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT----PTV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~----~~~ 495 (632)
++.-+... ++.+.+...++.+..+|++|||+. +=+|||||-.|||+++.+.+|++|||.+-.+.. ...
T Consensus 100 Qdiy~~Tg-----plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks 171 (829)
T KOG0576|consen 100 QDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS 171 (829)
T ss_pred cceeeecc-----cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence 99988653 688888888999999999999998 889999999999999999999999999866543 234
Q ss_pred CCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 496 PSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 496 ~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
..||+.|||||+.. .+.|..++|||+.|++..|+---..|...... .... .+ .....+++.- .+
T Consensus 172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-----mr~l---~L---mTkS~~qpp~--lk 238 (829)
T KOG0576|consen 172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-----MRAL---FL---MTKSGFQPPT--LK 238 (829)
T ss_pred ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-----HHHH---HH---hhccCCCCCc--cc
Confidence 56999999999873 45689999999999999999877777432110 0000 00 0111122211 11
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
........+.++++.|+.++|++||+++.+++
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22223445777888999999999999987554
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=264.53 Aligned_cols=189 Identities=18% Similarity=0.225 Sum_probs=138.3
Q ss_pred CC-CCccceeEEE-------EeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCc
Q 006747 390 QH-PNVVPIRAYY-------FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461 (632)
Q Consensus 390 ~h-~niv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 461 (632)
+| +||++++++| ...+..+.++||+ +++|.+++... ..++++..+..++.|+++||+|||+. +|
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 45 6888888887 2334567889988 55999999743 23588999999999999999999998 99
Q ss_pred eecCCCCCCeeecC-------------------CCCeEEcccCCCCCCCCC--------------------CCCCCCCcc
Q 006747 462 ILGNIKSSNVLLSQ-------------------DLQGCISDFGLTPLMNTP--------------------TVPSRSAGY 502 (632)
Q Consensus 462 vHrDlk~~NILl~~-------------------~~~~ki~DfGla~~~~~~--------------------~~~~~t~~y 502 (632)
+||||||+||||+. ++.+|++|||+++..... ....+|+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 556777888877643210 012367779
Q ss_pred cCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHH
Q 006747 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQML 582 (632)
Q Consensus 503 ~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 582 (632)
||||++.+..++.++|||||||+||||++|..|+.... ..... +... ...+. .........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~-~~~~----~~~~~------~~~~~~~~~ 242 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSS-LRHR----VLPPQ------ILLNWPKEA 242 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHH-HHHh----hcChh------hhhcCHHHH
Confidence 99999999999999999999999999999988864211 00111 0000 00100 011123355
Q ss_pred HHHHHccCCCCCCCCCHHHHHHH
Q 006747 583 QIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 583 ~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+++.+||+.+|.+||+|.|++++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhc
Confidence 77889999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=209.22 Aligned_cols=168 Identities=21% Similarity=0.295 Sum_probs=126.4
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVP 496 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 496 (632)
|+|.++++... .+++|..+..|+.|++.||+|||+. + ||+|||++.++.+|+ ||+++...... .
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~ 64 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-S 64 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-C
Confidence 68999987532 3589999999999999999999987 3 999999999999999 99998765433 3
Q ss_pred CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHH
Q 006747 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEE 576 (632)
Q Consensus 497 ~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 576 (632)
.++..|||||++.+..++.++|||||||++|||+||+.||..... ............... ++. .......
T Consensus 65 ~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~---~~~--~~~~~~~ 134 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMPAD---DPR--DRSNLES 134 (176)
T ss_pred CCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhccC---Ccc--ccccHHH
Confidence 578899999999999999999999999999999999999864321 111111111110000 000 0001111
Q ss_pred HH--HHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 577 EM--VQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 577 ~~--~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
.. ..+.+++.+||+.+|++||++.|+++++..+.
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 11 25888999999999999999999999987763
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=221.80 Aligned_cols=187 Identities=26% Similarity=0.414 Sum_probs=157.9
Q ss_pred HhHhCccceeEEEEEEEc----CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|.|++||++.+. ..+.||+|.+..... ...+..|++.|.++..+.||+++.+++...+...+|+||++.
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H 119 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH 119 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence 568999999999999843 467899999976543 345889999999999999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeEEcccCCCCCC-----
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGCISDFGLTPLM----- 490 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~----- 490 (632)
....++... ++......+...+.+||+|+|.. +||||||||+|+|.+.. +.-.|.|||+|...
T Consensus 120 ~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 120 DRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred cCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 999988864 45677788899999999999998 99999999999999864 67889999997511
Q ss_pred ------------CC-C----------C--------------------CCCCCCcccCCccccCCC-CCccchhhHHHHHH
Q 006747 491 ------------NT-P----------T--------------------VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLL 526 (632)
Q Consensus 491 ------------~~-~----------~--------------------~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl 526 (632)
.. . . ...||+||+|||++.... .++++||||.|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 00 0 0 012789999999987644 68999999999999
Q ss_pred HHHHhCCCCCCCC
Q 006747 527 LEMLTGKAPIQAP 539 (632)
Q Consensus 527 ~elltg~~p~~~~ 539 (632)
+-+++++.||-..
T Consensus 269 Lslls~~~PFf~a 281 (418)
T KOG1167|consen 269 LSLLSRRYPFFKA 281 (418)
T ss_pred ehhhccccccccC
Confidence 9999999998654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=201.87 Aligned_cols=247 Identities=21% Similarity=0.344 Sum_probs=186.1
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
...|.+...|..|+|++. |..+++|+++..... .++|..|.-.+.-+ .||||..++|.|....+..++..||+.|
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccCCCCceEeeeeccch
Confidence 346888899999999987 566777887654332 46788888888777 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCCC
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPS 497 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~ 497 (632)
+|+..||+.. ...++-.+.++++.++|+|++|||+. .+-|.---|.+..+++|++.+++|+- +-+++.-......
T Consensus 273 slynvlhe~t---~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kfsfqe~gr~ 347 (448)
T KOG0195|consen 273 SLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSFQEVGRA 347 (448)
T ss_pred HHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccceeeeeccccc
Confidence 9999999864 23467788899999999999999986 34455557899999999999998742 2223322222233
Q ss_pred CCCcccCCccccCCCC---CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 498 RSAGYRAPEVIETKKP---TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 498 ~t~~y~aPE~~~~~~~---~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..+.||+||.+...+. -..+|+|||.+++||+.|.+.||......+..- .+..++. +..-+
T Consensus 348 y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------kialegl----------rv~ip 411 (448)
T KOG0195|consen 348 YSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------KIALEGL----------RVHIP 411 (448)
T ss_pred cCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------hhhhccc----------cccCC
Confidence 4567999999987664 356899999999999999999997654333211 0011111 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
+.-...+.+++.-|+..||.+||.+..++-.||.+.
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 122345778888999999999999999999999874
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=245.76 Aligned_cols=182 Identities=40% Similarity=0.674 Sum_probs=151.4
Q ss_pred CChhHHHHHHHHHHhCCCC--CCCCCCCCCCCCCCCcceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccC
Q 006747 22 DLNSDKQALLDFAANVPHA--RKLNWNSSTSVCTSWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRS 99 (632)
Q Consensus 22 ~~~~~~~~l~~~~~~~~~~--~~~~w~~~~~~c~~w~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~ 99 (632)
....|..||++||+++.++ ...+|+...++| .|.||+|++ .++|+.|+|++++++|.+|+ .+..+++|+.|+|++
T Consensus 26 ~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~ 102 (968)
T PLN00113 26 LHAEELELLLSFKSSINDPLKYLSNWNSSADVC-LWQGITCNN-SSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSN 102 (968)
T ss_pred CCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-cCcceecCC-CCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCC
Confidence 3568999999999998533 345898766666 899999985 46999999999999999987 799999999999999
Q ss_pred CccCCCCCcccc-CCCCCCeEeecCCcCCccCCCCccCCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCC
Q 006747 100 NHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN 178 (632)
Q Consensus 100 N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 178 (632)
|+++|.+|..+. .+++|++|+|++|+++|.+|....++|++|+|++|.+++.+|..++++++|+.|+|++|.+++.+|.
T Consensus 103 n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 182 (968)
T PLN00113 103 NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPN 182 (968)
T ss_pred CccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCCh
Confidence 999999998876 8999999999999999988887667888888888888888888888888888888888888877775
Q ss_pred C--CCCCCcEEEcccCCCCCCCcccccCCC
Q 006747 179 F--NLSRLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 179 ~--~~~~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
. .+++|++|+|++|.+++.+|..+.+++
T Consensus 183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 212 (968)
T PLN00113 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMK 212 (968)
T ss_pred hhhhCcCCCeeeccCCCCcCcCChHHcCcC
Confidence 3 677777777777777777776655443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=203.69 Aligned_cols=161 Identities=16% Similarity=0.237 Sum_probs=122.3
Q ss_pred HhHhCccceeEEEEEEEc--CCcEEEEEEeccccc------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE--EGTTVVVKRLKEVVM------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||+||+|... +++.||||++..... ....+.+|++++.++ +|+|++..+.. .+..++|||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~---~~~~~LVmE 98 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA---TGKDGLVRG 98 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE---cCCcEEEEE
Confidence 367999999999999864 577889998753311 145689999999999 89999863322 256899999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCC-CCCCeeecCCCCeEEcccCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNI-KSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDl-k~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
|+++++|... ... . ...++.+++++|+|||+. +|+|||| ||+|||++.++.+||+|||+|+...
T Consensus 99 ~~~G~~L~~~-~~~--------~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 99 WTEGVPLHLA-RPH--------G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred ccCCCCHHHh-Ccc--------c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 9999999732 110 0 135678899999999998 9999999 9999999999999999999998654
Q ss_pred CCC------------CCCCCCcccCCccccCCC------CCccchhh
Q 006747 492 TPT------------VPSRSAGYRAPEVIETKK------PTQKSDVY 520 (632)
Q Consensus 492 ~~~------------~~~~t~~y~aPE~~~~~~------~~~~~DV~ 520 (632)
... ...++..|+|||.+...+ .+..+|-|
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 322 123566799999986543 23346666
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-19 Score=187.96 Aligned_cols=251 Identities=25% Similarity=0.380 Sum_probs=187.5
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCC-CccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHP-NVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~-niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||.|+||.||++... ..+++|.+..... ....+.+|+.++..+ .|+ +++++.+++......++++||+.+
T Consensus 6 ~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 56899999999999876 8899999976533 256789999999999 566 899999999777778999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-CeEEcccCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~-- 493 (632)
+++.+++...... ..+.......+..+++.++.|+|+. +++|||+||+||+++... .++++|||.++.....
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999777644211 2477788899999999999999998 899999999999999998 7999999998755432
Q ss_pred --------CCCCCCCcccCCccccC---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 494 --------TVPSRSAGYRAPEVIET---KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 494 --------~~~~~t~~y~aPE~~~~---~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
....++..|+|||.+.+ ..+....|+||+|++++++++|..||...... .........+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-
Confidence 33457888999999988 57889999999999999999999997543321 0011111111111110
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...... ...........+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPL-SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccc-CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000 000001122456678889999999999999987765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-19 Score=186.70 Aligned_cols=253 Identities=19% Similarity=0.244 Sum_probs=183.9
Q ss_pred HhHhCccceeEEEEEEEcCC--cEEEEEEecccccC-HHHHHHHHHHHHhhcC---CCCccceeEEE-EeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILEEG--TTVVVKRLKEVVMG-KREFEQQMEVVGRLSQ---HPNVVPIRAYY-FSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~--~~vavK~~~~~~~~-~~~~~~e~~~l~~l~~---h~niv~l~~~~-~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||++..... ..+|+|........ ...+..|+.++..+.. -+++..+++.. ......++||+.
T Consensus 23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l 102 (322)
T KOG1164|consen 23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSL 102 (322)
T ss_pred eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEec
Confidence 46799999999999996553 47888887654322 2267788888888842 25888888888 467788999998
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-----CCeEEcccCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-----LQGCISDFGLTP 488 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-----~~~ki~DfGla~ 488 (632)
+ |-+|.++..... ...++..+.++|+.|+..+|++||+. +++||||||.|+.+... ..+.+.|||+++
T Consensus 103 ~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 103 L-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred c-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 7 669999875443 24588899999999999999999998 99999999999999865 469999999998
Q ss_pred --CCC-CC-----------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH
Q 006747 489 --LMN-TP-----------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV 554 (632)
Q Consensus 489 --~~~-~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 554 (632)
... .. ....||..|.++....+...+.+.|+||++.++.|+..|..||........ ...+...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~~~ 252 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFEKD 252 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHHHH
Confidence 321 11 112378889999999999999999999999999999999999865432211 1111111
Q ss_pred hhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 555 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
..+... .. .....+++ +.++...+-+.+..++|....+...|++.....
T Consensus 253 ~~~~~~----~~---~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLLT----DR---FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhcc----cc---ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111100 00 01122233 344444455689999999999999998875553
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=197.06 Aligned_cols=212 Identities=23% Similarity=0.372 Sum_probs=161.5
Q ss_pred hhcCCCCccceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCC
Q 006747 387 RLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNI 466 (632)
Q Consensus 387 ~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDl 466 (632)
.+ .|.|+.+++|.+.+....++|.+|+..|+|.+.+... ...++|.....+..++++||+|+|.. +...|+.+
T Consensus 3 ~l-~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 3 QL-DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred cc-chhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 45 8999999999999999999999999999999999863 35699999999999999999999986 23399999
Q ss_pred CCCCeeecCCCCeEEcccCCCCCCCCCC------CCCCCCcccCCccccCCC-------CCccchhhHHHHHHHHHHhCC
Q 006747 467 KSSNVLLSQDLQGCISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKK-------PTQKSDVYSFGVLLLEMLTGK 533 (632)
Q Consensus 467 k~~NILl~~~~~~ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~-------~~~~~DV~s~Gvvl~elltg~ 533 (632)
+++|+++|....+|++|||+........ ......-|.|||.+.+.. .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987774311 111122399999997642 366799999999999999999
Q ss_pred CCCCCCCCCCC-CChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 534 APIQAPGHEDV-VDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 534 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.||+....... ..+...+. + .....+.+.+.... +....+..++.+||..+|++||++++|-..++.+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~----~-~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVK----K-GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHH----h-cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99976432221 11222221 1 11222223222111 2223577888999999999999999999999988665
Q ss_pred C
Q 006747 613 D 613 (632)
Q Consensus 613 ~ 613 (632)
.
T Consensus 228 ~ 228 (484)
T KOG1023|consen 228 G 228 (484)
T ss_pred c
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-21 Score=213.08 Aligned_cols=245 Identities=20% Similarity=0.238 Sum_probs=173.0
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecc---cccCHHH----HHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKE---VVMGKRE----FEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~---~~~~~~~----~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+++|.|++|.|+.... ......+.|.... .....+. +..|..+-..+ +|+|++..+..+.+....+-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccchhhhh
Confidence 46799999997777653 2333344443321 1111111 33444455566 89999888877777766666699
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++ ||..++.... .+.-..+..+..|+..|+.|||+. +|.|||+|++|++++.++.+||+|||.+.....
T Consensus 402 ~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9999 9999987642 356677788999999999999999 999999999999999999999999999866543
Q ss_pred CC--------CCCCCCcccCCccccCCCCCcc-chhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 493 PT--------VPSRSAGYRAPEVIETKKPTQK-SDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 493 ~~--------~~~~t~~y~aPE~~~~~~~~~~-~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
.. ...|+..|+|||++.+..|++. .||||.|+++..|++|+.||.....++... ....+.. -
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~-~ 543 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSD-Q 543 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhcccc-c
Confidence 22 2347778999999999999765 799999999999999999997654333211 0000000 0
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.........-..+...+...++.++++.+|.+|.|+++|++
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000000011222344667889999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.7e-20 Score=175.50 Aligned_cols=138 Identities=17% Similarity=0.230 Sum_probs=106.7
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccC--H-------------------------HHHHHHHHHHHhhcCCCCc
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG--K-------------------------REFEQQMEVVGRLSQHPNV 394 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~-------------------------~~~~~e~~~l~~l~~h~ni 394 (632)
..||+|+||.||+|...+|+.||||+++..... . .....|++.+.++ .|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTAGI 81 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHCCC
Confidence 469999999999999888999999999754211 0 1123488899999 77776
Q ss_pred cceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHH-HhccCCCceecCCCCCCeee
Q 006747 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI-HAAVGGKFILGNIKSSNVLL 473 (632)
Q Consensus 395 v~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHrDlk~~NILl 473 (632)
.....+.. ...++||||++++++....... .++++....+++.+++.+|.|+ |+. +|+||||||+|||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence 54433322 2348999999998776543221 2477888999999999999999 576 99999999999999
Q ss_pred cCCCCeEEcccCCCCCCC
Q 006747 474 SQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 474 ~~~~~~ki~DfGla~~~~ 491 (632)
+ ++.++|+|||+|....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.5e-21 Score=202.15 Aligned_cols=186 Identities=26% Similarity=0.399 Sum_probs=157.7
Q ss_pred HhCccceeEEEEEE----EcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 343 VLGKGSYGTTYKAI----LEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 343 ~lg~G~fg~V~~~~----~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
++|+|+||.|+++. .+.|..+|+|++++.... +.....|..++..+.+||.+|++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999865 344788999998765321 12345666777788569999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 495 (632)
+|++...+.... .++......+...+|.+++++|+. +|+|||+|++||+++.+|++|+.|||+++..-....
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999998887543 355566667788889999999998 999999999999999999999999999998876666
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCC
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQA 538 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~ 538 (632)
.+||.-|||||++. .....+|.||||++++||+||..||..
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 68999999999998 457789999999999999999999975
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=170.34 Aligned_cols=180 Identities=12% Similarity=0.104 Sum_probs=137.9
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHH-----HHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKR-----EFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~-----~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
...|++|+||+||.+.- ++..++.+.+.......+ -+.+|++++.++.+|++|++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35799999999997766 678888888876543222 578999999999667889999886 45799999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCC-CCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNI-KSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDl-k~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
|.+|...+.. ....+..+++.+|.++|+. +|+|||| ||+|||++.++.++|+|||++.......
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9998654321 1134677889999999998 9999999 7999999999999999999998554322
Q ss_pred CC-----------------CCCCcccCCccccCC-CCC-ccchhhHHHHHHHHHHhCCCCCCCCC
Q 006747 495 VP-----------------SRSAGYRAPEVIETK-KPT-QKSDVYSFGVLLLEMLTGKAPIQAPG 540 (632)
Q Consensus 495 ~~-----------------~~t~~y~aPE~~~~~-~~~-~~~DV~s~Gvvl~elltg~~p~~~~~ 540 (632)
.. ..++.|++|+...-. ..+ ...+.++-|+-+|.++|++.+..+.+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 124556666644322 222 55788899999999999999976544
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=201.63 Aligned_cols=134 Identities=31% Similarity=0.566 Sum_probs=88.4
Q ss_pred ccCChhHHHHHHHHHHhCCCCCCCCCCCCCCCCC----CCcceEecCCC----CeEEEEEeCCCCcccccCchhhcCCCC
Q 006747 20 IADLNSDKQALLDFAANVPHARKLNWNSSTSVCT----SWVGITCTKNG----SRVLAVRLPGVGLYGPIPANTLEKLDS 91 (632)
Q Consensus 20 ~~~~~~~~~~l~~~~~~~~~~~~~~w~~~~~~c~----~w~gv~c~~~~----~~v~~l~l~~~~l~g~lp~~~l~~l~~ 91 (632)
......|.+||+++|.++.....++|+. ++|+ .|.||+|+.+. .+|+.|+|+++++.|.+|. .+..|++
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~-~i~~L~~ 443 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRH 443 (623)
T ss_pred cccCchHHHHHHHHHHhcCCcccCCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCH-HHhCCCC
Confidence 3456679999999999986544468964 3453 69999996321 2477777777777777776 5777777
Q ss_pred CcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccc
Q 006747 92 LMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASI 156 (632)
Q Consensus 92 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~ 156 (632)
|+.|+|++|+|.|.+|..++.+++|+.|+|++|+|+|.+|..+. ++|+.|+|++|+|+|.+|..+
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l 510 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHH
Confidence 77777777777777777777777777666666666655444443 344444444444444444333
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3e-19 Score=170.55 Aligned_cols=138 Identities=20% Similarity=0.263 Sum_probs=109.0
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccC---------------------------HHHHHHHHHHHHhhcCCCCc
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---------------------------KREFEQQMEVVGRLSQHPNV 394 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~~h~ni 394 (632)
..||+|+||.||+|...+|+.||||+++..... ...+..|.+.+.++ .|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhCCC
Confidence 469999999999999878999999998754211 11235778889998 78887
Q ss_pred cceeEEEEeCCceEEEEecccCCCHhhh-hccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-ccCCCceecCCCCCCee
Q 006747 395 VPIRAYYFSKDEKLLVYDFIEAGSFSAL-LHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA-AVGGKFILGNIKSSNVL 472 (632)
Q Consensus 395 v~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NIL 472 (632)
.....+... ..++||||++++++... +.. .+++.....+++.+++.++.++|+ . +|+||||||+||+
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEE
Confidence 655444433 34899999998855433 332 235677888999999999999999 7 9999999999999
Q ss_pred ecCCCCeEEcccCCCCCCCC
Q 006747 473 LSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 473 l~~~~~~ki~DfGla~~~~~ 492 (632)
++ ++.++|+|||+++....
T Consensus 151 l~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EE-CCCEEEEEcccceecCC
Confidence 99 89999999999977654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-18 Score=169.03 Aligned_cols=192 Identities=18% Similarity=0.262 Sum_probs=161.8
Q ss_pred HHhHhCccceeEEEEEE-EcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 340 SAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+++.||+|+||.++.|+ +-+++.||||.-.... ..-+...|.+..+.+..-++|...+.|-.+..+-.||+|++ |-+
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS 109 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS 109 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence 46889999999999998 6679999999865432 23457778888888877899999988888888889999988 568
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-----CCeEEcccCCCCCCCCC
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-----LQGCISDFGLTPLMNTP 493 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-----~~~ki~DfGla~~~~~~ 493 (632)
|.++..-+. ..++..+...||+|+..-++|+|++ .+|.|||||+|+||..- ..+.|+|||+|+.+.+.
T Consensus 110 LEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 110 LEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred HHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 888876442 2488899999999999999999999 99999999999999743 46899999999987544
Q ss_pred C-----------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 006747 494 T-----------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540 (632)
Q Consensus 494 ~-----------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~ 540 (632)
. .-.||+.||+--...|..-+.+-|.-|+|-++++.+.|..||++..
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 2 2248999999999999999999999999999999999999998743
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=174.35 Aligned_cols=163 Identities=12% Similarity=0.165 Sum_probs=126.2
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHH----------HHHHHHHHHhhcCCCCccceeEEEEeC------
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKRE----------FEQQMEVVGRLSQHPNVVPIRAYYFSK------ 404 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~~h~niv~l~~~~~~~------ 404 (632)
.+++|.|+||.||.... ++..+|+|.+......... +++|++.+.++ +|++|..+..++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeeeccccccc
Confidence 46899999999999766 5778999999755332222 68899999999 999999999886643
Q ss_pred --CceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEc
Q 006747 405 --DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS 482 (632)
Q Consensus 405 --~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 482 (632)
...++||||++|.+|.++.. ++. ....+++.++..+|+. +++|||+||+||++++++ ++|+
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEE
Confidence 35789999999999987732 221 2355888999999998 999999999999999998 9999
Q ss_pred ccCCCCCCCCCCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHH
Q 006747 483 DFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEML 530 (632)
Q Consensus 483 DfGla~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ell 530 (632)
|||..+........ ..+.....+..++|+|+||+++.-+.
T Consensus 177 Dfg~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 177 DLSGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ECCCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence 99988665332211 01333445667899999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-19 Score=166.46 Aligned_cols=191 Identities=22% Similarity=0.284 Sum_probs=156.2
Q ss_pred HhHhCccceeEEEEEE-EcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||.|+||.+|.|. ..+|..||||.-.... .......|.++...+..-..|..+..|..+...-.+|||.+ |-+|
T Consensus 20 vrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsL 97 (341)
T KOG1163|consen 20 VRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSL 97 (341)
T ss_pred EEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccH
Confidence 3679999999999998 6789999999875432 23456677888888866678888888888888999999988 5699
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---CCCeEEcccCCCCCCCCCC--
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~~~-- 494 (632)
.+++.-.. ..++..+.+-++-|+..-++|+|.+ ++|||||||+|+|..= ...+.++|||+|+.+-+..
T Consensus 98 EdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 98 EDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred HHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 98876442 2478889999999999999999999 9999999999999864 3568899999998764332
Q ss_pred ---------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 006747 495 ---------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540 (632)
Q Consensus 495 ---------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~ 540 (632)
...||..|.+--...+...+.+-|+-|+|.+|..+-.|..||++..
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence 2247888877766666667888999999999999999999998754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.6e-19 Score=195.76 Aligned_cols=240 Identities=23% Similarity=0.314 Sum_probs=172.0
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEeccc--ccCHHHHHHHHHHHH-hhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEV--VMGKREFEQQMEVVG-RLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~-~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||.+.|=+|.+++.++|. |+||++.+. ...-+.|.++++.++ .+.+|||++.+.-.-.+....|||=+|..+
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 467999999999999988777 889998654 234455665555443 333899999988776677778888889876
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC--CCCC-
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM--NTPT- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~--~~~~- 494 (632)
+|+|.+.. ++.+...+..=|++|+.+|+.-+|.. +|+|+|||.+||||+.-..+.|+||..-|-. .++.
T Consensus 106 nLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 106 NLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred hhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 88888864 34566677778999999999999998 9999999999999999999999999875432 2211
Q ss_pred --------CCCCCCcccCCccccCCC-----------CCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 006747 495 --------VPSRSAGYRAPEVIETKK-----------PTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSV 554 (632)
Q Consensus 495 --------~~~~t~~y~aPE~~~~~~-----------~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 554 (632)
+..+-..|+|||.+.... .+++-||||.||++.||++ |++||.-. ++..+.+
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr~-- 249 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYRS-- 249 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHhc--
Confidence 112334599999885411 4567899999999999998 78888521 1111100
Q ss_pred hhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 555 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
. ...+++. ..+.++ -..+..++..|++.||++|-++++.++.-.
T Consensus 250 --~----~~~~~e~-~Le~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 250 --G----NADDPEQ-LLEKIE--DVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred --c----CccCHHH-HHHhCc--CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 0 0011100 000001 114667888999999999999999998743
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=158.78 Aligned_cols=133 Identities=14% Similarity=0.149 Sum_probs=102.6
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEeccc-ccCHHHHHHHHHHHHhhc----CCCCccceeEEEEeCC---ceE-EEEe
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEV-VMGKREFEQQMEVVGRLS----QHPNVVPIRAYYFSKD---EKL-LVYD 412 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~---~~~-lv~E 412 (632)
+.||+|+||.||. .++....+||++... ....+++.+|++++..+. +||||++++|++.++. ..+ +|+|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e 85 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD 85 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence 5799999999996 433333468887654 224567999999999984 4799999999999874 333 7899
Q ss_pred c--ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHH-HHHHhccCCCceecCCCCCCeeecC----CCCeEEcccC
Q 006747 413 F--IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGI-AHIHAAVGGKFILGNIKSSNVLLSQ----DLQGCISDFG 485 (632)
Q Consensus 413 ~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivHrDlk~~NILl~~----~~~~ki~DfG 485 (632)
| +.+|+|.+++.... +++. ..++.+++.++ +|||+. +|+||||||+|||++. +..++|+||+
T Consensus 86 ~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 86 FDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred CCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 9 55899999996531 3333 35577777777 999998 9999999999999974 3489999955
Q ss_pred CC
Q 006747 486 LT 487 (632)
Q Consensus 486 la 487 (632)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-18 Score=167.89 Aligned_cols=229 Identities=17% Similarity=0.307 Sum_probs=140.8
Q ss_pred HhHhCccceeEEEEEEEcC-CcEEEEEEeccccc----CHHHHHHHHHHHHhhc---------CCCCccceeEEEE----
Q 006747 341 AEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVM----GKREFEQQMEVVGRLS---------QHPNVVPIRAYYF---- 402 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~---------~h~niv~l~~~~~---- 402 (632)
.+.||.|+++.||.+...+ ++.+|||+...... .-+++++|.-.+..+. +|-.++.-++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 3579999999999999754 89999999854322 1244555543333321 1212221122111
Q ss_pred -----eCC--------ceEEEEecccCCCHhhhhcc---CCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCC
Q 006747 403 -----SKD--------EKLLVYDFIEAGSFSALLHG---NRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNI 466 (632)
Q Consensus 403 -----~~~--------~~~lv~E~~~~g~L~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDl 466 (632)
... +.+++|+-+ .+||.+++.. ... ....+....++.+..|+.+.+++||+. ++||+||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 111 235677777 4588887542 111 123455677888889999999999999 9999999
Q ss_pred CCCCeeecCCCCeEEcccCCCCCCCCCCC-CCCCCcccCCccccCC--------CCCccchhhHHHHHHHHHHhCCCCCC
Q 006747 467 KSSNVLLSQDLQGCISDFGLTPLMNTPTV-PSRSAGYRAPEVIETK--------KPTQKSDVYSFGVLLLEMLTGKAPIQ 537 (632)
Q Consensus 467 k~~NILl~~~~~~ki~DfGla~~~~~~~~-~~~t~~y~aPE~~~~~--------~~~~~~DV~s~Gvvl~elltg~~p~~ 537 (632)
||+|++++++|.++++||+.....+.... ...+.+|.+||..... .++.+.|.|++|+++|.|++|+.||.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~ 251 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFG 251 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STC
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCC
Confidence 99999999999999999987765544322 2344669999977442 36889999999999999999999997
Q ss_pred CCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCC
Q 006747 538 APGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMR 596 (632)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R 596 (632)
....+.... | ...... +..+.+.+|+...++.+|.+|
T Consensus 252 ~~~~~~~~~---~----------------~f~~C~---~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 252 LSSPEADPE---W----------------DFSRCR---DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CCGGGSTSG---G----------------GGTTSS------HHHHHHHHHHT-SSGGGS
T ss_pred CCCcccccc---c----------------cchhcC---CcCHHHHHHHHHHccCCcccC
Confidence 543221110 0 111111 334455667779999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.5e-16 Score=154.87 Aligned_cols=133 Identities=20% Similarity=0.374 Sum_probs=112.7
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEeccccc---------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM---------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
+.||+|++|.||+|.. +|..|++|+...... ....+.+|++++..+ +|++|.....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCCCCEEEEE
Confidence 4689999999999987 578899998654321 123577889999999 89999888888878888999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
|+++++|.+++.... + .+..++.+++.+|.++|+. +++|||++|+||+++ ++.++|+|||.++.
T Consensus 80 ~~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999986431 2 7788999999999999998 999999999999999 78999999998765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=156.90 Aligned_cols=138 Identities=17% Similarity=0.222 Sum_probs=105.8
Q ss_pred HhHhCccceeEEEEEE--EcCCcEEEEEEecccccC-------------------------HHHHHHHHHHHHhhcCCCC
Q 006747 341 AEVLGKGSYGTTYKAI--LEEGTTVVVKRLKEVVMG-------------------------KREFEQQMEVVGRLSQHPN 393 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~~h~n 393 (632)
.+.||+|+||.||+|. ..+|+.||+|+++..... ...+..|++.+.++ .+..
T Consensus 33 ~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L-~~~~ 111 (237)
T smart00090 33 GGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL-YEAG 111 (237)
T ss_pred CCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-HhcC
Confidence 5689999999999998 568999999998743210 12356889999999 4433
Q ss_pred --ccceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCC-ceecCCCCCC
Q 006747 394 --VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK-FILGNIKSSN 470 (632)
Q Consensus 394 --iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivHrDlk~~N 470 (632)
+.+.+++ ...++||||+++++|....... .++.......++.+++.+++|||+. + |+||||||+|
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 3333332 2458999999998887654322 1244455678999999999999998 8 9999999999
Q ss_pred eeecCCCCeEEcccCCCCCCCC
Q 006747 471 VLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 471 ILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++ ++.++|+|||.+.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999999875543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=158.09 Aligned_cols=193 Identities=20% Similarity=0.290 Sum_probs=132.4
Q ss_pred cCCCCccceeEEEEeC---------------------------CceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHH
Q 006747 389 SQHPNVVPIRAYYFSK---------------------------DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK 441 (632)
Q Consensus 389 ~~h~niv~l~~~~~~~---------------------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~ 441 (632)
.+|||||++.++|.+. ...|+||.-.+. +|+.++..+. .+...+.-
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~ 345 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRV 345 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHH
Confidence 4799999998886532 245788887765 8888887542 33345556
Q ss_pred HHHHHHHHHHHHHhccCCCceecCCCCCCeee--cCCC--CeEEcccCCCCCCCC---------CCC-CCCCCcccCCcc
Q 006747 442 ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL--SQDL--QGCISDFGLTPLMNT---------PTV-PSRSAGYRAPEV 507 (632)
Q Consensus 442 i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl--~~~~--~~ki~DfGla~~~~~---------~~~-~~~t~~y~aPE~ 507 (632)
+..|+++|+.|||.+ +|.|||+|++|||+ |+|. .+.|+|||.+-.-+. ... ..|...-||||+
T Consensus 346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 788999999999998 99999999999998 4444 567899997633221 111 124556899999
Q ss_pred ccCCC------CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHH
Q 006747 508 IETKK------PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQM 581 (632)
Q Consensus 508 ~~~~~------~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~ 581 (632)
....+ ...|+|.|+.|.+.||+++...||...++. ..+.. .+. +..... + .+.....+
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r----~Yq-e~qLPa-----l-----p~~vpp~~ 486 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTR----TYQ-ESQLPA-----L-----PSRVPPVA 486 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechh----hhh-hhhCCC-----C-----cccCChHH
Confidence 86543 257899999999999999999999874321 11111 111 111111 1 01122346
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 582 LQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 582 ~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
.+++...++.||++|++..-....|.
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 67888899999999999776655543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=151.17 Aligned_cols=129 Identities=19% Similarity=0.334 Sum_probs=106.3
Q ss_pred HhCccceeEEEEEEEcCCcEEEEEEecccc--c-------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 343 VLGKGSYGTTYKAILEEGTTVVVKRLKEVV--M-------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~--~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.||+|+||.||+|.. ++..|++|...... . ....+.+|++++..+ +|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999985 57889999865321 1 124567899999999 788776666666677778999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
+++++|.+++.... . .++.+++.+|.+||+. +++|+|++|+||+++ ++.+++.|||+++.
T Consensus 79 ~~g~~l~~~~~~~~-----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN-----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH-----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998875421 0 7889999999999998 999999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.9e-16 Score=151.10 Aligned_cols=133 Identities=15% Similarity=0.157 Sum_probs=104.0
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEeccccc-----------------------CHHHHHHHHHHHHhhcCCCC--cc
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM-----------------------GKREFEQQMEVVGRLSQHPN--VV 395 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~e~~~l~~l~~h~n--iv 395 (632)
.+.||+|+||.||++...+|+.||||++..... ....+..|...+..+ .|++ +.
T Consensus 20 ~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~v~ 98 (198)
T cd05144 20 GNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEGFPVP 98 (198)
T ss_pred CCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcCCCCC
Confidence 568999999999999988899999998754321 012356778888888 6764 44
Q ss_pred ceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC
Q 006747 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ 475 (632)
Q Consensus 396 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~ 475 (632)
..++ ....++||||+++++|...... .....++.+++.++.++|+. +|+||||||+||++++
T Consensus 99 ~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 99 KPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDD 160 (198)
T ss_pred ceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcC
Confidence 4443 2456899999999998765431 12356788999999999997 9999999999999999
Q ss_pred CCCeEEcccCCCCCCCC
Q 006747 476 DLQGCISDFGLTPLMNT 492 (632)
Q Consensus 476 ~~~~ki~DfGla~~~~~ 492 (632)
++.++|+|||.+.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5e-17 Score=182.70 Aligned_cols=185 Identities=25% Similarity=0.310 Sum_probs=145.7
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhc--CCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS--QHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
...||+|+||+||+|...+|+.||+|+-+-..... |---.+++.||. --+-|..+...+.-.+.-++|+||.+.|+
T Consensus 703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE--fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt 780 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE--FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT 780 (974)
T ss_pred EeeeccccceEEEEeecCCCcEEEEEeecCCCcee--eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence 45799999999999998889999999976543321 111112233331 12455666666666778899999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec-------CCCCeEEcccCCCCCCC
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS-------QDLQGCISDFGLTPLMN 491 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~-------~~~~~ki~DfGla~~~~ 491 (632)
|.+++...+ -++|...+.++.++++-+++||.. +|||+||||+|+||. ++..++|+|||-+-.|.
T Consensus 781 lld~~N~~~-----~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 781 LLDLINTNK-----VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred HHHhhccCC-----CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999998443 478999999999999999999998 999999999999994 34679999999986543
Q ss_pred ---CC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCC
Q 006747 492 ---TP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535 (632)
Q Consensus 492 ---~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p 535 (632)
.. .....|-++-.+|...|+..+..+|-|.++-+++-|+.|+.-
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 22 122456678899999999999999999999999999999754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=173.63 Aligned_cols=132 Identities=18% Similarity=0.296 Sum_probs=107.5
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEeccccc--------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM--------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|.+.....++.+++.+... ..+.+.+|++++.++ +|++++....++......++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeCCCCEEEEE
Confidence 467999999999999876444333333322111 124578999999999 89999988888888788899999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
|+++++|.+++. .+..++.+++.+|.|||+. +++||||||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998875 3457889999999999998 99999999999999 6789999999998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=9.3e-17 Score=176.98 Aligned_cols=198 Identities=22% Similarity=0.322 Sum_probs=134.2
Q ss_pred HHhHhCccceeEEEEEEEcC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 340 SAEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.+.|..|+||.||.++++. .+.+|+|+-+... +.+. ++... ..|.+| ||
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~kiNkq~l-----ilRn--ilt~a-~npfvv---------------------gD 137 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----ILRN--ILTFA-GNPFVV---------------------GD 137 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhhcccccch-----hhhc--ccccc-CCccee---------------------ch
Confidence 34789999999999998654 4667774433211 1110 22222 344443 55
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC------
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT------ 492 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~------ 492 (632)
-...++.. +..|.+. +.+++|||+. +|+|||+||+|.+|+.-|++|+.|||+++..-.
T Consensus 138 c~tllk~~---g~lPvdm----------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 138 CATLLKNI---GPLPVDM----------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred hhhhcccC---CCCcchh----------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 55555543 2333332 6789999998 999999999999999999999999999865311
Q ss_pred -------------CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 493 -------------PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 493 -------------~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
+...++|+.|+|||++....|...+|+|++|+|+||.+-|+.||.+...++.. ...+.+..
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~visd~i 275 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVISDDI 275 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhhhhhc
Confidence 12236899999999999999999999999999999999999999876544432 12222211
Q ss_pred -ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCC
Q 006747 560 -TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPT 598 (632)
Q Consensus 560 -~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs 598 (632)
+.+ ..+....+..+++.+.++.+|..|--
T Consensus 276 ~wpE----------~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 276 EWPE----------EDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred cccc----------cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 111 11111234555666888899988843
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.2e-15 Score=139.38 Aligned_cols=134 Identities=17% Similarity=0.155 Sum_probs=112.6
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC-CCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQH-PNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
+.||+|.++.||++...+ ..+++|....... ...+..|++.+..+.++ .+++++++++...+..++++||++++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 468999999999999754 7899999866433 56789999999999444 68899998888878899999999987765
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
.+ +......++.+++.++++||.....+++|+|++|+||++++++.+++.|||.++.
T Consensus 82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 43 3456677889999999999986545799999999999999999999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.9e-16 Score=163.67 Aligned_cols=170 Identities=21% Similarity=0.276 Sum_probs=125.3
Q ss_pred ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 406 EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 406 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
..|+.|+++...+|.+++...+.. ...+|...+.++.+++.|+.| + +.+|||+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~--e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG--EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc--cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 468999999999999999865532 335778889999999999999 4 89999999999999999999999999
Q ss_pred CCCCCCCCC----------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 006747 486 LTPLMNTPT----------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSV 554 (632)
Q Consensus 486 la~~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 554 (632)
+...+.... ...+|..||+||.+.+..|+.|+||||+|++|+|+++ -..+++.... ...
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t----------~~d 471 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT----------LTD 471 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh----------hhh
Confidence 986654332 3357889999999999999999999999999999997 3333321110 011
Q ss_pred hhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006747 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603 (632)
Q Consensus 555 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl 603 (632)
++++... +.. ......-..+..+.+...|.+||++.++.
T Consensus 472 ~r~g~ip----~~~------~~d~p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 472 IRDGIIP----PEF------LQDYPEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhcCCCC----hHH------hhcCcHHHHHHHHhcCCCcccCchHHHHh
Confidence 2222211 110 00111223456689999999999555543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.1e-15 Score=142.56 Aligned_cols=135 Identities=21% Similarity=0.244 Sum_probs=96.8
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccCHH---H----------------------HHHHHHHHHhhcCCC--Cc
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKR---E----------------------FEQQMEVVGRLSQHP--NV 394 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~---~----------------------~~~e~~~l~~l~~h~--ni 394 (632)
+.||+|+||.||+|...+++.||||+++....... . ...|.+.+.++ .+. .+
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~ 81 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL-YEAGVPV 81 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH-HHcCCCC
Confidence 56999999999999988899999999875422111 1 13455555555 333 23
Q ss_pred cceeEEEEeCCceEEEEecccCCCHhhh-hccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-ccCCCceecCCCCCCee
Q 006747 395 VPIRAYYFSKDEKLLVYDFIEAGSFSAL-LHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA-AVGGKFILGNIKSSNVL 472 (632)
Q Consensus 395 v~l~~~~~~~~~~~lv~E~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NIL 472 (632)
.+.+++ ...++||||++++.+... +.... .. ....+++.+++.++.++|. . +|+||||||+||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEE
Confidence 444433 346899999999654321 11110 11 4567789999999999998 6 9999999999999
Q ss_pred ecCCCCeEEcccCCCCCCCC
Q 006747 473 LSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 473 l~~~~~~ki~DfGla~~~~~ 492 (632)
++ ++.++++|||.+.....
T Consensus 148 i~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EE-CCcEEEEECcccccccC
Confidence 99 99999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=5e-14 Score=139.06 Aligned_cols=135 Identities=21% Similarity=0.239 Sum_probs=104.4
Q ss_pred HhHhC-ccceeEEEEEEEcCCcEEEEEEecccc--------------cCHHHHHHHHHHHHhhcCCCCc--cceeEEEEe
Q 006747 341 AEVLG-KGSYGTTYKAILEEGTTVVVKRLKEVV--------------MGKREFEQQMEVVGRLSQHPNV--VPIRAYYFS 403 (632)
Q Consensus 341 ~~~lg-~G~fg~V~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~~h~ni--v~l~~~~~~ 403 (632)
...|| .|+.|+||++... +..++||++.... .....+.+|++++.++ +|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 56788 8999999999875 7788999885311 1124578899999999 78775 667776544
Q ss_pred CCc----eEEEEecccC-CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC
Q 006747 404 KDE----KLLVYDFIEA-GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ 478 (632)
Q Consensus 404 ~~~----~~lv~E~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~ 478 (632)
... .++|+||+++ .+|.+++... +++.. ...+++.++.+||+. +|+||||||.|||++.++.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~ 180 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGK 180 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCC
Confidence 322 2599999997 6898887642 23332 356788999999998 9999999999999999999
Q ss_pred eEEcccCCCCCC
Q 006747 479 GCISDFGLTPLM 490 (632)
Q Consensus 479 ~ki~DfGla~~~ 490 (632)
++|+|||.+...
T Consensus 181 v~LIDfg~~~~~ 192 (239)
T PRK01723 181 FWLIDFDRGELR 192 (239)
T ss_pred EEEEECCCcccC
Confidence 999999988653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-15 Score=134.55 Aligned_cols=138 Identities=27% Similarity=0.493 Sum_probs=122.4
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
..++.+.|+.|.++ .+|+ .+..|.+|+.|++++|+++ .+|.++++|++|+.|+++-|++. .+|..|+ +.|+.||
T Consensus 33 s~ITrLtLSHNKl~-~vpp-nia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPP-NIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhcccCcee-ecCC-cHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 46888999999998 6777 5899999999999999999 78999999999999999999999 8999987 7899999
Q ss_pred ccCCCCcc-cCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCCC
Q 006747 143 LSFNSITG-NIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFPP 207 (632)
Q Consensus 143 Ls~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 207 (632)
|++|+|+. .+|..|..++.|+.|+|++|.|.-.+|+. .+++|+.|.+..|.+- ++|.+++.+..
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~ 174 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTR 174 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHH
Confidence 99999985 58999999999999999999999887775 8899999999999887 67877765543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.1e-15 Score=162.41 Aligned_cols=243 Identities=24% Similarity=0.327 Sum_probs=172.8
Q ss_pred hHhCccceeEEEEEEEc--CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE--EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+|+.|-..... ....+|+|.+...... ......|..+-..+.+|+|++++++.....+..+++.||..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 45899999999887643 3456677766544322 223334555555664599999999999999999999999999
Q ss_pred CCHhhhh-ccCCCCCCCcCCHHHHHHHHHHHHHHHHHHH-hccCCCceecCCCCCCeeecCCC-CeEEcccCCCCCCCC-
Q 006747 417 GSFSALL-HGNRGIGRTPLDWESRVKISLGSAKGIAHIH-AAVGGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLMNT- 492 (632)
Q Consensus 417 g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~- 492 (632)
|++.+.+ +... ...+......+..++..++.|+| .. ++.|||+||+|.+++..+ ..|++|||+|.....
T Consensus 106 ~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 106 GSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccCCc----cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 9999888 4332 12333445667889999999999 66 999999999999999999 999999999976654
Q ss_pred CC------CCCC-CCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 493 PT------VPSR-SAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 493 ~~------~~~~-t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.. ...| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....+. ....|.... . .+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~----~~ 250 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---G----RF 250 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---c----cc
Confidence 21 2346 8889999999885 457789999999999999999999876543331 111111110 0 00
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
....+.... ....++..+++..+|..|.+.+++..
T Consensus 251 --~~~~~~~~~---~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 251 --TQLPWNSIS---DQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred --ccCccccCC---hhhhhcccccccCCchhccccccccc
Confidence 011111222 23455666888899999999887644
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.9e-15 Score=131.10 Aligned_cols=135 Identities=27% Similarity=0.418 Sum_probs=120.1
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCc-cCCCCcc--CCCcEEEc
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG-NIPSSLS--PQLNWVDL 143 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~--~~L~~L~L 143 (632)
+..+++.+|.+. .+|. .++.|++|++|+++-|.+. .+|..|++++.|+.|||++|+++. .+|..|+ ..|+-|+|
T Consensus 58 levln~~nnqie-~lp~-~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl 134 (264)
T KOG0617|consen 58 LEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYL 134 (264)
T ss_pred hhhhhcccchhh-hcCh-hhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHh
Confidence 345678888887 7887 7999999999999999998 889999999999999999999985 6888887 67999999
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
+.|.|. .+|..+++|++|+.|.+..|.+-..+.+. .++.|+.|++.+|+++ .+|.+++++.
T Consensus 135 ~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~ 196 (264)
T KOG0617|consen 135 GDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT-VLPPELANLD 196 (264)
T ss_pred cCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-ecChhhhhhh
Confidence 999998 89999999999999999999998775554 7899999999999999 7787776553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.1e-12 Score=140.86 Aligned_cols=141 Identities=18% Similarity=0.294 Sum_probs=97.6
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccC-----------------------------------------HHHHHH
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG-----------------------------------------KREFEQ 380 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-----------------------------------------~~~~~~ 380 (632)
+.||.|++|.||+|.+++|+.||||+.+..... +-+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 469999999999999999999999998542100 002344
Q ss_pred HHHHHHhhc----CCCCccceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHH-HHHHHHh
Q 006747 381 QMEVVGRLS----QHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAK-GIAHIHA 455 (632)
Q Consensus 381 e~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~ 455 (632)
|.+.+.++. ++++|.-..-|+......++||||++|++|.++...... .. .+.+++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHHh
Confidence 444444442 234433222222334567999999999999887653211 12 23456665555 3567787
Q ss_pred ccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 456 ~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
. +++|+|++|.||++++++.+++.|||++..+..
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6 999999999999999999999999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-12 Score=126.97 Aligned_cols=199 Identities=20% Similarity=0.306 Sum_probs=135.8
Q ss_pred HHhhcCCCCccceeEEEEeCC-----ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCC
Q 006747 385 VGRLSQHPNVVPIRAYYFSKD-----EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459 (632)
Q Consensus 385 l~~l~~h~niv~l~~~~~~~~-----~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~ 459 (632)
+-.+ .|-|||++..||.+.. +..++.|||+-|++..+|++.+. ....+....-.+++-||..||.|||+ |.|
T Consensus 121 llql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 121 LLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 3344 6999999999987643 46889999999999999986542 22335555667899999999999998 589
Q ss_pred CceecCCCCCCeeecCCCCeEEcccCCCCCCC--------CCCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh
Q 006747 460 KFILGNIKSSNVLLSQDLQGCISDFGLTPLMN--------TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT 531 (632)
Q Consensus 460 ~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt 531 (632)
+|+|+++..+-|++..++-+||.----...-. ......+-++|-|||+-.....+..+|||+||...+||.-
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 99999999999999999999984321111100 0111234678999998877778889999999999999988
Q ss_pred CCCC-CCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 006747 532 GKAP-IQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607 (632)
Q Consensus 532 g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~ 607 (632)
+..- ..+....+. ..-.... ++.. +. . .=..++..|++..|..||+|++++.+.-
T Consensus 278 lEiq~tnseS~~~~---ee~ia~~--------i~~l-----en---~--lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 278 LEIQSTNSESKVEV---EENIANV--------IIGL-----EN---G--LQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred heeccCCCcceeeh---hhhhhhh--------eeec-----cC---c--cccCcCcccccCCCCCCcchhhhhcCce
Confidence 7643 211110000 0000000 0000 00 0 0123456899999999999999877543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.2e-13 Score=141.48 Aligned_cols=120 Identities=31% Similarity=0.329 Sum_probs=84.5
Q ss_pred ccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCc--cCCCcEEEccCCCCcccCCcccc
Q 006747 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL--SPQLNWVDLSFNSITGNIPASIR 157 (632)
Q Consensus 80 ~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~--~~~L~~L~Ls~N~l~g~~p~~~~ 157 (632)
.+..+.|..|.++++|+|+.|+++..--.++.+|+.|+.||||+|.+...-+... .++|++||||+|+|+...+..|.
T Consensus 259 kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~ 338 (873)
T KOG4194|consen 259 KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFR 338 (873)
T ss_pred cccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHH
Confidence 4555677777788888888888876666677788888888888888875545433 37888888888888876777777
Q ss_pred CCCCccceecccccccccCCC-C-CCCCCcEEEcccCCCCCCCc
Q 006747 158 NLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLNGSVP 199 (632)
Q Consensus 158 ~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l~g~~p 199 (632)
-|..|+.|+|++|.++..-.. | .+++|+.|||++|.|++.|-
T Consensus 339 ~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IE 382 (873)
T KOG4194|consen 339 VLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIE 382 (873)
T ss_pred HHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEe
Confidence 777777777777777654333 1 56667777777776665443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.7e-11 Score=114.74 Aligned_cols=129 Identities=16% Similarity=0.085 Sum_probs=95.2
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCcc-ceeEEEEeCCceEEEEecccCCCHh
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVV-PIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv-~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
+.++.|.++.||++... +..|++|...........++.|.+.+..+ .+.+++ +++++. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLA-AEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHH-HHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46789999999999875 78899999865433334578889998888 444444 454433 33468999999998875
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc--CCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV--GGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
..- .....+..+++++|+.||... ...++|+|++|.||+++ ++.++++|||.+.
T Consensus 80 ~~~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 80 TED-------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc-------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 430 011235678899999999873 22369999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.6e-12 Score=129.50 Aligned_cols=83 Identities=27% Similarity=0.462 Sum_probs=65.3
Q ss_pred CCCCCCCCcc--eEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCC
Q 006747 48 STSVCTSWVG--ITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSL 116 (632)
Q Consensus 48 ~~~~c~~w~g--v~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 116 (632)
..+-|..-+| |+|+..+ ...|.|+|..|+++ .||+++|+.+++|+.||||+|+|+-+-|..|.+|++|
T Consensus 39 ~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 39 APCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred CCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 3444533233 7887543 24688999999999 8999999999999999999999998889999999988
Q ss_pred CeEeecC-CcCCccCCC
Q 006747 117 RFLYLQN-NNFSGNIPS 132 (632)
Q Consensus 117 ~~L~Ls~-N~l~g~~p~ 132 (632)
..|-+.+ |+|+ .+|.
T Consensus 118 ~~Lvlyg~NkI~-~l~k 133 (498)
T KOG4237|consen 118 LSLVLYGNNKIT-DLPK 133 (498)
T ss_pred hHHHhhcCCchh-hhhh
Confidence 7766555 8887 5664
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.2e-13 Score=139.40 Aligned_cols=137 Identities=34% Similarity=0.443 Sum_probs=98.1
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCc----cCCC---------
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG----NIPS--------- 132 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g----~~p~--------- 132 (632)
..+-|+|++|++. +||...+-+|+.|-.||||+|.|. .+|+.+..|.+|++|+||+|.|.- .+|.
T Consensus 127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence 3455777777776 677767777888888888888887 677778888888888888887642 3332
Q ss_pred ------------Ccc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCC
Q 006747 133 ------------SLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGS 197 (632)
Q Consensus 133 ------------~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~ 197 (632)
++- .+|..+|||.|+|. .+|..+.++.+|+.|+||+|+++..--.. ...+|++|+||.|+|+ .
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~ 282 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-V 282 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-c
Confidence 111 25667788888887 78888888888888888888887543322 4567778888888887 6
Q ss_pred CcccccCCC
Q 006747 198 VPLALQKFP 206 (632)
Q Consensus 198 ~p~~~~~~~ 206 (632)
+|.++.+++
T Consensus 283 LP~avcKL~ 291 (1255)
T KOG0444|consen 283 LPDAVCKLT 291 (1255)
T ss_pred chHHHhhhH
Confidence 777666554
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.1e-13 Score=136.92 Aligned_cols=129 Identities=28% Similarity=0.242 Sum_probs=94.0
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
++-.|+|..|+++ .+..+.+.+|++|+.|+||.|.|...-++.+...++|+.|+||+|+++..-+..|. .+|+.|+|
T Consensus 270 kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL 348 (873)
T KOG4194|consen 270 KMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL 348 (873)
T ss_pred ccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence 4567888888887 56667888999999999999999988899999999999999999999955555553 56666666
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCCC-----CCCCCcEEEcccCCCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-----NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-----~~~~L~~l~ls~N~l~ 195 (632)
+.|.++..-...|..+++|+.|||++|.|++.+.+. .+++|+.|+|.+|+|.
T Consensus 349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk 405 (873)
T KOG4194|consen 349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLK 405 (873)
T ss_pred cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceee
Confidence 666666555555666666666666666666655541 4555555555555555
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=5.2e-11 Score=129.33 Aligned_cols=140 Identities=18% Similarity=0.282 Sum_probs=89.1
Q ss_pred hHhCccceeEEEEEEEcC-CcEEEEEEeccccc---------------------------C--------H------HHHH
Q 006747 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVM---------------------------G--------K------REFE 379 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~---------------------------~--------~------~~~~ 379 (632)
+.||.|++|.||+|.+++ |+.||||+.+.... . . -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 99999999963310 0 0 1234
Q ss_pred HHHHHHHhhc---CCCCccceeEEEEe-CCceEEEEecccCCCHhhhh--ccCCCCCCCcCCHHHHHHHHHHHHHHHHHH
Q 006747 380 QQMEVVGRLS---QHPNVVPIRAYYFS-KDEKLLVYDFIEAGSFSALL--HGNRGIGRTPLDWESRVKISLGSAKGIAHI 453 (632)
Q Consensus 380 ~e~~~l~~l~---~h~niv~l~~~~~~-~~~~~lv~E~~~~g~L~~~l--~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L 453 (632)
+|...+.++. .+.+.+.+-..+.+ ....++||||++|+.+.++- ... + .+ +..++...+. .|+
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~-g-----~d---~~~la~~~v~--~~~ 273 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA-G-----TD---MKLLAERGVE--VFF 273 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc-C-----CC---HHHHHHHHHH--HHH
Confidence 4444444442 23333333333332 45678999999999998742 221 1 11 1112222221 122
Q ss_pred HhccCCCceecCCCCCCeeecCCC----CeEEcccCCCCCCCC
Q 006747 454 HAAVGGKFILGNIKSSNVLLSQDL----QGCISDFGLTPLMNT 492 (632)
Q Consensus 454 H~~~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~~~~~ 492 (632)
++....+++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 274 ~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 222223999999999999999988 999999999876643
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-12 Score=136.32 Aligned_cols=126 Identities=28% Similarity=0.449 Sum_probs=65.4
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCc-cCCCCcc--CCCcEEE
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG-NIPSSLS--PQLNWVD 142 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~--~~L~~L~ 142 (632)
+++-|.|...+|. .+|. .++.|.+|++|.+++|+|. .+-.+++.|+.|+.+++.+|+|.. -||..++ ..|+.||
T Consensus 33 ~~~WLkLnrt~L~-~vPe-EL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lD 109 (1255)
T KOG0444|consen 33 QMTWLKLNRTKLE-QVPE-ELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILD 109 (1255)
T ss_pred heeEEEechhhhh-hChH-HHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeee
Confidence 5666666666665 5665 5667777777777777665 333444555555555555555532 2444443 3455555
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~ 195 (632)
||.|+|. +.|..+.+-+++-.|+||+|++..++-.. +++.|-.||||+|+|.
T Consensus 110 LShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 110 LSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred cchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence 5555554 34555544455555555555554332221 4444444444444444
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-11 Score=137.09 Aligned_cols=88 Identities=40% Similarity=0.609 Sum_probs=77.5
Q ss_pred CCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecc
Q 006747 91 SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQ 168 (632)
Q Consensus 91 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~ 168 (632)
.++.|+|++|.|.|.+|..+..|++|+.|+|++|+|+|.+|..+. ++|+.|||++|+|+|.+|..+++|++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 478899999999999999999999999999999999988887776 688888888888888888888888888888888
Q ss_pred cccccccCCC
Q 006747 169 NNSLTGFIPN 178 (632)
Q Consensus 169 ~N~l~~~~p~ 178 (632)
+|+|+|.+|.
T Consensus 499 ~N~l~g~iP~ 508 (623)
T PLN03150 499 GNSLSGRVPA 508 (623)
T ss_pred CCcccccCCh
Confidence 8888888775
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-11 Score=129.45 Aligned_cols=252 Identities=19% Similarity=0.268 Sum_probs=167.7
Q ss_pred CCHHHHHHHHHhHhCc--cceeEEEEEEE---cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEE
Q 006747 331 FDLEDLLRASAEVLGK--GSYGTTYKAIL---EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYF 402 (632)
Q Consensus 331 ~~~~~l~~~~~~~lg~--G~fg~V~~~~~---~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 402 (632)
++..+-.......+|. |.+|.||.+.. .++..+|+|+-+.... ....-.+|...-+++..|+|.|+....+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3444444445677899 99999999886 4578899998543321 22223344555556667999999999999
Q ss_pred eCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeEE
Q 006747 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGCI 481 (632)
Q Consensus 403 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~ki 481 (632)
..+..++-+|++. .+|..+.+.....-...+-|.....+...-+.|+.++|.. .++|-|+||.||+..++ ...++
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence 9999999999986 6888888765332222233333333333233399999988 99999999999999999 89999
Q ss_pred cccCCCCCCCCCCC---------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006747 482 SDFGLTPLMNTPTV---------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 482 ~DfGla~~~~~~~~---------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 552 (632)
.|||+...+..... ..+...|++||... +.++...|+|++|.+..|..++-.+........ |..
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~~ 337 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------WSQ 337 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------ccc
Confidence 99999876654331 13455699999875 456889999999999999999876654321111 110
Q ss_pred HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 553 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
++..+.. .+....-..++......+++.+|-.|++.+.+..
T Consensus 338 --~r~~~ip---------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 --LRQGYIP---------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --cccccCc---------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0011100 0000001112333566788999999998776543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.8e-13 Score=131.85 Aligned_cols=141 Identities=30% Similarity=0.459 Sum_probs=109.1
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEcc
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLS 144 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls 144 (632)
.+.+++.+|.+. .+|++.+. ++.|++||+.+|-++ .+|++++.|.+|..|||.+|++. .+| +|. ..|..|+++
T Consensus 162 l~~l~~~~n~l~-~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g 236 (565)
T KOG0472|consen 162 LSKLDLEGNKLK-ALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVG 236 (565)
T ss_pred HHHhhccccchh-hCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhc
Confidence 445677777777 56665554 888888888888887 78888999999999999999988 777 554 568888888
Q ss_pred CCCCcccCCcccc-CCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCC--CCCccCCC
Q 006747 145 FNSITGNIPASIR-NLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFP--PSSFEGNS 214 (632)
Q Consensus 145 ~N~l~g~~p~~~~-~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~--~~~~~~n~ 214 (632)
.|++. .+|.+.. ++++|..|||.+|+++..+-+. .+.+|..||+|+|.++ ++|.+++++. .....||+
T Consensus 237 ~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNP 308 (565)
T KOG0472|consen 237 ENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNP 308 (565)
T ss_pred ccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCc
Confidence 88887 6888775 8889999999999998664444 6678899999999998 5677777663 23456665
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.3e-12 Score=124.63 Aligned_cols=127 Identities=35% Similarity=0.467 Sum_probs=96.2
Q ss_pred eEEEEEeCCCCcccccCc-----------------------hhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeec
Q 006747 66 RVLAVRLPGVGLYGPIPA-----------------------NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQ 122 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~-----------------------~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls 122 (632)
-|+.+++++|.+. ++|. ..+..+++|..|+|++|-+. .+|.+++.+..||.||+|
T Consensus 389 ~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS 466 (565)
T KOG0472|consen 389 IVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLS 466 (565)
T ss_pred ceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccc
Confidence 4888999988765 3332 25667777777888777776 677777777778888888
Q ss_pred CCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCC
Q 006747 123 NNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 123 ~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~ 195 (632)
+|+|. .+|..+. ..|+.+-.++|++....|..+.++.+|..|||.+|.+...+|.. ++++|++|+|++|.|.
T Consensus 467 ~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 467 FNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 88777 6666554 34555556667777655566888999999999999999888876 8899999999999887
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=5e-10 Score=126.60 Aligned_cols=121 Identities=31% Similarity=0.506 Sum_probs=92.0
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEccCC
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFN 146 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N 146 (632)
.+.++|.+++++ .+|.. + .++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+..+|+.|+|++|
T Consensus 180 ~~~L~L~~~~Lt-sLP~~-I--p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N 251 (754)
T PRK15370 180 KTELRLKILGLT-TIPAC-I--PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLPDTIQEMELSIN 251 (754)
T ss_pred ceEEEeCCCCcC-cCCcc-c--ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhhccccEEECcCC
Confidence 355777777777 56652 3 357889999999998 5676554 58999999999998 678777788999999999
Q ss_pred CCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcc
Q 006747 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPL 200 (632)
Q Consensus 147 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~ 200 (632)
++. .+|..+. ++|+.|+|++|+|+.. |..-..+|+.|+|++|+|++ +|.
T Consensus 252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~~L-P~~l~~sL~~L~Ls~N~Lt~-LP~ 300 (754)
T PRK15370 252 RIT-ELPERLP--SALQSLDLFHNKISCL-PENLPEELRYLSVYDNSIRT-LPA 300 (754)
T ss_pred ccC-cCChhHh--CCCCEEECcCCccCcc-ccccCCCCcEEECCCCcccc-Ccc
Confidence 988 6777664 5788999999998864 44333578899999998884 454
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.8e-10 Score=108.12 Aligned_cols=142 Identities=18% Similarity=0.227 Sum_probs=107.5
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcC-CCCccceeEEEEeCC---ceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQ-HPNVVPIRAYYFSKD---EKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~---~~~lv~E~~~ 415 (632)
+.|+.|.++.||++...+|..+++|....... ....+..|.+++..+.+ +.++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 45899999999999987778999999865432 35678999999998843 234567777766542 5689999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc--------------------------------------
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV-------------------------------------- 457 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------- 457 (632)
++++.+.+.. ..++...+..++.++++.|++||+..
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888765531 13566677777888888888887421
Q ss_pred ---------------CCCceecCCCCCCeeecC--CCCeEEcccCCCCC
Q 006747 458 ---------------GGKFILGNIKSSNVLLSQ--DLQGCISDFGLTPL 489 (632)
Q Consensus 458 ---------------~~~ivHrDlk~~NILl~~--~~~~ki~DfGla~~ 489 (632)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 67789999997653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-09 Score=102.66 Aligned_cols=137 Identities=15% Similarity=0.162 Sum_probs=96.6
Q ss_pred hHhCccceeEEEEEEEcC-------CcEEEEEEeccccc----------------------C-HHH----HHHHHHHHHh
Q 006747 342 EVLGKGSYGTTYKAILEE-------GTTVVVKRLKEVVM----------------------G-KRE----FEQQMEVVGR 387 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~~----------------------~-~~~----~~~e~~~l~~ 387 (632)
..||.|-=+.||.|...+ +..+|||+.+.... + .+. .++|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 368999999999998553 47999998753210 0 112 2378888888
Q ss_pred hcCC-CCccceeEEEEeCCceEEEEecccCCCHhh-hhccCCCCCCCcCCHHHHHHHHHHHHHHHHHH-HhccCCCceec
Q 006747 388 LSQH-PNVVPIRAYYFSKDEKLLVYDFIEAGSFSA-LLHGNRGIGRTPLDWESRVKISLGSAKGIAHI-HAAVGGKFILG 464 (632)
Q Consensus 388 l~~h-~niv~l~~~~~~~~~~~lv~E~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHr 464 (632)
+.+. -++...+++ ...++||||+.++.+.. .+++ ..++......+..+++.+|.+| |.. ++||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8433 355566654 56789999998754422 2221 1233345566788999999998 666 99999
Q ss_pred CCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 465 NIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 465 Dlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
||++.||+++ ++.+.|+|||.+....+
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999997 46899999998765543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.7e-09 Score=113.28 Aligned_cols=162 Identities=15% Similarity=0.219 Sum_probs=121.1
Q ss_pred EcCCcEEEEEEecccccC-HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCC
Q 006747 357 LEEGTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLD 435 (632)
Q Consensus 357 ~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~ 435 (632)
..++.+|.|+..+..... .....+.++.++.+ +||||++++..+...+..|+|+|-+. -|..++.+..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------- 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------- 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--------
Confidence 456888888888765432 23466777888888 99999999999999999999999864 4555665431
Q ss_pred HHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCCC----CCCcccCCccccCC
Q 006747 436 WESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPS----RSAGYRAPEVIETK 511 (632)
Q Consensus 436 ~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~----~t~~y~aPE~~~~~ 511 (632)
-....-.+.||+.||.|||..+ +++|++|.-..|++++.|+.||++|.++.......... --..|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence 2334456789999999999776 89999999999999999999999998875443322111 11135666654322
Q ss_pred CCCccchhhHHHHHHHHHHhCC
Q 006747 512 KPTQKSDVYSFGVLLLEMLTGK 533 (632)
Q Consensus 512 ~~~~~~DV~s~Gvvl~elltg~ 533 (632)
. -..|.|-|||+++|++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 2 3469999999999999993
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=3.6e-10 Score=127.79 Aligned_cols=119 Identities=24% Similarity=0.398 Sum_probs=89.1
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEccC
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~ 145 (632)
.++.|+|++|.++ .+|... ..+|+.|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+..+|+.|+|++
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l---~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~s~L~~L~Ls~ 271 (754)
T PRK15370 200 QITTLILDNNELK-SLPENL---QGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLPSALQSLDLFH 271 (754)
T ss_pred CCcEEEecCCCCC-cCChhh---ccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHhCCCCEEECcC
Confidence 5788999999998 688743 257899999999998 5666553 46888888888888 77877777888888888
Q ss_pred CCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCC
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g 196 (632)
|+|+ .+|..+. ++|+.|+|++|+|++.++.+ .++|+.|+|++|+|++
T Consensus 272 N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~l-p~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 272 NKIS-CLPENLP--EELRYLSVYDNSIRTLPAHL-PSGITHLNVQSNSLTA 318 (754)
T ss_pred CccC-ccccccC--CCCcEEECCCCccccCcccc-hhhHHHHHhcCCcccc
Confidence 8888 4676654 47888888888888654322 2456777777777763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.7e-10 Score=122.30 Aligned_cols=240 Identities=19% Similarity=0.216 Sum_probs=167.7
Q ss_pred hHhCccceeEEEEEEE--cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAIL--EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
..||.|.|+.|++... .++..|++|.+...... +..-..|+-+...+.-|.+++.+...|...++.|+=-||+++
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~ 350 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG 350 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence 5689999999998764 35788999988765332 122344555555666799999998888888889999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeEEcccCCCCCCCCCC-
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~~- 494 (632)
+++.....- ...++...++++..+++.++.++|+. .++|+|+||+||++..+ +..++.|||.+..+.-..
T Consensus 351 ~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 351 GSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred cchhhhhHH-----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceecc
Confidence 998776522 12356677888999999999999987 99999999999999886 899999999986533221
Q ss_pred CCCCCCccc--CCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 495 VPSRSAGYR--APEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 495 ~~~~t~~y~--aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
......+++ +++......+..+.|++|||..+.|.+++..--+. ... | ..+.........
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~~~-------~----------~~i~~~~~p~~~ 484 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-GVQ-------S----------LTIRSGDTPNLP 484 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCcc-ccc-------c----------eeeecccccCCC
Confidence 122333444 45555556678999999999999999998653221 100 0 000000011111
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
... .++..++......++..||.+.++..+.+...
T Consensus 485 ~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 485 GLK---LQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred chH---HhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 111 33444555677899999999998877666543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=8.8e-09 Score=94.05 Aligned_cols=131 Identities=20% Similarity=0.334 Sum_probs=97.8
Q ss_pred HhCccceeEEEEEEEcCCcEEEEEE-eccccc--------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 343 VLGKGSYGTTYKAILEEGTTVVVKR-LKEVVM--------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~~~~vavK~-~~~~~~--------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+++|+=+.+|.+.+. |..+++|. +++.-. ....-.+|..++.++ +--.|..-.-|..+.+...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEEEE
Confidence 5789999999999765 44455553 333211 123467788888888 444555555566778888999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
+++-.|.+.+... +..++..+-.-+.-||.. +|+|+||.++||++.++. +.++|||++.+..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9999999888653 234566666677889998 999999999999998866 9999999987543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.3e-10 Score=125.17 Aligned_cols=104 Identities=31% Similarity=0.395 Sum_probs=65.0
Q ss_pred CCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEccCCCCcccCCccccCCCCccceeccc
Q 006747 90 DSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQN 169 (632)
Q Consensus 90 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~ 169 (632)
.+|+.|+|++|+|++ +|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +|.. .++|+.|+|++
T Consensus 342 ~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~-~LP~l-~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~ 411 (788)
T PRK15387 342 SGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLT-SLPAL-PSGLKELIVSGNRLTS-LPVL---PSELKELMVSG 411 (788)
T ss_pred cccceEecCCCccCC-CCCCC---cccceehhhccccc-cCccc-ccccceEEecCCcccC-CCCc---ccCCCEEEccC
Confidence 368888888888884 55432 45666777777777 35543 3567777777777774 5543 24566777777
Q ss_pred ccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCC
Q 006747 170 NSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 170 N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
|+|++. |.. ..+|+.|+|++|+|+ .+|..+.+++
T Consensus 412 N~LssI-P~l-~~~L~~L~Ls~NqLt-~LP~sl~~L~ 445 (788)
T PRK15387 412 NRLTSL-PML-PSGLLSLSVYRNQLT-RLPESLIHLS 445 (788)
T ss_pred CcCCCC-Ccc-hhhhhhhhhccCccc-ccChHHhhcc
Confidence 777653 332 245666667777666 5666554443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.9e-11 Score=130.01 Aligned_cols=125 Identities=30% Similarity=0.416 Sum_probs=99.2
Q ss_pred CCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc---CCCcEEEccCCCCcccCCccccCCCCccce
Q 006747 89 LDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS---PQLNWVDLSFNSITGNIPASIRNLSHLVGL 165 (632)
Q Consensus 89 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~---~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l 165 (632)
+..|+.|+|.+|.|+...=+.+.+..+|+.|+|++|+|+ .+|.... ..|+.|+||+|+|+ .+|.++.++..|+.|
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL 435 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTL 435 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHH
Confidence 334677888888888666667888899999999999998 7777665 56788899999998 788999999999999
Q ss_pred ecccccccccCCCCCCCCCcEEEcccCCCCC-CCcccc--cCCCCCCccCCCC
Q 006747 166 NLQNNSLTGFIPNFNLSRLRHLNLSYNHLNG-SVPLAL--QKFPPSSFEGNSM 215 (632)
Q Consensus 166 ~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g-~~p~~~--~~~~~~~~~~n~~ 215 (632)
...+|+|..++....++.|+.+|||.|+|+- .+|... .++....+.||.+
T Consensus 436 ~ahsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 436 RAHSNQLLSFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhcCCceeechhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999877533488999999999999873 344433 3566778888875
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.95 E-value=2.5e-09 Score=120.46 Aligned_cols=93 Identities=25% Similarity=0.382 Sum_probs=44.7
Q ss_pred EEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCC----------------
Q 006747 70 VRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSS---------------- 133 (632)
Q Consensus 70 l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~---------------- 133 (632)
|+|++++|+ .||+ .+. .+|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|..
T Consensus 206 LdLs~~~Lt-sLP~-~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~lp~sL~~L~Ls~N~L~~ 276 (788)
T PRK15387 206 LNVGESGLT-TLPD-CLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTH 276 (788)
T ss_pred EEcCCCCCC-cCCc-chh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCcccccceeeccCCchhh
Confidence 455555555 4554 222 24555555555555 2332 1345555555555555 33321
Q ss_pred ---ccCCCcEEEccCCCCcccCCccccCCCCccceeccccccccc
Q 006747 134 ---LSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGF 175 (632)
Q Consensus 134 ---~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 175 (632)
+..+|+.|+|++|+|+ .+|.. +++|+.|+|++|+|++.
T Consensus 277 Lp~lp~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~L 317 (788)
T PRK15387 277 LPALPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASL 317 (788)
T ss_pred hhhchhhcCEEECcCCccc-ccccc---ccccceeECCCCccccC
Confidence 2234455555555554 23331 34566666666666653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.4e-10 Score=102.61 Aligned_cols=107 Identities=32% Similarity=0.372 Sum_probs=29.2
Q ss_pred hcCCCCCcEEeccCCccCCCCCcccc-CCCCCCeEeecCCcCCccCCCCccCCCcEEEccCCCCcccCCccc-cCCCCcc
Q 006747 86 LEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASI-RNLSHLV 163 (632)
Q Consensus 86 l~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~ 163 (632)
+.+..+++.|+|++|.|+ .|. .++ .+.+|+.|||++|.++..-.-...+.|+.|+|++|+|+. +...+ ..+++|+
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKLEGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S--TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccccCccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 344445666677776666 232 344 456666677777766632211122566677777777763 43333 3566777
Q ss_pred ceecccccccccCCC---CCCCCCcEEEcccCCCC
Q 006747 164 GLNLQNNSLTGFIPN---FNLSRLRHLNLSYNHLN 195 (632)
Q Consensus 164 ~l~l~~N~l~~~~p~---~~~~~L~~l~ls~N~l~ 195 (632)
.|+|++|++...--- ..+++|+.|+|.+|.++
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 777777776543211 15666777777777665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.9e-10 Score=102.07 Aligned_cols=116 Identities=30% Similarity=0.424 Sum_probs=49.7
Q ss_pred eEEEEEeCCCCcccccCchhhc-CCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCc---cCCCcEE
Q 006747 66 RVLAVRLPGVGLYGPIPANTLE-KLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SPQLNWV 141 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~---~~~L~~L 141 (632)
+...|+|.|+.++ .|. .++ .+.+|+.|+||+|.|+ .++ .+..|++|+.|+|++|+++ .+...+ .++|+.|
T Consensus 20 ~~~~L~L~~n~I~-~Ie--~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TIE--NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred ccccccccccccc-ccc--chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 5788999999997 453 355 5889999999999999 444 5888999999999999999 454333 3899999
Q ss_pred EccCCCCcccCC-ccccCCCCccceecccccccccCCCC------CCCCCcEEE
Q 006747 142 DLSFNSITGNIP-ASIRNLSHLVGLNLQNNSLTGFIPNF------NLSRLRHLN 188 (632)
Q Consensus 142 ~Ls~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~~~~p~~------~~~~L~~l~ 188 (632)
+|++|+|...-- ..+..+++|+.|+|.+|.++.. +.. .+++|+.||
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence 999999985322 4567899999999999999855 442 689999987
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.2e-11 Score=122.15 Aligned_cols=129 Identities=30% Similarity=0.537 Sum_probs=82.8
Q ss_pred ccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCcccc
Q 006747 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIR 157 (632)
Q Consensus 80 ~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~ 157 (632)
.||. .+.+|..|+.|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|..++ ..|..||.|.|.+. .+|..++
T Consensus 112 ~ip~-~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~ 186 (722)
T KOG0532|consen 112 TIPE-AICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLG 186 (722)
T ss_pred ecch-hhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhh
Confidence 3443 4556666666666666665 5555555554 666666666665 5555554 45556666666666 4666666
Q ss_pred CCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCCCC---CccCCC
Q 006747 158 NLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPS---SFEGNS 214 (632)
Q Consensus 158 ~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~~---~~~~n~ 214 (632)
.+.+|+.|++..|++...+++...-.|..||+|.|+++ .||.+|.++..+ .+..|+
T Consensus 187 ~l~slr~l~vrRn~l~~lp~El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNP 245 (722)
T KOG0532|consen 187 YLTSLRDLNVRRNHLEDLPEELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNP 245 (722)
T ss_pred hHHHHHHHHHhhhhhhhCCHHHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCC
Confidence 66666666666666666655554456889999999998 899888777644 344554
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.1e-10 Score=124.59 Aligned_cols=190 Identities=21% Similarity=0.264 Sum_probs=133.4
Q ss_pred HhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
-+-+|.++.++.+.- ..|...+.|....... ..+....+-.+.-.. +||-+++...-+......++|++|..++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCCCCCCcchhhHHhccC
Confidence 677889998887652 2244444444433211 112222333333223 5677777666666678899999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC------
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN------ 491 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~------ 491 (632)
+|...++.... .+..........+..+.+|||.. .++|||++|.|+|...++..+++|||......
T Consensus 890 ~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~ 961 (1205)
T KOG0606|consen 890 DLPSKLHNSGC-----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT 961 (1205)
T ss_pred CchhhhhcCCC-----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence 99999987542 22222223344566789999987 79999999999999999999999998432110
Q ss_pred ---------------C--------------CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 006747 492 ---------------T--------------PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGH 541 (632)
Q Consensus 492 ---------------~--------------~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~ 541 (632)
. .....+|+.|.|||...+......+|.|++|++++|.++|..||.....
T Consensus 962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence 0 0011357789999999999999999999999999999999999976543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.9e-10 Score=126.16 Aligned_cols=124 Identities=24% Similarity=0.315 Sum_probs=103.2
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
.+..+.|.+|.|+...-+ .|.+..+|+.|+|++|.|.......+.++..|+.|+||+|+|+ .+|..+. ..|++|..
T Consensus 360 ~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 360 ALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHhcCcccccchh-hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence 466678888888866544 6889999999999999998444456679999999999999999 8887775 78999999
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccC-CCC-CCCCCcEEEcccCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFI-PNF-NLSRLRHLNLSYNH 193 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~-p~~-~~~~L~~l~ls~N~ 193 (632)
.+|+|. ..| .+..+++|+.+|++.|+|+-.. |.. ..++|++|||++|.
T Consensus 438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence 999998 677 8999999999999999998543 332 44799999999996
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=6e-08 Score=96.93 Aligned_cols=140 Identities=16% Similarity=0.114 Sum_probs=98.9
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEeccccc------------CHHHHHHHHHHHHhhcCCCCc--cceeEEEEe----
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM------------GKREFEQQMEVVGRLSQHPNV--VPIRAYYFS---- 403 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~------------~~~~~~~e~~~l~~l~~h~ni--v~l~~~~~~---- 403 (632)
+.+-......|++..+ +|+.|.||+...... ....+.+|.+.+.++ ...+| ...+++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L-~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRL-HEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHH-HHcCCCCCCeeEEEEecCCC
Confidence 4444444445777666 478899997743221 112477888888877 33333 345556543
Q ss_pred -CCceEEEEecccCC-CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC------
Q 006747 404 -KDEKLLVYDFIEAG-SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ------ 475 (632)
Q Consensus 404 -~~~~~lv~E~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~------ 475 (632)
....++|+|++++. +|.+++.... ..+.+...+..++.+++..+.-||.. +|+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCC
Confidence 23578999999986 7988875321 12344566778999999999999999 9999999999999985
Q ss_pred -CCCeEEcccCCCCC
Q 006747 476 -DLQGCISDFGLTPL 489 (632)
Q Consensus 476 -~~~~ki~DfGla~~ 489 (632)
+..+.++||+.+..
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 57899999998754
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.6e-08 Score=121.85 Aligned_cols=73 Identities=23% Similarity=0.311 Sum_probs=39.8
Q ss_pred CcceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCC
Q 006747 55 WVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS 132 (632)
Q Consensus 55 w~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 132 (632)
|.|+.+- .++..|+|+++...+.+|. ++.+++|+.|+|++|..-..+|..+.+|++|+.|+|++|..-+.+|.
T Consensus 627 ~~~~~~l---~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~ 699 (1153)
T PLN03210 627 WDGVHSL---TGLRNIDLRGSKNLKEIPD--LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT 699 (1153)
T ss_pred ccccccC---CCCCEEECCCCCCcCcCCc--cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCC
Confidence 5555332 2455666665544445553 55666666666666554445666666666666666665432224443
|
syringae 6; Provisional |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1e-09 Score=105.87 Aligned_cols=109 Identities=25% Similarity=0.261 Sum_probs=89.3
Q ss_pred hhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEccCCCCcccCCccccCCCCccc
Q 006747 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVG 164 (632)
Q Consensus 85 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 164 (632)
....++.|+.||||+|.++ .+..++.-++.++.|++|+|.+...-.-.+.++|+.||||+|.|+ .+-..-.+|.|++.
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT 356 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence 4556778899999999998 788889999999999999999983333334489999999999998 46666678889999
Q ss_pred eecccccccccCCCCCCCCCcEEEcccCCCC
Q 006747 165 LNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195 (632)
Q Consensus 165 l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~ 195 (632)
|+|+.|.+...----.+-+|..||+++|+|.
T Consensus 357 L~La~N~iE~LSGL~KLYSLvnLDl~~N~Ie 387 (490)
T KOG1259|consen 357 LKLAQNKIETLSGLRKLYSLVNLDLSSNQIE 387 (490)
T ss_pred eehhhhhHhhhhhhHhhhhheeccccccchh
Confidence 9999999875533336788999999999886
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.3e-10 Score=106.55 Aligned_cols=125 Identities=26% Similarity=0.311 Sum_probs=99.9
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCc-cCCCcEEEccC
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL-SPQLNWVDLSF 145 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~~L~~L~Ls~ 145 (632)
++.+||++|.++ .|.. +..-++.++.|+||+|.+. .+. .+..|++|+.||||+|.|+...--.. ..+++.|.|+.
T Consensus 286 LtelDLS~N~I~-~iDE-SvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 286 LTELDLSGNLIT-QIDE-SVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhccccccchh-hhhh-hhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhh
Confidence 567899999987 5655 7888999999999999998 333 48889999999999999983221111 16889999999
Q ss_pred CCCcccCCccccCCCCccceecccccccccCCC---CCCCCCcEEEcccCCCCCC
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNLSYNHLNGS 197 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~---~~~~~L~~l~ls~N~l~g~ 197 (632)
|.|.. -+.+++|.+|..||+++|++...-.- .+++-|++|.|.+|.+.+.
T Consensus 362 N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 362 NKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 99873 35688999999999999998744221 2788999999999999853
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.2e-08 Score=87.67 Aligned_cols=140 Identities=16% Similarity=0.324 Sum_probs=97.9
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEE-eccc--------ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKR-LKEV--------VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~-~~~~--------~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
..+-+|+-+.|+++.+. |+...||. +.+. ...+....+|.+.+.++ +--.|.--.-++.+...-.|+||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeEEEE
Confidence 46889999999999875 67666664 3221 12345678889999888 44455444445666667789999
Q ss_pred cccC-CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC---CeEEcccCCCC
Q 006747 413 FIEA-GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL---QGCISDFGLTP 488 (632)
Q Consensus 413 ~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~---~~ki~DfGla~ 488 (632)
|+++ -++.+++...-. .+..-.....++..+-..+.-||.. .|||+||..+||++..++ .+.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 9977 467777654321 1111122256677777888999998 999999999999997654 45799999975
Q ss_pred C
Q 006747 489 L 489 (632)
Q Consensus 489 ~ 489 (632)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=6.4e-08 Score=91.23 Aligned_cols=125 Identities=21% Similarity=0.285 Sum_probs=79.5
Q ss_pred EEEEEEEcCCcEEEEEEeccccc----------------------C-----HHHHHHHHHHHHhhcCCC--CccceeEEE
Q 006747 351 TTYKAILEEGTTVVVKRLKEVVM----------------------G-----KREFEQQMEVVGRLSQHP--NVVPIRAYY 401 (632)
Q Consensus 351 ~V~~~~~~~~~~vavK~~~~~~~----------------------~-----~~~~~~e~~~l~~l~~h~--niv~l~~~~ 401 (632)
.||.|...+|..+|||..+.... . .....+|.+.|.++ ... ++.+.+++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l-~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRL-YEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHC-CCTT-SS--EEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHH-HHCCccCCcEEEE-
Confidence 48999998999999998753210 0 12367888899998 444 45556544
Q ss_pred EeCCceEEEEeccc--CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHH-HhccCCCceecCCCCCCeeecCCCC
Q 006747 402 FSKDEKLLVYDFIE--AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI-HAAVGGKFILGNIKSSNVLLSQDLQ 478 (632)
Q Consensus 402 ~~~~~~~lv~E~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivHrDlk~~NILl~~~~~ 478 (632)
....+||||++ +..+..+.... ++......+..++...+..+ |.. +|+|+||.+.||+++++ .
T Consensus 79 ---~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~ 144 (188)
T PF01163_consen 79 ---NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-K 144 (188)
T ss_dssp ---ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-C
T ss_pred ---eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-e
Confidence 25689999998 54454433221 11123345666677766664 566 99999999999999988 9
Q ss_pred eEEcccCCCCCCC
Q 006747 479 GCISDFGLTPLMN 491 (632)
Q Consensus 479 ~ki~DfGla~~~~ 491 (632)
+.|+|||.+....
T Consensus 145 ~~iIDf~qav~~~ 157 (188)
T PF01163_consen 145 VYIIDFGQAVDSS 157 (188)
T ss_dssp EEE--GTTEEETT
T ss_pred EEEEecCcceecC
Confidence 9999999875443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.4e-09 Score=110.97 Aligned_cols=131 Identities=27% Similarity=0.283 Sum_probs=88.0
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCC---CcEEeccCCccCC----CCCccccCC-CCCCeEeecCCcCCccCCCC---
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDS---LMILSLRSNHLSG----DLPSNVLSL-SSLRFLYLQNNNFSGNIPSS--- 133 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~---L~~L~Ls~N~l~g----~~p~~~~~l-~~L~~L~Ls~N~l~g~~p~~--- 133 (632)
.++..|+++++.+.+..+. .+..+.+ |++|+|++|.+++ .+...+..+ ++|+.|+|++|.+++.....
T Consensus 81 ~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 81 CGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred CceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 4688888888888754444 4444444 8888888888873 233445566 78888888888887432222
Q ss_pred -cc--CCCcEEEccCCCCccc----CCccccCCCCccceecccccccccCCC-----C-CCCCCcEEEcccCCCCC
Q 006747 134 -LS--PQLNWVDLSFNSITGN----IPASIRNLSHLVGLNLQNNSLTGFIPN-----F-NLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 134 -~~--~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~~~p~-----~-~~~~L~~l~ls~N~l~g 196 (632)
+. .+|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++.... + .+++|++|++++|.+++
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 22 4688888888888742 344455667888888888887643221 1 46778888888888774
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.4e-10 Score=118.00 Aligned_cols=142 Identities=28% Similarity=0.423 Sum_probs=124.2
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc-CCCcEEEccC
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS-PQLNWVDLSF 145 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-~~L~~L~Ls~ 145 (632)
.+..||+.|.+. ++|. .+..+..|+.|.|.+|.+. .+|..+.+|..|++|||+.|+++ .+|..++ --|+.|-+++
T Consensus 77 t~~aDlsrNR~~-elp~-~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sN 152 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPE-EACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSN 152 (722)
T ss_pred hhhhhccccccc-cCch-HHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCcceeEEEec
Confidence 345678888887 7887 5778889999999999998 89999999999999999999999 7888776 5699999999
Q ss_pred CCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCCC--CCccCCC
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFPP--SSFEGNS 214 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~--~~~~~n~ 214 (632)
|+++ .+|..++.+..|..||.+.|++...++.. .+.+|+.|++..|++. .+|+++..++- +.|.-|.
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNk 222 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNK 222 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCc
Confidence 9998 79999999999999999999999888876 8999999999999998 78888887764 4555554
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.9e-08 Score=76.52 Aligned_cols=57 Identities=46% Similarity=0.575 Sum_probs=27.2
Q ss_pred CCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCC
Q 006747 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNH 193 (632)
Q Consensus 137 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~ 193 (632)
+|++|+|++|+|+...+..|.++++|+.|++++|.++...|.. .+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3444444444444333344455555555555555554444432 44555555555554
|
... |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.1e-07 Score=114.68 Aligned_cols=143 Identities=24% Similarity=0.279 Sum_probs=103.5
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCc-cCCCcEEEccC
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL-SPQLNWVDLSF 145 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~~L~~L~Ls~ 145 (632)
+..|.+.++.+. .+|. .+ ...+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|..- .++|+.|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~-~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPS-NF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCC-cC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecC
Confidence 445555555554 6666 33 5688899999999887 678888889999999998876555777522 27899999998
Q ss_pred CCCcccCCccccCCCCccceecccccccccCCC-CCCCCCcEEEcccCCCCCCCcccccCCCCCCccCC
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-FNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGN 213 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n 213 (632)
|..-..+|..++++++|+.|+|++|..-+.+|. .++++|+.|+|++|...+.+|....++....+.+|
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n 735 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDET 735 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCC
Confidence 876678899999999999999998654444454 47888899999888766666655444444444443
|
syringae 6; Provisional |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.2e-08 Score=76.15 Aligned_cols=58 Identities=41% Similarity=0.529 Sum_probs=33.6
Q ss_pred CCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccc
Q 006747 115 SLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSL 172 (632)
Q Consensus 115 ~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l 172 (632)
+|++|+|++|+++...+..|. ++|++|+|++|+++...|..|..+++|+.|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555522222222 4555556666666655566777777777777777764
|
... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.1e-06 Score=89.32 Aligned_cols=260 Identities=15% Similarity=0.202 Sum_probs=150.9
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEE------eCCc-eEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYF------SKDE-KLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~------~~~~-~~lv~E~ 413 (632)
+..||+|+-+.+|..--- +.. +.|+........ -.+.++.|.....||-+-.-+.+=. ..+. .-++|..
T Consensus 16 gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~--~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAA--QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CccccCCccceeeecchh-hch-hheeecCCCchH--HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 457999999999964311 122 345554432211 1233455555556765443121110 1122 4566666
Q ss_pred ccCC-CHhhhhc-cCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 414 IEAG-SFSALLH-GNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 414 ~~~g-~L~~~l~-~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
+++. -..+++. ..+....+..+|...++++..+|.+.+-||.. +.+-+|+.++|+|+++++.+.+.|-..-..-.
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ 168 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA 168 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeecc
Confidence 6553 2222222 11222345689999999999999999999998 88999999999999999999998854332222
Q ss_pred CCC---CCCCCCcccCCcccc-----CCCCCccchhhHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 492 TPT---VPSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTG-KAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 492 ~~~---~~~~t~~y~aPE~~~-----~~~~~~~~DV~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
... ...+...|.+||.-. +-..+...|-|.+||++++++.| +.||.+........-+- ...+..+....
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~--E~~Ia~g~f~y 246 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL--ETDIAHGRFAY 246 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc--hhhhhcceeee
Confidence 221 234667799999765 22346778999999999999885 99998653211100000 00000010000
Q ss_pred cccccc--------cccCCcHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHHHhhhCCC
Q 006747 563 VFDVEL--------MRYENIEEEMVQMLQIAMSCVAK--VPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 563 ~~d~~~--------~~~~~~~~~~~~~~~l~~~Cl~~--~P~~RPs~~evl~~L~~i~~~ 612 (632)
.-|... ..+......+.. +..+|+.. ++.-|||++..+..|.++.+.
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqA---lF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQA---LFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHH---HHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 011100 011112233333 34478765 367899999998888776543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.56 E-value=1e-08 Score=106.33 Aligned_cols=130 Identities=28% Similarity=0.348 Sum_probs=97.1
Q ss_pred CeEEEEEeCCCCccc----ccCchhhcCC-CCCcEEeccCCccCCC----CCccccCCCCCCeEeecCCcCCcc----CC
Q 006747 65 SRVLAVRLPGVGLYG----PIPANTLEKL-DSLMILSLRSNHLSGD----LPSNVLSLSSLRFLYLQNNNFSGN----IP 131 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g----~lp~~~l~~l-~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p 131 (632)
.++..|+++++.+.+ .+.. .+..+ ++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++. ++
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~-~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~ 186 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAK-GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALA 186 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHH-HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHH
Confidence 358899999998873 2222 45667 8999999999999843 344566778999999999999852 22
Q ss_pred CCcc--CCCcEEEccCCCCccc----CCccccCCCCccceecccccccccCCC-C------CCCCCcEEEcccCCCC
Q 006747 132 SSLS--PQLNWVDLSFNSITGN----IPASIRNLSHLVGLNLQNNSLTGFIPN-F------NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 132 ~~~~--~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~~~p~-~------~~~~L~~l~ls~N~l~ 195 (632)
..+. ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.... + ..+.|++|++++|.++
T Consensus 187 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 187 EGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 2222 5899999999998754 345567788999999999998852211 1 2478999999999987
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.2e-06 Score=89.54 Aligned_cols=170 Identities=24% Similarity=0.323 Sum_probs=125.5
Q ss_pred eeEEEEEE-EcCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEe----CCceEEEEecccC-CCHhh
Q 006747 349 YGTTYKAI-LEEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFS----KDEKLLVYDFIEA-GSFSA 421 (632)
Q Consensus 349 fg~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~E~~~~-g~L~~ 421 (632)
-.+.||+. ..||..|++|++.-.. ........-++..+++ .|.|||++..++.+ +..+++||+|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34778887 4579999999994221 1222234556778888 89999999998874 3467899999986 46666
Q ss_pred hhccCCC----------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 422 LLHGNRG----------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 422 ~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
+-..... ......++...+.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5432211 1123467788899999999999999998 88889999999999999999999999877665
Q ss_pred CCCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCC
Q 006747 492 TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535 (632)
Q Consensus 492 ~~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p 535 (632)
.+.. |.+.+ -.+-|.=.||.+++.|.||..-
T Consensus 445 ~d~~----------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT----------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC----------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 5431 11111 2356888999999999999543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.1e-06 Score=85.37 Aligned_cols=137 Identities=19% Similarity=0.212 Sum_probs=92.8
Q ss_pred HHHHHhHhCccceeEEEEEEEcCCcEEEEEEecccc-----------------------cCHHHHHHHHHHHHhhcCC-C
Q 006747 337 LRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVV-----------------------MGKREFEQQMEVVGRLSQH-P 392 (632)
Q Consensus 337 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~e~~~l~~l~~h-~ 392 (632)
..+.++.||-|-=+.||.|..++|.++|||.=+... ......++|.+.|.++..+ -
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 334578899999999999999999999999653211 0123467888899998333 2
Q ss_pred CccceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCee
Q 006747 393 NVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVL 472 (632)
Q Consensus 393 niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIL 472 (632)
.|.+.+++ +...+||||+++-.|...-- ...+... |+-.|..-+.-.-.. +|||+|+.+-||+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~---il~~il~~~~~~~~~---GiVHGDlSefNIl 234 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDE---ILDKILEEVRKAYRR---GIVHGDLSEFNIL 234 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC-------cccCHHH---HHHHHHHHHHHHHHc---CccccCCchheEE
Confidence 45555543 56789999999866553321 0112222 222333333222234 9999999999999
Q ss_pred ecCCCCeEEcccCCCCCC
Q 006747 473 LSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 473 l~~~~~~ki~DfGla~~~ 490 (632)
+++||.+.++||--+...
T Consensus 235 V~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 235 VTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred EecCCCEEEEeCcccccC
Confidence 999999999999765433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.3e-06 Score=94.57 Aligned_cols=141 Identities=18% Similarity=0.328 Sum_probs=91.0
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEeccccc----------------------C-----H----H----------HHHH
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM----------------------G-----K----R----------EFEQ 380 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~----------------------~-----~----~----------~~~~ 380 (632)
+.|+.++-|.||+|++++|+.||||+.+-... + . + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 45678999999999999999999999752110 0 0 0 1333
Q ss_pred HHHHHHhhc----CCCCccceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHH-HHHHHh
Q 006747 381 QMEVVGRLS----QHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKG-IAHIHA 455 (632)
Q Consensus 381 e~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~-l~~LH~ 455 (632)
|...+.++. +.++|.--.-|+.-.....++|||++|-.+.+...-.. ...+ +..++...+++ +.-+=.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCC---HHHHHHHHHHHHHHHHHh
Confidence 443333332 34444433334444577899999999988888742211 1233 22333333322 111212
Q ss_pred ccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 456 ~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
. +++|.|..|.||+++.++.+.+.|||+...+..
T Consensus 284 d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred c---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2 899999999999999999999999999876654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.42 E-value=8.1e-08 Score=103.57 Aligned_cols=93 Identities=30% Similarity=0.480 Sum_probs=73.7
Q ss_pred HHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-CC------------CCCCcccCCccccC
Q 006747 444 LGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-VP------------SRSAGYRAPEVIET 510 (632)
Q Consensus 444 ~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~------------~~t~~y~aPE~~~~ 510 (632)
.+++.|+.|+|.. .++||++|.|++|.+++.+..||+.|+.+....... .. .....|.|||++.+
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455899999986 499999999999999999999999999875433311 11 12345999999999
Q ss_pred CCCCccchhhHHHHHHHHHHh-CCCCCCC
Q 006747 511 KKPTQKSDVYSFGVLLLEMLT-GKAPIQA 538 (632)
Q Consensus 511 ~~~~~~~DV~s~Gvvl~ellt-g~~p~~~ 538 (632)
...+.++|+||+||++|.+.. |+.-+..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhc
Confidence 888999999999999999995 5444443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=6.5e-06 Score=78.15 Aligned_cols=137 Identities=15% Similarity=0.134 Sum_probs=101.5
Q ss_pred CccceeEEEEEEEcCCcEEEEEEeccc-------ccCHHHHHHHHHHHHhhcCC-CCccceeEEEE-eC----CceEEEE
Q 006747 345 GKGSYGTTYKAILEEGTTVVVKRLKEV-------VMGKREFEQQMEVVGRLSQH-PNVVPIRAYYF-SK----DEKLLVY 411 (632)
Q Consensus 345 g~G~fg~V~~~~~~~~~~vavK~~~~~-------~~~~~~~~~e~~~l~~l~~h-~niv~l~~~~~-~~----~~~~lv~ 411 (632)
|+||-+.|++..+. |..+-+|+-... ..+...|.+|...+.++... -.+.+.. ++. .. ..-+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 77888899998775 457888987521 23567899999999888422 1244444 333 21 2357999
Q ss_pred ecccC-CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC--eEEcccCCCC
Q 006747 412 DFIEA-GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ--GCISDFGLTP 488 (632)
Q Consensus 412 E~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~--~ki~DfGla~ 488 (632)
|-+++ -+|.+++.+.. ..+.+...+..+..+++..++-||.. ++.|+|+.+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97753 58888886532 23456677889999999999999999 9999999999999986666 9999998765
Q ss_pred C
Q 006747 489 L 489 (632)
Q Consensus 489 ~ 489 (632)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.6e-08 Score=98.16 Aligned_cols=159 Identities=28% Similarity=0.326 Sum_probs=117.4
Q ss_pred CCCCCCcceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCcc
Q 006747 50 SVCTSWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGN 129 (632)
Q Consensus 50 ~~c~~w~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 129 (632)
..| -.+.+|++.. =..++-.+.+|+ ++|.+ + =..-..++|..|+|+...|..|+.+++|+.||||+|+|+-.
T Consensus 35 ~~C--P~pC~Cs~~~--g~~VdCr~~GL~-eVP~~-L--P~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I 106 (498)
T KOG4237|consen 35 SAC--PAPCTCSDVE--GGIVDCRGKGLT-EVPAN-L--PPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFI 106 (498)
T ss_pred ccC--CCCcccCCCC--CceEEccCCCcc-cCccc-C--CCcceEEEeccCCcccCChhhccchhhhceecccccchhhc
Confidence 345 3677887644 345677888887 66653 1 12346799999999988888999999999999999999977
Q ss_pred CCCCcc--C-CCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcc-ccc
Q 006747 130 IPSSLS--P-QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPL-ALQ 203 (632)
Q Consensus 130 ~p~~~~--~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~-~~~ 203 (632)
-|..|. . -++.+++++|+|+...-..|++|.+|+.|.++-|++.-...+. .+++|..|.|-.|.+. .|+. .+.
T Consensus 107 ~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~ 185 (498)
T KOG4237|consen 107 APDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQ 185 (498)
T ss_pred ChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhcccccc
Confidence 777775 3 4455677779999766678999999999999999998665553 7888999999999887 4443 343
Q ss_pred CCC---CCCccCCCCCC
Q 006747 204 KFP---PSSFEGNSMLC 217 (632)
Q Consensus 204 ~~~---~~~~~~n~~~c 217 (632)
.+. ..-...|+..|
T Consensus 186 ~l~~i~tlhlA~np~ic 202 (498)
T KOG4237|consen 186 GLAAIKTLHLAQNPFIC 202 (498)
T ss_pred chhccchHhhhcCcccc
Confidence 333 22334455444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.1e-07 Score=99.64 Aligned_cols=125 Identities=34% Similarity=0.471 Sum_probs=96.4
Q ss_pred eEEEEEeCCCCcccccCchhhcCCC-CCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCC--ccCCCcEEE
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLD-SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSS--LSPQLNWVD 142 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~--~~~~L~~L~ 142 (632)
.+..+++.++.++ .||+ ....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.. ..+.|+.|+
T Consensus 117 ~l~~L~l~~n~i~-~i~~-~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 117 NLTSLDLDNNNIT-DIPP-LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred ceeEEecCCcccc-cCcc-ccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 5788899999988 6776 456664 8999999999998 67778899999999999999999 66665 347899999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCC-CCCCCCcEEEcccCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-FNLSRLRHLNLSYNHLN 195 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~L~~l~ls~N~l~ 195 (632)
+++|+++ .+|..+..+..|+.|.+++|.+...+.. ..+..+..|.+++|++.
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~ 245 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE 245 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee
Confidence 9999998 6888777777788888888853333332 35556666666666655
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.5e-07 Score=99.09 Aligned_cols=132 Identities=31% Similarity=0.467 Sum_probs=104.5
Q ss_pred EEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCC-CCCeEeecCCcCCccC--CCCccCCCcEEEccC
Q 006747 69 AVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLS-SLRFLYLQNNNFSGNI--PSSLSPQLNWVDLSF 145 (632)
Q Consensus 69 ~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~--p~~~~~~L~~L~Ls~ 145 (632)
.+++..+.+...+. .+..++.++.|++.+|.++ .+|+....+. +|+.|++++|++. .+ |....++|+.|++++
T Consensus 97 ~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCch--hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 47777777754444 3667789999999999999 7888888885 9999999999999 55 444458999999999
Q ss_pred CCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCC
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
|+++ .+|...+.+++|+.|++++|+++..++.. ....|+.|.+++|++. .++..+.++.
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~ 232 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLSNLK 232 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcce-ecchhhhhcc
Confidence 9999 68888778999999999999999776654 4556999999999643 3444444433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.8e-06 Score=79.37 Aligned_cols=108 Identities=19% Similarity=0.223 Sum_probs=82.3
Q ss_pred HHHHHHHHHHHHhhcC-CCCccceeEEEEeCC----ceEEEEecccCC-CHhhhhccCCCCCCCcCCHHHHHHHHHHHHH
Q 006747 375 KREFEQQMEVVGRLSQ-HPNVVPIRAYYFSKD----EKLLVYDFIEAG-SFSALLHGNRGIGRTPLDWESRVKISLGSAK 448 (632)
Q Consensus 375 ~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~----~~~lv~E~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 448 (632)
.....+|.+.+.++.+ .=.+.+.+++..... ..++|+|++++. +|.+++..... .+...+..++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHH
Confidence 3457777777776632 223456677766532 358999999884 79998875321 344567788999999
Q ss_pred HHHHHHhccCCCceecCCCCCCeeecCCC---CeEEcccCCCCCC
Q 006747 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDL---QGCISDFGLTPLM 490 (632)
Q Consensus 449 ~l~~LH~~~~~~ivHrDlk~~NILl~~~~---~~ki~DfGla~~~ 490 (632)
.++-||.. +|+|+|+++.|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999 999999999999999887 8999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.31 E-value=9.9e-09 Score=109.89 Aligned_cols=122 Identities=28% Similarity=0.322 Sum_probs=94.0
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCC--ccCCCcEEEcc
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSS--LSPQLNWVDLS 144 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~--~~~~L~~L~Ls 144 (632)
+..++.+.|.|. .+. +++.-++.|+.|||++|++... ..+..|++|++|||++|.|. .+|.- .+..|+.|.|+
T Consensus 166 L~~a~fsyN~L~-~mD-~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMD-ESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHH-HHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhhheeeeec
Confidence 334455566664 233 3788899999999999999843 37889999999999999998 66643 23569999999
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCC---CCCCCCcEEEcccCCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNLSYNHLN 195 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~---~~~~~L~~l~ls~N~l~ 195 (632)
+|.++. -..+.+|.+|+.|||+.|-|.+.-.- ..+..|+.|+|.+|.+-
T Consensus 241 nN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 999984 24578999999999999998865322 26778899999999764
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=8.9e-09 Score=110.25 Aligned_cols=128 Identities=34% Similarity=0.447 Sum_probs=97.9
Q ss_pred CCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEccCCCCcccCCc-cccCCCCccceec
Q 006747 89 LDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPA-SIRNLSHLVGLNL 167 (632)
Q Consensus 89 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~l~l 167 (632)
+..|...+.+.|.|. .+..++.-++.|+.|||++|+|+..---.-.+.|+.|||++|.|+ .+|. ....+. |+.|+|
T Consensus 163 Wn~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 163 WNKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVDNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hhhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhHHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 345667789999998 778889999999999999999985431111379999999999999 4554 334555 999999
Q ss_pred ccccccccCCCCCCCCCcEEEcccCCCCCCC---cc-cccCCCCCCccCCCCCCCC
Q 006747 168 QNNSLTGFIPNFNLSRLRHLNLSYNHLNGSV---PL-ALQKFPPSSFEGNSMLCGP 219 (632)
Q Consensus 168 ~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~---p~-~~~~~~~~~~~~n~~~c~~ 219 (632)
.+|.++..---.++.+|+.||||+|.|.+-- |. .+..+..+.+.||+.-|.+
T Consensus 240 rnN~l~tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 240 RNNALTTLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred cccHHHhhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 9999997755568999999999999887521 21 2334445667899887764
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.29 E-value=9.7e-07 Score=61.61 Aligned_cols=37 Identities=43% Similarity=0.900 Sum_probs=26.7
Q ss_pred hhHHHHHHHHHHhCCC---CCCCCCCCC--CCCCCCCcceEec
Q 006747 24 NSDKQALLDFAANVPH---ARKLNWNSS--TSVCTSWVGITCT 61 (632)
Q Consensus 24 ~~~~~~l~~~~~~~~~---~~~~~w~~~--~~~c~~w~gv~c~ 61 (632)
++|++||++||+++.. ....+|+.. .++| +|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-SWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-CSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-eeccEEeC
Confidence 5799999999999963 234599987 5666 89999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.2e-05 Score=76.84 Aligned_cols=141 Identities=16% Similarity=0.207 Sum_probs=85.7
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCC-ccceeEEEEeCCceEEEEecccCCC-H
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPN-VVPIRAYYFSKDEKLLVYDFIEAGS-F 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lv~E~~~~g~-L 419 (632)
..||+|..+.||+. .+..+++|..... .......+|.+++..+....- +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 2556778887643 345567889999988843322 4667777777777889999999863 1
Q ss_pred hhh---------------------hccCCCCCCCcCCH-HHHHH--HH------HHHH-HHHHHHHhcc-CCCceecCCC
Q 006747 420 SAL---------------------LHGNRGIGRTPLDW-ESRVK--IS------LGSA-KGIAHIHAAV-GGKFILGNIK 467 (632)
Q Consensus 420 ~~~---------------------l~~~~~~~~~~l~~-~~~~~--i~------~~ia-~~l~~LH~~~-~~~ivHrDlk 467 (632)
... +|.... ...++.- ..++. +. ..+. ....+|.... .+.++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 111 222110 0111110 00000 00 0011 1123333221 3457899999
Q ss_pred CCCeeecCCCCeEEcccCCCC
Q 006747 468 SSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 468 ~~NILl~~~~~~ki~DfGla~ 488 (632)
|.||++++++ +.|.||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999988 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.9e-06 Score=92.04 Aligned_cols=179 Identities=18% Similarity=0.184 Sum_probs=128.0
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCC-ccceeEEEEeCCceEEEEecccCC-CH
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPN-VVPIRAYYFSKDEKLLVYDFIEAG-SF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lv~E~~~~g-~L 419 (632)
.-+++|+++++||.+--..+...++.+... ....-++++|.++ +||| .+..++-+..++..+++++|+..| +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~-n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKV-NNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHc-cCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 457899999999876333344445554332 4566788899999 9999 777777777778889999999877 21
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---CCC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---TVP 496 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---~~~ 496 (632)
..-.. ..+..+...+...+...-+++++|+|+. .=+||| ||+..+ ...|..||+....+... ...
T Consensus 323 ~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~ 390 (829)
T KOG0576|consen 323 ALEMT----VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTA 390 (829)
T ss_pred cccCC----hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcccccccC
Confidence 11110 0111122233344555567889999986 568998 777665 78899999998777654 334
Q ss_pred CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCC
Q 006747 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQ 537 (632)
Q Consensus 497 ~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~ 537 (632)
.+++.|+|||+.....+..+.|+|+.|+--.++--|-.|-.
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 57888999999999999999999999997778777776643
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=5.6e-07 Score=77.64 Aligned_cols=82 Identities=23% Similarity=0.358 Sum_probs=49.2
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.+++.++|++|++. .+|+..-...+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+. .+|..||
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 45666677777766 455544444556666777777776 56666667777777777666666 4444433 2344455
Q ss_pred ccCCCCc
Q 006747 143 LSFNSIT 149 (632)
Q Consensus 143 Ls~N~l~ 149 (632)
..+|.+.
T Consensus 130 s~~na~~ 136 (177)
T KOG4579|consen 130 SPENARA 136 (177)
T ss_pred CCCCccc
Confidence 5555554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.1e-05 Score=75.41 Aligned_cols=141 Identities=16% Similarity=0.145 Sum_probs=86.5
Q ss_pred hCccce-eEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhhh
Q 006747 344 LGKGSY-GTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSAL 422 (632)
Q Consensus 344 lg~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 422 (632)
|..|.. ..||+.... +..+.+|+..... ..+..+|++++..+.++--+.+++++....+..++||||++|.++...
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 444444 789998764 4778888876543 345778999988886664555777777666678999999998776643
Q ss_pred h-------------------ccCCCCCCCcCC--HHHHHHHHHH--------------------HHHHHHHHHhc----c
Q 006747 423 L-------------------HGNRGIGRTPLD--WESRVKISLG--------------------SAKGIAHIHAA----V 457 (632)
Q Consensus 423 l-------------------~~~~~~~~~~l~--~~~~~~i~~~--------------------ia~~l~~LH~~----~ 457 (632)
. |.... ...+.. +..+...... +......|-.. .
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPV-ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCc-ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 1 21110 011111 0011100000 11112222111 1
Q ss_pred CCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 458 ~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
.+.++|+|+.|.||+++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 3468999999999999998888999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.02 E-value=1.8e-07 Score=80.65 Aligned_cols=106 Identities=25% Similarity=0.344 Sum_probs=74.5
Q ss_pred CCcEEeccCCccCCCCCcccc---CCCCCCeEeecCCcCCccCCCCcc---CCCcEEEccCCCCcccCCccccCCCCccc
Q 006747 91 SLMILSLRSNHLSGDLPSNVL---SLSSLRFLYLQNNNFSGNIPSSLS---PQLNWVDLSFNSITGNIPASIRNLSHLVG 164 (632)
Q Consensus 91 ~L~~L~Ls~N~l~g~~p~~~~---~l~~L~~L~Ls~N~l~g~~p~~~~---~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 164 (632)
.+..|+|++.+|- .++..+. ....|+..+|++|.|. .+|..|. +.++.|+|++|.|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 3456777777765 4554444 4445566688888887 5665554 46788888888888 68888888888888
Q ss_pred eecccccccccCCCC-CCCCCcEEEcccCCCCCCCcc
Q 006747 165 LNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPL 200 (632)
Q Consensus 165 l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~ 200 (632)
||++.|.|...+..+ .+.+|-.||..+|.+. .||-
T Consensus 105 lNl~~N~l~~~p~vi~~L~~l~~Lds~~na~~-eid~ 140 (177)
T KOG4579|consen 105 LNLRFNPLNAEPRVIAPLIKLDMLDSPENARA-EIDV 140 (177)
T ss_pred cccccCccccchHHHHHHHhHHHhcCCCCccc-cCcH
Confidence 888888888664433 6777778888777765 4443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.6e-05 Score=84.33 Aligned_cols=151 Identities=16% Similarity=0.232 Sum_probs=91.6
Q ss_pred HHHHHHHH-HhHhCccceeEEEEEEEcCCcEEEEEEecccccC-------------------------------------
Q 006747 333 LEDLLRAS-AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG------------------------------------- 374 (632)
Q Consensus 333 ~~~l~~~~-~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~------------------------------------- 374 (632)
++++.... .+.||.-+.|.||+|++++|+.||||+-+.....
T Consensus 157 ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~ 236 (538)
T KOG1235|consen 157 IEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP 236 (538)
T ss_pred HHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence 34443333 3578889999999999999999999986532100
Q ss_pred -HHHHHHHHHHHHhhc---CCCCc---cceeEE-EEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHH
Q 006747 375 -KREFEQQMEVVGRLS---QHPNV---VPIRAY-YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS 446 (632)
Q Consensus 375 -~~~~~~e~~~l~~l~---~h~ni---v~l~~~-~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i 446 (632)
+-+|.+|.+-..++. .|-+. |..=.. +.-.....|+||||+|.-+.+.-.-.+ ..++-.. |+..+
T Consensus 237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~----~gi~~~~---i~~~l 309 (538)
T KOG1235|consen 237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK----RGISPHD---ILNKL 309 (538)
T ss_pred hhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH----cCCCHHH---HHHHH
Confidence 012444444333221 34441 112222 223456899999999987776532111 1133332 33222
Q ss_pred HHHHHHHHhccCCCceecCCCCCCeeecC----CCCeEEcccCCCCCCCC
Q 006747 447 AKGIAHIHAAVGGKFILGNIKSSNVLLSQ----DLQGCISDFGLTPLMNT 492 (632)
Q Consensus 447 a~~l~~LH~~~~~~ivHrDlk~~NILl~~----~~~~ki~DfGla~~~~~ 492 (632)
.+ +|++.....|++|+|=.|.||++.. ++.+.+-|||+.....+
T Consensus 310 ~~--~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 310 VE--AYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HH--HHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 22 2333333348999999999999983 68899999999876654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00012 Score=70.66 Aligned_cols=137 Identities=18% Similarity=0.248 Sum_probs=88.8
Q ss_pred HhCccceeEEEEEEEcCCcEEEEEEecccccC--------------------HH-----HHHHHHHHHHhhcC-CCCccc
Q 006747 343 VLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG--------------------KR-----EFEQQMEVVGRLSQ-HPNVVP 396 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--------------------~~-----~~~~e~~~l~~l~~-h~niv~ 396 (632)
.|++|--+.||+|.-.++..+|||+.+..... .+ -.+.|..-|.++.+ +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 57888889999999888999999998643211 11 12344555555521 223334
Q ss_pred eeEEEEeCCceEEEEecccCCC-HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC
Q 006747 397 IRAYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ 475 (632)
Q Consensus 397 l~~~~~~~~~~~lv~E~~~~g~-L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~ 475 (632)
-+++ .+..|||||+.... -.-.|. ..++.......+..++.+++.-|-..+ ++||+||..=|||+.
T Consensus 135 Pi~~----~~nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~- 201 (268)
T COG1718 135 PIAF----RNNVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH- 201 (268)
T ss_pred ceee----cCCeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-
Confidence 4433 24579999996531 111121 122222234556666777777776532 999999999999999
Q ss_pred CCCeEEcccCCCCCCCC
Q 006747 476 DLQGCISDFGLTPLMNT 492 (632)
Q Consensus 476 ~~~~ki~DfGla~~~~~ 492 (632)
++.+.|+|||-|....+
T Consensus 202 ~~~p~iID~~QaV~~~h 218 (268)
T COG1718 202 DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CCeEEEEECccccccCC
Confidence 89999999998866553
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.4e-06 Score=57.98 Aligned_cols=37 Identities=38% Similarity=0.556 Sum_probs=31.3
Q ss_pred CCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCC
Q 006747 90 DSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFS 127 (632)
Q Consensus 90 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 127 (632)
++|++|+|++|+|+ .+|+.+++|++|++|+|++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 47899999999999 67778999999999999999988
|
... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.97 E-value=2.6e-05 Score=73.88 Aligned_cols=105 Identities=16% Similarity=0.182 Sum_probs=79.9
Q ss_pred HHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCC
Q 006747 380 QQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459 (632)
Q Consensus 380 ~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~ 459 (632)
.|.-++..+.+.+++.+++|+| ..++|.||...+++...-..-. ....-+|..|.+|+.++++.+.++++....
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~--~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLS--QFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccc--cccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 3555666674446999999999 3467889998876653210000 012368999999999999999999987655
Q ss_pred CceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 460 KFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 460 ~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
.+.-+|++++|+-+++++++|+.|.......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 6888999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 632 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-25 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-25 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-17 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-15 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-15 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-13 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 5e-13 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 5e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 9e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 7e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 9e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-06 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 7e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-05 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 8e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-04 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-04 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 2e-78
Identities = 101/291 (34%), Positives = 170/291 (58%), Gaps = 17/291 (5%)
Query: 331 FDLEDLLRA-----SAEVLGKGSYGTTYKAILEEGTTVVVKRLKE--VVMGKREFEQQME 383
F L +L A + +LG+G +G YK L +GT V VKRLKE G+ +F+ ++E
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 384 VVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKIS 443
++ H N++ +R + + E+LLVY ++ GS ++ L + PLDW R +I+
Sbjct: 80 MISMA-VHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIA 137
Query: 444 LGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--VPSRSAG 501
LGSA+G+A++H K I ++K++N+LL ++ + + DFGL LM+ V + G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG 197
Query: 502 ---YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQA--PGHEDVVDLPRWVQSVVR 556
+ APE + T K ++K+DV+ +GV+LLE++TG+ ++D V L WV+ +++
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607
E+ + DV+L + +EE+ Q++Q+A+ C P RP M EVVRM+E
Sbjct: 258 EKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 5e-72
Identities = 83/295 (28%), Positives = 145/295 (49%), Gaps = 20/295 (6%)
Query: 328 SYNFDLEDLLRA-----SAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM-GKREFEQQ 381
SY L DL A ++G G +G YK +L +G V +KR G EFE +
Sbjct: 26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETE 85
Query: 382 MEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK 441
+E + +HP++V + + ++E +L+Y ++E G+ L+G + + WE R++
Sbjct: 86 IETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLE 143
Query: 442 ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP------TV 495
I +G+A+G+ ++H I ++KS N+LL ++ I+DFG++ TV
Sbjct: 144 ICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200
Query: 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV 555
+ GY PE + T+KSDVYSFGV+L E+L ++ I ++V+L W
Sbjct: 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260
Query: 556 REEWTSEVFDVELM-RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
++ D L + E + + A+ C+A + RP+M +V+ +E
Sbjct: 261 NNGQLEQIVDPNLADKIR--PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-67
Identities = 89/295 (30%), Positives = 146/295 (49%), Gaps = 25/295 (8%)
Query: 330 NFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM-----GKREFEQQMEV 384
NFD E + +G+G +G YK + TTV VK+L +V K++F+Q+++V
Sbjct: 26 NFD-ERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKV 83
Query: 385 VGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISL 444
+ + QH N+V + + D+ LVY ++ GS L G PL W R KI+
Sbjct: 84 MAKC-QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQ 140
Query: 445 GSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL---TPLMNTPTVPSRSAG 501
G+A GI +H I +IKS+N+LL + ISDFGL + + SR G
Sbjct: 141 GAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVG 197
Query: 502 ---YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE 558
Y APE + + T KSD+YSFGV+LLE++TG + L + + EE
Sbjct: 198 TTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDIKEEIEDEE 254
Query: 559 WT-SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612
T + D ++ + + M +A C+ + + RP +++V ++++++ S
Sbjct: 255 KTIEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-58
Identities = 69/316 (21%), Positives = 113/316 (35%), Gaps = 44/316 (13%)
Query: 328 SYNFDLEDLLRAS-----AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQM 382
+ E+L S EV +G +G +KA L V VK + E ++
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEV 69
Query: 383 EVVGRLSQHPNVVPIRAY----YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWES 438
+ + +H N++ + L+ F E GS S L N + W
Sbjct: 70 YSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNE 122
Query: 439 RVKISLGSAKGIAHIHAAVGGKFILGN-------IKSSNVLLSQDLQGCISDFGL----- 486
I+ A+G+A++H + G IKS NVLL +L CI+DFGL
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 487 ---TPLMNTPTVPSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTGKAPIQA 538
+ V +R Y APEV+E + + D+Y+ G++L E+ +
Sbjct: 183 AGKSAGDTHGQVGTR--RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 539 PGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE-----NIEEEMVQMLQIAMSCVAKVP 593
P E ++ + E EV + R M + + C
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 594 DMRPTMEEVVRMIEDI 609
+ R + V I +
Sbjct: 301 EARLSAGCVGERITQM 316
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-49
Identities = 63/191 (32%), Positives = 101/191 (52%), Gaps = 13/191 (6%)
Query: 24 NSDKQALLDFAANVPHARKL-NWNSSTSVCT-SWVGITCTKNG--SRVLAVRLPGVGLYG 79
DKQALL ++ + L +W +T C +W+G+ C + RV + L G+ L
Sbjct: 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 80 --PIPANTLEKLDSLMILSLRS-NHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS- 135
PIP++ L L L L + N+L G +P + L+ L +LY+ + N SG IP LS
Sbjct: 65 PYPIPSS-LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 136 -PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRL-RHLNLSY 191
L +D S+N+++G +P SI +L +LVG+ N ++G IP+ + S+L + +S
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 192 NHLNGSVPLAL 202
N L G +P
Sbjct: 184 NRLTGKIPPTF 194
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-43
Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 30/178 (16%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSL-RFLYLQNNNFSGNIPSSLS 135
L G +P ++ L +L+ ++ N +SG +P + S S L + + N +G IP + +
Sbjct: 137 LSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFA 195
Query: 136 -PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNH 193
L +VDLS N + G+ + + ++L NSL + L L+L N
Sbjct: 196 NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNR 255
Query: 194 LNGSVP--------------------------LALQKFPPSSFEGNSMLCGPPLNQCS 225
+ G++P LQ+F S++ N LCG PL C+
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 68/306 (22%), Positives = 134/306 (43%), Gaps = 30/306 (9%)
Query: 332 DLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQH 391
D +++ EV+G+G++G KA V +K+++ ++ F ++ + R+ H
Sbjct: 6 DYKEIEVE--EVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-RKAFIVELRQLSRV-NH 60
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIA 451
PN+V + + LV ++ E GS +LHG + L ++G+A
Sbjct: 61 PNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVA 116
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGC-ISDFGLTPLMNTPTVPSR-SAGYRAPEVIE 509
++H+ I ++K N+LL I DFG + T ++ SA + APEV E
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFE 176
Query: 510 TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569
++K DV+S+G++L E++T + P +++ + V +
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKP-----FDEIGGPAFRIMWAVHNGTRPPLI----- 226
Query: 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR----PSDSENQPSSEDKLK 625
+N+ + + ++ C +K P RP+MEE+V+++ + +D Q + L
Sbjct: 227 --KNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281
Query: 626 DSNTQT 631
Sbjct: 282 PGEDGR 287
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-43
Identities = 60/318 (18%), Positives = 109/318 (34%), Gaps = 48/318 (15%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVG-RLSQHPNVVP---- 396
E++G+G YG YK L+ V VK ++ F + + L +H N+
Sbjct: 19 ELIGRGRYGAVYKGSLD-ERPVAVKVFSF--ANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 397 -IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
R + E LLV ++ GS L DW S +++ +G+A++H
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 456 AVGG------KFILGNIKSSNVLLSQDLQGCISDFGL---------TPLMNTPTVPSRSA 500
+ ++ S NVL+ D ISDFGL
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 501 G---YRAPEVIE-------TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP-- 548
G Y APEV+E + ++ D+Y+ G++ E+ + +
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 549 RWVQSVVREEWTSEVFDVELMR------YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEV 602
V + E + E R ++ + + + C + + R T +
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309
Query: 603 VRMIEDIRPSDSENQPSS 620
+ ++ N+ S
Sbjct: 310 EERMAELMMIWERNKSVS 327
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-43
Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 7/164 (4%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS- 135
G L +L + ++ S G + S+ FL + N SG IP +
Sbjct: 596 FQGIRSEQ-LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654
Query: 136 -PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYN 192
P L ++L N I+G+IP + +L L L+L +N L G IP L+ L ++LS N
Sbjct: 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714
Query: 193 HLNGSVP--LALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPS 234
+L+G +P + FPP+ F N LCG PL +C
Sbjct: 715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAH 758
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-38
Identities = 52/243 (21%), Positives = 90/243 (37%), Gaps = 64/243 (26%)
Query: 23 LNSDKQALLDFAANVPHARKL-NWNSSTSVCTSWVGITCTKNGSRVLAVRLPGVG----- 76
L + L+ F +P L +W+S+ + C ++ G+TC +V ++ L
Sbjct: 10 LYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTC--RDDKVTSIDLSSKPLNVGF 66
Query: 77 ----------------------LYGPIPA----NTLEKLD-------------------- 90
+ G + +L LD
Sbjct: 67 SAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126
Query: 91 SLMILSLRSNHLSGDLP-SNVLSLSSLRFLYLQNNNFSGNIPSSLS-----PQLNWVDLS 144
L L++ SN L S L L+SL L L N+ SG +L + +S
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186
Query: 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQ 203
N I+G++ S +L L++ +N+ + IP + S L+HL++S N L+G A+
Sbjct: 187 GNKISGDVDVS--RCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAIS 244
Query: 204 KFP 206
Sbjct: 245 TCT 247
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-36
Identities = 52/130 (40%), Positives = 72/130 (55%), Gaps = 5/130 (3%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS- 135
L G IP ++L L L L L N L G++P ++ + +L L L N+ +G IPS LS
Sbjct: 430 LSGTIP-SSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 136 -PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYN 192
LNW+ LS N +TG IP I L +L L L NNS +G IP + L L+L+ N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 193 HLNGSVPLAL 202
NG++P A+
Sbjct: 549 LFNGTIPAAM 558
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-36
Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 9/139 (6%)
Query: 76 GLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS 135
L G + L +L++ SN G +P L L SL++L L N F+G IP LS
Sbjct: 234 KLSGDFSRA-ISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLS 290
Query: 136 ---PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNL 189
L +DLS N G +P + S L L L +N+ +G +P + L+ L+L
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350
Query: 190 SYNHLNGSVPLALQKFPPS 208
S+N +G +P +L S
Sbjct: 351 SFNEFSGELPESLTNLSAS 369
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-36
Identities = 53/134 (39%), Positives = 70/134 (52%), Gaps = 5/134 (3%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS- 135
G IP TL L+ L L N+LSG +PS++ SLS LR L L N G IP L
Sbjct: 406 FTGKIPP-TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 136 -PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYN 192
L + L FN +TG IP+ + N ++L ++L NN LTG IP + L L L LS N
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524
Query: 193 HLNGSVPLALQKFP 206
+G++P L
Sbjct: 525 SFSGNIPAELGDCR 538
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 9e-36
Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 5/134 (3%)
Query: 72 LPGVGLYGPIPAN--TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGN 129
L + G + L L++ N +SGD+ V +L FL + +NNFS
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG 215
Query: 130 IPS-SLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLN 188
IP L +D+S N ++G+ +I + L LN+ +N G IP L L++L+
Sbjct: 216 IPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLS 275
Query: 189 LSYNHLNGSVPLAL 202
L+ N G +P L
Sbjct: 276 LAENKFTGEIPDFL 289
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-35
Identities = 39/126 (30%), Positives = 57/126 (45%), Gaps = 5/126 (3%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP 136
IP L +L L + N LSGD + + + L+ L + +N F G IP
Sbjct: 212 FSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLK 269
Query: 137 QLNWVDLSFNSITGNIPASIR-NLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNH 193
L ++ L+ N TG IP + L GL+L N G +P + S L L LS N+
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 194 LNGSVP 199
+G +P
Sbjct: 330 FSGELP 335
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-34
Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 5/135 (3%)
Query: 77 LYGPIPANTLE-KLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS 135
GPI N + ++L L L++N +G +P + + S L L+L N SG IPSSL
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 136 --PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSY 191
+L + L N + G IP + + L L L N LTG IP+ N + L ++LS
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 192 NHLNGSVPLALQKFP 206
N L G +P + +
Sbjct: 500 NRLTGEIPKWIGRLE 514
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-34
Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 11/154 (7%)
Query: 58 ITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLR 117
+ + + + G + G + + + +L L + SN+ S +P + S+L+
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD---VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQ 226
Query: 118 FLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGF 175
L + N SG+ ++S +L +++S N G IP L L L+L N TG
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGE 284
Query: 176 IPNF---NLSRLRHLNLSYNHLNGSVPLALQKFP 206
IP+F L L+LS NH G+VP
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 10/140 (7%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLS 135
GPIP L SL LSL N +G++P + + +L L L N+F G +P
Sbjct: 259 FVGPIPP---LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 136 --PQLNWVDLSFNSITGNIPA-SIRNLSHLVGLNLQNNSLTGFIPN--FNLS-RLRHLNL 189
L + LS N+ +G +P ++ + L L+L N +G +P NLS L L+L
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 190 SYNHLNGSVPLALQKFPPSS 209
S N+ +G + L + P ++
Sbjct: 376 SSNNFSGPILPNLCQNPKNT 395
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 48/134 (35%), Positives = 65/134 (48%), Gaps = 8/134 (5%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIP-SSLS 135
G IP D+L L L NH G +P S S L L L +NNFSG +P +L
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 136 --PQLNWVDLSFNSITGNIPASIRNLS-HLVGLNLQNNSLTGFIP----NFNLSRLRHLN 188
L +DLSFN +G +P S+ NLS L+ L+L +N+ +G I + L+ L
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 189 LSYNHLNGSVPLAL 202
L N G +P L
Sbjct: 401 LQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 41/132 (31%), Positives = 62/132 (46%), Gaps = 3/132 (2%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS- 135
L G IP + L +L +SL +N L+G++P + L +L L L NN+FSGNIP+ L
Sbjct: 478 LTGEIP-SGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 136 -PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
L W+DL+ N G IPA++ S + N +I N + + H +
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEF 596
Query: 195 NGSVPLALQKFP 206
G L +
Sbjct: 597 QGIRSEQLNRLS 608
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-27
Identities = 33/127 (25%), Positives = 53/127 (41%), Gaps = 7/127 (5%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP 136
L G IP + +L++L IL L +N SG++P+ + SL +L L N F+G IP+++
Sbjct: 502 LTGEIP-KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMF- 559
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNN--SLTGFIPN--FNLSRLRHLNLSYN 192
++ N I G I+N + N G LS N++
Sbjct: 560 -KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618
Query: 193 HLNGSVP 199
G
Sbjct: 619 VYGGHTS 625
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-24
Identities = 29/129 (22%), Positives = 47/129 (36%), Gaps = 11/129 (8%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS- 135
G IPA L SL+ L L +N +G +P+ + S + N +G +
Sbjct: 526 FSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKN 580
Query: 136 -PQLNWVDLSFN--SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLS 190
+ N G + LS N+ + G N + L++S
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640
Query: 191 YNHLNGSVP 199
YN L+G +P
Sbjct: 641 YNMLSGYIP 649
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-41
Identities = 70/293 (23%), Positives = 123/293 (41%), Gaps = 41/293 (13%)
Query: 332 DLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLK-----EVVMGKREFEQQMEVVG 386
D +L E++G G +G Y+A G V VK + ++ Q+ ++
Sbjct: 5 DFAELTLE--EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 387 RLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS 446
L +HPN++ +R + LV +F G + +L G R + + V ++
Sbjct: 62 ML-KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQI 114
Query: 447 AKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC--------ISDFGLTPLMNTPTVPSR 498
A+G+ ++H I ++KSSN+L+ Q ++ I+DFGL + T S
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174
Query: 499 --SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR 556
+ + APEVI ++ SDV+S+GVLL E+LTG+ P +D V
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP-----FRG-IDGLAVAYGVAM 228
Query: 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
+ L E ++++ C P RP+ ++ + I
Sbjct: 229 N-------KLALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-40
Identities = 58/298 (19%), Positives = 125/298 (41%), Gaps = 41/298 (13%)
Query: 329 YNFDLEDLLRASAEVLGKGSYGTTYKAILEE-GTTVVVKRLK--------EVVMGKREFE 379
++ + +GKG +G +K L + + V +K L E++ +EF+
Sbjct: 14 PTLADNEIEYE--KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 380 QQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR 439
+++ ++ L HPN+V + + +V +F+ G L P+ W +
Sbjct: 72 REVFIMSNL-NHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVK 124
Query: 440 VKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC-----ISDFGLTPLMNTPT 494
+++ L A GI ++ + +++S N+ L + ++DFGL+
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV 183
Query: 495 VPSR-SAGYRAPEVIETKKP--TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWV 551
+ + APE I ++ T+K+D YSF ++L +LTG+ P ++
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP-----FDEYSYGKIKF 238
Query: 552 QSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
+++REE + E+ + +++ C + P RP +V+ + ++
Sbjct: 239 INMIREE------GLRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-39
Identities = 74/287 (25%), Positives = 125/287 (43%), Gaps = 52/287 (18%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGK---REFEQQMEVVGRLSQHPNVVPIR 398
E +G GS+GT ++A G+ V VK L E EF +++ ++ RL +HPN+V
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFM 100
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+V +++ GS LLH + R LD R+ ++ AKG+ ++H
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNR-N 157
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA----GYRAPEVIETKKPT 514
+ N+KS N+L+ + + DFGL+ L + + S+SA + APEV+ +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 515 QKSDVYSFGVLLLEMLTGKAP------IQAPGHEDVV------DLPRWVQSVVREEWTSE 562
+KSDVYSFGV+L E+ T + P Q V ++PR + V
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVA--AVGFKCKRLEIPRNLNPQVA------ 269
Query: 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
++ C P RP+ ++ ++ +
Sbjct: 270 ----AIIE----------------GCWTNEPWKRPSFATIMDLLRPL 296
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 66/305 (21%), Positives = 111/305 (36%), Gaps = 55/305 (18%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVP----I 397
E +GKG YG ++ + G V VK E ++ L +H N++
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFIASD 71
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
S + L+ + E GS L T LD S ++I L A G+AH+H +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 458 GGKFILGNI-----KSSNVLLSQDLQGCISDFGL----TPLMNTPTVPSRS-AG---YRA 504
G I KS N+L+ ++ Q CI+D GL + N V + G Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 505 PEVIE------TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE 558
PEV++ ++ D+++FG++L E+ G + P +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS---NGIVEDYKPP-------FYD 235
Query: 559 WTSEVFDVELMRY--------------ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
E MR + + + ++ C + P R T + +
Sbjct: 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
Query: 605 MIEDI 609
+ I
Sbjct: 296 TLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 64/301 (21%), Positives = 108/301 (35%), Gaps = 47/301 (15%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ +GKG YG + G V VK E ++ + +H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLM-RHENIL---GFI 97
Query: 402 -------FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
S + L+ D+ E GS L T LD +S +K++ S G+ H+H
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLH 151
Query: 455 AAVGGKFILGNI-----KSSNVLLSQDLQGCISDFGL----TPLMNTPTVPSRS-AG--- 501
+ I KS N+L+ ++ CI+D GL N +P + G
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 502 YRAPEVIETKKP------TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP----RWV 551
Y PEV++ +D+YSFG++L E+ G + LP
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS---GGIVEEYQLPYHDLVPS 268
Query: 552 QSVVREEWTSEVFD---VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
+ + +E + QM ++ C A P R T V + +
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
Query: 609 I 609
+
Sbjct: 329 M 329
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-38
Identities = 60/287 (20%), Positives = 111/287 (38%), Gaps = 51/287 (17%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGK---REFEQQMEVVGRLSQHPNVVPIR 398
L + G +K + G +VVK LK R+F ++ + S HPNV+P+
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVL 73
Query: 399 AYYFSKDEKLL--VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
S + ++ GS +LH +D VK +L A+G+A +H
Sbjct: 74 GACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFALDMARGMAFLHTL 130
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKK---P 513
+ S +V++ +D+ IS + +P + + APE ++ K
Sbjct: 131 -EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY-APAWVAPEALQKKPEDTN 188
Query: 514 TQKSDVYSFGVLLLEMLTGKAP---------IQAPGHEDV-VDLPRWVQSVVREEWTSEV 563
+ +D++SF VLL E++T + P E + +P + V
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVS------- 241
Query: 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610
+LM+ C+ + P RP + +V ++E ++
Sbjct: 242 ---KLMK----------------ICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 73/320 (22%), Positives = 127/320 (39%), Gaps = 69/320 (21%)
Query: 331 FDLEDLLRASAEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEV-VMGKREFEQQMEVVGRL 388
F DL+ EVLGKG +G K E G +V+K L +R F ++++V+ L
Sbjct: 7 FRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 389 SQHPNVVP-IRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS 446
+HPNV+ I Y KD++L + ++I+ G+ ++ W RV +
Sbjct: 65 -EHPNVLKFIGVLY--KDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDI 117
Query: 447 AKGIAHIHAAVGGKFILGNI-----KSSNVLLSQDLQGCISDFGLTPLM-NTPTVPSRSA 500
A G+A++H+ NI S N L+ ++ ++DFGL LM + T P
Sbjct: 118 ASGMAYLHSM--------NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
Query: 501 GYR-----------------APEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED 543
+ APE+I + +K DV+SFG++L E++
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-------- 221
Query: 544 VVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQ-----MLQIAMSCVAKVPDMRPT 598
++ D L ++ I + C P+ RP+
Sbjct: 222 ------------DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPS 269
Query: 599 MEEVVRMIEDIRPSDSENQP 618
++ +E +R + + P
Sbjct: 270 FVKLEHWLETLRMHLAGHLP 289
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 64/313 (20%), Positives = 115/313 (36%), Gaps = 61/313 (19%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVV----PI 397
E +GKG +G ++ G V VK E ++ L +H N++
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAAD 105
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
+ + LV D+ E GS L+ R + E +K++L +A G+AH+H +
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 458 GGKFILGNI-----KSSNVLLSQDLQGCISDFGL-----TPLMNTPTVPSRSAG---YRA 504
G I KS N+L+ ++ CI+D GL + P+ G Y A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 505 PEVIE------TKKPTQKSDVYSFGVLLLEMLTGKA------PIQAPGHEDVVDLP---R 549
PEV++ + +++D+Y+ G++ E+ + Q P ++ V P
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 550 WVQSVVRE--------EWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEE 601
+ V + W S E + M +I C R T
Sbjct: 280 MRKVVCEQKLRPNIPNRWQS-------------CEALRVMAKIMRECWYANGAARLTALR 326
Query: 602 VVRMIEDIRPSDS 614
+ + + + +
Sbjct: 327 IKKTLSQLSQQEG 339
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 68/281 (24%), Positives = 131/281 (46%), Gaps = 37/281 (13%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKR---EFEQQMEVVGRLSQHPNVVPIR 398
+ +G GS+GT YK V VK L + F+ ++ V+ + +H N++
Sbjct: 30 QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFM 86
Query: 399 AYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
Y S +L +V + E S LH + + + + I+ +A+G+ ++HA
Sbjct: 87 GY--STAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAK- 139
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG------YRAPEVI--E 509
I ++KS+N+ L +D I DFGL + + + + APEVI +
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 510 TKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568
P + +SDVY+FG++L E++TG+ P + ++ + + ++ V R + ++ V
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP-----YSNINNRDQIIEMVGRGSLSPDLSKV-- 250
Query: 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
N + M +++ C+ K D RP+ ++ IE++
Sbjct: 251 --RSNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 53/292 (18%), Positives = 107/292 (36%), Gaps = 54/292 (18%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGK---REFEQQMEVVGRLSQHPNVVPIR 398
E++GKG +G Y V ++ + + + F++++ + +H NVV
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFM 95
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
S ++ + + +++ + LD +I+ KG+ ++HA
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAK-- 149
Query: 459 GKFILGNIKSSNVLLSQDLQGC-ISDFGL------TPLMNTPTVPSRSAG---YRAPEVI 508
+ ++KS NV D I+DFGL G + APE+I
Sbjct: 150 -GILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
Query: 509 ETKKP---------TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRW-VQSVVREE 558
P ++ SDV++ G + E+ + P + P + +
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK--------TQPAEAIIWQMGTG 258
Query: 559 WTSEVFDVELMRYENIEEEM-VQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
M+ + M ++ I + C A + RPT +++ M+E +
Sbjct: 259 ----------MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 36/137 (26%), Positives = 55/137 (40%), Gaps = 5/137 (3%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL-- 134
L + L +L+ L + H LSSL L + N+F N +
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 135 -SPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSY 191
L ++DLS + P + +LS L LN+ +N+ L+ L+ L+ S
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 192 NHLNGSVPLALQKFPPS 208
NH+ S LQ FP S
Sbjct: 528 NHIMTSKKQELQHFPSS 544
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 27/129 (20%), Positives = 50/129 (38%), Gaps = 6/129 (4%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLS--PQLNW 140
+ L+ L L + ++L +V SL +L +L + + + + L
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449
Query: 141 VDLSFNSITGNI-PASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGS 197
+ ++ NS N P L +L L+L L P +LS L+ LN+S+N+
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509
Query: 198 VPLALQKFP 206
+
Sbjct: 510 DTFPYKCLN 518
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 31/132 (23%), Positives = 43/132 (32%), Gaps = 7/132 (5%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SPQ 137
+ + SL L L N + + SN L L L L Q++N S+
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYNHL 194
L ++D+S LS L L + NS L L L+LS L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 195 NGSVPLALQKFP 206
P A
Sbjct: 483 EQLSPTAFNSLS 494
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 33/166 (19%), Positives = 53/166 (31%), Gaps = 9/166 (5%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNF-SGNIPSSLS--PQ 137
+ L SL L +L+ + L +L+ L + +N S +P S
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 138 LNWVDLSFNSITGNIPASIRNLSHL----VGLNLQNNSLTGFIPN-FNLSRLRHLNLSYN 192
L +DLS N I +R L + + L+L N + P F RL L L N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210
Query: 193 HLNGSVP-LALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATN 237
+ +V +Q + + N
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 26/130 (20%), Positives = 41/130 (31%), Gaps = 11/130 (8%)
Query: 91 SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSI 148
S L L N L + S L+ L L + L+ + L+ N I
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 149 TGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFP 206
+ LS L L +L +L L+ LN+++N +
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK-------L 141
Query: 207 PSSFEGNSML 216
P F + L
Sbjct: 142 PEYFSNLTNL 151
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-25
Identities = 29/131 (22%), Positives = 48/131 (36%), Gaps = 5/131 (3%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQL 138
+ + + L +L L + SLS L L L N + S L
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSL 102
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGF-IPNF--NLSRLRHLNLSYNHLN 195
+ ++ I +L L LN+ +N + F +P + NL+ L HL+LS N +
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 196 GSVPLALQKFP 206
L+
Sbjct: 163 SIYCTDLRVLH 173
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 30/132 (22%), Positives = 50/132 (37%), Gaps = 9/132 (6%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQL 138
I + L L L L N + LSSL+ L N + + L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 139 NWVDLSFNSITG-NIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLR----HLNLSY 191
++++ N I +P NL++L L+L +N + L ++ L+LS
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 192 NHLNGSVPLALQ 203
N +N P A +
Sbjct: 187 NPMNFIQPGAFK 198
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 27/125 (21%), Positives = 44/125 (35%), Gaps = 8/125 (6%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
+E + ++ + N +P N+ S + L L N S P+L +DL
Sbjct: 4 VEVVPNITYQCMELNFYK--IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLNGSVPLA 201
S I + ++LSHL L L N + LS L+ L +L
Sbjct: 60 SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 202 LQKFP 206
+
Sbjct: 120 IGHLK 124
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-21
Identities = 32/141 (22%), Positives = 49/141 (34%), Gaps = 7/141 (4%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS- 135
+ +L +L L L L P+ SLSSL+ L + +NNF
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516
Query: 136 -PQLNWVDLSFNSITGNIPASIRNL-SHLVGLNLQNNSLTGFIPN----FNLSRLRHLNL 189
L +D S N I + +++ S L LNL N + + R L +
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLV 576
Query: 190 SYNHLNGSVPLALQKFPPSSF 210
+ + P Q P S
Sbjct: 577 EVERMECATPSDKQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 35/191 (18%), Positives = 57/191 (29%), Gaps = 43/191 (22%)
Query: 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNF 126
+ RL + Y + L ++ SL S + + + L L N F
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKF 316
Query: 127 SGNIPSSLS---------------------PQLNWVDLSFNSIT--GNIPASIRNLSHLV 163
L P L ++DLS N ++ G S + L
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 164 GLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLA-----------------LQKF 205
L+L N + NF L +L HL+ +++L + +
Sbjct: 377 YLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 206 PPSSFEGNSML 216
F G S L
Sbjct: 437 FNGIFNGLSSL 447
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-18
Identities = 23/158 (14%), Positives = 47/158 (29%), Gaps = 13/158 (8%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGN-----IPSSL 134
I +++ L L+LR+N S ++ + L+ L L F S
Sbjct: 192 IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 135 SPQLNWVDLSFNSIT------GNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLN 188
L + + + +I L+++ +L + ++ +HL
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 189 LSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCST 226
L L L+ +F N +
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 348
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-17
Identities = 24/98 (24%), Positives = 34/98 (34%), Gaps = 11/98 (11%)
Query: 121 LQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF- 179
NF IP +L +DLSFN + S + L L+L +
Sbjct: 14 CMELNFY-KIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAY 72
Query: 180 -NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
+LS L L L+ N + +F G S L
Sbjct: 73 QSLSHLSTLILTGNPIQS--------LALGAFSGLSSL 102
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 12/140 (8%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLS---GDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP 136
+ LE L +L I R +L D+ L+++ L + S +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNG 196
++L +++L L + + + + +L L L+LS N L+
Sbjct: 305 GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV---DLPSLEFLDLSRNGLS- 360
Query: 197 SVPLALQKFPPSSFEGNSML 216
+ S G + L
Sbjct: 361 -----FKGCCSQSDFGTTSL 375
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 60/280 (21%), Positives = 118/280 (42%), Gaps = 37/280 (13%)
Query: 342 EVLGKGSYGTTYKAILEEGTT-VVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIR 398
E +G+G++G + L T V VK +E + K +F Q+ ++ + HPN+V +
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLI 178
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
K +V + ++ G F L L ++ +++ +A G+ ++ +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESK-- 232
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR------APEVIETKK 512
I ++ + N L+++ ISDFG++ + + APE + +
Sbjct: 233 -CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 513 PTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571
+ +SDV+SFG+LL E + G +P ++ +V+ R L
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQTR---EFVEKGGR-----------LPCP 337
Query: 572 ENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610
E + + + M Q C A P RP+ + + ++ IR
Sbjct: 338 ELCPDAVFRLMEQ----CWAYEPGQRPSFSTIYQELQSIR 373
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-28
Identities = 34/191 (17%), Positives = 68/191 (35%), Gaps = 19/191 (9%)
Query: 44 NWNSSTSVC--TSWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNH 101
NWN + + + G++ NG RV + L G G G +P + + +L L +L+L S+
Sbjct: 59 NWNFNKELDMWGAQPGVSLNSNG-RVTGLSLEGFGASGRVP-DAIGQLTELEVLALGSHG 116
Query: 102 LSGD----LPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGN-----I 152
+ P + + S ++ P+ ++ DL + I + I
Sbjct: 117 EKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYD-PREDFSDLIKDCINSDPQQKSI 175
Query: 153 PASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLNGSVPLALQKFPPSSF 210
S R + +N++T + L++LR + + + +
Sbjct: 176 KKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWE--NENS 232
Query: 211 EGNSMLCGPPL 221
E L
Sbjct: 233 EYAQQYKTEDL 243
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 28/150 (18%), Positives = 62/150 (41%), Gaps = 8/150 (5%)
Query: 72 LPGVGLYGPIPANTLEKLDSLMILSLRSNHL-SGDLPSNVLSLSSLRFLYLQNNNFSGNI 130
+ A+ + + I+ + N+L + + +++ + L L N G +
Sbjct: 288 GEQLKDDWQALAD-APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKL 346
Query: 131 PS-SLSPQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF---NLSRLR 185
P+ +L ++L++N IT IPA+ + L+ +N L F ++S +
Sbjct: 347 PAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMS 405
Query: 186 HLNLSYNHLNGSVPLALQKFPPSSFEGNSM 215
++ SYN + P+ F+G ++
Sbjct: 406 AIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 26/136 (19%), Positives = 48/136 (35%), Gaps = 20/136 (14%)
Query: 81 IPANT-LEKLDSLMILSLRSNHLSG-------DLPSNVLSLSSLRFLYLQNNNFSGNIPS 132
IP + + + + N + L ++ + L NN S
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451
Query: 133 SLS--PQLNWVDLSFNSITG-------NIPASIRNLSHLVGLNLQNNSLTGFIPNF---N 180
S L+ ++L N +T + + +N L ++L+ N LT +F
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATT 511
Query: 181 LSRLRHLNLSYNHLNG 196
L L ++LSYN +
Sbjct: 512 LPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 30/136 (22%), Positives = 47/136 (34%), Gaps = 21/136 (15%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSN--VLSLSSLRFLYLQNNNFSGNIPSSLSP-- 136
IPAN + + LS N L +P+ S+S + + N + P
Sbjct: 368 IPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 137 -------QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---------N 180
++ ++LS N I+ S L +NL N LT N N
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 181 LSRLRHLNLSYNHLNG 196
L ++L +N L
Sbjct: 487 TYLLTSIDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 21/156 (13%), Positives = 48/156 (30%), Gaps = 7/156 (4%)
Query: 63 NGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQ 122
+ S ++ + I ++ L + SN+++ + V+ L+ LR Y+
Sbjct: 157 DFSDLIKDCINSDPQQKSIKKSSRITL-KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMG 214
Query: 123 NNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FN 180
N+ F + + NL L + + N +P
Sbjct: 215 NSPFVAENICEA---WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKA 271
Query: 181 LSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
L ++ +N++ N L + +
Sbjct: 272 LPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 7e-20
Identities = 21/125 (16%), Positives = 44/125 (35%), Gaps = 15/125 (12%)
Query: 81 IPAN-TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQN------NNFSGNIPSS 133
+ + L L+ + L N S P+ L+ S+L+ ++N N P
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEG 561
Query: 134 LS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNL 189
++ P L + + N I + I ++ L++++N + L
Sbjct: 562 ITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYML 618
Query: 190 SYNHL 194
Y+
Sbjct: 619 FYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-15
Identities = 12/90 (13%), Positives = 30/90 (33%), Gaps = 1/90 (1%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDL 143
+TL+ + N + P + SL L + +N+ + ++P ++ +D+
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNISVLDI 594
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLT 173
N + + L +
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 17/114 (14%), Positives = 34/114 (29%), Gaps = 10/114 (8%)
Query: 122 QNNNFSGNIPSSLSPQLNW-VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-- 178
+N + G + NW + + S+ + + GL+L+ +G +P+
Sbjct: 45 KNWSQQGFGTQPGA---NWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAI 101
Query: 179 FNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPS 232
L+ L L L + + L P N +
Sbjct: 102 GQLTELEVLALGSHGEKVNERLFG----PKGISANMSDEQKQKMRMHYQKTFVD 151
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 71/285 (24%), Positives = 124/285 (43%), Gaps = 39/285 (13%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ LG G +G + A + T V VK +K M F + V+ L QH +V + A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAV- 251
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
+K+ ++ +F+ GS L + G + + S A+G+A I +
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQK 516
I +++++N+L+S L I+DFGL ++ +R + APE I T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 517 SDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSEVFDVELMRY 571
SDV+SFG+LL+E++T G+ P + +V+ ++ R E E++ +M
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA---LERGYRMPRPENCPEELY--NIM-- 418
Query: 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSEN 616
M C P+ RPT E + +++D +
Sbjct: 419 --------------MRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 74/299 (24%), Positives = 127/299 (42%), Gaps = 40/299 (13%)
Query: 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
LG G YG Y+ + + TV VK LKE M EF ++ V+ + +HPN+V +
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 284
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
+ ++ +F+ G+ L R R + + ++ + + ++
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 461 FILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQ 515
FI N+ + N L+ ++ ++DFGL+ LM T + + + APE + K +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 516 KSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSEVFDVELMR 570
KSDV++FGVLL E+ T G +P V +L ++ R E +V+ ELMR
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRMERPEGCPEKVY--ELMR 453
Query: 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSENQPSSEDKLKDSNT 629
+C P RP+ E+ + E + +S E +L T
Sbjct: 454 ----------------ACWQWNPSDRPSFAEIHQAFETMF-QESSISDEVEKELGKRGT 495
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 55/276 (19%), Positives = 101/276 (36%), Gaps = 45/276 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFE---QQMEVVGRLSQHPNVVPI 397
LG GSYG +K E+G VKR G ++ ++ ++ QHP V
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV-- 120
Query: 398 RAYYFS--KDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKGIAHI 453
+ + L L + + E++V L +AH+
Sbjct: 121 -RLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLP------EAQVWGYLRDTLLALAHL 173
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEVIET 510
H+ + ++K +N+ L + + DFGL + T G Y APE+++
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ- 229
Query: 511 KKPTQKSDVYSFGVLLLEMLTGK-APIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569
+DV+S G+ +LE+ P G + + Q + E+T+
Sbjct: 230 GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL------RQGYLPPEFTA-------- 275
Query: 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605
+ E+ +L + P +R T E ++ +
Sbjct: 276 ---GLSSELRSVLV---MMLEPDPKLRATAEALLAL 305
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 73/291 (25%), Positives = 128/291 (43%), Gaps = 40/291 (13%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
LG+G +G + T V +K LK M F Q+ +V+ +L +H +V + A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAV- 247
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
S++ +V +++ GS L G G L V ++ A G+A++ +
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQK 516
+ +++++N+L+ ++L ++DFGL L+ +R + APE + T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 517 SDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSEVFDVELMRY 571
SDV+SFG+LL E+ T G+ P + +V+D V+ R E + +LM
Sbjct: 362 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYRMPCPPECPESLH--DLM-- 414
Query: 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI-RPSDSENQPSSE 621
C K P+ RPT E + +ED ++ + QP
Sbjct: 415 --------------CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 72/299 (24%), Positives = 128/299 (42%), Gaps = 40/299 (13%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVV-VKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
LG G YG Y+ + ++ + V VK LKE M EF ++ V+ + +HPN+V +
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 77
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
+ ++ +F+ G+ L R R + + ++ + + ++
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 461 FILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQ 515
FI ++ + N L+ ++ ++DFGL+ LM T + + + APE + K +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 516 KSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSEVFDVELMR 570
KSDV++FGVLL E+ T G +P V +L ++ R E +V+ ELMR
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDYRMERPEGCPEKVY--ELMR 246
Query: 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSENQPSSEDKLKDSNT 629
+C P RP+ E+ + E + +S E +L T
Sbjct: 247 ----------------ACWQWNPSDRPSFAEIHQAFETMF-QESSISDEVEKELGKRGT 288
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 57/271 (21%), Positives = 107/271 (39%), Gaps = 34/271 (12%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIR 398
+G+GS+ T YK + E V L++ + K E ++ E L HPN+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 399 AYYFS---KDEKLLVY-DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
+ S + +++ + + +G+ L + + + KG+ +H
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 146
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGC--ISDFGLTPLMNTPTVPS--RSAGYRAPEVIET 510
I ++K N+ + G I D GL L + + + APE+ E
Sbjct: 147 TR-TPPIIHRDLKCDNIFI-TGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE 204
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570
K + DVY+FG+ +LEM T + P ++ + R V S V+ +V E+
Sbjct: 205 KY-DESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKPASFDKVAIPEVK- 260
Query: 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEE 601
+I C+ + D R ++++
Sbjct: 261 ------------EIIEGCIRQNKDERYSIKD 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 63/298 (21%), Positives = 125/298 (41%), Gaps = 46/298 (15%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLK-EVVMGKREFEQQMEVVGRLSQ--HPNVVPI 397
+ +G+G + Y+A L +G V +K+++ +M + ++ + L Q HPNV+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI-- 95
Query: 398 RAYY--FSKDEKLLVY-DFIEAGSFSALLHGNRGIGRTPLDWESRV-KISLGSAKGIAHI 453
YY F +D +L + + +AG S ++ + + + E V K + + H+
Sbjct: 96 -KYYASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIP-ERTVWKYFVQLCSALEHM 152
Query: 454 HAAVGGKFIL-GNIKSSNVLLSQDLQGCI--SDFGL-TPLMNTPTVPSRSAG---YRAPE 506
H+ + ++ +IK +NV ++ G + D GL + T G Y +PE
Sbjct: 153 HS----RRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT---SEV 563
I KSD++S G LL EM ++P D ++L + + + ++ S+
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKIEQCDYPPLPSDH 262
Query: 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSENQPSSE 621
+ EL Q+ C+ P+ RP + V + + + + +
Sbjct: 263 YSEELR-------------QLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 7e-26
Identities = 57/293 (19%), Positives = 113/293 (38%), Gaps = 59/293 (20%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ LG G +G V +K +KE M + EF ++ +V+ L H +V +
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC 88
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH------IH- 454
+ ++ +++ G L R + +++ + + + +H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 455 --AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR------APE 506
AA N L++ +SDFGL+ + + S G + PE
Sbjct: 145 DLAA------------RNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPE 191
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----EEWTS 561
V+ K + KSD+++FGVL+ E+ + GK P + + + + + +R +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IAQGLRLYRPHLASE 248
Query: 562 EVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614
+V+ +M SC + D RPT + ++ I D+ +S
Sbjct: 249 KVY--TIM----------------YSCWHEKADERPTFKILLSNILDVMDEES 283
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 73/288 (25%), Positives = 128/288 (44%), Gaps = 34/288 (11%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
LG+G +G + T V +K LK M F Q+ +V+ +L +H +V + A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAV- 330
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
S++ +V +++ GS L G G L V ++ A G+A++ +
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIETKKPTQK 516
+ +++++N+L+ ++L ++DFGL L+ +R + APE + T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 517 SDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575
SDV+SFG+LL E+ T G+ P + +V+D V+ R +
Sbjct: 445 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VERGYR-----------MPCPPECP 490
Query: 576 EEMVQ-MLQIAMSCVAKVPDMRPTMEEVVRMIEDI-RPSDSENQPSSE 621
E + M Q C K P+ RPT E + +ED ++ + QP
Sbjct: 491 ESLHDLMCQ----CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 534
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 41/284 (14%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ LG G +G + V VK +KE M + EF Q+ + + +L HP +V
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVC 72
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
+ +V ++I G L + L+ +++ +G+A + + +F
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESH---QF 125
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR------APEVIETKKPTQ 515
I ++ + N L+ +DL +SDFG+T + S G + APEV K +
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-DQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 516 KSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSEVFDVELMR 570
KSDV++FG+L+ E+ + GK P + +VV V R + ++ ++M
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK---VSQGHRLYRPHLASDTIY--QIM- 238
Query: 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614
SC ++P+ RPT ++++ IE +R D
Sbjct: 239 ---------------YSCWHELPEKRPTFQQLLSSIEPLREKDK 267
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
E LG G +G + T V VK LK+ M F + ++ +L QH +V + A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAV- 76
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
+++ ++ +++E GS L G L + ++ A+G+A I +
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YR--APEVIETKKPTQK 516
I +++++N+L+S L I+DFGL L+ +R + APE I T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 517 SDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSEVFDVELMRY 571
SDV+SFG+LL E++T G+ P + +V+ ++ R + E++ +LM
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN---LERGYRMVRPDNCPEELY--QLM-- 243
Query: 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI-RPSDSENQP 618
C + P+ RPT + + ++ED ++ + QP
Sbjct: 244 --------------RLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 43/222 (19%), Positives = 95/222 (42%), Gaps = 36/222 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFE---QQMEVVGRLSQHPNVVPI 397
E +G G +G+ +K + +G +KR K+ + G + + +++ L QH +VV
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV-- 74
Query: 398 RAYY--FSKDEKLLVY-DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKGIAHI 453
Y+ +++D+ +L+ ++ GS + + N I E+ +K L +G+ +I
Sbjct: 75 -RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS-YFK-EAELKDLLLQVGRGLRYI 131
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGC-------------------ISDFGLTPLMNTPT 494
H+ + +IK SN+ +S+ I D G +++P
Sbjct: 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 495 VPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAP 535
V + + A EV++ K+D+++ + ++ +
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 31/131 (23%), Positives = 45/131 (34%), Gaps = 6/131 (4%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQL 138
+ T +L L L SN + + + +L L L +N S + L
Sbjct: 88 LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENL 147
Query: 139 NWVDLSFNSITGNIPA--SIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHL 194
+ LS N I I S L L L +N + F P + RL L L+ L
Sbjct: 148 QELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207
Query: 195 NGSVPLALQKF 205
S+ L
Sbjct: 208 GPSLTEKLCLE 218
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 31/157 (19%), Positives = 53/157 (33%), Gaps = 16/157 (10%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFS--------GNIP 131
+ + L +L IL L +N+++ + L L L LQ+NN + G
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529
Query: 132 SSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHL 187
L L+ ++L N ++L L ++L N+L + N L+ L
Sbjct: 530 YFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSL 589
Query: 188 NLSYNHLNGSVPLALQKFPPS----SFEGNSMLCGPP 220
NL N + + N C
Sbjct: 590 NLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 30/145 (20%), Positives = 55/145 (37%), Gaps = 17/145 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS----- 135
I + + L L L++ N + G + L +L++L L N+ S ++ +
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379
Query: 136 -PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNLSY 191
L+ ++L+ N I+ + L HL L+L N + + L + + LSY
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 192 NHLNGSVPLALQKFPPSSFEGNSML 216
N +SF L
Sbjct: 440 NKYLQ--------LTRNSFALVPSL 456
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-24
Identities = 29/140 (20%), Positives = 51/140 (36%), Gaps = 15/140 (10%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQL 138
+P + ++ +L+L N L +N S L L + N S P P L
Sbjct: 19 VPDDLPT---NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLNG 196
++L N ++ + ++L L+L +NS+ N L L+LS+N L+
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 197 SVPLALQKFPPSSFEGNSML 216
+ L
Sbjct: 136 --------TKLGTQVQLENL 147
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 32/154 (20%), Positives = 53/154 (34%), Gaps = 22/154 (14%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG--NIPSSL 134
+ + L+++ + L N ++ + SL+ L L+ + PS
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
Query: 135 S--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF----------NLS 182
L +DLS N+I + L L L+LQ+N+L + LS
Sbjct: 477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536
Query: 183 RLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
L LNL N + P F+ L
Sbjct: 537 HLHILNLESNGFDE--------IPVEVFKDLFEL 562
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 27/164 (16%), Positives = 54/164 (32%), Gaps = 12/164 (7%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS---- 135
+ SL L L SN + P ++ L L+L N ++ L
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELA 220
Query: 136 -PQLNWVDLSFNSITGNIPASIRNL--SHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLS 190
+ + LS + ++ + L ++L L+L N+L + L +L + L
Sbjct: 221 NTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLE 280
Query: 191 YNHLNGSVPLALQKFPPSSF---EGNSMLCGPPLNQCSTVPPAP 231
YN++ +L + + + L +
Sbjct: 281 YNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 31/150 (20%), Positives = 54/150 (36%), Gaps = 21/150 (14%)
Query: 81 IPANTLEKLD--SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSS----- 133
T L +L +L L N+L+ + L L + +L+ NN S
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296
Query: 134 ------LSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLR 185
L +S S+ S + L L LN+++N + G N L L+
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356
Query: 186 HLNLSYNHLNGSVPLALQKFPPSSFEGNSM 215
+L+LS + + L+ +F +
Sbjct: 357 YLSLSNSFTS------LRTLTNETFVSLAH 380
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-18
Identities = 20/104 (19%), Positives = 39/104 (37%), Gaps = 11/104 (10%)
Query: 115 SLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTG 174
S + + +P L + ++L+ N + A+ S L L++ N+++
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 175 FIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
P L L+ LNL +N L+ +F + L
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQ--------LSDKTFAFCTNL 99
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 29/119 (24%), Positives = 50/119 (42%), Gaps = 10/119 (8%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSP--- 136
IP + L L I+ L N+L+ LP++V + SL+ L LQ N + P
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNT-LPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFR 609
Query: 137 QLNWVDLSFNSITGNIPA-----SIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLS 190
L +D+ FN + + N +H L ++ L P+++ +R + S
Sbjct: 610 NLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTS 668
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 66/287 (22%), Positives = 122/287 (42%), Gaps = 57/287 (19%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ +G G +G + V +K ++E M + +F ++ EV+ +L HP +V +
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC 72
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH------IH- 454
+ LV +F+E G S L RG E+ + + L +G+A+ IH
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 455 --AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEV 507
AA N L+ ++ +SDFG+T + S + + +PEV
Sbjct: 129 DLAA------------RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176
Query: 508 IETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSE 562
+ + KSDV+SFGVL+ E+ + GK P + + +VV+ + + R ++
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFRLYKPRLASTH 233
Query: 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
V+ ++M C + P+ RP ++R + +I
Sbjct: 234 VY--QIM----------------NHCWRERPEDRPAFSRLLRQLAEI 262
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-25
Identities = 37/154 (24%), Positives = 61/154 (39%), Gaps = 10/154 (6%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL-- 134
L + L+ L+ L + + D L L+SL L + N+F N S++
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470
Query: 135 -SPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSY 191
+ L ++DLS + L L LN+ +N+L + L L L+ S+
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530
Query: 192 NHLNGSVPLALQKFPPS----SFEGNSMLCGPPL 221
N + + LQ FP S + NS+ C
Sbjct: 531 NRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-21
Identities = 28/136 (20%), Positives = 44/136 (32%), Gaps = 7/136 (5%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQ 137
+ + + L L L + + L L L L N P S S
Sbjct: 47 LKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS 105
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNLSYNHL 194
L + + I L L LN+ +N + NL+ L H++LSYN++
Sbjct: 106 LENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYI 165
Query: 195 NGSVPLALQKFPPSSF 210
LQ +
Sbjct: 166 QTITVNDLQFLRENPQ 181
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 27/135 (20%), Positives = 47/135 (34%), Gaps = 15/135 (11%)
Query: 88 KLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SPQLNWVDLS 144
+SL L L N + +N + L L+ L Q++ S +L ++D+S
Sbjct: 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYNHLNGSVPLA 201
+ + + L+ L L + NS + N + L L+LS L
Sbjct: 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ----- 487
Query: 202 LQKFPPSSFEGNSML 216
F+ L
Sbjct: 488 ---ISWGVFDTLHRL 499
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 28/128 (21%), Positives = 48/128 (37%), Gaps = 10/128 (7%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSG-NIPSSLS--P 136
+ L SL L L+ L S + L +L+ L + +N +P+ S
Sbjct: 95 FSPGSFSGLTSLENLVAVETKLAS-LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT 153
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHL----VGLNLQNNSLTGFIPN-FNLSRLRHLNLSY 191
L VDLS+N I ++ L + L++ N + F +L L L
Sbjct: 154 NLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRG 213
Query: 192 NHLNGSVP 199
N + ++
Sbjct: 214 NFNSSNIM 221
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-20
Identities = 26/111 (23%), Positives = 40/111 (36%), Gaps = 6/111 (5%)
Query: 91 SLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNS 147
S + L N L L S S S L++L L + L+ + L+ N
Sbjct: 33 STKNIDLSFNPLKI-LKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 148 ITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNG 196
I P S L+ L L L L L+ LN+++N ++
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 20/133 (15%), Positives = 43/133 (32%), Gaps = 12/133 (9%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSP--- 136
I + + L L+LR N S ++ L L+ L L F +
Sbjct: 196 IQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 137 -------QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNL 189
++ L++ + + L+++ ++L S+ + + L++
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314
Query: 190 SYNHLNGSVPLAL 202
L L L
Sbjct: 315 IRCQLKQFPTLDL 327
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 31/146 (21%), Positives = 52/146 (35%), Gaps = 13/146 (8%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSG-DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP--- 136
+ + + +L +L L++ N + LP+ +L++L + L N + L
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 137 ---QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNLS 190
+D+S N I I L L L+ N + I NL+ L L
Sbjct: 179 NPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 191 YNHLNGSVPLALQKFPPSSFEGNSML 216
L+ F PS EG +
Sbjct: 238 LGEFKDERN--LEIFEPSIMEGLCDV 261
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-17
Identities = 22/131 (16%), Positives = 42/131 (32%), Gaps = 5/131 (3%)
Query: 81 IPANTLEKLDSLMI--LSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQL 138
+ +E L + I L + D L+++ + L + +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKW 309
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSV 198
+ + + P +L L L L N + L L +L+LS N L+ S
Sbjct: 310 QSLSIIRCQLK-QFPTL--DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSG 366
Query: 199 PLALQKFPPSS 209
+ +S
Sbjct: 367 CCSYSDLGTNS 377
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 26/115 (22%), Positives = 41/115 (35%), Gaps = 12/115 (10%)
Query: 104 GDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLV 163
G L + + ++ + S +P + +DLSFN + S N S L
Sbjct: 2 GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQ 59
Query: 164 GLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
L+L + L L +L L+ N + F P SF G + L
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS--------FSPGSFSGLTSL 106
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 60/277 (21%), Positives = 103/277 (37%), Gaps = 33/277 (11%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIR 398
+G GSYG K +G +V K L M + E + + V L + HPN+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 399 AYYFSKDEKLL--VYDFIEAGSFSALLHGNRGIGRTPLDWESRV-KISLGSAKGIAHIHA 455
+ L V ++ E G ++++ + LD E V ++ + H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLD-EEFVLRVMTQLTLALKECHR 129
Query: 456 A-VGGKFIL-GNIKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSRSAG---YRAPEVIE 509
GG +L ++K +NV L + DFGL L + + G Y +PE +
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN 189
Query: 510 TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569
+KSD++S G LL E+ P A +++ +
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREG------------ 231
Query: 570 RYENIEEEMVQMLQ-IAMSCVAKVPDMRPTMEEVVRM 605
++ I L I + RP++EE++
Sbjct: 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 39/282 (13%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ +GKG +G G V VK +K + F + V+ +L +H N+V +
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 255
Query: 402 FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
+ L +V +++ GS L R GR+ L + +K SL + + ++
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---N 309
Query: 461 FILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR--APEVIETKKPTQKSD 518
F+ ++ + NVL+S+D +SDFGLT ++ + + APE + KK + KSD
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VKWTAPEALREKKFSTKSD 368
Query: 519 VYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSEVFDVELMRYEN 573
V+SFG+LL E+ + G+ P +DVV V+ + + V+ ++M+
Sbjct: 369 VWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCPPAVY--DVMK--- 420
Query: 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSE 615
+C RPT ++ +E IR +
Sbjct: 421 -------------NCWHLDAATRPTFLQLREQLEHIRTHELH 449
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 57/304 (18%), Positives = 112/304 (36%), Gaps = 48/304 (15%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQ-QMEV-VGRLSQHPNVVPIR 398
+ LG+G + L +G +KR+ +++ E+ Q E + RL HPN++ +
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 399 AYYFSKDEK----LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRV-KISLGSAKGIAHI 453
AY + L+ F + G+ + L E ++ + LG +G+ I
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIE-RLKDKGNFLT-EDQILWLLLGICRGLEAI 150
Query: 454 HAAVGGKFILGN-IKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSR------------S 499
HA K +K +N+LL + Q + D G + +
Sbjct: 151 HA----KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 500 AGYRAPEVIETKK---PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR 556
YRAPE+ + +++DV+S G +L M+ G+ P + V V+
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----VALAVQ 261
Query: 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSEN 616
+ + + + + M+ P RP + ++ +E ++P
Sbjct: 262 NQLS---IPQSPRHSSALWQLLNSMMT-------VDPHQRPHIPLLLSQLEALQPPAPGQ 311
Query: 617 QPSS 620
+
Sbjct: 312 HTTQ 315
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-24
Identities = 71/293 (24%), Positives = 121/293 (41%), Gaps = 65/293 (22%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ +GKG +G G V VK +K + F + V+ +L +H N+V +
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 83
Query: 402 FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH------IH 454
+ L +V +++ GS L R GR+ L + +K SL + + + +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 455 ---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR------AP 505
AA NVL+S+D +SDFGLT ++ + AP
Sbjct: 141 RDLAA------------RNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAP 183
Query: 506 EVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----EEWT 560
E + KK + KSDV+SFG+LL E+ + G+ P +DVV V+ + +
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEKGYKMDAPDGCP 240
Query: 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613
V+ E+M+ +C MRP+ ++ +E I+ +
Sbjct: 241 PAVY--EVMK----------------NCWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 64/309 (20%), Positives = 124/309 (40%), Gaps = 45/309 (14%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIR 398
+ +G+GS+G E+G V+K + M +E E+ V L+ HPN+V R
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRV-KISLGSAKGIAHIHAAV 457
+ +V D+ E G ++ +G E ++ + + H+H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQKG---VLFQ-EDQILDWFVQICLALKHVHD-- 143
Query: 458 GGKFIL-GNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA-G---YRAPEVIETKK 512
+ IL +IKS N+ L++D + DFG+ ++N+ +R+ G Y +PE+ E K
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201
Query: 513 PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT--SEVFDVELMR 570
KSD+++ G +L E+ T K +A + V ++ + S + +L
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAG------SMKNLVLKIISGSFPPVSLHYSYDLR- 254
Query: 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV-------RMIEDIRPSDSENQPSSEDK 623
+ + P RP++ ++ R+ + + P + +
Sbjct: 255 ------------SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTF 302
Query: 624 LKDSNTQTP 632
K + P
Sbjct: 303 SKFGSQPIP 311
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 59/296 (19%), Positives = 109/296 (36%), Gaps = 68/296 (22%)
Query: 342 EVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNV 394
+VLG G++GT YK + + V +K L+E K +E + V+ + +P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 79
Query: 395 VPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH- 452
R + L+ + G + ++ + + + + AKG+ +
Sbjct: 80 C--RLLGICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYL 133
Query: 453 -----IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR- 503
+H AA NVL+ I+DFGL L+ + G +
Sbjct: 134 EDRRLVHRDLAA------------RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 504 -----APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR- 556
A E I + T +SDV+S+GV + E++T G P ++ + ++ R
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERL 238
Query: 557 ---EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
T +V+ + M + C D RP E++ +
Sbjct: 239 PQPPICTIDVYMI--------------MRK----CWMIDADSRPKFRELIIEFSKM 276
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 69/319 (21%), Positives = 119/319 (37%), Gaps = 69/319 (21%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
LG+GS+G Y+ + E T V +K + E + EF + V+ +
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHH 89
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNR-----GIGRTPLDWESRVKISLGSAK 448
VV + L++ + + G + L R P ++++ A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR----- 503
G+A+++A KF+ ++ + N ++++D I DFG+T + YR
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY------YRKGGKG 200
Query: 504 -------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVV 555
+PE ++ T SDV+SFGV+L E+ T + P Q +E V+ V
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF---VMEGG 257
Query: 556 R----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611
+ +F ELMR C P MRP+ E++ I++
Sbjct: 258 LLDKPDNCPDMLF--ELMR----------------MCWQYNPKMRPSFLEIISSIKEEME 299
Query: 612 SD--------SENQPSSED 622
SE E
Sbjct: 300 PGFREVSFYYSEENKLPEP 318
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 69/323 (21%), Positives = 126/323 (39%), Gaps = 56/323 (17%)
Query: 342 EVLGKGSYGTTYKAIL--------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQH 391
+ LG+G++G A T V VK LK + +ME++ + +H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG-----------RTPLDWESRV 440
N++ + ++ ++ G+ L R G L + V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 441 KISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA 500
+ A+G+ ++ + K I ++ + NVL+++D I+DFGL ++ ++
Sbjct: 195 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 501 GYR------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQS 553
R APE + + T +SDV+SFGVLL E+ T G +P E++ L ++
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL---LKE 308
Query: 554 VVR----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
R T+E++ +MR C VP RPT +++V ++ I
Sbjct: 309 GHRMDKPSNCTNELY--MMMR----------------DCWHAVPSQRPTFKQLVEDLDRI 350
Query: 610 RPSDSENQPSSEDKLKDSNTQTP 632
S + + P
Sbjct: 351 VALTSNQEMGYYHHHHHHDYDIP 373
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 63/308 (20%), Positives = 117/308 (37%), Gaps = 80/308 (25%)
Query: 342 EVLGKGSYGTTYKAIL---EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVP 396
+V+G+G++G KA + +KR+KE R+F ++EV+ +L HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR-----------VKISLG 445
+ + L ++ G+ L +R + P + + +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 446 SAKGIAH------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVP 496
A+G+ + IH AA N+L+ ++ I+DFGL
Sbjct: 151 VARGMDYLSQKQFIHRDLAA------------RNILVGENYVAKIADFGL---------- 188
Query: 497 SRSAG-YR------------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHE 542
SR Y A E + T SDV+S+GVLL E+++ G P
Sbjct: 189 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248
Query: 543 DVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEE 601
++ + + R L + N ++E+ M Q C + P RP+ +
Sbjct: 249 ELYEK---LPQGYR-----------LEKPLNCDDEVYDLMRQ----CWREKPYERPSFAQ 290
Query: 602 VVRMIEDI 609
++ + +
Sbjct: 291 ILVSLNRM 298
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 60/290 (20%), Positives = 113/290 (38%), Gaps = 46/290 (15%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVV 395
+G+G +G ++ I V +K K + +F Q+ + + HP++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 79
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ +++ ++ + G + L + LD S + + + +A++ +
Sbjct: 80 KLIGV-ITENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLES 134
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIET 510
+F+ +I + NVL+S + + DFGL+ M T S G + APE I
Sbjct: 135 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 511 KKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSEVFD 565
++ T SDV+ FGV + E+L G P Q + DV+ +++ R ++
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGERLPMPPNCPPTLY- 247
Query: 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSE 615
LM C A P RP E+ + I +
Sbjct: 248 -SLM----------------TKCWAYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 56/312 (17%), Positives = 114/312 (36%), Gaps = 76/312 (24%)
Query: 342 EVLGKGSYGTTYKAIL--------EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHP 392
E LG+G++ +K + T V++K L + F + ++ +L H
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHK 72
Query: 393 NVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
++V DE +LV +F++ GS L N+ ++ +++++ A +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHF 128
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGC--------ISDFGLTPLMNTPTVPSRSAGYR- 503
+ I GN+ + N+LL ++ +SD G++ + +
Sbjct: 129 LEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL------PKDILQE 179
Query: 504 -----APEVIETKKP-TQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDL--------- 547
PE IE K +D +SFG L E+ + G P+ A + +
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239
Query: 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607
P+ +E+ ++ + C+ PD RP+ ++R +
Sbjct: 240 PKA----------AELANL--------------INN----CMDYEPDHRPSFRAIIRDLN 271
Query: 608 DIRPSDSENQPS 619
+ D + S
Sbjct: 272 SLFTPDLVPRGS 283
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 64/315 (20%), Positives = 122/315 (38%), Gaps = 63/315 (20%)
Query: 342 EVLGKGSYGTTYKA---ILEEGTTVVVKRLKEVVMGKREFEQ--QMEV--VGRLSQHPNV 394
+ LG G T Y A IL V +K + K E + + EV +LS H N+
Sbjct: 17 DKLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNI 73
Query: 395 VPIRAYYFSKDEKL--LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
V + +++ LV ++IE + S + + PL ++ + + GI H
Sbjct: 74 VSM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKH 126
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-----SAGYRAPEV 507
H + + +IK N+L+ + I DFG+ ++ ++ + Y +PE
Sbjct: 127 AHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 508 IETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG---------HEDVVDLPRWVQSVVREE 558
+ + + +D+YS G++L EML G+ P + V ++ V+ + +
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQS 243
Query: 559 WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRP-TMEEVVRMIEDIRPSDSENQ 617
++ + K R T++E M +D+ EN+
Sbjct: 244 L----------------SNVI------LRATEKDKANRYKTIQE---MKDDLSSVLHENR 278
Query: 618 PSSEDKLKDSNTQTP 632
+ED + +T
Sbjct: 279 A-NEDVYELDKMKTI 292
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 59/302 (19%), Positives = 112/302 (37%), Gaps = 64/302 (21%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVV 395
+LG+G +G Y+ + E V VK K+ K +F + ++ L HP++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIV 76
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH--- 452
+ ++ ++ + G L N+ L + V SL K +A+
Sbjct: 77 KLIGI-IEEEPTWIIMELYPYGELGHYLERNKN----SLKVLTLVLYSLQICKAMAYLES 131
Query: 453 ---IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG----- 501
+H A N+L++ + DFGL+ + S
Sbjct: 132 INCVHRDIAV------------RNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK 179
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR---- 556
+ +PE I ++ T SDV+ F V + E+L+ GK P ++DV+ + ++ R
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV---LEKGDRLPKP 236
Query: 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSEN 616
+ ++ + M + C P RP E+V + D+ + +
Sbjct: 237 DLCPPVLYTL--------------MTR----CWDYDPSDRPRFTELVCSLSDVYQMEKDI 278
Query: 617 QP 618
Sbjct: 279 AM 280
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 37/268 (13%), Positives = 88/268 (32%), Gaps = 27/268 (10%)
Query: 342 EVLGKGSYGTTYKAI------LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVV 395
+LG+G++ Y+A + V+K K + Q+ + S +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ + ++ +LV + G+ ++ + + + ++ I +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 456 AVGGKFILGNIKSSNVLLSQDLQG-----------CISDFGLTPLMN------TPTVPSR 498
+ I G+IK N +L + D G + M T
Sbjct: 191 C---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247
Query: 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE 558
++G++ E++ K + D + + ML G ++ + + +
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT-YMKVKNEGGECKPEGLFRRLPHLD 306
Query: 559 WTSEVFDVELMRYENIEEEMVQMLQIAM 586
+E F V L + + +L+ +
Sbjct: 307 MWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-23
Identities = 32/144 (22%), Positives = 55/144 (38%), Gaps = 16/144 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS---- 135
+ + SL LS++ N +L + L L +LR L L +++ + +L
Sbjct: 316 LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYN 192
L ++LS+N + + L L+L L NL L+ LNLS++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 193 HLNGSVPLALQKFPPSSFEGNSML 216
L+ F+G L
Sbjct: 436 LLDI--------SSEQLFDGLPAL 451
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 38/147 (25%), Positives = 55/147 (37%), Gaps = 12/147 (8%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSG-DLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL 134
+ LE L++L L L + + D + L LS L+ L L N +
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396
Query: 135 S--PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNL 189
PQL +DL+F + S +NL L LNL ++ L L L+HLNL
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456
Query: 190 SYNHLNGSVPLALQKFPPSSFEGNSML 216
NH +S + L
Sbjct: 457 QGNHFPKGNIQ-----KTNSLQTLGRL 478
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-22
Identities = 30/146 (20%), Positives = 41/146 (28%), Gaps = 18/146 (12%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---S 135
L L L L+L N L + L L L S
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-----NLSRLRHLNLS 190
L ++LS + + + L L LNLQ N L RL L LS
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 191 YNHLNGSVPLALQKFPPSSFEGNSML 216
+ L+ +F M+
Sbjct: 485 FCDLSS--------IDQHAFTSLKMM 502
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 6e-21
Identities = 28/141 (19%), Positives = 49/141 (34%), Gaps = 12/141 (8%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQ 137
I +T + L L L +N L + LS +L+ L+ S L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLN 195
L + L N I+ L L+ QNN++ +L + +L+L+ N +
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 196 GSVPLALQKFPPSSFEGNSML 216
+ P +F+
Sbjct: 191 ------IAGIEPGAFDSAVFQ 205
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 8e-21
Identities = 29/142 (20%), Positives = 54/142 (38%), Gaps = 14/142 (9%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS----- 135
+ + L L +L+L + L L +L+ L LQ N+F +
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-FNLSRLRHLNLSYNHL 194
+L + LSF ++ + +L + ++L +N LT + + +LNL+ NH+
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535
Query: 195 NGSVPLALQKFPPSSFEGNSML 216
+ PS S
Sbjct: 536 SI--------ILPSLLPILSQQ 549
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-20
Identities = 26/144 (18%), Positives = 45/144 (31%), Gaps = 16/144 (11%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNV---LSLSSLRFLYLQNNNFSGNIPSSLS- 135
+ SL + + D+ V L S+ + LQ + F ++
Sbjct: 218 IFKGLKNSTIQSLWLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHC 276
Query: 136 -PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYN 192
L +DL+ ++ +P+ + LS L L L N N L HL++ N
Sbjct: 277 FSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGN 335
Query: 193 HLNGSVPLALQKFPPSSFEGNSML 216
+ E L
Sbjct: 336 TKRLEL-------GTGCLENLENL 352
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 27/142 (19%), Positives = 47/142 (33%), Gaps = 7/142 (4%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQ 137
+ L +L L +S + L +L LYL +N+ S +
Sbjct: 96 MAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154
Query: 138 LNWVDLSFNSITGNIPASIRNLSHL--VGLNLQNNSLTGFIPN-FNLSRLRHLNLSYNHL 194
L +D N+I + +L + LNL N + G P F+ + + LN
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQN 214
Query: 195 NGSVPLALQKFPPSSFEGNSML 216
+ L+ S +
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFE 236
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-20
Identities = 22/131 (16%), Positives = 36/131 (27%), Gaps = 14/131 (10%)
Query: 91 SLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNS 147
S L N L + + S L +L FL L + +L+ + L+ N
Sbjct: 34 STECLEFSFNVLPT-IQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92
Query: 148 ITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKF 205
+ ++ L L ++ N L L L NH +
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH--------ISSI 144
Query: 206 PPSSFEGNSML 216
L
Sbjct: 145 KLPKGFPTEKL 155
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-19
Identities = 34/144 (23%), Positives = 54/144 (37%), Gaps = 16/144 (11%)
Query: 81 IPANTLEKLD--SLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS-- 135
I E L S+ ++L+ ++ + SN S L+ L L + S +PS L
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFN-ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGL 300
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYN 192
L + LS N S N L L+++ N+ + NL LR L+LS++
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 193 HLNGSVPLALQKFPPSSFEGNSML 216
+ S S L
Sbjct: 361 DIETS------DCCNLQLRNLSHL 378
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 28/139 (20%), Positives = 39/139 (28%), Gaps = 9/139 (6%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP---- 136
I L +L L L SNH+S L+ L QNN +S
Sbjct: 120 IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIP----NFNLSRLRHLNLSYN 192
++L+ N I G I + + LN I N + L
Sbjct: 180 TNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 193 HLNGSVPLALQKFPPSSFE 211
P + S E
Sbjct: 239 DDEDISPAVFEGLCEMSVE 257
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 27/121 (22%), Positives = 51/121 (42%), Gaps = 5/121 (4%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSP-Q 137
N+L+ L L IL L LS + + + L + + L +N + + +LS +
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGS 197
+++L+ N I+ +P+ + LS +NL+ N L N L + L +
Sbjct: 525 GIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYF--LEWYKENMQKLEDT 582
Query: 198 V 198
Sbjct: 583 E 583
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 19/102 (18%), Positives = 35/102 (34%), Gaps = 11/102 (10%)
Query: 117 RFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFI 176
+ +N + IP +L ++ SFN + + L +L L+L +
Sbjct: 15 KTYNCENLGLN-EIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 177 PNF--NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
+ + RL L L+ N L ++ G L
Sbjct: 74 EDTFQSQHRLDTLVLTANP--------LIFMAETALSGPKAL 107
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 19/135 (14%), Positives = 37/135 (27%), Gaps = 9/135 (6%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQ-NNNFSGNIPSSL--SPQ 137
I + L +L ++N + ++ SL L L N N I S
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 138 LNWVDLSFNSITGNIPASIRN--LSHLVGLNLQNNSLTGFIPN----FNLSRLRHLNLSY 191
++ I ++N + L ++ P + +NL
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 192 NHLNGSVPLALQKFP 206
++ F
Sbjct: 264 HYFFNISSNTFHCFS 278
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 6e-09
Identities = 24/93 (25%), Positives = 36/93 (38%), Gaps = 3/93 (3%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
L L + L+L SNH+S LPS + LS R + L+ N S L W
Sbjct: 515 SSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC--SNIYFLEW 571
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT 173
+ + N L G+ L + +L+
Sbjct: 572 YKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 67/316 (21%), Positives = 114/316 (36%), Gaps = 72/316 (22%)
Query: 342 EVLGKGSYGTTYKAILE-----EGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNV 394
LG+G +G + G V VK LK + ++Q+++++ L H ++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHI 95
Query: 395 VPIRAYYFSKDEK--LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
+ + LV +++ GS L + + + + +G+A+
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAY 149
Query: 453 ------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR 503
IH AA NVLL D I DFGL VP YR
Sbjct: 150 LHAQHYIHRDLAA------------RNVLLDNDRLVKIGDFGLAKA-----VPEGHEYYR 192
Query: 504 ------------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAP-GHEDVVDLPR 549
APE ++ K SDV+SFGV L E+LT + P +++ + +
Sbjct: 193 VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252
Query: 550 WVQSVVREEWTSEVFD-VE----LMRYENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEEVV 603
+V + + +E L R + E+ M C RPT E ++
Sbjct: 253 GQMTV------LRLTELLERGERLPRPDKCPAEVYHLMKN----CWETEASFRPTFENLI 302
Query: 604 RMIEDIRPSDSENQPS 619
+++ + PS
Sbjct: 303 PILKTVHEKYQGQAPS 318
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-23
Identities = 63/284 (22%), Positives = 118/284 (41%), Gaps = 52/284 (18%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVV----- 395
E++G G +G +KA +G T V+KR+K + E++++ + +L H N+V
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEKAEREVKALAKL-DHVNIVHYNGC 72
Query: 396 ----------PIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISL 444
+ SK + L + +F + G+ + RG LD +++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFE 129
Query: 445 GSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG--- 501
KG+ +IH+ K I ++K SN+ L Q I DFGL + +RS G
Sbjct: 130 QITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLR 186
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTS 561
Y +PE I ++ ++ D+Y+ G++L E+L E ++ + +
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHV----CDTAFETSKFFTDLRDGIISDIFDK 242
Query: 562 EVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605
+ + + ++L K P+ RP E++R
Sbjct: 243 KEKTL-----------LQKLLS-------KKPEDRPNTSEILRT 268
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 61/285 (21%), Positives = 110/285 (38%), Gaps = 43/285 (15%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEV--VMGKREFEQQMEVVGRLSQHPNVV 395
V+GKG +G Y + +K L + + F ++ ++ L HPNV+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVL 85
Query: 396 PIRAYYFSKDE-KLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
+ + ++ ++ G + + + + L A+G+ ++
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISFGLQVARGMEYLA 141
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM--NTPTVPSRSAGYR------APE 506
KF+ ++ + N +L + ++DFGL + + R A E
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565
++T + T KSDV+SFGVLL E+LT G P + D+ + R
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---LAQGRR--------- 246
Query: 566 VELMRYENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
L + E + + Q M Q C P +RPT +V +E I
Sbjct: 247 --LPQPEYCPDSLYQVMQQ----CWEADPAVRPTFRVLVGEVEQI 285
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 74/303 (24%), Positives = 121/303 (39%), Gaps = 50/303 (16%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
+ LG+G++G +A TV VK LKE R +++++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 394 VVPIRAYYFSKDEKLLV-YDFIEAGSFSALLHGNRG-----------IGRTPLDWESRVK 441
VV + L+V +F + G+ S L R + + L E +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 442 ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG 501
S AKG+ + + K I ++ + N+LLS+ I DFGL + R
Sbjct: 153 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 502 YR------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQA-PGHEDVVDLPRWVQS 553
R APE I + T +SDV+SFGVLL E+ + G +P E+ ++
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR---LKE 266
Query: 554 VVREEWTSEVFDVELMRYENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612
R + + EM Q ML C P RPT E+V + ++ +
Sbjct: 267 GTR-----------MRAPDYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNLLQA 311
Query: 613 DSE 615
+++
Sbjct: 312 NAQ 314
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-22
Identities = 61/286 (21%), Positives = 114/286 (39%), Gaps = 40/286 (13%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVV 395
+G+G +G ++ I V +K K + +F Q+ + + HP++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 454
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ +++ ++ + G + L + LD S + + + +A++ +
Sbjct: 455 KLIGV-ITENPVWIIMELCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLES 509
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIET 510
+F+ +I + NVL+S + + DFGL+ M T S G + APE I
Sbjct: 510 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 511 KKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569
++ T SDV+ FGV + E+L G P Q + DV+ +++ R L
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR---IENGER-----------LP 612
Query: 570 RYENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614
N + M + C A P RP E+ + I +
Sbjct: 613 MPPNCPPTLYSLMTK----CWAYDPSRRPRFTELKAQLSTILEEEK 654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 61/314 (19%), Positives = 107/314 (34%), Gaps = 57/314 (18%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
LG G++G Y+ + V VK L EV + +F + ++ + H N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQN 94
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG--RTPLDWESRVKISLGSAKGIA 451
+V + ++ + + G + L R + L + ++ A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQG---CISDFGLT-PLMNTPTVPSRSAGYR---- 503
++ FI +I + N LL+ G I DFG+ +
Sbjct: 155 YLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 504 -APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----E 557
PE T K+D +SFGVLL E+ + G P + +++V++ V S R +
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGGRMDPPK 268
Query: 558 EWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR------- 610
V+ +M C P+ RP ++ IE
Sbjct: 269 NCPGPVY--RIMT----------------QCWQHQPEDRPNFAIILERIEYCTQDPDVIN 310
Query: 611 -PSDSENQPSSEDK 623
E P E++
Sbjct: 311 TALPIEYGPLVEEE 324
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 66/294 (22%), Positives = 110/294 (37%), Gaps = 61/294 (20%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEV--VMGKREFEQQMEVVGRLSQHPNVV 395
EV+G+G +G Y L + VK L + + +F + ++ HPNV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 89
Query: 396 PIRAYYFSKDEKLL-VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH-- 452
+ + L V +++ G + + + L AKG+ +
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKYLA 145
Query: 453 ----IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM--NTPTVPSRSAGYR 503
+H AA N +L + ++DFGL M G +
Sbjct: 146 SKKFVHRDLAA------------RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 504 ------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR 556
A E ++T+K T KSDV+SFGVLL E++T G P D+ + R
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGRR 250
Query: 557 EEWTSEVFDVELMRYENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
L++ E + + + ML+ C +MRP+ E+V I I
Sbjct: 251 -----------LLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISAI 289
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 63/295 (21%), Positives = 115/295 (38%), Gaps = 65/295 (22%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVV 395
+++G G G L + V +K LK +R+F + ++G+ HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNII 113
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH--- 452
+ ++V +++E GS L + G V + G G+ +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSD 169
Query: 453 ---IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM--NTPTVPSRSAG--- 501
+H AA NVL+ +L +SDFGL+ ++ + + + G
Sbjct: 170 LGYVHRDLAA------------RNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 502 YR--APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR-- 556
R APE I + + SDV+SFGV++ E+L G+ P + DV+ V+ R
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS---VEEGYRLP 274
Query: 557 --EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
+ +LM + C K RP ++V +++ +
Sbjct: 275 APMGCPHALH--QLM----------------LDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-22
Identities = 25/154 (16%), Positives = 50/154 (32%), Gaps = 25/154 (16%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG-------- 128
Y + L L + L + LP + L L+ L + N
Sbjct: 479 QYENEE-LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 129 -NIPSSLS--PQLNWVDLSFNSITGNIPAS--IRNLSHLVGLNLQNNSLTGFIPNF-NLS 182
+ P++ + +N++ PAS ++ + L L+ +N + + F
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNV 595
Query: 183 RLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
+L L L YN +++ P +
Sbjct: 596 KLTDLKLDYNQ--------IEEIPEDFCAFTDQV 621
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 28/156 (17%), Positives = 57/156 (36%), Gaps = 9/156 (5%)
Query: 63 NGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQ 122
N S +L + PI ++ L I +L +N ++ + + L+ L+ +Y
Sbjct: 399 NLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL-TNRITF-ISKAIQRLTKLQIIYFA 456
Query: 123 NNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FN 180
N+ F+ + + + + N S NL L + L N +P+ ++
Sbjct: 457 NSPFTYDNIAVD---WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYD 513
Query: 181 LSRLRHLNLSYNHLNG--SVPLALQKFPPSSFEGNS 214
L L+ LN++ N + + G
Sbjct: 514 LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 3e-20
Identities = 25/134 (18%), Positives = 41/134 (30%), Gaps = 19/134 (14%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL--SLSSLRFLYLQNNNFSGNIPSSLSP-- 136
IP + D + L N L +P+ S+ + + N +
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668
Query: 137 -----QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---------NLS 182
+ V LS+N I S + + L NN +T N N
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTY 728
Query: 183 RLRHLNLSYNHLNG 196
L ++L +N L
Sbjct: 729 LLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-20
Identities = 25/153 (16%), Positives = 50/153 (32%), Gaps = 18/153 (11%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVL--SLSSLRFLYLQNNNFSGNIPSSLS--PQLN 139
+ L + LR N L+ L + +L L + + N FS P+ QL
Sbjct: 722 GNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLK 779
Query: 140 WVDLSF------NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNH 193
+ N I P I L+ L + +N + + +L L+++ N
Sbjct: 780 AFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTPQLYILDIADNP 838
Query: 194 LNGSVPLALQKFPPSS-----FEGNSMLCGPPL 221
++ + + ++ + G
Sbjct: 839 NISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA 871
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 7e-20
Identities = 36/217 (16%), Positives = 62/217 (28%), Gaps = 56/217 (25%)
Query: 44 NWNSSTSVCT--SWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNH 101
NWN + + G+ NG RV + L G G G +P + + +L L +LS ++
Sbjct: 301 NWNFNKELDMWGDQPGVDLDNNG-RVTGLSLAGFGAKGRVP-DAIGQLTELKVLSFGTHS 358
Query: 102 LSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS---SLSPQLNWVDLSFNSITGN------- 151
+ + + + + +LN DL ++I N
Sbjct: 359 ETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418
Query: 152 ---------------------IPASIRNLSHLVGLNLQNNSLTGFIPNF----------- 179
I +I+ L+ L + N+ T
Sbjct: 419 KDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAK 478
Query: 180 ----------NLSRLRHLNLSYNHLNGSVPLALQKFP 206
NL L + L +P L P
Sbjct: 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLP 515
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 2e-19
Identities = 25/159 (15%), Positives = 49/159 (30%), Gaps = 23/159 (14%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPS-SLSPQLNWV 141
+ + + I + N+L S L + L L +N ++ + + +L +
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDL 600
Query: 142 DLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYNHLNGS 197
L +N I IP + GL +N L F ++ + ++ SYN +
Sbjct: 601 KLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS- 658
Query: 198 VPLALQKFPPSSFEGNSMLCGPPL-------NQCSTVPP 229
+ G N+ P
Sbjct: 659 -------EGRNISCSMDDYKGINASTVTLSYNEIQKFPT 690
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 19/132 (14%), Positives = 45/132 (34%), Gaps = 17/132 (12%)
Query: 82 PANTLEKLDSLMILSLRSNHLSGDLPS-----NVLSLSSLRFLYLQNNNFSGNIPSSLS- 135
+ + + + N + + + + + + L N +
Sbjct: 636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT 695
Query: 136 -PQLNWVDLSFNSIT-------GNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRL 184
++ + LS N +T + +N L ++L+ N LT +F L L
Sbjct: 696 GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYL 755
Query: 185 RHLNLSYNHLNG 196
++++SYN +
Sbjct: 756 SNMDVSYNCFSS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 16/119 (13%), Positives = 37/119 (31%), Gaps = 7/119 (5%)
Query: 95 LSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS---SLSPQLNWVDLSFNSITGN 151
L ++ +N + + F + + G+ P + ++ + L+ G
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNFN--KELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338
Query: 152 IPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRH--LNLSYNHLNGSVPLALQKFPPS 208
+P +I L+ L L+ +S T F L + + +
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 61/314 (19%), Positives = 107/314 (34%), Gaps = 57/314 (18%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
LG G++G Y+ + V VK L EV + +F + ++ + H N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQN 135
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG--RTPLDWESRVKISLGSAKGIA 451
+V + ++ + + G + L R + L + ++ A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQG---CISDFGLT-PLMNTPTVPSRSAGYR---- 503
++ FI +I + N LL+ G I DFG+ +
Sbjct: 196 YLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 504 -APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR----E 557
PE T K+D +SFGVLL E+ + G P + +++V++ V S R +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VTSGGRMDPPK 309
Query: 558 EWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR------- 610
V+ +M C P+ RP ++ IE
Sbjct: 310 NCPGPVY--RIMT----------------QCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351
Query: 611 -PSDSENQPSSEDK 623
E P E++
Sbjct: 352 TALPIEYGPLVEEE 365
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 63/304 (20%), Positives = 117/304 (38%), Gaps = 61/304 (20%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVMGKRE---FEQQMEVVGRLSQHPNV 394
++LG+G +G+ + L V VK +K +RE F + + HPNV
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNV 98
Query: 395 VP-----IRAYYFSKDEKLLVYDFIEAGSFSALLHGNR-GIGRTPLDWESRVKISLGSAK 448
+ I + +++ F++ G L +R G + ++ +K + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 449 GIAH------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS 499
G+ + +H AA N +L D+ C++DFGL+ + + +
Sbjct: 159 GMEYLSNRNFLHRDLAA------------RNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 500 AGYR------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQ 552
+ A E + + T KSDV++FGV + E+ T G P + ++ D +
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY---LL 263
Query: 553 SVVREEWTSEVFDVELMRYENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611
R L + E+ +E+ + M C P RPT + +E +
Sbjct: 264 HGHR-----------LKQPEDCLDELYEIMYS----CWRTDPLDRPTFSVLRLQLEKLLE 308
Query: 612 SDSE 615
S +
Sbjct: 309 SLPD 312
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-22
Identities = 63/306 (20%), Positives = 115/306 (37%), Gaps = 70/306 (22%)
Query: 342 EVLGKGSYGTTYKAILE-----EGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNV 394
LG+G +G + G V VK LK + ++++E++ L H N+
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENI 85
Query: 395 VPIRA--YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
V + + L+ +F+ +GS L N+ ++ + ++K ++ KG+ +
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDY 141
Query: 453 ------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR 503
+H AA NVL+ + Q I DFGLT + + Y
Sbjct: 142 LGSRQYVHRDLAA------------RNVLVESEHQVKIGDFGLTKA-----IETDKEYYT 184
Query: 504 ------------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGH-EDVVDLPR 549
APE + K SDV+SFGV L E+LT + ++
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244
Query: 550 WVQSVVREEWTSEVFD-VE----LMRYENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEEVV 603
+V + + + ++ L N +E+ Q M + C P R + + ++
Sbjct: 245 GQMTV------TRLVNTLKEGKRLPCPPNCPDEVYQLMRK----CWEFQPSNRTSFQNLI 294
Query: 604 RMIEDI 609
E +
Sbjct: 295 EGFEAL 300
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 66/296 (22%), Positives = 124/296 (41%), Gaps = 48/296 (16%)
Query: 342 EVLGKGSYGTTYKAIL--------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQH 391
+ LG+G++G A +E TV VK LK+ + +ME++ + +H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR-----------V 440
N++ + ++ ++ G+ L R G +R V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 441 KISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA 500
+ A+G+ ++ + K I ++ + NVL++++ I+DFGL +N ++
Sbjct: 161 SCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 501 GYR------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQS 553
R APE + + T +SDV+SFGVL+ E+ T G +P E++ L ++
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL---LKE 274
Query: 554 VVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
R + + N E+ M+ C VP RPT +++V ++ I
Sbjct: 275 GHR-----------MDKPANCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 68/306 (22%), Positives = 115/306 (37%), Gaps = 77/306 (25%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPN 393
E LG GS+G + + +V VK LK V+ +F +++ + L H N
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN 82
Query: 394 VVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
++ R Y + +V + GS L ++G + + ++ A+G+ +
Sbjct: 83 LI--RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGY 136
Query: 453 ------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSRSAGY 502
IH AA N+LL+ I DFGL L
Sbjct: 137 LESKRFIHRDLAA------------RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 503 R------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVD--------L 547
+ APE ++T+ + SD + FGV L EM T G+ P ++ L
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244
Query: 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607
PR E+ ++++V M+Q C A P+ RPT + +
Sbjct: 245 PR------PEDCPQDIYNV--------------MVQ----CWAHKPEDRPTFVALRDFLL 280
Query: 608 DIRPSD 613
+ +P+D
Sbjct: 281 EAQPTD 286
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 64/311 (20%), Positives = 119/311 (38%), Gaps = 62/311 (19%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVMGKRE---FEQQMEVVGRLSQHPNV 394
+LGKG +G+ +A L V VK LK ++ + F ++ + HP+V
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHV 87
Query: 395 VPI------RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGR-TPLDWESRVKISLGSA 447
+ +++ F++ G A L +R L ++ V+ + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 448 KGIAH------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR 498
G+ + IH AA N +L++D+ C++DFGL+ + + +
Sbjct: 148 CGMEYLSSRNFIHRDLAA------------RNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 499 SAGYR------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWV 551
+ A E + T SDV++FGV + E++T G+ P + ++ + +
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY---L 252
Query: 552 QSVVREEWTSEVFDVELMRYENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610
R L + EE+ M Q C + P RP+ + +E+I
Sbjct: 253 IGGNR-----------LKQPPECMEEVYDLMYQ----CWSADPKQRPSFTCLRMELENIL 297
Query: 611 PSDSENQPSSE 621
S S +
Sbjct: 298 GHLSVLSTSQD 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 62/316 (19%), Positives = 120/316 (37%), Gaps = 88/316 (27%)
Query: 342 EVLGKGSYGTTYKAILE-----EGTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNVV 395
+ LGKG++G+ + G V VK+L+ R+FE+++E++ L QH N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIV 74
Query: 396 PIRAYYFSKDEK--LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH- 452
+ +S + L+ +++ GS L ++ +D ++ + KG+ +
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYL 130
Query: 453 -----IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR- 503
IH A N+L+ + + I DFGLT + +P ++
Sbjct: 131 GTKRYIHRDLAT------------RNILVENENRVKIGDFGLTKV-----LPQDKEFFKV 173
Query: 504 -----------APEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ 552
APE + K + SDV+SFGV+L E+ T ++P E + +
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--- 230
Query: 553 SVVREEWTSEVFDVELMRYENIE-EEMVQML-----------------QIAMSCVAKVPD 594
+ + ++++L I C +
Sbjct: 231 ----------------DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVN 274
Query: 595 MRPTMEEVVRMIEDIR 610
RP+ ++ ++ IR
Sbjct: 275 QRPSFRDLALRVDQIR 290
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 69/320 (21%), Positives = 117/320 (36%), Gaps = 69/320 (21%)
Query: 342 EVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEV--VMGKREFEQQMEVVGRLSQHPNV 394
+VLG G +GT +K + V +K +++ + M +G L H ++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHI 77
Query: 395 VPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH- 452
V R L LV ++ GS + +RG L + + + AKG+ +
Sbjct: 78 V--RLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYYL 131
Query: 453 -----IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR- 503
+H AA NVLL Q ++DFG+ L+ + +
Sbjct: 132 EEHGMVHRNLAA------------RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 504 -----APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR- 556
A E I K T +SDV+S+GV + E++T G P +V DL ++ R
Sbjct: 180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---LEKGERL 236
Query: 557 ---EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI-RPS 612
+ T +V+ V M++ C ++RPT +E+ + R
Sbjct: 237 AQPQICTIDVYMV--------------MVK----CWMIDENIRPTFKELANEFTRMARDP 278
Query: 613 DSENQPSSEDKLKDSNTQTP 632
E + P
Sbjct: 279 PRYLVIKRESGPGIAPGPEP 298
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 60/316 (18%), Positives = 112/316 (35%), Gaps = 67/316 (21%)
Query: 342 EVLGKGSYGTTYKAIL-----EEGTTVVVKRLKE-VVMGKREFEQQMEVVGRLSQHPNVV 395
LGKG++G+ G V VK+L+ +R+F+++++++ L +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIV 87
Query: 396 PIRAYYFSKDEK--LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH- 452
R + + LV +++ +G L +R LD + S KG+ +
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYL 143
Query: 453 -----IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR- 503
+H AA N+L+ + I+DFGL L +P Y
Sbjct: 144 GSRRCVHRDLAA------------RNILVESEAHVKIADFGLAKL-----LPLDKDYYVV 186
Query: 504 -----------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWV 551
APE + +++SDV+SFGV+L E+ T +
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246
Query: 552 QSVVREEWTSEVFD-VE----LMRYENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEEVVRM 605
+ + + +E L E+ + M C A P RP+ +
Sbjct: 247 VPALS-----RLLELLEEGQRLPAPPACPAEVHELMKL----CWAPSPQDRPSFSALGPQ 297
Query: 606 IEDIRPSDSENQPSSE 621
++ + + +
Sbjct: 298 LDMLWSGSRGCETHAF 313
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 62/304 (20%), Positives = 113/304 (37%), Gaps = 67/304 (22%)
Query: 344 LGKGSYGTTYKAIL---EEGTTVVVKRLKE--VVMGKREFEQQMEVVGRLSQHPNVVPIR 398
LG G++G+ + + ++ V +K LK+ E ++ +++ +L +P +V R
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIV--R 74
Query: 399 AYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH----- 452
+ E L LV + G L G R + + ++ + G+ +
Sbjct: 75 LIGVCQAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 453 -IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSRSAGYR---- 503
+H AA NVLL ISDFGL+ L + + + +
Sbjct: 131 FVHRDLAA------------RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 178
Query: 504 --APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR---- 556
APE I +K + +SDV+S+GV + E L+ G+ P + +V+ ++ R
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IEQGKRMECP 235
Query: 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSEN 616
E E++ LM C + RP V + + S +
Sbjct: 236 PECPPELY--ALM----------------SDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277
Query: 617 QPSS 620
Sbjct: 278 VEGH 281
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 63/306 (20%), Positives = 115/306 (37%), Gaps = 55/306 (17%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
+ LG G++G +A + TV VK LK + +++V+ L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS------- 446
+V + L++ ++ G L R + ++ +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 447 ------AKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA 500
AKG+A + + I ++ + N+LL+ I DFGL + +
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 501 GYR------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQS 553
R APE I T +SDV+S+G+ L E+ + G +P PG + ++
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPVDSKFYKMIKE 263
Query: 554 VVR----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
R E +E++D +M+ +C P RPT +++V++IE
Sbjct: 264 GFRMLSPEHAPAEMYD--IMK----------------TCWDADPLKRPTFKQIVQLIEKQ 305
Query: 610 RPSDSE 615
+
Sbjct: 306 ISESTN 311
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 63/318 (19%), Positives = 120/318 (37%), Gaps = 88/318 (27%)
Query: 342 EVLGKGSYGTTYKAILE-----EGTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNVV 395
+ LGKG++G+ + G V VK+L+ R+FE+++E++ L QH N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIV 105
Query: 396 PIRAYYFSKDEK--LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH- 452
+ +S + L+ +++ GS L ++ +D ++ + KG+ +
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYL 161
Query: 453 -----IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR- 503
IH A N+L+ + + I DFGLT + +P Y+
Sbjct: 162 GTKRYIHRDLAT------------RNILVENENRVKIGDFGLTKV-----LPQDKEYYKV 204
Query: 504 -----------APEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ 552
APE + K + SDV+SFGV+L E+ T ++P E + +
Sbjct: 205 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN--- 261
Query: 553 SVVREEWTSEVFDVELMRYENIE-EEMVQML-----------------QIAMSCVAKVPD 594
+ + ++++L I C +
Sbjct: 262 ----------------DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVN 305
Query: 595 MRPTMEEVVRMIEDIRPS 612
RP+ ++ ++ IR
Sbjct: 306 QRPSFRDLALRVDQIRDQ 323
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 60/310 (19%), Positives = 112/310 (36%), Gaps = 68/310 (21%)
Query: 342 EVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNV 394
+VLG G++GT YK + + V +K L+E K +E + V+ + +P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 79
Query: 395 VPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH- 452
R + L+ + G + ++ + + + + AKG+ +
Sbjct: 80 C--RLLGICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYL 133
Query: 453 -----IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR- 503
+H AA NVL+ I+DFGL L+ + G +
Sbjct: 134 EDRRLVHRDLAA------------RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 504 -----APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR- 556
A E I + T +SDV+S+GV + E++T G P ++ + ++ R
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEKGERL 238
Query: 557 ---EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613
T +V+ + M++ C D RP E++ +
Sbjct: 239 PQPPICTIDVYMI--------------MVK----CWMIDADSRPKFRELIIEFSKMARDP 280
Query: 614 SENQPSSEDK 623
D+
Sbjct: 281 QRYLVIQGDE 290
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 65/318 (20%), Positives = 120/318 (37%), Gaps = 85/318 (26%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNV 394
LG+G++G + A ++ V VK LKE +++F+++ E++ L QH ++
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHI 105
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNR----------GIGRTPLDWESRVKISL 444
V L+V++++ G + L + + PL + ++
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 445 GSAKGIAH------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPT 494
A G+ + +H A N L+ Q L I DFG++ + +T
Sbjct: 166 QVAAGMVYLAGLHFVHRDLAT------------RNCLVGQGLVVKIGDFGMSRDIYSTDY 213
Query: 495 VPSRSAGYR------------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGH 541
YR PE I +K T +SDV+SFGV+L E+ T GK P +
Sbjct: 214 -------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266
Query: 542 EDVVDLPRWVQSVVR----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRP 597
+ +D + EV+ +MR C + P R
Sbjct: 267 TEAIDC---ITQGRELERPRACPPEVY--AIMR----------------GCWQREPQQRH 305
Query: 598 TMEEVVRMIEDIRPSDSE 615
++++V ++ + +
Sbjct: 306 SIKDVHARLQALAQAPPV 323
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 68/310 (21%), Positives = 128/310 (41%), Gaps = 67/310 (21%)
Query: 342 EVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNV 394
+V+G G +G YK +L ++ V +K LK + +F + ++G+ H N+
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNI 108
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH-- 452
+ + +++ +++E G+ L G V + G A G+ +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLA 164
Query: 453 ----IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM--NTPTVPSRSAG-- 501
+H AA N+L++ +L +SDFGL+ ++ + + S G
Sbjct: 165 NMNYVHRDLAA------------RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 502 -YR--APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR- 556
R APE I +K T SDV+SFG+++ E++T G+ P + +V+ + R
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA---INDGFRL 269
Query: 557 ---EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED-IRPS 612
+ S ++ +LM M C + RP ++V +++ IR
Sbjct: 270 PTPMDCPSAIY--QLM----------------MQCWQQERARRPKFADIVSILDKLIRAP 311
Query: 613 DSENQPSSED 622
DS + D
Sbjct: 312 DSLKTLADFD 321
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 67/312 (21%), Positives = 129/312 (41%), Gaps = 72/312 (23%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNVV 395
+V+G G +G L ++ +V +K LK K R+F + ++G+ HPN++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNII 109
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH--- 452
+ ++V +++E GS + L + V + G A G+ +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSD 165
Query: 453 ---IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM--NTPTVPSRSAG--- 501
+H AA N+L++ +L +SDFGL ++ + + G
Sbjct: 166 MGYVHRDLAA------------RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 502 --YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVD-------LPRWV 551
+ +PE I +K T SDV+S+G++L E+++ G+ P ++DV+ LP
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-- 271
Query: 552 QSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED-IR 610
+ + ++ +LM + C K + RP E++V +++ IR
Sbjct: 272 ----PMDCPAALY--QLM----------------LDCWQKDRNNRPKFEQIVSILDKLIR 309
Query: 611 PSDSENQPSSED 622
S +S
Sbjct: 310 NPGSLKIITSAA 321
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E +G+G+ GT Y A+ + G V ++++ K+E +V R +++PN+V Y
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV---NY 82
Query: 401 Y--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
+ ++L +V +++ GS + ++ T +D + + + +H+
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS-- 134
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS--AG---YRAPEVIETKK 512
+ I +IKS N+LL D ++DFG TP RS G + APEV+ K
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 513 PTQKSDVYSFGVLLLEMLTGKAP 535
K D++S G++ +EM+ G+ P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 3e-21
Identities = 41/330 (12%), Positives = 92/330 (27%), Gaps = 86/330 (26%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVK--------------RLKEVVMGKREFEQQMEV-- 384
VLG+ +A E G + V ++KE V+ R
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 385 ------------VGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHG---NRGI 429
+ + Q ++ +R + + S +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 430 GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489
L +R++++L + +A +H + ++ +++L Q ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 490 MNTPTVPSRSAGYRAPEVIETKKP-----------TQKSDVYSFGVLLLEMLTGKAPIQA 538
V S S G+ PE+ + T D ++ G+++ + PI
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 539 PG--------HEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVA 590
++P+ V++++ L+
Sbjct: 316 DAALGGSEWIFRSCKNIPQPVRALLE-----------------------GFLR------- 345
Query: 591 KVPDMRPTMEEVVRM--IEDIRPSDSENQP 618
+ R + + E +R S P
Sbjct: 346 YPKEDRLLPLQAMETPEYEQLRTELSAALP 375
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 70/313 (22%), Positives = 111/313 (35%), Gaps = 79/313 (25%)
Query: 335 DLLRASAEVLGKGSYGTTYKAIL---EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRL 388
LL + LG G++GT K + TV VK LK K E + V+ +L
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 389 SQHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA 447
+P +V R + E LV + E G + L NR + + +++ +
Sbjct: 76 -DNPYIV--RMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVS 127
Query: 448 KGIAH------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR 498
G+ + +H AA NVLL ISDFGL+ + +
Sbjct: 128 MGMKYLEESNFVHRDLAA------------RNVLLVTQHYAKISDFGLSKA-----LRAD 170
Query: 499 SAGYR------------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVV 545
Y+ APE I K + KSDV+SFGVL+ E + G+ P + +V
Sbjct: 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230
Query: 546 DLPRWVQSVVR----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEE 601
+ ++ R E++ +LM C + RP
Sbjct: 231 AM---LEKGERMGCPAGCPREMY--DLM----------------NLCWTYDVENRPGFAA 269
Query: 602 VVRMIEDIRPSDS 614
V + +
Sbjct: 270 VELRLRNYYYDVV 282
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 65/259 (25%), Positives = 114/259 (44%), Gaps = 37/259 (14%)
Query: 292 TAATKSKGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGT 351
T ++ S ++ P+ + GV EK K V +E Y ++ + +G+GS+G
Sbjct: 19 TWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYE---YREEVHWMTHQ--PRVGRGSFGE 73
Query: 352 TYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY--FSKDEKL 408
++ + G VK+++ V E + L P +VP Y + +
Sbjct: 74 VHRMKDKQTGFQCAVKKVRLEVFRVEE----LVACAGL-SSPRIVP---LYGAVREGPWV 125
Query: 409 LVY-DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA-KGIAHIHAAVGGKFILGNI 466
++ + +E GS L+ + +G P E R LG A +G+ ++H + + G++
Sbjct: 126 NIFMELLEGGSLGQLI---KQMGCLP---EDRALYYLGQALEGLEYLHTR---RILHGDV 176
Query: 467 KSSNVLLSQDLQGC-ISDFG----LTPLMNTPTVPSRSA--G---YRAPEVIETKKPTQK 516
K+ NVLLS D + DFG L P ++ + G + APEV+ K K
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 517 SDVYSFGVLLLEMLTGKAP 535
D++S ++L ML G P
Sbjct: 237 VDIWSSCCMMLHMLNGCHP 255
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 56/278 (20%), Positives = 110/278 (39%), Gaps = 43/278 (15%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+VLG G+ GT + + V VKR+ + E ++++ +HPNV+ R +
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE--VQLLRESDEHPNVI--RYFC 85
Query: 402 FSKDEKLLVYDFIE--AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459
KD + Y IE A + + + L+ + + + G+AH+H+
Sbjct: 86 TEKDRQ-FQYIAIELCAATLQEYVE-QKDFAHLGLE---PITLLQQTTSGLAHLHSL--- 137
Query: 460 KFILGNIKSSNVLLSQ-----DLQGCISDFGLTPLMNTPTVPSR-------SAGYRAPEV 507
+ ++K N+L+S ++ ISDFGL + + G+ APE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 508 IE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564
+ + PT D++S G + +++ + P +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSH------------PFGKSLQRQANILLGAC 245
Query: 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEV 602
++ + E E+ + + L I +A P RP+ + V
Sbjct: 246 SLDCLHPEKHEDVIAREL-I-EKMIAMDPQKRPSAKHV 281
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 67/311 (21%), Positives = 118/311 (37%), Gaps = 78/311 (25%)
Query: 342 EVLGKGSYGTTYKAIL--------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQH 391
+ LG+G +G A +E TV VK LK+ + +ME++ + +H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR-----------V 440
N++ + ++ ++ G+ L R G +R V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 441 KISLGSAKGIAH------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491
+ A+G+ + IH AA NVL++++ I+DFGL +N
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAA------------RNVLVTENNVMKIADFGLARDIN 254
Query: 492 TPTVPSRSAGYR------------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQA 538
Y+ APE + + T +SDV+SFGVL+ E+ T G +P
Sbjct: 255 ------NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 539 PGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPT 598
E++ L ++ R + + N E + + C VP RPT
Sbjct: 309 IPVEELFKL---LKEGHR-----------MDKPANCTNE---LYMMMRDCWHAVPSQRPT 351
Query: 599 MEEVVRMIEDI 609
+++V ++ I
Sbjct: 352 FKQLVEDLDRI 362
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 4e-21
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 30/215 (13%)
Query: 342 EVLGKG--SYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQ-QMEV-VGRLSQHPNVVP 396
V+GKG T A G V V+R+ Q E+ V +L HPN+VP
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 397 IRAYY--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI 453
Y F D +L +V F+ GS L+ + ++ + I G K + +I
Sbjct: 91 ---YRATFIADNELWVVTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYI 144
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFG----LTPLMN----TPTVPSRSAG---Y 502
H ++ ++K+S++L+S D + +S + P S +
Sbjct: 145 HHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 503 RAPEVIETKKP--TQKSDVYSFGVLLLEMLTGKAP 535
+PEV++ KSD+YS G+ E+ G P
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 23/126 (18%), Positives = 45/126 (35%), Gaps = 7/126 (5%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSG-DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS-PQL 138
+ + L L+ N + + S +L L LQ N ++ + +L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKL 193
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLNG 196
+DLS N + + ++ + + ++L+NN L I L H +L N +
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251
Query: 197 SVPLAL 202
Sbjct: 252 GTLRDF 257
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 21/137 (15%), Positives = 47/137 (34%), Gaps = 16/137 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSPQLN 139
A+ + ++ L L N LS + + L+ + L L L +N + L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSNVLYETLDLESLSTLR 83
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199
+DL+ N + + + L+ NN+++ + +++ L+ N
Sbjct: 84 TLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNK------ 131
Query: 200 LALQKFPPSSFEGNSML 216
+ S +
Sbjct: 132 --ITMLRDLDEGCRSRV 146
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 27/125 (21%), Positives = 47/125 (37%), Gaps = 7/125 (5%)
Query: 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142
L S+ L +N++S + + + +YL NN + ++ ++D
Sbjct: 94 ELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 143 LSFNSITG-NIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
L N I N + L LNLQ N + ++L+ L+LS N L +
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPE 209
Query: 202 LQKFP 206
Q
Sbjct: 210 FQSAA 214
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 22/127 (17%), Positives = 49/127 (38%), Gaps = 17/127 (13%)
Query: 89 LDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSF 145
+ I + + L +++ +++ L L N S + L+ +L ++LS
Sbjct: 9 GNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKF 205
N + + +LS L L+L NN + + L+ + N+++ +
Sbjct: 68 NVLY-ETL-DLESLSTLRTLDLNNNYVQEL---LVGPSIETLHAANNNIS--------RV 114
Query: 206 PPSSFEG 212
S +G
Sbjct: 115 SCSRGQG 121
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 19/91 (20%), Positives = 41/91 (45%), Gaps = 2/91 (2%)
Query: 106 LPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLV 163
+ + + + + +++ + S + +DLS N ++ A + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 164 GLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
LNL +N L + +LS LR L+L+ N++
Sbjct: 62 LLNLSSNVLYETLDLESLSTLRTLDLNNNYV 92
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 16/115 (13%), Positives = 35/115 (30%), Gaps = 6/115 (5%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
+ + + +SLR+N L + + +L L+ N F +
Sbjct: 206 MGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 141 V-DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
V ++ ++ + + L +P RL L ++H
Sbjct: 264 VQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIA--LGHHHH 315
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 55/317 (17%), Positives = 116/317 (36%), Gaps = 51/317 (16%)
Query: 321 LVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFE 379
+ + +D + LG G+ G +K + G + K + + +
Sbjct: 20 FLTQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRN 76
Query: 380 Q-QMEV-VGRLSQHPNVVPIRAYY--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPL 434
Q E+ V P +V +Y F D ++ + + ++ GS +L I L
Sbjct: 77 QIIRELQVLHECNSPYIV---GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL 133
Query: 435 DWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-TPLMNTP 493
K+S+ KG+ ++ K + ++K SN+L++ + + DFG+ L+++
Sbjct: 134 -----GKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185
Query: 494 TVPSRSAG---YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRW 550
+ + G Y +PE ++ + +SD++S G+ L+EM G+ PI P +++ +
Sbjct: 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 244
Query: 551 VQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAM------------------------ 586
E + + M +
Sbjct: 245 QVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 304
Query: 587 --SCVAKVPDMRPTMEE 601
C+ K P R +++
Sbjct: 305 VNKCLIKNPAERADLKQ 321
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 68/326 (20%), Positives = 118/326 (36%), Gaps = 65/326 (19%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKR-LKEVVMGKREFEQQMEVVGRLSQHPNVVPIRA 399
VL +G + Y+A + G +KR L R Q++ + +LS HPN+V +
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 400 YYFSKDEK--------LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRV-KISLGSAKGI 450
E+ LL+ + + L + R PL V KI + + +
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFL---KKMESRGPLS-CDTVLKIFYQTCRAV 149
Query: 451 AHIHAAVGGKFILGN-IKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-------- 501
H+H I+ +K N+LLS + DFG ++ S SA
Sbjct: 150 QHMHRQ--KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 502 --------YRAPEVIET--KKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV----D 546
YR PE+I+ P +K D+++ G +L + + P + +V
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS 267
Query: 547 LPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606
+P +Y + MLQ P+ R ++ EVV +
Sbjct: 268 IPPHDT-----------------QYTVFHSLIRAMLQ-------VNPEERLSIAEVVHQL 303
Query: 607 EDIRPSDSENQPSSEDKLKDSNTQTP 632
++I + + N S +L + N
Sbjct: 304 QEIAAARNVNPKSPITELLEQNGGYG 329
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 5e-21
Identities = 28/299 (9%), Positives = 71/299 (23%), Gaps = 50/299 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQME----------------- 383
E L G + +E +K R +++
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 384 ----------VVGRLSQHPNVVPIRAYY--FSKDEKLLVYDFIEAGSFSAL-LHGNRGIG 430
+ P + ++ LL+ +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 431 RTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-TPL 489
R + ++ + A++ + + G+ N+ + D + + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 490 MNTPTVPSRSAGYRAPEVIETKKP--TQKSDVYSFGVLLLEMLTGKAP--IQAPGHEDVV 545
S Y E + T + + G+ + + P + PG +
Sbjct: 245 GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304
Query: 546 DLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
P ++ + F + ++ + + L R E +
Sbjct: 305 KRPS-LRVPGTDSLA---FGSCTPLPDFVKTLIGRFLN-------FDRRRRLLPLEAME 352
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 59/310 (19%), Positives = 103/310 (33%), Gaps = 54/310 (17%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
+VLG G++G A V VK LKE + +++++ +L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS------- 446
+V + L++++ G L R K
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 447 -----------AKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495
AKG+ + + ++ + NVL++ I DFGL + + +
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 496 PSRSAGYR------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLP 548
R APE + T KSDV+S+G+LL E+ + G P PG +
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY--PGIPVDANFY 285
Query: 549 RWVQSVVREEWTSEVFDVELMRYENIEEEMVQ-MLQIAMSCVAKVPDMRPTMEEVVRMIE 607
+ +Q+ + + + EE+ M C A RP+ + +
Sbjct: 286 KLIQNGFK-----------MDQPFYATEEIYIIMQS----CWAFDSRKRPSFPNLTSFLG 330
Query: 608 DIRPSDSENQ 617
E
Sbjct: 331 CQLADAEEAM 340
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 94.7 bits (235), Expect = 6e-21
Identities = 32/313 (10%), Positives = 83/313 (26%), Gaps = 83/313 (26%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQME----------------- 383
VLG+ +A E G + V +QM+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 384 -----------VVGRLSQHPNVVPIRAYY--FSKDEKLLVYDFIEAGSFSAL-LHGNRGI 429
+ + Q ++ +R + +Y +++ + + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 430 GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489
L +R++++L + +A +H + ++ +++L Q ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 490 MNTPTVPSRSAGYRAPEVI----------ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539
V G+ PE T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 540 G--------HEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAK 591
++P+ V++++ L+
Sbjct: 321 AALGGSEWIFRSCKNIPQPVRALLE-----------------------GFLR-------Y 350
Query: 592 VPDMRPTMEEVVR 604
+ R + +
Sbjct: 351 PKEDRLLPLQAME 363
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 62/298 (20%), Positives = 127/298 (42%), Gaps = 54/298 (18%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG-KREFEQQMEVVGRLSQHPNV 394
LG+G++G + A ++ V VK LK+ + +++F+++ E++ L QH ++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHI 79
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR-----------VKIS 443
V D ++V+++++ G + L + +D + R + I+
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 444 LGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSRSAGY 502
A G+ ++ + F+ ++ + N L+ +L I DFG++ + +T
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 503 ---R--APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR 556
R PE I +K T +SDV+SFGV+L E+ T GK P + +V++ +
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---ITQGRV 253
Query: 557 ----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610
EV+D +M C + P R ++E+ +++ +
Sbjct: 254 LERPRVCPKEVYD--VML----------------GCWQREPQQRLNIKEIYKILHALG 293
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 7e-21
Identities = 33/143 (23%), Positives = 49/143 (34%), Gaps = 15/143 (10%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SP 136
+ + SL L L N + + SN L L L L Q++N S+
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYNH 193
L ++D+S LS L L + NS L L L+LS
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 194 LNGSVPLALQKFPPSSFEGNSML 216
L++ P++F S L
Sbjct: 482 --------LEQLSPTAFNSLSSL 496
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 33/161 (20%), Positives = 66/161 (40%), Gaps = 13/161 (8%)
Query: 43 LNWNSSTSVCTSWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHL 102
L++N ++ ++++G+ ++ + L + L +L+ L + H
Sbjct: 380 LSFNGVITMSSNFLGLEQLEH------LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 103 SGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS---PQLNWVDLSFNSITGNIPASIRN 158
+ + + LSSL L + N+F N + L ++DLS + P + +
Sbjct: 434 R-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 159 LSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGS 197
LS L LN+ +N L L+ L+ + L N + S
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 6e-19
Identities = 34/167 (20%), Positives = 55/167 (32%), Gaps = 11/167 (6%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNF-SGNIPSSLS--P 136
+ L SL L +L+ L + + L +L+ L + +N S +P S
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHL----VGLNLQNNSLTGFIPN-FNLSRLRHLNLSY 191
L +DLS N I +R L + + L+L N + P F RL L L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN 209
Query: 192 NHLNGSVP-LALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPSATN 237
N + +V +Q + + N
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 27/142 (19%), Positives = 46/142 (32%), Gaps = 15/142 (10%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQ 137
+ + + L +L L + + LS L L L N + S
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNLSYNHL 194
L + ++ I +L L LN+ +N + F NL+ L HL+LS N
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK- 160
Query: 195 NGSVPLALQKFPPSSFEGNSML 216
+Q + +
Sbjct: 161 -------IQSIYCTDLRVLHQM 175
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 8e-17
Identities = 25/122 (20%), Positives = 39/122 (31%), Gaps = 7/122 (5%)
Query: 91 SLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNS 147
S L L N L L S L+ L L + L+ + L+ N
Sbjct: 29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 148 ITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLN-GSVPLALQK 204
I + LS L L +L +L L+ LN+++N + +P
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 205 FP 206
Sbjct: 148 LT 149
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 30/151 (19%), Positives = 50/151 (33%), Gaps = 26/151 (17%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L +++ + L L SL+ L +N P L ++DLS
Sbjct: 303 NFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSR 356
Query: 146 NSIT--GNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLA- 201
N ++ G S + L L+L N + NF L +L HL+ +++L +
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
Query: 202 ----------------LQKFPPSSFEGNSML 216
+ F G S L
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 26/124 (20%), Positives = 38/124 (30%), Gaps = 15/124 (12%)
Query: 97 LRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPA 154
+ +P N+ S + L L N S P+L +DLS I
Sbjct: 14 CMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 155 SIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEG 212
+ ++LSHL L L N + LS L+ L + L
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN--------LASLENFPIGH 122
Query: 213 NSML 216
L
Sbjct: 123 LKTL 126
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 27/140 (19%), Positives = 46/140 (32%), Gaps = 12/140 (8%)
Query: 80 PIPANTLEKLDSLMILSLRSNHL--SGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSP 136
+ LE L +L I R +L D ++ + L+++ L + S +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF 304
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNG 196
++L P L L L +N +L L L+LS N L+
Sbjct: 305 GWQHLELVNCKFG-QFPTL--KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS- 360
Query: 197 SVPLALQKFPPSSFEGNSML 216
+ S G + L
Sbjct: 361 -----FKGCCSQSDFGTTSL 375
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 23/157 (14%), Positives = 45/157 (28%), Gaps = 13/157 (8%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGN-----IPSSL 134
I +++ L L+LR+N S ++ + L+ L L F S
Sbjct: 192 IQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 135 SPQLNWVDLSFNSITGN------IPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLN 188
L + + + I L+++ +L + ++ +HL
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 189 LSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCS 225
L L L+ +F N
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 347
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 15/73 (20%), Positives = 32/73 (43%), Gaps = 3/73 (4%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLSPQLN 139
+ L SL +L++ SN L +P + L+SL+ ++L N + + +
Sbjct: 485 LSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCS-CPRIDYLSR 542
Query: 140 WVDLSFNSITGNI 152
W++ + G+
Sbjct: 543 WLNKNSQKEQGSA 555
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 65/314 (20%), Positives = 110/314 (35%), Gaps = 85/314 (27%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
E LG+ +G YK L E+ V +K LK+ G + EF + + RL QHPN
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPN 73
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR-----------VKI 442
VV + +++ + G L + R V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 443 SLGSAKGIAH------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493
A G+ + +H A NVL+ L ISD GL +
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLAT------------RNVLVYDKLNVKISDLGLFREVY-- 179
Query: 494 TVPSRSAGYR------------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPG 540
+ Y+ APE I K + SD++S+GV+L E+ + G P
Sbjct: 180 ----AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
Query: 541 HEDVVDLPRWVQSVVR----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMR 596
++DVV++ +++ ++ + V+ LM C + P R
Sbjct: 236 NQDVVEM---IRNRQVLPCPDDCPAWVY--ALMI----------------ECWNEFPSRR 274
Query: 597 PTMEEVVRMIEDIR 610
P +++ +
Sbjct: 275 PRFKDIHSRLRAWG 288
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 63/309 (20%), Positives = 110/309 (35%), Gaps = 65/309 (21%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
+ LG G++G +A + V VK LK K +++++ L QH N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNR---------GIGRTPLDWESRVKISL 444
+V + L++ ++ G L I + + S
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 445 GSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-PLMNTPTVPSRSAGYR 503
A+G+A + + I ++ + NVLL+ I DFGL +MN Y
Sbjct: 172 QVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN-------YI 221
Query: 504 ------------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRW 550
APE I T +SDV+S+G+LL E+ + G P PG +
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY--PGILVNSKFYKL 279
Query: 551 VQSVVR----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606
V+ + ++ +M+ +C A P RPT +++ +
Sbjct: 280 VKDGYQMAQPAFAPKNIYS--IMQ----------------ACWALEPTHRPTFQQICSFL 321
Query: 607 EDIRPSDSE 615
++ D
Sbjct: 322 QEQAQEDRR 330
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 28/214 (13%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQ-QMEV-VGRLSQHPNVVPIR 398
EV+G G+ A + V +KR+ + + ++ E+ HPN+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIV--- 76
Query: 399 AYY--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRT---PLDWESRVKISLGSA-KGIA 451
+YY F ++L LV + GS ++ G LD ES + L +G+
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEGLE 135
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG----LTPLMNTPTVPSRS--AG---Y 502
++H I ++K+ N+LL +D I+DFG L + R G +
Sbjct: 136 YLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 503 RAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAP 535
APEV+E + K+D++SFG+ +E+ TG AP
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 64/301 (21%), Positives = 103/301 (34%), Gaps = 75/301 (24%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEV--VMGKREFEQQMEVVGRLSQHPNVV 395
EV+G+G +G Y L + VK L + + +F + ++ HPNV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVL 153
Query: 396 PIRAYYFSKDEKLL-VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH-- 452
+ + L V +++ G + + + L AKG+
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLA 209
Query: 453 ----IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYR-- 503
+H AA N +L + ++DFGL M
Sbjct: 210 SKKFVHRDLAA------------RNCMLDEKFTVKVADFGLARDMYD----KEFDSVHNK 253
Query: 504 ----------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQ 552
A E ++T+K T KSDV+SFGVLL E++T G P D+ +
Sbjct: 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LL 310
Query: 553 SVVR----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608
R E ++ E+M C +MRP+ E+V I
Sbjct: 311 QGRRLLQPEYCPDPLY--EVML----------------KCWHPKAEMRPSFSELVSRISA 352
Query: 609 I 609
I
Sbjct: 353 I 353
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 3e-20
Identities = 48/219 (21%), Positives = 70/219 (31%), Gaps = 19/219 (8%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS-------PQ 137
L ++ L IL L N S S SL L+L N + L
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGS 197
L + L+ N + P +L+ L GL+L +N LT N + L L++S N L
Sbjct: 482 LQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAP 541
Query: 198 VPLALQKFPPSSFEGNSMLCGPP-------LNQCSTVPPAPSPSATNFPPPP----TVLP 246
P N +C LN + P P ++
Sbjct: 542 NPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFS 601
Query: 247 KPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLK 285
EG +E+ ++ V LFLM K
Sbjct: 602 LSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTK 640
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 33/158 (20%), Positives = 56/158 (35%), Gaps = 26/158 (16%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNF------------- 126
+ ++ L + + L+ NH++ + L L+ L L++N
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIF 387
Query: 127 -SGNIPSSL---SPQLNWVDLSFNSITG-NIPASIRNLSHLVGLNLQNNSLTGFIPNF-- 179
SGN +L + N + LS N + +I + + HL L L N + +
Sbjct: 388 LSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTP 447
Query: 180 -NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
L L L N L + + FEG S L
Sbjct: 448 SENPSLEQLFLGENMLQLAWE---TELCWDVFEGLSHL 482
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 3e-16
Identities = 29/126 (23%), Positives = 53/126 (42%), Gaps = 7/126 (5%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQ 137
+ + E L L +L+L N ++ + L +L+ L L N S+ P+
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPK 339
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGS 197
+ ++DL N I + + L L L+L++N+LT + + + LS N L
Sbjct: 340 VAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI---HFIPSIPDIFLSGNKLVTL 396
Query: 198 VPLALQ 203
+ L
Sbjct: 397 PKINLT 402
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 4e-15
Identities = 28/123 (22%), Positives = 46/123 (37%), Gaps = 15/123 (12%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
+P L++ L L N++ + ++ L L+ L L + I P
Sbjct: 19 VPQV----LNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLP 73
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF----NLSRLRHLNLSY 191
L +DL + I + + L HL L L L+ + NL L L+LS
Sbjct: 74 NLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSK 132
Query: 192 NHL 194
N +
Sbjct: 133 NQI 135
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 5e-15
Identities = 29/145 (20%), Positives = 56/145 (38%), Gaps = 18/145 (12%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNV---LSLSSLRFLYLQNNNFSGNIPSSL--- 134
A +L +M +++ D N L+ SS+R L L + ++ S +
Sbjct: 231 SQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFET 288
Query: 135 SPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYN 192
L ++L++N I + L +L LNL N L + + L ++ +++L N
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 193 HLNGSVPLALQKFPPSSFEGNSMLC 217
H + +F+ L
Sbjct: 349 H--------IAIIQDQTFKFLEKLQ 365
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 30/119 (25%), Positives = 53/119 (44%), Gaps = 11/119 (9%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQ 137
I LD+L +L+L N L +L S+ L + ++ LQ N+ + + +
Sbjct: 305 IADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNG 196
L +DL N++T +I + + + L N L +P NL+ ++LS N L
Sbjct: 364 LQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT-LPKINLT-ANLIHLSENRLEN 415
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 31/151 (20%), Positives = 54/151 (35%), Gaps = 22/151 (14%)
Query: 79 GPIPANTLEKLD------SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS 132
P LE LD ++ I SN +S +++ + +N +
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQN 258
Query: 133 SLSP----QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF--NLSRLR 185
+ + + +DLS + ++ + + L L LNL N + L L+
Sbjct: 259 TFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQ 317
Query: 186 HLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
LNLSYN L + S+F G +
Sbjct: 318 VLNLSYNL--------LGELYSSNFYGLPKV 340
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 5e-13
Identities = 33/151 (21%), Positives = 54/151 (35%), Gaps = 10/151 (6%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSPQLN 139
+ + E L L +L L N+L+ LP V S L++LR L L +N + + L L
Sbjct: 471 LCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLE 529
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSR-LRHLNLSYNHLNGSV 198
+D+S N + P +LS L++ +N L H N++ +
Sbjct: 530 ILDISRNQLLAPNPDVFVSLSV---LDITHNKFICECELSTFINWLNHTNVTIAGPPADI 586
Query: 199 ----PLALQKFPPSSFEGNSMLCGPPLNQCS 225
P + S L
Sbjct: 587 YCVYPDSFSGVSLFSLSTEGCDEEEVLKSLK 617
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 4e-12
Identities = 26/174 (14%), Positives = 52/174 (29%), Gaps = 27/174 (15%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSG-DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--- 135
+ L +L L L N + L + L+SL+ + +N L
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172
Query: 136 -PQLNWVDLSFNSITGNIPASIRNLS------HLVGLNLQNNSLTGFIPNF---NLSRLR 185
L++ L+ NS+ + L L++ N T I +S+ +
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 186 HLNLSYNHLNGSVPLA---LQKFPPSSFEGNSMLCGPPL-------NQCSTVPP 229
+L H ++ ++F G L + ++
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAG---LARSSVRHLDLSHGFVFSLNS 283
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 5e-12
Identities = 26/106 (24%), Positives = 38/106 (35%), Gaps = 13/106 (12%)
Query: 114 SSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT 173
R + + N + +P L + LSFN I +S L L L L +
Sbjct: 4 FDGRIAFYRFCNLT-QVPQVL-NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 174 GFIPN--F-NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
I F NL LR L+L + + P +F+G L
Sbjct: 62 LTIDKEAFRNLPNLRILDLGSSK--------IYFLHPDAFQGLFHL 99
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 29/161 (18%), Positives = 49/161 (30%), Gaps = 34/161 (21%)
Query: 82 PANTLEKLDSLMILSLRSNHLSGDLPS--NVLSLSSLRFLYLQNNNFSGNIPSSLS---- 135
+ KL+SL + SN + L +L F L N+ +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 136 ----PQLNWVDLSFNSITGNIPA------------SIRNLSHLVGLNLQNNSLT----GF 175
L +D+S N T +I S+ H++G +++
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 176 IPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
S +RHL+LS+ + FE L
Sbjct: 260 FAGLARSSVRHLDLSHGF--------VFSLNSRVFETLKDL 292
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
+G+GS G A G V VK + +RE V+ R QH NVV
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVV---EM 107
Query: 401 Y--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
Y + E+L ++ +F++ G+ + ++ + L+ E + + +A++HA
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHA-- 159
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS--AG---YRAPEVIETKK 512
I +IKS ++LL+ D + +SDFG + + VP R G + APEVI
Sbjct: 160 -QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI-SKDVPKRKSLVGTPYWMAPEVISRSL 217
Query: 513 PTQKSDVYSFGVLLLEMLTGKAP 535
+ D++S G++++EM+ G+ P
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPP 240
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 3e-20
Identities = 26/153 (16%), Positives = 52/153 (33%), Gaps = 11/153 (7%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSG-DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS-PQL 138
+ + L L+ N + + S +L L LQ N ++ + +L
Sbjct: 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKL 193
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLNG 196
+DLS N + + ++ + + ++L+NN L I L H +L N +
Sbjct: 194 KTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251
Query: 197 SVPLALQKFPPS----SFEGNSMLCGPPLNQCS 225
+ + L G +C+
Sbjct: 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 27/126 (21%), Positives = 47/126 (37%), Gaps = 7/126 (5%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWV 141
L S+ L +N++S + + + +YL NN + ++ ++
Sbjct: 93 QELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149
Query: 142 DLSFNSITG-NIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPL 200
DL N I N + L LNLQ N + ++L+ L+LS N L +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGP 208
Query: 201 ALQKFP 206
Q
Sbjct: 209 EFQSAA 214
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 21/127 (16%), Positives = 46/127 (36%), Gaps = 8/127 (6%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSPQLN 139
A+ + ++ L L N LS + + L+ + L L L +N + L
Sbjct: 25 ALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSNVLYETLDLESLSTLR 83
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199
+DL+ N + + + L+ NN+++ + +++ L+ N +
Sbjct: 84 TLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYLANNKITMLRD 137
Query: 200 LALQKFP 206
L
Sbjct: 138 LDEGCRS 144
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 22/127 (17%), Positives = 49/127 (38%), Gaps = 17/127 (13%)
Query: 89 LDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSF 145
+ I + + L +++ +++ L L N S + L+ +L ++LS
Sbjct: 9 GNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKF 205
N + + +LS L L+L NN + + L+ + N+++ +
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQEL---LVGPSIETLHAANNNIS--------RV 114
Query: 206 PPSSFEG 212
S +G
Sbjct: 115 SCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 16/135 (11%), Positives = 37/135 (27%), Gaps = 4/135 (2%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFS-GNIPSSLSPQLN 139
+ + + +SLR+N L + + +L L+ N F G + S
Sbjct: 206 MGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199
++ ++ + + + +P RL L + L
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED-LPAPFADRLIALKRKEHALLSGQG 322
Query: 200 LALQKFPPSSFEGNS 214
++
Sbjct: 323 SETERLECERENQAR 337
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 17/131 (12%), Positives = 30/131 (22%), Gaps = 11/131 (8%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNV------LSLSSLRFLYLQNNNFSG-NIPSS 133
+ E+ + + DLP+ L L Q +
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLSGQGSETERLECERE 333
Query: 134 LSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNH 193
+ +D I + L + +L + N R H L
Sbjct: 334 NQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSN---GRRAHAELDGTL 390
Query: 194 LNGSVPLALQK 204
+ LQ
Sbjct: 391 QQAVGQIELQH 401
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 10/67 (14%), Positives = 24/67 (35%), Gaps = 10/67 (14%)
Query: 152 IPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPPSS 209
I +N + + ++SL + + + ++ L+LS N L + +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNP--------LSQISAAD 53
Query: 210 FEGNSML 216
+ L
Sbjct: 54 LAPFTKL 60
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKR--LKEVVMGKREFEQQMEVVGRLSQHPNVVPIR 398
E +GKGS+G +K I V +K L+E + +Q++ V+ P V
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL-SQCDSPYVT--- 83
Query: 399 AYY--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
YY + KD KL ++ +++ GS LL PLD I KG+ ++H+
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS 137
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS--AG---YRAPEVIET 510
K I +IK++NVLLS+ + ++DFG+ + T T R+ G + APEVI+
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAP 535
K+D++S G+ +E+ G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 61/306 (19%), Positives = 119/306 (38%), Gaps = 40/306 (13%)
Query: 310 GSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLK 369
GS ++ + G Y ++ DL +G G+ G +K + V+ +
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQM 58
Query: 370 EVVMGKREFEQ-QME--VVGRLSQHPNVVPIRAYY--FSKDEKL-LVYDFIEAGSFSALL 423
K E ++ M+ VV + P +V + F + + + + + +
Sbjct: 59 RRSGNKEENKRILMDLDVVLKSHDCPYIV---QCFGTFITNTDVFIAMELMGTCAEKLKK 115
Query: 424 HGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISD 483
I L K+++ K + ++ I ++K SN+LL + Q + D
Sbjct: 116 RMQGPIPERIL-----GKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCD 168
Query: 484 FGLTPLMNTPTVPSRSAG---YRAPEVIETKKPTQ-----KSDVYSFGVLLLEMLTGKAP 535
FG++ + RSAG Y APE I+ PT+ ++DV+S G+ L+E+ TG+ P
Sbjct: 169 FGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
Query: 536 IQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDM 595
+ ++ + V++EE L + + ++ C+ K
Sbjct: 229 Y--KNCKTDFEV---LTKVLQEEPPL------LPGHMGFSGDFQSFVK---DCLTKDHRK 274
Query: 596 RPTMEE 601
RP +
Sbjct: 275 RPKYNK 280
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 5e-20
Identities = 67/315 (21%), Positives = 117/315 (37%), Gaps = 67/315 (21%)
Query: 334 EDLLRASAEVLGKGSYGTTYKAILEEG---TTVVVKRLKE--VVMGKREFEQQMEVVGRL 388
D L + LG G++G+ + + V +K LK+ E ++ +++ +L
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 389 SQHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA 447
+P +V R + E L LV + G L G R + + ++ +
Sbjct: 394 -DNPYIV--RLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVS 446
Query: 448 KGIAH------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM--NTPTVP 496
G+ + +H AA NVLL ISDFGL+ + +
Sbjct: 447 MGMKYLEEKNFVHRNLAA------------RNVLLVNRHYAKISDFGLSKALGADDSYYT 494
Query: 497 SRSAG-----YRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRW 550
+RSAG + APE I +K + +SDV+S+GV + E L+ G+ P + +V+
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF--- 551
Query: 551 VQSVVR----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606
++ R E E++ LM C + RP V + +
Sbjct: 552 IEQGKRMECPPECPPELY--ALM----------------SDCWIYKWEDRPDFLTVEQRM 593
Query: 607 EDIRPSDSENQPSSE 621
S +
Sbjct: 594 RACYYSLASKVEGGS 608
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 52/295 (17%), Positives = 95/295 (32%), Gaps = 58/295 (19%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS-QHPNVV---- 395
+ LG+G +G ++A + +KR++ + EV +HP +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 396 -----PIRAYYFSKDEKLLVY---DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA 447
K+ +Y + ++G + + I L A
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIA 128
Query: 448 KGIAHIHAAVGGKFIL-GNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG----- 501
+ + +H+ K ++ ++K SN+ + D + DFGL M+
Sbjct: 129 EAVEFLHS----KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 502 -----------YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRW 550
Y +PE I + K D++S G++L E+L P
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR------ 235
Query: 551 VQSVVREEWTSEVFDVELMRYENIEEEMV-QMLQIAMSCVAKVPDMRPTMEEVVR 604
+ VR +F + E MV ML P RP ++
Sbjct: 236 TLTDVRNLKFPPLFT----QKYPCEYVMVQDMLS-------PSPMERPEAINIIE 279
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 65/294 (22%), Positives = 113/294 (38%), Gaps = 51/294 (17%)
Query: 328 SYNFDLEDLLRASAEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQ-QME-- 383
S +DL LG+G+YG K G + VKR++ + +E ++ M+
Sbjct: 1 SMEVKADDLEPI--MELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLD 57
Query: 384 VVGRLSQHPNVVPIRAYY--FSKDEKLLVYDFIE--AGSFSALL-HGNRGIGRTPLDWES 438
+ R P V +Y ++ + + +E S P D
Sbjct: 58 ISMRTVDCPFTV---TFYGALFREGDVWI--CMELMDTSLDKFYKQVIDKGQTIPEDILG 112
Query: 439 RVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPS 497
KI++ K + H+H+ I ++K SNVL++ Q + DFG+ L++
Sbjct: 113 --KIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKD 167
Query: 498 RSAG---YRAPEVIETKKP----TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRW 550
AG Y APE I + + KSD++S G+ ++E+ + P + G +
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQ 222
Query: 551 VQSVVREE---WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEE 601
++ VV E ++ F E + C+ K RPT E
Sbjct: 223 LKQVVEEPSPQLPADKFSAEF-------VDFTS------QCLKKNSKERPTYPE 263
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 31/116 (26%), Positives = 57/116 (49%), Gaps = 3/116 (2%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L L L L + +N ++ S + +L++LR LYL +N S P + ++ ++L
Sbjct: 84 LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGA 141
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
N ++ + N++ L L + + + P NL+ L L+L+YN + PLA
Sbjct: 142 NHNLSDLSP-LSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISPLA 196
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 29/116 (25%), Positives = 51/116 (43%), Gaps = 3/116 (2%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L L + L+L +NH D S + +++ L +L + + P + L + L++
Sbjct: 128 LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNY 186
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
N I P + +L+ L N +T P N++RL L + N + PLA
Sbjct: 187 NQIEDISP--LASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSPLA 240
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 9e-18
Identities = 29/111 (26%), Positives = 50/111 (45%), Gaps = 6/111 (5%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
L L L L + +N +S + V L+ L+ L + +N S S L+ QLN + L
Sbjct: 239 LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFL 294
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
+ N + I L++L L L N +T P +LS++ + + +
Sbjct: 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 1e-17
Identities = 31/121 (25%), Positives = 57/121 (47%), Gaps = 4/121 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L L SL + N ++ + V +++ L L + NN + P + QL W+++
Sbjct: 195 LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGT 252
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKF 205
N I+ +I A +++L+ L LN+ +N ++ NLS+L L L+ N L +
Sbjct: 253 NQIS-DINA-VKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGL 310
Query: 206 P 206
Sbjct: 311 T 311
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
+ + L L + +N ++ S + +LS L +L + N S +++ +L +++
Sbjct: 217 VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNV 272
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLA 201
N I+ +I + NLS L L L NN L L+ L L LS NH+ PLA
Sbjct: 273 GSNQIS-DISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA 330
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 27/111 (24%), Positives = 48/111 (43%), Gaps = 4/111 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L + L L++ + + + + +L+ L L L N P + L++
Sbjct: 151 LSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYV 208
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNG 196
N IT P + N++ L L + NN +T P NLS+L L + N ++
Sbjct: 209 NQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 26/130 (20%), Positives = 53/130 (40%), Gaps = 22/130 (16%)
Query: 85 TLEKLDSLMILSLRSNHLSG-------------DLPSNVLS-------LSSLRFLYLQNN 124
L + L+ ++ + ++ L++L +L L N
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVASIQGIEYLTNLEYLNLNGN 76
Query: 125 NFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRL 184
+ P S +L + + N IT ++++NL++L L L ++++ P NL+++
Sbjct: 77 QITDISPLSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISPLANLTKM 134
Query: 185 RHLNLSYNHL 194
LNL NH
Sbjct: 135 YSLNLGANHN 144
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 6e-13
Identities = 20/110 (18%), Positives = 41/110 (37%), Gaps = 4/110 (3%)
Query: 92 LMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGN 151
L+ ++ + L+ LQ + + + + + ++ + +
Sbjct: 2 AATLATLPAPIN-QI-FPDADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVA-S 58
Query: 152 IPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
I I L++L LNL N +T P NL +L +L + N + L
Sbjct: 59 IQG-IEYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDISALQ 107
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 25/92 (27%), Positives = 41/92 (44%), Gaps = 6/92 (6%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWV 141
N ++ L L +L++ SN +S S + +LS L L+L NN + L +
Sbjct: 259 NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLT 173
LS N IT P + +LS + + N +
Sbjct: 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 9e-20
Identities = 56/216 (25%), Positives = 92/216 (42%), Gaps = 41/216 (18%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK-REFEQQMEVVGRLSQHPNVVPIRA 399
VLGKG+YG Y L + +K + E + +++ + L +H N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIV---Q 83
Query: 400 YY--FSKDEKLLVY-DFIEAGSFSALLHGNRGIGRTPLDWESRVK-----ISLGSA---- 447
Y FS++ + ++ + + GS SALL G + D E + I G
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK---DNEQTIGFYTKQILEGLKYLHD 140
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCI--SDFGLTPLMNTPTVPSRS-AG--- 501
I H +IK NVL++ G + SDFG + + + + G
Sbjct: 141 NQIVH-----------RDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQ 188
Query: 502 YRAPEVIETKKP--TQKSDVYSFGVLLLEMLTGKAP 535
Y APE+I+ + +D++S G ++EM TGK P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 8/131 (6%)
Query: 81 IPANTLEKLDSLMILSLRSNHL-SGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSPQL 138
+ + L+ ++++ L +N L S + + + L ++ + + N + IP L P L
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL 194
Query: 139 NWVDLSFNSITGNIPA-SIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLN 195
+ L N IT + A S++ L++L L L NS++ N LR L+L+ N L
Sbjct: 195 TELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253
Query: 196 GSVPLALQKFP 206
VP L
Sbjct: 254 -KVPGGLADHK 263
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 30/146 (20%), Positives = 55/146 (37%), Gaps = 18/146 (12%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS-SLS--P 136
I + + L + + +++ +P + SL L+L N + + + SL
Sbjct: 161 GIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGNKIT-KVDAASLKGLN 216
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHL 194
L + LSFNSI+ S+ N HL L+L NN L +P + ++ + L N+
Sbjct: 217 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNN- 274
Query: 195 NGSVPLALQKFPPSSFEGNSMLCGPP 220
+ + F
Sbjct: 275 -------ISAIGSNDFCPPGYNTKKA 293
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 27/120 (22%), Positives = 51/120 (42%), Gaps = 9/120 (7%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSPQLN 139
I + L +L L L +N +S + + L L LYL N +P + L
Sbjct: 67 IKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQ 124
Query: 140 WVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLT-GFIPN--F-NLSRLRHLNLSYNHL 194
+ + N IT + S+ L+ ++ + L N L I N F + +L ++ ++ ++
Sbjct: 125 ELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 27/126 (21%), Positives = 52/126 (41%), Gaps = 17/126 (13%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQ 137
+ A +L+ L++L L L N +S + + L+ LR L+L NN +P L+
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 264
Query: 138 LNWVDLSFNSITGNIPAS-------IRNLSHLVGLNLQNNSLTGF-IPN---FNLSRLRH 186
+ V L N+I+ I ++ + G++L +N + + I +
Sbjct: 265 IQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323
Query: 187 LNLSYN 192
+ L
Sbjct: 324 VQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 27/124 (21%), Positives = 41/124 (33%), Gaps = 14/124 (11%)
Query: 91 SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSI 148
L ++ L +P ++ L LQNN + L+ + L N I
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 149 TGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPS 208
+ P + L L L L N L +P L+ L + N + K S
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENE--------ITKVRKS 139
Query: 209 SFEG 212
F G
Sbjct: 140 VFNG 143
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 53/213 (24%), Positives = 84/213 (39%), Gaps = 37/213 (17%)
Query: 342 EVLGKGSYGTTYKA---ILEEGTTVVVKRLKEVVMGKREFEQQME----VVGRLSQHPNV 394
++G+G G Y+A + E V +K + E + F +M+ GRL P+V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHV 96
Query: 395 VPIRAYYFSKDEKL--LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
VPI + F + + + I +A+L + PL V I +
Sbjct: 97 VPI--HDFGEIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDA 149
Query: 453 IHAAVGGKFILG----NIKSSNVLLSQDLQGCISDFGL------TPLMNTPTVPSRSAGY 502
HAA G ++K N+L+S D + DFG+ L + Y
Sbjct: 150 AHAA-------GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVG-TLYY 201
Query: 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
APE T ++D+Y+ +L E LTG P
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 26/137 (18%), Positives = 45/137 (32%), Gaps = 14/137 (10%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLN 139
L L +L L + N +P + +RFL L + + + + L
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLE 434
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199
+D+S N++ + L L L + N L L + +S N L
Sbjct: 435 VLDVSNNNLD-SFSL---FLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLK---- 486
Query: 200 LALQKFPPSSFEGNSML 216
P F+ + L
Sbjct: 487 ----SVPDGIFDRLTSL 499
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-18
Identities = 31/131 (23%), Positives = 53/131 (40%), Gaps = 10/131 (7%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSN---VLSLSSLRFLYLQNNNFS--GNIPSSLS 135
+P + + L SL L L N + + N + SL+ L L N+ L
Sbjct: 325 VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILL 384
Query: 136 --PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNH 193
L +D+S N+ +P S + + LNL + + + L L++S N+
Sbjct: 385 TLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSNNN 442
Query: 194 LNGSVPLALQK 204
L+ S L L +
Sbjct: 443 LD-SFSLFLPR 452
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 31/133 (23%), Positives = 49/133 (36%), Gaps = 8/133 (6%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
I + L SL L L NHLS L S+ LSSL++L L N + +SL
Sbjct: 65 IEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123
Query: 137 QLNWVDLSFNSITGNIPA-SIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNH 193
L + + I L+ L L ++ SL + ++ + HL L +
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE 183
Query: 194 LNGSVPLALQKFP 206
+ +
Sbjct: 184 SAFLLEIFADILS 196
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 28/142 (19%), Positives = 51/142 (35%), Gaps = 17/142 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQ 137
IP+ ++ L L N ++ + L ++L+ L L+++ + +
Sbjct: 20 IPSGLTA---AMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYNHL 194
L +DLS N ++ + LS L LNL N NL+ L+ L +
Sbjct: 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 195 NGSVPLALQKFPPSSFEGNSML 216
+ F G + L
Sbjct: 136 -------FSEIRRIDFAGLTSL 150
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 31/142 (21%), Positives = 56/142 (39%), Gaps = 18/142 (12%)
Query: 70 VRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSG----DLPSNVLS-LSSLRFLYLQNN 124
L G+G + P ++ + +L + +++R H+ S V S L ++ + ++N+
Sbjct: 261 CTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 125 NFSGNIPSSLS---PQLNWVDLSFNSITGNI---PASIRNLSHLVGLNLQNNSLTGFIPN 178
+P S S L ++DLS N + A L L L N L +
Sbjct: 321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQK 378
Query: 179 F-----NLSRLRHLNLSYNHLN 195
L L L++S N +
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 32/108 (29%), Positives = 51/108 (47%), Gaps = 11/108 (10%)
Query: 111 LSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNN 170
LS + ++ +F+ +IPS L+ + +DLSFN IT +R ++L L L+++
Sbjct: 2 LSCDASGVCDGRSRSFT-SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 171 SLTGFIPN-F-NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
+ + F +L L HL+LS NH L S F S L
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNH--------LSSLSSSWFGPLSSL 100
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 27/154 (17%), Positives = 53/154 (34%), Gaps = 22/154 (14%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQ--- 137
+ +L+ + + L+L + + L LSS+R+L L++ N + S L
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222
Query: 138 ----------LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-----NLS 182
D SFN + + I LS + + N L F P+ L
Sbjct: 223 SPMKKLAFRGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELG 281
Query: 183 RLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
++ + + H+ L + + +
Sbjct: 282 KVETVTIRRLHIPQ---FYLFYDLSTVYSLLEKV 312
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 22/132 (16%), Positives = 47/132 (35%), Gaps = 19/132 (14%)
Query: 82 PANTLEKLDSLMILSLRSNHLSG-------DLPSNVLSLSSLRFLYLQNNN---FSGNIP 131
P E + L+ R + L+ L +L LS + F N F+ +
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES 274
Query: 132 SSLS-------PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLS 182
+S + + + + ++ L + + ++N+ + +F +L
Sbjct: 275 DVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLK 334
Query: 183 RLRHLNLSYNHL 194
L L+LS N +
Sbjct: 335 SLEFLDLSENLM 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 21/151 (13%), Positives = 45/151 (29%), Gaps = 16/151 (10%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLS--PQ 137
I L SL L +++ L + S L S+ + L L + + +
Sbjct: 139 IRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSS 197
Query: 138 LNWVDLSFNSITGNIPASI---RNLSHLVGLNLQNNSLTG---------FIPNFNLSRLR 185
+ +++L ++ + + S + L + + LT LS +
Sbjct: 198 VRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
Query: 186 HLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
+ + N L P +
Sbjct: 258 FDDCTLNGLGDFNPSESDVVSELGKVETVTI 288
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 19/84 (22%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 89 LDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSI 148
+L +L + +N+L L L+ LY+ N +SL P L + +S N +
Sbjct: 430 PQTLEVLDVSNNNLD-SFSLF---LPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQL 485
Query: 149 TGNIPASIRNLSHLVGLNLQNNSL 172
L+ L + L N
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 74/300 (24%), Positives = 129/300 (43%), Gaps = 39/300 (13%)
Query: 318 KNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKR 376
KL ++F EDL +G+G+YG+ K + + G + VKR++ + ++
Sbjct: 6 SGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIR-STVDEK 62
Query: 377 EFEQ-QME--VVGRLSQHPNVVPIRAYY--FSKDEKLLVYDFIE--AGSFSALLHGNRGI 429
E +Q M+ VV R S P +V +Y ++ + +E + SF +
Sbjct: 63 EQKQLLMDLDVVMRSSDCPYIV---QFYGALFREGDCWI--CMELMSTSFDKFYKYVYSV 117
Query: 430 GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-TP 488
+ E KI+L + K + H+ K I +IK SN+LL + + DFG+
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175
Query: 489 LMNTPTVPSRSAG---YRAPEVIETKKPTQ----KSDVYSFGVLLLEMLTGKAPIQAPGH 541
L+++ +R AG Y APE I+ Q +SDV+S G+ L E+ TG+ P +
Sbjct: 176 LVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP-----Y 229
Query: 542 EDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEE 601
+ + VV+ + ++ + E + V C+ K RP +E
Sbjct: 230 PKWNSVFDQLTQVVKGD-PPQLSNSEEREFSPSFINFVN------LCLTKDESKRPKYKE 282
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 36/144 (25%), Positives = 62/144 (43%), Gaps = 19/144 (13%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
+PA + +L IL L SN L+ + + + L+ L L L +N ++ +
Sbjct: 47 VPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLG 105
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYN 192
+L+ + L + + + R L+ L L LQ+N+L +P+ F +L L HL L N
Sbjct: 106 RLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGN 163
Query: 193 HLNGSVPLALQKFPPSSFEGNSML 216
+ P +F G L
Sbjct: 164 R--------ISSVPERAFRGLHSL 179
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 37/143 (25%), Positives = 54/143 (37%), Gaps = 18/143 (12%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
+ T L L L L L +L + L++L++LYLQ+N +P
Sbjct: 96 VDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLG 153
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNH 193
L + L N I+ ++P R L L L L N + P+ F +L RL L L N
Sbjct: 154 NLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN- 211
Query: 194 LNGSVPLALQKFPPSSFEGNSML 216
L P + L
Sbjct: 212 -------NLSALPTEALAPLRAL 227
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 31/144 (21%), Positives = 46/144 (31%), Gaps = 19/144 (13%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
I A L L L L N + L L L+L + L
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLA 129
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYN 192
L ++ L N++ +P R+L +L L L N ++ +P L L L L N
Sbjct: 130 ALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQN 187
Query: 193 HLNGSVPLALQKFPPSSFEGNSML 216
+ P +F L
Sbjct: 188 R--------VAHVHPHAFRDLGRL 203
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 32/124 (25%), Positives = 53/124 (42%), Gaps = 14/124 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIP----SSLS 135
+ L +L L L+ N L LP + L +L L+L N S ++P L
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGL- 176
Query: 136 PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNLSY 191
L+ + L N + ++ R+L L+ L L N+L+ +P L L++L L+
Sbjct: 177 HSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLND 234
Query: 192 NHLN 195
N
Sbjct: 235 NPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 24/108 (22%), Positives = 35/108 (32%), Gaps = 12/108 (11%)
Query: 112 SLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNS 171
+P + + L N I+ AS R +L L L +N
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 172 LTGFIPN---FNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
L I L+ L L+LS N L+ P++F G L
Sbjct: 68 LA-RIDAAAFTGLALLEQLDLSDNAQ-------LRSVDPATFHGLGRL 107
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 32/140 (22%), Positives = 48/140 (34%), Gaps = 17/140 (12%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SP 136
+ + SL L L N + + SN L L L L Q++N S+
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNLSYN 192
L ++D+S I LS L L + NS L L L+LS
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 193 HLNGSVPLALQKFPPSSFEG 212
L++ P++F
Sbjct: 186 Q--------LEQLSPTAFNS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 27/152 (17%), Positives = 48/152 (31%), Gaps = 13/152 (8%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS---P 136
L SL +L + N + ++ + L +L FL L + +
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLS 199
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNL-SRLRHLNLSYNH 193
L +++S N+ + L+ L L+ N + + S L LNL+ N
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 259
Query: 194 LN---GSVPLA--LQKFPPSSFEGNSMLCGPP 220
++ E M C P
Sbjct: 260 FACTCEHQSFLQWIKDQRQLLVEVERMECATP 291
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 39/144 (27%), Positives = 58/144 (40%), Gaps = 21/144 (14%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS---- 135
+P S L L SN L LP V L+ L L L +N S S S
Sbjct: 22 VPTGIPS---SATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGT 77
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYN 192
L ++DLSFN + + ++ L L L+ Q+++L F +L L +L++S+
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 193 HLNGSVPLALQKFPPSSFEGNSML 216
H + F G S L
Sbjct: 137 H--------TRVAFNGIFNGLSSL 152
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 17/85 (20%), Positives = 40/85 (47%), Gaps = 7/85 (8%)
Query: 115 SLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLT 173
S + + + ++P+ + ++L N + ++P + L+ L L+L +N L+
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 174 GFIPN----FNLSRLRHLNLSYNHL 194
F + L++L+LS+N +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGV 90
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 43/139 (30%), Positives = 56/139 (40%), Gaps = 19/139 (13%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
I L SL L L N L+ +PS LS LR L+L+NN +IPS P
Sbjct: 114 IEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVP 171
Query: 137 QLNWVDLS-FNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNH 193
L +DL + I L +L LNL ++ +PN L L L +S NH
Sbjct: 172 SLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNH 229
Query: 194 LNGSVPLALQKFPPSSFEG 212
+ P SF G
Sbjct: 230 --------FPEIRPGSFHG 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 32/142 (22%), Positives = 55/142 (38%), Gaps = 17/142 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPS-SLS--P 136
IP+ E L L L LR+N + +PS + + SL L L I +
Sbjct: 138 IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLF 196
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHL 194
L +++L +I ++P + L L L + N P LS L+ L + +
Sbjct: 197 NLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ- 253
Query: 195 NGSVPLALQKFPPSSFEGNSML 216
+ ++F+G + L
Sbjct: 254 -------VSLIERNAFDGLASL 268
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 35/141 (24%), Positives = 55/141 (39%), Gaps = 15/141 (10%)
Query: 81 IPANTLEKLDSLMILSL-RSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS-PQ 137
IP+ ++ SLM L L L + L +L++L L N ++P+
Sbjct: 162 IPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVG 219
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLN 195
L +++S N P S LS L L + N+ ++ N L+ L LNL++N
Sbjct: 220 LEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHN--- 276
Query: 196 GSVPLALQKFPPSSFEGNSML 216
L P F L
Sbjct: 277 -----NLSSLPHDLFTPLRYL 292
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 25/106 (23%), Positives = 38/106 (35%), Gaps = 13/106 (12%)
Query: 114 SSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT 173
+ + S +P + +++L N+I + R+L HL L L NS+
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 174 GFIPN---FNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
I L+ L L L N L P +FE S L
Sbjct: 113 -QIEVGAFNGLASLNTLELFDNW--------LTVIPSGAFEYLSKL 149
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 17/47 (36%), Positives = 26/47 (55%), Gaps = 2/47 (4%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNF 126
I N + L SL+ L+L N+LS LP ++ L L L+L +N +
Sbjct: 257 IERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLHHNPW 302
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 30/151 (19%), Positives = 58/151 (38%), Gaps = 23/151 (15%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSPQLN 139
+P L LS+ +N+L + + +SL+ L L +N + ++ SL P L
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLF 189
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199
++S+N ++ ++ + L+ +NS+ + L L L +N+L +
Sbjct: 190 HANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNNLTDTAW 243
Query: 200 LA--------------LQKFPPSSFEGNSML 216
L L+K F L
Sbjct: 244 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 26/135 (19%), Positives = 59/135 (43%), Gaps = 18/135 (13%)
Query: 89 LDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SPQLNWVDLS 144
L++ I++ +++ + LP+ +L + L L + I + + + + +
Sbjct: 44 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 101
Query: 145 FNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLA 201
FN+I +P + +N+ L L L+ N L+ N +L L++S N+
Sbjct: 102 FNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN-------- 152
Query: 202 LQKFPPSSFEGNSML 216
L++ +F+ + L
Sbjct: 153 LERIEDDTFQATTSL 167
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 33/144 (22%), Positives = 61/144 (42%), Gaps = 22/144 (15%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSG------------DLPSNVLS----LSSLRFLYLQNN 124
I +T + SL L L SN L+ ++ N+LS ++ L +N
Sbjct: 156 IEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHN 215
Query: 125 NFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLS 182
+ + + ++ +L + L N++T + + N LV ++L N L + + +
Sbjct: 216 SIN-VVRGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272
Query: 183 RLRHLNLSYNHLNGSVPLALQKFP 206
RL L +S N L ++ L Q P
Sbjct: 273 RLERLYISNNRLV-ALNLYGQPIP 295
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 34/126 (26%), Positives = 53/126 (42%), Gaps = 9/126 (7%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS-PQLNWVD 142
+TL ++ L N ++ + V L L LQ+NN + + L+ P L VD
Sbjct: 199 STLAIPIAVEELDASHNSIN-VVRGPVNV--ELTILKLQHNNLT-DTAWLLNYPGLVEVD 254
Query: 143 LSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPL 200
LS+N + I + L L + NN L + L+ L+LS+NHL V
Sbjct: 255 LSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVER 312
Query: 201 ALQKFP 206
+F
Sbjct: 313 NQPQFD 318
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 25/137 (18%), Positives = 48/137 (35%), Gaps = 21/137 (15%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SPQ 137
+ +L L L+ N+L+ D +L+ L + L N I +
Sbjct: 220 VRGPVNVELTIL---KLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQR 273
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLN 195
L + +S N + + + + L L+L +N L + RL +L L +N
Sbjct: 274 LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN--- 328
Query: 196 GSVPLALQKFPPSSFEG 212
++ S+
Sbjct: 329 -----SIVTLKLSTHHT 340
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 23/142 (16%), Positives = 48/142 (33%), Gaps = 17/142 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SPQ 137
I +N L+ + + ++L++ + + +N+ +P++L Q
Sbjct: 13 IDSN-LQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 138 LNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHL 194
+ ++L+ I I + L + N++ P+ N+ L L L N
Sbjct: 71 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND- 128
Query: 195 NGSVPLALQKFPPSSFEGNSML 216
L P F L
Sbjct: 129 -------LSSLPRGIFHNTPKL 143
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 22/125 (17%), Positives = 43/125 (34%), Gaps = 7/125 (5%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQL 138
I + K+ L L + +N L L + +L+ L L +N+ ++ + +L
Sbjct: 263 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRL 320
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSV 198
+ L NSI + S L L L +N + + + +
Sbjct: 321 ENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 377
Query: 199 PLALQ 203
L+
Sbjct: 378 DYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 14/78 (17%), Positives = 29/78 (37%), Gaps = 4/78 (5%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
+ N + D L L L N + L + + +L+ L L +N++ N +L +
Sbjct: 310 VERN-QPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVAR 365
Query: 141 VDLSFNSITGNIPASIRN 158
+ I + +
Sbjct: 366 PAVDDADQHCKIDYQLEH 383
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 74/312 (23%), Positives = 124/312 (39%), Gaps = 75/312 (24%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
+ LG+G +G KA TTV VK LKE R+ + V+ ++ HP+
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPH 87
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS------- 446
V+ + LL+ ++ + GS L +R +G L S
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 447 ------------AKGIAH------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485
++G+ + +H AA N+L+++ + ISDFG
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAA------------RNILVAEGRKMKISDFG 195
Query: 486 LTPLMNTPTVPSRSAGYR------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQA 538
L+ + + + R A E + T +SDV+SFGVLL E++T G P
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 539 PGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQ-MLQIAMSCVAKVPDMRP 597
E + +L +++ R + R +N EEM + MLQ C + PD RP
Sbjct: 256 IPPERLFNL---LKTGHR-----------MERPDNCSEEMYRLMLQ----CWKQEPDKRP 297
Query: 598 TMEEVVRMIEDI 609
++ + +E +
Sbjct: 298 VFADISKDLEKM 309
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 6e-19
Identities = 56/314 (17%), Positives = 106/314 (33%), Gaps = 78/314 (24%)
Query: 342 EVLGKGSYGTTYKA---ILEEGTTVVVKRLKEVVMGKREFEQ--QMEV--VGRLSQHPNV 394
E+LG G + A V VK L+ + F + E L+ HP +
Sbjct: 18 EILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAI 74
Query: 395 VPI-----------RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKIS 443
V + Y +V ++++ + ++H P+ + +++
Sbjct: 75 VAVYDTGEAETPAGPLPY-------IVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVI 122
Query: 444 LGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL--------TPLMNTPTV 495
+ + + H I ++K +N+++S + DFG+ + T V
Sbjct: 123 ADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG---------HEDVVD 546
+A Y +PE +SDVYS G +L E+LTG+ P ED +
Sbjct: 180 IG-TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238
Query: 547 LPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRP-TMEEVVRM 605
+ + S D + + +AK P+ R T E+
Sbjct: 239 PSARHEGL------SADLD-----------------AVVLKALAKNPENRYQTAAEMRAD 275
Query: 606 IEDIRPSDSENQPS 619
+ + + P
Sbjct: 276 LVRVHNGEPPEAPK 289
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 8e-19
Identities = 28/139 (20%), Positives = 56/139 (40%), Gaps = 18/139 (12%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
+PA L+ + +L+L + ++ + + +++ LY+ N +P + P
Sbjct: 66 LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVP 123
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNH 193
L + L N ++ ++P I N L L++ NN+L + + L++L LS N
Sbjct: 124 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182
Query: 194 LNGSVPLALQKFPPSSFEG 212
L S
Sbjct: 183 --------LTHVDLSLIPS 193
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 26/135 (19%), Positives = 59/135 (43%), Gaps = 18/135 (13%)
Query: 89 LDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SPQLNWVDLS 144
L++ I++ +++ + LP+ +L + L L + I + + + + +
Sbjct: 50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 107
Query: 145 FNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLA 201
FN+I +P + +N+ L L L+ N L+ N +L L++S N+
Sbjct: 108 FNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNN-------- 158
Query: 202 LQKFPPSSFEGNSML 216
L++ +F+ + L
Sbjct: 159 LERIEDDTFQATTSL 173
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 4e-17
Identities = 35/137 (25%), Positives = 53/137 (38%), Gaps = 19/137 (13%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
I +T + SL L L SN L+ + ++ + SL + N S + +
Sbjct: 162 IEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-TLAI--PIAVEE 215
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVP 199
+D S NSI + + L L LQ+N+LT N L ++LSYN
Sbjct: 216 LDASHNSIN-VVRGPV--NVELTILKLQHNNLTD-TAWLLNYPGLVEVDLSYNE------ 265
Query: 200 LALQKFPPSSFEGNSML 216
L+K F L
Sbjct: 266 --LEKIMYHPFVKMQRL 280
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 1e-15
Identities = 33/125 (26%), Positives = 53/125 (42%), Gaps = 7/125 (5%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS-PQLNWVD 142
+TL ++ L N ++ + V L L LQ+NN + + L+ P L VD
Sbjct: 205 STLAIPIAVEELDASHNSIN-VVRGPVNV--ELTILKLQHNNLT-DTAWLLNYPGLVEVD 260
Query: 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLA 201
LS+N + + + L L + NN L + L+ L+LS+NHL V
Sbjct: 261 LSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERN 319
Query: 202 LQKFP 206
+F
Sbjct: 320 QPQFD 324
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 7e-15
Identities = 29/119 (24%), Positives = 48/119 (40%), Gaps = 12/119 (10%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
+P + + + L +L L N LS LP + L L + NNN I +
Sbjct: 114 LPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATT 171
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
L + LS N +T ++ S + L N+ N L+ + L+ S+N +N
Sbjct: 172 SLQNLQLSSNRLT-HVDLS--LIPSLFHANVSYNLLSTL---AIPIAVEELDASHNSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 26/156 (16%), Positives = 49/156 (31%), Gaps = 30/156 (19%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
I + K+ L L + +N L L + +L+ L L +N+
Sbjct: 269 IMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL------------- 314
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPL 200
++ + L L L +NS+ + L++L LS+N + +
Sbjct: 315 ----------HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWDCNSLR 363
Query: 201 AL-QKFPPSSFEGNSMLCGPPLNQ----CSTVPPAP 231
AL + + + C C P
Sbjct: 364 ALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKP 399
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 2e-14
Identities = 21/133 (15%), Positives = 47/133 (35%), Gaps = 18/133 (13%)
Query: 92 LMILSLRSNHLSGDLPSNV--LSLSSLRFLYLQNNNFSGNIPSSL---SPQLNWVDLSFN 146
+ + + + D+ ++L++ + + +N+ +P++L Q+ ++L+
Sbjct: 27 CVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDL 85
Query: 147 SITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQ 203
I I + L + N++ P+ N+ L L L N L
Sbjct: 86 QIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND--------LS 136
Query: 204 KFPPSSFEGNSML 216
P F L
Sbjct: 137 SLPRGIFHNTPKL 149
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 62/322 (19%), Positives = 120/322 (37%), Gaps = 95/322 (29%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
+G+G++G ++A E T V VK LKE + +F+++ ++ +PN
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPN 111
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR-------------- 439
+V + L+++++ G + L L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 440 -----VKISLGSAKGIAH------IH---AAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485
+ I+ A G+A+ +H A N L+ +++ I+DFG
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLAT------------RNCLVGENMVVKIADFG 219
Query: 486 LT-PLMNTPTVPSRSAGYR------------APEVIETKKPTQKSDVYSFGVLLLEMLT- 531
L+ + + Y+ PE I + T +SDV+++GV+L E+ +
Sbjct: 220 LSRNIYSADY-------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272
Query: 532 GKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSEVFDVELMRYENIEEEMVQMLQIAMS 587
G P HE+V+ V+ E E+++ LMR
Sbjct: 273 GLQPYYGMAHEEVIYY---VRDGNILACPENCPLELYN--LMR----------------L 311
Query: 588 CVAKVPDMRPTMEEVVRMIEDI 609
C +K+P RP+ + R+++ +
Sbjct: 312 CWSKLPADRPSFCSIHRILQRM 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 34/142 (23%), Positives = 54/142 (38%), Gaps = 16/142 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SPQ 137
I + ++L L +L + + N L +L L + + N + +P
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVY 249
Query: 138 LNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHL 194
L +++LS+N I+ I S+ L L + L L P F L+ LR LN+S N
Sbjct: 250 LRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN-- 306
Query: 195 NGSVPLALQKFPPSSFEGNSML 216
L S F L
Sbjct: 307 ------QLTTLEESVFHSVGNL 322
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 9e-16
Identities = 29/139 (20%), Positives = 53/139 (38%), Gaps = 17/139 (12%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIP----SSLS 135
IP L +L L + N + L + L +L+ L + +N+ I S L
Sbjct: 95 IPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGL- 151
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNH 193
L + L ++T ++ +L L+ L L++ ++ L RL+ L +S+
Sbjct: 152 NSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211
Query: 194 LNGSVPLALQKFPPSSFEG 212
L P+ G
Sbjct: 212 Y-------LDTMTPNCLYG 223
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 28/133 (21%), Positives = 46/133 (34%), Gaps = 18/133 (13%)
Query: 91 SLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SPQLNWVDLSFN 146
+L L N + L + + L L L N S + L + L N
Sbjct: 33 ETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSN 90
Query: 147 SITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLNGSVPLALQ 203
+ IP + LS+L L++ N + + F +L L+ L + N L
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND--------LV 141
Query: 204 KFPPSSFEGNSML 216
+F G + L
Sbjct: 142 YISHRAFSGLNSL 154
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 33/122 (27%), Positives = 51/122 (41%), Gaps = 11/122 (9%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
+ N L L +L LS+ +L+ +P + L LRFL L N S I S+
Sbjct: 216 MTPNCLYGL-NLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELL 272
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNH 193
+L + L + + R L++L LN+ N LT + ++ L L L N
Sbjct: 273 RLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNP 331
Query: 194 LN 195
L
Sbjct: 332 LA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 25/106 (23%), Positives = 36/106 (33%), Gaps = 13/106 (12%)
Query: 114 SSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT 173
+ R + F +P + + +DL N I + HL L L N ++
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69
Query: 174 GFIPNF---NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
+ NL LR L L N L+ P F G S L
Sbjct: 70 -AVEPGAFNNLFNLRTLGLRSNR--------LKLIPLGVFTGLSNL 106
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 22/119 (18%), Positives = 53/119 (44%), Gaps = 5/119 (4%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
+E ++ L++ + H + + + + LS+L L + + + + +LS L +D+
Sbjct: 62 IEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLA 201
S ++ +I I L + ++L N I L L+ LN+ ++ ++ +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRGIE 178
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-18
Identities = 25/113 (22%), Positives = 53/113 (46%), Gaps = 3/113 (2%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
+ L +L L + ++ D N+ L+SL L + ++ +I + ++ P++N +DL
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNG 196
S+N +I ++ L L LN+Q + + + + +L L + G
Sbjct: 144 SYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-11
Identities = 17/96 (17%), Positives = 38/96 (39%), Gaps = 5/96 (5%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQL 138
L L SL +L + + + + + +L + + L N +I L P+L
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPEL 161
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTG 174
+++ F+ + + I + L L + ++ G
Sbjct: 162 KSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 23/124 (18%), Positives = 49/124 (39%), Gaps = 7/124 (5%)
Query: 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144
+ + L + + + ++SL ++ L N N + + + + ++
Sbjct: 18 PDSTFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVTDLTGIEYAHNIKDLTIN 74
Query: 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGF-IPNF-NLSRLRHLNLSYNHLNGSVPLAL 202
T N I LS+L L + +T IPN L+ L L++S++ + S+ +
Sbjct: 75 NIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 203 QKFP 206
P
Sbjct: 133 NTLP 136
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 45/139 (32%), Positives = 61/139 (43%), Gaps = 19/139 (13%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
I L +L L L N L+ +P+ LS L+ L+L+NN +IPS P
Sbjct: 103 IEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIP 160
Query: 137 QLNWVDLS-FNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNH 193
L +DL ++ I LS+L LNL +L IPN L +L L+LS NH
Sbjct: 161 SLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNH 218
Query: 194 LNGSVPLALQKFPPSSFEG 212
L P SF+G
Sbjct: 219 --------LSAIRPGSFQG 229
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 40/181 (22%), Positives = 68/181 (37%), Gaps = 18/181 (9%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQL 138
I E L +L L+L +L ++P+ + L L L L N+ S P S L
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLN- 195
+ + + I + NL LV +NL +N+LT + L L ++L +N N
Sbjct: 234 QKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293
Query: 196 --GSVPLA--LQKFPPSSFEGNSMLCGPPLNQ---CSTVPPA----PSPSATNFPPPPTV 244
+ L+ ++ PS+ + PP + + +P P V
Sbjct: 294 NCDILWLSWWIKDMAPSNTACCARCNTPPNLKGRYIGELDQNYFTCYAPVIVEPPADLNV 353
Query: 245 L 245
Sbjct: 354 T 354
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 37/139 (26%), Positives = 54/139 (38%), Gaps = 24/139 (17%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQ 137
I NT +L+L N + + N L L L L N+ + +
Sbjct: 62 ISTNTR-------LLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN 113
Query: 138 LNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYNH 193
LN ++L N +T IP LS L L L+NN + IP++ + LR L+L
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLG--E 169
Query: 194 LNGSVPLALQKFPPSSFEG 212
L L +FEG
Sbjct: 170 LK-----RLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 24/106 (22%), Positives = 35/106 (33%), Gaps = 13/106 (12%)
Query: 114 SSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT 173
+ + N +P +S ++L N I S ++L HL L L N +
Sbjct: 43 NQFSKVICVRKNLR-EVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
Query: 174 GFIPN---FNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
I L+ L L L N L P +F S L
Sbjct: 102 -TIEIGAFNGLANLNTLELFDNR--------LTTIPNGAFVYLSKL 138
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 24/211 (11%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVP---- 396
E++G G+YG YK ++ G +K + + E +Q++ ++ + S H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 397 -IRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
I+ D++L LV +F AGS + L+ +G L E I +G++H+H
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH 146
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS--AG---YRAPEVIE 509
K I +IK NVLL+++ + + DFG++ + TV R+ G + APEVI
Sbjct: 147 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIA 202
Query: 510 TKKPTQ-----KSDVYSFGVLLLEMLTGKAP 535
+ KSD++S G+ +EM G P
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-18
Identities = 37/116 (31%), Positives = 53/116 (45%), Gaps = 4/116 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L L +L LSL N L + SL++L L L NN S P S +L + L
Sbjct: 217 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGA 274
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
N I+ P + L+ L L L N L P NL L +L L +N+++ P++
Sbjct: 275 NQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS 328
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 33/116 (28%), Positives = 53/116 (45%), Gaps = 4/116 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L L L L L +N +S S + L++L L L N P S L ++ L F
Sbjct: 261 LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF 318
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
N+I+ P + +L+ L L NN ++ NL+ + L+ +N ++ PLA
Sbjct: 319 NNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTPLA 372
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-18
Identities = 33/118 (27%), Positives = 54/118 (45%), Gaps = 4/118 (3%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDL 143
TL L +L L L +N +S + + L+ L L L N S P + L ++L
Sbjct: 237 GTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLEL 294
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
+ N + P I NL +L L L N+++ P +L++L+ L N ++ LA
Sbjct: 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSSLA 350
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 31/117 (26%), Positives = 50/117 (42%), Gaps = 4/117 (3%)
Query: 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144
+ LD + L + V L++L + NN + P +L + ++
Sbjct: 41 SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMN 98
Query: 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
N I P + NL++L GL L NN +T P NL+ L L LS N ++ L+
Sbjct: 99 NNQIADITP--LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALS 153
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 30/119 (25%), Positives = 52/119 (43%), Gaps = 4/119 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L L +L L L N L S + +L +L +L L NN S P S +L +
Sbjct: 283 LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYN 340
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQK 204
N ++ +S+ NL+++ L+ +N ++ P NL+R+ L L+ +
Sbjct: 341 NKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQAWTNAPVNYKAN 397
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 33/118 (27%), Positives = 55/118 (46%), Gaps = 5/118 (4%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDL 143
+ L+ L +L L L SN +S S + L+SL+ L N + P + L +D+
Sbjct: 128 DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPLANLTTLERLDI 184
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
S N ++ + + L++L L NN ++ P L+ L L+L+ N L LA
Sbjct: 185 SSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLA 240
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 26/119 (21%), Positives = 43/119 (36%), Gaps = 8/119 (6%)
Query: 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142
T L M L +++ + L + L + L ++
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQIN 74
Query: 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
S N +T P ++NL+ LV + + NN + P NL+ L L L N + PL
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 131
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 28/135 (20%), Positives = 57/135 (42%), Gaps = 21/135 (15%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L+ L L+ + + +N ++ + + +L++L L L NN + P LN ++LS
Sbjct: 86 LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 143
Query: 146 NSITG-----------------NI--PASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRH 186
N+I+ + + NL+ L L++ +N ++ L+ L
Sbjct: 144 NTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLES 203
Query: 187 LNLSYNHLNGSVPLA 201
L + N ++ PL
Sbjct: 204 LIATNNQISDITPLG 218
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 31/118 (26%), Positives = 54/118 (45%), Gaps = 9/118 (7%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
L L SL LS N ++ + +L++L L + +N S S L+ L +
Sbjct: 152 LSGLTSLQQLSF-GNQVTD--LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIA 206
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
+ N I+ P + L++L L+L N L +L+ L L+L+ N ++ PL+
Sbjct: 207 TNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLS 262
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 17/110 (15%), Positives = 43/110 (39%), Gaps = 2/110 (1%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
+ L L L +N +S S++ +L+++ +L +N S P + ++ + L+
Sbjct: 327 VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGLND 384
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+ T N+S + +L + ++++N +
Sbjct: 385 QAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 25/110 (22%), Positives = 44/110 (40%), Gaps = 6/110 (5%)
Query: 96 SLRSNHLSGDLPSNVLS----LSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGN 151
L S ++ D P N + L+ L N + + + Q+ + I
Sbjct: 2 PLGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-- 59
Query: 152 IPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
+ L++L +N NN LT P NL++L + ++ N + PLA
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLA 109
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 21/123 (17%), Positives = 50/123 (40%), Gaps = 7/123 (5%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDL 143
++L L ++ LS N +S + + +L+ + L L + ++ N P + ++ +
Sbjct: 347 SSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNT 403
Query: 144 SFNSITGNI-PASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLNGSVPL 200
N I PA+I + ++ N + + + S+ + +G+V
Sbjct: 404 VKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQ 462
Query: 201 ALQ 203
L+
Sbjct: 463 PLK 465
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 50/237 (21%)
Query: 343 VLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM--EV-VGRLSQHPNVVPIR 398
LGKG +G Y A + + +K L + + K E Q+ EV + +HPN++ +
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKIS-LGSA------KGIA 451
Y+ L+ ++ G+ L + + + + + I+ L +A K +
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYREL---QKLSKFD-EQRTATYITELANALSYCHSKRVI 131
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN---------TPTVPSRSAGY 502
H IK N+LL + I+DFG + T Y
Sbjct: 132 HRD-----------IKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLD-------Y 173
Query: 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV--------VDLPRWV 551
PE+IE + +K D++S GVL E L GK P +A +++ P +V
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E LG+GSYG+ YKAI E G V +K++ V + + + + P+VV Y
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVV---KY 89
Query: 401 Y--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
Y + K+ L +V ++ AGS S ++ L + I + KG+ ++H
Sbjct: 90 YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHF-- 143
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFG----LTPLMN-------TPTVPSRSAGYRAPE 506
+ I +IK+ N+LL+ + ++DFG LT M TP + APE
Sbjct: 144 -MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-------WMAPE 195
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
VI+ +D++S G+ +EM GK P
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 7e-18
Identities = 46/281 (16%), Positives = 92/281 (32%), Gaps = 54/281 (19%)
Query: 342 EVLGKGSYGTTYKA--ILEEGTTVVVKRLKEV--VMGKREFEQQMEVVGRLSQHPNVVPI 397
+ G G Y A G VV+K L + + + + + HP++V I
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQI 144
Query: 398 RAYYFSKDEKL-------LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
+ F + +V +++ S L + L +
Sbjct: 145 --FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPAL 195
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIET 510
+++H+ + ++K N++L+++ Q + D G +N+ + G++APE++ T
Sbjct: 196 SYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRT 251
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570
PT +D+Y+ G L + + T + + L R
Sbjct: 252 G-PTVATDIYTVGRTLAALTLDLPTRNG-------RYVDGLPEDDPVLKTYDSYGRLLRR 303
Query: 571 YENIEEEMVQMLQIAMSCVAKVPDMRP-TMEEVVRMIEDIR 610
+ P R T EE M +
Sbjct: 304 -----------------AIDPDPRQRFTTAEE---MSAQLT 324
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 45/215 (20%), Positives = 82/215 (38%), Gaps = 39/215 (18%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
LG G++G YKA E G K ++ + E + HP +V
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIV---KL 81
Query: 401 Y--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
+ D KL ++ +F G+ A++ L + + + +H+
Sbjct: 82 LGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHS-- 135
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFG----LTPLMN-------TPTVPSRSAGY-RAP 505
+ I ++K+ NVL++ + ++DFG + TP Y AP
Sbjct: 136 -KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP--------YWMAP 186
Query: 506 EVIETKKPTQ-----KSDVYSFGVLLLEMLTGKAP 535
EV+ + K+D++S G+ L+EM + P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 9e-18
Identities = 59/307 (19%), Positives = 110/307 (35%), Gaps = 80/307 (26%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKR-LKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
++LG GS GT +G V VKR L + +++++ HPNV IR Y
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTESDDHPNV--IRYY 75
Query: 401 YFSKDEKLL----------VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
++ L + D +E+ + + + A G+
Sbjct: 76 CSETTDRFLYIALELCNLNLQDLVES-------KNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 451 AHIHAAVGGKFILG----NIKSSNVLLSQDLQGC-------------ISDFGL------- 486
AH+H+ L ++K N+L+S + ISDFGL
Sbjct: 129 AHLHS-------LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 487 ----TPLMNTPTVPSRSAGYRAPEVIE-------TKKPTQKSDVYSFGVLLLEMLTGKAP 535
+N P+ ++G+RAPE++E ++ T+ D++S G + +L+
Sbjct: 182 QSSFRTNLNNPS---GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 536 IQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDM 595
P + +F ++ M+ + + + + + P
Sbjct: 239 ------------PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLK 286
Query: 596 RPTMEEV 602
RPT +V
Sbjct: 287 RPTAMKV 293
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 29/127 (22%), Positives = 52/127 (40%), Gaps = 9/127 (7%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSPQLN 139
+ + + L L L L +N +S + S L L+ LY+ N+ IP +L L
Sbjct: 69 LRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLV 126
Query: 140 WVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLT-GFIPN--FNLSRLRHLNLSYNHLN 195
+ + N I +P + L ++ + + N L F+ +L +L +S L
Sbjct: 127 ELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185
Query: 196 GSVPLAL 202
+P L
Sbjct: 186 -GIPKDL 191
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 31/145 (21%), Positives = 53/145 (36%), Gaps = 26/145 (17%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIP----SSLS 135
IP + ++L L L N + + L S L L L +N I S L
Sbjct: 187 IPKDLP---ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFL- 240
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT--------GFIPNFNLSRLRHL 187
P L + L N ++ +PA + +L L + L N++T + +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 188 NLSYNHLNGSVPLALQKFPPSSFEG 212
+L N P+ + P++F
Sbjct: 300 SLFNN------PVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 38/175 (21%), Positives = 52/175 (29%), Gaps = 52/175 (29%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS----------------------LSSLRF 118
I L L L + NHL ++P N+ S L ++
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNC 151
Query: 119 LYLQNNN----------FSG--------------NIPSSLSPQLNWVDLSFNSITGNIPA 154
+ + N F G IP L LN + L N I I
Sbjct: 152 IEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQ-AIEL 210
Query: 155 -SIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLNGSVPLALQKFP 206
+ S L L L +N + L LR L+L N L+ VP L
Sbjct: 211 EDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLK 264
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 28/126 (22%), Positives = 49/126 (38%), Gaps = 17/126 (13%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS--PQ 137
I L + L L L N + + + LS L +LR L+L NN S +P+ L
Sbjct: 208 IELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKL 265
Query: 138 LNWVDLSFNSITGNIPASI-------RNLSHLVGLNLQNNSLTGF-IPN---FNLSRLRH 186
L V L N+IT + + ++ G++L NN + + + ++
Sbjct: 266 LQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLA 324
Query: 187 LNLSYN 192
+
Sbjct: 325 IQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 28/128 (21%), Positives = 41/128 (32%), Gaps = 14/128 (10%)
Query: 91 SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSI 148
L ++ L +P + L LQNN+ S L + L N I
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 149 TGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPS 208
+ + L L L + N L IP S L L + N ++K P
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVE-IPPNLPSSLVELRIHDNR--------IRKVPKG 141
Query: 209 SFEGNSML 216
F G +
Sbjct: 142 VFSGLRNM 149
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 4e-17
Identities = 55/239 (23%), Positives = 94/239 (39%), Gaps = 44/239 (18%)
Query: 343 VLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM--EV-VGRLSQHPNVVPIR 398
LGKG +G Y A + + +K L + + K E Q+ E+ + +HPN++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKIS-LGSA------KGIA 451
Y+ + L+ +F G L + GR + S + L A + +
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFD-EQRSATFMEELADALHYCHERKVI 136
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL---TPLMNTPTV---PSRSAGYRAP 505
H +IK N+L+ + I+DFG P + T+ Y P
Sbjct: 137 H-----------RDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLD----YLPP 181
Query: 506 EVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV--------VDLPRWVQSVVR 556
E+IE K +K D++ GVL E L G P +P H + + P ++ +
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSK 240
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 5e-17
Identities = 32/117 (27%), Positives = 51/117 (43%), Gaps = 6/117 (5%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSPQL 138
A ++ SL L + N +S D S SL L + +N + I L P++
Sbjct: 364 SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRI 423
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNLSYN 192
+DL N I +IP + L L LN+ +N L +P+ L+ L+ + L N
Sbjct: 424 KVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 30/133 (22%), Positives = 51/133 (38%), Gaps = 10/133 (7%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLS---- 135
+ K+ + L +N L+ D L+ L L LQ N +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQ 372
Query: 136 -PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNH 193
L +D+S NS++ + L+ LN+ +N LT I R++ L+L N
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNK 432
Query: 194 LNGSVPLALQKFP 206
+ S+P + K
Sbjct: 433 IK-SIPKQVVKLE 444
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 19/140 (13%), Positives = 40/140 (28%), Gaps = 8/140 (5%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFS----GNIPSSLSP 136
+ + + L L L N L + + +L+ L L N F ++
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNM-S 115
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNG 196
QL ++ LS + + I +L+ L + + L +L
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175
Query: 197 SVPLALQKFPPSSFEGNSML 216
+ + +
Sbjct: 176 KEFHFILDVSVKTVANLELS 195
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 36/205 (17%), Positives = 69/205 (33%), Gaps = 14/205 (6%)
Query: 7 FAALSFIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNGSR 66
A L + + + S ++L P L N+ + S++ I +
Sbjct: 189 VANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTT 248
Query: 67 VLAVRLPGVGLYGPIPANTLE----KLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQ 122
V + V L G + + L +L I + S+ S++
Sbjct: 249 VWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFT 308
Query: 123 NNN---FSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF 179
+ PS +S +D S N +T + + +L+ L L LQ N L +
Sbjct: 309 VSGTRMVHMLCPSKIS-PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKI 366
Query: 180 -----NLSRLRHLNLSYNHLNGSVP 199
+ L+ L++S N ++
Sbjct: 367 AEMTTQMKSLQQLDISQNSVSYDEK 391
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 35/128 (27%), Positives = 55/128 (42%), Gaps = 15/128 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQL 138
+ T L+ + N++S S++LSLS LR L + +N S +L
Sbjct: 19 LSQKT-TILN------ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT--GFIPNF-NLSRLRHLNLSYNHLN 195
++DLS N + I +L L+L N+ F N+S+L+ L LS HL
Sbjct: 72 EYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 196 GSVPLALQ 203
S L +
Sbjct: 129 KSSVLPIA 136
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 24/110 (21%), Positives = 45/110 (40%), Gaps = 7/110 (6%)
Query: 94 ILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGN 151
++ N L +P ++ L + N S S + +L + +S N I
Sbjct: 4 LVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 152 IPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
+ + L L+L +N L I L+HL+LS+N + ++P+
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVK-ISCHPTVNLKHLDLSFNAFD-ALPIC 108
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 42/224 (18%), Positives = 82/224 (36%), Gaps = 41/224 (18%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVV----- 395
VLG+G++G KA + +K+++ ++ ++ L H VV
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAA 70
Query: 396 -------PIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA 447
K L + ++ E G+ L+H + W +I
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI----L 126
Query: 448 KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSR-------- 498
+ +++IH+ I ++K N+ + + I DFGL + + +
Sbjct: 127 EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 499 ---------SAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTG 532
+A Y A EV++ +K D+YS G++ EM+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 34/128 (26%), Positives = 60/128 (46%), Gaps = 14/128 (10%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS-------- 135
+T+++ L L+L N L LP+++ SL+ LR L ++ +P L+
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 136 ---PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSY 191
L + L + I ++PASI NL +L L ++N+ L+ P +L +L L+L
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRG 238
Query: 192 NHLNGSVP 199
+ P
Sbjct: 239 CTALRNYP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 23/117 (19%), Positives = 44/117 (37%), Gaps = 7/117 (5%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWV 141
++ L +L L +R++ LS L + L L L L+ N P L +
Sbjct: 200 ASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 142 DLS-FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLN 195
L +++ +P I L+ L L+L+ +P+ L + + +
Sbjct: 259 ILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 27/121 (22%), Positives = 55/121 (45%), Gaps = 8/121 (6%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWV 141
+ L +L L L + LP+++ +L +L+ L ++N+ S + ++ P+L +
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQN-NSLTGFIPNF--NLSRLRHLNLSYNHLNGSV 198
DL + N P + L L L++ ++L +P L++L L+L +
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 199 P 199
P
Sbjct: 294 P 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 19/120 (15%), Positives = 40/120 (33%), Gaps = 10/120 (8%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNV--LSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWV 141
++ I + L + + L L++ P L +
Sbjct: 52 QANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHM 109
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVP 199
+ + +P +++ + L L L N L +P +L+RLR L++ +P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELP 167
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 17/117 (14%), Positives = 33/117 (28%), Gaps = 13/117 (11%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL----SPQLN 139
+ L + H + + ++ + L P
Sbjct: 30 DVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRTGRALK-ATADLLEDATQPGRV 84
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHL 194
++L + P LSHL + + L +P+ + L L L+ N L
Sbjct: 85 ALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPL 139
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 17/97 (17%), Positives = 33/97 (34%), Gaps = 2/97 (2%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWV 141
+ L L L LR + P + L+ L L++ + +P + QL +
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN 178
DL +P+ I L + + + +
Sbjct: 283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 52/321 (16%), Positives = 111/321 (34%), Gaps = 81/321 (25%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKRE---FEQQMEVVGRLSQHPNVVPIR 398
+ +G G ++ + E+ +K + + + ++ + +L Q + IR
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 92
Query: 399 AYYFSKDEKLLVYDFIEA--GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
Y + ++ + Y +E ++ L + +D R + + IH
Sbjct: 93 LYDYEITDQYI-YMVMECGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 457 VGGKFILGNIKSSNVLLSQDLQGC--ISDFGLTPLMNTPTVPSR------SAGYRAPEVI 508
+ ++K +N L+ G + DFG+ M T + Y PE I
Sbjct: 147 ---GIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200
Query: 509 E-----------TKKPTQKSDVYSFGVLLLEMLTGKAP-------------IQAPGHEDV 544
+ K + KSDV+S G +L M GK P I P HE
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-- 258
Query: 545 VDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
++ P + ++ ++++ L+ + P R ++ E++
Sbjct: 259 IEFPDIPEKDLQ----------DVLK---------CCLK-------RDPKQRISIPELLA 292
Query: 605 ---MIEDIRPSDSENQPSSED 622
+ P + + ++E+
Sbjct: 293 HPYVQIQTHPVNQMAKGTTEE 313
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-16
Identities = 29/146 (19%), Positives = 49/146 (33%), Gaps = 20/146 (13%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLP--SNVLSLSSLRFLYLQNNNFSGNIP----SSL 134
I + L++L L L + + L P + V S L + +N + +IP L
Sbjct: 96 IDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGL 154
Query: 135 SPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FN--LSRLRHLNLS 190
+ + L N T ++ N + L + L N I F S L++S
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213
Query: 191 YNHLNGSVPLALQKFPPSSFEGNSML 216
++ P E L
Sbjct: 214 QT--------SVTALPSKGLEHLKEL 231
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 26/141 (18%), Positives = 54/141 (38%), Gaps = 18/141 (12%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPS----SLS 135
+ +++ L + + +R+ + + L L L+FL + N P +
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYST 129
Query: 136 PQLNWVDLSFNSITGNIPA-SIRNL-SHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSY 191
++++ N +IP + + L + + L L NN T + FN ++L + L+
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188
Query: 192 NHLNGSVPLALQKFPPSSFEG 212
N L +F G
Sbjct: 189 NKY-------LTVIDKDAFGG 202
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 20/124 (16%), Positives = 41/124 (33%), Gaps = 11/124 (8%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
IP++ L ++ + + + L S+ LS + + ++N I P
Sbjct: 46 IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELP 105
Query: 137 QLNWVDLSFNSITGNIPA--SIRNLSHLVGLNLQNNSLTGFIPN--FN--LSRLRHLNLS 190
L ++ + + P + + L + +N IP F + L L
Sbjct: 106 LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLY 164
Query: 191 YNHL 194
N
Sbjct: 165 NNGF 168
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 22/95 (23%), Positives = 40/95 (42%), Gaps = 9/95 (9%)
Query: 81 IPANTLEKLDS-LMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIP----SSLS 135
IP N + L + + L L +N + + + + L +YL N + I +
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNN 170
+ +D+S S+T +P+ L HL L +N
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 20/105 (19%), Positives = 39/105 (37%), Gaps = 16/105 (15%)
Query: 113 LSSLRFLYLQNNNFSGNIPS-SLS--PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQ 168
S + L L + IPS + S P ++ + +S + + + NLS + + ++
Sbjct: 30 PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88
Query: 169 NNSLTGFIPN--F-NLSRLRHLNLSYNHLNGSVPLALQKFPPSSF 210
N +I L L+ L + L+ FP +
Sbjct: 89 NTRNLTYIDPDALKELPLLKFLGIFNTG--------LKMFPDLTK 125
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 50/225 (22%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKR-LKEVVMGKREFEQQMEVVGRLSQHPNVVPIRA 399
+ G+G++GT + G +V +K+ +++ RE + ++ + HPN+V +++
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDL--AVLHHPNIVQLQS 86
Query: 400 YYFSKDEK-------LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISL-GSAKGIA 451
Y+++ E+ +V +++ + R P +K+ L + I
Sbjct: 87 YFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI---LIKVFLFQLIRSIG 143
Query: 452 HIHAAVGGKFIL-GNIKSSNVLLSQDLQGC---ISDFGL----TPLM-NTPTVPSRSAGY 502
+H + +IK NVL+ + + DFG +P N + SR Y
Sbjct: 144 CLHLPSVN--VCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNVAYICSRY--Y 197
Query: 503 RAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
RAPE+I + T D++S G + EM+ G+ PI G ++
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI-FRG-DNSAG 239
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 35/133 (26%), Positives = 51/133 (38%), Gaps = 12/133 (9%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSN----VLSLSSLRFLYLQNNNF---SGNIPSS 133
+ +L L L N G+ L +L+ L L+N SG +
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223
Query: 134 LS--PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLS 190
+ QL +DLS NS+ A S L LNL L +P ++L L+LS
Sbjct: 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPAKLSVLDLS 282
Query: 191 YNHLNGSVPLALQ 203
YN L+ P +
Sbjct: 283 YNRLD-RNPSPDE 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 31/126 (24%), Positives = 53/126 (42%), Gaps = 9/126 (7%)
Query: 75 VGLYGPIPANTLEKLDSLMILSLRSNH---LSGDLPSNVLSLSSLRFLYLQNNNFSGNIP 131
+G G I A K +L +L+LR+ SG + + L+ L L +N+
Sbjct: 186 LGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245
Query: 132 S---SLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLN 188
+ QLN ++LSF + +P + + L L+L N L L ++ +L+
Sbjct: 246 APSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDRNPSPDELPQVGNLS 302
Query: 189 LSYNHL 194
L N
Sbjct: 303 LKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 36/207 (17%), Positives = 63/207 (30%), Gaps = 21/207 (10%)
Query: 22 DLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTK---NGSRVLAVRLPGVGLY 78
D +A L ++ + L + + + S + + L + +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 79 GPIPANTLE-KLDSLMILSLRSNHLSGDLPS----NVLSLSSLRFLYLQNNNFSGNIPSS 133
G P LE L IL+LR+ + L+ L + + N
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFSCE 167
Query: 134 LS---PQLNWVDLSFNSITGNIP----ASIRNLSHLVGLNLQNNSLTGFIPNF-----NL 181
P L+ +DLS N G L L L+N +
Sbjct: 168 QVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR 227
Query: 182 SRLRHLNLSYNHLNGSVPLALQKFPPS 208
+L+ L+LS+N L + +P
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 26/161 (16%), Positives = 47/161 (29%), Gaps = 21/161 (13%)
Query: 72 LPGVGLYGPIPANTLEKLD--SLMILSLRSNHLSGDLPSNVLSLS--SLRFLYLQNN--- 124
+ + I L L L L+L + ++G P +L + L L L+N
Sbjct: 75 VRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWA 134
Query: 125 ---NFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFN- 180
+ + L P L + ++ +R L L+L +N G +
Sbjct: 135 TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194
Query: 181 -----LSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
L+ L L + + L
Sbjct: 195 LCPLKFPTLQVLALRNAGME-----TPSGVCSALAAARVQL 230
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 32/124 (25%), Positives = 45/124 (36%), Gaps = 13/124 (10%)
Query: 91 SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS------PQLNWVDLS 144
L +LS+ H V +L L L +N G + P L + L
Sbjct: 150 GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALR 209
Query: 145 FN---SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFN---LSRLRHLNLSYNHLNGSV 198
+ +G A L GL+L +NSL + S+L LNLS+ L V
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QV 268
Query: 199 PLAL 202
P L
Sbjct: 269 PKGL 272
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 8e-12
Identities = 22/96 (22%), Positives = 34/96 (35%), Gaps = 4/96 (4%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSPQL 138
+ + L L L N L + S L L L +P L +L
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPAKL 276
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTG 174
+ +DLS+N + P S L + L+L+ N
Sbjct: 277 SVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 16/74 (21%), Positives = 24/74 (32%), Gaps = 3/74 (4%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP 136
L A + + L L+L L +P + + L L L N N P
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLDRNPSPDELP 296
Query: 137 QLNWVDLSFNSITG 150
Q+ + L N
Sbjct: 297 QVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 20/106 (18%), Positives = 35/106 (33%), Gaps = 21/106 (19%)
Query: 91 SLMILSLRSNHLSGDLP-SNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSIT 149
SL L R + + ++++ SL+ L ++ I L
Sbjct: 44 SLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLG---------- 93
Query: 150 GNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+S L L L+N +TG P L +L+ +L
Sbjct: 94 ---------ISGLQELTLENLEVTGTAP-PPLLEATGPDLNILNLR 129
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQ--QMEV-VGRLSQHPNVVPI 397
+G GS+G Y A + V +K++ E Q EV + +HPN +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI-- 117
Query: 398 RAYY--FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
Y + ++ LV ++ GS S LL ++ PL ++ G+ +G+A++H
Sbjct: 118 -QYRGCYLREHTAWLVMEYC-LGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH 171
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN-------TPTVPSRSAGYRAPEV 507
+ I ++K+ N+LLS+ + DFG +M TP + APEV
Sbjct: 172 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY-------WMAPEV 221
Query: 508 IETKKPTQ---KSDVYSFGVLLLEMLTGKAP 535
I Q K DV+S G+ +E+ K P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 32/143 (22%), Positives = 51/143 (35%), Gaps = 16/143 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS---P 136
I ++ L SL L L N+LS +L S+ LSSL FL L N + +SL
Sbjct: 91 IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT 149
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNH 193
+L + + I L+ L L + + L + P ++ + HL L
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209
Query: 194 LNGSVPLALQKFPPSSFEGNSML 216
+ S +
Sbjct: 210 --------HILLLEIFVDVTSSV 224
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 7e-15
Identities = 23/129 (17%), Positives = 46/129 (35%), Gaps = 17/129 (13%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS---- 135
+L+ + ++ L L L + SS+ L L++ + S LS
Sbjct: 189 YEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGET 247
Query: 136 ------PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRH 186
V ++ S+ + + +S L+ L N L +P+ L+ L+
Sbjct: 248 NSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQK 305
Query: 187 LNLSYNHLN 195
+ L N +
Sbjct: 306 IWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 35/140 (25%), Positives = 56/140 (40%), Gaps = 18/140 (12%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SP 136
I + L++ +L L L SN ++ + + S L SL L L N S N+ SS
Sbjct: 67 ISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLS 124
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYN 192
L +++L N S+ +L+ L L + N I F L+ L L + +
Sbjct: 125 SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 193 HLNGSVPLALQKFPPSSFEG 212
LQ + P S +
Sbjct: 185 D--------LQSYEPKSLKS 196
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 23/143 (16%), Positives = 51/143 (35%), Gaps = 11/143 (7%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIP----SSLS 135
+ ++ + L SL L+L N +++ S L+ L+ L + N + I + L
Sbjct: 115 LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL- 173
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNH 193
L +++ + + P S++++ ++ L L + F S + L L
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTD 233
Query: 194 LNGSVPLALQKFPPSSFEGNSML 216
L+ +
Sbjct: 234 LDT---FHFSELSTGETNSLIKK 253
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 34/129 (26%), Positives = 52/129 (40%), Gaps = 15/129 (11%)
Query: 92 LMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGN 151
++ + S LS + + + +IPS L+ + +DLS N IT
Sbjct: 9 WVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGLTEAVKSLDLSNNRIT-Y 66
Query: 152 IPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYNHLNGSVPLALQKFPP 207
I S + +L L L +N + I F +L L HL+LSYN+ L
Sbjct: 67 ISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY--------LSNLSS 117
Query: 208 SSFEGNSML 216
S F+ S L
Sbjct: 118 SWFKPLSSL 126
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 77.8 bits (191), Expect = 4e-15
Identities = 59/291 (20%), Positives = 103/291 (35%), Gaps = 45/291 (15%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEV-VGRLSQHPNVVPIRA 399
E LG G +G + I + G V +K+ ++ + K +E+ + + HPNVV R
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 400 YYFSK------DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKIS-LGSAKGIAH 452
D LL ++ E G L+ + R +S + SA + +
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK-EGPIRTLLSDISSA--LRY 136
Query: 453 IHAAVGGKFILGNI-----KSSNVLLSQDLQGC---ISDFGLTPLMNTPTVPSRSAG--- 501
+H I K N++L Q I D G ++ + + G
Sbjct: 137 LHEN--------RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGH----------EDVVDLPRWV 551
Y APE++E KK T D +SFG L E +TG P + + +
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 552 QSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEV 602
+++S + + ++ + LQ + R T +
Sbjct: 249 DLTGAVKFSSVLPT-PNHLSGILAGKLERWLQCMLMW---HQRQRGTDPQN 295
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 5e-15
Identities = 21/107 (19%), Positives = 45/107 (42%), Gaps = 11/107 (10%)
Query: 89 LDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSI 148
+ +L++ + L+ LP + + + L + +NN + ++P+ P+L +++S N +
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALP-PELRTLEVSGNQL 93
Query: 149 TGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
T ++P L L + L L L + N L
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALPSG-----LCKLWIFGNQLT 134
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 30/116 (25%), Positives = 48/116 (41%), Gaps = 13/116 (11%)
Query: 89 LDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSI 148
L LS+ N L+ LP+ S L L+ NN + ++P S L + +S N +
Sbjct: 140 PPGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLT-SLPMLPS-GLQELSVSDNQL 193
Query: 149 TGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQK 204
++P L L N + SL L+ L +S N L S+P+ +
Sbjct: 194 A-SLPTLPSELYKLWAYNNRLTSLPALPSG-----LKELIVSGNRLT-SLPVLPSE 242
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 12/108 (11%)
Query: 87 EKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFN 146
L LS+ N L+ LP+ S L L+ NN + ++P+ S L + +S N
Sbjct: 178 MLPSGLQELSVSDNQLA-SLPT---LPSELYKLWAYNNRLT-SLPALPS-GLKELIVSGN 231
Query: 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
+T ++P L L + N LT +P S L L++ N L
Sbjct: 232 RLT-SLPVLPSELKEL---MVSGNRLTS-LPM-LPSGLLSLSVYRNQL 273
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 6e-12
Identities = 27/116 (23%), Positives = 42/116 (36%), Gaps = 13/116 (11%)
Query: 87 EKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFN 146
L L + N L+ LP L L + +PS L +L + N
Sbjct: 78 ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLC-KL---WIFGN 131
Query: 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLAL 202
+T ++P L L++ +N L +P S L L N L S+P+
Sbjct: 132 QLT-SLPVLPPGLQE---LSVSDNQLAS-LPA-LPSELCKLWAYNNQLT-SLPMLP 180
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 17/81 (20%), Positives = 36/81 (44%), Gaps = 6/81 (7%)
Query: 122 QNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNL 181
+ + L+ +++ + +T +P + +H+ L + +N+LT +P
Sbjct: 26 GRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA-LP 80
Query: 182 SRLRHLNLSYNHLNGSVPLAL 202
LR L +S N L S+P+
Sbjct: 81 PELRTLEVSGNQLT-SLPVLP 100
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 19/109 (17%), Positives = 31/109 (28%), Gaps = 28/109 (25%)
Query: 87 EKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFN 146
L L + N L+ LP S L L + N +
Sbjct: 238 VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT------------------- 274
Query: 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+P S+ +LS +NL+ N L+ L + +
Sbjct: 275 ----RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPII 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 52/321 (16%), Positives = 111/321 (34%), Gaps = 81/321 (25%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKRE---FEQQMEVVGRLSQHPNVVPIR 398
+ +G G ++ + E+ +K + + + ++ + +L Q + IR
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 73
Query: 399 AYYFSKDEKLLVYDFIEA--GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
Y + ++ + Y +E ++ L + +D R + + IH
Sbjct: 74 LYDYEITDQYI-YMVMECGNIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIHQH 127
Query: 457 VGGKFILGNIKSSNVLLSQDLQGC--ISDFGLTPLMNTPTVPSR------SAGYRAPEVI 508
+ ++K +N L+ G + DFG+ M T + Y PE I
Sbjct: 128 ---GIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181
Query: 509 E-----------TKKPTQKSDVYSFGVLLLEMLTGKAP-------------IQAPGHEDV 544
+ K + KSDV+S G +L M GK P I P HE
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE-- 239
Query: 545 VDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
++ P + ++ ++++ L+ + P R ++ E++
Sbjct: 240 IEFPDIPEKDLQ----------DVLK---------CCLK-------RDPKQRISIPELLA 273
Query: 605 ---MIEDIRPSDSENQPSSED 622
+ P + + ++E+
Sbjct: 274 HPYVQIQTHPVNQMAKGTTEE 294
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 33/151 (21%), Positives = 56/151 (37%), Gaps = 21/151 (13%)
Query: 82 PANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---SPQ 137
T +L +L L L NHL+ + S + +LR+L L +N+ + L
Sbjct: 56 AEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQA 113
Query: 138 LNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTG-----FIPNFNLSRLRHLNLSY 191
L + L N I + + +++ L L L N ++ L +L L+LS
Sbjct: 114 LEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSS 172
Query: 192 NHLNGSVPLALQKFPPSSFEGNSMLCGPPLN 222
N L+K P + + L
Sbjct: 173 NK--------LKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 37/165 (22%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIP----SSLS 135
+P+ T LD L N+LS + L++L L L +N+ + I +
Sbjct: 37 LPSYT-ALLD------LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV- 87
Query: 136 PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSY 191
P L ++DLS N + + + +L L L L NN + + F ++++L+ L LS
Sbjct: 88 PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145
Query: 192 NHLNGSVPLALQKFPPSSFEGNSMLCGPPL-------NQCSTVPP 229
N + +FP + + L P L N+ +P
Sbjct: 146 NQ--------ISRFPVELIKDGNKL--PKLMLLDLSSNKLKKLPL 180
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 29/103 (28%), Positives = 44/103 (42%), Gaps = 13/103 (12%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIP-------S 132
+ L +L +L L +NH+ + N ++ L+ LYL N S P +
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGN 160
Query: 133 SLSPQLNWVDLSFNSITGNIPASIRNLSHLV--GLNLQNNSLT 173
L P+L +DLS N + ++ L V GL L NN L
Sbjct: 161 KL-PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 27/92 (29%), Positives = 40/92 (43%), Gaps = 15/92 (16%)
Query: 130 IPSSLSPQLNWVDLSFNSITGNIPASI--RNLSHLVGLNLQNNSLTGFIPN--F-NLSRL 184
+P SL +DLS N+++ + A L++L L L +N L FI + F + L
Sbjct: 33 VPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNL 90
Query: 185 RHLNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
R+L+LS NH L F L
Sbjct: 91 RYLDLSSNH--------LHTLDEFLFSDLQAL 114
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 35/158 (22%), Positives = 53/158 (33%), Gaps = 20/158 (12%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNV-LSLSSLRFLYLQNNNFSGNIPS----SLS 135
I + L +L L + + + LP + L +Q+N I LS
Sbjct: 95 INPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNL-QNNSLTGFIPN--F-NLSRLRHLNLSY 191
+ + L+ N I I S N + L LNL NN+L +PN F S L++S
Sbjct: 154 FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISR 211
Query: 192 NHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPP 229
+ P E L +P
Sbjct: 212 TR--------IHSLPSYGLENLKKLRARSTYNLKKLPT 241
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 30/147 (20%), Positives = 54/147 (36%), Gaps = 12/147 (8%)
Query: 81 IPANTLEKL-DSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SP 136
I N+ L +IL L N + ++ ++ + + L L L +NN +P+ + +
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGAS 202
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYN-H 193
+D+S I ++P+ NL L + N +P L L +L+Y H
Sbjct: 203 GPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKK---LPTLEKLVALMEASLTYPSH 258
Query: 194 LNGSVPLALQKFPPSSFEGNSMLCGPP 220
Q S+L
Sbjct: 259 CCAFANWRRQISELHPICNKSILRQEV 285
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 4e-11
Identities = 22/133 (16%), Positives = 47/133 (35%), Gaps = 19/133 (14%)
Query: 91 SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SPQLNWVDLSFNS 147
S + + + ++ ++PS++ + L I L +++S N
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQND 65
Query: 148 ITGNIPASI-RNLSHLVGLNLQN-NSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQ 203
+ I A + NL L + ++ N+L P NL L++L +S ++
Sbjct: 66 VLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTG--------IK 117
Query: 204 KFPPSSFEGNSML 216
P +
Sbjct: 118 HLPDVHKIHSLQK 130
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 28/145 (19%), Positives = 51/145 (35%), Gaps = 18/145 (12%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS---P 136
I L + + N + + ++V S L L + ++ N I P
Sbjct: 45 IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLP 104
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN---FNLS-RLRHLNLSY 191
L ++ +S I ++P + V L++Q+N I LS L L+
Sbjct: 105 NLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163
Query: 192 NHLNGSVPLALQKFPPSSFEGNSML 216
N +Q+ S+F G +
Sbjct: 164 NG--------IQEIHNSAFNGTQLD 180
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 51/236 (21%), Positives = 93/236 (39%), Gaps = 42/236 (17%)
Query: 332 DLEDLLRASAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ 390
+ D + S +VLG G G + G +K L + ++E ++ + S
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE----VDHHWQASG 80
Query: 391 HPNVVPIRAYY----FSKDEKLLVYDFIEAGS-FSALLHGNRGIGR-TPLDWE---SRVK 441
P++V I Y K L++ + +E G FS + RG T E + +
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ--ERGDQAFT----EREAAEIM 134
Query: 442 ISLGSA------KGIAHIHAAVGGKFILGNIKSSNVLL---SQDLQGCISDFGLTPLMNT 492
+G+A IAH ++K N+L +D ++DFG
Sbjct: 135 RDIGTAIQFLHSHNIAH-----------RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 493 PTVPSR--SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
+ + + Y APEV+ +K + D++S GV++ +L G P + + +
Sbjct: 184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP 239
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 52/310 (16%), Positives = 113/310 (36%), Gaps = 59/310 (19%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKRE---FEQQMEVVGRLSQHPNVVPIR 398
+ +G G ++ + E+ +K + + + ++ + +L Q + IR
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQHSDKIIR 120
Query: 399 AYYFSKDEKLLVYDFIEA--GSFSALLHGNRGIGRTPLDWESRVKIS--LGSAKGIAHIH 454
Y + ++ + Y +E ++ L + I WE + L + + IH
Sbjct: 121 LYDYEITDQYI-YMVMECGNIDLNSWLKKKKSID----PWERKSYWKNML---EAVHTIH 172
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGC--ISDFGLTPLMNTPTVPSR------SAGYRAPE 506
+ ++K +N L+ G + DFG+ M T + Y PE
Sbjct: 173 QH---GIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 507 VIE-----------TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV 555
I+ K + KSDV+S G +L M GK P Q + + +
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--------QIINQISKLH 278
Query: 556 REEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR---MIEDIRPS 612
+ + + E+++ +L+ C+ + P R ++ E++ + P
Sbjct: 279 AIIDPNHEIEF----PDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHPYVQIQTHPV 331
Query: 613 DSENQPSSED 622
+ + ++E+
Sbjct: 332 NQMAKGTTEE 341
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 56/287 (19%), Positives = 111/287 (38%), Gaps = 69/287 (24%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM--EV-VGRLSQHPNVVPIRA 399
LGKGS+ Y+A + G V +K + + M K Q++ EV + +HP+++ +
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 400 YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLD-WESRVKIS-LGSA------KGIA 451
Y+ + LV + G + L P E+R + + + GI
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQIITGMLYLHSHGIL 134
Query: 452 HIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR------SAGYRAP 505
H ++ SN+LL++++ I+DFGL + P + + Y +P
Sbjct: 135 H-----------RDLTLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISP 181
Query: 506 EVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED--------VVDLPRWVQSVVRE 557
E+ +SDV+S G + +L G+ P ++ ++P ++ +
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK- 240
Query: 558 EWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+L+ Q+L+ + P R ++ V+
Sbjct: 241 ---------DLIH---------QLLR-------RNPADRLSLSSVLD 262
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 59/275 (21%), Positives = 109/275 (39%), Gaps = 42/275 (15%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKRE---FEQQMEVVGRLSQHPNVVPI 397
+ LG G+YG +K +++ + +++ V+ L HPN++ +
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKL 101
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
++ K LV + + G L I R + I G+ ++H
Sbjct: 102 YDFFEDKRNYYLVMECYKGGE---LFD--EIIHRMKFNEVDAAVIIKQVLSGVTYLHKH- 155
Query: 458 GGKFILGNIKSSNVLLSQDLQGC---ISDFGLTPLMNTPTVPSR---SAGYRAPEVIETK 511
+ ++K N+LL + I DFGL+ + +A Y APEV+ K
Sbjct: 156 --NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-K 212
Query: 512 KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571
K +K DV+S GV+L +L G P +++ ++ V + ++T FD +
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI------LRKVEKGKYT---FDSP--EW 261
Query: 572 ENIEEE----MVQMLQIAMSCVAKVPDMRPTMEEV 602
+N+ E + QMLQ R + ++
Sbjct: 262 KNVSEGAKDLIKQMLQ-------FDSQRRISAQQA 289
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 27/112 (24%), Positives = 44/112 (39%), Gaps = 9/112 (8%)
Query: 84 NTLEKL-DSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVD 142
L L L L + +N L LP + + S L+ + + NN+ +P P L ++
Sbjct: 124 KALSDLPPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLP-PSLEFIA 179
Query: 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
N + +P ++NL L + NNSL L + N L
Sbjct: 180 AGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLPD--LPLSLESIVAGNNIL 227
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 26/128 (20%), Positives = 42/128 (32%), Gaps = 22/128 (17%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLS-------------SLRFLYLQNNNFS 127
+P E + S + + P L L N S
Sbjct: 26 MPVE-AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 128 GNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHL 187
++P P L + S NS+T +P ++L L+ N +L+ P L +L
Sbjct: 85 -SLPELP-PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-----LEYL 136
Query: 188 NLSYNHLN 195
+S N L
Sbjct: 137 GVSNNQLE 144
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 27/109 (24%), Positives = 48/109 (44%), Gaps = 10/109 (9%)
Query: 87 EKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFN 146
+ SL + +N L +LP + +L L +Y NN +P P L +++ N
Sbjct: 212 DLPLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLP-PSLEALNVRDN 267
Query: 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+T ++P ++L+ L + L+ PN L +LN S N +
Sbjct: 268 YLT-DLPELPQSLTFLDVSENIFSGLSELPPN-----LYYLNASSNEIR 310
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 28/125 (22%), Positives = 38/125 (30%), Gaps = 22/125 (17%)
Query: 87 EKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS----SLS------- 135
E L L N L+ +LP SL SL S P +S
Sbjct: 88 ELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKL 146
Query: 136 ------PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNL 189
L +D+ NS+ +P +L + NN L NL L +
Sbjct: 147 PELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLEELPELQNLPFLTAIYA 202
Query: 190 SYNHL 194
N L
Sbjct: 203 DNNSL 207
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 25/133 (18%), Positives = 49/133 (36%), Gaps = 24/133 (18%)
Query: 89 LDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSS--------------- 133
L S++L+ ++P ++ S Y + + N P
Sbjct: 10 NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 134 LSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSY 191
L Q + ++L+ ++ ++P +L L NSLT +P +L L N +
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNL 123
Query: 192 NHLNGSVPLALQK 204
L+ +P L+
Sbjct: 124 KALS-DLPPLLEY 135
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-12
Identities = 21/134 (15%), Positives = 46/134 (34%), Gaps = 25/134 (18%)
Query: 87 EKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFN 146
+ SL L++ +N L +LP+ L L N+ + +P L + + +N
Sbjct: 314 DLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPELPQ-NLKQLHVEYN 367
Query: 147 SITGNIPASIRNL----------------SHLVGLNLQNNSLTGFIPNFNLSRLRHLNLS 190
+ P ++ +L L+++ N L P+ + L ++
Sbjct: 368 PLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPD-IPESVEDLRMN 424
Query: 191 YNHLNGSVPLALQK 204
+ A +
Sbjct: 425 SERVVDPYEFAHET 438
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 27/109 (24%), Positives = 42/109 (38%), Gaps = 12/109 (11%)
Query: 87 EKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFN 146
E SL L + N SG L +L +L +N ++ P L +++S N
Sbjct: 274 ELPQSLTFLDVSENIFSG-LSE---LPPNLYYLNASSNEIR-SLCDLP-PSLEELNVSNN 327
Query: 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+ +PA L L N L +P L+ L++ YN L
Sbjct: 328 KLI-ELPALPPRLERL---IASFNHLA-EVPE-LPQNLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 18/103 (17%), Positives = 30/103 (29%), Gaps = 19/103 (18%)
Query: 107 PSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLS---- 160
P N +S + L+ ++N + +P +++ N P
Sbjct: 5 PRN-VSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 161 ---------HLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
L L N L+ +P L L S N L
Sbjct: 63 SRLRDCLDRQAHELELNNLGLS-SLPE-LPPHLESLVASCNSL 103
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 11/92 (11%), Positives = 30/92 (32%), Gaps = 7/92 (7%)
Query: 84 NTLEKLDSLM--ILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWV 141
N L + + + LR N ++P +L+ L+++ N P + +
Sbjct: 367 NPLREFPDIPESVEDLRMNSHLAEVPE---LPQNLKQLHVETNPLR-EFPDIPE-SVEDL 421
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLT 173
++ + + L +++
Sbjct: 422 RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 37/172 (21%), Positives = 55/172 (31%), Gaps = 13/172 (7%)
Query: 70 VRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNF-S 127
+++ I NT L SL+IL L N L + L++L L L N
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDG 117
Query: 128 GNIPSSL---SPQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLT----GFIPNF 179
+ + L + L N+I PAS N+ L+L N + + NF
Sbjct: 118 AVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNF 177
Query: 180 NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPL--NQCSTVPP 229
L LS L L + N+ + L N
Sbjct: 178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA 229
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 25/124 (20%), Positives = 46/124 (37%), Gaps = 18/124 (14%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSL---S 135
+PA+ + L N ++ +L S L L+FL ++ I ++
Sbjct: 27 ELPAHV-------NYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGL 78
Query: 136 PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTG-FIPNF---NLSRLRHLNLS 190
L + L +N + L++L L L +L G + L+ L L L
Sbjct: 79 SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 191 YNHL 194
N++
Sbjct: 138 DNNI 141
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 30/120 (25%), Positives = 49/120 (40%), Gaps = 12/120 (10%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSL---SP 136
+ + L L+L N ++ + N L+ L L L N +I S +
Sbjct: 290 LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLD 347
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYN 192
+L +DLS+N I + L +L L L N L +P+ F L+ L+ + L N
Sbjct: 348 KLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 31/155 (20%), Positives = 49/155 (31%), Gaps = 31/155 (20%)
Query: 79 GPIPANTLEKLDSLMILSLRSNHLSGDLPS---NVLSLSSLRFLYLQNNN-----FSGNI 130
G K S+ L L N + + ++ + ++ L L N+ F
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTN 260
Query: 131 PSSLS---------PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN-- 178
+ DLS + I + S+ + + L L L N + I +
Sbjct: 261 FKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNA 318
Query: 179 F-NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEG 212
F L+ L LNLS N L FE
Sbjct: 319 FWGLTHLLKLNLSQNF--------LGSIDSRMFEN 345
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 27/178 (15%), Positives = 56/178 (31%), Gaps = 32/178 (17%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSL---- 134
+ N + L SL +L LR N++ P++ ++ L L N +I
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNF 177
Query: 135 -SPQLNWVDLSFN--------SITGNIPASIRNLSHLVGLNLQNNSLT-----GFIPNFN 180
+ LS + + + + L+L N F
Sbjct: 178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIA 237
Query: 181 LSRLRHLNLSYNHLNGSV--PLALQKFPPSSFEGNSMLCGPPL-------NQCSTVPP 229
++++ L LS ++ GS + +F+G L + ++ +
Sbjct: 238 GTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG---LEASGVKTCDLSKSKIFALLK 292
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 23/100 (23%), Positives = 44/100 (44%), Gaps = 13/100 (13%)
Query: 105 DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASI-RNLSH 161
+LP++ + ++ L N+ + +S S L ++ + + I + R LS
Sbjct: 27 ELPAH------VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 162 LVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYNHLNGSV 198
L+ L L N + F L+ L L L+ +L+G+V
Sbjct: 81 LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAV 119
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 27/90 (30%), Positives = 36/90 (40%), Gaps = 12/90 (13%)
Query: 130 IPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRH 186
+P L +N+VDLS NSI S L L L ++ + I N F LS L
Sbjct: 25 VPE-LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII 83
Query: 187 LNLSYNHLNGSVPLALQKFPPSSFEGNSML 216
L L YN + +F G + L
Sbjct: 84 LKLDYNQ--------FLQLETGAFNGLANL 105
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 12/47 (25%), Positives = 24/47 (51%), Gaps = 2/47 (4%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNF 126
+ + L +L L+L +N L +P + L+SL+ ++L N +
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 62/276 (22%), Positives = 111/276 (40%), Gaps = 43/276 (15%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM----EVVGRLSQHPNVVP 396
VLGKGS+G G VK + + + ++ ++ + +++ +L HPN++
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMK 90
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ ++ K LV + G L I R +I GI ++H
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGE---LFD--EIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 457 VGGKFILGNIKSSNVLLSQDLQGC---ISDFGLTPLMNTPTVPSR---SAGYRAPEVIET 510
K + ++K N+LL + I DFGL+ +A Y APEV+
Sbjct: 146 ---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH- 201
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570
+K DV+S GV+L +L+G P D+ ++ V + + + EL +
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI------LKKVEKGK-----YTFELPQ 250
Query: 571 YENIEEE----MVQMLQIAMSCVAKVPDMRPTMEEV 602
++ + E + +ML VP MR + +
Sbjct: 251 WKKVSESAKDLIRKMLT-------YVPSMRISARDA 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 41/239 (17%), Positives = 75/239 (31%), Gaps = 45/239 (18%)
Query: 387 RLSQHPNVVPIRAYYFSKDEKLLVY---DFIEAGSFSALLHGNRGIGRTPLDWESRVKIS 443
R + K+ +Y + + NR + + I
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSLEDREHGVCLHIF 170
Query: 444 LGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSRSAG- 501
+ A+ + +H+ + ++K SN+ + D + DFGL T + +
Sbjct: 171 IQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227
Query: 502 --------------YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547
Y +PE I + K D++S G++L E+L + E V +
Sbjct: 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF----STQMERVRII 283
Query: 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMV-QMLQIAMSCVAKVPDMRPTMEEVVRM 605
VR +F + E MV ML P RP +++
Sbjct: 284 TD-----VRNLKFPLLFT----QKYPQEHMMVQDMLS-------PSPTERPEATDIIEN 326
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 33/116 (28%), Positives = 54/116 (46%), Gaps = 4/116 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L+ L + L L N L ++ S + L S++ L L + + P + L + L
Sbjct: 81 LKNLTKITELELSGNPLK-NV-SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
N IT NI + L++L L++ N ++ P NLS+L L N ++ PLA
Sbjct: 139 NQIT-NISP-LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 28/116 (24%), Positives = 54/116 (46%), Gaps = 4/116 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
+ L S+ L L S ++ + + LS+L+ LYL N + P + L ++ +
Sbjct: 103 IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGN 160
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
++ ++ + NLS L L +N ++ P +L L ++L N ++ PLA
Sbjct: 161 AQVS-DLTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSPLA 214
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 20/116 (17%), Positives = 43/116 (37%), Gaps = 4/116 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L + + ++ ++++ L + L + L ++L
Sbjct: 15 DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKD 72
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
N IT ++ ++NL+ + L L N L L ++ L+L+ + PLA
Sbjct: 73 NQIT-DLAP-LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 27/119 (22%), Positives = 56/119 (47%), Gaps = 4/119 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L L +L +L L N ++ ++ S + L++L++L + N S P + +L +
Sbjct: 125 LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQK 204
N I+ +I + +L +L+ ++L+NN ++ P N S L + L+ +
Sbjct: 183 NKIS-DISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFYNNN 239
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 28/120 (23%), Positives = 52/120 (43%), Gaps = 10/120 (8%)
Query: 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144
T LD + LS ++ + V L++L L L++N + P ++ ++LS
Sbjct: 36 TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELS 93
Query: 145 FNSITGNIPASIRNLSHLVGL---NLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
N + ++ ++ L + +L + +T P LS L+ L L N + PLA
Sbjct: 94 GNPLK-----NVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLA 148
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 31/107 (28%), Positives = 50/107 (46%), Gaps = 5/107 (4%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L L +L LS+ + +S DL + + +LS L L +N S P + P L V L
Sbjct: 147 LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKN 204
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYN 192
N I+ ++ + N S+L + L N ++T P F + L N+
Sbjct: 205 NQIS-DVSP-LANTSNLFIVTLTNQTITN-QPVFYNNNLVVPNVVKG 248
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 19/88 (21%), Positives = 41/88 (46%), Gaps = 2/88 (2%)
Query: 108 SNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNL 167
+L++ + +N + + + + + +T I ++ L++L+GL L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLEL 70
Query: 168 QNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
++N +T P NL+++ L LS N L
Sbjct: 71 KDNQITDLAPLKNLTKITELELSGNPLK 98
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 26/110 (23%), Positives = 44/110 (40%), Gaps = 2/110 (1%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L L L L N +S D+ S + SL +L ++L+NN S P + + L V L+
Sbjct: 169 LANLSKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+IT NL + + + + NL++N +
Sbjct: 227 QTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 13/81 (16%), Positives = 25/81 (30%), Gaps = 2/81 (2%)
Query: 121 LQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFN 180
Q + P + +++T + +L + L+ +T
Sbjct: 4 TQPTAINVIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQY 61
Query: 181 LSRLRHLNLSYNHLNGSVPLA 201
L+ L L L N + PL
Sbjct: 62 LNNLIGLELKDNQITDLAPLK 82
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 32/163 (19%), Positives = 56/163 (34%), Gaps = 25/163 (15%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNN---NFSGNIPSSLSP 136
+ + + L +L L + + LS L L L N + + S LS
Sbjct: 43 LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLS- 100
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYN 192
L + ++ ++ +L L LN+ +N + F F NL+ L HL+LS N
Sbjct: 101 SLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 193 HLNGSVPLALQKFPPSSFEGNSMLCGPPL------NQCSTVPP 229
+Q + + L N + + P
Sbjct: 160 K--------IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 35/148 (23%), Positives = 57/148 (38%), Gaps = 24/148 (16%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIP-----SSL 134
+ L SL L +L+ L + + L +L+ L + +N + S+L
Sbjct: 91 LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNL 148
Query: 135 SPQLNWVDLSFNSITGNIPASI-RNLSHL----VGLNLQNNSLTGFIPN-FNLSRLRHLN 188
L +DLS N I +I + R L + + L+L N + P F RL+ L
Sbjct: 149 -TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELA 206
Query: 189 LSYNHLNGSVPLALQKFPPSSFEGNSML 216
L N L+ P F+ + L
Sbjct: 207 LDTNQ--------LKSVPDGIFDRLTSL 226
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 32/144 (22%), Positives = 53/144 (36%), Gaps = 23/144 (15%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS---P 136
I + L L L L N + L S LSSL+ L N + ++ +
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLK 124
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNFNLSRLR-------HLN 188
L ++++ N I NL++L L+L +N + I +L L L+
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLD 183
Query: 189 LSYNHLNGSVPLALQKFPPSSFEG 212
LS N + P +F+
Sbjct: 184 LSLNP--------MNFIQPGAFKE 199
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 9e-12
Identities = 26/124 (20%), Positives = 45/124 (36%), Gaps = 16/124 (12%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL--SLSSLRFLYLQNNNFSGNIP------- 131
+ + L +L L++ N + +L++L L L +N +I
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVL 172
Query: 132 SSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLN 188
+ +DLS N + I L L L N L +P+ F L+ L+ +
Sbjct: 173 HQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIW 230
Query: 189 LSYN 192
L N
Sbjct: 231 LHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 26/107 (24%), Positives = 37/107 (34%), Gaps = 20/107 (18%)
Query: 114 SSLRFLYLQNNNFSGNIPS----SLSPQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQ 168
S + L L N ++ S S P+L +DLS I I ++LSHL L L
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSF-PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILT 84
Query: 169 NNSLTGFIPN--F-NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEG 212
N + + F LS L+ L + L
Sbjct: 85 GNPIQ-SLALGAFSGLSSLQKLVAVETN--------LASLENFPIGH 122
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 22/86 (25%), Positives = 34/86 (39%), Gaps = 12/86 (13%)
Query: 130 IPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRH 186
IP +L +DLSFN + S + L L+L + I + + +LS L
Sbjct: 22 IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLST 80
Query: 187 LNLSYNHLNGSVPLALQKFPPSSFEG 212
L L+ N +Q +F G
Sbjct: 81 LILTGNP--------IQSLALGAFSG 98
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 41/157 (26%), Positives = 61/157 (38%), Gaps = 21/157 (13%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQL 138
TL L L+L L+ L + +L L L L +N ++P P L
Sbjct: 46 FSLATLMPYTRLTQLNLDRAELT-KLQVDG-TLPVLGTLDLSHNQLQ-SLPLLGQTLPAL 102
Query: 139 NWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYNHL 194
+D+SFN +T ++P R L L L L+ N L +P +L L+L+ N+
Sbjct: 103 TVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNN- 159
Query: 195 NGSVPLALQKFPPSSFEGNSMLCGPPL--NQCSTVPP 229
L + P G L L N T+P
Sbjct: 160 -------LTELPAGLLNGLENLDTLLLQENSLYTIPK 189
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 30/117 (25%), Positives = 46/117 (39%), Gaps = 12/117 (10%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
+P +T IL L N L + ++ + L L L + P L
Sbjct: 29 LPKDTT-------ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYNHL 194
+DLS N + ++P + L L L++ N LT +P L L+ L L N L
Sbjct: 82 LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL 136
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 38/119 (31%), Positives = 56/119 (47%), Gaps = 12/119 (10%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSL---SP 136
+P + L +L +L + N L+ LP L L L+ LYL+ N +P L +P
Sbjct: 92 LPL-LGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYN 192
+L + L+ N++T +PA + L +L L LQ NSL IP F L L N
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 4/95 (4%)
Query: 113 LSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSL 172
++S + N + +P L + LS N + A++ + L LNL L
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 173 TGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFP 206
T + L L L+LS+N L S+PL Q P
Sbjct: 68 TK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLP 100
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 65/329 (19%), Positives = 111/329 (33%), Gaps = 87/329 (26%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRL-KEVVMGKREFEQQMEVVGRLSQHPNVVPIRA 399
E +G GSY + I VK + K E +E++ R QHPN++ ++
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKD 83
Query: 400 YYFSKDEKLLVYDF----------IEAGSFSALLHGNRGIGRTPLDWE---SRVKISLGS 446
Y +V + + FS E S V ++
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKILRQKFFS----------------EREASAVLFTITK 127
Query: 447 AKGIAHIHAAVGGKFILG----NIKSSNVLLSQDLQGC----ISDFGLTPLMNTPTVPSR 498
+ ++HA G ++K SN+L + I DFG +
Sbjct: 128 T--VEYLHA-------QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 499 ----SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ-- 552
+A + APEV+E + D++S GVLL MLTG P + ++ +
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238
Query: 553 --SVVREEWTSEVFDVELMRYENIEEE----MVQMLQIAMSCVAKVPDMRPTMEEVVR-- 604
S+ W ++ + + +ML + P R T V+R
Sbjct: 239 KFSLSGGYW------------NSVSDTAKDLVSKMLHVD-------PHQRLTAALVLRHP 279
Query: 605 --MIEDIRPSDSENQPSSEDKLKDSNTQT 631
+ D P N+ + +K + T
Sbjct: 280 WIVHWDQLPQYQLNRQDAPHLVKGAMAAT 308
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 15/128 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPS----SLS 135
+PA ++L +L L + N L LP V L +L L L N ++P SL+
Sbjct: 76 LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLT 133
Query: 136 PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSY 191
+L ++ L +N + ++P + L+ L L L NN L +P F L+ L+ L L
Sbjct: 134 -KLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDN 190
Query: 192 NHLNGSVP 199
N L VP
Sbjct: 191 NQLK-RVP 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 43/140 (30%), Positives = 61/140 (43%), Gaps = 27/140 (19%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNN---NFSGNIPSSLSP 136
IPA+T L L+SN LS LPS L+ LR LYL +N I L
Sbjct: 35 IPADT-------KKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK- 85
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYN 192
L + ++ N + +P + L +L L L N L +P F +L++L +L+L YN
Sbjct: 86 NLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN 143
Query: 193 HLNGSVPLALQKFPPSSFEG 212
LQ P F+
Sbjct: 144 E--------LQSLPKGVFDK 155
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 35/121 (28%), Positives = 52/121 (42%), Gaps = 14/121 (11%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPS----SLS 135
+P ++L +L L L N L LP V SL+ L +L L N ++P L+
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLT 157
Query: 136 PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSY 191
L + L N + +P L+ L L L NN L +P +L +L+ L L
Sbjct: 158 -SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQE 214
Query: 192 N 192
N
Sbjct: 215 N 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 21/74 (28%), Positives = 36/74 (48%), Gaps = 7/74 (9%)
Query: 130 IPSSLSPQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--FN-LSRLR 185
IPS++ +DL N ++ ++P+ L+ L L L +N L +P F L L
Sbjct: 31 IPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLE 88
Query: 186 HLNLSYNHLNGSVP 199
L ++ N L ++P
Sbjct: 89 TLWVTDNKLQ-ALP 101
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 31/148 (20%), Positives = 53/148 (35%), Gaps = 14/148 (9%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
I + L L N ++ +L V L L NN + + + + QL +
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLDLNQNIQLTF 216
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL---NGS 197
+D S N +T I + L+ L + N LT + LS+L L+ L + +
Sbjct: 217 LDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTE-LDVSTLSKLTTLHCIQTDLLEIDLT 272
Query: 198 VPLALQKFPPSSFEGNSMLCGPPLNQCS 225
L F EG + + +
Sbjct: 273 HNTQLIYF---QAEGCRKIKELDVTHNT 297
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 26/109 (23%), Positives = 51/109 (46%), Gaps = 7/109 (6%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L + +L L+ SN L+ +L V L+ L +L N + + S +P L +++ +
Sbjct: 81 LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCAR 136
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
N++T I S + + L L+ N + ++L L+ S+N +
Sbjct: 137 NTLT-EIDVS--HNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKI 182
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 31/123 (25%), Positives = 48/123 (39%), Gaps = 13/123 (10%)
Query: 84 NTLEKLD-----SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQL 138
N L KLD L L+ N L+ ++ V + L L N + + QL
Sbjct: 116 NKLTKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVTPQTQL 172
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSV 198
+D SFN IT + + L LN N++T + +L L+ S N L +
Sbjct: 173 TTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK-LDLNQNIQLTFLDCSSNKLT-EI 227
Query: 199 PLA 201
+
Sbjct: 228 DVT 230
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 19/143 (13%), Positives = 48/143 (33%), Gaps = 15/143 (10%)
Query: 84 NTLEKLD---SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
L ++D + ++ ++ +V + L L Q + + S +P+L +
Sbjct: 264 TDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVY 322
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPL 200
+ L+ +T + + + + L L+ N + F + L + +
Sbjct: 323 LYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQ------- 372
Query: 201 ALQKFPPSSFEGNSMLCGPPLNQ 223
P + NS+ +
Sbjct: 373 -TITMPKETLTNNSLTIAVSPDL 394
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-12
Identities = 20/110 (18%), Positives = 40/110 (36%), Gaps = 7/110 (6%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
+ L L L L ++ + + L + + + + + QL +D
Sbjct: 250 VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQA 306
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
IT + + LV L L N LT + + ++L+ L+ H+
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELTE-LDVSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 21/115 (18%), Positives = 42/115 (36%), Gaps = 4/115 (3%)
Query: 80 PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLN 139
N D+ + + + L++L L N++ + L
Sbjct: 8 TQSFNDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLT 67
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
+ + N+IT + + ++L L +N LT + L++L +LN N L
Sbjct: 68 KLICTSNNIT-TLD--LSQNTNLTYLACDSNKLTN-LDVTPLTKLTYLNCDTNKL 118
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 16/117 (13%), Positives = 38/117 (32%), Gaps = 6/117 (5%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
I + L +L ++ ++ +L + L +LYL N + + S + +L
Sbjct: 288 IKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNTKLKS 343
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGS 197
+ I + S+ + L + + +S + L+
Sbjct: 344 LSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 16/82 (19%), Positives = 27/82 (32%), Gaps = 5/82 (6%)
Query: 116 LRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT 173
S L +D +SIT ++ I L+ L L +N++T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77
Query: 174 GFIPNFNLSRLRHLNLSYNHLN 195
+ + L +L N L
Sbjct: 78 T-LDLSQNTNLTYLACDSNKLT 98
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 19/119 (15%), Positives = 39/119 (32%), Gaps = 8/119 (6%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L + L+ L L + L+ +L V + L+ L N + P LN +
Sbjct: 314 LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAE 370
Query: 146 NSITGNIPASIRNLS-----HLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199
++ N S L+ N + + + +++ +L+ P
Sbjct: 371 GQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 122 QNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNL 181
Q +F+ P + + S L+ L L+ N+S+T L
Sbjct: 7 QTQSFNDWFPD---DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKL 63
Query: 182 SRLRHLNLSYNHL 194
+ L L + N++
Sbjct: 64 TGLTKLICTSNNI 76
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 41/225 (18%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKR-LKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
+V+G GS+G ++A L E V +K+ L++ RE Q M R+ +HPNVV ++A+
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL-QIM----RIVKHPNVVDLKAF 100
Query: 401 YFSKDEKL------LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISL-GSAKGIAHI 453
++S +K LV +++ + A H + P+ +K+ + + +A+I
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML---LIKLYMYQLLRSLAYI 157
Query: 454 HAAVGGKFILGNI-----KSSNVLLSQDLQGC-ISDFGL----TPL-MNTPTVPSRSAGY 502
H+ I K N+LL + DFG N + SR Y
Sbjct: 158 HSI--------GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY--Y 207
Query: 503 RAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
RAPE+I T D++S G ++ E++ G+ P+ PG E +D
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ-PL-FPG-ESGID 249
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 7e-14
Identities = 57/281 (20%), Positives = 105/281 (37%), Gaps = 54/281 (19%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM--EV-VGRLSQHPNVVPI 397
LGKG + ++ + K + + ++ K ++M E+ + R H +VV
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
++ D +V + S L E+R G ++H
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEP-EAR-YYLRQIVLGCQYLHRN- 134
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR------SAGYRAPEVIETK 511
+ I ++K N+ L++DL+ I DFGL + R + Y APEV+ K
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKK 190
Query: 512 KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED--------VVDLPRWVQSVVREEWTSEV 563
+ + DV+S G ++ +L GK P + ++ +P+ + V
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA------- 243
Query: 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
L++ +MLQ P RPT+ E++
Sbjct: 244 ---SLIQ---------KMLQ-------TDPTARPTINELLN 265
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 72.3 bits (177), Expect = 8e-14
Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 34/196 (17%)
Query: 431 RTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490
+ L E + S AKG+ + + K I ++ + N+LLS+ I DFGL +
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 491 NTPTVPSRSAGYR------APEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHED 543
R R APE I + T +SDV+SFGVLL E+ + G +P PG +
Sbjct: 244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKI 301
Query: 544 VVDLPRWVQSVVR----EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTM 599
+ R ++ R + T E++ + M C P RPT
Sbjct: 302 DEEFCRRLKEGTRMRAPDYTTPEMY--QTML----------------DCWHGEPSQRPTF 343
Query: 600 EEVVRMIEDIRPSDSE 615
E+V + ++ ++++
Sbjct: 344 SELVEHLGNLLQANAQ 359
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 24/96 (25%), Positives = 40/96 (41%), Gaps = 9/96 (9%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPN 393
+ LG+G++G +A TV VK LKE R +++++ + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 394 VVPIRAYYFSKDEKLLV-YDFIEAGSFSALLHGNRG 428
VV + L+V +F + G+ S L R
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 123
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 32/282 (11%), Positives = 76/282 (26%), Gaps = 51/282 (18%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVP 396
G ++A+ V + + + +E + + R+ P V
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVAR 95
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ ++ L+V ++I GS + T ++ A H A
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQK 516
G L S V +S D ++ +
Sbjct: 149 --G-VALSIDHPSRVRVSIDGDVVLAYPA----------------TMPDA-------NPQ 182
Query: 517 SDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEE 576
D+ G L +L + P+ G + + + + + + +I
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGL-------APAERDTAGQPIEPADID-RDIPF 234
Query: 577 EMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSENQP 618
++ +A V +R ++ +++ +
Sbjct: 235 QIS---AVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEV 272
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 9e-14
Identities = 53/236 (22%), Positives = 97/236 (41%), Gaps = 44/236 (18%)
Query: 335 DLLRASAEVLGKGSYGTTYKAIL----EEGTTVVVKRL-KEVVMGKREF-----EQQMEV 384
+ R ++G+G +G + + G +K L K+ + K+ E+ M
Sbjct: 192 SVHR----IIGRGGFG---EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244
Query: 385 VGRLSQHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-- 441
+ P +V + +Y F +KL + D + G L + E+ ++
Sbjct: 245 LVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS------EADMRFY 297
Query: 442 ---ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG--CISDFGLTPLMNTPTVP 496
I LG + H+H + ++K +N+LL D G ISD GL +
Sbjct: 298 AAEIILG----LEHMHNR---FVVYRDLKPANILL--DEHGHVRISDLGLACDFSKKKPH 348
Query: 497 SR--SAGYRAPEVIETKKPTQKS-DVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPR 549
+ + GY APEV++ S D +S G +L ++L G +P + +D ++ R
Sbjct: 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 9e-14
Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 41/214 (19%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM-------EVVG-RLSQHP 392
+ +G G+ G A V +K+L F+ Q E+V + H
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 121
Query: 393 NVVPIR-----AYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS 446
N++ + + + + LV + ++A L + + L R+ L
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQ---VIQMEL-DHERMSYLLYQ 172
Query: 447 A-KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL-----TPLMNTPTVPSRSA 500
GI H+H+A I ++K SN+++ D I DFGL T M TP V +R
Sbjct: 173 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY- 228
Query: 501 GYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKA 534
YRAPEVI + D++S G ++ EM+ K
Sbjct: 229 -YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-13
Identities = 68/226 (30%), Positives = 102/226 (45%), Gaps = 42/226 (18%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGK-REFEQQMEVVGRLSQHPNVVPIRA 399
+V+G GS+G Y+A L + G V +K++ + K RE Q M R H N+V +R
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL-QIM----RKLDHCNIVRLRY 114
Query: 400 YYFSKDEKL------LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISL-GSAKGIAH 452
+++S EK LV D++ + H +R P+ VK+ + + +A+
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI---YVKLYMYQLFRSLAY 171
Query: 453 IHAAVGGKFILGNI-----KSSNVLLSQDLQGC-ISDFGL-----TPLMNTPTVPSRSAG 501
IH+ I K N+LL D + DFG N + SR
Sbjct: 172 IHSF--------GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-- 221
Query: 502 YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
YRAPE+I T DV+S G +L E+L G+ PI PG + VD
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI-FPG-DSGVD 264
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 52/246 (21%), Positives = 95/246 (38%), Gaps = 54/246 (21%)
Query: 343 VLGKGSYGTTYKAIL-EEGTTVVVKRL-KEVVMGKREFEQQM---EVVGRLSQHPNVVPI 397
+LG+GS+ T A +K L K ++ + + +V+ RL HP V +
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKL 95
Query: 398 RAYYFSKDEKL-LVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVK-----ISLGSAKGI 450
+ F DEKL + + G + R IG E+ + I +
Sbjct: 96 Y-FTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFD---ETCTRFYTAEIVSA----L 143
Query: 451 AHIHAAVGGKFILGNI----KSSNVLLSQDLQG--CISDFGLTPLMNTPTVPSRS----- 499
++H G I K N+LL + I+DFG +++ + +R+
Sbjct: 144 EYLHG-------KGIIHRDLKPENILL--NEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 500 -AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV--------VDLPRW 550
A Y +PE++ K + SD+++ G ++ +++ G P +A + D P
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK 254
Query: 551 VQSVVR 556
R
Sbjct: 255 FFPKAR 260
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 58/281 (20%), Positives = 109/281 (38%), Gaps = 54/281 (19%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM--EV-VGRLSQHPNVVPI 397
LGKG + ++ + K + + ++ K ++M E+ + R H +VV
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
++ D +V + S LL ++ + E+R G ++H
Sbjct: 107 HGFFEDNDFVFVVLELCRRRS---LLELHKRRKALT-EPEAR-YYLRQIVLGCQYLHRN- 160
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR------SAGYRAPEVIETK 511
+ I ++K N+ L++DL+ I DFGL + R + Y APEV+ K
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKK 216
Query: 512 KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED--------VVDLPRWVQSVVREEWTSEV 563
+ + DV+S G ++ +L GK P + ++ +P+ + V
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA------- 269
Query: 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
L++ +MLQ P RPT+ E++
Sbjct: 270 ---SLIQ---------KMLQ-------TDPTARPTINELLN 291
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 66/308 (21%), Positives = 118/308 (38%), Gaps = 48/308 (15%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLK--------------EVVMGKREFEQQMEVVG 386
LG G+YG + +K +K + E ++ ++
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 387 RLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS 446
L HPN++ + + K LV +F E G L + I R D I
Sbjct: 102 SLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGE---LFE--QIINRHKFDECDAANIMKQI 155
Query: 447 AKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC---ISDFGLTPLMNTPTVPSR---SA 500
GI ++H + +IK N+LL I DFGL+ + +A
Sbjct: 156 LSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 501 GYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT 560
Y APEV++ KK +K DV+S GV++ +L G P +D+ ++ V + ++
Sbjct: 213 YYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI------IKKVEKGKYY 265
Query: 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR---MIEDIRPSDSENQ 617
FD ++NI +E ++++ + + R T EE + + + + +Q
Sbjct: 266 ---FDFN--DWKNISDEAKELIK---LMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQ 317
Query: 618 PSSEDKLK 625
+ L
Sbjct: 318 KTLCGALS 325
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 32/117 (27%), Positives = 54/117 (46%), Gaps = 6/117 (5%)
Query: 80 PIPANTLEKLDSLMILSLRSNHL-SGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQL 138
A + + SL L + N L S S+ L L +N +G++ L P++
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKV 452
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYN 192
+DL N I +IP + +L L LN+ +N L +P+ F L+ L+++ L N
Sbjct: 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 33/160 (20%), Positives = 56/160 (35%), Gaps = 25/160 (15%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SPQ 137
+P T LSL N +S ++ LS LR L L +N ++ + +
Sbjct: 50 LPPRTK-------ALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT--GFIPNF-NLSRLRHLNLSYNHL 194
L ++D+S N + NI ++ L L+L N F NL++L L LS
Sbjct: 102 LEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAK- 157
Query: 195 NGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPPAPSPS 234
++ + C + + S
Sbjct: 158 -------FRQLDLLPVAHLHLSCILLDLVSYHIKGGETES 190
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 26/126 (20%), Positives = 51/126 (40%), Gaps = 11/126 (8%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG------NIPSSL 134
L L L L+ N L + L ++ L + + + + +
Sbjct: 368 SVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAW 426
Query: 135 SPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNH 193
+ + ++LS N +TG++ + + L+L NN + + +L L+ LN++ N
Sbjct: 427 AESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQ 484
Query: 194 LNGSVP 199
L SVP
Sbjct: 485 LK-SVP 489
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 37/212 (17%), Positives = 70/212 (33%), Gaps = 15/212 (7%)
Query: 11 SFIWLIPQMIADLNSDKQALLDFAANVPHARKLNWNSSTSVCTSWVGITC---TKNGSRV 67
+ L I + + Q L+ F + + L + + T+W V
Sbjct: 219 ALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278
Query: 68 LAVRLPGVGLYGPI----PANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQN 123
+ + + + I + L SLMI +++ + + + L
Sbjct: 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSI 338
Query: 124 NN---FSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT----GFI 176
++ P S S +++ + N T ++ L L L LQ N L +
Sbjct: 339 SDTPFIHMVCPPSPS-SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL 397
Query: 177 PNFNLSRLRHLNLSYNHLNGSVPLALQKFPPS 208
N+S L L++S N LN + S
Sbjct: 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 5/87 (5%)
Query: 111 LSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNN 170
S + N N + ++P L P+ + LS NSI+ I LS L L L +N
Sbjct: 28 FSNELESMVDYSNRNLT-HVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHN 86
Query: 171 SLTGFIPN--F-NLSRLRHLNLSYNHL 194
+ + F L +L++S+N L
Sbjct: 87 RIR-SLDFHVFLFNQDLEYLDVSHNRL 112
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 47/234 (20%), Positives = 85/234 (36%), Gaps = 72/234 (30%)
Query: 337 LRASAEVLGKGSYGTTYKAILEEGTT------VVVKRLKEVVMGKREFEQQMEVVGRLSQ 390
L + LG+GS+ K + + + ++ KR++ ++E + +
Sbjct: 12 LDLKDKPLGEGSFSICRKCV-HKKSNQAFAVKIISKRMEANT--QKE----ITALKLCEG 64
Query: 391 HPNVVPIRAYYFSKDEKLLVYDF----------IEAGSFSALLHGNRGIGRTPLDWE--- 437
HPN+V + + + LV + + FS E
Sbjct: 65 HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFS----------------ETEA 108
Query: 438 SRVKISLGSA------KGIAHIHAAVGGKFILGNIKSSNVLL---SQDLQGCISDFGL-- 486
S + L SA G+ H ++K N+L + +L+ I DFG
Sbjct: 109 SYIMRKLVSAVSHMHDVGVVH-----------RDLKPENLLFTDENDNLEIKIIDFGFAR 157
Query: 487 -----TPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ TP + Y APE++ + D++S GV+L ML+G+ P
Sbjct: 158 LKPPDNQPLKTPC---FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 46/305 (15%), Positives = 98/305 (32%), Gaps = 49/305 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEV-VGRLSQHPNVVPIRA 399
++LG+G+ ++ + G +K + + Q E V + H N+V + A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 400 YYFSKDEKL--LVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKIS-LGSAKGIAHIHA 455
+ L+ +F GS ++ L + G + E + + + + H+
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP--ESEFLIVLRDVVGG--MNHLRE 130
Query: 456 AVGGKFILGNI-----KSSNVLLSQDLQGC----ISDFGLTPLMNTPTVPSRSAG---YR 503
I K N++ G ++DFG + G Y
Sbjct: 131 N--------GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYL 182
Query: 504 APEVIET--------KKPTQKSDVYSFGVLLLEMLTGKAP-IQAPGHEDVVDL------- 547
P++ E KK D++S GV TG P G ++
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 548 --PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKV-PDMRPTMEEVVR 604
+ V + E + ++ ++ + +L ++ + + + ++
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 605 MIEDI 609
DI
Sbjct: 303 ETSDI 307
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 39/231 (16%), Positives = 76/231 (32%), Gaps = 55/231 (23%)
Query: 343 VLGKGSYGTTYKAILEEGTTVVVKRL-KEVVMGKREFEQQMEVVG--------------- 386
L +G + ++ +K+ K ++ KR+F +
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 387 -RLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISL 444
++ + + DE ++Y+++E S + LD I +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV------LDKNYTCFIPI 150
Query: 445 GSAK--------GIAHIHAAVGGKFIL-GNIKSSNVLLSQDLQGCISDFGLTPLMN---- 491
K ++IH K I ++K SN+L+ ++ + +SDFG + M
Sbjct: 151 QVIKCIIKSVLNSFSYIHNE---KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 492 -----TPTVPSRSAGYRAPEVIETKKPT--QKSDVYSFGVLLLEMLTGKAP 535
T + PE + K D++S G+ L M P
Sbjct: 208 KGSRGTYE-------FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 40/219 (18%), Positives = 71/219 (32%), Gaps = 36/219 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEV-VGRLSQHPNVVPIRA 399
++LG+G+ ++ + G +K + + Q E V + H N+V + A
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 400 YYFSKDEKL--LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKIS-LGSAKGIAHIHAA 456
+ L+ +F GS +L P E + + + + H+
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFLIVLRDVVGG--MNHLREN 131
Query: 457 VGGKFILGNI-----KSSNVLLSQDLQGC----ISDFGLTPLMNTPTVPSRSAG---YRA 504
I K N++ G ++DFG + G Y
Sbjct: 132 --------GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 505 PEVIE--------TKKPTQKSDVYSFGVLLLEMLTGKAP 535
P++ E KK D++S GV TG P
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 61/281 (21%), Positives = 103/281 (36%), Gaps = 77/281 (27%)
Query: 328 SYNFDLEDLLRASAEVLGKGSYGTTYKAI-LEEGTTVVVKRL-KEVVMGKREFEQQMEVV 385
S++ ED+ + +VLG+G++ I L VK + K+ + +++E++
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 386 GRLSQHPNVVPIRAYYFSKDEKLLVYDF----------IEAGSFSALLHGNRGIGRTPLD 435
+ H NV+ + ++ +D LV++ + F+
Sbjct: 65 YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN--------------- 109
Query: 436 WE---SRVKISLGSA------KGIAHIHAAVGGKFILGNIKSSNVLL---SQDLQGCISD 483
E S V + SA KGIAH ++K N+L +Q I D
Sbjct: 110 -ELEASVVVQDVASALDFLHNKGIAH-----------RDLKPENILCEHPNQVSPVKICD 157
Query: 484 FGL--------------TPLMNTPTVPSRSAGYRAPEVIETKKPTQKS-----DVYSFGV 524
F L TP + TP SA Y APEV+E D++S GV
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPC---GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGV 214
Query: 525 LLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565
+L +L+G P D W + + +F+
Sbjct: 215 ILYILLSGYPPFVGRCGSD----CGWDRGEACPACQNMLFE 251
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 3e-13
Identities = 38/111 (34%), Positives = 62/111 (55%), Gaps = 8/111 (7%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
L L +L L L N + DL S++ L L+ L L++N S +I + L PQL + L
Sbjct: 83 LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYL 138
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
N IT +I + L+ L L+L++N ++ +P L++L++L LS NH+
Sbjct: 139 GNNKIT-DIT-VLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 187
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 33/111 (29%), Positives = 51/111 (45%), Gaps = 8/111 (7%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
L+ L L LSL N +S D+ + ++ L L LYL NN + +I + LS +L+ + L
Sbjct: 105 LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSL 160
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
N I+ +I + L+ L L L N ++ L L L L
Sbjct: 161 EDNQIS-DIV-PLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQEC 209
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 20/112 (17%), Positives = 49/112 (43%), Gaps = 8/112 (7%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
+ + +L+ ++ L+S+ + N++ ++ + P + + L
Sbjct: 17 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+ N +T +I + NL +L L L N + +L +L+ L+L +N ++
Sbjct: 73 NGNKLT-DIK-PLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHNGIS 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 25/117 (21%), Positives = 54/117 (46%), Gaps = 4/117 (3%)
Query: 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144
T +L+S+ + ++ + + + L ++ L+L N + P + L W+ L
Sbjct: 38 TQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLD 95
Query: 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
N I ++ S+++L L L+L++N ++ +L +L L L N + L+
Sbjct: 96 ENKIK-DLS-SLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLS 150
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 24/129 (18%), Positives = 46/129 (35%), Gaps = 2/129 (1%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L +L L LSL N +S D+ + L+ L+ LYL N+ S + L+ ++L
Sbjct: 149 LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFS 206
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKF 205
NL + + SL + N+ ++ + ++ +
Sbjct: 207 QECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFY 266
Query: 206 PPSSFEGNS 214
P +
Sbjct: 267 QPVTIGKAK 275
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 17/101 (16%), Positives = 37/101 (36%), Gaps = 4/101 (3%)
Query: 95 LSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPA 154
S + + + + L+ + + + + ++ + + + I ++
Sbjct: 4 TITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG 60
Query: 155 SIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
I+ L ++ L L N LT P NL L L L N +
Sbjct: 61 -IQYLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIK 100
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 30/109 (27%), Positives = 52/109 (47%), Gaps = 5/109 (4%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
++ +L L L N +S DL S + L+ L L + N N+ S L+ + L
Sbjct: 59 MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGIPSACLSRLFLDN 115
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
N + + S+ +L +L L+++NN L + LS+L L+L N +
Sbjct: 116 NELR-DTD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEI 162
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 22/114 (19%), Positives = 51/114 (44%), Gaps = 13/114 (11%)
Query: 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142
+ ++L + + ++++ L + + ++L+ L+L +N S ++ S L +L +
Sbjct: 36 SQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELS 91
Query: 143 LSFNSITGNIPASIRNLSH--LVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
++ N + ++ + L L L NN L +L L L++ N L
Sbjct: 92 VNRNRLK-----NLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKL 140
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 23/111 (20%), Positives = 48/111 (43%), Gaps = 9/111 (8%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
L + + +L ++ DL + LS ++ N+N ++ + + L + L
Sbjct: 15 DPGLANAVKQNLGKQSVT-DL-VSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
S N I+ ++ +++L+ L L++ N L + + L L L N L
Sbjct: 71 SHNQIS-DLSP-LKDLTKLEELSVNRNRLKN-LNGIPSACLSRLFLDNNEL 118
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 9/111 (8%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
L+ L L LS+ N L +L + + L L+L NN + SL L + +
Sbjct: 81 LKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELR-DT-DSLIHLKNLEILSI 135
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
N + +I + LS L L+L N +T L ++ ++L+
Sbjct: 136 RNNKLK-SIV-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 26/120 (21%), Positives = 44/120 (36%), Gaps = 13/120 (10%)
Query: 84 NTLEKLDSLMILSLRSNHLSG----DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQ 137
N L+ L+ + L L D +++ L +L L ++NN +I L +
Sbjct: 95 NRLKNLNGIPSACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLK-SI-VMLGFLSK 151
Query: 138 LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGS 197
L +DL N IT N + L + ++L P L N + +G
Sbjct: 152 LEVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKD-PDGR 207
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 14/99 (14%), Positives = 42/99 (42%), Gaps = 4/99 (4%)
Query: 97 LRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASI 156
R ++ + L++ L + + + + + ++I ++ +
Sbjct: 4 QRPTPIN-QV-FPDPGLANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQ-SLA-GM 59
Query: 157 RNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+ ++L L+L +N ++ P +L++L L+++ N L
Sbjct: 60 QFFTNLKELHLSHNQISDLSPLKDLTKLEELSVNRNRLK 98
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 2/110 (1%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
L L +L ILS+R+N L + + LS L L L N + + ++NW+DL+
Sbjct: 124 LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTG 181
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
L + + N + +
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 5e-13
Identities = 47/218 (21%), Positives = 87/218 (39%), Gaps = 50/218 (22%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKRE-FEQQMEVVGRLSQHPNVVPIRA 399
EVLG G++ + G +K +K+ + E ++ V+ ++ H N+V +
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-HENIVTLED 73
Query: 400 YYFSKDEKLLV---------YDFI-EAGSFS---ALLHGNRGIGRTPLDWESRVKISLGS 446
Y S LV +D I E G ++ A + + L
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA-----SLVIQQVLS----------- 117
Query: 447 AKGIAHIHAAVGGKFILG----NIKSSNVLL---SQDLQGCISDFGLTPLMNTPTVPSR- 498
+ ++H G ++K N+L ++ + I+DFGL+ + + +
Sbjct: 118 --AVKYLHE-------NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC 168
Query: 499 -SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ GY APEV+ K ++ D +S GV+ +L G P
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 66/260 (25%), Positives = 109/260 (41%), Gaps = 80/260 (30%)
Query: 335 DLLRASAEVLGKGSYGTTYKAIL-EEGTTVVVKRL-------KEVVMGKREFEQQME-VV 385
+LL+ VLG+GS+G K L ++ + ++L K + + +ME +
Sbjct: 27 ELLK----VLGQGSFG---KVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 386 GRLSQHPNVVPIRAYYFSKDEKL-LVYDFI----------EAGSFSALLHGNRGIGRTPL 434
HP +V + Y F + KL L+ DF+ + F+
Sbjct: 80 LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT-------------- 124
Query: 435 DWESRVK-----ISLGSAKGIAHIHAAVGGKFILGNI----KSSNVLLSQDLQG--CISD 483
E VK ++L + H+H+ LG I K N+LL D +G ++D
Sbjct: 125 --EEDVKFYLAELALA----LDHLHS-------LGIIYRDLKPENILL--DEEGHIKLTD 169
Query: 484 FGLTPLMNTPTVPSRS----AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539
FGL+ + S Y APEV+ + TQ +D +SFGVL+ EMLTG P Q
Sbjct: 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 540 GHEDV--------VDLPRWV 551
++ + +P+++
Sbjct: 230 DRKETMTMILKAKLGMPQFL 249
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 68/288 (23%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFE---QQMEVVGRLSQHPNVVPI 397
+LGKGS+G K VK + + ++ +++E++ +L HPN++ +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKL 86
Query: 398 RAYYFSKDEKLLVYDF----------IEAGSFS---ALLHGNRGIGRTPLDWESRVKISL 444
+V + I+ FS A I +
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-----ARIIKQVFS--------- 132
Query: 445 GSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC---ISDFGLTPLMNTPTVPSR--- 498
GI ++H + ++K N+LL + C I DFGL+ T
Sbjct: 133 ----GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE 558
+A Y APEV+ +K DV+S GV+L +L+G P D+ ++ V +
Sbjct: 186 TAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI------LKRVETGK 238
Query: 559 WTSEVFDVELMRYENIEEE----MVQMLQIAMSCVAKVPDMRPTMEEV 602
+ FD+ ++ I ++ + +ML P +R T +
Sbjct: 239 YA---FDLP--QWRTISDDAKDLIRKMLT-------FHPSLRITATQC 274
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 27/117 (23%), Positives = 49/117 (41%), Gaps = 12/117 (10%)
Query: 88 KLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNS 147
++ L L +LS LP N+ + L + N ++P + L ++D N
Sbjct: 57 LINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA-SLEYLDACDNR 111
Query: 148 ITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQK 204
++ +P +L H L++ NN LT +P + L ++N N L +P
Sbjct: 112 LS-TLPELPASLKH---LDVDNNQLT-MLPE-LPALLEYINADNNQLT-MLPELPTS 161
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 32/108 (29%), Positives = 50/108 (46%), Gaps = 12/108 (11%)
Query: 87 EKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFN 146
E SL L N LS LP +SL+ L + NN + +P + L +++ N
Sbjct: 97 ELPASLEYLDACDNRLS-TLPE---LPASLKHLDVDNNQLT-MLPELPA-LLEYINADNN 150
Query: 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
+T +P +L L +++NN LT F+P L L++S N L
Sbjct: 151 QLT-MLPELPTSLEVL---SVRNNQLT-FLPEL-PESLEALDVSTNLL 192
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 12/105 (11%)
Query: 91 SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITG 150
+ +L + N L LP +SL +L +N S +P L +D+ N +T
Sbjct: 81 QITVLEITQNALI-SLPE---LPASLEYLDACDNRLS-TLPELP-ASLKHLDVDNNQLT- 133
Query: 151 NIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+P L ++ N NN LT +P + L L++ N L
Sbjct: 134 MLPELPALLEYI---NADNNQLT-MLPE-LPTSLEVLSVRNNQLT 173
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 18/106 (16%), Positives = 40/106 (37%), Gaps = 8/106 (7%)
Query: 93 MILSLRSNHLSG---DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSIT 149
+ + N +SG D S N + L Q + + L+ +++
Sbjct: 13 LSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLS 72
Query: 150 GNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
++P ++ + L + N+L +P + L +L+ N L+
Sbjct: 73 -SLPDNL--PPQITVLEITQNALI-SLPE-LPASLEYLDACDNRLS 113
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 17/124 (13%), Positives = 38/124 (30%), Gaps = 8/124 (6%)
Query: 87 EKLDSLMILSLRSNHLSGDLPSNVLSLSSLR----FLYLQNNNFSGNIPSSLS--PQLNW 140
E +SL L + +N L LP+ + F + N + +IP ++
Sbjct: 177 ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPL 200
+ L N ++ I S+ + + + N + +
Sbjct: 235 IILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294
Query: 201 ALQK 204
+ +
Sbjct: 295 DVSQ 298
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 1/99 (1%)
Query: 89 LDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSI 148
++ + R N ++ +P N+LSL + L++N S I SLS Q D I
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264
Query: 149 TGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHL 187
++ +N H + +
Sbjct: 265 YFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAF 303
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 11/69 (15%), Positives = 24/69 (34%), Gaps = 8/69 (11%)
Query: 129 NIPSSLSPQLNWVDLSFNSITG---NIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLR 185
N SLS + +N+I+G + ++ N + +++
Sbjct: 8 NNNFSLSQ-----NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFS 62
Query: 186 HLNLSYNHL 194
L L+ +L
Sbjct: 63 ELQLNRLNL 71
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 6e-13
Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 62/231 (26%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVK---------RLKEVVMGKRE-FEQQMEVVGRLSQ 390
E+LG+G + I + VK E V RE ++++++ ++S
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 391 HPNVVPIRAYYFSKDEKLLV---------YDFI-EAGSFS---ALLHGNRGIGRTPLDWE 437
HPN++ ++ Y + LV +D++ E + S R I R L+
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET-----RKIMRALLE-- 135
Query: 438 SRVKISLGSAKGIAHIHAAVGGKFILG----NIKSSNVLLSQDLQGCISDFGLTPLMNTP 493
I +H L ++K N+LL D+ ++DFG + ++
Sbjct: 136 -----------VICALHK-------LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG 177
Query: 494 TVPSR---SAGYRAPEVIETKKP------TQKSDVYSFGVLLLEMLTGKAP 535
+ Y APE+IE ++ D++S GV++ +L G P
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 58/228 (25%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 335 DLLRASAEVLGKGSYGTTYKAIL--EEGTTVV--VKRL-KEVVMGKREFEQQM--EVVGR 387
+ L+ +LGKG++G K IL E+ T +K L KEV++ K E + V +
Sbjct: 151 EYLK----LLGKGTFG---KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203
Query: 388 LSQHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS 446
S+HP + ++ Y F ++L V ++ G L R E R +
Sbjct: 204 NSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFS------EDRARFYGAE 256
Query: 447 -AKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG--CISDFGLTPLMNTPTVPSRS---- 499
+ ++H+ + ++K N++L D G I+DFGL ++
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLML--DKDGHIKITDFGLCKEGIKDGATMKTFCGT 312
Query: 500 AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547
Y APEV+E + D + GV++ EM+ G+ P HE + +L
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 8/111 (7%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
++ L ++ L L N L+ D+ + +L +L +L+L N ++ SSL +L + L
Sbjct: 64 IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSL 119
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
N I+ +I + +L L L L NN +T L++L L+L N +
Sbjct: 120 EHNGIS-DING-LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQI 168
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 38/111 (34%), Positives = 62/111 (55%), Gaps = 8/111 (7%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
L L +L L L N + DL S++ L L+ L L++N S +I + L PQL + L
Sbjct: 86 LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYL 141
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
N IT +I + L+ L L+L++N ++ +P L++L++L LS NH+
Sbjct: 142 GNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 190
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 33/111 (29%), Positives = 51/111 (45%), Gaps = 8/111 (7%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
L+ L L LSL N +S D+ + ++ L L LYL NN + +I + LS +L+ + L
Sbjct: 108 LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DI-TVLSRLTKLDTLSL 163
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
N I+ +I + L+ L L L N ++ L L L L
Sbjct: 164 EDNQIS-DIV-PLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQEC 212
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 20/110 (18%), Positives = 46/110 (41%), Gaps = 4/110 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
+ + +L+ ++ L+S+ + N++ P + + L+
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNG 77
Query: 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
N +T +I + NL +L L L N + +L +L+ L+L +N ++
Sbjct: 78 NKLT-DIK-PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 17/94 (18%), Positives = 36/94 (38%), Gaps = 2/94 (2%)
Query: 108 SNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNL 167
+ + + L+ + + + + ++ + + + I ++ I+ L ++ L L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75
Query: 168 QNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
N LT P NL L L L N + L
Sbjct: 76 NGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLK 109
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 24/112 (21%), Positives = 44/112 (39%), Gaps = 6/112 (5%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143
L +L L LSL N +S D+ + L+ L+ LYL N+ S ++ +L+ L+ ++L
Sbjct: 152 LSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLEL 207
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
NL + + SL + N+ ++
Sbjct: 208 FSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 259
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 53/295 (17%)
Query: 287 KDSEGTAATKSKGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLED--LLRASAEVL 344
+ SEG + K R + + + A G L D L VL
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM----VL 349
Query: 345 GKGSYGTTYKAILEE----GTTVVVKRL-KEVVMGKREFEQQM---EVVGRLSQHPNVVP 396
GKGS+G K +L E VK L K+VV+ + E M V+ + P +
Sbjct: 350 GKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 397 IRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-----ISLGSAKGI 450
+ F ++L V +++ G + GR E I++G +
Sbjct: 407 LH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV---GRFK---EPHAVFYAAEIAIG----L 455
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQG--CISDFGLTPLMNTPTVPSRS----AGYRA 504
+ + I ++K NV+L D +G I+DFG+ V +++ Y A
Sbjct: 456 FFLQSK---GIIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIA 510
Query: 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV--------VDLPRWV 551
PE+I + + D ++FGVLL EML G+AP + +++ V P+ +
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSM 565
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 66/249 (26%), Positives = 102/249 (40%), Gaps = 59/249 (23%)
Query: 335 DLLRASAEVLGKGSYGTTYKAILEE----GTTVVVKRL-KEVVMGKREFEQQM---EVVG 386
L + +LGKGS+G K L E +K L K+VV+ + E M V+
Sbjct: 20 ILHK----MLGKGSFG---KVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 387 RLSQHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK---- 441
+HP + + F E L V +++ G L++ + + SR
Sbjct: 73 LAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGD---LMYHIQSCHKFD---LSRATFYAA 125
Query: 442 -ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG--CISDFGL-----TPLMNTP 493
I LG + +H+ + ++K N+LL D G I+DFG+ T
Sbjct: 126 EIILG----LQFLHSK---GIVYRDLKLDNILL--DKDGHIKIADFGMCKENMLGDAKTN 176
Query: 494 TV---PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV------ 544
T P Y APE++ +K D +SFGVLL EML G++P E++
Sbjct: 177 TFCGTPD----YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232
Query: 545 --VDLPRWV 551
PRW+
Sbjct: 233 DNPFYPRWL 241
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 53/254 (20%), Positives = 94/254 (37%), Gaps = 40/254 (15%)
Query: 302 NEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE-- 359
+ P ++F + + + E D R VLG+G +G + +
Sbjct: 155 GQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFR----VLGRGGFG---EVFACQMK 207
Query: 360 --GTTVVVKRL-KEVVMGKREFEQQM--EVVGRLSQHPNVVPIRAYYFSKDEKL-LVYDF 413
G K+L K+ + ++ ++ M + + +V + AY F L LV
Sbjct: 208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTI 266
Query: 414 IEAGS-FSALLHGNRGIGRTPLDWESRVK-----ISLGSAKGIAHIHAAVGGKFILGNIK 467
+ G + + + E R I G + H+H I ++K
Sbjct: 267 MNGGDIRYHIYNVDEDNPGFQ---EPRAIFYTAQIVSG----LEHLHQR---NIIYRDLK 316
Query: 468 SSNVLLSQDLQG--CISDFGLTPLMNTPTVPSRS----AGYRAPEVIETKKPTQKSDVYS 521
NVLL D G ISD GL + ++ G+ APE++ ++ D ++
Sbjct: 317 PENVLL--DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFA 374
Query: 522 FGVLLLEMLTGKAP 535
GV L EM+ + P
Sbjct: 375 LGVTLYEMIAARGP 388
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 45/257 (17%), Positives = 85/257 (33%), Gaps = 72/257 (28%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK-REFEQQMEVVGRLSQHPNVVPIRA 399
+ LG GS+G + +E G +K++ + K RE M ++ H N++ +
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNREL-DIM----KVLDHVNIIKLVD 67
Query: 400 YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRV-----------------KI 442
Y+++ ++ N + K+
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKV 127
Query: 443 SLGSAK-------------------GIAHIHAAVGGKFILGNI-----KSSNVLLSQDLQ 478
+ + IH+ I K N+L+ + +
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--------GICHRDIKPQNLLV--NSK 177
Query: 479 GC---ISDFGL----TPL-MNTPTVPSRSAGYRAPEVI-ETKKPTQKSDVYSFGVLLLEM 529
+ DFG P + + SR YRAPE++ + T D++S G + E+
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYICSRF--YRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 530 LTGKAPIQAPGHEDVVD 546
+ GK P+ G E +D
Sbjct: 236 ILGK-PL-FSG-ETSID 249
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 43/215 (20%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM-------EVVG-RLSQHP 392
+ +G G+ G A V +K+L F+ Q E+V + H
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHK 84
Query: 393 NVVPIR------AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS 446
N++ + + +V + ++A L + + LD R+ L
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQ---VIQMELD-HERMSYLLYQ 135
Query: 447 A-KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL------TPLMNTPTVPSRS 499
GI H+H+A I ++K SN+++ D I DFGL + +M TP V +R
Sbjct: 136 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM-TPYVVTRY 191
Query: 500 AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKA 534
YRAPEVI + D++S G ++ EM+ G
Sbjct: 192 --YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 51/236 (21%)
Query: 335 DLLRASAEVLGKGSYGTTYKAILEE----GTTVVVKRL-KEVVMGKREFEQQM---EVVG 386
DLLR V+G+GSY K +L +K + KE+V + + V
Sbjct: 12 DLLR----VIGRGSYA---KVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 387 RLSQHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK---- 441
+ S HP +V + F + +L V +++ G L+ + + P E +
Sbjct: 65 QASNHPFLVGLH-SCFQTESRLFFVIEYVNGGD---LMFHMQRQRKLP---EEHARFYSA 117
Query: 442 -ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG--CISDFGL-----TPLMNTP 493
ISL + ++H I ++K NVLL D +G ++D+G+ P T
Sbjct: 118 EISLA----LNYLHER---GIIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTS 168
Query: 494 TV---PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
T P+ Y APE++ + D ++ GVL+ EM+ G++P G D D
Sbjct: 169 TFCGTPN----YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 49/219 (22%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
+VLG G G + +K L++ +RE +E+ R SQ P++V I
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDV 123
Query: 401 Y----FSKDEKLLVYDFIEAGS-FSALLHGNRGIGR-TPLDWE---SRVKISLGSA---- 447
Y + L+V + ++ G FS + +RG T E S + S+G A
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFT----EREASEIMKSIGEAIQYL 177
Query: 448 --KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC---ISDFGL------TPLMNTPTVP 496
IAH ++K N+L + ++DFG + TP
Sbjct: 178 HSINIAH-----------RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC-- 224
Query: 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ Y APEV+ +K + D++S GV++ +L G P
Sbjct: 225 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 61/283 (21%)
Query: 288 DSEGTAATKSKGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKG 347
++ GI EK + + + L F+ LLR V+G+G
Sbjct: 18 ENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFD----------LLR----VIGRG 63
Query: 348 SYGTTYKAILEE----GTTVVVKRL-KEVVMGKREFEQQM---EVVGRLSQHPNVVPIRA 399
SY K +L ++ + KE+V + + V + S HP +V +
Sbjct: 64 SYA---KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH- 119
Query: 400 YYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-----ISLGSAKGIAHI 453
F + +L V +++ G L+ + + P E + ISL + ++
Sbjct: 120 SCFQTESRLFFVIEYVNGGD---LMFHMQRQRKLP---EEHARFYSAEISLA----LNYL 169
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQG--CISDFGL-----TPLMNTPTV---PSRSAGYR 503
H I ++K NVLL D +G ++D+G+ P T T P+ Y
Sbjct: 170 HER---GIIYRDLKLDNVLL--DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN----YI 220
Query: 504 APEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
APE++ + D ++ GVL+ EM+ G++P G D D
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 52/222 (23%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 343 VLGKGSYGTTYKAILEE----GTTVVVKRL-KEVVMGKREFEQQM--EVVGRLSQHPNVV 395
VLGKG +G + + G K+L K+ + ++ + + + VV
Sbjct: 191 VLGKGGFG---EVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247
Query: 396 PIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-----ISLGSAKG 449
+ AY + + L LV + G L +G+ E+R I G
Sbjct: 248 SL-AYAYETKDALCLVLTLMNGGD---LKFHIYHMGQAGFP-EARAVFYAAEICCG---- 298
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQG--CISDFGLTPLMNTPTVPSRSAG---YRA 504
+ +H + + ++K N+LL D G ISD GL + G Y A
Sbjct: 299 LEDLHRE---RIVYRDLKPENILL--DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
PEV++ ++ T D ++ G LL EM+ G++P Q + +
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 48/217 (22%), Positives = 80/217 (36%), Gaps = 36/217 (16%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKRE---FEQQM-------EV-VGRLSQ 390
+ GSYG + EG V +KR+ V R E+ +
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 391 HPNVVPI----RAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLG 445
HPN++ + + KL LV + + L R + ++ +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTD-----LAQVIHDQRIVIS-PQHIQYFMY 141
Query: 446 SA-KGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL------TPLMNTPTVPSR 498
G+ +H A + ++ N+LL+ + I DF L T V R
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVTHR 197
Query: 499 SAGYRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
YRAPE++ + K T+ D++S G ++ EM KA
Sbjct: 198 W--YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 62/263 (23%), Positives = 105/263 (39%), Gaps = 55/263 (20%)
Query: 300 IRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGTTYKAIL 357
+R EK ++ E K + ED +L+ V+G+G++G + +
Sbjct: 46 LRREKNILEY------LEWAKPFTSKVKQMRLHREDFEILK----VIGRGAFG---EVAV 92
Query: 358 --EEGTTVV--VKRL-KEVVMGKREFEQQME--VVGRLSQHPNVVPIRAYYFSKDEKL-L 409
+ V +K L K ++ + E E V + + Y F D L L
Sbjct: 93 VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYL 151
Query: 410 VYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-----ISLGSAKGIAHIHAAVGGKFILG 464
V D+ G LL ++ R P E + + + I +H ++
Sbjct: 152 VMDYYVGGDLLTLL--SKFEDRLP---EEMARFYLAEMVIA----IDSVHQL---HYVHR 199
Query: 465 NIKSSNVLLSQDLQG--CISDFGL-TPLMNTPTVPSRSA-G---YRAPEVIETKKPTQKS 517
+IK N+L+ D+ G ++DFG LM TV S A G Y +PE+++ + +
Sbjct: 200 DIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257
Query: 518 -----DVYSFGVLLLEMLTGKAP 535
D +S GV + EML G+ P
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETP 280
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 44/245 (17%), Positives = 78/245 (31%), Gaps = 52/245 (21%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVK-----RLKEVVMGKRE-FEQQMEVVGRLSQHPNV 394
+G+GSYG AI + +K +++++ E + ++ ++ +L HPN+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNI 90
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI 453
+ Y + LV + G L + +I I
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 454 HAAVGGKFILGN-------------------------------IKSSNVLLSQDLQGC-- 480
+ ++ G + IK N L S +
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 481 ISDFGLTPLMNTPTVPSR--------SAGYRAPEVIE--TKKPTQKSDVYSFGVLLLEML 530
+ DFGL+ + + APEV+ + K D +S GVLL +L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 531 TGKAP 535
G P
Sbjct: 271 MGAVP 275
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 60/252 (23%), Positives = 99/252 (39%), Gaps = 54/252 (21%)
Query: 322 VFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAIL----EEGTTVVVKRL-KEVVMGKR 376
VF E NFD ++LR +GKGS+G K + + +K + K+ + +
Sbjct: 5 VFDENEDVNFDHFEILR----AIGKGSFG---KVCIVQKNDTKKMYAMKYMNKQKCVERN 57
Query: 377 EFEQQM---EVVGRLSQHPNVVPIRAYYFSKDEKL-LVYDFIEAGS-FSALLHGNRGIGR 431
E +++ L HP +V + Y F +E + +V D + G L +
Sbjct: 58 EVRNVFKELQIMQGLE-HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL----QQNVH 111
Query: 432 TPLDWESRVKI---SLGSAKGIAHIHAAVGGKFILGNI-----KSSNVLLSQDLQG--CI 481
E VK+ L A + ++ I K N+LL D G I
Sbjct: 112 FK---EETVKLFICELVMA--LDYLQNQ--------RIIHRDMKPDNILL--DEHGHVHI 156
Query: 482 SDFGLTPLMNTPTVPSRSAG---YRAPEVIETKKPTQKS---DVYSFGVLLLEMLTGKAP 535
+DF + ++ T + AG Y APE+ ++K S D +S GV E+L G+ P
Sbjct: 157 TDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
Query: 536 IQAPGHEDVVDL 547
++
Sbjct: 217 YHIRSSTSSKEI 228
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 9e-12
Identities = 62/245 (25%), Positives = 107/245 (43%), Gaps = 51/245 (20%)
Query: 335 DLLRASAEVLGKGSYGTTYKAILEE----GTTVVVKRL-KEVVMGKREFEQQM---EVVG 386
+ L VLGKGS+G K +L E VK L K+VV+ + E M V+
Sbjct: 23 NFLM----VLGKGSFG---KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 75
Query: 387 RLSQHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK---- 441
+ P + + F ++L V +++ G L++ + +GR E
Sbjct: 76 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGD---LMYHIQQVGRFK---EPHAVFYAA 128
Query: 442 -ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG--CISDFGLTPLMNTPTVPSR 498
I++G + + + I ++K NV+L D +G I+DFG+ V ++
Sbjct: 129 EIAIG----LFFLQSK---GIIYRDLKLDNVML--DSEGHIKIADFGMCKENIWDGVTTK 179
Query: 499 S----AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV--------VD 546
+ Y APE+I + + D ++FGVLL EML G+AP + +++ V
Sbjct: 180 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 239
Query: 547 LPRWV 551
P+ +
Sbjct: 240 YPKSM 244
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 9e-12
Identities = 71/277 (25%), Positives = 112/277 (40%), Gaps = 61/277 (22%)
Query: 303 EKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE--- 359
E KE G GV + + + FE +R VLGKGS+G K +L
Sbjct: 4 ESSKEGNGIGVNSSNRLGIDNFE----------FIR----VLGKGSFG---KVMLARVKE 46
Query: 360 -GTTVVVKRL-KEVVMGKREFEQQM---EVVGRLSQHPNVVPIRAYYFSKDEKL-LVYDF 413
G VK L K+V++ + E M ++ HP + + F ++L V +F
Sbjct: 47 TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEF 105
Query: 414 IEAGSFSALLHGNRGIGRTPLDWESRVK-----ISLGSAKGIAHIHAAVGGKFILGNIKS 468
+ G L+ + R E+R + I + +H I ++K
Sbjct: 106 VNGGD---LMFHIQKSRRFD---EARARFYAAEIISA----LMFLH---DKGIIYRDLKL 152
Query: 469 SNVLLSQDLQG--CISDFGLTPLMNTPTVPSRS----AGYRAPEVIETKKPTQKSDVYSF 522
NVLL D +G ++DFG+ V + + Y APE+++ D ++
Sbjct: 153 DNVLL--DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAM 210
Query: 523 GVLLLEMLTGKAPIQAPGHEDV--------VDLPRWV 551
GVLL EML G AP +A +D+ V P W+
Sbjct: 211 GVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 247
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 53/265 (20%), Positives = 97/265 (36%), Gaps = 57/265 (21%)
Query: 300 IRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGTTYKAIL 357
+ +K DF + + + +D +L+ V+G+G++ + +
Sbjct: 33 LAQDKYVADF------LQWAEPIVVRLKEVRLQRDDFEILK----VIGRGAFS---EVAV 79
Query: 358 --EEGTTVV--VKRL-KEVVMGKREFEQQME--VVGRLSQHPNVVPIRAYYFSKDEKL-L 409
+ T V +K + K ++ + E E V + + + F + L L
Sbjct: 80 VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYL 138
Query: 410 VYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-----ISLGSAKGIAHIHAAVGGKFILG 464
V ++ G LL ++ R P + I + I +H ++
Sbjct: 139 VMEYYVGGDLLTLL--SKFGERIP---AEMARFYLAEIVMA----IDSVHRL---GYVHR 186
Query: 465 NIKSSNVLLSQDLQG--CISDFGL-TPLMNTPTVPSRSA-G---YRAPEVIETKKPTQKS 517
+IK N+LL D G ++DFG L TV S A G Y +PE+++ +
Sbjct: 187 DIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGT 244
Query: 518 DVY-------SFGVLLLEMLTGKAP 535
Y + GV EM G+ P
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 21/128 (16%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPS----SLS 135
IP T E L L +N + + + L LR + NN + +I S
Sbjct: 30 IPQYTAE-------LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 136 PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSY 191
+N + L+ N + N+ + + L L L L++N +T + N F LS +R L+L
Sbjct: 82 -GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYD 138
Query: 192 NHLNGSVP 199
N + +V
Sbjct: 139 NQIT-TVA 145
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 26/120 (21%), Positives = 41/120 (34%), Gaps = 30/120 (25%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLSPQLN 139
I E + + L SN L ++ + L SL+ L L++N +
Sbjct: 72 IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT------------ 118
Query: 140 WVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYNHLN 195
+ LS + L+L +N +T + F L L LNL N N
Sbjct: 119 -----------CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 18/86 (20%), Positives = 29/86 (33%), Gaps = 11/86 (12%)
Query: 130 IPSSLSPQLNWVDLSFNSITGNIP-ASIRNLSHLVGLNLQNNSLTGFIPN-FN-LSRLRH 186
IP + + L+ N T + L L +N NN +T F S +
Sbjct: 26 IPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNE 85
Query: 187 LNLSYNHLNGSVPLALQKFPPSSFEG 212
+ L+ N L+ F+G
Sbjct: 86 ILLTSNR--------LENVQHKMFKG 103
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 42/208 (20%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRL-KEVVMGKREFEQQMEVVGRLSQHPNVVPIRA 399
E LG G++G ++ + G V K + + K + ++ ++ +L HP ++ +
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHD 115
Query: 400 YYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+ K E +L+ +F+ G F + + + + ++ + G+ H+H
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACE---GLKHMHEH-- 168
Query: 459 GKFILGNI-----KSSNVLLS--QDLQGCISDFGLTPLMNTPTVPSR----SAGYRAPEV 507
+I K N++ + I DFGL +N P + +A + APE+
Sbjct: 169 ------SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEI 221
Query: 508 IETKKPTQKSDVYSFGVLLLEMLTGKAP 535
++ + +D+++ GVL +L+G +P
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 47/231 (20%), Positives = 93/231 (40%), Gaps = 63/231 (27%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRL--------KEVVMGKRE-FEQQMEVVGRLSQH 391
+V+G+G + + G VK + E + RE ++ ++ +++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 392 PNVVPIRAYYFSKDEKLLV---------YDFI-EAGSFS---ALLHGNRGIGRTPLDWES 438
P+++ + Y S LV +D++ E + S R I R+ L+
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET-----RSIMRSLLE--- 211
Query: 439 RVKISLGSAKGIAHIHAAVGGKFILG----NIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494
++ +HA ++K N+LL ++Q +SDFG + + P
Sbjct: 212 ----------AVSFLHA-------NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-PG 253
Query: 495 VPSR----SAGYRAPEVIETKKP------TQKSDVYSFGVLLLEMLTGKAP 535
R + GY APE+++ ++ D+++ GV+L +L G P
Sbjct: 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 64/274 (23%), Positives = 108/274 (39%), Gaps = 66/274 (24%)
Query: 291 GTAATKSKGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLED--LLRASAEVLGKGS 348
G AA KG E KE ++ K + L+ ++ LG GS
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKK---WETPSQNTAQLDQFDRIK----TLGTGS 53
Query: 349 YGTTYKAIL----EEGTTVVVKRL-KEVVMGKREFEQQM---EVVGRLSQHPNVVPIRAY 400
+G + +L E G +K L K+ V+ ++ E + ++ ++ P +V + +
Sbjct: 54 FG---RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLE-F 108
Query: 401 YFSKDEKL-LVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVK-----ISLGSAKGIAHI 453
F + L +V +++ G FS L R IGR E + I L ++
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFS---EPHARFYAAQIVLT----FEYL 157
Query: 454 HAAVGGKFILGNI-----KSSNVLLSQDLQG--CISDFGLTPLMNTPT-----VPSRSAG 501
H+ ++ K N+L+ D QG ++DFG + T P
Sbjct: 158 HSL--------DLIYRDLKPENLLI--DQQGYIQVTDFGFAKRVKGRTWTLCGTPE---- 203
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
APE+I +K + D ++ GVL+ EM G P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 63/280 (22%), Positives = 107/280 (38%), Gaps = 50/280 (17%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRL-KEVVMGKRE-FEQQMEVVGRLSQHPNVVPIR 398
LG G++G + G V+K + K+ E E ++EV+ L HPN++ I
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIF 86
Query: 399 AYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGR-TPLDWESRVKISLGSAKGIAHIHAA 456
+ +V + E G ++ + +K + +A+ H+
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN---ALAYFHS- 142
Query: 457 VGGKFILG----NIKSSNVLL---SQDLQGCISDFGLTPLMNTPTVPSR---SAGYRAPE 506
++K N+L S I DFGL L + + +A Y APE
Sbjct: 143 ------QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE 196
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566
V + + T K D++S GV++ +LTG P E+V Q +E + V
Sbjct: 197 VFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV------QQKATYKEPN---YAV 246
Query: 567 ELMRYENIEEE----MVQMLQIAMSCVAKVPDMRPTMEEV 602
E + + + QML K P+ RP+ +V
Sbjct: 247 E---CRPLTPQAVDLLKQMLT-------KDPERRPSAAQV 276
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 58/259 (22%), Positives = 97/259 (37%), Gaps = 79/259 (30%)
Query: 335 DLLRASAEVLGKGSYGTTYKAILEE--GTTVV--VKRL-KEVVMGKREFEQQM---EVVG 386
L+ V+GKGS+G K +L V VK L K+ ++ K+E + M V+
Sbjct: 41 HFLK----VIGKGSFG---KVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 387 RLSQHPNVVPIRAYYFSKDEKL-LVYDFI----------EAGSFSALLHGNRGIGRTPLD 435
+ +HP +V + + F +KL V D+I F
Sbjct: 94 KNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFL--------------- 137
Query: 436 WESRVK-----ISLGSAKGIAHIHAAVGGKFILGNI----KSSNVLLSQDLQG--CISDF 484
E R + I+ + ++H+ L + K N+LL D QG ++DF
Sbjct: 138 -EPRARFYAAEIASA----LGYLHS-------LNIVYRDLKPENILL--DSQGHIVLTDF 183
Query: 485 GLTPLMNTPTVPSRS----AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540
GL + + Y APEV+ + + D + G +L EML G P +
Sbjct: 184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243
Query: 541 HEDV--------VDLPRWV 551
++ + L +
Sbjct: 244 TAEMYDNILNKPLQLKPNI 262
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 62/305 (20%), Positives = 109/305 (35%), Gaps = 100/305 (32%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVK-----RLKEVVMGKREFEQQMEV-----VGRLSQ 390
+LGKG +GT + L + V +K R+ +EV VG
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 391 HPNVVPIRAYYFSKDEKLLV----------YDFIEAGSFSALLHGNRGIGRTPLD-WESR 439
HP V+ + ++ +++ +LV +D+I G L SR
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-------KGP-------LGEGPSR 142
Query: 440 VK----ISLGSAKGIAHIHAAVGGKFILG----NIKSSNVLLSQDLQGC--ISDFGLTPL 489
++ I H H+ G +IK N+L+ +GC + DFG L
Sbjct: 143 CFFGQVVA-----AIQHCHS-------RGVVHRDIKDENILIDLR-RGCAKLIDFGSGAL 189
Query: 490 MNTPTVPSRSAG---YRAPEVIETKK---PTQKSDVYSFGVLLLEMLTGKAPIQAPGHED 543
+ + G Y PE I + + V+S G+LL +M+ G P + ++
Sbjct: 190 L-HDEPYTDFDGTRVYSPPEWISRHQYHAL--PATVWSLGILLYDMVCGDIPFE--RDQE 244
Query: 544 VVD----LPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTM 599
+++ P V + + L+R + L P RP++
Sbjct: 245 ILEAELHFPAHV--------SPDCCA--LIR---------RCLAPK-------PSSRPSL 278
Query: 600 EEVVR 604
EE++
Sbjct: 279 EEILL 283
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 3e-11
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 61/228 (26%)
Query: 335 DLLRASAEVLGKGSYGTTYKAIL----EEGTTVVVKRL-KEVVMGKREFEQQM---EVVG 386
+LR LG GS+G + L G +K L KE+V+ ++ E ++
Sbjct: 9 QILR----TLGTGSFG---RVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 387 RLSQHPNVVPIRAYYFSKDEKL-LVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVK--- 441
++ HP ++ + F +++ ++ D+IE G FS L R R P K
Sbjct: 62 IVT-HPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL----RKSQRFP---NPVAKFYA 112
Query: 442 --ISLGSAKGIAHIHAAVGGKFILGNI-----KSSNVLLSQDLQG--CISDFGLTPLMNT 492
+ L + ++H+ +I K N+LL D G I+DFG +
Sbjct: 113 AEVCLA----LEYLHSK--------DIIYRDLKPENILL--DKNGHIKITDFGFAKYVPD 158
Query: 493 PTV-----PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
T P Y APEV+ TK + D +SFG+L+ EML G P
Sbjct: 159 VTYTLCGTPD----YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-11
Identities = 44/219 (20%), Positives = 80/219 (36%), Gaps = 52/219 (23%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRL-KEVVMGKREFEQQMEVVGRLSQHPNVVPIRA 399
+G+GS+G A+ + K++ K V F+Q++E++ L HPN++ +
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD-HPNIIRLYE 73
Query: 400 YYFSKDEKLLV---------YDFI-EAGSFS---ALLHGNRGIGRTPLDWESRVKISLGS 446
+ + LV ++ + F A I + L
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA-----ARIMKDVLS----------- 117
Query: 447 AKGIAHIHAAVGGKFILG----NIKSSNVLL---SQDLQGCISDFGLTPLMNTPTVPSR- 498
+A+ H L ++K N L S D + DFGL +
Sbjct: 118 --AVAYCHK-------LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168
Query: 499 --SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ Y +P+V+E + D +S GV++ +L G P
Sbjct: 169 VGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 46/220 (20%), Positives = 83/220 (37%), Gaps = 44/220 (20%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRL-KEVVMGKREFEQQME---VVGRLSQHPNVVP 396
++LG+GSYG + + E VK L K+ + E ++ + R +H NV+
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 397 IR--AYYFSKDEKLLVYDFIEAGS---FSALLHGNRGIGRTPLDWESRVK----ISLGSA 447
+ Y K + +V ++ G ++ R P ++ I
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-----RFP-VCQAHGYFCQLID---- 120
Query: 448 KGIAHIHAAVGGKFILG----NIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR----- 498
G+ ++H+ G +IK N+LL+ IS G+ ++
Sbjct: 121 -GLEYLHS-------QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 499 -SAGYRAPEVIETKKP--TQKSDVYSFGVLLLEMLTGKAP 535
S ++ PE+ K D++S GV L + TG P
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 63/322 (19%), Positives = 115/322 (35%), Gaps = 87/322 (27%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRL-KEVVMGKREFEQQM------EV-VGRLSQHP 392
LG G++G + A+ E+ VVVK + KE V+ E E+ + +H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 393 NVVPIRAYYFSKDEKLLVYDFIEAGSFSAL---LHGNRG------IGRTPLD-WESRVK- 441
N++ K+ D E F L HG+ LD +
Sbjct: 90 NII-----------KV--LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 442 ---ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR 498
+S + ++ I +IK N+++++D + DFG + +
Sbjct: 137 RQLVS-----AVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 499 SAG---YRAPEVIETKK---PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD----LP 548
G Y APEV+ P + +++S GV L ++ + P E+ V+ P
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGP--ELEMWSLGVTLYTLVFEENPFC--ELEETVEAAIHPP 244
Query: 549 RWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR---M 605
V + E+ L+ +LQ VP+ R T+E++V +
Sbjct: 245 YLV--------SKELMS--LVS---------GLLQ-------PVPERRTTLEKLVTDPWV 278
Query: 606 IEDIRPSDSENQPSSEDKLKDS 627
+ + +D + +S
Sbjct: 279 TQPVNLADYTWEEVFRVNKPES 300
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.8 bits (157), Expect = 4e-11
Identities = 24/116 (20%), Positives = 48/116 (41%), Gaps = 7/116 (6%)
Query: 84 NTLEKLDSLMIL--SLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS-PQLNW 140
+TL+ +D + + + + + +R L+L + + + + +
Sbjct: 409 STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCHLEQLLLVTH 467
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLN 195
+DLS N + +P ++ L L L +N+L + NL RL+ L L N L
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 28/106 (26%), Positives = 44/106 (41%), Gaps = 10/106 (9%)
Query: 94 ILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGN 151
+L L L+ + ++ L + L L +N +P +L+ L + S N++ N
Sbjct: 445 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-N 500
Query: 152 IPASIRNLSHLVGLNLQNN---SLTGFIPNFNLSRLRHLNLSYNHL 194
+ + NL L L L NN P + RL LNL N L
Sbjct: 501 VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 57.5 bits (138), Expect = 8e-09
Identities = 29/92 (31%), Positives = 42/92 (45%), Gaps = 8/92 (8%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIP--SSLSPQLNWVDL 143
LE+L + L L N L LP + +L L L +N N+ ++L P+L + L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANL-PRLQELLL 515
Query: 144 SFNSITGNIPA--SIRNLSHLVGLNLQNNSLT 173
N + A + + LV LNLQ NSL
Sbjct: 516 CNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.4 bits (104), Expect = 9e-05
Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 2/111 (1%)
Query: 87 EKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG--NIPSSLSPQLNWVDLS 144
+L+S L L + +L + +L L + + + + ++D
Sbjct: 366 SELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL 425
Query: 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+ + + L+L + LT L + HL+LS+N L
Sbjct: 426 RSKFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLR 476
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 43/221 (19%), Positives = 82/221 (37%), Gaps = 52/221 (23%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQ-QMEV-VGRLSQHPNVVPIR 398
E LGKG++ + + + G + + R+ ++ + E + RL +HPN+V +
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 399 AYYFSKDEKLLVYDF----------IEAGSFS---ALLHGNRGIGRTPLDWESRVKISLG 445
+ L++D + +S A + L+
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA-----SHCIQQILE---------- 121
Query: 446 SAKGIAHIHAAVGGKFILG----NIKSSNVLL---SQDLQGCISDFGLTPLMNTPTVPSR 498
+ H H +G N+K N+LL + ++DFGL +
Sbjct: 122 ---AVLHCHQ-------MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 499 ----SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ GY +PEV+ + D+++ GV+L +L G P
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 43/235 (18%), Positives = 84/235 (35%), Gaps = 58/235 (24%)
Query: 332 DLEDLLRASAEVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKR---EFEQQMEVVGR 387
+ + +++ LG+G + + I G K LK+ G+ E ++ V+
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 388 LSQHPNVVPIRAYYFSKDEKLLVYDFIE------------AGSFS---ALLHGNRGIGRT 432
P V+ + Y + E +L+ ++ A S + +
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV-----IRLIKQ 139
Query: 433 PLDWESRVKISLGSAKGIAHIHAAVGGKFILGNI-----KSSNVLLSQDLQGC---ISDF 484
L+ G+ ++H NI K N+LLS I DF
Sbjct: 140 ILE-------------GVYYLHQN--------NIVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 485 GLTPLMNTPTVPSR----SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
G++ + R + Y APE++ T +D+++ G++ +LT +P
Sbjct: 179 GMSRKIG-HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 34/210 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVP 396
+G G+YG+ AI G V +K+L + KR + + + + + QH NV+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL--LLKHMQHENVIG 87
Query: 397 IR-----AYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA-KG 449
+ A LV F++ L I E +++ + KG
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFMQTD-----LQK---IMGLKFS-EEKIQYLVYQMLKG 138
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL----TPLMNTPTVPSRSAGYRAP 505
+ +IH+A + ++K N+ +++D + I DFGL M T V +R YRAP
Sbjct: 139 LKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-TGYVVTRW--YRAP 192
Query: 506 EVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
EVI Q D++S G ++ EMLTGK
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 38/207 (18%), Positives = 84/207 (40%), Gaps = 28/207 (13%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E LG+G +G ++ + T + K +K + ++++ ++ +H N++ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHES 69
Query: 401 YFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459
+ S +E +++++FI F + + S V + + +H+
Sbjct: 70 FESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVC---EALQFLHSH--- 121
Query: 460 KFILGNI-----KSSNVLLS--QDLQGCISDFGLTPLMNTPTVPSR----SAGYRAPEVI 508
NI + N++ + I +FG + P R + Y APEV
Sbjct: 122 -----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPEYYAPEVH 175
Query: 509 ETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ + +D++S G L+ +L+G P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 38/228 (16%), Positives = 84/228 (36%), Gaps = 62/228 (27%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVK-------RLKEVVMGKREFEQQMEVVGRLSQHPN 393
E LG G + K G K + + E E+++ ++ + HPN
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPN 69
Query: 394 VVPIRAYYFSKDEKLLVYDF----------IEAGSFS---ALLHGNRGIGRTPLDWESRV 440
++ + + +K + +L+ + E S + A + LD
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA-----TQFLKQILD----- 119
Query: 441 KISLGSAKGIAHIHAAVGGKFILGNI-----KSSNVLL-SQDLQGC---ISDFGLTPLMN 491
G+ ++H+ I K N++L +++ + DFG+ +
Sbjct: 120 --------GVHYLHSK--------RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 492 TPTVPSR----SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ + + APE++ + ++D++S GV+ +L+G +P
Sbjct: 164 -AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 59/265 (22%), Positives = 103/265 (38%), Gaps = 62/265 (23%)
Query: 300 IRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLED--LLRASAEVLGKGSYGTTYKAIL 357
+R K ++F + K + ED +++ V+G+G++G + L
Sbjct: 41 LRKNKNIDNF------LSRYKDTINKIRDLRMKAEDYEVVK----VIGRGAFG---EVQL 87
Query: 358 --EEGTTVV--VKRL-KEVVMGKREFEQQME--VVGRLSQHPNVVPIRAYYFSKDEKL-L 409
+ T V +K L K ++ + + E + + P VV + Y F D L +
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYM 146
Query: 410 VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAK--------GIAHIHAAVGGKF 461
V +++ G L+ S + A+ + IH+ F
Sbjct: 147 VMEYMPGGDLVNLM--------------SNYDVPEKWARFYTAEVVLALDAIHSM---GF 189
Query: 462 ILGNIKSSNVLLSQDLQG--CISDFGL-TPLMNTPTVPSRSA-G---YRAPEVIETKKPT 514
I ++K N+LL D G ++DFG + V +A G Y +PEV++++
Sbjct: 190 IHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 515 QK----SDVYSFGVLLLEMLTGKAP 535
D +S GV L EML G P
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 60/288 (20%), Positives = 113/288 (39%), Gaps = 73/288 (25%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVK-----RLKEVVMGK--REFEQQMEVVGRLSQHPNVV 395
+GKG++ A + G V +K +L + K RE + M ++ HPN+V
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREV-RIM----KILNHPNIV 77
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKIS-LGSA------K 448
+ ++ L+ ++ G L + GR E+R K + SA K
Sbjct: 78 KLFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRMKEK-EARSKFRQIVSAVQYCHQK 133
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAP 505
I H ++K+ N+LL D+ I+DFG + G Y AP
Sbjct: 134 RIVH-----------RDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182
Query: 506 EVIETKKPT-QKSDVYSFGVLLLEMLTGKAPIQAPGHED--------VVDLPRWVQSVVR 556
E+ + KK + DV+S GV+L +++G P ++ +P ++
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYM----- 237
Query: 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+++ + L++ + L + P R T+E++++
Sbjct: 238 ---STDCEN--LLK---------RFLVLN-------PIKRGTLEQIMK 264
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 50/221 (22%), Positives = 83/221 (37%), Gaps = 54/221 (24%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFE---QQMEVVGRLSQHPNVVPI 397
+LGKGS+G K VK + + ++ +++E++ +L HPN++ +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKL 86
Query: 398 RAYYFSKDEKLLVYDF----------IEAGSFS---ALLHGNRGIGRTPLDWESRVKISL 444
+V + I+ FS A I +
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-----ARIIKQVFS--------- 132
Query: 445 GSAKGIAHIHAAVGGKFILG----NIKSSNVLL---SQDLQGCISDFGLTPLMNTPTVPS 497
GI ++H ++K N+LL +D I DFGL+ T
Sbjct: 133 ----GITYMHK-------HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 498 R---SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+A Y APEV+ +K DV+S GV+L +L+G P
Sbjct: 182 DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 66/279 (23%)
Query: 288 DSEGTAATKSKGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLED--LLRASAEVLG 345
+ +A G + K + + K+ +E+ LL+ VLG
Sbjct: 18 AAGTSADGGDGGEQLLTVKHELRTANLTGHAEKV----------GIENFELLK----VLG 63
Query: 346 KGSYGTTY--KAILEEGTTVV--VKRL-KEVVMGKREFEQQM----EVVGRLSQHPNVVP 396
G+YG + + I T + +K L K ++ K + + +V+ + Q P +V
Sbjct: 64 TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 123
Query: 397 IRAYYFSKDEKL-LVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVK-----ISLGSAKG 449
+ Y F + KL L+ D+I G F+ L R E V+ I L
Sbjct: 124 LH-YAFQTETKLHLILDYINGGELFTHL----SQRERFT---EHEVQIYVGEIVLA---- 171
Query: 450 IAHIHAAVGGKFILGNI----KSSNVLLSQDLQG--CISDFGLT-PLMNTPTVPSRS--- 499
+ H+H LG I K N+LL D G ++DFGL+ + T +
Sbjct: 172 LEHLHK-------LGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 500 -AGYRAPEVI-ETKKPTQKS-DVYSFGVLLLEMLTGKAP 535
Y AP+++ K+ D +S GVL+ E+LTG +P
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 50/244 (20%)
Query: 335 DLLRASAEVLGKGSYGTTYKAIL--EEGTTVV--VKRL-KEVVMGKREFEQQM--EVVGR 387
D L+ +LGKG++G K IL E+ T +K L KEV++ K E + V +
Sbjct: 8 DYLK----LLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 388 LSQHPNVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK----- 441
++HP + ++ Y F ++L V ++ G H + R + E R +
Sbjct: 61 NTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL--FFH----LSRERVFTEERARFYGAE 113
Query: 442 ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG--CISDFGLTPLMNTPTVPSRS 499
I + ++H+ + +IK N++L D G I+DFGL + ++
Sbjct: 114 IVSA----LEYLHSR---DVVYRDIKLENLML--DKDGHIKITDFGLCKEGISDGATMKT 164
Query: 500 ----AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV--------VDL 547
Y APEV+E + D + GV++ EM+ G+ P HE + +
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 548 PRWV 551
PR +
Sbjct: 225 PRTL 228
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 49/220 (22%), Positives = 89/220 (40%), Gaps = 51/220 (23%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQ-QMEV-VGRLSQHPNVVPIR 398
E LGKG++ + + + G K + + R+F++ + E + R QHPN+V +
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 399 AYYFSKDEKLLV---------YDFI-EAGSFS---ALLHGNRGIGRTPLDWESRVKISLG 445
+ LV ++ I +S A + L+
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA-----SHCIQQILE---------- 116
Query: 446 SAKGIAHIHAAVGGKFILG----NIKSSNVLLSQDLQGC---ISDFGLTPLMNTPTVPSR 498
IA+ H+ G N+K N+LL+ +G ++DFGL +N
Sbjct: 117 ---SIAYCHS-------NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166
Query: 499 ---SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ GY +PEV++ ++ D+++ GV+L +L G P
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 45/216 (20%), Positives = 85/216 (39%), Gaps = 45/216 (20%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKRE-FEQQMEVVGRLSQHPNVVPIRA 399
E LG G++G ++ G K + +E ++++ + L +HP +V +
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHD 221
Query: 400 YYFSKDEKLLVYDFIEAGS-FSALLHGN--------RGIGRTPLDWESRVKISLGSAKGI 450
+ +E +++Y+F+ G F + + R G+
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK-------------GL 268
Query: 451 AHIHAAVGGKFILGNI-----KSSNVLLSQDLQGCI--SDFGLTPLMNTPTVPSR----S 499
H+H N K N++ + + DFGLT ++ P + +
Sbjct: 269 CHMHEN--------NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGT 319
Query: 500 AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
A + APEV E K +D++S GVL +L+G +P
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 45/224 (20%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNVVPIR 398
LG+G Y ++AI + VVVK LK V K RE ++++ L PN++ +
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE----IKILENLRGGPNIITLA 97
Query: 399 AYYFSKDEK--LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ LV++ + F L T D + L K + + H+
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEIL---KALDYCHSM 149
Query: 457 VGGKFILGNI-----KSSNVLLSQDLQGC---ISDFGL----TPLMN-TPTVPSRSAGYR 503
I K NV++ D + + D+GL P V SR ++
Sbjct: 150 --------GIMHRDVKPHNVMI--DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY--FK 197
Query: 504 APEVI-ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546
PE++ + + D++S G +L M+ K P GH D D
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF-FHGH-DNYD 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 40/228 (17%), Positives = 86/228 (37%), Gaps = 62/228 (27%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVK-------RLKEVVMGKREFEQQMEVVGRLSQHPN 393
E LG G + K G K + + + + E+++ ++ + HPN
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPN 75
Query: 394 VVPIRAYYFSKDEKLLVYDF----------IEAGSFS---ALLHGNRGIGRTPLDWESRV 440
V+ + Y +K + +L+ + E S + A + L+
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA-----TEFLKQILN----- 125
Query: 441 KISLGSAKGIAHIHAAVGGKFILGNI-----KSSNVLL-SQDLQGC---ISDFGLTPLMN 491
G+ ++H+ I K N++L +++ I DFGL ++
Sbjct: 126 --------GVYYLHSL--------QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
Query: 492 TPTVPSR----SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ + + APE++ + ++D++S GV+ +L+G +P
Sbjct: 170 -FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 49/218 (22%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRL---KEVVMGKRE------FEQQMEVVGRLSQH 391
+ LG G+ G A + V ++ + K + RE E ++E++ +L+ H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-H 199
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
P ++ I+ ++ ++D +V + +E G F ++ +G L + +
Sbjct: 200 PCIIKIKNFFDAED-YYIVLELMEGGELF------DKVVGNKRLKEATCKLYFYQMLLAV 252
Query: 451 AHIHAAVGGKFILG----NIKSSNVLLSQDLQGC---ISDFGLTPLMNTPTVPSRSAG-- 501
++H G ++K NVLLS + C I+DFG + ++ ++ G
Sbjct: 253 QYLHE-------NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 502 -YRAPEVIETKKP---TQKSDVYSFGVLLLEMLTGKAP 535
Y APEV+ + + D +S GV+L L+G P
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRL-KEVVMGKREFEQQMEVVGRLSQHPNVVPIRA 399
E+LG G +G +K G + K + + K E + ++ V+ +L H N++ +
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD-HANLIQLYD 153
Query: 400 YYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+ SK++ +LV ++++ G F ++ T LD +K GI H+H
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIID--ESYNLTELDTILFMKQICE---GIRHMHQ--- 205
Query: 459 GKFILG-NIKSSNVLLS--QDLQGCISDFGLTPLMNTPTVPSR----SAGYRAPEVIETK 511
+IL ++K N+L Q I DFGL P + + + APEV+
Sbjct: 206 -MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPEFLAPEVVNYD 263
Query: 512 KPTQKSDVYSFGVLLLEMLTGKAP 535
+ +D++S GV+ +L+G +P
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 41/228 (17%), Positives = 85/228 (37%), Gaps = 62/228 (27%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVK-------RLKEVVMGKREFEQQMEVVGRLSQHPN 393
E LG G + K G K R + + E E+++ ++ ++ H N
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHN 76
Query: 394 VVPIRAYYFSKDEKLLVYDF----------IEAGSFS---ALLHGNRGIGRTPLDWESRV 440
V+ + Y ++ + +L+ + + S S A + LD
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----TSFIKQILD----- 126
Query: 441 KISLGSAKGIAHIHAAVGGKFILGNI-----KSSNVLL-SQDLQGC---ISDFGLTPLMN 491
G+ ++H I K N++L +++ + DFGL +
Sbjct: 127 --------GVNYLHTK--------KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 492 TPTVPSR----SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
V + + + APE++ + ++D++S GV+ +L+G +P
Sbjct: 171 -DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.2 bits (147), Expect = 5e-10
Identities = 56/269 (20%), Positives = 91/269 (33%), Gaps = 96/269 (35%)
Query: 335 DLLRASAEVLGKGSYGTTYKAILEEGTT----------------VVVKRLKEV--VMGKR 376
+LLR VLGKG YG K T ++V+ K+ +R
Sbjct: 20 ELLR----VLGKGGYG---KVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 377 EFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKL-LVYDFI----------EAGSFSALLHG 425
+ +HP +V + Y F KL L+ +++ G F
Sbjct: 73 N-------ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFM----- 119
Query: 426 NRGIGRTPLDWESRVK-----ISLGSAKGIAHIHAAVGGKFILGNI----KSSNVLLSQD 476
E IS+ + H+H G I K N++L +
Sbjct: 120 -----------EDTACFYLAEISMA----LGHLHQ-------KGIIYRDLKPENIML--N 155
Query: 477 LQG--CISDFGLTPLMNTPTVPSRS----AGYRAPEVIETKKPTQKSDVYSFGVLLLEML 530
QG ++DFGL + + Y APE++ + D +S G L+ +ML
Sbjct: 156 HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
Query: 531 TGKAPIQAPGHEDV--------VDLPRWV 551
TG P + ++LP ++
Sbjct: 216 TGAPPFTGENRKKTIDKILKCKLNLPPYL 244
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-10
Identities = 28/113 (24%), Positives = 44/113 (38%), Gaps = 9/113 (7%)
Query: 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFS--GNIPSSLSPQLNWVD 142
T + L++ + RSN L L FL N + N+P +L ++
Sbjct: 15 TPSDVKELVLDNSRSNEGK--LEGLTDEFEELEFLSTINVGLTSIANLPKL--NKLKKLE 70
Query: 143 LSFNSITGNIPASIRNLSHLVGLNLQNN---SLTGFIPNFNLSRLRHLNLSYN 192
LS N ++G + +L LNL N L+ P L L+ L+L
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 24/93 (25%), Positives = 45/93 (48%), Gaps = 5/93 (5%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG--NIPSSLSPQLNWV 141
++ + L LS + L+ + +N+ L+ L+ L L +N SG + + P L +
Sbjct: 36 GLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93
Query: 142 DLSFNSITG-NIPASIRNLSHLVGLNLQNNSLT 173
+LS N I + ++ L +L L+L N +T
Sbjct: 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-06
Identities = 22/91 (24%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 112 SLSSLRFLYLQNNNFS-GNIPSSLS--PQLNWVDLSFNSIT--GNIPASIRNLSHLVGLN 166
+ S ++ L L N+ + G + +L ++ +T N+P L+ L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLE 70
Query: 167 LQNNSLTGFIPNF--NLSRLRHLNLSYNHLN 195
L +N ++G + L HLNLS N +
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 6e-04
Identities = 18/72 (25%), Positives = 31/72 (43%), Gaps = 3/72 (4%)
Query: 137 QLNWVDLSFNSIT-GNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHL 194
+ + L + G + L L+ N LT I N L++L+ L LS N +
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNRV 76
Query: 195 NGSVPLALQKFP 206
+G + + +K P
Sbjct: 77 SGGLEVLAEKCP 88
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 52/222 (23%), Positives = 92/222 (41%), Gaps = 53/222 (23%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLK---EVVMGKREF-E----QQMEVVGRLSQHP 392
+G+G+YG A V +K++ +R E + +H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-------RHE 85
Query: 393 NVVPI----RAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKI----S 443
N++ I RA + + + +V D +E L+ + + L +
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETD-----LY--KLLKTQHLS-NDHICYFLYQI 137
Query: 444 LGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL----------TPLMNTP 493
L +G+ +IH+A + ++K SN+LL+ I DFGL T + T
Sbjct: 138 L---RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL-TE 190
Query: 494 TVPSRSAGYRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
V +R YRAPE++ +K T+ D++S G +L EML+ +
Sbjct: 191 YVATR--WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 33/210 (15%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEV----VMGKREF-EQQMEVVGRLSQHPNVV 395
+ +G G+YG A+ G V +K+L + KR + E ++ + +H NV+
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL---KHMRHENVI 87
Query: 396 PIR------AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKG 449
+ + LV F+ L + + L + + KG
Sbjct: 88 GLLDVFTPDETLDDFTDFYLVMPFMGTD-----LG--KLMKHEKLGEDRIQFLVYQMLKG 140
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL----TPLMNTPTVPSRSAGYRAP 505
+ +IHAA I ++K N+ +++D + I DFGL M T V +R YRAP
Sbjct: 141 LRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-TGYVVTRW--YRAP 194
Query: 506 EVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
EVI + TQ D++S G ++ EM+TGK
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 47/221 (21%), Positives = 87/221 (39%), Gaps = 57/221 (25%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRL---KEVVMGKREFEQQMEVVGRLSQHPNVVPI 397
LG+G+ Y+ +K L + + + E + V+ RLS HPN++ +
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTE----IGVLLRLS-HPNIIKL 113
Query: 398 RAYYFSKDEKLLV---------YDFI-EAGSFS---ALLHGNRGIGRTPLDWESRVKISL 444
+ + + E LV +D I E G +S A + L+
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA-----ADAVKQILE--------- 159
Query: 445 GSAKGIAHIHAAVGGKFILG----NIKSSNVLL---SQDLQGCISDFGLTPLMNTPTVPS 497
+A++H G ++K N+L + D I+DFGL+ ++ +
Sbjct: 160 ----AVAYLHE-------NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 498 R---SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ GY APE++ + D++S G++ +L G P
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 46/227 (20%), Positives = 90/227 (39%), Gaps = 56/227 (24%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLK---EVVMGKREF-E----QQMEVVGRLSQHP 392
+LG+G+YG A G V +K+++ + + R E + +H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-------KHE 69
Query: 393 NVVPI----RAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-----I 442
N++ I R F ++ ++ + ++ LH R I L + ++
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTD-----LH--RVISTQMLS-DDHIQYFIYQT 121
Query: 443 SLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL----TPLMNTPTVPSR 498
L + + +H + I ++K SN+L++ + + DFGL + P+
Sbjct: 122 -L---RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 499 SAG----------YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
YRAPEV+ + K ++ DV+S G +L E+ +
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 41/228 (17%), Positives = 86/228 (37%), Gaps = 62/228 (27%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVK-------RLKEVVMGKREFEQQMEVVGRLSQHPN 393
E LG G + K G K R + + E E+++ ++ ++ HPN
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPN 76
Query: 394 VVPIRAYYFSKDEKLLVYDF----------IEAGSFS---ALLHGNRGIGRTPLDWESRV 440
++ + Y ++ + +L+ + + S S A + LD
Sbjct: 77 IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----TSFIKQILD----- 126
Query: 441 KISLGSAKGIAHIHAAVGGKFILGNI-----KSSNVLL-SQDLQGC---ISDFGLTPLMN 491
G+ ++H I K N++L +++ + DFGL +
Sbjct: 127 --------GVNYLHTK--------KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 492 TPTVPSR----SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
V + + + APE++ + ++D++S GV+ +L+G +P
Sbjct: 171 -DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 46/224 (20%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM---EVVGRLSQHP----- 392
+V+GKGS+G KA + V +K ++ KR Q ++ L +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 393 NVVPIRAYYFSKD------EKLL--VYDFIEAGSFSAL-LHGNRGIGRTPLDWESRVKIS 443
NV+ + + ++ E L +Y+ I+ F L R + L
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL--------- 210
Query: 444 LGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS--DFGLTPLMN---TPTVPSR 498
+ + +H + I ++K N+LL Q + I DFG + + + SR
Sbjct: 211 ----QCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR 263
Query: 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHE 542
YRAPEVI + D++S G +L E+LTG + PG +
Sbjct: 264 F--YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL--PGED 303
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 54/234 (23%), Positives = 101/234 (43%), Gaps = 37/234 (15%)
Query: 344 LGKGSYGTTYKAILEEGTT---VVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPI 397
+G+G+YG YKA ++G +K+++ + RE E+ +HPNV+ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-----KHPNVISL 83
Query: 398 RAYYFSK-DEKL-LVYDFIE---AGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGIA 451
+ + S D K+ L++D+ E L VK + GI
Sbjct: 84 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP-RGMVKSLLYQILDGIH 142
Query: 452 HIHAAVGGKFIL-GNIKSSNVLLSQDL--QGC--ISDFGLTPLMNTPTVPSRSAG----- 501
++HA ++L ++K +N+L+ + +G I+D G L N+P P
Sbjct: 143 YLHA----NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 502 --YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ 552
YRAPE++ + T+ D+++ G + E+LT + PI ++ +
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI-FHCRQEDIKTSNPYH 250
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEV----VMGKREFEQQMEV-VGRLSQHPNVV 395
+G G+YG+ A + G V VK+L + KR + E+ + + +H NV+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR---ELRLLKHMKHENVI 91
Query: 396 PIR-----AYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA-K 448
+ A + + LV + A L+ + L + V+ + +
Sbjct: 92 GLLDVFTPARSLEEFNDVYLVTHLMGAD-----LN--NIVKCQKLT-DDHVQFLIYQILR 143
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL----TPLMNTPTVPSRSAGYRA 504
G+ +IH+A I ++K SN+ +++D + I DFGL M T V +R YRA
Sbjct: 144 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-TGYVATRW--YRA 197
Query: 505 PEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
PE++ Q D++S G ++ E+LTG+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 48/217 (22%), Positives = 84/217 (38%), Gaps = 40/217 (18%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGK----------REFEQQMEVVGRLSQH 391
+G+G+YG +KA + V LK V + RE + +H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVA-LKRVRVQTGEEGMPLSTIREVAVLRHL--ETFEH 73
Query: 392 PNVVP----IRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLG 445
PNVV ++ KL LV++ ++ + L G +K +
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT----ETIKDMMFQ 128
Query: 446 SAKGIAHIHAAVGGKFIL-GNIKSSNVLLSQDLQGC--ISDFGL-----TPLMNTPTVPS 497
+G+ +H+ ++ ++K N+L++ G ++DFGL + T V +
Sbjct: 129 LLRGLDFLHS----HRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVT 182
Query: 498 RSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKA 534
YRAPEV+ D++S G + EM K
Sbjct: 183 L--WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 27/115 (23%), Positives = 50/115 (43%), Gaps = 16/115 (13%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFS--GNIPSSLSPQLNWVDL 143
L L + L+L +N++ + S++ + +LR L L N N+ +++ L + +
Sbjct: 44 LSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIENL-DAVADTLEELWI 100
Query: 144 SFNSITGNIPASIRNLSHLVGL---NLQNN---SLTGFIPNFNLSRLRHLNLSYN 192
S+N I S+ + LV L + NN + L +L L L+ N
Sbjct: 101 SYNQIA-----SLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 29/120 (24%), Positives = 45/120 (37%), Gaps = 20/120 (16%)
Query: 83 ANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNW 140
A EK++ L + + + + +L + + L L NN I SSLS L
Sbjct: 22 ATEAEKVE----LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRI 74
Query: 141 VDLSFNSITGNIPASIRNLSHLVG----LNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLN 195
+ L N I I NL + L + N + + L LR L +S N +
Sbjct: 75 LSLGRNLIK-----KIENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKIT 128
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 43/228 (18%), Positives = 91/228 (39%), Gaps = 56/228 (24%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRL--KEVVMGKREF-E----QQMEVVGRLSQHPN 393
+ LG G G + A+ + V +K++ + K E +++ H N
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-------DHDN 69
Query: 394 VVPIR--------------AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR 439
+V + + +V +++E L + + PL E
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD-----LA--NVLEQGPLL-EEH 121
Query: 440 VKISLGSA-KGIAHIHAAVGGKFILGNIKSSNVLL-SQDLQGCISDFGL----------T 487
++ + +G+ +IH+A + ++K +N+ + ++DL I DFGL
Sbjct: 122 ARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHK 178
Query: 488 PLMNTPTVPSRSAGYRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
+ + + ++ YR+P ++ T+ D+++ G + EMLTGK
Sbjct: 179 GHL-SEGLVTK--WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 39/214 (18%), Positives = 82/214 (38%), Gaps = 31/214 (14%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKRE------FEQQMEVVGRLSQHPNV 394
EV+GKG + + I E G VK + +++ + L HP++
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHI 88
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGS-FSALL-HGNRGIGRTPLDWESRVKISLGSAKGIAH 452
V + Y S +V++F++ ++ + G + ++ L + + +
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EALRY 145
Query: 453 IHAAVGGKFILG----NIKSSNVLLSQDLQGC---ISDFGLTPLMNTPTVPSR----SAG 501
H ++K VLL+ + FG+ + + + +
Sbjct: 146 CHD-------NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPH 198
Query: 502 YRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ APEV++ + + DV+ GV+L +L+G P
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 43/214 (20%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGK----------REFEQQMEVVGRLSQH 391
E +G+G+YG YKA +G V +KR++ + RE E+ H
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR---LDAEDEGIPSTAIREISLLKEL-----HH 78
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGI 450
PN+V + S+ LV++F+E +L N+ L +S++K +G+
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT----GLQ-DSQIKIYLYQLLRGV 132
Query: 451 AHIHAAVGGKFIL-GNIKSSNVLLSQDLQGC--ISDFGL-----TPLMN-TPTVPSRSAG 501
AH H IL ++K N+L++ D G ++DFGL P+ + T V +
Sbjct: 133 AHCHQ----HRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVRSYTHEVVTL--W 184
Query: 502 YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
YRAP+V+ +KK + D++S G + EM+TGK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 51/220 (23%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQ-QMEV-VGRLSQHPNVVPIR 398
E LGKG++ + + G K + + R+F++ + E + R QHPN+V +
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 399 AYYFSKDEKLLV---------YDFI-EAGSFS---ALLHGNRGIGRTPLDWESRVKISLG 445
+ LV ++ I +S A + L+
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA-----SHCIQQILE---------- 139
Query: 446 SAKGIAHIHAAVGGKFILG----NIKSSNVLLSQDLQGC---ISDFGLTPLMNTPTVPSR 498
IA+ H+ G N+K N+LL+ +G ++DFGL +N
Sbjct: 140 ---SIAYCHS-------NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 189
Query: 499 ---SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
+ GY +PEV++ ++ D+++ GV+L +L G P
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 22/114 (19%), Positives = 35/114 (30%), Gaps = 12/114 (10%)
Query: 86 LEKLDSLMILSLRSNHLS--GDLPSNVLSLSSLRFLYLQNNNFS--GNIPSSLSPQLNWV 141
L LR + +L + L + +N P +L +
Sbjct: 15 YTNAVRDRELDLRGYKIPVIENLGAT---LDQFDAIDFSDNEIRKLDGFPLL--RRLKTL 69
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQNN---SLTGFIPNFNLSRLRHLNLSYN 192
++ N I + L L L L NN L P +L L +L + N
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-08
Identities = 20/95 (21%), Positives = 32/95 (33%), Gaps = 13/95 (13%)
Query: 108 SNVLSLSSLRFLYLQNNNFS--GNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGL 165
+ + R L L+ N+ ++L Q + +D S N I + L L
Sbjct: 13 AQYTNAVRDRELDLRGYKIPVIENLGATL-DQFDAIDFSDNEIR-----KLDGFPLLRRL 66
Query: 166 ---NLQNNSLTGFIPNF--NLSRLRHLNLSYNHLN 195
+ NN + L L L L+ N L
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 29/165 (17%), Positives = 58/165 (35%), Gaps = 37/165 (22%)
Query: 474 SQDLQGCISDFGL-TPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTG 532
++ L+ I+D G + T ++ YR+ EV+ +D++S + E+ TG
Sbjct: 230 AEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATG 289
Query: 533 KAPIQAPGHEDVVD--------------LPR-WVQSVVREEWTSEVFD------------ 565
+ E+ +PR + +++ E F
Sbjct: 290 DYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV---AGKYSKEFFTKKGDLKHITKLK 346
Query: 566 ------VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
V + +YE +EE + + +P+ R T E +R
Sbjct: 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 20/104 (19%), Positives = 36/104 (34%), Gaps = 8/104 (7%)
Query: 97 LRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS-SLS--PQLNWVDLSFNSITGNIP 153
R L ++ +L LY++N ++ L +L + + + + +
Sbjct: 16 TRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA 72
Query: 154 ASI-RNLSHLVGLNLQNNSLTGFIPN-FNLSRLRHLNLSYNHLN 195
L LNL N+L L+ L LS N L+
Sbjct: 73 PDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 13/100 (13%), Positives = 30/100 (30%), Gaps = 14/100 (14%)
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYNH 193
+ + + + + + +L L ++N + L LR+L + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 194 LNGSVPLALQKFPPSSFEGNSMLCGPPL--NQCSTVPPAP 231
L+ P +F L L N ++
Sbjct: 68 --------LRFVAPDAFHFTPRLSRLNLSFNALESLSWKT 99
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 48/211 (22%), Positives = 84/211 (39%), Gaps = 54/211 (25%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
+VLG G G + +K L++ +RE +E+ R SQ P++V I
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDV 79
Query: 401 Y----FSKDEKLLVYDFIEAGS-FSALLHGNRGIGR-TPLDWE---SRVKISLGSAKGIA 451
Y + L+V + ++ G FS + +RG T E S + S+G A I
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFT----EREASEIMKSIGEA--IQ 131
Query: 452 HIHAAVGGKFILG----NIKSSNVLL---SQDLQGCISDFGLTPLMNTPTVPSRSAGYRA 504
++H+ + ++K N+L + ++DFG A
Sbjct: 132 YLHS-------INIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------A 167
Query: 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535
E +K + D++S GV++ +L G P
Sbjct: 168 KETTG-EKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.1 bits (142), Expect = 4e-09
Identities = 72/587 (12%), Positives = 152/587 (25%), Gaps = 173/587 (29%)
Query: 74 GVGLYGPIPANTLEKLDSL--MILSLRSNH---LSGDLPS--NVLSLSSLRFLYLQNNNF 126
++ + L+ L +L LR + G L S ++L +Q
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK-M 180
Query: 127 SGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNL----S 182
I W++L + + ++ L + + N + S + +
Sbjct: 181 DFKI--------FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA 232
Query: 183 RLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSML-----CGPPL-----NQCSTVPPAPS 232
LR L L + + N +L C +
Sbjct: 233 ELRRL------------LKSKPYE------NCLLVLLNVQNAKAWNAFNLSCKILLTTRF 274
Query: 233 PSATNFPPPPTVLPKPREGSEEKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLKKKDSEGT 292
T+F T + L+ L L +L L
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDE--------VKSLLLKYLDCRPQDL-------- 318
Query: 293 AATKSKGIRNEKPKED----------FGSGVQEAEKNKLVFFEGCSYNFD-LEDLLRASA 341
P+E +++ ++ N D L ++ +S
Sbjct: 319 ------------PREVLTTNPRRLSIIAESIRD-GLATWDNWK--HVNCDKLTTIIESSL 363
Query: 342 EVLGKGSYGTTYK--AILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRA 399
VL Y + ++ + L ++ M VV +L +
Sbjct: 364 NVLEPAEYRKMFDRLSVFPPSAHIPTILL-SLIWFDVIKSDVMVVVNKLHK--------- 413
Query: 400 YYFS---KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+S K K + + E +VK+ +H +
Sbjct: 414 --YSLVEKQPKESTIS----------IPS--------IYLELKVKLE-----NEYALHRS 448
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEV---IETKKP 513
+ + N+ + D I P Y + ++ +
Sbjct: 449 I--------VDHYNIPKTFDSDDLI--------------PPYLDQYFYSHIGHHLKNIEH 486
Query: 514 TQKSDVYSFGVLLLEMLTGK-----APIQAPGH--EDVVDLPRWVQSVVREEWTSEVFDV 566
++ ++ L L K A G + L + + + E
Sbjct: 487 PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVN 546
Query: 567 ELMRY-ENIEEEMVQ-----MLQIAMSCVAKVPDMRPTMEEVVRMIE 607
++ + IEE ++ +L+IA+ + EE + ++
Sbjct: 547 AILDFLPKIEENLICSKYTDLLRIALM-----AEDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 68/412 (16%), Positives = 121/412 (29%), Gaps = 138/412 (33%)
Query: 308 DFGSGVQEAEKNKL--VFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVV- 364
DF +G + + + VF + NFD +D+ +L K I+ V
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK----EEIDHIIMSKDAVSG 63
Query: 365 VKRLKEVVMGKREFEQQMEVVGRLSQHPN----VVPIRAYYFSKDEKLLVYDFIEAGS-- 418
RL ++ K+E Q V L N + PI+ + ++ +IE
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLR--INYKFLMSPIKTEQ--RQPSMMTRMYIEQRDRL 119
Query: 419 ------FS---------------AL----------LHGNRGIGRTPLDWE--SRVKISLG 445
F+ AL + G G G+T + + K+
Sbjct: 120 YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCK 179
Query: 446 SAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAP 505
I ++ L N S +L + + + P + + S + R
Sbjct: 180 MDFKIFWLN--------LKNCNSPETVLEMLQKLL---YQIDPNWTSRSDHSSNIKLRIH 228
Query: 506 EVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565
+ + KS Y +L+L +V F+
Sbjct: 229 SIQAELRRLLKSKPYENCLLVL--------------LNV-----Q------NAKAWNAFN 263
Query: 566 VE---LM--RYENI----------------------EEEMVQMLQIAMSCVAKVPDMRPT 598
+ L+ R++ + +E+ +L K D RP
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL-------LKYLDCRPQ 316
Query: 599 M--EEVVR-------MI-EDIR--PSDSEN-QPSSEDKLKDS-----NTQTP 632
EV+ +I E IR + +N + + DKL N P
Sbjct: 317 DLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP 368
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 8e-07
Identities = 38/231 (16%), Positives = 64/231 (27%), Gaps = 69/231 (29%)
Query: 22 DLNSDKQALLDFAANVPHARKL----NWNSSTSVCTSWV----GITC-----TKNGSRVL 68
++S + L + P+ L N V + ++C T+
Sbjct: 226 RIHSIQAELRRLLKSKPYENCLLVLLN------VQNAKAWNAFNLSCKILLTTRFKQVTD 279
Query: 69 AVRLPGVGLYGPIPAN----TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSL-------- 116
+ I + TL + +L + DLP VL+ +
Sbjct: 280 FL---SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAES 336
Query: 117 ---------RFLYLQNNNFSGNIPSS---LSP---QLNWVDLS-FNSITGNIPAS----- 155
+ ++ + + I SS L P + + LS F +IP
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA-HIPTILLSLI 395
Query: 156 -----------IRNLSHLVGL-NLQNNSLTGFIPNFNLSRLRHL-NLSYNH 193
+ N H L Q T IP+ L L N H
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 50/212 (23%), Positives = 87/212 (41%), Gaps = 36/212 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQME---VVGRLSQHPNVVPI 397
+ LG G++G G V VK L + + +++ +L +HP+++ +
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 398 RAYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKIS-LGSA------KG 449
+ + +V +++ G F + GR E+R + SA
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKH----GRVEEM-EARRLFQQILSAVDYCHRHM 131
Query: 450 IAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPE 506
+ H ++K NVLL + I+DFGL+ +M+ S G Y APE
Sbjct: 132 VVH-----------RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPE 180
Query: 507 VIETKK---PTQKSDVYSFGVLLLEMLTGKAP 535
VI + P + D++S GV+L +L G P
Sbjct: 181 VISGRLYAGP--EVDIWSCGVILYALLCGTLP 210
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 40/127 (31%), Positives = 58/127 (45%), Gaps = 13/127 (10%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFS---GNIPSSLSP 136
+ T L L L+L N L L + V L+ L L L NN + + L+
Sbjct: 50 LSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLASLPLGVFDHLT- 107
Query: 137 QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--FN-LSRLRHLNLSYN 192
QL+ + L N + +P+ + L+ L L L N L IP F+ L+ L+ L+LS N
Sbjct: 108 QLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTN 165
Query: 193 HLNGSVP 199
L SVP
Sbjct: 166 QLQ-SVP 171
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 30/161 (18%)
Query: 52 CTSWVGITCTKNGSRV------LAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGD 105
C + G TC + V L G IPA+T EKLD L+S L+
Sbjct: 4 CETVTGCTCNEGKKEVDCQGKSLDSVPSG------IPADT-EKLD------LQSTGLATL 50
Query: 106 LPSNVLSLSSLRFLYLQNNNFS---GNIPSSLSPQLNWVDLSFNSITGNIPASI-RNLSH 161
+ L+ L +L L N + L+ +L + L+ N + ++P + +L+
Sbjct: 51 SDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT-ELGTLGLANNQLA-SLPLGVFDHLTQ 108
Query: 162 LVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYNHLNGSVP 199
L L L N L +P+ F L++L+ L L+ N L S+P
Sbjct: 109 LDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIP 147
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 6e-09
Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK-------------REFEQQMEVVGR 387
+G G+YGT YKA G V +K ++ + RE +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVALLRRL--E 69
Query: 388 LSQHPNVVP----IRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK- 441
+HPNVV ++ K+ LV++ ++ L G +K
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA----ETIKD 124
Query: 442 ISLGSAKGIAHIHAAVGGKFIL-GNIKSSNVLLSQDLQGC--ISDFGL-----TPLMNTP 493
+ +G+ +HA I+ ++K N+L++ G ++DFGL + TP
Sbjct: 125 LMRQFLRGLDFLHA----NCIVHRDLKPENILVTSG--GTVKLADFGLARIYSYQMALTP 178
Query: 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKA 534
V + YRAPEV+ D++S G + EM K
Sbjct: 179 VVVTL--WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 54/241 (22%), Positives = 97/241 (40%), Gaps = 74/241 (30%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM-------EVV--GRLSQH 391
+ LGKG+YG +K+I G V VK++ + F+ E++ LS H
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDAQRTFREIMILTELSGH 68
Query: 392 PNVVPIRAYYFSKDEK--LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-----ISL 444
N+V + + +++ LV+D++E A++ N L+ + + +
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN------ILE-PVHKQYVVYQL-I 119
Query: 445 GSAKGIAHIHAAVGGKFILGNI-----KSSNVLLSQDLQGCISDFGL----TPLMNTPTV 495
K I ++H+ + K SN+LL+ + ++DFGL +
Sbjct: 120 ---KVIKYLHSG--------GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 496 PSRSAG---------------------YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGK 533
S YRAPE++ + K T+ D++S G +L E+L GK
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
Query: 534 A 534
Sbjct: 229 P 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 9e-09
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 43/214 (20%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGK----------REFEQQMEVVGRLSQH 391
E +G+G+YG YKA G T +K+++ + K RE E+ +H
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR---LEKEDEGIPSTTIREISILKEL-----KH 59
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGI 450
N+V + +K +LV++ ++ LL G L+ K L GI
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG----GLE-SVTAKSFLLQLLNGI 113
Query: 451 AHIHAAVGGKFIL-GNIKSSNVLLSQDLQGC--ISDFGL-----TPLMN-TPTVPSRSAG 501
A+ H + +L ++K N+L++++ G I+DFGL P+ T + +
Sbjct: 114 AYCHD----RRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTL--W 165
Query: 502 YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
YRAP+V+ +KK + D++S G + EM+ G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 62/318 (19%), Positives = 110/318 (34%), Gaps = 95/318 (29%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVK-----RLKEVVMGKREFEQQMEV-VGRLSQH--P 392
+LG G +G+ Y I + + V +K R+ + MEV + +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 393 NVVPIRAYYFSKDEKLLV----------YDFIEAGSFSALLHGNRGIGRTPLD-WESRVK 441
V+ + ++ D +L+ +DFI G L +R
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-------RGA-------LQEELARSF 154
Query: 442 ----ISLGSAKGIAHIHAAVGGKFIL-GNIKSSNVLLSQDLQGC--ISDFGLTPLMNTPT 494
+ + H H +L +IK N+L+ + +G + DFG L+ T
Sbjct: 155 FWQVLE-----AVRHCHN----CGVLHRDIKDENILIDLN-RGELKLIDFGSGALL-KDT 203
Query: 495 VPSRSAG---YRAPEVIETKK---PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD-- 546
V + G Y PE I + + V+S G+LL +M+ G P + E+++
Sbjct: 204 VYTDFDGTRVYSPPEWIRYHRYHGR--SAAVWSLGILLYDMVCGDIPFE--HDEEIIRGQ 259
Query: 547 --LPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+ V S + L+R L + P RPT EE+
Sbjct: 260 VFFRQRVSSECQ----------HLIR---------WCLALR-------PSDRPTFEEIQN 293
Query: 605 ---MIEDIRPSDSENQPS 619
M + + P ++
Sbjct: 294 HPWMQDVLLPQETAEIHL 311
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK---------REFEQQMEVVGRLSQH 391
E LG G+Y T YK + G V +K +K + RE E+ +H
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVK---LDSEEGTPSTAIREISLMKEL-----KH 62
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA-KGI 450
N+V + ++++ LV++F++ + G L+ + VK +G+
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLE-LNLVKYFQWQLLQGL 121
Query: 451 AHIHAAVGGKFIL-GNIKSSNVLLSQDLQGC--ISDFGLTPLMNTPTVPSRSAG------ 501
A H IL ++K N+L+++ G + DFGL +P +
Sbjct: 122 AFCHE----NKILHRDLKPQNLLINKR--GQLKLGDFGLARAFG---IPVNTFSSEVVTL 172
Query: 502 -YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
YRAP+V+ ++ + D++S G +L EM+TGK
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 54/235 (22%), Positives = 92/235 (39%), Gaps = 69/235 (29%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVG------------RL 388
+G+G++G +KA + G V +K++ E + E G +L
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL--------MENEKE--GFPITALREIKILQL 72
Query: 389 SQHPNVVPIR-------AYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRV 440
+H NVV + + Y + LV+DF E H G+ V
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDLAGLLSNV-----LV 119
Query: 441 KISLGSAK--------GIAHIHAAVGGKFIL-GNIKSSNVLLSQDLQGCISDFGLTPLMN 491
K +L K G+ +IH IL ++K++NVL+++D ++DFGL +
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHR----NKILHRDMKAANVLITRDGVLKLADFGLARAFS 175
Query: 492 TPTVPSRSAG---------YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKAPI 536
S+ YR PE++ + D++ G ++ EM T PI
Sbjct: 176 LA-KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PI 228
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 28/104 (26%), Positives = 42/104 (40%), Gaps = 8/104 (7%)
Query: 95 LSLRSNHLS-GDLPSNVLSLSSLRFLYLQNNNFS--GNIPSSLSPQLNWVDLSFNSITGN 151
L L + + G + +L FL L N N+P P+L ++LS N I G
Sbjct: 29 LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLPKL--PKLKKLELSENRIFGG 86
Query: 152 IPASIRNLSHLVGLNLQNN---SLTGFIPNFNLSRLRHLNLSYN 192
+ L +L LNL N ++ P L L+ L+L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 5/93 (5%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG--NIPSSLSPQLNWV 141
+ +L LSL + L + SN+ L L+ L L N G ++ + P L +
Sbjct: 43 GLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100
Query: 142 DLSFNSITG-NIPASIRNLSHLVGLNLQNNSLT 173
+LS N + + ++ L L L+L N +T
Sbjct: 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 25/92 (27%), Positives = 37/92 (40%), Gaps = 11/92 (11%)
Query: 111 LSLSSLRFLYLQNNNFS-GNIPSSLS--PQLNWVDLSFNSIT--GNIPASIRNLSHLVGL 165
+ +++R L L N + G I + L ++ L + N+P L L L
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKL 76
Query: 166 NLQNNSLTGFIPNF--NLSRLRHLNLSYNHLN 195
L N + G + L L HLNLS N L
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 52/236 (22%), Positives = 89/236 (37%), Gaps = 61/236 (25%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRL-KEVVMGKREFEQQMEVVG--------------- 386
+GKGSYG A + T +K L K+ ++ + F ++ G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 387 ----------RLSQHPNVVPIRAY----YFSKDEKLLVYDFIEAGS-FSALLHGNRGIGR 431
+ HPNVV + ++D +V++ + G
Sbjct: 81 EQVYQEIAILKKLDHPNVV--KLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------ 132
Query: 432 TPLD-WESRVK----ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486
PL ++R I GI ++H K I +IK SN+L+ +D I+DFG+
Sbjct: 133 -PLSEDQARFYFQDLIK-----GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 487 TPLMNTPTVP-SRSAG---YRAPEVIETKKPT---QKSDVYSFGVLLLEMLTGKAP 535
+ S + G + APE + + + DV++ GV L + G+ P
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 28/155 (18%), Positives = 46/155 (29%), Gaps = 45/155 (29%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLSPQLN 139
+P E + L N + +P LR + L NN Q++
Sbjct: 30 LPETITE-------IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNN------------QIS 69
Query: 140 WVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLNG 196
+ + L L L L N +T + F L L+ L L+ N
Sbjct: 70 -----------ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANK--- 115
Query: 197 SVPLALQKFPPSSFEGNSMLCGPPL--NQCSTVPP 229
+ +F+ L L N+ T+
Sbjct: 116 -----INCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 8/95 (8%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIP----SSLS 135
+ + + L SL L L N ++ +LP ++ L SL+ L L N + + L
Sbjct: 71 LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDL- 127
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNN 170
LN + L N + + L + ++L N
Sbjct: 128 HNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 22/86 (25%), Positives = 35/86 (40%), Gaps = 12/86 (13%)
Query: 130 IPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FN-LSRLRH 186
IP++L + + L N+I P + L ++L NN ++ + F L L
Sbjct: 26 IPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNS 84
Query: 187 LNLSYNHLNGSVPLALQKFPPSSFEG 212
L L N + + P S FEG
Sbjct: 85 LVLYGNK--------ITELPKSLFEG 102
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 55.3 bits (132), Expect = 3e-08
Identities = 34/210 (16%), Positives = 66/210 (31%), Gaps = 30/210 (14%)
Query: 22 DLNSDKQALLDFAANVPHARKLNWNSSTSV--CTSWVGITCTKNGSRVLA--VRLPGVGL 77
D + +++ H L W SW + S VL L + +
Sbjct: 123 DCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISW---IEQVDLSPVLDAMPLLNNLKI 179
Query: 78 Y-GPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLS--LSSLRFL--YLQNNNFSGN--- 129
+ + +L L + S L + ++L L +L L Y+ ++ +
Sbjct: 180 KGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDM 239
Query: 130 ------IPSSLSPQLNWVDLSFNSITGNIP---ASIRNLSHLVGLNLQNNSLTGFIPNF- 179
P L W+ + + L L +++ LT
Sbjct: 240 NVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLL 299
Query: 180 -----NLSRLRHLNLSYNHLNGSVPLALQK 204
+ L+ +N+ YN+L+ + LQK
Sbjct: 300 LDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 53/288 (18%), Positives = 105/288 (36%), Gaps = 68/288 (23%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGR------LSQHPNVVP 396
LG+G+YG A+ V VK ++ + E + + + H NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-----IVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 397 IRAYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVK----ISLGSAKGIA 451
+ + + L ++ G F + P +++ ++ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEP-DAQRFFHQLMA-----GVV 119
Query: 452 HIHAAVGGKFILG----NIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR------SAG 501
++H +G +IK N+LL + ISDFGL + +
Sbjct: 120 YLHG-------IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 502 YRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT 560
Y APE+++ ++ + DV+S G++L ML G+ P P + + W +
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP-SDSCQEYSDWKEK------- 224
Query: 561 SEVFDVELMRYENIEEE----MVQMLQIAMSCVAKVPDMRPTMEEVVR 604
L ++ I+ + ++L P R T+ ++ +
Sbjct: 225 ----KTYLNPWKKIDSAPLALLHKILVEN-------PSARITIPDIKK 261
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 58/324 (17%), Positives = 111/324 (34%), Gaps = 80/324 (24%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGR------LSQHPNVVP 396
LG+G+YG A+ V VK ++ + E + + + H NVV
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-----IVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 397 IRAYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVK----ISLGSAKGIA 451
+ + + L ++ G F + P +++ ++ G+
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEP-DAQRFFHQLMA-----GVV 119
Query: 452 HIHAAVGGKFILG----NIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR------SAG 501
++H +G +IK N+LL + ISDFGL + +
Sbjct: 120 YLHG-------IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 502 YRAPEVIETKKPT-QKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT 560
Y APE+++ ++ + DV+S G++L ML G+ P P + + W +
Sbjct: 173 YVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP-SDSCQEYSDWKEK------- 224
Query: 561 SEVFDVELMRYENIEEE----MVQMLQIAMSCVAKVPDMRPTMEEVVR------------ 604
L ++ I+ + ++L P R T+ ++ +
Sbjct: 225 ----KTYLNPWKKIDSAPLALLHKILVEN-------PSARITIPDIKKDRWYNKPLKKGA 273
Query: 605 MIEDIRPSDSENQPSSEDKLKDSN 628
+ PS K SN
Sbjct: 274 KRPRVTSGGVSESPSGFSKHIQSN 297
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 44/217 (20%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK----------REFEQQMEVVGRLSQ 390
E +G+G+YGT +KA E V +KR++ + RE E+ +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR---LDDDDEGVPSSALREICLLKEL-----K 59
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKG 449
H N+V + S + LV++F + G LD VK KG
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG----DLD-PEIVKSFLFQLLKG 113
Query: 450 IAHIHAAVGGKFIL-GNIKSSNVLLSQDLQGC--ISDFGL-----TPLMN-TPTVPSRSA 500
+ H+ + +L ++K N+L++++ G +++FGL P+ + V +
Sbjct: 114 LGFCHS----RNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTL-- 165
Query: 501 GYRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKAPI 536
YR P+V+ K + D++S G + E+ P+
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 5e-08
Identities = 47/234 (20%), Positives = 84/234 (35%), Gaps = 71/234 (30%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVK---RLKEVVMGKRE------FEQQMEVVGRLSQH 391
+ LG G+ G A + V +K + K + RE E ++E++ +L+ H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-H 74
Query: 392 PNVVPIRAYYFSKDEKLLVY------------DFI-EAGSFS---ALLHGNRGIGRTPLD 435
P ++ I+ ++ ++D Y D + + L
Sbjct: 75 PCIIKIKNFFDAED----YYIVLELMEGGELFDKVVGNKRLKEATC-----KLYFYQMLL 125
Query: 436 WESRVKISLGSAKGIAHIHAAVGGKFILGNI-----KSSNVLLSQDLQGC---ISDFGLT 487
+ ++H I K NVLLS + C I+DFG +
Sbjct: 126 -------------AVQYLHEN--------GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
Query: 488 PLMNTPTVPSRSAG---YRAPEVIETKKP---TQKSDVYSFGVLLLEMLTGKAP 535
++ ++ G Y APEV+ + + D +S GV+L L+G P
Sbjct: 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 47/212 (22%), Positives = 83/212 (39%), Gaps = 42/212 (19%)
Query: 344 LGKGSYGTTYKAI-LEEGTTVVVKRL-KEVVMG---KREFEQQMEVVGRLSQHPNVVPIR 398
+G G++G V VK + + + +RE R +HPN+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREI-INH----RSLRHPNIVRFK 82
Query: 399 AYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVK----ISLGSAKGIAHI 453
+ ++ ++ G + + + GR D E+R +S G+++
Sbjct: 83 EVILTPTHLAIIMEYASGGELYERICNA----GRFSED-EARFFFQQLLS-----GVSYC 132
Query: 454 HAAVGGKFILG----NIKSSNVLLSQDLQGC--ISDFGLTPLMNTPTVPSRSAG---YRA 504
H+ + ++K N LL I DFG + + P + G Y A
Sbjct: 133 HS-------MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 185
Query: 505 PEVIETKKPT-QKSDVYSFGVLLLEMLTGKAP 535
PEV+ ++ + +DV+S GV L ML G P
Sbjct: 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 34/211 (16%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQME---VVGRLSQHPNVVPI 397
+ LG G++G G V VK L + + ++ +L +HP+++ +
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKIS-LGSA------KGI 450
+ + +V +++ G + N GR ESR + S +
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKN---GRLDEK-ESRRLFQQILSGVDYCHRHMV 137
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEV 507
H ++K NVLL + I+DFGL+ +M+ S G Y APEV
Sbjct: 138 VH-----------RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
Query: 508 IETKK---PTQKSDVYSFGVLLLEMLTGKAP 535
I + P + D++S GV+L +L G P
Sbjct: 187 ISGRLYAGP--EVDIWSSGVILYALLCGTLP 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 9e-08
Identities = 58/226 (25%), Positives = 88/226 (38%), Gaps = 65/226 (28%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVK-----RLKEVVMG---KREFEQQMEVVGRLSQHP 392
E LG+GS+G A + V +K LK+ M +RE + +L +HP
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI-SYL----KLLRHP 69
Query: 393 NVVPIRAYYFSKDEKLLV--------YDFIEAGSFSALLHGNRGIGRTPLDWESRVK--- 441
+++ + + + ++V +D+I R D E R
Sbjct: 70 HIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK------------KRMTED-EGRRFFQQ 116
Query: 442 -ISLGSAKGIAHIHAAVGGKFILGNI-----KSSNVLLSQDLQGCISDFGLTPLMNTPTV 495
I I + H I K N+LL +L I+DFGL+ +M
Sbjct: 117 IIC-----AIEYCHRH--------KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
Query: 496 PSRSAG---YRAPEVIETKK---PTQKSDVYSFGVLLLEMLTGKAP 535
S G Y APEVI K P + DV+S G++L ML G+ P
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGP--EVDVWSCGIVLYVMLVGRLP 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 48/219 (21%), Positives = 82/219 (37%), Gaps = 48/219 (21%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK----------REFEQQMEVVGRLSQ 390
LG+G+YG YKAI TV +KR++ + RE E+ Q
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR---LEHEEEGVPGTAIREVSLLKEL-----Q 91
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKG 449
H N++ +++ L++++ E + N + +K L G
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS------MRVIKSFLYQLING 144
Query: 450 IAHIHAAVGGKFIL-GNIKSSNVLLSQDL---QGC--ISDFGLTPLMNTPTVPSRSAG-- 501
+ H+ + L ++K N+LLS I DFGL +P R
Sbjct: 145 VNFCHS----RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF---GIPIRQFTHE 197
Query: 502 -----YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
YR PE++ ++ + D++S + EML
Sbjct: 198 IITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 54/217 (24%), Positives = 96/217 (44%), Gaps = 45/217 (20%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVG------------RL 388
+ LG+G + T YKA V +K++K +G R + G +
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKD----GINRTALREIKLLQE 68
Query: 389 SQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSA 447
HPN++ + + K LV+DF+E ++ N L S +K L +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL----VLT-PSHIKAYMLMTL 122
Query: 448 KGIAHIHAAVGGKFIL-GNIKSSNVLLSQDLQGC--ISDFGL-----TPLMN-TPTVPSR 498
+G+ ++H +IL ++K +N+LL ++ G ++DFGL +P T V +R
Sbjct: 123 QGLEYLHQ----HWILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTR 176
Query: 499 SAGYRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
YRAPE++ + D+++ G +L E+L
Sbjct: 177 --WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 21/124 (16%)
Query: 88 KLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLSP-------QLN 139
+L +L L L N L LP+ V L++L+ L L N SL L
Sbjct: 83 ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-----SLPDGVFDKLTNLT 136
Query: 140 WVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--FN-LSRLRHLNLSYNHLN 195
+++L+ N + ++P + L++L L+L N L +P F+ L++L+ L L N L
Sbjct: 137 YLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLK 194
Query: 196 GSVP 199
SVP
Sbjct: 195 -SVP 197
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 8e-06
Identities = 36/124 (29%), Positives = 56/124 (45%), Gaps = 20/124 (16%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLSP--- 136
+P +KL +L L L N L LP V L++L +L L +N SL
Sbjct: 100 LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQL-----QSLPKGVF 153
Query: 137 ----QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLN 188
L +DLS+N + ++P + L+ L L L N L +P+ F L+ L+++
Sbjct: 154 DKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIW 211
Query: 189 LSYN 192
L N
Sbjct: 212 LHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 31/129 (24%), Positives = 60/129 (46%), Gaps = 20/129 (15%)
Query: 88 KLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS--SLSPQLNWVDLSF 145
+L+S+ + ++ + L ++R+L L N +I + L+ L ++ L+
Sbjct: 39 ELNSIDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLH-DISALKELT-NLTYLILTG 94
Query: 146 NSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--FN-LSRLRHLNLSYNHLNGSVPLA 201
N + ++P + L++L L L N L +P+ F+ L+ L +LNL++N
Sbjct: 95 NQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQ-------- 144
Query: 202 LQKFPPSSF 210
LQ P F
Sbjct: 145 LQSLPKGVF 153
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 41/229 (17%), Positives = 84/229 (36%), Gaps = 58/229 (25%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQ----MEVVGRLSQ------ 390
LG G + T + A + T V +K +V G + + + ++++ R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK----IVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 391 ----HPNVVPIRAY-YFSKDEK--------LL---VYDFIEAGSFSAL-LHGNRGIGRTP 433
+++ + + +L + I+ + L + I +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 140
Query: 434 LDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC------ISDFGLT 487
L G+ ++H G I +IK NVL+ I+D G
Sbjct: 141 L-------------LGLDYMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
Query: 488 PLMN---TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGK 533
+ T ++ +R YR+PEV+ +D++S L+ E++TG
Sbjct: 186 CWYDEHYTNSIQTRE--YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 45/213 (21%), Positives = 87/213 (40%), Gaps = 40/213 (18%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS----------Q 390
+G+GSYG +K + G V +K+ E + V+ +++ +
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLE--------SEDDPVIKKIALREIRMLKQLK 60
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKG 449
HPN+V + + K LV+++ + L RG+ E VK I+ + +
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVP------EHLVKSITWQTLQA 114
Query: 450 IAHIHAAVGGKFIL-GNIKSSNVLLSQDLQGCISDFGL-----TPLMN-TPTVPSRSAGY 502
+ H + ++K N+L+++ + DFG P V +R Y
Sbjct: 115 VNFCHK----HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR--WY 168
Query: 503 RAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
R+PE++ + DV++ G + E+L+G
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 48/249 (19%), Positives = 82/249 (32%), Gaps = 76/249 (30%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM-------EV-VGRLSQHP 392
++G+GSYG Y A V +K++ + FE + E+ + +
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREITILNRLKSD 85
Query: 393 NVVPI----RAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-----I 442
++ + K ++L +V + ++ L L E +K +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI-----FLT-EEHIKTILYNL 138
Query: 443 SLGSAKGIAHIHAAVGGKFILGNI-----KSSNVLLSQDLQGCISDFGL----TPLMNTP 493
L G IH + I K +N LL+QD + DFGL +T
Sbjct: 139 -L---LGENFIHES--------GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 494 TVPSRSAG----------------------YRAPEVI-ETKKPTQKSDVYSFGVLLLEML 530
V YRAPE+I + T+ D++S G + E+L
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 531 TGKAPIQAP 539
Sbjct: 247 NMLQSHIND 255
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 50/220 (22%), Positives = 94/220 (42%), Gaps = 50/220 (22%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQ----MEVVGRLSQHP---- 392
++GKGS+G KA E V +K ++ K+ F Q + ++ +++H
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK----IIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 393 -NVVPIRAYYFSKD------EKLLV--YDFIEAGSFSAL-LHGNRGIGR---TPLDWESR 439
+V ++ ++ ++ E L YD + +F + L+ R + T L + +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 440 VKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS--DFGLTPLMN---TPT 494
++S+ IH ++K N+LL + I DFG + +
Sbjct: 176 PELSI--------IHC---------DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQY 218
Query: 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKA 534
+ SR YR+PEV+ D++S G +L+EM TG+
Sbjct: 219 IQSRF--YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 51/319 (15%), Positives = 96/319 (30%), Gaps = 100/319 (31%)
Query: 285 KKKDSEGTAATKSKGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVL 344
+ + S+ ++ + + + Y ++
Sbjct: 11 QHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIR---------HLI 61
Query: 345 GKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM-------EV-VGRLSQHPNVV 395
G GSYG +A E V +K++ V FE + E+ + H +VV
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIKKILRV------FEDLIDCKRILREIAILNRLNHDHVV 115
Query: 396 PI----RAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSA--- 447
+ K ++L +V + ++ + R + L
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSD-----FK--KLF---------RTPVYLTELHIK 159
Query: 448 -------KGIAHIHAAVGGKFILGNI-----KSSNVLLSQDLQGCISDFGLTPLMNTPTV 495
G+ ++H+A I K +N L++QD + DFGL ++ P
Sbjct: 160 TLLYNLLVGVKYVHSA--------GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 496 PSRSAG-------------------------------YRAPEVI-ETKKPTQKSDVYSFG 523
+ YRAPE+I + T+ DV+S G
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271
Query: 524 VLLLEMLTGKAPIQAPGHE 542
+ E+L A +
Sbjct: 272 CIFAELLNMIKENVAYHAD 290
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 44/214 (20%), Positives = 90/214 (42%), Gaps = 43/214 (20%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGK---------REFEQQMEVVGRLSQH 391
+ LG+G+Y T YK + V +K ++ + RE ++ +H
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDL-----KH 59
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGS-AKGI 450
N+V + ++ LV+++++ L + G VK+ L +G+
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD-DCGNIINM----HNVKLFLFQLLRGL 113
Query: 451 AHIHAAVGGKFIL-GNIKSSNVLLSQDLQGC--ISDFGL-----TPLMN-TPTVPSRSAG 501
A+ H + +L ++K N+L+++ G ++DFGL P V +
Sbjct: 114 AYCHR----QKVLHRDLKPQNLLINER--GELKLADFGLARAKSIPTKTYDNEVVTL--W 165
Query: 502 YRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
YR P+++ + + + D++ G + EM TG+
Sbjct: 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 33/124 (26%), Positives = 47/124 (37%), Gaps = 20/124 (16%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPS----SLS 135
IP +T E L L N L + L L L L+ N + I S
Sbjct: 27 IPLHTTE-------LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGAS 78
Query: 136 PQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSY 191
+ + L N I I + L L LNL +N ++ + F +L+ L LNL+
Sbjct: 79 -HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLAS 135
Query: 192 NHLN 195
N N
Sbjct: 136 NPFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 25/88 (28%), Positives = 36/88 (40%), Gaps = 10/88 (11%)
Query: 119 LYLQNNNFSGNIPSSL---SPQLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTG 174
L L +N L P L ++L N +T I + SH+ L L N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE 92
Query: 175 FIPN--FN-LSRLRHLNLSYNHLNGSVP 199
I N F L +L+ LNL N ++ V
Sbjct: 93 -ISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 38/212 (17%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM-------EV-VGRLSQHP 392
++G+GSYG K + G V +K+ E + +M E+ + + +H
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLE------SDDDKMVKKIAMREIKLLKQLRHE 84
Query: 393 NVVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK-ISLGSAKGI 450
N+V + K ++ LV++F++ + L LD V+ GI
Sbjct: 85 NLVNLLE-VCKKKKRWYLVFEFVDH-TILDDLELFPN----GLD-YQVVQKYLFQIINGI 137
Query: 451 AHIHAAVGGKFIL-GNIKSSNVLLSQDLQGCISDFGL-----TPLMN-TPTVPSRSAGYR 503
H+ I+ +IK N+L+SQ + DFG P V +R YR
Sbjct: 138 GFCHS----HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR--WYR 191
Query: 504 APEVI-ETKKPTQKSDVYSFGVLLLEMLTGKA 534
APE++ K + DV++ G L+ EM G+
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 39/130 (30%), Positives = 55/130 (42%), Gaps = 26/130 (20%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP---- 136
IPA T L L +N L L+SL LYL N SL
Sbjct: 26 IPAQTTY-------LDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-----QSLPNGVFN 73
Query: 137 ---QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--FN-LSRLRHLNL 189
L +++LS N + ++P + L+ L L L N L +P+ F+ L++L+ L L
Sbjct: 74 KLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRL 131
Query: 190 SYNHLNGSVP 199
N L SVP
Sbjct: 132 YQNQLK-SVP 140
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 41/130 (31%), Positives = 57/130 (43%), Gaps = 27/130 (20%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLSP--- 136
IP N IL L N ++ L V SL +L+ LYL +N +L
Sbjct: 38 IPTNA-------QILYLHDNQITK-LEPGVFDSLINLKELYLGSNQL-----GALPVGVF 84
Query: 137 ----QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNL 189
QL +DL N +T +P+++ L HL L + N LT +P L+ L HL L
Sbjct: 85 DSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLAL 142
Query: 190 SYNHLNGSVP 199
N L S+P
Sbjct: 143 DQNQLK-SIP 151
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 34/122 (27%), Positives = 49/122 (40%), Gaps = 35/122 (28%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
IP + E L L N + +P + + L + L NN S+LS Q
Sbjct: 29 IPRDVTE-------LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRI-----STLSNQ--- 72
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FN-LSRLRHLNLSYNHLNGS 197
SF+ N++ L+ L L N L IP F+ L LR L+L N ++
Sbjct: 73 ---SFS-----------NMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDIS-V 116
Query: 198 VP 199
VP
Sbjct: 117 VP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 29/92 (31%), Positives = 42/92 (45%), Gaps = 15/92 (16%)
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYNHLNGSV 198
L N T +P + N HL ++L NN ++ + N N+++L L LSYN
Sbjct: 37 YLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNR----- 89
Query: 199 PLALQKFPPSSFEGNSMLCGPPL--NQCSTVP 228
L+ PP +F+G L L N S VP
Sbjct: 90 ---LRCIPPRTFDGLKSLRLLSLHGNDISVVP 118
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 27/158 (17%), Positives = 42/158 (26%), Gaps = 46/158 (29%)
Query: 83 ANTLEKLDSLMILSLRSNHLSGD--------LPSNVLSLSSLRFLYLQNNNFS------- 127
L K L + L N L + + L LYL NN
Sbjct: 87 LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH----TPLEHLYLHNNGLGPQAGAKI 142
Query: 128 --------GNIPSSLSPQLNWVDLSFNSITGN----IPASIRNLSHLVGLNLQNNSLT-- 173
N + +P L + N + + ++ L + + N +
Sbjct: 143 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 202
Query: 174 --------GFIPNFNLSRLRHLNLSYNHL--NGSVPLA 201
G L+ L+L N GS LA
Sbjct: 203 GIEHLLLEGLAYC---QELKVLDLQDNTFTHLGSSALA 237
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 25/136 (18%), Positives = 48/136 (35%), Gaps = 24/136 (17%)
Query: 83 ANTLEKLDSLMILSLRSNHLSGDLPSNVLSL-----SSLRFLYLQNNNFSGN----IPSS 133
A T + L + + N + + ++L L+ L LQ+N F+ + +
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239
Query: 134 LS--PQLNWVDLSFNSITGN----IPASIRNLSH--LVGLNLQNNSLT--GFIP-----N 178
L P L + L+ ++ + + L + L L LQ N + +
Sbjct: 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 299
Query: 179 FNLSRLRHLNLSYNHL 194
+ L L L+ N
Sbjct: 300 EKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 28/148 (18%), Positives = 43/148 (29%), Gaps = 37/148 (25%)
Query: 83 ANTLEKLDSLMILSLRSNHLSGD--------LPSNVLSLSSLRFLYLQNNNFSGNIPSSL 134
L + DS+ + L N + + + S L F + IP +L
Sbjct: 25 FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK-DLEIAEFSDIFTGRVKDEIPEAL 83
Query: 135 S---------PQLNWVDLSFNSITGN----IPASIRNLSHLVGLNLQNNSLT-------- 173
P+L+ V LS N+ + + + L L L NN L
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 174 -------GFIPNFNLSRLRHLNLSYNHL 194
N LR + N L
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRL 171
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 33/124 (26%), Positives = 48/124 (38%), Gaps = 27/124 (21%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSGNIPSSLSP--- 136
IP++ L L SN L LP V L+ L L L N SL
Sbjct: 26 IPSSA-------TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQI-----QSLPDGVF 72
Query: 137 ----QLNWVDLSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLN 188
+L + L N + ++P + L+ L L L N L +P+ F L+ L+ +
Sbjct: 73 DKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIW 130
Query: 189 LSYN 192
L N
Sbjct: 131 LHTN 134
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 30/143 (20%), Positives = 49/143 (34%), Gaps = 34/143 (23%)
Query: 83 ANTLEKLDSLMILSLRSNHLSGDLPSNVLSLS--------SLRFLYLQNNNFS----GNI 130
++ L +L L+LRSN L V + ++ L LQN + G +
Sbjct: 49 SSALRVNPALAELNLRSNELG---DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL 105
Query: 131 PSSLS--PQLNWVDLSFNSITGN-----IPASIRNLSHLVGLNLQNNSLT---------G 174
S+L P L + LS N + + L L L+ SL+
Sbjct: 106 SSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165
Query: 175 FIPNFNLSRLRHLNLSYNHLNGS 197
+ L +S N +N +
Sbjct: 166 LRAK---PDFKELTVSNNDINEA 185
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 27/132 (20%), Positives = 48/132 (36%), Gaps = 24/132 (18%)
Query: 86 LEKLDSLMILSLRSNHLS----GDLPSNVLSLSSLRFLYLQNNNFS-------GNIPSSL 134
L L ++ L L+ D+ S + +L L L++N +
Sbjct: 24 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83
Query: 135 SPQLNWVDLSFNSIT----GNIPASIRNLSHLVGLNLQNNSLT--------GFIPNFNLS 182
S ++ + L +T G + +++R L L L+L +N L + +
Sbjct: 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQ-C 142
Query: 183 RLRHLNLSYNHL 194
RL L L Y L
Sbjct: 143 RLEKLQLEYCSL 154
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 31/140 (22%), Positives = 48/140 (34%), Gaps = 34/140 (24%)
Query: 83 ANTLEKLDSLMILSLRSNHLSGDLPSNVLSLS--------SLRFLYLQNNNFSGNIPSSL 134
L +SL LSL N L GD L L L++++ +F+ S
Sbjct: 277 CRVLRAKESLKELSLAGNEL-GD--EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF 333
Query: 135 S------PQLNWVDLSFNSITG----NIPASIR-NLSHLVGLNLQNNSLT---------G 174
S L + +S N + + + S L L L + ++
Sbjct: 334 SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 393
Query: 175 FIPNFNLSRLRHLNLSYNHL 194
+ N LR L+LS N L
Sbjct: 394 LLAN---HSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 3e-04
Identities = 25/126 (19%), Positives = 41/126 (32%), Gaps = 22/126 (17%)
Query: 91 SLMILSLRSNHLS----GDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP-------QLN 139
L L L LS L S + + + L + NN+ + L QL
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202
Query: 140 WVDLSFNSIT----GNIPASIRNLSHLVGLNLQNNSLTGF-------IPNFNLSRLRHLN 188
+ L +T ++ + + + L L L +N L SRLR L
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262
Query: 189 LSYNHL 194
+ +
Sbjct: 263 IWECGI 268
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 29/138 (21%), Positives = 45/138 (32%), Gaps = 30/138 (21%)
Query: 83 ANTLEKLDSLMILSLRSNHLSGDLPSNVLS------LSSLRFLYLQNNNFS----GNIPS 132
+ SL L+L SN L GD+ L S LR L++ + G++
Sbjct: 220 CGIVASKASLRELALGSNKL-GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCR 278
Query: 133 SL--SPQLNWVDLSFNSITGN-----IPASIRNLSHLVGLNLQNNSLT---------GFI 176
L L + L+ N + + L L +++ S T
Sbjct: 279 VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLA 338
Query: 177 PNFNLSRLRHLNLSYNHL 194
N L L +S N L
Sbjct: 339 QN---RFLLELQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 23/131 (17%), Positives = 39/131 (29%), Gaps = 30/131 (22%)
Query: 91 SLMILSLRSNHLSGD--------LPSNVLSLSSLRFLYLQNNNFSGNIPSSLS------- 135
L L ++S + L N L L + NN L
Sbjct: 314 QLESLWVKSCSFTAACCSHFSSVLAQN----RFLLELQISNNRLEDAGVRELCQGLGQPG 369
Query: 136 PQLNWVDLSFNSIT----GNIPASIRNLSHLVGLNLQNNSLT--GFIP-----NFNLSRL 184
L + L+ ++ ++ A++ L L+L NN L G + L
Sbjct: 370 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 429
Query: 185 RHLNLSYNHLN 195
L L + +
Sbjct: 430 EQLVLYDIYWS 440
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 27/166 (16%), Positives = 54/166 (32%), Gaps = 10/166 (6%)
Query: 50 SVCTSWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSN 109
VC W + + S + L G L+ + L + +
Sbjct: 34 GVCKRWYRLAS--DESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFS 91
Query: 110 VLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQN 169
+ + + + S +L + L ++ I ++ S+LV LNL
Sbjct: 92 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 151
Query: 170 -NSLT----GFIPNFNLSRLRHLNLSYNHL--NGSVPLALQKFPPS 208
+ + + + + SRL LNLS+ V +A+ +
Sbjct: 152 CSGFSEFALQTLLS-SCSRLDELNLSWCFDFTEKHVQVAVAHVSET 196
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 40/231 (17%), Positives = 79/231 (34%), Gaps = 52/231 (22%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQ----MEVVGRLSQHP---- 392
+G G++G ++ VK VV +++ + +++ ++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVK----VVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 393 NVVPIRAYYFSKD------EKLL--VYDFIEAGSFSAL-LHGNRGIGR---TPLDWESRV 440
N+V + D E L +Y+ I +++ + + L++ ++
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM 156
Query: 441 KI--------------SLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486
+ I G K + KS+ + + DFG
Sbjct: 157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI--------KLIDFGC 208
Query: 487 TPLMN---TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKA 534
+ + +R YRAPEVI SD++SFG +L E+ TG
Sbjct: 209 ATFKSDYHGSIINTRQ--YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 30/132 (22%), Positives = 50/132 (37%), Gaps = 32/132 (24%)
Query: 91 SLMILSLRSNHLS---GDLPSNVLSL--SSLRFLYLQNNNFS-------GNIPSSLSPQL 138
++ L+L N LS D L+ ++ L L N+FS S+L +
Sbjct: 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI 140
Query: 139 NWVDLSFNSITGNIPASIRNLS--------HLVGLNLQNNSLT--------GFIPNFNLS 182
++L N + S L ++ LNL+ N+L F+ + S
Sbjct: 141 TSLNLRGNDLG---IKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 183 RLRHLNLSYNHL 194
+ L+LS N L
Sbjct: 198 -VTSLDLSANLL 208
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 24/142 (16%), Positives = 51/142 (35%), Gaps = 31/142 (21%)
Query: 91 SLMILSLRSNHLSGDLPSNVLSLS--------SLRFLYLQNNNFS-------GNIPSSLS 135
++ L+LR N+L+ N L+ S+ L L N I SS+
Sbjct: 168 NVNSLNLRGNNLA---SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIP 224
Query: 136 PQLNWVDLSFNSITG----NIPASIRNLSHLVGLNLQNNSLTGFIPNF---------NLS 182
+ ++L N + G N+ +L HL + L + + N+
Sbjct: 225 NHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQ 284
Query: 183 RLRHLNLSYNHLNGSVPLALQK 204
++ ++ + ++ S + +
Sbjct: 285 KIILVDKNGKEIHPSHSIPISN 306
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 632 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.91 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.84 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.84 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.73 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.71 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.7 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.7 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.69 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.69 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.68 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.67 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.66 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.65 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.65 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.65 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.65 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.65 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.65 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.64 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.64 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.64 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.64 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.64 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.63 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.63 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.62 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.61 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.61 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.61 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.61 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.61 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.61 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.61 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.6 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.6 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.6 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.58 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.57 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.57 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.56 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.56 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.56 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.56 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.56 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.55 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.55 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.55 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.55 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.55 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.54 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.54 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.54 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.53 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.53 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.52 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.52 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.52 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.52 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.52 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.52 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.52 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.51 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.51 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.51 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.51 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.51 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.51 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.51 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.49 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.49 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.49 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.49 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.49 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.47 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.46 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.45 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.44 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.44 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.42 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.41 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.41 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.41 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.41 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.4 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.4 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.39 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.38 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.37 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.36 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.36 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.35 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.35 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.35 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.35 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.32 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.32 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.24 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.21 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.2 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.2 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.19 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.17 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.12 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.96 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.95 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.92 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.91 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.83 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.77 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.61 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.59 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.54 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.5 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.5 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.48 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.23 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.23 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.21 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.21 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.11 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.09 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.0 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.98 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.96 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.96 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.76 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.74 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.71 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 97.62 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.53 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.5 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.41 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 97.39 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.2 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.14 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.08 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.01 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.89 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.81 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.69 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.45 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.44 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.05 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.94 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 95.91 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 95.61 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 95.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.34 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.31 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 94.9 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 94.58 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.51 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 93.88 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.59 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.52 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.68 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.97 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 80.59 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=436.91 Aligned_cols=249 Identities=22% Similarity=0.345 Sum_probs=204.0
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|++++.++ +|||||+++|+|.+.+..++|||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~~lV~E 109 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQPLSMIFS 109 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCEEEEEEE
Confidence 357999999999999862 468899999976532 357899999999999 99999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEE
Q 006747 413 FIEAGSFSALLHGNRGI-----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCI 481 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki 481 (632)
||++|+|.++|+..... ....++|..+++|+.|+|.||+|||+. +||||||||+||||++++++||
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEE
Confidence 99999999999754211 124689999999999999999999998 9999999999999999999999
Q ss_pred cccCCCCCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHH
Q 006747 482 SDFGLTPLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSV 554 (632)
Q Consensus 482 ~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 554 (632)
+|||+|+..... ....+|+.|||||++.++.|+.++|||||||+||||+| |+.||.+... ...+. .
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------~~~~~-~ 259 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDVVE-M 259 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------HHHHH-H
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------HHHHH-H
Confidence 999999865322 23458889999999999999999999999999999999 8999975432 11122 2
Q ss_pred hhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 555 ~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
+..+.... ...+....+.+|+.+||+.||++||||+||+++|+.+.
T Consensus 260 i~~~~~~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 260 IRNRQVLP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHTTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHcCCCCC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22221111 11123345778899999999999999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=439.71 Aligned_cols=251 Identities=23% Similarity=0.380 Sum_probs=200.9
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||+||+|++. +++.||||+++.... ..++|.+|++++.++ +|||||+++|+|.+.+..+|||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey 124 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTEGRPLLMVFEY 124 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999864 478999999976532 356799999999999 999999999999999999999999
Q ss_pred ccCCCHhhhhccCCCC----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcc
Q 006747 414 IEAGSFSALLHGNRGI----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISD 483 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~D 483 (632)
|++|+|.++++..... ...+++|..++.|+.|+|.||+|||+. +||||||||+||||++++++||+|
T Consensus 125 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~D 201 (329)
T 4aoj_A 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGD 201 (329)
T ss_dssp CTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECC
T ss_pred CCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcc
Confidence 9999999999865321 234699999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 006747 484 FGLTPLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR 556 (632)
Q Consensus 484 fGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 556 (632)
||+|+..... ....+|+.|||||++.+..|+.++|||||||+||||+| |+.||.+... ...+.. +.
T Consensus 202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~~-i~ 274 (329)
T 4aoj_A 202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEAIDC-IT 274 (329)
T ss_dssp CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------HHHHHH-HH
T ss_pred cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------HHHHHH-HH
Confidence 9999876432 23458889999999999999999999999999999999 8999975331 111222 22
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.+... ..+. ....++.+|+.+||+.||++||||+||+++|+.+.+.
T Consensus 275 ~g~~~-------~~p~---~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 275 QGREL-------ERPR---ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HTCCC-------CCCT---TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCCCC-------CCcc---cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 22111 0111 1234577889999999999999999999999998654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=435.08 Aligned_cols=250 Identities=22% Similarity=0.418 Sum_probs=202.7
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||+||+|.+. ++..||||+++.... ..++|.+|++++.++ +|||||+++|+|.+.+..++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~~~lV~Ey 96 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDPLIMVFEY 96 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSEEEEEEC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEc
Confidence 467999999999999863 478899999976532 356799999999999 999999999999999999999999
Q ss_pred ccCCCHhhhhccCC--------CCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 414 IEAGSFSALLHGNR--------GIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 414 ~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
|++|+|.++|+..+ ......++|..++.|+.|+|.||+|||+. +||||||||+|||+++++.+||+|||
T Consensus 97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFG 173 (299)
T 4asz_A 97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFG 173 (299)
T ss_dssp CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCS
T ss_pred CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcc
Confidence 99999999997542 12345699999999999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006747 486 LTPLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREE 558 (632)
Q Consensus 486 la~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (632)
+|+..... ....+|+.|||||++.+..|+.++|||||||+||||+| |+.||.+... ...... +..+
T Consensus 174 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~~-i~~~ 246 (299)
T 4asz_A 174 MSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIEC-ITQG 246 (299)
T ss_dssp CHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHH-HHHT
T ss_pred cceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-HHcC
Confidence 99765432 12247889999999999999999999999999999999 8999975431 111222 2222
Q ss_pred cccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 559 WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 559 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.... .+. ....++.+|+.+||+.||++||||+||++.|+++..
T Consensus 247 ~~~~-------~p~---~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 247 RVLQ-------RPR---TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp CCCC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCC-------CCc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1110 111 123457788999999999999999999999998854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=427.47 Aligned_cols=248 Identities=29% Similarity=0.437 Sum_probs=197.4
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||+||+|.+. ..||||+++..... .+.|.+|++++.++ +|||||+++|+|. .+..+||||||++|
T Consensus 41 ~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~-~~~~~iVmEy~~gG 116 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMT-KDNLAIVTQWCEGS 116 (307)
T ss_dssp EEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEEECCSSC
T ss_pred eeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEE-CCeEEEEEEcCCCC
Confidence 467999999999999875 36999999755333 45799999999999 9999999999885 46789999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.++++... .+++|..++.|+.|+|.||+|||+. +||||||||+||||++++++||+|||+|+.....
T Consensus 117 sL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 117 SLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp BHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999997543 3599999999999999999999998 9999999999999999999999999999876432
Q ss_pred --CCCCCCCcccCCccccC---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIET---KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~---~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
....||+.|||||++.+ +.|+.++|||||||+||||+||+.||.+... ...+...+..+.. .+.+
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~------~~~~~~~~~~~~~----~p~~ 259 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN------RDQIIFMVGRGYA----SPDL 259 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHTTCC----CCCS
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcCCC----CCCc
Confidence 23468999999999964 4589999999999999999999999975332 1122222222211 1111
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.. ...+....+.+|+.+||+.||++||||.||++.|+.+..
T Consensus 260 ~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 260 SK--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp TT--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred cc--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 10 111223457788899999999999999999999998854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-53 Score=433.67 Aligned_cols=261 Identities=22% Similarity=0.313 Sum_probs=198.8
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC----ceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD----EKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lv~E~~~~ 416 (632)
.+.||+|+||+||+|++ +|+.||||+++........++.|+..+.++ +|||||+++|+|.+.+ ..+||||||++
T Consensus 8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 36799999999999998 589999999976533233344455555677 8999999999998754 57999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc-----CCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV-----GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
|+|.++++.. +++|..+.+++.|+|.||+|||+.+ .++||||||||+|||||+++++||+|||+|+...
T Consensus 86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9999999754 4899999999999999999999763 4689999999999999999999999999997654
Q ss_pred CCC--------CCCCCCcccCCccccCC------CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC--------ChhH
Q 006747 492 TPT--------VPSRSAGYRAPEVIETK------KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV--------DLPR 549 (632)
Q Consensus 492 ~~~--------~~~~t~~y~aPE~~~~~------~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~--------~~~~ 549 (632)
... ...||+.|||||++.+. .++.++|||||||+||||+||+.||......... ....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 321 23589999999999764 3678999999999999999998887543221110 0111
Q ss_pred HHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 550 WVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 550 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
.+.....++ ..++.+.......+....+.+|+.+||+.||++||||.||++.|+++.+..
T Consensus 240 ~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 240 EMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp HHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 222222111 122222221122345667889999999999999999999999999986553
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=425.67 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=204.4
Q ss_pred HhHhCccceeEEEEEEEcC------CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeC-CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILEE------GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK-DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~ 411 (632)
.+.||+|+||+||+|.... ++.||||+++.... ..+.|.+|++++.++.+|||||+++|+|.+. +..++||
T Consensus 69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~ 148 (353)
T 4ase_A 69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 148 (353)
T ss_dssp EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence 4689999999999998542 35899999976532 2467999999999996669999999999765 5689999
Q ss_pred ecccCCCHhhhhccCCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeE
Q 006747 412 DFIEAGSFSALLHGNRG-----------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC 480 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~k 480 (632)
|||++|+|.++|+..+. .....++|..++.++.|+|+||+|||+. +||||||||+|||+++++++|
T Consensus 149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK 225 (353)
T ss_dssp ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEE
Confidence 99999999999975432 1234589999999999999999999998 999999999999999999999
Q ss_pred EcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 006747 481 ISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQS 553 (632)
Q Consensus 481 i~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 553 (632)
|+|||+|+...... ...+|+.|||||++.+..|+.++|||||||+||||+| |+.||.+.... ..+..
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~------~~~~~ 299 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCR 299 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------HHHHH
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 99999998765432 2246888999999999999999999999999999998 99999764321 12222
Q ss_pred HhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 554 VVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 554 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.+.++.... .+. ....++.+++.+||+.||++||||.||+++|+.+.+.
T Consensus 300 ~i~~g~~~~-------~p~---~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 300 RLKEGTRMR-------APD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHTCCCC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCC-------CCc---cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 333322111 111 1234577888999999999999999999999988554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=420.67 Aligned_cols=239 Identities=22% Similarity=0.364 Sum_probs=198.0
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|+||+||+|... +|+.||||+++... ...+.+.+|++++.++ +|||||+++++|.+.+..||||||+++|+|
T Consensus 80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 56999999999999964 68999999997553 3356689999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 495 (632)
.+++... .+++.....++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+..... ..
T Consensus 159 ~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 159 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence 9999753 388999999999999999999998 9999999999999999999999999999876432 34
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..||+.|||||++.+..|+.++|||||||++|||++|+.||.+... ...... +.+.... .+....
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~-i~~~~~~-----~~~~~~--- 294 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKM-IRDNLPP-----RLKNLH--- 294 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSSCC-----CCSCGG---
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHH-HHcCCCC-----CCCccc---
Confidence 5699999999999999999999999999999999999999975321 111111 1221111 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....++.+|+.+||+.||++|||++|++++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 122356778889999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=418.33 Aligned_cols=240 Identities=21% Similarity=0.266 Sum_probs=196.1
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
+.||+|+||.||+|+. .+|+.||||+++.... ..+|++++.++ +|||||++++++.+.+..||||||+++|+|.
T Consensus 64 ~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 138 (336)
T 4g3f_A 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGL-SSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred cEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCCcHH
Confidence 5799999999999996 4589999999976432 24689999999 9999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-CeEEcccCCCCCCCCC------
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLMNTP------ 493 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~------ 493 (632)
++++... ++++.....++.|++.||+|||+. +||||||||+||||+.++ .+||+|||+|+.....
T Consensus 139 ~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 139 QLIKQMG-----CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp HHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred HHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 9997643 489999999999999999999998 999999999999999998 6999999999876432
Q ss_pred ---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.+....+. .. .+..+..... . .
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~---~i~~~~~~~~----~--~ 278 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CL---KIASEPPPIR----E--I 278 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HH---HHHHSCCGGG----G--S
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HH---HHHcCCCCch----h--c
Confidence 123589999999999999999999999999999999999999976543322 11 1111111000 0 0
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.... ...+.+++.+||+.||++|||+.|++++|...
T Consensus 279 ~~~~---s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 279 PPSC---APLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccC---CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 1112 23466788899999999999999999887654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=404.81 Aligned_cols=241 Identities=23% Similarity=0.375 Sum_probs=191.6
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEe----CCceEEEEec
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFS----KDEKLLVYDF 413 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~E~ 413 (632)
+.||+|+||+||+|... ++..||+|++...... .+.|.+|++++.++ +|||||+++++|.+ .+..|+||||
T Consensus 32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 46999999999999864 5889999999765433 35689999999999 99999999999875 2457999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-CCCeEEcccCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-DLQGCISDFGLTPLMNT 492 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~ 492 (632)
|++|+|.++++... ++++.....++.|++.||+|||++ +++||||||||+||||++ ++.+||+|||+|+....
T Consensus 111 ~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999997642 588999999999999999999987 224999999999999985 79999999999986544
Q ss_pred C--CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 493 P--TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 493 ~--~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
. ....||+.|||||++.+ .|+.++|||||||++|||+||+.||.+... ... +...+..+.....++
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~-~~~~i~~~~~~~~~~----- 252 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQ-IYRRVTSGVKPASFD----- 252 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHH-HHHHHTTTCCCGGGG-----
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHH-HHHHHHcCCCCCCCC-----
Confidence 3 23469999999998865 699999999999999999999999964321 111 112222221111111
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ..++.+|+.+||+.||++|||++|++++
T Consensus 253 -~~~---~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 -KVA---IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -GCC---CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -ccC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 1246778889999999999999999863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=417.34 Aligned_cols=240 Identities=21% Similarity=0.396 Sum_probs=193.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||+||+|+. .+|+.||||+++..... .+.+.+|++++.++ +|||||++++++.+.+..||||||+++
T Consensus 29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiVmEy~~g 107 (350)
T 4b9d_A 29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIVMDYCEG 107 (350)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 36799999999999985 46899999999765433 45689999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|+|.+++...+ ...+++.....|+.|++.||+|||+. +||||||||+||||++++.+||+|||+|+......
T Consensus 108 g~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 108 GDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred CcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence 99999997543 23578888999999999999999998 99999999999999999999999999999876431
Q ss_pred --CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 495 --VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
...||+.|||||++.+..|+.++|||||||++|||+||+.||.+.. .......+....... ...
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~~~~~~--------~~~ 247 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIISGSFPP--------VSL 247 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHTCCCC--------CCT
T ss_pred ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHcCCCCC--------CCc
Confidence 2359999999999999999999999999999999999999997532 222233333222110 011
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.. ..++.+|+.+||+.||++|||++|+++
T Consensus 248 ~~---s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 HY---SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 234677888999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=420.92 Aligned_cols=239 Identities=22% Similarity=0.370 Sum_probs=197.9
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|+||.||+|... +|+.||||++.... ...+.+.+|++++.++ +|||||+++++|.+.+..|||||||++|+|
T Consensus 157 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 57999999999999964 58999999997553 3356689999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 495 (632)
.+++... .+++.....|+.|++.||+|||+. +||||||||+||||+.++.+||+|||+|+..... ..
T Consensus 236 ~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 236 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence 9999754 388999999999999999999998 9999999999999999999999999999876432 23
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..||+.|||||++.+..|+.++|||||||++|||++|+.||.+... ...... +.+... +.+.......
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~-i~~~~~-----~~~~~~~~~s 374 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKM-IRDNLP-----PRLKNLHKVS 374 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSCC-----CCCSCTTSSC
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHH-HHcCCC-----CCCcccccCC
Confidence 4689999999999999999999999999999999999999975321 111111 222111 1111111222
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.++.+|+.+||+.||++|||+.|++++
T Consensus 375 ---~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 375 ---PSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp ---HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 346678889999999999999999874
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=402.38 Aligned_cols=237 Identities=18% Similarity=0.296 Sum_probs=197.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||+||+|+. .+|+.||||++.+. ....+.+.+|++++.++ +|||||++++++.+.+..|+||||++
T Consensus 37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 46899999999999995 46899999999754 23356799999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++...+ .+++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 116 gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 116 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999997643 488899999999999999999998 9999999999999999999999999999876432
Q ss_pred ----CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
...+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.. .......+...... .
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~------~~~~~~~i~~~~~~-------~- 253 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN------EGLIFAKIIKLEYD-------F- 253 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC-------C-
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCCC-------C-
Confidence 23469999999999999999999999999999999999999997532 12222222222110 0
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..... .++.+|+.+||+.||++|||++|++.
T Consensus 254 -p~~~s---~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 254 -PEKFF---PKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -CTTCC---HHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -CcccC---HHHHHHHHHHccCCHhHCcChHHHcC
Confidence 11122 34667888999999999999998743
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=390.56 Aligned_cols=236 Identities=23% Similarity=0.375 Sum_probs=184.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||+||+|.. .+|+.||||++++... ..+.+.+|++++.++ +|||||++++++.+.+..|+||||+
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~- 95 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMVIEYA- 95 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEeCC-
Confidence 36799999999999985 4689999999975432 245789999999999 8999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++.... ++++.....++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 96 ~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 96 GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCc
Confidence 679999987542 488999999999999999999998 9999999999999999999999999999876543
Q ss_pred -CCCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 -TVPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....||+.|||||++.+..| +.++||||+||++|||+||+.||.+.. .....+........ + .
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~~~~~-------~--p 232 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISNGVYT-------L--P 232 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCC-------C--C
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCC-------C--C
Confidence 33469999999999998876 579999999999999999999997532 22222222221110 0 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.... .++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~s---~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 233 KFLS---PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp TTSC---HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCC---HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1122 34667888999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=398.16 Aligned_cols=237 Identities=23% Similarity=0.348 Sum_probs=187.9
Q ss_pred HhHhCccceeEEEEEEEc----CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE----EGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||+||+|+.. .++.||||++++.. .....+.+|++++.++ +|||||++++++.+.+..|+||||
T Consensus 29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy 107 (304)
T 3ubd_A 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLYLILDF 107 (304)
T ss_dssp EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEEEEECC
T ss_pred EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEEEEc
Confidence 468999999999999852 46899999997542 1234688899999999 999999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC-
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT- 492 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~- 492 (632)
+++|+|.+++.... ++++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 108 LRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp CTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999997643 488999999999999999999998 999999999999999999999999999986532
Q ss_pred ---CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 493 ---PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 493 ---~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
.....||+.|||||++.+..|+.++||||+||++|||+||+.||.+... ......+......
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~~--------- 244 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILKAKLG--------- 244 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHcCCCC---------
Confidence 2344699999999999999999999999999999999999999975321 1222222221110
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTM-----EEVVR 604 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~evl~ 604 (632)
.+.... .++.+|+.+||+.||++|||+ +|+++
T Consensus 245 ~p~~~s---~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 MPQFLS---PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CCTTSC---HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCCcCC---HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 111122 346678889999999999994 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=392.43 Aligned_cols=239 Identities=18% Similarity=0.329 Sum_probs=182.4
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc-----------
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE----------- 406 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----------- 406 (632)
.+.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|++++.++ +|||||+++++|.+.+.
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~~~~~~ 88 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQPSSPKV 88 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC----------CE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccccCCCc
Confidence 36799999999999985 4689999999975432 245789999999999 89999999999976543
Q ss_pred -eEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 407 -KLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 407 -~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
.|+||||+++|+|.+++..... ....++.....|+.|++.||+|||+. +||||||||+|||++.++.+||+|||
T Consensus 89 ~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 89 YLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp EEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred EEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCc
Confidence 6899999999999999986532 23456777889999999999999998 99999999999999999999999999
Q ss_pred CCCCCCCCC----------------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 006747 486 LTPLMNTPT----------------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPR 549 (632)
Q Consensus 486 la~~~~~~~----------------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 549 (632)
+|+...... ...||+.|||||++.+..|+.++|||||||++|||++ ||.... +...
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~ 235 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERVR 235 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHH
Confidence 998764321 2358999999999999999999999999999999996 774310 0011
Q ss_pred HHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 550 WVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 550 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.... ...... .....+......+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~-~~~~~~----------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTD-VRNLKF----------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHH-HHTTCC----------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHH-HhcCCC----------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 111110 0111222344567899999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=380.73 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=193.0
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 410 (632)
.+.||+|+||+||+|.. .+|+.||||+++..... .+.+.+|+++|.++ +|||||++++++... +..|+|
T Consensus 59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~~~~iv 137 (398)
T 4b99_A 59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFKSVYVV 137 (398)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCCEEEEE
Confidence 36799999999999996 46899999999765433 35688999999999 899999999997643 578999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
||||+ |+|.+++...+ ++++.....++.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+.+
T Consensus 138 mE~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 138 LDLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EeCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 99996 68999997543 589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCC--------CCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---c
Q 006747 491 NTP--------TVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE---E 558 (632)
Q Consensus 491 ~~~--------~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 558 (632)
... ....||+.|||||++.+.. ++.++||||+||++|||++|+.||.+....+. ...+...... .
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~---l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ---LQLIMMVLGTPSPA 285 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCCCCGG
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCCChH
Confidence 321 2346899999999988754 69999999999999999999999976432111 1111110000 0
Q ss_pred ccccccc-------ccccc--cCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhh
Q 006747 559 WTSEVFD-------VELMR--YENIE----EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDI 609 (632)
Q Consensus 559 ~~~~~~d-------~~~~~--~~~~~----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i 609 (632)
....+-. ..+.. ..... ....++.+|+.+||+.||++|||+.|++++ +++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcC
Confidence 0000000 00000 00000 012356788999999999999999999874 5544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=376.50 Aligned_cols=187 Identities=22% Similarity=0.413 Sum_probs=163.3
Q ss_pred HhHhCccceeEEEEEEEc----CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||+||+|..+ .++.||+|++.... ....+.+|++++.++.+|||||++++++.+.+..|+||||+++
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g 104 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH 104 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence 357999999999999853 46789999987543 4566889999999987899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeEEcccCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~~-- 493 (632)
|+|.+++. .+++.....++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 105 ~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 105 ESFLDILN--------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp CCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred ccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 99999984 277888999999999999999998 99999999999999877 79999999999754321
Q ss_pred ------------------------------CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 494 ------------------------------TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 494 ------------------------------~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
....||++|||||++.+. .|+.++||||+||++|||+||+.||...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 123589999999999876 4899999999999999999999999653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=366.00 Aligned_cols=264 Identities=29% Similarity=0.532 Sum_probs=222.9
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++.++ +||||+++++++...+..++||||+++|+|.
T Consensus 45 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 45 FLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred ceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 57999999999999988899999999876533 356789999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC------C
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP------T 494 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~------~ 494 (632)
+++..... ....++|..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++..... .
T Consensus 124 ~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 199 (321)
T 2qkw_B 124 RHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199 (321)
T ss_dssp GGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred HHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 99976532 334689999999999999999999998 9999999999999999999999999999764322 1
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...+|..|+|||.+.+..++.++|||||||++|||+||+.||......+......|.......+.....+++.... ...
T Consensus 200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 278 (321)
T 2qkw_B 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KIR 278 (321)
T ss_dssp CCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT-CSC
T ss_pred ccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc-ccC
Confidence 2236888999999998899999999999999999999999998766666666666665555454444555544322 234
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.+....+.+++.+||+.||++|||+.|++++|+.+..
T Consensus 279 ~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 279 PESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp HHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 5677789999999999999999999999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=369.72 Aligned_cols=269 Identities=36% Similarity=0.661 Sum_probs=222.6
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|...+++.||||++..... ....+.+|++++.++ +||||+++++++...+..++||||+++|+
T Consensus 35 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 113 (326)
T 3uim_A 35 KNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLLVYPYMANGS 113 (326)
T ss_dssp TTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECCSSCCEEEEECCTTCB
T ss_pred ceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEecCCceEEEEEeccCCC
Confidence 467999999999999988899999999976532 234689999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 494 (632)
|.+++..... ...+++|..+..++.+++.||+|||+.+.++|+||||||+|||+++++.+||+|||+++......
T Consensus 114 L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (326)
T 3uim_A 114 VASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192 (326)
T ss_dssp HHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEE
T ss_pred HHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccccccc
Confidence 9999986542 34569999999999999999999999877799999999999999999999999999997654322
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCC--CCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP--GHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...+|+.|+|||.+.+..++.++|||||||++|||+||+.||... ..........|+.............+.... .
T Consensus 193 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 271 (326)
T 3uim_A 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQ-G 271 (326)
T ss_dssp CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCT-T
T ss_pred ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhc-c
Confidence 234889999999998888999999999999999999999999632 122333455666555555544555554432 2
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
....++...+.+++.+||+.||++|||+.||+++|++....
T Consensus 272 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 272 NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 34567778899999999999999999999999999975443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=393.02 Aligned_cols=240 Identities=18% Similarity=0.294 Sum_probs=190.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHH---HHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQ---MEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e---~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.++||+|+||+||+|+.. +|+.||||++++.. .....+..| ++++..+ +|||||+++++|.+.+..|+|||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~lylVmE 272 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILD 272 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCEEEEEEe
Confidence 467999999999999964 58999999997542 223334444 4445555 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|++||+|.+++.... .+++.....++.|++.||+|||+. +||||||||+||||+.+|++||+|||+|+....
T Consensus 273 y~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 273 LMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp CCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999997643 488899999999999999999998 999999999999999999999999999987654
Q ss_pred C--CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 493 P--TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 493 ~--~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
. ...+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.+....+. ............ .
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~---~~i~~~i~~~~~---------~ 412 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTLTMAV---------E 412 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH---HHHHHHHHHCCC---------C
T ss_pred CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhhcCCCC---------C
Confidence 3 34579999999999975 5799999999999999999999999975432221 111111111110 0
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPT-----MEEVVR 604 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 604 (632)
.+.... .++.+|+.+||+.||++|++ ++||.+
T Consensus 413 ~p~~~S---~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 LPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCTTSC---HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCccCC---HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 111122 34667888999999999998 677765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=364.95 Aligned_cols=258 Identities=24% Similarity=0.338 Sum_probs=202.3
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC----ceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD----EKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lv~E~~~~ 416 (632)
.+.||+|+||.||+|... ++.||||++.........++.|+.++.++ +||||+++++++.... ..++||||+++
T Consensus 29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 367999999999999875 79999999976654455677788889999 8999999999998754 36999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc-------CCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV-------GGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
|+|.++++.. +++|..+..++.|++.||+|||+.+ .++|+||||||+|||+++++.+||+|||+++.
T Consensus 107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 9999999754 3899999999999999999999862 34899999999999999999999999999966
Q ss_pred CCCC------CCCCCCCcccCCccccCC-----CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhH---------
Q 006747 490 MNTP------TVPSRSAGYRAPEVIETK-----KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPR--------- 549 (632)
Q Consensus 490 ~~~~------~~~~~t~~y~aPE~~~~~-----~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~--------- 549 (632)
.... ....+|+.|+|||.+.+. .++.++|||||||++|||+||+.||.+...........
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 5432 223578899999999873 45678899999999999999999998754433222111
Q ss_pred -HHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 550 -WVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 550 -~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
+..... ... ..+.+............+.+++.+||+.||++|||+.||++.|+++..
T Consensus 261 ~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 261 DMQEVVV-HKK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHHT-TSC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhh-ccc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111111 111 111111111122345668899999999999999999999999998854
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=388.74 Aligned_cols=243 Identities=21% Similarity=0.400 Sum_probs=198.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|+++|.++ +|||||++++++.+.+..|+|||||++|+
T Consensus 162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 46799999999999986 468999999997643 2356788999999999 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC--CCeEEcccCCCCCCCCCC--
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD--LQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~--~~~ki~DfGla~~~~~~~-- 494 (632)
|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 241 L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 241 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp HHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred HHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999986542 2488999999999999999999998 99999999999999854 899999999998876543
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...||+.|||||++.+..|+.++||||+||++|||++|+.||.+... ......+...... +... ....
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~~i~~~~~~---~~~~--~~~~ 382 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDWN---MDDS--AFSG 382 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCCC---CCSG--GGTT
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHhCCCC---CCcc--cccC
Confidence 23689999999999999999999999999999999999999975431 1112222211111 0000 1111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. .++.+|+.+||+.||++|||+.|++++
T Consensus 383 ~s---~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 383 IS---EDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp SC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 22 346678889999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=357.67 Aligned_cols=252 Identities=29% Similarity=0.422 Sum_probs=195.6
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|.. ++..||||++...... .+.+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus 42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 46799999999999987 5889999999765433 34688999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK--FILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|.+++.... ....+++..+..++.|++.||+|||+. + |+||||||+|||+++++.+||+|||+++.....
T Consensus 120 ~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 120 SLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp BHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred cHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence 9999998642 123488999999999999999999998 7 999999999999999999999999999765433
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....+|+.|+|||.+.+..++.++|||||||++|||+||+.||..... ..............
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~------~~~~~~~~~~~~~~---------- 258 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP------AQVVAAVGFKCKRL---------- 258 (309)
T ss_dssp -------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHHSCCCC----------
T ss_pred ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCCCC----------
Confidence 234588899999999999999999999999999999999999965321 11111111011000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCCC
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSE 615 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 615 (632)
.........+.+++.+||+.||++|||+.++++.|+.+.....+
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 00111223577888899999999999999999999999776543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=361.80 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=202.1
Q ss_pred HhHhCccceeEEEEEEEc--------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEE
Q 006747 341 AEVLGKGSYGTTYKAILE--------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 410 (632)
.+.||+|+||.||+|... ++..||||+++.... ..+.+.+|++++.++.+||||++++++|...+..++|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 467999999999999852 356799999976532 2357899999999997899999999999999999999
Q ss_pred EecccCCCHhhhhccCCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCe
Q 006747 411 YDFIEAGSFSALLHGNRG-----------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG 479 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ 479 (632)
|||+++|+|.+++...+. .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVM 242 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCCE
Confidence 999999999999986532 1224589999999999999999999998 99999999999999999999
Q ss_pred EEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 006747 480 CISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 480 ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 552 (632)
||+|||+++...... ...+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+ +.
T Consensus 243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~~---- 315 (370)
T 2psq_A 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---LF---- 315 (370)
T ss_dssp EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH----
T ss_pred EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----
Confidence 999999997654321 2235678999999999999999999999999999999 999997543211 11
Q ss_pred HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 553 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
..+....... ........+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 316 ~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 316 KLLKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HHHHTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111110 011122457788899999999999999999999998753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=351.31 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=201.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 93 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFITEYIKGGT 93 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEEEEecCCCc
Confidence 367999999999999964 58999999986542 2356799999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC----
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT---- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~---- 494 (632)
|.+++.... ..++|..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 94 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 94 LRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp HHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 999998642 3589999999999999999999998 99999999999999999999999999997654321
Q ss_pred --------------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 495 --------------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 495 --------------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
...+|+.|+|||.+.+..++.++|||||||++|||++|..|+........... ............
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 245 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-LNVRGFLDRYCP 245 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-BCHHHHHHHTCC
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-hhhhccccccCC
Confidence 23578899999999999999999999999999999999999865432221100 000111111000
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
......+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 246 --------------~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 246 --------------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp --------------TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01112467888999999999999999999999988644
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=349.59 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=193.5
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHh--hcCCCCccceeEEEEeC----CceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGR--LSQHPNVVPIRAYYFSK----DEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~~h~niv~l~~~~~~~----~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|.. +++.||||++... ....+..|.+++.. + +||||+++++++... ...++||||+
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l-~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVML-RHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCC-CCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhc-cCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 36799999999999988 6899999999754 34556667776665 5 899999999997653 3578999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHH--------hccCCCceecCCCCCCeeecCCCCeEEcccCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH--------AAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 486 (632)
++|+|.++++.. .+++..+.+++.|++.||+||| +. +|+||||||+|||++.++.+||+|||+
T Consensus 89 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 89 EMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp TTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred cCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 999999999643 4899999999999999999999 65 999999999999999999999999999
Q ss_pred CCCCCCC--------CCCCCCCcccCCccccCC------CCCccchhhHHHHHHHHHHhC----------CCCCCCCCCC
Q 006747 487 TPLMNTP--------TVPSRSAGYRAPEVIETK------KPTQKSDVYSFGVLLLEMLTG----------KAPIQAPGHE 542 (632)
Q Consensus 487 a~~~~~~--------~~~~~t~~y~aPE~~~~~------~~~~~~DV~s~Gvvl~elltg----------~~p~~~~~~~ 542 (632)
++..... ....+|+.|+|||.+.+. .++.++|||||||++|||+|| +.||......
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~ 239 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence 9654332 223688999999999877 345789999999999999999 7887654322
Q ss_pred CCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 543 DVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
+. .... .......... .+..............+.+++.+||+.||++|||+.||++.|+++
T Consensus 240 ~~-~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 240 DP-SFED-MRKVVCVDQQ----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SC-CHHH-HHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc-chhh-hhHHHhccCC----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 21 1111 1111111111 111111111234556788999999999999999999999999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=348.84 Aligned_cols=239 Identities=22% Similarity=0.366 Sum_probs=196.7
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++|+|
T Consensus 26 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 5799999999999984 568999999997553 3467789999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 495 (632)
.+++... .+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (297)
T 3fxz_A 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (297)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence 9999754 378899999999999999999998 9999999999999999999999999998765432 23
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..+|+.|+|||.+.+..++.++|||||||++|||+||+.||..... ............. .. ....
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~-~~--------~~~~ 240 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP-EL--------QNPE 240 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC-CC--------SCGG
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC-CC--------CCcc
Confidence 4588899999999999999999999999999999999999965321 1111111111111 00 1111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.....+.+++.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122456788899999999999999999873
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=341.59 Aligned_cols=247 Identities=25% Similarity=0.444 Sum_probs=206.1
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|...++..||+|++.......+++.+|++++.++ +||||+++++++.+.+..++||||+++|+|.
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 367999999999999998899999999988777788899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-----CC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-----TV 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-----~~ 495 (632)
+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 94 ~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 94 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 9997543 3588999999999999999999998 9999999999999999999999999999866432 23
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... ...... .. ...
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------~~~~~~~-~~~~~~--~~-----~~~- 231 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDI-STGFRL--YK-----PRL- 231 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHH-HTTCCC--CC-----CTT-
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHH-hcCccC--CC-----CCc-
Confidence 345677999999998999999999999999999999 9999965321 1111111 111100 00 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
....+.+++.+||+.||++|||+.+++++|+++.+.
T Consensus 232 --~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 232 --ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 123577888899999999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=348.11 Aligned_cols=239 Identities=22% Similarity=0.331 Sum_probs=196.4
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|+||.||+|... +|+.||||++.... ...+.+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 129 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEEEecCCCCCH
Confidence 36999999999999976 69999999997553 3456789999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 495 (632)
.+++... .+++..+..++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ..
T Consensus 130 ~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (321)
T 2c30_A 130 TDIVSQV------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 200 (321)
T ss_dssp HHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence 9998643 489999999999999999999998 9999999999999999999999999998765432 23
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..+|+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...... +....... ... ..
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~~~~-~~~~~~~~-----~~~---~~ 265 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKR-LRDSPPPK-----LKN---SH 265 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHH-HHHSSCCC-----CTT---GG
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HhcCCCCC-----cCc---cc
Confidence 4588999999999999999999999999999999999999965321 111111 11111110 000 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.....+.+++.+||+.||++|||+.|++++
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112346778889999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.70 Aligned_cols=271 Identities=30% Similarity=0.533 Sum_probs=214.5
Q ss_pred cCCCHHHHHHHHH-----------hHhCccceeEEEEEEEcCCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCC
Q 006747 329 YNFDLEDLLRASA-----------EVLGKGSYGTTYKAILEEGTTVVVKRLKEVV-----MGKREFEQQMEVVGRLSQHP 392 (632)
Q Consensus 329 ~~~~~~~l~~~~~-----------~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~h~ 392 (632)
..|+++++..++. +.||+|+||.||+|.. +++.||||++.... ...+.+.+|++++.++ +||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 90 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHE 90 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCC
Confidence 3466777766652 5799999999999987 58899999987532 1246789999999999 899
Q ss_pred CccceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCee
Q 006747 393 NVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVL 472 (632)
Q Consensus 393 niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NIL 472 (632)
||+++++++...+..++||||+++|+|.+++.... ...+++|..+..++.+++.||+|||+. +|+||||||+||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil 165 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence 99999999999999999999999999999987543 234689999999999999999999998 9999999999999
Q ss_pred ecCCCCeEEcccCCCCCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 006747 473 LSQDLQGCISDFGLTPLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD 546 (632)
Q Consensus 473 l~~~~~~ki~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~ 546 (632)
+++++.+||+|||+++..... ....++..|+|||.+.+ .++.++||||||+++|||++|+.||........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-- 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence 999999999999998765432 22357889999998865 478999999999999999999999976543222
Q ss_pred hhHHHHHHhhhc-cccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 547 LPRWVQSVVREE-WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 547 ~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
+..+........ ...+.++..+ ..........+.+++.+||+.||++|||+.+++++|+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 122222221111 1111222222 12334566778899999999999999999999999999865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=339.75 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=205.0
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|...++..||+|+++......+++.+|++++.++ +||||+++++++......++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 357999999999999998888999999988777788899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----C
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-----V 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-----~ 495 (632)
+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 92 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 92 NYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp HHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred HHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 9997542 3588999999999999999999998 99999999999999999999999999997664432 2
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++||||||+++|||+| |+.||..... ........ .... ... ...
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~-~~~~--~~~-----~~~- 229 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------SEVVLKVS-QGHR--LYR-----PHL- 229 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHH-TTCC--CCC-----CTT-
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh------HHHHHHHH-cCCC--CCC-----CCc-
Confidence 235667999999998889999999999999999999 9999964321 11111111 1110 000 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
....+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 230 --~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 --ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp --SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred --ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 123577888999999999999999999999999765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=366.75 Aligned_cols=247 Identities=27% Similarity=0.463 Sum_probs=204.6
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|...++..||||+++......+.|.+|++++.++ +|||||++++++. .+..++||||+++|+|.
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 367999999999999998899999999987766788999999999999 8999999999986 66789999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-----CC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-----TV 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-----~~ 495 (632)
++++... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 271 ~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~ 344 (454)
T 1qcf_A 271 DFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344 (454)
T ss_dssp HHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCS
T ss_pred HHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCC
Confidence 9997542 12478889999999999999999998 9999999999999999999999999999876432 22
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++|||||||++|||+| |+.||.+... ...... +..+... ...
T Consensus 345 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------~~~~~~-i~~~~~~----------~~~ 407 (454)
T 1qcf_A 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PEVIRA-LERGYRM----------PRP 407 (454)
T ss_dssp SSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHH-HHHTCCC----------CCC
T ss_pred CcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HHcCCCC----------CCC
Confidence 335678999999998999999999999999999999 9999975321 111111 1111110 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
......+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11234577888999999999999999999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=356.27 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=205.8
Q ss_pred HhHhCccceeEEEEEEEc--------CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEE
Q 006747 341 AEVLGKGSYGTTYKAILE--------EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 410 (632)
.+.||+|+||.||+|... ++..||||+++..... .+.+.+|++++.++.+||||+++++++...+..++|
T Consensus 74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 367999999999999852 2357999999765322 366889999999998899999999999999999999
Q ss_pred EecccCCCHhhhhccCCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCe
Q 006747 411 YDFIEAGSFSALLHGNRGI-----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG 479 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ 479 (632)
|||+++|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcE
Confidence 9999999999999765321 124589999999999999999999998 99999999999999999999
Q ss_pred EEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 006747 480 CISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 480 ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 552 (632)
||+|||+++...... ...+|..|+|||.+.+..++.++|||||||++|||+| |+.||..... ....
T Consensus 231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~------~~~~- 303 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------EELF- 303 (382)
T ss_dssp EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHH-
T ss_pred EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHH-
Confidence 999999998765422 2235678999999999999999999999999999999 9999965321 1111
Q ss_pred HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCCCCCCCCc
Q 006747 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSENQPSSE 621 (632)
Q Consensus 553 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~~~~~~~ 621 (632)
..+....... .... ...++.+++.+||+.||++|||++|+++.|+.+...........+
T Consensus 304 ~~~~~~~~~~-------~~~~---~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 304 KLLKEGHRMD-------KPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp HHHHTTCCCC-------CCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred HHHHcCCCCC-------CCcc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 1122211110 0111 223577888899999999999999999999998665444443333
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=351.06 Aligned_cols=248 Identities=23% Similarity=0.401 Sum_probs=200.0
Q ss_pred HhHhCccceeEEEEEEEc----CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|... .+..||||+++.... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 132 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRLAMIVTEYM 132 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGCCEEEEECC
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCccEEEeeCC
Confidence 367999999999999974 355699999986432 246799999999999 8999999999999989999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.++++... ..+++..+..++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 133 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 133 ENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred CCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999997542 3589999999999999999999998 99999999999999999999999999998765432
Q ss_pred -------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 495 -------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 495 -------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
...+|..|+|||.+.+..++.++|||||||++|||++ |+.||..... ....... ......
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~~-~~~~~~----- 273 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------RDVISSV-EEGYRL----- 273 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHH-HTTCCC-----
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHH-HcCCCC-----
Confidence 1234667999999998899999999999999999999 9999965321 1111111 111110
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
.........+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 274 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 274 -----PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred -----CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 011112245778889999999999999999999999986653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=370.61 Aligned_cols=248 Identities=25% Similarity=0.400 Sum_probs=206.3
Q ss_pred HhHhCccceeEEEEEEEcC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||+|.... +..||||+++......+.|.+|++++.++ +|||||+++++|...+..++||||+++|+|
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv~E~~~~g~L 303 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 303 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEEEEEccCCCCH
Confidence 4679999999999999765 88999999987766788899999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT----- 494 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~----- 494 (632)
.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 304 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 377 (495)
T 1opk_A 304 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377 (495)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCT
T ss_pred HHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecC
Confidence 99997642 34588999999999999999999998 99999999999999999999999999998765332
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||.+....+ +. ..+...... ..
T Consensus 378 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~----------~~ 440 (495)
T 1opk_A 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY----ELLEKDYRM----------ER 440 (495)
T ss_dssp TCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH----HHHHTTCCC----------CC
T ss_pred CCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCC----------CC
Confidence 2234567999999998889999999999999999999 999997643211 11 111111110 11
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.......+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 441 ~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 441 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 111224577888999999999999999999999998644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=346.49 Aligned_cols=238 Identities=19% Similarity=0.318 Sum_probs=196.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 98 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLIMEYASG 98 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEEEECCCC
Confidence 36799999999999996 57899999999765433 34688999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 170 (328)
T 3fe3_A 99 GEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170 (328)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence 99999997542 488899999999999999999998 9999999999999999999999999999765433
Q ss_pred CCCCCCCcccCCccccCCCCC-ccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 TVPSRSAGYRAPEVIETKKPT-QKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~-~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....+|+.|+|||.+.+..++ .++|||||||++|||++|+.||.+.. .............. ...
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~---------~p~ 235 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------LKELRERVLRGKYR---------IPF 235 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------CCT
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC---------CCC
Confidence 334689999999999988875 78999999999999999999997532 12222222211110 001
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. ....+.+++.+||+.||++|||++|++++
T Consensus 236 ~---~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 236 Y---MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp T---SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C---CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 12346678889999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=362.13 Aligned_cols=246 Identities=26% Similarity=0.416 Sum_probs=201.4
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC-ceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-EKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||+|... ++.||||+++... ..+.|.+|++++.++ +||||+++++++...+ ..++||||+++|+|
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 467999999999999885 7899999998654 457899999999999 8999999999988765 78999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-CCCCC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-TVPSR 498 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~~~~~ 498 (632)
.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ....+
T Consensus 275 ~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 348 (450)
T 1k9a_A 275 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 348 (450)
T ss_dssp HHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------CC
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCC
Confidence 99998642 23478899999999999999999998 9999999999999999999999999999765432 22346
Q ss_pred CCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHH
Q 006747 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEE 577 (632)
Q Consensus 499 t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 577 (632)
+..|+|||.+.+..++.++|||||||++|||+| |+.||......+. .. .+..+... ......
T Consensus 349 ~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~----~i~~~~~~----------~~p~~~ 411 (450)
T 1k9a_A 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP----RVEKGYKM----------DAPDGC 411 (450)
T ss_dssp CTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH----HHHTTCCC----------CCCTTC
T ss_pred CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcCCCC----------CCCCcC
Confidence 778999999999999999999999999999999 9999976543221 11 11121111 011112
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 578 MVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 578 ~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
...+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 34577888999999999999999999999988543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=363.96 Aligned_cols=247 Identities=26% Similarity=0.413 Sum_probs=200.5
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|...++..||||+++......+.|.+|++++.++ +||||+++++++.. +..++||||+++|+|.
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 357999999999999998888999999987666778899999999999 89999999999866 6789999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----C
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-----V 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-----~ 495 (632)
+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 267 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 340 (452)
T 1fmk_A 267 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340 (452)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccC
Confidence 9997532 13488999999999999999999998 99999999999999999999999999998765322 1
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++|||||||++|||+| |+.||.+... ...... +..+... ...
T Consensus 341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~~-i~~~~~~----------~~~ 403 (452)
T 1fmk_A 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQ-VERGYRM----------PCP 403 (452)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHH-HHTTCCC----------CCC
T ss_pred CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HHcCCCC----------CCC
Confidence 235667999999999999999999999999999999 9999975321 111111 1111110 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
......+.+++.+||+.||++|||++++++.|+.+...
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 12234577888999999999999999999999998655
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.14 Aligned_cols=246 Identities=21% Similarity=0.346 Sum_probs=202.2
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||++...++..||+|+++......+++.+|++++.++ +||||+++++++.+.+..++||||+++|+|.
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 367999999999999998888999999998777788899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-----CC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-----TV 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-----~~ 495 (632)
+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++..... ..
T Consensus 108 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 108 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp HHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence 9997642 2488999999999999999999998 9999999999999999999999999999866432 22
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..+|..|+|||.+.+..++.++||||||+++|||+| |+.||..... ...... +...... . ....
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------~~~~~~-~~~~~~~--~-----~~~~- 245 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEH-IAQGLRL--Y-----RPHL- 245 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHH-HHTTCCC--C-----CCTT-
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh------hHHHHH-HhcccCC--C-----CCCc-
Confidence 345678999999998899999999999999999999 9999965321 111111 1111100 0 0011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
....+.+++.+||+.||++|||+.+++++|+++.+
T Consensus 246 --~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 246 --ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp --CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 12357788899999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=355.58 Aligned_cols=247 Identities=22% Similarity=0.441 Sum_probs=191.6
Q ss_pred HhHhCccceeEEEEEEEc----CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|... ++..||||+++.... ..+.+.+|++++.++ +||||+++++++...+..++||||+
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 128 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYM 128 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCceEEEEeCC
Confidence 367999999999999864 577899999975432 246799999999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 129 ENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp TTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 9999999997542 3589999999999999999999998 99999999999999999999999999998765432
Q ss_pred C-------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 495 V-------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 495 ~-------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
. ..++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ..... .+......
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------~~~~~-~i~~~~~~----- 269 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------QDVIK-AVDEGYRL----- 269 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------HHHHH-HHHTTEEC-----
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH-HHHcCCCC-----
Confidence 1 123567999999999999999999999999999998 9999965321 11111 11111110
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.........+.+++.+||+.||++||++.+|++.|+.+...
T Consensus 270 -----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 270 -----PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -----CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 01112234577889999999999999999999999988543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=359.05 Aligned_cols=246 Identities=23% Similarity=0.388 Sum_probs=199.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... +++.||||+++..... ...+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~g 197 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIVMELVQGG 197 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence 467999999999999975 6899999999754221 34688999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 198 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 198 DFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp BHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999997542 3488999999999999999999998 99999999999999999999999999997654321
Q ss_pred ---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
...++..|+|||.+.+..++.++|||||||++|||+| |+.||..... ..+...+..+... ..
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~-------~~ 336 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-------QQTREFVEKGGRL-------PC 336 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-------HHHHHHHHTTCCC-------CC
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC-------CC
Confidence 1123567999999998889999999999999999999 9999975321 1111222221110 01
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.. .....+.+++.+||+.||++|||+.++++.|+++..
T Consensus 337 ~~---~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 337 PE---LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 11 122357788899999999999999999999998853
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=344.71 Aligned_cols=258 Identities=24% Similarity=0.371 Sum_probs=195.5
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCCccceeEEEEeC----CceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRL-SQHPNVVPIRAYYFSK----DEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~----~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... ++.||||++.... ...+..|.+++... .+||||+++++++... ...++||||++
T Consensus 42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 118 (337)
T 3mdy_A 42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE 118 (337)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT
T ss_pred EeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC
Confidence 468999999999999886 8999999996543 33445555555433 2899999999999987 67899999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc-----CCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV-----GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
+|+|.++++.. .+++..+..++.+++.||+|||+.. .++|+||||||+|||++.++.+||+|||+++..
T Consensus 119 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 119 NGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192 (337)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence 99999999753 4889999999999999999999752 348999999999999999999999999999665
Q ss_pred CCCC--------CCCCCCcccCCccccCCCCCcc------chhhHHHHHHHHHHhC----------CCCCCCCCCCCCCC
Q 006747 491 NTPT--------VPSRSAGYRAPEVIETKKPTQK------SDVYSFGVLLLEMLTG----------KAPIQAPGHEDVVD 546 (632)
Q Consensus 491 ~~~~--------~~~~t~~y~aPE~~~~~~~~~~------~DV~s~Gvvl~elltg----------~~p~~~~~~~~~~~ 546 (632)
.... ...+|+.|+|||.+.+..++.+ +|||||||++|||+|| +.||........ .
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-~ 271 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP-S 271 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-C
T ss_pred ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC-c
Confidence 4321 2358889999999988776665 9999999999999999 555543222111 1
Q ss_pred hhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 547 LPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
. ........... ..+.........+....+.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus 272 ~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 272 Y-EDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp H-HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred h-hhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 1 11111111111 11111111112345667889999999999999999999999999986653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.68 Aligned_cols=251 Identities=14% Similarity=0.188 Sum_probs=200.8
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||+|.. .+++.||||++.... ....+..|++++.++.+||||+++++++...+..++||||+ +|+|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL 91 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence 36799999999999995 568999999987543 23458899999999988999999999999999999999999 9999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC-----eEEcccCCCCCCCCC-
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ-----GCISDFGLTPLMNTP- 493 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~-----~ki~DfGla~~~~~~- 493 (632)
.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~ 164 (330)
T 2izr_A 92 EDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164 (330)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence 99998542 3589999999999999999999998 9999999999999999887 999999999765332
Q ss_pred ----------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 494 ----------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 494 ----------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.+....+. ..............
T Consensus 165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~---~~~~~~i~~~~~~~-- 239 (330)
T 2izr_A 165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL---KERYQKIGDTKRAT-- 239 (330)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH---HHHHHHHHHHHHHS--
T ss_pred CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH---HHHHHHHHhhhccC--
Confidence 234588999999999999999999999999999999999999986543322 11111111110000
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.... ..... .++.+++..||+.||.+||++.+|.+.|+++..
T Consensus 240 -~~~~-~~~~~----p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~ 281 (330)
T 2izr_A 240 -PIEV-LCENF----PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD 281 (330)
T ss_dssp -CHHH-HTTTC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred -CHHH-HhccC----hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 0000 00011 167888899999999999999999999987743
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=336.87 Aligned_cols=261 Identities=17% Similarity=0.229 Sum_probs=204.5
Q ss_pred hHhCccceeEEEEEEEcC-CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC--ceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD--EKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|.... ++.||||+++... ...+.+.+|++++.++ +||||+++++++.... ..++||||+++
T Consensus 15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 579999999999999654 8999999997543 3457788999999999 8999999999998765 67999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee----cCCCCeEEcccCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL----SQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl----~~~~~~ki~DfGla~~~~~ 492 (632)
|+|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 94 ~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 94 GSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp CBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred CCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 999999986532 23489999999999999999999998 99999999999999 8888999999999987654
Q ss_pred CC---CCCCCCcccCCcccc--------CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc--
Q 006747 493 PT---VPSRSAGYRAPEVIE--------TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW-- 559 (632)
Q Consensus 493 ~~---~~~~t~~y~aPE~~~--------~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 559 (632)
.. ...+|..|+|||.+. +..++.++|||||||++|||+||+.||....... .....+........
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKPSG 246 (319)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG--GCHHHHHHHHHHCCTT
T ss_pred CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHhcCCCcc
Confidence 32 335888999999986 5678999999999999999999999997543221 11222222222111
Q ss_pred -ccccc---------cccccc-cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 560 -TSEVF---------DVELMR-YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 560 -~~~~~---------d~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
...+. ...... ..........+.+++.+||+.||++|||++|++++..+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 00000 001111 1123455566888999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=336.82 Aligned_cols=253 Identities=14% Similarity=0.178 Sum_probs=201.7
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
+.||+|+||.||+|.. .+++.||||++.... ....+.+|++++.++.+|+|++++++++......++||||+ +|+|.
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~ 93 (298)
T 1csn_A 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE 93 (298)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHH
Confidence 5799999999999995 568999999986542 33458889999999988999999999999999999999999 99999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC-----eEEcccCCCCCCCCC--
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ-----GCISDFGLTPLMNTP-- 493 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~-----~ki~DfGla~~~~~~-- 493 (632)
+++.... .++++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++.....
T Consensus 94 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 94 DLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 9998642 3589999999999999999999998 9999999999999988776 999999999765432
Q ss_pred ---------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 494 ---------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 494 ---------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
....+|+.|+|||.+.+..++.++|||||||++|||++|+.||..............+..........
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 243 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR--- 243 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH---
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH---
Confidence 22357889999999999999999999999999999999999997643322211111111100000000
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
.. .. .....+.+++.+||+.||++|||+++|++.|+++....
T Consensus 244 --~~--~~---~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 244 --EL--CA---GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp --HH--TT---TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred --HH--Hh---hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 00 00 11245778889999999999999999999999986543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=342.30 Aligned_cols=254 Identities=22% Similarity=0.392 Sum_probs=196.3
Q ss_pred HhHhCccceeEEEEEEE-----cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E 412 (632)
.+.||+|+||.||+|.+ .+++.||||++..... ..+.+.+|++++.++ +||||+++++++... ...++|||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 93 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIME 93 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCCceEEEEE
Confidence 36799999999999984 3588999999975432 246789999999999 899999999998654 45899999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 94 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp CCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred eCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 999999999997653 2488999999999999999999998 999999999999999999999999999987643
Q ss_pred CC-------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCC--------CCCCC-hhHHHHHHhh
Q 006747 493 PT-------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGH--------EDVVD-LPRWVQSVVR 556 (632)
Q Consensus 493 ~~-------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~--------~~~~~-~~~~~~~~~~ 556 (632)
.. ...++..|+|||.+.+..++.++|||||||++|||+||..|+..... ..... ..........
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 32 22355669999999999999999999999999999999999854210 00000 0001111111
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.... ..........+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 247 ~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 247 NNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp TTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ccCc----------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1110 011112234577888999999999999999999999998543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=338.54 Aligned_cols=257 Identities=22% Similarity=0.364 Sum_probs=196.6
Q ss_pred HhHhCccceeEEEEEEEcC-C-------cEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILEE-G-------TTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~-------~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.||+|+||.||+|.... + ..||+|++.... ...+.+.+|++++.++ +||||+++++++...+..++||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 91 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVCGDENILVQ 91 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECCTTCCEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEeCCCCEEEE
Confidence 3579999999999998543 3 479999997653 3457799999999999 8999999999999999999999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC--------eEEcc
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ--------GCISD 483 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~--------~ki~D 483 (632)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 92 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 92 EFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp ECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred ECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 9999999999998643 3488999999999999999999998 9999999999999999887 99999
Q ss_pred cCCCCCCCCCCCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 484 FGLTPLMNTPTVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 484 fGla~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
||+++.........++..|+|||.+.+ ..++.++|||||||++|||++|..|+.... ...... ........
T Consensus 165 fg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~-~~~~~~~~-- 236 (289)
T 4fvq_A 165 PGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-----DSQRKL-QFYEDRHQ-- 236 (289)
T ss_dssp CCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHHHH-HHHHTTCC--
T ss_pred CcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-----chHHHH-HHhhccCC--
Confidence 999977655444457888999999987 678999999999999999999655543221 111111 11111100
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCCCCCCCCccc
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSENQPSSEDK 623 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~~~~~~~~~ 623 (632)
+. .. ....+.+++.+||+.||++|||+.|+++.|+++......+..++.+.
T Consensus 237 -~~------~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~~~~~~ 287 (289)
T 4fvq_A 237 -LP------AP---KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHH 287 (289)
T ss_dssp -CC------CC---SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------------
T ss_pred -CC------CC---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCCccccc
Confidence 00 00 01246678889999999999999999999999987766555554443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=336.37 Aligned_cols=245 Identities=26% Similarity=0.407 Sum_probs=187.5
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEeccccc-----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM-----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +..||||+++.... ..+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCLVMEFAR 89 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEEEEECCT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEEEEEcCC
Confidence 357999999999999975 89999999875422 246789999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC--------CCCeEEcccCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ--------DLQGCISDFGLT 487 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~--------~~~~ki~DfGla 487 (632)
+|+|.+++... ++++..+..++.+++.||+|||+....+|+||||||+||+++. ++.+||+|||++
T Consensus 90 ~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~ 163 (271)
T 3dtc_A 90 GGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163 (271)
T ss_dssp TEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-
T ss_pred CCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcc
Confidence 99999998643 4889999999999999999999982223999999999999986 778999999999
Q ss_pred CCCCCCC--CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 488 PLMNTPT--VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 488 ~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
+...... ...+++.|+|||.+.+..++.++||||||+++|||+||+.||..... ..............
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~---- 233 (271)
T 3dtc_A 164 REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNKLAL---- 233 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTSCCCC----
T ss_pred cccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcCCCCC----
Confidence 8765432 34578899999999999999999999999999999999999975321 11111111111110
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.........+.+++.+||+.||++|||+.|++++|+++
T Consensus 234 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 234 ------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 00111224577888999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.99 Aligned_cols=242 Identities=18% Similarity=0.309 Sum_probs=197.7
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
+.||+|+||.||++... ++..||+|.++........+.+|++++.++ +||||+++++++.+.+..++||||+++|+|.
T Consensus 11 ~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~ 89 (321)
T 1tki_A 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDIF 89 (321)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEEEEEeCCCCCHH
Confidence 57999999999999865 578999999976554556789999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC--CCCeEEcccCCCCCCCCCCC---
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ--DLQGCISDFGLTPLMNTPTV--- 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~--~~~~ki~DfGla~~~~~~~~--- 495 (632)
+++.... .++++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.......
T Consensus 90 ~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 162 (321)
T 1tki_A 90 ERINTSA----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp HHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence 9997542 3588999999999999999999998 9999999999999997 79999999999987654322
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..+|+.|+|||.+.+..++.++|||||||++|||++|+.||..... ............. ++.. ....
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~---~~~~--~~~~-- 229 (321)
T 1tki_A 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYT---FDEE--AFKE-- 229 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC---CCHH--HHTT--
T ss_pred ccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCCCC---CChh--hhcc--
Confidence 3478899999999988899999999999999999999999975321 1122222211111 0000 0011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...++.+++.+||+.||++|||+.|++++
T Consensus 230 -~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 230 -ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12356788899999999999999999983
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.73 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=192.9
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|+||.||+|...+|+.||+|+++..... ...+.+|++++.++ +||||+++++++.+.+..++||||+++ +
T Consensus 27 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~-~ 104 (311)
T 3niz_A 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCLTLVFEFMEK-D 104 (311)
T ss_dssp EEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCEEEEEECCSE-E
T ss_pred hhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEEEEEEcCCCC-C
Confidence 579999999999999988999999999754322 35788999999999 899999999999999999999999985 8
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 105 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 177 (311)
T 3niz_A 105 LKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177 (311)
T ss_dssp HHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence 888876542 3488999999999999999999998 9999999999999999999999999999776432 2
Q ss_pred CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc---cccc----
Q 006747 495 VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSE---VFDV---- 566 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~d~---- 566 (632)
...+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+. ...+........... ..+.
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 178 HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred CCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhccchhh
Confidence 3357889999999876 4589999999999999999999999976543332 111111111100000 0000
Q ss_pred --ccc--ccCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 567 --ELM--RYENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 567 --~~~--~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
... ..... .....++.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 00000 011245778899999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=341.29 Aligned_cols=238 Identities=21% Similarity=0.300 Sum_probs=195.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... +|+.||+|++++. ......+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv~E~~~ 88 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 367999999999999965 5899999999754 23456788999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|..++...+ .+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 89 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp TCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 999999987542 478899999999999999999998 9999999999999999999999999999864322
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............. . .
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~~~-------~--p 225 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILMEEIR-------F--P 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC-------C--C
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC------HHHHHHHHHcCCCC-------C--C
Confidence 23358899999999999999999999999999999999999996532 11122222211110 0 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
... ...+.+++.+||+.||++|| +++|++++
T Consensus 226 ~~~---s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 226 RTL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCC---CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111 23467788899999999999 89999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=348.19 Aligned_cols=240 Identities=20% Similarity=0.310 Sum_probs=191.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.++||+|+||+||+|+.. +++.||+|++++.... .+.+..|..++.++.+|||||++++++.+.+..++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 468999999999999965 4789999999865322 23578899999888789999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
+|+|..++...+ .+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 208 (396)
T 4dc2_A 137 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 208 (396)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence 999999997543 488999999999999999999998 999999999999999999999999999986322
Q ss_pred -CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCC--CChhHHHHHHhhhcccccccccccc
Q 006747 493 -PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV--VDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+...+..... .
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--------~ 280 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--------R 280 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--------C
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--------C
Confidence 2334689999999999999999999999999999999999999975432221 1111222222222111 0
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTM 599 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~ 599 (632)
.... ....+.+++.+||+.||++||++
T Consensus 281 ~p~~---~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 IPRS---LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCTT---SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCc---CCHHHHHHHHHHhcCCHhHcCCC
Confidence 0111 12356788889999999999995
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=350.70 Aligned_cols=252 Identities=26% Similarity=0.368 Sum_probs=200.4
Q ss_pred HhHhCccceeEEEEEEE------cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc-eEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE-KLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-~~lv~ 411 (632)
.+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|++++.++.+||||++++++|.+.+. .++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 36799999999999973 2457899999976432 235699999999999889999999999987654 89999
Q ss_pred ecccCCCHhhhhccCCCC-------------------------------------------------------------C
Q 006747 412 DFIEAGSFSALLHGNRGI-------------------------------------------------------------G 430 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~-------------------------------------------------------------~ 430 (632)
||+++|+|.++++..... .
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 999999999999865321 0
Q ss_pred CCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC------CCCCCCcccC
Q 006747 431 RTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT------VPSRSAGYRA 504 (632)
Q Consensus 431 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~------~~~~t~~y~a 504 (632)
...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...+|..|+|
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a 263 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 263 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence 12388999999999999999999998 99999999999999999999999999998664322 2236778999
Q ss_pred CccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHH
Q 006747 505 PEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQ 583 (632)
Q Consensus 505 PE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 583 (632)
||.+.+..++.++|||||||++|||+| |+.||.+....+ .+........... .... ....+.+
T Consensus 264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~~~~-------~~~~---~~~~l~~ 327 (359)
T 3vhe_A 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMR-------APDY---TTPEMYQ 327 (359)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTCCCC-------CCTT---CCHHHHH
T ss_pred hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCCCCC-------CCCC---CCHHHHH
Confidence 999999999999999999999999999 999997543221 1111122211110 0011 1235778
Q ss_pred HHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 584 IAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 584 l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
++.+||+.||++|||+.|++++|+++.+
T Consensus 328 li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 8899999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.24 Aligned_cols=253 Identities=21% Similarity=0.318 Sum_probs=200.4
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|.. .++..||+|++...... .+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 5799999999999985 46889999998654322 35688999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|+|.+++.... ++++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 167 (294)
T 4eqm_A 96 PTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence 99999997542 588999999999999999999998 99999999999999999999999999998765432
Q ss_pred ---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...+|+.|+|||.+.+..++.++|||||||++|||+||+.||.+... .........+.... ......
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~----~~~~~~ 237 (294)
T 4eqm_A 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDSVPN----VTTDVR 237 (294)
T ss_dssp -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSCCCC----HHHHSC
T ss_pred ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhccCCC----cchhcc
Confidence 23478999999999999999999999999999999999999975321 11111111111100 000000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhhCCCCCCC
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRP-TMEEVVRMIEDIRPSDSEN 616 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~i~~~~~~~ 616 (632)
.. ....+.+++.+||+.||++|| +++++.+.|+.+......+
T Consensus 238 ~~---~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~ 280 (294)
T 4eqm_A 238 KD---IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN 280 (294)
T ss_dssp TT---SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred cC---CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence 11 123567788899999999998 9999999999986664433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=365.82 Aligned_cols=247 Identities=26% Similarity=0.411 Sum_probs=204.5
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|...++..||||+++......++|.+|++++.++ +|+||+++++++.+ +..++||||+++|+|.
T Consensus 272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred heecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 467999999999999998888999999987766778899999999999 89999999999866 6789999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-----CC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-----TV 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-----~~ 495 (632)
++++... ...+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++..... ..
T Consensus 350 ~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~ 423 (535)
T 2h8h_A 350 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423 (535)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCS
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccC
Confidence 9997532 13488999999999999999999998 9999999999999999999999999999876532 22
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++|||||||++|||+| |+.||.+... ..... .+..+... ...
T Consensus 424 ~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~-~i~~~~~~----------~~~ 486 (535)
T 2h8h_A 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLD-QVERGYRM----------PCP 486 (535)
T ss_dssp TTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHH-HHHTTCCC----------CCC
T ss_pred CcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHH-HHHcCCCC----------CCC
Confidence 345678999999999999999999999999999999 9999975321 11111 11121110 011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
......+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 11234577888999999999999999999999998655
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=331.36 Aligned_cols=247 Identities=25% Similarity=0.437 Sum_probs=205.5
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||++...++..||+|++.......+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 357999999999999988889999999988766778899999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-----CC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-----TV 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-----~~ 495 (632)
+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++..... ..
T Consensus 92 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 164 (267)
T 3t9t_A 92 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164 (267)
T ss_dssp HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred HHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence 9997642 3588999999999999999999998 9999999999999999999999999999866432 23
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... ...... . ....
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i-~~~~~~--~-----~~~~- 229 (267)
T 3t9t_A 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDI-STGFRL--Y-----KPRL- 229 (267)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHH-HTTCCC--C-----CCTT-
T ss_pred ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHH-hcCCcC--C-----CCcc-
Confidence 346678999999998899999999999999999999 8999865321 1111111 111110 0 0011
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
....+.+++.+||+.||++|||+.+++++|+++.+.
T Consensus 230 --~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 230 --ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 123567888999999999999999999999998653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.26 Aligned_cols=247 Identities=19% Similarity=0.314 Sum_probs=179.0
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
+.||+|+||.||++... +++.||||++... ....+.+|++++.++.+||||+++++++.+....++||||+++|+|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 57999999999999964 5899999999753 35678899999999956999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC---CeEEcccCCCCCCCCC----
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL---QGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~---~~ki~DfGla~~~~~~---- 493 (632)
+++... .++++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 95 ~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 95 ERIKKK-----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp HHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 999764 2589999999999999999999998 999999999999998765 8999999999765433
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....+|..|+|||.+.+..++.++|||||||++|||++|+.||..................+..+... +.. ..
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--~~~-----~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--FEG-----EA 239 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--CCS-----HH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--CCc-----cc
Confidence 23357889999999999999999999999999999999999997654322211111121222111110 000 00
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
......++.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 01123457788899999999999999998753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.26 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=201.3
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|... +++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 130 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFE 130 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCCceEEEEe
Confidence 357999999999999974 348899999976432 246789999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC-------------------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee
Q 006747 413 FIEAGSFSALLHGNRGI-------------------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL 473 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl 473 (632)
|+++|+|.+++...... ...++++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~ 207 (343)
T 1luf_A 131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLV 207 (343)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEE
Confidence 99999999999764211 125689999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccCCCCCCCC------CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006747 474 SQDLQGCISDFGLTPLMNT------PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVD 546 (632)
Q Consensus 474 ~~~~~~ki~DfGla~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~ 546 (632)
++++.+||+|||+++.... .....+|..|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus 208 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----- 282 (343)
T 1luf_A 208 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH----- 282 (343)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----
T ss_pred CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh-----
Confidence 9999999999999865432 223356788999999998899999999999999999999 9999965321
Q ss_pred hhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 547 LPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
..... .+.+..... ... .....+.+++.+||+.||++|||+.++++.|+++.+..
T Consensus 283 -~~~~~-~~~~~~~~~-------~~~---~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 283 -EEVIY-YVRDGNILA-------CPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp -HHHHH-HHHTTCCCC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred -HHHHH-HHhCCCcCC-------CCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 11111 111211110 001 12235778889999999999999999999999987653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=343.04 Aligned_cols=242 Identities=20% Similarity=0.348 Sum_probs=196.4
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc-------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM-------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||++... +|..||+|+++.... ..+.+.+|++++.++ +||||+++++++.+....++|||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 94 (326)
T 2y0a_A 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILE 94 (326)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEE
Confidence 467999999999999965 589999999975422 357799999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC----CeEEcccCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL----QGCISDFGLTP 488 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~ 488 (632)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++ .+||+|||+++
T Consensus 95 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 95 LVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp CCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999754 2588999999999999999999998 999999999999999887 89999999997
Q ss_pred CCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 489 LMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 489 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
..... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+... ............. +.
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~---~~ 237 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVNYE---FE 237 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHTCCC---CC
T ss_pred ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHHhcCCC---cC
Confidence 76432 334588999999999999999999999999999999999999965321 1111111111000 00
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... .. .....+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~--~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DEY--FS---NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHH--HT---TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccc--cc---cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 00 112356788899999999999999999873
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=344.09 Aligned_cols=241 Identities=20% Similarity=0.345 Sum_probs=196.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc-------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM-------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||++... +|+.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~e 95 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYENRTDVVLILE 95 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEeCCEEEEEEE
Confidence 367999999999999965 589999999976432 246799999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC----CeEEcccCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL----QGCISDFGLTP 488 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~ 488 (632)
|+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++ .+||+|||+++
T Consensus 96 ~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 96 LVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp CCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999754 2588999999999999999999998 999999999999998877 79999999998
Q ss_pred CCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 489 LMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 489 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
..... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ............. ++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~---~~ 238 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITAVSYD---FD 238 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCCC---CC
T ss_pred EcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcCCC---CC
Confidence 76543 334589999999999999999999999999999999999999975321 1111221111100 01
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
... +.. ....+.+++.+||..||++|||+.|+++
T Consensus 239 ~~~--~~~---~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 239 EEF--FSQ---TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHH--HTT---SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chh--ccC---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 100 011 1234677888999999999999999885
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.86 Aligned_cols=245 Identities=22% Similarity=0.373 Sum_probs=192.9
Q ss_pred HhHhCccceeEEEEEEEc-CCc----EEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGT----TVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|... +++ .||+|.++... ...+.+.+|++++.++ +||||++++++|.+. ..++|+||
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~v~e~ 97 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 97 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS-SEEEEEEC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC-CeEEEEEe
Confidence 367999999999999853 344 35888876432 3457899999999999 899999999999875 47899999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999998643 3588999999999999999999998 9999999999999999999999999998765432
Q ss_pred C------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 T------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
. ...+|..|+|||.+.+..++.++|||||||++|||+| |+.||......+ +. ..+......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~~~~----- 238 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERL----- 238 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCC-----
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HH----HHHHcCCCC-----
Confidence 2 2235678999999999999999999999999999999 999997543221 11 111111100
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.........+.+++.+||+.||++|||+.+++++|+.+..
T Consensus 239 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 -----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0111123457788899999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=351.04 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=199.3
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|... ++..||||+++.... ....+.+|+.++.++ +||||+++++++......++|||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e 154 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILLE 154 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCCCEEEEE
Confidence 367999999999999843 467899999975422 245688999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC--CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC---CeEEcccCCC
Q 006747 413 FIEAGSFSALLHGNRGI--GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL---QGCISDFGLT 487 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~---~~ki~DfGla 487 (632)
|+++|+|.+++...+.. ....+++..++.++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||++
T Consensus 155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a 231 (367)
T 3l9p_A 155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231 (367)
T ss_dssp CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccc
Confidence 99999999999765321 224589999999999999999999998 999999999999999554 5999999998
Q ss_pred CCCC------CCCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 488 PLMN------TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 488 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
+... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ....... .....
T Consensus 232 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~~i-~~~~~ 304 (367)
T 3l9p_A 232 RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFV-TSGGR 304 (367)
T ss_dssp HHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHH-HTTCC
T ss_pred cccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-HcCCC
Confidence 6432 1222346788999999999999999999999999999998 9999965321 1111111 11111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.. ... .....+.+++.+||+.||++|||+.+|+++|+.+...
T Consensus 305 ~~-------~~~---~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 305 MD-------PPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC-------CCc---cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 00 011 1223577888999999999999999999999987544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=346.28 Aligned_cols=255 Identities=17% Similarity=0.206 Sum_probs=190.7
Q ss_pred HhHhCccceeEEEEEEEcC------CcEEEEEEecccccC------------HHHHHHHHHHHHhhcCCCCccceeEEEE
Q 006747 341 AEVLGKGSYGTTYKAILEE------GTTVVVKRLKEVVMG------------KREFEQQMEVVGRLSQHPNVVPIRAYYF 402 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~~h~niv~l~~~~~ 402 (632)
.+.||+|+||.||+|.... ++.||||++...... ...+..|+..+..+ +|+||+++++++.
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~ 118 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVPKYWGSGL 118 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSCCEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCCeEEeeee
Confidence 3679999999999998754 478999998654210 11122333344455 6999999999998
Q ss_pred eC----CceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec--CC
Q 006747 403 SK----DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS--QD 476 (632)
Q Consensus 403 ~~----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~--~~ 476 (632)
.. ...++||||+ +|+|.+++.... .++++..+..++.|++.||+|||+. +|+||||||+|||++ .+
T Consensus 119 ~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 119 HDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp EEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCT
T ss_pred eccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCC
Confidence 75 3479999999 999999997642 3589999999999999999999998 999999999999999 88
Q ss_pred CCeEEcccCCCCCCCCC-----------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC
Q 006747 477 LQGCISDFGLTPLMNTP-----------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV 545 (632)
Q Consensus 477 ~~~ki~DfGla~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~ 545 (632)
+.+||+|||+++.+... ....+|+.|+|||.+.+..++.++|||||||++|||+||+.||.+.....
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~-- 268 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP-- 268 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH--
Confidence 99999999999765321 12238899999999999999999999999999999999999997532211
Q ss_pred ChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 546 DLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 546 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
....+....... ....+++..+.. .. ...++.+++..||+.+|++||++.++++.|+++..
T Consensus 269 ~~~~~~~~~~~~-~~~~~~~~~~~~-~~---~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 269 KYVRDSKIRYRE-NIASLMDKCFPA-AN---APGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HHHHHHHHHHHH-CHHHHHHHHSCT-TC---CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhh-hHHHHHHHhccc-cc---CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 111111111111 111122221111 11 12357788889999999999999999999988744
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=342.54 Aligned_cols=240 Identities=17% Similarity=0.311 Sum_probs=190.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc-----------
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE----------- 406 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----------- 406 (632)
.+.||+|+||.||+|... +|+.||||+++.... ..+.+.+|++++.++ +||||++++++|.+...
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~~~~ 89 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEEMDEIW 89 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence 367999999999999975 789999999975432 356799999999999 89999999999876542
Q ss_pred ----------------------------------------------eEEEEecccCCCHhhhhccCCCCCCCcCCHHHHH
Q 006747 407 ----------------------------------------------KLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRV 440 (632)
Q Consensus 407 ----------------------------------------------~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~ 440 (632)
.++||||+++|+|.+++..... .....+..+.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~ 167 (332)
T 3qd2_B 90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCL 167 (332)
T ss_dssp ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHH
T ss_pred hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHH
Confidence 7999999999999999986542 3446777889
Q ss_pred HHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----------------CCCCCCCcccC
Q 006747 441 KISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----------------TVPSRSAGYRA 504 (632)
Q Consensus 441 ~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----------------~~~~~t~~y~a 504 (632)
.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... ....+|+.|+|
T Consensus 168 ~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 168 HIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 9999999999999998 9999999999999999999999999999776543 22357889999
Q ss_pred CccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHH
Q 006747 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQI 584 (632)
Q Consensus 505 PE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l 584 (632)
||.+.+..++.++|||||||++|||++|..|+.. ....... ...... ..........+.++
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~~~~~-~~~~~~----------~~~~~~~~~~~~~l 305 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITD-VRNLKF----------PLLFTQKYPQEHMM 305 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHHHHHH-HHTTCC----------CHHHHHHCHHHHHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHHHHHH-hhccCC----------CcccccCChhHHHH
Confidence 9999999999999999999999999998776421 0001111 111100 01112233456789
Q ss_pred HHHccCCCCCCCCCHHHHHHH
Q 006747 585 AMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 585 ~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+.+||+.||++|||+.|++++
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCCCcCCCHHHHhhc
Confidence 999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=336.72 Aligned_cols=250 Identities=27% Similarity=0.431 Sum_probs=193.0
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|... ++.||||++... ...+.+.+|++++.++ +||||+++++++. +..++||||+++|+|.
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRV-NHPNIVKLYGACL--NPVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHC-CCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcC-CCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence 367999999999999875 789999999753 2356799999999999 8999999999876 4589999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC-eEEcccCCCCCCCCC-CCCCC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ-GCISDFGLTPLMNTP-TVPSR 498 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~-~ki~DfGla~~~~~~-~~~~~ 498 (632)
+++..... ...+++..++.++.++++||+|||+....+|+||||||+||+++.++. +||+|||+++..... ....+
T Consensus 88 ~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~g 165 (307)
T 2eva_A 88 NVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKG 165 (307)
T ss_dssp HHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------C
T ss_pred HHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCC
Confidence 99986532 234788899999999999999999943338999999999999998886 799999999766543 23458
Q ss_pred CCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHH
Q 006747 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEM 578 (632)
Q Consensus 499 t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 578 (632)
|..|+|||.+.+..++.++|||||||++|||+||+.||...... ........ ....... ......
T Consensus 166 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~-~~~~~~~----------~~~~~~ 230 (307)
T 2eva_A 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP----AFRIMWAV-HNGTRPP----------LIKNLP 230 (307)
T ss_dssp CTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS----HHHHHHHH-HTTCCCC----------CBTTCC
T ss_pred CCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc----HHHHHHHH-hcCCCCC----------cccccC
Confidence 89999999999999999999999999999999999999753321 11111111 1111110 011112
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 579 VQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 579 ~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
..+.+++.+||+.||++|||+.++++.|+.+.+.
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 264 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 3567888899999999999999999999988654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=345.91 Aligned_cols=238 Identities=23% Similarity=0.318 Sum_probs=193.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +++.||||++++. ....+.+..|.+++..+.+||||+++++++.+.+..++||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 367999999999999965 5899999999754 22345688899999988689999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|..++...+ .+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 108 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~ 179 (353)
T 3txo_A 108 GGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV 179 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence 999999997643 488999999999999999999998 9999999999999999999999999999864322
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... -.
T Consensus 180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~~~~---------~p 244 (353)
T 3txo_A 180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILNDEVV---------YP 244 (353)
T ss_dssp ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------CC
T ss_pred cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCC---------CC
Confidence 234589999999999988899999999999999999999999975321 1222222221110 01
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTM------EEVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~------~evl~ 604 (632)
.. ....+.+++.+||+.||++||++ .|+++
T Consensus 245 ~~---~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 245 TW---LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CC---CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11 12346678889999999999998 67665
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=332.83 Aligned_cols=244 Identities=23% Similarity=0.418 Sum_probs=193.8
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC--------HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG--------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
+.||+|+||.||+|.. .+++.||+|++...... .+.+.+|++++.++ +||||+++++++.+.. ++|||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~--~lv~e 101 (287)
T 4f0f_A 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPP--RMVME 101 (287)
T ss_dssp EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTTT--EEEEE
T ss_pred hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCCC--eEEEE
Confidence 5799999999999996 46899999998654221 16789999999999 8999999999985543 79999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCeeecCCCC-----eEEcccC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK--FILGNIKSSNVLLSQDLQ-----GCISDFG 485 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrDlk~~NILl~~~~~-----~ki~DfG 485 (632)
|+++|+|.+++.... .++++..+..++.+++.||+|||+. + |+||||||+||+++.++. +||+|||
T Consensus 102 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg 174 (287)
T 4f0f_A 102 FVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174 (287)
T ss_dssp CCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred ecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence 999999999887542 3589999999999999999999998 7 999999999999988776 9999999
Q ss_pred CCCCCCCC-CCCCCCCcccCCcccc--CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 486 LTPLMNTP-TVPSRSAGYRAPEVIE--TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 486 la~~~~~~-~~~~~t~~y~aPE~~~--~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
+++..... ....+|+.|+|||.+. ...++.++|||||||++|||++|+.||....... ...............
T Consensus 175 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 175 LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEGLRPT 250 (287)
T ss_dssp TCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH----HHHHHHHHHSCCCCC
T ss_pred ccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH----HHHHHHHhccCCCCC
Confidence 99865543 2345888999999984 4457899999999999999999999997543221 111111111111110
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
........+.+++.+||+.||++|||+.|+++.|+++
T Consensus 251 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 251 ----------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ----------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0111224577888999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.24 Aligned_cols=243 Identities=19% Similarity=0.307 Sum_probs=188.8
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe----CCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS----KDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~E~~~~ 416 (632)
+.||+|+||+||++... +++.||||+++. ...+.+|++++.++.+||||+++++++.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 47999999999999865 588999999964 34677888888777799999999999876 5568999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---CCCeEEcccCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~~ 493 (632)
|+|.+++.... ...+++..+..|+.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 144 g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~ 217 (400)
T 1nxk_A 144 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217 (400)
T ss_dssp EEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred CcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence 99999998642 34589999999999999999999998 9999999999999998 789999999999866432
Q ss_pred ---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC-ChhHHHHHHhhhcccccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV-DLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||......... ..... ....... ... .
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~~~~~~--~~~---~ 289 (400)
T 1nxk_A 218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IRMGQYE--FPN---P 289 (400)
T ss_dssp ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HHHTCCC--CCT---T
T ss_pred CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HHcCccc--CCC---c
Confidence 3345789999999999999999999999999999999999999765432211 11111 1111110 000 0
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.... ...++.+++.+||+.||++|||+.|++++
T Consensus 290 ~~~~---~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 EWSE---VSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TTTT---SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccc---CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0111 22356788889999999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=342.35 Aligned_cols=241 Identities=21% Similarity=0.311 Sum_probs=192.7
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... +++.||||++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++|
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~~ 90 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 90 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEEcCCCC
Confidence 367999999999999865 689999999865432 235688999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999754 2488999999999999999999998 9999999999999999999999999999765321
Q ss_pred --CCCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
....+|+.|+|||.+.+..+ +.++|||||||++|||++|+.||........ ....+. .... ..
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~-----~~~~--~~------ 228 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK-----EKKT--YL------ 228 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH-----TTCT--TS------
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh-----cccc--cC------
Confidence 23468899999999988775 7789999999999999999999975432211 111111 1000 00
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.........+.+++.+||+.||++|||+.|++++
T Consensus 229 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011122346678889999999999999999875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=344.26 Aligned_cols=244 Identities=17% Similarity=0.305 Sum_probs=195.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc------cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV------MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus 29 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~ 107 (351)
T 3c0i_A 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEF 107 (351)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEeC
Confidence 468999999999999864 68999999986431 2467899999999999 899999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC---eEEcccCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ---GCISDFGLTPLM 490 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~---~ki~DfGla~~~ 490 (632)
+++|+|.+++..... ....+++.....++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++..
T Consensus 108 ~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 108 MDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp CSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred CCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 999999888764321 223578899999999999999999998 9999999999999987654 999999999776
Q ss_pred CCC----CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 491 NTP----TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 491 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ............. ..+
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~i~~~~~~---~~~ 253 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLFEGIIKGKYK---MNP 253 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHHHHHHHTCCC---CCH
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHHHHHHcCCCC---CCc
Confidence 543 23458999999999999999999999999999999999999997521 1111111111110 000
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
. .... ....+.+++.+||+.||++|||+.|+++
T Consensus 254 ~--~~~~---~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 254 R--QWSH---ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp H--HHTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred c--cccc---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0011 1235678888999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=330.22 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=198.5
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +..||||+++..... .+.+.+|++++.++ +||||+++++++.+. ...++||||++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 92 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTLITHWMP 92 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEeeecccC
Confidence 367999999999999985 899999999865433 35688999999999 899999999999887 67899999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 495 (632)
+|+|.++++... ..++++..+..++.|++.||+|||+. +++|+||||||+||++++++.+||+|||++..... ..
T Consensus 93 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-~~ 167 (271)
T 3kmu_A 93 YGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-PG 167 (271)
T ss_dssp TCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-TT
T ss_pred CCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCcceeEEeccceeeecc-cC
Confidence 999999998653 23589999999999999999999987 12299999999999999999999999998765433 23
Q ss_pred CCCCCcccCCccccCCCCCc---cchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 496 PSRSAGYRAPEVIETKKPTQ---KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~---~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
..+|+.|+|||.+.+..++. ++|||||||++|||+||+.||..... ............... . ..
T Consensus 168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~-----~--~~ 234 (271)
T 3kmu_A 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRPT-----I--PP 234 (271)
T ss_dssp CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCCC-----C--CT
T ss_pred ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCCC-----C--CC
Confidence 45788999999998765544 79999999999999999999965321 111122221211111 0 01
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.....+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 235 ---~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 235 ---GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 122357788889999999999999999999999865
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=344.09 Aligned_cols=244 Identities=19% Similarity=0.282 Sum_probs=189.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||++... +++.||||++.......+.+.+|+.++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 103 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGEL 103 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEEEEeCCCCCH
Confidence 367999999999999965 689999999987655567899999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC--eEEcccCCCCCCCC---CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ--GCISDFGLTPLMNT---PT 494 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~--~ki~DfGla~~~~~---~~ 494 (632)
.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.... ..
T Consensus 104 ~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~ 175 (361)
T 3uc3_A 104 YERICNAG-----RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175 (361)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----------
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCC
Confidence 99987542 488999999999999999999998 9999999999999988765 99999999975432 23
Q ss_pred CCCCCCcccCCccccCCCCCcc-chhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 VPSRSAGYRAPEVIETKKPTQK-SDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~-~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...+|+.|+|||.+.+..++.+ +|||||||++|||++|+.||....... ............... ......
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~-------~~~~~~ 246 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKYS-------IPDDIR 246 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCCC-------CCTTSC
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCCC-------CCCcCC
Confidence 3458899999999988887666 899999999999999999997643222 222222222221110 001111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. ...+.+++.+||+.||++|||+.|++++
T Consensus 247 ~---s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 247 I---SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp C---CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred C---CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1 2356788889999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.67 Aligned_cols=237 Identities=22% Similarity=0.319 Sum_probs=194.0
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|++++..+ +||||+++++++.+.+..++||||+
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~E~~- 91 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIVMVIEYA- 91 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEECC-
Confidence 36799999999999996 568999999997532 2345789999999999 8999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 92 ~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 92 GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 689998886542 488999999999999999999999 9999999999999999999999999999876543
Q ss_pred -CCCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 -TVPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....+|+.|+|||.+.+..+ +.++|||||||++|||++|+.||........... +........
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------i~~~~~~~p 228 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------VNSCVYVMP 228 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------CCSSCCCCC
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------HHcCCCCCc
Confidence 33468999999999988776 7899999999999999999999976433221110 000000001
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. ....+.+++.+||+.||++|||++|++++
T Consensus 229 ~~---~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 229 DF---LSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp TT---SCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cc---CCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11 12346678889999999999999999874
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.63 Aligned_cols=245 Identities=20% Similarity=0.319 Sum_probs=194.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|+.. +++.||+|+++..... .+.+.+|.+++.++.+||||+++++++.+.+..++||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 367999999999999965 5889999999865332 24577889999887789999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 94 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 999999997542 488999999999999999999998 999999999999999999999999999986432
Q ss_pred -CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC--ChhHHHHHHhhhcccccccccccc
Q 006747 493 -PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV--DLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+.. .........+..... .+
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~- 238 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI- 238 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------CC-
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------CC-
Confidence 23346899999999999999999999999999999999999999754322111 111122222211111 00
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTM------EEVVR 604 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~------~evl~ 604 (632)
... ....+.+++.+||+.||++||++ .|+++
T Consensus 239 -p~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 239 -PRS---LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp -CTT---SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred -CCC---CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 111 12356778889999999999995 56654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=341.40 Aligned_cols=252 Identities=23% Similarity=0.400 Sum_probs=189.6
Q ss_pred HhHhCccceeEEEEEEEcCC----cEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCce------
Q 006747 341 AEVLGKGSYGTTYKAILEEG----TTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEK------ 407 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~----~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~------ 407 (632)
.+.||+|+||.||+|..... ..||||+++... ...+.+.+|++++.++ +||||+++++++......
T Consensus 28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 106 (323)
T 3qup_A 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAKGRLPIP 106 (323)
T ss_dssp EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-------CE
T ss_pred eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccccccCCCcc
Confidence 46799999999999986543 279999997642 2246789999999999 999999999999887655
Q ss_pred EEEEecccCCCHhhhhccCCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCC
Q 006747 408 LLVYDFIEAGSFSALLHGNRG-IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486 (632)
Q Consensus 408 ~lv~E~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 486 (632)
++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+
T Consensus 107 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~ 183 (323)
T 3qup_A 107 MVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGL 183 (323)
T ss_dssp EEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccc
Confidence 999999999999999864421 1223589999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 487 TPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 487 a~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
++...... ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ ..........
T Consensus 184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~ 257 (323)
T 3qup_A 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYLIGGNR 257 (323)
T ss_dssp -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCC
T ss_pred cccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH------HHHHHhcCCC
Confidence 98764332 2235667999999999999999999999999999999 999997543211 1111111111
Q ss_pred ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 560 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
. .........+.+++.+||+.||++|||+.++++.|+++....
T Consensus 258 ~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 258 L-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp C-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred C-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0 011112245778889999999999999999999999986553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=337.04 Aligned_cols=238 Identities=22% Similarity=0.343 Sum_probs=186.4
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---------------------------CHHHHHHHHHHHHhhcCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---------------------------GKREFEQQMEVVGRLSQHP 392 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---------------------------~~~~~~~e~~~l~~l~~h~ 392 (632)
.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|++++.++ +||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ 96 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL-DHP 96 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC-CCT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC-CCC
Confidence 36799999999999986 4588999999965421 124588999999999 899
Q ss_pred CccceeEEEEe--CCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCC
Q 006747 393 NVVPIRAYYFS--KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSN 470 (632)
Q Consensus 393 niv~l~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~N 470 (632)
||+++++++.+ .+..++||||+++|+|.+++.. .++++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 97 ~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 167 (298)
T 2zv2_A 97 NVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSN 167 (298)
T ss_dssp TBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred CCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHH
Confidence 99999999987 5678999999999999886543 3589999999999999999999998 99999999999
Q ss_pred eeecCCCCeEEcccCCCCCCCCC----CCCCCCCcccCCccccCCC---CCccchhhHHHHHHHHHHhCCCCCCCCCCCC
Q 006747 471 VLLSQDLQGCISDFGLTPLMNTP----TVPSRSAGYRAPEVIETKK---PTQKSDVYSFGVLLLEMLTGKAPIQAPGHED 543 (632)
Q Consensus 471 ILl~~~~~~ki~DfGla~~~~~~----~~~~~t~~y~aPE~~~~~~---~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~ 543 (632)
||++.++.+||+|||+++..... ....+|+.|+|||.+.+.. ++.++|||||||++|||++|+.||....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--- 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER--- 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc---
Confidence 99999999999999999766433 2346889999999998765 3788999999999999999999996432
Q ss_pred CCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 544 VVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
...+... +...... ....... ...+.+++.+||+.||++|||+.|+++
T Consensus 245 ---~~~~~~~-~~~~~~~------~~~~~~~---~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 ---IMCLHSK-IKSQALE------FPDQPDI---AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp ---HHHHHHH-HHHCCCC------CCSSSCC---CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---HHHHHHH-HhcccCC------CCCcccc---CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1111111 1111110 0001111 235677888999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=341.30 Aligned_cols=263 Identities=21% Similarity=0.309 Sum_probs=192.9
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHH--HhhcCCCCccceeEEEEeC-----CceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVV--GRLSQHPNVVPIRAYYFSK-----DEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l--~~l~~h~niv~l~~~~~~~-----~~~~lv~E~ 413 (632)
.+.||+|+||.||+|.. +++.||||++.... ...+..|.++. ..+ +|+||+++++++... ...++||||
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceEEEEEec
Confidence 36799999999999977 58999999997543 33444444443 346 899999999876532 256899999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc------CCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV------GGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
+++|+|.+++.... .++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a 167 (336)
T 3g2f_A 94 YPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167 (336)
T ss_dssp CTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence 99999999997542 588999999999999999999863 238999999999999999999999999999
Q ss_pred CCCCCC------------CCCCCCCcccCCccccC-------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC-Ch
Q 006747 488 PLMNTP------------TVPSRSAGYRAPEVIET-------KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV-DL 547 (632)
Q Consensus 488 ~~~~~~------------~~~~~t~~y~aPE~~~~-------~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~-~~ 547 (632)
+..... ....+|..|+|||.+.+ ..++.++|||||||++|||+||+.||......... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 765422 12347889999999987 34677899999999999999998776443221111 10
Q ss_pred ----------hHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCCCC
Q 006747 548 ----------PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSEN 616 (632)
Q Consensus 548 ----------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~~ 616 (632)
................+.. ...........+.+++.+||+.||++|||++|+++.|+++...-.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 0111111111111100000 11122334557889999999999999999999999999987665444
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=345.97 Aligned_cols=241 Identities=21% Similarity=0.342 Sum_probs=191.5
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|+||.||+|.. .+|+.||+|+++... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 5699999999999986 468999999997643 2356799999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee--cCCCCeEEcccCCCCCCCCC---C
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL--SQDLQGCISDFGLTPLMNTP---T 494 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl--~~~~~~ki~DfGla~~~~~~---~ 494 (632)
.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++..... .
T Consensus 174 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 174 FDRIIDES----YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp HHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 99886532 3588999999999999999999998 99999999999999 56789999999999876543 2
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...+|++|+|||++.+..++.++|||||||++|||++|+.||.+... ...........+.. ... ....
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~~~~--~~~---~~~~- 314 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACRWDL--EDE---EFQD- 314 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCS--CSG---GGTT-
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhccCCC--Chh---hhcc-
Confidence 33589999999999998999999999999999999999999975321 12222222221110 000 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
....+.+++.+||+.||++|||+.|+++
T Consensus 315 --~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 --ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp --SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1235678888999999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=338.03 Aligned_cols=236 Identities=21% Similarity=0.303 Sum_probs=186.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||+||+|... +++.||||++...... ...+..|+..+.++.+|+||++++++|.+.+..++||||+ +
T Consensus 62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~ 140 (311)
T 3p1a_A 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140 (311)
T ss_dssp EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence 457999999999999975 6899999998765333 2345566666666668999999999999999999999999 6
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... .+++|..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 141 ~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 213 (311)
T 3p1a_A 141 PSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG 213 (311)
T ss_dssp CBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence 79998887542 3589999999999999999999998 9999999999999999999999999998776543
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....+|++|+|||++.+ .++.++|||||||++|||++|..|+.... .| . .+..... .+...
T Consensus 214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~-~-~~~~~~~----~~~~~---- 274 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GW-Q-QLRQGYL----PPEFT---- 274 (311)
T ss_dssp -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HH-H-HHTTTCC----CHHHH----
T ss_pred cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HH-H-HHhccCC----Ccccc----
Confidence 23358899999999876 78999999999999999999977764311 01 0 1111111 11110
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
......+.+++.+||+.||++|||++|+++
T Consensus 275 -~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 -AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011245778889999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=342.66 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=200.2
Q ss_pred HhHhCccceeEEEEEEE------cCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|.. .++..||||+++... ...+.+.+|++++.++.+||||+++++++...+..++|||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 129 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence 46899999999999985 245689999997542 2346799999999999789999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC------------------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec
Q 006747 413 FIEAGSFSALLHGNRGI------------------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS 474 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~ 474 (632)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~ 206 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVT 206 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEc
Confidence 99999999999765321 013479999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCCCCCCCCCCC------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCCh
Q 006747 475 QDLQGCISDFGLTPLMNTPTV------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDL 547 (632)
Q Consensus 475 ~~~~~ki~DfGla~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~ 547 (632)
.++.+||+|||+++....... ..+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.......
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---- 282 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---- 282 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----
T ss_pred CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH----
Confidence 999999999999986643321 235677999999999999999999999999999998 999997643211
Q ss_pred hHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
............. ... .....+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 283 --~~~~~~~~~~~~~-------~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 283 --NFYKLIQNGFKMD-------QPF---YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp --HHHHHHHTTCCCC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred --HHHHHHhcCCCCC-------CCC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 1112222211100 001 11245778888999999999999999999999987654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=340.67 Aligned_cols=242 Identities=20% Similarity=0.328 Sum_probs=195.4
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||++... +++.||+|++...... .+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~g 112 (362)
T 2bdw_A 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTG 112 (362)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 467999999999999864 5899999999765433 35688999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC---CCeEEcccCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD---LQGCISDFGLTPLMNTP 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~---~~~ki~DfGla~~~~~~ 493 (632)
|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 113 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 113 GELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999998754 2588999999999999999999998 99999999999999865 45999999999876543
Q ss_pred C---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 T---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 ~---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
. ...+|+.|+|||++.+..++.++|||||||++|||++|+.||..... .............. ..+ .
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~~--~~~---~ 253 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYDY--PSP---E 253 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCC--CTT---G
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCCC--Ccc---c
Confidence 2 34689999999999999999999999999999999999999975321 11122211111100 000 0
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+. .....+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~---~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 254 WD---TVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp GG---GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cc---CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01 112356788889999999999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=348.92 Aligned_cols=192 Identities=19% Similarity=0.304 Sum_probs=169.4
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhc----CCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS----QHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~----~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. .+++.||||+++......+.+..|++++.++. +||||+++++++...+..++||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~- 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL- 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence 36799999999999996 46889999999865444567888999999884 3999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC--------------------
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-------------------- 475 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-------------------- 475 (632)
+++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 119 ~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~ 192 (360)
T 3llt_A 119 GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192 (360)
T ss_dssp CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccccccc
Confidence 899999998653 23588999999999999999999998 9999999999999975
Q ss_pred -----CCCeEEcccCCCCCCCCC-CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 476 -----DLQGCISDFGLTPLMNTP-TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 476 -----~~~~ki~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
++.+||+|||+++..... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 889999999999865543 3446889999999999999999999999999999999999999754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=345.23 Aligned_cols=240 Identities=18% Similarity=0.290 Sum_probs=194.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... +++.||+|++... ....+.+.+|++++.++ +|||||++++++.+.+..++||||++
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv~e~~~ 98 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMVVDLLL 98 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 467999999999999865 4789999999754 23456788999999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|..++... ..+++..+..++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 99 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 170 (384)
T 4fr4_A 99 GGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170 (384)
T ss_dssp TEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCc
Confidence 99999999854 2488999999999999999999998 9999999999999999999999999999876433
Q ss_pred -CCCCCCCcccCCccccC---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 494 -TVPSRSAGYRAPEVIET---KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~---~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........... .
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~---~~~~~~~~~~~-~--------- 237 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS---KEIVHTFETTV-V--------- 237 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH---HHHHHHHHHCC-C---------
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH---HHHHHHHhhcc-c---------
Confidence 34468999999999974 4589999999999999999999999975433221 11111111110 0
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPT-MEEVVR 604 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~evl~ 604 (632)
.........+.+++.+||+.||++||+ ++++.+
T Consensus 238 --~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 --TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 000111235778888999999999999 666654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=364.59 Aligned_cols=242 Identities=21% Similarity=0.351 Sum_probs=196.7
Q ss_pred HhCccceeEEEEEEEc---CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILE---EGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||+|.+. ++..||||+++... ...+++.+|++++.++ +|||||+++++|.. +..++||||+++|
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 6999999999999864 46679999998653 3467899999999999 99999999999976 5699999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 421 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 421 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp BHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 9999997542 3589999999999999999999998 99999999999999999999999999998764322
Q ss_pred ----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 495 ----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 495 ----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
...++..|+|||++.+..++.++|||||||++|||+| |+.||......+ ... .+..+...
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~-~i~~~~~~-------- 558 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMA-FIEQGKRM-------- 558 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH------HHH-HHHTTCCC--------
T ss_pred eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHH-HHHcCCCC--------
Confidence 1124578999999999999999999999999999998 999997643211 111 11121111
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
.........+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 559 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 559 --ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp --CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111122346778899999999999999999999999873
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.74 Aligned_cols=237 Identities=20% Similarity=0.312 Sum_probs=196.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... +|+.||+|++++.. ...+.+.+|+.++..+ +||||+++++++.+.+..++||||++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv~e~~~ 89 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIE 89 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEEEeCCC
Confidence 367999999999999965 68999999997542 3456788899999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-C
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-T 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~ 494 (632)
+|+|.+++.... .+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 90 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~ 161 (318)
T 1fot_A 90 GGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 161 (318)
T ss_dssp SCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence 999999997643 478899999999999999999998 9999999999999999999999999999876543 3
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...+|+.|+|||.+.+..++.++|||||||++|||++|+.||.... .............. -....
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~---------~p~~~ 226 (318)
T 1fot_A 162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAELR---------FPPFF 226 (318)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCCCC---------CCTTS
T ss_pred cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCC---------CCCCC
Confidence 3468999999999999999999999999999999999999996532 11222222221110 01111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVR 604 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 604 (632)
..++.+++.+|++.||++|| +++|+++
T Consensus 227 ---~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 227 ---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 23466788899999999999 8899885
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.26 Aligned_cols=241 Identities=25% Similarity=0.390 Sum_probs=196.0
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. .+++.||||++...... .+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEEEEEecCC
Confidence 35799999999999985 57899999999754322 35688999999999 89999999999999999999999997
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 495 (632)
|+|.+++.... .++++..+..++.+++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 138 -g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 209 (348)
T 1u5q_A 138 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 209 (348)
T ss_dssp -EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCc
Confidence 68888875432 3589999999999999999999998 999999999999999999999999999988877666
Q ss_pred CCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 496 PSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 496 ~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
..+|+.|+|||.+. ...++.++|||||||++|||+||+.||.... .............. . . ...
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~~-~-----~-~~~ 276 (348)
T 1u5q_A 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESP-A-----L-QSG 276 (348)
T ss_dssp CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCCC-C-----C-CCT
T ss_pred ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCCC-C-----C-CCC
Confidence 78999999999984 5678999999999999999999999996432 11222222221111 0 0 011
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
.. ...+.+++.+||+.||++|||+.+++++.
T Consensus 277 ~~---~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 277 HW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred CC---CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11 23466788899999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=335.58 Aligned_cols=247 Identities=25% Similarity=0.403 Sum_probs=203.7
Q ss_pred HhHhCccceeEEEEEEEcC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||+|.... +..||+|++.......+.+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 96 (288)
T 3kfa_A 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 96 (288)
T ss_dssp EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEEEECCTTEEH
T ss_pred EeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCEEEEEEcCCCCcH
Confidence 3579999999999999764 78999999987665667899999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC----
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV---- 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 495 (632)
.+++.... ...+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 97 ~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 170 (288)
T 3kfa_A 97 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 170 (288)
T ss_dssp HHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEET
T ss_pred HHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcccccc
Confidence 99997642 34589999999999999999999999 999999999999999999999999999987654332
Q ss_pred -CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 496 -PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 496 -~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .... ........ ..
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~----~~~~~~~~----------~~ 233 (288)
T 3kfa_A 171 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE----LLEKDYRM----------ER 233 (288)
T ss_dssp TEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH----HHHTTCCC----------CC
T ss_pred CCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHhccCCC----------CC
Confidence 124667999999998999999999999999999999 99998754321 1111 11111110 00
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.......+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 11122457788889999999999999999999998744
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=341.82 Aligned_cols=237 Identities=20% Similarity=0.325 Sum_probs=193.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +|+.||+|+++.. ......+..|.+++.++.+||||+++++++.+.+..++||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 367999999999999975 5889999999764 23456678889998887689999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
+|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 102 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 102 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 999999997542 488999999999999999999998 999999999999999999999999999986432
Q ss_pred -CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 493 -PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ......+.... . .. .
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~-~------~~--p 238 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDN-P------FY--P 238 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-C------CC--C
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHhCC-C------CC--C
Confidence 2334689999999999999999999999999999999999999975321 11122221111 0 00 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTME-EVV 603 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl 603 (632)
... ...+.+++.+||+.||++||++. ++.
T Consensus 239 ~~~---s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 239 RWL---EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp TTS---CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ccc---CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111 23567788899999999999997 665
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=337.05 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=203.3
Q ss_pred HhHhCccceeEEEEEEE------cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|++++.++.+||||+++++++...+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 36799999999999984 3467899999975432 246789999999999789999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC-------------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCe
Q 006747 413 FIEAGSFSALLHGNRGI-------------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG 479 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ 479 (632)
|+++|+|.+++...... ...++++..+..++.+++.||+|||+. +|+||||||+||++++++.+
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRIT 184 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCE
Confidence 99999999999765321 123589999999999999999999998 99999999999999999999
Q ss_pred EEcccCCCCCCCCCCC------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 006747 480 CISDFGLTPLMNTPTV------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 480 ki~DfGla~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 552 (632)
||+|||+++....... ..++..|+|||.+.+..++.++|||||||++|||+| |+.||....... ...
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~ 258 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------KFY 258 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH------HHH
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh------HHH
Confidence 9999999987654322 234667999999999999999999999999999999 999997543211 111
Q ss_pred HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 553 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.......... .. ......+.+++.+||+.||++|||+.|++++|+++...
T Consensus 259 ~~~~~~~~~~-------~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 259 KMIKEGFRML-------SP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp HHHHHTCCCC-------CC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhccCCCCC-------Cc---ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1122211100 00 11224577888999999999999999999999987543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=342.52 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=193.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcE----EEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTT----VVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~----vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|... ++.. ||+|.+.... .....+.+|+.++.++ +||||+++++++. .+..++||||
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~~~v~e~ 95 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GSSLQLVTQY 95 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BSSEEEEEEC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CCccEEEEEe
Confidence 367999999999999854 3444 7788775432 2235677899999999 8999999999885 5678999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++...+ ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 96 LPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp CTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred CCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 99999999997642 3578889999999999999999998 9999999999999999999999999999876433
Q ss_pred C------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 T------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
. ...++.+|+|||.+.+..++.++|||||||++|||+| |+.||......+ ... .+....... .+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~--~~ 239 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---VPD----LLEKGERLA--QP 239 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---HHH----HHHTTCBCC--CC
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---HHH----HHHcCCCCC--CC
Confidence 2 2236678999999999999999999999999999999 999997643221 111 111111000 00
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
. .....+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 240 -----~---~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 240 -----Q---ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -----T---TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -----C---cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 0112466788899999999999999999999988643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=347.98 Aligned_cols=242 Identities=19% Similarity=0.321 Sum_probs=194.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||++.. .+|+.||+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~lv~E~~~g 94 (444)
T 3soa_A 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYLIFDLVTG 94 (444)
T ss_dssp EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSSEEEEEECCCBC
T ss_pred EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECCEEEEEEEeCCC
Confidence 46799999999999985 4689999999976532 245688999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec---CCCCeEEcccCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS---QDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~---~~~~~ki~DfGla~~~~~~ 493 (632)
|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+++.....
T Consensus 95 g~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 95 GELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 99999987542 488999999999999999999998 999999999999998 4688999999999876543
Q ss_pred C----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 494 T----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 494 ~----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
. ...||++|+|||++.+..++.++||||+||++|||++|+.||.+... ............ +....
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~-----~~~~~ 235 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIKAGAY-----DFPSP 235 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC-----CCCTT
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhCCC-----CCCcc
Confidence 2 24689999999999999999999999999999999999999965321 111122111111 00000
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..... ...+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~---s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 236 EWDTV---TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccC---CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11112 2356678889999999999999999873
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=335.98 Aligned_cols=252 Identities=22% Similarity=0.354 Sum_probs=191.6
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++ +
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 57999999999999998899999999965432 246788999999999 899999999999999999999999986 9
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 86 LKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp HHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 998887542 3488899999999999999999998 9999999999999999999999999998765422 2
Q ss_pred CCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc----cc----ccccc
Q 006747 495 VPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE----WT----SEVFD 565 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~----~~~~d 565 (632)
...+|+.|+|||.+.+. .++.++|||||||++|||+||+.||.+....+ ....+....... +. ...++
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhcccccc
Confidence 33578899999999764 58999999999999999999999997532111 111111111000 00 00001
Q ss_pred cccccc------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 566 VELMRY------ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 566 ~~~~~~------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+..... .........+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111000 0001122456788899999999999999999863
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=339.05 Aligned_cols=250 Identities=25% Similarity=0.405 Sum_probs=200.9
Q ss_pred HhHhCccceeEEEEEEE------cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|.. .++..||||+++.... ..+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCCceEEEEe
Confidence 36799999999999985 2357899999975432 236788999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC-------------------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee
Q 006747 413 FIEAGSFSALLHGNRGI-------------------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL 473 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl 473 (632)
|+++|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli 183 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILV 183 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEE
Confidence 99999999999865321 123589999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccCCCCCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 006747 474 SQDLQGCISDFGLTPLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVD 546 (632)
Q Consensus 474 ~~~~~~ki~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~ 546 (632)
++++.+||+|||+++..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.....
T Consensus 184 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--- 260 (314)
T 2ivs_A 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER--- 260 (314)
T ss_dssp ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 99999999999999765432 22245677999999998889999999999999999999 999997543211
Q ss_pred hhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 547 LPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
+. ..+....... ... .....+.+++.+||+.||++|||+.|++++|+++..
T Consensus 261 ~~----~~~~~~~~~~-------~~~---~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 261 LF----NLLKTGHRME-------RPD---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp HH----HHHHTTCCCC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----HHhhcCCcCC-------CCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11 1111111100 011 122457788899999999999999999999998743
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=329.78 Aligned_cols=246 Identities=28% Similarity=0.454 Sum_probs=201.5
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|...++..||+|+++......+.+.+|++++.++ +||||+++++++. .+..++||||+++|+|.
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEc-CCCcEEEEecCCCCCHH
Confidence 357999999999999988888999999987766778899999999999 8999999999876 45689999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----C
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-----V 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-----~ 495 (632)
+++.... ...+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++...... .
T Consensus 96 ~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T 1qpc_A 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (279)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccC
Confidence 9997532 12488999999999999999999998 99999999999999999999999999997664332 2
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... ....... ....
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~-~~~~~~~-------~~~~- 234 (279)
T 1qpc_A 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNL-ERGYRMV-------RPDN- 234 (279)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHH-HTTCCCC-------CCTT-
T ss_pred CCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HHHHHHH-hcccCCC-------Cccc-
Confidence 235678999999988889999999999999999999 9999865321 1111111 1111100 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
....+.+++.+||+.||++|||+.++++.|+++..
T Consensus 235 --~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 235 --CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 12357788889999999999999999999998743
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=339.17 Aligned_cols=262 Identities=20% Similarity=0.344 Sum_probs=189.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... +|+.||+|+++... ...+.+.+|++++.++ +||||+++++++...+..++||||++ |
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 87 (317)
T 2pmi_A 10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVFEFMD-N 87 (317)
T ss_dssp ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEEEecC-C
Confidence 468999999999999854 58999999997543 2346788999999999 89999999999999999999999998 5
Q ss_pred CHhhhhccCCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 418 SFSALLHGNRG-IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 418 ~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
+|.+++..... .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCC
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCccc
Confidence 99998864321 1223588999999999999999999998 9999999999999999999999999999765432
Q ss_pred -CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---cccccc-----
Q 006747 494 -TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE---EWTSEV----- 563 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----- 563 (632)
....+|+.|+|||.+.+. .++.++|||||||++|||+||+.||.+....+ ....+...... ......
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhhhhhhhh
Confidence 234578899999999764 58999999999999999999999997543211 11111111100 000000
Q ss_pred ccccccc--cCCcH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhC
Q 006747 564 FDVELMR--YENIE---------EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIR 610 (632)
Q Consensus 564 ~d~~~~~--~~~~~---------~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~ 610 (632)
+.+.... ..... .....+.+++.+||+.||++|||+.|++++ +.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 0000000 00000 112357788999999999999999999874 55543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=339.11 Aligned_cols=241 Identities=19% Similarity=0.311 Sum_probs=181.4
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|.
T Consensus 59 ~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 136 (349)
T 2w4o_A 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEISLVLELVTGGELF 136 (349)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred eEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEEEEEEeCCCCCHH
Confidence 57999999999999975 47899999997643 356688999999999 8999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---CCCeEEcccCCCCCCCCC---C
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGCISDFGLTPLMNTP---T 494 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~~---~ 494 (632)
+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++..... .
T Consensus 137 ~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 137 DRIVEK-----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp HHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 999754 2488999999999999999999998 9999999999999975 899999999999876543 2
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... ............. ...+ ..
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~~~~~~--~~~~------~~ 275 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRILNCEYY--FISP------WW 275 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHHTTCCC--CCTT------TT
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHHhCCCc--cCCc------hh
Confidence 345789999999999999999999999999999999999999653211 1111121111110 0000 00
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.+....+.+++.+||+.||++|||+.|++++
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122356788889999999999999999873
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=326.10 Aligned_cols=254 Identities=16% Similarity=0.195 Sum_probs=198.0
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEE-EeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY-FSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~-~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|.. .+++.||||++.... ....+.+|++++.++ +|++++..++++ ...+..++||||+ +|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHh-hcCCCCCccccccCCCCceEEEEEec-CCC
Confidence 35799999999999995 678999999987543 234688999999999 676666555555 5667789999999 899
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee---cCCCCeEEcccCCCCCCCCC--
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL---SQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~-- 493 (632)
|.+++.... .++++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999997432 3589999999999999999999998 99999999999999 58899999999999765432
Q ss_pred ---------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 494 ---------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 494 ---------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
....+|..|+|||.+.+..++.++|||||||++|||++|+.||......+.......+......... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-- 240 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-E-- 240 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-H--
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-H--
Confidence 2335788999999999999999999999999999999999999875443333222211111000000 0
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCC
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~ 614 (632)
.+ ... ....+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 241 --~~--~~~---~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 241 --VL--CKG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp --HH--TTT---SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --HH--Hhh---CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 00 001 12357788899999999999999999999999865543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.41 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=200.6
Q ss_pred HhHhCccceeEEEEEEE--------cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEE
Q 006747 341 AEVLGKGSYGTTYKAIL--------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~--------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 410 (632)
.+.||+|+||.||+|.. .++..||+|+++.... ..+.+.+|++++.++.+||||+++++++...+..++|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 46799999999999986 3467899999976432 2456889999999997899999999999999999999
Q ss_pred EecccCCCHhhhhccCCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCe
Q 006747 411 YDFIEAGSFSALLHGNRGI-----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG 479 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ 479 (632)
|||+++|+|.+++...... ....+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVM 196 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCE
Confidence 9999999999999865421 123489999999999999999999998 99999999999999999999
Q ss_pred EEcccCCCCCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 006747 480 CISDFGLTPLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 480 ki~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 552 (632)
||+|||+++..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||.+... .....
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~ 270 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------EELFK 270 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHH
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH------HHHHH
Confidence 99999999765432 22245678999999988889999999999999999999 9999965321 11111
Q ss_pred HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 553 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.+....... ........+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 271 -~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 271 -LLKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp -HHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHhcCCCCC----------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111110 0011223577888999999999999999999999998543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=339.38 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=199.1
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhh-cCCCCccceeEEEEeCC----ceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRL-SQHPNVVPIRAYYFSKD----EKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~h~niv~l~~~~~~~~----~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. +++.||||++... ....+.+|.+++..+ .+||||+++++++.... ..++||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~ 123 (342)
T 1b6c_B 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE 123 (342)
T ss_dssp EEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred EeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence 46899999999999988 4899999999754 356678888888773 28999999999998876 7899999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHH--------hccCCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH--------AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
+|+|.+++... ++++..+..++.+++.||+||| +. +|+||||||+|||++.++.+||+|||++
T Consensus 124 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 124 HGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 99999999753 4889999999999999999999 55 9999999999999999999999999999
Q ss_pred CCCCCC--------CCCCCCCcccCCccccCCC------CCccchhhHHHHHHHHHHhC----------CCCCCCCCCCC
Q 006747 488 PLMNTP--------TVPSRSAGYRAPEVIETKK------PTQKSDVYSFGVLLLEMLTG----------KAPIQAPGHED 543 (632)
Q Consensus 488 ~~~~~~--------~~~~~t~~y~aPE~~~~~~------~~~~~DV~s~Gvvl~elltg----------~~p~~~~~~~~ 543 (632)
+..... ....+|..|+|||.+.+.. ++.++|||||||++|||+|| +.||......+
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 765432 2335888999999998763 33689999999999999999 67776533221
Q ss_pred CCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 544 VVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 544 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
. ....+......... .+.+.......+....+.+++.+||+.||++|||+.+|+++|+++.+.
T Consensus 275 ~-~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 275 P-SVEEMRKVVCEQKL-----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp C-CHHHHHHHHTTSCC-----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred c-cHHHHHHHHHHHHh-----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 1 12222222211111 111111111234566788999999999999999999999999998654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.55 Aligned_cols=241 Identities=19% Similarity=0.277 Sum_probs=193.7
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||+||+|... +++.||+|++++.. .....+.+|++++..+ +|||||+++++|.+.+..++||||++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lV~E~~~ 152 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMP 152 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 357999999999999965 48899999997532 2234588899999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.++++.. .+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 153 gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 153 GGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp TEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 99999999753 378888999999999999999998 9999999999999999999999999999776543
Q ss_pred ---CCCCCCCcccCCccccCCC----CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETKK----PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~----~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+... ......+.......
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~----- 292 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSL----- 292 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHHHHC-----
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHHHHhccccc-----
Confidence 2456899999999998765 78999999999999999999999975321 11222222111000
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDM--RPTMEEVVRM 605 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~ 605 (632)
......... ..+.+++.+||+.+|++ ||+++||+++
T Consensus 293 ~~p~~~~~s---~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TFPDDNDIS---KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCTTCCCC---HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cCCCccccc---HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000111122 34667888999999988 9999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=341.54 Aligned_cols=255 Identities=15% Similarity=0.228 Sum_probs=190.3
Q ss_pred HhHhCccceeEEEEEEEc----CCcEEEEEEeccccc------------CHHHHHHHHHHHHhhcCCCCccceeEEEEe-
Q 006747 341 AEVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVM------------GKREFEQQMEVVGRLSQHPNVVPIRAYYFS- 403 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~- 403 (632)
.+.||+|+||.||+|... ++..||+|++..... ....+.+|+..+..+ +||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~~~~~~~ 120 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFYGSGLTE 120 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEEEEEEEE
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceeecccccc
Confidence 367999999999999975 578899999875421 123456777778888 89999999999988
Q ss_pred ---CCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC--C
Q 006747 404 ---KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL--Q 478 (632)
Q Consensus 404 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~--~ 478 (632)
....++||||+ +++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .
T Consensus 121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 121 FKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp SSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTS
T ss_pred cCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCc
Confidence 67889999999 999999998643 589999999999999999999998 999999999999999887 9
Q ss_pred eEEcccCCCCCCCCC-----------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 006747 479 GCISDFGLTPLMNTP-----------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547 (632)
Q Consensus 479 ~ki~DfGla~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~ 547 (632)
+||+|||+++..... ....+|..|+|||.+.+..++.++|||||||++|||+||+.||........ .
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~ 269 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV--A 269 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH--H
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH--H
Confidence 999999999765321 223578899999999999999999999999999999999999964221111 0
Q ss_pred hHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.............. .+............+.+++.+||+.||++|||+.+|++.|+++...
T Consensus 270 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 270 VQTAKTNLLDELPQ-----SVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp HHHHHHHHHHTTTH-----HHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred HHHHHHhhcccccH-----HHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 11111111111100 0000000001223577888899999999999999999999987553
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.85 Aligned_cols=255 Identities=20% Similarity=0.289 Sum_probs=192.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc------CHHHHHHHHHHHHhhc--CCCCccceeEEEEeCC-----c
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM------GKREFEQQMEVVGRLS--QHPNVVPIRAYYFSKD-----E 406 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~-----~ 406 (632)
.+.||+|+||.||+|.. .+++.||||++..... ....+.+|++++.++. +||||+++++++.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 35799999999999995 5689999999974321 1356778888877763 4999999999998765 4
Q ss_pred eEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCC
Q 006747 407 KLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486 (632)
Q Consensus 407 ~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 486 (632)
.++||||+. |+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGL 166 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred EEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence 799999997 59999998653 23489999999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCCCC---CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hcc
Q 006747 487 TPLMNTPTV---PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR----EEW 559 (632)
Q Consensus 487 a~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~ 559 (632)
++....... ..+|+.|+|||.+.+..++.++|||||||++|||++|+.||.+....+ ....+..... +.+
T Consensus 167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHCCCCTTTS
T ss_pred ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChhhc
Confidence 987654322 357889999999999999999999999999999999999997543211 1111111110 011
Q ss_pred ccccccc--cccc--cCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 560 TSEVFDV--ELMR--YENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 560 ~~~~~d~--~~~~--~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
......+ .... .... .+....+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 1000000 0000 0000 0122456788899999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=336.95 Aligned_cols=249 Identities=20% Similarity=0.274 Sum_probs=192.0
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|+||.||+|.. .+++.||||++.... .....+.+|++++.++.+||||+++++++.+.+..++||||+++|+|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 4699999999999984 468999999997653 34677999999999966899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC---eEEcccCCCCCCCCC---
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ---GCISDFGLTPLMNTP--- 493 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~---~ki~DfGla~~~~~~--- 493 (632)
.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 170 (316)
T 2ac3_A 99 LSHIHKRR-----HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170 (316)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred HHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence 99997642 488899999999999999999998 9999999999999998776 999999998765321
Q ss_pred --------CCCCCCCcccCCccccC-----CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC-----h---hHHHH
Q 006747 494 --------TVPSRSAGYRAPEVIET-----KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD-----L---PRWVQ 552 (632)
Q Consensus 494 --------~~~~~t~~y~aPE~~~~-----~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~-----~---~~~~~ 552 (632)
....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......+... . .....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 250 (316)
T 2ac3_A 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250 (316)
T ss_dssp -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence 12247889999999875 457899999999999999999999998654332110 0 00011
Q ss_pred HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 553 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..+...... .... .... ....+.+++.+||+.||++|||+.|++++
T Consensus 251 ~~i~~~~~~-~~~~---~~~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 251 ESIQEGKYE-FPDK---DWAH---ISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHCCCC-CCHH---HHTT---SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhccCcc-cCch---hccc---CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111100 0000 0001 12357788899999999999999999884
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=330.10 Aligned_cols=244 Identities=22% Similarity=0.360 Sum_probs=187.7
Q ss_pred HhHhCccceeEEEEEEEcC----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|.... +..||+|+++.... ..+.+.+|++++.++ +||||+++++++ ..+..++||||+
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~e~~ 97 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI-TENPVWIIMELC 97 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEE-ccCccEEEEecC
Confidence 3679999999999998643 45799999875432 245688999999999 899999999997 456789999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 98 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 98 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 9999999997542 3588999999999999999999998 99999999999999999999999999998765432
Q ss_pred -----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 495 -----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 495 -----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
...+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+ .. .... ......
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~---~~i~-~~~~~~------ 237 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI---GRIE-NGERLP------ 237 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HHHH-TTCCCC------
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH---HHHH-cCCCCC------
Confidence 2235678999999998899999999999999999997 999997543221 11 1111 111000
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
... .....+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 238 -~~~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 238 -MPP---NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCC---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 001 12245678888999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=366.48 Aligned_cols=241 Identities=25% Similarity=0.348 Sum_probs=195.1
Q ss_pred hHhCccceeEEEEEEEc---CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAILE---EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
+.||+|+||.||+|.+. .++.||||+++..... .+++.+|++++.++ +|||||+++++|. .+..++||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-~~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE-AESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCCEEEEEEccC
Confidence 46999999999999753 4578999999865332 57899999999999 8999999999996 456899999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++.... .+++..+..|+.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 453 ~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 453 LGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp TEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 999999997542 488999999999999999999998 99999999999999999999999999997654322
Q ss_pred ------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccccc
Q 006747 495 ------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567 (632)
Q Consensus 495 ------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 567 (632)
...+|..|+|||++.+..++.++|||||||++|||+| |+.||.+.... .+...+..+....
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~~~----- 592 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMG----- 592 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-------HHHHHHHTTCCCC-----
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCC-----
Confidence 1235677999999999999999999999999999999 99999754321 1111222211110
Q ss_pred ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 568 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
........+.+++.+||+.||++|||+.+|++.|+++
T Consensus 593 -----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 593 -----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111234577888999999999999999999999976
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.77 Aligned_cols=239 Identities=22% Similarity=0.281 Sum_probs=194.5
Q ss_pred HhHhCccceeEEEEEEEcC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.... ++.||+|+++... ...+.+..|.+++..+.+||||+++++++.+.+..|+||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 3679999999999999754 7899999997642 3456688899999887789999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
+|+|.+++.... .+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 176 (353)
T 2i0e_A 105 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCc
Confidence 999999997542 488899999999999999999998 999999999999999999999999999986432
Q ss_pred -CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 493 -PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. .......+...... -.
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~~~---------~p 241 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHNVA---------YP 241 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCC---------CC
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC------HHHHHHHHHhCCCC---------CC
Confidence 233468999999999999999999999999999999999999997532 11222222221110 01
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPT-----MEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 605 (632)
.. ...++.+++.+||+.||++||+ ++|++++
T Consensus 242 ~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 242 KS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp TT---SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 1235677888999999999995 5777653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=345.26 Aligned_cols=247 Identities=24% Similarity=0.425 Sum_probs=189.1
Q ss_pred HhHhCccceeEEEEEEEcC----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEe-CCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFS-KDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|...+ +..||||.++.... ..+.+.+|++++.++ +||||++++++|.. .+..++||||
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~lv~e~ 172 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 172 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCCeEEEEEC
Confidence 3579999999999998542 24689999875432 246789999999999 89999999999765 4578999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 173 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 173 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred CCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999997542 3478899999999999999999998 9999999999999999999999999999865332
Q ss_pred C--------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 494 T--------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 494 ~--------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
. ...++..|+|||.+.+..++.++|||||||++|||+| |..||......+ ....+ ..+.. ..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~~~----~~~~~--~~ 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYL----LQGRR--LL 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHHHH----HTTCC--CC
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHHHH----HcCCC--CC
Confidence 1 1235667999999999999999999999999999999 677776543222 11111 11110 00
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.... ....+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 317 -----~p~~---~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 317 -----QPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp -----CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0111 123577888999999999999999999999998654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=341.82 Aligned_cols=261 Identities=22% Similarity=0.320 Sum_probs=196.9
Q ss_pred HhHhCcc--ceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKG--SYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G--~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+| +||.||+|... +++.||||+++..... .+.+.+|++++.++ +|||||++++++.+.+..++||||+
T Consensus 30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 108 (389)
T 3gni_B 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELWVVTSFM 108 (389)
T ss_dssp EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEEEEEEEcc
Confidence 3679999 99999999975 6899999999865433 35678899999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC---
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN--- 491 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~--- 491 (632)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.+....
T Consensus 109 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 109 AYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp TTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred CCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 9999999997642 23488999999999999999999998 99999999999999999999999999875431
Q ss_pred --------CCCCCCCCCcccCCccccC--CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh----
Q 006747 492 --------TPTVPSRSAGYRAPEVIET--KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE---- 557 (632)
Q Consensus 492 --------~~~~~~~t~~y~aPE~~~~--~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 557 (632)
......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+.. ..........
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDT 260 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-----------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCccccc
Confidence 1122357888999999987 57899999999999999999999999764332211 0000000000
Q ss_pred -----c-------------ccccccccc--------ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhh
Q 006747 558 -----E-------------WTSEVFDVE--------LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDI 609 (632)
Q Consensus 558 -----~-------------~~~~~~d~~--------~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i 609 (632)
. ...+..... .............+.+|+.+||+.||++|||+.|++++ ++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 0 000000000 00000011123457889999999999999999999975 5555
Q ss_pred C
Q 006747 610 R 610 (632)
Q Consensus 610 ~ 610 (632)
.
T Consensus 341 ~ 341 (389)
T 3gni_B 341 K 341 (389)
T ss_dssp -
T ss_pred h
Confidence 4
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=337.95 Aligned_cols=236 Identities=17% Similarity=0.220 Sum_probs=195.6
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++... +|+.||+|+++... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 47 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 57999999999999965 68999999997542 3456788999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-C
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-V 495 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-~ 495 (632)
|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 126 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~ 197 (350)
T 1rdq_E 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT 197 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCCccc
Confidence 99999997542 488899999999999999999998 99999999999999999999999999998765432 3
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............ . . -...
T Consensus 198 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~------~~~~~~~i~~~~-~------~--~p~~-- 260 (350)
T 1rdq_E 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSGK-V------R--FPSH-- 260 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCC-C------C--CCTT--
T ss_pred ccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC------HHHHHHHHHcCC-C------C--CCCC--
Confidence 458999999999999999999999999999999999999997532 111222222111 1 0 0011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPT-----MEEVVR 604 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 604 (632)
....+.+++.+||+.||++||+ ++|+++
T Consensus 261 -~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 261 -FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1235678888999999999998 888876
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=333.05 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=196.5
Q ss_pred HhHhCccceeEEEEEEE-----cCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 411 (632)
.+.||+|+||.||+|.+ .+++.||+|+++... ...+.+.+|++++.++ +||||+++++++... ...++||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~ 104 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNGIKLIM 104 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---CCEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCceEEEEE
Confidence 36799999999999983 468899999997543 3357799999999999 899999999999876 6689999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 105 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 105 EFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp ECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999996542 3488999999999999999999998 99999999999999999999999999997765
Q ss_pred CCC-------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCC--------CCCCChhHHHHHHhh
Q 006747 492 TPT-------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGH--------EDVVDLPRWVQSVVR 556 (632)
Q Consensus 492 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~--------~~~~~~~~~~~~~~~ 556 (632)
... ...+|..|+|||.+.+..++.++|||||||++|||+||+.|+..... ...............
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 432 23467779999999998899999999999999999999998643210 000000011111111
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
.... ..........+.+++.+||+.||++|||+.++++.|+++.
T Consensus 258 ~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGKR----------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCC----------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1110 0011112245778889999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=338.34 Aligned_cols=252 Identities=22% Similarity=0.351 Sum_probs=198.7
Q ss_pred HhHhCccceeEEEEEEEc-----CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-----EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~ 411 (632)
.+.||+|+||.||++.+. +++.||||+++.... ..+.+.+|++++.++ +||||+++++++.+. ...++||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~ 114 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQLVM 114 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEEEEEE
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceEEEEE
Confidence 367999999999998642 588999999986532 245689999999999 899999999999884 5689999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++|+|.+++... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 115 e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 115 EYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp CCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred ecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 999999999999754 388999999999999999999998 99999999999999999999999999998765
Q ss_pred CCC-------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCC-----CC-Ch--hHHHHHHhh
Q 006747 492 TPT-------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHED-----VV-DL--PRWVQSVVR 556 (632)
Q Consensus 492 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~-----~~-~~--~~~~~~~~~ 556 (632)
... ...++..|+|||.+.+..++.++|||||||++|||+||+.||....... .. .. .........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 432 2346777999999998889999999999999999999999986421100 00 00 000011111
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
... ...........+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 266 ~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 266 RGE----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccc----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 110 0011112234677888999999999999999999999988654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=339.87 Aligned_cols=244 Identities=15% Similarity=0.187 Sum_probs=195.8
Q ss_pred hHhCccceeEEEEEE------EcCCcEEEEEEecccccCHHHHHHHHHHHHhhc--CCCCccceeEEEEeCCceEEEEec
Q 006747 342 EVLGKGSYGTTYKAI------LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS--QHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
+.||+|+||.||+|. ..+++.||||+++.. ...++..|++++.++. .|+||+++++++...+..++||||
T Consensus 71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~ 148 (365)
T 3e7e_A 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL 148 (365)
T ss_dssp EEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECC
T ss_pred EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEec
Confidence 579999999999993 556899999999753 4567888888888873 289999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-----------CCCeEEc
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-----------DLQGCIS 482 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-----------~~~~ki~ 482 (632)
+++|+|.+++...+......++|..+..|+.|++.||+|||+. +|+||||||+|||++. ++.+||+
T Consensus 149 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~ 225 (365)
T 3e7e_A 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225 (365)
T ss_dssp CCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEEC
T ss_pred cCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEEe
Confidence 9999999999754333345699999999999999999999998 9999999999999998 8999999
Q ss_pred ccCCCCCCC---C---CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 006747 483 DFGLTPLMN---T---PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR 556 (632)
Q Consensus 483 DfGla~~~~---~---~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 556 (632)
|||+++.+. . .....||.+|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 226 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------------ 293 (365)
T 3e7e_A 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------------ 293 (365)
T ss_dssp CCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------------
T ss_pred eCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------------
Confidence 999996543 1 1334589999999999999999999999999999999999999864321110
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhhhCCC
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMR-PTMEEVVRMIEDIRPS 612 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R-Ps~~evl~~L~~i~~~ 612 (632)
. ........ ... ..+.+++..|++.+|.+| |+++++.+.|+++.+.
T Consensus 294 ---~---~~~~~~~~-~~~---~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 ---K---PEGLFRRL-PHL---DMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ---E---ECSCCTTC-SSH---HHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ---e---echhcccc-CcH---HHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0 00011111 112 245567779999999988 7888888888877543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=342.17 Aligned_cols=243 Identities=21% Similarity=0.402 Sum_probs=196.4
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|... +++.||+|++.... .....+.+|++++.++ +||||+++++++.+....++||||+++|+
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~gg~ 134 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGE 134 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence 367999999999999864 58899999997543 2345789999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC--CCCeEEcccCCCCCCCCCC--
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ--DLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~--~~~~ki~DfGla~~~~~~~-- 494 (632)
|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 135 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 135 LFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp HHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 999987542 3589999999999999999999998 9999999999999974 5789999999998765432
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...+|+.|+|||++.+..++.++|||||||++|||+||+.||.+... ...........+. ++.. .
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~~~---~~~~-----~ 273 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWE---FDED-----A 273 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCC---CCSS-----T
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---CCcc-----c
Confidence 23588999999999999999999999999999999999999975321 1112222111111 0100 0
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.......+.+++.+||+.||++|||+.|++++
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01112356788889999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=328.21 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=188.7
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... ..||+|+++..... .+.+.+|++++.++ +||||+++++++ .....++||||++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 367999999999999864 46999999765433 35689999999999 899999999965 556789999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 105 SLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 9999997542 3589999999999999999999998 9999999999999999999999999999765431
Q ss_pred --CCCCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
....+|..|+|||.+. +..++.++|||||||++|||++|+.||...... ..+........... ..
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~----~~ 247 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIEMVGRGSLSP----DL 247 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH------HHHHHHHHHTSCCC----CT
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH------HHHHHHhcccccCc----ch
Confidence 1234788999999986 566888999999999999999999999753321 11111221211111 00
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.. ........+.+++.+||+.||++|||+.++++.|+++..
T Consensus 248 ~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 248 SK--VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp TS--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hh--ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 011123467788899999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=333.85 Aligned_cols=237 Identities=18% Similarity=0.308 Sum_probs=186.3
Q ss_pred HhHhCccceeEEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVV-----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.||+|+||.||++.. .+++.||+|+++... .....+.+|++++.++ +||||+++++++...+..++||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 100 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGGKLYLIL 100 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSSCEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCCEEEEEE
Confidence 36799999999999986 478999999997642 1234578899999999 8999999999999999999999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 101 EYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp ECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred eCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 9999999999997542 478889999999999999999998 99999999999999999999999999997643
Q ss_pred CC----CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccc
Q 006747 492 TP----TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567 (632)
Q Consensus 492 ~~----~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 567 (632)
.. ....+|+.|+|||.+.+..++.++|||||||++|||++|+.||..... ............ .
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~-------~ 239 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKCKL-------N 239 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC-------C
T ss_pred cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC-------C
Confidence 22 234588999999999999999999999999999999999999975321 112222221110 0
Q ss_pred ccccCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006747 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVR 604 (632)
Q Consensus 568 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 604 (632)
.... ....+.+++.+||+.||++|| ++.|+++
T Consensus 240 --~p~~---~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 --LPPY---LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp --CCTT---SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred --CCCC---CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0011 123567788899999999999 7788876
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=328.16 Aligned_cols=253 Identities=19% Similarity=0.283 Sum_probs=189.9
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||+||+|... +++.||+|+++..... ...+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 57999999999999964 5889999999754332 36788999999999 899999999999999999999999986
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
++.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (292)
T 3o0g_A 86 DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence 5555554322 3588999999999999999999998 9999999999999999999999999999766432
Q ss_pred CCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---cccccccc----
Q 006747 494 TVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE---EWTSEVFD---- 565 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d---- 565 (632)
....+|..|+|||.+.+.. ++.++|||||||++|||+||+.||..... .......+...... .......+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 2345788999999998766 79999999999999999999888643211 11111111111100 00000000
Q ss_pred -------ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 566 -------VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 566 -------~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...............+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000011123456788899999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=327.97 Aligned_cols=245 Identities=21% Similarity=0.334 Sum_probs=198.2
Q ss_pred hHhCccceeEEEEEEEc---CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE---EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|... ++..||+|+++.... ..+.+.+|++++.++ +||||+++++++ ..+..++||||+++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~ 93 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEALMLVMEMAGG 93 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence 37999999999999853 578899999986432 346789999999999 899999999999 55679999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 94 ~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 94 GPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 99999997532 3589999999999999999999998 9999999999999999999999999999766432
Q ss_pred ----CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
....+|..|+|||.+.+..++.++|||||||++|||+| |+.||...... ..... +......
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~-i~~~~~~------- 232 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAF-IEQGKRM------- 232 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHH-HHTTCCC-------
T ss_pred eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------HHHHH-HhcCCcC-------
Confidence 12235778999999988889999999999999999999 99999754321 11111 1111110
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.........+.+++.+||+.||++|||+.+++++|+++..+
T Consensus 233 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 233 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00111224577888999999999999999999999988444
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=325.91 Aligned_cols=254 Identities=16% Similarity=0.194 Sum_probs=196.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEE-EeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY-FSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~-~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|.. .+++.||||++..... ...+.+|++++.++ +|++++..++++ ...+..++||||+ +|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMM-QGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHH-TTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred eeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHh-cCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 36799999999999995 5688999998765422 23588899999999 666666655555 5677889999999 999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee---cCCCCeEEcccCCCCCCCCC--
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL---SQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~-- 493 (632)
|.+++.... .++++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.....
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp HHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999997532 2489999999999999999999998 99999999999999 78999999999999765432
Q ss_pred ---------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 494 ---------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 494 ---------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
....+|..|+|||.+.+..++.++|||||||++|||++|+.||........................ ..
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~- 241 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EV- 241 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HH-
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-hh-
Confidence 1235788999999999999999999999999999999999999875544433322211111100000 00
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCC
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~ 614 (632)
.... ....+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 242 -----~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 242 -----LCKG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp -----HTTT---SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred -----hhcc---CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0001 12357788899999999999999999999999865543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=354.59 Aligned_cols=243 Identities=23% Similarity=0.325 Sum_probs=197.9
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|... +|+.||+|++... ......+.+|++++.++ +|||||++++++.+.+..++||||+++
T Consensus 190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 57999999999999964 6899999999754 23456788999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 269 g~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~ 342 (576)
T 2acx_A 269 GDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 342 (576)
T ss_dssp CBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCE
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCccc
Confidence 99999997643 33588999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+...+..... .. ...
T Consensus 343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~---~~~i~~~i~~~~~------~~--p~~ 411 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK---REEVERLVKEVPE------EY--SER 411 (576)
T ss_dssp ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC---HHHHHHHHHHCCC------CC--CTT
T ss_pred cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh---HHHHHHHhhcccc------cC--Ccc
Confidence 234689999999999998899999999999999999999999976432211 1111111111100 00 011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
....+.+++.+||+.||++|| +++|++++
T Consensus 412 ---~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 412 ---FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 123567788899999999999 78888763
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=334.04 Aligned_cols=246 Identities=21% Similarity=0.431 Sum_probs=194.0
Q ss_pred hHhCccceeEEEEEEEcC-----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 342 EVLGKGSYGTTYKAILEE-----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
+.||+|+||.||+|.... +..||||+++.... ....+.+|++++.++ +||||+++++++...+..++||||+
T Consensus 50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEECC
T ss_pred cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCCcEEEEeCC
Confidence 679999999999998643 23599999975432 245688999999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 129 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 201 (333)
T 1mqb_A 129 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 201 (333)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccc
Confidence 9999999997542 3588999999999999999999998 99999999999999999999999999998764321
Q ss_pred -------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 495 -------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 495 -------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
...++..|+|||.+.+..++.++|||||||++|||++ |+.||..... ...... +.+.....
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~-~~~~~~~~---- 270 (333)
T 1mqb_A 202 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKA-INDGFRLP---- 270 (333)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHH-HHTTCCCC----
T ss_pred ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HHHHHH-HHCCCcCC----
Confidence 1124667999999999999999999999999999999 9999965321 111111 11111100
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.. ......+.+++.+||+.||++||++.++++.|+++...
T Consensus 271 ---~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 271 ---TP---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ---CC---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ---Cc---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01 11223577888999999999999999999999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=347.30 Aligned_cols=190 Identities=27% Similarity=0.433 Sum_probs=154.7
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCC--ceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD--EKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~E~~ 414 (632)
.+.||+|+||.||+|.. .+|+.||||++...... ...+.+|+.++.++.+||||+++++++...+ ..|+||||+
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 35799999999999985 46899999999754332 3557789999999955999999999998654 689999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC--
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT-- 492 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~-- 492 (632)
+ |+|..++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 8 5999998753 478899999999999999999998 999999999999999999999999999976432
Q ss_pred -----------------------CCCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 006747 493 -----------------------PTVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540 (632)
Q Consensus 493 -----------------------~~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~ 540 (632)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 112357889999999987 568999999999999999999999997643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=342.41 Aligned_cols=264 Identities=17% Similarity=0.234 Sum_probs=205.7
Q ss_pred HhHhCccceeEEEEEEEcC-CcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC--ceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD--EKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.... ++.||||+++... ...+.+.+|++++.++ +||||+++++++...+ ..++||||++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~lv~e~~~ 92 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKVLIMEFCP 92 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence 3579999999999999654 8999999997643 3457788999999999 8999999999998765 6799999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee----cCCCCeEEcccCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL----SQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl----~~~~~~ki~DfGla~~~~ 491 (632)
+|+|.+++..... ...+++..+..++.+++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 93 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp TEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999986532 23489999999999999999999998 99999999999999 788889999999998765
Q ss_pred CCC---CCCCCCcccCCccccC--------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 492 TPT---VPSRSAGYRAPEVIET--------KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 492 ~~~---~~~~t~~y~aPE~~~~--------~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
... ...+|..|+|||.+.+ ..++.++|||||||++|||+||+.||........ ....+.........
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~p~ 245 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGKPS 245 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHSCCT
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcCCCc
Confidence 432 3458889999999865 4578899999999999999999999975432221 12222222221110
Q ss_pred ---ccc---------ccccccc-cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 561 ---SEV---------FDVELMR-YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 561 ---~~~---------~d~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
... +...+.. ..........+.+++.+||+.||++|||+.|+++.++++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 000 0001111 112244556678899999999999999999999999988654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.28 Aligned_cols=240 Identities=19% Similarity=0.301 Sum_probs=188.2
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCC-CCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQH-PNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h-~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||++...+++.||||++...... .+.+.+|++++.++.+| +||+++++++.+.+..++|||| .+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CC
Confidence 3679999999999999888999999999765433 35688999999999432 9999999999999999999995 67
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++......
T Consensus 93 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 93 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp EEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 89999998642 488999999999999999999998 999999999999997 6789999999998765332
Q ss_pred ----CCCCCCcccCCccccC-----------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 495 ----VPSRSAGYRAPEVIET-----------KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 495 ----~~~~t~~y~aPE~~~~-----------~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..............
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNH 238 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTTS
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHhcCCc
Confidence 3358999999999864 668999999999999999999999996432 11111222211111
Q ss_pred ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 560 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ..... ...+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~-------~~~~~---~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 239 EIE-------FPDIP---EKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp CCC-------CCCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccC-------CcccC---CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 100 00111 1356788889999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.84 Aligned_cols=240 Identities=18% Similarity=0.295 Sum_probs=189.8
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcC-CCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQ-HPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||++...+++.||||++...... .+.+.+|++++.++.+ |+||+++++++...+..++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 3679999999999999888999999999755333 3568999999999953 6999999999999999999999 567
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 140 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 140 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 89999998643 578889999999999999999998 999999999999995 589999999999876532
Q ss_pred ---CCCCCCCcccCCccccC-----------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 494 ---TVPSRSAGYRAPEVIET-----------KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~-----------~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..............
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~~~~ 285 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNH 285 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHCTTS
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhCccc
Confidence 23358999999999865 368999999999999999999999996432 11112222221111
Q ss_pred ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 560 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. .. .... ...+.+++.+||+.||++|||+.|++++
T Consensus 286 ~~-----~~--~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 286 EI-----EF--PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CC-----CC--CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cC-----CC--Cccc---hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 10 00 0111 2356788889999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=325.33 Aligned_cols=244 Identities=24% Similarity=0.405 Sum_probs=196.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe----------------
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS---------------- 403 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~---------------- 403 (632)
.+.||+|+||.||+|... +++.||+|+++... ..+.+|++++.++ +||||+++++++..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccccccC
Confidence 467999999999999975 78999999997542 4577899999999 89999999999864
Q ss_pred CCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcc
Q 006747 404 KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISD 483 (632)
Q Consensus 404 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~D 483 (632)
....++||||+++|+|.+++.... ...+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred cceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECc
Confidence 345799999999999999997542 23588999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 484 FGLTPLMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 484 fGla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
||+++..... ....+++.|+|||.+.+..++.++||||||+++|||++|..|+... ...... ......
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~~~~-~~~~~~ 236 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKFFTD-LRDGII 236 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHHHHH-HHTTCC
T ss_pred chhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHHHHH-hhcccc
Confidence 9998766543 2345888999999999999999999999999999999999886421 111111 111111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCCCC
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSEN 616 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~~ 616 (632)
. ... ...+.+++.+||+.||++|||+.|++++|+.+......+
T Consensus 237 ~----------~~~---~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 237 S----------DIF---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp C----------TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred c----------ccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 1 111 124667888999999999999999999999998765443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=330.62 Aligned_cols=255 Identities=20% Similarity=0.358 Sum_probs=193.4
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. .+|+.||+|+++.... ....+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 115 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNIVLELAD 115 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcEEEEEecCC
Confidence 36799999999999985 5689999999975321 245688999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++..... ....+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 116 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 191 (310)
T 2wqm_A 116 AGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 191 (310)
T ss_dssp SCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-----------
T ss_pred CCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc
Confidence 9999999864321 124588999999999999999999998 99999999999999999999999999997764432
Q ss_pred ---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.+... .......... ....... ..
T Consensus 192 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~-~~~~~~~------~~ 260 (310)
T 2wqm_A 192 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE-QCDYPPL------PS 260 (310)
T ss_dssp -------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C----CHHHHHHHHH-TTCSCCC------CT
T ss_pred cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch----hHHHHHHHhh-cccCCCC------cc
Confidence 23478889999999999999999999999999999999999965321 1122222211 1111100 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCC
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~ 614 (632)
.. ....+.+++.+||+.||++|||+.++++.|+++.+...
T Consensus 261 ~~---~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 261 DH---YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cc---cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11 12357788889999999999999999999999976643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=339.46 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=198.3
Q ss_pred HhHhCccceeEEEEEEE-----cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEe--CCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFS--KDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~E 412 (632)
.+.||+|+||.||++.+ .++..||||++..... ..+.+.+|++++.++ +||||+++++++.. ....++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e 106 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVME 106 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCceEEEEEe
Confidence 36799999999999984 4588999999976532 245689999999999 99999999999874 456899999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 107 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 107 YLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred ecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999997642 2589999999999999999999998 999999999999999999999999999986643
Q ss_pred CC-------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCC--------CCCChhHHHHHHhhh
Q 006747 493 PT-------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHE--------DVVDLPRWVQSVVRE 557 (632)
Q Consensus 493 ~~-------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~ 557 (632)
.. ...++..|+|||.+.+..++.++|||||||++|||++|+.||...... ...............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 22 234677799999999888999999999999999999999998642210 000000111111111
Q ss_pred ccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 558 EWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 558 ~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
... ..........+.+++.+||+.||++|||+.|++++|+.+....
T Consensus 260 ~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 260 GQR----------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 110 0111122345778889999999999999999999999986553
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=326.33 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=195.5
Q ss_pred HhHhCccceeEEEEEEEcC-C---cEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCce-EEEEec
Q 006747 341 AEVLGKGSYGTTYKAILEE-G---TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEK-LLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~-~lv~E~ 413 (632)
.+.||+|+||.||+|...+ + ..||+|.+..... ..+.+.+|++++.++ +||||+++++++.+.+.. ++||||
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEECC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecCCCCcEEEEec
Confidence 3679999999999998533 2 2799999975432 246788999999999 899999999999877665 999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+.+|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 105 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 105 MCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred ccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999997632 3578999999999999999999998 9999999999999999999999999999765332
Q ss_pred --------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 494 --------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 494 --------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
....++..|+|||.+.+..++.++|||||||++|||+||..|+..... ....... ........
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~~----~~~~~~~~--- 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTHF----LAQGRRLP--- 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHHH----HHTTCCCC---
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHHH----hhcCCCCC---
Confidence 223467789999999999999999999999999999996666543211 1111111 11111000
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.... ....+.+++.+||+.||++|||+.++++.|+++...
T Consensus 249 ----~~~~---~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 249 ----QPEY---CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ----CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCcc---chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0111 123577888999999999999999999999988544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=347.41 Aligned_cols=244 Identities=17% Similarity=0.263 Sum_probs=193.3
Q ss_pred HhHhCccceeEEEEEEEcC-CcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.++||+|+||+||+|...+ ++.||+|++++.. .....+.+|++++..+ +||||++++++|.+.+..++||||++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lV~Ey~~ 157 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMDYYV 157 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEEEEecCC
Confidence 3679999999999999764 7899999997532 1233488899999998 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++.... ..+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 158 gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 158 GGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 999999997632 3488999999999999999999998 9999999999999999999999999999765432
Q ss_pred ---CCCCCCCcccCCcccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~-----~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.+... ......+........ +
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~-~- 302 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQ-F- 302 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHHHHCC-C-
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh------hHHHHhhhhcccccc-C-
Confidence 2246899999999997 45689999999999999999999999975321 111222211110000 0
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDM--RPTMEEVVRM 605 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~--RPs~~evl~~ 605 (632)
+. ..... ...+.+++.+|+..+|++ ||+++|++++
T Consensus 303 p~--~~~~~---s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 PT--QVTDV---SENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CS--SCCCS---CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred Cc--ccccC---CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 00 00111 234667788999888888 9999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=335.21 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=191.7
Q ss_pred HhHhCccceeEEEEEEEc-CCcE----EEEEEeccc--ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTT----VVVKRLKEV--VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~----vavK~~~~~--~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|... +++. ||+|.+... ....+.+.+|++++.++ +||||+++++++.... .++|+||
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~-~~~v~~~ 97 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST-VQLITQL 97 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-EEEEECC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-ceEEEEe
Confidence 367999999999999853 4444 577777543 23467899999999999 8999999999998754 8899999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp CSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 99999999997643 3588999999999999999999998 9999999999999999999999999999876432
Q ss_pred C------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 T------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
. ...+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+ +. ..+......
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~----~~~~~~~~~----- 238 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERL----- 238 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCC-----
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCC-----
Confidence 2 1235667999999999999999999999999999999 999997543221 11 111111100
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.........+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 239 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 239 -----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 00111223577888999999999999999999999987643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.84 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=182.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEe--------CCceEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFS--------KDEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--------~~~~~lv 410 (632)
.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|++++.++.+||||+++++++.. ....++|
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 36799999999999995 4689999999865432 346788999999999569999999999953 2347999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK--FILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
|||+. |+|.+++.... ...++++..+..++.+++.||+|||+. + |+||||||+|||+++++.+||+|||+++
T Consensus 113 ~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 186 (337)
T 3ll6_A 113 TELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186 (337)
T ss_dssp EECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCB
T ss_pred EEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccce
Confidence 99996 69999886532 123589999999999999999999998 6 9999999999999999999999999998
Q ss_pred CCCCCC----------------CCCCCCcccCCccc---cCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhH
Q 006747 489 LMNTPT----------------VPSRSAGYRAPEVI---ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPR 549 (632)
Q Consensus 489 ~~~~~~----------------~~~~t~~y~aPE~~---~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~ 549 (632)
...... ...+|+.|+|||.+ .+..++.++|||||||++|||+||+.||........
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~----- 261 (337)
T 3ll6_A 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI----- 261 (337)
T ss_dssp CCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------------
T ss_pred eccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-----
Confidence 765321 22378889999998 566789999999999999999999999965322111
Q ss_pred HHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCCCC
Q 006747 550 WVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSEN 616 (632)
Q Consensus 550 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~~ 616 (632)
........ .... ....+.+++.+||+.||++|||+.|++++|+.+......+
T Consensus 262 -----~~~~~~~~-------~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 262 -----VNGKYSIP-------PHDT---QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ---------CCCC-------TTCC---SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred -----hcCcccCC-------cccc---cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 00000000 0001 1123667888999999999999999999999986554333
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=325.45 Aligned_cols=238 Identities=21% Similarity=0.390 Sum_probs=176.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLVLEMCH 94 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEEEecCC
Confidence 35799999999999986 568999999996542 2246789999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+++|.+++.... .++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 95 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 95 NGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp TEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 999999997542 3588999999999999999999998 9999999999999999999999999999765432
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....+++.|+|||.+.+..++.++||||||+++|||++|+.||......+... ... .. +.. ..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~----~~---~~~--~~ 232 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KVV----LA---DYE--MP 232 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CC----SS---CCC--CC
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HHh----hc---ccC--Cc
Confidence 22357889999999999889999999999999999999999997543222110 000 00 000 01
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.. ....+.+++.+||+.||++|||+.++++
T Consensus 233 ~~---~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 SF---LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TT---SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc---cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11 1235678889999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.35 Aligned_cols=237 Identities=21% Similarity=0.363 Sum_probs=195.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +|+.||||++.... .....+.+|++++..+ +||||+++++++.+.+..++||||++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~lv~E~~~ 99 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFMVMEYVS 99 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 367999999999999965 68999999997542 2346789999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 100 GGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp SEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999754 2488999999999999999999998 9999999999999999999999999999876543
Q ss_pred -CCCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 -TVPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....+|+.|+|||.+.+..+ +.++|||||||++|||++|+.||..... ............. ..
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~~---------~p 236 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICDGIFY---------TP 236 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHTTCCC---------CC
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhcCCcC---------CC
Confidence 23468999999999988775 7899999999999999999999975321 1222222211100 01
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
... ...+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~---s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 237 QYL---NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp TTC---CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccC---CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 111 234678888999999999999999997
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=332.85 Aligned_cols=255 Identities=22% Similarity=0.340 Sum_probs=191.3
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... +|+.||+|++...... .+.+.+|++++.++ +||||+++++++...+..++||||++++
T Consensus 9 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEEEEeCCCc
Confidence 57999999999999975 4899999998765433 35678999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++.... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (311)
T 4agu_A 88 VLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159 (311)
T ss_dssp HHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred hHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccccc
Confidence 9999887542 488999999999999999999998 9999999999999999999999999999776532
Q ss_pred CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCCh---------hHHHHHHhhhcccccc
Q 006747 494 TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL---------PRWVQSVVREEWTSEV 563 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 563 (632)
....+|..|+|||.+.+ ..++.++|||||||++|||+||+.||.+....+.... +.+........+....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 23357888999999976 5679999999999999999999999976432211100 0000000000000000
Q ss_pred ccccccccCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 564 FDVELMRYENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 564 ~d~~~~~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..+........ ......+.+++.+||+.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000 1122357788999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=325.81 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=192.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYVDMRLIN 117 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEEEEEEecC
Confidence 367999999999999964 6889999999765322 36688999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+++|.+++.... ++++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 118 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 118 GVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 999999997542 488999999999999999999998 99999999999999999999999999987664432
Q ss_pred ----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 495 ----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 495 ----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
...++..|+|||.+.+..++.++||||||+++|||+||+.||.... .............. +.. .
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~~~~~~~~~~~~~----~~~-~ 257 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ-------LSVMGAHINQAIPR----PST-V 257 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH-------HHHHHHHHHSCCCC----GGG-T
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch-------HHHHHHHhccCCCC----ccc-c
Confidence 2357888999999999999999999999999999999999996432 11122222111110 000 0
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhhCCCCC
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRP-TMEEVVRMIEDIRPSDS 614 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~i~~~~~ 614 (632)
... ....+.+++.+||+.||++|| |++++++.|+++.....
T Consensus 258 ~~~---~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 258 RPG---IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp STT---CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred CCC---CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 011 123466788899999999999 99999999999866643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=331.73 Aligned_cols=252 Identities=26% Similarity=0.368 Sum_probs=200.3
Q ss_pred HhHhCccceeEEEEEEE------cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC-ceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-EKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~ 411 (632)
.+.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|++++.++.+||||+++++++...+ ..++||
T Consensus 32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~ 111 (316)
T 2xir_A 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 111 (316)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence 46799999999999974 3468999999976532 23568899999999978999999999998755 489999
Q ss_pred ecccCCCHhhhhccCCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeE
Q 006747 412 DFIEAGSFSALLHGNRGI-----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC 480 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~k 480 (632)
||+++|+|.+++...... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK 188 (316)
T ss_dssp ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEE
Confidence 999999999999865321 022378999999999999999999998 999999999999999999999
Q ss_pred EcccCCCCCCCCCCC------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHH
Q 006747 481 ISDFGLTPLMNTPTV------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQS 553 (632)
Q Consensus 481 i~DfGla~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 553 (632)
|+|||+++....... ..+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ ....
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~ 262 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCR 262 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------HHHH
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH------HHHH
Confidence 999999987644321 235678999999999999999999999999999998 999997543211 1111
Q ss_pred HhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 554 VVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 554 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
......... .... ....+.+++.+||+.||++|||+.|++++|+.+.+
T Consensus 263 ~~~~~~~~~-------~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 263 RLKEGTRMR-------APDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp HHHHTCCCC-------CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhccCccCC-------CCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111211110 0011 12357788889999999999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=349.07 Aligned_cols=237 Identities=20% Similarity=0.293 Sum_probs=187.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. .+|+.||||+++... .....+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 46899999999999985 468999999997542 2234577888899998 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-ccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA-AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 493 (632)
+|+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++.....
T Consensus 232 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 232 GGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp SCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 999999997542 48899999999999999999998 6 8999999999999999999999999999864322
Q ss_pred ---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
....||++|+|||++.+..++.++|||||||++|||++|+.||..... ............. .
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~~~~---------~ 368 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILMEEIR---------F 368 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCC---------C
T ss_pred cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCC---------C
Confidence 334689999999999999999999999999999999999999965321 1122222211110 0
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVR 604 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 604 (632)
... ....+.+++.+||+.||++|| +++|+++
T Consensus 369 p~~---~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PRT---LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CTT---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred Ccc---CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 011 123567888899999999999 9999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=331.66 Aligned_cols=244 Identities=19% Similarity=0.294 Sum_probs=195.3
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... +++.||+|+++.... ....+.+|++++.++.+||||+++++++...+..++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 67999999999999865 589999999976532 35789999999999977899999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---CCCeEEcccCCCCCCCCC-
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~~- 493 (632)
+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 188 (327)
T 3lm5_A 115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188 (327)
T ss_dssp EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence 9999986542 24589999999999999999999998 9999999999999998 789999999999876543
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....+|+.|+|||.+.+..++.++|||||||++|||++|+.||..... ........... . +.. .
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~-~----~~~---~ 254 (327)
T 3lm5_A 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN------QETYLNISQVN-V----DYS---E 254 (327)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC-C----CCC---T
T ss_pred ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHHHhcc-c----ccC---c
Confidence 233588999999999999999999999999999999999999965321 11111111110 0 000 0
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.........+.+++.+||+.||++|||++|++++
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0111122456788889999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.15 Aligned_cols=250 Identities=22% Similarity=0.395 Sum_probs=189.7
Q ss_pred HhHhCccceeEEEEEEEc----CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCc-----eE
Q 006747 341 AEVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE-----KL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~ 408 (632)
.+.||+|+||.||+|... .+..||+|+++..... .+.+.+|++++.++ +||||+++++++...+. .+
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 117 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSSQGIPKPM 117 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC-------CEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccccCCcccE
Confidence 467999999999999854 2458999999765333 35688999999999 89999999999987653 49
Q ss_pred EEEecccCCCHhhhhccCCC-CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRG-IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
+||||+++|+|.+++..... .....+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 118 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 118 VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp EEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC
T ss_pred EEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcc
Confidence 99999999999999853321 1335689999999999999999999998 9999999999999999999999999999
Q ss_pred CCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 488 PLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 488 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
+..... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ..... ....
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~~~~-~~~~ 267 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---M---YDYLL-HGHR 267 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H---HHHHH-TTCC
T ss_pred eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H---HHHHH-cCCC
Confidence 876432 12235678999999999999999999999999999999 888986543211 1 11111 1111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
. .........+.+++.+||+.||++|||+.+++++|+++..
T Consensus 268 ~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 268 L----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp C----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 0111122457788899999999999999999999998754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.24 Aligned_cols=243 Identities=23% Similarity=0.336 Sum_probs=190.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||++.. .++..||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++|
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeEEEEEEeCCCC
Confidence 46899999999999986 458899999997653 3467899999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee---cCCCCeEEcccCCCCCCCCC-
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL---SQDLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~- 493 (632)
+|.+++..... ....+++..+..++.+++.||+|||+. +|+||||||+||++ +.++.+||+|||+++.....
T Consensus 106 ~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~ 181 (285)
T 3is5_A 106 ELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181 (285)
T ss_dssp BHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----
T ss_pred cHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc
Confidence 99998864321 123588999999999999999999998 99999999999999 45688999999999876543
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....++..|+|||.+. ..++.++|||||||++|||++|+.||.+... .............. .. ..
T Consensus 182 ~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~---~~---~~ 248 (285)
T 3is5_A 182 HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYKEPNY---AV---EC 248 (285)
T ss_dssp -----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC---CC-----
T ss_pred cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccCCccc---cc---cc
Confidence 2345788999999885 5689999999999999999999999975321 11111111111000 00 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.. ....+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~---~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 RP---LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC---CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Cc---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01 1235668888999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=337.67 Aligned_cols=243 Identities=21% Similarity=0.335 Sum_probs=191.3
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||++... +++.||+|+++.... ...+|++++.++.+||||+++++++.+.+..++||||+++|+|
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L 103 (342)
T 2qr7_A 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103 (342)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence 467999999999999865 588999999976532 3456888888887899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC----CCeEEcccCCCCCCCCC--
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD----LQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~----~~~ki~DfGla~~~~~~-- 493 (632)
.+++.... .+++.....++.+++.||+|||+. +|+||||||+|||+.++ +.+||+|||+++.....
T Consensus 104 ~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 104 LDKILRQK-----FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp HHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 99987542 488999999999999999999998 99999999999998543 35999999999765432
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||....... ........ ..+... +... .+
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~~~~i-~~~~~~--~~~~--~~ 247 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEEILARI-GSGKFS--LSGG--YW 247 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHHHHHHH-HHCCCC--CCST--TT
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHHHHHHH-ccCCcc--cCcc--cc
Confidence 23457889999999988888999999999999999999999997532211 11222222 111110 0000 01
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ...+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~---s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 248 NSV---SDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTS---CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ccC---CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 112 2346678889999999999999999873
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=331.79 Aligned_cols=249 Identities=20% Similarity=0.317 Sum_probs=189.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCce----EEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEK----LLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~----~lv~ 411 (632)
.+.||+|+||.||+|.. .+++.||||+++..... ...+.+|++++.++ +||||+++++++...... ++||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~lv~ 95 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVM 95 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCcccEEEE
Confidence 36799999999999995 56899999999765322 24688899999999 899999999998876543 9999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++|+|.++++... ++++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 96 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 96 EYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp ECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred ecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 9999999999997542 488999999999999999999998 99999999999999999999999999998664
Q ss_pred CCC-------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 492 TPT-------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 492 ~~~-------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
... ...+|+.|+|||.+.+..++.++|||||||++|||+||+.||..... ..............
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~--- 238 (311)
T 3ork_A 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP--- 238 (311)
T ss_dssp --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC---
T ss_pred ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC---
Confidence 321 22478899999999999999999999999999999999999965321 11111111111110
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH-HHHhhhCCC
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV-RMIEDIRPS 612 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl-~~L~~i~~~ 612 (632)
+.. .... ....+.+++.+||+.||++||++.+++ ..+..+...
T Consensus 239 -~~~-~~~~---~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 239 -PSA-RHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp -HHH-HSTT---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred -ccc-ccCC---CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 000 0011 123567888899999999999666544 566665443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=328.29 Aligned_cols=242 Identities=19% Similarity=0.326 Sum_probs=196.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc-------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM-------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|... +|+.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEecCCEEEEEEE
Confidence 467999999999999965 589999999975422 357799999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC----CeEEcccCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL----QGCISDFGLTP 488 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~ 488 (632)
|+++|+|.+++... .++++..+..++.+++.||+|||+. +|+||||||+||++++++ .+||+|||+++
T Consensus 96 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 96 LVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp CCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999754 2588999999999999999999998 999999999999999888 79999999997
Q ss_pred CCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 489 LMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 489 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
..... ....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.+... ............ .++
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~---~~~ 238 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITSVSY---DFD 238 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTCC---CCC
T ss_pred ecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhccc---ccC
Confidence 76543 234588899999999999999999999999999999999999965321 111111111100 001
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.... .. ....+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~--~~---~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 239 EEFF--SH---TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHH--TT---CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhhh--cc---cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1000 01 12356788899999999999999999873
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.78 Aligned_cols=244 Identities=20% Similarity=0.324 Sum_probs=196.8
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++... +|+.||+|++.+.. .....+..|++++.++ +||||+++++++.+.+..|+||||+++
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 46999999999999975 58999999997542 3356788999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|+|.+++..... ....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 270 g~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~ 345 (543)
T 3c4z_A 270 GDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK 345 (543)
T ss_dssp CBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred CCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence 999999876432 234689999999999999999999998 99999999999999999999999999998764332
Q ss_pred --CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 495 --VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
...||+.|+|||++.+..++.++|||||||++|||+||+.||....... ............... ...
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~i~~~~~~---------~p~ 414 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRVLEQAVT---------YPD 414 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHHHHHCCCC---------CCT
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHHHhhcccC---------CCc
Confidence 2368999999999999999999999999999999999999997643211 122222222211100 011
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTM-----EEVVR 604 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~evl~ 604 (632)
.. ...+.+++.+||+.||++||++ .++++
T Consensus 415 ~~---s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 415 KF---SPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp TS---CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cc---CHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11 2356678889999999999975 56654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=331.87 Aligned_cols=252 Identities=22% Similarity=0.399 Sum_probs=198.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcE--EEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTT--VVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~--vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... ++.. ||+|+++... ...+.+.+|++++.++.+||||+++++++.+.+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 467999999999999854 4554 4999987532 2345689999999999789999999999999999999999999
Q ss_pred CCCHhhhhccCCC-----------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEccc
Q 006747 416 AGSFSALLHGNRG-----------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDF 484 (632)
Q Consensus 416 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~Df 484 (632)
+|+|.+++..... ....++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Df 186 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 186 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCT
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEccc
Confidence 9999999976530 1234689999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 485 GLTPLMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 485 Gla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
|+++..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||..... ...... +.....
T Consensus 187 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~-~~~~~~ 259 (327)
T 1fvr_A 187 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEK-LPQGYR 259 (327)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHH-GGGTCC
T ss_pred CcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHHHHH-hhcCCC
Confidence 998754322 22346778999999988889999999999999999998 9999965321 111111 111111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
. . .... ....+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 260 ~-----~--~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 260 L-----E--KPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp C-----C--CCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred C-----C--CCCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 0 0111 123577888899999999999999999999988554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.37 Aligned_cols=241 Identities=25% Similarity=0.355 Sum_probs=193.3
Q ss_pred HhCccceeEEEEEEE---cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 343 VLGKGSYGTTYKAIL---EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~---~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.||+|+||.||+|.. ..+..||||+++..... .+.+.+|++++.++ +||||+++++++ ..+..++||||+++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~ 101 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAESWMLVMEMAEL 101 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCCcEEEEEeCCC
Confidence 799999999999964 24678999999765322 46789999999999 899999999999 66778999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
|+|.+++.... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (291)
T 1xbb_A 102 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173 (291)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence 99999997642 488999999999999999999998 99999999999999999999999999997664332
Q ss_pred -----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 495 -----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 495 -----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
...++..|+|||.+.+..++.++||||||+++|||+| |+.||...... . +...+.......
T Consensus 174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~-~~~~~~~~~~~~------ 240 (291)
T 1xbb_A 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------E-VTAMLEKGERMG------ 240 (291)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCCC------
T ss_pred ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcCCCCC------
Confidence 1235677999999988889999999999999999999 99999753211 1 111111111110
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
........+.+++.+||+.||++|||+.++++.|+++-
T Consensus 241 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 241 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112245778889999999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=344.80 Aligned_cols=243 Identities=17% Similarity=0.223 Sum_probs=191.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+++.. +|+.||+|++++... ..+.+.+|.+++.++ +||||+++++++.+.+..|+||||++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~lVmE~~~ 144 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYLVMEYYV 144 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEEEEcCCC
Confidence 357999999999999974 689999999975321 223478899999998 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++.... ..+++.....++.+++.||+|||+. +|+||||||+|||++.++++||+|||+++......
T Consensus 145 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 145 GGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp SCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 999999997542 2488899999999999999999998 99999999999999999999999999997764432
Q ss_pred ----CCCCCCcccCCcccc-------CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 495 ----VPSRSAGYRAPEVIE-------TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 495 ----~~~~t~~y~aPE~~~-------~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
...||+.|+|||++. +..++.++|||||||++|||++|+.||..... ......+........
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~~~- 290 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------AETYGKIVHYKEHLS- 290 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHHHHCC-
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhcccCcC-
Confidence 346899999999997 35689999999999999999999999975321 111122211100000
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMR---PTMEEVVRM 605 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~R---Ps~~evl~~ 605 (632)
-+.. ... ...++.+++.+||+ +|++| |+++|++++
T Consensus 291 -~p~~--~~~---~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 -LPLV--DEG---VPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -CC------C---CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -CCcc--ccC---CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0000 011 12356778889999 99998 689998764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.97 Aligned_cols=237 Identities=12% Similarity=0.155 Sum_probs=182.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc----cCHHHHHHHHHHHHhhc--CCCCcccee-------EEEEeCCc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV----MGKREFEQQMEVVGRLS--QHPNVVPIR-------AYYFSKDE 406 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~--~h~niv~l~-------~~~~~~~~ 406 (632)
.+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|++++..+. +|||||+++ +++...+.
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 36799999999999995 569999999997432 22467889995444332 899999998 66665532
Q ss_pred -----------------eEEEEecccCCCHhhhhccCCCCC--CCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCC
Q 006747 407 -----------------KLLVYDFIEAGSFSALLHGNRGIG--RTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIK 467 (632)
Q Consensus 407 -----------------~~lv~E~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk 467 (632)
.++||||+ +|+|.+++....... ..+++|..+..|+.|++.||+|||+. +|+|||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDik 233 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR 233 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 78999999 689999997543211 23456788899999999999999998 99999999
Q ss_pred CCCeeecCCCCeEEcccCCCCCCCCCC-CCCCCCcccCCccccCC-----------CCCccchhhHHHHHHHHHHhCCCC
Q 006747 468 SSNVLLSQDLQGCISDFGLTPLMNTPT-VPSRSAGYRAPEVIETK-----------KPTQKSDVYSFGVLLLEMLTGKAP 535 (632)
Q Consensus 468 ~~NILl~~~~~~ki~DfGla~~~~~~~-~~~~t~~y~aPE~~~~~-----------~~~~~~DV~s~Gvvl~elltg~~p 535 (632)
|+|||++.++.+||+|||+++...... ...+ +.|+|||.+.+. .++.++|||||||++|||+||+.|
T Consensus 234 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~P 312 (377)
T 3byv_A 234 PVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312 (377)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCC
T ss_pred HHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCC
Confidence 999999999999999999998655432 2346 889999999887 799999999999999999999999
Q ss_pred CCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 536 IQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
|........... +.. ..... ...+.+++.+||+.||++|||+.|+++
T Consensus 313 f~~~~~~~~~~~---------------~~~----~~~~~---~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 313 ITKDAALGGSEW---------------IFR----SCKNI---PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp C------CCSGG---------------GGS----SCCCC---CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred Ccccccccchhh---------------hhh----hccCC---CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 975432221110 000 01111 235677888999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.24 Aligned_cols=238 Identities=24% Similarity=0.361 Sum_probs=192.4
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... ++..||+|++.... .....+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAP 92 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEEEEEecCC
Confidence 367999999999999865 46789999986532 2356788999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++.... ++++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~ 164 (279)
T 3fdn_A 93 LGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 164 (279)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcccc
Confidence 999999987542 488899999999999999999998 9999999999999999999999999998665433
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ............. . ....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-------~--~~~~ 229 (279)
T 3fdn_A 165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------YQETYKRISRVEF-------T--FPDF 229 (279)
T ss_dssp ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCC-------C--CCTT
T ss_pred cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc------HHHHHHHHHhCCC-------C--CCCc
Confidence 23457889999999999999999999999999999999999996432 1111111111100 0 0011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
....+.+++.+||+.||++|||+.|++++
T Consensus 230 ---~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 ---VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 12346678889999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=347.70 Aligned_cols=193 Identities=22% Similarity=0.319 Sum_probs=168.4
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhc-----CCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLS-----QHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|... +++.||||+++......+.+.+|++++..+. +|+||+++++++......++||||+
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 181 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL 181 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence 368999999999999864 4889999999865444567888888888773 5779999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC--eEEcccCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ--GCISDFGLTPLMNT 492 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~--~ki~DfGla~~~~~ 492 (632)
. |+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++....
T Consensus 182 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~ 254 (429)
T 3kvw_A 182 S-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ 254 (429)
T ss_dssp C-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred C-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence 6 69999887653 23589999999999999999999998 9999999999999999987 99999999976654
Q ss_pred C-CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 006747 493 P-TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540 (632)
Q Consensus 493 ~-~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~ 540 (632)
. ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.+..
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 3 33468899999999999999999999999999999999999997643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=327.35 Aligned_cols=247 Identities=24% Similarity=0.409 Sum_probs=193.4
Q ss_pred HhHhCccceeEEEEEEEcC----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEe-CCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFS-KDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|...+ ...||+|.++.... ..+.+.+|++++.++ +||||+++++++.. .+..++||||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~v~e~ 108 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPY 108 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCCCceEEEEeC
Confidence 3679999999999998543 23689999875432 245688999999999 89999999999754 5578999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 109 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 109 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999997542 3578899999999999999999998 9999999999999999999999999999866432
Q ss_pred --------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhC-CCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 494 --------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTG-KAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 494 --------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
....+|+.|+|||.+.+..++.++||||||+++|||++| ..||......+ ... ........ .
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~---~~~~~~~~---~ 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV---YLLQGRRL---L 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH---HHHTTCCC---C
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH---HHhcCCCC---C
Confidence 222456789999999999999999999999999999994 55554432211 111 11111100 0
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.... ....+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 253 -----~~~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 253 -----QPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp -----CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCcc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0111 123577888999999999999999999999998543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=332.76 Aligned_cols=232 Identities=19% Similarity=0.307 Sum_probs=192.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 410 (632)
.+.||+|+||.||+|.. .+++.||||+++.... ....+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEeeCCEEEEE
Confidence 45799999999999985 5688999999976532 223577899999999 899999999999999999999
Q ss_pred EecccCC-CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 411 YDFIEAG-SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 411 ~E~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
|||+.+| +|.+++.... .+++..+..++.+++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 108 ~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp EECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 9999777 9999997542 488999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCC---CCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 490 MNTPT---VPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 490 ~~~~~---~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
..... ...+|+.|+|||.+.+..+ +.++|||||||++|||++|+.||...... ..
T Consensus 180 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------------~~ 238 (335)
T 3dls_A 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------------VE 238 (335)
T ss_dssp CCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------------TT
T ss_pred CCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------------Hh
Confidence 65433 2358899999999988876 78999999999999999999999642100 00
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
......... ...+.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~~---~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 AAIHPPYLV---SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TCCCCSSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hccCCCccc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000011111 2346788889999999999999999985
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=336.16 Aligned_cols=255 Identities=13% Similarity=0.160 Sum_probs=197.6
Q ss_pred HhHhCccceeEEEEEEEcC---------CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccc---------------
Q 006747 341 AEVLGKGSYGTTYKAILEE---------GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVP--------------- 396 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~--------------- 396 (632)
.+.||+|+||.||+|.... ++.||+|++... +.+.+|++++.++ +||||++
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHH-CCHHHHHHHHHHTTCTTCSCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHh-cccchhhhhhhhccCCccCccc
Confidence 3679999999999999753 789999999754 4588999999999 8999987
Q ss_pred eeEEEEe-CCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC
Q 006747 397 IRAYYFS-KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ 475 (632)
Q Consensus 397 l~~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~ 475 (632)
+++++.. ....++||||+ +|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEET
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcC
Confidence 6778876 67889999999 999999998642 23589999999999999999999998 9999999999999999
Q ss_pred CC--CeEEcccCCCCCCCCC-----------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCC
Q 006747 476 DL--QGCISDFGLTPLMNTP-----------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHE 542 (632)
Q Consensus 476 ~~--~~ki~DfGla~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~ 542 (632)
++ .+||+|||+++..... ....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 98 9999999999765422 2235788999999999999999999999999999999999999754311
Q ss_pred CCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCC
Q 006747 543 DVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614 (632)
Q Consensus 543 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~ 614 (632)
. ..+........ . ......+... ..... ...+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 275 ~-~~~~~~~~~~~-~-~~~~~~~~~~-~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 275 T-EDIMKQKQKFV-D-KPGPFVGPCG-HWIRP---SETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp H-HHHHHHHHHHH-H-SCCCEECTTS-CEECC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred H-HHHHHHHHhcc-C-Chhhhhhhcc-ccCCC---cHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 1 11111111111 1 1111111100 00111 2457778889999999999999999999999865543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=334.16 Aligned_cols=252 Identities=19% Similarity=0.220 Sum_probs=192.8
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc------cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV------MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|.. .++..||+|++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||
T Consensus 31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhccCCeEEEEEeC
Confidence 46899999999999986 457899999986541 2246789999999999 899999999999999999999999
Q ss_pred ccCCCHhhhhccCCCC-----------------------------------CCCcCCHHHHHHHHHHHHHHHHHHHhccC
Q 006747 414 IEAGSFSALLHGNRGI-----------------------------------GRTPLDWESRVKISLGSAKGIAHIHAAVG 458 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~ 458 (632)
+++|+|.+++...... ....+++.....++.|++.||+|||+.
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-- 187 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-- 187 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC--
Confidence 9999999998531100 011245677788999999999999998
Q ss_pred CCceecCCCCCCeeecCCC--CeEEcccCCCCCCCC--------CCCCCCCCcccCCccccC--CCCCccchhhHHHHHH
Q 006747 459 GKFILGNIKSSNVLLSQDL--QGCISDFGLTPLMNT--------PTVPSRSAGYRAPEVIET--KKPTQKSDVYSFGVLL 526 (632)
Q Consensus 459 ~~ivHrDlk~~NILl~~~~--~~ki~DfGla~~~~~--------~~~~~~t~~y~aPE~~~~--~~~~~~~DV~s~Gvvl 526 (632)
+|+||||||+||+++.++ .+||+|||+++.... .....+|+.|+|||.+.+ ..++.++|||||||++
T Consensus 188 -~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il 266 (345)
T 3hko_A 188 -GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266 (345)
T ss_dssp -TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHH
T ss_pred -CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHH
Confidence 999999999999998776 899999999975432 123457889999999975 6789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--
Q 006747 527 LEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR-- 604 (632)
Q Consensus 527 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~-- 604 (632)
|||++|+.||..... .............. ..+. .......+.+++.+||+.||++|||+.|+++
T Consensus 267 ~el~~g~~pf~~~~~------~~~~~~~~~~~~~~--~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp 332 (345)
T 3hko_A 267 HLLLMGAVPFPGVND------ADTISQVLNKKLCF--ENPN------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332 (345)
T ss_dssp HHHHHSSCSSCCSSH------HHHHHHHHHCCCCT--TSGG------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSH
T ss_pred HHHHHCCCCCCCCCh------HHHHHHHHhccccc--CCcc------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCh
Confidence 999999999965321 11122222111100 0000 0111235678888999999999999999988
Q ss_pred HHhhhC
Q 006747 605 MIEDIR 610 (632)
Q Consensus 605 ~L~~i~ 610 (632)
.++++.
T Consensus 333 ~~~~~~ 338 (345)
T 3hko_A 333 WISQFS 338 (345)
T ss_dssp HHHTTS
T ss_pred hhccCh
Confidence 355543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=326.64 Aligned_cols=245 Identities=22% Similarity=0.350 Sum_probs=194.5
Q ss_pred HhHhCccceeEEEEEEEcC----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|...+ +..||+|.+..... ..+.+.+|++++.++ +||||+++++++.+ +..++||||+
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~v~e~~ 94 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE-EPTWIIMELY 94 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC-CCCEEEEecC
Confidence 3679999999999998543 23699999976422 346789999999999 89999999999764 5678999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 95 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 95 PYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp TTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred CCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 9999999997542 3488999999999999999999998 99999999999999999999999999998765432
Q ss_pred -----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 495 -----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 495 -----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
...++..|+|||.+.+..++.++||||||+++|||+| |+.||......+ .... ........
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~----~~~~~~~~------ 234 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGV----LEKGDRLP------ 234 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHH----HHHTCCCC------
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHH----HhcCCCCC------
Confidence 2345678999999998899999999999999999998 999996533221 1111 11111000
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.... ....+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 235 -~~~~---~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 235 -KPDL---CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCC---CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0011 12357788889999999999999999999998743
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=336.35 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=199.8
Q ss_pred HhHhCccceeEEEEEEEcC------CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILEE------GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|.... ...||+|.++.... ..+.+.+|++++.++.+||||+++++++...+..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 4679999999999998643 24799999976532 245688999999999779999999999999999999999
Q ss_pred cccCCCHhhhhccCCC---------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcc
Q 006747 413 FIEAGSFSALLHGNRG---------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISD 483 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~D 483 (632)
|+++|+|.+++..... ....++++..+..++.+++.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 207 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGD 207 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBCC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEECc
Confidence 9999999999875321 0123578999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhh
Q 006747 484 FGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR 556 (632)
Q Consensus 484 fGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 556 (632)
||+++...... ...++..|+|||.+.+..++.++|||||||++|||+| |..||....... .......
T Consensus 208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~ 281 (333)
T 2i1m_A 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------KFYKLVK 281 (333)
T ss_dssp CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------HHHHHHH
T ss_pred cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------HHHHHHh
Confidence 99998654322 2235667999999998899999999999999999999 999997543211 1112222
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
...... .... ....+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 282 ~~~~~~-------~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 282 DGYQMA-------QPAF---APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HTCCCC-------CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCC-------CCCC---CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 211110 0011 12357788899999999999999999999998743
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=330.59 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=195.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEe----CCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFS----KDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~E~~ 414 (632)
.+.||+|+||.||++.. .+++.||||++.... ...+.+.+|++++.++ +||||+++++++.. ....++||||+
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~~ 112 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFF 112 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence 36799999999999996 578999999986542 2356789999999999 99999999999973 34688999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.+++..... ...++++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 113 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 188 (317)
T 2buj_A 113 KRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188 (317)
T ss_dssp TTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEE
T ss_pred CCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccccc
Confidence 99999999875321 234689999999999999999999998 99999999999999999999999999987654211
Q ss_pred -------------CCCCCCcccCCccccCCC---CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc
Q 006747 495 -------------VPSRSAGYRAPEVIETKK---PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE 558 (632)
Q Consensus 495 -------------~~~~t~~y~aPE~~~~~~---~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 558 (632)
...+|..|+|||.+.+.. ++.++|||||||++|||++|+.||........ .... .....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~~~~~ 263 (317)
T 2buj_A 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----AVQNQ 263 (317)
T ss_dssp ESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----HHHCC
T ss_pred ccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----Hhhcc
Confidence 112588899999987654 68999999999999999999999853211100 1110 01110
Q ss_pred cccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 559 WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 559 ~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
.. . .........+.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 264 ~~-------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 264 LS-------I---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp ---------C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred CC-------C---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 00 0 000112235778889999999999999999999999986553
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=331.17 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=200.3
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|... ++..||+|++..... ....+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccCCccEEEEE
Confidence 367999999999999854 368899999975432 234688999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCC-----CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 413 FIEAGSFSALLHGNRG-----IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
|+++|+|.+++...+. ....++++..+.+++.+++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~ 185 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 185 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccc
Confidence 9999999999875321 1124578999999999999999999998 9999999999999999999999999999
Q ss_pred CCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 488 PLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 488 ~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
+...... ...+++.|+|||.+.+..++.++|||||||++|||+| |+.||..... ........ ....
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~-~~~~ 258 (322)
T 1p4o_A 186 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVLRFVM-EGGL 258 (322)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHHHHHH-TTCC
T ss_pred cccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH------HHHHHHHH-cCCc
Confidence 7654321 2235678999999999899999999999999999999 8899865321 11111111 1111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.. ... .....+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 259 ~~-------~~~---~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 259 LD-------KPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp CC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CC-------CCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 00 011 1223577888899999999999999999999988554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=320.52 Aligned_cols=241 Identities=20% Similarity=0.335 Sum_probs=194.3
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|... +++.||+|++...... .+.+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 57999999999999864 5889999999765433 35678899999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC---eEEcccCCCCCCCCCC
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ---GCISDFGLTPLMNTPT 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~---~ki~DfGla~~~~~~~ 494 (632)
+|.+.+.... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++. +||+|||++.......
T Consensus 91 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (284)
T 3kk8_A 91 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 162 (284)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc
Confidence 9998887542 488999999999999999999998 9999999999999987655 9999999997665433
Q ss_pred ---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ............. ......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~-----~~~~~~ 231 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYD-----YPSPEW 231 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC-----CCTTTT
T ss_pred cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hHHHHHHHhcccc-----CCchhh
Confidence 24578899999999999999999999999999999999999965321 1111111111110 000001
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. ....+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~---~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 232 DT---VTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TT---SCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cc---cCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11 12346788889999999999999999883
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=342.62 Aligned_cols=249 Identities=18% Similarity=0.250 Sum_probs=197.1
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
+.||+|+||.||+|.. .+++.||||++..... ..++..|++++..+.+|++|..+..++...+..++||||+ +++|.
T Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~ 90 (483)
T 3sv0_A 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (483)
T ss_dssp CCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHH
Confidence 5799999999999995 5689999998865432 3458889999999955577777777778888899999999 99999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee---cCCCCeEEcccCCCCCCCCCC---
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL---SQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+++.... ..+++..++.|+.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++......
T Consensus 91 ~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 91 DLFNFCS----RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp HHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 9997532 3589999999999999999999998 99999999999999 688999999999997654322
Q ss_pred --------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 495 --------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 495 --------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
...+|..|+|||.+.+..++.++|||||||++|||++|+.||.+............+.. ... .....
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---~~~-~~~~~- 238 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---KKV-ATSIE- 238 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH---HHH-HSCHH-
T ss_pred ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh---ccc-cccHH-
Confidence 34588899999999999999999999999999999999999986543322111111111 100 00000
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.+ ... ...++.+++..||+.+|++||++.+|++.|+++
T Consensus 239 ~l--~~~---~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 239 AL--CRG---YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH--HTT---SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HH--hcC---CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 00 001 124577888999999999999999999999987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=321.99 Aligned_cols=241 Identities=18% Similarity=0.338 Sum_probs=194.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||+|... +++.||+|+++.... ....+.+|+..+.++.+||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 95 (289)
T 1x8b_A 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95 (289)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence 367999999999999975 689999999976422 2456888899888887899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-------------------CC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-------------------DL 477 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-------------------~~ 477 (632)
|+|.+++..... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ..
T Consensus 96 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 96 GSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CC
T ss_pred CcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 999999975421 113588999999999999999999998 9999999999999984 44
Q ss_pred CeEEcccCCCCCCCCCCCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh
Q 006747 478 QGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR 556 (632)
Q Consensus 478 ~~ki~DfGla~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 556 (632)
.+||+|||.+..........+|..|+|||.+.+. .++.++|||||||++|||++|+.|+.... .+ .. +.
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~-~~-~~ 241 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD--------QW-HE-IR 241 (289)
T ss_dssp CEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--------HH-HH-HH
T ss_pred EEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh--------HH-HH-HH
Confidence 8999999999888777667799999999999876 56789999999999999999988764211 01 11 11
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...... + .... ...+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~-----~--~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 242 QGRLPR-----I--PQVL---SQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp TTCCCC-----C--SSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred cCCCCC-----C--Cccc---CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111111 0 0111 2356788889999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=325.66 Aligned_cols=245 Identities=25% Similarity=0.424 Sum_probs=191.8
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeC-CceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK-DEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||++... |+.||||+++... ..+.+.+|++++.++ +||||+++++++.+. +..++||||+++|+|
T Consensus 26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 467999999999999875 8899999997543 456789999999999 899999999997654 478999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-CCCCC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-TVPSR 498 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~~~~~ 498 (632)
.+++.... ...+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++..... ....+
T Consensus 103 ~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 176 (278)
T 1byg_A 103 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 176 (278)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred HHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccccCCCc
Confidence 99997542 22478899999999999999999998 9999999999999999999999999999765543 23346
Q ss_pred CCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHH
Q 006747 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEE 577 (632)
Q Consensus 499 t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 577 (632)
+..|+|||.+.+..++.++||||||+++|||+| |+.||......+ .... ....... ......
T Consensus 177 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~-~~~~~~~----------~~~~~~ 239 (278)
T 1byg_A 177 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPR-VEKGYKM----------DAPDGC 239 (278)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HHHH-HTTTCCC----------CCCTTC
T ss_pred cccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHH-HhcCCCC----------CCcccC
Confidence 778999999998899999999999999999998 999997533211 1111 1111110 001112
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 578 MVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 578 ~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
...+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 2457788889999999999999999999998854
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=320.50 Aligned_cols=250 Identities=18% Similarity=0.343 Sum_probs=198.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc-------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM-------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||++... +++.||+|+++.... ..+.+.+|++++.++ +||||+++++++......++|||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCCeEEEEEe
Confidence 467999999999999975 589999999875421 357899999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC----CeEEcccCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL----QGCISDFGLTP 488 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~ 488 (632)
|+++++|.+++... .++++..+..++.+++.||+|||+. +|+||||||+||++++++ .+||+|||+++
T Consensus 89 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 89 LVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred ecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999754 2488999999999999999999998 999999999999999877 89999999997
Q ss_pred CCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 489 LMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 489 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
..... ....+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........ .... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~--~~~ 231 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK------QETLTNIS-AVNY--DFD 231 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH-TTCC--CCC
T ss_pred eccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch------HHHHHHhH-hccc--CCc
Confidence 66433 223578889999999999999999999999999999999999965321 11111111 1000 000
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhhCCCC
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDIRPSD 613 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i~~~~ 613 (632)
... .. .....+.+++.+||+.||++|||+.|+++ .++.+....
T Consensus 232 ~~~--~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 232 EEY--FS---NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHH--HT---TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred chh--cc---cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 000 00 11235678889999999999999999998 566665443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=346.98 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=186.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 410 (632)
.+.||+|+||.||+|... +++.||||++...... .+.+.+|++++..+ +||||+++++++... ...++|
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv 145 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLV 145 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccCCeEEEE
Confidence 367999999999999854 5889999999764322 45688999999999 999999999999755 356999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
|||++++ |.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 146 ~E~~~~~-l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 146 MELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred EeCCCCC-HHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 9999864 6666642 278899999999999999999998 9999999999999999999999999999876
Q ss_pred CCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCCh---------hH-------HH
Q 006747 491 NTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL---------PR-------WV 551 (632)
Q Consensus 491 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~---------~~-------~~ 551 (632)
... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.... +. ..
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 543 234689999999999999999999999999999999999999976432111000 00 00
Q ss_pred HHHhhhccc-c-----ccccccccccCC--cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 552 QSVVREEWT-S-----EVFDVELMRYEN--IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 552 ~~~~~~~~~-~-----~~~d~~~~~~~~--~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+........ . ..+...+..... ......++.+|+.+||+.||++|||++|++++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0 000000000000 01124568899999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.75 Aligned_cols=259 Identities=18% Similarity=0.262 Sum_probs=196.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhc-------CCCCccceeEEEE----eCCceE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS-------QHPNVVPIRAYYF----SKDEKL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-------~h~niv~l~~~~~----~~~~~~ 408 (632)
.+.||+|+||.||+|.. .+++.||||+++......+.+.+|++++.++. +|+||+++++++. .....+
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~ 121 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC 121 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEE
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEE
Confidence 36799999999999985 45889999999865444567889999999884 2888999999988 455789
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-----------
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL----------- 477 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~----------- 477 (632)
+||||+ +|++.+++.... ...+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++
T Consensus 122 lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~ 195 (397)
T 1wak_A 122 MVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEAT 195 (397)
T ss_dssp EEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC
T ss_pred EEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhH
Confidence 999999 556666655432 235889999999999999999999853 799999999999999775
Q ss_pred --------------------------------------CeEEcccCCCCCCCCC-CCCCCCCcccCCccccCCCCCccch
Q 006747 478 --------------------------------------QGCISDFGLTPLMNTP-TVPSRSAGYRAPEVIETKKPTQKSD 518 (632)
Q Consensus 478 --------------------------------------~~ki~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~D 518 (632)
.+||+|||+++..... ....+|..|+|||++.+..++.++|
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 275 (397)
T 1wak_A 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275 (397)
T ss_dssp ---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHH
T ss_pred HHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHHH
Confidence 8999999999766543 3346899999999999999999999
Q ss_pred hhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh------------hcccccccccc------------------c
Q 006747 519 VYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR------------EEWTSEVFDVE------------------L 568 (632)
Q Consensus 519 V~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~d~~------------------~ 568 (632)
||||||++|||+||+.||......+............. ..+....+... .
T Consensus 276 iwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (397)
T 1wak_A 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLV 355 (397)
T ss_dssp HHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHH
T ss_pred HHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhh
Confidence 99999999999999999986554332211111111100 00000111000 0
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.......+....+.+|+.+||+.||++|||++|++++
T Consensus 356 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 356 EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0112234556778899999999999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=338.64 Aligned_cols=238 Identities=21% Similarity=0.286 Sum_probs=183.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC----HHHHHHHHHHH-HhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG----KREFEQQMEVV-GRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l-~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|+.. +++.||+|++++.... ...+..|..++ ..+ +||||+++++++.+.+..|+||||+
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 367999999999999965 4789999999765322 23455666654 445 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC--
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT-- 492 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~-- 492 (632)
++|+|.+++.... .+++.....++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 122 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 122 NGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCC
Confidence 9999999997543 477888899999999999999998 999999999999999999999999999976322
Q ss_pred --CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 493 --PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 493 --~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+...... .
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~~~---------~ 258 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKPLQ---------L 258 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB------HHHHHHHHHHSCCC---------C
T ss_pred CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHhcccC---------C
Confidence 233468999999999999999999999999999999999999996532 11222222221100 0
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.... ...+.+++.+||+.||++||++.+.+..
T Consensus 259 ~~~~---~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 259 KPNI---TNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp CSSS---CHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred CCCC---CHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 1111 2346678889999999999998643333
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=336.23 Aligned_cols=244 Identities=21% Similarity=0.331 Sum_probs=194.6
Q ss_pred HhHhCccceeEEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVV-----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.||+|+||.||++.. .+++.||||+++... ...+.+.+|++++.++.+||||+++++++...+..++||
T Consensus 59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 138 (355)
T 1vzo_A 59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 138 (355)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence 46799999999999987 468999999997532 234567789999999977999999999999999999999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 139 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 139 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred ecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 9999999999997542 488899999999999999999998 99999999999999999999999999997653
Q ss_pred CC-----CCCCCCCcccCCccccCC--CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 492 TP-----TVPSRSAGYRAPEVIETK--KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 492 ~~-----~~~~~t~~y~aPE~~~~~--~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.. ....+|+.|+|||.+.+. .++.++|||||||++|||+||+.||....... ..............
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~----- 283 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEP----- 283 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCCC-----
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhccCC-----
Confidence 22 223588999999999863 47899999999999999999999997543222 12222222211110
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRMI 606 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~L 606 (632)
....+....+.+++.+||+.||++|| |+.|++++.
T Consensus 284 -------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 -------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 00111123467788899999999999 999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=319.89 Aligned_cols=240 Identities=21% Similarity=0.314 Sum_probs=193.8
Q ss_pred HhHhCccceeEEEEEEEcC-CcEEEEEEeccc-ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAILEE-GTTVVVKRLKEV-VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|.... +..||+|++... ....+.+.+|++++.++ +||||+++++++.+.+..++||||+++++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 4679999999999999654 678999999765 34567899999999999 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee---cCCCCeEEcccCCCCCCCCC--
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL---SQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~-- 493 (632)
|.+++.... .+++..+..++.+++.||+|||+. +|+||||||+||++ +.++.+||+|||++......
T Consensus 93 L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 93 LFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp HHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 999887542 488999999999999999999998 99999999999999 78899999999999765433
Q ss_pred -CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 -TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....+|+.|+|||.+.+. ++.++||||||+++|||++|+.||..... ...... +...... .... ...
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~-~~~~~~~-~~~~---~~~ 232 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD------SEVMLK-IREGTFT-FPEK---DWL 232 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH-HHHCCCC-CCHH---HHT
T ss_pred hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH------HHHHHH-HHhCCCC-CCch---hhh
Confidence 234588899999998654 89999999999999999999999965321 111111 1111100 0000 000
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.....+.+++.+||+.||++|||+.++++
T Consensus 233 ---~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 233 ---NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11245778889999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=343.53 Aligned_cols=247 Identities=11% Similarity=0.016 Sum_probs=176.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhc-CCCCcccee-------EEEEeC---
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLS-QHPNVVPIR-------AYYFSK--- 404 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-~h~niv~l~-------~~~~~~--- 404 (632)
.+.||+|+||.||+|... +++.||||+++.... ..+.+.+|++++..+. +||||++++ +++...
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~ 146 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence 367999999999999964 689999999987543 2345778876666663 499987754 455433
Q ss_pred --------------CceEEEEecccCCCHhhhhccCCCCCCCcCCHHHH------HHHHHHHHHHHHHHHhccCCCceec
Q 006747 405 --------------DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESR------VKISLGSAKGIAHIHAAVGGKFILG 464 (632)
Q Consensus 405 --------------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~ivHr 464 (632)
...++||||++ |+|.+++..... .+.+..+ ..++.|++.||+|||+. +|+||
T Consensus 147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr 218 (371)
T 3q60_A 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218 (371)
T ss_dssp SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence 23799999999 899999986421 2344555 77889999999999998 99999
Q ss_pred CCCCCCeeecCCCCeEEcccCCCCCCCCCC-CCCCCCcccCCccccC--CCCCccchhhHHHHHHHHHHhCCCCCCCCCC
Q 006747 465 NIKSSNVLLSQDLQGCISDFGLTPLMNTPT-VPSRSAGYRAPEVIET--KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGH 541 (632)
Q Consensus 465 Dlk~~NILl~~~~~~ki~DfGla~~~~~~~-~~~~t~~y~aPE~~~~--~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~ 541 (632)
||||+|||++.++.+||+|||+++...... ...+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||.....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999998776544 4456789999999987 6799999999999999999999999976532
Q ss_pred CCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 542 EDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 542 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
...... ............. ...........+.+++.+||+.||++|||+.|+++
T Consensus 299 ~~~~~~--------~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 299 GIKGSW--------KRPSLRVPGTDSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TCTTCC--------CBCCTTSCCCCSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccch--------hhhhhhhcccccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 211100 0000000000000 00000112345677888999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=318.67 Aligned_cols=239 Identities=23% Similarity=0.381 Sum_probs=189.8
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEe----CCceEEEEec
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFS----KDEKLLVYDF 413 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~E~ 413 (632)
+.||+|+||.||+|.. .++..||+|++...... .+.+.+|++++.++ +||||+++++++.. ....++||||
T Consensus 32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 4699999999999986 45788999999765433 35688999999999 89999999999876 3458999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCC--ceecCCCCCCeeec-CCCCeEEcccCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK--FILGNIKSSNVLLS-QDLQGCISDFGLTPLM 490 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivHrDlk~~NILl~-~~~~~ki~DfGla~~~ 490 (632)
+++|+|.+++.... .+++..+..++.+++.||+|||+. + |+||||||+||+++ +++.+||+|||++...
T Consensus 111 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred cCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 99999999997542 478899999999999999999998 6 99999999999998 7899999999999765
Q ss_pred CCCC--CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 491 NTPT--VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 491 ~~~~--~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
.... ...+++.|+|||.+.+ .++.++|||||||++|||++|+.||..... ....... .........++.
T Consensus 183 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~-~~~~~~~~~~~~-- 253 (290)
T 1t4h_A 183 RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRR-VTSGVKPASFDK-- 253 (290)
T ss_dssp CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHH-HTTTCCCGGGGG--
T ss_pred cccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-----HHHHHHH-HhccCCccccCC--
Confidence 4432 2358889999998864 589999999999999999999999965321 1111111 111111111110
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. ....+.+++.+||+.||++|||+.|++++
T Consensus 254 ----~---~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 254 ----V---AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----C---CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----C---CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 11357788899999999999999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=334.77 Aligned_cols=259 Identities=17% Similarity=0.289 Sum_probs=191.1
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|+||.||+|... +++.||+|+++..... ...+.+|++++.++ +||||+++++++...+..++||||++ |+
T Consensus 8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (324)
T 3mtl_A 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFEYLD-KD 85 (324)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence 57999999999999965 6899999999754322 12355789999999 89999999999999999999999998 58
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 86 LKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence 998887642 3588999999999999999999998 9999999999999999999999999999765432 2
Q ss_pred CCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---cccccccccc---
Q 006747 495 VPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE---EWTSEVFDVE--- 567 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~~--- 567 (632)
...+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+ ....+...... ..........
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchhhc
Confidence 2356889999999877 568999999999999999999999997643211 11111111110 0000000000
Q ss_pred ---cc--ccCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhhCCC
Q 006747 568 ---LM--RYENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDIRPS 612 (632)
Q Consensus 568 ---~~--~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i~~~ 612 (632)
.. ..... ......+.+++.+||+.||++|||++|+++ .+..+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 00 00000 011235678899999999999999999988 45665444
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.59 Aligned_cols=181 Identities=27% Similarity=0.429 Sum_probs=146.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC-----CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK-----DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~ 411 (632)
.+.||+|+||.||+|... +++.||||++...... .+.+.+|++++.++ +|||||++++++... ...|+||
T Consensus 58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCceEEEEE
Confidence 367999999999999854 6899999999764333 35688999999999 899999999999543 4689999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+. |+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 137 e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 137 EIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9985 6999998754 3588999999999999999999998 99999999999999999999999999998764
Q ss_pred CC-------------------------------CCCCCCCcccCCccc-cCCCCCccchhhHHHHHHHHHHh
Q 006747 492 TP-------------------------------TVPSRSAGYRAPEVI-ETKKPTQKSDVYSFGVLLLEMLT 531 (632)
Q Consensus 492 ~~-------------------------------~~~~~t~~y~aPE~~-~~~~~~~~~DV~s~Gvvl~ellt 531 (632)
.. ....+|+.|+|||++ .+..++.++|||||||++|||+|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 21 122468889999986 45669999999999999999999
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=317.94 Aligned_cols=241 Identities=21% Similarity=0.315 Sum_probs=194.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++|
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 357999999999999965 689999999975432 246789999999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC-----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT----- 492 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~----- 492 (632)
+|.+++... ..+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 999998753 3588999999999999999999998 999999999999999999999999999875432
Q ss_pred -CCCCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 493 -PTVPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
.....++..|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....| ..... ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~-----~~~~~--~~------ 228 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW-----KEKKT--YL------ 228 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHH-----HTTCT--TS------
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHh-----hhccc--cc------
Confidence 123457889999999987765 7789999999999999999999976432211 11111 11100 00
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.........+.+++.+||+.||++|||+.|++++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 -NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0001112356678889999999999999999763
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.14 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=196.5
Q ss_pred HhHhCccceeEEEEEEE--cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC------CccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL--EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHP------NVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~------niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|.. .+++.||||+++......+.+.+|++++..+ +|+ +++++++++...+..++|||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~~~~~~lv~e 97 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEHHGHICIVFE 97 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeecccccCCcEEEEEc
Confidence 35799999999999986 3688999999986544456788999999888 555 59999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-----------------
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ----------------- 475 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~----------------- 475 (632)
|+ +++|.+++.... ..++++..+..++.|++.||+|||+. +|+||||||+|||++.
T Consensus 98 ~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 98 LL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred CC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 99 889999987653 34688999999999999999999998 9999999999999987
Q ss_pred --CCCeEEcccCCCCCCCCC-CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006747 476 --DLQGCISDFGLTPLMNTP-TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 476 --~~~~ki~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 552 (632)
++.+||+|||+++..... ....+|..|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+.
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~ 247 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH---LAMME 247 (339)
T ss_dssp ESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH---HHHHH
T ss_pred ccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHH
Confidence 678999999999876543 334688999999999999999999999999999999999999975432111 11111
Q ss_pred HHhhh--------cccccccc---------------------ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006747 553 SVVRE--------EWTSEVFD---------------------VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603 (632)
Q Consensus 553 ~~~~~--------~~~~~~~d---------------------~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl 603 (632)
..... ......+. +..............+.+++.+||+.||++|||+.|++
T Consensus 248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell 327 (339)
T 1z57_A 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL 327 (339)
T ss_dssp HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence 11000 00000000 00000011223456788999999999999999999998
Q ss_pred HH
Q 006747 604 RM 605 (632)
Q Consensus 604 ~~ 605 (632)
++
T Consensus 328 ~h 329 (339)
T 1z57_A 328 KH 329 (339)
T ss_dssp TS
T ss_pred cC
Confidence 64
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=327.69 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=191.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 108 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLVFEFVDH 108 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEEEecCCc
Confidence 367999999999999965 4899999998655433 34578999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
++|.+++.... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 109 ~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 109 TILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred chHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 99998876432 488999999999999999999998 9999999999999999999999999999775432
Q ss_pred -CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC-h--------hHHHHHHhhhccccc
Q 006747 494 -TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD-L--------PRWVQSVVREEWTSE 562 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~ 562 (632)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+... + +.+............
T Consensus 181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 234578899999999876 68999999999999999999999997543211100 0 000000000000000
Q ss_pred cccccccccCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 563 VFDVELMRYENIE----EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 563 ~~d~~~~~~~~~~----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...+......... .....+.+++.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111110001111 123457888999999999999999998863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=321.57 Aligned_cols=242 Identities=20% Similarity=0.356 Sum_probs=193.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||++... +|+.||+|+++.... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 467999999999999964 689999999976532 345688999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee---cCCCCeEEcccCCCCCCCCCCC
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL---SQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~~~~ 495 (632)
|.+++.... ++++.....++.+++.||+|||+. +|+||||||+||++ ++++.+||+|||+++.......
T Consensus 93 L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 93 LFDRILERG-----VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp HHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 999987542 478899999999999999999998 99999999999999 7889999999999976544321
Q ss_pred --CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 496 --PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 496 --~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
..+++.|+|||.+.+..++.++|||||||++|||++|+.||..... ....... .++... +... ...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i-~~~~~~--~~~~--~~~- 232 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------SKLFEKI-KEGYYE--FESP--FWD- 232 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHH-HHCCCC--CCTT--TTT-
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH-HcCCCC--CCcc--ccc-
Confidence 2378899999999999999999999999999999999999965321 1111111 111110 0000 001
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.....+.+++.+||+.||++|||+.|++++
T Consensus 233 --~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 233 --DISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp --TSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred --cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 122457788889999999999999999873
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=338.36 Aligned_cols=242 Identities=22% Similarity=0.350 Sum_probs=184.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 410 (632)
.+.||+|+||.||+|... +++.||||++..... ....+.+|++++.++ +||||+++++++. .+..++|
T Consensus 140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEE-SSEEEEE
T ss_pred EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCceEEE
Confidence 467999999999999864 578999999975421 112478999999999 9999999999975 4568999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC---CCeEEcccCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD---LQGCISDFGLT 487 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~---~~~ki~DfGla 487 (632)
|||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||++
T Consensus 218 ~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 218 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp EECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred EEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccc
Confidence 9999999999988754 2588999999999999999999998 99999999999999754 45999999999
Q ss_pred CCCCCCC---CCCCCCcccCCccccC---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006747 488 PLMNTPT---VPSRSAGYRAPEVIET---KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTS 561 (632)
Q Consensus 488 ~~~~~~~---~~~~t~~y~aPE~~~~---~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (632)
+...... ...+|+.|+|||++.+ ..++.++|||||||++|||+||+.||....... .+... +......
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~----i~~~~~~ 363 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ----ITSGKYN 363 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH----HHTTCCC
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH----HhcCCCC
Confidence 8876432 3458899999999864 567889999999999999999999997543221 11111 1111100
Q ss_pred ccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 562 EVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 562 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..+.. .. .....+.+++.+||+.||++|||+.|++++
T Consensus 364 --~~~~~--~~---~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 364 --FIPEV--WA---EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp --CCHHH--HT---TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --CCchh--hc---ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 00 112457788899999999999999999873
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=330.46 Aligned_cols=242 Identities=19% Similarity=0.359 Sum_probs=193.3
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC---------HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
+.||+|+||.||+|... +|+.||||++...... .+.+.+|++++.++.+||||+++++++......++||
T Consensus 100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 179 (365)
T 2y7j_A 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF 179 (365)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence 68999999999999975 6999999998654311 3457889999999877999999999999999999999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++....
T Consensus 180 e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 180 DLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999754 2488999999999999999999998 99999999999999999999999999987665
Q ss_pred CC---CCCCCCCcccCCccccC------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccc
Q 006747 492 TP---TVPSRSAGYRAPEVIET------KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562 (632)
Q Consensus 492 ~~---~~~~~t~~y~aPE~~~~------~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 562 (632)
.. ....+|+.|+|||++.+ ..++.++|||||||++|||+||+.||..... ........ .....
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~~~i~-~~~~~- 323 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILMLRMIM-EGQYQ- 323 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HTCCC-
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-hCCCC-
Confidence 43 23468899999999863 3578899999999999999999999965321 11111111 11100
Q ss_pred cccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 563 ~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...+ .... ....+.+++.+||+.||++|||+.|++++
T Consensus 324 ~~~~---~~~~---~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 324 FSSP---EWDD---RSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp CCHH---HHSS---SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCc---cccc---CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 0011 12357788899999999999999999873
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=337.87 Aligned_cols=194 Identities=22% Similarity=0.397 Sum_probs=153.1
Q ss_pred HhHhCccceeEEEEEEEc---CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe--CCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE---EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS--KDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~E~~~ 415 (632)
.++||+|+||.||+|... ++..||||++..... ...+.+|++++.++ +||||+++++++.. ....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 457999999999999965 478999999976533 35688999999999 89999999999965 567899999997
Q ss_pred CCCHhhhhccCC----CCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee----cCCCCeEEcccCCC
Q 006747 416 AGSFSALLHGNR----GIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL----SQDLQGCISDFGLT 487 (632)
Q Consensus 416 ~g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl----~~~~~~ki~DfGla 487 (632)
+ +|.+++.... ......+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5 7877775321 11223589999999999999999999998 99999999999999 77899999999999
Q ss_pred CCCCCC-------CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 006747 488 PLMNTP-------TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540 (632)
Q Consensus 488 ~~~~~~-------~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~ 540 (632)
+..... ....+|+.|+|||++.+. .++.++|||||||++|||+||+.||.+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 876532 223578899999999874 48999999999999999999999997654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.07 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=188.3
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCC------ceEEEE
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD------EKLLVY 411 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~ 411 (632)
+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|++++.++ +||||+++++++.... ..++||
T Consensus 31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccccCceEEEEE
Confidence 5799999999999986 46899999999654332 35688999999999 8999999999998653 469999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+ +++|.+++... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 110 e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 110 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 999 78999998753 378899999999999999999998 99999999999999999999999999998765
Q ss_pred CC-CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---cc-------
Q 006747 492 TP-TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE---EW------- 559 (632)
Q Consensus 492 ~~-~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~------- 559 (632)
.. ....+|..|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+. ...+...... ..
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 180 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHTCSCH
T ss_pred cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHHHHHhhhH
Confidence 43 33467889999999887 6789999999999999999999999976432111 0000000000 00
Q ss_pred --------ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCCC
Q 006747 560 --------TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRPS 612 (632)
Q Consensus 560 --------~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~~ 612 (632)
.......... .........+.+++.+||+.||++|||+.|++++ ++++...
T Consensus 257 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 257 EAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp HHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 0000000000 0001123457788899999999999999999984 5555433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.43 Aligned_cols=252 Identities=23% Similarity=0.403 Sum_probs=196.9
Q ss_pred HhHhCccceeEEEEEEE-----cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC--ceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD--EKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--~~~lv~E 412 (632)
.+.||+|+||.||++.. .+++.||||++..... ..+.+.+|++++.++ +||||+++++++...+ ..++|||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCceEEEEE
Confidence 36799999999999984 3688999999976432 246799999999999 8999999999987654 6899999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 125 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred CCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 999999999997643 3588999999999999999999998 999999999999999999999999999977654
Q ss_pred CC-------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCC--------CCCCCC-hhHHHHHHhh
Q 006747 493 PT-------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG--------HEDVVD-LPRWVQSVVR 556 (632)
Q Consensus 493 ~~-------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~--------~~~~~~-~~~~~~~~~~ 556 (632)
.. ...++..|+|||.+.+..++.++|||||||++|||+||+.|+.... ...... ........+.
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 32 2235667999999998889999999999999999999999875321 000000 0001111111
Q ss_pred hccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 557 ~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
.... . ........++.+++.+||+.||++|||+.|+++.|+++.
T Consensus 278 ~~~~-------~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 278 NNGR-------L---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp TTCC-------C---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC-------C---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1100 0 011112345778889999999999999999999999875
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=331.82 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=190.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeC--------CceE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--------DEKL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--------~~~~ 408 (632)
.+.||+|+||.||+|.. .+|+.||+|++..... ....+.+|++++.++ +||||+++++++... +..+
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeeccccccccCCceEE
Confidence 36799999999999996 5689999999865432 245788999999999 899999999999874 4689
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
+||||+++ +|.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 101 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 101 LVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp EEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 99999985 7777776542 3488999999999999999999998 99999999999999999999999999997
Q ss_pred CCCCC--------CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh--
Q 006747 489 LMNTP--------TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE-- 557 (632)
Q Consensus 489 ~~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 557 (632)
..... ....+|+.|+|||.+.+. .++.++|||||||++|||+||+.||.+....+. ...+......
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCC
Confidence 65421 223478889999998764 579999999999999999999999976432111 1111111100
Q ss_pred -ccccccccccc--------cccCCcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 558 -EWTSEVFDVEL--------MRYENIEEE------MVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 558 -~~~~~~~d~~~--------~~~~~~~~~------~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
......-.... .......+. ...+.+++.+||+.||++|||++|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000000 000111121 1347789999999999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=324.99 Aligned_cols=243 Identities=22% Similarity=0.322 Sum_probs=192.4
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+||+|+||.||+|.. .++..||||.+..... ..+.+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 4799999999999995 5688999999976533 356789999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-CCCeEEcccCCCCCCCCC----C
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-DLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~~~~~----~ 494 (632)
.+++.... +...+++..+..++.+++.||+|||+. +|+||||||+||+++. ++.+||+|||+++..... .
T Consensus 107 ~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 107 SALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp HHHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred HHHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 99997653 234567888999999999999999998 9999999999999998 899999999999766432 2
Q ss_pred CCCCCCcccCCccccCCC--CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 495 VPSRSAGYRAPEVIETKK--PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~--~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
...++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ........ .... +.+ ..
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~-~~~~-----~~~--~~ 249 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKVGM-FKVH-----PEI--PE 249 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHHHH-HCCC-----CCC--CT
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhhcc-cccc-----ccc--cc
Confidence 345788999999997654 7899999999999999999999996432110 00000000 0000 011 01
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.....+.+++.+||+.||++|||+.|++++
T Consensus 250 ---~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 250 ---SMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp ---TSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ---cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 112356778889999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=324.26 Aligned_cols=249 Identities=20% Similarity=0.285 Sum_probs=191.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe--CCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS--KDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|.. .+++.||||+++. ...+.+.+|++++.++.+||||+++++++.. ....++||||++++
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 118 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence 36799999999999985 5689999999974 3467899999999999559999999999998 56789999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-CeEEcccCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~--- 493 (632)
+|.+++.. +++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 119 ~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 119 DFKQLYQT--------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp CHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred hHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 99998852 67888999999999999999998 999999999999999776 8999999999765433
Q ss_pred CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH--------Hhhhccccccc
Q 006747 494 TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQS--------VVREEWTSEVF 564 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 564 (632)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+...... .+..... ..
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~--~~ 264 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKYNI--EL 264 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHTTC--CC
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHhcc--cc
Confidence 23457888999999987 66899999999999999999999999543211 0011110000 0000000 00
Q ss_pred ccc---------------ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 565 DVE---------------LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 565 d~~---------------~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
++. .............+.+++.+||+.||++|||++|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 00000111123457788999999999999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=331.97 Aligned_cols=190 Identities=22% Similarity=0.383 Sum_probs=166.5
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|+||.||++... ++..||+|++..... ..+.+.+|++++.++ +||||+++++++...+..++||||+++|+
T Consensus 39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 57999999999999965 689999999976422 245788999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC--CCCC
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--PTVP 496 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~~ 496 (632)
|.+++.... .+++.....++.+++.||+|||+.. +|+||||||+||+++.++.+||+|||+++.... ....
T Consensus 118 L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 190 (360)
T 3eqc_A 118 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190 (360)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCC
Confidence 999997643 4788999999999999999999842 799999999999999999999999999865422 2334
Q ss_pred CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 497 ~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
.+|+.|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus 191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6889999999999999999999999999999999999999754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.97 Aligned_cols=242 Identities=25% Similarity=0.412 Sum_probs=190.0
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe------CCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS------KDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|.. .+++.||||++.........+.+|++++.++.+||||+++++++.. .+..++||||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 108 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence 36799999999999996 4689999999987666678899999999999789999999999987 4578999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++|+|.+++.... ...+++.....++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 109 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 182 (326)
T 2x7f_A 109 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182 (326)
T ss_dssp CTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-----
T ss_pred CCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcC
Confidence 99999999997642 23588899999999999999999998 9999999999999999999999999999876432
Q ss_pred ----CCCCCCCcccCCcccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~-----~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
....++..|+|||.+. +..++.++|||||||++|||+||+.||..... ........... .....
T Consensus 183 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~~~ 255 (326)
T 2x7f_A 183 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------MRALFLIPRNP-APRLK 255 (326)
T ss_dssp --------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC-CCCCS
T ss_pred ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHhhcCc-cccCC
Confidence 2335788999999987 56689999999999999999999999964321 11111111111 11000
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.... ...+.+++.+||+.||++|||+.++++
T Consensus 256 ------~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 256 ------SKKW---SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp ------CSCS---CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------cccc---CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0111 235677888999999999999999987
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=357.16 Aligned_cols=238 Identities=21% Similarity=0.281 Sum_probs=195.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +++.||||++++. ....+.+..|.+++..+.+||||+++++++.+.+..|+||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 367999999999999965 5788999999754 23346688899999988789999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC---
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--- 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--- 492 (632)
+|+|.++++... .+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+++....
T Consensus 426 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~ 497 (674)
T 3pfq_A 426 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 497 (674)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence 999999998643 488999999999999999999998 999999999999999999999999999975322
Q ss_pred -CCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 493 -PTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
.....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+... ......+..... .-.
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~---------~~p 562 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIMEHNV---------AYP 562 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHSSCC---------CCC
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHhCCC---------CCC
Confidence 2334689999999999999999999999999999999999999975321 122222222111 001
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTM-----EEVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~-----~evl~ 604 (632)
.. ...++.+|+.+||+.||++||++ +||++
T Consensus 563 ~~---~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 KS---MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp TT---SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred cc---CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 11 22356778889999999999997 66654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=334.50 Aligned_cols=194 Identities=21% Similarity=0.303 Sum_probs=166.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCC-----ccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPN-----VVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~n-----iv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|... +++.||||+++........+..|++++..+.+|++ |+++++++...+..++||||+
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 138 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML 138 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence 367999999999999865 57899999998654445677888888888855664 999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec--CCCCeEEcccCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS--QDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~--~~~~~ki~DfGla~~~~~ 492 (632)
+ |+|.+++.... ...+++..+..++.|++.||+|||++ ..+|+||||||+|||++ +++.+||+|||+++....
T Consensus 139 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~ 213 (382)
T 2vx3_A 139 S-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ 213 (382)
T ss_dssp C-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred C-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence 6 59999987653 23488999999999999999999952 23899999999999995 578899999999987654
Q ss_pred C-CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCC
Q 006747 493 P-TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539 (632)
Q Consensus 493 ~-~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~ 539 (632)
. ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.+.
T Consensus 214 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 3 3446889999999999999999999999999999999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.54 Aligned_cols=239 Identities=24% Similarity=0.393 Sum_probs=196.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++.++ +||||+++++++......++||||++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 105 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWIIMEYLGGG 105 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEEEEeCCCC
Confidence 35799999999999985 468899999997543 3457899999999999 9999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++... ++++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 106 ~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 106 SALDLLEPG------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 999998643 488999999999999999999998 9999999999999999999999999999765432
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ......... +. ..
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~-~~~~~~~~~-~~------~~ 242 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------MKVLF-LIPKNNPPT-LE------GN 242 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHH-HHHHSCCCC-CC------SS
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHHH-HhhcCCCCC-Cc------cc
Confidence 233578889999999999999999999999999999999999964321 11111 111111110 00 11
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI 606 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L 606 (632)
....+.+++.+||+.||++|||+.|++++.
T Consensus 243 ---~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 243 ---YSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp ---CCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ---cCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 123477888899999999999999998853
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=340.32 Aligned_cols=245 Identities=21% Similarity=0.319 Sum_probs=196.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccc---ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEV---VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||++... +++.||||++... ......+.+|++++.++ +||||+++++++.+....++||||+++
T Consensus 27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 105 (486)
T 3mwu_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTG 105 (486)
T ss_dssp EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence 468999999999999964 6899999999653 23467899999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec---CCCCeEEcccCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS---QDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~---~~~~~ki~DfGla~~~~~~ 493 (632)
|+|.+++.... .+++.....++.+++.||+|||+. +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 106 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 106 GELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999887542 488999999999999999999998 999999999999995 4668999999999876543
Q ss_pred ---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
....+|+.|+|||++.+ .++.++||||+||++|||++|+.||.+... .............. ....
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~-----~~~~ 245 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYAF-----DLPQ 245 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCCS-----CSGG
T ss_pred CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCC-----CCcc
Confidence 23458899999999876 589999999999999999999999975321 11112211111110 0001
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhh
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDI 609 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i 609 (632)
+.. ....+.+++.+||+.||++|||+.|++++ ++..
T Consensus 246 ~~~---~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 246 WRT---ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp GGG---SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred cCC---CCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 111 12346788889999999999999999985 5554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.38 Aligned_cols=259 Identities=19% Similarity=0.270 Sum_probs=193.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhc----------CCCCccceeEEEEeCC----
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS----------QHPNVVPIRAYYFSKD---- 405 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~----------~h~niv~l~~~~~~~~---- 405 (632)
.+.||+|+||.||+|.. .+++.||||++.........+.+|++++.++. .|+||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 103 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 103 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCc
Confidence 36799999999999985 56899999999865444567889999988873 2899999999998654
Q ss_pred ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec------CCCCe
Q 006747 406 EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS------QDLQG 479 (632)
Q Consensus 406 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~------~~~~~ 479 (632)
..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+.+ +|+||||||+|||++ .++.+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~ 177 (373)
T 1q8y_A 104 HVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQI 177 (373)
T ss_dssp EEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred eEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceE
Confidence 689999999 889999997643 234889999999999999999999853 899999999999994 44589
Q ss_pred EEcccCCCCCCCCC-CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh--
Q 006747 480 CISDFGLTPLMNTP-TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR-- 556 (632)
Q Consensus 480 ki~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 556 (632)
||+|||+++..... ....+|+.|+|||.+.+..++.++|||||||++|||+||+.||....................
T Consensus 178 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (373)
T 1q8y_A 178 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257 (373)
T ss_dssp EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred EEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhc
Confidence 99999999776543 344688999999999999999999999999999999999999976543221111111111110
Q ss_pred -h--------c-ccccccc----------cc--------ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 557 -E--------E-WTSEVFD----------VE--------LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 557 -~--------~-~~~~~~d----------~~--------~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. . +....+. .. .............+.+++.+||+.||++|||++|++++
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 258 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 0 0 0000000 00 00112234556778899999999999999999999883
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.13 Aligned_cols=251 Identities=21% Similarity=0.335 Sum_probs=195.4
Q ss_pred HhHhCccceeEEEEEEE------cCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|.. .++..||||++.... .....+.+|+.++.++ +||||+++++++...+..++|||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 113 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSLPRFILME 113 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCCCcEEEEe
Confidence 36799999999999983 347789999997542 2245788999999999 99999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC--CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---CCCeEEcccCCC
Q 006747 413 FIEAGSFSALLHGNRGI--GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGCISDFGLT 487 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla 487 (632)
|+++|+|.+++...... ....+++..+..++.+++.||+|||+. +|+||||||+|||++. +..+||+|||++
T Consensus 114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~ 190 (327)
T 2yfx_A 114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190 (327)
T ss_dssp CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHH
T ss_pred cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccc
Confidence 99999999999865321 124588999999999999999999998 9999999999999994 456999999998
Q ss_pred CCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 488 PLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 488 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
+..... ....++..|+|||.+.+..++.++|||||||++|||+| |+.||..... ....... .....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~-~~~~~ 263 (327)
T 2yfx_A 191 RDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFV-TSGGR 263 (327)
T ss_dssp HHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHH-HTTCC
T ss_pred cccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HHHHHHH-hcCCC
Confidence 643221 22346778999999998899999999999999999999 9999865321 1111111 11111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.. ... .....+.+++.+||+.||++|||+.+++++|+.+...
T Consensus 264 ~~-------~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 264 MD-------PPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp CC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CC-------CCC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 00 001 1223577888999999999999999999999987544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=316.53 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=198.3
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... ++..||+|++.... .....+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 97 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAP 97 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence 367999999999999965 57889999996532 2356789999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++.... .+++.....++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 169 (284)
T 2vgo_A 98 RGELYKELQKHG-----RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR 169 (284)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCB
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccccc
Confidence 999999997542 488899999999999999999998 9999999999999999999999999998655432
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ............ .. ...
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~-------~~--~~~ 234 (284)
T 2vgo_A 170 RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVNVDL-------KF--PPF 234 (284)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC-------CC--CTT
T ss_pred ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhcccc-------CC--CCc
Confidence 234578899999999999999999999999999999999999965321 111111111100 00 011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhhCCC
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDIRPS 612 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i~~~ 612 (632)
. ...+.+++.+||+.||++|||+.|+++ .++.....
T Consensus 235 ~---~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~ 272 (284)
T 2vgo_A 235 L---SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272 (284)
T ss_dssp S---CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred C---CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence 1 234677888999999999999999987 45554433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=331.87 Aligned_cols=250 Identities=21% Similarity=0.302 Sum_probs=190.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC------HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||.||+|... +|+.||||+++..... .+.+.+|++++.++ +||||+++++++...+..++||||
T Consensus 15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCCceEEEEEc
Confidence 467999999999999964 5899999999753221 24678999999999 899999999999999999999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++ +|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 94 MET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp CSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred CCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 986 8888887542 3577888999999999999999998 9999999999999999999999999999876432
Q ss_pred ----CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh------ccccc
Q 006747 494 ----TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE------EWTSE 562 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 562 (632)
....+|+.|+|||.+.+. .++.++|||||||++|||++|..||.+... .......... ....+
T Consensus 166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~------~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCTTTSSS
T ss_pred cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHHcCCCChhhhhh
Confidence 234578899999999764 479999999999999999999999865321 1111111111 00000
Q ss_pred ccc-cccc---c-cCCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 563 VFD-VELM---R-YENI-----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 563 ~~d-~~~~---~-~~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... +... . .... ......+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 0000 0 0000 1112457788999999999999999999885
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.13 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=193.5
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEe--CCceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFS--KDEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~E~~~ 415 (632)
+.||+|+||.||++... +++.||+|++...... .+.+.+|++++.++ +||||+++++++.. ....++||||++
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 57999999999999864 6899999999765332 45688999999999 89999999998865 567899999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCC-----ceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK-----FILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
+|+|.+++..... ....+++..+..++.+++.||+|||+. + |+||||||+||++++++.+||+|||+++..
T Consensus 91 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 91 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166 (279)
T ss_dssp TEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred CCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence 9999999875421 234589999999999999999999998 6 999999999999999999999999998766
Q ss_pred CCCCC----CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 491 NTPTV----PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 491 ~~~~~----~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
..... ..++..|+|||.+.+..++.++||||||+++|||+||+.||..... .... ..+..+.....
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~-~~i~~~~~~~~--- 236 (279)
T 2w5a_A 167 NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELA-GKIREGKFRRI--- 236 (279)
T ss_dssp ---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH-HHHHHTCCCCC---
T ss_pred ccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HHHH-HHHhhcccccC---
Confidence 54321 2478889999999998999999999999999999999999965321 1111 11122211110
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.. .....+.+++.+||+.||++|||+.|+++++..
T Consensus 237 ----~~---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 ----PY---RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ----CT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----Cc---ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 01 112357788889999999999999999987654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.66 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=188.3
Q ss_pred HhHhCccceeEEEEEEEc--CCc--EEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE--EGT--TVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~--~~~--~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|... ++. .||||+++.... ..+.+.+|++++.++ +||||+++++++.... .++|+|
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~-~~~v~e 100 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP-MKMVTE 100 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-CEEEEE
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-ceeeEe
Confidence 367999999999999853 233 689999875421 246788999999999 8999999999997754 899999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++|+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 101 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 173 (291)
T 1u46_A 101 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 173 (291)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred cccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccc
Confidence 999999999997542 3488999999999999999999998 999999999999999999999999999977643
Q ss_pred CC-------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 493 PT-------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 493 ~~-------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.. ...++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ..............
T Consensus 174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~~--- 244 (291)
T 1u46_A 174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERL--- 244 (291)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCC---
T ss_pred cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccCCCC---
Confidence 32 2235668999999988889999999999999999999 9999965321 12222221111110
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCCC
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSE 615 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~~ 615 (632)
.........+.+++.+||+.||++|||+.++++.|+++.+....
T Consensus 245 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 288 (291)
T 1u46_A 245 -------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288 (291)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred -------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence 00111224577888999999999999999999999998776543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.86 Aligned_cols=238 Identities=20% Similarity=0.331 Sum_probs=188.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|... +++.||||++.... ...+.+.+|++++.++ +||||+++++++...+..++||||++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTDFFMVMEYVS 94 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCeEEEEEeccC
Confidence 357999999999999975 68999999996532 2356789999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+++|.+++.... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 166 (276)
T 2h6d_A 95 GGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166 (276)
T ss_dssp SCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred CCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence 999999997542 478899999999999999999998 99999999999999999999999999998765432
Q ss_pred --CCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 --VPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 --~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.... ....... +...... ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~-~~~~~~~--------~~ 231 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH------VPTLFKK-IRGGVFY--------IP 231 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHH-HHHCCCC--------CC
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHH-hhcCccc--------Cc
Confidence 3357888999999988765 689999999999999999999996432 1111111 1111100 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. ....+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~---~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 EY---LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp TT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hh---cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 12346778889999999999999999984
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=316.30 Aligned_cols=238 Identities=21% Similarity=0.339 Sum_probs=194.5
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... +++.||+|++..... ..+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~ 98 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCR 98 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEEEEEecCC
Confidence 367999999999999975 478899999875432 245688899999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 99 ~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 99 RRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp TCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 99999988754 2488999999999999999999998 9999999999999999999999999999765422
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.... ............. . ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~-------~--~~ 235 (294)
T 2rku_A 171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNEY-------S--IP 235 (294)
T ss_dssp CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCC-------C--CC
T ss_pred ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhhccC-------C--Cc
Confidence 23357889999999999889999999999999999999999996532 1111111111110 0 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ...+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 236 KHI---NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TTS---CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccc---CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 2346678889999999999999999984
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=326.20 Aligned_cols=237 Identities=21% Similarity=0.341 Sum_probs=194.1
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++... +++.||+|++..... ..+.+.+|++++.++ +|+||+++++++.+.+..++||||+++
T Consensus 47 ~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 57999999999999965 478999999875432 245688999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 126 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 126 RSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp CBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 9999998754 2488999999999999999999998 9999999999999999999999999999765422
Q ss_pred -CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 494 -TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 494 -~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
....++..|+|||.+.+..++.++|||||||++|||++|+.||.... .............. ...
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~---------~~~ 262 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNEYS---------IPK 262 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHTCCC---------CCT
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC------HHHHHHHHhcCCCC---------CCc
Confidence 23357889999999999999999999999999999999999996432 11111111111100 001
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. ...+.+++.+||+.||++|||+.|++++
T Consensus 263 ~~---~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 263 HI---NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cC---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 2346678889999999999999999973
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=322.05 Aligned_cols=240 Identities=25% Similarity=0.391 Sum_probs=191.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||+|... +|+.||+|++.... ....+.+|++++.++ +||||+++++++...+..++||||+++|+|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 357999999999999865 48999999997643 356789999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 495 (632)
.+++... ...+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++...... ..
T Consensus 112 ~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 112 SDIIRLR----NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp HHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence 9998632 23588999999999999999999998 9999999999999999999999999999765432 23
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....... ........ ....
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~~~~~~--------~~~~ 249 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMI-PTNPPPTF--------RKPE 249 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHH-HHSCCCCC--------SSGG
T ss_pred cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHH-hcCCCccc--------CCcc
Confidence 4578889999999999999999999999999999999999964321 1111111 11111000 0011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.....+.+++.+||+.||++|||+.++++
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11245778889999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=342.42 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=197.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||++... +++.||||++... ....+.+.+|++++.++ +||||+++++++.+.+..++||||+.
T Consensus 31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~ 109 (484)
T 3nyv_A 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYT 109 (484)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEEEecCC
Confidence 467999999999999965 6899999999654 23467899999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee---cCCCCeEEcccCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL---SQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl---~~~~~~ki~DfGla~~~~~ 492 (632)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++....
T Consensus 110 ~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 110 GGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp SCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 999999987542 488999999999999999999998 99999999999999 5678999999999976654
Q ss_pred CCC---CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 493 PTV---PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 493 ~~~---~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
... ..+|+.|+|||.+.+ .++.++||||+||++|||++|+.||.+... .............. ...
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~-----~~~ 249 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE------YDILKKVEKGKYTF-----ELP 249 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC-----CSG
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCCCCC-----CCc
Confidence 332 358899999999876 689999999999999999999999975321 11112211111110 001
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhh
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDI 609 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i 609 (632)
.+.. ....+.+++.+||+.||++|||+.|+++ .++..
T Consensus 250 ~~~~---~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 250 QWKK---VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp GGGG---SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred cccc---CCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 1111 1235678888999999999999999987 34444
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=332.16 Aligned_cols=252 Identities=20% Similarity=0.292 Sum_probs=184.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||+|.. .+++.||||+++..... .+.+.+|++++.++ +||||+++++++.+.+..++||||+++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLHLIFEYAEN 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEEEEEecCCC
Confidence 36799999999999985 46889999999754322 34678999999999 899999999999999999999999985
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee-----cCCCCeEEcccCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL-----SQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl-----~~~~~~ki~DfGla~~~~ 491 (632)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||+ ++++.+||+|||+++...
T Consensus 118 -~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 118 -DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp -EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred -CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999987643 488999999999999999999998 99999999999999 455669999999987654
Q ss_pred CC----CCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh--hhccccccc
Q 006747 492 TP----TVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV--REEWTSEVF 564 (632)
Q Consensus 492 ~~----~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 564 (632)
.. ....+|..|+|||.+.+.. ++.++|||||||++|||++|+.||......+. +........ .+.......
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSTTGG
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCchhhhhhhh
Confidence 22 2335788999999998754 89999999999999999999999975321110 111111000 000000000
Q ss_pred -----ccccc--ccCCcHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 565 -----DVELM--RYENIEE-----EMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 565 -----d~~~~--~~~~~~~-----~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..... ....... ...++.+++.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 0001111 1245678899999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=323.41 Aligned_cols=246 Identities=19% Similarity=0.320 Sum_probs=189.2
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|...+ .||+|+++.... ..+.+.+|++++.++ +||||+++++++...+..++||||++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceEEEeecccCC
Confidence 3679999999999998753 599999875422 234577899999999 8999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 115 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 115 TLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp EHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 9999997642 3588899999999999999999998 999999999999998 689999999998765321
Q ss_pred -----CCCCCCCcccCCccccC---------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 494 -----TVPSRSAGYRAPEVIET---------KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 494 -----~~~~~t~~y~aPE~~~~---------~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...... .....
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~-~~~~~ 259 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------EAIIWQ-MGTGM 259 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------HHHHHH-HHTTC
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-hccCC
Confidence 12247788999999875 3478899999999999999999999965321 111111 11111
Q ss_pred ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 560 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
....... . ....+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 260 ~~~~~~~------~---~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 260 KPNLSQI------G---MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCCCCS------S---CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCcC------C---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111000 1 1124678888999999999999999999999997664
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=340.11 Aligned_cols=241 Identities=22% Similarity=0.354 Sum_probs=189.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||+|... ++..||+|++.... .....+.+|++++.++ +|||||+++++|.+....++||||+++
T Consensus 42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv~e~~~~ 120 (494)
T 3lij_A 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKRNYYLVMECYKG 120 (494)
T ss_dssp EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence 467999999999999965 68899999997643 2356789999999999 899999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---CCCeEEcccCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~~ 493 (632)
|+|.+++.... ++++.....++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 121 g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 121 GELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999887542 488899999999999999999998 9999999999999976 456999999999766433
Q ss_pred ---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
....+|+.|+|||++. ..++.++||||+||++|||++|+.||.+... ............. ++.. .
T Consensus 193 ~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~---~~~~--~ 260 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEILRKVEKGKYT---FDSP--E 260 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC---CCSG--G
T ss_pred ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---CCch--h
Confidence 3346899999999986 5689999999999999999999999975321 1122222111111 0000 1
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+... ...+.+++.+||+.||++|||+.|++++
T Consensus 261 ~~~~---s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 261 WKNV---SEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred cccC---CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1111 2346678889999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.09 Aligned_cols=250 Identities=16% Similarity=0.233 Sum_probs=195.2
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCH------------------HHHHHHHHHHHhhcCCCCccceeEEEE
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGK------------------REFEQQMEVVGRLSQHPNVVPIRAYYF 402 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~------------------~~~~~e~~~l~~l~~h~niv~l~~~~~ 402 (632)
.+.||+|+||.||+|.. +++.||+|++....... +.+.+|++++.++ +||||+++++++.
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 113 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCLTCEGIIT 113 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBCCCSEEEE
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcceEEEEEe
Confidence 36799999999999999 89999999997542211 7899999999999 8999999999999
Q ss_pred eCCceEEEEecccCCCHhhh------hccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHh-ccCCCceecCCCCCCeeecC
Q 006747 403 SKDEKLLVYDFIEAGSFSAL------LHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA-AVGGKFILGNIKSSNVLLSQ 475 (632)
Q Consensus 403 ~~~~~~lv~E~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivHrDlk~~NILl~~ 475 (632)
+.+..++||||+++|+|.++ +... ...++++..+..++.+++.||+|||+ . +|+||||||+||+++.
T Consensus 114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK 187 (348)
T ss_dssp SSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT
T ss_pred eCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC
Confidence 99999999999999999998 5432 13568999999999999999999998 7 9999999999999999
Q ss_pred CCCeEEcccCCCCCCCCC--CCCCCCCcccCCccccCC-CCCc-cchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHH
Q 006747 476 DLQGCISDFGLTPLMNTP--TVPSRSAGYRAPEVIETK-KPTQ-KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWV 551 (632)
Q Consensus 476 ~~~~ki~DfGla~~~~~~--~~~~~t~~y~aPE~~~~~-~~~~-~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 551 (632)
++.+||+|||+++..... ....++..|+|||.+.+. .++. ++|||||||++|||++|+.||...... ....
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~ 262 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-----VELF 262 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-----HHHH
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-----HHHH
Confidence 999999999999765432 334588899999999887 5666 999999999999999999999754321 1111
Q ss_pred HHHhhhcccccccc-----cccccc---CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 552 QSVVREEWTSEVFD-----VELMRY---ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 552 ~~~~~~~~~~~~~d-----~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.... ........+ ...... .........+.+++.+||+.||++|||+.|+++
T Consensus 263 ~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 263 NNIR-TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHT-SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHh-ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 111000000 000000 000112345778889999999999999999987
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.43 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=191.3
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc--------------cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV--------------MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD 405 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~ 405 (632)
.+.||+|+||.||+|... ++..||+|+++... ...+.+.+|++++.++ +||||+++++++.+..
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 119 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKK 119 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEEEEECSS
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCC
Confidence 367999999999999965 57899999997543 2246789999999999 8999999999999999
Q ss_pred ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC---CeEEc
Q 006747 406 EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL---QGCIS 482 (632)
Q Consensus 406 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~---~~ki~ 482 (632)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 120 ~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 120 YFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9999999999999999987542 488999999999999999999998 999999999999999876 69999
Q ss_pred ccCCCCCCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 483 DFGLTPLMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 483 DfGla~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
|||+++..... ....+|+.|+|||++. +.++.++||||+||++|||++|+.||.+... ............
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~ 264 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND------QDIIKKVEKGKY 264 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC
Confidence 99999876543 3346899999999987 4689999999999999999999999975321 111222111111
Q ss_pred ccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 560 TSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 560 ~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. ++ ...+... ...+.+++.+||+.||++|||+.|++++
T Consensus 265 ~---~~--~~~~~~~---s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 Y---FD--FNDWKNI---SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp C---CC--HHHHTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C---CC--ccccCCC---CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 00 0001111 2356788889999999999999999873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=325.77 Aligned_cols=263 Identities=18% Similarity=0.271 Sum_probs=182.4
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc-------eEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE-------KLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-------~~lv~E 412 (632)
.+.||+|+||.||+|... +++.||||++.........+.++++.+..+ +||||+++++++..... .++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~~lv~e 106 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIYLNVVME 106 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccccceeEEEEee
Confidence 367999999999999964 589999999876554455677788888888 89999999999976543 789999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHH--hccCCCceecCCCCCCeeecC-CCCeEEcccCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH--AAVGGKFILGNIKSSNVLLSQ-DLQGCISDFGLTPL 489 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivHrDlk~~NILl~~-~~~~ki~DfGla~~ 489 (632)
|+++ +|...+..... ....+++.....++.+++.||.||| +. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 107 ~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~ 181 (360)
T 3e3p_A 107 YVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181 (360)
T ss_dssp CCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBC
T ss_pred cccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCcee
Confidence 9987 54444332110 2235788899999999999999999 66 9999999999999997 89999999999987
Q ss_pred CCCCC---CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH-----------H
Q 006747 490 MNTPT---VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQS-----------V 554 (632)
Q Consensus 490 ~~~~~---~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-----------~ 554 (632)
..... ...+|..|+|||.+.+.. ++.++|||||||++|||+||+.||......+. +...++. .
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp CCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHH
T ss_pred cCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHHcCCCCHHHHHhc
Confidence 65432 335788999999987655 89999999999999999999999976432111 1111110 0
Q ss_pred hhhcccccccccccc-----ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCC
Q 006747 555 VREEWTSEVFDVELM-----RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRP 611 (632)
Q Consensus 555 ~~~~~~~~~~d~~~~-----~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~ 611 (632)
..........+.... ...........+.+++.+||+.||++|||+.|++++ ++++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 000000000000000 000011134567889999999999999999999984 666644
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.05 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=184.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCC------ceEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD------EKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv 410 (632)
.+.||+|+||.||+|... +++.||||++...... .+.+.+|++++.++ +||||+++++++...+ ..++|
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~~~lv 108 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIV 108 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccccceEEE
Confidence 367999999999999854 5889999999764332 35688999999999 8999999999998654 67999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
|||+++ +|.+++.. .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 ~e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 109 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred EEcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 999985 78888753 278899999999999999999998 9999999999999999999999999999876
Q ss_pred CCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC---------ChhHH-------H
Q 006747 491 NTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV---------DLPRW-------V 551 (632)
Q Consensus 491 ~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~---------~~~~~-------~ 551 (632)
... ....+|..|+|||.+.+..++.++|||||||++|||++|+.||.+....+.. ..+.+ +
T Consensus 178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 543 2345788999999999999999999999999999999999999764321100 00000 0
Q ss_pred HHHhhhccc--cc----cccccccccC--CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 552 QSVVREEWT--SE----VFDVELMRYE--NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 552 ~~~~~~~~~--~~----~~d~~~~~~~--~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
......... .. .+........ ........+.+++.+||+.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 00 0000000000 011224568899999999999999999999884
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=325.68 Aligned_cols=253 Identities=24% Similarity=0.372 Sum_probs=177.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|++++.++ +||||+++++++...+..++||||+++|
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 98 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLVMKLLSGG 98 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEEehhccCC
Confidence 36799999999999985 468999999987542 2346688899999999 8999999999999999999999999999
Q ss_pred CHhhhhccCC---CCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-
Q 006747 418 SFSALLHGNR---GIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 418 ~L~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 493 (632)
+|.+++.... ......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 175 (303)
T 2vwi_A 99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGG 175 (303)
T ss_dssp BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---
T ss_pred chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCC
Confidence 9999986421 11234589999999999999999999998 9999999999999999999999999998654322
Q ss_pred --------CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 494 --------TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 494 --------~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... . ........ ....
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~~~~~~-~~~~- 247 (303)
T 2vwi_A 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---V---LMLTLQND-PPSL- 247 (303)
T ss_dssp ------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHHHHTSS-CCCT-
T ss_pred CccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---H---HHHHhccC-CCcc-
Confidence 12347888999999876 568999999999999999999999997533211 1 11111111 0000
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
................+.+++.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000000001112356788889999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=336.54 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=183.3
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhh
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSA 421 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~ 421 (632)
+.||+|+||+||.+...+|+.||||++.... .+.+.+|++++.++.+|||||++++++.+.+..++||||+. |+|.+
T Consensus 21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~ 97 (434)
T 2rio_A 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQD 97 (434)
T ss_dssp EEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHH
T ss_pred CeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHH
Confidence 5799999999987777789999999986532 45678899999887689999999999999999999999996 69999
Q ss_pred hhccCCCCCCC--cCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-------------CCeEEcccCC
Q 006747 422 LLHGNRGIGRT--PLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-------------LQGCISDFGL 486 (632)
Q Consensus 422 ~l~~~~~~~~~--~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-------------~~~ki~DfGl 486 (632)
++......... ...+..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~ 174 (434)
T 2rio_A 98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174 (434)
T ss_dssp HHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred HHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence 99865321110 112334578999999999999998 99999999999999754 5899999999
Q ss_pred CCCCCCCC--------CCCCCCcccCCccccC-------CCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHH
Q 006747 487 TPLMNTPT--------VPSRSAGYRAPEVIET-------KKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRW 550 (632)
Q Consensus 487 a~~~~~~~--------~~~~t~~y~aPE~~~~-------~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 550 (632)
++...... ...+|++|+|||++.+ ..++.++|||||||++|||+| |+.||......+
T Consensus 175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------- 247 (434)
T 2rio_A 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------- 247 (434)
T ss_dssp CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-------
T ss_pred ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-------
Confidence 98765432 2358899999999976 568999999999999999999 999996432110
Q ss_pred HHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 551 VQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 551 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
........... .. ..........++.+++.+||+.||++|||+.|+++
T Consensus 248 -~~i~~~~~~~~----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -SNIIRGIFSLD----EM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HHHHHTCCCCC----CC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHhcCCCCcc----cc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11111111000 00 11112334566888999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=334.90 Aligned_cols=251 Identities=21% Similarity=0.319 Sum_probs=174.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv 410 (632)
.+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|++++.++ +||||+++++++... ...++|
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~~~~~lv 112 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV 112 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccCCeEEEE
Confidence 36799999999999985 56899999999754332 45688999999999 899999999999754 567999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
+||+ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 113 ~e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 113 THLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp EECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred eccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 9999 67999888642 488999999999999999999998 9999999999999999999999999999876
Q ss_pred CCC-CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh---cccccccc
Q 006747 491 NTP-TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE---EWTSEVFD 565 (632)
Q Consensus 491 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d 565 (632)
... ....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+. ...+...... .....+..
T Consensus 183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 183 ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHTTCCC
T ss_pred cccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHHhhh
Confidence 543 33468899999999987 6789999999999999999999999976432111 1111110000 00000000
Q ss_pred c-------cccc--cCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 566 V-------ELMR--YENIE----EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 566 ~-------~~~~--~~~~~----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. .+.. ..... .....+.+|+.+||+.||++|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 0000 00000 112457788999999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=338.20 Aligned_cols=187 Identities=25% Similarity=0.382 Sum_probs=159.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC-----CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK-----DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~ 411 (632)
.+.||+|+||.||+|... +++.||||+++..... .+.+.+|++++.++ +|+||+++++++... ...|+||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~~lv~ 109 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVL 109 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcCCeEEEEE
Confidence 367999999999999864 5789999999764332 45788999999999 899999999999876 5689999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||++ |+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 110 e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 110 EIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp ECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred ecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 9997 5999999754 3489999999999999999999998 99999999999999999999999999998754
Q ss_pred CC--------------------------CCCCCCCcccCCccc-cCCCCCccchhhHHHHHHHHHHhCCCCCC
Q 006747 492 TP--------------------------TVPSRSAGYRAPEVI-ETKKPTQKSDVYSFGVLLLEMLTGKAPIQ 537 (632)
Q Consensus 492 ~~--------------------------~~~~~t~~y~aPE~~-~~~~~~~~~DV~s~Gvvl~elltg~~p~~ 537 (632)
.. ....+|+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 32 234578899999986 55669999999999999999998655543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.30 Aligned_cols=253 Identities=20% Similarity=0.307 Sum_probs=185.3
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccC------------HHHHHHHHHHHHhhcCCCCccceeEEEEeCC---
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG------------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD--- 405 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~--- 405 (632)
.+.||+|+||.||+|...+|..||||++...... .+.+.+|++++.++ +||||+++++++...+
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 105 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPA 105 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEEEECCTTT
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeeeEEeccCCC
Confidence 3579999999999999888999999999654221 26789999999999 8999999999996533
Q ss_pred --ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcc
Q 006747 406 --EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISD 483 (632)
Q Consensus 406 --~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~D 483 (632)
..++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 106 MHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp CCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred cceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEe
Confidence 5799999998 58888887542 3589999999999999999999998 999999999999999999999999
Q ss_pred cCCCCCCCCC---CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcc
Q 006747 484 FGLTPLMNTP---TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEW 559 (632)
Q Consensus 484 fGla~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 559 (632)
||+++..... ....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+. ...+........
T Consensus 178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~ 254 (362)
T 3pg1_A 178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ---LNKIVEVVGTPK 254 (362)
T ss_dssp TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCC
Confidence 9999765432 23357888999999887 6689999999999999999999999975431111 000000000000
Q ss_pred -----------cccccccccccc--CC----cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 560 -----------TSEVFDVELMRY--EN----IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 560 -----------~~~~~d~~~~~~--~~----~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..+.+....... .. .......+.+++.+||+.||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000000000 00 01112457788999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=316.11 Aligned_cols=244 Identities=22% Similarity=0.362 Sum_probs=176.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC--HHHHHHHHH-HHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG--KREFEQQME-VVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~e~~-~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||+|.. .+++.||+|+++..... ...+..+.. .+..+ +||||+++++++...+..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~~lv~e~~~~ 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDVWICMELMDT 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSEEEEEECCSE
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCEEEEEehhcc
Confidence 35799999999999996 56899999999765322 223333444 35555 999999999999999999999999984
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC--
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-- 494 (632)
+|.+++..... ...++++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||+++......
T Consensus 91 -~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 166 (290)
T 3fme_A 91 -SLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK 166 (290)
T ss_dssp -EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC------------
T ss_pred -chHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccccccc
Confidence 88777654211 1245899999999999999999999853 89999999999999999999999999998765432
Q ss_pred -CCCCCCcccCCccc----cCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 495 -VPSRSAGYRAPEVI----ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 495 -~~~~t~~y~aPE~~----~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
...+|+.|+|||.+ .+..++.++|||||||++|||+||+.||..... ............... .
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-~------ 234 (290)
T 3fme_A 167 DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-----PFQQLKQVVEEPSPQ-L------ 234 (290)
T ss_dssp ---CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-----HHHHHHHHHHSCCCC-C------
T ss_pred cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-----hHHHHHHHhccCCCC-c------
Confidence 23588899999996 556689999999999999999999999964221 111111111111110 0
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.. ......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 PA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00 111235778888999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=317.46 Aligned_cols=241 Identities=19% Similarity=0.327 Sum_probs=188.8
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|... ++..||+|++.... ...+.+.+|++++.++ +||||+++++++...+..++||||+++|+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence 357999999999999975 48899999987553 3467899999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC----CCC
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN----TPT 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~----~~~ 494 (632)
|.+++.... ..+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++.... ...
T Consensus 103 l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 103 VDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 999887532 2488999999999999999999998 99999999999999999999999999874321 123
Q ss_pred CCCCCCcccCCccc-----cCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 495 VPSRSAGYRAPEVI-----ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 495 ~~~~t~~y~aPE~~-----~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
...++..|+|||.+ .+..++.++|||||||++|||++|+.||.... ............. ....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~~~----- 243 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSDP-PTLL----- 243 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC-CCCS-----
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC------HHHHHHHHhccCC-cccC-----
Confidence 34578899999998 46678999999999999999999999996532 1111111111111 1000
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
........+.+++.+||+.||++|||+.++++
T Consensus 244 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 ---TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01111235778889999999999999999876
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=325.73 Aligned_cols=243 Identities=19% Similarity=0.288 Sum_probs=166.4
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe----CCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS----KDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~E~~~~ 416 (632)
++||+|+||.||+|... +++.||||++... ....+|+..+.+..+||||+++++++.. ....++||||+++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g 110 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG 110 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence 46999999999999975 6899999999653 2233444444444499999999999986 3458999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---CCCeEEcccCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~~ 493 (632)
|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 111 g~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~ 184 (336)
T 3fhr_A 111 GELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184 (336)
T ss_dssp EEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred CCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence 99999998653 24689999999999999999999998 9999999999999976 456999999999766433
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....+|+.|+|||.+.+..++.++|||||||++|||++|+.||.......... ........... ....
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~-----~~~~--- 254 (336)
T 3fhr_A 185 ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIRLGQY-----GFPN--- 254 (336)
T ss_dssp -------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCT---
T ss_pred ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhhcccc-----ccCc---
Confidence 23457889999999988889999999999999999999999997543222110 00000000000 0000
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.........+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000112345678888999999999999999998
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=349.56 Aligned_cols=244 Identities=22% Similarity=0.363 Sum_probs=195.3
Q ss_pred HhHhCccceeEEEEEEEcC----CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|.... +..||+|+++.... ..+.+.+|+.++.++ +||||+++++++ ..+..++||||+
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~-~~~~~~lv~E~~ 472 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI-TENPVWIIMELC 472 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEE-ecCceEEEEEcC
Confidence 4679999999999998642 46799999875432 236789999999999 899999999998 456789999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 473 ~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 473 TLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp TTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 9999999997542 3588999999999999999999998 99999999999999999999999999998775432
Q ss_pred C-----CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 495 V-----PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 495 ~-----~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
. ..+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+... ............. .
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~~~~~~i~~~~~~-~------ 612 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRIENGERL-P------ 612 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHHTCCC-C------
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHcCCCC-C------
Confidence 2 235678999999998899999999999999999997 9999975321 1111111111110 0
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
........+.+++.+||+.||++|||+.++++.|+++.
T Consensus 613 ----~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 613 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01112245778889999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=315.52 Aligned_cols=242 Identities=20% Similarity=0.328 Sum_probs=193.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc----------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM----------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLL 409 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 409 (632)
.+.||+|+||.||+|... +++.||||+++.... ..+.+.+|++++.++.+||||+++++++...+..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 357999999999999965 588999999965421 134578899999999569999999999999999999
Q ss_pred EEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 410 VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 410 v~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
||||+++|+|.+++... ..+++..+..++.+++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 102 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999754 2488999999999999999999998 999999999999999999999999999976
Q ss_pred CCCC---CCCCCCCcccCCcccc------CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 490 MNTP---TVPSRSAGYRAPEVIE------TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 490 ~~~~---~~~~~t~~y~aPE~~~------~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
.... ....++..|+|||.+. ...++.++||||||+++|||++|+.||..... .............
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~ 247 (298)
T 1phk_A 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNYQ 247 (298)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC
T ss_pred cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHHHhcCCcc
Confidence 5433 2335788999999985 45678999999999999999999999965321 1111111111110
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
. .. .........+.+++.+||+.||++|||+.|+++
T Consensus 248 ~--~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 248 F--GS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp C--CT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c--Cc------ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 00 011112345778889999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.94 Aligned_cols=253 Identities=18% Similarity=0.289 Sum_probs=192.7
Q ss_pred HhHhCccceeEEEEEEEc-CC-cEEEEEEecccccCHHHHHHHHHHHHhhcCCCC------ccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE-EG-TTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPN------VVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~n------iv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|... ++ ..||+|+++......+.+.+|++++.++ +|++ ++.+.+++...+..++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~~~~~~lv~e 102 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNFHGHMCIAFE 102 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEETTEEEEEEE
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeeeCCeEEEEEe
Confidence 367999999999999864 34 6899999986544456788899999988 5655 8999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee-------------------
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL------------------- 473 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl------------------- 473 (632)
|+ +|++.+++.... ..++++..+..++.|++.||+|||+. +|+||||||+|||+
T Consensus 103 ~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 103 LL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp CC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred cc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccc
Confidence 99 567777766542 24588999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccCCCCCCCCC-CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHH
Q 006747 474 SQDLQGCISDFGLTPLMNTP-TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 474 ~~~~~~ki~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 552 (632)
+.++.+||+|||+++..... ....+|..|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+.
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~ 252 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH---LVMME 252 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHH
T ss_pred cCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 67899999999999865443 344688999999999999999999999999999999999999975432111 11111
Q ss_pred HHhhh--------ccccccc-cccc--------------------cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 006747 553 SVVRE--------EWTSEVF-DVEL--------------------MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVV 603 (632)
Q Consensus 553 ~~~~~--------~~~~~~~-d~~~--------------------~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl 603 (632)
..... ......+ .... ........+...+.+++.+||+.||++|||+.|++
T Consensus 253 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 332 (355)
T 2eu9_A 253 KILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL 332 (355)
T ss_dssp HHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred HHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 11000 0000000 0000 00011123345788999999999999999999998
Q ss_pred H
Q 006747 604 R 604 (632)
Q Consensus 604 ~ 604 (632)
+
T Consensus 333 ~ 333 (355)
T 2eu9_A 333 L 333 (355)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=331.35 Aligned_cols=251 Identities=20% Similarity=0.294 Sum_probs=190.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeC-----CceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK-----DEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~E 412 (632)
.+.||+|+||.||+|... ++..||||++..... ..+.+.+|++++.++ +||||+++++++... ...++|||
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~iv~e 110 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQD 110 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccceEEEEEc
Confidence 367999999999999854 678999999975432 236788999999999 899999999999765 36899999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|++ |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 111 ~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 111 LME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred ccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 998 5999988753 388999999999999999999998 999999999999999999999999999976543
Q ss_pred C-------CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc---c
Q 006747 493 P-------TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT---S 561 (632)
Q Consensus 493 ~-------~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 561 (632)
. ....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.+....+. ...+......... .
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQEDLN 257 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCHHHHH
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCHHHHH
Confidence 2 233688899999987654 489999999999999999999999976432221 1111111000000 0
Q ss_pred cccc-------ccccc--cCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 562 EVFD-------VELMR--YENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 562 ~~~d-------~~~~~--~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...+ ..... .... ......+.+++.+||+.||++|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000 0000 0112457788999999999999999999873
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=332.92 Aligned_cols=260 Identities=20% Similarity=0.326 Sum_probs=189.1
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc------eEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE------KLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lv~E~~ 414 (632)
.+.||+|+||.||+|...++..||+|++.... +...+|++++.++ +||||+++++++..... .++||||+
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~---~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEEECCT---TSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred eEEEeeCCCeEEEEEEECCCCeEEEEEEecCc---chHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 36899999999999998877789999886432 2234689999999 89999999999976543 78999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec-CCCCeEEcccCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS-QDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~-~~~~~ki~DfGla~~~~~~ 493 (632)
+++.+....+... ....+++.....++.|++.||+|||+. +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 121 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 121 PETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp SEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred CccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 8755444332111 123588999999999999999999998 999999999999999 7999999999999765432
Q ss_pred ---CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH-------hhhccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV-------VREEWTSE 562 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~ 562 (632)
....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||.+....+. +...+... +... ...
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~~-~~~ 272 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSREQIKTM-NPN 272 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHH-CGG
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhh-Chh
Confidence 234578889999998765 489999999999999999999999976432111 11111100 0000 000
Q ss_pred cccccccc--cCCcH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCCC
Q 006747 563 VFDVELMR--YENIE-----EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRPS 612 (632)
Q Consensus 563 ~~d~~~~~--~~~~~-----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~~ 612 (632)
........ ..... ....++.+++.+||+.||++|||+.|++++ +++++..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 00000000 00001 122467788999999999999999999985 6655443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.08 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=184.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC--------------
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-------------- 405 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-------------- 405 (632)
.+.||+|+||.||+|.. .+|+.||||++.... ....+|++++.++ +||||+++++++....
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTC-CCTTBCCEEEEEEEC---------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHc-CCCCccchhheeeecCcccccccccccccc
Confidence 36799999999999985 568999999986542 2234789999999 9999999999985532
Q ss_pred ------------------------ceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCc
Q 006747 406 ------------------------EKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461 (632)
Q Consensus 406 ------------------------~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 461 (632)
..++||||++ |+|.+.+..... ....+++..+..++.|++.||+|||+. +|
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi 162 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSL---GI 162 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTT---TE
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---cC
Confidence 3789999998 487777653211 123588999999999999999999998 99
Q ss_pred eecCCCCCCeeec-CCCCeEEcccCCCCCCCCC---CCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCC
Q 006747 462 ILGNIKSSNVLLS-QDLQGCISDFGLTPLMNTP---TVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPI 536 (632)
Q Consensus 462 vHrDlk~~NILl~-~~~~~ki~DfGla~~~~~~---~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~ 536 (632)
+||||||+|||++ +++.+||+|||+++..... ....+|..|+|||.+.+.. ++.++||||+||++|||++|+.||
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 9999999999998 6899999999999865433 2345788899999988754 899999999999999999999999
Q ss_pred CCCCCCCCCChhHHHHHH----------hhhccccccccccccccCC-----cHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 006747 537 QAPGHEDVVDLPRWVQSV----------VREEWTSEVFDVELMRYEN-----IEEEMVQMLQIAMSCVAKVPDMRPTMEE 601 (632)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~d~~~~~~~~-----~~~~~~~~~~l~~~Cl~~~P~~RPs~~e 601 (632)
.+....+. +...+... ....+. +..-+.. .... .......+.+++.+||+.||++|||+.|
T Consensus 243 ~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 243 SGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYT-EVRFPTL-KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp CCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC---CCCCCC-CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCChHHH--HHHHHHHhCCCCHHHHHHhCcccc-cccCCcc-CcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 76432111 11111100 000000 0000000 0000 0112245778899999999999999999
Q ss_pred HHH
Q 006747 602 VVR 604 (632)
Q Consensus 602 vl~ 604 (632)
+++
T Consensus 319 ~l~ 321 (383)
T 3eb0_A 319 AMA 321 (383)
T ss_dssp HHT
T ss_pred Hhc
Confidence 985
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=321.43 Aligned_cols=260 Identities=20% Similarity=0.329 Sum_probs=193.3
Q ss_pred HhHhCccceeEEEEEEE--cCCcEEEEEEecccccC---HHHHHHHHHHHHhhc--CCCCccceeEEEE-----eCCceE
Q 006747 341 AEVLGKGSYGTTYKAIL--EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLS--QHPNVVPIRAYYF-----SKDEKL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--~h~niv~l~~~~~-----~~~~~~ 408 (632)
.+.||+|+||.||+|.. .+++.||+|+++..... ...+.+|++++..+. +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 35799999999999997 46889999999754321 235667777776654 7999999999987 455789
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
+||||++ |+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 96 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred EEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 9999998 69999987643 23488999999999999999999998 99999999999999999999999999998
Q ss_pred CCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh----hhcccc
Q 006747 489 LMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV----REEWTS 561 (632)
Q Consensus 489 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~ 561 (632)
..... ....++..|+|||.+.+..++.++|||||||++|||+||+.||.+....+ ....+.... .+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGGGSCT
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCcccCcc
Confidence 76532 23457889999999999999999999999999999999999997543111 111111100 001110
Q ss_pred cccccc--cc------ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhC
Q 006747 562 EVFDVE--LM------RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIR 610 (632)
Q Consensus 562 ~~~d~~--~~------~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~ 610 (632)
....+. .. ...........+.+++.+||+.||++|||+.|++++ ++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 000000 00 000001122356788889999999999999999963 55443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=323.33 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=187.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCce------EEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEK------LLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~------~lv 410 (632)
.+.||+|+||.||+|... +|+.||||++...... .+.+.+|++++.++ +||||+++++++...+.. ++|
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv 125 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLV 125 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcccceeEEEE
Confidence 357999999999999854 5899999999765333 35688999999999 899999999999877654 999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
|||+. |+|.+++.. .+++..+..++.+++.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 126 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 126 MPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp EECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred Ecccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99998 588888742 388999999999999999999998 9999999999999999999999999999876
Q ss_pred CCC-CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc------cccc
Q 006747 491 NTP-TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE------WTSE 562 (632)
Q Consensus 491 ~~~-~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 562 (632)
... ....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+ ......... ....
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~~~~~~~~~ 268 (371)
T 4exu_A 195 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD------QLTQILKVTGVPGTEFVQK 268 (371)
T ss_dssp -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCCCHHHHTT
T ss_pred ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHHHhCCCcHHHHHH
Confidence 543 33467899999999987 678999999999999999999999997543111 111111000 0000
Q ss_pred ccc-------cccc--ccCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 563 VFD-------VELM--RYENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 563 ~~d-------~~~~--~~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
+.+ ..+. ..... ......+.+++.+||+.||++|||+.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 0000 00000 0113457788999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=314.64 Aligned_cols=241 Identities=20% Similarity=0.334 Sum_probs=185.1
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe-------------CCc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS-------------KDE 406 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-------------~~~ 406 (632)
.+.||+|+||.||+|.. .+++.||||++.......+.+.+|++++.++ +||||+++++++.+ .+.
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAVKKKST 89 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC------CEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhcccccCCc
Confidence 36799999999999996 4689999999976544456789999999999 89999999999865 346
Q ss_pred eEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCC
Q 006747 407 KLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGL 486 (632)
Q Consensus 407 ~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGl 486 (632)
.++||||+++|+|.+++.... ..+++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 90 LFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp EEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 799999999999999997532 3578889999999999999999998 999999999999999999999999999
Q ss_pred CCCCCCC------------------CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCCh
Q 006747 487 TPLMNTP------------------TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDL 547 (632)
Q Consensus 487 a~~~~~~------------------~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~ 547 (632)
++..... ....++..|+|||.+.+. .++.++|||||||++|||++ ||... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-----~~~ 234 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-----MER 234 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc-----hhH
Confidence 9876421 123477889999999865 68999999999999999998 54321 011
Q ss_pred hHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...... +..... .+.+. ........+.+++.+||+.||++|||+.+++++
T Consensus 235 ~~~~~~-~~~~~~--~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILKK-LRSVSI--EFPPD-----FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHH-HHSTTC--CCCTT-----CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHh-cccccc--ccCcc-----ccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111111 111100 00000 111223456788899999999999999999873
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.77 Aligned_cols=258 Identities=23% Similarity=0.320 Sum_probs=186.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC------ceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD------EKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~E~ 413 (632)
.+.||+|+||.||+|... +|+.||||++.... +...+|++++.++ +|||||+++++|.... ..++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 367999999999999975 58999999986532 2344789999999 8999999999986532 25799999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeEEcccCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGCISDFGLTPLMNT 492 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~~~~ 492 (632)
+++ ++.+.+..... ....+++..+..++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+++....
T Consensus 135 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 135 VPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 986 66655542211 224589999999999999999999998 99999999999999965 6789999999986543
Q ss_pred C---CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH-------hhhcccc
Q 006747 493 P---TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV-------VREEWTS 561 (632)
Q Consensus 493 ~---~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 561 (632)
. ....+|..|+|||++.+. .++.++|||||||++|||++|+.||.+....+ .+...+... +.... .
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~~~-~ 286 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMN-P 286 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHHHC-S
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhC-h
Confidence 2 234578899999999765 68999999999999999999999997643211 111111110 00000 0
Q ss_pred cccccccccc--CCc-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhhC
Q 006747 562 EVFDVELMRY--ENI-----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDIR 610 (632)
Q Consensus 562 ~~~d~~~~~~--~~~-----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i~ 610 (632)
...+..+... ... .....++.+|+.+||+.||++|||+.|+++ .++++.
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 0000000000 000 011245778899999999999999999986 345553
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.31 Aligned_cols=239 Identities=18% Similarity=0.296 Sum_probs=187.4
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccC---HHHHHHHHHHHHhhcC-CCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQ-HPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||.||++...+++.||||++...... .+.+.+|++++.++.+ |+||+++++++...+..++||| +.++
T Consensus 34 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~ 112 (313)
T 3cek_A 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI 112 (313)
T ss_dssp EEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred EEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCC
Confidence 579999999999999888999999999754333 3568899999999943 6999999999999999999999 5678
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++.... .+++..+..++.+++.||+|||+. +|+||||||+||++++ +.+||+|||+++......
T Consensus 113 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 113 DLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp EHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 9999997642 578899999999999999999998 9999999999999964 899999999998764432
Q ss_pred ---CCCCCCcccCCccccC-----------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 495 ---VPSRSAGYRAPEVIET-----------KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~-----------~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ..............
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~ 258 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHE 258 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTSC
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHhcccc
Confidence 2347889999999876 4688899999999999999999999964321 11112222111111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. . .... ...+.+++.+||+.||++|||+.|++++
T Consensus 259 ~~-----~--~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 259 IE-----F--PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp CC-----C--CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cC-----C--cccc---hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 00 0 0111 2356788889999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=319.40 Aligned_cols=241 Identities=24% Similarity=0.361 Sum_probs=186.9
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc---------CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEE
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM---------GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 410 (632)
.+.||+|+||.||+|... +++.||||++..... ....+.+|++++.++ +||||+++++++...+ .++|
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~lv 92 (322)
T 2ycf_A 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIV 92 (322)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESSS-EEEE
T ss_pred eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCCc-eEEE
Confidence 467999999999999864 578999999865321 123588999999999 9999999999987654 8999
Q ss_pred EecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC---eEEcccCCC
Q 006747 411 YDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ---GCISDFGLT 487 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~---~ki~DfGla 487 (632)
|||+++|+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||++.++. +||+|||++
T Consensus 93 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 93 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp EECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred EecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 9999999999998754 3588999999999999999999998 9999999999999987654 999999999
Q ss_pred CCCCCCC---CCCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc
Q 006747 488 PLMNTPT---VPSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTS 561 (632)
Q Consensus 488 ~~~~~~~---~~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 561 (632)
+...... ...+|..|+|||.+. ...++.++|||||||++|||++|+.||....... .+...+ ..+...
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----~~~~~~ 238 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----TSGKYN 238 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----HHTCCC
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----HhCccc
Confidence 8765432 124788999999974 5668999999999999999999999997543221 121111 111100
Q ss_pred ccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 562 EVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 562 ~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..+.. .. .....+.+++.+||+.||++|||+.++++
T Consensus 239 --~~~~~--~~---~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 239 --FIPEV--WA---EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --CCHHH--HT---TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cCchh--hh---hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 00 11245778889999999999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=311.55 Aligned_cols=243 Identities=19% Similarity=0.292 Sum_probs=189.5
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCCCccceeEEEE--eCCceEEEEec
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV-----MGKREFEQQMEVVGRLSQHPNVVPIRAYYF--SKDEKLLVYDF 413 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~--~~~~~~lv~E~ 413 (632)
+.||+|+||.||++.. .+++.||+|+++... .....+.+|++++.++ +||||+++++++. +....++||||
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 5799999999999996 458899999997542 2346789999999999 8999999999985 34578999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+++| |.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 90 CVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp CSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred ccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9986 777766432 24588999999999999999999998 9999999999999999999999999999765432
Q ss_pred ------CCCCCCCcccCCccccCCC--CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 494 ------TVPSRSAGYRAPEVIETKK--PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 494 ------~~~~~t~~y~aPE~~~~~~--~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
....++..|+|||.+.+.. ++.++|||||||++|||++|+.||.... ......... .....
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~-~~~~~---- 231 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIG-KGSYA---- 231 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHH-HCCCC----
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHh-cCCCC----
Confidence 2335788999999997654 3789999999999999999999997532 111111111 11100
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhC
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIR 610 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~ 610 (632)
.... ....+.+++.+||+.||++|||+.|++++ +++..
T Consensus 232 ----~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 232 ----IPGD---CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp ----CCSS---SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred ----CCCc---cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 0011 12356788889999999999999999974 55443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=324.99 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=188.4
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCc------eEEEE
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE------KLLVY 411 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~------~~lv~ 411 (632)
+.||+|+||.||+|... +|+.||||++...... .+.+.+|+.++.++ +||||+++++++...+. .++||
T Consensus 30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccceeEEEEe
Confidence 57999999999999864 5899999999765333 35688999999999 89999999999987654 49999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||++ |+|.+++.. .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 109 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 109 PFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp ECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 9998 588877742 388999999999999999999998 99999999999999999999999999998765
Q ss_pred CC-CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh---hcccccccc-
Q 006747 492 TP-TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR---EEWTSEVFD- 565 (632)
Q Consensus 492 ~~-~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d- 565 (632)
.. ....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+. ...+..... ..+...+.+
T Consensus 178 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHHTTCSCH
T ss_pred CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHHHHhhH
Confidence 43 23357889999999887 6789999999999999999999999975431110 100000000 000000000
Q ss_pred -----------ccccc-cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhh
Q 006747 566 -----------VELMR-YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDI 609 (632)
Q Consensus 566 -----------~~~~~-~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i 609 (632)
..... ..........+.+++.+||+.||++|||+.|++++ ++.+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00000 00011223457788899999999999999999874 4444
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=319.25 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=170.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||.||+|... +|+.||||+++.... ....+..|+..+.+..+||||+++++++...+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 367999999999999974 689999999976432 2345566666444434999999999999999999999999985
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++..........+++..+..++.+++.||.|||+.. +|+||||||+||+++.++.+||+|||+++......
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 183 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT 183 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecccccccc
Confidence 8877765321112345889999999999999999999853 89999999999999999999999999998765432
Q ss_pred CCCCCCcccCCccc----cCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 495 VPSRSAGYRAPEVI----ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 495 ~~~~t~~y~aPE~~----~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
...+|..|+|||.+ .+..++.++|||||||++|||++|+.||........ ...... .... +.+..
T Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~-~~~~-----~~~~~ 252 (327)
T 3aln_A 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVV-KGDP-----PQLSN 252 (327)
T ss_dssp ----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC-CSCC-----CCCCC
T ss_pred cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHh-cCCC-----CCCCC
Confidence 23578889999998 456689999999999999999999999975321100 000000 0000 00000
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.........+.+++.+||+.||++|||+.|+++
T Consensus 253 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 253 -SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000112235778889999999999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=317.51 Aligned_cols=257 Identities=17% Similarity=0.268 Sum_probs=191.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeC-----CceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK-----DEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~E 412 (632)
.+.||+|+||.||+|... +|+.||||++..... ....+.+|++++.++ +||||+++++++... ...++|||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e 94 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFNEVYIIQE 94 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCCCEEEEEC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccceEEEEEe
Confidence 357999999999999965 588999999964322 235678999999999 899999999998764 57899999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+. |+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 95 LMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 997 5999988753 488999999999999999999998 999999999999999999999999999976542
Q ss_pred C--------------CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh
Q 006747 493 P--------------TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE 557 (632)
Q Consensus 493 ~--------------~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 557 (632)
. ....+|..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....+ ....+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~ 241 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGIIGT 241 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCC
Confidence 2 11246888999998765 678999999999999999999999997543111 00001110000
Q ss_pred cc----ccccccc-------cccc--cCCc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhhCC
Q 006747 558 EW----TSEVFDV-------ELMR--YENI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDIRP 611 (632)
Q Consensus 558 ~~----~~~~~d~-------~~~~--~~~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i~~ 611 (632)
.. ....... .+.. .... ......+.+++.+||+.||++|||+.|+++ .++.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 00 0000000 0000 0000 012245678899999999999999999987 3555433
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=307.12 Aligned_cols=245 Identities=22% Similarity=0.325 Sum_probs=194.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||+|... +++.||+|++.... .....+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (287)
T 2wei_A 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSSFYIVGELYTG 105 (287)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCeEEEEEEccCC
Confidence 467999999999999975 68999999997543 3467899999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC---CCeEEcccCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD---LQGCISDFGLTPLMNTP 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~---~~~ki~DfGla~~~~~~ 493 (632)
++|.+++.... .+++..+..++.+++.||+|||+. +|+||||||+||+++.+ +.+||+|||+++.....
T Consensus 106 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 106 GELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999886542 488999999999999999999998 99999999999999754 47999999999876543
Q ss_pred CCC---CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 TVP---SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 ~~~---~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
... .++..|+|||.+.+. ++.++||||||+++|||++|+.||..... .............. ....
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~-----~~~~ 245 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVETGKYAF-----DLPQ 245 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCC-----CSGG
T ss_pred CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCCC-----Cchh
Confidence 322 357779999998764 89999999999999999999999975321 11111111111100 0001
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhh
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDI 609 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i 609 (632)
.... ...+.+++.+||+.||++|||+.|+++ .+++.
T Consensus 246 ~~~~---~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 246 WRTI---SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp GTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred hhhc---CHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 1111 235678888999999999999999998 44443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=318.67 Aligned_cols=248 Identities=20% Similarity=0.304 Sum_probs=181.5
Q ss_pred HhHhCccceeEEEEEEEcC-CcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEE--------------eC
Q 006747 341 AEVLGKGSYGTTYKAILEE-GTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYF--------------SK 404 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~--------------~~ 404 (632)
.+.||+|+||.||+|.... ++.||+|++.... ...+.+.+|++++.++ +||||+++++++. ..
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~~~~~~ 94 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTEL 94 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC----CCSC
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccccccccc
Confidence 3579999999999999764 8999999987543 2246788999999999 8999999999874 34
Q ss_pred CceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec-CCCCeEEcc
Q 006747 405 DEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS-QDLQGCISD 483 (632)
Q Consensus 405 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~-~~~~~ki~D 483 (632)
...++||||++ |+|.+++... ++++.....++.|++.||+|||+. +|+||||||+||+++ +++.+||+|
T Consensus 95 ~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 95 NSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp SEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred CceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence 57899999998 6999998642 478899999999999999999998 999999999999997 567999999
Q ss_pred cCCCCCCCCC-------CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh
Q 006747 484 FGLTPLMNTP-------TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV 555 (632)
Q Consensus 484 fGla~~~~~~-------~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 555 (632)
||+++..... ....++..|+|||.+.+ ..++.++|||||||++|||+||+.||......+ ......
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~~~ 238 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE------QMQLIL 238 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH------HHHHHH
Confidence 9999876432 12235778999998865 678999999999999999999999997543111 111111
Q ss_pred hhcc-------------ccccccccccccC-Cc----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 556 REEW-------------TSEVFDVELMRYE-NI----EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 556 ~~~~-------------~~~~~d~~~~~~~-~~----~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.... ............. .. ......+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000 0000000000000 00 0112457788999999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=328.93 Aligned_cols=238 Identities=20% Similarity=0.340 Sum_probs=179.1
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhh
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSA 421 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~ 421 (632)
++||+|+||+||.....+++.||||++..... ..+.+|++++.++.+|||||++++++.+....++||||+. |+|.+
T Consensus 30 ~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~ 106 (432)
T 3p23_A 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQE 106 (432)
T ss_dssp EEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHH
T ss_pred CeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHH
Confidence 57999999997666666799999999965422 2356789999988789999999999999999999999997 59999
Q ss_pred hhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-----CCCeEEcccCCCCCCCCC---
Q 006747 422 LLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-----DLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 422 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-----~~~~ki~DfGla~~~~~~--- 493 (632)
++..... ...+.....++.|++.||+|||+. +|+||||||+|||++. ...+||+|||+++.....
T Consensus 107 ~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 107 YVEQKDF----AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp HHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred HHHhcCC----CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 9976532 233345578999999999999998 9999999999999943 346889999999876432
Q ss_pred ----CCCCCCCcccCCcccc---CCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIE---TKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~---~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
....+|++|+|||++. ...++.++|||||||++|||+| |+.||..... ....... .......
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------~~~~~~~-~~~~~~~-- 249 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------RQANILL-GACSLDC-- 249 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------HHHHHHT-TCCCCTT--
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------HHHHHHh-ccCCccc--
Confidence 2235899999999997 4567889999999999999999 8999854221 1111111 1111000
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..........+.+++.+||+.||++|||+.||++
T Consensus 250 -----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 -----LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -----SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0111123344678899999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.84 Aligned_cols=242 Identities=19% Similarity=0.298 Sum_probs=170.0
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccC--HHHHHHHH-HHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG--KREFEQQM-EVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~-~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
.+.||+|+||.||+|... +|+.||||++...... ...+..|. .++..+ +||||+++++++...+..++||||+ +
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv~e~~-~ 107 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIAMELM-G 107 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEEECCC-S
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEEEecc-C
Confidence 467999999999999975 6899999999765322 22333333 455566 9999999999999999999999999 4
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC---
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~--- 493 (632)
+.+..+.... ..++++..+..++.+++.||+|||+.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 108 ~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (318)
T 2dyl_A 108 TCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181 (318)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred CcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence 5555555432 135889999999999999999999832 8999999999999999999999999999765433
Q ss_pred CCCCCCCcccCCcccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 494 TVPSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~-----~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
....++..|+|||.+. ...++.++|||||||++|||++|+.||..... .............. ..
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~------~~ 250 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQEEPP------LL 250 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHSCCC------CC
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhccCCC------CC
Confidence 2235788999999994 45688999999999999999999999964221 11222222222111 00
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
...... ...+.+++.+||+.||++|||+.++++
T Consensus 251 ~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 PGHMGF---SGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CSSSCC---CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccCCC---CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011111 235677888999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=317.26 Aligned_cols=233 Identities=20% Similarity=0.366 Sum_probs=189.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-------CHHHHHHHHHHHHhhc-CCCCccceeEEEEeCCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-------GKREFEQQMEVVGRLS-QHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.||+|+||.||+|.. .+++.||||+++.... ....+..|++++.++. .|+||+++++++...+..++|+
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 36799999999999985 5688999999976532 1245778999999995 3699999999999999999999
Q ss_pred ecccC-CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec-CCCCeEEcccCCCCC
Q 006747 412 DFIEA-GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS-QDLQGCISDFGLTPL 489 (632)
Q Consensus 412 E~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~-~~~~~ki~DfGla~~ 489 (632)
||+.+ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+++.
T Consensus 128 e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~ 199 (320)
T 3a99_A 128 ERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 199 (320)
T ss_dssp ECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence 99986 89999987542 488899999999999999999998 999999999999999 789999999999977
Q ss_pred CCCCC--CCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 490 MNTPT--VPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 490 ~~~~~--~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
..... ...+|..|+|||.+.+..+ +.++|||||||++|||+||+.||.... ....... .+
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~~~~~---~~-- 262 (320)
T 3a99_A 200 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV---FF-- 262 (320)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC---CC--
T ss_pred cccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhhcccc---cc--
Confidence 65432 3358889999999987765 678999999999999999999996321 0011100 00
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.... ...+.+++.+||+.||++|||+.|++++
T Consensus 263 ----~~~~---~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 ----RQRV---SSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----SSCC---CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----cccC---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 2356788889999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=313.14 Aligned_cols=233 Identities=21% Similarity=0.337 Sum_probs=183.8
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC-------HHHHHHHHHHHHhhc---CCCCccceeEEEEeCCceEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG-------KREFEQQMEVVGRLS---QHPNVVPIRAYYFSKDEKLL 409 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~---~h~niv~l~~~~~~~~~~~l 409 (632)
.+.||+|+||.||+|.. .+++.||||++...... ...+.+|++++.++. +|+||+++++++...+..++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~ 115 (312)
T 2iwi_A 36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML 115 (312)
T ss_dssp EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence 36799999999999985 46889999999754321 223567888888874 69999999999999999999
Q ss_pred EEec-ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec-CCCCeEEcccCCC
Q 006747 410 VYDF-IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS-QDLQGCISDFGLT 487 (632)
Q Consensus 410 v~E~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~-~~~~~ki~DfGla 487 (632)
|+|| +.+++|.+++.... ++++..+..++.+++.||+|||+. +|+||||||+||+++ +++.+||+|||++
T Consensus 116 v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 116 VLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp EEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred EEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 9999 78999999997642 488999999999999999999998 999999999999999 8899999999999
Q ss_pred CCCCCC--CCCCCCCcccCCccccCCCCC-ccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 488 PLMNTP--TVPSRSAGYRAPEVIETKKPT-QKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 488 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~-~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
+..... ....++..|+|||.+.+..+. .++|||||||++|||++|+.||.... .......
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------------~~~~~~~----- 250 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------------EILEAEL----- 250 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHTCC-----
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------------HHhhhcc-----
Confidence 776543 233578899999999877664 58999999999999999999996310 0011100
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..... ....+.+++.+||+.||++|||+.|++++
T Consensus 251 ----~~~~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 ----HFPAH---VSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----CCCTT---SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----CCccc---CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011 12356788889999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-36 Score=303.14 Aligned_cols=227 Identities=13% Similarity=0.124 Sum_probs=176.3
Q ss_pred hHhCccceeEEEEEEEcC-CcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||+|.... ++.||||++...... .+.+.+|++.+.++ +||||+++++++...+..|+||||+++
T Consensus 37 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcEEEEEEecCC
Confidence 579999999999999754 899999999865432 26789999999999 999999999999999999999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVP 496 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 496 (632)
++|.+++... .......+++.|++.||+|||+. +|+||||||+|||+++++.+||+++|
T Consensus 116 ~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 116 GSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred CCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 9999999542 23456788999999999999998 99999999999999999999998553
Q ss_pred CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHH
Q 006747 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEE 576 (632)
Q Consensus 497 ~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 576 (632)
|++| ++.++|||||||++|||+||+.||.+....+..... ............. ....
T Consensus 175 -----~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~--- 231 (286)
T 3uqc_A 175 -----TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIEPAD-IDRD--- 231 (286)
T ss_dssp -----CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------CBCTTSCBCCHHH-HCTT---
T ss_pred -----ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------HHHhccCCCChhh-cccC---
Confidence 4443 688999999999999999999999865432211000 0000000000000 0011
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCCC
Q 006747 577 EMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614 (632)
Q Consensus 577 ~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~~ 614 (632)
....+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 232 ~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 232 IPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 12346788889999999999 99999999999876543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=341.02 Aligned_cols=232 Identities=18% Similarity=0.271 Sum_probs=187.0
Q ss_pred HhHhCccceeEEEEEEEc--CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCc-----eEEEE
Q 006747 341 AEVLGKGSYGTTYKAILE--EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE-----KLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~-----~~lv~ 411 (632)
.+.||+|+||.||+|... +++.||||++..... ....+.+|++++.++ +||||+++++++...+. .|+||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~~~~lv~ 163 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDPVGYIVM 163 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCceeEEEE
Confidence 357999999999999975 589999999865422 235688999999999 89999999999998765 69999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++++|.+++.. +++|..+..++.|++.||+|||+. +|+||||||+|||++++ .+||+|||+++...
T Consensus 164 E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 164 EYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp ECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 99999999887653 489999999999999999999998 99999999999999986 99999999998887
Q ss_pred CCCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 492 TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 492 ~~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
......+|++|+|||++.+.. +.++|||||||++|||++|..||.+....... ..
T Consensus 233 ~~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------------~~ 287 (681)
T 2pzi_A 233 SFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------------ED 287 (681)
T ss_dssp CCSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------------TT
T ss_pred cCCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc------------------------cc
Confidence 766677999999999987654 88999999999999999999887642211100 00
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHhhh
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPT-MEEVVRMIEDI 609 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs-~~evl~~L~~i 609 (632)
.........+.+++.+||+.||++||+ ++++...|..+
T Consensus 288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 001112245778899999999999995 56666666544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.67 Aligned_cols=225 Identities=18% Similarity=0.256 Sum_probs=174.3
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe----CCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS----KDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~E~~~~ 416 (632)
+.||+|+||.||++.. .+++.||+|+++. ...+.+|++++.++.+||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 5699999999999986 4689999999964 35678888888666699999999999987 6678999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---CCCeEEcccCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~~ 493 (632)
|+|.+++.... ..++++..+..++.+++.||+|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 100 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 100 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp CBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 99999998653 24589999999999999999999998 9999999999999998 7899999999986433
Q ss_pred CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc-C
Q 006747 494 TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY-E 572 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~ 572 (632)
+..++.++|||||||++|||+||+.||......... ............... .
T Consensus 172 ----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-----------~~~~~~~~~~~~~~~~~ 224 (299)
T 3m2w_A 172 ----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKTRIRMGQYEFPNP 224 (299)
T ss_dssp ----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTTCCSSCHH
T ss_pred ----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------HHHHHHHhhccccCCch
Confidence 244678999999999999999999999754321110 000000000000000 0
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
........+.+++.+||+.||++|||+.|++++
T Consensus 225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 001123457788899999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=332.64 Aligned_cols=262 Identities=21% Similarity=0.288 Sum_probs=195.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEe------CCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFS------KDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~------~~~~~lv~ 411 (632)
.+.||+|+||.||+|.. .+|+.||||+++.... ..+.+.+|++++.++ +||||+++++++.. .+..++||
T Consensus 19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~~~LVm 97 (676)
T 3qa8_A 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDLPLLAM 97 (676)
T ss_dssp CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSSCCCEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCeEEEEE
Confidence 46799999999999986 4589999999875422 245688999999999 89999999998765 56789999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC---eEEcccCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ---GCISDFGLTP 488 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~---~ki~DfGla~ 488 (632)
||+++|+|.+++..... ...+++..+..++.+++.||+|||+. +|+||||||+||+++.++. +||+|||+++
T Consensus 98 Ey~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 98 EYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp ECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 99999999999986532 23578888999999999999999998 9999999999999997765 9999999998
Q ss_pred CCCCCC---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc----ccc
Q 006747 489 LMNTPT---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE----WTS 561 (632)
Q Consensus 489 ~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~ 561 (632)
...... ...+|..|+|||.+.+..++.++|||||||++|||++|+.||..... ...|........ ...
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------CCSC
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchhhhhh
Confidence 765432 33588899999999999999999999999999999999999965310 001100000000 000
Q ss_pred c------ccccccccc-CCcHHHHHHHHHHHHHccCCCCCCCCCHHH-----HHHHHhhhCCCC
Q 006747 562 E------VFDVELMRY-ENIEEEMVQMLQIAMSCVAKVPDMRPTMEE-----VVRMIEDIRPSD 613 (632)
Q Consensus 562 ~------~~d~~~~~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~e-----vl~~L~~i~~~~ 613 (632)
+ .+....... .........+.+++.+||+.||++|||+.+ ..+.++.+....
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 0 000010001 111223456788899999999999999988 556666665443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=314.27 Aligned_cols=235 Identities=13% Similarity=0.129 Sum_probs=171.9
Q ss_pred hHhCccceeEEEEEE-EcCCcEEEEEEecccc----cCHHHHHHHHHHHHhhcCC-CCccce---------e--------
Q 006747 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVV----MGKREFEQQMEVVGRLSQH-PNVVPI---------R-------- 398 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~h-~niv~l---------~-------- 398 (632)
+.||+|+||.||+|. ..+|+.||||+++... ...+.+.+|+.++..+ +| +|.... .
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchhhcccCCC
Confidence 579999999999999 4568999999987432 2246788999998888 55 322111 1
Q ss_pred ----EEEEe-----CCceEEEEecccCCCHhhhhccCC--CCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCC
Q 006747 399 ----AYYFS-----KDEKLLVYDFIEAGSFSALLHGNR--GIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIK 467 (632)
Q Consensus 399 ----~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk 467 (632)
.++.. ....+++|+++ +|+|.+++.... .....+++|..++.++.|++.||+|||+. +|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcc
Confidence 11111 12356777765 579999884210 01234688899999999999999999998 99999999
Q ss_pred CCCeeecCCCCeEEcccCCCCCCCCC-CCCCCCCcccCCccc----------cCCCCCccchhhHHHHHHHHHHhCCCCC
Q 006747 468 SSNVLLSQDLQGCISDFGLTPLMNTP-TVPSRSAGYRAPEVI----------ETKKPTQKSDVYSFGVLLLEMLTGKAPI 536 (632)
Q Consensus 468 ~~NILl~~~~~~ki~DfGla~~~~~~-~~~~~t~~y~aPE~~----------~~~~~~~~~DV~s~Gvvl~elltg~~p~ 536 (632)
|+|||++.++.+||+|||+++..... ....+ +.|+|||++ .+..++.++|||||||++|||+||+.||
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf 317 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCC
T ss_pred cceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999998776543 23356 899999999 5556889999999999999999999999
Q ss_pred CCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 537 QAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
......+... .++. .....+ ..+.+++.+||+.||++|||+.++++
T Consensus 318 ~~~~~~~~~~---------------~~~~----~~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 318 TDDAALGGSE---------------WIFR----SCKNIP---QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CTTGGGSCSG---------------GGGS----SCCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCcchhhhHH---------------HHHh----hcccCC---HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 7543221110 0111 111122 35778888999999999999766643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=305.01 Aligned_cols=237 Identities=14% Similarity=0.166 Sum_probs=179.0
Q ss_pred HHhHhCccceeEEEEEEEcCCcEEEEEEeccccc---------CHHHHHHHHHHHHhhc--------CCCCccceeEEEE
Q 006747 340 SAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM---------GKREFEQQMEVVGRLS--------QHPNVVPIRAYYF 402 (632)
Q Consensus 340 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~--------~h~niv~l~~~~~ 402 (632)
..+.||+|+||.||+|+. +|+.||||+++.... ..+.+.+|++++.++. +|||||++.+.+.
T Consensus 24 ~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~ 102 (336)
T 2vuw_A 24 RCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHC 102 (336)
T ss_dssp TCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEE
T ss_pred heeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeE
Confidence 457899999999999988 689999999975421 2377999999999884 3777777777643
Q ss_pred ------------------------------eCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHH
Q 006747 403 ------------------------------SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452 (632)
Q Consensus 403 ------------------------------~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~ 452 (632)
..+..++||||+++|++.+.+.. ..+++.....++.|++.||+|
T Consensus 103 ~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHHHH
Confidence 16789999999999977766643 247889999999999999999
Q ss_pred HH-hccCCCceecCCCCCCeeecCCC--------------------CeEEcccCCCCCCCCCCCCCCCCcccCCccccCC
Q 006747 453 IH-AAVGGKFILGNIKSSNVLLSQDL--------------------QGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETK 511 (632)
Q Consensus 453 LH-~~~~~~ivHrDlk~~NILl~~~~--------------------~~ki~DfGla~~~~~~~~~~~t~~y~aPE~~~~~ 511 (632)
|| +. +|+||||||+|||++.++ .+||+|||+|+..... ...+|+.|+|||++.+.
T Consensus 177 lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 177 AEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCCC
T ss_pred HHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcCC
Confidence 99 88 999999999999999887 9999999999876543 34688999999999877
Q ss_pred CCCccchhhHHHHH-HHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccC
Q 006747 512 KPTQKSDVYSFGVL-LLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVA 590 (632)
Q Consensus 512 ~~~~~~DV~s~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~ 590 (632)
. +.++||||+|++ .+++++|..||.. ..|................. ...........++.+|+.+||+
T Consensus 253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~~L~ 321 (336)
T 2vuw_A 253 G-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTFKTK-CNTPAMKQIKRKIQEFHRTMLN 321 (336)
T ss_dssp S-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCCSSC-CCSHHHHHHHHHHHHHHHHGGG
T ss_pred C-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhccCcc-cchhhhhhcCHHHHHHHHHHhc
Confidence 6 899999998877 7778889999842 11211111110000000000 0011123345678899999999
Q ss_pred CCCCCCCCHHHHH
Q 006747 591 KVPDMRPTMEEVV 603 (632)
Q Consensus 591 ~~P~~RPs~~evl 603 (632)
.| |++|++
T Consensus 322 ~d-----sa~e~l 329 (336)
T 2vuw_A 322 FS-----SATDLL 329 (336)
T ss_dssp SS-----SHHHHH
T ss_pred cC-----CHHHHH
Confidence 76 899988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-29 Score=279.49 Aligned_cols=180 Identities=14% Similarity=0.063 Sum_probs=127.7
Q ss_pred hCccceeEEEEEE-EcCCcEEEEEEecccc-----------cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 344 LGKGSYGTTYKAI-LEEGTTVVVKRLKEVV-----------MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 344 lg~G~fg~V~~~~-~~~~~~vavK~~~~~~-----------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.|++|.+..++ +--|+.+|+|++.... ...++|.+|+++|.++.+|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666665544 3348999999996542 123569999999999988999999999999999999999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||++||+|.+++.... +++.. +|+.|++.||+|+|++ +||||||||+|||+++++.+||+|||+|+...
T Consensus 322 Eyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp ECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred ecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999998653 35543 5889999999999999 99999999999999999999999999998775
Q ss_pred CCCC----CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCC
Q 006747 492 TPTV----PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535 (632)
Q Consensus 492 ~~~~----~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p 535 (632)
.... ..||++|||||++.+. +..++|+||+|++++++.++..+
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 4432 2478899999999764 57789999999998887665444
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-27 Score=240.05 Aligned_cols=184 Identities=33% Similarity=0.647 Sum_probs=166.6
Q ss_pred cCChhHHHHHHHHHHhCCCCCC-CCCCCCCCCCCC--CcceEecCCC--CeEEEEEeCCCCccc--ccCchhhcCCCCCc
Q 006747 21 ADLNSDKQALLDFAANVPHARK-LNWNSSTSVCTS--WVGITCTKNG--SRVLAVRLPGVGLYG--PIPANTLEKLDSLM 93 (632)
Q Consensus 21 ~~~~~~~~~l~~~~~~~~~~~~-~~w~~~~~~c~~--w~gv~c~~~~--~~v~~l~l~~~~l~g--~lp~~~l~~l~~L~ 93 (632)
.|.+.|++||++||+++.++.. .+|+.++++| . |.||+|+... ++|+.|+|+++++.| .+|. .+.++++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C-~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTT-TTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCC-cCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCC
Confidence 4778999999999999965433 4898777777 5 9999998654 799999999999999 8998 799999999
Q ss_pred EEeccC-CccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccc
Q 006747 94 ILSLRS-NHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNN 170 (632)
Q Consensus 94 ~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N 170 (632)
+|+|++ |++.+.+|..|.++++|++|+|++|++++.+|..+. ++|++|+|++|.+++.+|..++++++|+.|+|++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 999995 999999999999999999999999999999999886 79999999999999999999999999999999999
Q ss_pred cccccCCCC--CCC-CCcEEEcccCCCCCCCcccccCCC
Q 006747 171 SLTGFIPNF--NLS-RLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 171 ~l~~~~p~~--~~~-~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
++++.+|.. .++ .|+.|+|++|+++|.+|..+..+.
T Consensus 160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~ 198 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN 198 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC
T ss_pred cccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc
Confidence 999888863 666 899999999999999998887654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-26 Score=252.25 Aligned_cols=177 Identities=14% Similarity=0.195 Sum_probs=145.2
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccC---------HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMG---------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.||+|+||.||+|.. .+..+++|+....... .+.+.+|++++.++ +||||+++..++...+..++||
T Consensus 341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTEEEE
T ss_pred CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccEEEE
Confidence 56899999999999954 5788999986543211 23479999999999 9999998888888888899999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++|+|.+++.. +..++.|++.||+|||+. +|+||||||+|||+++ .+||+|||+++...
T Consensus 419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 99999999999874 357899999999999998 9999999999999999 99999999998876
Q ss_pred CCC-----------CCCCCCcccCCccccC--CCCCccchhhHHHHHHHHHHhCCCCCC
Q 006747 492 TPT-----------VPSRSAGYRAPEVIET--KKPTQKSDVYSFGVLLLEMLTGKAPIQ 537 (632)
Q Consensus 492 ~~~-----------~~~~t~~y~aPE~~~~--~~~~~~~DV~s~Gvvl~elltg~~p~~ 537 (632)
... ...+|+.|||||++.. ..|+..+|+|+..+-.++-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 531 2347889999999987 557888999999999999988887763
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=249.80 Aligned_cols=186 Identities=25% Similarity=0.359 Sum_probs=152.9
Q ss_pred hhccCChhHHHHHHHHHHhCCCC-CCCCCCCCCCCCCCCcceEecCCCCeEEEEEeCCCCcccc---cCc----------
Q 006747 18 QMIADLNSDKQALLDFAANVPHA-RKLNWNSSTSVCTSWVGITCTKNGSRVLAVRLPGVGLYGP---IPA---------- 83 (632)
Q Consensus 18 ~~~~~~~~~~~~l~~~~~~~~~~-~~~~w~~~~~~c~~w~gv~c~~~~~~v~~l~l~~~~l~g~---lp~---------- 83 (632)
+..++.++|++||++||+++.++ ...+|+.++++| +|.||+|+ .++|+.|+|+++++.|. +|+
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C-~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG-GSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc-CCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 34555778999999999998544 334998767666 89999998 58999999999999987 554
Q ss_pred ------------hhhcCCCCCcEEeccCCccCCCCCc--cccCCCCCCeEeecCCcCCccCCCCcc---CCCcEEEccCC
Q 006747 84 ------------NTLEKLDSLMILSLRSNHLSGDLPS--NVLSLSSLRFLYLQNNNFSGNIPSSLS---PQLNWVDLSFN 146 (632)
Q Consensus 84 ------------~~l~~l~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~L~Ls~N~l~g~~p~~~~---~~L~~L~Ls~N 146 (632)
..++.+++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+. ++|++|||++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 3678889999999999999999998 999999999999999999998887762 78999999999
Q ss_pred CCcccCCcc---ccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCCC
Q 006747 147 SITGNIPAS---IRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPP 207 (632)
Q Consensus 147 ~l~g~~p~~---~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 207 (632)
++++..|.. +.++++|+.|+|++|.+++.+|...+++|++|+|++|++++.+|. +.+++.
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~ 224 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSA 224 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCS
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCC
Confidence 999888877 788888888888888888777766777788888888877776665 554443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-23 Score=242.93 Aligned_cols=181 Identities=23% Similarity=0.394 Sum_probs=157.9
Q ss_pred CChhHHHHHHHHHHhCCCCCCCCCCCCC-----CC-CCCC------------cceEecCCCCeEEEEEeCCCCcccccCc
Q 006747 22 DLNSDKQALLDFAANVPHARKLNWNSST-----SV-CTSW------------VGITCTKNGSRVLAVRLPGVGLYGPIPA 83 (632)
Q Consensus 22 ~~~~~~~~l~~~~~~~~~~~~~~w~~~~-----~~-c~~w------------~gv~c~~~~~~v~~l~l~~~~l~g~lp~ 83 (632)
+...|.+||++||+++.++ +|+.++ ++ ||.| .||+|+. .+||+.|+|++++|.|.+|+
T Consensus 266 ~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECG
T ss_pred cchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCch
Confidence 3457999999999999644 897665 44 2499 9999986 58999999999999999998
Q ss_pred hhhcCCCCCcEEec-cCCccCCC---------------------------------------------------------
Q 006747 84 NTLEKLDSLMILSL-RSNHLSGD--------------------------------------------------------- 105 (632)
Q Consensus 84 ~~l~~l~~L~~L~L-s~N~l~g~--------------------------------------------------------- 105 (632)
.+++|++|+.|+| ++|.++|.
T Consensus 342 -~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 342 -AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp -GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred -HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 8999999999999 88876554
Q ss_pred -------------------CCccccCCCCCCeEeecCCcCCc-----------------cCCCCcc----CCCcEEEccC
Q 006747 106 -------------------LPSNVLSLSSLRFLYLQNNNFSG-----------------NIPSSLS----PQLNWVDLSF 145 (632)
Q Consensus 106 -------------------~p~~~~~l~~L~~L~Ls~N~l~g-----------------~~p~~~~----~~L~~L~Ls~ 145 (632)
+|..|++|++|++|+|++|+|+| .+|..+. ++|++|+|++
T Consensus 421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence 88899999999999999999998 4898875 7899999999
Q ss_pred CCCcccCCccccCCCCccceeccccc-ccc-cCCC---------CCCCCCcEEEcccCCCCCCCcc--cccCCCCC
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNS-LTG-FIPN---------FNLSRLRHLNLSYNHLNGSVPL--ALQKFPPS 208 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~-l~~-~~p~---------~~~~~L~~l~ls~N~l~g~~p~--~~~~~~~~ 208 (632)
|++.|.+|..|+++++|+.|+|++|+ |+| .+|. ..+++|+.|+|++|+|+ .+|. .+.+++..
T Consensus 501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L 575 (876)
T 4ecn_A 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKL 575 (876)
T ss_dssp CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTC
T ss_pred CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCC
Confidence 99999999999999999999999998 998 6664 14569999999999999 8998 77766654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=234.36 Aligned_cols=180 Identities=24% Similarity=0.412 Sum_probs=156.2
Q ss_pred hhHHHHHHHHHHhCCCC----------CCCCCCCCCCCCCCC---cceEecCCCCeEEEEEeCCCCcccccCchhhcCCC
Q 006747 24 NSDKQALLDFAANVPHA----------RKLNWNSSTSVCTSW---VGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLD 90 (632)
Q Consensus 24 ~~~~~~l~~~~~~~~~~----------~~~~w~~~~~~c~~w---~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~ 90 (632)
..|.+||.+++.++... ...+|+.++++| .| .||+|+.. +||+.|+|+++++.|.+|+ .+++|+
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~-~l~~L~ 105 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPD-AIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-GTTCCTTEEECTT-CCEEEEECTTSCCEEEECG-GGGGCT
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEEcCC-CCEEEEEecCcccCCcCCh-HHhcCc
Confidence 46999999999998422 123798877777 89 99999865 8999999999999999997 899999
Q ss_pred CCcEEeccCCc---------------------------------------------------------------------
Q 006747 91 SLMILSLRSNH--------------------------------------------------------------------- 101 (632)
Q Consensus 91 ~L~~L~Ls~N~--------------------------------------------------------------------- 101 (632)
+|+.|+|++|.
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 99999999994
Q ss_pred ---------cCCCCCccccCCCCCCeEeecCCcCCcc-----------------CCCCcc----CCCcEEEccCCCCccc
Q 006747 102 ---------LSGDLPSNVLSLSSLRFLYLQNNNFSGN-----------------IPSSLS----PQLNWVDLSFNSITGN 151 (632)
Q Consensus 102 ---------l~g~~p~~~~~l~~L~~L~Ls~N~l~g~-----------------~p~~~~----~~L~~L~Ls~N~l~g~ 151 (632)
|+| +|..|+++++|++|+|++|+|+|. +|..+. ++|++|+|++|++.|.
T Consensus 186 l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~ 264 (636)
T 4eco_A 186 TQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTK 264 (636)
T ss_dssp TTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSS
T ss_pred hhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCcc
Confidence 445 899999999999999999999986 898876 7899999999999999
Q ss_pred CCccccCCCCccceeccccc-ccc-cCCCC--C------CCCCcEEEcccCCCCCCCcc--cccCCCCC
Q 006747 152 IPASIRNLSHLVGLNLQNNS-LTG-FIPNF--N------LSRLRHLNLSYNHLNGSVPL--ALQKFPPS 208 (632)
Q Consensus 152 ~p~~~~~l~~L~~l~l~~N~-l~~-~~p~~--~------~~~L~~l~ls~N~l~g~~p~--~~~~~~~~ 208 (632)
+|..|+++++|+.|+|++|+ ++| .+|.. . +++|+.|+|++|+++ .+|. .+.+++..
T Consensus 265 ~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L 332 (636)
T 4eco_A 265 LPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKL 332 (636)
T ss_dssp CCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTC
T ss_pred ChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCC
Confidence 99999999999999999998 998 66652 3 389999999999999 8888 77766544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.6e-22 Score=202.83 Aligned_cols=138 Identities=17% Similarity=0.209 Sum_probs=113.0
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEeccccc-------------------CHHHHHHHHHHHHhhcCCCCccceeEEEE
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM-------------------GKREFEQQMEVVGRLSQHPNVVPIRAYYF 402 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~~h~niv~l~~~~~ 402 (632)
+.||+|+||.||+|...+|+.||+|.++.... ....+.+|++++.++ + | +++.+++.
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~-~~v~~~~~ 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G-LAVPKVYA 171 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-SSSCCEEE
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-CCcCeEEe
Confidence 68999999999999997799999999964321 134588999999999 4 5 66666554
Q ss_pred eCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEc
Q 006747 403 SKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCIS 482 (632)
Q Consensus 403 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~ 482 (632)
. +..++||||+++|+|.+ +... ....++.|++.||+|||+. +|+||||||+|||++ ++.+||+
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~~-----------~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRVE-----------NPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCCS-----------CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEEC
T ss_pred c-cceEEEEEecCCCcHHH-cchh-----------hHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEE
Confidence 4 56799999999999998 4321 1346999999999999998 999999999999999 9999999
Q ss_pred ccCCCCCCCCCCCCCCCCcccCCcccc
Q 006747 483 DFGLTPLMNTPTVPSRSAGYRAPEVIE 509 (632)
Q Consensus 483 DfGla~~~~~~~~~~~t~~y~aPE~~~ 509 (632)
|||+++.. ..|+|||++.
T Consensus 235 DFG~a~~~---------~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVEV---------GEEGWREILE 252 (282)
T ss_dssp CCTTCEET---------TSTTHHHHHH
T ss_pred ECCCCeEC---------CCCCHHHHHH
Confidence 99998643 3478999874
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-21 Score=224.82 Aligned_cols=114 Identities=39% Similarity=0.681 Sum_probs=89.5
Q ss_pred CCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEE
Q 006747 113 LSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLN 188 (632)
Q Consensus 113 l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ 188 (632)
+++|++|||++|+|+|.+|..+. ++|+.|+|++|+|+|.+|..|+++++|+.|||++|+|+|.+|.. .+++|+.||
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 45566777777777777777665 67778888888888888888888888888888888888887764 678888888
Q ss_pred cccCCCCCCCccc--ccCCCCCCccCCCCCCCCCCCCCCC
Q 006747 189 LSYNHLNGSVPLA--LQKFPPSSFEGNSMLCGPPLNQCST 226 (632)
Q Consensus 189 ls~N~l~g~~p~~--~~~~~~~~~~~n~~~c~~~~~~c~~ 226 (632)
|++|+|+|.||.. +..++..+|.||+.+||.|+..|..
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~ 750 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDP 750 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCS
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCC
Confidence 8888888888864 6677788899999999998877754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.6e-21 Score=200.13 Aligned_cols=185 Identities=18% Similarity=0.306 Sum_probs=144.9
Q ss_pred hhccCChhHHHHHHHHHHhCC-CC--CCCCCC----CCCCCCCCCcceEecC--------CCCeEEEEEeCCCCcccccC
Q 006747 18 QMIADLNSDKQALLDFAANVP-HA--RKLNWN----SSTSVCTSWVGITCTK--------NGSRVLAVRLPGVGLYGPIP 82 (632)
Q Consensus 18 ~~~~~~~~~~~~l~~~~~~~~-~~--~~~~w~----~~~~~c~~w~gv~c~~--------~~~~v~~l~l~~~~l~g~lp 82 (632)
+..++..+|.+||++||.++. +. ...+|. ...++| .|.|+.|.. ...+|+.|+|+++++. .+|
T Consensus 20 ~~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~-~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp 97 (328)
T 4fcg_A 20 QGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE-TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFP 97 (328)
T ss_dssp C--CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC-CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCC
T ss_pred eccccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc-ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcC
Confidence 345677889999999999872 22 223784 344556 899999952 3468999999999998 888
Q ss_pred chhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccC--
Q 006747 83 ANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRN-- 158 (632)
Q Consensus 83 ~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~-- 158 (632)
+ .+..+++|++|+|++|.++ .+|..++++++|++|+|++|+++ .+|..+. ++|++|+|++|++.+.+|..++.
T Consensus 98 ~-~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~ 174 (328)
T 4fcg_A 98 D-QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174 (328)
T ss_dssp S-CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC
T ss_pred h-hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhcc
Confidence 7 5777999999999999998 88988999999999999999998 7887776 68999999998888888887765
Q ss_pred -------CCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCCCC
Q 006747 159 -------LSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFPPS 208 (632)
Q Consensus 159 -------l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~~ 208 (632)
+++|+.|+|++|+++..+..+ .+++|+.|+|++|++++ +|..+..++..
T Consensus 175 ~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L 231 (328)
T 4fcg_A 175 ASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKL 231 (328)
T ss_dssp -CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTC
T ss_pred chhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCC
Confidence 888888888888888433333 67888888888888884 56566655543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.4e-19 Score=176.96 Aligned_cols=152 Identities=25% Similarity=0.265 Sum_probs=123.4
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
.+..|+|+++++.+..+ ..+.++++|++|+|++|.|++..|..|.++++|++|+|++|++++..+..+. ++|++|+|
T Consensus 36 ~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSD-ATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TCCEEECTTSCCCCCCT-TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEccCCCcCccCH-hHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 46678888888886444 4788999999999999999988888889999999999999999965555554 78999999
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccCCCCCCCcccccCCCC---CCccCCCCCCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLNGSVPLALQKFPP---SSFEGNSMLCG 218 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~~~~n~~~c~ 218 (632)
++|+|++..+..|..+++|+.|+|++|+|++.++. + .+++|+.|+|++|+|++..+..+..++. ..+.+|.+.|.
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 99999977777788999999999999999988774 3 7889999999999999776666665543 45677776654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.9e-19 Score=173.97 Aligned_cols=153 Identities=24% Similarity=0.247 Sum_probs=113.8
Q ss_pred CCCCCCCCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCC
Q 006747 44 NWNSSTSVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLS 114 (632)
Q Consensus 44 ~w~~~~~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 114 (632)
-|+..++.| +|.+|.|+++. ..+..|+|++|.+++..|. .|..+++|+.|+|++|+|++..+..|.+++
T Consensus 11 ~~~~~~~~C-s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~ 88 (229)
T 3e6j_A 11 AACPSQCSC-SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPG-VFDSLINLKELYLGSNQLGALPVGVFDSLT 88 (229)
T ss_dssp CCCCTTCEE-ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTT-TTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred ccCCCCCEE-eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHH-HhhCccCCcEEECCCCCCCCcChhhcccCC
Confidence 456667778 89999998632 2466788888888765444 677888888888888888755556677888
Q ss_pred CCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcc
Q 006747 115 SLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLS 190 (632)
Q Consensus 115 ~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls 190 (632)
+|++|+|++|+|++..+..+. ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++.. .+++|+.|+|+
T Consensus 89 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 167 (229)
T 3e6j_A 89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLF 167 (229)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEee
Confidence 888888888888855444443 67888888888887 67778888888888888888888776642 67788888888
Q ss_pred cCCCCCCCc
Q 006747 191 YNHLNGSVP 199 (632)
Q Consensus 191 ~N~l~g~~p 199 (632)
+|.+++..+
T Consensus 168 ~N~~~c~c~ 176 (229)
T 3e6j_A 168 GNPWDCECR 176 (229)
T ss_dssp TSCBCTTBG
T ss_pred CCCccCCcc
Confidence 888876544
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-18 Score=168.04 Aligned_cols=149 Identities=24% Similarity=0.322 Sum_probs=123.9
Q ss_pred CCCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeE
Q 006747 49 TSVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFL 119 (632)
Q Consensus 49 ~~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 119 (632)
.+.| .|.+|.|+..+ .+++.|+|++++++ .+++..+..+++|++|+|++|++++..+..|.++++|++|
T Consensus 4 ~C~C-~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 81 (208)
T 2o6s_A 4 RCSC-SGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL 81 (208)
T ss_dssp TCEE-ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCEE-CCCEEEecCCCccCCCCCCCCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEE
Confidence 4456 89999998643 25788999999998 5666678899999999999999997666678899999999
Q ss_pred eecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccCCCC
Q 006747 120 YLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 120 ~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l~ 195 (632)
+|++|++++..+..+. ++|++|+|++|+|++..+..|.++++|+.|+|++|++++.++. + .+++|+.|+|++|.+.
T Consensus 82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 9999999965555454 7899999999999987777789999999999999999987775 3 6889999999999887
Q ss_pred CCCc
Q 006747 196 GSVP 199 (632)
Q Consensus 196 g~~p 199 (632)
+..|
T Consensus 162 ~~~~ 165 (208)
T 2o6s_A 162 CTCP 165 (208)
T ss_dssp CCTT
T ss_pred cCCC
Confidence 7655
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.8e-19 Score=172.17 Aligned_cols=150 Identities=21% Similarity=0.200 Sum_probs=98.4
Q ss_pred CCCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeE
Q 006747 49 TSVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFL 119 (632)
Q Consensus 49 ~~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 119 (632)
.+.| .|..+.|+++. ..+..|+|++|.+++..|.+.|..+++|+.|+|++|+|++..+..|.++++|++|
T Consensus 8 ~C~C-~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 86 (220)
T 2v70_A 8 KCRC-EGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI 86 (220)
T ss_dssp TCEE-ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCEE-CCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence 3444 67777776532 1345667777777655555456677777777777777776656667777777777
Q ss_pred eecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCC
Q 006747 120 YLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 120 ~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~ 195 (632)
+|++|++++..|..|. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+|.. .+++|+.|+|++|.|+
T Consensus 87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 7777777655554443 56777777777777666677777777777777777777665542 5667777777777766
Q ss_pred CCCc
Q 006747 196 GSVP 199 (632)
Q Consensus 196 g~~p 199 (632)
+..+
T Consensus 167 c~c~ 170 (220)
T 2v70_A 167 CNCY 170 (220)
T ss_dssp CSGG
T ss_pred CCCc
Confidence 5544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.77 E-value=2.3e-19 Score=184.25 Aligned_cols=138 Identities=24% Similarity=0.403 Sum_probs=102.9
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCC-CCCeEeecCCcCCccCCCCcc-CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLS-SLRFLYLQNNNFSGNIPSSLS-PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~-~~L~~L~ 142 (632)
.++..|+|++|.+.|.+|. .+..+++|++|+|++|.++|.+|..+.+++ +|++|+|++|+++|.+|..+. ..|+.|+
T Consensus 125 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~ 203 (313)
T 1ogq_A 125 KTLVTLDFSYNALSGTLPP-SISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD 203 (313)
T ss_dssp TTCCEEECCSSEEESCCCG-GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEE
T ss_pred CCCCEEeCCCCccCCcCCh-HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEE
Confidence 3577889999999988887 788899999999999999988899999888 899999999999888887765 3477777
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCccccc
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQ 203 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~ 203 (632)
|++|++++.+|..|.++++|+.|+|++|++++.+|.+ .+++|+.|+|++|+|+|.+|..+.
T Consensus 204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 265 (313)
T 1ogq_A 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT 265 (313)
T ss_dssp CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGG
T ss_pred CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHh
Confidence 7777777777777777777777777666666655543 445555555555555555554443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.6e-18 Score=168.36 Aligned_cols=144 Identities=24% Similarity=0.343 Sum_probs=85.0
Q ss_pred CCCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeE
Q 006747 49 TSVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFL 119 (632)
Q Consensus 49 ~~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 119 (632)
.+.| .|..|.|++++ ..++.|+|++|++++ +++..|..+++|+.|+|++|+|++..|..|.++++|++|
T Consensus 8 ~C~C-~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~-i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 85 (220)
T 2v9t_B 8 ACTC-SNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL 85 (220)
T ss_dssp TSEE-ETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCE-ECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEE
T ss_pred CCEE-CCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCC-cCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEE
Confidence 3445 67778886532 135556666666653 444456666666666666666665556666666666666
Q ss_pred eecCCcCCccCCCC-cc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccCCC
Q 006747 120 YLQNNNFSGNIPSS-LS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHL 194 (632)
Q Consensus 120 ~Ls~N~l~g~~p~~-~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l 194 (632)
+|++|+|+ .+|.. |. ++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.++. + .+++|+.|+|++|.+
T Consensus 86 ~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 86 VLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp ECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred ECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 66666666 33332 22 4566666666666665566666666666666666666665554 2 455666666666655
Q ss_pred C
Q 006747 195 N 195 (632)
Q Consensus 195 ~ 195 (632)
.
T Consensus 165 ~ 165 (220)
T 2v9t_B 165 I 165 (220)
T ss_dssp E
T ss_pred C
Confidence 4
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.6e-18 Score=172.81 Aligned_cols=131 Identities=15% Similarity=0.171 Sum_probs=101.5
Q ss_pred hHhCccceeEEEEEEE-cCCcE--EEEEEecccccC-------------------------HHHHHHHHHHHHhhcCCCC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTT--VVVKRLKEVVMG-------------------------KREFEQQMEVVGRLSQHPN 393 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~~h~n 393 (632)
+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|++.+.++ +|++
T Consensus 53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 131 (258)
T 1zth_A 53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA-KEAG 131 (258)
T ss_dssp EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-HhCC
Confidence 5799999999999997 67889 999987543111 12578899999999 7776
Q ss_pred c--cceeEEEEeCCceEEEEecccC-C----CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHH-hccCCCceecC
Q 006747 394 V--VPIRAYYFSKDEKLLVYDFIEA-G----SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH-AAVGGKFILGN 465 (632)
Q Consensus 394 i--v~l~~~~~~~~~~~lv~E~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivHrD 465 (632)
+ ...+++ +..++||||+.+ | +|.++... .++.....++.+++.+|.||| +. +|+|||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 4 333332 367899999942 4 66665432 113345688999999999999 77 999999
Q ss_pred CCCCCeeecCCCCeEEcccCCCCCC
Q 006747 466 IKSSNVLLSQDLQGCISDFGLTPLM 490 (632)
Q Consensus 466 lk~~NILl~~~~~~ki~DfGla~~~ 490 (632)
|||+|||+++ .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.73 E-value=4e-18 Score=178.63 Aligned_cols=170 Identities=25% Similarity=0.292 Sum_probs=141.4
Q ss_pred CCCCCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhc-CCCCCcEEeccCCccCCCCCccccCCCCC
Q 006747 47 SSTSVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLE-KLDSLMILSLRSNHLSGDLPSNVLSLSSL 116 (632)
Q Consensus 47 ~~~~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~-~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 116 (632)
+..+.| .|..|.|.++. ..+..|+|++|.+++ +++..+. ++++|+.|+|++|+|++..|..|.++++|
T Consensus 13 p~~C~C-~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~-l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L 90 (361)
T 2xot_A 13 PANCLC-ASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNL 90 (361)
T ss_dssp CTTCEE-ETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCE-ECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred CCCCEE-CCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCc-cChhhhhhcccccCEEECCCCcCCccChhhccCCCCC
Confidence 344555 68889997632 236789999999985 5555777 99999999999999998888889999999
Q ss_pred CeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC-----CCCCCcEEEc
Q 006747 117 RFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-----NLSRLRHLNL 189 (632)
Q Consensus 117 ~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-----~~~~L~~l~l 189 (632)
++|+|++|+|++..+..|. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++.. .+++|+.|+|
T Consensus 91 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L 170 (361)
T 2xot_A 91 RYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDL 170 (361)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEEC
T ss_pred CEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEEC
Confidence 9999999999976666665 79999999999999988999999999999999999999876652 5899999999
Q ss_pred ccCCCCCCCcccccCCC-----CCCccCCCCCCC
Q 006747 190 SYNHLNGSVPLALQKFP-----PSSFEGNSMLCG 218 (632)
Q Consensus 190 s~N~l~g~~p~~~~~~~-----~~~~~~n~~~c~ 218 (632)
++|+|++..+..+..++ ...+.+|++.|.
T Consensus 171 ~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 171 SSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred CCCCCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence 99999965555666654 356788888775
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-17 Score=165.42 Aligned_cols=137 Identities=23% Similarity=0.292 Sum_probs=73.0
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEcc
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLS 144 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls 144 (632)
+..|+|+++.++ .+++..|.++++|++|+|++|.++...+..|.++++|++|+|++|++++..+..+. ++|++|+|+
T Consensus 39 l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp CSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 344555555554 23333455566666666666666543333445566666666666665533333332 456666666
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccCCCCCCCcccccC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLNGSVPLALQK 204 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~ 204 (632)
+|++++..|..|+++++|+.|+|++|++++.++. + .+++|+.|+|++|++++..+..+.+
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 179 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDK 179 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTT
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhcc
Confidence 6666555555555666666666666666555443 2 4555666666666655443333433
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=4.8e-18 Score=161.35 Aligned_cols=128 Identities=27% Similarity=0.316 Sum_probs=111.3
Q ss_pred EEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCc-cccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccC
Q 006747 69 AVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPS-NVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSF 145 (632)
Q Consensus 69 ~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~ 145 (632)
.++++++++. .+|.. +. .+|+.|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|. ++|++|+|++
T Consensus 12 ~l~~s~~~l~-~ip~~-~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRD-IP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp EEECTTSCCS-SCCSC-CC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred EEEcCCCCcC-cCccC-CC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 4556667774 78873 32 3899999999999976664 489999999999999999988888886 7999999999
Q ss_pred CCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcc
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPL 200 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~ 200 (632)
|+|++..|..|.++++|+.|+|++|+|++.+|.. .+++|+.|+|++|.|++..+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 9999998989999999999999999999998864 789999999999999988764
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-16 Score=155.40 Aligned_cols=154 Identities=21% Similarity=0.229 Sum_probs=130.4
Q ss_pred cceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCC-ccccCCCCCCeEeecCCcCCccCCCCc
Q 006747 56 VGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLP-SNVLSLSSLRFLYLQNNNFSGNIPSSL 134 (632)
Q Consensus 56 ~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 134 (632)
.+.+|.. ..+++++++++ .+|.. + ...++.|+|++|+|++..| ..|.++++|++|+|++|++++..|..|
T Consensus 7 ~~C~C~~-----~~l~~s~n~l~-~iP~~-~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~ 77 (220)
T 2v70_A 7 EKCRCEG-----TTVDCSNQKLN-KIPEH-I--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAF 77 (220)
T ss_dssp TTCEEET-----TEEECCSSCCS-SCCSC-C--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTT
T ss_pred CCCEECC-----CEeEeCCCCcc-cCccC-C--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHh
Confidence 5677764 27899999997 58873 3 3457899999999997755 458899999999999999998777677
Q ss_pred c--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCCC---
Q 006747 135 S--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPP--- 207 (632)
Q Consensus 135 ~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~--- 207 (632)
. ++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+|.. .+++|+.|+|++|+|++..|..|..++.
T Consensus 78 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 157 (220)
T 2v70_A 78 EGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLST 157 (220)
T ss_dssp TTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCE
T ss_pred CCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCE
Confidence 5 78999999999999988888999999999999999999998763 7899999999999999888888876654
Q ss_pred CCccCCCCCCC
Q 006747 208 SSFEGNSMLCG 218 (632)
Q Consensus 208 ~~~~~n~~~c~ 218 (632)
..+.+|++.|.
T Consensus 158 L~L~~N~l~c~ 168 (220)
T 2v70_A 158 LNLLANPFNCN 168 (220)
T ss_dssp EECCSCCEECS
T ss_pred EEecCcCCcCC
Confidence 45678877764
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.70 E-value=9.2e-17 Score=155.97 Aligned_cols=154 Identities=25% Similarity=0.292 Sum_probs=131.0
Q ss_pred cceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc
Q 006747 56 VGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS 135 (632)
Q Consensus 56 ~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 135 (632)
.+.+|.. ..+++.+++++ .+|.. + .++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..|.
T Consensus 7 ~~C~C~~-----~~v~c~~~~l~-~iP~~-l--~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~ 77 (220)
T 2v9t_B 7 AACTCSN-----NIVDCRGKGLT-EIPTN-L--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ 77 (220)
T ss_dssp TTSEEET-----TEEECTTSCCS-SCCSS-C--CTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred CCCEECC-----CEEEcCCCCcC-cCCCc-c--CcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhh
Confidence 4677864 25789999998 68763 3 27899999999999987777999999999999999999988888886
Q ss_pred --CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCCC---C
Q 006747 136 --PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPP---S 208 (632)
Q Consensus 136 --~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~ 208 (632)
++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|.. .+++|+.|+|++|+|++..+..+..++. .
T Consensus 78 ~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 157 (220)
T 2v9t_B 78 GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTM 157 (220)
T ss_dssp TCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEE
Confidence 79999999999999766667899999999999999999998863 7899999999999999877766766554 4
Q ss_pred CccCCCCCCC
Q 006747 209 SFEGNSMLCG 218 (632)
Q Consensus 209 ~~~~n~~~c~ 218 (632)
.+.+|++.|.
T Consensus 158 ~L~~N~~~c~ 167 (220)
T 2v9t_B 158 HLAQNPFICD 167 (220)
T ss_dssp ECCSSCEECS
T ss_pred EeCCCCcCCC
Confidence 5678887764
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.6e-16 Score=159.60 Aligned_cols=151 Identities=23% Similarity=0.295 Sum_probs=129.4
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
..+..|+|++|.+.+ ++ .+..+++|++|+|++|.+++..+..+.++++|++|+|++|++++..|..+. ++|++|+
T Consensus 63 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 63 PNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp TTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 468899999999986 43 689999999999999999988788889999999999999999976666554 7899999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCCC---CCccCCCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPP---SSFEGNSMLC 217 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~~~~n~~~c 217 (632)
|++|++++..|..|+++++|+.|+|++|++++.++.. .+++|+.|+|++|++++..|..+..++. ..+.+|+..|
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 9999999887888899999999999999999888763 7899999999999999877766665554 4556777665
Q ss_pred C
Q 006747 218 G 218 (632)
Q Consensus 218 ~ 218 (632)
.
T Consensus 220 ~ 220 (272)
T 3rfs_A 220 T 220 (272)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.3e-16 Score=158.24 Aligned_cols=153 Identities=23% Similarity=0.304 Sum_probs=131.4
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.++..|+|+++.++ .+|+..+.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..+. ++|++|+
T Consensus 61 ~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 139 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139 (270)
T ss_dssp TTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence 46889999999998 67777889999999999999999987777889999999999999999977666664 7999999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccCCCCCCCcccccCCCC---CCccCCCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLNGSVPLALQKFPP---SSFEGNSMLC 217 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~~~~n~~~c 217 (632)
|++|+|++..+..|..+++|+.|+|++|++++.++. + .+++|+.|+|++|+|++..+..+..++. ..+.+|++.|
T Consensus 140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC 219 (270)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence 999999987777799999999999999999998775 3 7899999999999999665555655544 4567887766
Q ss_pred C
Q 006747 218 G 218 (632)
Q Consensus 218 ~ 218 (632)
.
T Consensus 220 ~ 220 (270)
T 2o6q_A 220 T 220 (270)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.1e-16 Score=154.47 Aligned_cols=155 Identities=26% Similarity=0.296 Sum_probs=127.2
Q ss_pred CcceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCc
Q 006747 55 WVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL 134 (632)
Q Consensus 55 w~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 134 (632)
|..-.|+. ..++.+++++. .+|.. + .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..+
T Consensus 14 ~~~~~Cs~-----~~v~c~~~~l~-~ip~~-~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~ 84 (229)
T 3e6j_A 14 PSQCSCSG-----TTVDCRSKRHA-SVPAG-I--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF 84 (229)
T ss_dssp CTTCEEET-----TEEECTTSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred CCCCEEeC-----CEeEccCCCcC-ccCCC-C--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhc
Confidence 55567863 35888999986 78873 3 4889999999999999889999999999999999999984444444
Q ss_pred c--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCCC---C
Q 006747 135 S--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFPP---S 208 (632)
Q Consensus 135 ~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~ 208 (632)
. ++|++|+|++|+|++..+..|..+++|+.|+|++|+|+..+..+ .+++|+.|+|++|+|++..+..+..++. .
T Consensus 85 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 164 (229)
T 3e6j_A 85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHA 164 (229)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEE
Confidence 4 78999999999999877788999999999999999999654444 8899999999999999766666665554 4
Q ss_pred CccCCCCCCC
Q 006747 209 SFEGNSMLCG 218 (632)
Q Consensus 209 ~~~~n~~~c~ 218 (632)
.+.+|++.|.
T Consensus 165 ~l~~N~~~c~ 174 (229)
T 3e6j_A 165 YLFGNPWDCE 174 (229)
T ss_dssp ECTTSCBCTT
T ss_pred EeeCCCccCC
Confidence 5677877664
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.7e-16 Score=150.60 Aligned_cols=129 Identities=24% Similarity=0.270 Sum_probs=113.7
Q ss_pred CCCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeE
Q 006747 49 TSVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFL 119 (632)
Q Consensus 49 ~~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 119 (632)
.+.| .|..+.|+++. ..++.|+|++|.+++..+...+..+++|+.|+|++|+|++..|..|.++++|++|
T Consensus 5 ~C~C-~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 83 (192)
T 1w8a_A 5 MCHC-EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TSEE-ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCEE-CCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEE
Confidence 4456 79999998642 2678899999999865554468999999999999999999989999999999999
Q ss_pred eecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCC
Q 006747 120 YLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN 178 (632)
Q Consensus 120 ~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 178 (632)
+|++|+|++..|..+. ++|++|+|++|+|++.+|..|..+++|+.|+|++|.+++..+.
T Consensus 84 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 9999999988887775 7999999999999999999999999999999999999987653
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.68 E-value=8e-17 Score=166.36 Aligned_cols=146 Identities=21% Similarity=0.321 Sum_probs=117.8
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccC---------CCCCCeEeecCCcCCccCCCCcc
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLS---------LSSLRFLYLQNNNFSGNIPSSLS 135 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~---------l~~L~~L~Ls~N~l~g~~p~~~~ 135 (632)
.++..|+|++|.++ .+|. .+.++++|+.|+|++|++.+.+|..+.. +++|++|+|++|+++ .+|..+.
T Consensus 127 ~~L~~L~Ls~n~l~-~lp~-~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~ 203 (328)
T 4fcg_A 127 AGLETLTLARNPLR-ALPA-SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203 (328)
T ss_dssp TTCSEEEEESCCCC-CCCG-GGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGG
T ss_pred CCCCEEECCCCccc-cCcH-HHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhc
Confidence 35778899999998 8887 6888999999999998888888887765 888999999999888 7787765
Q ss_pred --CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCCCC---
Q 006747 136 --PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPPS--- 208 (632)
Q Consensus 136 --~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~~--- 208 (632)
++|+.|+|++|++++ +|..++++++|+.|+|++|++.+.+|.. .+++|+.|+|++|++.+.+|..+.+++..
T Consensus 204 ~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L 282 (328)
T 4fcg_A 204 NLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282 (328)
T ss_dssp GCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEE
T ss_pred CCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEE
Confidence 688888888888885 6777888888888888888888888763 67888888888888888888777666544
Q ss_pred CccCCC
Q 006747 209 SFEGNS 214 (632)
Q Consensus 209 ~~~~n~ 214 (632)
.+.+|.
T Consensus 283 ~L~~n~ 288 (328)
T 4fcg_A 283 DLRGCV 288 (328)
T ss_dssp ECTTCT
T ss_pred eCCCCC
Confidence 344444
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.67 E-value=3.4e-16 Score=155.17 Aligned_cols=132 Identities=22% Similarity=0.242 Sum_probs=118.1
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.++..|+|++|.+++. ++..+..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..+. ++|+.|+
T Consensus 59 ~~L~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 59 TKLTWLNLDYNQLQTL-SAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp TTCCEEECTTSCCCCC-CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCCEEECCCCcCCcc-CHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 4688999999999964 445799999999999999999988788899999999999999999965555554 7999999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGS 197 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~ 197 (632)
|++|+|++..+..|+.+++|+.|+|++|+|++.++.. .+++|+.|+|++|.|++.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 9999999877778999999999999999999888753 789999999999999976
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=3.2e-16 Score=158.40 Aligned_cols=141 Identities=23% Similarity=0.236 Sum_probs=96.7
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCc-cCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNH-LSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
++..|+|+++.+++..|. .+..+++|++|+|++|. ++...|..+..+++|++|+|++|.+++..|..+. ++|++|+
T Consensus 57 ~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 57 NLTILWLHSNVLARIDAA-AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEECCCCccceeCHh-hcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 567777777777654443 67777777777777776 6655566777777777777777777765565554 5677777
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccCCCCCCCcccccCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLNGSVPLALQKFPP 207 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 207 (632)
|++|++++..+..|+++++|+.|+|++|++++.++. + .+++|+.|+|++|++++..|..+..++.
T Consensus 136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 202 (285)
T 1ozn_A 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202 (285)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCccc
Confidence 777777765556677777777777777777766554 2 5677777777777777666666655443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.3e-16 Score=145.69 Aligned_cols=133 Identities=25% Similarity=0.290 Sum_probs=111.0
Q ss_pred CCCCCCcceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCcc
Q 006747 50 SVCTSWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGN 129 (632)
Q Consensus 50 ~~c~~w~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 129 (632)
+.| +|.++.|+++ +++ .+|.. ..++|+.|+|++|++++..+..+.++++|++|+|++|++++.
T Consensus 5 C~C-~~~~l~~~~~------------~l~-~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (177)
T 2o6r_A 5 CSC-SGTEIRCNSK------------GLT-SVPTG---IPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSL 67 (177)
T ss_dssp CEE-ETTEEECCSS------------CCS-SCCTT---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred CEe-CCCEEEecCC------------CCc-cCCCC---CCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEe
Confidence 344 6888888653 333 45542 247899999999999977777789999999999999999965
Q ss_pred CCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCc
Q 006747 130 IPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVP 199 (632)
Q Consensus 130 ~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p 199 (632)
.+..+. ++|+.|+|++|+|++..+..+..+++|+.|+|++|++++.++.. .+++|+.|+|++|.+++..|
T Consensus 68 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 68 PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 555554 79999999999999877778899999999999999999887763 68999999999999998776
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.3e-16 Score=161.20 Aligned_cols=153 Identities=30% Similarity=0.436 Sum_probs=91.0
Q ss_pred CCCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccC--CCCCccccCCCCCC
Q 006747 49 TSVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLS--GDLPSNVLSLSSLR 117 (632)
Q Consensus 49 ~~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~--g~~p~~~~~l~~L~ 117 (632)
.+.| .|.+|.|++.+ ..++.|+|++++++ .+|...+.++++|+.|+|++|.++ +.+|..+..+++|+
T Consensus 4 ~C~C-~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~ 81 (306)
T 2z66_A 4 RCSC-SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLK 81 (306)
T ss_dssp TCEE-ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCC
T ss_pred CCee-CCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccC
Confidence 3445 89999998643 36889999999998 788777889999999999999887 32344444555555
Q ss_pred eEeecCCcCCccCCCCcc---------------------------CCCcEEEccCCCCcccCCccccCCCCccceecccc
Q 006747 118 FLYLQNNNFSGNIPSSLS---------------------------PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNN 170 (632)
Q Consensus 118 ~L~Ls~N~l~g~~p~~~~---------------------------~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N 170 (632)
+|+|++|.++ .+|..+. ++|++|+|++|.+++..|..+..+++|+.|+|++|
T Consensus 82 ~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 160 (306)
T 2z66_A 82 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 160 (306)
T ss_dssp EEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTC
T ss_pred EEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCC
Confidence 5555555554 2332222 34555555555555444444555555555555555
Q ss_pred cccc-cCCC-C-CCCCCcEEEcccCCCCCCCcccccC
Q 006747 171 SLTG-FIPN-F-NLSRLRHLNLSYNHLNGSVPLALQK 204 (632)
Q Consensus 171 ~l~~-~~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~ 204 (632)
.+++ .+|. + .+++|+.|+|++|++++..|..+..
T Consensus 161 ~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 197 (306)
T 2z66_A 161 SFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197 (306)
T ss_dssp EEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred ccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcC
Confidence 5544 2222 1 4455555555555555444444433
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.2e-16 Score=170.56 Aligned_cols=152 Identities=23% Similarity=0.344 Sum_probs=132.3
Q ss_pred CCcc--eEecCCC--------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCC-CccccCCCCCCeEeec
Q 006747 54 SWVG--ITCTKNG--------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDL-PSNVLSLSSLRFLYLQ 122 (632)
Q Consensus 54 ~w~g--v~c~~~~--------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls 122 (632)
.|.+ |.|+..+ .+++.|+|+++.+++..|. .+.++++|++|+|++|.+.+.+ |..|.++++|++|+|+
T Consensus 9 ~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNET-SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTT-TTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChh-HhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence 4544 8887643 4689999999999875555 8999999999999999998766 5679999999999999
Q ss_pred CCcCCccCCCCcc--CCCcEEEccCCCCcccCCcc--ccCCCCccceecccccccccCCC--C-CCCCCcEEEcccCCCC
Q 006747 123 NNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPAS--IRNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 123 ~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~--~~~l~~L~~l~l~~N~l~~~~p~--~-~~~~L~~l~ls~N~l~ 195 (632)
+|++++..|..+. ++|++|+|++|++++.+|.. |+++++|+.|+|++|++++..|. + .+++|+.|+|++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 167 (455)
T 3v47_A 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167 (455)
T ss_dssp TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence 9999988888886 79999999999999866665 99999999999999999999886 3 7899999999999999
Q ss_pred CCCcccccCCC
Q 006747 196 GSVPLALQKFP 206 (632)
Q Consensus 196 g~~p~~~~~~~ 206 (632)
+..|..+..+.
T Consensus 168 ~~~~~~l~~l~ 178 (455)
T 3v47_A 168 SICEEDLLNFQ 178 (455)
T ss_dssp CCCTTTSGGGT
T ss_pred ccChhhhhccc
Confidence 98888776654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.65 E-value=6.8e-16 Score=154.98 Aligned_cols=134 Identities=24% Similarity=0.311 Sum_probs=120.3
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.++..|+|++|.+++ +++..+..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..+. ++|+.|+
T Consensus 85 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 85 TNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCc-cChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 468899999999985 5555789999999999999999988888899999999999999999966665554 7999999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCc
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVP 199 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p 199 (632)
|++|++++..+..|+.+++|+.|+|++|++++.++.. .+++|+.|+|++|.+.+..|
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 9999999888888999999999999999999988863 78999999999999998776
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.8e-16 Score=175.85 Aligned_cols=169 Identities=17% Similarity=0.178 Sum_probs=134.6
Q ss_pred CCCCCCCCCCC---CcceEecCC----C------------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCC
Q 006747 44 NWNSSTSVCTS---WVGITCTKN----G------------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSG 104 (632)
Q Consensus 44 ~w~~~~~~c~~---w~gv~c~~~----~------------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g 104 (632)
+|.+...||.. |.++.|+.. . ..+..+++.++.+. .+|+..+..+++|+.|+|++|.+++
T Consensus 11 ~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~ 89 (597)
T 3oja_B 11 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE 89 (597)
T ss_dssp CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCE
T ss_pred CCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCC
Confidence 78776666644 555544410 0 13456778888775 6888788999999999999999998
Q ss_pred CCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCC-C-C
Q 006747 105 DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-N 180 (632)
Q Consensus 105 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~ 180 (632)
..|..|.++++|++|+|++|.+++..|..|. ++|++|+|++|.|++..+..|+++++|+.|+|++|.+++.+|. + .
T Consensus 90 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 169 (597)
T 3oja_B 90 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 169 (597)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTT
T ss_pred CChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhc
Confidence 8888999999999999999999987777665 7999999999999976666689999999999999999999886 3 7
Q ss_pred CCCCcEEEcccCCCCCCCcccccCCCCCCccCC
Q 006747 181 LSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGN 213 (632)
Q Consensus 181 ~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n 213 (632)
+++|+.|+|++|.|++..+..+.++....+.+|
T Consensus 170 l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 170 TTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 202 (597)
T ss_dssp CTTCCEEECTTSCCSBCCGGGCTTCSEEECCSS
T ss_pred CCcCcEEECcCCCCCCcChhhhhhhhhhhcccC
Confidence 899999999999999765445555444444444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-15 Score=154.87 Aligned_cols=136 Identities=26% Similarity=0.292 Sum_probs=90.7
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
.++.|+|++|.+++..+ ..+..+++|+.|+|++|.|++..+ . ..+++|++|+|++|+|+ .+|..+. ++|++|+|
T Consensus 32 ~l~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSL-ATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TCCEEECTTSCCSEEEG-GGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCEEEcCCCcCCccCH-HHhhcCCCCCEEECCCCccCcccC-C-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 56778888888875444 367778888888888877774322 2 66777777777777776 5565543 56777777
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKF 205 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~ 205 (632)
++|+|++..|..|.++++|+.|+|++|+|++.++.. .+++|+.|+|++|+|++..+..+..+
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l 171 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTC
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCc
Confidence 777777665666777777777777777777665542 56677777777777764333333333
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=1.5e-16 Score=176.26 Aligned_cols=154 Identities=21% Similarity=0.254 Sum_probs=131.5
Q ss_pred CCCCCcceEecCCC-----------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeE
Q 006747 51 VCTSWVGITCTKNG-----------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFL 119 (632)
Q Consensus 51 ~c~~w~gv~c~~~~-----------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 119 (632)
.| .|.|+ |+... .+++.|+|+++.+++..|. .+.++++|++|+|++|++++..|..|.++++|++|
T Consensus 3 ~C-~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 79 (549)
T 2z81_A 3 SC-DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHG-DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHL 79 (549)
T ss_dssp EE-CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSS-TTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred cC-CCCce-EECCCCccccccccCCCCccEEECcCCccCccChh-hhhcCCcccEEECCCCCcCccChhhccccccCCEE
Confidence 46 79998 87421 3688999999999865554 79999999999999999998888999999999999
Q ss_pred eecCCcCCccCCCCcc--CCCcEEEccCCCCcc-cCCccccCCCCccceecccccccccCCC--C-CCCCCcEEEcccCC
Q 006747 120 YLQNNNFSGNIPSSLS--PQLNWVDLSFNSITG-NIPASIRNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYNH 193 (632)
Q Consensus 120 ~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~~~~p~--~-~~~~L~~l~ls~N~ 193 (632)
+|++|++++..|..+. ++|++|+|++|++++ .+|..++++++|+.|+|++|++.+.+|. + .+++|++|++++|+
T Consensus 80 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~ 159 (549)
T 2z81_A 80 DLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159 (549)
T ss_dssp ECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred ECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCc
Confidence 9999999977666565 789999999999997 4678999999999999999996555553 3 78999999999999
Q ss_pred CCCCCcccccCCCC
Q 006747 194 LNGSVPLALQKFPP 207 (632)
Q Consensus 194 l~g~~p~~~~~~~~ 207 (632)
+++.+|..+.+++.
T Consensus 160 l~~~~~~~l~~l~~ 173 (549)
T 2z81_A 160 LRNYQSQSLKSIRD 173 (549)
T ss_dssp CCEECTTTTTTCSE
T ss_pred ccccChhhhhcccc
Confidence 99988888776553
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=2e-16 Score=165.11 Aligned_cols=158 Identities=25% Similarity=0.314 Sum_probs=124.0
Q ss_pred CCCCCCCCCCCCcceEecCC-----------CCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccC
Q 006747 44 NWNSSTSVCTSWVGITCTKN-----------GSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLS 112 (632)
Q Consensus 44 ~w~~~~~~c~~w~gv~c~~~-----------~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~ 112 (632)
.|....+.| .|.|+ |+.. ...++.|+|+++++++ +|++.+.++++|+.|+|++|++++..|..|.+
T Consensus 22 ~~~~~~~~C-~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (353)
T 2z80_A 22 SSNQASLSC-DRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINTIEEDSFSS 98 (353)
T ss_dssp -----CCEE-CTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCEECTTTTTT
T ss_pred CCCccCCCC-CCCeE-eeCCCCCcccccccccccCcEEECCCCcCcc-cCHHHhccCCCCCEEECCCCccCccCHhhcCC
Confidence 455555666 79887 6532 1267889999999984 66667899999999999999999887888999
Q ss_pred CCCCCeEeecCCcCCccCCCC-cc--CCCcEEEccCCCCcccCCc--cccCCCCccceecccc-cccccCCC-C-CCCCC
Q 006747 113 LSSLRFLYLQNNNFSGNIPSS-LS--PQLNWVDLSFNSITGNIPA--SIRNLSHLVGLNLQNN-SLTGFIPN-F-NLSRL 184 (632)
Q Consensus 113 l~~L~~L~Ls~N~l~g~~p~~-~~--~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~l~l~~N-~l~~~~p~-~-~~~~L 184 (632)
+++|++|+|++|++++ +|.. +. ++|++|+|++|++++ +|. .+.++++|+.|++++| .+.+..+. + .+++|
T Consensus 99 l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L 176 (353)
T 2z80_A 99 LGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFL 176 (353)
T ss_dssp CTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEE
T ss_pred CCCCCEEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCC
Confidence 9999999999999995 4443 43 789999999999985 554 7899999999999999 46666554 3 78899
Q ss_pred cEEEcccCCCCCCCcccccCCC
Q 006747 185 RHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 185 ~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
+.|++++|++++..|..+.+++
T Consensus 177 ~~L~l~~n~l~~~~~~~l~~l~ 198 (353)
T 2z80_A 177 EELEIDASDLQSYEPKSLKSIQ 198 (353)
T ss_dssp EEEEEEETTCCEECTTTTTTCS
T ss_pred CEEECCCCCcCccCHHHHhccc
Confidence 9999999999987787776654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.5e-16 Score=165.56 Aligned_cols=169 Identities=17% Similarity=0.170 Sum_probs=128.3
Q ss_pred CCCCCCCCCCCCcceEecCCC-------------------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCC
Q 006747 44 NWNSSTSVCTSWVGITCTKNG-------------------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSG 104 (632)
Q Consensus 44 ~w~~~~~~c~~w~gv~c~~~~-------------------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g 104 (632)
+|....+||+.|.+..|.... ..+..+++.++.+. .+|+..+..+++|+.|+|++|.+++
T Consensus 5 ~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~~ 83 (390)
T 3o6n_A 5 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE 83 (390)
T ss_dssp --CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCCE
T ss_pred CCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCcccc
Confidence 677766677666655553111 24556788888876 6888788999999999999999998
Q ss_pred CCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--C
Q 006747 105 DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--N 180 (632)
Q Consensus 105 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~ 180 (632)
..+..|..+++|++|+|++|++++..|..+. ++|++|+|++|+++...+..|+++++|+.|+|++|.+++..|.. .
T Consensus 84 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 163 (390)
T 3o6n_A 84 IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA 163 (390)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSS
T ss_pred cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccC
Confidence 7788999999999999999999977777665 78999999999999654455799999999999999999988763 7
Q ss_pred CCCCcEEEcccCCCCCCCcccccCCCCCCccCC
Q 006747 181 LSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGN 213 (632)
Q Consensus 181 ~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n 213 (632)
+++|+.|++++|++++.-...+.++....+.+|
T Consensus 164 l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 164 TTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYN 196 (390)
T ss_dssp CTTCCEEECCSSCCSBCCGGGCTTCSEEECCSS
T ss_pred CCCCCEEECCCCcCCccccccccccceeecccc
Confidence 899999999999998654344444443344443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-16 Score=182.17 Aligned_cols=178 Identities=21% Similarity=0.292 Sum_probs=116.1
Q ss_pred CChhHHHHHHHHHHhCC---CCCCCCCCCCCCCCCCCcceEecCCCCeEEEEEeCCCCc------------------cc-
Q 006747 22 DLNSDKQALLDFAANVP---HARKLNWNSSTSVCTSWVGITCTKNGSRVLAVRLPGVGL------------------YG- 79 (632)
Q Consensus 22 ~~~~~~~~l~~~~~~~~---~~~~~~w~~~~~~c~~w~gv~c~~~~~~v~~l~l~~~~l------------------~g- 79 (632)
....++++|+++..+.. ......|......+..|.+++++. .+++.++|.++++ .+
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~ 206 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEANQALLQHKKLSQYSIDED 206 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcchhhHhhcCccCcccccCc
Confidence 34578899999987762 122235654444445798888875 4555555544332 21
Q ss_pred -------ccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcc
Q 006747 80 -------PIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITG 150 (632)
Q Consensus 80 -------~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g 150 (632)
.++++.+..+.+|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..+. ++|++|||++|+|+
T Consensus 207 ~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~- 283 (727)
T 4b8c_D 207 DDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT- 283 (727)
T ss_dssp ---------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-
T ss_pred cccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-
Confidence 244557889999999999999999 78888999999999999999999 8998876 79999999999999
Q ss_pred cCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccC
Q 006747 151 NIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQK 204 (632)
Q Consensus 151 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~ 204 (632)
.+|..|++|++|+.|+|++|.|+..+..+ .+++|+.|+|++|+|+|.+|..+..
T Consensus 284 ~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 284 SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTE 338 (727)
T ss_dssp SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHH
T ss_pred ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhh
Confidence 78999999999999999999998654445 7899999999999999998877643
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.3e-16 Score=160.02 Aligned_cols=137 Identities=21% Similarity=0.248 Sum_probs=84.4
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCC-ccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLP-SNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
++..|+|++|.+. .+|. .+..+++|++|+|++|.+++..+ ..+.++++|++|+|++|.+++..|..+. ++|+.|+
T Consensus 79 ~L~~L~Ls~n~i~-~l~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 156 (306)
T 2z66_A 79 SLKYLDLSFNGVI-TMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 156 (306)
T ss_dssp CCCEEECCSCSEE-EEEE-EEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEE
T ss_pred ccCEEECCCCccc-cChh-hcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEE
Confidence 4566777777766 3554 36666667777777766664443 4566666666666666666655555553 5666666
Q ss_pred ccCCCCcc-cCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccC
Q 006747 143 LSFNSITG-NIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQK 204 (632)
Q Consensus 143 Ls~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~ 204 (632)
|++|.+++ .+|..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|++++..+..+..
T Consensus 157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 66666665 45666666666666666666666665542 5566666666666666544444443
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.4e-16 Score=177.26 Aligned_cols=150 Identities=21% Similarity=0.241 Sum_probs=127.3
Q ss_pred cceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcC
Q 006747 56 VGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNF 126 (632)
Q Consensus 56 ~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 126 (632)
..|.|.+.+ ..++.|+|++|.|+ .||+..|.++++|++|+|++|+|++..|..|.+|++|++|+|++|+|
T Consensus 34 ~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l 112 (635)
T 4g8a_A 34 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 112 (635)
T ss_dssp TEEECTTSCCSSCCSSSCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CEEECCCCCcCccCCCCCcCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcC
Confidence 357787422 35789999999998 57777899999999999999999987788899999999999999999
Q ss_pred CccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceeccccccccc-CCCC--CCCCCcEEEcccCCCCCCCccc
Q 006747 127 SGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGF-IPNF--NLSRLRHLNLSYNHLNGSVPLA 201 (632)
Q Consensus 127 ~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~-~p~~--~~~~L~~l~ls~N~l~g~~p~~ 201 (632)
++..+..|. ++|++|+|++|+|++..+..|+++++|+.|+|++|++++. +|.. .+++|++|+|++|+|++..|..
T Consensus 113 ~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 192 (635)
T 4g8a_A 113 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 192 (635)
T ss_dssp CEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccccc
Confidence 965555565 7899999999999987777899999999999999999875 3443 6899999999999999887777
Q ss_pred ccCCC
Q 006747 202 LQKFP 206 (632)
Q Consensus 202 ~~~~~ 206 (632)
+..+.
T Consensus 193 l~~L~ 197 (635)
T 4g8a_A 193 LRVLH 197 (635)
T ss_dssp GHHHH
T ss_pred ccchh
Confidence 65443
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.9e-15 Score=143.03 Aligned_cols=154 Identities=21% Similarity=0.275 Sum_probs=125.1
Q ss_pred ceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc-
Q 006747 57 GITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS- 135 (632)
Q Consensus 57 gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~- 135 (632)
+..|.. ..+++.+++++ .+|.. ..++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+.
T Consensus 4 ~C~C~~-----~~v~c~~~~l~-~~p~~---~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 74 (208)
T 2o6s_A 4 RCSCSG-----TTVECYSQGRT-SVPTG---IPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNK 74 (208)
T ss_dssp TCEEET-----TEEECCSSCCS-SCCSC---CCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTT
T ss_pred CCEECC-----CEEEecCCCcc-CCCCC---CCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCC
Confidence 456743 46788899887 57653 356899999999999977777789999999999999999955554454
Q ss_pred -CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCCC---CC
Q 006747 136 -PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPP---SS 209 (632)
Q Consensus 136 -~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~ 209 (632)
++|++|+|++|+|++..+..|.++++|+.|+|++|++++.++.. .+++|+.|+|++|+|++..+..+.+++. ..
T Consensus 75 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 154 (208)
T 2o6s_A 75 LTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154 (208)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred CCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEE
Confidence 79999999999999877777899999999999999999888763 7899999999999999766655655544 45
Q ss_pred ccCCCCCCCC
Q 006747 210 FEGNSMLCGP 219 (632)
Q Consensus 210 ~~~n~~~c~~ 219 (632)
+.+|...|..
T Consensus 155 l~~N~~~~~~ 164 (208)
T 2o6s_A 155 LHDNPWDCTC 164 (208)
T ss_dssp CCSCCBCCCT
T ss_pred ecCCCeecCC
Confidence 6777766543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=7.2e-16 Score=167.71 Aligned_cols=158 Identities=20% Similarity=0.198 Sum_probs=133.1
Q ss_pred CCCCC-CCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCe
Q 006747 49 TSVCT-SWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRF 118 (632)
Q Consensus 49 ~~~c~-~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 118 (632)
.+.|. .|..|.|.+.. ..+..|+|++|.+++..| ..|.++++|+.|+|++|.+++..|..|.++++|++
T Consensus 6 ~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 84 (477)
T 2id5_A 6 RCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQ-DEFASFPHLEELELNENIVSAVEPGAFNNLFNLRT 84 (477)
T ss_dssp TCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECH-hHccCCCCCCEEECCCCccCEeChhhhhCCccCCE
Confidence 34453 47889997532 357789999999996444 48999999999999999999888999999999999
Q ss_pred EeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCC
Q 006747 119 LYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHL 194 (632)
Q Consensus 119 L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l 194 (632)
|+|++|++++..+..|. ++|++|+|++|++++..|..|.++++|+.|+|++|.+++..+.. .+++|+.|+|++|++
T Consensus 85 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 164 (477)
T 2id5_A 85 LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL 164 (477)
T ss_dssp EECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCC
T ss_pred EECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcC
Confidence 99999999954444454 79999999999999999999999999999999999999887753 789999999999999
Q ss_pred CCCCcccccCCCC
Q 006747 195 NGSVPLALQKFPP 207 (632)
Q Consensus 195 ~g~~p~~~~~~~~ 207 (632)
++..+..+..++.
T Consensus 165 ~~~~~~~l~~l~~ 177 (477)
T 2id5_A 165 TSIPTEALSHLHG 177 (477)
T ss_dssp SSCCHHHHTTCTT
T ss_pred cccChhHhcccCC
Confidence 9765555655543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-15 Score=153.69 Aligned_cols=143 Identities=25% Similarity=0.286 Sum_probs=124.3
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCc-CCccCCCCcc--CCCcEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNN-FSGNIPSSLS--PQLNWV 141 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~--~~L~~L 141 (632)
..+..|+|+++.+++ ++++.+..+++|++|+|++|.+++..|..|.++++|++|+|++|. +++..|..+. ++|++|
T Consensus 32 ~~l~~L~l~~n~i~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L 110 (285)
T 1ozn_A 32 AASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL 110 (285)
T ss_dssp TTCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred CCceEEEeeCCcCCc-cCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence 367899999999985 555589999999999999999998889999999999999999998 7755566665 799999
Q ss_pred EccCCCCcccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccCCCCCCCcccccCCCCC
Q 006747 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLNGSVPLALQKFPPS 208 (632)
Q Consensus 142 ~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~~ 208 (632)
+|++|.+++..|..|.++++|+.|+|++|++++.++. + .+++|+.|+|++|++++..+..+..++..
T Consensus 111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 179 (285)
T 1ozn_A 111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSL 179 (285)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTC
T ss_pred ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCcccc
Confidence 9999999998899999999999999999999988776 3 78999999999999996555556655443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-15 Score=164.61 Aligned_cols=146 Identities=22% Similarity=0.268 Sum_probs=105.1
Q ss_pred CCCCC-CCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCe
Q 006747 49 TSVCT-SWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRF 118 (632)
Q Consensus 49 ~~~c~-~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 118 (632)
.+.|. .|..|.|.+.+ ..+..|+|++|++++..| +.|.++++|+.|+|++|+|++..|..|.++++|++
T Consensus 49 ~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 127 (452)
T 3zyi_A 49 VCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQA-DTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNT 127 (452)
T ss_dssp TSEECSSSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCEECCCCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECH-HHcCCCCCCCEEECCCCccCCcChhhccCcccCCE
Confidence 34443 46789997532 367889999999996544 48999999999999999999888899999999999
Q ss_pred EeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCC--C-CCCCCcEEEcccCC
Q 006747 119 LYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYNH 193 (632)
Q Consensus 119 L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~--~-~~~~L~~l~ls~N~ 193 (632)
|+|++|+|++..+..+. ++|++|+|++|+|++..+..|.++++|+.|+|++|+..+.++. + .+++|+.|+|++|+
T Consensus 128 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~ 207 (452)
T 3zyi_A 128 LELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN 207 (452)
T ss_dssp EECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSC
T ss_pred EECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCc
Confidence 99999999955555554 7899999999999876665666666666666665332222222 1 34444444444444
Q ss_pred CC
Q 006747 194 LN 195 (632)
Q Consensus 194 l~ 195 (632)
|+
T Consensus 208 l~ 209 (452)
T 3zyi_A 208 IK 209 (452)
T ss_dssp CS
T ss_pred cc
Confidence 44
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.62 E-value=6.2e-16 Score=152.06 Aligned_cols=153 Identities=19% Similarity=0.258 Sum_probs=123.9
Q ss_pred CCCCCCCCCCCcceE--ecC------CCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCc-cCCCCCccccCCCC
Q 006747 45 WNSSTSVCTSWVGIT--CTK------NGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNH-LSGDLPSNVLSLSS 115 (632)
Q Consensus 45 w~~~~~~c~~w~gv~--c~~------~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~ 115 (632)
|.+..+.|..|.++. |.+ -...+..|+|++++++ .+|+..+.++++|+.|+|++|. +++..+..|.++++
T Consensus 3 ~cp~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~ 81 (239)
T 2xwt_C 3 CSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81 (239)
T ss_dssp CCSSSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTT
T ss_pred CCCCCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcC
Confidence 445556665446555 864 2236889999999998 4666689999999999999997 88666678999999
Q ss_pred CCeEeecC-CcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCcc---ceecccc-cccccCCC-C-CCCCCc-
Q 006747 116 LRFLYLQN-NNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLV---GLNLQNN-SLTGFIPN-F-NLSRLR- 185 (632)
Q Consensus 116 L~~L~Ls~-N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~---~l~l~~N-~l~~~~p~-~-~~~~L~- 185 (632)
|++|+|++ |++++..+..|. ++|+.|+|++|++++ +|. |..+++|+ .|+|++| ++++.++. + .+++|+
T Consensus 82 L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~ 159 (239)
T 2xwt_C 82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL 159 (239)
T ss_dssp CCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEE
T ss_pred CcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhccee
Confidence 99999998 999966556664 789999999999996 776 88888888 9999999 99888775 3 788999
Q ss_pred EEEcccCCCCCCCccc
Q 006747 186 HLNLSYNHLNGSVPLA 201 (632)
Q Consensus 186 ~l~ls~N~l~g~~p~~ 201 (632)
.|++++|+++ .+|..
T Consensus 160 ~L~l~~n~l~-~i~~~ 174 (239)
T 2xwt_C 160 TLKLYNNGFT-SVQGY 174 (239)
T ss_dssp EEECCSCCCC-EECTT
T ss_pred EEEcCCCCCc-ccCHh
Confidence 9999999998 66653
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.62 E-value=2.4e-15 Score=155.47 Aligned_cols=160 Identities=23% Similarity=0.364 Sum_probs=131.3
Q ss_pred CCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEe
Q 006747 50 SVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLY 120 (632)
Q Consensus 50 ~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 120 (632)
+.| .|..+.|++.. ..++.|+|+++.+.+ +++..+.++++|+.|+|++|++++..|..|.++++|++|+
T Consensus 31 c~c-~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 31 CHC-HLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp CEE-ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred Ccc-cCCEEECCCCCccccCCCCCCCCeEEECCCCcCCc-cCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence 334 79999998532 367889999999985 5555899999999999999999988899999999999999
Q ss_pred ecCCcCCccCCCCccCCCcEEEccCCCCcccCCccccCCCCccceecccccccc--cCCC-C-CCCCCcEEEcccCCCCC
Q 006747 121 LQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTG--FIPN-F-NLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 121 Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~--~~p~-~-~~~~L~~l~ls~N~l~g 196 (632)
|++|+++ .+|..+.++|++|+|++|++++..+..|.++++|+.|+|++|.++. ..+. + .+ +|+.|++++|++++
T Consensus 109 L~~n~l~-~l~~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 109 ISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp CCSSCCC-SCCSSCCTTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCCCcCC-ccCccccccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 9999999 7888888999999999999998777789999999999999999963 4444 2 34 88999999999885
Q ss_pred CCcccc-cCCCCCCccCCC
Q 006747 197 SVPLAL-QKFPPSSFEGNS 214 (632)
Q Consensus 197 ~~p~~~-~~~~~~~~~~n~ 214 (632)
+|..+ ..+....+.+|.
T Consensus 187 -l~~~~~~~L~~L~l~~n~ 204 (332)
T 2ft3_A 187 -IPKDLPETLNELHLDHNK 204 (332)
T ss_dssp -CCSSSCSSCSCCBCCSSC
T ss_pred -cCccccCCCCEEECCCCc
Confidence 55443 344444555543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=4.7e-16 Score=144.10 Aligned_cols=132 Identities=25% Similarity=0.239 Sum_probs=113.8
Q ss_pred CeEEEEEeCCCCcc-cccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEE
Q 006747 65 SRVLAVRLPGVGLY-GPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWV 141 (632)
Q Consensus 65 ~~v~~l~l~~~~l~-g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L 141 (632)
.+++.|+|++++++ |.+|. .+..+++|+.|+|++|.+++. ..+..+++|++|+|++|++++.+|..+. ++|++|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 46889999999998 88987 588999999999999999965 7889999999999999999977776663 799999
Q ss_pred EccCCCCcccC-CccccCCCCccceecccccccccCC----CC-CCCCCcEEEcccCCCCCCCcc
Q 006747 142 DLSFNSITGNI-PASIRNLSHLVGLNLQNNSLTGFIP----NF-NLSRLRHLNLSYNHLNGSVPL 200 (632)
Q Consensus 142 ~Ls~N~l~g~~-p~~~~~l~~L~~l~l~~N~l~~~~p----~~-~~~~L~~l~ls~N~l~g~~p~ 200 (632)
+|++|++++.. +..+..+++|+.|+|++|.+++.++ .+ .+++|+.|++++|.+. .+|.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~ 164 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD 164 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence 99999998642 2789999999999999999998877 22 7899999999999887 4454
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.61 E-value=2.8e-15 Score=151.88 Aligned_cols=147 Identities=26% Similarity=0.278 Sum_probs=79.4
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
++..|+|++|.+++ ++. .+.+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|. ++|+.|+|
T Consensus 56 ~L~~L~L~~n~l~~-~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 56 RLTQLNLDRAELTK-LQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (290)
T ss_dssp TCCEEECTTSCCCE-EEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred CCCEEECCCCccCc-ccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence 45555666666553 332 245566666666666665 4555555666666666666666644334443 45666666
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCC---CCCccCCCCCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFP---PSSFEGNSMLC 217 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~---~~~~~~n~~~c 217 (632)
++|+|++..+..|..+++|+.|+|++|+|++.++.. .+++|+.|+|++|+|+ .+|..+.... ...+.+|++.|
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 666666554555556666666666666666554432 4556666666666665 4454433322 22334555444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.4e-15 Score=141.69 Aligned_cols=124 Identities=28% Similarity=0.352 Sum_probs=108.3
Q ss_pred EEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCC
Q 006747 69 AVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFN 146 (632)
Q Consensus 69 ~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N 146 (632)
.+++++++++ .+|.. + .++|+.|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|. ++|+.|+|++|
T Consensus 14 ~l~~~~~~l~-~ip~~-~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKG-I--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp EEECTTSCCS-SCCSC-C--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEcCCCCCC-cCCCC-C--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 3566667776 67763 3 368999999999998 7889999999999999999999977777675 79999999999
Q ss_pred CCcccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccCCCCCC
Q 006747 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLNGS 197 (632)
Q Consensus 147 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l~g~ 197 (632)
+|++..|..|..+++|+.|+|++|+|++.++. + .+++|+.|+|++|.+...
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99998888999999999999999999988775 3 789999999999998754
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-15 Score=152.95 Aligned_cols=139 Identities=23% Similarity=0.247 Sum_probs=119.9
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
.+..|+|+++++++ +++..+.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..+. ++|++|+|
T Consensus 29 ~l~~L~ls~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 29 STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TCCEEECTTCCCCE-ECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CccEEECCCCcccc-cCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 57899999999985 4545799999999999999999977777899999999999999999977777775 79999999
Q ss_pred cCCCCcccCCccccCCCCccceeccccccccc-CCC-C-CCCCCcEEEcccCCCCCCCcccccCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGF-IPN-F-NLSRLRHLNLSYNHLNGSVPLALQKF 205 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~-~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~~ 205 (632)
++|++++..+..++++++|+.|+|++|++++. +|. + .+++|+.|+|++|++++..+..+..+
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 172 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 172 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhh
Confidence 99999987777899999999999999999874 354 3 78999999999999997666655443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-15 Score=155.07 Aligned_cols=147 Identities=20% Similarity=0.330 Sum_probs=123.2
Q ss_pred CCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEe
Q 006747 50 SVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLY 120 (632)
Q Consensus 50 ~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 120 (632)
+.| .|..+.|++.+ ..++.|+|+++.+++ +++..+.++++|++|+|++|.+++..|..|.++++|++|+
T Consensus 29 c~c-~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 29 CQC-HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp CEE-ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCC-BCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CcC-CCeEEEecCCCccccCccCCCCCeEEECCCCcCCE-eChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 344 79999998532 357789999999985 5555799999999999999999988899999999999999
Q ss_pred ecCCcCCccCCCCccCCCcEEEccCCCCcccCCccccCCCCccceecccccccc--cCCCC--CCCCCcEEEcccCCCCC
Q 006747 121 LQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTG--FIPNF--NLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 121 Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~--~~p~~--~~~~L~~l~ls~N~l~g 196 (632)
|++|+++ .+|..+.++|+.|+|++|++++..+..|.++++|+.|+|++|.++. ..+.. .+++|+.|++++|.++.
T Consensus 107 Ls~n~l~-~l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 185 (330)
T 1xku_A 107 LSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 185 (330)
T ss_dssp CCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred CCCCcCC-ccChhhcccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence 9999999 7888888999999999999998777788999999999999999864 44432 67788888888888773
Q ss_pred CCcc
Q 006747 197 SVPL 200 (632)
Q Consensus 197 ~~p~ 200 (632)
+|.
T Consensus 186 -l~~ 188 (330)
T 1xku_A 186 -IPQ 188 (330)
T ss_dssp -CCS
T ss_pred -CCc
Confidence 444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=9.4e-16 Score=171.96 Aligned_cols=152 Identities=22% Similarity=0.286 Sum_probs=88.0
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCc-cCCCCcc--CCCcEEEc
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG-NIPSSLS--PQLNWVDL 143 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~--~~L~~L~L 143 (632)
+..|+|++|.+.+..|...+..+++|+.|+|++|.+.+.+|..+.++++|++|+|++|++++ .+|..+. ++|+.|+|
T Consensus 401 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L 480 (606)
T 3vq2_A 401 LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480 (606)
T ss_dssp CCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred CCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEEC
Confidence 44445555555544443345556666666666666665555566666666666666666665 2454443 56666666
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCCC----CCccCCCCCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPP----SSFEGNSMLC 217 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~----~~~~~n~~~c 217 (632)
++|++++.+|..|+++++|+.|+|++|++++.+|.. .+++|+.|+|++|+|+ .+|..+..++. ..+.+|++.|
T Consensus 481 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c 559 (606)
T 3vq2_A 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVAC 559 (606)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCC
T ss_pred CCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCccc
Confidence 666666666666666666666666666666655542 5566666666666666 45555544432 3455666655
Q ss_pred CC
Q 006747 218 GP 219 (632)
Q Consensus 218 ~~ 219 (632)
..
T Consensus 560 ~c 561 (606)
T 3vq2_A 560 IC 561 (606)
T ss_dssp SS
T ss_pred CC
Confidence 43
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.5e-15 Score=163.99 Aligned_cols=133 Identities=23% Similarity=0.260 Sum_probs=80.5
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
.+..++|+++.+.+.+|. .+..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..+. ++|+.|+|
T Consensus 276 ~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 276 GVKTCDLSKSKIFALLKS-VFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp CCCEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred CceEEEecCccccccchh-hcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 455566666666654444 566666666666666666655555666666666666666666655554443 55666666
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCc
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVP 199 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p 199 (632)
++|++++..|..|..+++|+.|+|++|++++.++.. .+++|+.|+|++|++++..|
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 666666655666666666666666666666554432 45666666666666666555
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=170.75 Aligned_cols=163 Identities=16% Similarity=0.122 Sum_probs=136.1
Q ss_pred CCCCCCCCC-CCcceEecCC---------CCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCC
Q 006747 45 WNSSTSVCT-SWVGITCTKN---------GSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLS 114 (632)
Q Consensus 45 w~~~~~~c~-~w~gv~c~~~---------~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 114 (632)
|....+.|. .+..|.|.+. ...++.|+|++|.+++..| ..|+++++|++|+|++|++++..|..|.+++
T Consensus 3 ~~~~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~ 81 (606)
T 3t6q_A 3 SSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQN-TTFSRLINLTFLDLTRCQIYWIHEDTFQSQH 81 (606)
T ss_dssp ---CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECT-TTSTTCTTCSEEECTTCCCCEECTTTTTTCT
T ss_pred cccCceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCCh-hHhccCccceEEECCCCccceeChhhccCcc
Confidence 333344442 3566888753 2368899999999996544 4899999999999999999988899999999
Q ss_pred CCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceeccccccccc-CCC-CCCCCCcEEEcc
Q 006747 115 SLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGF-IPN-FNLSRLRHLNLS 190 (632)
Q Consensus 115 ~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~-~p~-~~~~~L~~l~ls 190 (632)
+|++|+|++|++++..|..+. ++|++|+|++|++++..|..++++++|+.|+|++|++++. +|. ..+++|+.|+|+
T Consensus 82 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 161 (606)
T 3t6q_A 82 RLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQ 161 (606)
T ss_dssp TCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECC
T ss_pred ccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcc
Confidence 999999999999988888886 7999999999999987788999999999999999999985 344 378999999999
Q ss_pred cCCCCCCCcccccCCCCC
Q 006747 191 YNHLNGSVPLALQKFPPS 208 (632)
Q Consensus 191 ~N~l~g~~p~~~~~~~~~ 208 (632)
+|.+++..|..+..++..
T Consensus 162 ~n~l~~~~~~~~~~l~~L 179 (606)
T 3t6q_A 162 NNAIHYLSKEDMSSLQQA 179 (606)
T ss_dssp SSCCCEECHHHHHTTTTC
T ss_pred cCcccccChhhhhhhccc
Confidence 999998778777666544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-15 Score=170.46 Aligned_cols=140 Identities=24% Similarity=0.207 Sum_probs=124.0
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.+++.|+|+++.+++..+ ..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|. ++|++|+
T Consensus 32 ~~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 110 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKS-YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV 110 (606)
T ss_dssp TTCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred CCcCEEECCCCCcCEeCh-hhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence 468899999999986544 4799999999999999999988899999999999999999999988888886 7999999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccc-cCCC-C-CCCCCcEEEcccCCCCCCCcccccCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTG-FIPN-F-NLSRLRHLNLSYNHLNGSVPLALQKF 205 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~-~~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~~ 205 (632)
|++|++++..|..++++++|+.|+|++|++++ .+|. + .+++|++|+|++|++++..|..+..+
T Consensus 111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 176 (606)
T 3vq2_A 111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176 (606)
T ss_dssp CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHH
T ss_pred ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhh
Confidence 99999998887899999999999999999986 4465 3 79999999999999998777766543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.6e-15 Score=176.60 Aligned_cols=135 Identities=24% Similarity=0.255 Sum_probs=115.2
Q ss_pred hcCCCCCcEEeccCCccCCCCCc-cccCCCCCCeEeecCCcCCccC-----CCCcc--CCCcEEEccCCCCcccCCcccc
Q 006747 86 LEKLDSLMILSLRSNHLSGDLPS-NVLSLSSLRFLYLQNNNFSGNI-----PSSLS--PQLNWVDLSFNSITGNIPASIR 157 (632)
Q Consensus 86 l~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~Ls~N~l~g~~-----p~~~~--~~L~~L~Ls~N~l~g~~p~~~~ 157 (632)
+.++++|+.|+|++|++++..+. .+..+++|++|+|++|.+++.. |..+. ++|+.|+|++|+|++.+|..|.
T Consensus 422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 501 (844)
T 3j0a_A 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501 (844)
T ss_dssp HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence 55789999999999999865443 4567899999999999997433 33343 6899999999999999999999
Q ss_pred CCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCCCCCccCCCCCCCCC
Q 006747 158 NLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPP 220 (632)
Q Consensus 158 ~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n~~~c~~~ 220 (632)
.+++|+.|+|++|+|++.++....++|+.|+|++|+|++.+|..+.++....+.+|++.|..+
T Consensus 502 ~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 502 HLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE 564 (844)
T ss_dssp SCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred chhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence 999999999999999998887655899999999999999999999888888899999988543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=3.3e-15 Score=150.21 Aligned_cols=112 Identities=21% Similarity=0.241 Sum_probs=79.2
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.++..|+|+++.+.+ +++..+.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..+. ++|+.|+
T Consensus 52 ~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 52 PELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp TTCSEEECTTCCCCE-ECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred cCCcEEECCCCcCCc-cCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence 356777777777763 4444677777777777777777766667777777777777777777755554444 5777777
Q ss_pred ccCCCCccc-CCccccCCCCccceecccccccccCC
Q 006747 143 LSFNSITGN-IPASIRNLSHLVGLNLQNNSLTGFIP 177 (632)
Q Consensus 143 Ls~N~l~g~-~p~~~~~l~~L~~l~l~~N~l~~~~p 177 (632)
|++|++++. +|..++++++|+.|+|++|++++.++
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred CcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 777777753 57777777777777777777776544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.59 E-value=1.8e-15 Score=166.63 Aligned_cols=151 Identities=25% Similarity=0.361 Sum_probs=122.8
Q ss_pred CCCCCCCCCC----CCcce-EecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCe
Q 006747 44 NWNSSTSVCT----SWVGI-TCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRF 118 (632)
Q Consensus 44 ~w~~~~~~c~----~w~gv-~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 118 (632)
+|.....+|. .|.|+ .|.. .+++.|+|++++|++ ||.. + +++|+.|+|++|+|+ .+| ..+++|++
T Consensus 35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~-l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~ 104 (571)
T 3cvr_A 35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDN-L--PPQITVLEITQNALI-SLP---ELPASLEY 104 (571)
T ss_dssp HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSC-C--CTTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHh-H--cCCCCEEECcCCCCc-ccc---cccCCCCE
Confidence 6766666774 49999 7875 479999999999997 8874 3 488999999999999 677 56899999
Q ss_pred EeecCCcCCccCCCCccCCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCC
Q 006747 119 LYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSV 198 (632)
Q Consensus 119 L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~ 198 (632)
|+|++|+|++ +|. +..+|+.|+|++|+|++ +|. .+++|+.|+|++|+|++. |. .+++|+.|+|++|+|++ +
T Consensus 105 L~Ls~N~l~~-ip~-l~~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l-p~-~l~~L~~L~Ls~N~L~~-l 175 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPASLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTML-PE-LPTSLEVLSVRNNQLTF-L 175 (571)
T ss_dssp EECCSSCCSC-CCC-CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-CC-CCTTCCEEECCSSCCSC-C
T ss_pred EEccCCCCCC-cch-hhcCCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcC-CC-cCCCcCEEECCCCCCCC-c
Confidence 9999999997 888 77799999999999997 777 689999999999999985 44 67899999999999996 7
Q ss_pred ccccc-CCCCCCccCCC
Q 006747 199 PLALQ-KFPPSSFEGNS 214 (632)
Q Consensus 199 p~~~~-~~~~~~~~~n~ 214 (632)
|. +. ++....+.+|.
T Consensus 176 p~-l~~~L~~L~Ls~N~ 191 (571)
T 3cvr_A 176 PE-LPESLEALDVSTNL 191 (571)
T ss_dssp CC-CCTTCCEEECCSSC
T ss_pred ch-hhCCCCEEECcCCC
Confidence 76 43 33333344443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=4.2e-15 Score=154.21 Aligned_cols=133 Identities=13% Similarity=0.108 Sum_probs=95.0
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEeccccc---------------CHHH--------HHHHHHHHHhhcCCCCccce
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM---------------GKRE--------FEQQMEVVGRLSQHPNVVPI 397 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---------------~~~~--------~~~e~~~l~~l~~h~niv~l 397 (632)
.+.||+|+||.||+|...+|+.||||+++.... .... ...|...|.++ .+.++...
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~gv~vp 178 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEGFPVP 178 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTTCSCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcCCCCC
Confidence 357999999999999998999999998763211 1111 23455566666 34333222
Q ss_pred eEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC
Q 006747 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL 477 (632)
Q Consensus 398 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~ 477 (632)
.-+.. ...+|||||++++.|..+.... ....++.|++.+|.|||+. +||||||||.|||+++++
T Consensus 179 ~p~~~--~~~~LVME~i~G~~L~~l~~~~-----------~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 179 EPIAQ--SRHTIVMSLVDALPMRQVSSVP-----------DPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CEEEE--ETTEEEEECCSCEEGGGCCCCS-----------CHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred eeeec--cCceEEEEecCCccHhhhcccH-----------HHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 11211 2347999999998887654311 1245788999999999998 999999999999998877
Q ss_pred C----------eEEcccCCCCCC
Q 006747 478 Q----------GCISDFGLTPLM 490 (632)
Q Consensus 478 ~----------~ki~DfGla~~~ 490 (632)
. +.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3 899999976543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1e-15 Score=138.85 Aligned_cols=124 Identities=27% Similarity=0.304 Sum_probs=94.2
Q ss_pred CeEEEEEeCCCCcc-cccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEE
Q 006747 65 SRVLAVRLPGVGLY-GPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWV 141 (632)
Q Consensus 65 ~~v~~l~l~~~~l~-g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L 141 (632)
.+++.|++++++++ |.+|. .+..+++|+.|+|++|.+++. ..+.++++|++|+|++|++++.+|..+. ++|++|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred ccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 35777888888887 77776 677888888888888888765 6777888888888888888876666553 678888
Q ss_pred EccCCCCccc-CCccccCCCCccceecccccccccCC---C-C-CCCCCcEEEccc
Q 006747 142 DLSFNSITGN-IPASIRNLSHLVGLNLQNNSLTGFIP---N-F-NLSRLRHLNLSY 191 (632)
Q Consensus 142 ~Ls~N~l~g~-~p~~~~~l~~L~~l~l~~N~l~~~~p---~-~-~~~~L~~l~ls~ 191 (632)
+|++|++++. .|..++.+++|+.|+|++|.+++.++ . + .+++|+.||+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 8888888763 34778888888888888888887766 2 2 677888887763
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.6e-15 Score=165.12 Aligned_cols=146 Identities=18% Similarity=0.189 Sum_probs=99.2
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc---CCCcEEE
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS---PQLNWVD 142 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~---~~L~~L~ 142 (632)
.+..|+|++|.+++..+. .+++|+.|+|++|.|++..|..++++++|++|+|++|.+++.+|..+. ++|+.|+
T Consensus 100 ~L~~L~L~~N~l~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 100 SIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TCCEEECCSSCCCCEEEC----CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CcCEEECcCCcCCCCCcc----ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 455667777777654332 356777777777777777777777777777777777777776666654 6777777
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCC---CCCccCCCCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFP---PSSFEGNSMLCG 218 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~---~~~~~~n~~~c~ 218 (632)
|++|.|++. | .+..+++|+.|+|++|.|++.+|.+ .+++|+.|+|++|.|++ +|..+..++ ...+.+|...|+
T Consensus 176 Ls~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~ 252 (487)
T 3oja_A 176 LQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG 252 (487)
T ss_dssp CTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred cCCCccccc-c-ccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence 777777765 2 2335777777777777777776665 66777777777777774 565554443 334566666654
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=9.4e-15 Score=157.21 Aligned_cols=153 Identities=26% Similarity=0.263 Sum_probs=112.3
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCcccc-------------------------CCCCCCeE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVL-------------------------SLSSLRFL 119 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~-------------------------~l~~L~~L 119 (632)
.++..|+|++|.++ .+|++.|..+++|+.|+|++|.+++..+..|. ++++|++|
T Consensus 112 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L 190 (440)
T 3zyj_A 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190 (440)
T ss_dssp SSCCEEECCSSCCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEE
T ss_pred ccCCEEECCCCcCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCee
Confidence 35778888888887 56666788888888888888887754444444 45555555
Q ss_pred eecCCcCCccCCCCc-cCCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCC
Q 006747 120 YLQNNNFSGNIPSSL-SPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 120 ~Ls~N~l~g~~p~~~-~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g 196 (632)
+|++|+++ .+|... .++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|+|++
T Consensus 191 ~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 269 (440)
T 3zyj_A 191 NLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269 (440)
T ss_dssp ECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCC
T ss_pred cCCCCcCc-cccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCc
Confidence 55555555 333211 157888888888888888888899999999999999998887763 78899999999999997
Q ss_pred CCcccccCCC---CCCccCCCCCCCC
Q 006747 197 SVPLALQKFP---PSSFEGNSMLCGP 219 (632)
Q Consensus 197 ~~p~~~~~~~---~~~~~~n~~~c~~ 219 (632)
..+..+..++ ...+.+|++.|..
T Consensus 270 ~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 270 LPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp CCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred cChhHhccccCCCEEEcCCCCccCCC
Confidence 6666665554 4467888887754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.57 E-value=7.2e-16 Score=173.74 Aligned_cols=140 Identities=19% Similarity=0.371 Sum_probs=126.3
Q ss_pred CeEEEEEeCCCCcccc-----------------cCchhhc--CCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCc
Q 006747 65 SRVLAVRLPGVGLYGP-----------------IPANTLE--KLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNN 125 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~-----------------lp~~~l~--~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 125 (632)
.++..|+|++|.++|. +|. .++ ++++|++|+|++|++.|.+|..|+++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 4688999999999996 888 688 99999999999999999999999999999999999998
Q ss_pred -CCc-cCCCCcc--------CCCcEEEccCCCCcccCCc--cccCCCCccceecccccccccCCCC-CCCCCcEEEcccC
Q 006747 126 -FSG-NIPSSLS--------PQLNWVDLSFNSITGNIPA--SIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYN 192 (632)
Q Consensus 126 -l~g-~~p~~~~--------~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N 192 (632)
++| .+|..+. ++|+.|+|++|+++ .+|. .++++++|+.|+|++|+++|.+|.+ .+++|+.|+|++|
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYN 363 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCC
Confidence 999 8888764 68999999999999 8998 9999999999999999999888855 6788999999999
Q ss_pred CCCCCCcccccCCCC
Q 006747 193 HLNGSVPLALQKFPP 207 (632)
Q Consensus 193 ~l~g~~p~~~~~~~~ 207 (632)
+++ .+|..+.+++.
T Consensus 364 ~l~-~lp~~l~~l~~ 377 (636)
T 4eco_A 364 QIT-EIPANFCGFTE 377 (636)
T ss_dssp EEE-ECCTTSEEECT
T ss_pred ccc-cccHhhhhhcc
Confidence 998 88887766554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=8.4e-15 Score=170.55 Aligned_cols=148 Identities=19% Similarity=0.206 Sum_probs=124.9
Q ss_pred CCcceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCC-CccccCCCCCCeEeecCCcCCccCCC
Q 006747 54 SWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDL-PSNVLSLSSLRFLYLQNNNFSGNIPS 132 (632)
Q Consensus 54 ~w~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~ 132 (632)
+|..|.+ ...+++.|+|++|.+++..|. .|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|.
T Consensus 15 ~L~~vP~--lp~~l~~LdLs~N~i~~i~~~-~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 15 NLTQVPQ--VLNTTERLLLSFNYIRTVTAS-SFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CSSCCCS--SCTTCCEEEEESCCCCEECSS-SCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCC--CCCCcCEEECCCCcCCccChh-HCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 5666666 346788999999999865555 7999999999999999777676 77899999999999999999988888
Q ss_pred Ccc--CCCcEEEccCCCCcccCCcc--ccCCCCccceecccccccccCCC--C-CCCCCcEEEcccCCCCCCCcccccC
Q 006747 133 SLS--PQLNWVDLSFNSITGNIPAS--IRNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYNHLNGSVPLALQK 204 (632)
Q Consensus 133 ~~~--~~L~~L~Ls~N~l~g~~p~~--~~~l~~L~~l~l~~N~l~~~~p~--~-~~~~L~~l~ls~N~l~g~~p~~~~~ 204 (632)
.|. ++|++|+|++|.+++.+|.. |+++++|+.|+|++|.+++..+. + .+++|+.|+|++|.+++..|..+..
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~ 170 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEP 170 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccc
Confidence 886 78999999999999877765 89999999999999999887664 3 7899999999999999888876643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.56 E-value=1.4e-14 Score=156.47 Aligned_cols=153 Identities=24% Similarity=0.225 Sum_probs=115.9
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCcc-------------------------ccCCCCCCeE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSN-------------------------VLSLSSLRFL 119 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~-------------------------~~~l~~L~~L 119 (632)
.++..|+|++|.++ .+|+..+..+++|++|+|++|.|++..+.. |.++++|++|
T Consensus 123 ~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L 201 (452)
T 3zyi_A 123 ASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL 201 (452)
T ss_dssp TTCCEEECCSSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEE
T ss_pred ccCCEEECCCCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEE
Confidence 35778889998888 566667888888888888888887544434 4455566666
Q ss_pred eecCCcCCccCCCCc-cCCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCC
Q 006747 120 YLQNNNFSGNIPSSL-SPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 120 ~Ls~N~l~g~~p~~~-~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g 196 (632)
+|++|++++ +|... .++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+.. .+++|+.|+|++|+|++
T Consensus 202 ~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 280 (452)
T 3zyi_A 202 NLGMCNIKD-MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS 280 (452)
T ss_dssp ECTTSCCSS-CCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred ECCCCcccc-cccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCc
Confidence 666666663 33211 267889999999999888999999999999999999999887763 78999999999999997
Q ss_pred CCcccccCCC---CCCccCCCCCCCC
Q 006747 197 SVPLALQKFP---PSSFEGNSMLCGP 219 (632)
Q Consensus 197 ~~p~~~~~~~---~~~~~~n~~~c~~ 219 (632)
..+..+..++ ...+.+|++.|..
T Consensus 281 ~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 281 LPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp CCTTSSTTCTTCCEEECCSSCEECST
T ss_pred cChHHhccccCCCEEEccCCCcCCCC
Confidence 6666665554 4567889887764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=9.2e-15 Score=166.21 Aligned_cols=148 Identities=24% Similarity=0.256 Sum_probs=122.8
Q ss_pred CCcceEecCC---------CCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCC
Q 006747 54 SWVGITCTKN---------GSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNN 124 (632)
Q Consensus 54 ~w~gv~c~~~---------~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 124 (632)
.+..|.|+.. ..+++.|+|+++++++ +|+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 5 ~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 5 SHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRR-LPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp BSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCC-CCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred ECCeeECCCCCccccccccCCCCcEEECCCCCCCC-cCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 3555677642 2468899999999985 55557999999999999999999888999999999999999999
Q ss_pred cCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcc
Q 006747 125 NFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPL 200 (632)
Q Consensus 125 ~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~ 200 (632)
++++..+..|. ++|++|+|++|++++..|..|+++++|+.|+|++|.+++.+|.. .+++|++|+|++|.+++..|.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99954444554 78999999999999877788999999999999999999887763 788999999999998877665
Q ss_pred cc
Q 006747 201 AL 202 (632)
Q Consensus 201 ~~ 202 (632)
.+
T Consensus 164 ~~ 165 (680)
T 1ziw_A 164 EL 165 (680)
T ss_dssp HH
T ss_pred Hh
Confidence 43
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-14 Score=161.35 Aligned_cols=151 Identities=21% Similarity=0.262 Sum_probs=125.1
Q ss_pred CCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCC--CCCccccCCCCCCeEeecCCcCCccCCCCcc---CCC
Q 006747 64 GSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSG--DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS---PQL 138 (632)
Q Consensus 64 ~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~---~~L 138 (632)
-.++..|+|++|.+++.+|. .+.++++|+.|+|++|++++ .+|..+.++++|++|+|++|++++.+|.... ++|
T Consensus 352 l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 352 PSSFTFLNFTQNVFTDSVFQ-GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp CCCCCEEECCSSCCCTTTTT-TCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCceEEECCCCccccchhh-hhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 35788999999999987876 78999999999999999996 3456789999999999999999987776543 789
Q ss_pred cEEEccCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCccc-ccCCCC---CCccCC
Q 006747 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLA-LQKFPP---SSFEGN 213 (632)
Q Consensus 139 ~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~-~~~~~~---~~~~~n 213 (632)
+.|+|++|++++.+|..+. ++|+.|+|++|+++..++.. .+++|+.|+|++|+|+ .+|.. +..++. ..+.+|
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N 507 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSC
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCC
Confidence 9999999999988887765 78999999999999665543 8899999999999999 56665 655544 456788
Q ss_pred CCCCC
Q 006747 214 SMLCG 218 (632)
Q Consensus 214 ~~~c~ 218 (632)
++.|.
T Consensus 508 ~~~c~ 512 (562)
T 3a79_B 508 PWDCT 512 (562)
T ss_dssp CBCCC
T ss_pred CcCCC
Confidence 87764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.2e-14 Score=138.02 Aligned_cols=124 Identities=22% Similarity=0.283 Sum_probs=108.9
Q ss_pred CCCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeE
Q 006747 49 TSVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFL 119 (632)
Q Consensus 49 ~~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 119 (632)
.+.| .|..|.|+++. ..++.|+|++|.++ .+|. .+.++++|+.|+|++|.|++..+..|.++++|++|
T Consensus 7 ~C~C-~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~-~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L 83 (193)
T 2wfh_A 7 ECTC-LDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPK-ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTL 83 (193)
T ss_dssp TCEE-ETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCG-GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCEe-CCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHH-HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEE
Confidence 3445 68889997542 35788999999998 7885 89999999999999999998888899999999999
Q ss_pred eecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceeccccccccc
Q 006747 120 YLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGF 175 (632)
Q Consensus 120 ~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 175 (632)
+|++|+|++..|..|. ++|+.|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus 84 ~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 84 ILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp ECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 9999999977777776 7999999999999977777899999999999999999754
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.55 E-value=3.3e-15 Score=152.99 Aligned_cols=136 Identities=22% Similarity=0.173 Sum_probs=86.7
Q ss_pred CeEEEEEeCCCCcccccC---chhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCcc--CC-CCc---c
Q 006747 65 SRVLAVRLPGVGLYGPIP---ANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGN--IP-SSL---S 135 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp---~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~--~p-~~~---~ 135 (632)
.++..|+|++|.+.+..+ ...+..+++|++|+|++|.+++..|..|+++++|++|+|++|++.+. ++ ... .
T Consensus 117 ~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 117 LALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp BCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred CCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 356677777777776554 12344677777777777777777677777777777777777776642 22 111 1
Q ss_pred CCCcEEEccCCCCcccCCc----cccCCCCccceecccccccccCCC-C-C---CCCCcEEEcccCCCCCCCcccc
Q 006747 136 PQLNWVDLSFNSITGNIPA----SIRNLSHLVGLNLQNNSLTGFIPN-F-N---LSRLRHLNLSYNHLNGSVPLAL 202 (632)
Q Consensus 136 ~~L~~L~Ls~N~l~g~~p~----~~~~l~~L~~l~l~~N~l~~~~p~-~-~---~~~L~~l~ls~N~l~g~~p~~~ 202 (632)
++|++|+|++|++++ +|. .++++++|+.|+|++|++++..|. + . +++|++|+|++|+|+ .+|..+
T Consensus 197 ~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~ 270 (310)
T 4glp_A 197 PAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGL 270 (310)
T ss_dssp CCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCC
T ss_pred CCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhh
Confidence 567777777777752 232 245667777777777777776443 1 2 257777777777777 555543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.2e-15 Score=154.46 Aligned_cols=127 Identities=19% Similarity=0.275 Sum_probs=80.1
Q ss_pred EEEEEeCCCCc-ccccCchhhc-------CCCCCcEEeccCCccCCCCCccc--cCCCCCCeEeecCCcCCccCCCCcc-
Q 006747 67 VLAVRLPGVGL-YGPIPANTLE-------KLDSLMILSLRSNHLSGDLPSNV--LSLSSLRFLYLQNNNFSGNIPSSLS- 135 (632)
Q Consensus 67 v~~l~l~~~~l-~g~lp~~~l~-------~l~~L~~L~Ls~N~l~g~~p~~~--~~l~~L~~L~Ls~N~l~g~~p~~~~- 135 (632)
+..++|+++.+ .+.+|. .+. ++++|++|+|++|++++.+|..+ ..+++|++|+|++|++++. |..+.
T Consensus 65 L~~L~L~~n~l~~~~~~~-~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~ 142 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPS-RILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE 142 (312)
T ss_dssp HHHCCCCEEEEEEEECBH-HHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH
T ss_pred HhhcccccccccCCCcCH-HHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH
Confidence 45566666666 345554 233 56677777777777776666665 6677777777777777655 54432
Q ss_pred ------CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCC---C---CCCCCCcEEEcccCCCC
Q 006747 136 ------PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIP---N---FNLSRLRHLNLSYNHLN 195 (632)
Q Consensus 136 ------~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p---~---~~~~~L~~l~ls~N~l~ 195 (632)
++|++|+|++|++++..|..|+++++|+.|+|++|++.+.++ . ..+++|+.|+|++|+|+
T Consensus 143 l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~ 214 (312)
T 1wwl_A 143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214 (312)
T ss_dssp HHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCC
T ss_pred HHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCc
Confidence 567777777777766666667777777777777777655421 1 25566666666666666
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.55 E-value=8.2e-15 Score=139.53 Aligned_cols=133 Identities=19% Similarity=0.348 Sum_probs=110.7
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
++..++++++++. .+| .+..+++|+.|+|++|.++ .++.+..+++|++|+|++|++++..|..+. ++|++|+|
T Consensus 45 ~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp TCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 5788999999988 677 4888999999999999775 345788999999999999999987777776 78999999
Q ss_pred cCCCCcccCCccccCCCCccceeccccc-ccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNS-LTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~-l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
++|++++..|..++.+++|+.|+|++|. ++.. |.+ .+++|+.|++++|++++ ++ .+..++
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~ 181 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD-YR-GIEDFP 181 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-GGGGGCSSCCEEECTTBCCCC-CT-TGGGCS
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-HhhcCCCCCCEEECCCCCCcC-hH-HhccCC
Confidence 9999998889999999999999999998 5544 444 78999999999999985 33 444443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.6e-15 Score=173.09 Aligned_cols=139 Identities=19% Similarity=0.336 Sum_probs=125.4
Q ss_pred CeEEEEEeCCCCccc-----------------ccCchhhc--CCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCc
Q 006747 65 SRVLAVRLPGVGLYG-----------------PIPANTLE--KLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNN 125 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g-----------------~lp~~~l~--~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 125 (632)
.++..|+|++|.|+| .+|. .++ +|++|+.|+|++|++.|.+|..|++|++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 468899999999999 4888 566 99999999999999999999999999999999999998
Q ss_pred -CCc-cCCCCcc---------CCCcEEEccCCCCcccCCc--cccCCCCccceecccccccccCCCC-CCCCCcEEEccc
Q 006747 126 -FSG-NIPSSLS---------PQLNWVDLSFNSITGNIPA--SIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSY 191 (632)
Q Consensus 126 -l~g-~~p~~~~---------~~L~~L~Ls~N~l~g~~p~--~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~ 191 (632)
|+| .+|..+. ++|+.|+|++|+|+ .+|. .|+++++|+.|+|++|+++ .+|.+ .+++|+.|+|++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDY 604 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECCS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECcC
Confidence 998 8887654 38999999999999 8999 9999999999999999999 66665 789999999999
Q ss_pred CCCCCCCcccccCCCC
Q 006747 192 NHLNGSVPLALQKFPP 207 (632)
Q Consensus 192 N~l~g~~p~~~~~~~~ 207 (632)
|+|+ .+|..+.+++.
T Consensus 605 N~l~-~lp~~l~~l~~ 619 (876)
T 4ecn_A 605 NQIE-EIPEDFCAFTD 619 (876)
T ss_dssp SCCS-CCCTTSCEECT
T ss_pred Cccc-cchHHHhhccc
Confidence 9999 89987776554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.55 E-value=8.8e-15 Score=164.04 Aligned_cols=143 Identities=20% Similarity=0.190 Sum_probs=95.3
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCcc-ccCCCCCCeEeecCCcCCccCCCCcc--CCCcEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSN-VLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWV 141 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L 141 (632)
.++..|+|++|.+.+..|. .+..+++|+.|+|++|.+.+..|.. +.++++|++|+|++|.+++..|..+. ++|+.|
T Consensus 376 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 454 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTE-AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL 454 (606)
T ss_dssp TTCCEEECCSCSCEEECTT-TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE
T ss_pred CCCCEEECCCCcCCcCCHH-HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE
Confidence 3566777777777755444 6777777777777777777665543 66777777777777777766666554 567777
Q ss_pred EccCCCCccc---CCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCCCC
Q 006747 142 DLSFNSITGN---IPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPPS 208 (632)
Q Consensus 142 ~Ls~N~l~g~---~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~~ 208 (632)
+|++|++++. .+..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|++++.+|..+..++..
T Consensus 455 ~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L 526 (606)
T 3t6q_A 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI 526 (606)
T ss_dssp ECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC
T ss_pred ECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc
Confidence 7777777652 2345667777777777777777666542 56677777777777776666666555543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=2.9e-14 Score=147.17 Aligned_cols=140 Identities=25% Similarity=0.362 Sum_probs=119.0
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccC--CCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLS--GDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~--g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~L 143 (632)
.+..|+++++.+. .+++..+.++++|+.|+|++|.+. +..+..+.++++|++|+|++|.++ .+|..+.++|+.|+|
T Consensus 122 ~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~L~~L~l 199 (330)
T 1xku_A 122 TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHL 199 (330)
T ss_dssp TCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCCTTCSEEEC
T ss_pred cccEEECCCCccc-ccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCccccccCCEEEC
Confidence 4556666666666 355557889999999999999996 477888999999999999999998 678888899999999
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCCCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPPS 208 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~~ 208 (632)
++|++++..|..|..+++|+.|+|++|.+++..+.. .+++|+.|+|++|+++ .+|..+..++..
T Consensus 200 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L 265 (330)
T 1xku_A 200 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265 (330)
T ss_dssp TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSC
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCc
Confidence 999999988999999999999999999999988753 7899999999999999 788877665543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.54 E-value=1.2e-14 Score=163.56 Aligned_cols=153 Identities=24% Similarity=0.311 Sum_probs=132.6
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCc-cCCCCcc--CCCcEEE
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSG-NIPSSLS--PQLNWVD 142 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g-~~p~~~~--~~L~~L~ 142 (632)
.+..+++.+++..+..+...+..+.+|+.++++.|.+.+..|..+..+++|++|+|++|++.+ .+|..+. ++|+.||
T Consensus 421 ~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~ 500 (635)
T 4g8a_A 421 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 500 (635)
T ss_dssp TCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred cccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEE
Confidence 445667777777777777778899999999999999999999999999999999999998654 5666665 7899999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCC----CCCccCCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFP----PSSFEGNSML 216 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~----~~~~~~n~~~ 216 (632)
|++|+|++.+|..|.++++|+.|+|++|+|++.+|.. .+++|+.|||++|+|++..|..+..++ .....+|++.
T Consensus 501 Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 501 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred CCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 9999999999999999999999999999999988863 789999999999999999998887663 3467899988
Q ss_pred CC
Q 006747 217 CG 218 (632)
Q Consensus 217 c~ 218 (632)
|.
T Consensus 581 C~ 582 (635)
T 4g8a_A 581 CT 582 (635)
T ss_dssp CS
T ss_pred cc
Confidence 85
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-14 Score=160.30 Aligned_cols=150 Identities=23% Similarity=0.276 Sum_probs=111.3
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCC--CCCccccCCCCCCeEeecCCcCCccCCCC-cc--CCCc
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSG--DLPSNVLSLSSLRFLYLQNNNFSGNIPSS-LS--PQLN 139 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~--~~L~ 139 (632)
..+..|+|++|.+++.+|. .+..+++|+.|+|++|++++ .+|..+.++++|++|+|++|++++.+|.. +. ++|+
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFE-NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCEEECCSSCCCTTTTT-TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CcccEEEeECCccChhhhh-hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 4577888888888877776 67888888888888888886 55677888888888888888888756654 32 6788
Q ss_pred EEEccCCCCcccCCccccCCCCccceecccccccccCCC-CCCCCCcEEEcccCCCCCCCccc-ccCCCC---CCccCCC
Q 006747 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-FNLSRLRHLNLSYNHLNGSVPLA-LQKFPP---SSFEGNS 214 (632)
Q Consensus 140 ~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~~L~~l~ls~N~l~g~~p~~-~~~~~~---~~~~~n~ 214 (632)
.|+|++|++++.+|..+. ++|+.|+|++|+++..++. +.+++|+.|+|++|+|+ .+|.. +..++. ..+.+|+
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~ 479 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNP 479 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCC
Confidence 888888888877777665 6888888888888844333 37788888888888888 56654 554443 4456777
Q ss_pred CCCC
Q 006747 215 MLCG 218 (632)
Q Consensus 215 ~~c~ 218 (632)
..|.
T Consensus 480 ~~c~ 483 (520)
T 2z7x_B 480 WDCS 483 (520)
T ss_dssp BCCC
T ss_pred Cccc
Confidence 6664
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.53 E-value=3.8e-14 Score=152.44 Aligned_cols=145 Identities=23% Similarity=0.305 Sum_probs=104.9
Q ss_pred CCCC-CCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeE
Q 006747 50 SVCT-SWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFL 119 (632)
Q Consensus 50 ~~c~-~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 119 (632)
+.|. .|..|.|.+.. ..+..|+|++|.+.+ +++..|.++++|+.|+|++|++++..+..|.++++|++|
T Consensus 39 C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L 117 (440)
T 3zyj_A 39 CSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQI-IKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTL 117 (440)
T ss_dssp SEECTTSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCE-ECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEE
T ss_pred CEeCCCCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCe-eCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEE
Confidence 3443 47789997532 246779999999985 444578999999999999999997777889999999999
Q ss_pred eecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCC--C-CCCCCcEEEcccCCC
Q 006747 120 YLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--F-NLSRLRHLNLSYNHL 194 (632)
Q Consensus 120 ~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~--~-~~~~L~~l~ls~N~l 194 (632)
+|++|+|++..+..+. ++|+.|+|++|+|++..+..|.++++|+.|+|++|+..+.++. + .+++|+.|+|++|+|
T Consensus 118 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 197 (440)
T 3zyj_A 118 ELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL 197 (440)
T ss_dssp ECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCC
T ss_pred ECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcC
Confidence 9999999855444554 6888999999888876666677777777777776433333332 1 455566666666655
Q ss_pred C
Q 006747 195 N 195 (632)
Q Consensus 195 ~ 195 (632)
+
T Consensus 198 ~ 198 (440)
T 3zyj_A 198 R 198 (440)
T ss_dssp S
T ss_pred c
Confidence 5
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.4e-14 Score=157.22 Aligned_cols=146 Identities=18% Similarity=0.220 Sum_probs=95.7
Q ss_pred EEEEEeCCCCcccccC-chhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEccC
Q 006747 67 VLAVRLPGVGLYGPIP-ANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp-~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~ 145 (632)
+..|+|++|.+++-.+ ...+..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+++ .+|..+.++|+.|||++
T Consensus 363 L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~Ls~ 440 (549)
T 2z81_A 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDVSN 440 (549)
T ss_dssp CCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEECCS
T ss_pred CcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhcCCceEEECCC
Confidence 4445555555442111 123555666666666666666 45666666666666666666665 44555556677777777
Q ss_pred CCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCCC---CCccCCCCCCC
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPP---SSFEGNSMLCG 218 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~~~~n~~~c~ 218 (632)
|+|++.+ ..+++|+.|+|++|+|+..++...+++|+.|+|++|+|++.+|..+..++. ..+.+|++.|.
T Consensus 441 N~l~~~~----~~l~~L~~L~Ls~N~l~~ip~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 441 NNLDSFS----LFLPRLQELYISRNKLKTLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp SCCSCCC----CCCTTCCEEECCSSCCSSCCCGGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred CChhhhc----ccCChhcEEECCCCccCcCCCcccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 7777532 478889999999999985443347889999999999999888876665554 45677877664
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.52 E-value=3e-15 Score=153.41 Aligned_cols=133 Identities=22% Similarity=0.242 Sum_probs=82.5
Q ss_pred eEEEEEeCCCCcccccCchhh-cCCCCCcEEeccCCccCCCCCccccCC-----CCCCeEeecCCcCCccCCCCcc--CC
Q 006747 66 RVLAVRLPGVGLYGPIPANTL-EKLDSLMILSLRSNHLSGDLPSNVLSL-----SSLRFLYLQNNNFSGNIPSSLS--PQ 137 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l-~~l~~L~~L~Ls~N~l~g~~p~~~~~l-----~~L~~L~Ls~N~l~g~~p~~~~--~~ 137 (632)
++..|+|+++.++|.+|...+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..+. ++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 566677777777766666322 6677777777777777655 6666655 6677777777777655555554 56
Q ss_pred CcEEEccCCCCccc--CCccc--cCCCCccceecccccccccC--C-CC--CCCCCcEEEcccCCCCCCCc
Q 006747 138 LNWVDLSFNSITGN--IPASI--RNLSHLVGLNLQNNSLTGFI--P-NF--NLSRLRHLNLSYNHLNGSVP 199 (632)
Q Consensus 138 L~~L~Ls~N~l~g~--~p~~~--~~l~~L~~l~l~~N~l~~~~--p-~~--~~~~L~~l~ls~N~l~g~~p 199 (632)
|+.|+|++|++.|. +|..+ +++++|+.|+|++|++++.. + .. .+++|+.|+|++|+|++.+|
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 245 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG 245 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence 77777777766654 23333 66666666666666666321 1 11 45666666666666666553
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.52 E-value=1.2e-14 Score=138.38 Aligned_cols=128 Identities=20% Similarity=0.327 Sum_probs=107.8
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.++..|+++++.+. .++ .+..+++|++|+|++|.+++..|..+..+++|++|+|++|++++..|..+. ++|+.|+
T Consensus 66 ~~L~~L~l~~n~~~--~~~-~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 66 HNIKDLTINNIHAT--NYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp TTCSEEEEESCCCS--CCG-GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCEEEccCCCCC--cch-hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 35888999999664 333 689999999999999999988899999999999999999999987776665 7999999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g 196 (632)
|++|.+.+.+| .+..+++|+.|+|++|++++..+-..+++|+.|++++|++.+
T Consensus 143 L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 143 LSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred ccCCCCccccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 99998334566 799999999999999999986543488999999999999874
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=3.7e-14 Score=161.23 Aligned_cols=151 Identities=23% Similarity=0.257 Sum_probs=111.7
Q ss_pred EEEeCCCCcc--cccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCC--------Ccc--C
Q 006747 69 AVRLPGVGLY--GPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS--------SLS--P 136 (632)
Q Consensus 69 ~l~l~~~~l~--g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~--------~~~--~ 136 (632)
.+++.++.+. +.+|. .+..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..+. .+. +
T Consensus 458 ~L~l~~n~l~~~~~~p~-~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~ 536 (680)
T 1ziw_A 458 RLMLRRVALKNVDSSPS-PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLS 536 (680)
T ss_dssp EEECTTSCCBCTTCSSC-TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCT
T ss_pred cchhccccccccccCCc-ccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCC
Confidence 3344444433 34554 677888888888888888877777788888888888888888753221 122 6
Q ss_pred CCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccc----cCCCCCCc
Q 006747 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLAL----QKFPPSSF 210 (632)
Q Consensus 137 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~----~~~~~~~~ 210 (632)
+|+.|+|++|+|+...+..|.++++|+.|+|++|++++.++.. .+++|+.|+|++|+|++..|..+ .++....+
T Consensus 537 ~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l 616 (680)
T 1ziw_A 537 HLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDM 616 (680)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEEC
T ss_pred CCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEc
Confidence 7888999999988544456889999999999999999877763 78899999999999997776643 45666678
Q ss_pred cCCCCCCCCC
Q 006747 211 EGNSMLCGPP 220 (632)
Q Consensus 211 ~~n~~~c~~~ 220 (632)
.+|++.|..+
T Consensus 617 ~~N~~~c~c~ 626 (680)
T 1ziw_A 617 RFNPFDCTCE 626 (680)
T ss_dssp TTCCCCBCCC
T ss_pred cCCCcccCCc
Confidence 8999888643
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.52 E-value=8.4e-14 Score=145.68 Aligned_cols=139 Identities=24% Similarity=0.291 Sum_probs=118.2
Q ss_pred CCCCCCcceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCcccc-CCCCCCeEeecCCcCCc
Q 006747 50 SVCTSWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNNNFSG 128 (632)
Q Consensus 50 ~~c~~w~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N~l~g 128 (632)
..|. ....|.. ..+++++++|+ .+|.. + ...++.|+|++|+|++..+..+. ++++|++|+|++|+|++
T Consensus 10 ~~Cp--~~C~C~~-----~~l~c~~~~l~-~iP~~-~--~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~ 78 (361)
T 2xot_A 10 VSCP--ANCLCAS-----NILSCSKQQLP-NVPQS-L--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF 78 (361)
T ss_dssp TTCC--TTCEEET-----TEEECCSSCCS-SCCSS-C--CTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCE
T ss_pred CCCC--CCCEECC-----CEEEeCCCCcC-ccCcc-C--CCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCc
Confidence 4563 5677864 25789999998 58863 3 34689999999999987777787 99999999999999997
Q ss_pred cCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcc
Q 006747 129 NIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPL 200 (632)
Q Consensus 129 ~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~ 200 (632)
..|..|. ++|++|+|++|+|++..+..|.++++|+.|+|++|++++..|.. .+++|+.|+|++|+|++ +|.
T Consensus 79 i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~ 153 (361)
T 2xot_A 79 ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPV 153 (361)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCG
T ss_pred cChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCH
Confidence 7777675 79999999999999888888999999999999999999987763 78999999999999995 444
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=9.2e-15 Score=159.21 Aligned_cols=128 Identities=30% Similarity=0.238 Sum_probs=67.7
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCC-------------
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS------------- 132 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~------------- 132 (632)
+++.|+|++|.+++. ++..|..+++|+.|+|++|.+++.+| +..+++|++|+|++|.|++..+.
T Consensus 35 ~L~~L~Ls~n~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l 111 (487)
T 3oja_A 35 NVKELDLSGNPLSQI-SAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNI 111 (487)
T ss_dssp GCCEEECCSSCCCCC-CGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCC
T ss_pred CccEEEeeCCcCCCC-CHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcC
Confidence 455566666666542 22355566666666666666654433 55555555555555554432110
Q ss_pred -----CccCCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC---CCCCCcEEEcccCCCCC
Q 006747 133 -----SLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 133 -----~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~---~~~~L~~l~ls~N~l~g 196 (632)
...++|+.|+|++|.|++..|..++++++|+.|+|++|.+++.+|.. .+++|+.|+|++|.|++
T Consensus 112 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 112 SRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp CCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 11134556666666666555555666666666666666666544431 34555555555555553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.6e-14 Score=146.68 Aligned_cols=145 Identities=23% Similarity=0.351 Sum_probs=106.1
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccC--CCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLS--GDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~--g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~L 143 (632)
.+..|+|++|.+. .+|+..+..+++|+.|+|++|.++ +..|..+..+ +|++|+|++|+++ .+|..+.++|+.|+|
T Consensus 124 ~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~~~L~~L~l 200 (332)
T 2ft3_A 124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLPETLNELHL 200 (332)
T ss_dssp TCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSCSSCSCCBC
T ss_pred cCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-ccCccccCCCCEEEC
Confidence 3445555555555 344445666777777777777764 3556666666 7777777777776 366666678999999
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccCCCCCCCcccccCCCCC---CccCCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLNGSVPLALQKFPPS---SFEGNS 214 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~~---~~~~n~ 214 (632)
++|.+++..|..|..+++|+.|+|++|++++.++. + .+++|+.|+|++|+|+ .+|..+..++.. .+.+|.
T Consensus 201 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~ 275 (332)
T 2ft3_A 201 DHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNN 275 (332)
T ss_dssp CSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSC
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCC
Confidence 99999988888899999999999999999988775 3 7889999999999998 788777665543 344444
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.52 E-value=3.6e-14 Score=158.72 Aligned_cols=109 Identities=18% Similarity=0.177 Sum_probs=94.3
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
.+..|+|+++.+++..| ..|+.+++|+.|+|++|.|++..|..|+++++|++|+|++|.|++..+..|. ++|++|+|
T Consensus 76 ~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 76 QVELLNLNDLQIEEIDT-YAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCcEEECCCCCCCCCCh-HHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 57889999999986544 4799999999999999999988888889999999999999999944444343 78999999
Q ss_pred cCCCCcccCCccccCCCCccceeccccccccc
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGF 175 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 175 (632)
++|.|++..|..|+++++|+.|+|++|.+++.
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence 99999998888999999999999999998875
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.6e-14 Score=158.85 Aligned_cols=154 Identities=21% Similarity=0.275 Sum_probs=131.7
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCC-ccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLP-SNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWV 141 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L 141 (632)
.++..|+|+++.+.+ +|+. +..+++|+.|+|++|.+.+..| ..+.++++|++|+|++|.+++.+|..+. ++|+.|
T Consensus 373 ~~L~~L~l~~n~l~~-~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 450 (570)
T 2z63_A 373 TSLKYLDLSFNGVIT-MSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450 (570)
T ss_dssp SCCCEEECCSCSEEE-EEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred CccCEEECCCCcccc-cccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence 467889999999985 5553 8999999999999999997766 5788999999999999999988888775 799999
Q ss_pred EccCCCCc-ccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCCC---CCccCCCC
Q 006747 142 DLSFNSIT-GNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPP---SSFEGNSM 215 (632)
Q Consensus 142 ~Ls~N~l~-g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~~~~n~~ 215 (632)
+|++|.++ +.+|..+..+++|+.|+|++|++++.+|.. .+++|+.|+|++|++++..|..+..++. ..+.+|+.
T Consensus 451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~ 530 (570)
T 2z63_A 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530 (570)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcc
Confidence 99999998 679999999999999999999999987753 7899999999999999887777766554 45678887
Q ss_pred CCCCC
Q 006747 216 LCGPP 220 (632)
Q Consensus 216 ~c~~~ 220 (632)
.|..+
T Consensus 531 ~~~~~ 535 (570)
T 2z63_A 531 DCSCP 535 (570)
T ss_dssp CCCTT
T ss_pred cCCCc
Confidence 77543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.8e-14 Score=155.14 Aligned_cols=143 Identities=20% Similarity=0.143 Sum_probs=124.9
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.++..|+|++|.+++..|. .|.++++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..+. ++|+.|+
T Consensus 56 ~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 134 (477)
T 2id5_A 56 PHLEELELNENIVSAVEPG-AFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE 134 (477)
T ss_dssp TTCCEEECTTSCCCEECTT-TTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccCEeChh-hhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEE
Confidence 4688999999999965555 899999999999999999976667789999999999999999988887776 7999999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCC--CCCCCCcEEEcccCCCCCCCcccccCCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLNGSVPLALQKFPPS 208 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~--~~~~~L~~l~ls~N~l~g~~p~~~~~~~~~ 208 (632)
|++|.+++..|..|.++++|+.|+|++|++++.++. ..+++|+.|+|++|.+++..+..+..++..
T Consensus 135 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L 202 (477)
T 2id5_A 135 VGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRL 202 (477)
T ss_dssp ECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTC
T ss_pred CCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCccc
Confidence 999999998999999999999999999999987664 278999999999999997666666655443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.6e-14 Score=157.67 Aligned_cols=148 Identities=24% Similarity=0.260 Sum_probs=123.7
Q ss_pred CeEEEEEeCCCCccccc--CchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCC-Ccc--CCCc
Q 006747 65 SRVLAVRLPGVGLYGPI--PANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS-SLS--PQLN 139 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~l--p~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~--~~L~ 139 (632)
.++..|+|+++.+++.. |. .+..+++|+.|+|++|.+.+. |..+..+++|++|+|++|.+++..|. .+. ++|+
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~-~~~~~~~L~~L~l~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 424 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQ-SDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEH-HHHTCSCCCEEECCSCSEEEE-EEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred CCCCEEeCcCCccCccccccc-cccccCccCEEECCCCccccc-cccccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence 46888999999998653 44 688999999999999999965 44599999999999999999977663 333 7899
Q ss_pred EEEccCCCCcccCCccccCCCCccceeccccccc-ccCCCC--CCCCCcEEEcccCCCCCCCcccccCCCCC---CccCC
Q 006747 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT-GFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPPS---SFEGN 213 (632)
Q Consensus 140 ~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~-~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~~---~~~~n 213 (632)
+|+|++|.+++.+|..+.++++|+.|+|++|.++ +.+|.. .+++|+.|+|++|++++..|..+..++.. .+.+|
T Consensus 425 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 504 (570)
T 2z63_A 425 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504 (570)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence 9999999999999999999999999999999998 566653 78999999999999998888888766544 34455
Q ss_pred C
Q 006747 214 S 214 (632)
Q Consensus 214 ~ 214 (632)
.
T Consensus 505 ~ 505 (570)
T 2z63_A 505 Q 505 (570)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.1e-14 Score=131.99 Aligned_cols=119 Identities=20% Similarity=0.275 Sum_probs=102.0
Q ss_pred CCCCCcEEeccCCccC-CCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccc
Q 006747 88 KLDSLMILSLRSNHLS-GDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVG 164 (632)
Q Consensus 88 ~l~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 164 (632)
..++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+. ++|++|+|++|.+++.+|..+..+++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3578999999999998 89999999999999999999999966 4444 79999999999999889999999999999
Q ss_pred eecccccccccC--CCC-CCCCCcEEEcccCCCCCCCc---ccccCCCCC
Q 006747 165 LNLQNNSLTGFI--PNF-NLSRLRHLNLSYNHLNGSVP---LALQKFPPS 208 (632)
Q Consensus 165 l~l~~N~l~~~~--p~~-~~~~L~~l~ls~N~l~g~~p---~~~~~~~~~ 208 (632)
|+|++|++++.. ..+ .+++|+.|++++|.+++..+ ..+..++..
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L 142 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQL 142 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCc
Confidence 999999999853 333 78999999999999996655 355555543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.51 E-value=2.5e-14 Score=132.32 Aligned_cols=119 Identities=24% Similarity=0.305 Sum_probs=102.5
Q ss_pred CCCCCcEEeccCCccC-CCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccc
Q 006747 88 KLDSLMILSLRSNHLS-GDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVG 164 (632)
Q Consensus 88 ~l~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 164 (632)
..++|+.|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+. ++|++|+|++|++++.+|..+.++++|+.
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 4578999999999998 88999999999999999999999965 4444 78999999999999889999999999999
Q ss_pred eecccccccccC--CCC-CCCCCcEEEcccCCCCCCCc---ccccCCCCC
Q 006747 165 LNLQNNSLTGFI--PNF-NLSRLRHLNLSYNHLNGSVP---LALQKFPPS 208 (632)
Q Consensus 165 l~l~~N~l~~~~--p~~-~~~~L~~l~ls~N~l~g~~p---~~~~~~~~~ 208 (632)
|+|++|++++.. +.+ .+++|+.|++++|.+++..+ ..+..++..
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L 149 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQL 149 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSC
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccC
Confidence 999999999864 333 78999999999999996554 356655544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.51 E-value=6.4e-14 Score=139.76 Aligned_cols=141 Identities=22% Similarity=0.249 Sum_probs=113.6
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEcc
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls 144 (632)
.++..|++++++++ .+| .+..+++|+.|+|++|++++..| +.++++|++|+|++|++++ +|....++|+.|+|+
T Consensus 41 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~~~L~~L~L~ 114 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPSACLSRLFLD 114 (263)
T ss_dssp TTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCCSSCCEEECC
T ss_pred CcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccccCcccEEEcc
Confidence 35788999999987 566 58899999999999999996544 9999999999999999996 444333899999999
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCCCC---CccCCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPS---SFEGNSM 215 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~~---~~~~n~~ 215 (632)
+|++++ +| .+..+++|+.|+|++|++++..+-..+++|+.|+|++|++++. ..+..++.. .+.+|..
T Consensus 115 ~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~ 184 (263)
T 1xeu_A 115 NNELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKC 184 (263)
T ss_dssp SSCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEE
T ss_pred CCccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcc
Confidence 999996 44 6999999999999999999875334789999999999999865 444444433 3445543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.51 E-value=4.9e-14 Score=156.51 Aligned_cols=139 Identities=22% Similarity=0.234 Sum_probs=110.9
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEcc
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls 144 (632)
.+++.|+|++|.+++ ++++.|.++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|..-.++|++|+|+
T Consensus 52 ~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~l~~L~~L~Ls 129 (562)
T 3a79_B 52 PRTKALSLSQNSISE-LRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCCPMASLRHLDLS 129 (562)
T ss_dssp TTCCEEECCSSCCCC-CCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSCCCTTCSEEECC
T ss_pred CCcCEEECCCCCccc-cChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCccccccCCEEECC
Confidence 367888999998884 55457888999999999999998877888889999999999999988 6666644789999999
Q ss_pred CCCCcc-cCCccccCCCCccceecccccccccCCCCCCCCC--cEEEcccCCC--CCCCcccccCCC
Q 006747 145 FNSITG-NIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRL--RHLNLSYNHL--NGSVPLALQKFP 206 (632)
Q Consensus 145 ~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L--~~l~ls~N~l--~g~~p~~~~~~~ 206 (632)
+|++++ .+|..|+++++|+.|+|++|++++. .-..+++| +.|+|++|++ ++..|..+..+.
T Consensus 130 ~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~ 195 (562)
T 3a79_B 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL-DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195 (562)
T ss_dssp SSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT-TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECC
T ss_pred CCCccccCchHhhcccCcccEEecCCCccccC-chhhhhhceeeEEEeecccccccccCcccccccC
Confidence 999887 4568889999999999999988762 22244555 8999999988 777787776654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.49 E-value=4.7e-14 Score=156.00 Aligned_cols=117 Identities=26% Similarity=0.256 Sum_probs=91.3
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEcc
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLS 144 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls 144 (632)
+..|+|++|.|++ +|. ++.+++|+.|+|++|+|+ .+|..|++|++|++|+|++|+|++ +| .+. ++|+.|+|+
T Consensus 443 L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp CSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred ceEEEecCCCCCC-CcC--ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 5568888888875 664 778888888888888888 778888888888888888888885 66 554 678888888
Q ss_pred CCCCcccC-CccccCCCCccceecccccccccCCCC-----CCCCCcEEEc
Q 006747 145 FNSITGNI-PASIRNLSHLVGLNLQNNSLTGFIPNF-----NLSRLRHLNL 189 (632)
Q Consensus 145 ~N~l~g~~-p~~~~~l~~L~~l~l~~N~l~~~~p~~-----~~~~L~~l~l 189 (632)
+|+|++.+ |..|+.+++|+.|+|++|.|++.+|.. .+++|+.||+
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 88888766 888888888888888888888877753 3677887764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.3e-14 Score=148.41 Aligned_cols=140 Identities=19% Similarity=0.196 Sum_probs=106.9
Q ss_pred eEEEEEeCCCCcccccCchhh-cCCCCCcEEeccCCccCCCCC----ccccCCCCCCeEeecCCcCCccCCCCcc--CCC
Q 006747 66 RVLAVRLPGVGLYGPIPANTL-EKLDSLMILSLRSNHLSGDLP----SNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQL 138 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l-~~l~~L~~L~Ls~N~l~g~~p----~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L 138 (632)
++..|+|+++.+.+.+|...+ ..+++|+.|+|++|.+++..| ..+..+++|++|+|++|++++..|..+. ++|
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L 171 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL 171 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence 377888888888888887322 788889999999999887655 3455788899999999998877777664 788
Q ss_pred cEEEccCCCCccc--C--CccccCCCCccceecccccccccCCC---C--CCCCCcEEEcccCCCCCCCcccccCC
Q 006747 139 NWVDLSFNSITGN--I--PASIRNLSHLVGLNLQNNSLTGFIPN---F--NLSRLRHLNLSYNHLNGSVPLALQKF 205 (632)
Q Consensus 139 ~~L~Ls~N~l~g~--~--p~~~~~l~~L~~l~l~~N~l~~~~p~---~--~~~~L~~l~ls~N~l~g~~p~~~~~~ 205 (632)
++|||++|++.+. + +..++.+++|+.|+|++|+++...+. . .+++|++|+|++|+|++.+|..+..+
T Consensus 172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 8999999988753 2 23347888899999999988754332 1 56889999999999988877766544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.49 E-value=3.6e-14 Score=139.33 Aligned_cols=138 Identities=20% Similarity=0.220 Sum_probs=116.8
Q ss_pred CeEEEEEeCCCC-cccccCchhhcCCCCCcEEeccC-CccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCc-
Q 006747 65 SRVLAVRLPGVG-LYGPIPANTLEKLDSLMILSLRS-NHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLN- 139 (632)
Q Consensus 65 ~~v~~l~l~~~~-l~g~lp~~~l~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~- 139 (632)
.++..|+|++|. ++ .+++..|.++++|++|+|++ |++++..+..|.++++|++|+|++|++++ +|. +. ++|+
T Consensus 55 ~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 55 PNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp TTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 468899999997 65 67777899999999999999 99997777889999999999999999996 776 43 6777
Q ss_pred --EEEccCC-CCcccCCccccCCCCcc-ceecccccccccCCC-CCCCCCcEEEcccCC-CCCCCcccccCC
Q 006747 140 --WVDLSFN-SITGNIPASIRNLSHLV-GLNLQNNSLTGFIPN-FNLSRLRHLNLSYNH-LNGSVPLALQKF 205 (632)
Q Consensus 140 --~L~Ls~N-~l~g~~p~~~~~l~~L~-~l~l~~N~l~~~~p~-~~~~~L~~l~ls~N~-l~g~~p~~~~~~ 205 (632)
+|+|++| ++++..+..|.++++|+ .|+|++|+++..++. +..++|+.|+|++|+ +++..+..+..+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l 203 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTC
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhcc
Confidence 9999999 99987777899999999 999999999965554 345789999999995 885545556555
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.49 E-value=4.9e-15 Score=168.94 Aligned_cols=138 Identities=27% Similarity=0.328 Sum_probs=118.2
Q ss_pred CCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEE
Q 006747 64 GSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWV 141 (632)
Q Consensus 64 ~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L 141 (632)
...+..|+|++|.+. .||.+ +..+++|+.|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..+. ++|++|
T Consensus 223 l~~L~~L~Ls~n~l~-~l~~~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 223 DQLWHALDLSNLQIF-NISAN-IFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCEEECTTSCCS-CCCGG-GGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred CCCCcEEECCCCCCC-CCChh-hcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 356889999999998 89884 568999999999999999 89999999999999999999999 8899887 799999
Q ss_pred EccCCCCcccCCccccCCCCccceecccccccccCCCC--CC-CCCcEEEcccCCCCCCCcccccCCC
Q 006747 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NL-SRLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 142 ~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~-~~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
+|++|.|+ .+|..|++|++|+.|+|++|.|++.+|.. .+ ..+..|+|++|.++|.+|..+..+.
T Consensus 299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l~ 365 (727)
T 4b8c_D 299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFIE 365 (727)
T ss_dssp ECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-----
T ss_pred ECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccceeE
Confidence 99999998 78999999999999999999999988863 11 1223578999999999998876554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.6e-14 Score=148.30 Aligned_cols=144 Identities=18% Similarity=0.181 Sum_probs=86.7
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc---CCCcEEEc
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS---PQLNWVDL 143 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~---~~L~~L~L 143 (632)
+..|++++|.+++..+ ..+++|+.|+|++|++++..|..+..+++|++|+|++|.+++..|..+. ++|++|+|
T Consensus 101 L~~L~l~~n~l~~~~~----~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L 176 (317)
T 3o53_A 101 IETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176 (317)
T ss_dssp CCEEECCSSCCSEEEE----CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred cCEEECCCCccCCcCc----cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEEC
Confidence 3445555555553322 2356677777777777766666666777777777777777765555543 56777777
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCCC---CCccCCCCCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFPP---SSFEGNSMLC 217 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~~~~n~~~c 217 (632)
++|.+++. |. ...+++|+.|+|++|++++.++.+ .+++|+.|+|++|+|+ .+|..+..++. ..+.+|...|
T Consensus 177 ~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 177 QYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp TTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBH
T ss_pred CCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccC
Confidence 77777653 22 223667777777777777665554 5666777777777776 45555544333 3345555544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.49 E-value=2.9e-14 Score=156.70 Aligned_cols=139 Identities=22% Similarity=0.231 Sum_probs=120.9
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEcc
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls 144 (632)
.+++.|+|+++.+++ ++++.|.++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|..-.++|++|+|+
T Consensus 21 ~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~l~~L~~L~L~ 98 (520)
T 2z7x_B 21 QKTTILNISQNYISE-LWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHLDLS 98 (520)
T ss_dssp TTCSEEECCSSCCCC-CCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECCCCCCCSEEECC
T ss_pred ccccEEECCCCcccc-cChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCccccCCccEEecc
Confidence 478899999999985 44458999999999999999999888999999999999999999999 6776645899999999
Q ss_pred CCCCcc-cCCccccCCCCccceecccccccccCCCCCCCCC--cEEEcccCCC--CCCCcccccCCC
Q 006747 145 FNSITG-NIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRL--RHLNLSYNHL--NGSVPLALQKFP 206 (632)
Q Consensus 145 ~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L--~~l~ls~N~l--~g~~p~~~~~~~ 206 (632)
+|++++ .+|..|+++++|+.|+|++|++++. .-..+++| +.|++++|.+ ++.+|..+..+.
T Consensus 99 ~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~ 164 (520)
T 2z7x_B 99 FNAFDALPICKEFGNMSQLKFLGLSTTHLEKS-SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFN 164 (520)
T ss_dssp SSCCSSCCCCGGGGGCTTCCEEEEEESSCCGG-GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred CCccccccchhhhccCCcceEEEecCcccchh-hccccccceeeEEEeecccccccccccccccccc
Confidence 999998 5889999999999999999999872 22256777 9999999999 888888877655
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.7e-13 Score=127.06 Aligned_cols=105 Identities=23% Similarity=0.239 Sum_probs=71.1
Q ss_pred EEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCC
Q 006747 69 AVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFN 146 (632)
Q Consensus 69 ~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N 146 (632)
.|++++++|+ .+|.. + .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|. ++|++|+|++|
T Consensus 13 ~l~~s~n~l~-~ip~~-~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTG-I--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp EEECTTSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCcc-C--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 4556666666 46653 3 37788888888888877777788888888888888888744444332 56777777777
Q ss_pred CCcccCCccccCCCCccceecccccccccCC
Q 006747 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIP 177 (632)
Q Consensus 147 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p 177 (632)
+|++..+..|.++++|+.|+|++|.++...+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 7776555566666666666666666665433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.6e-13 Score=145.06 Aligned_cols=108 Identities=20% Similarity=0.271 Sum_probs=91.9
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCc-c--CCCcEEE
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL-S--PQLNWVD 142 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~--~~L~~L~ 142 (632)
++..|+|+++.+.+ +++..+..+++|+.|+|++|.+++..|..|.++++|++|+|++|+++ .+|..+ . ++|++|+
T Consensus 70 ~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 70 QVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred cCcEEECCCCcccc-cChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 57788999999874 55557899999999999999999888888899999999999999998 555543 3 7899999
Q ss_pred ccCCCCcccCCccccCCCCccceeccccccccc
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGF 175 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~ 175 (632)
|++|++++..|..|.++++|+.|+|++|++++.
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 999999988888899999999999999998864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=128.27 Aligned_cols=113 Identities=23% Similarity=0.272 Sum_probs=99.1
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
..++.|+|+++.++ .+|+..+..+++|+.|+|++|+|++..+..|.++++|++|+|++|++++..+..+. ++|+.|+
T Consensus 28 ~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 106 (177)
T 2o6r_A 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA 106 (177)
T ss_dssp TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence 46889999999998 46666789999999999999999977777789999999999999999966665554 7999999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN 178 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 178 (632)
|++|+|++..+..+..+++|+.|+|++|.+++..|.
T Consensus 107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 142 (177)
T 2o6r_A 107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 142 (177)
T ss_dssp CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCcc
Confidence 999999976666789999999999999999987663
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.45 E-value=4.8e-14 Score=144.73 Aligned_cols=133 Identities=22% Similarity=0.167 Sum_probs=105.5
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
..+..|+|++|.+++ ++ .+++|+.|+|++|.+++..+. .+++|++|+|++|++++..|..+. ++|++|+
T Consensus 80 ~~L~~L~Ls~n~l~~-l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 150 (317)
T 3o53_A 80 STLRTLDLNNNYVQE-LL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150 (317)
T ss_dssp TTCCEEECCSSEEEE-EE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEE
T ss_pred CCCCEEECcCCcccc-cc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEE
Confidence 467888999998873 33 348899999999999865443 367899999999999976666664 7899999
Q ss_pred ccCCCCcccCCccc-cCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCCC
Q 006747 143 LSFNSITGNIPASI-RNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPP 207 (632)
Q Consensus 143 Ls~N~l~g~~p~~~-~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 207 (632)
|++|.+++..|..+ ..+++|+.|+|++|.+++..+...+++|+.|+|++|+|++ +|..+..++.
T Consensus 151 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~ 215 (317)
T 3o53_A 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAG 215 (317)
T ss_dssp CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE-ECGGGGGGTT
T ss_pred CCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCc-chhhhcccCc
Confidence 99999998777777 4789999999999999988665678899999999999985 4544555443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.7e-13 Score=125.31 Aligned_cols=106 Identities=23% Similarity=0.245 Sum_probs=79.3
Q ss_pred EEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccC
Q 006747 68 LAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSF 145 (632)
Q Consensus 68 ~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~ 145 (632)
..+++++++|. .+|.. + .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|. ++|++|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~-~--~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAG-I--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCC-c--CCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 45788888885 78773 3 37888999999999888888888899999998888888854443333 6778888888
Q ss_pred CCCcccCCccccCCCCccceecccccccccCC
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIP 177 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p 177 (632)
|+|++..+..|..+++|+.|+|++|.+....+
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~ 122 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR 122 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence 88876555557777777777777777765543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.45 E-value=2.6e-13 Score=125.83 Aligned_cols=105 Identities=25% Similarity=0.364 Sum_probs=93.6
Q ss_pred CcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceeccc
Q 006747 92 LMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQN 169 (632)
Q Consensus 92 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~ 169 (632)
.+.|++++|.|+ .+|..+. ++|++|+|++|+|++..|..|. ++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 468999999999 5777663 8999999999999988788776 7999999999999987777889999999999999
Q ss_pred ccccccCCC-C-CCCCCcEEEcccCCCCCCCc
Q 006747 170 NSLTGFIPN-F-NLSRLRHLNLSYNHLNGSVP 199 (632)
Q Consensus 170 N~l~~~~p~-~-~~~~L~~l~ls~N~l~g~~p 199 (632)
|+|++.++. + .+++|+.|+|++|.|++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 999998886 4 78999999999999997654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.44 E-value=1.3e-13 Score=128.69 Aligned_cols=124 Identities=20% Similarity=0.224 Sum_probs=101.4
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCC-CCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCc-c--CCCcE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLD-SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL-S--PQLNW 140 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~-~--~~L~~ 140 (632)
..+..|+|++|+++ .+|. +..+. +|+.|+|++|.|++. ..+..+++|++|+|++|++++. |..+ . ++|++
T Consensus 19 ~~L~~L~l~~n~l~-~i~~--~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~ 92 (176)
T 1a9n_A 19 VRDRELDLRGYKIP-VIEN--LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRI-GEGLDQALPDLTE 92 (176)
T ss_dssp TSCEEEECTTSCCC-SCCC--GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEE-CSCHHHHCTTCCE
T ss_pred CCceEEEeeCCCCc-hhHH--hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccccc-CcchhhcCCCCCE
Confidence 35888999999998 5654 44444 999999999999965 6788999999999999999954 5433 3 78999
Q ss_pred EEccCCCCcccCCc--cccCCCCccceecccccccccCCC----C-CCCCCcEEEcccCCCC
Q 006747 141 VDLSFNSITGNIPA--SIRNLSHLVGLNLQNNSLTGFIPN----F-NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 141 L~Ls~N~l~g~~p~--~~~~l~~L~~l~l~~N~l~~~~p~----~-~~~~L~~l~ls~N~l~ 195 (632)
|+|++|+|+ .+|. .+..+++|+.|+|++|.++..++. + .+++|+.||+++|.+.
T Consensus 93 L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 93 LILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp EECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred EECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 999999996 5676 889999999999999999866543 2 7899999999999765
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=4.4e-13 Score=124.80 Aligned_cols=103 Identities=22% Similarity=0.353 Sum_probs=91.7
Q ss_pred cEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccc
Q 006747 93 MILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNN 170 (632)
Q Consensus 93 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N 170 (632)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|. ++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999997 7787775 8999999999999988887775 79999999999999866667899999999999999
Q ss_pred cccccCCC-C-CCCCCcEEEcccCCCCCCC
Q 006747 171 SLTGFIPN-F-NLSRLRHLNLSYNHLNGSV 198 (632)
Q Consensus 171 ~l~~~~p~-~-~~~~L~~l~ls~N~l~g~~ 198 (632)
+|++.++. + .+++|+.|+|++|.|....
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 99998876 4 7899999999999998543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.44 E-value=7.1e-14 Score=153.96 Aligned_cols=133 Identities=22% Similarity=0.334 Sum_probs=101.9
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEcc
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls 144 (632)
.++..|+|++|.|++ ||. +.. +|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. ..++|+.|+|+
T Consensus 100 ~~L~~L~Ls~N~l~~-ip~--l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~-~l~~L~~L~Ls 168 (571)
T 3cvr_A 100 ASLEYLDACDNRLST-LPE--LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE-LPTSLEVLSVR 168 (571)
T ss_dssp TTCCEEECCSSCCSC-CCC--CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CCTTCCEEECC
T ss_pred CCCCEEEccCCCCCC-cch--hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC-cCCCcCEEECC
Confidence 467788999999987 876 544 89999999999987 666 68899999999999985 676 55789999999
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCCCCCCC-------cEEEcccCCCCCCCcccccCCCCC---CccCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRL-------RHLNLSYNHLNGSVPLALQKFPPS---SFEGNS 214 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L-------~~l~ls~N~l~g~~p~~~~~~~~~---~~~~n~ 214 (632)
+|+|++ +|. |. ++|+.|+|++|+|+..++ +. .+| +.|+|++|+|+ .+|..+.+++.. .+.+|.
T Consensus 169 ~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~-~~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~ 241 (571)
T 3cvr_A 169 NNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VP-VRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNP 241 (571)
T ss_dssp SSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC---------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSS
T ss_pred CCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HH-HhhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCc
Confidence 999987 777 66 889999999999985544 42 266 88999999988 678776665543 345554
Q ss_pred C
Q 006747 215 M 215 (632)
Q Consensus 215 ~ 215 (632)
.
T Consensus 242 l 242 (571)
T 3cvr_A 242 L 242 (571)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.44 E-value=3.5e-13 Score=136.46 Aligned_cols=131 Identities=31% Similarity=0.406 Sum_probs=96.6
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.++..|+|++|.+++ +++ +..+++|+.|+|++|.+++ +| .+..+++|++|+|++|++++. + .+. ++|+.|+
T Consensus 68 ~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~-~l~~l~~L~~L~ 140 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-N-GLVHLPQLESLY 140 (291)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-G-GGGGCTTCCEEE
T ss_pred CCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-h-hhcCCCCCCEEE
Confidence 357788888888875 333 7788888888888888875 33 478888888888888888753 3 232 6788888
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
|++|++++. ..+..+++|+.|+|++|++++..+-..+++|+.|+|++|+|++ +|. +..++
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~-l~~-l~~l~ 200 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRA-LAGLK 200 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CGG-GTTCT
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC-Chh-hccCC
Confidence 888888864 5778888888888888888877664477888888888888874 442 44443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.42 E-value=3.2e-13 Score=140.57 Aligned_cols=147 Identities=23% Similarity=0.268 Sum_probs=94.0
Q ss_pred CCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCc-cccCCCCCCe-
Q 006747 50 SVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPS-NVLSLSSLRF- 118 (632)
Q Consensus 50 ~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~- 118 (632)
+.| +|..|.|++++ ..++.|+|++|.|+ .||++.|.+|++|++|+|++|++.+.+|. .|.++++|++
T Consensus 7 C~C-~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~ 84 (350)
T 4ay9_X 7 CHC-SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 84 (350)
T ss_dssp SEE-ETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEE
T ss_pred cEe-eCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhh
Confidence 335 79999998632 25788999999998 78888899999999999999998766553 4566666553
Q ss_pred EeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCC-------------------------ccccCCC-Cccceecccc
Q 006747 119 LYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIP-------------------------ASIRNLS-HLVGLNLQNN 170 (632)
Q Consensus 119 L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p-------------------------~~~~~l~-~L~~l~l~~N 170 (632)
++++.|++++..|..|. ++|++|++++|+|++..+ ..|..+. .|+.|+|++|
T Consensus 85 l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N 164 (350)
T 4ay9_X 85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 164 (350)
T ss_dssp EEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred hcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence 44555666644444443 456666665555553222 1222232 4566777777
Q ss_pred cccccCCC-CCCCCCcEEEccc-CCCCCCCc
Q 006747 171 SLTGFIPN-FNLSRLRHLNLSY-NHLNGSVP 199 (632)
Q Consensus 171 ~l~~~~p~-~~~~~L~~l~ls~-N~l~g~~p 199 (632)
+|+...+. +...+|+.|++++ |.++ .+|
T Consensus 165 ~i~~i~~~~f~~~~L~~l~l~~~n~l~-~i~ 194 (350)
T 4ay9_X 165 GIQEIHNSAFNGTQLDELNLSDNNNLE-ELP 194 (350)
T ss_dssp CCCEECTTSSTTEEEEEEECTTCTTCC-CCC
T ss_pred cccCCChhhccccchhHHhhccCCccc-CCC
Confidence 77765544 2455666666654 3333 444
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=2.2e-13 Score=141.98 Aligned_cols=133 Identities=23% Similarity=0.250 Sum_probs=114.0
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCC--Ccc--CCCcE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS--SLS--PQLNW 140 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~--~~~--~~L~~ 140 (632)
.++..|+|++|.+++..| ..+.++++|++|+|++|++++..+..+.++++|++|+|++|+++ .+|. .+. ++|+.
T Consensus 76 ~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 76 VNLQALVLTSNGINTIEE-DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp TTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCEEECCCCccCccCH-hhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 468899999999996444 47999999999999999999655555899999999999999999 4555 443 79999
Q ss_pred EEccCC-CCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcc
Q 006747 141 VDLSFN-SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPL 200 (632)
Q Consensus 141 L~Ls~N-~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~ 200 (632)
|+|++| .+++..|..|+++++|+.|++++|++++..|.. .+++|++|++++|+++ .+|.
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~ 215 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLE 215 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHH
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchh
Confidence 999999 577777889999999999999999999987763 7889999999999986 4554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.41 E-value=5.4e-13 Score=136.26 Aligned_cols=127 Identities=24% Similarity=0.336 Sum_probs=93.8
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEcc
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls 144 (632)
.++..|+|+++.+.+ +++ +..+++|+.|+|++|.+++. +.+..+++|++|+|++|++++..+-.-.++|+.|+|+
T Consensus 63 ~~L~~L~L~~n~i~~-~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~ 137 (308)
T 1h6u_A 63 NNLIGLELKDNQITD-LAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (308)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCEEEccCCcCCC-Chh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCCchhhcCCCCCCEEECC
Confidence 357788888888874 443 77888888888888888753 3688888888888888888753221112678888888
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSV 198 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~ 198 (632)
+|++++..+ ++.+++|+.|+|++|++++..+-..+++|+.|+|++|++++..
T Consensus 138 ~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~ 189 (308)
T 1h6u_A 138 LNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDIS 189 (308)
T ss_dssp SSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCG
T ss_pred CCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcCh
Confidence 888876433 7788888888888888887665346778888888888887543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.41 E-value=5.9e-13 Score=134.80 Aligned_cols=130 Identities=25% Similarity=0.389 Sum_probs=110.1
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
++..|+++++++. .++ .+..+++|+.|+|++|++++..+ +.++++|++|+|++|++++ +|. +. ++|+.|+|
T Consensus 47 ~L~~L~l~~~~i~-~~~--~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L 119 (291)
T 1h6t_A 47 SIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSL 119 (291)
T ss_dssp TCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEEC
T ss_pred cccEEEccCCCcc-cCh--hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEEC
Confidence 5788999999987 455 48899999999999999996544 9999999999999999996 333 43 79999999
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFPP 207 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 207 (632)
++|++++. ..+..+++|+.|+|++|++++. +.+ .+++|+.|+|++|++++..| +..++.
T Consensus 120 ~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~ 179 (291)
T 1h6t_A 120 EHNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTK 179 (291)
T ss_dssp TTSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred CCCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCc
Confidence 99999963 5789999999999999999987 443 88999999999999997555 555543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.41 E-value=6.8e-13 Score=135.52 Aligned_cols=122 Identities=22% Similarity=0.360 Sum_probs=77.6
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
+++.|++.++++. .+| .+..+++|+.|+|++|.+++. +. +..+++|++|+|++|++++ +| .+. ++|+.|+|
T Consensus 42 ~L~~L~l~~~~i~-~l~--~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l 114 (308)
T 1h6u_A 42 GITTLSAFGTGVT-TIE--GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDL 114 (308)
T ss_dssp TCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEEC
T ss_pred CcCEEEeeCCCcc-Cch--hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEEC
Confidence 4566666766665 344 366677777777777777643 33 6677777777777777664 23 232 56777777
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g 196 (632)
++|++++ +|. +..+++|+.|+|++|++++..+-..+++|+.|+|++|++++
T Consensus 115 ~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 115 TSTQITD-VTP-LAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp TTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC
T ss_pred CCCCCCC-chh-hcCCCCCCEEECCCCccCcCccccCCCCccEEEccCCcCCC
Confidence 7777765 332 66677777777777777665553356677777777777664
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.40 E-value=1.1e-15 Score=145.66 Aligned_cols=130 Identities=28% Similarity=0.345 Sum_probs=109.3
Q ss_pred eEEEEEeCCCCcccccCc-----hhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCC
Q 006747 66 RVLAVRLPGVGLYGPIPA-----NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQL 138 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~-----~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L 138 (632)
+++.+++..+.++|.+|. ..+..+++|+.|+|++|++++ +| .+.++++|++|+|++|+++ .+|..+. ++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 455556666666666653 268899999999999999996 77 8999999999999999999 6777654 789
Q ss_pred cEEEccCCCCcccCCccccCCCCccceecccccccccCC--C-CCCCCCcEEEcccCCCCCCCcc
Q 006747 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIP--N-FNLSRLRHLNLSYNHLNGSVPL 200 (632)
Q Consensus 139 ~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p--~-~~~~~L~~l~ls~N~l~g~~p~ 200 (632)
++|+|++|++++ +| .+..+++|+.|+|++|++++..+ . ..+++|+.|++++|.+++.+|.
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 999999999997 55 68999999999999999997544 2 3789999999999999877665
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.40 E-value=1.2e-13 Score=148.95 Aligned_cols=101 Identities=23% Similarity=0.230 Sum_probs=51.7
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCC-------------CeEeecCCcCCccCC
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSL-------------RFLYLQNNNFSGNIP 131 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L-------------~~L~Ls~N~l~g~~p 131 (632)
.++..++++++++ |.||+ .+++|++|++|+|++|.+.|.+|..++++++| ++|++++|.+++ +|
T Consensus 11 ~~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp 87 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LP 87 (454)
T ss_dssp -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CC
T ss_pred ccchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CC
Confidence 4677888999998 89987 68999999999999999998899888887754 777777777774 34
Q ss_pred CCccCCCcEEEccCCCCcccCCccccCCCCccceeccccccc
Q 006747 132 SSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT 173 (632)
Q Consensus 132 ~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 173 (632)
. +.++|+.|+|++|++++ +|..+ ++|+.|++++|+++
T Consensus 88 ~-~~~~L~~L~l~~n~l~~-lp~~~---~~L~~L~l~~n~l~ 124 (454)
T 1jl5_A 88 E-LPPHLESLVASCNSLTE-LPELP---QSLKSLLVDNNNLK 124 (454)
T ss_dssp S-CCTTCSEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS
T ss_pred C-CcCCCCEEEccCCcCCc-ccccc---CCCcEEECCCCccC
Confidence 3 33566666666666665 55432 34444444444444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.39 E-value=8.7e-13 Score=146.78 Aligned_cols=132 Identities=32% Similarity=0.429 Sum_probs=109.1
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
..+..|+|++|.+.+ +++ +..|++|+.|+|++|.|++ +| .+..|++|++|+|++|+|++ ++ .+. ++|+.|+
T Consensus 65 ~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~ 137 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTD-IKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLY 137 (605)
T ss_dssp TTCCEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEE
T ss_pred CCCCEEEeeCCCCCC-Chh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEE
Confidence 468899999999986 443 8899999999999999985 34 78999999999999999985 33 233 7899999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPP 207 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 207 (632)
|++|+|++. ..+..|++|+.|+|++|+|++.+|-..+++|+.|+|++|+|++ +| .+..++.
T Consensus 138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~ 198 (605)
T 1m9s_A 138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LR-ALAGLKN 198 (605)
T ss_dssp CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB-CG-GGTTCTT
T ss_pred CCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCC-Ch-HHccCCC
Confidence 999999974 6789999999999999999998885588999999999999985 34 4554443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=5.8e-13 Score=147.26 Aligned_cols=104 Identities=27% Similarity=0.290 Sum_probs=85.6
Q ss_pred CCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecc
Q 006747 91 SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQ 168 (632)
Q Consensus 91 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~ 168 (632)
.|+.|+|++|+|++ +|. |+++++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|++ +| .++++++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 46788888888885 665 888888999999998888 7787776 788889999998886 67 78888889999999
Q ss_pred cccccccC-CC-C-CCCCCcEEEcccCCCCCCCc
Q 006747 169 NNSLTGFI-PN-F-NLSRLRHLNLSYNHLNGSVP 199 (632)
Q Consensus 169 ~N~l~~~~-p~-~-~~~~L~~l~ls~N~l~g~~p 199 (632)
+|+|++.+ |. + .+++|+.|+|++|+|++.+|
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 99888885 54 3 78888899999988886554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=140.89 Aligned_cols=123 Identities=21% Similarity=0.160 Sum_probs=80.9
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEccC
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~ 145 (632)
.+..+++.+|...|.++ +..+++|+.|+|++|++++ +| +..+++|+.|+|++|++++. +-.-.++|+.|+|++
T Consensus 149 ~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~ 221 (457)
T 3bz5_A 149 QLTELDCHLNKKITKLD---VTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSS 221 (457)
T ss_dssp TCCEEECTTCSCCCCCC---CTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCS
T ss_pred cCCEEECCCCCcccccc---cccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcC
Confidence 46677777776666663 5677777888888887775 44 67777777777777777753 322236777777777
Q ss_pred CCCcccCCccccCCCCccceecccccccccCCCCCCC----------CCcEEEcccCCCCCCCc
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLS----------RLRHLNLSYNHLNGSVP 199 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~----------~L~~l~ls~N~l~g~~p 199 (632)
|+|++ +| ++.+++|+.|+|++|++++.++. .++ +|+.|++++|.+.|.+|
T Consensus 222 N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~-~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~ 281 (457)
T 3bz5_A 222 NKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS-TLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ 281 (457)
T ss_dssp SCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT-TCTTCCEEECTTCCCSCCCCTTCTTCCEEE
T ss_pred Ccccc-cC--ccccCCCCEEEeeCCcCCCcCHH-HCCCCCEEeccCCCCCEEECCCCccCCccc
Confidence 77776 55 67777777777777777775432 222 34445555555555555
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.36 E-value=1.4e-12 Score=135.51 Aligned_cols=108 Identities=25% Similarity=0.339 Sum_probs=77.5
Q ss_pred CCCCCcceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccC-CccCCCCCccccCCCCCCeEeecCCcCCcc
Q 006747 51 VCTSWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRS-NHLSGDLPSNVLSLSSLRFLYLQNNNFSGN 129 (632)
Q Consensus 51 ~c~~w~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ 129 (632)
.| .|.+|.|+++ |+|+ .||. +..+++|+.|+|++ |.|++..|..|.+|++|++|+|++|+|++.
T Consensus 7 ~C-~~~~v~~~~~-----------n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 71 (347)
T 2ifg_A 7 PH-GSSGLRCTRD-----------GALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71 (347)
T ss_dssp CS-SSSCEECCSS-----------CCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEE
T ss_pred cc-cCCEEEcCCC-----------CCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCcccee
Confidence 35 6777777542 1455 4776 88888999999986 899877778888898888888888888876
Q ss_pred CCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccc
Q 006747 130 IPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTG 174 (632)
Q Consensus 130 ~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~ 174 (632)
.|..|. ++|+.|||++|+|++..+..|..++ |+.|+|++|.|..
T Consensus 72 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 666554 5677777777777754444555444 6677777666653
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.1e-12 Score=142.09 Aligned_cols=134 Identities=25% Similarity=0.358 Sum_probs=110.5
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEcc
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls 144 (632)
.++..|+++++.+.+..+ +..+++|+.|+|++|.+++..+ +..+++|++|+|++|++++..|-.-.++|+.|+|+
T Consensus 243 ~~L~~L~l~~n~l~~~~~---~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~ 317 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLY 317 (466)
T ss_dssp TTCSEEECCSSCCCCCGG---GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECC
T ss_pred CCCCEEECCCCccccchh---hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchhhcCCCCCCEEECc
Confidence 367889999999986543 7889999999999999996544 88999999999999999976553334889999999
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPP 207 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 207 (632)
+|++++..| +..+++|+.|++++|.+++...-..+++|+.|++++|++++.+| +..++.
T Consensus 318 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~ 376 (466)
T 1o6v_A 318 FNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTR 376 (466)
T ss_dssp SSCCSCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCGG--GTTCTT
T ss_pred CCcCCCchh--hccCccCCEeECCCCccCCchhhccCCCCCEEeCCCCccCccch--hhcCCC
Confidence 999998766 78999999999999999987433488999999999999998777 555444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.36 E-value=1.5e-12 Score=141.02 Aligned_cols=134 Identities=28% Similarity=0.320 Sum_probs=113.7
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEcc
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls 144 (632)
.++..|+|+++.+.+ ++ .+..+++|+.|+|++|.+++..| +..+++|++|+|++|.+++..|-.-.++|+.|+|+
T Consensus 221 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~ 295 (466)
T 1o6v_A 221 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 295 (466)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCCCEEECCCCCccc-ch--hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCccccccCCCccCeEEcC
Confidence 468899999999985 43 58899999999999999997655 89999999999999999976553333899999999
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPP 207 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 207 (632)
+|++++..| ++.+++|+.|+|++|++++..|...+++|+.|++++|++++. ..+..++.
T Consensus 296 ~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~ 354 (466)
T 1o6v_A 296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTN 354 (466)
T ss_dssp SSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTT
T ss_pred CCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc--hhhccCCC
Confidence 999997554 899999999999999999988856899999999999999975 34555444
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.35 E-value=6.7e-13 Score=147.95 Aligned_cols=140 Identities=26% Similarity=0.365 Sum_probs=96.5
Q ss_pred CCCCCCCCCCCCcce--------EecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCC
Q 006747 44 NWNSSTSVCTSWVGI--------TCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSS 115 (632)
Q Consensus 44 ~w~~~~~~c~~w~gv--------~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 115 (632)
.|....++| .|.|. .|.. ..++.|++++++|+ .+|.. +. ++|+.|+|++|+|+ .+|. .+++
T Consensus 14 ~W~~~~~~~-~~~~r~~~~~~~~~c~~--~~l~~L~ls~n~L~-~lp~~-l~--~~L~~L~L~~N~l~-~lp~---~l~~ 82 (622)
T 3g06_A 14 AWRRAAPAE-ESRGRAAVVQKMRACLN--NGNAVLNVGESGLT-TLPDC-LP--AHITTLVIPDNNLT-SLPA---LPPE 82 (622)
T ss_dssp HHHHTCCGG-GHHHHHHHHHHHHHHHH--HCCCEEECCSSCCS-CCCSC-CC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred HHHhcCCcc-hhccccccCcccccccC--CCCcEEEecCCCcC-ccChh-hC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence 576555555 78654 3322 34778888888888 77763 33 78888888888888 4565 5788
Q ss_pred CCeEeecCCcCCccCCCCccCCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCC
Q 006747 116 LRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195 (632)
Q Consensus 116 L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~ 195 (632)
|++|+|++|+|+ .+|. ..++|++|+|++|+|++ +|. .+++|+.|+|++|++++.++. +++|++|+|++|+|+
T Consensus 83 L~~L~Ls~N~l~-~lp~-~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~~--l~~L~~L~Ls~N~l~ 154 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV-LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPVL--PPGLQELSVSDNQLA 154 (622)
T ss_dssp CCEEEECSCCCS-CCCC-CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCCS
T ss_pred CCEEEcCCCcCC-cCCC-CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCCC--CCCCCEEECcCCcCC
Confidence 888888888887 5666 44778888888888875 454 556777777777777764432 367777777777776
Q ss_pred CCCccccc
Q 006747 196 GSVPLALQ 203 (632)
Q Consensus 196 g~~p~~~~ 203 (632)
+ +|..+.
T Consensus 155 ~-l~~~~~ 161 (622)
T 3g06_A 155 S-LPALPS 161 (622)
T ss_dssp C-CCCCCT
T ss_pred C-cCCccC
Confidence 4 343333
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.35 E-value=1.7e-12 Score=144.40 Aligned_cols=131 Identities=25% Similarity=0.408 Sum_probs=110.7
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.++..|+|+++.+. .+| .+..|++|+.|+|++|+|++..| +..|++|++|+|++|+|++ +| .+. ++|+.|+
T Consensus 43 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~ 115 (605)
T 1m9s_A 43 NSIDQIIANNSDIK-SVQ--GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLS 115 (605)
T ss_dssp TTCCCCBCTTCCCC-CCT--TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEE
T ss_pred CCCCEEECcCCCCC-CCh--HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEE
Confidence 35777888888887 455 48999999999999999997554 9999999999999999995 44 343 7999999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCcccccCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVPLALQKFPP 207 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 207 (632)
|++|+|++ + ..+..|++|+.|+|++|+|++. +.+ .+++|+.|+|++|.|++..| +..++.
T Consensus 116 Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~ 176 (605)
T 1m9s_A 116 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTK 176 (605)
T ss_dssp CTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTT
T ss_pred ecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCC
Confidence 99999996 3 4699999999999999999987 443 89999999999999998766 555544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.35 E-value=2e-12 Score=128.92 Aligned_cols=123 Identities=23% Similarity=0.264 Sum_probs=104.4
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
..+..|+|++|.+++ +++ +..+++|+.|+|++|++++ +|.. .. ++|++|+|++|++++. + .+. ++|+.|+
T Consensus 63 ~~L~~L~L~~N~i~~-~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 63 TNLKELHLSHNQISD-LSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILS 134 (263)
T ss_dssp TTCCEEECCSSCCCC-CGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCccCC-Chh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCCC-h-hhcCcccccEEE
Confidence 468999999999985 544 8999999999999999996 4543 33 9999999999999963 3 343 7999999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGS 197 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~ 197 (632)
|++|+|++. | .+..+++|+.|+|++|++++...-..+++|+.|++++|++++.
T Consensus 135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBCTTSTTCCCCCEEEEEEEEEECC
T ss_pred CCCCcCCCC-h-HHccCCCCCEEECCCCcCcchHHhccCCCCCEEeCCCCcccCC
Confidence 999999974 4 7999999999999999999882223889999999999999865
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-12 Score=122.21 Aligned_cols=119 Identities=18% Similarity=0.124 Sum_probs=96.6
Q ss_pred hhcCCCCCcEEeccCCccCCCCCccccCCC-CCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCC
Q 006747 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLS-SLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSH 161 (632)
Q Consensus 85 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~ 161 (632)
.+.++.+|+.|+|++|+++ .+|. +..+. +|++|+|++|.+++. ..+. ++|++|+|++|+|++..|..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4677899999999999999 4554 55554 999999999999975 3444 79999999999999765566699999
Q ss_pred ccceecccccccccCC--CC-CCCCCcEEEcccCCCCCCCccc----ccCCCCC
Q 006747 162 LVGLNLQNNSLTGFIP--NF-NLSRLRHLNLSYNHLNGSVPLA----LQKFPPS 208 (632)
Q Consensus 162 L~~l~l~~N~l~~~~p--~~-~~~~L~~l~ls~N~l~g~~p~~----~~~~~~~ 208 (632)
|+.|+|++|+++..++ .+ .+++|+.|++++|.++ .+|.. +..++..
T Consensus 90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L 142 (176)
T 1a9n_A 90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQV 142 (176)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTC
T ss_pred CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCcc
Confidence 9999999999976544 33 7899999999999998 55653 5555544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.5e-12 Score=135.22 Aligned_cols=141 Identities=24% Similarity=0.311 Sum_probs=110.9
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
..+..+++.++.+.+..+ +..+++|+.|+|++|.+++..+ +..+++|++|+|++|.+++. + .+. ++|+.|+
T Consensus 199 ~~L~~L~l~~n~l~~~~~---~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~ 271 (347)
T 4fmz_A 199 TSLHYFTAYVNQITDITP---VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-N-AVKDLTKLKMLN 271 (347)
T ss_dssp TTCCEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred CccceeecccCCCCCCch---hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC-h-hHhcCCCcCEEE
Confidence 457788999998885432 7889999999999999985433 88999999999999999853 3 232 7899999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCc-ccccCCCCCCccCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVP-LALQKFPPSSFEGNS 214 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p-~~~~~~~~~~~~~n~ 214 (632)
|++|++++. ..+..+++|+.|+|++|++++..|.. .+++|+.|+|++|++++..| ..+.++....+.+|.
T Consensus 272 l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~ 344 (347)
T 4fmz_A 272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQV 344 (347)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC-
T ss_pred ccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhc
Confidence 999999864 46889999999999999999887763 78999999999999997766 223333344455553
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.7e-12 Score=133.20 Aligned_cols=144 Identities=24% Similarity=0.326 Sum_probs=117.9
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEcc
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls 144 (632)
..+..++++++.+.+ ++. +..+++|+.|++++|.+.+..+ +..+++|++|+|++|++++..+-.-.++|+.|+|+
T Consensus 177 ~~L~~L~l~~n~l~~-~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~ 251 (347)
T 4fmz_A 177 TDLYSLSLNYNQIED-ISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIG 251 (347)
T ss_dssp TTCSEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCEEEccCCcccc-ccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECC
Confidence 467889999999874 443 7899999999999999996544 88999999999999999965442223899999999
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCCCC---CccCCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPS---SFEGNSM 215 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~~~---~~~~n~~ 215 (632)
+|.+++ + ..+..+++|+.|++++|++++...-..+++|+.|++++|++++..|..+..++.. .+.+|..
T Consensus 252 ~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l 323 (347)
T 4fmz_A 252 TNQISD-I-NAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI 323 (347)
T ss_dssp SSCCCC-C-GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSC
T ss_pred CCccCC-C-hhHhcCCCcCEEEccCCccCCChhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcc
Confidence 999996 3 5789999999999999999986322378999999999999998888777766544 4456654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.31 E-value=9.6e-12 Score=134.02 Aligned_cols=117 Identities=26% Similarity=0.348 Sum_probs=74.2
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.++..|+|++|.+++ +| .++++++|++|+|++|++++ +|..+ .+|++|+|++|++++ +| .+. ++|+.|+
T Consensus 131 ~~L~~L~L~~n~l~~-lp--~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~ 201 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP--ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIY 201 (454)
T ss_dssp TTCCEEECCSSCCSS-CC--CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEE
T ss_pred CCCCEEECcCCCCCC-Cc--ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEE
Confidence 368889999999986 87 38899999999999999885 55433 466777777777664 44 232 4566666
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCCCC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~ 195 (632)
+++|++++ +|... ++|+.|++++|+++. +|.+ .+++|+.|++++|+++
T Consensus 202 l~~N~l~~-l~~~~---~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~l~~N~l~ 250 (454)
T 1jl5_A 202 ADNNSLKK-LPDLP---LSLESIVAGNNILEE-LPELQNLPFLTTIYADNNLLK 250 (454)
T ss_dssp CCSSCCSS-CCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCS
T ss_pred CCCCcCCc-CCCCc---CcccEEECcCCcCCc-ccccCCCCCCCEEECCCCcCC
Confidence 66666654 33322 355555555555552 2333 4555555555555555
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.31 E-value=9.8e-12 Score=134.06 Aligned_cols=123 Identities=22% Similarity=0.172 Sum_probs=91.5
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEcc
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls 144 (632)
.++..|+|++|.+++ +| ++.+++|+.|+|++|+|++. + ++.+++|++|+|++|++.+.++-.-.++|+.|+|+
T Consensus 106 ~~L~~L~L~~N~l~~-l~---~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls 178 (457)
T 3bz5_A 106 TKLTYLNCDTNKLTK-LD---VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCS 178 (457)
T ss_dssp TTCCEEECCSSCCSC-CC---CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECC
T ss_pred CcCCEEECCCCcCCe-ec---CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCcccccccccCCcCCEEECC
Confidence 367888999999886 54 78889999999999999873 3 77888888888888866666644334678888888
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCc
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p 199 (632)
+|++++ +| ++.+++|+.|++++|++++. +-..+++|+.|+|++|+|++ +|
T Consensus 179 ~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~-~l~~l~~L~~L~Ls~N~l~~-ip 228 (457)
T 3bz5_A 179 FNKITE-LD--VSQNKLLNRLNCDTNNITKL-DLNQNIQLTFLDCSSNKLTE-ID 228 (457)
T ss_dssp SSCCCC-CC--CTTCTTCCEEECCSSCCSCC-CCTTCTTCSEEECCSSCCSC-CC
T ss_pred CCccce-ec--cccCCCCCEEECcCCcCCee-ccccCCCCCEEECcCCcccc-cC
Confidence 888876 44 67777777777777777765 33366777777777777776 44
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=6.5e-12 Score=130.43 Aligned_cols=102 Identities=23% Similarity=0.180 Sum_probs=90.3
Q ss_pred EEeccCC-ccCCCCCccccCCCCCCeEeecC-CcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceeccc
Q 006747 94 ILSLRSN-HLSGDLPSNVLSLSSLRFLYLQN-NNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQN 169 (632)
Q Consensus 94 ~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~ 169 (632)
.+++++| +|+ .+|. |..+++|++|+|++ |+|++..|..|. ++|+.|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 5789998 898 5788 99999999999996 999977777775 7999999999999999999999999999999999
Q ss_pred ccccccCCCC-CCCCCcEEEcccCCCCCC
Q 006747 170 NSLTGFIPNF-NLSRLRHLNLSYNHLNGS 197 (632)
Q Consensus 170 N~l~~~~p~~-~~~~L~~l~ls~N~l~g~ 197 (632)
|+|++.++.. ....|+.|+|++|.|...
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c~ 118 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHCS 118 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCccCC
Confidence 9999887763 434499999999999854
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.24 E-value=3.6e-13 Score=139.15 Aligned_cols=125 Identities=22% Similarity=0.186 Sum_probs=65.8
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCC-CCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGD-LPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
.+..+++.++.+.+.++. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|.+++..|..+. ++|+.|+
T Consensus 71 ~l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TCSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred cceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 455566666666555443 34556666666666665543 555555566666666666655544444333 4555555
Q ss_pred ccCC-CCccc-CCccccCCCCccceecccc-ccccc-CCCC--CCC-CCcEEEcccC
Q 006747 143 LSFN-SITGN-IPASIRNLSHLVGLNLQNN-SLTGF-IPNF--NLS-RLRHLNLSYN 192 (632)
Q Consensus 143 Ls~N-~l~g~-~p~~~~~l~~L~~l~l~~N-~l~~~-~p~~--~~~-~L~~l~ls~N 192 (632)
|++| .+++. +|..+.++++|+.|+|++| .+++. ++.. .++ +|++|+|++|
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 5555 45542 4444555555555555555 55432 1221 344 5555555555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.21 E-value=6.5e-13 Score=140.22 Aligned_cols=143 Identities=20% Similarity=0.332 Sum_probs=97.8
Q ss_pred CeEEEEEeCCC---CcccccCchh------hcCCCCCcEEeccCCccCC----CCCccccCCCCCCeEeecCCcCCccCC
Q 006747 65 SRVLAVRLPGV---GLYGPIPANT------LEKLDSLMILSLRSNHLSG----DLPSNVLSLSSLRFLYLQNNNFSGNIP 131 (632)
Q Consensus 65 ~~v~~l~l~~~---~l~g~lp~~~------l~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~~p 131 (632)
.++..|+|+++ .++|.+|... +..+++|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..+
T Consensus 60 ~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~ 139 (386)
T 2ca6_A 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 139 (386)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHH
Confidence 35677777774 4556666532 3677888888888888876 467777788888888888888764433
Q ss_pred CCcc---------------CCCcEEEccCCCCc-ccCC---ccccCCCCccceeccccccc--c---cCC-CC-CCCCCc
Q 006747 132 SSLS---------------PQLNWVDLSFNSIT-GNIP---ASIRNLSHLVGLNLQNNSLT--G---FIP-NF-NLSRLR 185 (632)
Q Consensus 132 ~~~~---------------~~L~~L~Ls~N~l~-g~~p---~~~~~l~~L~~l~l~~N~l~--~---~~p-~~-~~~~L~ 185 (632)
..+. ++|+.|+|++|+++ +.+| ..+..+++|+.|+|++|+++ | ..| .+ .+++|+
T Consensus 140 ~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~ 219 (386)
T 2ca6_A 140 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219 (386)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred HHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCcc
Confidence 3332 57888888888887 4455 46667788888888888877 3 334 33 667888
Q ss_pred EEEcccCCCC----CCCcccccCCCC
Q 006747 186 HLNLSYNHLN----GSVPLALQKFPP 207 (632)
Q Consensus 186 ~l~ls~N~l~----g~~p~~~~~~~~ 207 (632)
.|+|++|.|+ +.+|..+..++.
T Consensus 220 ~L~Ls~n~l~~~g~~~l~~~l~~~~~ 245 (386)
T 2ca6_A 220 VLDLQDNTFTHLGSSALAIALKSWPN 245 (386)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred EEECcCCCCCcHHHHHHHHHHccCCC
Confidence 8888888875 456655554443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.20 E-value=1.1e-12 Score=138.33 Aligned_cols=150 Identities=21% Similarity=0.299 Sum_probs=117.4
Q ss_pred CeEEEEEeCCCCcccc----cCchhhcCC---------CCCcEEeccCCccC-CCCC---ccccCCCCCCeEeecCCcCC
Q 006747 65 SRVLAVRLPGVGLYGP----IPANTLEKL---------DSLMILSLRSNHLS-GDLP---SNVLSLSSLRFLYLQNNNFS 127 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~----lp~~~l~~l---------~~L~~L~Ls~N~l~-g~~p---~~~~~l~~L~~L~Ls~N~l~ 127 (632)
.++..|+|++|.+.+. ++. .+..+ ++|++|+|++|+++ +.+| ..+..+++|++|+|++|+++
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~-~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~ 200 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIAR-ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHH-HHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred CCCCEEECcCCCCCHHHHHHHHH-HHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 4688999999999633 333 46566 89999999999998 4555 46778999999999999998
Q ss_pred --c---cCCCCcc--CCCcEEEccCCCCc----ccCCccccCCCCccceeccccccccc----CCC----CCCCCCcEEE
Q 006747 128 --G---NIPSSLS--PQLNWVDLSFNSIT----GNIPASIRNLSHLVGLNLQNNSLTGF----IPN----FNLSRLRHLN 188 (632)
Q Consensus 128 --g---~~p~~~~--~~L~~L~Ls~N~l~----g~~p~~~~~l~~L~~l~l~~N~l~~~----~p~----~~~~~L~~l~ 188 (632)
| .+|..+. ++|+.|+|++|.++ +.+|..+..+++|+.|+|++|.+++. ++. ..+++|+.|+
T Consensus 201 ~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~ 280 (386)
T 2ca6_A 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 280 (386)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred HhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEE
Confidence 3 3443454 78999999999997 67899999999999999999999876 333 2489999999
Q ss_pred cccCCCCC----CCcccc-c---CCCCCCccCCCC
Q 006747 189 LSYNHLNG----SVPLAL-Q---KFPPSSFEGNSM 215 (632)
Q Consensus 189 ls~N~l~g----~~p~~~-~---~~~~~~~~~n~~ 215 (632)
|++|.|++ .+|..+ . ++....+.+|..
T Consensus 281 L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l 315 (386)
T 2ca6_A 281 LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315 (386)
T ss_dssp CCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred CcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence 99999997 477765 3 333444555543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.20 E-value=5.6e-13 Score=137.67 Aligned_cols=138 Identities=24% Similarity=0.278 Sum_probs=63.1
Q ss_pred eEEEEEeCCCCcccc-cCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCC-cCCcc-CCCCcc--CCCcE
Q 006747 66 RVLAVRLPGVGLYGP-IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNN-NFSGN-IPSSLS--PQLNW 140 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~-lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~g~-~p~~~~--~~L~~ 140 (632)
++..|+|+++.+++. +|. .+..+++|++|+|++|.+++..|..+..+++|++|+|++| .+++. +|..+. ++|+.
T Consensus 94 ~L~~L~L~~~~l~~~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 94 RVQHMDLSNSVIEVSTLHG-ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp CCCEEECTTCEECHHHHHH-HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCEEEccCCCcCHHHHHH-HHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 344455555554433 333 3445555555555555555444444555555555555555 34431 222221 44555
Q ss_pred EEccCC-CCccc-CCccccCCC-Cccceecccc--ccc-ccCCCC--CCCCCcEEEcccCC-CCCCCcccccC
Q 006747 141 VDLSFN-SITGN-IPASIRNLS-HLVGLNLQNN--SLT-GFIPNF--NLSRLRHLNLSYNH-LNGSVPLALQK 204 (632)
Q Consensus 141 L~Ls~N-~l~g~-~p~~~~~l~-~L~~l~l~~N--~l~-~~~p~~--~~~~L~~l~ls~N~-l~g~~p~~~~~ 204 (632)
|+|++| .+++. ++..+..++ +|+.|+|++| .++ +.+|.. .+++|+.|+|++|. +++..+..+.+
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~ 245 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQ 245 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGG
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhC
Confidence 555555 55432 344445555 5555555555 222 112221 34455555555554 44344434333
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=9.5e-11 Score=116.49 Aligned_cols=134 Identities=16% Similarity=0.080 Sum_probs=105.9
Q ss_pred HhCccceeEEEEEEEcCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhh
Q 006747 343 VLGKGSYGTTYKAILEEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSA 421 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~ 421 (632)
.++.|+.+.||++... +..+++|+..... .....+.+|.+++..+.+|..+.++++++...+..|+||||++|.+|.+
T Consensus 21 ~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 99 (263)
T 3tm0_A 21 DTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE 99 (263)
T ss_dssp CCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred eccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhh
Confidence 4677888999998754 6899999987532 2234688999999999667788899999998889999999999999987
Q ss_pred hhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc--------------------------------------------
Q 006747 422 LLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV-------------------------------------------- 457 (632)
Q Consensus 422 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------------- 457 (632)
..... .....++.+++++++.||+..
T Consensus 100 ~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 100 EYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp HCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred ccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 64211 123467888999999999810
Q ss_pred ------------CCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 458 ------------GGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 458 ------------~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
.+.++|+|+++.||+++++..+.|+||+.+
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 135899999999999988766789999875
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.19 E-value=8.2e-11 Score=131.11 Aligned_cols=125 Identities=24% Similarity=0.306 Sum_probs=82.4
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEccC
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~ 145 (632)
++..|+|++|.++ .||. .+++|+.|+|++|+|+ .+|. .+++|++|+|++|++++ +|. ..++|+.|+|++
T Consensus 62 ~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~-~l~~L~~L~L~~ 130 (622)
T 3g06_A 62 HITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA-LPSGLCKLWIFG 130 (622)
T ss_dssp TCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC-CCTTCCEEECCS
T ss_pred CCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC-CCCCcCEEECCC
Confidence 5778888888887 5765 4678888888888887 4555 67788888888888874 454 446777777777
Q ss_pred CCCcccCCccccCCCCccceecccccccccCCC------------------CCCCCCcEEEcccCCCCCCCcccccCCC
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN------------------FNLSRLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~------------------~~~~~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
|+|++ +|.. +++|+.|+|++|++++.++. ..+++|+.|+|++|+|++ +|..+.++.
T Consensus 131 N~l~~-lp~~---l~~L~~L~Ls~N~l~~l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~~~~L~ 204 (622)
T 3g06_A 131 NQLTS-LPVL---PPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTLPSELY 204 (622)
T ss_dssp SCCSC-CCCC---CTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCCCTTCC
T ss_pred CCCCc-CCCC---CCCCCEEECcCCcCCCcCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCccchhh
Confidence 77774 5543 36677777777777654321 122566666666666663 444333333
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.8e-12 Score=132.33 Aligned_cols=133 Identities=21% Similarity=0.253 Sum_probs=71.8
Q ss_pred EEEEEeCCCCcccccCc---hhhcCCC-CCcEEeccCCccCCCCCccccCC-----CCCCeEeecCCcCCccCCCCcc--
Q 006747 67 VLAVRLPGVGLYGPIPA---NTLEKLD-SLMILSLRSNHLSGDLPSNVLSL-----SSLRFLYLQNNNFSGNIPSSLS-- 135 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~---~~l~~l~-~L~~L~Ls~N~l~g~~p~~~~~l-----~~L~~L~Ls~N~l~g~~p~~~~-- 135 (632)
++.|+|++|.+++.-+. +.+..++ +|++|+|++|.+++..+..+..+ ++|++|+|++|++++..+..+.
T Consensus 24 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~ 103 (362)
T 3goz_A 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103 (362)
T ss_dssp CCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHH
T ss_pred ceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHH
Confidence 56666666666532220 3455565 66666666666665555555443 6666666666666644443221
Q ss_pred -----CCCcEEEccCCCCcccCCcccc----C-CCCccceecccccccccCCCC------CC-CCCcEEEcccCCCCCCC
Q 006747 136 -----PQLNWVDLSFNSITGNIPASIR----N-LSHLVGLNLQNNSLTGFIPNF------NL-SRLRHLNLSYNHLNGSV 198 (632)
Q Consensus 136 -----~~L~~L~Ls~N~l~g~~p~~~~----~-l~~L~~l~l~~N~l~~~~p~~------~~-~~L~~l~ls~N~l~g~~ 198 (632)
++|+.|+|++|+|++..+..+. . .++|+.|+|++|.++...... .+ ++|++|+|++|++++..
T Consensus 104 l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~ 183 (362)
T 3goz_A 104 LAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKN 183 (362)
T ss_dssp HHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSC
T ss_pred HHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhh
Confidence 3566666666666654444332 2 246666666666665432210 22 26666666666665444
Q ss_pred c
Q 006747 199 P 199 (632)
Q Consensus 199 p 199 (632)
+
T Consensus 184 ~ 184 (362)
T 3goz_A 184 C 184 (362)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.15 E-value=6.1e-12 Score=131.53 Aligned_cols=126 Identities=18% Similarity=0.114 Sum_probs=66.8
Q ss_pred EEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCC----ccccCCC-CCCeEeecCCcCCccCCCCcc-------CC
Q 006747 70 VRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLP----SNVLSLS-SLRFLYLQNNNFSGNIPSSLS-------PQ 137 (632)
Q Consensus 70 l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p----~~~~~l~-~L~~L~Ls~N~l~g~~p~~~~-------~~ 137 (632)
.+|+.++++|.+|. .+...++|++|+|++|.+++..+ ..+..++ +|++|+|++|++++..+..+. ++
T Consensus 3 ~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 34555556655554 44444446666666666654444 4455555 566666666666544443331 45
Q ss_pred CcEEEccCCCCcccCCccccC----C-CCccceecccccccccCCCC------C-CCCCcEEEcccCCCCC
Q 006747 138 LNWVDLSFNSITGNIPASIRN----L-SHLVGLNLQNNSLTGFIPNF------N-LSRLRHLNLSYNHLNG 196 (632)
Q Consensus 138 L~~L~Ls~N~l~g~~p~~~~~----l-~~L~~l~l~~N~l~~~~p~~------~-~~~L~~l~ls~N~l~g 196 (632)
|+.|+|++|++++..+..+.. + ++|+.|+|++|++++..+.. . .++|++|+|++|.|++
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~ 152 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI 152 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCH
Confidence 666666666665544443322 2 56666666666665543321 1 2456666666666553
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.12 E-value=1.2e-10 Score=120.98 Aligned_cols=129 Identities=16% Similarity=0.155 Sum_probs=102.2
Q ss_pred eEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--
Q 006747 58 ITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS-- 135 (632)
Q Consensus 58 v~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~-- 135 (632)
.+|+. + .++.++++|+ .||.+ + .++++.|+|++|+|+...+..|.+|++|++|+|++|++.+.+|...+
T Consensus 7 C~C~~---~--~v~C~~~~Lt-~iP~~-l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~ 77 (350)
T 4ay9_X 7 CHCSN---R--VFLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN 77 (350)
T ss_dssp SEEET---T--EEEEESTTCC-SCCTT-C--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCS
T ss_pred cEeeC---C--EEEecCCCCC-ccCcC-c--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhc
Confidence 46764 2 3678899998 78874 3 46899999999999955556799999999999999999888886543
Q ss_pred -CCC-cEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEccc-CCCC
Q 006747 136 -PQL-NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSY-NHLN 195 (632)
Q Consensus 136 -~~L-~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~-N~l~ 195 (632)
+++ +.+++++|+|++..|..|..+++|+.|++++|++++.++.. ...++..|++++ |++.
T Consensus 78 L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~ 142 (350)
T 4ay9_X 78 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 142 (350)
T ss_dssp CTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC
T ss_pred chhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc
Confidence 344 46888899999888999999999999999999999876653 445566777755 4454
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.10 E-value=8.4e-13 Score=125.62 Aligned_cols=118 Identities=25% Similarity=0.273 Sum_probs=100.2
Q ss_pred hcCCCCCcEEeccCCccCCCCCc------cccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCcccc
Q 006747 86 LEKLDSLMILSLRSNHLSGDLPS------NVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIR 157 (632)
Q Consensus 86 l~~l~~L~~L~Ls~N~l~g~~p~------~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~ 157 (632)
+.....++.++|+.|.++|.+|. .+..+++|++|+|++|++++ +| .+. ++|++|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 56678889999999999999887 89999999999999999996 77 555 89999999999999 6898889
Q ss_pred CCCCccceecccccccccCCCC-CCCCCcEEEcccCCCCCCCc-ccccCCCC
Q 006747 158 NLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLNGSVP-LALQKFPP 207 (632)
Q Consensus 158 ~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~g~~p-~~~~~~~~ 207 (632)
.+++|+.|+|++|++++.+ .+ .+++|+.|+|++|++++..+ ..+..++.
T Consensus 91 ~~~~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~ 141 (198)
T 1ds9_A 91 VADTLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDK 141 (198)
T ss_dssp HHHHCSEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTT
T ss_pred cCCcCCEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCC
Confidence 9999999999999999854 43 67899999999999985322 24444443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.10 E-value=2.8e-10 Score=112.69 Aligned_cols=129 Identities=10% Similarity=0.030 Sum_probs=96.2
Q ss_pred CccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCC-ccceeEEEEeCCceEEEEecccCCCHhhhh
Q 006747 345 GKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPN-VVPIRAYYFSKDEKLLVYDFIEAGSFSALL 423 (632)
Q Consensus 345 g~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~n-iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l 423 (632)
+.|..+.||++...+|..+++|..... ....+..|++++..+.+|.- +.+++++....+..++||||++|.++. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 456669999998777888999997654 23457889999998854522 556888888777889999999998874 2
Q ss_pred ccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc----------------------------------------------
Q 006747 424 HGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV---------------------------------------------- 457 (632)
Q Consensus 424 ~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------------- 457 (632)
.. .+ ...++.++++.|+.||+..
T Consensus 105 ~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 105 SH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp SC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred Cc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 11 11 2256667777777777642
Q ss_pred ---------CCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 458 ---------GGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 458 ---------~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
...++|+|++|.||+++++..++|+|||.+.
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1239999999999999887777899999863
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.96 E-value=3.3e-12 Score=126.22 Aligned_cols=145 Identities=19% Similarity=0.165 Sum_probs=94.7
Q ss_pred CCCCCcceEecCCCCeEEEEEeCC---CCcccccCchhhcCCCCCcEEeccCCccCCCCCc-cccCCCCCCe--EeecCC
Q 006747 51 VCTSWVGITCTKNGSRVLAVRLPG---VGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPS-NVLSLSSLRF--LYLQNN 124 (632)
Q Consensus 51 ~c~~w~gv~c~~~~~~v~~l~l~~---~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~--L~Ls~N 124 (632)
.| +|.|+.|+.++.+|..+-.++ ..+.|.++++.+..|+. .|...+|..++.++- .+...+.|.. ++++.|
T Consensus 77 l~-~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 77 LK-AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HH-HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HH-hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 45 799999998777886666655 45667887766555543 344444444443332 2455555655 667777
Q ss_pred cCCccCCCCc------cCCCcEEEccCCCCcc--cCCccccCCCCccceecccccccccCCCCCCC--CCcEEEcccCCC
Q 006747 125 NFSGNIPSSL------SPQLNWVDLSFNSITG--NIPASIRNLSHLVGLNLQNNSLTGFIPNFNLS--RLRHLNLSYNHL 194 (632)
Q Consensus 125 ~l~g~~p~~~------~~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~--~L~~l~ls~N~l 194 (632)
+.. .++..+ .++|+.|+||+|+|++ .+|..+..+++|+.|+|++|+|++...-..+. +|+.|+|++|.+
T Consensus 154 ~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l~L~~L~L~~Npl 232 (267)
T 3rw6_A 154 RRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 232 (267)
T ss_dssp SHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTSCCSEEECTTSTT
T ss_pred HHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccCCcceEEccCCcC
Confidence 533 222211 2678888888888887 55677778888888888888888752211222 888888888888
Q ss_pred CCCCc
Q 006747 195 NGSVP 199 (632)
Q Consensus 195 ~g~~p 199 (632)
++.+|
T Consensus 233 ~~~~~ 237 (267)
T 3rw6_A 233 CDTFR 237 (267)
T ss_dssp GGGCS
T ss_pred ccccC
Confidence 87666
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.95 E-value=2.4e-09 Score=111.59 Aligned_cols=140 Identities=16% Similarity=0.215 Sum_probs=103.7
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEec--ccc--cCHHHHHHHHHHHHhhcC-CCCccceeEEEEeC---CceEEEEec
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLK--EVV--MGKREFEQQMEVVGRLSQ-HPNVVPIRAYYFSK---DEKLLVYDF 413 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~--~~~--~~~~~~~~e~~~l~~l~~-h~niv~l~~~~~~~---~~~~lv~E~ 413 (632)
+.++.|.++.||+.... +..+++|+.. ... .....+.+|.+++..+.+ +..+.++++++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 35788999999998876 4678888876 332 224568889999998843 34578888888766 347999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc------------------------------------
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV------------------------------------ 457 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------ 457 (632)
++|..+.+... ..++...+..++.++++.|+.||+..
T Consensus 123 v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99977643211 23667788889999999999999731
Q ss_pred -------------------CCCceecCCCCCCeeecCCCC--eEEcccCCCCC
Q 006747 458 -------------------GGKFILGNIKSSNVLLSQDLQ--GCISDFGLTPL 489 (632)
Q Consensus 458 -------------------~~~ivHrDlk~~NILl~~~~~--~ki~DfGla~~ 489 (632)
.+.++|+|+++.||++++++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999998753 68999998754
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.92 E-value=2.3e-11 Score=131.19 Aligned_cols=150 Identities=19% Similarity=0.120 Sum_probs=113.7
Q ss_pred CeEEEEEeCCCCcccc----cCchhhcCCCCCcEEeccCCccCCC----CCccccCCCCCCeEeecCCcCCccCCCCcc-
Q 006747 65 SRVLAVRLPGVGLYGP----IPANTLEKLDSLMILSLRSNHLSGD----LPSNVLSLSSLRFLYLQNNNFSGNIPSSLS- 135 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~----lp~~~l~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~- 135 (632)
..+..|+|+++.+.+. +.+..+..+++|+.|+|++|.+++. ++..+..+++|++|+|++|.+++..+..+.
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 4688899999988753 2232344689999999999999854 677788899999999999998754433332
Q ss_pred ------CCCcEEEccCCCCccc----CCccccCCCCccceecccccccccCCC-C------CCCCCcEEEcccCCCCC--
Q 006747 136 ------PQLNWVDLSFNSITGN----IPASIRNLSHLVGLNLQNNSLTGFIPN-F------NLSRLRHLNLSYNHLNG-- 196 (632)
Q Consensus 136 ------~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~~~p~-~------~~~~L~~l~ls~N~l~g-- 196 (632)
++|+.|+|++|.+++. ++..+..+++|+.|+|++|.+++..+. + ..++|+.|+|++|++++
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~ 386 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS 386 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence 4899999999999876 567778889999999999998865432 1 26799999999999986
Q ss_pred --CCcccccCCCC---CCccCCC
Q 006747 197 --SVPLALQKFPP---SSFEGNS 214 (632)
Q Consensus 197 --~~p~~~~~~~~---~~~~~n~ 214 (632)
.+|..+..++. ..+.+|.
T Consensus 387 ~~~l~~~l~~~~~L~~L~l~~N~ 409 (461)
T 1z7x_W 387 CSSLAATLLANHSLRELDLSNNC 409 (461)
T ss_dssp HHHHHHHHHHCCCCCEEECCSSS
T ss_pred HHHHHHHHHhCCCccEEECCCCC
Confidence 67766544443 3455554
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.91 E-value=5.2e-11 Score=128.49 Aligned_cols=134 Identities=21% Similarity=0.221 Sum_probs=107.1
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCC----CCCccccCCCCCCeEeecCCcCCccCCCCcc---C-
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSG----DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS---P- 136 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~---~- 136 (632)
.+++.|+|+++.++.......+..+++|+.|+|++|.+++ .++..+..+++|++|+|++|.+++..+..+. .
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 3688999999998754444347889999999999999984 4577788899999999999999764443332 2
Q ss_pred ---CCcEEEccCCCCcc----cCCccccCCCCccceecccccccccCCC-------CCCCCCcEEEcccCCCCCCC
Q 006747 137 ---QLNWVDLSFNSITG----NIPASIRNLSHLVGLNLQNNSLTGFIPN-------FNLSRLRHLNLSYNHLNGSV 198 (632)
Q Consensus 137 ---~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~~~~p~-------~~~~~L~~l~ls~N~l~g~~ 198 (632)
+|++|+|++|+++. .+|..+.++++|+.|+|++|.+++..+. ...++|++|+|++|++++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 158 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS 158 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH
Confidence 69999999999984 5788999999999999999998764332 13568999999999998643
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.83 E-value=1.3e-10 Score=121.70 Aligned_cols=132 Identities=18% Similarity=0.181 Sum_probs=76.2
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccc-----cCCCCCCeEeecCCcCCcc----CCCCc-
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNV-----LSLSSLRFLYLQNNNFSGN----IPSSL- 134 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~-----~~l~~L~~L~Ls~N~l~g~----~p~~~- 134 (632)
..+..|+|++|.+...-.......+++|+.|+|++|+|+..-...+ ...++|++|+|++|.|+.. ++..+
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 3577777777776533222223345567777777777763322222 2356677777777777531 11111
Q ss_pred -cCCCcEEEccCCCCccc----CCccccCCCCccceecccccccccCCC-----C-CCCCCcEEEcccCCCCC
Q 006747 135 -SPQLNWVDLSFNSITGN----IPASIRNLSHLVGLNLQNNSLTGFIPN-----F-NLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 135 -~~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~~~p~-----~-~~~~L~~l~ls~N~l~g 196 (632)
.++|++|||++|.|+.. ++..+..+++|+.|+|++|.|+..... . ..++|++|||++|.|+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 25677777777777642 345556666777777777777542211 1 34667777777777663
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.77 E-value=3.1e-09 Score=107.96 Aligned_cols=180 Identities=16% Similarity=0.215 Sum_probs=115.9
Q ss_pred HhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCc--cceeEEEEeCC---ceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNV--VPIRAYYFSKD---EKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~ni--v~l~~~~~~~~---~~~lv~E~~~~g 417 (632)
.++.|....||+.. ..+++|+.... .....+.+|.+++..+..+..+ .+.+++....+ ..|+||||++|.
T Consensus 27 ~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp EEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred ecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 47889999999862 56888886533 2245788999999888544433 34444433322 347899999998
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA----------------------------------------- 456 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------------------------------------- 456 (632)
.+...... .++...+..++.++++.++.||+.
T Consensus 102 ~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 102 PLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp ECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred ECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 87653221 245566677777777777777751
Q ss_pred --------------cCCCceecCCCCCCeeecC--CCCeEEcccCCCCCCCCCC------CC---CCCC-------cc--
Q 006747 457 --------------VGGKFILGNIKSSNVLLSQ--DLQGCISDFGLTPLMNTPT------VP---SRSA-------GY-- 502 (632)
Q Consensus 457 --------------~~~~ivHrDlk~~NILl~~--~~~~ki~DfGla~~~~~~~------~~---~~t~-------~y-- 502 (632)
..+.++|+|+++.||++++ ...+.|.||+.+....... .. .+.. +|
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1245899999999999998 5668899999875532210 00 0000 01
Q ss_pred cC-CccccCCCCCccchhhHHHHHHHHHHhCCCCC
Q 006747 503 RA-PEVIETKKPTQKSDVYSFGVLLLEMLTGKAPI 536 (632)
Q Consensus 503 ~a-PE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~ 536 (632)
.. |+.... .....+.|++|.++|++.+|..+|
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 111110 112258999999999999998775
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.61 E-value=5.1e-10 Score=117.06 Aligned_cols=131 Identities=21% Similarity=0.162 Sum_probs=96.7
Q ss_pred eEEEEEeCCCCcccccCch---hhc-CCCCCcEEeccCCccCCCCCccc-cCCCCCCeEeecCCcCCccCCCCc------
Q 006747 66 RVLAVRLPGVGLYGPIPAN---TLE-KLDSLMILSLRSNHLSGDLPSNV-LSLSSLRFLYLQNNNFSGNIPSSL------ 134 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~---~l~-~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~N~l~g~~p~~~------ 134 (632)
.+..|+|+++.++..-... .+. ...+|+.|+|++|.|+..-...+ ..+++|++|+|++|.|+..-...+
T Consensus 73 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~ 152 (372)
T 3un9_A 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLH 152 (372)
T ss_dssp TCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHS
T ss_pred hCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHh
Confidence 5789999999987432220 222 23799999999999974333333 356789999999999975433332
Q ss_pred -cCCCcEEEccCCCCcc----cCCccccCCCCccceecccccccccC----CC-C-CCCCCcEEEcccCCCCC
Q 006747 135 -SPQLNWVDLSFNSITG----NIPASIRNLSHLVGLNLQNNSLTGFI----PN-F-NLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 135 -~~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~~~~----p~-~-~~~~L~~l~ls~N~l~g 196 (632)
.++|+.|+|++|.|+. .++..+..+++|+.|+|++|.|+..- .. + ..++|+.|+|++|.|+.
T Consensus 153 ~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~ 225 (372)
T 3un9_A 153 DQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD 225 (372)
T ss_dssp TTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred cCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence 2679999999999975 35556678999999999999997532 11 1 45789999999999974
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.59 E-value=1.2e-07 Score=97.33 Aligned_cols=36 Identities=19% Similarity=0.224 Sum_probs=25.2
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccC
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLS 103 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~ 103 (632)
.+..|+|+. +++ .|+..+|.++++|+.|+|++|.+.
T Consensus 102 ~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~ 137 (329)
T 3sb4_A 102 TLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAP 137 (329)
T ss_dssp TCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCC
T ss_pred CCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCcc
Confidence 466677777 665 577777778888888888877764
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.54 E-value=8.4e-08 Score=98.51 Aligned_cols=47 Identities=11% Similarity=0.147 Sum_probs=40.1
Q ss_pred ccCchhhcC--------CCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCC
Q 006747 80 PIPANTLEK--------LDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFS 127 (632)
Q Consensus 80 ~lp~~~l~~--------l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 127 (632)
.||...|.+ +++|+.|+|++ +++..-+..|.++++|+.|+|++|.++
T Consensus 83 ~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~ 137 (329)
T 3sb4_A 83 FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP 137 (329)
T ss_dssp EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC
T ss_pred ccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc
Confidence 577778888 99999999999 888666678999999999999999875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.50 E-value=7.4e-09 Score=97.02 Aligned_cols=111 Identities=11% Similarity=0.174 Sum_probs=84.4
Q ss_pred hhcCCCCCcEEeccCC-ccCC----CCCccccCCCCCCeEeecCCcCCccCCCCc----c--CCCcEEEccCCCCccc--
Q 006747 85 TLEKLDSLMILSLRSN-HLSG----DLPSNVLSLSSLRFLYLQNNNFSGNIPSSL----S--PQLNWVDLSFNSITGN-- 151 (632)
Q Consensus 85 ~l~~l~~L~~L~Ls~N-~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~----~--~~L~~L~Ls~N~l~g~-- 151 (632)
.+...++|++|+|++| .+.. .+...+...++|++|+|++|.++..-...+ . ++|+.|+|++|.|+..
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~ 110 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 110 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence 6778899999999999 8873 234556677899999999999874221122 1 6899999999999854
Q ss_pred --CCccccCCCCccceec--ccccccccCCC-----C-CCCCCcEEEcccCCCC
Q 006747 152 --IPASIRNLSHLVGLNL--QNNSLTGFIPN-----F-NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 152 --~p~~~~~l~~L~~l~l--~~N~l~~~~p~-----~-~~~~L~~l~ls~N~l~ 195 (632)
+...+...++|+.|+| ++|.+...-.. . ..++|+.|+|++|.+.
T Consensus 111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 5667788889999999 88998743211 1 4578999999999875
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.50 E-value=5.4e-09 Score=116.37 Aligned_cols=131 Identities=15% Similarity=0.142 Sum_probs=82.0
Q ss_pred eEEEEEeCCCCcccccCchhhc-CCCCCcEEecc----CCccCCC-----CCccccCCCCCCeEeecCC--cCCccCCCC
Q 006747 66 RVLAVRLPGVGLYGPIPANTLE-KLDSLMILSLR----SNHLSGD-----LPSNVLSLSSLRFLYLQNN--NFSGNIPSS 133 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~-~l~~L~~L~Ls----~N~l~g~-----~p~~~~~l~~L~~L~Ls~N--~l~g~~p~~ 133 (632)
++..|+|..+.+++..+. .+. .+++|+.|+|+ .|.+++. ++..+.++++|++|+|+++ .+++..+..
T Consensus 379 ~L~~L~l~~~~l~~~~~~-~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~ 457 (592)
T 3ogk_B 379 ELEYMAVYVSDITNESLE-SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSY 457 (592)
T ss_dssp TCSEEEEEESCCCHHHHH-HHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHH
T ss_pred cCeEEEeecCCccHHHHH-HHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHH
Confidence 355556655666655444 233 36677777775 5666643 2333556777777777642 355443333
Q ss_pred c---cCCCcEEEccCCCCcc-cCCccccCCCCccceeccccccccc-CCCC--CCCCCcEEEcccCCCCCC
Q 006747 134 L---SPQLNWVDLSFNSITG-NIPASIRNLSHLVGLNLQNNSLTGF-IPNF--NLSRLRHLNLSYNHLNGS 197 (632)
Q Consensus 134 ~---~~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~~~-~p~~--~~~~L~~l~ls~N~l~g~ 197 (632)
+ .++|++|+|++|++++ .++..+..+++|+.|+|++|.+++. ++.+ .+++|+.|+|++|+++..
T Consensus 458 ~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 458 IGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 3 2578888888888876 3455567778888888888887643 2222 577888888888887754
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.48 E-value=8.2e-09 Score=101.83 Aligned_cols=101 Identities=24% Similarity=0.296 Sum_probs=65.4
Q ss_pred hcCCCCCcE--EeccCCccC---CCCCccccCCCCCCeEeecCCcCCc--cCCCCc--cCCCcEEEccCCCCcccCCccc
Q 006747 86 LEKLDSLMI--LSLRSNHLS---GDLPSNVLSLSSLRFLYLQNNNFSG--NIPSSL--SPQLNWVDLSFNSITGNIPASI 156 (632)
Q Consensus 86 l~~l~~L~~--L~Ls~N~l~---g~~p~~~~~l~~L~~L~Ls~N~l~g--~~p~~~--~~~L~~L~Ls~N~l~g~~p~~~ 156 (632)
+...+.|.. ++++.|... +.++....++++|+.|+|++|+|++ .+|..+ .++|+.|+|++|+|++. ..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l 214 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL 214 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence 444444444 566777432 2222223467788888888888886 444443 27788888888888864 344
Q ss_pred cCCC--CccceecccccccccCCCC---------CCCCCcEEE
Q 006747 157 RNLS--HLVGLNLQNNSLTGFIPNF---------NLSRLRHLN 188 (632)
Q Consensus 157 ~~l~--~L~~l~l~~N~l~~~~p~~---------~~~~L~~l~ 188 (632)
..+. +|+.|+|++|.+++.+|.. .+++|+.||
T Consensus 215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 5454 8888888888888876631 577777775
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=6.7e-06 Score=81.48 Aligned_cols=133 Identities=16% Similarity=0.172 Sum_probs=91.8
Q ss_pred Ccccee-EEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhhh
Q 006747 345 GKGSYG-TTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSAL 422 (632)
Q Consensus 345 g~G~fg-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 422 (632)
..|..| .||+.... ++..+++|+-... ...++.+|.+.+..+..+--|.++++++.+.+..++|||++++.++.+.
T Consensus 33 ~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 33 NVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp ECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred cCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 334444 68987654 4667888986543 2456888999998886555577899999999999999999999877664
Q ss_pred hccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 006747 423 LHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA---------------------------------------------- 456 (632)
Q Consensus 423 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------------------- 456 (632)
..... ..+..+..+++..|+-||..
T Consensus 111 ~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 111 LEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred ccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 43210 11223344444444444431
Q ss_pred -----c----CCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 457 -----V----GGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 457 -----~----~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
. .+.++|+|+.+.||++++++.+-|.||+.+.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1 1237999999999999988878899999763
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.23 E-value=1.9e-07 Score=103.76 Aligned_cols=135 Identities=16% Similarity=0.135 Sum_probs=93.6
Q ss_pred eEEEEEeCCCC-ccc-ccCchhhcCCCCCcEEeccCCccCCC----CCccccCCCCCCeEeecCCcCCccCCCCc-----
Q 006747 66 RVLAVRLPGVG-LYG-PIPANTLEKLDSLMILSLRSNHLSGD----LPSNVLSLSSLRFLYLQNNNFSGNIPSSL----- 134 (632)
Q Consensus 66 ~v~~l~l~~~~-l~g-~lp~~~l~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~----- 134 (632)
++..|+|.++. +.. .++. ...++++|++|+|++|.+++. ++..+.++++|++|+|++|.+++.-+..+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~ 217 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLS-IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHH-HHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHH-HHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence 38888888775 221 1222 345789999999999998765 44456788999999999999984322222
Q ss_pred -cCCCcEEEccCCCCcccCCccccCCCCccceecccccccccCC---C--CCCCCCcEEEcccCCCCCCCccccc
Q 006747 135 -SPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIP---N--FNLSRLRHLNLSYNHLNGSVPLALQ 203 (632)
Q Consensus 135 -~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p---~--~~~~~L~~l~ls~N~l~g~~p~~~~ 203 (632)
.++|+.|+|++|.+.+ +|..+.++++|+.|+++++......+ . ..+++|+.|+++++.. +.+|..+.
T Consensus 218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~ 290 (592)
T 3ogk_B 218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFP 290 (592)
T ss_dssp HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGG
T ss_pred hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHh
Confidence 2789999999999986 77888999999999998643321111 1 1567788888877532 34554443
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=7.5e-06 Score=82.94 Aligned_cols=134 Identities=16% Similarity=0.164 Sum_probs=87.0
Q ss_pred HhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC--CccceeEEEE-eCCceEEEEecccCCCH
Q 006747 343 VLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHP--NVVPIRAYYF-SKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~--niv~l~~~~~-~~~~~~lv~E~~~~g~L 419 (632)
.++.|....||+. +..+++|+-... .....+..|.+++..+.+|- .|.+.+.++. ..+..++||||++|..+
T Consensus 26 ~l~~G~~n~v~~v----g~~~VlR~~~~~-~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 26 SLGEGFRNYAILV----NGDWVFRFPKSQ-QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEECSSEEEEEE----TTTEEEEEESSH-HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred ecCCCcceeEEEE----CCEEEEEecCCc-hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 4678888899987 567888885322 22457899999999995442 2556676664 34457899999999877
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA------------------------------------------- 456 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------------- 456 (632)
...... .++...+..++.++++.|+.||+.
T Consensus 101 ~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 101 GEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp HHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred chhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 653111 012223333333333333333321
Q ss_pred --------------cCCCceecCCCCCCeeecC---CCC-eEEcccCCCC
Q 006747 457 --------------VGGKFILGNIKSSNVLLSQ---DLQ-GCISDFGLTP 488 (632)
Q Consensus 457 --------------~~~~ivHrDlk~~NILl~~---~~~-~ki~DfGla~ 488 (632)
..+.++|+|+++.||++++ ++. +.|.||+.+.
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 2346799999999999997 455 4899999764
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.11 E-value=1.3e-07 Score=105.14 Aligned_cols=106 Identities=11% Similarity=0.063 Sum_probs=49.7
Q ss_pred CCCCCcEEeccCCccCCCCCcccc-CCCCCCeEeec--C----CcCCccCCC--C----c--cCCCcEEEccCCCCcccC
Q 006747 88 KLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQ--N----NNFSGNIPS--S----L--SPQLNWVDLSFNSITGNI 152 (632)
Q Consensus 88 ~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls--~----N~l~g~~p~--~----~--~~~L~~L~Ls~N~l~g~~ 152 (632)
.+++|+.|+++.|++++..+..+. ++++|+.|+|+ + |.+++ .|. . + .++|+.|+|++ .+++..
T Consensus 370 ~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~ 447 (594)
T 2p1m_B 370 GCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKV 447 (594)
T ss_dssp HCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC-CCTHHHHHHHHHHCTTCCEEECCS-SCCHHH
T ss_pred hchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC-CchhhHHHHHHhhCCCccEEeecC-cccHHH
Confidence 355666666666666544333443 35666666666 2 33431 111 0 0 14555555544 444433
Q ss_pred CccccC-CCCccceecccccccccCCC---CCCCCCcEEEcccCCCC
Q 006747 153 PASIRN-LSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNLSYNHLN 195 (632)
Q Consensus 153 p~~~~~-l~~L~~l~l~~N~l~~~~p~---~~~~~L~~l~ls~N~l~ 195 (632)
+..+.. +++|+.|+|++|.+++.... ..+++|+.|+|++|.++
T Consensus 448 ~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred HHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 333333 55555555555555432221 13455555555555553
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=8e-06 Score=84.57 Aligned_cols=78 Identities=13% Similarity=0.120 Sum_probs=55.4
Q ss_pred Hh-CccceeEEEEEEEc-------CCcEEEEEEecccc---c-CHHHHHHHHHHHHhhcCC--CCccceeEEEEeC---C
Q 006747 343 VL-GKGSYGTTYKAILE-------EGTTVVVKRLKEVV---M-GKREFEQQMEVVGRLSQH--PNVVPIRAYYFSK---D 405 (632)
Q Consensus 343 ~l-g~G~fg~V~~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~---~ 405 (632)
.| +.|....+|+.... ++..+++|+..... . ....+..|.+++..+..+ -.+.++++++.+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 56 78889999998764 26778888865432 1 224578888888888554 3466788777654 3
Q ss_pred ceEEEEecccCCCHh
Q 006747 406 EKLLVYDFIEAGSFS 420 (632)
Q Consensus 406 ~~~lv~E~~~~g~L~ 420 (632)
..++||||++|..+.
T Consensus 107 ~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 107 TPFFLMDYVEGVVPP 121 (357)
T ss_dssp SCEEEEECCCCBCCC
T ss_pred CceEEEEecCCCChh
Confidence 468999999987654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.00 E-value=4.5e-07 Score=84.73 Aligned_cols=108 Identities=15% Similarity=0.191 Sum_probs=82.6
Q ss_pred CeEEEEEeCCC-Ccccc----cCchhhcCCCCCcEEeccCCccCC----CCCccccCCCCCCeEeecCCcCCcc----CC
Q 006747 65 SRVLAVRLPGV-GLYGP----IPANTLEKLDSLMILSLRSNHLSG----DLPSNVLSLSSLRFLYLQNNNFSGN----IP 131 (632)
Q Consensus 65 ~~v~~l~l~~~-~l~g~----lp~~~l~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~----~p 131 (632)
..++.|+|+++ .+... +. ..+...++|++|+|++|.|+. .+...+...++|++|+|++|.++.. +.
T Consensus 36 ~~L~~L~L~~n~~i~~~g~~~l~-~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 36 PDLEEVNLNNIMNIPVPTLKACA-EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHH-HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCEEEecCCCCCCHHHHHHHH-HHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 46888999998 77521 32 256778999999999999973 2344566678999999999999843 22
Q ss_pred CCcc--CCCcEEEc--cCCCCccc----CCccccCCCCccceeccccccc
Q 006747 132 SSLS--PQLNWVDL--SFNSITGN----IPASIRNLSHLVGLNLQNNSLT 173 (632)
Q Consensus 132 ~~~~--~~L~~L~L--s~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~ 173 (632)
..+. .+|+.|+| ++|.|+.. +...+...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2333 68999999 88999864 4455667799999999999985
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.98 E-value=4.9e-07 Score=100.43 Aligned_cols=104 Identities=17% Similarity=0.214 Sum_probs=55.3
Q ss_pred cCCCCCcEEeccCCccCCCCCcccc-CCCCCCeEeecCC-cCCcc-CCCCc--cCCCcEEEccCCCCcccCCcccc----
Q 006747 87 EKLDSLMILSLRSNHLSGDLPSNVL-SLSSLRFLYLQNN-NFSGN-IPSSL--SPQLNWVDLSFNSITGNIPASIR---- 157 (632)
Q Consensus 87 ~~l~~L~~L~Ls~N~l~g~~p~~~~-~l~~L~~L~Ls~N-~l~g~-~p~~~--~~~L~~L~Ls~N~l~g~~p~~~~---- 157 (632)
..+++|+.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+ .++|+.|+|++|.+++..+..+.
T Consensus 102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~ 181 (594)
T 2p1m_B 102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPD 181 (594)
T ss_dssp HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCT
T ss_pred HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhh
Confidence 3456666666666666654444454 4666666666666 33321 22111 15666666666666554333332
Q ss_pred CCCCccceecccccccccCCC-----C--CCCCCcEEEcccC
Q 006747 158 NLSHLVGLNLQNNSLTGFIPN-----F--NLSRLRHLNLSYN 192 (632)
Q Consensus 158 ~l~~L~~l~l~~N~l~~~~p~-----~--~~~~L~~l~ls~N 192 (632)
.+++|+.|+|++|. +.+.. . .+++|++|+|++|
T Consensus 182 ~~~~L~~L~l~~~~--~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 182 TYTSLVSLNISCLA--SEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp TCCCCCEEECTTCC--SCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred cCCcCcEEEecccC--CcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 44566666666665 11111 0 3466666666666
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=3.9e-05 Score=78.60 Aligned_cols=141 Identities=18% Similarity=0.226 Sum_probs=80.1
Q ss_pred HhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC-CCccceeE------EEEeCCceEEEEeccc
Q 006747 343 VLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQH-PNVVPIRA------YYFSKDEKLLVYDFIE 415 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h-~niv~l~~------~~~~~~~~~lv~E~~~ 415 (632)
.|+.|..+.||+....+| .+++|+... .......|.+++..+.++ -.+.+++. +....+..++||||++
T Consensus 39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 456677889999887654 588998875 234445556655555321 12333332 1234567899999999
Q ss_pred CCCHh--------------hhhccCC-CC--C------CCcCCHHHHHH-------------------------------
Q 006747 416 AGSFS--------------ALLHGNR-GI--G------RTPLDWESRVK------------------------------- 441 (632)
Q Consensus 416 ~g~L~--------------~~l~~~~-~~--~------~~~l~~~~~~~------------------------------- 441 (632)
|..+. ..+|... .. . ...-.|.....
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 1122110 00 0 01123432110
Q ss_pred HHHHHHHHHHHHHh----------ccCCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 442 ISLGSAKGIAHIHA----------AVGGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 442 i~~~ia~~l~~LH~----------~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
+...+.+++++|+. .....++|+|+++.||+++.++.+.|+||+.+
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 11123345666663 13468999999999999988889999999965
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.96 E-value=2.1e-06 Score=88.98 Aligned_cols=40 Identities=13% Similarity=0.160 Sum_probs=17.2
Q ss_pred hhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCC
Q 006747 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFS 127 (632)
Q Consensus 85 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 127 (632)
.+..+++|+.|+|++|.-. .++. +. +++|++|+|..|.++
T Consensus 167 ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~ 206 (362)
T 2ra8_A 167 VLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLP 206 (362)
T ss_dssp HHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCC
T ss_pred HHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCC
Confidence 3444555555555554200 1222 22 445555555544443
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00015 Score=73.27 Aligned_cols=139 Identities=17% Similarity=0.137 Sum_probs=91.8
Q ss_pred HhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC--CCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 343 VLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQH--PNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.|+.|.+..+|+... ++..+++|+.... ....+..|.+.|..+..+ ..+.+.++++...+..++||||+++..+.
T Consensus 43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~ 119 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK 119 (312)
T ss_dssp EECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred EeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence 578899999999876 4678888887643 356788999988888543 56788898888888899999999987642
Q ss_pred h-----------hhccCCC---CCC--------------CcCCHHHHH-----HHHHH--------------HHHH-HHH
Q 006747 421 A-----------LLHGNRG---IGR--------------TPLDWESRV-----KISLG--------------SAKG-IAH 452 (632)
Q Consensus 421 ~-----------~l~~~~~---~~~--------------~~l~~~~~~-----~i~~~--------------ia~~-l~~ 452 (632)
. .+|.... .+. -.-+|.... .-..+ +... ...
T Consensus 120 ~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~ 199 (312)
T 3jr1_A 120 QSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADT 199 (312)
T ss_dssp TTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHH
Confidence 1 2332211 000 012564321 11111 1111 123
Q ss_pred HHh-ccCCCceecCCCCCCeeecCCCCeEEcccC
Q 006747 453 IHA-AVGGKFILGNIKSSNVLLSQDLQGCISDFG 485 (632)
Q Consensus 453 LH~-~~~~~ivHrDlk~~NILl~~~~~~ki~DfG 485 (632)
|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 200 L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 200 LSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred hccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 321 2256899999999999999887 8899974
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00021 Score=74.95 Aligned_cols=74 Identities=11% Similarity=0.188 Sum_probs=48.7
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccc--------cCHHHHHHHHHHHHhhcCC-CCcc-ceeEEEEeCCceEEE
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV--------MGKREFEQQMEVVGRLSQH-PNVV-PIRAYYFSKDEKLLV 410 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~~h-~niv-~l~~~~~~~~~~~lv 410 (632)
+.+|.|.++.||++... +++.++||...... .....+..|.+++..+..+ +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999754 46889999764321 1234567788888877433 3334 45433 45567899
Q ss_pred EecccCC
Q 006747 411 YDFIEAG 417 (632)
Q Consensus 411 ~E~~~~g 417 (632)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00011 Score=77.10 Aligned_cols=121 Identities=17% Similarity=0.165 Sum_probs=80.0
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
.+..+.|+.+ +. .|+..+|.++++|+.++|..| ++..-...|.+ .+|+.++| .|.++..-...|. .+|+.++|
T Consensus 204 ~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l 278 (401)
T 4fdw_A 204 GIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTT 278 (401)
T ss_dssp CCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEE
T ss_pred ccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEe
Confidence 4666777744 44 677788889999999999875 44333455666 67888888 4555522233443 57888888
Q ss_pred cCCCCc-----ccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccC
Q 006747 144 SFNSIT-----GNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYN 192 (632)
Q Consensus 144 s~N~l~-----g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N 192 (632)
.+|.+. ..-+..|.+|++|+.++|.+ .++..... | .+.+|+.++|..|
T Consensus 279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp ESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT
T ss_pred CCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc
Confidence 877765 34456778888888888873 45544333 2 5677888877554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00018 Score=75.53 Aligned_cols=96 Identities=14% Similarity=0.152 Sum_probs=52.3
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDL 143 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~L 143 (632)
.+..+.|++ .+. .|+...|.++.+|+.++|++|+++......|. .++|+.+.|.+| ++..-...|. .+|+.++|
T Consensus 158 ~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l 233 (401)
T 4fdw_A 158 TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEI 233 (401)
T ss_dssp CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEEC
T ss_pred CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEec
Confidence 466777775 454 57777788888888888888877733233333 466666666533 4422222222 35555555
Q ss_pred cCCCCcccCCccccCCCCccceec
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNL 167 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l 167 (632)
..| ++..-..+|.+ .+|+.+.|
T Consensus 234 ~~~-l~~I~~~aF~~-~~L~~i~l 255 (401)
T 4fdw_A 234 PEN-VSTIGQEAFRE-SGITTVKL 255 (401)
T ss_dssp CTT-CCEECTTTTTT-CCCSEEEE
T ss_pred CCC-ccCcccccccc-CCccEEEe
Confidence 543 33222333333 34444444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00011 Score=63.85 Aligned_cols=56 Identities=16% Similarity=0.220 Sum_probs=42.2
Q ss_pred eEeecCCcCC-ccCCCCccCCCcEEEccCCCCcccCCccccCCCCccceeccccccc
Q 006747 118 FLYLQNNNFS-GNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT 173 (632)
Q Consensus 118 ~L~Ls~N~l~-g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~ 173 (632)
.++.+++.|+ ..+|..+..+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCCTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCCcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5667777765 4667777778888888888888666667788888888888888654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00057 Score=72.27 Aligned_cols=75 Identities=12% Similarity=0.055 Sum_probs=46.6
Q ss_pred CCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCC---C--CCCcccCCccccCC---CCCccchhhHHHHHHHHH
Q 006747 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVP---S--RSAGYRAPEVIETK---KPTQKSDVYSFGVLLLEM 529 (632)
Q Consensus 458 ~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~---~--~t~~y~aPE~~~~~---~~~~~~DV~s~Gvvl~el 529 (632)
.+.++|+|+++.||++++++ ++|.||+.+......... . -...|.+|+..... ......++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45899999999999999876 999999987543211000 0 01125555544311 112234556788888887
Q ss_pred HhCC
Q 006747 530 LTGK 533 (632)
Q Consensus 530 ltg~ 533 (632)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00077 Score=67.23 Aligned_cols=73 Identities=18% Similarity=0.275 Sum_probs=53.2
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCC--ccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPN--VVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~n--iv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.+|.|..+.||+..+.||+.|++|+-.... .....|+.|.+.|..+.+... +.+.+++ +..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 3578899999999999999999999876432 224568899999988854322 3444443 23478999998765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0013 Score=66.85 Aligned_cols=142 Identities=17% Similarity=0.143 Sum_probs=82.6
Q ss_pred hCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC-CccceeEE-----EEeCCceEEEEecccCC
Q 006747 344 LGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHP-NVVPIRAY-----YFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 344 lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~-----~~~~~~~~lv~E~~~~g 417 (632)
++ |....||+....+|+.+++|...........+..|.+++..+..+. .+++++.. ....+..++||||++|.
T Consensus 34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~ 112 (328)
T 1zyl_A 34 LN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 112 (328)
T ss_dssp EC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCC
Confidence 45 6677899887777778999998744345667788888888774332 24444443 12244567899999875
Q ss_pred CHhh--------------hhcc----CCCCCCCcCCHHHH----HHH---------------HHHHHHHHHHHHhc----
Q 006747 418 SFSA--------------LLHG----NRGIGRTPLDWESR----VKI---------------SLGSAKGIAHIHAA---- 456 (632)
Q Consensus 418 ~L~~--------------~l~~----~~~~~~~~l~~~~~----~~i---------------~~~ia~~l~~LH~~---- 456 (632)
.+.. .+|. .........++... ..+ ...+...++.+...
T Consensus 113 ~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 192 (328)
T 1zyl_A 113 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 192 (328)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhc
Confidence 4320 1221 10001112232211 000 00111223333322
Q ss_pred cCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 457 ~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
....++|+|+++.||+++ + .+.|.||+.+.
T Consensus 193 ~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 193 FTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp SCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred CCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 234689999999999999 4 89999998764
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00013 Score=75.50 Aligned_cols=133 Identities=16% Similarity=0.133 Sum_probs=87.7
Q ss_pred CeEEEEEeCCCCccc-cc-------CchhhcCCCCCcEEeccCCccC---------CCCCccccCCCCCCeEeecCCcCC
Q 006747 65 SRVLAVRLPGVGLYG-PI-------PANTLEKLDSLMILSLRSNHLS---------GDLPSNVLSLSSLRFLYLQNNNFS 127 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g-~l-------p~~~l~~l~~L~~L~Ls~N~l~---------g~~p~~~~~l~~L~~L~Ls~N~l~ 127 (632)
.+|+.|.+...+..| .+ .. ++..+++|+.|.+..+.+. +.+...+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~-s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVE-NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHT-THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHH-hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 357777777555443 21 11 3557889999999776432 234455678899999999988411
Q ss_pred ccCCCCccCCCcEEEccCCCCcccCCcccc--CCCCccceeccc--cccccc---------CCCCCCCCCcEEEcccCCC
Q 006747 128 GNIPSSLSPQLNWVDLSFNSITGNIPASIR--NLSHLVGLNLQN--NSLTGF---------IPNFNLSRLRHLNLSYNHL 194 (632)
Q Consensus 128 g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~--~l~~L~~l~l~~--N~l~~~---------~p~~~~~~L~~l~ls~N~l 194 (632)
.++..-.++|+.|+|..|.++...-..+. .+++|+.|+|+. |...+. +....+++|++|+|++|.+
T Consensus 186 -~l~~~~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i 264 (362)
T 2ra8_A 186 -SIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEE 264 (362)
T ss_dssp -BCCSCBCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTT
T ss_pred -eeccccCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCC
Confidence 23332247999999999988754444454 789999999863 332221 1112578999999999988
Q ss_pred CCCCc
Q 006747 195 NGSVP 199 (632)
Q Consensus 195 ~g~~p 199 (632)
+...+
T Consensus 265 ~~~~~ 269 (362)
T 2ra8_A 265 QNVVV 269 (362)
T ss_dssp HHHHH
T ss_pred chHHH
Confidence 74433
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.20 E-value=3.4e-05 Score=71.89 Aligned_cols=111 Identities=15% Similarity=0.161 Sum_probs=74.6
Q ss_pred hhcCCCCCcEEeccCC-ccCC----CCCccccCCCCCCeEeecCCcCCccCCCCcc------CCCcEEEccCCCCccc--
Q 006747 85 TLEKLDSLMILSLRSN-HLSG----DLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS------PQLNWVDLSFNSITGN-- 151 (632)
Q Consensus 85 ~l~~l~~L~~L~Ls~N-~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~------~~L~~L~Ls~N~l~g~-- 151 (632)
.+.+-+.|+.|+|++| +|.. .+-..+..-+.|+.|+|++|++...--..+. ..|+.|+|++|.|+..
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 4556778999999985 7752 1334556667899999999999744333332 6899999999999853
Q ss_pred --CCccccCCCCccceecccccc---cccC----CC-C-CCCCCcEEEcccCCCC
Q 006747 152 --IPASIRNLSHLVGLNLQNNSL---TGFI----PN-F-NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 152 --~p~~~~~l~~L~~l~l~~N~l---~~~~----p~-~-~~~~L~~l~ls~N~l~ 195 (632)
+-..+..-+.|+.|+|++|.. .... -. . .-++|+.|+++.|.+.
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 333455567799999986532 2110 00 0 3467888888877543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0026 Score=64.33 Aligned_cols=144 Identities=11% Similarity=0.095 Sum_probs=80.5
Q ss_pred HhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC-CccceeEE------EEeCCceEEEEeccc
Q 006747 343 VLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHP-NVVPIRAY------YFSKDEKLLVYDFIE 415 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~------~~~~~~~~lv~E~~~ 415 (632)
.|+.|....+|+....+| .+++|..... .....+..|.+++..+.++. .+.+++.. ....+..++|+||++
T Consensus 29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~ 106 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 106 (322)
T ss_dssp EECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred ccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence 467788889999887655 6778888652 12335667777777764432 12333321 122456789999999
Q ss_pred CCCHhh--------------hhccC-CCCCC------CcCCHHHHHHH------------HHHHHHHHHHHHhc----cC
Q 006747 416 AGSFSA--------------LLHGN-RGIGR------TPLDWESRVKI------------SLGSAKGIAHIHAA----VG 458 (632)
Q Consensus 416 ~g~L~~--------------~l~~~-~~~~~------~~l~~~~~~~i------------~~~ia~~l~~LH~~----~~ 458 (632)
|..+.. .+|.. ..... ....|.....- ...+...++++++. ..
T Consensus 107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~ 186 (322)
T 2ppq_A 107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 186 (322)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence 864321 12211 00010 01124331110 11234456666542 13
Q ss_pred CCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 459 ~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
..++|+|+.+.||+++++..+.|.||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 479999999999999987667899998653
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0013 Score=68.29 Aligned_cols=142 Identities=12% Similarity=0.169 Sum_probs=82.9
Q ss_pred HhCccceeEEEEEEEc--------CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 343 VLGKGSYGTTYKAILE--------EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+..|-...+|+.... ++..+++|+............+|.+++..+..+.-..++++++.+ .+||||+
T Consensus 57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i 132 (379)
T 3feg_A 57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYI 132 (379)
T ss_dssp EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECC
T ss_pred EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEe
Confidence 4666777788888764 247888888644333456677899999888666555667766532 2899999
Q ss_pred cCCCHhh-----------------hhccCC-CCCCCcC-CHHHHHHHHHHHH-------------------HHHHHHHhc
Q 006747 415 EAGSFSA-----------------LLHGNR-GIGRTPL-DWESRVKISLGSA-------------------KGIAHIHAA 456 (632)
Q Consensus 415 ~~g~L~~-----------------~l~~~~-~~~~~~l-~~~~~~~i~~~ia-------------------~~l~~LH~~ 456 (632)
+|..+.. .+|... ..+..+. -|.+..++..++. ..+.+|.+.
T Consensus 133 ~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~ 212 (379)
T 3feg_A 133 PSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKL 212 (379)
T ss_dssp SEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHH
T ss_pred cCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHH
Confidence 9755431 122221 1111221 2333333333221 223343321
Q ss_pred -----cCCCceecCCCCCCeeecCC----CCeEEcccCCCC
Q 006747 457 -----VGGKFILGNIKSSNVLLSQD----LQGCISDFGLTP 488 (632)
Q Consensus 457 -----~~~~ivHrDlk~~NILl~~~----~~~ki~DfGla~ 488 (632)
....++|+|+.+.||+++++ +.+.|+||..+.
T Consensus 213 L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 213 LESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 12368999999999999887 789999998753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.08 E-value=9.2e-05 Score=67.66 Aligned_cols=82 Identities=10% Similarity=0.027 Sum_probs=56.0
Q ss_pred CCCcEEeccCCccCCCCCccccCCCCCCeEeecCCc-CCccCCCCcc------CCCcEEEccCCC-CcccCCccccCCCC
Q 006747 90 DSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNN-FSGNIPSSLS------PQLNWVDLSFNS-ITGNIPASIRNLSH 161 (632)
Q Consensus 90 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~------~~L~~L~Ls~N~-l~g~~p~~~~~l~~ 161 (632)
-+|+.|||+++.++..--..+.++++|++|+|+++. ++..--..+. ++|+.|+|+++. ++..-=..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 368888998888874333456788899999999885 6532111122 368888888874 77543345677888
Q ss_pred ccceeccccc
Q 006747 162 LVGLNLQNNS 171 (632)
Q Consensus 162 L~~l~l~~N~ 171 (632)
|+.|+|++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888888764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0017 Score=65.12 Aligned_cols=139 Identities=11% Similarity=0.035 Sum_probs=74.3
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc-cCCCHh
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI-EAGSFS 420 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~-~~g~L~ 420 (632)
+.|+.|....+|+. ..+++|+.........+...|.+++..+..+.-..+++++ ..+.-++|+||+ ++..+.
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l~ 96 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTMS 96 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEECC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccCC
Confidence 45788888999998 5678888764321111235677777776444333455543 344567899999 554332
Q ss_pred h------------------hhccCCCCCCCcCCHHHHHHHHH---------------HHHHHHHHHH----h-ccCCCce
Q 006747 421 A------------------LLHGNRGIGRTPLDWESRVKISL---------------GSAKGIAHIH----A-AVGGKFI 462 (632)
Q Consensus 421 ~------------------~l~~~~~~~~~~l~~~~~~~i~~---------------~ia~~l~~LH----~-~~~~~iv 462 (632)
. .+|..........+...++.-.. .+...+..+. . .....++
T Consensus 97 ~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~ 176 (301)
T 3dxq_A 97 PEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAAC 176 (301)
T ss_dssp HHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEE
T ss_pred HhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceee
Confidence 1 12221110001111111111100 0111112121 1 1234589
Q ss_pred ecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 463 LGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 463 HrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
|+|+.+.||+ .+++.+.|+||..+.
T Consensus 177 HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 177 HCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp CSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ccCCCcCCEE-ECCCCEEEEeccccc
Confidence 9999999999 666778999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.002 Score=65.59 Aligned_cols=142 Identities=14% Similarity=0.106 Sum_probs=71.8
Q ss_pred hCccceeE-EEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC-CccceeEEEEeCCceEEEEecccCCCHhh
Q 006747 344 LGKGSYGT-TYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHP-NVVPIRAYYFSKDEKLLVYDFIEAGSFSA 421 (632)
Q Consensus 344 lg~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~~~~~~~~~lv~E~~~~g~L~~ 421 (632)
|+.|.... +|+....++..+++|...... ..++..|++++..+..+. .+.+++.+.. +.-++|||++.+..+.+
T Consensus 26 l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l~~ 101 (333)
T 3csv_A 26 LAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALFTE 101 (333)
T ss_dssp --------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBHHH
T ss_pred CCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcchHH
Confidence 44444443 667665446777777654321 123455667766664442 3456666532 23378999997766654
Q ss_pred hhccC---------------------CCCCCCcCCHHHHH-------H-------------HHHHHHHHHHHHHh---cc
Q 006747 422 LLHGN---------------------RGIGRTPLDWESRV-------K-------------ISLGSAKGIAHIHA---AV 457 (632)
Q Consensus 422 ~l~~~---------------------~~~~~~~l~~~~~~-------~-------------i~~~ia~~l~~LH~---~~ 457 (632)
++... .......++..... . ....+...++.+.. ..
T Consensus 102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~ 181 (333)
T 3csv_A 102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG 181 (333)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence 33211 00001111111000 0 00011122233321 12
Q ss_pred CCCceecCCCCCCeeecCC----CCeEEcccCCCCC
Q 006747 458 GGKFILGNIKSSNVLLSQD----LQGCISDFGLTPL 489 (632)
Q Consensus 458 ~~~ivHrDlk~~NILl~~~----~~~ki~DfGla~~ 489 (632)
...++|+|+.+.||+++.+ ..+.|.||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3579999999999999875 6899999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0051 Score=65.46 Aligned_cols=74 Identities=8% Similarity=0.083 Sum_probs=46.9
Q ss_pred hHhCccceeEEEEEEEcC-CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.|+.|-...+|+....+ +..+++|+........-+...|..++..+..+.-..++++++ .+ ..||||+++..+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 357788889999998765 477888887532211112357888888885544445677766 22 359999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0028 Score=65.54 Aligned_cols=72 Identities=13% Similarity=0.084 Sum_probs=43.1
Q ss_pred HhCccceeEEEEEEEcC---------CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 343 VLGKGSYGTTYKAILEE---------GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.++.|....+|+....+ +..+++|+.........+...|.+++..+..+.-+.++++.. . -++||||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e~ 115 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEEW 115 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEEE
Confidence 46778788899988654 267888887543211112467777887775453344666543 2 3789999
Q ss_pred ccCCC
Q 006747 414 IEAGS 418 (632)
Q Consensus 414 ~~~g~ 418 (632)
++|..
T Consensus 116 i~G~~ 120 (369)
T 3c5i_A 116 LYGDP 120 (369)
T ss_dssp CCSEE
T ss_pred ecCCc
Confidence 98754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.01 Score=62.78 Aligned_cols=71 Identities=10% Similarity=0.070 Sum_probs=49.2
Q ss_pred HhCccceeEEEEEEEcC--------CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 343 VLGKGSYGTTYKAILEE--------GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.|+.|....+|+....+ +..+++|+.... .....+..|..++..+.++.-..++++.+. + .+|+||+
T Consensus 80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l 154 (429)
T 1nw1_A 80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYI 154 (429)
T ss_dssp EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCC
T ss_pred EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEe
Confidence 47788888999998753 478889888432 122556678888888865544466776543 2 3899999
Q ss_pred cCCC
Q 006747 415 EAGS 418 (632)
Q Consensus 415 ~~g~ 418 (632)
++..
T Consensus 155 ~G~~ 158 (429)
T 1nw1_A 155 PSRP 158 (429)
T ss_dssp CEEE
T ss_pred CCcc
Confidence 8643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0049 Score=53.37 Aligned_cols=56 Identities=25% Similarity=0.253 Sum_probs=39.7
Q ss_pred EEEeCCCCcc-cccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCC
Q 006747 69 AVRLPGVGLY-GPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFS 127 (632)
Q Consensus 69 ~l~l~~~~l~-g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 127 (632)
.++.++++|+ ..+|.+ + -.+|+.|+|++|+|+...+..|..+++|++|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~-l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTA-F--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSC-C--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCC-C--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5677777775 456652 1 235788888888888655666778888888888887764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.44 E-value=0.01 Score=60.64 Aligned_cols=69 Identities=19% Similarity=0.158 Sum_probs=43.4
Q ss_pred CccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCC--CCccceeEE------EEeCCceEEEEecccC
Q 006747 345 GKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQH--PNVVPIRAY------YFSKDEKLLVYDFIEA 416 (632)
Q Consensus 345 g~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h--~niv~l~~~------~~~~~~~~lv~E~~~~ 416 (632)
|.|....||+....+| .+++|+...... ..|.+++..+.++ +.|.+.+.. ....+..++||||++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 4444679999987777 899998765432 3455555555322 224444432 2334667899999998
Q ss_pred CCH
Q 006747 417 GSF 419 (632)
Q Consensus 417 g~L 419 (632)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 765
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.29 E-value=0.00058 Score=63.55 Aligned_cols=109 Identities=13% Similarity=0.167 Sum_probs=75.3
Q ss_pred CCeEEEEEeCCC-Cccc----ccCchhhcCCCCCcEEeccCCccCC----CCCccccCCCCCCeEeecCCcCCccCCCCc
Q 006747 64 GSRVLAVRLPGV-GLYG----PIPANTLEKLDSLMILSLRSNHLSG----DLPSNVLSLSSLRFLYLQNNNFSGNIPSSL 134 (632)
Q Consensus 64 ~~~v~~l~l~~~-~l~g----~lp~~~l~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 134 (632)
...++.|+|+++ .+.. .|- +.+..=++|+.|+|++|+|.. .+-..+..-+.|++|+|++|+|+..--..+
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la-~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLI-EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHH-HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHH-HHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 356888999875 5531 122 356777899999999999982 233445556889999999999984322222
Q ss_pred ------cCCCcEEEccCC---CCcc----cCCccccCCCCccceeccccccc
Q 006747 135 ------SPQLNWVDLSFN---SITG----NIPASIRNLSHLVGLNLQNNSLT 173 (632)
Q Consensus 135 ------~~~L~~L~Ls~N---~l~g----~~p~~~~~l~~L~~l~l~~N~l~ 173 (632)
...|+.|+|++| .+.. .+-..+..-++|+.|+|+.|.+-
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 157999999876 3332 23445666688999999888653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.05 E-value=0.054 Score=50.69 Aligned_cols=103 Identities=9% Similarity=0.014 Sum_probs=66.0
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVP 496 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~ 496 (632)
-+|.++|.... .|+++.+.+.++.|.+++|.-+-....+ ..+=+-|..|++..+|.+...+ +.+.
T Consensus 33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc--------
Confidence 37888988653 5899999999999999887665211111 1223346889999999999875 2211
Q ss_pred CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCC
Q 006747 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP 535 (632)
Q Consensus 497 ~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p 535 (632)
.....+.|||... ...+.+.-|||+|+++|.-+--..|
T Consensus 98 ~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ---------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122367888763 3457888999999999998864443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.017 Score=60.17 Aligned_cols=109 Identities=15% Similarity=0.232 Sum_probs=72.1
Q ss_pred cCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCC-cc--CCCcEEEccCCCCcccCCcccc
Q 006747 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSS-LS--PQLNWVDLSFNSITGNIPASIR 157 (632)
Q Consensus 81 lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~--~~L~~L~Ls~N~l~g~~p~~~~ 157 (632)
+...+|.++.+|+.+.+..+..+ .-...|.++++|+.+.+. +.++ .|+.. |. .+|+.++|..| ++..-..+|.
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~ 331 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFA 331 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhh
Confidence 44456778888888888766543 335567788888888885 4455 34433 32 57888888755 5544556788
Q ss_pred CCCCccceecccccccccCCC-C-CCCCCcEEEcccCCC
Q 006747 158 NLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHL 194 (632)
Q Consensus 158 ~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l 194 (632)
+|.+|+.+.|..| ++..-.. | ++.+|+.+++.+|..
T Consensus 332 ~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 332 GCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred CCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 8888888888654 4432222 2 678888888877643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.024 Score=58.57 Aligned_cols=102 Identities=15% Similarity=0.187 Sum_probs=51.7
Q ss_pred hhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCC-Ccc--CCCcEEEccCCCCcccCCccccCCCC
Q 006747 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS-SLS--PQLNWVDLSFNSITGNIPASIRNLSH 161 (632)
Q Consensus 85 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~ 161 (632)
.+....+|+.+.+..+ +...-...+.++.+|+.+.+..+ ++ .|.. .+. .+|+.+.+..+ +...-...|.++++
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~ 287 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN 287 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-EeCccccceeehhcccccccc-ceeccccccccccc
Confidence 4455566666666544 22233445556666666666544 33 2222 221 35666666443 33333445566666
Q ss_pred ccceecccccccccCCC-C-CCCCCcEEEcc
Q 006747 162 LVGLNLQNNSLTGFIPN-F-NLSRLRHLNLS 190 (632)
Q Consensus 162 L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls 190 (632)
|+.+.+.+|.++..... | .+.+|+.++|.
T Consensus 288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp CCEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred cccccccccccceehhhhhcCCCCCCEEEcC
Confidence 66666666555543332 2 45566666554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=95.61 E-value=0.003 Score=57.62 Aligned_cols=82 Identities=11% Similarity=0.092 Sum_probs=57.1
Q ss_pred CCCCeEeecCCcCCccCCCCc--cCCCcEEEccCCC-CcccCCccccCC----CCccceeccccc-ccc--cCCCCCCCC
Q 006747 114 SSLRFLYLQNNNFSGNIPSSL--SPQLNWVDLSFNS-ITGNIPASIRNL----SHLVGLNLQNNS-LTG--FIPNFNLSR 183 (632)
Q Consensus 114 ~~L~~L~Ls~N~l~g~~p~~~--~~~L~~L~Ls~N~-l~g~~p~~~~~l----~~L~~l~l~~N~-l~~--~~p~~~~~~ 183 (632)
-+|+.|||+++.++..--..+ .++|+.|+|+++. ++..-=..++.+ ++|+.|+|+++. ++. ...-..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999874322222 2789999999985 775433445554 479999999975 552 111126899
Q ss_pred CcEEEcccCC-CC
Q 006747 184 LRHLNLSYNH-LN 195 (632)
Q Consensus 184 L~~l~ls~N~-l~ 195 (632)
|++|+|++.. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999874 44
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=95.48 E-value=0.038 Score=57.50 Aligned_cols=82 Identities=15% Similarity=0.200 Sum_probs=41.7
Q ss_pred CccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCC-C-CCC
Q 006747 107 PSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLS 182 (632)
Q Consensus 107 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~ 182 (632)
...|.++.+|+.+.+.++..+ .-...|. .+|+.+++. +.++..-...|.++.+|+.++|..| ++..-.. | .+.
T Consensus 258 ~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~ 334 (394)
T 4gt6_A 258 THAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE 334 (394)
T ss_dssp TTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred cceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC
Confidence 345566666666666544322 1112222 456666664 3444344456666666666666544 3322222 2 456
Q ss_pred CCcEEEccc
Q 006747 183 RLRHLNLSY 191 (632)
Q Consensus 183 ~L~~l~ls~ 191 (632)
+|+.+.|..
T Consensus 335 ~L~~i~ip~ 343 (394)
T 4gt6_A 335 QLERIAIPS 343 (394)
T ss_dssp TCCEEEECT
T ss_pred CCCEEEECc
Confidence 666666643
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.31 E-value=0.041 Score=57.78 Aligned_cols=73 Identities=12% Similarity=0.103 Sum_probs=47.1
Q ss_pred HhCccceeEEEEEEEcC--------CcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 343 VLGKGSYGTTYKAILEE--------GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+..|-...+|+....+ +..+++|+........-+..+|.+++..+..+.-..++++.+ . -+.||||+
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~efI 152 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEFI 152 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEEe
Confidence 45667777888887653 578888886543221123457788887775554455666533 2 37899999
Q ss_pred cCCCH
Q 006747 415 EAGSF 419 (632)
Q Consensus 415 ~~g~L 419 (632)
+|..|
T Consensus 153 ~G~~l 157 (424)
T 3mes_A 153 DGEPL 157 (424)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=94.90 E-value=0.092 Score=54.50 Aligned_cols=95 Identities=16% Similarity=0.102 Sum_probs=43.4
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCc--cCCCcEEEcc
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL--SPQLNWVDLS 144 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~--~~~L~~L~Ls 144 (632)
+..+.++..- + .|....+.++..|+.+.+..|... .....|.++..|+.+.+..+.+.. ..+ ..+|+.+.+.
T Consensus 232 l~~i~ip~~~-~-~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~---~~F~~~~~L~~i~l~ 305 (394)
T 4fs7_A 232 VKNIIIPDSF-T-ELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE---KTFYGCSSLTEVKLL 305 (394)
T ss_dssp CCEEEECTTC-C-EECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT---TTTTTCTTCCEEEEC
T ss_pred CceEEECCCc-e-ecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc---ccccccccccccccc
Confidence 4445554332 1 344445666677777776665443 233445555555555544433210 011 1344444444
Q ss_pred CCCCcccCCccccCCCCccceecc
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQ 168 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~ 168 (632)
.| ++..-..+|.++++|+.++|.
T Consensus 306 ~~-i~~I~~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 306 DS-VKFIGEEAFESCTSLVSIDLP 328 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCC
T ss_pred cc-cceechhhhcCCCCCCEEEeC
Confidence 33 332233344455555555443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=94.58 E-value=0.016 Score=37.78 Aligned_cols=32 Identities=28% Similarity=0.334 Sum_probs=21.4
Q ss_pred ccccccceeeehhhHHHHHHHHHHHHHhhhhc
Q 006747 254 EKLSTGAIVAIAIGGSAVLFLLFLMIAFCCLK 285 (632)
Q Consensus 254 ~~~s~~~ii~ivi~~~~~v~l~~~~i~~~~~~ 285 (632)
+.++.+++.+++++.++.+.+++.+++|+++|
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 34677888888888777666655555555443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.51 E-value=0.095 Score=53.98 Aligned_cols=132 Identities=15% Similarity=0.211 Sum_probs=91.4
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCC-cc--CCCcEEEc
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSS-LS--PQLNWVDL 143 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~--~~L~~L~L 143 (632)
+..+.++.. +. .+....+.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++ .++.. |. .+|+.+++
T Consensus 219 l~~i~~~~~-~~-~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 219 LKKITITSG-VT-TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp CSEEECCTT-CC-EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEE
T ss_pred cceeeeccc-ee-EEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccc
Confidence 444555433 22 455667888999999999876 55344667889999999999654 55 44433 32 68999999
Q ss_pred cCCCCcccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccCCCCCCCcccccCCCCCCccCC
Q 006747 144 SFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGN 213 (632)
Q Consensus 144 s~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n 213 (632)
.+|.++..-..+|.+|.+|+.+.|..| ++..-.. | ++.+|+.+.+ |..+..+...+|.+.
T Consensus 294 ~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i---------p~~v~~I~~~aF~~c 355 (379)
T 4h09_A 294 DNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY---------PKSITLIESGAFEGS 355 (379)
T ss_dssp CCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC---------CTTCCEECTTTTTTS
T ss_pred cccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE---------CCccCEEchhHhhCC
Confidence 999998666789999999999999765 5533232 3 6778887755 444445555666553
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=93.88 E-value=0.085 Score=54.77 Aligned_cols=118 Identities=18% Similarity=0.181 Sum_probs=86.2
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCC-CCcc--CCCcEEE
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIP-SSLS--PQLNWVD 142 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~--~~L~~L~ 142 (632)
.+..+.++.+.. .+....+..+..|+.+.+..+.+. ...|..+.+|+.+.+.++ ++ .|+ ..|. .+|+.++
T Consensus 254 ~l~~~~~~~~~~--~i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~-~I~~~aF~~c~~L~~i~ 326 (394)
T 4fs7_A 254 DLESISIQNNKL--RIGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VK-FIGEEAFESCTSLVSID 326 (394)
T ss_dssp SCCEEEECCTTC--EECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CC-EECTTTTTTCTTCCEEC
T ss_pred cceeEEcCCCcc--eeeccccccccccceeccCceeec---cccccccccccccccccc-cc-eechhhhcCCCCCCEEE
Confidence 455566665543 366667889999999988877643 346788999999999765 55 343 3443 6899999
Q ss_pred ccCCCCcccCCccccCCCCccceecccccccccCCC-C-CCCCCcEEEcccC
Q 006747 143 LSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-F-NLSRLRHLNLSYN 192 (632)
Q Consensus 143 Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~-~~~~L~~l~ls~N 192 (632)
|..+ ++..-..+|.+|++|+.++|..| ++..-.. | .+.+|+.+++..|
T Consensus 327 lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 327 LPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred eCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 9755 76555678999999999999877 6544333 3 7889999998765
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.59 E-value=0.071 Score=35.73 Aligned_cols=31 Identities=29% Similarity=0.273 Sum_probs=16.4
Q ss_pred cceeeehhhHHHHHHHHHHHHHhhhhccCCC
Q 006747 259 GAIVAIAIGGSAVLFLLFLMIAFCCLKKKDS 289 (632)
Q Consensus 259 ~~ii~ivi~~~~~v~l~~~~i~~~~~~~~~~ 289 (632)
++|.+.+++++++++++++.++++++||+.+
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 4455556665555555555455555554443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.52 E-value=0.1 Score=35.10 Aligned_cols=30 Identities=17% Similarity=0.227 Sum_probs=15.2
Q ss_pred cceeeehhhHHHHHHHHHHHHHhhhhccCC
Q 006747 259 GAIVAIAIGGSAVLFLLFLMIAFCCLKKKD 288 (632)
Q Consensus 259 ~~ii~ivi~~~~~v~l~~~~i~~~~~~~~~ 288 (632)
++|.+.++++++++++++++++++++||+.
T Consensus 11 ~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 11 PSIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred ceEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 345555555555555445444445554443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.68 E-value=0.58 Score=48.57 Aligned_cols=28 Identities=25% Similarity=0.421 Sum_probs=23.8
Q ss_pred ceecCCCCCCeee------cCCCCeEEcccCCCC
Q 006747 461 FILGNIKSSNVLL------SQDLQGCISDFGLTP 488 (632)
Q Consensus 461 ivHrDlk~~NILl------~~~~~~ki~DfGla~ 488 (632)
++|+|+.+.||++ +++..++++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456789999998763
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.97 E-value=1.9 Score=40.13 Aligned_cols=123 Identities=10% Similarity=0.095 Sum_probs=81.1
Q ss_pred HHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCC
Q 006747 381 QMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460 (632)
Q Consensus 381 e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ 460 (632)
|+.+|.. .||+.+.. ..-.+.+.+.+.|+.-+.+-=...++ .++...+++++..++.-..+++.
T Consensus 36 el~LL~~--~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--------~~~~~eKlr~l~ni~~l~~~~~~----- 99 (215)
T 4ann_A 36 LMYLLEQ--HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--------SFTKNEKLRYLLNIKNLEEVNRT----- 99 (215)
T ss_dssp GGGGGGS--CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--------GSCHHHHHHHHHHGGGGGGGGGS-----
T ss_pred HHHHHhc--cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--------hcCHHHHHHHHHHHHHHHHHhcC-----
Confidence 3444443 68888876 45555666666666544222222232 25678899999988877766553
Q ss_pred ceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCC
Q 006747 461 FILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQ 537 (632)
Q Consensus 461 ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~ 537 (632)
-+|--|.|+||++|.++.+++.=.|+-..+ +|. ..++..=.-.+=+++..+++++..|+
T Consensus 100 r~tf~L~P~NL~f~~~~~p~i~~RGik~~l-------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 100 RYTFVLAPDELFFTRDGLPIAKTRGLQNVV-------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp SEECCCSGGGEEECTTSCEEESCCEETTTB-------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEEecceEEEcCCCCEEEEEccCccCC-------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 377889999999999999999888864322 221 11233334467888999999998885
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=80.59 E-value=0.71 Score=30.87 Aligned_cols=26 Identities=12% Similarity=0.342 Sum_probs=11.0
Q ss_pred eeeehhhHHHHHHHHHHHHHhhhhccC
Q 006747 261 IVAIAIGGSAVLFLLFLMIAFCCLKKK 287 (632)
Q Consensus 261 ii~ivi~~~~~v~l~~~~i~~~~~~~~ 287 (632)
++++++| +++++++.++++++.+||+
T Consensus 14 Ia~~vVG-vll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 14 IISAVVG-ILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHH-HHHHHHHHHHHHHHHHHHC
T ss_pred hHHHHHH-HHHHHHHHHHHHhheehhh
Confidence 4555555 3333333333344444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 632 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-52 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-52 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-48 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-45 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-38 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-37 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-34 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-34 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-33 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-32 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 6e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 9e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-54
Identities = 70/276 (25%), Positives = 125/276 (45%), Gaps = 29/276 (10%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
E LG G +G + T V VK LK+ M F + ++ +L QH +V + A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYA-V 76
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
+++ ++ +++E GS L GI L + ++ A+G+A I +
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA-----GYRAPEVIETKKPTQK 516
I +++++N+L+S L I+DFGL L+ +R + APE I T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 517 SDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEE 576
SDV+SFG+LL E++T ++ + ++ R ++R +N E
Sbjct: 191 SDVWSFGILLTEIVTHGRIPY--PGMTNPEVIQNLERGYR-----------MVRPDNCPE 237
Query: 577 EMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612
E+ Q+ C + P+ RPT + + ++ED +
Sbjct: 238 ELY---QLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-52
Identities = 54/274 (19%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ LG G +G V +K +KE M + EF ++ +V+ L H +V +
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVC 68
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
+ ++ +++ G L R + +++ + + ++ + +F
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK---QF 121
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-----SAGYRAPEVIETKKPTQK 516
+ ++ + N L++ +SDFGL+ + S + PEV+ K + K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 517 SDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575
SD+++FGVL+ E+ + GK P + + + + + R SE
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE------------- 228
Query: 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
++ I SC + D RPT + ++ I D+
Sbjct: 229 ----KVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-52
Identities = 68/283 (24%), Positives = 123/283 (43%), Gaps = 35/283 (12%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIR 398
+ +G GS+GT YK V VK L + F+ ++ V+ + +H N++
Sbjct: 14 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFM 70
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
Y + + +V + E S LH + + I+ +A+G+ ++HA
Sbjct: 71 GYS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAK-- 123
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR------SAGYRAPEVIETKK 512
I ++KS+N+ L +DL I DFGL + + + + S + APEVI +
Sbjct: 124 -SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 513 P---TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569
+ +SDVY+FG++L E++TG+ P + D + +V + S
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPDLS---K 233
Query: 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612
N + M ++ C+ K D RP +++ IE + S
Sbjct: 234 VRSNCPKAMK---RLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 6e-52
Identities = 64/277 (23%), Positives = 120/277 (43%), Gaps = 31/277 (11%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ +G G +G + V +K ++E M + +F ++ EV+ +L HP +V +
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVC 69
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
+ LV++F+E G S L R E+ + + L +G+A++ A
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEA---CV 122
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-----SAGYRAPEVIETKKPTQK 516
I ++ + N L+ ++ +SDFG+T + S + +PEV + + K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 517 SDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575
SDV+SFGVL+ E+ + GK P + + +VV+ + + S
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST------------- 229
Query: 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612
+ QI C + P+ RP ++R + +I S
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 6e-52
Identities = 58/300 (19%), Positives = 112/300 (37%), Gaps = 35/300 (11%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
E +GKG +G ++ G V VK E ++ L +H N++ A
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAAD 66
Query: 402 FSKDEKL----LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
+ LV D+ E GS L+ R + E +K++L +A G+AH+H +
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 458 GG-----KFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA--------GYRA 504
G ++KS N+L+ ++ CI+D GL ++ T A Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 505 PEVIETK------KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDV----VDLPRWVQSV 554
PEV++ + +++D+Y+ G++ E+ + + +
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614
+R+ + + E + M +I C R T + + + + +
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 3e-51
Identities = 62/271 (22%), Positives = 114/271 (42%), Gaps = 27/271 (9%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
+ +GKG +G G V VK +K + F + V+ +L +H N+V +
Sbjct: 13 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLGVI 69
Query: 402 FSKDEKL-LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
+ L +V +++ GS L GR+ L + +K SL + + ++
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGN---N 123
Query: 461 FILGNIKSSNVLLSQDLQGCISDFGLTPLMN-TPTVPSRSAGYRAPEVIETKKPTQKSDV 519
F+ ++ + NVL+S+D +SDFGLT + T + APE + KK + KSDV
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDV 183
Query: 520 YSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMV 579
+SFG+LL E+ + + D+ V+ + +
Sbjct: 184 WSFGILLWEIYSFGRVPY--PRIPLKDVVPRVEKGYKMDAPDGCPP-------------- 227
Query: 580 QMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610
+ ++ +C MRP+ ++ +E I+
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 1e-49
Identities = 67/286 (23%), Positives = 121/286 (42%), Gaps = 30/286 (10%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYY 401
LG+G +G + T V +K LK M F Q+ +V+ +L +H +V + A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYA-V 80
Query: 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKF 461
S++ +V +++ GS L G G L V ++ A G+A++ +
Sbjct: 81 VSEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERM---NY 134
Query: 462 ILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA-----GYRAPEVIETKKPTQK 516
+ +++++N+L+ ++L ++DFGL L+ +R + APE + T K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 517 SDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEE 576
SDV+SFG+LL E+ T ++ V+ R E +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVERGYRMPCPPECPE----------- 241
Query: 577 EMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED-IRPSDSENQPSSE 621
+ + C K P+ RPT E + +ED ++ + QP
Sbjct: 242 ---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-48
Identities = 65/302 (21%), Positives = 115/302 (38%), Gaps = 46/302 (15%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLK--EVVMGKREFEQQMEVVGRLSQHPN 393
+ LG G++G +A + TV VK LK + + +++V+ L H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGI-------------GRTPLDWESRV 440
+V + L++ ++ G L R LD E +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 441 KISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP------T 494
S AKG+A + + I ++ + N+LL+ I DFGL +
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV 554
+ APE I T +SDV+S+G+ L E+ + + + + +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFYKM 260
Query: 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614
++E + R + E +M I +C P RPT +++V++IE S+S
Sbjct: 261 IKEGF----------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI-SES 309
Query: 615 EN 616
N
Sbjct: 310 TN 311
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 8e-46
Identities = 54/298 (18%), Positives = 118/298 (39%), Gaps = 38/298 (12%)
Query: 342 EVLGKGSYGTTYKAILEEG---TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVP 396
+V+G+G++G KA +++ +KR+KE R+F ++EV+ +L HPN++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGI-----------GRTPLDWESRVKISLG 445
+ + L ++ G+ L +R + + L + + +
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 446 SAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---Y 502
A+G+ ++ +FI ++ + N+L+ ++ I+DFGL+ + +
Sbjct: 136 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192
Query: 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSE 562
A E + T SDV+S+GVLL E+++ +L + R E
Sbjct: 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTCAELYEKLPQGYRLEKPLN 250
Query: 563 VFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSENQPSS 620
D ++ + C + P RP+ +++ + + ++
Sbjct: 251 CDD--------------EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 294
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-45
Identities = 55/293 (18%), Positives = 113/293 (38%), Gaps = 45/293 (15%)
Query: 330 NFDLEDLLRASAEVLGKGSYGTTYKAIL---EEGTTVVVKRLKEVVM--GKREFEQQMEV 384
N + D+ LG G++G+ + + ++ V +K LK+ E ++ ++
Sbjct: 9 NLLIADI------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 62
Query: 385 VGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISL 444
+ +L +P +V + + +LV + G L G R + + ++
Sbjct: 63 MHQL-DNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLH 116
Query: 445 GSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT-------PLMNTPTVPS 497
+ G+ ++ F+ ++ + NVLL ISDFGL+ +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 498 RSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVR 556
+ APE I +K + +SDV+S+GV + E L+ G+ P + +V+ +++ R
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGKR 230
Query: 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
E E ++ + C + RP V + +
Sbjct: 231 MECPPECPP--------------ELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-45
Identities = 65/313 (20%), Positives = 124/313 (39%), Gaps = 48/313 (15%)
Query: 315 EAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE----GTTVVVKRLKE 370
+A ++ ++ +F+ EV+G+G +G Y L + VK L
Sbjct: 15 QAVQHVVIGPSSLIVHFN---------EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 65
Query: 371 VVMGK--REFEQQMEVVGRLSQHPNVVPIRAYYFSKDEK-LLVYDFIEAGSFSALLHGNR 427
+ +F + ++ HPNV+ + + L+V +++ G +
Sbjct: 66 ITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET 124
Query: 428 GIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT 487
+ + L AKG+ + + KF+ ++ + N +L + ++DFGL
Sbjct: 125 H----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 177
Query: 488 PLMNTPTVPSR--------SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAP 539
M S + A E ++T+K T KSDV+SFGVLL E++T AP
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-- 235
Query: 540 GHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTM 599
+ D+ ++ R L++ E + + ++ + C +MRP+
Sbjct: 236 PDVNTFDITVYLLQGRR-----------LLQPEYCPDPLY---EVMLKCWHPKAEMRPSF 281
Query: 600 EEVVRMIEDIRPS 612
E+V I I +
Sbjct: 282 SELVSRISAIFST 294
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (407), Expect = 2e-45
Identities = 64/279 (22%), Positives = 119/279 (42%), Gaps = 29/279 (10%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
LG G YG Y+ + ++ TV VK LKE M EF ++ V+ + +HPN+V +
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGV 81
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
+ ++ +F+ G+ L R + + ++ + + ++
Sbjct: 82 CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK---N 135
Query: 461 FILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS-----AGYRAPEVIETKKPTQ 515
FI ++ + N L+ ++ ++DFGL+ LM T + + + APE + K +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 516 KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575
KSDV++FGVLL E+ T D+ + ++ R E R E
Sbjct: 196 KSDVWAFGVLLWEIATYGMSP--YPGIDLSQVYELLEKDYRME-----------RPEGCP 242
Query: 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614
E++ ++ +C P RP+ E+ + E + S
Sbjct: 243 EKVY---ELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (407), Expect = 2e-45
Identities = 59/302 (19%), Positives = 123/302 (40%), Gaps = 55/302 (18%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPN 393
+G+G++G ++A E T V VK LKE + +F+++ ++ +PN
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPN 77
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRG-------------------IGRTPL 434
+V + L+++++ G + L G PL
Sbjct: 78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 137
Query: 435 DWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP- 493
++ I+ A G+A++ KF+ ++ + N L+ +++ I+DFGL+ + +
Sbjct: 138 SCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194
Query: 494 -----TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDL 547
+ + PE I + T +SDV+++GV+L E+ + G P HE+V+
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 254
Query: 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607
V E +++ + C +K+P RP+ + R+++
Sbjct: 255 ------VRDGN-----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 608 DI 609
+
Sbjct: 298 RM 299
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (403), Expect = 8e-45
Identities = 58/284 (20%), Positives = 124/284 (43%), Gaps = 41/284 (14%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVV 395
+V+G G +G L + V +K LK +R+F + ++G+ HPNV+
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVI 90
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ +++ +F+E GS + L N G V + G A G+ ++
Sbjct: 91 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLAD 146
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN---------TPTVPSRSAGYRAPE 506
++ ++ + N+L++ +L +SDFGL+ + + + APE
Sbjct: 147 M---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565
I+ +K T SDV+S+G+++ E+++ G+ P ++DV++ + +++
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-------IEQDY------ 250
Query: 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
R + + Q+ + C K + RP ++V ++ +
Sbjct: 251 ----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 48/294 (16%), Positives = 116/294 (39%), Gaps = 39/294 (13%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIR 398
LG G+ G +K G + K + + + + ++++V+ P +V
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFY 70
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
++S E + + ++ GS +L + + K+S+ KG+ ++
Sbjct: 71 GAFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLM--NTPTVPSRSAGYRAPEVIETKKPTQK 516
+ ++K SN+L++ + + DFG++ + + + Y +PE ++ + +
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183
Query: 517 SDVYSFGVLLLEMLTGKAPIQAPGHEDV------------VDLPRWVQSVVREEWTSEVF 564
SD++S G+ L+EM G+ PI P +++ + P ++ R + +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 565 DVELMRYENIEEEMV--------------QMLQIAMSCVAKVPDMRPTMEEVVR 604
M + + +V + C+ K P R +++++
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-44
Identities = 59/299 (19%), Positives = 104/299 (34%), Gaps = 52/299 (17%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPN 393
+VLG G++G A V VK LKE + +++++ +L H N
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRG------------------IGRTPLD 435
+V + L++++ G L R L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 436 WESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN---- 491
+E + + AKG+ + + ++ + NVL++ I DFGL +
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 492 --TPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLP 548
+ APE + T KSDV+S+G+LL E+ + G P PG +
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY--PGIPVDANFY 277
Query: 549 RWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE 607
+ +Q+ + + EE+ I SC A RP+ + +
Sbjct: 278 KLIQNGFKMDQP-----------FYATEEIY---IIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-44
Identities = 53/294 (18%), Positives = 120/294 (40%), Gaps = 38/294 (12%)
Query: 342 EVLGKGSYGTTYKAILEEGT-----TVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNV 394
+V+G G +G YK +L+ + V +K LK + +F + ++G+ H N+
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNI 71
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
+ + +++ +++E G+ L G V + G A G+ ++
Sbjct: 72 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLA 127
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN-------TPTVPSRSAGYRAPEV 507
++ ++ + N+L++ +L +SDFGL+ ++ T + + APE
Sbjct: 128 NM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 508 IETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567
I +K T SDV+SFG+++ E++T ++ + + R
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSNHEVMKAINDGFRLPT-------- 234
Query: 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSENQPSSE 621
+ + Q+ M C + RP ++V +++ + + + ++
Sbjct: 235 ------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLAD 282
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-43
Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 31/275 (11%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPI 397
+G GSYG K +G +V K L M K+ ++ ++ L +HPN+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRY 68
Query: 398 RAYYFSKDEKLL--VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH- 454
+ L V ++ E G ++++ R LD E +++ + H
Sbjct: 69 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 455 -AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS----AGYRAPEVIE 509
+ G + ++K +NV L + DFGL ++N T +++ Y +PE +
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN 187
Query: 510 TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569
+KSD++S G LL E+ P A +++ + + R
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG--KIREGKFRRIP---------- 235
Query: 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+E+ +++ + RP++EE++
Sbjct: 236 --YRYSDELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (394), Expect = 2e-43
Identities = 57/271 (21%), Positives = 111/271 (40%), Gaps = 33/271 (12%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKRE----FEQQMEVVGRLSQHPNVVP 396
+G GS+G Y A + V +K++ E +++ + +L +HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQ 79
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
R Y + LV ++ + L + PL ++ G+ +G+A++H+
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH 134
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIET---KKP 513
I ++K+ N+LLS+ + DFG +M + + APEVI +
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 514 TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573
K DV+S G+ +E+ K P+ + + + E + ++ +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNESPA-------LQSGH 238
Query: 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
E + SC+ K+P RPT E +++
Sbjct: 239 WSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-43
Identities = 61/281 (21%), Positives = 107/281 (38%), Gaps = 41/281 (14%)
Query: 343 VLGKGSYGTTYKAILEE---GTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVP 396
LG G++GT K + TV VK LK K E + V+ +L +P +V
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVR 72
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ + +LV + E G + L NR + ++ +++ + G+ ++ +
Sbjct: 73 MIGI-CEAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES 126
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM-------NTPTVPSRSAGYRAPEVIE 509
F+ ++ + NVLL ISDFGL+ + T + APE I
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 510 TKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568
K + KSDV+SFGVL+ E + G+ P + +V + + +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR------ 237
Query: 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
+M + C + RP V + +
Sbjct: 238 -----------EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 5e-43
Identities = 59/269 (21%), Positives = 106/269 (39%), Gaps = 32/269 (11%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQM--EV-VGRLSQHPNVVPI 397
LGKG +G Y A ++ + +K L + + K E Q+ EV + +HPN++ +
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
Y+ L+ ++ G+ L D + A +++ H+
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK- 125
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR--SAGYRAPEVIETKKPTQ 515
+ I +IK N+LL + I+DFG + + + + Y PE+IE + +
Sbjct: 126 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183
Query: 516 KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575
K D++S GVL E L GK P +A +++ V+ + T D
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD---------- 233
Query: 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+ + P RP + EV+
Sbjct: 234 --------LISRLLKHNPSQRPMLREVLE 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-42
Identities = 61/274 (22%), Positives = 114/274 (41%), Gaps = 34/274 (12%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKRE---FEQQMEVVGRLSQHPNVVPI 397
+G+GS+ T YK + E V L++ + K E F+++ E++ L QHPN+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRF 73
Query: 398 RAYYFS----KDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI 453
+ S K +LV + + +G+ L + + + KG+ +
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFL 128
Query: 454 HAAVGGKFILGNIKSSNVLL-SQDLQGCISDFGLTPLMNTPTVPSR--SAGYRAPEVIET 510
H I ++K N+ + I D GL L + + + APE+ E
Sbjct: 129 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 186
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570
+K + DVY+FG+ +LEM T + P ++ + R V S V+ +V E+
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKPASFDKVAIPEVK- 243
Query: 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+I C+ + D R ++++++
Sbjct: 244 ------------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-41
Identities = 58/285 (20%), Positives = 114/285 (40%), Gaps = 41/285 (14%)
Query: 342 EVLGKGSYGTTYKAILE----EGTTVVVKRLKEVVMGK----REFEQQMEVVGRLSQHPN 393
E LG GS+G + + + +V VK LK V+ + +F +++ + L H N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN 72
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI 453
++ + + K+ V + GS L ++G + + ++ A+G+ ++
Sbjct: 73 LIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYL 127
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN-------TPTVPSRSAGYRAPE 506
+ +FI ++ + N+LL+ I DFGL + + APE
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565
++T+ + SD + FGV L EM T G+ P ++ + +E
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------IDKEGE------ 232
Query: 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610
R E+ + + + C A P+ RPT + + + +
Sbjct: 233 ----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 2e-41
Identities = 62/295 (21%), Positives = 118/295 (40%), Gaps = 46/295 (15%)
Query: 342 EVLGKGSYGTTYKAIL--------EEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQH 391
+ LG+G++G A T V VK LK K + +ME++ + +H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 392 PNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG-----------RTPLDWESRV 440
N++ + ++ ++ G+ L R G L + V
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 441 KISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS- 499
+ A+G+ ++ + K I ++ + NVL+++D I+DFGL ++ ++
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 500 -----AGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV 554
+ APE + + T +SDV+SFGVLL E+ T V +L + ++
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVPVEELFKLLKEG 253
Query: 555 VREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
R + S + ++ + C VP RPT +++V ++ I
Sbjct: 254 HRMDKPSNCTN--------------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 2e-41
Identities = 70/299 (23%), Positives = 118/299 (39%), Gaps = 44/299 (14%)
Query: 342 EVLGKGSYGTTYKAI------LEEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPN 393
+ LG+G++G +A TV VK LKE R +++++ + H N
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 394 VVPIRAYYFSKDEKL-LVYDFIEAGSFSALLHGNRG-----------IGRTPLDWESRVK 441
VV + L ++ +F + G+ S L R + + L E +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 442 ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSA- 500
S AKG+ + + K I ++ + N+LLS+ I DFGL + R
Sbjct: 139 YSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 501 -----GYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV 555
+ APE I + T +SDV+SFGVLL E+ + A PG + + R ++
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDEEFCRRLKEGT 254
Query: 556 REEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDS 614
R +M Q + C P RPT E+V + ++ +++
Sbjct: 255 RMRAPDYTTP--------------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 299
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 150 bits (381), Expect = 4e-41
Identities = 55/289 (19%), Positives = 118/289 (40%), Gaps = 32/289 (11%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRL-KEVVMGKREFEQQMEVVGRLSQHPNVVPIRA 399
E LG G++G ++ G K + K ++++ + L +HP +V +
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHD 90
Query: 400 YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459
+ +E +++Y+F+ G + + + V+ KG+ H+H
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHEN--- 143
Query: 460 KFILGNIKSSNVLLSQDLQGCI--SDFGLTPLMNTPT---VPSRSAGYRAPEVIETKKPT 514
++ ++K N++ + + DFGLT ++ V + +A + APEV E K
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 515 QKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574
+D++S GVL +L+G +P ++ +++V +W ++ + I
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWN-----MDDSAFSGI 252
Query: 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVR---MIEDIRPSDSENQPSS 620
E+ ++ + P+ R T+ + + + P PSS
Sbjct: 253 SEDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSS 298
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 9e-41
Identities = 54/292 (18%), Positives = 115/292 (39%), Gaps = 35/292 (11%)
Query: 324 FEGCSYNFDLEDLLRASAEVLGKGSYGTTYKAILEE-GTTVVVKRL-KEVVMGKREFEQQ 381
+E + + + ED LG G++G YKA +E K + + ++ +
Sbjct: 1 YEHVTRDLNPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59
Query: 382 MEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVK 441
++++ HPN+V + ++ ++ ++ +F G+ A++ PL
Sbjct: 60 IDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQV 114
Query: 442 ISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS-- 499
+ + + ++H K I ++K+ N+L + D ++DFG++ S
Sbjct: 115 VCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171
Query: 500 --AGYRAPEVI-----ETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQ 552
+ APEV+ + + K+DV+S G+ L+EM + P V +
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LL 225
Query: 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+ + E L + L+ C+ K D R T ++++
Sbjct: 226 KIAKSEP------PTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-40
Identities = 57/280 (20%), Positives = 108/280 (38%), Gaps = 38/280 (13%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVV 395
+G+G +G ++ I V +K K + +F Q+ + + HP++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIV 71
Query: 396 PIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHA 455
+ +++ ++ + G + L + LD S + + + +A++ +
Sbjct: 72 KLIGV-ITENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLES 126
Query: 456 AVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG-----YRAPEVIET 510
+F+ +I + NVL+S + + DFGL+ M T S G + APE I
Sbjct: 127 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 511 KKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569
++ T SDV+ FGV + E+L G P Q + DV+ + +
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP------- 236
Query: 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
+ + C A P RP E+ + I
Sbjct: 237 ----------TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 56/269 (20%), Positives = 112/269 (41%), Gaps = 31/269 (11%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKRE-FEQQMEVVGRLSQHPNVVPIRA 399
E +G+G+ GT Y A+ + G V ++++ K+E ++ V+ ++PN+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLD 84
Query: 400 YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459
Y DE +V +++ GS + ++ T +D + + + +H+
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 460 KFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TVPSRSAGYRAPEVIETKKPTQ 515
+ I +IKS N+LL D ++DFG + + + + APEV+ K
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 516 KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575
K D++S G++ +EM+ G+ P + L + EL E +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYL------IATNGT------PELQNPEKLS 243
Query: 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
L C+ + R + +E+++
Sbjct: 244 AIFRDFLN---RCLDMDVEKRGSAKELLQ 269
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-39
Identities = 54/273 (19%), Positives = 106/273 (38%), Gaps = 34/273 (12%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRL--KEVVMGKREFEQQMEVVGRLSQHPNVVPIR 398
+ LG+G+YG A+ V VK + K V ++++ + L H NVV
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFY 69
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+ + + L ++ G + + G + + G+ ++H
Sbjct: 70 GHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGI-- 122
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGL---TPLMNTPTVPSRSAG---YRAPEVIETKK 512
+IK N+LL + ISDFGL N + ++ G Y APE+++ ++
Sbjct: 123 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 513 P-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571
+ DV+S G++L ML G+ P P + + W + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQP-SDSCQEYSDWKEKKTYLN-----------PW 229
Query: 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+ I+ + +L + + P R T+ ++ +
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 143 bits (362), Expect = 2e-38
Identities = 56/307 (18%), Positives = 123/307 (40%), Gaps = 38/307 (12%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRL-KEVVMGKREFEQQMEVVGRLSQHPNVVPIRA 399
E LG G++G ++ + G V K + + K + ++ ++ +L HP ++ +
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHD 93
Query: 400 YYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGG 459
+ K E +L+ +F+ G + + + + +G+ H+H
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEH--- 146
Query: 460 KFILGNIKSSNVLLSQDLQG--CISDFGLTPLMNTPTVPSRSAG---YRAPEVIETKKPT 514
+ +IK N++ I DFGL +N + + + APE+++ +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 515 QKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574
+D+++ GVL +L+G +P + +Q+V R +W FD + + ++
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDWE---FDEDA--FSSV 255
Query: 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM---------IEDIRPSDSENQPSSEDKLK 625
E ++ + + K P R T+ + + + PS N+ + K K
Sbjct: 256 SPEAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEK 312
Query: 626 DSNTQTP 632
++ P
Sbjct: 313 YADWPAP 319
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-38
Identities = 63/295 (21%), Positives = 118/295 (40%), Gaps = 42/295 (14%)
Query: 342 EVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPN 393
LG+GS+G Y+ + E T V +K + E + EF + V+ +
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHH 84
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIG-----RTPLDWESRVKISLGSAK 448
VV + L++ + + G + L R P ++++ A
Sbjct: 85 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144
Query: 449 GIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN------TPTVPSRSAGY 502
G+A+++A KF+ ++ + N ++++D I DFG+T + +
Sbjct: 145 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201
Query: 503 RAPEVIETKKPTQKSDVYSFGVLLLEMLTG-KAPIQAPGHEDVVDLPRWVQSVVREEWTS 561
+PE ++ T SDV+SFGV+L E+ T + P Q +E V+ R+V +
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---RFVMEGGLLDKPD 258
Query: 562 EVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIE-DIRPSDSE 615
D + ++ C P MRP+ E++ I+ ++ P E
Sbjct: 259 NCPD--------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-37
Identities = 53/282 (18%), Positives = 106/282 (37%), Gaps = 40/282 (14%)
Query: 342 EVLGKGSYGTTYKAIL-----EEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNV 394
+VLG G++GT YK + + V +K L+E K +E + V+ + +P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHV 73
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
+ L+ + G L + + + + + AKG+ ++
Sbjct: 74 CRLL-GICLTSTVQLITQLMPFGC----LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG------YRAPEVI 508
+ + ++ + NVL+ I+DFGL L+ + G + A E I
Sbjct: 129 DR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 509 ETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567
+ T +SDV+S+GV + E++T G P ++ + + + + +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI----- 240
Query: 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
+ I + C D RP E++ +
Sbjct: 241 ------------DVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 50/307 (16%), Positives = 119/307 (38%), Gaps = 38/307 (12%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
E LG+G +G ++ + T + K +K + ++++ ++ +H N++ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHES 69
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
+ S +E +++++FI ++ + L+ V + + +H+
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSH---N 122
Query: 461 FILGNIKSSNVLLSQDLQG--CISDFGLTPLM---NTPTVPSRSAGYRAPEVIETKKPTQ 515
+I+ N++ I +FG + + + + Y APEV + +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVST 182
Query: 516 KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575
+D++S G L+ +L+G P A ++ + +++++ E+T FD E ++ I
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYT---FDEEA--FKEIS 231
Query: 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVV----------RMIEDIRPSDSENQPSSEDKLK 625
E + + + K R T E + R+ + + + K
Sbjct: 232 IEAMDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288
Query: 626 DSNTQTP 632
D N
Sbjct: 289 DLNMVVS 295
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (345), Expect = 1e-36
Identities = 55/298 (18%), Positives = 114/298 (38%), Gaps = 28/298 (9%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKRE--FEQQMEVVGRLSQHPNVVPIR 398
+VLG G++ A V +K + + + +E E ++ V+ ++ +HPN+V +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALD 73
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
Y S L+ + G + ++ + ++H
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEVIETKKPTQ 515
L L +D + ISDFGL+ + + +V S + G Y APEV+ K ++
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188
Query: 516 KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575
D +S GV+ +L G P + E+ ++ + +++I
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLF-----------EQILKAEYEFDSPYWDDIS 237
Query: 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRPSDSENQPSSEDKLKDSNTQT 631
+ ++ + K P+ R T E+ ++ I D S +++K + ++
Sbjct: 238 DSAKDFIR---HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKS 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 56/303 (18%), Positives = 115/303 (37%), Gaps = 34/303 (11%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
+VLG G G + +K L++ +RE E R SQ P++V I
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHW----RASQCPHIVRIVDV 73
Query: 401 YFSKDEK----LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
Y + L+V + ++ G + + G +I + I ++H+
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 457 VGGKFILGNIKSSNVLLS---QDLQGCISDFG---LTPLMNTPTVPSRSAGYRAPEVIET 510
++K N+L + + ++DFG T N+ T P + Y APEV+
Sbjct: 131 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP 187
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570
+K + D++S GV++ +L G P + + P + + ++
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPF--YSNHGLAISPGMKTRIRMGQ-----YEFPNPE 240
Query: 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR---MIEDIRPSDSENQPSSEDKLKDS 627
+ + EE+ +++ + + P R T+ E + +++ + + S K
Sbjct: 241 WSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 628 NTQ 630
+
Sbjct: 298 RWE 300
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 134 bits (339), Expect = 3e-36
Identities = 52/281 (18%), Positives = 105/281 (37%), Gaps = 42/281 (14%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLK----------EVVMGKREFEQQMEVVGRLSQ 390
E+LG+G + I VK + EV + ++++++ ++S
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
HPN++ ++ Y + LV+D ++ G L L + KI + I
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVI 123
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEV 507
+H + ++K N+LL D+ ++DFG + ++ G Y APE+
Sbjct: 124 CALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180
Query: 508 IET------KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTS 561
IE ++ D++S GV++ +L G P ++ S
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-----------RMIMS 229
Query: 562 EVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEV 602
+ +++ + + ++ + P R T EE
Sbjct: 230 GNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 4e-36
Identities = 46/272 (16%), Positives = 105/272 (38%), Gaps = 38/272 (13%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKRE----FEQQMEVVGRLSQHPNVVP 396
++LG+GS+ T A L +K L++ + K ++ +V+ RL HP V
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVK 72
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ + ++ + + G + D + + ++H
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK 127
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS------AGYRAPEVIET 510
I ++K N+LL++D+ I+DFG +++ + +R+ A Y +PE++
Sbjct: 128 ---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570
K + SD+++ G ++ +++ G P +A + ++ +E
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ---------------KIIKLEYDF 229
Query: 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEV 602
E + +++ + R EE+
Sbjct: 230 PEKFFPKARDLVE---KLLVLDATKRLGCEEM 258
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 130 bits (328), Expect = 1e-34
Identities = 54/286 (18%), Positives = 109/286 (38%), Gaps = 40/286 (13%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK----REFEQQMEVVGRLSQHPNVVP 396
E+LG G + A L V VK L+ + F ++ + L HP +V
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVA 71
Query: 397 IRAYYFSKDEKL----LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
+ ++ +V ++++ + ++H P+ + +++ + + +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNF 126
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR-------SAGYRAP 505
H I ++K +N+++S + DFG+ + +A Y +P
Sbjct: 127 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 506 EVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565
E +SDVYS G +L E+LTG+ P V VRE+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPIP---- 233
Query: 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRP-TMEEVVRMIEDIR 610
R+E + ++ ++ + +AK P+ R T E+ + +
Sbjct: 234 -PSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 130 bits (328), Expect = 2e-34
Identities = 36/285 (12%), Positives = 80/285 (28%), Gaps = 36/285 (12%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
+G+GS+G ++ L V +K + + L+ + + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
+LV D + L R ++ + + IH
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---S 121
Query: 461 FILGNIKSSNVLLSQDLQG-----CISDFGLTPLMNTPTVPSR-----------SAGYRA 504
+ +IK N L+ + + DFG+ P +A Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 505 PEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564
++ +++ D+ + G + + L G P Q + + E+
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609
EE + + D P + + + +
Sbjct: 242 A-------GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKV 276
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 3e-33
Identities = 46/306 (15%), Positives = 95/306 (31%), Gaps = 36/306 (11%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
+G GS+G Y + G V +K V + + ++ + + IR
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 401 YFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGK 460
D ++V + + +R ++ + ++ I +IH+
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---N 123
Query: 461 FILGNIKSSNVLLSQDLQG---CISDFGLTPLMNTPTVPSR-----------SAGYRAPE 506
FI ++K N L+ +G I DFGL +A Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566
+ +++ D+ S G +L+ G P Q + +
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC-- 241
Query: 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI--RPSDSENQPSSEDKL 624
+ E L C + D +P + ++ ++ R S + + L
Sbjct: 242 -----KGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 293
Query: 625 KDSNTQ 630
K ++
Sbjct: 294 KFGASR 299
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 54/272 (19%), Positives = 104/272 (38%), Gaps = 35/272 (12%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKRE----FEQQMEVVGRLSQHPNVVP 396
++LGKGS+G + A ++ +K LK+ V+ + + V+ +HP +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 397 IRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAA 456
+ + +K+ V +++ G + D + G+ +H+
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK 122
Query: 457 VGGKFILGNIKSSNVLLSQDLQGCISDFGL----TPLMNTPTVPSRSAGYRAPEVIETKK 512
+ ++K N+LL +D I+DFG+ + Y APE++ +K
Sbjct: 123 ---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179
Query: 513 PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572
D +SFGVLL EML G++P E++ R E D+
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDL------ 233
Query: 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+V++ + P+ R + +R
Sbjct: 234 -----LVKLFV-------REPEKRLGVRGDIR 253
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-32
Identities = 54/295 (18%), Positives = 115/295 (38%), Gaps = 39/295 (13%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLK-------EVVMGKREFEQQMEVVGRLSQHPN 393
E LG G + K G K +K + + + E+++ ++ + QHPN
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPN 74
Query: 394 VVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI 453
V+ + Y +K + +L+ + + G L L E + G+ ++
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYL 129
Query: 454 HAAVGGKFILGNIKSSNVLLSQD----LQGCISDFGLTPLMNTPTVPSRSAG---YRAPE 506
H+ + ++K N++L + I DFGL ++ G + APE
Sbjct: 130 HSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 507 VIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566
++ + ++D++S GV+ +L+G +P ++ + V +E+
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY------- 239
Query: 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSDSENQPSSE 621
+ N ++ + K P R T+++ ++ I+P D++ SS
Sbjct: 240 ----FSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQH-PWIKPKDTQQALSSA 286
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 3e-32
Identities = 48/281 (17%), Positives = 97/281 (34%), Gaps = 23/281 (8%)
Query: 342 EVLGKGSYGTTYKA--ILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS-----QHPNV 394
+G+G+YG +KA + G V +KR++ + + V L +HPNV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGS-FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHI 453
V + + L + + E+ + +G+ +
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 454 HAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEVIET 510
H+ + + ++K N+L++ Q ++DFGL + + + YRAPEV+
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570
D++S G + EM K + D + V + EE +
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 571 YENIEEEMVQMLQIAMS---------CVAKVPDMRPTMEEV 602
+ + + ++ + C+ P R +
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 125 bits (315), Expect = 4e-32
Identities = 48/279 (17%), Positives = 105/279 (37%), Gaps = 35/279 (12%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQM----EVVGRLSQ--HPNV 394
++G+G +G Y + G +K L + + ++ E ++ +S P +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
V + + + D+ + D + G L + + G+ H+H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH 124
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLM--NTPTVPSRSAGYRAPEVIETKK 512
+ ++K +N+LL + ISD GL P + GY APEV++
Sbjct: 125 NR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 181
Query: 513 P-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571
+D +S G +L ++L G +P + +D ++ R ++ E
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP------------ 229
Query: 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610
++ E+ +L+ + + + R R ++++
Sbjct: 230 DSFSPELRSLLE---GLLQRDVNRRLGCLG--RGAQEVK 263
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 2e-31
Identities = 69/318 (21%), Positives = 119/318 (37%), Gaps = 41/318 (12%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
+V+G GS+G Y+A L + G V +K++ + KR ++++++ +L H N+V +R +
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKL-DHCNIVRLRYF 81
Query: 401 YFSKDEK------LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
++S EK LV D++ + H +R + L + +A+IH
Sbjct: 82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGC-ISDFGLTPLMNTPTVPS---RSAGYRAPEVIET 510
+ +IK N+LL D + DFG + S YRAPE+I
Sbjct: 140 SF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 511 KKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV------ 563
T DV+S G +L E+L G+ D + V E E+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 564 --------FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIR-PS 612
+ E + + + P R T E +++R P+
Sbjct: 257 FKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACAHSFFDELRDPN 313
Query: 613 DSENQPSSEDKLKDSNTQ 630
L + TQ
Sbjct: 314 VKLPNGRDTPALFNFTTQ 331
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 120 bits (302), Expect = 4e-31
Identities = 53/282 (18%), Positives = 112/282 (39%), Gaps = 28/282 (9%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGK---REFEQQMEVVGRLSQHPNVVPIR 398
E +G+G+YG YKA G T +K+++ + +++ ++ L +H N+V +
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLY 66
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+K +LV++ ++ L L+ + L GIA+ H
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR-- 119
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRS----AGYRAPEVIETKKP- 513
+ + ++K N+L++++ + I+DFGL P YRAP+V+ K
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 514 TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV----------DLPRWVQSVVREEWTSEV 563
+ D++S G + EM+ G D + + W ++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 564 FDVELMRYENIEEEM-VQMLQIAMSCVAKVPDMRPTMEEVVR 604
E + +E+ + + + + + P+ R T ++ +
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 5e-31
Identities = 49/276 (17%), Positives = 99/276 (35%), Gaps = 44/276 (15%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLK-------EVVMGKREFEQQMEVVGRLS-QHP 392
+LG G +G+ Y I + + V +K ++ + ++ ++ ++S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 393 NVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
V+ + ++ D +L+ + E RG L E + + H
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGC-ISDFGLTPLMNTPTVPSR--SAGYRAPEVIE 509
H + +IK N+L+ + + DFG L+ + Y PE I
Sbjct: 126 CHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182
Query: 510 TKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568
+ + + V+S G+LL +M+ G P + E+ ++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------------------EEIIRGQV 221
Query: 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604
+ + E +++ C+A P RPT EE+
Sbjct: 222 FFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-30
Identities = 68/314 (21%), Positives = 121/314 (38%), Gaps = 32/314 (10%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK---REFEQQMEVVGRLSQHPNVVPI 397
+ +G G+YG A+ G V +K+L + + +++ ++ + +H NV+ +
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGL 82
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
+ + DF F G + L + + KG+ +IHAA
Sbjct: 83 LDVFTPDETLDDFTDFYLVMPFMGTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAA- 140
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-TVPSRSAGYRAPEVI-ETKKPTQ 515
I ++K N+ +++D + I DFGL ++ T + YRAPEVI + TQ
Sbjct: 141 --GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQ 198
Query: 516 KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY---- 571
D++S G ++ EM+TGK + H D + V E+ + E Y
Sbjct: 199 TVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
Query: 572 ------------ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRPSDSENQ 617
N V +L+ + + R T E + E + ++ E Q
Sbjct: 259 PELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQ 315
Query: 618 PSSEDKLKDSNTQT 631
D D +T
Sbjct: 316 VQKYDDSFDDVDRT 329
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 53/308 (17%), Positives = 115/308 (37%), Gaps = 33/308 (10%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK--REFEQQMEVVGRLSQHPNVVPIR 398
+G+G+YG A V +K++ + ++++++ R +H N++ I
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGIN 72
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+ + + ++ A L+ + + L + +G+ +IH+A
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHICYFLYQILRGLKYIHSA-- 128
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGL-------TPLMNTPTVPSRSAGYRAPEVIETK 511
+ ++K SN+LL+ I DFGL T + YRAPE++
Sbjct: 129 -NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 512 KP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570
K T+ D++S G +L EML+ + + D ++ + +E + + +++
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247
Query: 571 YENIEEEMV-------------QMLQIAMSCVAKVPDMRPTMEEVVR---MIEDIRPSDS 614
Y + L + + P R +E+ + + + PSD
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDE 307
Query: 615 ENQPSSED 622
+
Sbjct: 308 PIAEAPFK 315
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 5e-30
Identities = 50/280 (17%), Positives = 106/280 (37%), Gaps = 26/280 (9%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIR 398
E +G+G+YG YKA G V +K+++ + + + L + HPN+V +
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
++++ LV++F+ + + +G+A H+
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSH-- 121
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TVPSRSAGYRAPEVI-ETKKP 513
+ + ++K N+L++ + ++DFGL P T + YRAPE++ K
Sbjct: 122 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 514 TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD-----LPRWVQSVVREEWTSEVFDVEL 568
+ D++S G + EM+T +A D + L + V + +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 569 MRYENIEEEMV------QMLQIAMSCVAKVPDMRPTMEEV 602
++ + V + + P+ R + +
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 5e-30
Identities = 53/305 (17%), Positives = 112/305 (36%), Gaps = 40/305 (13%)
Query: 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEVVMGK------REFEQQMEVVGRLSQHPNV 394
+ LG+G + T YKA + V +K++K + R ++++++ L HPN+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNI 62
Query: 395 VPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIH 454
+ + + K LV+DF+E + + L L + +G+ ++H
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH 117
Query: 455 AAVGGKFILGNIKSSNVLLSQDLQGCISDFG----LTPLMNTPTVPSRSAGYRAPEVIET 510
+ ++K +N+LL ++ ++DFG T + YRAPE++
Sbjct: 118 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 511 KKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV-------------DLPRWVQSVVR 556
+ D+++ G +L E+L + D + P
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 557 EEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMI---EDIRPSD 613
+ S + ++++ ++Q P R T + ++M P+
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKMKYFSNRPGPTP 291
Query: 614 SENQP 618
P
Sbjct: 292 GCQLP 296
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 5e-28
Identities = 49/266 (18%), Positives = 107/266 (40%), Gaps = 26/266 (9%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQME---VVGRLSQHPNVVPI 397
LG GS+G + G +K LK+ ++ + + + ++ + HP ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
+ + ++ D+IE G +LL ++ + + ++H+
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSK- 123
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSRSAGYRAPEVIETKKPTQK 516
I ++K N+LL ++ I+DFG + + + Y APEV+ TK +
Sbjct: 124 --DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181
Query: 517 SDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEE 576
D +SFG+L+ EML G P + + + +V D+
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDL---------- 231
Query: 577 EMVQMLQIAMSCVAKVPDMRPTMEEV 602
+ +++ +S ++ +++ E+V
Sbjct: 232 -LSRLITRDLS--QRLGNLQNGTEDV 254
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 109 bits (273), Expect = 1e-26
Identities = 52/317 (16%), Positives = 113/317 (35%), Gaps = 31/317 (9%)
Query: 291 GTAATKSKGIRNEKPKEDFGSGVQEAEKNKLVFFEGCSYNFDLEDLLRASAEVLGKGSYG 350
G AA KG E KE ++ K + + + + + LG GS+G
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRI-----KTLGTGSFG 55
Query: 351 TTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQM--EV-VGRLSQHPNVVPIRAYYFSKDE 406
E G +K L + + K + + E + + P +V + +
Sbjct: 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115
Query: 407 KLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNI 466
+V +++ G + L + ++H+ I ++
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDL 167
Query: 467 KSSNVLLSQDLQGCISDFGL-TPLMNTPTVPSRSAGYRAPEVIETKKPTQKSDVYSFGVL 525
K N+L+ Q ++DFG + + APE+I +K + D ++ GVL
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVL 227
Query: 526 LLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIA 585
+ EM G P A + + + ++S++ D+ + +LQ+
Sbjct: 228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL-----------LRNLLQVD 276
Query: 586 MSCVAKVPDMRPTMEEV 602
++ + +++ + ++
Sbjct: 277 LT--KRFGNLKNGVNDI 291
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (269), Expect = 2e-26
Identities = 49/289 (16%), Positives = 100/289 (34%), Gaps = 41/289 (14%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAY 400
LG+G Y ++AI + VVVK LK V K++ +++++++ L PN++ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADI 98
Query: 401 YFSKDEKL--LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+ LV++ + F L L K + + H+
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM-- 148
Query: 459 GKFILGNIKSSNVLL-SQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEVIETKKP- 513
+ ++K NV++ + + + D+GL + + ++ PE++ +
Sbjct: 149 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 514 TQKSDVYSFGVLLLEMLTGKAP--------------IQAPGHEDVVDLPRWVQSVVREEW 559
D++S G +L M+ K P + G ED+ D + +
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267
Query: 560 TSEVFDVELMRYENIEEEMV------QMLQIAMSCVAKVPDMRPTMEEV 602
+ R+E + L + R T E
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-25
Identities = 52/292 (17%), Positives = 109/292 (37%), Gaps = 30/292 (10%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIR 398
E +G+G+YGT +KA E V +KR++ + + + L + H N+V +
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
S + LV++F + N + D E KG+ H+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHSR-- 120
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TVPSRSAGYRAPEVIETKKP- 513
+ ++K N+L++++ + +++FGL P + + YR P+V+ K
Sbjct: 121 -NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 514 TQKSDVYSFGVLLLEMLTGKAPI-QAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572
+ D++S G + E+ P+ +D + + EE + + +
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 573 NIEEEMVQMLQIA-----------MSCVAKVPDMRPTMEEVVRM--IEDIRP 611
+ ++ + + + P R + EE ++ D P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 9e-25
Identities = 46/233 (19%), Positives = 91/233 (39%), Gaps = 16/233 (6%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEV---VGRLSQHPNVVPI 397
++LGKG++G G +K L++ V+ ++ V + ++HP + +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
+ + + D V ++ G L R E + ++H+
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR- 124
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR----SAGYRAPEVIETKKP 513
+ +IK N++L +D I+DFGL + + + Y APEV+E
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 514 TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566
+ D + GV++ EM+ G+ P HE + +L + + E +
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL 235
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 6e-24
Identities = 51/302 (16%), Positives = 109/302 (36%), Gaps = 31/302 (10%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGK---REFEQQMEVVGRLSQHPNVVPI 397
+G+G++G +KA + G V +K++ + ++++++ L +H NVV +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNL 74
Query: 398 RAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV 457
+K F H G+ L + +I + ++
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134
Query: 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSR--------SAGYRAPEVIE 509
K + ++K++NVL+++D ++DFGL + + YR PE++
Sbjct: 135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194
Query: 510 TKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568
++ D++ G ++ EM T +Q + + L + + E V + EL
Sbjct: 195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254
Query: 569 MRYENIEEEMV--------------QMLQIAMSCVAKVPDMRPTMEEVVR---MIEDIRP 611
+ + L + + P R ++ + D P
Sbjct: 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 314
Query: 612 SD 613
SD
Sbjct: 315 SD 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 54/285 (18%), Positives = 104/285 (36%), Gaps = 40/285 (14%)
Query: 342 EVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVVMGKRE-----FEQQMEVVGRLSQHP 392
+VLG G+YG + + G +K LK+ + ++ + +V+ + Q P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 393 NVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
+V + + ++ + L+ D+I G L R + H
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEH 144
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-----VPSRSAGYRAPEV 507
+H I +IK N+LL + ++DFGL+ + Y AP++
Sbjct: 145 LHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201
Query: 508 IETKK--PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565
+ + D +S GVL+ E+LTG +P G ++ E + +
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-----------AEISRRILK 250
Query: 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610
E + + ++Q + K P R R ++I+
Sbjct: 251 SEPPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGP--RDADEIK 290
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 56/316 (17%), Positives = 119/316 (37%), Gaps = 36/316 (11%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLK---EVVMGKREFEQQMEVVGRLSQHPNVVPI 397
+G G+YG+ A + G V VK+L + ++ + +++ ++ + +H NV+ +
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGL 82
Query: 398 RAYY-----FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAH 452
+ + + + + + ++ + L + + +G+ +
Sbjct: 83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKY 136
Query: 453 IHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-TVPSRSAGYRAPEVI-ET 510
IH+A I ++K SN+ +++D + I DFGL + T + YRAPE++
Sbjct: 137 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 193
Query: 511 KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570
Q D++S G ++ E+LTG+ H D + L + E ++
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253
Query: 571 YENIEEEMVQM-------------LQIAMSCVAKVPDMRPTMEEVVRM--IEDIRPSDSE 615
Y +M +M + + + D R T + + D E
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 313
Query: 616 NQPSSEDKLKDSNTQT 631
D+ +S
Sbjct: 314 PVADPYDQSFESRDLL 329
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.3 bits (246), Expect = 4e-23
Identities = 53/337 (15%), Positives = 109/337 (32%), Gaps = 58/337 (17%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ---------- 390
LG G + T + A + T V +K ++ + E +++++ R++
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
+++ + ++ K + + LL + + +IS G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 451 AHIHAAVGGKFILGNIKSSNVLL-SQDLQGCISDFGLTPLMNTPTVPSRSA------GYR 503
++H G I +IK NVL+ D + + L N YR
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 504 APEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR------- 556
+PEV+ +D++S L+ E++TG + + ++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 557 -----EEWTSEVF------------------DVELMRYENIEEEMVQMLQIAMSCVAKVP 593
++T F DV +Y+ ++E ++ + P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
Query: 594 DMRPTMEEV--------VRMIEDIRPSDSENQPSSED 622
R + +E+IR D E S D
Sbjct: 317 RKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSD 353
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 5e-22
Identities = 54/327 (16%), Positives = 109/327 (33%), Gaps = 45/327 (13%)
Query: 342 EVLGKGSYGTTYKAI-LEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQ--HPNVVPIR 398
+ +G G+ G A V +K+L + ++ + + H N++ +
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 399 AYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVG 458
+ + D + + + LD E + GI H+H+
Sbjct: 83 NVFTPQKTLEEFQDVYLVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS--- 137
Query: 459 GKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAG---YRAPEVIETKKPTQ 515
I ++K SN+++ D I DFGL T + + YRAPEVI +
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197
Query: 516 KSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD---------------------------LP 548
D++S G ++ EM+ K + D + P
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257
Query: 549 RWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR---M 605
++ + + +F + + + +L + P R ++++ ++ +
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKRISVDDALQHPYI 314
Query: 606 IEDIRPSDSENQPSSE-DKLKDSNTQT 631
P++ E P DK D T
Sbjct: 315 NVWYDPAEVEAPPPQIYDKQLDEREHT 341
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 82.4 bits (202), Expect = 2e-17
Identities = 32/136 (23%), Positives = 55/136 (40%), Gaps = 25/136 (18%)
Query: 77 LYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLS--------------------LSSL 116
+ P L L L L L +N +S P L+ L +L
Sbjct: 253 ISNLAP---LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 117 RFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFI 176
+L L NN S P S +L + + N ++ +S+ NL+++ L+ +N ++
Sbjct: 310 TYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 177 PNFNLSRLRHLNLSYN 192
P NL+R+ L L+
Sbjct: 368 PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.4 bits (171), Expect = 1e-13
Identities = 39/159 (24%), Positives = 61/159 (38%), Gaps = 29/159 (18%)
Query: 91 SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITG 150
+L LSL N L + SL++L L L NN S P S +L + L N I+
Sbjct: 220 NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISN 277
Query: 151 NIP--------------------ASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLS 190
P + I NL +L L L N+++ P +L++L+ L +
Sbjct: 278 ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFA 337
Query: 191 YNHLNGSVPLA----LQKFPPSSFEGNSMLCGPPLNQCS 225
N ++ LA + S N + PL +
Sbjct: 338 NNKVSDVSSLANLTNINWL---SAGHNQISDLTPLANLT 373
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.7 bits (151), Expect = 4e-11
Identities = 24/89 (26%), Positives = 43/89 (48%), Gaps = 2/89 (2%)
Query: 112 SLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNS 171
L++L L NN S P + L+ + L+ N + ++ +L++L L+L NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252
Query: 172 LTGFIPNFNLSRLRHLNLSYNHLNGSVPL 200
++ P L++L L L N ++ PL
Sbjct: 253 ISNLAPLSGLTKLTELKLGANQISNISPL 281
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 8e-08
Identities = 23/101 (22%), Positives = 43/101 (42%), Gaps = 6/101 (5%)
Query: 97 LRSNHLSGDLPSNVL----SLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNI 152
L S ++ D P N + +L+ L N + + + Q+ + I +I
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SI 59
Query: 153 PASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNH 193
+ L++L +N NN LT P NL++L + ++ N
Sbjct: 60 D-GVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQ 99
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 1e-05
Identities = 13/60 (21%), Positives = 21/60 (35%), Gaps = 2/60 (3%)
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
L ++T + S +L + L + L+ L +N S N L PL
Sbjct: 28 VLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITPLK 85
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 9/57 (15%), Positives = 21/57 (36%), Gaps = 4/57 (7%)
Query: 143 LSFNSITGNIPASI----RNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
L +IT + P + L+ + L ++T + +L ++ L +
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK 57
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 75.9 bits (185), Expect = 1e-15
Identities = 28/90 (31%), Positives = 37/90 (41%), Gaps = 20/90 (22%)
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
LN +DL N I G +P + L L LN+ N+L G IP
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG--------------- 288
Query: 196 GSVPLALQKFPPSSFEGNSMLCGPPLNQCS 225
LQ+F S++ N LCG PL C+
Sbjct: 289 -----NLQRFDVSAYANNKCLCGSPLPACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 73.2 bits (178), Expect = 1e-14
Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 8/179 (4%)
Query: 25 SDKQALLDFAANVPHARKL-NWNSSTSVCT-SWVGITCTKNGS--RVLAVRLPGVGLYGP 80
DKQALL ++ + L +W +T C +W+G+ C + RV + L G+ L P
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 81 IP-ANTLEKLDSLMILSLRSNH-LSGDLPSNVLSLSSLRFLYLQNNNFSGNIP--SSLSP 136
P ++L L L L + + L G +P + L+ L +LY+ + N SG IP S
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 137 QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
L +D S+N+++G +P SI +L +LVG+ N ++G IP+ S + N
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 16/80 (20%), Positives = 29/80 (36%), Gaps = 2/80 (2%)
Query: 52 CTSWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVL 111
+ + + + L +YG +P L +L L L++ N+L G++P
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP-QGLTQLKFLHSLNVSFNNLCGEIPQ-GG 288
Query: 112 SLSSLRFLYLQNNNFSGNIP 131
+L NN P
Sbjct: 289 NLQRFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.4 bits (145), Expect = 2e-10
Identities = 27/106 (25%), Positives = 40/106 (37%), Gaps = 4/106 (3%)
Query: 115 SLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTG 174
LR + + +P L P +DL N IT +NL +L L L NN ++
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 175 FIPN--FNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCG 218
P L +L L LS N L +P + K + +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITK 114
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 59.3 bits (142), Expect = 4e-10
Identities = 31/163 (19%), Positives = 52/163 (31%), Gaps = 28/163 (17%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNW 140
I + L +L L L +N +S P L L LYL N +P + L
Sbjct: 46 IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQE 104
Query: 141 VDLSFNSIT--------------------------GNIPASIRNLSHLVGLNLQNNSLTG 174
+ + N IT G + + + L + + + ++T
Sbjct: 105 LRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 163
Query: 175 FIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLC 217
IP L L+L N + +L+ + G S
Sbjct: 164 TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.5 bits (140), Expect = 6e-10
Identities = 33/242 (13%), Positives = 73/242 (30%), Gaps = 51/242 (21%)
Query: 11 SFIWLIPQMIADLNS------DKQALLDFAANVPHARKLNWNSSTSVCTSWVGITCTKNG 64
+ P A L K L + +P + + + N
Sbjct: 66 KISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQ 125
Query: 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNN 124
V+ + + G + + L + + +++ +P + SL L+L N
Sbjct: 126 MIVVELGTNPLKSSGIEN-GAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHLDGN 181
Query: 125 NFSGNIPSSL--------------------------SPQLNWVDLSFNSITGNIPASIRN 158
+ +SL +P L + L+ N + +P + +
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 240
Query: 159 LSHLVGLNLQNNSLTGFIPNF--------NLSRLRHLNLSYNHLNGSVPLALQKFPPSSF 210
++ + L NN+++ N + ++L N P+ + PS+F
Sbjct: 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN------PVQYWEIQPSTF 294
Query: 211 EG 212
Sbjct: 295 RC 296
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 55.4 bits (132), Expect = 7e-09
Identities = 25/158 (15%), Positives = 48/158 (30%), Gaps = 34/158 (21%)
Query: 88 KLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNS 147
++ L SG + L ++ + + N + IP L P L + L N
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNK 182
Query: 148 ITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-------------------------FNLS 182
IT AS++ L++L L L NS++ +
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK 242
Query: 183 RLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPP 220
++ + L N+++ + F
Sbjct: 243 YIQVVYLHNNNISA--------IGSNDFCPPGYNTKKA 272
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.1 bits (126), Expect = 3e-08
Identities = 31/152 (20%), Positives = 57/152 (37%), Gaps = 11/152 (7%)
Query: 91 SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSI 148
+L L++N ++ + +L +L L L NN S P + + +L + LS N +
Sbjct: 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 149 TGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPS 208
+ L L + + + N L+++ + L N L S
Sbjct: 92 KELPEKMPKTLQELRVHENEITKVRKSVFNG-LNQMIVVELGTNPLKSS------GIENG 144
Query: 209 SFEGNSMLCGPPL--NQCSTVPPAPSPSATNF 238
+F+G L + +T+P PS T
Sbjct: 145 AFQGMKKLSYIRIADTNITTIPQGLPPSLTEL 176
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 60.6 bits (145), Expect = 2e-10
Identities = 22/94 (23%), Positives = 39/94 (41%), Gaps = 8/94 (8%)
Query: 97 LRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASI 156
N S ++ S SL L + NN +P+ P+L + SFN + +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP-PRLERLIASFNHLA-EVPELP 323
Query: 157 RNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLS 190
+NL L+++ N L P+ + L ++
Sbjct: 324 QNLKQ---LHVEYNPLRE-FPDI-PESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 8e-08
Identities = 17/71 (23%), Positives = 30/71 (42%), Gaps = 8/71 (11%)
Query: 136 PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
P L +++S N + +PA L L N L +P L+ L++ YN L
Sbjct: 284 PSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAE-VPEL-PQNLKQLHVEYNPLR 337
Query: 196 G--SVPLALQK 204
+P +++
Sbjct: 338 EFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 3e-04
Identities = 19/65 (29%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199
N+ + I + L LN+ NN L +P RL L S+NHL VP
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPA-LPPRLERLIASFNHLA-EVP 320
Query: 200 LALQK 204
Q
Sbjct: 321 ELPQN 325
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 6e-04
Identities = 16/71 (22%), Positives = 30/71 (42%), Gaps = 6/71 (8%)
Query: 130 IPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNL 189
+ L Q + ++L+ ++ ++P +L L NSLT +P L+ L +
Sbjct: 32 LRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLTE-LPEL-PQSLKSLLV 85
Query: 190 SYNHLNGSVPL 200
N+L L
Sbjct: 86 DNNNLKALSDL 96
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.0 bits (129), Expect = 2e-09
Identities = 25/120 (20%), Positives = 41/120 (34%), Gaps = 8/120 (6%)
Query: 94 ILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIP 153
+L L L+ ++ L + L L +N P+ + + V + ++ N+
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 154 ASIRNLSHLVGLNLQNNSLTGFIPN---FNLSRLRHLNLSYNHLNG--SVPLALQKFPPS 208
L L NN L + RL LNL N L + L + PS
Sbjct: 60 GVANLPRLQE-LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 5e-07
Identities = 27/106 (25%), Positives = 41/106 (38%), Gaps = 4/106 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145
LE+L + L L N L P+ + +L L L +N + P+L + L
Sbjct: 16 LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQELLLCN 74
Query: 146 NSITG-NIPASIRNLSHLVGLNLQNNSLTGF--IPNFNLSRLRHLN 188
N + + + LV LNLQ NSL I L ++
Sbjct: 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 55.6 bits (133), Expect = 2e-09
Identities = 29/201 (14%), Positives = 61/201 (30%), Gaps = 29/201 (14%)
Query: 342 EVLGKGSYGTTYKAILEEGTTVVVKRLK-----------EVVMGKREFEQQMEVVGRLSQ 390
+++G+G + E+ VVK K + G F R +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN-E 64
Query: 391 HPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGI 450
+ ++ V + L+ + E+ ++ + +
Sbjct: 65 FRALQKLQGLA--------VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 451 AHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTVPSRSAGYRAPEVIET 510
A + + G++ NVL+S + I DF + + R R I T
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG--WREILERDVRNIIT 170
Query: 511 ---KKPTQKSDVYSFGVLLLE 528
+ + D+ S +L+
Sbjct: 171 YFSRTYRTEKDINSAIDRILQ 191
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 5e-09
Identities = 25/103 (24%), Positives = 41/103 (39%), Gaps = 5/103 (4%)
Query: 95 LSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP-QLNWVDLSFNSITGN-I 152
L L +L D+ +LS + + + SP ++ +DLS + I + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 153 PASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNH 193
+ S L L+L+ L+ I N S L LNLS
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 4e-04
Identities = 8/63 (12%), Positives = 30/63 (47%), Gaps = 2/63 (3%)
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIP-NFNLSRLRHLNLSYNHLNGSVP 199
+DL+ ++ ++ + + ++ + + + +F+ R++H++LS + + S
Sbjct: 5 LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 200 LAL 202
+
Sbjct: 64 HGI 66
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (127), Expect = 4e-08
Identities = 22/118 (18%), Positives = 37/118 (31%), Gaps = 7/118 (5%)
Query: 115 SLRFLYLQNNNFSGNIPSSLSPQLN---WVDLSFNSITG----NIPASIRNLSHLVGLNL 167
++ L +Q S + L P L V L +T +I +++R L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 168 QNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCS 225
++N L + L L+ + L+ L S
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 120
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.5 bits (121), Expect = 2e-07
Identities = 20/92 (21%), Positives = 34/92 (36%), Gaps = 15/92 (16%)
Query: 114 SSLRFLYLQNNNFSGNIPSSLS------PQLNWVDLSFNSITGNIPASI-----RNLSHL 162
S LR L+L + + S + SSL+ L +DLS N + + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 163 VGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194
L L + + + + L+ L L
Sbjct: 429 EQLVLYDIYWSEEMEDR----LQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 5e-07
Identities = 18/146 (12%), Positives = 40/146 (27%), Gaps = 13/146 (8%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLS------PQL 138
++ LD ++ LS + +L L + + L + + +S P L
Sbjct: 4 IQSLD------IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSV 198
++L N + + +Q SL + L +
Sbjct: 58 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 117
Query: 199 PLALQKFPPSSFEGNSMLCGPPLNQC 224
L+ + + P +
Sbjct: 118 HLSDNLLGDAGLQLLCEGLLDPQCRL 143
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 14/80 (17%), Positives = 26/80 (32%), Gaps = 11/80 (13%)
Query: 136 PQLNWVDLSFNSITGN----IPASIRNLSHLVGLNLQNNSLTGFIPNF-------NLSRL 184
L + L+ ++ + + A++ L L+L NN L L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 185 RHLNLSYNHLNGSVPLALQK 204
L L + + + LQ
Sbjct: 429 EQLVLYDIYWSEEMEDRLQA 448
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 19/94 (20%), Positives = 29/94 (30%), Gaps = 17/94 (18%)
Query: 91 SLMILSLRSNHLSGD----LPSNVLSLSSLRFLYLQNNNFSGNIPSSLS-------PQLN 139
L +L L +S L + +L+ SLR L L NN L L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLT 173
+ L + + ++ L SL
Sbjct: 430 QLVLYDIYWSEEMEDRLQALE------KDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 8e-04
Identities = 14/57 (24%), Positives = 20/57 (35%), Gaps = 5/57 (8%)
Query: 83 ANTLEKLDSLMILSLRSNHLSGDLPSNVLS-----LSSLRFLYLQNNNFSGNIPSSL 134
A TL SL L L +N L ++ L L L + +S + L
Sbjct: 390 AATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 7e-08
Identities = 17/69 (24%), Positives = 32/69 (46%), Gaps = 2/69 (2%)
Query: 122 QNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNL 181
N S P + +L + N I+ P + +L +L+ ++L+NN ++ P N
Sbjct: 159 GNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANT 216
Query: 182 SRLRHLNLS 190
S L + L+
Sbjct: 217 SNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 3e-05
Identities = 17/55 (30%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 115 SLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQN 169
L L +N S P + P L V L N I+ P + N S+L + L N
Sbjct: 174 KLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 9e-05
Identities = 20/82 (24%), Positives = 33/82 (40%)
Query: 120 YLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF 179
L + S L+ N LS + + + NLS L L +N ++ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192
Query: 180 NLSRLRHLNLSYNHLNGSVPLA 201
+L L ++L N ++ PLA
Sbjct: 193 SLPNLIEVHLKNNQISDVSPLA 214
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 18/59 (30%), Positives = 27/59 (45%), Gaps = 2/59 (3%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLS 144
L L L L N +S S + SL +L ++L+NN S P + + L V L+
Sbjct: 169 LANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 5e-04
Identities = 4/38 (10%), Positives = 16/38 (42%)
Query: 158 NLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
L++ + + +++T + +L + L+ +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT 54
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 7e-04
Identities = 9/54 (16%), Positives = 20/54 (37%), Gaps = 2/54 (3%)
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+++T + + +L + L+ +T L+ L L L N +
Sbjct: 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQIT 76
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.6 bits (122), Expect = 8e-08
Identities = 20/82 (24%), Positives = 33/82 (40%), Gaps = 1/82 (1%)
Query: 112 SLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNS 171
++S + N + +P L + LS N + A++ + L LNL
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 172 LTGFIPNFNLSRLRHLNLSYNH 193
LT + L L L+LS+N
Sbjct: 67 LTKLQVDGTLPVLGTLDLSHNQ 88
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 7e-05
Identities = 15/58 (25%), Positives = 21/58 (36%), Gaps = 1/58 (1%)
Query: 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-FNLSRLRHLNLSYNHLN 195
+ L+ N++T + L +L L LQ NSL F L L N
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 14/46 (30%), Positives = 21/46 (45%), Gaps = 1/46 (2%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNF 126
+PA L L++L L L+ N L +P L F +L N +
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.4 bits (116), Expect = 6e-07
Identities = 35/141 (24%), Positives = 53/141 (37%), Gaps = 12/141 (8%)
Query: 91 SLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSI 148
+L L L+ N L L +L L+L N S + L+ + L N +
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189
Query: 149 TGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLA----- 201
P + R+L L+ L L N+L+ L L++L L+ N
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAW 249
Query: 202 LQKFPPSSFEGNSMLCGPPLN 222
LQKF SS + + C P
Sbjct: 250 LQKFRGSS---SEVPCSLPQR 267
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.7 bits (109), Expect = 4e-06
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 4/95 (4%)
Query: 81 IPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIP-SSLSPQLN 139
+ + L LM L L +N+LS + L +L++L L +N + + L L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ 251
Query: 140 WVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTG 174
S + + ++P + L N L G
Sbjct: 252 KFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.2 bits (105), Expect = 1e-05
Identities = 24/129 (18%), Positives = 37/129 (28%), Gaps = 4/129 (3%)
Query: 100 NHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIR 157
L P+ L L L+L P L ++ L N++ + R
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 158 NLSHLVGLNLQNNSLTGFIPN--FNLSRLRHLNLSYNHLNGSVPLALQKFPPSSFEGNSM 215
+L +L L L N ++ L L L L N + P A +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 216 LCGPPLNQC 224
L
Sbjct: 211 NNLSALPTE 219
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.004
Identities = 8/51 (15%), Positives = 13/51 (25%), Gaps = 1/51 (1%)
Query: 112 SLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHL 162
+P + + L N I+ AS R +L
Sbjct: 9 YNEPKVTTSCPQQGLQ-AVPVGIPAASQRIFLHGNRISHVPAASFRACRNL 58
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 3e-05
Identities = 13/80 (16%), Positives = 24/80 (30%), Gaps = 2/80 (2%)
Query: 129 NIPSSLSP-QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHL 187
+ + +DL I I L ++ +N + L RL+ L
Sbjct: 10 QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTL 68
Query: 188 NLSYNHLNGSVPLALQKFPP 207
++ N + Q P
Sbjct: 69 LVNNNRICRIGEGLDQALPD 88
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 3e-04
Identities = 22/119 (18%), Positives = 38/119 (31%), Gaps = 7/119 (5%)
Query: 81 IPANTLEKLDS------LMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL 134
+ A +E+ L LR + + + +L + +N L
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPL 61
Query: 135 SPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNH 193
+L + ++ N I + L L L L NNSL L+ L+ L
Sbjct: 62 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCIL 120
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 4e-05
Identities = 13/60 (21%), Positives = 24/60 (40%), Gaps = 2/60 (3%)
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLA 201
+L S+T + + L+ + + N+ + L + L L+ N L PLA
Sbjct: 30 NLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDIKPLA 87
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 16/82 (19%), Positives = 31/82 (37%), Gaps = 2/82 (2%)
Query: 112 SLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNS 171
+ + L+ + + + + ++ + + + I I+ L ++ L L N
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNK 79
Query: 172 LTGFIPNFNLSRLRHLNLSYNH 193
LT P NL L L L N
Sbjct: 80 LTDIKPLANLKNLGWLFLDENK 101
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 9/61 (14%), Positives = 23/61 (37%), Gaps = 8/61 (13%)
Query: 146 NSITGNIPASI------RNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199
+IT +P I + + NL+ S+T + L+ + + + + +
Sbjct: 6 ETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG 63
Query: 200 L 200
+
Sbjct: 64 I 64
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 11/75 (14%), Positives = 28/75 (37%), Gaps = 5/75 (6%)
Query: 80 PIPANTL---EKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSP 136
P P + + + +L+ ++ + N L+S+ + N++ P
Sbjct: 11 PTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYLP 68
Query: 137 QLNWVDLSFNSITGN 151
+ + L+ N +T
Sbjct: 69 NVTKLFLNGNKLTDI 83
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 9/36 (25%), Positives = 13/36 (36%)
Query: 155 SIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLS 190
+ L+ L L L N ++ L L L L
Sbjct: 173 PLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELF 208
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 6e-05
Identities = 8/53 (15%), Positives = 20/53 (37%), Gaps = 4/53 (7%)
Query: 147 SITGNIPASI----RNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+IT + P + L+ + L ++T + +L ++ L +
Sbjct: 1 TITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK 53
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 5e-04
Identities = 14/84 (16%), Positives = 26/84 (30%), Gaps = 2/84 (2%)
Query: 122 QNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNL 181
Q+ + + + L ++T + S +L + L + L
Sbjct: 4 QDTPINQIFTDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKSIDGVEYL 61
Query: 182 SRLRHLNLSYNHLNGSVPLALQKF 205
+ L +N S N L PL
Sbjct: 62 NNLTQINFSNNQLTDITPLKNLTK 85
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.0 bits (84), Expect = 0.003
Identities = 19/73 (26%), Positives = 32/73 (43%), Gaps = 2/73 (2%)
Query: 115 SLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTG 174
+L L L +N S S L ++ S N +T P + NL+ L L++ +N ++
Sbjct: 129 NLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD 186
Query: 175 FIPNFNLSRLRHL 187
L+ L L
Sbjct: 187 ISVLAKLTNLESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 6e-05
Identities = 23/139 (16%), Positives = 43/139 (30%), Gaps = 9/139 (6%)
Query: 90 DSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS---PQLNWVDLSFN 146
L + D ++ +L LY++N ++ +L + + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPN-FNLSRLRHLNLSYNHLNGSVPLA---- 201
+ P + L LNL N+L L+ L LS N L+ S L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 202 LQKFPPSSFEGNSMLCGPP 220
++ + C
Sbjct: 127 WEEEGLGGVPEQKLQCHGQ 145
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 9e-04
Identities = 16/103 (15%), Positives = 32/103 (31%), Gaps = 11/103 (10%)
Query: 131 PSSLSPQ-LNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRH 186
P + P + + + + + + +L L ++N + L LR+
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 187 LNLSYNHLNGSVPLALQKFPPSSFEGNSMLCGPPLNQCSTVPP 229
L + + L P A P S S N ++
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSF------NALESLSW 97
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 7e-05
Identities = 24/116 (20%), Positives = 39/116 (33%), Gaps = 14/116 (12%)
Query: 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS----PQLNWV 141
L + ++L+ RS+ + L ++ L L L NN S P L +
Sbjct: 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 142 DLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---------NLSRLRHLN 188
+LS N + L L L NSL+ + +L L+
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (87), Expect = 0.001
Identities = 34/148 (22%), Positives = 48/148 (32%), Gaps = 27/148 (18%)
Query: 84 NTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDL 143
+E+L +I+S R + L L LR L Q V L
Sbjct: 7 EQVEQLK--LIMSKRYD-----GSQQALDLKGLRSD------------PDLVAQNIDVVL 47
Query: 144 S-FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF----NLSRLRHLNLSYNHLNGSV 198
+ +S+ + N+ L+ LNL NN L L+ LNLS N L
Sbjct: 48 NRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSER 107
Query: 199 PLALQKFPPS---SFEGNSMLCGPPLNQ 223
L K +GNS+
Sbjct: 108 ELDKIKGLKLEELWLDGNSLSDTFRDQS 135
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 11/89 (12%), Positives = 27/89 (30%), Gaps = 15/89 (16%)
Query: 120 YLQNNNFSGNIPSSLS--------PQLNWVDLSFNSITGNIPASI-----RNLSHLVGLN 166
L + S +++ L + L +N I + ++ + L+ L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 167 LQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
L N + + +R + +
Sbjct: 309 LNGNRFSEEDD--VVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 4e-04
Identities = 15/92 (16%), Positives = 30/92 (32%), Gaps = 10/92 (10%)
Query: 91 SLMILSLRSNHLSGD----LPSNVLSLSSLRFLYLQNNNFSGNIPSSLS------PQLNW 140
S+ SL+ + ++ + + + +L S++ + L N LS L
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 141 VDLSFNSITGNIPASIRNLSHLVGLNLQNNSL 172
+ S L L+ L+ L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.001
Identities = 15/87 (17%), Positives = 27/87 (31%), Gaps = 14/87 (16%)
Query: 97 LRSNHLSGDLPSNV------LSLSSLRFLYLQNNNFSGNIPSSLS-------PQLNWVDL 143
L LS + V L L+ L LQ N + +L P L +++L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 144 SFNSITGNIPASIRNLSHLVGLNLQNN 170
+ N + + + +
Sbjct: 310 NGNRF-SEEDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.2 bits (84), Expect = 0.004
Identities = 8/64 (12%), Positives = 19/64 (29%), Gaps = 10/64 (15%)
Query: 142 DLSFNSITGN----IPASIRNLSHLVGLNLQNNSLTG----FIPNF--NLSRLRHLNLSY 191
L ++IT + A + + + L N++ ++ + L S
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 192 NHLN 195
Sbjct: 69 IFTG 72
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 4e-04
Identities = 13/92 (14%), Positives = 24/92 (26%), Gaps = 12/92 (13%)
Query: 118 FLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIP 177
+L N + + N++ S V L++ +
Sbjct: 159 WLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218
Query: 178 NF--NLSRLRHLNLSYNHLNGSVPLALQKFPP 207
NL +LR + L+K P
Sbjct: 219 YGLENLKKLRARSTYN----------LKKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 5e-04
Identities = 10/66 (15%), Positives = 18/66 (27%), Gaps = 1/66 (1%)
Query: 115 SLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTG 174
S R Q + + IPS L + + + L + + N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 175 FIPNFN 180
I
Sbjct: 68 VIEADV 73
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 7e-04
Identities = 12/56 (21%), Positives = 19/56 (33%), Gaps = 5/56 (8%)
Query: 78 YGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPS 132
+P + +IL + + LPS L L LR N +P+
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHS-LPSYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.9 bits (86), Expect = 0.002
Identities = 14/98 (14%), Positives = 36/98 (36%), Gaps = 3/98 (3%)
Query: 100 NHLSGDLPSNVLS-LSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRN 158
+ ++ + + L L+ L L +N S +P S + L+ S N +
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146
Query: 159 LSHLVG-LNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195
+ + +L + P+ + ++ +L ++
Sbjct: 147 FAEWLRKKSLNGGAARCGAPS-KVRDVQIKDLPHSEFK 183
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 632 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.65 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.6 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.55 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.53 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.52 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.51 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.44 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.34 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.32 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.31 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.3 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.24 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.21 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.19 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.17 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.16 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.12 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.11 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.09 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.92 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.91 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.79 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.73 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.38 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.17 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.14 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.12 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.1 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.04 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.99 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 97.87 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.83 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.74 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.28 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.18 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.1 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.54 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.51 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 95.64 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.14 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=410.73 Aligned_cols=245 Identities=23% Similarity=0.407 Sum_probs=197.1
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhh
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSA 421 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~ 421 (632)
+.||+|+||+||+|.+.+++.||||+++......++|.+|++++.++ +|||||+++|+|...+..++||||+++|+|.+
T Consensus 11 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~ 89 (263)
T d1sm2a_ 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89 (263)
T ss_dssp EEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence 57999999999999998899999999988777788999999999999 89999999999999999999999999999999
Q ss_pred hhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----CC
Q 006747 422 LLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-----VP 496 (632)
Q Consensus 422 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-----~~ 496 (632)
++.... ..++|..+..++.|+|.||+|||+. +|+||||||+|||+|+++.+||+|||+++...... ..
T Consensus 90 ~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~ 162 (263)
T d1sm2a_ 90 YLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 162 (263)
T ss_dssp HHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred Hhhccc----cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence 987543 3588999999999999999999998 99999999999999999999999999998765432 23
Q ss_pred CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCC-CCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP-IQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 497 ~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
.+|..|+|||++.+..++.++|||||||++|||+|+..| |.... ....... +..+... .. +.
T Consensus 163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~------~~~~~~~-i~~~~~~--~~-----p~--- 225 (263)
T d1sm2a_ 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVED-ISTGFRL--YK-----PR--- 225 (263)
T ss_dssp --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC------HHHHHHH-HHHTCCC--CC-----CT---
T ss_pred ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC------HHHHHHH-HHhcCCC--CC-----cc---
Confidence 478889999999999999999999999999999995444 43211 1112221 1121110 01 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
....++.+++.+||+.||++||||+||+++|+++.+
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 122457788999999999999999999999999854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=405.07 Aligned_cols=245 Identities=27% Similarity=0.421 Sum_probs=200.9
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||.||+|.+++++.||||+++......+.|.+|++++.++ +|||||+++|++. .+..++||||+++|+|.
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVT-QEPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEEECCTTCBHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeec-cCCeEEEEEeCCCCcHH
Confidence 357999999999999998889999999987777788999999999999 9999999999875 46689999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-----CC
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-----TV 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-----~~ 495 (632)
+++.... ..+++|..+++|+.|+|+||+|||+. +|+||||||+|||+++++.+||+|||+|+..... ..
T Consensus 96 ~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~ 169 (272)
T d1qpca_ 96 DFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169 (272)
T ss_dssp HHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTT
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccccc
Confidence 9876542 23589999999999999999999998 9999999999999999999999999999876543 23
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..+|+.|||||++.++.++.++|||||||++|||+||+.|+.... ........ +..+.... .....
T Consensus 170 ~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~~~-i~~~~~~~-------~p~~~- 235 (272)
T d1qpca_ 170 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQN-LERGYRMV-------RPDNC- 235 (272)
T ss_dssp CCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHH-HHTTCCCC-------CCTTC-
T ss_pred cCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-----CHHHHHHH-HHhcCCCC-------CcccC-
Confidence 457888999999998899999999999999999999766654321 11111122 11211110 11112
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
..++.+|+.+||+.||++||||+||++.|+.+
T Consensus 236 --~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 236 --PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 23577888999999999999999999999875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-50 Score=405.45 Aligned_cols=249 Identities=25% Similarity=0.374 Sum_probs=206.3
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||+||+|... +++.||||+++......++|.+|++++.++ +|||||+++|+|.+.+..++||||+++|+|
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l 100 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNL 100 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEEEeecccCcch
Confidence 367999999999999975 588999999987777788899999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC----
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV---- 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~---- 495 (632)
.+++.... ...++|..+..|+.|+|.||+|||+. +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 101 ~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 101 LDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp HHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred HHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 99997542 34689999999999999999999998 999999999999999999999999999988754422
Q ss_pred -CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 -PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 -~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..+++.|+|||++.+..|+.++|||||||++|||++|+.|+..... .. .+...+..+.... ....
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~-~~~~~i~~~~~~~-------~~~~- 240 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LS-QVYELLEKDYRME-------RPEG- 240 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HH-HHHHHHHTTCCCC-------CCTT-
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HH-HHHHHHhcCCCCC-------CCcc-
Confidence 2367789999999999999999999999999999998777643211 11 1112222221111 1111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
...++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 241 --~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 241 --CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp --CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred --chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 223577888999999999999999999999988654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=396.72 Aligned_cols=244 Identities=21% Similarity=0.352 Sum_probs=205.7
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||+||+|+.++++.||||+++......++|.+|++++.++ +|||||+++|+|.+++..++||||+++|+|.
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~ 87 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITEYMANGCLL 87 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence 367999999999999998889999999998777888999999999999 9999999999999999999999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----C
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-----V 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-----~ 495 (632)
+++.... ..+++..+.+++.|+|+||+|||+. +|+||||||+|||+++++.+||+|||+++...... .
T Consensus 88 ~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 88 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp HHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred Hhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9976543 3588999999999999999999998 99999999999999999999999999998654332 2
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
..+|..|+|||.+.+..++.++|||||||++|||+| |+.||...... + +...+.+.... . .+.
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~-~~~~i~~~~~~--~-----~p~-- 224 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------E-TAEHIAQGLRL--Y-----RPH-- 224 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------H-HHHHHHTTCCC--C-----CCT--
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------H-HHHHHHhCCCC--C-----Ccc--
Confidence 347788999999999999999999999999999998 89999754321 1 11222222111 0 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
....++.+++.+||+.||++|||+++++++|.+|
T Consensus 225 -~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 -LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1224577889999999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=402.89 Aligned_cols=248 Identities=27% Similarity=0.404 Sum_probs=195.8
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||+||+|+.+ ..||||+++.... ..+.|.+|++++.++ +|||||++++++. .+..++||||+++|
T Consensus 13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~-~~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST-APQLAIVTQWCEGS 88 (276)
T ss_dssp CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEEEEECCCEE
T ss_pred EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEe-ccEEEEEEecCCCC
Confidence 367999999999999864 4699999975432 246799999999999 9999999999875 45689999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
+|.++++... .+++|..+..++.|+|+||+|||+. +||||||||+|||+++++.+||+|||+|+.....
T Consensus 89 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 89 SLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999997543 3589999999999999999999998 9999999999999999999999999999876532
Q ss_pred --CCCCCCCcccCCccccC---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIET---KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~---~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
....+|+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.... ..+......+... +.+
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~~----p~~ 231 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRGYLS----PDL 231 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHTSCC----CCG
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCC----Ccc
Confidence 22358899999999864 34799999999999999999999999754321 1122222222111 111
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.. ........+.+++.+||+.||++||||+||+++|+.+..
T Consensus 232 ~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 SK--VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GG--SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hh--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00 011122457788899999999999999999999998864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-49 Score=403.44 Aligned_cols=245 Identities=23% Similarity=0.451 Sum_probs=192.2
Q ss_pred hHhCccceeEEEEEEEcC-C---cEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAILEE-G---TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
+.||+|+||+||+|.... + ..||||++..... ..+.|.+|++++.++ +|||||+++|+|.+.+..++||||++
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEEEEEEecC
Confidence 579999999999998643 2 3689999875432 246799999999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 495 (632)
+|+|.+++.... ..++|..+.+++.|+|+||+|||+. +|+||||||+|||+++++++||+|||+|+.......
T Consensus 111 ~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 111 NGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp TEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 999999887543 3589999999999999999999998 999999999999999999999999999987653221
Q ss_pred ---------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 496 ---------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 496 ---------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
..+|+.|||||.+.++.++.++|||||||++|||+| |+.||.+... ....... ..+...
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~------~~~~~~i-~~~~~~---- 252 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------QDVINAI-EQDYRL---- 252 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHH-HTTCCC----
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH------HHHHHHH-HcCCCC----
Confidence 235778999999999999999999999999999998 8999975331 1112221 111110
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
....+....+.+|+.+||+.||++||||.||++.|+++.+
T Consensus 253 ------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 253 ------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1111223457788999999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-49 Score=395.90 Aligned_cols=241 Identities=21% Similarity=0.348 Sum_probs=196.5
Q ss_pred HhCccceeEEEEEEEc---CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 343 VLGKGSYGTTYKAILE---EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 343 ~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.||+|+||.||+|.+. ++..||||+++.... ..+.|.+|++++.++ +|||||+++|+|.+ +..++||||+++|
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~~lvmE~~~~g 93 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLVMEMAGGG 93 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECCTTE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeEEEEEEeCCCC
Confidence 3999999999999753 355799999975432 246799999999999 89999999999865 5689999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
+|.+++...+ ..+++..+..++.|+|.||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 94 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 94 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred cHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999986542 3589999999999999999999998 99999999999999999999999999998764321
Q ss_pred ----CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 495 ----VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 495 ----~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
...+|+.|+|||++.++.++.++|||||||++|||+| |+.||.+.... +.. ..+..+...+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------~~~-~~i~~~~~~~------- 232 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVM-AFIEQGKRME------- 232 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHH-HHHHTTCCCC-------
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH------HHH-HHHHcCCCCC-------
Confidence 2347788999999999999999999999999999998 99999754321 111 1222222111
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
... ....++.+|+.+||+.||++||||.+|++.|+.+
T Consensus 233 ~p~---~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 233 CPP---ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp CCT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC---cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 1224577889999999999999999999999865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=395.49 Aligned_cols=241 Identities=25% Similarity=0.351 Sum_probs=194.0
Q ss_pred hHhCccceeEEEEEEEcC---CcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAILEE---GTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
+.||+|+||+||+|.+.+ ++.||||+++....+ .+.|.+|++++.++ +|||||+++|+|.+ +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc-CCEEEEEEcCC
Confidence 469999999999998643 468999999754322 46799999999999 99999999999864 56799999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.++++... +++|..++.++.|+|.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 91 LGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp TEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999999997643 589999999999999999999998 99999999999999999999999999998764321
Q ss_pred ------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhcccccccccc
Q 006747 495 ------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567 (632)
Q Consensus 495 ------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 567 (632)
...+|+.|||||.+.+..++.++|||||||++|||+| |+.||.+... . .+...+..+....
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------~-~~~~~i~~~~~~~----- 230 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------S-EVTAMLEKGERMG----- 230 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------H-HHHHHHHTTCCCC-----
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH------H-HHHHHHHcCCCCC-----
Confidence 2347889999999999999999999999999999998 8999975321 1 1112222221111
Q ss_pred ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 568 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.... ...++.+|+.+||+.||++||||++|++.|+..
T Consensus 231 --~p~~---~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 231 --CPAG---CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp --CCTT---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCcc---cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1111 224577888999999999999999999988764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=396.22 Aligned_cols=238 Identities=22% Similarity=0.364 Sum_probs=197.3
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|++++.++ +|||||++++++.+.+..|+||||+++|+|
T Consensus 26 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp EECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 5799999999999985 568999999997653 3467799999999999 999999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----CC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----TV 495 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~~ 495 (632)
.+++... ++++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 105 ~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred HHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 9988653 388899999999999999999998 9999999999999999999999999999876432 23
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..||+.|+|||++.+..++.++|||||||++|||+||+.||.+... .............. . ....
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~~-~--------~~~~ 240 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTPE-L--------QNPE 240 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSCC-C--------SSGG
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCCC-C--------CCcc
Confidence 4589999999999999999999999999999999999999965321 11222222221110 0 0111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.....+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11235677888999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=393.57 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=200.0
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHh
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFS 420 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~ 420 (632)
.+.||+|+||+||+|..+++..||||+++......+.|.+|++++.++ +|||||+++|+|. .++.++||||+++|+|.
T Consensus 22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~ 99 (285)
T d1fmka3 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL 99 (285)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred eeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEe-cCCeEEEEEecCCCchh
Confidence 467999999999999998888999999987777788999999999999 9999999999984 56789999999999999
Q ss_pred hhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-----C
Q 006747 421 ALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT-----V 495 (632)
Q Consensus 421 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~-----~ 495 (632)
.++.... ...++|..++.|+.++|.||+|||+. +|+||||||+|||+|+++++||+|||+++...... .
T Consensus 100 ~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 173 (285)
T d1fmka3 100 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173 (285)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred hhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence 9987542 23589999999999999999999998 99999999999999999999999999998764332 2
Q ss_pred CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcH
Q 006747 496 PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIE 575 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 575 (632)
..+|+.|+|||++..+.++.++|||||||++|||+||+.|+.... ......... ..+.... .....
T Consensus 174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-----~~~~~~~~i-~~~~~~~-------~~~~~- 239 (285)
T d1fmka3 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQV-ERGYRMP-------CPPEC- 239 (285)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHH-HTTCCCC-------CCTTS-
T ss_pred ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-----CHHHHHHHH-HhcCCCC-------CCccc-
Confidence 347889999999999999999999999999999999777664322 111122211 1111111 11112
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 576 EEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 576 ~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
..++.+++.+||+.||++||||++|+++|+.+...
T Consensus 240 --~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 240 --PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp --CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred --CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 23577888999999999999999999999987654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=389.70 Aligned_cols=237 Identities=23% Similarity=0.371 Sum_probs=197.6
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||+||+|... +++.||+|++... ....+.+.+|++++.++ +|||||++++++.+.+..++||||++
T Consensus 11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEEEeecC
Confidence 468999999999999974 5889999998643 23356789999999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC-
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT- 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~- 494 (632)
+|+|.+++.... ++++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~ 161 (263)
T d2j4za1 90 LGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR 161 (263)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCC
T ss_pred CCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcc
Confidence 999999997543 488999999999999999999998 99999999999999999999999999998765432
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...||+.|||||++.+..++.++|||||||++|||+||+.||.+... ............ . ....
T Consensus 162 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~-------~--~p~~ 226 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVEF-------T--FPDF 226 (263)
T ss_dssp EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC-------C--CCTT
T ss_pred cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC-------C--CCcc
Confidence 34689999999999999999999999999999999999999965321 111222211111 0 0111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
. ..++.+++.+||+.||++|||++|+++
T Consensus 227 ~---s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 V---TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp S---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C---CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2 234667888999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-49 Score=393.18 Aligned_cols=240 Identities=21% Similarity=0.302 Sum_probs=192.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||+||+|.. .+|+.||||++..... ..+.+.+|++++.++ +|||||++++++.+.+..|+||||+++|
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~ivmEy~~gg 88 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLFLEYCSGG 88 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEEEeccCCC
Confidence 36799999999999996 4689999999975432 245689999999999 9999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC-----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT----- 492 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~----- 492 (632)
+|.+++... ..+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+....
T Consensus 89 ~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 89 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred cHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999754 3589999999999999999999998 999999999999999999999999999987532
Q ss_pred -CCCCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 493 -PTVPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 493 -~~~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
.....||+.|||||++.+..+ +.++|||||||++|||+||+.||........ ..... ...... .. .
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-----~~~~~-~~~~~~--~~----~ 228 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-----EYSDW-KEKKTY--LN----P 228 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-----HHHHH-HTTCTT--ST----T
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-----HHHHH-hcCCCC--CC----c
Confidence 233468999999999988876 5789999999999999999999975432211 11111 111000 00 0
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.... ..++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~---s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 WKKI---DSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGGS---CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccC---CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111 234667888999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=393.07 Aligned_cols=247 Identities=20% Similarity=0.385 Sum_probs=194.6
Q ss_pred hHhCccceeEEEEEEEcCC-----cEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 342 EVLGKGSYGTTYKAILEEG-----TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~-----~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
++||+|+||.||+|.++.+ ..||||+++.... ...+|.+|++++.++ +|||||+++|+|.+.+..++||||+
T Consensus 13 ~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCceEEEEEec
Confidence 6799999999999986542 4799999975432 235689999999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
.+|++.+++.... ..++|..+++++.|++.||+|||+. +|+||||||+||||++++.+||+|||+++......
T Consensus 92 ~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 164 (283)
T d1mqba_ 92 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164 (283)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred ccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence 9999999886542 3589999999999999999999998 99999999999999999999999999998764321
Q ss_pred -------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccc
Q 006747 495 -------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVE 567 (632)
Q Consensus 495 -------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 567 (632)
...+|+.|||||++.++.++.++|||||||++|||+||+.|+..... ..... ..+.++...
T Consensus 165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-----~~~~~-~~i~~~~~~------ 232 (283)
T d1mqba_ 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-----NHEVM-KAINDGFRL------ 232 (283)
T ss_dssp ---------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHH-HHHHTTCCC------
T ss_pred ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-----HHHHH-HHHhccCCC------
Confidence 12468889999999999999999999999999999997666543211 11111 122222111
Q ss_pred ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 568 LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 568 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
....+....+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 233 ----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 ----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11112234577889999999999999999999999987653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=402.00 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=198.7
Q ss_pred HhHhCccceeEEEEEEEcC-C-----cEEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILEE-G-----TTVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~-----~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||+||+|.... + ..||||.+.... .....+.+|++++.++.+|||||+++++|.+.+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 121 (325)
T d1rjba_ 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 121 (325)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence 4689999999999998643 2 369999986542 3346789999999998789999999999999999999999
Q ss_pred cccCCCHhhhhccCCCC------------------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec
Q 006747 413 FIEAGSFSALLHGNRGI------------------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS 474 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~ 474 (632)
|+++|+|.++++..+.. ....++|..++.++.|++.||+|||+. +||||||||+|||++
T Consensus 122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~ 198 (325)
T d1rjba_ 122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVT 198 (325)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEE
T ss_pred cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccc
Confidence 99999999999765321 123589999999999999999999998 999999999999999
Q ss_pred CCCCeEEcccCCCCCCCCCCC------CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCCh
Q 006747 475 QDLQGCISDFGLTPLMNTPTV------PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDL 547 (632)
Q Consensus 475 ~~~~~ki~DfGla~~~~~~~~------~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~ 547 (632)
.++.+||+|||+|+....... ..+|+.|||||.+.++.++.++|||||||++|||+| |+.||.+.....
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~---- 274 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA---- 274 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH----
Confidence 999999999999987654322 236888999999999999999999999999999998 899997543221
Q ss_pred hHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhh
Q 006747 548 PRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIED 608 (632)
Q Consensus 548 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~ 608 (632)
.+...+..+...+ .... ...++.+|+.+||+.||++||||+||+++|..
T Consensus 275 --~~~~~~~~~~~~~-------~p~~---~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 275 --NFYKLIQNGFKMD-------QPFY---ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp --HHHHHHHTTCCCC-------CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HHHHHHhcCCCCC-------CCCc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 1122222221110 1111 22357788899999999999999999999963
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=383.29 Aligned_cols=240 Identities=23% Similarity=0.379 Sum_probs=190.4
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEe----CCceEEEEec
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFS----KDEKLLVYDF 413 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~E~ 413 (632)
+.||+|+||+||+|... +++.||+|++...... .+.+.+|++++.++ +|||||+++++|.+ ....++||||
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 46999999999999964 5889999999765433 35689999999999 89999999999875 3457999999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec-CCCCeEEcccCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS-QDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~-~~~~~ki~DfGla~~~~~ 492 (632)
+++|+|.+++.... .+++.....++.|++.||+|||+. +++|+||||||+|||++ +++.+||+|||+|+....
T Consensus 94 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 94 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred CCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999997642 488999999999999999999987 22399999999999996 579999999999987554
Q ss_pred C--CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 493 P--TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 493 ~--~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
. ....||+.|||||++.+ .++.++|||||||++|||+||+.||..... ... +...+..+.....++
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-----~~~-~~~~i~~~~~~~~~~----- 235 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQ-IYRRVTSGVKPASFD----- 235 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHH-HHHHHTTTCCCGGGG-----
T ss_pred CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-----HHH-HHHHHHcCCCCcccC-----
Confidence 3 23468999999999875 599999999999999999999999964321 111 111122211111111
Q ss_pred cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 571 YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 571 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
... ..++.+++.+||+.||++|||++|+++
T Consensus 236 -~~~---~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 -KVA---IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -GCC---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -ccC---CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111 224677889999999999999999976
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=394.78 Aligned_cols=242 Identities=20% Similarity=0.319 Sum_probs=196.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||+||+|.. .+++.||||+++... ...+.+.+|++++.++ +|||||++++++.+.+..++||||+++|+
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvmEy~~~g~ 95 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILIEFCAGGA 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence 35799999999999996 468899999997643 3346789999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC----CC
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT----PT 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~----~~ 494 (632)
|.+++.... .++++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.... ..
T Consensus 96 L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 96 VDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 999976532 3589999999999999999999998 999999999999999999999999999976542 23
Q ss_pred CCCCCCcccCCcccc-----CCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 495 VPSRSAGYRAPEVIE-----TKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~-----~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
...||+.|||||++. +..|+.++|||||||++|||+||+.||.+....+ ........... . +
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~~~i~~~~~~-~-----~- 235 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPP-T-----L- 235 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHHSCCC-C-----C-
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCC-C-----C-
Confidence 456899999999984 4558999999999999999999999997543221 11122221111 0 0
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
........++.+++.+||+.||++|||++|++++
T Consensus 236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111122356788889999999999999999763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=390.91 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=185.8
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEe--CCceEEEEeccc
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFS--KDEKLLVYDFIE 415 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~--~~~~~lv~E~~~ 415 (632)
+.||+|+||+||+|+. .+|+.||||+++..... .+.+.+|++++.++ +|||||++++++.+ .+..|+||||++
T Consensus 10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 6799999999999986 46899999999765443 35688999999999 99999999999865 456899999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc--CCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV--GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+|+|.+++..... ....+++..+..++.|++.||+|||+.. ..+|+||||||+|||+++++.+||+|||+|+.....
T Consensus 89 ~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 89 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 9999999864321 1246899999999999999999999862 235999999999999999999999999999876443
Q ss_pred ----CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
....+|+.|||||++.+..|+.++|||||||++|||+||+.||.+... ...... +.+......
T Consensus 168 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~~-i~~~~~~~~------ 234 (269)
T d2java1 168 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGK-IREGKFRRI------ 234 (269)
T ss_dssp --------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH-HHHTCCCCC------
T ss_pred CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HHHHHH-HHcCCCCCC------
Confidence 234689999999999999999999999999999999999999975321 111111 222211110
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.... ..++.+++.+||+.||++|||++|+++
T Consensus 235 -~~~~---s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 -PYRY---SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -Cccc---CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1111 235677888999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-48 Score=391.87 Aligned_cols=239 Identities=23% Similarity=0.363 Sum_probs=197.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||+||+|.. .+++.||||+++..... .+.+.+|++++.++ +|||||++++++.+.+..|+||||++
T Consensus 20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv~E~~~ 98 (309)
T d1u5ra_ 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWLVMEYCL 98 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEEEEEecC
Confidence 46799999999999985 56889999999765332 24688999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCCC
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPTV 495 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~~ 495 (632)
+|+|..++... .++++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 99 ~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 99 GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170 (309)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred CCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence 99998776543 3589999999999999999999998 999999999999999999999999999998887777
Q ss_pred CCCCCcccCCccccC---CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccC
Q 006747 496 PSRSAGYRAPEVIET---KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYE 572 (632)
Q Consensus 496 ~~~t~~y~aPE~~~~---~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 572 (632)
..||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+... ............. ... ..
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~~-~~~------~~ 237 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNESP-ALQ------SG 237 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCCC-CCS------CT
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCC-CCC------CC
Confidence 889999999999864 4589999999999999999999999965321 1112222221111 110 11
Q ss_pred CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 573 NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 573 ~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
.. ...+.+++.+||+.||++|||++|+++
T Consensus 238 ~~---s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 HW---SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TS---CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC---CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11 235678888999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=399.71 Aligned_cols=191 Identities=21% Similarity=0.384 Sum_probs=169.3
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|+||+||+|.. .+|+.||+|+++..... ...+.+|++++.++ +|||||+++++|.+.++.++||||+++|+
T Consensus 12 ~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 5799999999999996 46899999999755322 46789999999999 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC--CCCC
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT--PTVP 496 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~--~~~~ 496 (632)
|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+|||+++++.+||+|||+|+.... ....
T Consensus 91 L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 163 (322)
T d1s9ja_ 91 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163 (322)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccc
Confidence 999997543 4889999999999999999999742 799999999999999999999999999986532 2345
Q ss_pred CCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCC
Q 006747 497 SRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPG 540 (632)
Q Consensus 497 ~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~ 540 (632)
.||+.|||||++.+..|+.++||||+||++|||+||+.||.+..
T Consensus 164 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred cCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 79999999999999999999999999999999999999997643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=393.28 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=196.4
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC----ceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD----EKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lv~E~~~~g 417 (632)
+.||+|+||.||+|++ +|+.||||+++........++.|+..+.++ +|||||+++++|.+.+ ..++||||+++|
T Consensus 9 ~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence 5799999999999987 589999999975432222233444444566 8999999999998754 579999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhcc-----CCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAV-----GGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
+|.++++.. +++|..+++++.++|.||+|||+.. .++|+||||||+||||++++.+||+|||+++....
T Consensus 87 ~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 87 SLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 999999754 4899999999999999999999742 35999999999999999999999999999976533
Q ss_pred C--------CCCCCCCcccCCccccCCC------CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCC--------ChhHH
Q 006747 493 P--------TVPSRSAGYRAPEVIETKK------PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVV--------DLPRW 550 (632)
Q Consensus 493 ~--------~~~~~t~~y~aPE~~~~~~------~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~ 550 (632)
. ....||++|+|||++.+.. ++.++|||||||+||||+||..||......... .....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 2 2345899999999987643 577899999999999999999887543222110 11122
Q ss_pred HHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 551 VQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 551 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
......++. .++.+.......+....+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 241 ~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 241 MRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 222222211 1222211112234556788999999999999999999999999998654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=384.41 Aligned_cols=244 Identities=25% Similarity=0.419 Sum_probs=192.5
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe-CCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS-KDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~-~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||+|.++ |..||||++++. ...+.|.+|+++++++ +|||||+++|+|.+ .+..++||||+++|+|
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 467999999999999985 789999999764 3457899999999999 99999999999865 4568999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-CCCCC
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-TVPSR 498 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~~~~~ 498 (632)
.+++.... ..+++|..+++|+.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++..... ....+
T Consensus 89 ~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~ 162 (262)
T d1byga_ 89 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162 (262)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------C
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCCCccccc
Confidence 99997542 23589999999999999999999998 9999999999999999999999999999876543 33457
Q ss_pred CCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCcHHH
Q 006747 499 SAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENIEEE 577 (632)
Q Consensus 499 t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 577 (632)
+..|+|||++.+..++.++|||||||++|||+| |+.||..... .++..++ ..+...+ .....
T Consensus 163 ~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i----~~~~~~~----------~~~~~ 225 (262)
T d1byga_ 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV----EKGYKMD----------APDGC 225 (262)
T ss_dssp CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHH----TTTCCCC----------CCTTC
T ss_pred cccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HcCCCCC----------CCccC
Confidence 788999999999999999999999999999999 6777764322 1222222 2221111 11112
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 578 MVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 578 ~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
..++.+++.+||+.||++||||.+++++|++++
T Consensus 226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 245678889999999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-47 Score=389.07 Aligned_cols=250 Identities=22% Similarity=0.394 Sum_probs=200.5
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||+||+|+.. +++.||||+++..... .++|.+|++++.++ +||||++++++|.+.+..++|||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~~v~e 96 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFE 96 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCCceEEEEE
Confidence 367999999999999864 3578999999754322 45799999999999 99999999999999999999999
Q ss_pred cccCCCHhhhhccCCC-------------------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeee
Q 006747 413 FIEAGSFSALLHGNRG-------------------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLL 473 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl 473 (632)
|+++|+|.++++.... .....++|..+++|+.|+|.||+|||+. +||||||||+|||+
T Consensus 97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILl 173 (301)
T d1lufa_ 97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLV 173 (301)
T ss_dssp CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEE
Confidence 9999999999864321 1233589999999999999999999998 99999999999999
Q ss_pred cCCCCeEEcccCCCCCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCC-CCCCCCCCCCCCC
Q 006747 474 SQDLQGCISDFGLTPLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGK-APIQAPGHEDVVD 546 (632)
Q Consensus 474 ~~~~~~ki~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~-~p~~~~~~~~~~~ 546 (632)
|.++++||+|||+|+.+... ....+++.|+|||.+.+..++.++|||||||++|||++|. .||.....
T Consensus 174 d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~----- 248 (301)
T d1lufa_ 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH----- 248 (301)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----
T ss_pred CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH-----
Confidence 99999999999998754322 2345778899999999999999999999999999999986 56654321
Q ss_pred hhHHHHHHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 547 LPRWVQSVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 547 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.+.. ..+.++.... ... ....++.+|+.+||+.||++||||.||+++|++|.+
T Consensus 249 -~e~~-~~v~~~~~~~-------~p~---~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 249 -EEVI-YYVRDGNILA-------CPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp -HHHH-HHHHTTCCCC-------CCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -HHHH-HHHHcCCCCC-------CCc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1112 2222222111 111 122357788999999999999999999999999863
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-47 Score=385.95 Aligned_cols=242 Identities=21% Similarity=0.367 Sum_probs=183.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
.+.||+|+||+||+|... +++.||||++..... ....+.+|++++.++ +|||||++++++.+.+..|+||||+++|
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 367999999999999964 589999999975532 245688999999999 9999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec---CCCCeEEcccCCCCCCCCCC
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS---QDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~---~~~~~ki~DfGla~~~~~~~ 494 (632)
+|.+++... .++++.....++.|++.||+|||+. +|+||||||+|||+. +++.+||+|||+|+......
T Consensus 93 ~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 93 ELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp BHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999999754 2589999999999999999999998 999999999999994 57899999999998765432
Q ss_pred ---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 495 ---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 495 ---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
...||+.|||||++.+..|+.++|||||||++|||+||+.||.+... .............. .. ...
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~~~---~~--~~~ 233 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND------AKLFEQILKAEYEF---DS--PYW 233 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHTTCCCC---CT--TTT
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHhccCCCC---CC--ccc
Confidence 34589999999999999999999999999999999999999975321 11112222211110 00 011
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ..++.+++.+||+.||++|||++|++++
T Consensus 234 ~~~---s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 234 DDI---SDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTS---CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cCC---CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 112 2356778889999999999999999884
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=384.01 Aligned_cols=238 Identities=18% Similarity=0.312 Sum_probs=195.8
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|++++.++ +|||||++++++.+.+..|+||||++
T Consensus 13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEEEEccC
Confidence 36899999999999996 46899999999753 23356799999999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++...+ ++++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 92 gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 92 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999987543 488999999999999999999998 9999999999999999999999999999876432
Q ss_pred ----CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.+... ............ .+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~-------~~- 229 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKIIKLEY-------DF- 229 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTCC-------CC-
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHHcCCC-------CC-
Confidence 233589999999999999999999999999999999999999975321 111222221111 00
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.... ..++.+|+.+||+.||++|||++|+++.
T Consensus 230 -p~~~---s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 230 -PEKF---FPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -CTTC---CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -CccC---CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1112 2346788889999999999999997543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=384.35 Aligned_cols=247 Identities=24% Similarity=0.418 Sum_probs=197.1
Q ss_pred hHhCccceeEEEEEEEcCC----cEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeC-CceEEEEecc
Q 006747 342 EVLGKGSYGTTYKAILEEG----TTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSK-DEKLLVYDFI 414 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~----~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-~~~~lv~E~~ 414 (632)
++||+|+||+||+|.+.++ ..||||+++.... ..++|.+|++++.++ +|||||+++|+|.+. ...++||||+
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEEEe
Confidence 5799999999999996542 3689999975322 246799999999999 899999999998864 5789999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT 494 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~ 494 (632)
++|+|.++++... ..+++..+++++.|+|.||.|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 9999999987643 3577889999999999999999998 99999999999999999999999999998764321
Q ss_pred --------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 495 --------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 495 --------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
...+|..|+|||.+.+..++.++||||||+++|||+||+.||..... ..++..+ .. .+... .
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~---i~-~g~~~--~-- 254 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVY---LL-QGRRL--L-- 254 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HH-TTCCC--C--
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHH---HH-cCCCC--C--
Confidence 12467889999999999999999999999999999998888764321 1112221 11 11111 0
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.... ....+.+++.+||+.||++||||.||+++|+.+...
T Consensus 255 ---~p~~---~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 255 ---QPEY---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ---CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---Cccc---CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1111 123577888999999999999999999999999654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=383.72 Aligned_cols=252 Identities=26% Similarity=0.338 Sum_probs=191.8
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC-ceEEEE
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD-EKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~-~~~lv~ 411 (632)
.+.||+|+||.||+|... +++.||||+++.... ..+.+..|.+.+.++.+|+|||.+++++...+ ..++||
T Consensus 18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~ 97 (299)
T d1ywna1 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 97 (299)
T ss_dssp EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence 467999999999999853 246899999975432 24568888899998878999999999987654 689999
Q ss_pred ecccCCCHhhhhccCCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeE
Q 006747 412 DFIEAGSFSALLHGNRGI-----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGC 480 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~k 480 (632)
||+++|+|.++++..+.. ....++|..+..++.|++.||+|||+. +||||||||+|||+++++.+|
T Consensus 98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVK 174 (299)
T ss_dssp ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEE
Confidence 999999999999754321 134589999999999999999999998 999999999999999999999
Q ss_pred EcccCCCCCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHH
Q 006747 481 ISDFGLTPLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGK-APIQAPGHEDVVDLPRWVQS 553 (632)
Q Consensus 481 i~DfGla~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~ 553 (632)
|+|||+|+..... ....||+.|+|||.+.+..++.++|||||||++|||+||. .||..... ...+..
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~------~~~~~~ 248 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------DEEFCR 248 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------SHHHHH
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH------HHHHHH
Confidence 9999999865432 2235788999999999999999999999999999999975 56754321 122223
Q ss_pred HhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 554 VVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 554 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
.+.++..... .. ....++.+++.+||+.||++|||++|++++|+++.+
T Consensus 249 ~~~~~~~~~~-------~~---~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 249 RLKEGTRMRA-------PD---YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHTCCCCC-------CT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCCCCC-------Cc---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 3333322111 11 122357788999999999999999999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=384.81 Aligned_cols=244 Identities=22% Similarity=0.371 Sum_probs=194.4
Q ss_pred HhHhCccceeEEEEEEEc-CCc----EEEEEEeccc--ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAILE-EGT----TVVVKRLKEV--VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
.+.||+|+||+||+|... +|+ .||+|+++.. ....+.|.+|++++.++ +|||||+++|+|.+. ..++++||
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~~~~v~e~ 91 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQLITQL 91 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEEEEEEC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-CeeEEEEe
Confidence 368999999999999864 343 5899988654 23467899999999999 999999999999864 57888999
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~ 493 (632)
+.+|+|.+++.... ..++|..+++++.|+|.||+|||+. +||||||||+|||++.++.+||+|||+|+.....
T Consensus 92 ~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 92 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp CTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred ccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999887543 4589999999999999999999998 9999999999999999999999999999876432
Q ss_pred C------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 494 T------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 494 ~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
. ...+|+.|+|||.+.++.++.++|||||||++|||+| |+.||.+....+ +. ..+..+...
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~----~~i~~~~~~----- 232 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERL----- 232 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HH----HHHHHTCCC-----
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCC-----
Confidence 2 2247889999999999999999999999999999999 788886543221 11 122221110
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
... ......+.+|+.+||+.||++|||+.|++++|+.+.
T Consensus 233 --~~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 233 --PQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp --CCC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 011 112245778899999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-46 Score=387.14 Aligned_cols=243 Identities=21% Similarity=0.381 Sum_probs=198.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|.. .+|+.||||++..... ..+.+.+|++++.++ +|||||++++++.+.+..++||||+++|+
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 46799999999999986 4689999999976532 346789999999999 89999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC--CCCeEEcccCCCCCCCCCCC-
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ--DLQGCISDFGLTPLMNTPTV- 495 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~--~~~~ki~DfGla~~~~~~~~- 495 (632)
|.+++.... .++++.....|+.|++.||+|||+. +||||||||+|||++. ++.+||+|||+|+.......
T Consensus 110 L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 110 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp HHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999986542 2589999999999999999999998 9999999999999964 68899999999987765432
Q ss_pred --CCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 496 --PSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 496 --~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
..||+.|||||++.+..++.++|||||||++|||+||+.||.+.. .......+....... ... ....
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~------~~~~~~~i~~~~~~~---~~~--~~~~ 251 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN------DDETLRNVKSCDWNM---DDS--AFSG 251 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCS---CCG--GGGG
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCCC---Ccc--cccC
Confidence 468999999999999999999999999999999999999997532 122222222221110 000 0011
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. ..++.+++.+||+.||++|||++|++++
T Consensus 252 ~---s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 252 I---SEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp C---CHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred C---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 2346778889999999999999999885
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=382.87 Aligned_cols=252 Identities=21% Similarity=0.386 Sum_probs=199.2
Q ss_pred HhHhCccceeEEEEEEEcC-Cc--EEEEEEecccc--cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILEE-GT--TVVVKRLKEVV--MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.++||+|+||.||+|.+.+ |. .||||+++... ...++|.+|++++.++.+|||||+++|+|.+.+..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 4679999999999998654 33 57888876432 2345799999999998679999999999999999999999999
Q ss_pred CCCHhhhhccCC-----------CCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEccc
Q 006747 416 AGSFSALLHGNR-----------GIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDF 484 (632)
Q Consensus 416 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~Df 484 (632)
+|+|.++++... ......++|..+.+++.|+|.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~Df 171 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF 171 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCT
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccc
Confidence 999999997542 11234689999999999999999999998 9999999999999999999999999
Q ss_pred CCCCCCCCCC---CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCC-CCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 485 GLTPLMNTPT---VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKA-PIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 485 Gla~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
|+++...... ...+|..|+|||.+.+..++.++|||||||++|||++|.. ||.+.. ....... +.++..
T Consensus 172 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~~-i~~~~~ 244 (309)
T d1fvra_ 172 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEK-LPQGYR 244 (309)
T ss_dssp TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHH-GGGTCC
T ss_pred cccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHHHH-HHhcCC
Confidence 9997765332 3357888999999999999999999999999999999765 564322 1222222 222211
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCC
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPS 612 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~ 612 (632)
.. ..... ..++.+|+.+||+.||++||||+||++.|+.+.+.
T Consensus 245 ~~-------~~~~~---~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 245 LE-------KPLNC---DDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp CC-------CCTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CC-------CCccC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 10 11122 23577888899999999999999999999998644
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=377.15 Aligned_cols=244 Identities=22% Similarity=0.368 Sum_probs=189.2
Q ss_pred HhHhCccceeEEEEEEEcC----CcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 341 AEVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
.+.||+|+||.||+|.... +..||||.++..... .+.|.+|++++.++ +|||||+++|++. .+..++||||+
T Consensus 12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCeEEEEEEec
Confidence 4679999999999998643 356899998754322 46799999999999 9999999999985 56789999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 493 (632)
++|+|.+++.... .++++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+|+.....
T Consensus 90 ~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 90 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred cCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 9999999876543 3589999999999999999999998 9999999999999999999999999999876532
Q ss_pred ----CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccccccc
Q 006747 494 ----TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVEL 568 (632)
Q Consensus 494 ----~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 568 (632)
....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +.. . +.++....
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~---~-i~~~~~~~------ 229 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG---R-IENGERLP------ 229 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---H-HHTTCCCC------
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH---H-HHcCCCCC------
Confidence 22346888999999999999999999999999999998 888987543221 111 1 11221111
Q ss_pred cccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 569 MRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 569 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
..... ...+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 230 -~~~~~---~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 230 -MPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11112 235778889999999999999999999999874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=376.84 Aligned_cols=242 Identities=20% Similarity=0.357 Sum_probs=196.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc-------cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV-------MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||+||+|.. .+|+.||||++++.. ...+.+.+|++++.++ +|||||++++++.+.+..++|||
T Consensus 15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEE
Confidence 46799999999999996 468999999996542 1357799999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC----CeEEcccCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL----QGCISDFGLTP 488 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~----~~ki~DfGla~ 488 (632)
|+++|+|.+++.... ++++.....++.|++.||+|||+. +|+||||||+|||++.++ .+|++|||+|+
T Consensus 94 ~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 94 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred cCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999997643 489999999999999999999998 999999999999998876 49999999998
Q ss_pred CCCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccc
Q 006747 489 LMNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFD 565 (632)
Q Consensus 489 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 565 (632)
..... ....+|+.|+|||++.+..++.++|||||||++|||+||+.||.+.... ............ +.
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~---~~ 236 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVNYE---FE 236 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTCCC---CC
T ss_pred hcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHHHHhcCCC---CC
Confidence 76543 2346888999999999999999999999999999999999999753211 111111111100 00
Q ss_pred ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 566 VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 566 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
... ... ....+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~--~~~---~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 237 DEY--FSN---TSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHH--HTT---SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chh--cCC---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 011 12356788899999999999999999873
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-46 Score=377.43 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=197.9
Q ss_pred HhHhCccceeEEEEEEEcC--------CcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEE
Q 006747 341 AEVLGKGSYGTTYKAILEE--------GTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLV 410 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv 410 (632)
.+.||+|+||.||+|+... +..||||+++.... ...++.+|...+.++.+|||||+++++|.+++..++|
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v 97 (299)
T d1fgka_ 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 97 (299)
T ss_dssp EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence 4679999999999998532 34799999976543 2467889999999998899999999999999999999
Q ss_pred EecccCCCHhhhhccCCCC-----------CCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCe
Q 006747 411 YDFIEAGSFSALLHGNRGI-----------GRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG 479 (632)
Q Consensus 411 ~E~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ 479 (632)
|||+++|+|.+++...+.. ....+++..+++++.|+|.||+|||+. +||||||||+|||++.++.+
T Consensus 98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVM 174 (299)
T ss_dssp ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCE
T ss_pred EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCe
Confidence 9999999999999765321 234689999999999999999999998 99999999999999999999
Q ss_pred EEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHH
Q 006747 480 CISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 480 ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 552 (632)
||+|||+++...... ...+++.|+|||.+.++.|+.++|||||||++|||+| |..||..... ..+.
T Consensus 175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-------~~~~ 247 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-------EELF 247 (299)
T ss_dssp EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHH
T ss_pred EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-------HHHH
Confidence 999999998764332 2347788999999999999999999999999999998 6888764321 1122
Q ss_pred HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 553 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
..+.++.... .... ....+.+|+.+||+.||++|||+.||++.|+++.+
T Consensus 248 ~~i~~~~~~~-------~p~~---~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 KLLKEGHRMD-------KPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHTTCCCC-------CCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCC-------CCcc---chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 2222222111 1111 12357788999999999999999999999998743
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.7e-46 Score=384.56 Aligned_cols=243 Identities=21% Similarity=0.408 Sum_probs=197.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
.+.||+|+||.||+|.. .+|+.||||+++... ...+.+.+|++++.++ +|||||++++++.+++..|+||||+++|+
T Consensus 34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 36799999999999996 569999999997653 2356788999999999 99999999999999999999999999999
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec--CCCCeEEcccCCCCCCCCCC--
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS--QDLQGCISDFGLTPLMNTPT-- 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~--~~~~~ki~DfGla~~~~~~~-- 494 (632)
|.+++.... .++++.....|+.|++.||+|||+. +|+||||||+|||++ +++.+||+|||+|+......
T Consensus 113 L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 113 LFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp HHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 998876432 3589999999999999999999998 999999999999998 67899999999998876543
Q ss_pred -CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCC
Q 006747 495 -VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYEN 573 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 573 (632)
...+|+.|+|||++.+..++.++||||+||++|||+||+.||.+... ............. +... ....
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~~---~~~~--~~~~ 254 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCDWE---FDED--AFSS 254 (352)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCCCC---CCSS--TTTT
T ss_pred eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---CCcc--cccC
Confidence 23688999999999999999999999999999999999999975321 1112222211110 0000 0111
Q ss_pred cHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 574 IEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 574 ~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...++.+|+.+||+.||++|||+.|++++
T Consensus 255 ---~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 255 ---VSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12356788889999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=374.88 Aligned_cols=244 Identities=23% Similarity=0.362 Sum_probs=188.3
Q ss_pred HhHhCccceeEEEEEEEcC----CcEEEEEEeccccc----CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILEE----GTTVVVKRLKEVVM----GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|++.. +..||||+++.... ..++|.+|++++.++ +|||||+++|+|.+ +..++|||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~~lv~e 90 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPMKMVTE 90 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEEE
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cchheeee
Confidence 3579999999999998532 23789999875422 135799999999999 99999999999965 56789999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++|++.+++.... .++++..++.++.|+|.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 91 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999877542 3589999999999999999999998 999999999999999999999999999987644
Q ss_pred CC-------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHh-CCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 493 PT-------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLT-GKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 493 ~~-------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.. ...++..|+|||.+.+..++.++|||||||++|||+| |+.||.+... ..............+
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~~~~~-- 235 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEGERLP-- 235 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSCCCCC--
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHHHHhCCCCCC--
Confidence 32 2236778999999999999999999999999999998 8999975321 222222222221111
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhh
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDI 609 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i 609 (632)
.... ....+.+++.+||+.||++||||.||.+.|++.
T Consensus 236 -----~~~~---~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 -----RPED---CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----Cccc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111 123577888999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-45 Score=375.07 Aligned_cols=238 Identities=20% Similarity=0.311 Sum_probs=197.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||+||+|+. .+|+.||||++++. ....+.+.+|++++.++ +|||||++++++.+.+..|+||||++
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~ivmE~~~ 87 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMIMDYIE 87 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeEeeecC
Confidence 46799999999999996 46899999999753 23456789999999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-C
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-T 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~ 494 (632)
+|+|..++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+..... .
T Consensus 88 gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~ 159 (316)
T d1fota_ 88 GGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY 159 (316)
T ss_dssp SCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred Cccccccccccc-----cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccccc
Confidence 999999987653 467788888999999999999998 9999999999999999999999999999887544 3
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...||+.|||||++.+..|+.++||||+||++|||+||+.||.+.. .............. .....
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~~~~---------~p~~~ 224 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN------TMKTYEKILNAELR---------FPPFF 224 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHHCCCC---------CCTTS
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC------HHHHHHHHHcCCCC---------CCCCC
Confidence 4569999999999999999999999999999999999999997532 11122222221110 01111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~~ 605 (632)
. .++.+++.+||+.||++|| |++|++++
T Consensus 225 s---~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 225 N---EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C---HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C---HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 2 3466788899999999996 89999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=380.12 Aligned_cols=243 Identities=20% Similarity=0.293 Sum_probs=192.4
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEe----CCceEEEEecccC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFS----KDEKLLVYDFIEA 416 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~----~~~~~lv~E~~~~ 416 (632)
++||+|+||+||+|.. .+++.||||+++. ...+.+|++++.++.+|||||+++++|.+ ....|+||||+++
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 4699999999999985 5689999999964 35678899988877689999999999876 3568999999999
Q ss_pred CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC---CCCeEEcccCCCCCCCCC
Q 006747 417 GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ---DLQGCISDFGLTPLMNTP 493 (632)
Q Consensus 417 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~---~~~~ki~DfGla~~~~~~ 493 (632)
|+|.+++.... ..++++.....|+.|++.||+|||+. +|+||||||+|||+++ ++.+||+|||+|+.....
T Consensus 94 g~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 94 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred CcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCC
Confidence 99999997542 34689999999999999999999998 9999999999999985 567999999999866443
Q ss_pred ---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccc
Q 006747 494 ---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMR 570 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 570 (632)
....||+.|||||++.+..|+.++|||||||++|||+||+.||.+........ ........ .....
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~--------~~~~~ 236 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRM--------GQYEF 236 (335)
T ss_dssp CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCS--------CSSSC
T ss_pred CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhc--------CCCCC
Confidence 34468999999999999999999999999999999999999997644322111 00000000 00000
Q ss_pred cC-CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 571 YE-NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 571 ~~-~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
.. .......++.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00 011223457788999999999999999999884
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=376.29 Aligned_cols=238 Identities=21% Similarity=0.305 Sum_probs=196.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|+. .+|+.||||++++. ....+.+.+|++++.++ +|||||++++++.+.+..|+||||++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv~ey~~ 88 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFVMEYAN 88 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccceeccC
Confidence 36799999999999996 56899999999754 22356789999999999 89999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.+++...+ .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 89 gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 89 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp TCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999988653 478888889999999999999998 9999999999999999999999999999876432
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+... ........... . . -+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~~~~-~------~--~p 225 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILMEE-I------R--FP 225 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-C------C--CC
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHhcCC-C------C--CC
Confidence 234589999999999999999999999999999999999999976431 11122221111 1 0 11
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPT-----MEEVVRM 605 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~~ 605 (632)
.... .++.+|+.+||+.||++||+ ++|++++
T Consensus 226 ~~~s---~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 226 RTLS---PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ccCC---HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1122 34667888999999999995 8888763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-46 Score=378.20 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=200.6
Q ss_pred HhHhCccceeEEEEEEE------cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAIL------EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|.+ .+++.||||+++.... ....|.+|++++.++.+|||||+++|+|.+.+..++|||
T Consensus 28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE 107 (311)
T d1t46a_ 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (311)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence 46799999999999985 2456899999976532 345789999999999789999999999999999999999
Q ss_pred cccCCCHhhhhccCCC-------------CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCe
Q 006747 413 FIEAGSFSALLHGNRG-------------IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQG 479 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ 479 (632)
|+++|+|.++++.... .....+++..+.+++.|++.||+|||+. +||||||||+|||++.++.+
T Consensus 108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRIT 184 (311)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEE
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcc
Confidence 9999999999976532 1234689999999999999999999998 99999999999999999999
Q ss_pred EEcccCCCCCCCCCC------CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCC-CCCCCCCCCCChhHHHH
Q 006747 480 CISDFGLTPLMNTPT------VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAP-IQAPGHEDVVDLPRWVQ 552 (632)
Q Consensus 480 ki~DfGla~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p-~~~~~~~~~~~~~~~~~ 552 (632)
|++|||+++...... ...+|+.|+|||.+.++.++.++|||||||++|||+|++.| |...... ..+.
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~------~~~~ 258 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD------SKFY 258 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS------HHHH
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH------HHHH
Confidence 999999998765432 23468889999999999999999999999999999995444 5432211 1122
Q ss_pred HHhhhccccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhC
Q 006747 553 SVVREEWTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIR 610 (632)
Q Consensus 553 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~ 610 (632)
..+..+.... ........+.+|+.+||+.||++||||.+|+++|+++.
T Consensus 259 ~~i~~~~~~~----------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 259 KMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCCCCC----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 2222221110 11112245778899999999999999999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-46 Score=378.11 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=202.7
Q ss_pred HhHhCccceeEEEEEEEc------CCcEEEEEEecccccC--HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE------EGTTVVVKRLKEVVMG--KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||+||+|.+. +++.||||+++..... ...|.+|++++.++ +|||||+++|+|...+..++|||
T Consensus 25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecCCceeEEEe
Confidence 467999999999999863 3578999999754322 34689999999999 89999999999999999999999
Q ss_pred cccCCCHhhhhccCCC-----CCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCC
Q 006747 413 FIEAGSFSALLHGNRG-----IGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLT 487 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla 487 (632)
|+++|+|.++++..+. .....++|..+.+++.++|.||.|||+. +|+||||||+|||+|+++++||+|||+|
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla 180 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccc
Confidence 9999999998864321 1234579999999999999999999998 9999999999999999999999999999
Q ss_pred CCCCCC------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCC-CCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 488 PLMNTP------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGK-APIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 488 ~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
+..... ....+|+.|+|||.+.+..++.++|||||||++|||+||+ .||.+. .......... ++..
T Consensus 181 ~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~~i~-~~~~ 253 (308)
T d1p4oa_ 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVM-EGGL 253 (308)
T ss_dssp CGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHH-TTCC
T ss_pred eeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHHHHHHH-hCCC
Confidence 876432 2224688899999999999999999999999999999985 666442 2222222222 2211
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCCCC
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRPSD 613 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~~~ 613 (632)
.. .... ....+.+++.+||+.+|++||||.+|+++|++..+..
T Consensus 254 ~~-------~p~~---~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 254 LD-------KPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp CC-------CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred CC-------Cccc---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 11 1111 2245778899999999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.6e-45 Score=366.60 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=194.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC----HHHHHHHHHHHHhhcCCCCccceeEEEEeCCc----eEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG----KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDE----KLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~----~~lv~ 411 (632)
.+.||+|+||.||+|.. .+|+.||||+++..... ...+.+|++++.++ +|||||++++++...+. .|+||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~~~~lvm 90 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVM 90 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCceEEEEE
Confidence 36799999999999985 56899999999765322 34689999999999 99999999999987543 78999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+++|+|.+++...+ ++++.....++.|++.||+|||+. +|+||||||+|||++.++..+|+|||.++...
T Consensus 91 E~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 91 EYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp ECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred ECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhc
Confidence 9999999999887543 589999999999999999999998 99999999999999999999999999986543
Q ss_pred CC-------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 492 TP-------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 492 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.. ....||+.|||||++.+..++.++|||||||++|||+||+.||.+.. ...............
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIP--- 233 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCC---
T ss_pred cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCC---
Confidence 22 23358999999999999999999999999999999999999997532 112222222222111
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhhhC
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRP-TMEEVVRMIEDIR 610 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RP-s~~evl~~L~~i~ 610 (632)
+.. .....+ ..+.+++.+||+.||++|| |++++...|.++.
T Consensus 234 -~~~-~~~~~s---~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -PSA-RHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -GGG-TSSSCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -Cch-hccCCC---HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000 111122 3466788899999999999 8999999998774
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-44 Score=362.87 Aligned_cols=243 Identities=20% Similarity=0.334 Sum_probs=195.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC----------HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG----------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLL 409 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~l 409 (632)
.+.||+|+||+||+|+. .+|+.||||+++..... .+.+.+|++++.++..|||||++++++.+++..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 36799999999999986 56899999999754321 23588999999999559999999999999999999
Q ss_pred EEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 410 VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 410 v~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
||||+++|+|.++++... ++++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 88 vmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeE
Confidence 999999999999997542 589999999999999999999998 999999999999999999999999999987
Q ss_pred CCCC---CCCCCCCcccCCccccC------CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccc
Q 006747 490 MNTP---TVPSRSAGYRAPEVIET------KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWT 560 (632)
Q Consensus 490 ~~~~---~~~~~t~~y~aPE~~~~------~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 560 (632)
.... ....||..|+|||.+.+ ..++.++||||+||++|||+||+.||.+... .............
T Consensus 160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~~~~~i~~~~~~ 233 (277)
T d1phka_ 160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRMIMSGNYQ 233 (277)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC
T ss_pred ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HHHHHHHHhCCCC
Confidence 6543 33458899999999853 3468899999999999999999999975321 1111222222111
Q ss_pred cccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 561 SEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 561 ~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
. .. ........++.+++.+||+.||++|||++||+++
T Consensus 234 ~--~~------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 F--GS------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp C--CT------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C--CC------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 00 0111122357788889999999999999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=374.25 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=189.6
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC------HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecc
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG------KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFI 414 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~ 414 (632)
++||+|+||+||+|.. .+|+.||||+++..... .+.+.+|++++.++ +|||||++++++.+++..++||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhhhh
Confidence 5799999999999996 45899999999754321 24588999999999 8999999999999999999999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~- 493 (632)
.++++..+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 83 ~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 998887776543 2477788899999999999999998 9999999999999999999999999999876543
Q ss_pred ---CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hcccccc--
Q 006747 494 ---TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSEV-- 563 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~-- 563 (632)
....+|+.|+|||++.+. .|+.++|||||||++|||+||+.||.+....+ ....+..... +.+....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhcc
Confidence 233588999999998755 57999999999999999999999997543211 1111111110 0000000
Q ss_pred -cccccccc-C-CcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 564 -FDVELMRY-E-NIE----EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 564 -~d~~~~~~-~-~~~----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
........ . ... ....++.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000000 0 000 112457788999999999999999999873
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=373.09 Aligned_cols=243 Identities=19% Similarity=0.325 Sum_probs=198.1
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||+||+|... +++.||||+++........+.+|++++.++ +|||||++++++.+.+..|+||||+++|+|
T Consensus 10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L 88 (321)
T d1tkia_ 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence 367999999999999864 588999999987655566788999999999 899999999999999999999999999999
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC--CCCeEEcccCCCCCCCCCC---
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ--DLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~--~~~~ki~DfGla~~~~~~~--- 494 (632)
.+++.... .++++.....++.|++.||+|||+. +|+||||||+|||++. ...+||+|||+++......
T Consensus 89 ~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 89 FERINTSA----FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 99997542 3589999999999999999999998 9999999999999985 4589999999998765433
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...+|+.|+|||.+.+..++.++||||+||++|||++|+.||..... ......+...... ++... ....
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~~~---~~~~~--~~~~ 230 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYT---FDEEA--FKEI 230 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCC---CCHHH--HTTS
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCC---CChhh--ccCC
Confidence 23478899999999999999999999999999999999999975321 1122222222111 00000 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
..++.+++.+||+.||++|||+.|++++
T Consensus 231 ---s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 231 ---SIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2346788889999999999999999873
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=372.58 Aligned_cols=238 Identities=21% Similarity=0.322 Sum_probs=193.3
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||+||+|+.. +|+.||||++++. ....+.+..|+.++.+..+|||||++++++.+++..|+||||++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 367999999999999964 6899999999753 23355677888877754499999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC--
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-- 493 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-- 493 (632)
+|+|.++++... .+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 999999998653 478888999999999999999998 9999999999999999999999999999865432
Q ss_pred --CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccccc
Q 006747 494 --TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRY 571 (632)
Q Consensus 494 --~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 571 (632)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.+... ..+...+..+.. .. .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~------~~--p 223 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNP------FY--P 223 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC------CC--C
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC------CC--C
Confidence 234689999999999999999999999999999999999999975321 111111211111 00 1
Q ss_pred CCcHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 006747 572 ENIEEEMVQMLQIAMSCVAKVPDMRPTME-EVVR 604 (632)
Q Consensus 572 ~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~-evl~ 604 (632)
...+ .++.+|+.+||+.||++|||+. |+++
T Consensus 224 ~~~s---~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 224 RWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TTSC---HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ccCC---HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1122 3467888899999999999995 6754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-44 Score=374.90 Aligned_cols=237 Identities=16% Similarity=0.217 Sum_probs=196.7
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccc----ccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEeccc
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEV----VMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIE 415 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~ 415 (632)
.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++.++ +|||||++++++.+....++||||+.
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v~e~~~ 124 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVA 124 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccccccccccccccc
Confidence 36799999999999986 46999999999643 23356789999999999 99999999999999999999999999
Q ss_pred CCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC-C
Q 006747 416 AGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP-T 494 (632)
Q Consensus 416 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~-~ 494 (632)
+|+|..++.... .+++.....++.|++.||.|||+. +||||||||+|||++.++.+||+|||+|+..... .
T Consensus 125 ~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~ 196 (350)
T d1rdqe_ 125 GGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW 196 (350)
T ss_dssp TCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred ccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccccc
Confidence 999999987643 488999999999999999999998 9999999999999999999999999999877543 3
Q ss_pred CCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccccccccCCc
Q 006747 495 VPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELMRYENI 574 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 574 (632)
...||+.|||||++.+..++.++|||||||++|||+||+.||.+.. ........... ... .....
T Consensus 197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~~-~~~--------~p~~~ 261 (350)
T d1rdqe_ 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVSG-KVR--------FPSHF 261 (350)
T ss_dssp CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHC-CCC--------CCTTC
T ss_pred cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhcC-CCC--------CCccC
Confidence 3458999999999999999999999999999999999999997532 11122222111 110 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 006747 575 EEEMVQMLQIAMSCVAKVPDMRP-----TMEEVVR 604 (632)
Q Consensus 575 ~~~~~~~~~l~~~Cl~~~P~~RP-----s~~evl~ 604 (632)
..++.+++.+||+.||++|+ |++|+++
T Consensus 262 ---s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 262 ---SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 23567788899999999994 8999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-44 Score=376.32 Aligned_cols=240 Identities=18% Similarity=0.300 Sum_probs=189.3
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccc----cCHHHHHHH---HHHHHhhcCCCCccceeEEEEeCCceEEEEe
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVV----MGKREFEQQ---MEVVGRLSQHPNVVPIRAYYFSKDEKLLVYD 412 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~e---~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E 412 (632)
.+.||+|+||.||+|+.. +|+.||||++.... .....+.+| ++++..+ +|||||++++++.+.+..|+|||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~~ivmE 87 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILD 87 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEEEEEEE
Confidence 367999999999999964 58999999996432 223445555 4455555 79999999999999999999999
Q ss_pred cccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC
Q 006747 413 FIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT 492 (632)
Q Consensus 413 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~ 492 (632)
|+++|+|.+++.... .+++.....++.|++.||+|||+. +||||||||+|||+++++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 88 LMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp CCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred ecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999997643 478889999999999999999998 999999999999999999999999999987654
Q ss_pred C--CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccccccccc
Q 006747 493 P--TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDVELM 569 (632)
Q Consensus 493 ~--~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 569 (632)
. ....||+.|+|||++.. ..|+.++|||||||++|||+||+.||......+. ....+... .. ...
T Consensus 160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~~~~~~-~~--------~~~ 227 (364)
T d1omwa3 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTL-TM--------AVE 227 (364)
T ss_dssp SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HHHHHHSS-SC--------CCC
T ss_pred CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhcc-cC--------CCC
Confidence 3 34569999999999975 5689999999999999999999999976433221 11111110 00 000
Q ss_pred ccCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006747 570 RYENIEEEMVQMLQIAMSCVAKVPDMRPT-----MEEVVR 604 (632)
Q Consensus 570 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 604 (632)
...... .++.+++.+||+.||++||| ++|+++
T Consensus 228 ~~~~~s---~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 LPDSFS---PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCSSSC---HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCC---HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 111122 34677888999999999999 688875
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=365.29 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=191.7
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEeccccc---CHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM---GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|++++.++ +|||||++++++.+.+..|+||||+.++
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~ 86 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQD 86 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEEeecCCc
Confidence 5799999999999996 5689999999975432 246789999999999 8999999999999999999999999865
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP---- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~---- 493 (632)
.+....... ...+++..+..++.|++.||+|||+. +||||||||+|||++.++.+||+|||+|+.....
T Consensus 87 ~~~~~~~~~----~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 87 LKKFMDASA----LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp HHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred hhhhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 444443332 23589999999999999999999998 9999999999999999999999999999765432
Q ss_pred CCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh--hhccccccc-----c
Q 006747 494 TVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV--REEWTSEVF-----D 565 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-----d 565 (632)
....+|+.|+|||.+.... ++.++||||+||++|||++|+.||.+....+. +........ .+....... .
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhccccccccccc
Confidence 2335889999999887766 58899999999999999999999975321110 000000000 000000000 0
Q ss_pred ccccc--cCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhh
Q 006747 566 VELMR--YENIE----EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDI 609 (632)
Q Consensus 566 ~~~~~--~~~~~----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i 609 (632)
..... ..... ....++.+++.+||+.||++|||++|++++ ++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00000 00001 112456788899999999999999999986 6554
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=358.68 Aligned_cols=233 Identities=21% Similarity=0.374 Sum_probs=187.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc-------CHHHHHHHHHHHHhhc-CCCCccceeEEEEeCCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM-------GKREFEQQMEVVGRLS-QHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~-~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.||+|+||+||+|.. .+|+.||||+++.... ....+.+|++++.++. .|||||++++++.+.+..++||
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence 36799999999999996 4689999999975422 1234678999999984 3999999999999999999999
Q ss_pred ecccC-CCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCC-CCeEEcccCCCCC
Q 006747 412 DFIEA-GSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQD-LQGCISDFGLTPL 489 (632)
Q Consensus 412 E~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~-~~~ki~DfGla~~ 489 (632)
||+.+ +++.+++.... .+++.....++.|++.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 89 e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp ECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccccee
Confidence 99976 67888876542 488999999999999999999998 99999999999999854 7999999999986
Q ss_pred CCCC--CCCCCCCcccCCccccCCCC-CccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccccc
Q 006747 490 MNTP--TVPSRSAGYRAPEVIETKKP-TQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVFDV 566 (632)
Q Consensus 490 ~~~~--~~~~~t~~y~aPE~~~~~~~-~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 566 (632)
.... ....||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... ....... .+.
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~---~~~- 224 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQV---FFR- 224 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCC---CCS-
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhccc---CCC-
Confidence 6543 33468999999999987775 567899999999999999999996421 1111110 011
Q ss_pred cccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 567 ELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 567 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...+ .++.+++.+||+.||++|||++|++++
T Consensus 225 -----~~~s---~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 225 -----QRVS---SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----SCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCC---HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1122 346678889999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1e-43 Score=359.27 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=191.8
Q ss_pred hHhCccceeEEEEEEEcCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCC
Q 006747 342 EVLGKGSYGTTYKAILEEGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGS 418 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~ 418 (632)
+.||+|+||+||+|..++|+.||||+++... ...+.+.+|++++.++ +|||||++++++...+..++++||+.++.
T Consensus 8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 5799999999999999999999999997542 2256799999999999 89999999999999999999999999887
Q ss_pred HhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCC----C
Q 006747 419 FSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTP----T 494 (632)
Q Consensus 419 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~----~ 494 (632)
+..+.... ..+++.....++.|++.||+|||+. +||||||||+|||++.++.+|++|||.+...... .
T Consensus 87 ~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (286)
T d1ob3a_ 87 KKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (286)
T ss_dssp HHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred HHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence 77776543 3589999999999999999999998 9999999999999999999999999998765432 2
Q ss_pred CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---ccccc-----cc
Q 006747 495 VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE---WTSEV-----FD 565 (632)
Q Consensus 495 ~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~d 565 (632)
...+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.+....+. +.. +....... ..... .+
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGGSTTCC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhCCCChhhccchhhhhhcc
Confidence 335788899999987654 68999999999999999999999975432111 000 00000000 00000 00
Q ss_pred ccccc------cCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 566 VELMR------YENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 566 ~~~~~------~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..... ..........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0001111245778899999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=358.85 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=189.8
Q ss_pred hHhCccceeEEEEEEE-cC-CcEEEEEEeccccc---CHHHHHHHHHHHHhhc--CCCCccceeEEEEeC-----CceEE
Q 006747 342 EVLGKGSYGTTYKAIL-EE-GTTVVVKRLKEVVM---GKREFEQQMEVVGRLS--QHPNVVPIRAYYFSK-----DEKLL 409 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~-~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~--~h~niv~l~~~~~~~-----~~~~l 409 (632)
+.||+|+||+||+|.. .+ ++.||||+++.... ....+.+|++++..+. +||||++++++|... ...++
T Consensus 13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~ 92 (305)
T d1blxa_ 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92 (305)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence 5799999999999986 34 56799999975422 2335667787776653 799999999998642 36799
Q ss_pred EEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 410 VYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 410 v~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
+|||+++|++....... ...+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 93 ~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 93 VFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 99999988776554432 23578899999999999999999998 999999999999999999999999999987
Q ss_pred CCCC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhh----hccccc
Q 006747 490 MNTP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVR----EEWTSE 562 (632)
Q Consensus 490 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 562 (632)
.... ....||+.|+|||++.+..|+.++||||+||++|||+||+.||.+....+. ...+..... ..+...
T Consensus 166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCGGGSCTT
T ss_pred hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCchhccccc
Confidence 6432 345689999999999999999999999999999999999999975432111 111111100 000000
Q ss_pred cccc------ccc--ccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhhh
Q 006747 563 VFDV------ELM--RYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDI 609 (632)
Q Consensus 563 ~~d~------~~~--~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i 609 (632)
.... ... ...........+.+|+.+||+.||++|||+.|++++ ++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 0000 000 000001112346678889999999999999999875 5554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=361.09 Aligned_cols=258 Identities=23% Similarity=0.312 Sum_probs=188.2
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCC------ceEEEEecc
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD------EKLLVYDFI 414 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~E~~ 414 (632)
++||+|+||+||+|+.. +|+.||||+++.... ...+|++++.++ +|+|||+++++|.... ..++||||+
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 57999999999999964 589999999976432 234789999999 9999999999986532 468999999
Q ss_pred cCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-CeEEcccCCCCCCCCC
Q 006747 415 EAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLMNTP 493 (632)
Q Consensus 415 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~ 493 (632)
++|.+..+.+... ...++++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+++.....
T Consensus 102 ~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 102 PETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp SEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred CCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 8765444433221 234689999999999999999999998 999999999999999775 8999999999876443
Q ss_pred ---CCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHH-------Hhhhccccc
Q 006747 494 ---TVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQS-------VVREEWTSE 562 (632)
Q Consensus 494 ---~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 562 (632)
....+|..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +...+.. .+... ...
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~~~-~~~ 253 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIREM-NPN 253 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHH-CC-
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhhhh-ccc
Confidence 33458889999998875 4689999999999999999999999975432111 1111000 00000 000
Q ss_pred ccccccccc-------CCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCC
Q 006747 563 VFDVELMRY-------ENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRP 611 (632)
Q Consensus 563 ~~d~~~~~~-------~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~ 611 (632)
..+...... ........++.+|+.+||+.||++|||+.|++++ ++++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 000000000 0001122357788899999999999999999974 666644
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-42 Score=351.09 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=186.6
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccc---cCHHHHHHHHHHHHhhcCCCCccceeEEEEe--------CCceE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVV---MGKREFEQQMEVVGRLSQHPNVVPIRAYYFS--------KDEKL 408 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~--------~~~~~ 408 (632)
.+.||+|+||+||+|.. .+|+.||||++.... ...+.+.+|++++.++ +||||+++++++.. ....+
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC----------CEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccccCceEE
Confidence 35799999999999996 579999999986542 2346788999999999 89999999999865 34579
Q ss_pred EEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 409 LVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 409 lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
+||||++++.+..+.... ..++......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 94 iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp EEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 999999988777665433 2477788889999999999999998 99999999999999999999999999997
Q ss_pred CCCCC--------CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhh--
Q 006747 489 LMNTP--------TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVRE-- 557 (632)
Q Consensus 489 ~~~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 557 (632)
..... ....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+. ...+......
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~ 242 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGSIT 242 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH---HHHHHHhcCCCC
Confidence 55421 223588999999998765 589999999999999999999999975321111 1111111100
Q ss_pred -ccccccccc--------cccccCCcHHH------HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 558 -EWTSEVFDV--------ELMRYENIEEE------MVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 558 -~~~~~~~d~--------~~~~~~~~~~~------~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
......... .........+. ...+.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000000 00001111111 2346789999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=356.41 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=187.9
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCC------ceEEEE
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKD------EKLLVY 411 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~------~~~lv~ 411 (632)
+.||+|+||+||+|.. .+|+.||||+++..... .+.+.+|++++.++ +|||||+++++|...+ +.++||
T Consensus 24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccccceEEEEE
Confidence 5799999999999996 46999999999865333 34688999999999 8999999999998654 469999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+ +++|..+.+.. .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+|+...
T Consensus 103 e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccC
Confidence 999 56788777543 489999999999999999999998 99999999999999999999999999998765
Q ss_pred CC-CCCCCCCcccCCccccCC-CCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH-------hhhc----
Q 006747 492 TP-TVPSRSAGYRAPEVIETK-KPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV-------VREE---- 558 (632)
Q Consensus 492 ~~-~~~~~t~~y~aPE~~~~~-~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-------~~~~---- 558 (632)
.. ....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+. +....... +...
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T d1cm8a_ 173 SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEFVQRLQSDE 250 (346)
T ss_dssp SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHTCSCHH
T ss_pred CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcHHHHhhhcchh
Confidence 43 345688999999998765 468999999999999999999999976432111 00000000 0000
Q ss_pred ------cccccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCCC
Q 006747 559 ------WTSEVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRPS 612 (632)
Q Consensus 559 ------~~~~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~~ 612 (632)
........... .........+.+|+.+||+.||++|||++|++++ ++++.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 251 AKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhhccCCcccccchH--HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 00000000000 0001112346788899999999999999999986 7776544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-41 Score=342.94 Aligned_cols=252 Identities=14% Similarity=0.194 Sum_probs=197.2
Q ss_pred HhHhCccceeEEEEEEEc-CCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||+||+|... +|+.||||++.... ....+.+|++++..+.+|+|++.+++++.+....++||||+ +|+|
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l 87 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 87 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCH
Confidence 367999999999999954 68999999886542 23457888999999967799999999999999999999999 6899
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecC-----CCCeEEcccCCCCCCCCC-
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQ-----DLQGCISDFGLTPLMNTP- 493 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~-----~~~~ki~DfGla~~~~~~- 493 (632)
.+++.... ..+++.....++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+|+.....
T Consensus 88 ~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 88 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 99887543 3588999999999999999999998 9999999999999974 578999999999765321
Q ss_pred ----------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccccc
Q 006747 494 ----------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEV 563 (632)
Q Consensus 494 ----------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 563 (632)
....||+.|||||.+.+..++.++|||||||++|||+||+.||.+............+... .....
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~---~~~~~- 236 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK---KQSTP- 236 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH---HHHSC-
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc---cCCCC-
Confidence 1235899999999999999999999999999999999999999765433221111111110 00000
Q ss_pred ccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 564 FDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 564 ~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
-..+ .... ..++.+++..|++.+|++||+++.+.+.|+++..
T Consensus 237 -~~~l--~~~~---p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 237 -LREL--CAGF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp -HHHH--TTTS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred -hHHh--cCCC---CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 0000 0111 1356778889999999999999999999888743
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-41 Score=345.05 Aligned_cols=251 Identities=16% Similarity=0.193 Sum_probs=187.7
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCH
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSF 419 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L 419 (632)
.+.||+|+||.||+|.. .+|+.||||++.... ...++..|++++.++.+|++|+.+.+++.+.+..++||||+. |++
T Consensus 12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l 89 (299)
T d1ckia_ 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSL 89 (299)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBH
T ss_pred eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cch
Confidence 36799999999999985 568999999987543 234578899999999444445555666677788899999995 566
Q ss_pred hhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeec---CCCCeEEcccCCCCCCCCC---
Q 006747 420 SALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLS---QDLQGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 420 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~---~~~~~ki~DfGla~~~~~~--- 493 (632)
.+.+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++ .+..+||+|||+|+.....
T Consensus 90 ~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 90 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred hhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 66654332 3589999999999999999999998 999999999999875 4568999999999876432
Q ss_pred --------CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChh-HHHHHHhhhccccccc
Q 006747 494 --------TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLP-RWVQSVVREEWTSEVF 564 (632)
Q Consensus 494 --------~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 564 (632)
....||+.|||||.+.+..++.++|||||||++|||+||+.||......+..... .+........ .
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~---- 237 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-I---- 237 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-H----
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-h----
Confidence 2235899999999999999999999999999999999999999765433322211 1111110000 0
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhhhCC
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRMIEDIRP 611 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~L~~i~~ 611 (632)
+.. ... ...++.+++..||+.+|++||+++++.+.|+.+..
T Consensus 238 -~~~--~~~---~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 -EVL--CKG---YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -HHH--TTT---SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -hHh--ccC---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 000 011 12357788889999999999999999999887633
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-41 Score=347.10 Aligned_cols=258 Identities=19% Similarity=0.272 Sum_probs=187.9
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEeccccc--CHHHHHHHHHHHHhhcCCCCccceeEEEEeCC----ceEEEEec
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVM--GKREFEQQMEVVGRLSQHPNVVPIRAYYFSKD----EKLLVYDF 413 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~----~~~lv~E~ 413 (632)
.+.||+|+||+||+|.. .+|+.||||+++.... ..+.+.+|++++.++ +||||+++++++.... ..++++||
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~~~l~~~ 91 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKDVYLVTH 91 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccceEEEEEe
Confidence 36799999999999985 5799999999975432 245688999999999 9999999999997653 23555567
Q ss_pred ccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCC-
Q 006747 414 IEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNT- 492 (632)
Q Consensus 414 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~- 492 (632)
+.+|+|.+++... .+++.....++.|++.||+|||+. +||||||||+|||+++++.+||+|||+++....
T Consensus 92 ~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 92 LMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp CCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred ecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 7799999999753 388999999999999999999998 999999999999999999999999999976532
Q ss_pred ------CCCCCCCCcccCCccccC-CCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhcccc---c
Q 006747 493 ------PTVPSRSAGYRAPEVIET-KKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTS---E 562 (632)
Q Consensus 493 ------~~~~~~t~~y~aPE~~~~-~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 562 (632)
.....+|+.|+|||.+.. ..++.++||||+||++|||++|+.||......+.. ............. .
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChhhhhh
Confidence 223457889999999855 45789999999999999999999999754321110 0000000000000 0
Q ss_pred cc-------ccccc--ccCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhhhCC
Q 006747 563 VF-------DVELM--RYENIE----EEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IEDIRP 611 (632)
Q Consensus 563 ~~-------d~~~~--~~~~~~----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~i~~ 611 (632)
.. ..... ...... ....++.+++.+||+.||++|||+.|++++ +++...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 00 00000 000000 011357789999999999999999999986 665533
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=338.16 Aligned_cols=253 Identities=20% Similarity=0.272 Sum_probs=192.9
Q ss_pred hHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCC
Q 006747 342 EVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAG 417 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g 417 (632)
+.||+|+||+||+|+. .+++.||||+++..... ...+.+|++++.++ +||||++++++|......++|+||+.++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~~~~~~~ 86 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEeeecccc
Confidence 5799999999999995 56889999999754322 46789999999999 9999999999999999999999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMNTPT--- 494 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~~~~--- 494 (632)
++..++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||.++......
T Consensus 87 ~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~ 158 (292)
T d1unla_ 87 LKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158 (292)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred cccccccccc-----ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence 9998887543 477889999999999999999998 99999999999999999999999999998765432
Q ss_pred -CCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhc---ccc--------
Q 006747 495 -VPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREE---WTS-------- 561 (632)
Q Consensus 495 -~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~-------- 561 (632)
...++..|+|||.+.... ++.++||||+||++|||++|+.||..... ..+....+....... ...
T Consensus 159 ~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC--HHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 224567799999987765 68999999999999999999999753221 111111111111100 000
Q ss_pred ---ccccccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 562 ---EVFDVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 562 ---~~~d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
...................+.+|+.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000001111122456788899999999999999999873
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-41 Score=344.54 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=191.5
Q ss_pred HhHhCccceeEEEEEEE----cCCcEEEEEEecccc-----cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL----EEGTTVVVKRLKEVV-----MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~ 411 (632)
.+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|++++.++.+||||+++++++.+....++||
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 46899999999999985 247899999987542 234568899999999955589999999999999999999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+.+|+|.+++...+ .+.......++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 109 e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 109 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred ecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 9999999999997654 356678888999999999999998 99999999999999999999999999997654
Q ss_pred CC-----CCCCCCCcccCCccccCCC--CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc
Q 006747 492 TP-----TVPSRSAGYRAPEVIETKK--PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF 564 (632)
Q Consensus 492 ~~-----~~~~~t~~y~aPE~~~~~~--~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 564 (632)
.. ....+++.|+|||.+.+.. ++.++|||||||+||||+||+.||.+....+.. ..+.........
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~~~~~---- 253 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSEP---- 253 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHCCC----
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcccCCC----
Confidence 32 2335788899999997654 688999999999999999999999876443321 111111111100
Q ss_pred cccccccCCcHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 006747 565 DVELMRYENIEEEMVQMLQIAMSCVAKVPDMRPT-----MEEVVR 604 (632)
Q Consensus 565 d~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs-----~~evl~ 604 (632)
........++.+++.+||+.||++||| ++|+++
T Consensus 254 -------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 -------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 001112345777888999999999994 788876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-40 Score=341.15 Aligned_cols=249 Identities=20% Similarity=0.291 Sum_probs=188.5
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeC--CceEEEEecccCC
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSK--DEKLLVYDFIEAG 417 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~--~~~~lv~E~~~~g 417 (632)
.+.||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|++++.++.+||||+++++++... ...++||||+++|
T Consensus 40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~ 117 (328)
T d3bqca1 40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence 46799999999999996 56899999999753 3577899999999996699999999999854 4689999999999
Q ss_pred CHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCC-CeEEcccCCCCCCCCC---
Q 006747 418 SFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDL-QGCISDFGLTPLMNTP--- 493 (632)
Q Consensus 418 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~-~~ki~DfGla~~~~~~--- 493 (632)
+|..+.+ .+++.....++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 118 ~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 118 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp BGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred cHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 9977642 378889999999999999999998 999999999999998755 6999999999876543
Q ss_pred CCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHh---------hhccc---
Q 006747 494 TVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVV---------REEWT--- 560 (632)
Q Consensus 494 ~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~--- 560 (632)
....+|..|+|||.+.+.. ++.++||||+||++|||++|+.||....... +....+.... .....
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhhhhcccccC
Confidence 3345788899999987755 7999999999999999999999997543211 0000000000 00000
Q ss_pred ---ccccc-------ccccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 006747 561 ---SEVFD-------VELMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVR 604 (632)
Q Consensus 561 ---~~~~d-------~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~ 604 (632)
..... ..............++.+|+.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000000011112245778899999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=339.60 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=182.0
Q ss_pred hHhCccceeEEEEEEEc-CCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC------CceEEEE
Q 006747 342 EVLGKGSYGTTYKAILE-EGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK------DEKLLVY 411 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~------~~~~lv~ 411 (632)
+.||+|+||+||+|... +|+.||||+++..... ...+.+|++++.++ +|||||+++++|... ...|+||
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCceeEEEE
Confidence 57999999999999964 6999999999865433 34588999999999 899999999999743 5789999
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+.++.+. .+.. .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+|++|||+++...
T Consensus 102 Ey~~~~l~~-~~~~-------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~ 170 (355)
T d2b1pa1 102 ELMDANLCQ-VIQM-------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_dssp ECCSEEHHH-HHTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred eccchHHHH-hhhc-------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccc
Confidence 999765554 4432 378899999999999999999998 99999999999999999999999999987665
Q ss_pred CC---CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCC---------hhH-------HHH
Q 006747 492 TP---TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVD---------LPR-------WVQ 552 (632)
Q Consensus 492 ~~---~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~---------~~~-------~~~ 552 (632)
.. ....+|+.|+|||++.+..++.++||||+||+++||++|+.||.+........ .++ ...
T Consensus 171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 43 33457889999999999999999999999999999999999997543111000 000 000
Q ss_pred HHhhhccc------cccccccccccC--CcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 006747 553 SVVREEWT------SEVFDVELMRYE--NIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM 605 (632)
Q Consensus 553 ~~~~~~~~------~~~~d~~~~~~~--~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~ 605 (632)
........ ...+........ ........+.+|+.+|++.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00010000 000000000000 112234568889999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=345.14 Aligned_cols=258 Identities=20% Similarity=0.288 Sum_probs=189.3
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccC---HHHHHHHHHHHHhhcCCCCccceeEEEEeC-----CceEEEE
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMG---KREFEQQMEVVGRLSQHPNVVPIRAYYFSK-----DEKLLVY 411 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~~h~niv~l~~~~~~~-----~~~~lv~ 411 (632)
.+.||+|+||+||+|.. .+|+.||||+++....+ .+.+.+|++++.++ +|||||++++++... ...++++
T Consensus 23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccCceEEEE
Confidence 36799999999999985 56999999999865433 34688999999999 899999999998743 3446777
Q ss_pred ecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEEcccCCCCCCC
Q 006747 412 DFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCISDFGLTPLMN 491 (632)
Q Consensus 412 E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki~DfGla~~~~ 491 (632)
||+.+|+|.++++.. .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+|++|||++....
T Consensus 102 ~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 102 THLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp EECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 888899999999643 388999999999999999999998 99999999999999999999999999997765
Q ss_pred CC-CCCCCCCcccCCccccCCC-CCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHHhhhccccccc-----
Q 006747 492 TP-TVPSRSAGYRAPEVIETKK-PTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSVVREEWTSEVF----- 564 (632)
Q Consensus 492 ~~-~~~~~t~~y~aPE~~~~~~-~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 564 (632)
.. ....++..|+|||.+.+.. ++.++||||+||++|||++|+.||.+...... ...+...... ...+..
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~-~~~~~~~~~~~ 248 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGT-PGAELLKKISS 248 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC-CCHHHHTTCCC
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCC-CChHHhhhccc
Confidence 43 3345778899999877655 68899999999999999999999975431111 0000000000 000000
Q ss_pred ------cccccc--cCCcH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhhhCCC
Q 006747 565 ------DVELMR--YENIE----EEMVQMLQIAMSCVAKVPDMRPTMEEVVR--MIEDIRPS 612 (632)
Q Consensus 565 ------d~~~~~--~~~~~----~~~~~~~~l~~~Cl~~~P~~RPs~~evl~--~L~~i~~~ 612 (632)
...... ..... ....++.+|+.+||+.||++|||++|+++ .++++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 000000 00000 11234678899999999999999999998 46665443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-36 Score=317.42 Aligned_cols=265 Identities=18% Similarity=0.220 Sum_probs=187.2
Q ss_pred HhHhCccceeEEEEEEE-cCCcEEEEEEecccccCHHHHHHHHHHHHhhc----------CCCCccceeEEEEeC--Cce
Q 006747 341 AEVLGKGSYGTTYKAIL-EEGTTVVVKRLKEVVMGKREFEQQMEVVGRLS----------QHPNVVPIRAYYFSK--DEK 407 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~----------~h~niv~l~~~~~~~--~~~ 407 (632)
.+.||+|+||+||+|+. .+|+.||||+++......+.+.+|++++.++. .|+||+++++++... ...
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~ 97 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 97 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence 46899999999999996 56999999999866444567888888888772 368899999988653 455
Q ss_pred EEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCC------eEE
Q 006747 408 LLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQ------GCI 481 (632)
Q Consensus 408 ~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~------~ki 481 (632)
+++++++..+.......... ....+++.....++.|++.||+|||+.. +|+||||||+|||++.++. +|+
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~~kl 173 (362)
T d1q8ya_ 98 HVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKI 173 (362)
T ss_dssp EEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred eeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccceeeE
Confidence 66666665544333322211 2345788889999999999999999831 8999999999999987654 999
Q ss_pred cccCCCCCCCCC-CCCCCCCcccCCccccCCCCCccchhhHHHHHHHHHHhCCCCCCCCCCCCCCChhHHHHHH---hh-
Q 006747 482 SDFGLTPLMNTP-TVPSRSAGYRAPEVIETKKPTQKSDVYSFGVLLLEMLTGKAPIQAPGHEDVVDLPRWVQSV---VR- 556 (632)
Q Consensus 482 ~DfGla~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DV~s~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~- 556 (632)
+|||.++..... ....+|+.|+|||.+.+..++.++||||+||+++||++|+.||.................. +.
T Consensus 174 ~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~ 253 (362)
T d1q8ya_ 174 ADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253 (362)
T ss_dssp CCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCS
T ss_pred eecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCC
Confidence 999999765443 3456899999999999999999999999999999999999999764332221111111000 00
Q ss_pred -------h-ccccccccc-----c-------------ccccCCcHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--Hhh
Q 006747 557 -------E-EWTSEVFDV-----E-------------LMRYENIEEEMVQMLQIAMSCVAKVPDMRPTMEEVVRM--IED 608 (632)
Q Consensus 557 -------~-~~~~~~~d~-----~-------------~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPs~~evl~~--L~~ 608 (632)
. ......++. . ............++.+|+.+|++.||++|||++|++++ +++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~ 333 (362)
T d1q8ya_ 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 333 (362)
T ss_dssp CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTT
T ss_pred CCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCC
Confidence 0 000000000 0 00112234566778999999999999999999999885 664
Q ss_pred h
Q 006747 609 I 609 (632)
Q Consensus 609 i 609 (632)
.
T Consensus 334 ~ 334 (362)
T d1q8ya_ 334 T 334 (362)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=1.3e-30 Score=266.04 Aligned_cols=203 Identities=37% Similarity=0.679 Sum_probs=151.3
Q ss_pred cCChhHHHHHHHHHHhCCCCCCC-CCCCCCCCCC-CCcceEecCCC--CeEEEEEeCCCCccc--ccCchhhcCCCCCcE
Q 006747 21 ADLNSDKQALLDFAANVPHARKL-NWNSSTSVCT-SWVGITCTKNG--SRVLAVRLPGVGLYG--PIPANTLEKLDSLMI 94 (632)
Q Consensus 21 ~~~~~~~~~l~~~~~~~~~~~~~-~w~~~~~~c~-~w~gv~c~~~~--~~v~~l~l~~~~l~g--~lp~~~l~~l~~L~~ 94 (632)
.|.+.|++||++||+++.++..+ +|+.++++|. .|.||+|+..+ .||+.|+|++++++| +||+ .+++|++|++
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~ 80 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNF 80 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCccccc
Confidence 37889999999999999655444 9998888884 59999998643 489999999999998 5777 7999999999
Q ss_pred EeccC-CccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--------------------------CCCcEEEccCCC
Q 006747 95 LSLRS-NHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--------------------------PQLNWVDLSFNS 147 (632)
Q Consensus 95 L~Ls~-N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--------------------------~~L~~L~Ls~N~ 147 (632)
|+|++ |+++|.+|.+|++|++|++|+|++|++++..|..+. +.|+.+++++|.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 899999999999999999999999999877664321 244455555555
Q ss_pred CcccCCccc-----------------------------------------------------------------------
Q 006747 148 ITGNIPASI----------------------------------------------------------------------- 156 (632)
Q Consensus 148 l~g~~p~~~----------------------------------------------------------------------- 156 (632)
++|.+|..+
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~ 240 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 554444322
Q ss_pred cCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCccc--ccCCCCCCccCCCCCCCCCCCCC
Q 006747 157 RNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLA--LQKFPPSSFEGNSMLCGPPLNQC 224 (632)
Q Consensus 157 ~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~n~~~c~~~~~~c 224 (632)
+.+++|+.|+|++|+|+|.+|.. .+++|++|+|++|+|+|.+|.. +..+....+.+|..+||.|+..|
T Consensus 241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence 22345555666666666666642 5667777777777777777652 34555566777877888777666
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.7e-22 Score=189.78 Aligned_cols=160 Identities=16% Similarity=0.137 Sum_probs=116.4
Q ss_pred HhHhCccceeEEEEEEEcCCcEEEEEEeccccc-------------------CHHHHHHHHHHHHhhcCCCCccceeEEE
Q 006747 341 AEVLGKGSYGTTYKAILEEGTTVVVKRLKEVVM-------------------GKREFEQQMEVVGRLSQHPNVVPIRAYY 401 (632)
Q Consensus 341 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~~h~niv~l~~~~ 401 (632)
++.||+|+||.||+|...+|+.||||+++.... .......|...+.++ .|.+++..+++.
T Consensus 5 g~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~~~~~ 83 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCEEEEE
T ss_pred CCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceEEEec
Confidence 468999999999999998999999998753211 012345677788888 899999877653
Q ss_pred EeCCceEEEEecccCCCHhhhhccCCCCCCCcCCHHHHHHHHHHHHHHHHHHHhccCCCceecCCCCCCeeecCCCCeEE
Q 006747 402 FSKDEKLLVYDFIEAGSFSALLHGNRGIGRTPLDWESRVKISLGSAKGIAHIHAAVGGKFILGNIKSSNVLLSQDLQGCI 481 (632)
Q Consensus 402 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivHrDlk~~NILl~~~~~~ki 481 (632)
..+++|||++++.+.++ +......++.|++.+++|||+. +|+||||||+|||+++++ ++|
T Consensus 84 ----~~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~l 143 (191)
T d1zara2 84 ----GNAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWI 143 (191)
T ss_dssp ----TTEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEE
T ss_pred ----CCEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEE
Confidence 34799999998665432 1223457899999999999998 999999999999999654 899
Q ss_pred cccCCCCCCCCCCCCCCCCcccC------CccccCCCCCccchhhHHHHHH
Q 006747 482 SDFGLTPLMNTPTVPSRSAGYRA------PEVIETKKPTQKSDVYSFGVLL 526 (632)
Q Consensus 482 ~DfGla~~~~~~~~~~~t~~y~a------PE~~~~~~~~~~~DV~s~Gvvl 526 (632)
+|||.|+........ .|.. .|. ..+.|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~----~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR----EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH----HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH----HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 999998765433210 1111 011 135578889999976443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=1.1e-18 Score=163.50 Aligned_cols=126 Identities=27% Similarity=0.301 Sum_probs=105.8
Q ss_pred EEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCC-CccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCC
Q 006747 70 VRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDL-PSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFN 146 (632)
Q Consensus 70 l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N 146 (632)
++.++++|+ .||.+ + -+++++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..+. ++|+.|+|++|
T Consensus 13 v~Cs~~~L~-~iP~~-l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRD-I--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EECTTSCCS-SCCSC-C--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEeCCCcC-ccCCC-C--CCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 455566777 78873 3 267899999999998755 55678999999999999999977777775 78999999999
Q ss_pred CCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCc
Q 006747 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVP 199 (632)
Q Consensus 147 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p 199 (632)
+|++..|..|.++++|+.|+|++|+|++.++.. .+++|++|+|++|.+.....
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 999888889999999999999999999988873 78999999999999886543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.65 E-value=4.2e-16 Score=145.65 Aligned_cols=170 Identities=21% Similarity=0.241 Sum_probs=139.9
Q ss_pred CCCCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCe
Q 006747 48 STSVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRF 118 (632)
Q Consensus 48 ~~~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 118 (632)
..+.| +|..|.|++++ ..++.|+|++|.|++.++...|.++++|+.|+|++|++.+..+..+..+++|++
T Consensus 4 ~~C~C-~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~ 82 (192)
T d1w8aa_ 4 AMCHC-EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQE 82 (192)
T ss_dssp TTSEE-ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CCCEE-cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccce
Confidence 34456 79999998643 357889999999998888888999999999999999999999999999999999
Q ss_pred EeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCCC-CCCCcEEEcccCCCC
Q 006747 119 LYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFN-LSRLRHLNLSYNHLN 195 (632)
Q Consensus 119 L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~-~~~L~~l~ls~N~l~ 195 (632)
|+|++|+|++..|..|. ++|++|+|++|+|++..|..|..+++|++|+|++|.+........ ...++.+.+..|.+.
T Consensus 83 L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~ 162 (192)
T d1w8aa_ 83 LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAAR 162 (192)
T ss_dssp EECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCB
T ss_pred eeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeE
Confidence 99999999966666665 799999999999999888999999999999999999987654321 223566677788888
Q ss_pred CCCcccccCCCCCCccCCCCCCC
Q 006747 196 GSVPLALQKFPPSSFEGNSMLCG 218 (632)
Q Consensus 196 g~~p~~~~~~~~~~~~~n~~~c~ 218 (632)
...|..+.++.-..+..|...|.
T Consensus 163 c~~p~~l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 163 CGAPSKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp BCSSTTTTTSBGGGSCTTTCCCC
T ss_pred eCCChhhcCCEeeecCHhhCcCC
Confidence 77887777665555555655564
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=3.6e-15 Score=146.73 Aligned_cols=148 Identities=26% Similarity=0.285 Sum_probs=106.2
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--C-------
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--P------- 136 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~------- 136 (632)
.++.|+|++|.++ .+|+..|.++++|+.|+|++|+|+ .+| .++.+++|++|+|++|++++. +..+. +
T Consensus 32 ~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQSL-PLLGQTLPALTVLDV 107 (266)
T ss_dssp TCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCSSC-CCCTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCC-CcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccccc-ccccccccccccccc
Confidence 4778999999998 467668899999999999999998 444 357888899999998888743 33322 3
Q ss_pred -----------------CCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCC
Q 006747 137 -----------------QLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGS 197 (632)
Q Consensus 137 -----------------~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~ 197 (632)
+++.|++++|.+++..+..+..+++|+.|++++|+|++.++.. .+++|++|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 4445555556665555555666777777788888877776653 5778888888888888 7
Q ss_pred CcccccCCCC---CCccCCCCCCC
Q 006747 198 VPLALQKFPP---SSFEGNSMLCG 218 (632)
Q Consensus 198 ~p~~~~~~~~---~~~~~n~~~c~ 218 (632)
+|..+..++. ..+.||++.|.
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCN 210 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCS
T ss_pred cChhHCCCCCCCEEEecCCCCCCC
Confidence 7776554443 44677877774
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.55 E-value=1.6e-14 Score=142.02 Aligned_cols=142 Identities=25% Similarity=0.268 Sum_probs=109.7
Q ss_pred EecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCC
Q 006747 59 TCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQL 138 (632)
Q Consensus 59 ~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L 138 (632)
.|++. .....++.++++|+ .||++ +. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+..-+....++|
T Consensus 5 ~~~~~-~~~~~v~C~~~~L~-~iP~~-lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~~~l~~L 79 (266)
T d1p9ag_ 5 EVSKV-ASHLEVNCDKRNLT-ALPPD-LP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVL 79 (266)
T ss_dssp EEECS-TTCCEEECTTSCCS-SCCSC-CC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECCSCCTTC
T ss_pred EEccc-CCCeEEEccCCCCC-eeCcC-cC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccccccccccc
Confidence 35432 33455788888998 68873 32 5799999999999977678899999999999999999943333344899
Q ss_pred cEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCC
Q 006747 139 NWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 139 ~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
+.|+|++|++++ ++..+..+++|+.|++++|.+.+..+.. .+.+++.|++++|.++...+..+..++
T Consensus 80 ~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~ 148 (266)
T d1p9ag_ 80 GTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148 (266)
T ss_dssp CEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCT
T ss_pred cccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccc
Confidence 999999999985 6788999999999999999998766653 667778888888877754444444333
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.53 E-value=3e-14 Score=142.89 Aligned_cols=156 Identities=28% Similarity=0.365 Sum_probs=114.7
Q ss_pred CCCCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCe
Q 006747 48 STSVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRF 118 (632)
Q Consensus 48 ~~~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 118 (632)
..+.| .|.+|.|++.+ ..++.|+|++|.++ .+|+..|.++++|+.|++++|.+....|..|.++++|++
T Consensus 6 ~~c~c-~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~ 83 (305)
T d1xkua_ 6 FRCQC-HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLER 83 (305)
T ss_dssp TTCEE-ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCE
T ss_pred CCCEe-cCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCE
Confidence 34556 79999998631 34778999999998 788778999999999999999999877889999999999
Q ss_pred EeecCCcCCccCCCCcc---------------------------------------------------------------
Q 006747 119 LYLQNNNFSGNIPSSLS--------------------------------------------------------------- 135 (632)
Q Consensus 119 L~Ls~N~l~g~~p~~~~--------------------------------------------------------------- 135 (632)
|+|++|+++ .+|..+.
T Consensus 84 L~l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l 162 (305)
T d1xkua_ 84 LYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 162 (305)
T ss_dssp EECCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred ecccCCccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCc
Confidence 999999987 4443211
Q ss_pred --------CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCC
Q 006747 136 --------PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKF 205 (632)
Q Consensus 136 --------~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~ 205 (632)
++|+.|++++|..++..+..|.++++++.|++++|.+++..+.. .+++|+.|+|++|+|+ .+|..+.++
T Consensus 163 ~~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l 241 (305)
T d1xkua_ 163 TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 241 (305)
T ss_dssp CSCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred cccCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccc
Confidence 13444555555555555666666677777777777777665553 5677777777777776 566666555
Q ss_pred CC
Q 006747 206 PP 207 (632)
Q Consensus 206 ~~ 207 (632)
+.
T Consensus 242 ~~ 243 (305)
T d1xkua_ 242 KY 243 (305)
T ss_dssp SS
T ss_pred cC
Confidence 44
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=2.9e-14 Score=141.54 Aligned_cols=150 Identities=25% Similarity=0.290 Sum_probs=122.7
Q ss_pred EEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCC
Q 006747 69 AVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFN 146 (632)
Q Consensus 69 ~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N 146 (632)
.+..........+++..+.++++|+.|+|++|.+.+..+..+..+.+|+.+++++|+|++..+..|. ++|+.|+|++|
T Consensus 84 ~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N 163 (284)
T d1ozna_ 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN 163 (284)
T ss_dssp EEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccC
Confidence 3333333333466666899999999999999999877777888999999999999999965555554 68999999999
Q ss_pred CCcccCCccccCCCCccceecccccccccCCCC--CCCCCcEEEcccCCCCCCCcccccCCCC---CCccCCCCCCC
Q 006747 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF--NLSRLRHLNLSYNHLNGSVPLALQKFPP---SSFEGNSMLCG 218 (632)
Q Consensus 147 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~---~~~~~n~~~c~ 218 (632)
+|++..+..|.++++|+.+++++|++++..|.. .+++|+.||+++|++++..|..|..++. ..+.+|++.|.
T Consensus 164 ~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred cccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 999888889999999999999999999988864 7889999999999999887777766554 45678887764
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=4.5e-14 Score=140.11 Aligned_cols=152 Identities=24% Similarity=0.296 Sum_probs=105.7
Q ss_pred CcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCC-------------------
Q 006747 55 WVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDL------------------- 106 (632)
Q Consensus 55 w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~------------------- 106 (632)
|.-|.|++.+ ..+..|+|++|.++ .+|+..|.++++|++|++++|++.+..
T Consensus 13 ~~~v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 13 KVTTSCPQQGLQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp SCEEECCSSCCSSCCTTCCTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred CeEEEcCCCCCCccCCCCCCCCCEEECcCCcCC-CCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 4557887532 13567999999998 788878999999999999999876433
Q ss_pred ------CccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCC
Q 006747 107 ------PSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPN 178 (632)
Q Consensus 107 ------p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~ 178 (632)
|..|.++++|++|+|++|.+.+..+..+. .+|+.+++++|+|++..+..|..+++|+.|+|++|+|++.++.
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 33455666777777777776644443333 5677777777777765566677777777777777777766554
Q ss_pred C--CCCCCcEEEcccCCCCCCCcccccCCCC
Q 006747 179 F--NLSRLRHLNLSYNHLNGSVPLALQKFPP 207 (632)
Q Consensus 179 ~--~~~~L~~l~ls~N~l~g~~p~~~~~~~~ 207 (632)
. .+++|+.+++++|++++..|..|..++.
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~ 202 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred hhccccccchhhhhhccccccChhHhhhhhh
Confidence 3 5677777777777777666666665543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.50 E-value=4.8e-15 Score=149.46 Aligned_cols=133 Identities=29% Similarity=0.398 Sum_probs=100.4
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCC-cE-----------------------EeccCCccCCCCCccccCCCCCCeEee
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSL-MI-----------------------LSLRSNHLSGDLPSNVLSLSSLRFLYL 121 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L-~~-----------------------L~Ls~N~l~g~~p~~~~~l~~L~~L~L 121 (632)
.+..+++.++.+.|.+|. .+..+.++ +. +++++|.+.|.+|..+..+++|+.|++
T Consensus 150 ~L~~l~l~~n~l~~~ip~-~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~ 228 (313)
T d1ogqa_ 150 NLVGITFDGNRISGAIPD-SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228 (313)
T ss_dssp TCCEEECCSSCCEEECCG-GGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEEC
T ss_pred ccceeecccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 344556666666666655 34444433 44 445555555555666667788888888
Q ss_pred cCCcCCccCCCCc-cCCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCC-CCCCCcEEEcccCC-CCCC-
Q 006747 122 QNNNFSGNIPSSL-SPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNH-LNGS- 197 (632)
Q Consensus 122 s~N~l~g~~p~~~-~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~-l~g~- 197 (632)
++|.+++.+|... .++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+|+|.+|.+ .+++|+.+++++|+ +.|.
T Consensus 229 ~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred ccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence 8888887766422 278999999999999999999999999999999999999999986 78899999999997 6664
Q ss_pred Cc
Q 006747 198 VP 199 (632)
Q Consensus 198 ~p 199 (632)
+|
T Consensus 309 lp 310 (313)
T d1ogqa_ 309 LP 310 (313)
T ss_dssp SS
T ss_pred CC
Confidence 44
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=1.1e-13 Score=118.78 Aligned_cols=99 Identities=28% Similarity=0.341 Sum_probs=48.9
Q ss_pred EEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCC
Q 006747 70 VRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNS 147 (632)
Q Consensus 70 l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~ 147 (632)
|+|++|+++ .++. ++.+++|++|+|++|.|+ .+|+.++.+++|++|++++|++++ +|. +. ++|++|++++|+
T Consensus 3 L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 3 LHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDG-VANLPRLQELLLCNNR 76 (124)
T ss_dssp EECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSC
T ss_pred EEcCCCCCC-CCcc--cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cCc-cccccccCeEECCCCc
Confidence 455555554 3332 455555555555555555 344455555555555555555552 221 22 445555555555
Q ss_pred CcccC-CccccCCCCccceecccccccc
Q 006747 148 ITGNI-PASIRNLSHLVGLNLQNNSLTG 174 (632)
Q Consensus 148 l~g~~-p~~~~~l~~L~~l~l~~N~l~~ 174 (632)
|+... ...+..+++|+.|++++|.++.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 54321 1234555555555555555543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.44 E-value=2.1e-13 Score=117.09 Aligned_cols=99 Identities=28% Similarity=0.306 Sum_probs=86.4
Q ss_pred cEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccc
Q 006747 93 MILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNN 170 (632)
Q Consensus 93 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N 170 (632)
++|+|++|+++ .++ .+..+++|++|||++|+|+ .+|..+. ++|+.|++++|+|++ +| .+.++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 57999999998 555 5899999999999999999 6787775 799999999999995 55 5999999999999999
Q ss_pred cccccCCC---CCCCCCcEEEcccCCCCC
Q 006747 171 SLTGFIPN---FNLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 171 ~l~~~~p~---~~~~~L~~l~ls~N~l~g 196 (632)
+++..... ..+++|+.|++++|+++.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence 99976542 278999999999999973
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.34 E-value=7.9e-13 Score=119.14 Aligned_cols=108 Identities=19% Similarity=0.150 Sum_probs=60.9
Q ss_pred hcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCC-CccCCCcEEEccCCCCcccCCccccCCCCccc
Q 006747 86 LEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS-SLSPQLNWVDLSFNSITGNIPASIRNLSHLVG 164 (632)
Q Consensus 86 l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 164 (632)
+.+..+|+.|+|++|+|+ .+|..+..+++|++|||++|+++ .++. .-.++|+.|+|++|+++...+..+..+++|+.
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccCCcccCcchhhhhcccccccCCCcccccccccccc
Confidence 445556666666666666 34544555666666666666666 2321 11156666666666666444444455666666
Q ss_pred eecccccccccCC--CC-CCCCCcEEEcccCCCC
Q 006747 165 LNLQNNSLTGFIP--NF-NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 165 l~l~~N~l~~~~p--~~-~~~~L~~l~ls~N~l~ 195 (632)
|+|++|+++.... .+ .+++|++|++++|.++
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ceeccccccccccccccccccccchhhcCCCccc
Confidence 6666666654321 11 4566666666666654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=1.2e-12 Score=117.98 Aligned_cols=118 Identities=23% Similarity=0.285 Sum_probs=98.0
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCc---cCCCcEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSL---SPQLNWV 141 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~---~~~L~~L 141 (632)
.++..|+|++|+++ .|+. .+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++. +|..+ .++|+.|
T Consensus 18 ~~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~-l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTEL 92 (162)
T ss_dssp TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCE-ECSCHHHHCTTCCEE
T ss_pred CcCcEEECCCCCCC-ccCc-cccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccC-CCccccccccccccc
Confidence 46788999999998 5764 6688999999999999999 454 58999999999999999994 44443 2799999
Q ss_pred EccCCCCcccCC--ccccCCCCccceecccccccccCCC-----CCCCCCcEEE
Q 006747 142 DLSFNSITGNIP--ASIRNLSHLVGLNLQNNSLTGFIPN-----FNLSRLRHLN 188 (632)
Q Consensus 142 ~Ls~N~l~g~~p--~~~~~l~~L~~l~l~~N~l~~~~p~-----~~~~~L~~l~ 188 (632)
+|++|+|+. ++ ..+..+++|+.|++++|.++..... ..+++|+.||
T Consensus 93 ~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 93 ILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eeccccccc-cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 999999985 44 4688999999999999999865421 2688999987
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.31 E-value=4.1e-12 Score=119.75 Aligned_cols=131 Identities=31% Similarity=0.415 Sum_probs=89.2
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCC-ccCCCcEEEcc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSS-LSPQLNWVDLS 144 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~~L~~L~Ls 144 (632)
+++.|+|++|.+++ +++ ++.+++|+.|+|++|++++ +| .+.++++|+.|++++|.+. .++.- -.+.|+.++++
T Consensus 69 ~L~~L~L~~n~i~~-l~~--~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~~~l~~l~~l~~l~~~ 142 (210)
T d1h6ta2 69 NVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLG 142 (210)
T ss_dssp TCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CCGGGGGCTTCCEEECC
T ss_pred CCCEEeCCCccccC-ccc--cccCccccccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 46777777777764 443 5677777777777777774 44 4777777777777777776 23221 12577788888
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
+|.+++ +..+..+++|+.+++++|++++..+-..+++|+.|+|++|+|+ .+| .+..++
T Consensus 143 ~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~ 200 (210)
T d1h6ta2 143 NNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLK 200 (210)
T ss_dssp SSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC-BCG-GGTTCT
T ss_pred cccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC-CCh-hhcCCC
Confidence 887764 3456777888888888888876554347788888888888887 454 344444
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.30 E-value=5.4e-12 Score=117.82 Aligned_cols=122 Identities=27% Similarity=0.398 Sum_probs=59.8
Q ss_pred EEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEccCC
Q 006747 67 VLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFN 146 (632)
Q Consensus 67 v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N 146 (632)
+..|+|++|.+++ +++ ++++++|+.|++++|.+.. ++ .+.++++|+.|++++|.+....+-.-.++|+.|++++|
T Consensus 64 L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n 138 (199)
T d2omxa2 64 LTQINFSNNQLTD-ITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 138 (199)
T ss_dssp CCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSS
T ss_pred cCcCccccccccC-ccc--ccCCccccccccccccccc-cc-ccccccccccccccccccccccccchhhhhHHhhhhhh
Confidence 4445555555443 221 4445555555555554442 22 24455555555555555443222111245556666666
Q ss_pred CCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCC
Q 006747 147 SITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195 (632)
Q Consensus 147 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~ 195 (632)
++.. ++ .+..+++|+.|++++|++++..+-..+++|+.|++++|+++
T Consensus 139 ~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 139 TISD-IS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CCCC-CG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred hhcc-cc-cccccccccccccccccccCCccccCCCCCCEEECCCCCCC
Confidence 5542 22 35555566666666666555433335556666666666655
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.29 E-value=4.6e-12 Score=118.32 Aligned_cols=124 Identities=25% Similarity=0.366 Sum_probs=103.5
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCC-CccCCCcEEEcc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS-SLSPQLNWVDLS 144 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~~L~~L~Ls 144 (632)
+++.|++.+++++ .++ .++.+++|++|+|++|++++..| +.++++|++|++++|.+.. ++. .-.+.|+.|+++
T Consensus 41 ~l~~L~l~~~~i~-~l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~ 114 (199)
T d2omxa2 41 QVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLF 114 (199)
T ss_dssp TCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECC
T ss_pred CCCEEECCCCCCC-Ccc--ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cccccccccccccccc
Confidence 5788999999987 454 48899999999999999996433 9999999999999999984 442 223789999999
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGS 197 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~ 197 (632)
+|.+... ..+..+++|+.|++++|++.....-..+++|+.|++++|++++.
T Consensus 115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~l~~~~~L~~L~l~~n~l~~l 165 (199)
T d2omxa2 115 NNQITDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDL 165 (199)
T ss_dssp SSCCCCC--GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCC
T ss_pred ccccccc--cccchhhhhHHhhhhhhhhcccccccccccccccccccccccCC
Confidence 9999853 35889999999999999998654334889999999999999854
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=8.7e-12 Score=111.38 Aligned_cols=109 Identities=23% Similarity=0.308 Sum_probs=63.5
Q ss_pred CCCCCCCcceEecCCCCeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCC-ccCCCCCccccCCCCCCeEeecCCcCC
Q 006747 49 TSVCTSWVGITCTKNGSRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSN-HLSGDLPSNVLSLSSLRFLYLQNNNFS 127 (632)
Q Consensus 49 ~~~c~~w~gv~c~~~~~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 127 (632)
.+.|+.+.+|+|.++ ++. .+|. .+..+++|+.|+|++| .|+...+..|.++++|+.|+|++|+|+
T Consensus 4 ~C~c~~~~~l~c~~~------------~~~-~~p~-~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 69 (156)
T d2ifga3 4 ACCPHGSSGLRCTRD------------GAL-DSLH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69 (156)
T ss_dssp SSCCSSSSCEECCSS------------CCC-TTTT-TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC
T ss_pred CCCcCCCCeEEecCC------------CCc-cCcc-cccCccccCeeecCCCccccccCchhhccccccCcceeeccccC
Confidence 344556777777643 222 3444 4667788888888765 477555566788888888887777777
Q ss_pred ccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCccceecccccc
Q 006747 128 GNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSL 172 (632)
Q Consensus 128 g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l 172 (632)
...|..|. ++|++|+|++|+|+. +|..+....+|+.|+|++|.+
T Consensus 70 ~i~~~~f~~l~~L~~L~Ls~N~l~~-l~~~~~~~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 70 FVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115 (156)
T ss_dssp EECTTGGGSCSCCCEEECCSSCCSC-CCSTTTCSCCCCEEECCSSCC
T ss_pred CcccccccccccccceeccCCCCcc-cChhhhccccccccccCCCcc
Confidence 44344343 455555555555553 333222222455555555544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.24 E-value=2e-11 Score=121.82 Aligned_cols=108 Identities=25% Similarity=0.353 Sum_probs=72.3
Q ss_pred hhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCc
Q 006747 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHL 162 (632)
Q Consensus 85 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L 162 (632)
.+..+++|+.+++++|+++ .+|..+ +++|+.|++++|..++..+..+. +.++.|++++|.+++..+..+.++++|
T Consensus 145 ~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L 221 (305)
T d1xkua_ 145 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221 (305)
T ss_dssp GGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred ccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccc
Confidence 5666777777777777766 344433 46677777777777766665554 566777777777776666677777777
Q ss_pred cceecccccccccCCCC-CCCCCcEEEcccCCCC
Q 006747 163 VGLNLQNNSLTGFIPNF-NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 163 ~~l~l~~N~l~~~~p~~-~~~~L~~l~ls~N~l~ 195 (632)
+.|+|++|+|+..++.+ .+++|++|+|++|+|+
T Consensus 222 ~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 222 RELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp CEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCC
T ss_pred eeeecccccccccccccccccCCCEEECCCCccC
Confidence 77777777776554443 5677777777777776
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.21 E-value=2.1e-11 Score=114.75 Aligned_cols=131 Identities=21% Similarity=0.299 Sum_probs=106.6
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCC-CccCCCcEEEcc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPS-SLSPQLNWVDLS 144 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~~L~~L~Ls 144 (632)
.++.+++.++.+.. ++ .+..+++|++|+|++|.|++. + .++++++|++|++++|++++ +|. .-.++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~-l~--~l~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKS-VQ--GIQYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCC-CT--TGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCC-ch--hHhhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cccccccccccccccc
Confidence 47788999998874 44 378899999999999999964 4 47899999999999999984 442 112789999999
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCcccccCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVPLALQKFP 206 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p~~~~~~~ 206 (632)
+|.+.. ...+..+++|+.+++++|.+++..+...+++|+.+++++|++++ ++. +.+++
T Consensus 121 ~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~ 178 (210)
T d1h6ta2 121 HNGISD--INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD-IVP-LAGLT 178 (210)
T ss_dssp TSCCCC--CGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC-CGG-GTTCT
T ss_pred cccccc--cccccccccccccccccccccccccccccccccccccccccccc-ccc-ccCCC
Confidence 999873 34688999999999999999876555588999999999999985 432 44444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.19 E-value=3.6e-11 Score=107.28 Aligned_cols=105 Identities=20% Similarity=0.139 Sum_probs=88.8
Q ss_pred CCCcEEeccCCccCCCCCccccCCCCCCeEeecCCc-CCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCcccee
Q 006747 90 DSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNN-FSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHLVGLN 166 (632)
Q Consensus 90 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~ 166 (632)
.....++++++++. .+|..+..+++|++|+|++|+ ++..-+..|. ++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34456899999998 678889999999999998764 8844445564 7999999999999988889999999999999
Q ss_pred cccccccccCCC-CCCCCCcEEEcccCCCC
Q 006747 167 LQNNSLTGFIPN-FNLSRLRHLNLSYNHLN 195 (632)
Q Consensus 167 l~~N~l~~~~p~-~~~~~L~~l~ls~N~l~ 195 (632)
|++|+|+..++. +...+|+.|+|++|.|.
T Consensus 87 Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 87 LSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccCCCCcccChhhhccccccccccCCCccc
Confidence 999999977766 35568999999999885
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.17 E-value=4.4e-11 Score=113.94 Aligned_cols=123 Identities=20% Similarity=0.334 Sum_probs=77.3
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc----------
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS---------- 135 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~---------- 135 (632)
++..|+|+++.+++.. .+..+++|+.|++++|.++ .++ .+..+++|++|++++|...+..+....
T Consensus 64 ~L~~L~ls~n~i~~~~---~l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~ 138 (227)
T d1h6ua2 64 NLIGLELKDNQITDLA---PLKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138 (227)
T ss_dssp TCCEEECCSSCCCCCG---GGTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCS
T ss_pred CCcEeecCCceeeccc---ccccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhchh
Confidence 5677777777776432 2667777777777777776 333 467777888888877776643321111
Q ss_pred ------------CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCC
Q 006747 136 ------------PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLN 195 (632)
Q Consensus 136 ------------~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~ 195 (632)
++|+.|++++|.+++. ..++++++|+.|+|++|++++..+-..+++|++|+|++|+++
T Consensus 139 ~~~~~~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~N~lt 208 (227)
T d1h6ua2 139 NQITNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQIS 208 (227)
T ss_dssp SCCCCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred hhhchhhhhccccccccccccccccccc--hhhcccccceecccCCCccCCChhhcCCCCCCEEECcCCcCC
Confidence 3566666666666532 236666677777777776665433235666777777777666
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.16 E-value=6.7e-11 Score=113.66 Aligned_cols=98 Identities=17% Similarity=0.258 Sum_probs=61.6
Q ss_pred CCCCCCcceEecCCC---------CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCC-ccccCCCCCCeE
Q 006747 50 SVCTSWVGITCTKNG---------SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLP-SNVLSLSSLRFL 119 (632)
Q Consensus 50 ~~c~~w~gv~c~~~~---------~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L 119 (632)
+.| .+..|.|.+.+ ..++.|+|+++.++ .+|...|.++++|++|+|++|.+...+| ..|.+++++++|
T Consensus 6 C~C-~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l 83 (242)
T d1xwdc1 6 CHC-SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 83 (242)
T ss_dssp EEE-CSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEE
T ss_pred CCC-cCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccc
Confidence 345 67888997432 25788999999987 6887788999999999999998875443 244555555555
Q ss_pred eecC-CcCCccCCCCcc--CCCcEEEccCCCCc
Q 006747 120 YLQN-NNFSGNIPSSLS--PQLNWVDLSFNSIT 149 (632)
Q Consensus 120 ~Ls~-N~l~g~~p~~~~--~~L~~L~Ls~N~l~ 149 (632)
++.. |++....+..+. ++|+.|++++|++.
T Consensus 84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp EEECCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccccccccchhhhc
Confidence 5432 344433333332 34444444444443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.12 E-value=6e-11 Score=121.96 Aligned_cols=128 Identities=27% Similarity=0.320 Sum_probs=88.3
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc---------
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--------- 135 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--------- 135 (632)
.++..+++.++.++. ++ .+..+++|+.|++++|.+++.. .+..+++|++|++++|++++..+-.-.
T Consensus 219 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~ 293 (384)
T d2omza2 219 TNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLELN 293 (384)
T ss_dssp TTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred CCCCEEECCCCCCCC-cc--hhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCcccccccccccccc
Confidence 456788899988874 43 5778899999999999988643 378888999999998888754332111
Q ss_pred -------------CCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCCCCCCc
Q 006747 136 -------------PQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHLNGSVP 199 (632)
Q Consensus 136 -------------~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l~g~~p 199 (632)
++++.|+|++|++++.. .+..+++|+.|+|++|+|++...-..+++|+.|+|++|+|++..|
T Consensus 294 ~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l~~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 294 ENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp SSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCBCGG
T ss_pred ccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCChhHcCCCCCCEEECCCCcCCCChh
Confidence 46667777777776532 266677777777777777653221256777777777777775443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.11 E-value=8.7e-13 Score=123.08 Aligned_cols=107 Identities=27% Similarity=0.360 Sum_probs=91.0
Q ss_pred hhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEEccCCCCcccCCccccCCCCc
Q 006747 85 TLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVDLSFNSITGNIPASIRNLSHL 162 (632)
Q Consensus 85 ~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~Ls~N~l~g~~p~~~~~l~~L 162 (632)
.+..|++|++|+|++|+|+ .++ .+.+|++|++|+|++|+++ .+|.... ++|++|++++|+++. + ..+.++++|
T Consensus 43 sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L 117 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNL 117 (198)
T ss_dssp HHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHS
T ss_pred HHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccccccc
Confidence 6889999999999999999 555 5899999999999999998 6665433 689999999999985 4 358899999
Q ss_pred cceecccccccccCC--C-CCCCCCcEEEcccCCCCC
Q 006747 163 VGLNLQNNSLTGFIP--N-FNLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 163 ~~l~l~~N~l~~~~p--~-~~~~~L~~l~ls~N~l~g 196 (632)
+.|+|++|+++.... . ..+++|+.|+|++|++..
T Consensus 118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred cccccccchhccccccccccCCCccceeecCCCcccc
Confidence 999999999986532 2 378999999999998763
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.09 E-value=9.6e-11 Score=120.37 Aligned_cols=122 Identities=25% Similarity=0.318 Sum_probs=94.6
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCC--------------------CccccCCCCCCeEeecCCc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDL--------------------PSNVLSLSSLRFLYLQNNN 125 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~--------------------p~~~~~l~~L~~L~Ls~N~ 125 (632)
.+..+++.++.+++.. .++.+++|+.|++++|.+++.. ...+..+++|++|+|++|+
T Consensus 242 ~L~~L~l~~n~l~~~~---~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~ 318 (384)
T d2omza2 242 NLTDLDLANNQISNLA---PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318 (384)
T ss_dssp TCSEEECCSSCCCCCG---GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSC
T ss_pred ccchhccccCccCCCC---cccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCC
Confidence 4556677777766432 2556666777777666665432 2346777899999999999
Q ss_pred CCccCCCCccCCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccC
Q 006747 126 FSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYN 192 (632)
Q Consensus 126 l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N 192 (632)
+++..|-.-.++|+.|+|++|+|++ +| .++++++|+.|+|++|++++.+|-..+++|+.|+|++|
T Consensus 319 l~~l~~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 319 ISDISPVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CSCCGGGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCCcccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 9975443344899999999999985 55 69999999999999999999887668999999999998
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.92 E-value=5.2e-12 Score=117.69 Aligned_cols=118 Identities=22% Similarity=0.255 Sum_probs=96.9
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCcc--CCCcEEE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLS--PQLNWVD 142 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~--~~L~~L~ 142 (632)
..+..|+|++|.++ .++ .+..|++|+.|+|++|.|+ .+|..+..+++|++|++++|+++. ++. +. ++|+.|+
T Consensus 48 ~~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~~-~~~l~~L~~L~ 121 (198)
T d1m9la_ 48 KACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSG-IEKLVNLRVLY 121 (198)
T ss_dssp TTCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HHH-HHHHHHSSEEE
T ss_pred cccceeECcccCCC-Ccc--cccCCccccChhhcccccc-cccccccccccccccccccccccc-ccc-ccccccccccc
Confidence 35789999999998 675 4889999999999999998 667666677889999999999984 332 32 7899999
Q ss_pred ccCCCCcccCC-ccccCCCCccceecccccccccCCCC------------CCCCCcEEE
Q 006747 143 LSFNSITGNIP-ASIRNLSHLVGLNLQNNSLTGFIPNF------------NLSRLRHLN 188 (632)
Q Consensus 143 Ls~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~~~~p~~------------~~~~L~~l~ 188 (632)
|++|+++.... ..+..+++|+.|+|++|.+....+.. .+++|+.||
T Consensus 122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 99999985322 46899999999999999998776642 477888876
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.91 E-value=1.5e-09 Score=102.96 Aligned_cols=121 Identities=24% Similarity=0.350 Sum_probs=87.3
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCC--------------------CccccCCCCCCeEeecCCc
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDL--------------------PSNVLSLSSLRFLYLQNNN 125 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~--------------------p~~~~~l~~L~~L~Ls~N~ 125 (632)
++..+++.++.++ .++ .+..+++|+.|+++++...+.. ...+.++++|++|++++|.
T Consensus 86 ~l~~l~~~~n~~~-~i~--~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 86 KITELELSGNPLK-NVS--AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp SCCEEECCSCCCS-CCG--GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccccccccc-ccc--cccccccccccccccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccc
Confidence 3445555555554 333 3555666666666665544321 1246778899999999999
Q ss_pred CCccCCCCccCCCcEEEccCCCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEccc
Q 006747 126 FSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSY 191 (632)
Q Consensus 126 l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~ 191 (632)
+++..+-.-.++|+.|||++|++++ +| .++++++|+.|+|++|++++..|-..+++|+.|++++
T Consensus 163 ~~~~~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 163 VSDLTPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226 (227)
T ss_dssp CCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEE
T ss_pred cccchhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcccccCCCCCEEEeeC
Confidence 9854442223799999999999996 44 3899999999999999999876655899999999974
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.85 E-value=3.2e-09 Score=101.58 Aligned_cols=123 Identities=15% Similarity=0.142 Sum_probs=96.4
Q ss_pred EEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCC-cc--CCCcEEEcc-
Q 006747 69 AVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSS-LS--PQLNWVDLS- 144 (632)
Q Consensus 69 ~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~--~~L~~L~Ls- 144 (632)
.++.++.+++ .+|++. .++++.|+|++|+|+...+..|.++++|++|+|++|.+...+|.. |. +.++.|++.
T Consensus 12 ~i~c~~~~l~-~iP~~l---~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp EEEEESCSCS-SCCSCS---CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred EEEEeCCCCC-CcCCCC---CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 4677788888 888743 257899999999999655667999999999999999998776654 32 678888875
Q ss_pred CCCCcccCCccccCCCCccceecccccccccCCCC---CCCCCcEEEcccCCCC
Q 006747 145 FNSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNF---NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 145 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~---~~~~L~~l~ls~N~l~ 195 (632)
.|++....+..|.++++|+.|++++|.+....+.. .+..+..+..+++.+.
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~ 141 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH 141 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC
T ss_pred cccccccccccccccccccccccchhhhcccccccccccccccccccccccccc
Confidence 57898888889999999999999999998665543 3445555566666665
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.79 E-value=1.4e-08 Score=102.10 Aligned_cols=114 Identities=28% Similarity=0.426 Sum_probs=89.1
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEccC
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSF 145 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~ 145 (632)
++..|+|++++|+ .+|+ .+++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++ .+.+.|++|+|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~----~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~-~lp~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPE----LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALS-DLPPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCS----CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCC-SCCTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCC----CCCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhh-hhccccccccccc
Confidence 4668999999997 6885 3678999999999999 77865 457899999999998 555 3557899999999
Q ss_pred CCCcccCCccccCCCCccceecccccccccCCCCCCCCCcEEEcccCCC
Q 006747 146 NSITGNIPASIRNLSHLVGLNLQNNSLTGFIPNFNLSRLRHLNLSYNHL 194 (632)
Q Consensus 146 N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~~L~~l~ls~N~l 194 (632)
|.++ .+|. ++++++|+.|++++|.++..+.. ...+..+++..+..
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~--~~~l~~l~~~~~~~ 152 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL--PPSLEFIAAGNNQL 152 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC--CTTCCEEECCSSCC
T ss_pred cccc-cccc-hhhhccceeeccccccccccccc--cccccchhhccccc
Confidence 9998 5674 68899999999999998866543 23455555555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.73 E-value=3.7e-08 Score=99.02 Aligned_cols=98 Identities=22% Similarity=0.198 Sum_probs=81.7
Q ss_pred CCCcEEeccCCccCCCCCccccCCCCCCeEeecCCcCCccCCCCccCCCcEEEccCCCCcccCCccccCCCCccceeccc
Q 006747 90 DSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNNNFSGNIPSSLSPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQN 169 (632)
Q Consensus 90 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~ 169 (632)
.+|+.|||++|.|+ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.. .++|++|++++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~-~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~ 107 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP-QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSN 107 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC-TTCCEEECCSSCCS-CCCSC---CTTCCEEECCS
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch-hhhhhhhhhhcccc-hhhhh---ccccccccccc
Confidence 46889999999998 57863 578999999999999 788654 68999999999998 45532 24699999999
Q ss_pred ccccccCCCCCCCCCcEEEcccCCCCCC
Q 006747 170 NSLTGFIPNFNLSRLRHLNLSYNHLNGS 197 (632)
Q Consensus 170 N~l~~~~p~~~~~~L~~l~ls~N~l~g~ 197 (632)
|.++..+....++.|+.|++++|.+...
T Consensus 108 n~l~~lp~~~~l~~L~~L~l~~~~~~~~ 135 (353)
T d1jl5a_ 108 NQLEKLPELQNSSFLKIIDVDNNSLKKL 135 (353)
T ss_dssp SCCSSCCCCTTCTTCCEEECCSSCCSCC
T ss_pred cccccccchhhhccceeecccccccccc
Confidence 9999765545889999999999998743
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.38 E-value=2.1e-08 Score=98.42 Aligned_cols=142 Identities=22% Similarity=0.233 Sum_probs=86.8
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCCCCCccccCCCCCCeEeecCC-cCCcc-CCC--CccCCCcE
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSGDLPSNVLSLSSLRFLYLQNN-NFSGN-IPS--SLSPQLNW 140 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N-~l~g~-~p~--~~~~~L~~ 140 (632)
.++..+||+++.+.+......+..+++|++|+|+++.+++..+..+..+++|++|+|+++ .++.. +.. .-.++|+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 367888888887765533346788889999999998888777778888889999999884 55521 111 11267888
Q ss_pred EEccCC-CCccc-CCccccC-CCCccceecccc--ccccc-CCCC--CCCCCcEEEcccC-CCCCCCcccccCCC
Q 006747 141 VDLSFN-SITGN-IPASIRN-LSHLVGLNLQNN--SLTGF-IPNF--NLSRLRHLNLSYN-HLNGSVPLALQKFP 206 (632)
Q Consensus 141 L~Ls~N-~l~g~-~p~~~~~-l~~L~~l~l~~N--~l~~~-~p~~--~~~~L~~l~ls~N-~l~g~~p~~~~~~~ 206 (632)
|+|+++ .++.. +...+.. .++|+.|++++. .++.. +..+ .+++|++|+|++| .+++.....+.+++
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 888874 45421 2222322 356777777653 22211 1111 4566777777664 35554555554444
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.17 E-value=6.4e-06 Score=78.81 Aligned_cols=131 Identities=17% Similarity=0.096 Sum_probs=88.7
Q ss_pred cceeEEEEEEEcCCcEEEEEEecccc-cCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEecccCCCHhhhhcc
Q 006747 347 GSYGTTYKAILEEGTTVVVKRLKEVV-MGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDFIEAGSFSALLHG 425 (632)
Q Consensus 347 G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 425 (632)
++.+.||+... +++.+++|+..... .....+.+|...+..+..+--+.+++++....+..++|||++++..+......
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 34468998764 46667788876542 23445788888888775555567888888888889999999999887654322
Q ss_pred CCCCCCCcCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------------
Q 006747 426 NRGIGRTPLDWESRVKISLGSAKGIAHIHAA------------------------------------------------- 456 (632)
Q Consensus 426 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------------------- 456 (632)
.. ....++.++++.++.||+.
T Consensus 104 ~~----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 104 EQ----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp CS----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred cc----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 10 1122333344444444431
Q ss_pred ----c---CCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 457 ----V---GGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 457 ----~---~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
. .+.++|+|+.|.||++++++.+-|.||+.+.
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1 1237899999999999988777899998753
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.14 E-value=2.5e-07 Score=96.18 Aligned_cols=109 Identities=21% Similarity=0.268 Sum_probs=73.4
Q ss_pred eEEEEEeCCCCcccccCchhhcCCCCCcEEeccCCccCC----CCCccccCCCCCCeEeecCCcCCc----cCCCCcc--
Q 006747 66 RVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRSNHLSG----DLPSNVLSLSSLRFLYLQNNNFSG----NIPSSLS-- 135 (632)
Q Consensus 66 ~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g----~~p~~~~-- 135 (632)
.+..||++++++++.-=...+..+++|+.|+|++|+++- .+...+..+++|++|||++|.++. .+...+.
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 577888888888743212245667888888888888761 344556778888888888888752 1122221
Q ss_pred -CCCcEEEccCCCCccc----CCccccCCCCccceecccccccc
Q 006747 136 -PQLNWVDLSFNSITGN----IPASIRNLSHLVGLNLQNNSLTG 174 (632)
Q Consensus 136 -~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~ 174 (632)
.+|+.|+|++|+++.. ++..+..+++|+.|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 4688888888887643 45566777778888888777653
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=6.6e-07 Score=87.34 Aligned_cols=143 Identities=27% Similarity=0.334 Sum_probs=92.1
Q ss_pred CeEEEEEeCCCCcccccCchhhcCCCCCcEEeccC-CccCCC-CCccccCCCCCCeEeecCC-cCCcc-CCC---CccCC
Q 006747 65 SRVLAVRLPGVGLYGPIPANTLEKLDSLMILSLRS-NHLSGD-LPSNVLSLSSLRFLYLQNN-NFSGN-IPS---SLSPQ 137 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~~~l~~l~~L~~L~Ls~-N~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~g~-~p~---~~~~~ 137 (632)
.++..|+|.++.+.+..+. .++.+++|+.|+|++ +.++.. +..-..++++|++|+|+++ .++.. +.. ...++
T Consensus 71 ~~L~~L~L~~~~l~~~~~~-~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~ 149 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVN-TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSET 149 (284)
T ss_dssp CCCSEEECTTCBCCHHHHH-HHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTT
T ss_pred CCcccccccccCCCcHHHH-HHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccc
Confidence 3678899999988876665 688899999999998 466521 2223457899999999984 45421 111 12357
Q ss_pred CcEEEccCC--CCccc-CCccccCCCCccceecccc-cccccCCC--CCCCCCcEEEccc-CCCCCCCcccccCCCCC
Q 006747 138 LNWVDLSFN--SITGN-IPASIRNLSHLVGLNLQNN-SLTGFIPN--FNLSRLRHLNLSY-NHLNGSVPLALQKFPPS 208 (632)
Q Consensus 138 L~~L~Ls~N--~l~g~-~p~~~~~l~~L~~l~l~~N-~l~~~~p~--~~~~~L~~l~ls~-N~l~g~~p~~~~~~~~~ 208 (632)
|+.|+|++. .++.. +...+.++++|+.|+|++| .+++.... ..+++|++|+|++ +.++......+.+++..
T Consensus 150 L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 150 ITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp CCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred cchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 888888764 34422 3333456788888888775 35533322 2677888888887 45665544455555443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.10 E-value=1e-07 Score=84.81 Aligned_cols=67 Identities=25% Similarity=0.196 Sum_probs=32.8
Q ss_pred cCCCCCCeEeecCCcCCccC--CCCc--cCCCcEEEccCCCCcccCCccccCCCCccceecccccccccCC
Q 006747 111 LSLSSLRFLYLQNNNFSGNI--PSSL--SPQLNWVDLSFNSITGNIPASIRNLSHLVGLNLQNNSLTGFIP 177 (632)
Q Consensus 111 ~~l~~L~~L~Ls~N~l~g~~--p~~~--~~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p 177 (632)
..+++|++|+|++|+++..- +..+ .++|+.|||++|.++...+-.+....+|+.|+|++|.++....
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~ 132 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcc
Confidence 44555666666666655221 1111 1455555555655553222222333456666666666655443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.04 E-value=1.8e-07 Score=94.18 Aligned_cols=130 Identities=19% Similarity=0.226 Sum_probs=78.6
Q ss_pred eEEEEEeCCCCcc--c--ccCc--------hhhcCCCCCcEEeccCCccCCC----CCccccCCCCCCeEeecCCcCCcc
Q 006747 66 RVLAVRLPGVGLY--G--PIPA--------NTLEKLDSLMILSLRSNHLSGD----LPSNVLSLSSLRFLYLQNNNFSGN 129 (632)
Q Consensus 66 ~v~~l~l~~~~l~--g--~lp~--------~~l~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~ 129 (632)
.+..|+++++.+. | .+.. ......+.|+.|++++|.++.. +...+...+.|+.|+|++|+++..
T Consensus 122 ~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~ 201 (344)
T d2ca6a1 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201 (344)
T ss_dssp TCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH
T ss_pred cchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccccccccc
Confidence 5677788777652 0 1100 1123566777888888777521 233345667788888888877631
Q ss_pred -----CCCCcc--CCCcEEEccCCCCccc----CCccccCCCCccceecccccccccCC--------CCCCCCCcEEEcc
Q 006747 130 -----IPSSLS--PQLNWVDLSFNSITGN----IPASIRNLSHLVGLNLQNNSLTGFIP--------NFNLSRLRHLNLS 190 (632)
Q Consensus 130 -----~p~~~~--~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~~~p--------~~~~~~L~~l~ls 190 (632)
+...+. ++|+.|+|++|.++.. +...+..+++|+.|+|++|.+++.-. ......|++||++
T Consensus 202 g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls 281 (344)
T d2ca6a1 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQ 281 (344)
T ss_dssp HHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECC
T ss_pred ccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECC
Confidence 122222 5677888888877532 34456677778888888887764311 1234567788888
Q ss_pred cCCCC
Q 006747 191 YNHLN 195 (632)
Q Consensus 191 ~N~l~ 195 (632)
+|+++
T Consensus 282 ~N~i~ 286 (344)
T d2ca6a1 282 YNEIE 286 (344)
T ss_dssp SSCCB
T ss_pred CCcCC
Confidence 88775
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.99 E-value=3.4e-07 Score=81.33 Aligned_cols=85 Identities=22% Similarity=0.253 Sum_probs=64.9
Q ss_pred hhcCCCCCcEEeccCCccCCC--CCccccCCCCCCeEeecCCcCCccCCC-Ccc--CCCcEEEccCCCCcccCCcc----
Q 006747 85 TLEKLDSLMILSLRSNHLSGD--LPSNVLSLSSLRFLYLQNNNFSGNIPS-SLS--PQLNWVDLSFNSITGNIPAS---- 155 (632)
Q Consensus 85 ~l~~l~~L~~L~Ls~N~l~g~--~p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~--~~L~~L~Ls~N~l~g~~p~~---- 155 (632)
....+++|+.|+|++|+|+.. ++..+..+++|+.|||++|+++. ++. ... ..|+.|+|++|.+.......
T Consensus 60 ~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~ 138 (162)
T d1koha1 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYI 138 (162)
T ss_dssp HHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHH
T ss_pred HHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcccchhHH
Confidence 456799999999999999853 34557789999999999999994 333 211 57899999999998765532
Q ss_pred ---ccCCCCccceecccccc
Q 006747 156 ---IRNLSHLVGLNLQNNSL 172 (632)
Q Consensus 156 ---~~~l~~L~~l~l~~N~l 172 (632)
+..+++|+.|| ++.+
T Consensus 139 ~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 139 SAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHTTSTTCCEET--TEEC
T ss_pred HHHHHHCCCCCEEC--cCCC
Confidence 56788888774 5554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.87 E-value=7.2e-07 Score=89.54 Aligned_cols=110 Identities=19% Similarity=0.250 Sum_probs=57.1
Q ss_pred hcCCCCCcEEeccCCccCCC----CCccccCCCCCCeEeecCCcCCccCCCCc---------------cCCCcEEEccCC
Q 006747 86 LEKLDSLMILSLRSNHLSGD----LPSNVLSLSSLRFLYLQNNNFSGNIPSSL---------------SPQLNWVDLSFN 146 (632)
Q Consensus 86 l~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~---------------~~~L~~L~Ls~N 146 (632)
+...++|+.|+|++|.++.. +...+...++|++|+|++|.++..-...+ .+.|+.|++++|
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 45566677777777766532 22334456667777777766541100000 135666666666
Q ss_pred CCccc----CCccccCCCCccceeccccccccc-----CCC-C-CCCCCcEEEcccCCCC
Q 006747 147 SITGN----IPASIRNLSHLVGLNLQNNSLTGF-----IPN-F-NLSRLRHLNLSYNHLN 195 (632)
Q Consensus 147 ~l~g~----~p~~~~~l~~L~~l~l~~N~l~~~-----~p~-~-~~~~L~~l~ls~N~l~ 195 (632)
+++.. +...+..+++|+.|+|++|+++.. +.. . .+++|+.|+|++|.|+
T Consensus 169 ~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 169 RLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp CCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred cccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence 65421 222344455666666666665421 111 1 3455666666666554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.83 E-value=6.1e-07 Score=93.10 Aligned_cols=132 Identities=23% Similarity=0.198 Sum_probs=79.6
Q ss_pred CeEEEEEeCCCCcccccCc---hhhcCCCCCcEEeccCCccCCCCCccc-----cCCCCCCeEeecCCcCCccCCCCcc-
Q 006747 65 SRVLAVRLPGVGLYGPIPA---NTLEKLDSLMILSLRSNHLSGDLPSNV-----LSLSSLRFLYLQNNNFSGNIPSSLS- 135 (632)
Q Consensus 65 ~~v~~l~l~~~~l~g~lp~---~~l~~l~~L~~L~Ls~N~l~g~~p~~~-----~~l~~L~~L~Ls~N~l~g~~p~~~~- 135 (632)
..+..+++.++.+...... ..+...+.+..+++++|.++......+ .....|+.+++++|.++..-...+.
T Consensus 255 ~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~ 334 (460)
T d1z7xw1 255 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS 334 (460)
T ss_dssp CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhccc
Confidence 3577788888877532111 134567778888888887763211111 1345678888888877643222221
Q ss_pred -----CCCcEEEccCCCCccc----CCcccc-CCCCccceeccccccccc----CCC-C-CCCCCcEEEcccCCCCC
Q 006747 136 -----PQLNWVDLSFNSITGN----IPASIR-NLSHLVGLNLQNNSLTGF----IPN-F-NLSRLRHLNLSYNHLNG 196 (632)
Q Consensus 136 -----~~L~~L~Ls~N~l~g~----~p~~~~-~l~~L~~l~l~~N~l~~~----~p~-~-~~~~L~~l~ls~N~l~g 196 (632)
.+|+.|||++|++++. ++..+. ..+.|+.|+|++|+|+.. +.. + .+++|++|||++|+|+.
T Consensus 335 ~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 335 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 4688888888887642 333333 356678888888887642 111 1 45778888888887763
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.74 E-value=3.8e-05 Score=72.74 Aligned_cols=141 Identities=12% Similarity=0.113 Sum_probs=83.8
Q ss_pred Cccc-eeEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC-CccceeEEEEeCCceEEEEecccCCCHhhh
Q 006747 345 GKGS-YGTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHP-NVVPIRAYYFSKDEKLLVYDFIEAGSFSAL 422 (632)
Q Consensus 345 g~G~-fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 422 (632)
..|. -+.||+....++..+++|...... ...+..|.+.+..+..+. .+.+++++..+.+..++||||+++-++...
T Consensus 19 ~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~~ 96 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLSS 96 (255)
T ss_dssp SCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTTS
T ss_pred CCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccccc
Confidence 3443 367999988878888999875442 234677777777664332 356678888888888999999987654321
Q ss_pred -----------------hccCCCCCCCcC--CHHHHHHHHH--------------------HHHHHHHHHHhcc----CC
Q 006747 423 -----------------LHGNRGIGRTPL--DWESRVKISL--------------------GSAKGIAHIHAAV----GG 459 (632)
Q Consensus 423 -----------------l~~~~~~~~~~l--~~~~~~~i~~--------------------~ia~~l~~LH~~~----~~ 459 (632)
||.... ...+. .+.....-.. .....+..+.... .+
T Consensus 97 ~~~~~~~~~~l~~~la~LH~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (255)
T d1nd4a_ 97 HLAPAEKVSIMADAMRRLHTLDP-ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDL 175 (255)
T ss_dssp CCCHHHHHHHHHHHHHHHTTSCG-GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCE
T ss_pred cccHHHHHHHHHHHHHHHccCCh-hhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCc
Confidence 111100 00000 1111100000 0111233333321 12
Q ss_pred CceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 460 KFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 460 ~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
.++|+|+.|.||+++++..+-|.||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999988778899998753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.50 E-value=1e-05 Score=71.80 Aligned_cols=108 Identities=16% Similarity=0.182 Sum_probs=68.3
Q ss_pred cCCCCCcEEeccCC-ccCCC----CCccccCCCCCCeEeecCCcCCccCCCCcc------CCCcEEEccCCCCccc----
Q 006747 87 EKLDSLMILSLRSN-HLSGD----LPSNVLSLSSLRFLYLQNNNFSGNIPSSLS------PQLNWVDLSFNSITGN---- 151 (632)
Q Consensus 87 ~~l~~L~~L~Ls~N-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~------~~L~~L~Ls~N~l~g~---- 151 (632)
.+.++|+.|+|+++ .++.. +-..+...++|++|+|++|.++..-...+. +.|+.|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45677888888863 45421 223455667788888888887643222222 6788888888888753
Q ss_pred CCccccCCCCccceecccccccccCCC----C-----CCCCCcEEEcccCCC
Q 006747 152 IPASIRNLSHLVGLNLQNNSLTGFIPN----F-----NLSRLRHLNLSYNHL 194 (632)
Q Consensus 152 ~p~~~~~l~~L~~l~l~~N~l~~~~p~----~-----~~~~L~~l~ls~N~l 194 (632)
+-..+...++|+.|+|++|.+...-.. + ..++|+.|+++++..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 223456667888888888876532111 1 346778888876643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.28 E-value=0.00055 Score=69.10 Aligned_cols=75 Identities=11% Similarity=0.115 Sum_probs=47.3
Q ss_pred hHhCccceeEEEEEEEcC-CcEEEEEEeccc--------ccCHHHHHHHHHHHHhhcCC--CCccceeEEEEeCCceEEE
Q 006747 342 EVLGKGSYGTTYKAILEE-GTTVVVKRLKEV--------VMGKREFEQQMEVVGRLSQH--PNVVPIRAYYFSKDEKLLV 410 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~--------~~~~~~~~~e~~~l~~l~~h--~niv~l~~~~~~~~~~~lv 410 (632)
+.||.|....||+....+ ++.|+||.-... .........|.+.+..+..+ ..+.++++ .+.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 358999999999998654 678889864321 11223345677777766444 23444543 356677899
Q ss_pred EecccCCC
Q 006747 411 YDFIEAGS 418 (632)
Q Consensus 411 ~E~~~~g~ 418 (632)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.18 E-value=0.0017 Score=63.60 Aligned_cols=138 Identities=13% Similarity=0.085 Sum_probs=81.3
Q ss_pred eEEEEEEEcCCcEEEEEEecccccCHHHHHHHHHHHHhhcCCC-Ccccee-----EEEEeCCceEEEEecccCCCHh---
Q 006747 350 GTTYKAILEEGTTVVVKRLKEVVMGKREFEQQMEVVGRLSQHP-NVVPIR-----AYYFSKDEKLLVYDFIEAGSFS--- 420 (632)
Q Consensus 350 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~-niv~l~-----~~~~~~~~~~lv~E~~~~g~L~--- 420 (632)
-.||++..++|..|++|+.+....+.+++..|.+.+..+.++. -++..+ ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~ 115 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN 115 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence 3799999999999999998776667788899999888875331 111111 1233456678899999864321
Q ss_pred ---------------hhhccCCCCCCCcCCHHH-------------------HHHHHHHHHHHHHHHHh----ccCCCce
Q 006747 421 ---------------ALLHGNRGIGRTPLDWES-------------------RVKISLGSAKGIAHIHA----AVGGKFI 462 (632)
Q Consensus 421 ---------------~~l~~~~~~~~~~l~~~~-------------------~~~i~~~ia~~l~~LH~----~~~~~iv 462 (632)
...+......+...++.. +..+...+.+.++.+.. ....++|
T Consensus 116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li 195 (325)
T d1zyla1 116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL 195 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence 111111111112222211 11111122223333332 2245789
Q ss_pred ecCCCCCCeeecCCCCeEEcccCCCCC
Q 006747 463 LGNIKSSNVLLSQDLQGCISDFGLTPL 489 (632)
Q Consensus 463 HrDlk~~NILl~~~~~~ki~DfGla~~ 489 (632)
|+|+.+.|||++++ ..+.||+-+..
T Consensus 196 HgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 196 HGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred cCCCCcccEEEeCC--ceEEechhccc
Confidence 99999999999754 45899997753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.10 E-value=4.2e-05 Score=67.65 Aligned_cols=107 Identities=13% Similarity=0.124 Sum_probs=74.3
Q ss_pred CeEEEEEeCCC-Ccccc----cCchhhcCCCCCcEEeccCCccCC----CCCccccCCCCCCeEeecCCcCCccCCCCc-
Q 006747 65 SRVLAVRLPGV-GLYGP----IPANTLEKLDSLMILSLRSNHLSG----DLPSNVLSLSSLRFLYLQNNNFSGNIPSSL- 134 (632)
Q Consensus 65 ~~v~~l~l~~~-~l~g~----lp~~~l~~l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~- 134 (632)
..++.|+|+++ .+... +- ..+...++|+.|+|++|.+.. .+...+...+.|++|+|++|.++..--..+
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~-~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLI-EAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHH-HHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHH-HHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 46888888864 34321 21 256778889999999999972 223345567889999999999984322222
Q ss_pred ---c--CCCcEEEccCCCCccc-------CCccccCCCCccceecccccc
Q 006747 135 ---S--PQLNWVDLSFNSITGN-------IPASIRNLSHLVGLNLQNNSL 172 (632)
Q Consensus 135 ---~--~~L~~L~Ls~N~l~g~-------~p~~~~~l~~L~~l~l~~N~l 172 (632)
. ++|+.|+|++|.+... +...+...++|+.|+++.+..
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 1 6799999999976532 344556678999999987754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.54 E-value=0.0047 Score=62.05 Aligned_cols=73 Identities=10% Similarity=0.051 Sum_probs=50.0
Q ss_pred hHhCccceeEEEEEEEcCC--------cEEEEEEecccccCHHHHHHHHHHHHhhcCCCCccceeEEEEeCCceEEEEec
Q 006747 342 EVLGKGSYGTTYKAILEEG--------TTVVVKRLKEVVMGKREFEQQMEVVGRLSQHPNVVPIRAYYFSKDEKLLVYDF 413 (632)
Q Consensus 342 ~~lg~G~fg~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~e~~~l~~l~~h~niv~l~~~~~~~~~~~lv~E~ 413 (632)
+.|+.|-.-.+|++...++ ..|.+++.- ......+..+|.+++..+..+.-..++++++. -.+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 3577788889999886543 456666654 33344566788888888876655557777763 2689999
Q ss_pred ccCCCH
Q 006747 414 IEAGSF 419 (632)
Q Consensus 414 ~~~g~L 419 (632)
+++-.+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.51 E-value=0.00014 Score=64.03 Aligned_cols=109 Identities=12% Similarity=0.202 Sum_probs=65.3
Q ss_pred hcCCCCCcEEeccC-CccCCC----CCccccCCCCCCeEeecCCcCCccCCCCcc------CCCcEEEccCCCCccc---
Q 006747 86 LEKLDSLMILSLRS-NHLSGD----LPSNVLSLSSLRFLYLQNNNFSGNIPSSLS------PQLNWVDLSFNSITGN--- 151 (632)
Q Consensus 86 l~~l~~L~~L~Ls~-N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~------~~L~~L~Ls~N~l~g~--- 151 (632)
..+.++|+.|+|++ |.++.. +-..+...++|++|+|++|.++...-..+. .+++.|++++|.++..
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 34567788888876 456511 223445677788888888877633222221 5788888888887643
Q ss_pred -CCccccCCCCccceec--ccccccccC----CC-C-CCCCCcEEEcccCCC
Q 006747 152 -IPASIRNLSHLVGLNL--QNNSLTGFI----PN-F-NLSRLRHLNLSYNHL 194 (632)
Q Consensus 152 -~p~~~~~l~~L~~l~l--~~N~l~~~~----p~-~-~~~~L~~l~ls~N~l 194 (632)
+-..+...++|+.++| ++|.+.... .. . ..++|+.|+++.|..
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 2345566777776444 456653211 11 1 456788888876654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.64 E-value=0.00041 Score=60.84 Aligned_cols=108 Identities=14% Similarity=0.149 Sum_probs=73.5
Q ss_pred CeEEEEEeCCC-Ccccc----cCchhhcCCCCCcEEeccCCccCCC----CCccccCCCCCCeEeecCCcCCccCCC---
Q 006747 65 SRVLAVRLPGV-GLYGP----IPANTLEKLDSLMILSLRSNHLSGD----LPSNVLSLSSLRFLYLQNNNFSGNIPS--- 132 (632)
Q Consensus 65 ~~v~~l~l~~~-~l~g~----lp~~~l~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~~p~--- 132 (632)
..++.|+|++. .++.. +- ..+...++|+.|+|++|.++.. +-..+...+.|+.|++++|.++..--.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~-~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACA-EALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHH-HHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHH-HHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 46777888873 44311 21 2466889999999999998733 223456678999999999998733211
Q ss_pred -Ccc--CCCcEEEc--cCCCCcc----cCCccccCCCCccceeccccccc
Q 006747 133 -SLS--PQLNWVDL--SFNSITG----NIPASIRNLSHLVGLNLQNNSLT 173 (632)
Q Consensus 133 -~~~--~~L~~L~L--s~N~l~g----~~p~~~~~l~~L~~l~l~~N~l~ 173 (632)
.+. ++|+.++| +.|.+.. .+...+...++|+.|+++.|+..
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 222 57876555 6777764 34556678899999999887653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.14 E-value=0.071 Score=50.99 Aligned_cols=31 Identities=19% Similarity=0.194 Sum_probs=27.4
Q ss_pred CCCceecCCCCCCeeecCCCCeEEcccCCCC
Q 006747 458 GGKFILGNIKSSNVLLSQDLQGCISDFGLTP 488 (632)
Q Consensus 458 ~~~ivHrDlk~~NILl~~~~~~ki~DfGla~ 488 (632)
..++||+|+.+.||+++++...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3479999999999999999888899999763
|